PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dietzel, U; Kuper, J; Doebbler, JA; Schulte, A; Truglio, JJ; Leimkuhler, S; Kisker, C				Dietzel, Uwe; Kuper, Jochen; Doebbler, Jennifer A.; Schulte, Antje; Truglio, James J.; Leimkuehler, Silke; Kisker, Caroline			Mechanism of Substrate and Inhibitor Binding of Rhodobacter capsulatus Xanthine Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; OXIDASE; CATALYSIS; PTERIN-6-ALDEHYDE; IDENTIFICATION; SPECIFICITY; INSERTION; RESIDUES; ENZYME	Rhodobacter capsulatus xanthine dehydrogenase (XDH) is an (alpha beta)(2) heterotetrameric cytoplasmic enzyme that resembles eukaryotic xanthine oxidoreductases in respect to both amino acid sequence and structural fold. To obtain a detailed understanding of the mechanism of substrate and inhibitor binding at the active site, we solved crystal structures of R. capsulatus XDH in the presence of its substrates hypoxanthine, xanthine, and the inhibitor pterin-6-aldehyde using either the inactive desulfo form of the enzyme or an active site mutant (E(B)232Q) to prevent substrate turnover. The hypoxanthine-and xanthine-bound structures reveal the orientation of both substrates at the active site and show the importance of residue GluB-232 for substrate positioning. The oxygen atom at the C-6 position of both substrates is oriented toward Arg(B)-310 in the active site. Thus the substrates bind in an orientation opposite to the one seen in the structure of the reduced enzyme with the inhibitor oxypurinol. The tightness of the substrates in the active site suggests that the intermediate products must exit the binding pocket to allow first the attack of the C-2, followed by oxidation of the C-8 atom to form the final product uric acid. Structural studies of pterin-6-aldehyde, a potent inhibitor of R. capsulatus XDH, contribute further to the understanding of the relative positioning of inhibitors and substrates in the binding pocket. Steady state kinetics reveal a competitive inhibition pattern with a K-i of 103.57 +/- 18.96 nM for pterin-6-aldehyde.	[Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Kisker, Caroline] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Germany; [Doebbler, Jennifer A.] SUNY Stony Brook, Dept Phys, Stony Brook, NY 11794 USA; [Doebbler, Jennifer A.; Schulte, Antje; Truglio, James J.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	University of Potsdam; University of Wurzburg; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany.	sleim@uni-potsdam.de; caroline.kisker@virchow.uni-wuerzburg.de	Kisker, Caroline/T-1724-2019	Leimkuhler, Silke/0000-0003-3238-2122; Kisker, Caroline/0000-0002-0216-6026; Strauss, Jennifer/0000-0002-8832-0265	National Institutes of Health [GM070873]; Deutsche Forschungsgemeinschaft [LE1171/3]; Forschungszentrum [FZ-82]; State University of New York and its Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungszentrum; State University of New York and its Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM070873. This work was also supported by Deutsche Forschungsgemeinschaft Grant LE1171/3 (to S. L.), Forschungszentrum Grant FZ-82 (to C. K.), and in part by the State University of New York and its Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BOSS GR, 1980, J LAB CLIN MED, V96, P783; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Dixon M, 1924, BIOCHEM J, V18, P976, DOI 10.1042/bj0180976; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HALPERN R, 1977, P NATL ACAD SCI USA, V74, P587, DOI 10.1073/pnas.74.2.587; HOFSTEE BHJ, 1955, J BIOL CHEM, V216, P235; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KALCKAR HM, 1950, BIOCHIM BIOPHYS ACTA, V5, P586, DOI 10.1016/0006-3002(50)90204-6; Leimkuhler S, 1998, MOL MICROBIOL, V27, P853, DOI 10.1046/j.1365-2958.1998.00733.x; Leimkuhler S, 1999, J BACTERIOL, V181, P2745; Leimkuhler S, 2004, J BIOL CHEM, V279, P40437, DOI 10.1074/jbc.M405778200; LOWRY OH, 1949, J BIOL CHEM, V180, P399; LOWRY OH, 1949, J BIOL CHEM, V180, P389; MASSEY V, 1970, J BIOL CHEM, V245, P2837; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Nishino T, 2005, J BIOL CHEM, V280, P24888, DOI 10.1074/jbc.M501830200; Okamoto K, 2004, P NATL ACAD SCI USA, V101, P7931, DOI 10.1073/pnas.0400973101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; Pauff JM, 2008, J BIOL CHEM, V283, P4818, DOI 10.1074/jbc.M707918200; Pauff JM, 2007, J BIOL CHEM, V282, P12785, DOI 10.1074/jbc.M700364200; Reginato AJ, 2005, HARRISONS PRINCIPLES, P2046; SPECTOR T, 1970, J BIOL CHEM, V245, P5079; Takano Y, 2005, LIFE SCI, V76, P1835, DOI 10.1016/j.lfs.2004.10.031; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Watanabe K, 1997, BIOCHEM BIOPH RES CO, V233, P447, DOI 10.1006/bbrc.1997.6479; WILLIAMS JW, 1981, BIOCHEM J, V195, P753, DOI 10.1042/bj1950753; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	30	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8759	8767		10.1074/jbc.M808114200	http://dx.doi.org/10.1074/jbc.M808114200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19109249	Green Published, hybrid			2022-12-27	WOS:000264397800060
J	Mascioni, A; Bentley, BE; Camarda, R; Dilts, DA; Fink, P; Gusarova, V; Hoiseth, SK; Jacob, J; Lin, SL; Malakian, K; McNeil, LK; Mininni, T; Moy, F; Murphy, E; Novikova, E; Sigethy, S; Wen, YX; Zlotnick, GW; Tsao, DHH				Mascioni, Alessandro; Bentley, Breagh E.; Camarda, Rosaria; Dilts, Deborah A.; Fink, Pamela; Gusarova, Viktoria; Hoiseth, Susan K.; Jacob, Jaison; Lin, Shuo L.; Malakian, Karl; McNeil, Lisa K.; Mininni, Terri; Moy, Franklin; Murphy, Ellen; Novikova, Elena; Sigethy, Scott; Wen, Yingxia; Zlotnick, Gary W.; Tsao, Desiree H. H.			Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; B NEISSERIA-MENINGITIDIS; ALTERNATIVE CONFORMATIONS; ANTIBODY COMPLEXES; NMR-SPECTROSCOPY; CHEMICAL-SHIFT; SEROGROUP-B; PROTEIN; LIPOPROTEIN; ANTIGEN	LP2086 is a family of outer membrane lipoproteins from Neisseria meningitidis, which elicits bactericidal antibodies and are currently undergoing human clinical trials in a bivalent formulation where each antigen represents one of the two known LP2086 subfamilies. Here we report the NMR structure of the recombinant LP2086 variant B01, a representative of the LP2086 subfamily B. The structure reveals a novel fold composed of two domains: a "taco-shaped" N-terminal beta-sheet and a C-terminal beta-barrel connected by a linker. The structure in micellar solution is consistent with a model of LP2086 anchored to the outer membrane bilayer through its lipidated N terminus. A long flexible chain connects the folded part of the protein to the lipid anchor and acts as spacer, making both domains accessible to the host immune system. Antibodies broadly reactive against members from both subfamilies have been mapped to the N terminus. A surface of subfamily-defining residues was identified on one face of the protein, offering an explanation for the induction of subfamily-specific bactericidal antibodies.	[Jacob, Jaison; Malakian, Karl; Moy, Franklin; Tsao, Desiree H. H.] Wyeth Res, Struct Biol & Computat Chem, Cambridge, MA 02140 USA; [Bentley, Breagh E.; Camarda, Rosaria; Dilts, Deborah A.; Fink, Pamela; Gusarova, Viktoria; Hoiseth, Susan K.; Lin, Shuo L.; McNeil, Lisa K.; Mininni, Terri; Murphy, Ellen; Novikova, Elena; Sigethy, Scott; Zlotnick, Gary W.] Wyeth Vaccines Res, Pearl River, NY 10965 USA	Pfizer; Pfizer	Tsao, DHH (corresponding author), Wyeth Res, Struct Biol & Computat Chem, 200 Cambridge Pk Dr, Cambridge, MA 02140 USA.	dtsao@wyeth.com						BENTLEY AT, 1988, J BACTERIOL, V170, P1063, DOI 10.1128/jb.170.3.1063-1068.1988; Buck-Koehntop BA, 2005, J MOL BIOL, V354, P652, DOI 10.1016/j.jmb.2005.09.038; Cantini F, 2006, J BIOL CHEM, V281, P7220, DOI 10.1074/jbc.M508595200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CRESPI HL, 1968, SCIENCE, V161, P796, DOI 10.1126/science.161.3843.795; Decanniere K, 2001, J MOL BIOL, V313, P473, DOI 10.1006/jmbi.2001.5075; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2000, PYMOL; Deschamps ML, 2005, J BIOMOL NMR, V31, P155, DOI 10.1007/s10858-004-7912-6; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499; Jodar L, 2002, LANCET, V359, P1499, DOI 10.1016/S0140-6736(02)08416-7; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEX A, 1986, J IMMUNOL, V137, P2676; Li YL, 2003, BIOCHEMISTRY-US, V42, P11, DOI 10.1021/bi020589+; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; MARKLEY JL, 1968, SCIENCE, V161, P1249, DOI 10.1126/science.161.3847.1249; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Metzler WJ, 1996, J AM CHEM SOC, V118, P6800, DOI 10.1021/ja9604875; Morley SL, 2001, VACCINE, V20, P666, DOI 10.1016/S0264-410X(01)00410-8; Nassif X, 2000, SCIENCE, V287, P1767, DOI 10.1126/science.287.5459.1767; Nietlispach D, 2005, J BIOMOL NMR, V31, P161, DOI 10.1007/s10858-004-8195-7; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pillai S, 2005, VACCINE, V23, P2206, DOI 10.1016/j.vaccine.2005.01.056; POOLMAN JT, 1995, INFECT AGENT DIS, V4, P13; Rosen O, 2005, BIOCHEMISTRY-US, V44, P7250, DOI 10.1021/bi047387t; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Walters KJ, 1999, P NATL ACAD SCI USA, V96, P7877, DOI 10.1073/pnas.96.14.7877; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu DZ, 2006, VACCINE, V24, P5420, DOI 10.1016/j.vaccine.2006.03.051; Zhu DZ, 2005, INFECT IMMUN, V73, P6838, DOI 10.1128/IAI.73.10.6838-6845.2005	39	62	92	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8729	8737		10.1074/jbc.M808831200	http://dx.doi.org/10.1074/jbc.M808831200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19103601	Green Published, hybrid			2022-12-27	WOS:000264397800057
J	Raichaudhuri, A; Peng, MS; Naponelli, V; Chen, S; Sanchez-Fernandez, R; Gu, HL; Gregory, JF; Hanson, AD; Rea, PA				Raichaudhuri, Ayan; Peng, Mingsheng; Naponelli, Valeria; Chen, Sixue; Sanchez-Fernandez, Rocio; Gu, Honglan; Gregory, Jesse F., III; Hanson, Andrew D.; Rea, Philip A.			Plant Vacuolar ATP-binding Cassette Transporters That Translocate Folates and Antifolates in Vitro and Contribute to Antifolate Tolerance in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANCE-ASSOCIATED PROTEIN; ABC TRANSPORTERS; FOLYLPOLYGLUTAMATE SYNTHETASE; ARABIDOPSIS; MEMBRANE; CELLS; POLYGLUTAMATES; DETOXIFICATION; CHLOROPHYLL; ATMRP2	The vacuoles of pea (Pisum sativum) leaves and red beet ( Beta vulgaris) storage root are major sites for the intracellular compartmentation of folates. In the light of these findings and preliminary experiments indicating that some plant multidrug resistance-associated protein (MRP) subfamily ATP-binding cassette transporters are able to transport compounds of this type, the Arabidopsis thaliana vacuolar MRP, AtMRP1(AtABCC1), and its functional equivalent(s) in vacuolar membrane vesicles purified from red beet storage root were studied. In so doing, it has been determined that heterologously expressed AtMRP1 and its equivalents in red beet vacuolar membranes are not only competent in the transport of glutathione conjugates but also folate monoglutamates and antifolates as exemplified by pteroyl-L-glutamicacid and methotrexate (MTX), respectively. In agreement with the results of these in vitro transport measurements, analyses of atmrp1 T-DNA insertion mutants of Arabidopsis ecotypes Wassilewskia and Columbia disclose an MTX-hypersensitive phenotype. atmrp1 knock-out mutants are more sensitive than wild-type plants to growth retardation by nanomolar concentrations of MTX, and this is associated with impaired vacuolar antifolate sequestration. The vacuoles of protoplasts isolated from the leaves of Wassilewskia atmrp1 mutants accumulate 50% less [H-3] MTX than the vacuoles of protoplasts from wild-type plants when incubated in media containing nanomolar concentrations of this antifolate, and vacuolar membrane-enriched vesicles purified from the mutant catalyze MgATP-dependent [H-3] MTX uptake at only 40% of the capacity of the equivalent membrane fraction from wild-type plants. AtMRP1 and its counterparts in other plant species therefore have the potential for participating in the vacuolar accumulation of folates and related compounds.	[Rea, Philip A.] Univ Penn, Inst Plant Sci, Dept Biol, Carolyn Hoff Lynch Biol Lab, Philadelphia, PA 19104 USA; [Naponelli, Valeria; Gregory, Jesse F., III] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Hanson, Andrew D.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA	University of Pennsylvania; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Rea, PA (corresponding author), Univ Penn, Inst Plant Sci, Dept Biol, Carolyn Hoff Lynch Biol Lab, 433 S Univ Ave, Philadelphia, PA 19104 USA.	parea@sas.upenn.edu		naponelli, valeria/0000-0001-5210-1522; Gregory, Jesse/0000-0002-9976-2085	United States Department of Energy [DE-FG02-91ER20055]; National Institutes of Health [RO1 GM071382]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071382] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Department of Energy Grant DE-FG02-91ER20055 ( to P. A. R.) and in part by National Institutes of Health Grant RO1 GM071382 ( to A. D. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARRUECO JR, 1992, J BIOL CHEM, V267, P15356; Bartholomew DM, 2002, PLANT PHYSIOL, V130, P1562, DOI 10.1104/pp.008334; Bedhomme M, 2005, J BIOL CHEM, V280, P34823, DOI 10.1074/jbc.M506045200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SX, 2000, J BIOL CHEM, V275, P22955, DOI 10.1074/jbc.M002768200; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Dean JV, 2004, PHYSIOL PLANTARUM, V120, P603, DOI 10.1111/j.0031-9317.2004.0263.x; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; FELDMANN KA, 1991, PLANT J, V1, P71, DOI 10.1111/j.1365-313X.1991.00071.x; Frelet-Barrand A, 2008, PLANT CELL PHYSIOL, V49, P557, DOI 10.1093/pcp/pcn034; Geisler M, 2004, MOL BIOL CELL, V15, P3393, DOI 10.1091/mbc.E03-11-0831; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Goyer A, 2005, J BIOL CHEM, V280, P26137, DOI 10.1074/jbc.M503106200; Hanson AD, 2002, CURR OPIN PLANT BIOL, V5, P244, DOI 10.1016/S1369-5266(02)00249-2; Ilias A, 2002, J BIOL CHEM, V277, P16860, DOI 10.1074/jbc.M110918200; Ishikawa T, 1997, BIOSCIENCE REP, V17, P189, DOI 10.1023/A:1027385513483; KIM EJ, 1995, J BIOL CHEM, V270, P2630, DOI 10.1074/jbc.270.6.2630; Klaus SMJ, 2005, J BIOL CHEM, V280, P38457, DOI 10.1074/jbc.M507432200; Klein M, 2004, PLANT J, V39, P219, DOI 10.1111/j.1365-313X.2004.02125.x; Kreuz K, 1996, PLANT PHYSIOL, V111, P349, DOI 10.1104/pp.111.2.349; Kruh GD, 2001, J BIOENERG BIOMEMBR, V33, P493, DOI 10.1023/A:1012827221844; LI ZS, 1995, PLANT PHYSIOL, V107, P1257, DOI 10.1104/pp.107.4.1257; Liu GS, 2001, J BIOL CHEM, V276, P8648, DOI 10.1074/jbc.M009690200; Lu YP, 1998, PLANT CELL, V10, P267, DOI 10.1105/tpc.10.2.267; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; *MAFF ROYAL SOC CH, 1991, MCCAN WIDD COMP FOOD, P237; MARTINOIA E, 1993, NATURE, V364, P247, DOI 10.1038/364247a0; Musgrave ME, 1998, ANN BOT-LONDON, V81, P503, DOI 10.1006/anbo.1998.0585; Naponelli V, 2007, ANAL BIOCHEM, V371, P127, DOI 10.1016/j.ab.2007.08.026; Orsomando G, 2005, J BIOL CHEM, V280, P28877, DOI 10.1074/jbc.M504306200; POOLE RJ, 1985, BIOCH FUNCTION ADENO, P114; Ravanel S, 2001, P NATL ACAD SCI USA, V98, P15360, DOI 10.1073/pnas.261585098; Rea P.A., 1990, METHODS PLANT BIOCH, V3, P385, DOI DOI 10.1016/B978-0-12-461013-2.50035-6; Rea PA, 1998, ANNU REV PLANT PHYS, V49, P727, DOI 10.1146/annurev.arplant.49.1.727; REA PA, 2003, ABC TRANSPORTERS BAC, P355; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; SAUNDERS JA, 1978, PLANT PHYSIOL, V61, P154, DOI 10.1104/pp.61.2.154; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; WILKINS TA, 1990, PLANT CELL, V2, P301, DOI 10.1105/tpc.2.4.301; WINTER H, 1994, PLANTA, V193, P530, DOI 10.1007/BF02411558; Zeng H, 2001, CANCER RES, V61, P7225; Zeng H, 2000, CANCER RES, V60, P4779	46	42	44	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8449	8460		10.1074/jbc.M808632200	http://dx.doi.org/10.1074/jbc.M808632200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19136566	Green Published, hybrid			2022-12-27	WOS:000264397800029
J	Yeeles, JTP; Cammack, R; Dillingham, MS				Yeeles, Joseph T. P.; Cammack, Richard; Dillingham, Mark S.			An Iron-Sulfur Cluster Is Essential for the Binding of Broken DNA by AddAB-type Helicase-Nucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; STRAND BREAK REPAIR; COLI RECBCD ENZYME; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ENDONUCLEASE-III; ATP HYDROLYSIS; YEAST DNA2; PROTEIN	The bacterial helicase-nuclease complex AddAB converts double-stranded DNA breaks into substrates for RecA-dependent recombinational repair. Here we show that the AddB subunit contains a novel class of nuclease domain distinguished by the presence of an iron-sulfur cluster. The cluster is coordinated by an unusual arrangement of cysteine residues that originate from both sides of the AddB nuclease, forming an "iron staple" that is required for the local structural integrity of this domain. Disruption of the iron-sulfur cluster by mutagenesis eliminates the ability of AddAB to bind to duplex DNA ends without affecting the single-stranded DNA-dependent ATPase activity. Sequence analysis suggests that a related iron staple nuclease domain is present in the eukaryotic DNA replication/repair factor Dna2, where it is also associated with a DNA helicase motor.	[Yeeles, Joseph T. P.; Dillingham, Mark S.] Univ Bristol, Sch Med Sci, Dept Biochem, DNA Prot Interact Unit, Bristol BS8 1TD, Avon, England; [Cammack, Richard] Kings Coll London, Pharmaceut Sci Res Div, Mol Biophys Grp, London SE1 9NH, England	University of Bristol; University of London; King's College London	Dillingham, MS (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, DNA Prot Interact Unit, Univ Walk, Bristol BS8 1TD, Avon, England.	Mark.Dillingham@bristol.ac.uk	Cammack, Richard/B-7841-2008	Yeeles, Joseph/0000-0002-2255-2119; Dillingham, Mark/0000-0002-4612-7141	Biotechnology and Biological Sciences Research Council; Royal Society University Research Fellowship	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society University Research Fellowship(Royal Society of London)	This work was supported by a Biotechnology and Biological Sciences Research Council doctoral training grant (to J.T.P.Y.) and a Royal Society University Research Fellowship (to M.S.D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amundsen SK, 2008, MOL MICROBIOL, V69, P994, DOI 10.1111/j.1365-2958.2008.06336.x; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; ARCHIBALD F, 1983, FEMS MICROBIOL LETT, V19, P29, DOI 10.1111/j.1574-6968.1983.tb00504.x; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; BEINERT H, 1983, ARCH BIOCHEM BIOPHYS, V222, P333, DOI 10.1016/0003-9861(83)90531-3; BRUSCHI M, 1976, BIOCHIM BIOPHYS ACTA, V449, P275, DOI 10.1016/0005-2728(76)90139-0; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Chedin F, 2000, J MOL BIOL, V298, P7, DOI 10.1006/jmbi.2000.3556; Chedin F, 2002, MOL MICROBIOL, V43, P823, DOI 10.1046/j.1365-2958.2002.02785.x; Chepanoske CL, 2000, ARCH BIOCHEM BIOPHYS, V380, P11, DOI 10.1006/abbi.2000.1890; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Eggleston AK, 1996, NUCLEIC ACIDS RES, V24, P1179, DOI 10.1093/nar/24.7.1179; Ferrer M, 2007, NATURE, V445, P91, DOI 10.1038/nature05362; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fiorentino DF, 1997, MOL BIOL CELL, V8, P2519, DOI 10.1091/mbc.8.12.2519; Gostick DO, 1998, MICROBIOL-SGM, V144, P705, DOI 10.1099/00221287-144-3-705; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Hogbom M, 2005, MOL CELL PROTEOMICS, V4, P827, DOI 10.1074/mcp.T400023-MCP200; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Lambert AR, 2008, STRUCTURE, V16, P558, DOI 10.1016/j.str.2008.01.017; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Mertens K, 2008, MOL MICROBIOL, V69, P1411, DOI 10.1111/j.1365-2958.2008.06373.x; MEYER J, 1988, TRENDS ECOL EVOL, V3, P222, DOI 10.1016/0169-5347(88)90162-0; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; MICHAELS ML, 1990, NUCLEIC ACIDS RES, V18, P3841, DOI 10.1093/nar/18.13.3841; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; PANDEY A, 1994, APPL MICROBIOL BIOT, V40, P735, DOI [10.1007/BF00173337, 10.1007/s002530050058]; Pieroni L, 2001, CLIN CHEM, V47, P2059; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Quiberoni A, 2001, J BACTERIOL, V183, P4071, DOI 10.1128/JB.183.13.4071-4078.2001; Rigden DJ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-9; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Sisakova E, 2008, NUCLEIC ACIDS RES, V36, P3939, DOI 10.1093/nar/gkn333; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; THOMSON AJ, 1981, BIOCHIM BIOPHYS ACTA, V637, P423, DOI 10.1016/0005-2728(81)90047-5; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Wang JD, 2000, J BIOL CHEM, V275, P507, DOI 10.1074/jbc.275.1.507; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yeeles JTP, 2007, J MOL BIOL, V371, P66, DOI 10.1016/j.jmb.2007.05.053; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zuniga-Castillo J, 2004, J BACTERIOL, V186, P7905, DOI 10.1128/JB.186.23.7905-7913.2004	62	83	87	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7746	7755		10.1074/jbc.M808526200	http://dx.doi.org/10.1074/jbc.M808526200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19129187	Green Published, hybrid			2022-12-27	WOS:000264195600036
J	Yamnik, RL; Digilova, A; Davis, DC; Brodt, ZN; Murphy, CJ; Holz, MK				Yamnik, Rachel L.; Digilova, Alla; Davis, Daphne C.; Brodt, Z. Nilly; Murphy, Christopher J.; Holz, Marina K.			S6 Kinase 1 Regulates Estrogen Receptor alpha in Control of Breast Cancer Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; CYCLE PROGRESSION; 17Q23 AMPLICON; MTOR; PROTEIN; PHOSPHORYLATION; GROWTH; TRANSLATION; LYMPHANGIOLEIOMYOMATOSIS; IDENTIFICATION	The 40 S ribosomal S6 kinase 1 (S6K1) acts downstream of mTOR (mammalian target of rapamycin) and is sensitive to inhibition by rapamycin. The chromosomal region 17q23 containing the RPS6KB1 gene is frequently amplified in breast cancer cells, leading to S6K1 overexpression. The role of S6K1 in disease development and progression is supported by the observation that S6K1 overexpression is associated with poor prognosis in breast cancer patients. However, the identity of mammary cell-specific S6K1 targets is not well understood. In this study, we report that overexpression of S6K1 endows breast cancer cells with a proliferative advantage in low serum conditions and enhanced sensitivity to rapamycin. We investigate the molecular mechanism behind this observation to show that S6K1 regulates estrogen receptor alpha (ER alpha) by phosphorylating it on serine 167, leading to transcriptional activation of ER alpha. By contributing to the activation of ER alpha, S6K1 promotes ER alpha-mediated cell proliferation and may be a target of therapeutic intervention in breast cancer.	[Yamnik, Rachel L.; Digilova, Alla; Davis, Daphne C.; Brodt, Z. Nilly; Murphy, Christopher J.; Holz, Marina K.] Yeshiva Univ, Stern Coll Women, Dept Biol, New York, NY 10016 USA; [Holz, Marina K.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Yeshiva University; Albert Einstein College of Medicine	Holz, MK (corresponding author), Yeshiva Univ, Stern Coll Women, Dept Biol, 245 Lexington Ave, New York, NY 10016 USA.	mholz@yu.edu			Atol Charitable Trust; Yeshiva University graduate research fellowship; S. Daniel Abraham Honors Program	Atol Charitable Trust; Yeshiva University graduate research fellowship; S. Daniel Abraham Honors Program	This work was supported by a grant from the Atol Charitable Trust (to M. K. H.), a Yeshiva University graduate research fellowship (to R. L.Y.), and the S. Daniel Abraham Honors Program (to A. D. and Z.N.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barlund M, 2000, J NATL CANCER I, V92, P1252, DOI 10.1093/jnci/92.15.1252; BORENFREUND E, 1990, IN VITRO CELL DEV B, V26, P1030; Boulay A, 2005, CLIN CANCER RES, V11, P5319, DOI 10.1158/1078-0432.CCR-04-2402; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; CHEATHAM L, 1995, P NATL ACAD SCI USA, V92, P11696, DOI 10.1073/pnas.92.25.11696; Chorianopoulos D, 2008, LUNG, V186, P197, DOI 10.1007/s00408-008-9087-5; Cohen EEW, 2008, J CLIN ONCOL, V26, P348, DOI 10.1200/JCO.2007.14.3164; Couch FJ, 1999, CANCER RES, V59, P1408; DeGraffenried LA, 2004, CLIN CANCER RES, V10, P8059, DOI 10.1158/1078-0432.CCR-04-0035; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hohman DW, 2008, EUR J INTERN MED, V19, P319, DOI 10.1016/j.ejim.2007.10.015; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; Johnston SRD, 2005, CLIN CANCER RES, V11, p889S; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; Nicholson RI, 1999, ENDOCR-RELAT CANCER, V6, P373, DOI 10.1677/erc.0.0060373; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Sinclair CS, 2003, BREAST CANCER RES TR, V78, P313, DOI 10.1023/A:1023081624133; van der Hage JA, 2004, BRIT J CANCER, V90, P1543, DOI 10.1038/sj.bjc.6601741; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wu GJ, 2000, CANCER RES, V60, P5371; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019	38	186	190	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6361	6369		10.1074/jbc.M807532200	http://dx.doi.org/10.1074/jbc.M807532200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19112174	hybrid			2022-12-27	WOS:000263742700039
J	Gubern, A; Barcelo-Torns, M; Casas, J; Barneda, D; Masgrau, R; Picatoste, F; Balsinde, J; Balboa, MA; Claro, E				Gubern, Albert; Barcelo-Torns, Miquel; Casas, Javier; Barneda, David; Masgrau, Roser; Picatoste, Fernando; Balsinde, Jesus; Balboa, Maria A.; Claro, Enrique			Lipid Droplet Biogenesis Induced by Stress Involves Triacylglycerol Synthesis That Depends on Group VIA Phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; PHOSPHATIDATE PHOSPHOHYDROLASE; INHIBITION; APOPTOSIS; PHOSPHATIDYLCHOLINE; ACCUMULATION; MECHANISM; PROTECTS	This work investigates the metabolic origin of triacylglycerol (TAG) formed during lipid droplet (LD) biogenesis induced by stress. Cytotoxic inhibitors of fatty acid synthase induced TAG synthesis and LD biogenesis in CHO-K1 cells, in the absence of external sources of fatty acids. TAG synthesis was required for LD biogenesis and was sensitive to inhibition and down-regulation of the expression of group VIA phospholipase A(2) (iPLA(2)-VIA). Induction of stress with acidic pH, C-2-ceramide, tunicamycin, or deprivation of glucose also stimulated TAG synthesis and LD formation in a manner dependent on iPLA(2)-VIA. Overexpression of the enzyme enhanced TAG synthesis from endogenous fatty acids and LD occurrence. During stress, LD biogenesis but not TAG synthesis required phosphorylation and activation of group IVA PLA(2) (cPLA(2)alpha). The results demonstrate that iPLA(2)-VIA provides fatty acids for TAG synthesis while cPLA(2)alpha allows LD biogenesis. LD biogenesis during stress may be a survival strategy, recycling structural phospholipids into energy-generating substrates.	[Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; Masgrau, Roser; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Inst Neurosci, E-08193 Barcelona, Spain; [Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; Masgrau, Roser; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Casas, Javier; Balsinde, Jesus; Balboa, Maria A.] CSIC, Inst Biol & Genet Mol, E-47003 Valladolid, Spain; [Casas, Javier; Balsinde, Jesus; Balboa, Maria A.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, E-47003 Valladolid, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Claro, E (corresponding author), Univ Autonoma Barcelona, Inst Neurosci, Edifici M2,Campus UAB, E-08193 Barcelona, Spain.	enrique.claro@uab.es	Claro, Enrique/D-5612-2009; Masgrau, Roser/D-3047-2011; Balboa, María A./V-9493-2018; Gubern, Albert/C-9902-2011; Casas, Javier/K-7190-2015; Balsinde, Jesús/C-7833-2018	Claro, Enrique/0000-0002-7592-7906; Masgrau, Roser/0000-0002-6722-5939; Balboa, María A./0000-0002-2130-5298; Gubern, Albert/0000-0001-6458-1498; Casas, Javier/0000-0002-6413-8127; Balsinde, Jesús/0000-0002-4157-6714; Barneda, David/0000-0002-4436-4100	Spanish Ministry of Education and Science [SAF 2004-01698, SAF 2007-60055, BFU 2007-67154/BMC]; Spanish Ministry of Health	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was supported in part by Grants SAF 2004-01698, SAF 2007-60055, and BFU 2007-67154/BMC from the Spanish Ministry of Education and Science and PI03/0528 from the Spanish Ministry of Health. The Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas is an initiative of the Instituto de Salud Carlos III.	Aki T, 2003, ONCOGENE, V22, P8529, DOI 10.1038/sj.onc.1207197; Al-Saffar NMS, 2002, BRIT J CANCER, V86, P963, DOI 10.1038/sj/bjc/6600188; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Baburina I, 1998, J BIOL CHEM, V273, P2169, DOI 10.1074/jbc.273.4.2169; Balboa MA, 1998, J BIOL CHEM, V273, P7684, DOI 10.1074/jbc.273.13.7684; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Balsinde J, 2006, BBA-MOL CELL BIOL L, V1761, P1344, DOI 10.1016/j.bbalip.2006.07.013; Barba I, 1999, CANCER RES, V59, P1861; Barba I, 2001, NMR BIOMED, V14, P33, DOI 10.1002/nbm.688; Barbour SE, 1999, BBA-MOL CELL BIOL L, V1439, P77, DOI 10.1016/S1388-1981(99)00078-5; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boggs K, 1998, BBA-LIPID LIPID MET, V1389, P1, DOI 10.1016/S0005-2760(97)00145-8; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Casas J, 2006, J BIOL CHEM, V281, P6106, DOI 10.1074/jbc.M505230200; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cui Z, 2002, BBA-MOL CELL BIOL L, V1585, P87, DOI 10.1016/S1388-1981(02)00328-1; Dricu A, 1997, CANCER RES, V57, P543; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Gubern A, 2008, J BIOL CHEM, V283, P27369, DOI 10.1074/jbc.M800696200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Iorio E, 2003, BBA-MOL CELL BIOL L, V1634, P1, DOI 10.1016/j.bbalip.2003.07.001; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Manguikian AD, 2004, J BIOL CHEM, V279, P52881, DOI 10.1074/jbc.M410659200; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Perez R, 2006, J IMMUNOL, V176, P2555, DOI 10.4049/jimmunol.176.4.2555; Perez R, 2004, J BIOL CHEM, V279, P40385, DOI 10.1074/jbc.M402562200; Ramos B, 2003, MOL PHARMACOL, V64, P502, DOI 10.1124/mol.64.2.502; Ramos B, 2002, MOL PHARMACOL, V62, P1068, DOI 10.1124/mol.62.5.1068; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Servitja JM, 1999, J NEUROCHEM, V72, P1441, DOI 10.1046/j.1471-4159.1999.721441.x; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Zhang XH, 2006, J CELL SCI, V119, P1005, DOI 10.1242/jcs.02821	55	67	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5697	5708		10.1074/jbc.M806173200	http://dx.doi.org/10.1074/jbc.M806173200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117952	hybrid, Green Published			2022-12-27	WOS:000263560600033
J	Lowry, JA; Gamsjaeger, R; Thong, SY; Hung, W; Kwan, AH; Broitman-Maduro, G; Matthews, JM; Maduro, M; Mackay, JP				Lowry, Jason A.; Gamsjaeger, Roland; Thong, Sock Yue; Hung, Wendy; Kwan, Ann H.; Broitman-Maduro, Gina; Matthews, Jacqueline M.; Maduro, Morris; Mackay, Joel P.			Structural Analysis of MED-1 Reveals Unexpected Diversity in the Mechanism of DNA Recognition by GATA- type Zinc Finger Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; BINDING DOMAIN; PROTEIN SECONDARY; DEVELOPING HEART; J-COUPLINGS; FAMILY; PREDICTION; COMPLEX; SPECIFICITY; MESENDODERM	MED-1 is a member of a group of divergent GATA-type zinc finger proteins recently identified in several species of Caenorhabditis. The med genes are transcriptional regulators that are involved in the specification of the mesoderm and endoderm precursor cells in nematodes. Unlike other GATA-type zinc fingers that recognize the consensus sequence (A/C/ T) GATA (A/G), the MED-1 zinc finger (MED1zf) binds the larger and atypical site GTATACT(T/C)(3). We have examined the basis for this unusual DNA specificity using a range of biochemical and biophysical approaches. Most strikingly, we show that although the core of the MED1zf structure is similar to that of GATA-1, the basic tail C-terminal to the zinc finger unexpectedly adopts an alpha-helical structure upon binding DNA. This additional helix appears to contact the major groove of the DNA, making contacts that explain the extended DNA consensus sequence observed for MED1zf. Our data expand the versatility of DNA recognition by GATA-type zinc fingers and perhaps shed new light on the DNA-binding properties of mammalian GATA factors.	[Lowry, Jason A.; Gamsjaeger, Roland; Thong, Sock Yue; Kwan, Ann H.; Matthews, Jacqueline M.; Mackay, Joel P.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Hung, Wendy; Broitman-Maduro, Gina; Maduro, Morris] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of Sydney; University of California System; University of California Riverside	Mackay, JP (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.	j.mackay@usyd.edu.au	Mackay, Joel P/D-6834-2011; Matthews, Jacqueline/A-7322-2013	Mackay, Joel P/0000-0001-7508-8033; Kwan, Ann/0000-0002-1506-2226; Matthews, Jacqueline/0000-0001-8518-3472; Broitman-Maduro, Gina/0000-0002-8059-8246; Gamsjaeger, Roland/0000-0003-1095-2569	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a program grant and a senior research fellowship (to J.P.M.) from the Australian National Health and Medical Research Council.	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bates DL, 2008, J MOL BIOL, V381, P1292, DOI 10.1016/j.jmb.2008.06.072; BAX A, 1994, METHOD ENZYMOL, V239, P79; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Broitman-Maduro G, 2005, DEV CELL, V8, P427, DOI 10.1016/j.devcel.2005.01.014; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Coroian C, 2006, DEV BIOL, V289, P444, DOI 10.1016/j.ydbio.2005.10.024; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Deane JE, 2003, EMBO J, V22, P2224, DOI 10.1093/emboj/cdg196; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; FENG B, 1993, NUCLEIC ACIDS RES, V21, P3989, DOI 10.1093/nar/21.17.3989; Gamsjaeger R, 2008, J BIOL CHEM, V283, P5158, DOI 10.1074/jbc.M703772200; Ghirlando R, 2003, J BIOL CHEM, V278, P45620, DOI 10.1074/jbc.M306410200; Goddard T. D., 2006, SPARKY 3; Hung HL, 1999, MOL CELL BIOL, V19, P3496; Kamphuis MB, 2006, J MOL BIOL, V357, P115, DOI 10.1016/j.jmb.2005.12.033; KELLEY C, 1993, DEVELOPMENT, V118, P817; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; KUDLA B, 1990, EMBO J, V9, P1355, DOI 10.1002/j.1460-2075.1990.tb08250.x; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Lejeune D, 2005, PROTEINS, V61, P258, DOI 10.1002/prot.20607; Liew CK, 2005, P NATL ACAD SCI USA, V102, P583, DOI 10.1073/pnas.0407511102; Liew CK, 2000, STRUCTURE, V8, P1157, DOI 10.1016/S0969-2126(00)00527-X; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Manfield IW, 2000, BBA-GENE STRUCT EXPR, V1493, P325, DOI 10.1016/S0167-4781(00)00197-4; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; OMICHINSKI JG, 1993, P NATL ACAD SCI USA, V90, P1676, DOI 10.1073/pnas.90.5.1676; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Page BD, 1997, GENE DEV, V11, P1651, DOI 10.1101/gad.11.13.1651; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Starich MR, 1998, J MOL BIOL, V277, P605, DOI 10.1006/jmbi.1998.1625; Teakle GR, 1998, TRENDS BIOCHEM SCI, V23, P100, DOI 10.1016/S0968-0004(98)01174-8; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Zweckstetter M, 2004, BIOPHYS J, V86, P3444, DOI 10.1529/biophysj.103.035790	43	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5827	5835		10.1074/jbc.M808712200	http://dx.doi.org/10.1074/jbc.M808712200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19095651	hybrid			2022-12-27	WOS:000263560600046
J	Sako, K; Fukuhara, S; Minami, T; Hamakubo, T; Song, HH; Kodama, T; Fukamizu, A; Gutkind, JS; Koh, GY; Mochizuki, N				Sako, Keisuke; Fukuhara, Shigetomo; Minami, Takashi; Hamakubo, Takao; Song, Haihua; Kodama, Tatsuhiko; Fukamizu, Akiyoshi; Gutkind, J. Silvio; Koh, Gou Young; Mochizuki, Naoki			Angiopoietin-1 Induces Kruppel-like Factor 2 Expression through a Phosphoinositide 3-Kinase/AKT-dependent Activation of Myocyte Enhancer Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; TRANSCRIPTION FACTOR MEF2C; CELL-CELL CONTACT; C-JUN PROMOTER; GENE-EXPRESSION; MUSCLE DIFFERENTIATION; INDEPENDENT PATHWAY; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; ADULT VASCULATURE	Angiopoietin-1 (Ang1) regulates both vascular quiescence and angiogenesis through the receptor tyrosine kinase Tie2. We and another group have recently shown that Ang1 and Tie2 form distinct signaling complexes at cell-cell and cell-matrix contacts and further demonstrated that the former selectively induces expression of Kruppel-like factor 2 (KLF2), a transcription factor involved in vascular quiescence. Here, we investigated the mechanism of how Ang1/Tie2 signal induces KLF2 expression to clarify the role of KLF2 in Ang1/Tie2 signal-mediated vascular quiescence. Ang1 stimulated KLF2 promoter driven reporter gene expression in endothelial cells, whereas it failed when a myocyte enhancer factor 2 (MEF2)-binding site of KLF2 promoter was mutated. Depletion of MEF2 by siRNAs abolished Ang1-induced KLF2 expression, indicating the requirement of MEF2 in KLF2 induction by Ang1. Constitutive active phosphoinositide 3-kinase (PI3K)and AKT increased the MEF2-dependent reporter gene expression by enhancing its transcriptional activity and stimulated the KLF2 promoter activity cooperatively with MEF2. Consistently, inhibition of either PI3K or AKT and depletion of AKT abrogated Ang1-induced KLF2 expression. In addition, we confirmed the dispensability of extracellular signal-regulated kinase 5 (ERK5) for Ang1-induced KLF2 expression. Furthermore, depletion of KLF2 resulted in the loss of the inhibitory effect of Ang1 on vascular endothelial growth factor (VEGF)-mediated expression of vascular cell adhesion molecule-1 in endothelial cells and VEGF-mediated monocyte adhesion to endothelial cells. Collectively, these findings indicate that Ang1/Tie2 signal stimulates transcriptional activity of MEF2 through a PI3K/AKT pathway to induce KLF2 expression, which may counteract VEGF-mediated inflammatory responses.	[Sako, Keisuke; Fukuhara, Shigetomo; Mochizuki, Naoki] Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, Osaka 5658565, Japan; [Minami, Takashi; Hamakubo, Takao; Song, Haihua; Kodama, Tatsuhiko] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Fukamizu, Akiyoshi] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Gutkind, J. Silvio] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Biomed Res Ctr, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	National Cerebral & Cardiovascular Center - Japan; University of Tokyo; University of Tsukuba; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Fukuhara, S (corresponding author), Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, 5-7-1 Fujishirodai, Osaka 5658565, Japan.	fuku@ri.ncvc.go.jp	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016; fukamizu, akiyoshi/J-5350-2012; Koh, Gou Young/C-1615-2011	Gutkind, J. Silvio/0000-0002-5150-4482; fukamizu, akiyoshi/0000-0002-8786-6020; sako, keisuke/0000-0002-6453-8075	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labour, and Welfare of Japan; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Naito Foundation; Takeda Science Foundation; Sagawa Foundation for Promotion of Cancer Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kowa Life Science Foundation; Kanae Foundation for the Promotion of Medical Science; Takeda Medical Research Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sagawa Foundation for Promotion of Cancer Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kowa Life Science Foundation; Kanae Foundation for the Promotion of Medical Science; Takeda Medical Research Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan ( to K. S., S. F., and N. M.); the Ministry of Health, Labour, and Welfare of Japan ( to N. M.); and the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation ( to S. F., T. M., T. K., and N. M.); the Naito Foundation ( to S. F.); Takeda Science Foundation ( to S. F.); the Sagawa Foundation for Promotion of Cancer Research ( to S. F.), Mochida Memorial Foundation for Medical and Pharmaceutical Research ( to S. F.), Kowa Life Science Foundation ( to S. F.), Kanae Foundation for the Promotion of Medical Science ( to S. F.), and Takeda Medical Research Foundation ( to N. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Bhattacharya R, 2005, J BIOL CHEM, V280, P28848, DOI 10.1074/jbc.C500200200; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Coso OA, 1997, J BIOL CHEM, V272, P20691, DOI 10.1074/jbc.272.33.20691; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Deng Y, 2007, AM J PHYSIOL-CELL PH, V293, pC1404, DOI 10.1152/ajpcell.00058.2007; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Huddleson JP, 2005, J BIOL CHEM, V280, P23371, DOI 10.1074/jbc.M413839200; Huddleson JP, 2004, BIOL CHEM, V385, P723, DOI 10.1515/BC.2004.088; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Lin PN, 1997, J CLIN INVEST, V100, P2072, DOI 10.1172/JCI119740; Lin ZY, 2006, ARTERIOSCL THROM VAS, V26, P1185, DOI 10.1161/01.ATV.0000215638.53414.99; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Olson EN, 2004, J CLIN INVEST, V113, P1110, DOI 10.1172/JCI200421497; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Sohn SJ, 2005, MOL CELL BIOL, V25, P8553, DOI 10.1128/MCB.25.19.8553-8566.2005; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200	55	57	63	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5592	5601		10.1074/jbc.M806928200	http://dx.doi.org/10.1074/jbc.M806928200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106103	hybrid			2022-12-27	WOS:000263560600022
J	Cullen, SP; Afonina, IS; Donadini, R; Luthi, AU; Medema, JP; Bird, PI; Martin, SJ				Cullen, Sean P.; Afonina, Inna S.; Donadini, Roberta; Luethi, Alexander U.; Medema, Jan Paul; Bird, Phillip I.; Martin, Seamus J.			Nucleophosmin Is Cleaved and Inactivated by the Cytotoxic Granule Protease Granzyme M during Natural Killer Cell-mediated Killing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOLAR PHOSPHOPROTEIN B23; ACUTE MYELOGENOUS LEUKEMIA; CYTOCHROME-C RELEASE; MONOCLONAL-ANTIBODY; RIBOSOME BIOGENESIS; SERINE-PROTEASE; ACTIVATION; APOPTOSIS; CYTOMEGALOVIRUS; EXPRESSION	Natural killer (NK) cells kill virus-infected or transformed target cells by delivering cytotoxic proteases called granzymes to the target cell cytosol. One of these proteases, granzyme M, is specifically expressed in NK cells and is thought to instigate a form of cell death distinct from that mediated by granzyme A or granzyme B. However, the mechanism of granzyme M-induced cell death is unclear at present, and few substrates for this granzyme have been reported to date. Here we show that the abundant nucleolar phosphoprotein, nucleophosmin (NPM), is cleaved and inactivated by granzyme M. NPMis essential for cell viability as RNA interference-mediated ablation of NPM expression in human cells resulted in spontaneous apoptosis. Significantly, overexpression of wild-type NPM rescued cells treated with NPM small interference RNA, whereas overexpression of the granzyme M-cleaved form of NPM did not. Because NPMis essential for cell viability, these data suggest that targeting of NPM by granzyme M may contribute to tumor cell eradication by abolishing NPM function.	[Cullen, Sean P.; Afonina, Inna S.; Luethi, Alexander U.; Martin, Seamus J.] Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland; [Donadini, Roberta; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Medema, Jan Paul] Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, NL-11005 AZ Amsterdam, Netherlands	Trinity College Dublin; Monash University	Martin, SJ (corresponding author), Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland.	martinsj@tcd.ie	Afonina, Inna/AAM-8978-2020; Lüthi, Alexander U/B-4398-2009	Afonina, Inna/0000-0001-8894-5305; Martin, Seamus/0000-0002-8539-3143; Medema, Jan Paul/0000-0003-3045-2924; Bird, Phillip/0000-0002-6695-606X	Science Foundation Ireland [PI/B038]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported in part by Science Foundation Ireland Grant PI/B038. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adrain C, 2005, J BIOL CHEM, V280, P4663, DOI 10.1074/jbc.M410915200; Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Cazzaniga G, 2005, BLOOD, V106, P1419, DOI 10.1182/blood-2005-03-0899; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Cullen SP, 2008, CELL DEATH DIFFER, V15, P251, DOI 10.1038/sj.cdd.4402244; Cullen SP, 2007, J CELL BIOL, V176, P435, DOI 10.1083/jcb.200612025; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Dergunova NN, 2002, IMMUNOL LETT, V83, P67, DOI 10.1016/S0165-2478(02)00085-8; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Grimwade D, 2000, BLOOD, V96, P1297; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grossman WJ, 2003, CURR OPIN IMMUNOL, V15, P544, DOI 10.1016/S0952-7915(03)00099-2; Gubin AN, 1999, GENOMICS, V59, P168, DOI 10.1006/geno.1999.5855; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Huang WH, 2001, J BIOL CHEM, V276, P25166, DOI 10.1074/jbc.M010087200; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kelly JM, 2004, J BIOL CHEM, V279, P22236, DOI 10.1074/jbc.M401670200; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; Li J, 2004, J BIOL CHEM, V279, P41275, DOI 10.1074/jbc.C400297200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li YP, 1997, J VIROL, V71, P4098, DOI 10.1128/JVI.71.5.4098-4102.1997; Lieberman J, 2003, CURR OPIN IMMUNOL, V15, P553, DOI 10.1016/S0952-7915(03)00108-0; Lu HX, 2006, J IMMUNOL, V177, P1171, DOI 10.4049/jimmunol.177.2.1171; Mahrus S, 2004, J BIOL CHEM, V279, P54275, DOI 10.1074/jbc.M411482200; Mai RT, 2006, ONCOGENE, V25, P448, DOI 10.1038/sj.onc.1209052; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martin SJ, 1996, EMBO J, V15, P2407, DOI 10.1002/j.1460-2075.1996.tb00598.x; Medema JP, 1997, EUR J IMMUNOL, V27, P3492, DOI 10.1002/eji.1830271250; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nozawa Y, 1996, J PATHOL, V178, P48; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Okuwaki M, 2001, J MOL BIOL, V311, P41, DOI 10.1006/jmbi.2001.4812; OLSON MOJ, 1986, BIOCHEMISTRY-US, V25, P484, DOI 10.1021/bi00350a031; Pao LI, 2005, J IMMUNOL, V175, P3235, DOI 10.4049/jimmunol.175.5.3235; Pinkoski MJ, 2001, J BIOL CHEM, V276, P12060, DOI 10.1074/jbc.M009038200; Redner RL, 2002, LEUKEMIA, V16, P1927, DOI 10.1038/sj.leu.2402720; Rukamp BJ, 2004, ARCH BIOCHEM BIOPHYS, V422, P9, DOI 10.1016/j.abb.2003.12.005; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Shields LBE, 1997, J SOC GYNECOL INVEST, V4, P298, DOI 10.1016/S1071-5576(97)00068-3; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; SMYTH MJ, 1992, J BIOL CHEM, V267, P24418; SMYTH MJ, 1993, J IMMUNOL, V151, P6195; Street SEA, 2004, J EXP MED, V199, P879, DOI 10.1084/jem.20031981; Subong ENP, 1999, PROSTATE, V39, P298; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; TANAKA M, 1992, CANCER RES, V52, P3372; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Ulanet DB, 2003, P NATL ACAD SCI USA, V100, P12361, DOI 10.1073/pnas.2035245100; Wu MH, 2002, INT J CANCER, V97, P297, DOI 10.1002/ijc.1606; Wu MH, 2002, CARCINOGENESIS, V23, P93, DOI 10.1093/carcin/23.1.93; YonedaKato N, 1996, ONCOGENE, V12, P265; Yun JP, 2003, J CELL BIOCHEM, V90, P1140, DOI 10.1002/jcb.10706; Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200	66	32	36	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5137	5147		10.1074/jbc.M807913200	http://dx.doi.org/10.1074/jbc.M807913200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103589	hybrid			2022-12-27	WOS:000263416600044
J	Hendriks, J; Hellingwerf, KJ				Hendriks, Johnny; Hellingwerf, Klaas J.			pH Dependence of the Photoactive Yellow Protein Photocycle Recovery Reaction Reveals a New Late Photocycle Intermediate with a Deprotonated Chromophore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECTOTHIORHODOSPIRA-HALOPHILA; ACTIVE-SITE; STRUCTURAL-CHANGES; COUMARIC ACID; PHOTORECEPTOR; ACTIVATION; DYNAMICS; KINETICS; SPECTROSCOPY; MUTANTS	The recovery reaction of the signaling state of photoactive yellow protein includes the following: (i) deprotonation of the p-coumaryl chromophore, (ii) refolding of the protein, and (iii) chromophore re-isomerization from the cis to the trans configuration. Through analysis of the pH dependence of this recovery reaction, we were able to provide proof for the existence of an additional photocycle intermediate. The spectral similarity between this new intermediate and the dark state indicates that the new intermediate has a deprotonated chromophore, which may facilitate chromophore re-isomerization. This spectral similarity also explains why this new intermediate has not been noticed in earlier studies. For our data analysis we introduce a photocycle model that takes into account the effect of the specific light regime selected, a model that was also used for simulations.	Univ Amsterdam, Swammerdam Inst Life Sci, Microbiol Lab, NL-1018 WV Amsterdam, Netherlands; Univ Amsterdam, Netherlands Inst Syst Biol, NL-1018 WV Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Hellingwerf, KJ (corresponding author), Nieuwe Achtergracht 166, NL-1018 WV Amsterdam, Netherlands.	K.J.Hellingwerf@uva.nl						Anderson S, 2004, STRUCTURE, V12, P1039, DOI 10.1016/j.str.2004.04.008; BACA M, 1994, BIOCHEMISTRY-US, V33, P14369, DOI 10.1021/bi00252a001; BORGSTAHL GEO, 1995, BIOCHEMISTRY-US, V34, P6278, DOI 10.1021/bi00019a004; Borucki B, 2006, BIOPHYS J, V91, P2991, DOI 10.1529/biophysj.106.086645; Chen EF, 2003, BIOCHEMISTRY-US, V42, P2062, DOI 10.1021/bi020577o; Dux P, 1998, BIOCHEMISTRY-US, V37, P12689, DOI 10.1021/bi9806652; Genick UK, 1997, BIOCHEMISTRY-US, V36, P8, DOI 10.1021/bi9622884; Getzoff ED, 2003, NAT STRUCT BIOL, V10, P663, DOI 10.1038/nsb958; Hellingwerf KJ, 2003, J PHYS CHEM A, V107, P1082, DOI 10.1021/jp027005y; HENDLER RW, 1994, J BIOCHEM BIOPH METH, V28, P1, DOI 10.1016/0165-022X(94)90061-2; Hendriks J, 1999, FEBS LETT, V458, P252, DOI 10.1016/S0014-5793(99)01136-9; Hendriks J, 1999, J BIOL CHEM, V274, P17655, DOI 10.1074/jbc.274.25.17655; Hendriks J, 2003, BIOPHYS J, V84, P1180, DOI 10.1016/S0006-3495(03)74932-7; Hendriks J, 2002, BIOPHYS J, V82, P1632, DOI 10.1016/S0006-3495(02)75514-8; HENDRIKS J, 2007, COMPUTATIONAL BIOPHY, P149; Hoersch D, 2007, BIOPHYS J, V93, P1687, DOI 10.1529/biophysj.107.106633; Hoff WD, 1996, BIOCHEMISTRY-US, V35, P1274, DOI 10.1021/bi951755z; HOFF WD, 1994, BIOCHEMISTRY-US, V33, P13959, DOI 10.1021/bi00251a001; Holiday ER, 1936, BIOCHEM J, V30, P1795, DOI 10.1042/bj0301795; Ihee H, 2005, P NATL ACAD SCI USA, V102, P7145, DOI 10.1073/pnas.0409035102; Joshi CP, 2005, BIOCHEMISTRY-US, V44, P656, DOI 10.1021/bi0481141; Kort R, 1996, EMBO J, V15, P3209, DOI 10.1002/j.1460-2075.1996.tb00685.x; KRAAYENHOF R, 1982, ANAL BIOCHEM, V127, P93, DOI 10.1016/0003-2697(82)90149-X; Kumauchi M, 2002, J BIOCHEM, V132, P205, DOI 10.1093/oxfordjournals.jbchem.a003211; Lee BC, 2008, PROTEIN SCI, V17, P2101, DOI 10.1110/ps.037655.108; Meyer TE, 2003, BIOCHEMISTRY-US, V42, P3319, DOI 10.1021/bi020702w; Schmidt M, 2004, P NATL ACAD SCI USA, V101, P4799, DOI 10.1073/pnas.0305983101; Sergi A, 2001, J PHYS CHEM B, V105, P4386, DOI 10.1021/jp002270+; Shimizu N, 2006, BIOCHEMISTRY-US, V45, P3542, DOI 10.1021/bi051430a; Shimizu N, 2006, J BIOL CHEM, V281, P4318, DOI 10.1074/jbc.M506403200; Shimizu N, 2002, J BIOCHEM, V132, P257, DOI 10.1093/oxfordjournals.jbchem.a003219; Takeshita K, 2002, BIOCHEMISTRY-US, V41, P3037, DOI 10.1021/bi0110600; Takeshita K, 2002, BIOPHYS J, V83, P1567, DOI 10.1016/S0006-3495(02)73926-X; van Wilderen LJGW, 2006, P NATL ACAD SCI USA, V103, P15050, DOI 10.1073/pnas.0603476103; VANBREDERODE ME, 1995, BIOPHYS J, V68, P1101, DOI 10.1016/S0006-3495(95)80284-5; VanBrederode ME, 1996, BIOPHYS J, V71, P365, DOI 10.1016/S0006-3495(96)79234-2; Vreede J, 2008, PROTEINS, V72, P136, DOI 10.1002/prot.21902; Xie AH, 2001, BIOCHEMISTRY-US, V40, P1510, DOI 10.1021/bi002449a	38	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5277	5288		10.1074/jbc.M805904200	http://dx.doi.org/10.1074/jbc.M805904200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19091750	hybrid			2022-12-27	WOS:000263416600058
J	Mori, K; Amano, M; Takefuji, M; Kato, K; Morita, Y; Nishioka, T; Matsuura, Y; Murohara, T; Kaibuchi, K				Mori, Kazutaka; Amano, Mutsuki; Takefuji, Mikito; Kato, Katsuhiro; Morita, Yasuhiro; Nishioka, Tomoki; Matsuura, Yoshiharu; Murohara, Toyoaki; Kaibuchi, Kozo			Rho-kinase Contributes to Sustained RhoA Activation through Phosphorylation of p190A RhoGAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; MYOSIN LIGHT-CHAIN; G-PROTEINS; CELL-ADHESION; RND PROTEINS; PHOSPHATASE; GTPASE; INHIBITION; FAMILY; PATHOPHYSIOLOGY	RhoA is transiently activated by specific extracellular signals such as endothelin-1 (ET-1) in vascular smooth muscle cells. RhoGAP negatively regulates RhoA activity: thus, RhoA becomes the GDP-bound inactive form afterward. Sustained activation of RhoA is induced with high doses of the extracellular signals and is implicated in certain diseases such as vasospasms. However, it remains largely unknown how prolonged activation of RhoA is induced. Here we show that Rho-kinase, an effector of RhoA, phosphorylated p190A RhoGAP at Ser(1150) and attenuated p190A RhoGAP activity in COS7 cells. Binding of Rnd to p190A RhoGAP is thought to enhance its activation. Phosphorylation of p190A RhoGAP by Rho-kinase impaired Rnd binding. Stimulation of vascular smooth muscle cells with a high dose of ET-1 provoked sustained RhoA activation and p190A RhoGAP phosphorylation, both of which were prohibited by a Rho-kinase inhibitor. The phosphomimic mutation of p190A RhoGAP weakened Rnd binding and RhoGAP activities. Taken together, these results suggest that ET-1 induces Rho-kinase activation and subsequent phosphorylation of p190A RhoGAP, leading to prolonged RhoA activation.	[Mori, Kazutaka; Amano, Mutsuki; Takefuji, Mikito; Kato, Katsuhiro; Morita, Yasuhiro; Nishioka, Tomoki; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Mori, Kazutaka; Takefuji, Mikito; Kato, Katsuhiro; Morita, Yasuhiro; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Nishioka, Tomoki] Kurume Univ, Sch Med, Dept Forens Med & Human Genet, Kurume, Fukuoka 830001, Japan; [Matsuura, Yoshiharu] Osaka Univ, Dept Mol Virol, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Nagoya University; Nagoya University; Kurume University; Osaka University	Kaibuchi, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	kaibuchi@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; Kato, Katsuhiro/AAV-8356-2020; Nishioka, Tomoki/M-4976-2014; Takefuji, Mikito/GXG-5982-2022; Amano, Mutsuki/M-4820-2014	Amano, Mutsuki/0000-0002-0662-1524	Ministry of Education, Culture, Sports, Science, and Technology of Japan [S: 20227006, C: 20590308]; National Institute of Biomedical Innovation [02-3]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by grants-in-aid for creative science research and a grant-in-aid for scientific research (S: 20227006; C: 20590308), by the Global Centers of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (Grant 02-3). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agapitov AV, 2002, J RENIN-ANGIO-ALDO S, V3, P1, DOI 10.3317/jraas.2002.001; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; Guilluy C, 2005, BRIT J PHARMACOL, V146, P1010, DOI 10.1038/sj.bjp.0706408; Harada A, 2005, J BIOL CHEM, V280, P18418, DOI 10.1074/jbc.M411356200; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hersch E, 2004, AM J PHYSIOL-CELL PH, V287, pC1209, DOI 10.1152/ajpcell.00198.2004; Hynynen Meri M, 2006, Recent Pat Cardiovasc Drug Discov, V1, P95; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kandabashi T, 2000, CIRCULATION, V101, P1319, DOI 10.1161/01.CIR.101.11.1319; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Ligeti E, 2006, METHOD ENZYMOL, V406, P104, DOI 10.1016/S0076-6879(06)06009-5; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Moriki N, 2004, HYPERTENS RES, V27, P263, DOI 10.1291/hypres.27.263; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Sakurada S, 2001, AM J PHYSIOL-CELL PH, V281, pC571, DOI 10.1152/ajpcell.2001.281.2.C571; Sato M, 2000, CIRC RES, V87, P195, DOI 10.1161/01.RES.87.3.195; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Vincent S, 1999, EUR J CELL BIOL, V78, P539, DOI 10.1016/S0171-9335(99)80019-3; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2; Woodsome TP, 2006, J CELL SCI, V119, P1769, DOI 10.1242/jcs.02805; Worth NF, 2004, CELL MOTIL CYTOSKEL, V59, P189, DOI 10.1002/cm.20036	40	48	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5067	5076		10.1074/jbc.M806853200	http://dx.doi.org/10.1074/jbc.M806853200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103606	hybrid			2022-12-27	WOS:000263416600037
J	Wu, CH; Yeh, SH; Tsay, YG; Shieh, YH; Kao, CL; Chen, YS; Wang, SH; Kuo, TJ; Chen, DS; Chen, PJ				Wu, Chia-Hsin; Yeh, Shiou-Hwei; Tsay, Yeou-Guang; Shieh, Ya-Hsiung; Kao, Chuan-Liang; Chen, Yen-Shun; Wang, Sheng-Han; Kuo, Ti-Jung; Chen, Ding-Shinn; Chen, Pei-Jer			Glycogen Synthase Kinase-3 Regulates the Phosphorylation of Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein and Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE HEPATITIS-VIRUS; INFECTIOUS-BRONCHITIS VIRUS; SARS-CORONAVIRUS; RNA-BINDING; SUBCELLULAR-LOCALIZATION; RICH MOTIF; B-VIRUS; MULTIMERIZATION; GENOME; DOMAIN	Coronavirus (CoV) nucleocapsid (N) protein is a highly phosphorylated protein required for viral replication, but whether its phosphorylation and the related kinases are involved in the viral life cycle is unknown. We found the severe acute respiratory syndrome CoVNprotein to be an appropriate system to address this issue. Using high resolution PAGE analysis, this protein could be separated into phosphorylated and unphosphorylated isoforms. Mass spectrometric analysis and deletion mapping showed that the major phosphorylation sites were located at the central serine-arginine (SR)-rich motif that contains several glycogen synthase kinase (GSK)-3 substrate consensus sequences. GSK-3-specific inhibitor treatment dephosphorylated the N protein, and this could be recovered by the constitutively active GSK-3 kinase. Immunoprecipitation brought down both N and GSK-3 proteins in the same complex, and the N protein could be phosphorylated directly at its SR-rich motif by GSK-3 using an in vitro kinase assay. Mutation of the two priming sites critical for GSK-3 phosphorylation in the SR-rich motif abolished N protein phosphorylation. Finally, GSK-3 inhibitor was found to reduce N phosphorylation in the severe acute respiratory syndrome CoV-infected VeroE6 cells and decrease the viral titer and cytopathic effects. The effect of GSK-3 inhibitor was reproduced in another coronavirus, the neurotropic JHM strain of mouse hepatitis virus. Our results indicate that GSK-3 is critical for CoV N protein phosphorylation and suggest that it plays a role in regulating the viral life cycle. This study, thus, provides new avenues to further investigate the specific role of N protein phosphorylation in CoV replication.	[Wu, Chia-Hsin; Yeh, Shiou-Hwei; Shieh, Ya-Hsiung; Chen, Yen-Shun; Wang, Sheng-Han; Chen, Ding-Shinn; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 100, Taiwan; [Yeh, Shiou-Hwei; Kuo, Ti-Jung; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Ctr Genom Med, Taipei 100, Taiwan; [Kao, Chuan-Liang] Natl Taiwan Univ, Coll Med, Dept Med Technol, Taipei 100, Taiwan; [Chen, Ding-Shinn; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 100, Taiwan; [Chen, Ding-Shinn; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 100, Taiwan; [Tsay, Yeou-Guang] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Yang Ming Chiao Tung University	Yeh, SH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Microbiol, 1 Jen Ai Rd,Sect 1, Taipei 100, Taiwan.	shyeh@ntu.edu.tw	Tsay, Yeou-Guang/HGE-2076-2022; CHEN, DING-SHINN/T-4395-2019	CHEN, DING-SHINN/0000-0001-7791-6154; KAO, CHUAN-LIANG/0000-0002-1020-2605; /0000-0003-4509-180X	National Science Council, Taiwan [NSC93-2751-B-002-008-Y, NSC95-3112-B-002-013]; Department of Health, Executive Yuan, Taiwan [DOH96-TD-O-113-101]; European Commission [SP22-CT-2004-511064]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan; European Commission(European CommissionEuropean Commission Joint Research Centre)	The study was supported by National Science Council, Taiwan ( Grants NSC93-2751-B-002-008-Y and NSC95-3112-B-002-013), by Department of Health, Executive Yuan, Taiwan ( DOH96-TD-O-113-101), and also in part by the European Commission in the context of the activities of the Euro-Asian SARS-DTV Network Grant SP22-CT-2004-511064.	Almazan F, 2004, J VIROL, V78, P12683, DOI 10.1128/JVI.78.22.12683-12688.2004; Calvo E, 2005, J GEN VIROL, V86, P2255, DOI 10.1099/vir.0.80975-0; Chen HY, 2005, J VIROL, V79, P1164, DOI 10.1128/JVI.79.2.1164-1179.2005; Chiu CM, 2007, P NATL ACAD SCI USA, V104, P2571, DOI 10.1073/pnas.0609498104; Darnell MER, 2006, TRANSFUSION, V46, P1770, DOI 10.1111/j.1537-2995.2006.00976.x; Denison MR, 1999, J VIROL, V73, P6862, DOI 10.1128/JVI.73.8.6862-6871.1999; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fan H, 2005, STRUCTURE, V13, P1859, DOI 10.1016/j.str.2005.08.021; Fang XN, 2005, J BIOCHEM MOL BIOL, V38, P381; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; He RT, 2003, BIOCHEM BIOPH RES CO, V311, P870, DOI 10.1016/j.bbrc.2003.10.075; Huang LR, 2004, J MED VIROL, V73, P338, DOI 10.1002/jmv.20096; Huang QL, 2004, BIOCHEMISTRY-US, V43, P6059, DOI 10.1021/bi036155b; Jayaram H, 2006, J VIROL, V80, P6612, DOI 10.1128/JVI.00157-06; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Law LMJ, 2003, J VIROL, V77, P1764, DOI 10.1128/JVI.77.3.1764-1771.2003; Law LJ, 2006, J VIROL, V80, P6917, DOI 10.1128/JVI.01152-05; Lin L, 2007, INT J MASS SPECTROM, V268, P296, DOI 10.1016/j.ijms.2007.05.009; Luo HB, 2006, BIOCHEMISTRY-US, V45, P11827, DOI 10.1021/bi0609319; Luo HB, 2005, BIOCHEMISTRY-US, V44, P15351, DOI 10.1021/bi051122c; Mizutani T, 2004, BIOCHEM BIOPH RES CO, V319, P1228, DOI 10.1016/j.bbrc.2004.05.107; MOHANDAS DV, 1991, FEBS LETT, V282, P419, DOI 10.1016/0014-5793(91)80528-B; Nelson GW, 2000, J GEN VIROL, V81, P181, DOI 10.1099/0022-1317-81-1-181; Peng TY, 2008, FEBS J, V275, P4152, DOI 10.1111/j.1742-4658.2008.06564.x; Schelle B, 2005, J VIROL, V79, P6620, DOI 10.1128/JVI.79.11.6620-6630.2005; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; Spencer KA, 2008, VIROLOGY, V370, P373, DOI 10.1016/j.virol.2007.08.016; STOHLMAN SA, 1982, J GEN VIROL, V63, P265, DOI 10.1099/0022-1317-63-2-265; STOHLMAN SA, 1983, VIROLOGY, V130, P527, DOI 10.1016/0042-6822(83)90106-X; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Surjit M, 2005, J VIROL, V79, P11476, DOI 10.1128/JVI.79.17.11476-11486.2005; Tahara SM, 1998, ADV EXP MED BIOL, V440, P313; van der Meer Y, 1999, J VIROL, V73, P7641, DOI 10.1128/JVI.73.9.7641-7657.1999; White TC, 2007, VIRUS RES, V126, P139, DOI 10.1016/j.virusres.2007.02.008; Ye Y, 2007, J VIROL, V81, P2554, DOI 10.1128/JVI.01634-06; Yeh SH, 2004, P NATL ACAD SCI USA, V101, P2542, DOI 10.1073/pnas.0307904100; Yeh SH, 2004, J HEPATOL, V41, P659, DOI 10.1016/j.jhep.2004.06.031	40	106	114	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5229	5239		10.1074/jbc.M805747200	http://dx.doi.org/10.1074/jbc.M805747200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106108	hybrid, Green Published			2022-12-27	WOS:000263416600053
J	Zitomer, NC; Mitchell, T; Voss, KA; Bondy, GS; Pruett, ST; Garnier-Amblard, EC; Liebeskind, LS; Park, H; Wang, E; Sullards, MC; Merrill, AH; Riley, RT				Zitomer, Nicholas C.; Mitchell, Trevor; Voss, Kenneth A.; Bondy, Genevieve S.; Pruett, Sarah T.; Garnier-Amblard, Ethel C.; Liebeskind, Lanny S.; Park, Hyejung; Wang, Elaine; Sullards, M. Cameron; Merrill, Alfred H., Jr.; Riley, Ronald T.			Ceramide Synthase Inhibition by Fumonisin B-1 Causes Accumulation of 1-Deoxysphinganine A NOVEL CATEGORY OF BIOACTIVE 1-DEOXYSPHINGOID BASES AND 1-DEOXYDIHYDROCERAMIDES BIOSYNTHESIZED BY MAMMALIAN CELL LINES AND ANIMALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISRUPTED SPHINGOLIPID METABOLISM; RENAL EPITHELIAL-CELLS; SERINE PALMITOYLTRANSFERASE; MASS-SPECTROMETRY; CYTOTOXICITY; SPHINGANINE; APOPTOSIS; LLC-PK1; KIDNEY; PURIFICATION	Fumonisin B-1 (FB1) is a mycotoxin that inhibits ceramide synthases (CerS) and causes kidney and liver toxicity and other disease. Inhibition of CerS by FB1 increases sphinganine (Sa), Sa 1-phosphate, and a previously unidentified metabolite. Analysis of the latter by quadrupole-time-of-flight mass spectrometry assigned an m/z = 286.3123 in positive ionization mode, consistent with the molecular formula for deoxysphinganine (C18H40NO). Comparison with a synthetic standard using liquid chromatography, electrospray tandem mass spectrometry identified the metabolite as 1-deoxysphinganine (1-deoxySa) based on LC mobility and production of a distinctive fragment ion (m/z 44, CH3CH = NH2+) upon collision-induced dissociation. This novel sphingoid base arises from condensation of alanine with palmitoyl-CoA via serine palmitoyltransferase (SPT), as indicated by incorporation of L-[U-C-13] alanine into 1-deoxySa by Vero cells; inhibition of its production in LLC-PK1 cells by myriocin, an SPT inhibitor; and the absence of incorporation of [U-C-13] palmitate into 1-[C-13] deoxySa in LY-B cells, which lack SPT activity. LY-B-LCB1 cells, in which SPT has been restored by stable transfection, however, produce large amounts of 1-[C-13] deoxySa. 1-DeoxySa was elevated in FB1-treated cells and mouse liver and kidney, and its cytotoxicity was greater than or equal to that of Sa for LLC-PK1 and DU-145 cells. Therefore, this compound is likely to contribute to pathologies associated with fumonisins. In the absence of FB1, substantial amounts of 1-deoxySa are made and acylated to N-acyl-1-deoxySa (i.e. 1-deoxydihydroceramides). Thus, these compounds are an underappreciated category of bioactive sphingoid bases and "ceramides" that might play important roles in cell regulation.	[Zitomer, Nicholas C.; Mitchell, Trevor; Voss, Kenneth A.; Riley, Ronald T.] USDA ARS, Toxicol & Mycotoxin Res Unit, Athens, GA 30604 USA; [Bondy, Genevieve S.] Hlth Canada, Food Directorate, Hlth Prod & Food Branch, Ottawa, ON K1A 0L2, Canada; [Pruett, Sarah T.] Emory Univ, Biomarkers Core Lab, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Garnier-Amblard, Ethel C.; Liebeskind, Lanny S.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Park, Hyejung; Wang, Elaine; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Dept Chem, Atlanta, GA 30332 USA	United States Department of Agriculture (USDA); Health Canada; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Riley, RT (corresponding author), USDA ARS, Toxicol & Mycotoxin Res Unit, POB 5677, Athens, GA 30604 USA.	ron.riley@ars.usda.gov	Pruett, Sarah/C-7433-2009	Zitomer, Nicholas/0000-0002-3900-4282; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [GM76217, GM69338, GM066153]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, R01GM066153, R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM76217 and GM69338 (LIPID MAPS) (to A. H. M., H. P., and M. C. S.) and GM066153 (to E. C. G.- A. and L. S. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Delongchamp RR, 2001, FOOD ADDIT CONTAM, V18, P255, DOI 10.1080/02652030118953; Enongene EN, 2002, TOXICOL SCI, V67, P173, DOI 10.1093/toxsci/67.2.173; Fyrst H, 2008, BBA-MOL CELL BIOL L, V1781, P448, DOI 10.1016/j.bbalip.2008.05.005; GELDERBLOM WCA, 1994, CARCINOGENESIS, V15, P209, DOI 10.1093/carcin/15.2.209; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; He QR, 2002, PHARMACOL TOXICOL, V90, P268, DOI 10.1034/j.1600-0773.2002.900507.x; Hornemann T, 2008, CHEM PHYS LIPIDS, V154, pS62, DOI 10.1016/j.chemphyslip.2008.05.170; Humpf HU, 1998, J BIOL CHEM, V273, P19060, DOI 10.1074/jbc.273.30.19060; Kim MS, 2001, TOXICOL APPL PHARM, V176, P118, DOI 10.1006/taap.2001.9188; Lanny HY, 2007, ORG LETT, V9, P2993, DOI 10.1021/ol070991m; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marasas WFO, 2004, J NUTR, V134, P711, DOI 10.1093/jn/134.4.711; Marasas WFO, 2001, ENVIRON HEALTH PERSP, V109, P239, DOI 10.2307/3435014; Meredith FI, 1996, J AGR FOOD CHEM, V44, P195, DOI 10.1021/jf950294l; Merrill AH, 2001, ENVIRON HEALTH PERSP, V109, P283, DOI 10.2307/3435020; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; National cholesterol education program National heart lung and blood institute National institutes of health, 2002, 3 REP NAT CHOL ED PR; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Quesney S, 2003, CYTOTECHNOLOGY, V42, P1, DOI 10.1023/A:1026185615650; Riley RT, 2006, TOXICOL SCI, V92, P335, DOI 10.1093/toxsci/kfj198; Riley RT, 1999, NAT TOXINS, V7, P407, DOI 10.1002/1522-7189(199911/12)7:6<407::AID-NT84>3.0.CO;2-0; Riley RT, 2001, ENVIRON HEALTH PERSP, V109, P301, DOI 10.2307/3435022; Riley RT, 1999, ENVIRON TOXICOL PHAR, V7, P109, DOI 10.1016/S1382-6689(98)00047-7; Riley RT, 1998, REV MED VET-TOULOUSE, V149, P617; Riley RT, 2000, METHOD ENZYMOL, V311, P348; Sanchez AM, 2008, EUR J PHARMACOL, V584, P237, DOI 10.1016/j.ejphar.2008.02.011; Schmelz EM, 1998, TOXICOL APPL PHARM, V148, P252, DOI 10.1006/taap.1997.8356; SCHROEDER JJ, 1994, J BIOL CHEM, V269, P3475; STEVENS VL, 1990, BIOCHIM BIOPHYS ACTA, V1051, P37, DOI 10.1016/0167-4889(90)90171-9; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Tolleson WH, 1999, INT J ONCOL, V14, P833; Tsunoda M, 1998, J BIOCHEM MOL TOXIC, V12, P281, DOI 10.1002/(SICI)1099-0461(1998)12:5<281::AID-JBT4>3.0.CO;2-H; Urs AN, 2007, MOL CELL ENDOCRINOL, V265, P174, DOI 10.1016/j.mce.2006.12.016; Voss KA, 2001, ENVIRON HEALTH PERSP, V109, P259, DOI 10.2307/3435017; WANG E, 1991, J BIOL CHEM, V266, P14486; YOO HS, 1992, TOXICOL APPL PHARM, V114, P9, DOI 10.1016/0041-008X(92)90090-F; Yoo HS, 1996, TOXICOL APPL PHARM, V138, P211, DOI 10.1006/taap.1996.0119; Yu CH, 2001, ARCH PHARM RES, V24, P136, DOI 10.1007/BF02976481; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zitomer NC, 2008, ANAL BIOANAL CHEM, V391, P2257, DOI 10.1007/s00216-008-2166-x	42	153	158	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4786	4795		10.1074/jbc.M808798200	http://dx.doi.org/10.1074/jbc.M808798200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095642	Green Published, hybrid			2022-12-27	WOS:000263416600006
J	Leferink, NGH; Fraaije, MW; Joosten, HJ; Schaap, PJ; Mattevi, A; van Berkel, WJH				Leferink, Nicole G. H.; Fraaije, Marco W.; Joosten, Henk-Jan; Schaap, Peter J.; Mattevi, Andrea; van Berkel, Willem J. H.			Identification of a Gatekeeper Residue That Prevents Dehydrogenases from Acting as Oxidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-LACTONE DEHYDROGENASE; MONOMERIC SARCOSINE OXIDASE; L-GALACTONO-1,4-LACTONE DEHYDROGENASE; OXYGEN REACTIVITY; ENZYME; PLANT; SITE; BINDING; ACTIVATION; DISCOVERY	The oxygen reactivity of flavoproteins is poorly understood. Here we show that a single Ala to Gly substitution in L-galactono-gamma-lactone dehydrogenase (GALDH) turns the enzyme into a catalytically competent oxidase. GALDH is an aldonolactone oxidoreductase with a vanillyl-alcohol oxidase (VAO) fold. We found that nearly all oxidases in the VAO family contain either a Gly or a Pro at a structurally conserved position near the C4a locus of the isoalloxazine moiety of the flavin, whereas dehydrogenases prefer another residue at this position. Mutation of the corresponding residue in GALDH (Ala-133 -> Gly) resulted in a striking 400-fold increase in oxygen reactivity, whereas the cytochrome c reductase activity is retained. The activity of the A113G variant shows a linear dependence on oxygen concentration (k(ox) = 3.5 x 10(5) M-1 s(-1)), similar to most other flavoprotein oxidases. The Ala-133 -> Gly replacement does not change the reduction potential of the flavin but creates space for molecular oxygen to react with the reduced flavin. In the wild-type enzyme, Ala-113 acts as a gatekeeper, preventing oxygen from accessing the isoalloxazine nucleus. The presence of such an oxygen access gate seems to be a key factor for the prevention of oxidase activity within the VAO family and is absent in members that act as oxidases.	[Leferink, Nicole G. H.; van Berkel, Willem J. H.] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands; [Fraaije, Marco W.] Univ Groningen, Biomol Sci & Biotechnol Inst, Biochem Lab, NL-9747 AG Groningen, Netherlands; [Joosten, Henk-Jan; Schaap, Peter J.] Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Mattevi, Andrea] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy	Wageningen University & Research; University of Groningen; Wageningen University & Research; University of Pavia	van Berkel, WJH (corresponding author), Wageningen Univ, Biochem Lab, Dreijenlaan 3, NL-6703 HA Wageningen, Netherlands.	willem.vanberkel@wur.nl	Leferink, Nicole G H/I-6867-2012; Leferink, Nicole/C-6273-2011; Fraaije, Marco/E-8421-2014; mattevi, andrea/K-5464-2012; Mattevi, Andrea/R-4469-2019; van Berkel, Willem J.H./O-2431-2014	Leferink, Nicole G H/0000-0003-4134-4339; mattevi, andrea/0000-0002-9523-7128; Mattevi, Andrea/0000-0002-9523-7128; van Berkel, Willem J.H./0000-0002-6551-2782; Fraaije, Marco/0000-0001-6346-5014; Schaap, Peter/0000-0002-4346-6084	Carbohydrate Research Centre Wageningen	Carbohydrate Research Centre Wageningen	This work was supported by a grant from the Carbohydrate Research Centre Wageningen.	Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; Arent S, 2008, PLANT PHYSIOL BIOCH, V46, P292, DOI 10.1016/j.plaphy.2007.12.014; Chen L, 2008, BIOCHEMISTRY-US, V47, P5368, DOI 10.1021/bi800228w; Coulombe R, 2001, J BIOL CHEM, V276, P30435, DOI 10.1074/jbc.M104103200; Dewanti AR, 2004, BIOCHEMISTRY-US, V43, P10692, DOI 10.1021/bi049005p; Forneris F, 2008, BIOCHEMISTRY-US, V47, P978, DOI 10.1021/bi701886t; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; Fraaije MW, 1998, TRENDS BIOCHEM SCI, V23, P206, DOI 10.1016/S0968-0004(98)01210-9; Frebortova J, 2004, BIOCHEM J, V380, P121, DOI 10.1042/BJ20031813; Heuts DPHM, 2007, J BIOL CHEM, V282, P20283, DOI 10.1074/jbc.M610849200; Huh WK, 1998, MOL MICROBIOL, V30, P895, DOI 10.1046/j.1365-2958.1998.01133.x; Jin JF, 2007, FEBS J, V274, P2311, DOI 10.1111/j.1742-4658.2007.05767.x; Joosten HJ, 2008, PROTEINS, V70, P157, DOI 10.1002/prot.21622; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEFERINK NGH, 2008, FLAVINS FLAVOPROTEIN, P75; Leferink NGH, 2008, ARCH BIOCHEM BIOPHYS, V474, P292, DOI 10.1016/j.abb.2008.01.027; Leferink NGH, 2008, FEBS J, V275, P713, DOI 10.1111/j.1742-4658.2007.06233.x; Mackenzie J, 2006, J BIOL CHEM, V281, P31012, DOI 10.1074/jbc.M603405200; Massey V, 1990, FLAVINS FLAVOPROTEIN, P59; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; Navrot N, 2007, PHYSIOL PLANTARUM, V129, P185, DOI 10.1111/j.1399-3054.2006.00777.x; Nishikimi M, 1979, Methods Enzymol, V62, P24; Noctor G, 2007, TRENDS PLANT SCI, V12, P125, DOI 10.1016/j.tplants.2007.01.005; OBA K, 1995, J BIOCHEM, V117, P120, DOI 10.1093/oxfordjournals.jbchem.a124697; Pineau B, 2008, J BIOL CHEM, V283, P32500, DOI 10.1074/jbc.M805320200; Piubelli L, 2008, J BIOL CHEM, V283, P24738, DOI 10.1074/jbc.M802321200; POLLEGIONI L, 2008, FLAVINS FLAVOPROTEIN, P497; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; STANKOVICH MT, 1991, CHEM BIOCH FLAVOENZY, P401; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; Sun WM, 1996, J BIOL CHEM, V271, P17226, DOI 10.1074/jbc.271.29.17226; Trickey P, 1999, STRUCTURE, V7, P331, DOI 10.1016/S0969-2126(99)80043-4; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van Berkel WJH, 1999, METH MOL B, V131, P61; Winkler A, 2007, J BIOL CHEM, V282, P24437, DOI 10.1074/jbc.M703642200; WINTER RT, 2008, FLAVINS FLAVOPROTEIN, P237; Zeng J, 2007, BBA-PROTEINS PROTEOM, V1774, P1628, DOI 10.1016/j.bbapap.2007.08.018; Zhao GH, 2008, BIOCHEMISTRY-US, V47, P9124, DOI 10.1021/bi8008642	40	73	73	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4392	4397		10.1074/jbc.M808202200	http://dx.doi.org/10.1074/jbc.M808202200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088070	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000263134400038
J	Minhajuddin, M; Bijli, KM; Fazal, F; Sassano, A; Nakayama, KI; Hay, N; Platanias, LC; Rahman, A				Minhajuddin, Mohd; Bijli, Kaiser M.; Fazal, Fabeha; Sassano, Antonella; Nakayama, Keiichi I.; Hay, Nissim; Platanias, Leonidas C.; Rahman, Arshad			Protein Kinase C-delta and Phosphatidylinositol 3-Kinase/Akt Activate Mammalian Target of Rapamycin to Modulate NF-kappa B Activation and Intercellular Adhesion Molecule-1 (ICAM-1) Expression in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; MICE LACKING; PHOSPHATASE 2A; PHOSPHORYLATION; MTOR; AKT; COMPLEX; ISOFORMS; SIGNALS; PATHWAY	We have shown that the mammalian target of rapamycin (mTOR) down-regulates thrombin-induced ICAM-1 expression in endothelial cells by suppressing the activation of NF-kappa B. However, the mechanisms by which mTOR is activated to modulate these responses remain to be addressed. Here, we show that thrombin engages protein kinase C (PKC)-delta and phosphattidylinositol 3-kinase (PI3K)/Akt pathways to activate mTOR and thereby dampens NF-kappa B activation and intercellular adhesion molecule 1 (ICAM-1) expression. Stimulation of human vascular endothelial cells with thrombin induced the phosphorylation of mTOR and its downstream target p70 S6 kinase in a PKC-delta- and PI3K/Akt-dependent manner. Consistent with this, thrombin-induced phosphorylation of p70 S6 kinase was defective in embryonic fibroblasts from mice with targeted disruption of PKC-delta (Pkc-delta(-/-)), p85 alpha and p85 beta subunits of the PI3K (p85 alpha(-/-)beta(-/-)), or Akt1 and Akt2 (Akt1(-/-)2(-/-)). Furthermore, we observed that expression of the constitutively active form of PKC-delta or Akt was sufficient to induce NF-kappa B activation and ICAM-1 expression, and that co-expression of mTOR suppressed these responses. In reciprocal experiments, inhibition/depletion of mTOR augmented NF-kappa B activation and ICAM-1 expression induced by PKC-delta or Akt. In control experiments, increasing or impairing mTOR signaling by the above approaches produced similar effects on NF-kappa B activation and ICAM-1 expression induced by thrombin. Thus, these data reveal an important role of PKC-delta and PI3K/Akt pathways in activating mTOR as an endogenous modulator to ensure a tight regulation of NF-kappa B signaling of ICAM-1 expression in endothelial cells.	[Minhajuddin, Mohd; Bijli, Kaiser M.; Fazal, Fabeha; Rahman, Arshad] Univ Rochester, Sch Med & Dent, Lung Biol & Dis Program, Dept Pediat Neonatol, Rochester, NY 14642 USA; [Sassano, Antonella; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Hay, Nissim] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA	University of Rochester; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Kyushu University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rahman, A (corresponding author), Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	Arshad_Rahman@urmc.rochester.edu			National Institutes of Health [CA77816, CA121192, CA100579]; NHLBI [HL67424]; NIEHSC [ES-01247]; American Lung Association; NATIONAL CANCER INSTITUTE [R01CA100579, R01CA077816, R01CA121192] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHSC; American Lung Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77816, CA121192, and CA100579 ( to L. C. P.), NHLBI Grant HL67424 ( to A. R.), and NIEHSC Grant ES-01247. This work was also supported by a Biomedical Research grant from the American Lung Association ( to F. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be here by marked" advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Aird WC, 2005, CRIT CARE CLIN, V21, P417, DOI 10.1016/j.ccc.2005.04.004; Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bijli KM, 2007, AM J PHYSIOL-LUNG C, V292, pL396, DOI 10.1152/ajplung.00163.2006; Brachmann SA, 2005, MOL CELL BIOL, V25, P2593, DOI 10.1128/MCB.25.7.2593-2606.2005; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Dan HC, 2008, J IMMUNOL, V180, P7582, DOI 10.4049/jimmunol.180.11.7582; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; DICKNEITE G, 1993, THROMB HAEMOSTASIS, V69, P98; Doerschuk CM, 2000, AM J RESP CELL MOL, V23, P133, DOI 10.1165/ajrcmb.23.2.f193; Fenton J W 2nd, 1981, Ann N Y Acad Sci, V370, P468, DOI 10.1111/j.1749-6632.1981.tb29757.x; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang SL, 2004, J BIOL CHEM, V279, P36490, DOI 10.1074/jbc.M401208200; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kumar V, 2000, EMBO J, V19, P1087, DOI 10.1093/emboj/19.5.1087; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mingo-Sion AM, 2005, BREAST CANCER RES TR, V91, P259, DOI 10.1007/s10549-005-0669-0; Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Nien WL, 2007, MOL CELL ENDOCRINOL, V263, P10, DOI 10.1016/j.mce.2006.08.015; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Pons S, 2000, J BIOL CHEM, V275, P38620, DOI 10.1074/jbc.M004531200; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Rahman A, 1999, J IMMUNOL, V162, P5466; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Song JS, 1998, ONCOGENE, V16, P3357, DOI 10.1038/sj.onc.1201886; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355	53	60	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4052	4061		10.1074/jbc.M805032200	http://dx.doi.org/10.1074/jbc.M805032200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074768	Green Published, hybrid			2022-12-27	WOS:000263134400003
J	Vempati, UD; Han, XL; Moraes, CT				Vempati, Uma D.; Han, Xianlin; Moraes, Carlos T.			Lack of Cytochrome c in Mouse Fibroblasts Disrupts Assembly/Stability of Respiratory Complexes I and IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN MITOCHONDRIA; SHOTGUN LIPIDOMICS; YEAST MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; SEQUENTIAL STABILIZATION; SACCHAROMYCES-CEREVISIAE; BIOLOGICAL SAMPLES; HEME-A; MEMBRANE; OXIDASE	Cytochrome c (cyt c) is a heme-containing protein that participates in electron transport in the respiratory chain and as a signaling molecule in the apoptotic cascade. Here we addressed the effect of removing mammalian cyt c on the integrity of the respiratory complexes in mammalian cells. Mitochondria from cyt c knockout mouse cells lacked fully assembled complexes I and IV and had reduced levels of complex III. A redox-deficient mutant of cyt c was unable to rescue the levels of complexes I and IV. We found that cyt c is associated with both complex IV and respiratory supercomplexes, providing a potential mechanism for the requirement for cyt c in the assembly/stability of complex IV.	[Vempati, Uma D.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Vempati, Uma D.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Han, Xianlin] Washington Univ, Dept Internal Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA	University of Miami; University of Miami; Washington University (WUSTL)	Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1095 NW,14th Terrace, Miami, FL 33136 USA.	cmoraes@med.miami.edu	Moraes, Carlos/AAT-3818-2021		National Institutes of Health [R01-CA85700, R01-NS41777]; NATIONAL CANCER INSTITUTE [R01CA085700] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010804] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA85700 and R01-NS41777 (to C. T. M.) and P01 HL57278 (to X. H.).	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210; Barrientos A, 2003, J BIOL CHEM, V278, P8881, DOI 10.1074/jbc.M212427200; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Bernard DG, 2003, J BIOL CHEM, V278, P49732, DOI 10.1074/jbc.M308881200; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Cheng H, 2008, BIOCHEMISTRY-US, V47, P5869, DOI 10.1021/bi7023282; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Diekert K, 2001, EMBO J, V20, P5626, DOI 10.1093/emboj/20.20.5626; DOWNIE JA, 1977, J MOL BIOL, V113, P369, DOI 10.1016/0022-2836(77)90147-4; DUMONT ME, 1991, MOL CELL BIOL, V11, P5487, DOI 10.1128/MCB.11.11.5487; DUTTA C, 1990, ANAL BIOCHEM, V184, P96, DOI 10.1016/0003-2697(90)90018-5; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Gottlieb RA, 2000, METHOD ENZYMOL, V322, P213; Han XL, 2006, J LIPID RES, V47, P864, DOI 10.1194/jlr.D500044-JLR200; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Krishna MMG, 2006, J MOL BIOL, V359, P1410, DOI 10.1016/j.jmb.2006.04.035; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Maity H, 2004, J MOL BIOL, V343, P223, DOI 10.1016/j.jmb.2004.08.005; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Mayer A, 1995, METHOD ENZYMOL, V260, P252, DOI 10.1016/0076-6879(95)60143-0; Moraes CT, 2004, BBA-BIOENERGETICS, V1659, P153, DOI 10.1016/j.bbabio.2004.09.002; PEARCE DA, 1995, J BIOL CHEM, V270, P20879, DOI 10.1074/jbc.270.36.20879; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Plant GW, 2002, J NEUROSCI, V22, P6083; Robinson BH, 2000, PEDIATR RES, V48, P581, DOI 10.1203/00006450-200011000-00004; Rumbley J, 2001, P NATL ACAD SCI USA, V98, P105, DOI 10.1073/pnas.98.1.105; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHWEINGRUBER ME, 1979, J BIOL CHEM, V254, P4132; Vempati UD, 2007, MOL CELL BIOL, V27, P1771, DOI 10.1128/MCB.00287-06; Zhao M, 1998, J BIOL CHEM, V273, P2402, DOI 10.1074/jbc.273.4.2402	37	56	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4383	4391		10.1074/jbc.M805972200	http://dx.doi.org/10.1074/jbc.M805972200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19075019	hybrid, Green Published			2022-12-27	WOS:000263134400037
J	Venza, I; Cucinotta, M; Visalli, M; De Grazia, G; Oliva, S; Teti, D				Venza, Isabella; Cucinotta, Maria; Visalli, Maria; De Grazia, Giuseppina; Oliva, Sabrina; Teti, Diana			Pseudomonas aeruginosa Induces Interleukin-8 (IL-8) Gene Expression in Human Conjunctiva through the Recruitment of Both RelA and CCAAT/Enhancer-binding Protein beta to the IL-8 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CORNEAL EPITHELIAL-CELLS; CYSTIC-FIBROSIS; TRANSCRIPTION; ACTIVATION; INFECTION; CYTOKINES; RESPONSES; ALPHA; MITOCHONDRIA	The purpose of this study was to identify the Pseudomonas aeruginosa-activated signaling pathway leading to interleukin (IL)-8 gene expression and protein synthesis by human conjunctival epithelium. IL-8 protein and mRNA were determined by enzyme-linked immunosorbent assay and reverse transcription-PCR, respectively. Activation of MAPKs and NF-kappa B was analyzed by Western blotting using phosphospecific antibodies. We used transfection with wild-type or mutated IL-8 promoters and cotransfection with transcription factor overexpressing plasmids or small interfering RNAs. Electrophoretic mobility shift assay and chromatin immunoprecipitation (ChIP) were performed for in vitro and in vivo protein-DNA binding studies, respectively. P. aeruginosa increased IL-8 expression at the transcriptional level by phosphorylating CCAAT/enhancer-binding protein beta (C/EBP beta) via p38MAPK and activating NF-kappa B. The simultaneous involvement of RelA and C/EBP beta and the integrity of the corresponding consensus sites were required, whereas c-Jun was involved only in basal IL-8 expression. Re-ChIP experiments showed that RelA and C/EBP beta act together at the IL-8 promoter level upon P. aeruginosa infection. Taken together, our results suggest that P. aeruginosa induces IL-8 promoter expression and protein production in conjunctival epithelial cells by activating RelA and C/EBP beta and by promoting the cooperative binding of these transcription factors to the IL-8 promoter that in turn activates transcription.	[Venza, Isabella] Univ Messina, Dept Surg Specialties, I-98125 Messina, Italy; [Cucinotta, Maria; Visalli, Maria; De Grazia, Giuseppina; Oliva, Sabrina; Teti, Diana] Univ Messina, Dept Expt Pathol & Microbiol, I-98125 Messina, Italy	University of Messina; University of Messina	Teti, D (corresponding author), Azienda Osped Univ, Dept Expt Pathol & Microbiol, Via Consolare Valeria 1, I-98125 Messina, Italy.	dteti@unime.it	Oliva, Sabrina/G-6809-2012	Oliva, Sabrina/0000-0002-0111-8276				Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barie, 2000, Am J Surg, V179, P2, DOI 10.1016/S0002-9610(00)00316-0; BAUM J, 1995, CLIN INFECT DIS, V21, P479, DOI 10.1093/clinids/21.3.479; Brito D. V. D., 2003, Braz J Infect Dis, V7, P234, DOI 10.1590/S1413-86702003000400001; Caristi S, 2005, J BIOL CHEM, V280, P14433, DOI 10.1074/jbc.M410725200; Delgado MA, 2006, INFECT IMMUN, V74, P2975, DOI 10.1128/IAI.74.5.2975-2984.2006; Eifrig CWG, 2003, OPHTHALMOLOGY, V110, P1714, DOI 10.1016/S0161-6420(03)00572-4; Epelman S, 2000, INFECT IMMUN, V68, P4811, DOI 10.1128/IAI.68.8.4811-4814.2000; Foca M, 2000, NEW ENGL J MED, V343, P695, DOI 10.1056/NEJM200009073431004; Gaili H, 2002, ARCH DIS CHILD-FETAL, V86, P204; Garg P, 1999, OPHTHALMOLOGY, V106, P1319, DOI 10.1016/S0161-6420(99)00717-4; Giagounidis AAN, 1997, ANN HEMATOL, V75, P121, DOI 10.1007/s002770050325; Hybiske K, 2004, CELL MICROBIOL, V6, P49, DOI 10.1046/j.1462-5822.2003.00342.x; Jendrossek V, 2001, INFECT IMMUN, V69, P2675, DOI 10.1128/IAI.69.4.2675-2683.2001; Joseph T, 2005, AM J PHYSIOL-LUNG C, V288, pL471, DOI 10.1152/ajplung.00066.2004; Kenzel S, 2006, J IMMUNOL, V176, P3181, DOI 10.4049/jimmunol.176.5.3181; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; KING S, 1998, INFECT CONT HOSP EP, V9, P77; Kojima K, 2008, BRIT J OPHTHALMOL, V92, P411, DOI 10.1136/bjo.2007.128322; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; KUNSCH C, 1994, J IMMUNOL, V153, P153; Lambertini E, 2008, J CELL PHYSIOL, V216, P101, DOI 10.1002/jcp.21379; Lang R, 2003, INVEST OPHTH VIS SCI, V44, P99, DOI 10.1167/iovs.02-0357; Li J, 2007, MOL VIS, V13, P813; Mancuso G, 2002, J IMMUNOL, V169, P1401, DOI 10.4049/jimmunol.169.3.1401; Matsumoto K, 2005, CORNEA, V24, pS43, DOI 10.1097/01.ico.0000178737.35297.d4; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Mori N, 1999, INFECT IMMUN, V67, P3872, DOI 10.1128/IAI.67.8.3872-3878.1999; Mukerjee R, 2007, J CELL BIOCHEM, V100, P1210, DOI 10.1002/jcb.21109; Narayanan S, 2003, INVEST OPHTH VIS SCI, V44, P3795, DOI 10.1167/iovs.02-1301; Oka M, 2006, BRIT J OPHTHALMOL, V90, P612, DOI 10.1136/bjo.2005.084525; Pruitt BA, 1998, WORLD J SURG, V22, P135; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Rudner XL, 2000, J IMMUNOL, V164, P6576, DOI 10.4049/jimmunol.164.12.6576; Ruocco MR, 1996, J BIOL CHEM, V271, P22479, DOI 10.1074/jbc.271.37.22479; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; Sawa T, 1997, J IMMUNOL, V159, P2858; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; Shah S S, 1999, J Perinatol, V19, P462, DOI 10.1038/sj.jp.7200247; Shah SS, 1998, PEDIATR INFECT DIS J, V17, P97, DOI 10.1097/00006454-199802000-00004; Smit EE, 2003, CORNEA, V22, P332, DOI 10.1097/00003226-200305000-00010; Smulders C, 1999, NETH J MED, V55, P106, DOI 10.1016/S0300-2977(99)00037-6; Talreja J, 2005, INFLAMMATION, V29, P170, DOI 10.1007/s10753-006-9014-y; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tuft SJ, 2000, BRIT J OPHTHALMOL, V84, P687, DOI 10.1136/bjo.84.7.687; van den Berg A, 2005, AM J RESP CELL MOL, V33, P97, DOI 10.1165/rcmb.2005-0022OC; Venza I, 2007, INVEST OPHTH VIS SCI, V48, P270, DOI 10.1167/iovs.06-0081; Wu Q, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-26; Xue ML, 2001, CLIN EXP OPHTHALMOL, V29, P171, DOI 10.1046/j.1442-9071.2001.00410.x; Yu YM, 2003, AM J PHYSIOL-GASTR L, V285, pG282, DOI 10.1152/ajpgi.00503.2002; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; Zhang J, 2005, CURR EYE RES, V30, P527, DOI 10.1080/02713680590968150	53	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4191	4199		10.1074/jbc.M805429200	http://dx.doi.org/10.1074/jbc.M805429200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19064995	hybrid			2022-12-27	WOS:000263134400016
J	Hamiaux, C; Stanley, D; Greenwood, DR; Baker, EN; Newcomb, RD				Hamiaux, Cyril; Stanley, Duncan; Greenwood, Dave R.; Baker, Edward N.; Newcomb, Richard D.			Crystal Structure of Epiphyas postvittana Takeout 1 with Bound Ubiquinone Supports a Role as Ligand Carriers for Takeout Proteins in Insects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-BINDING-PROTEIN; JUVENILE-HORMONE; MANDUCA-SEXTA; MACROMOLECULAR STRUCTURES; FEEDING-BEHAVIOR; GENE; DROSOPHILA; IDENTIFICATION; EXPRESSION; GENOMICS	Takeout (To) proteins are found exclusively in insects and have been proposed to have important roles in various aspects of their physiology and behavior. Limited sequence similarity with juvenile hormone-binding proteins (JHBPs), which specifically bind and transport juvenile hormones in Lepidoptera, suggested a role for To proteins in binding hydrophobic ligands. We present the first crystal structure of a To protein, EpTo1 from the light brown apple moth Epiphyas postvittana, solved in-house by the single-wavelength anomalous diffraction technique using sulfur anomalous dispersion, and refined to 1.3 angstrom resolution. EpTo1 adopts the unusual alpha/beta-wrap fold, seen only for JHBP and several mammalian lipid carrier proteins, a scaffold tailored for the binding and/or transport of hydrophobic ligands. EpTo1 has a 45 angstrom long, purely hydrophobic, internal tunnel that extends for the full length of the protein and accommodates a bound ligand. The latter was shown by mass spectrometry to be ubiquinone-8 and is probably derived from Escherichia coli. The structure provides the first direct experimental evidence that To proteins are ligand carriers; gives insights into the nature of endogenous ligand(s) of EpTo1; shows, by comparison with JHBP, a basis for different ligand specificities; and suggests a mechanism for the binding/release of ligands.	[Hamiaux, Cyril; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Struct Biol Lab, Auckland 1142, New Zealand; [Hamiaux, Cyril; Stanley, Duncan; Greenwood, Dave R.; Newcomb, Richard D.] Hort & Food Res Inst New Zealand Ltd, Auckland 1142, New Zealand	University of Auckland; New Zealand Institute for Plant & Food Research Ltd	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Struct Biol Lab, Private Bag 92019, Auckland 1142, New Zealand.	en.baker@auckland.ac.nz; rnewcomb@hortresearch.co.nz	Greenwood, David R/D-2375-2016; Hamiaux, Cyril/U-9978-2017; Newcomb, Richard/C-2067-2009	Greenwood, David R/0000-0001-5280-042X; Hamiaux, Cyril/0000-0001-9198-3441; Newcomb, Richard/0000-0002-7307-9755; Baker, Edward/0000-0003-2456-7661	New Zealand's Foundation for Research Science and Technology [UOAX0301, CO6X0301]	New Zealand's Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology)	This work was supported by New Zealand's Foundation for Research Science and Technology (contract IDs UOAX0301 and CO6X0301). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Charles JP, 1996, ARCH INSECT BIOCHEM, V31, P371, DOI 10.1002/(SICI)1520-6327(1996)31:4&lt;371::AID-ARCH2&gt;3.0.CO;2-Z; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Du JG, 2003, INSECT BIOCHEM MOLEC, V33, P803, DOI 10.1016/S0965-1748(03)00079-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fujikawa K, 2006, FEBS J, V273, P4311, DOI 10.1111/j.1742-4658.2006.05422.x; Gao MC, 2004, J BASIC MICROB, V44, P424, DOI 10.1002/jobm.200410436; Hagai T, 2007, INSECT BIOCHEM MOLEC, V37, P689, DOI 10.1016/j.ibmb.2007.04.002; Hojo M, 2005, INSECT BIOCHEM MOLEC, V35, P347, DOI 10.1016/j.ibmb.2005.01.007; Jordan MD, 2008, INSECT MOL BIOL, V17, P361, DOI 10.1111/j.1365-2583.2008.00812.x; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kolodziejczyk R, 2008, J MOL BIOL, V377, P870, DOI 10.1016/j.jmb.2008.01.026; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li H, 1998, INSECT BIOCHEM MOLEC, V28, P69, DOI 10.1016/S0965-1748(97)00098-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Noriega FG, 2006, INSECT BIOCHEM MOLEC, V36, P366, DOI 10.1016/j.ibmb.2006.01.013; PALLI SR, 1994, P NATL ACAD SCI USA, V91, P6191, DOI 10.1073/pnas.91.13.6191; Papanicolaou A, 2008, NUCLEIC ACIDS RES, V36, pD582, DOI 10.1093/nar/gkm853; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Saito K, 2006, INSECT MOL BIOL, V15, P245, DOI 10.1111/j.1365-2583.2006.00612.x; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Zhu HS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001345	34	38	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3496	3503		10.1074/jbc.M807467200	http://dx.doi.org/10.1074/jbc.M807467200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073605	hybrid			2022-12-27	WOS:000262872500016
J	Liu, Y; Hao, WL; Dawson, A; Liu, SR; Fassbender, K				Liu, Yang; Hao, Wenlin; Dawson, Alik; Liu, Shirong; Fassbender, Klaus			Expression of Amyotrophic Lateral Sclerosis-linked SOD1 Mutant Increases the Neurotoxic Potential of Microglia via TLR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DEGENERATION; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-4; MOUSE MODEL; OXIDATIVE STRESS; EXTEND SURVIVAL; NADPH OXIDASE; DISMUTASE; ACTIVATION; CELLS	Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease, in which activated microglia overexpressing ALS-linked SOD1 mutants (mSOD1) are known to contribute to neuronal death. However, it is unclear how mSOD1 expression affects micoglial activation and subsequently damages neurons. In this study, we created mSOD1-overexpressing BV-2 microglial cell lines. Following TLR2, but not TLR4 stimulation, we observed that overexpression of human SOD1 G93A, L8Q, or G10V mutant, as compared with the wild-type SOD1 or a mock control, significantly enhanced microglial secretion of a neurotoxic cytokine, tumor necrosis factor-alpha (TNF-alpha), which was dependent on the NADPH-oxidase-mediated increased generation of reactive oxygen species (ROS). In further experiments, we demonstrated that mSOD1 expression regulated TNF-alpha secretion at a post-transcriptional level and involved ROS-sensitive TNF-alpha-converting enzymes, e. g. ADAM10 and -17, which shed TNF-alpha from its membrane-anchored precursor. Together with a recent report that the function of SOD1, as a self-regulating redox sensor in NADPH oxidase-dependent ROS production, is lost due to its genetic mutations, we conclude that mSOD1 expression in ALS facilitates microglial neurotoxic inflammatory responses via TLR2, which is mediated by an uncontrolled ROS generation. The link, between mSOD1, innate immunity and NADPH oxidase, offers new opportunities in ALS therapies.	[Liu, Yang; Hao, Wenlin; Dawson, Alik; Liu, Shirong; Fassbender, Klaus] Univ Saarland, Dept Neurol, D-66421 Homburg, Germany	Saarland University	Liu, Y (corresponding author), Univ Saarland, Dept Neurol, Kirrberger Str, D-66421 Homburg, Germany.	a.liu@mx.uni-saarland.de	Liu, Yang/GSD-5476-2022; Liu, Shirong/AAB-7300-2021	Liu, Shirong/0000-0002-3821-9134; Fassbender, Klaus/0000-0003-3596-868X; , Shirong/0000-0001-9475-6236; Liu, Yang/0000-0002-7614-4233	Fritz Thyssen Stiftung; Homburger Forschungsforderungsprogramm [HOMFOR2008]; Forschungspreis2007 der Freunde des Universitatsklinikums des Saarlandes	Fritz Thyssen Stiftung; Homburger Forschungsforderungsprogramm; Forschungspreis2007 der Freunde des Universitatsklinikums des Saarlandes	This work was supported by Fritz Thyssen Stiftung (to Y. L. and K. F.), Homburger Forschungsforderungsprogramm (HOMFOR2008) (to Y. L.), and Forschungspreis2007 der Freunde des Universitatsklinikums des Saarlandes (to Y. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ascherio A, 2005, ANN NEUROL, V57, P104, DOI 10.1002/ana.20316; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bigini P, 2008, NEUROBIOL DIS, V29, P465, DOI 10.1016/j.nbd.2007.11.005; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Fassbender K, 2004, FASEB J, V18, P203, DOI 10.1096/fj.03-0364fje; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Gowing G, 2008, J NEUROSCI, V28, P10234, DOI 10.1523/JNEUROSCI.3494-08.2008; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Holvoet P, 2006, ARTERIOSCL THROM VAS, V26, P1558, DOI 10.1161/01.ATV.0000226553.01555.02; Ikeda K, 1996, J NEUROL SCI, V135, P109, DOI 10.1016/0022-510X(95)00263-2; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Kang J, 2007, J CELL BIOL, V179, P1219, DOI 10.1083/jcb.200705046; Kiaei M, 2006, J NEUROSCI, V26, P2467, DOI 10.1523/JNEUROSCI.5253-05.2006; Konat GW, 2006, J NEUROCHEM, V99, P1, DOI 10.1111/j.1471-4159.2006.04076.x; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; LAMPSON LA, 1990, ANN NEUROL, V28, P365, DOI 10.1002/ana.410280311; Leichsenring A, 2006, BRAIN RES, V1096, P180, DOI 10.1016/j.brainres.2006.04.029; LETIEMBRE M, 2007, NEUROBIOL A IN PRESS; Liu Y, 2005, BRAIN, V128, P1778, DOI 10.1093/brain/awh531; Liu Y, 2006, J NEUROSCI, V26, P12904, DOI 10.1523/JNEUROSCI.2531-06.2006; Lunn CA, 1997, FEBS LETT, V400, P333, DOI 10.1016/S0014-5793(96)01410-X; Marden JJ, 2007, J CLIN INVEST, V117, P2913, DOI 10.1172/JCI31265; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Orrell RW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002829.pub4; PINEAU I, 2008, IN PRESS; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008; TROOST D, 1990, NEUROPATH APPL NEURO, V16, P401, DOI 10.1111/j.1365-2990.1990.tb01276.x; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Udan MLD, 2008, J NEUROCHEM, V104, P524, DOI 10.1111/j.1471-4159.2007.05001.x; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Veldink JH, 2007, J NEUROL NEUROSUR PS, V78, P367, DOI 10.1136/jnnp.2005.083378; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Walton KA, 2003, J BIOL CHEM, V278, P29661, DOI 10.1074/jbc.M300738200; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Weydt P, 2004, GLIA, V48, P179, DOI 10.1002/glia.20062; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103; Zhang ZL, 2001, FASEB J, V15, P303; Zhong J, 1999, J NEUROSCI, V19, P4305	55	89	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3691	3699		10.1074/jbc.M804446200	http://dx.doi.org/10.1074/jbc.M804446200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19091752	hybrid			2022-12-27	WOS:000262872500037
J	Scheinman, EJ; Avni, O				Scheinman, Eyal J.; Avni, Orly			Transcriptional Regulation of Gata3 in T Helper Cells by the Integrated Activities of Transcription Factors Downstream of the Interleukin-4 Receptor and T Cell Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CYTOKINE GENE-EXPRESSION; IFN-GAMMA PRODUCTION; DEVELOPING TH1 CELLS; IN-VIVO; ENFORCED EXPRESSION; TRANSGENIC MICE; IL-4 RECEPTOR; CUTTING EDGE; HISTONE ACETYLATION	GATA3 is a critical transcription factor for many developmental processes. During T helper (Th) cell differentiation, GATA3 induces the Th2 and suppresses the Th1 pathway. Stimulation of the T cell receptor (TCR) of naive Th cells in the presence of interleukin 4 (IL-4) induces robust expression of GATA3; however, it is unclear where these signals integrate. Gata3 encodes two transcripts that differ in their alternative, untranslated first exons. We show here the involvement of the TCR-inducible transcription factor NFAT1 in the transcriptional regulation of both Gata3 transcripts following TCR stimulation of naive and differentiated Th2 cells. We also show that IL-4 is important for the initiation and establishment of Gata3 transcription in developing Th2 cells, especially from the distal promoter. The early function of IL-4 can be STAT6 dependent or independent. However, the establishment of the activity of the distal promoter is totally dependent on STAT6, whereas it is likely that the proximal promoter has additional activation mechanisms that are STAT6 independent. Our findings suggest that different combinations of transcription factors downstream of the IL-4 receptor (IL-4R) and TCR finely modulate Gata3 gene expression from its two promoters for optimal Th2 differentiation.	[Scheinman, Eyal J.; Avni, Orly] Technion Israel Inst Technol, Dept Immunol, Rappaport Fac Med, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Avni, O (corresponding author), Efron 1 St, IL-31096 Haifa, Israel.	oavni@tx.technion.ac.il			Israel Science Foundation [986/04]; Rappaport Family Institute for Research	Israel Science Foundation(Israel Science Foundation); Rappaport Family Institute for Research	This work was supported by Israel Science Foundation Grant 986/04 and the Rappaport Family Institute for Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Anderson MK, 2002, DEV BIOL, V246, P103, DOI 10.1006/dbio.2002.0674; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Benson RA, 2005, EUR J IMMUNOL, V35, P859, DOI 10.1002/eji.200425562; Bouchard MF, 2005, ENDOCRINOLOGY, V146, P4905, DOI 10.1210/en.2005-0187; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Chen CH, 2000, J IMMUNOL, V165, P5597, DOI 10.4049/jimmunol.165.10.5597; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; CORRY DB, 1994, J IMMUNOL, V153, P4142; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Ferber IA, 1999, CLIN IMMUNOL, V91, P134, DOI 10.1006/clim.1999.4718; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Gregoire JM, 1999, J BIOL CHEM, V274, P6567, DOI 10.1074/jbc.274.10.6567; Gulbinas A, 2006, J HISTOCHEM CYTOCHEM, V54, P161, DOI 10.1369/jhc.5A6626.2005; Hasegawa SL, 2007, DEV BIOL, V301, P568, DOI 10.1016/j.ydbio.2006.09.030; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Ho IC, 2007, CELL MOL IMMUNOL, V4, P15; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Hwang ES, 2002, J IMMUNOL, V169, P248, DOI 10.4049/jimmunol.169.1.248; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; Jacob E, 2008, J BIOL CHEM, V283, P13471, DOI 10.1074/jbc.M709886200; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kim ST, 2007, P NATL ACAD SCI USA, V104, P17052, DOI 10.1073/pnas.0708293104; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kubo M, 1999, J IMMUNOL, V163, P2432; Kurata H, 2002, J IMMUNOL, V168, P4538, DOI 10.4049/jimmunol.168.9.4538; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; LABASTIE MC, 1994, GENOMICS, V21, P1, DOI 10.1006/geno.1994.1217; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Lakshmanan G, 1999, MOL CELL BIOL, V19, P1558; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lieuw KH, 1997, DEV BIOL, V188, P1, DOI 10.1006/dbio.1997.8575; LING PD, 1994, J VIROL, V68, P5375, DOI 10.1128/JVI.68.9.5375-5383.1994; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; MCKNIGHT AJ, 1994, J IMMUNOL, V152, P5220; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; Nawijn MC, 2001, J IMMUNOL, V167, P724, DOI 10.4049/jimmunol.167.2.724; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; OOSTERWEGEL M, 1992, DEV IMMUNOL, V3, P1, DOI 10.1155/1992/27903; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Palmieri M, 1999, NUCLEIC ACIDS RES, V27, P2785, DOI 10.1093/nar/27.13.2785; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rulifson IC, 1997, J IMMUNOL, V158, P658; Schmitz ML, 2006, CELL DEATH DIFFER, V13, P834, DOI 10.1038/sj.cdd.4401845; SEDER RA, 1994, J EXP MED, V179, P299, DOI 10.1084/jem.179.1.299; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Steenbergen RDM, 2002, AM J PATHOL, V160, P1945, DOI 10.1016/S0002-9440(10)61143-1; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; Taghon T, 2001, J IMMUNOL, V167, P4468, DOI 10.4049/jimmunol.167.8.4468; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tsarovina K, 2004, DEVELOPMENT, V131, P4775, DOI 10.1242/dev.01370; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van der Wees J, 2004, NEUROBIOL DIS, V16, P169, DOI 10.1016/j.nbd.2004.02.004; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Wang CD, 2001, BIOL REPROD, V65, P1437, DOI 10.1095/biolreprod65.5.1437; Wang JH, 2001, J IMMUNOL, V167, P289, DOI 10.4049/jimmunol.167.1.289; Yamagata T, 2000, EMBO J, V19, P4676, DOI 10.1093/emboj/19.17.4676; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461	100	63	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3037	3048		10.1074/jbc.M807302200	http://dx.doi.org/10.1074/jbc.M807302200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19056736	hybrid			2022-12-27	WOS:000262700900048
J	Hindlet, P; Bado, A; Kamenicky, P; Delomenie, C; Bourasset, F; Nazaret, C; Farinotti, R; Buyse, M				Hindlet, Patrick; Bado, Andre; Kamenicky, Peter; Delomenie, Claudine; Bourasset, Fanchon; Nazaret, Corinne; Farinotti, Robert; Buyse, Marion			Reduced Intestinal Absorption of Dipeptides via PepT1 in Mice with Diet-induced Obesity Is Associated with Leptin Receptor Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUMINAL LEPTIN; LONG-FORM; CANCER CELLS; EXPRESSION; PROTEIN; ACTIVATION; SECRETION; COTRANSPORTER-1; INHIBITION; MECHANISMS	Leptin is a major determinant of energy homeostasis, acting both centrally and in the gastrointestinal tract. We previously reported that acute leptin treatment enhances the absorption of di- and tripeptides via the proton-dependent PepT1 transporter. In this study, we investigated the long term effect of leptin on PepT1 levels and activity in Caco2 cell monolayers in vitro. We then assessed the significance of the regulation of PepT1 in vivo in a model of diet-induced obesity. We demonstrated that 1) leptin regulated PepT1 at the transcriptional level, via the MAPK pathway, and at the translational level, via ribosomal protein S6 activation, in Caco2 cells and 2) this activation was systematically followed by a time-and concentration-dependent loss of leptin action reflecting desensitization. Deciphering this desensitization, we demonstrated that leptin induced a down-regulation of its own receptor protein and mRNA expression. More importantly, we showed, in mice with diet-induced obesity, that a 4-week hypercaloric diet resulted in a 46% decrease in PepT1-specific transport, because of a 30% decrease in PepT1 protein and a 50% decrease in PepT1 mRNA levels. As shown in Caco2 cells, these changes in PepT1 were supported by a parallel 2-fold decrease in leptin receptor expression in mice. Taken together, these results indicate that during induction of obesity, leptin resistance may also occur peripherally in the gastrointestinal tract, disrupting the absorption of oligopeptides and peptidomimetic drugs.	[Hindlet, Patrick; Bourasset, Fanchon; Farinotti, Robert; Buyse, Marion] Univ Paris 11, Fac Pharm, Lab Pharm Clin, UPRES EA2706, F-92296 Chatenay Malabry, France; [Hindlet, Patrick; Delomenie, Claudine; Bourasset, Fanchon; Farinotti, Robert; Buyse, Marion] Univ Paris 11, Fac Pharm, IFR 141, F-92296 Chatenay Malabry, France; [Bado, Andre; Nazaret, Corinne] Univ Paris 07, INSERM, Fac Med, Med Unite 773, F-75018 Paris, France; [Kamenicky, Peter] Univ Paris 11, Fac Med, INSERM, Med Unite 693, F-94270 Le Kremlin Bicetre, France; [Farinotti, Robert; Buyse, Marion] Hop La Pitie Salpetriere, AP HP, Serv Pharm, F-75013 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Hindlet, P (corresponding author), Univ Paris Sud, Fac Pharm, Lab Pharma Clin, UPRES EA2706, 11-5 Rue Jean Baptiste Clement, F-92296 Chatenay Malabry, France.	patrick.hindlet@u-psud.fr	Buyse, Marc/J-4658-2013; Bourasset, Fanchon/A-1870-2017; Kamenicky, Peter/S-4554-2018	Bourasset, Fanchon/0000-0002-1409-8323; Delomenie, Claudine/0000-0002-6326-966X; KAMENICKY, Peter/0000-0002-1994-4226; BADO, Andre/0000-0002-8007-1460				Anini Y, 2003, DIABETES, V52, P252, DOI 10.2337/diabetes.52.2.252; Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Barrenetxe J, 2004, BIOCHEM BIOPH RES CO, V317, P717, DOI 10.1016/j.bbrc.2004.03.106; Barrenetxe J, 2002, GUT, V50, P797, DOI 10.1136/gut.50.6.797; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; Buyse M, 2002, J BIOL CHEM, V277, P28182, DOI 10.1074/jbc.M203281200; Buyse M, 2001, J CLIN INVEST, V108, P1483, DOI 10.1172/JCI13219; Cammisotto PG, 2005, J HISTOCHEM CYTOCHEM, V53, P851, DOI 10.1369/jhc.5A6620.2005; Cinti S, 2000, INT J OBESITY, V24, P789, DOI 10.1038/sj.ijo.0801228; Darcel NP, 2005, J NUTR, V135, P1491, DOI 10.1093/jn/135.6.1491; Dube N, 2001, J CELL BIOCHEM, V81, P613, DOI 10.1002/jcb.1090; Ducroc R, 2005, DIABETES, V54, P348, DOI 10.2337/diabetes.54.2.348; El Homsi M, 2007, AM J PHYSIOL-GASTR L, V293, pG365, DOI 10.1152/ajpgi.00091.2007; Gong Y, 2007, J BIOL CHEM, V282, P31019, DOI 10.1074/jbc.M702838200; Guilmeau S, 2003, DIABETES, V52, P1664, DOI 10.2337/diabetes.52.7.1664; Hansen GH, 2008, J HISTOCHEM CYTOCHEM, V56, P677, DOI 10.1369/jhc.2008.950782; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Hikita M, 2000, BIOCHEM BIOPH RES CO, V271, P703, DOI 10.1006/bbrc.2000.2692; Hindlet P, 2007, J PHARMACOL EXP THER, V323, P192, DOI 10.1124/jpet.107.125799; Hoda MR, 2007, BRIT J SURG, V94, P346, DOI 10.1002/bjs.5530; Igel M, 2002, LIPIDS, V37, P153, DOI 10.1007/s11745-002-0875-5; Kiely JM, 2006, J PEDIATR SURG, V41, P1243, DOI 10.1016/j.jpedsurg.2006.03.047; Kiess W, 2008, BEST PRACT RES CL EN, V22, P135, DOI 10.1016/j.beem.2007.10.002; Martin RL, 2000, METABOLISM, V49, P1479, DOI 10.1053/meta.2000.17695; MELLINKOFF SM, 1956, J APPL PHYSIOL, V8, P535, DOI 10.1152/jappl.1956.8.5.535; Morton NM, 1998, J BIOL CHEM, V273, P26194, DOI 10.1074/jbc.273.40.26194; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Nduati V, 2007, J BIOL CHEM, V282, P1359, DOI 10.1074/jbc.M604267200; Ogunwobi OO, 2007, DIGEST DIS SCI, V52, P1934, DOI 10.1007/s10620-007-9784-6; Paddon-Jones D, 2008, AM J CLIN NUTR, V87, p1558S, DOI 10.1093/ajcn/87.5.1558S; Shimakura J, 2005, AM J PHYSIOL-GASTR L, V289, pG471, DOI 10.1152/ajpgi.00025.2005; SHIMAKURA J, 2006, AM J PHYSIOL, V291, pG951; Shimakura J, 2006, BIOCHEM PHARMACOL, V71, P1581, DOI 10.1016/j.bcp.2006.03.001; Valerio A, 2006, J BIOL CHEM, V281, P12950, DOI 10.1074/jbc.M508691200; van den Brink Gijs R., 2000, Molecular Cell Biology Research Communications, V4, P144, DOI 10.1006/mcbr.2001.0270; Wilsey J, 2004, J ENDOCRINOL, V181, P297, DOI 10.1677/joe.0.1810297; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	39	33	37	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6801	6808		10.1074/jbc.M805564200	http://dx.doi.org/10.1074/jbc.M805564200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19144638	Green Published, hybrid			2022-12-27	WOS:000263919000025
J	Akerboom, J; Rivera, JDV; Guilbe, MMR; Malave, ECA; Hernandez, HH; Tian, L; Hires, SA; Marvin, JS; Looger, LL; Schreiter, ER				Akerboom, Jasper; Rivera, Jonathan D. Velez; Guilbe, Maria M. Rodriguez; Malave, Elisa C. Alfaro; Hernandez, Hector H.; Tian, Lin; Hires, S. Andrew; Marvin, Jonathan S.; Looger, Loren L.; Schreiter, Eric R.			Crystal Structures of the GCaMP Calcium Sensor Reveal the Mechanism of Fluorescence Signal Change and Aid Rational Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; INDICATOR PROTEIN; DENDRITIC SPINES; CALMODULIN	The genetically encoded calcium indicator GCaMP2 shows promise for neural network activity imaging, but is currently limited by low signal-to-noise ratio. We describe x-ray crystal structures as well as solution biophysical and spectroscopic characterization of GCaMP2 in the calcium-free dark state, and in two calcium-bound bright states: a monomeric form that dominates at intracellular concentrations observed during imaging experiments and an unexpected domain-swapped dimer with decreased fluorescence. This series of structures provides insight into the mechanism of Ca2+-induced fluorescence change. Upon calcium binding, the calmodulin (CaM) domain wraps around the M13 peptide, creating a new domain interface between CaM and the circularly permuted enhanced green fluorescent protein domain. Residues from CaM alter the chemical environment of the circularly permuted enhanced green fluorescent protein chromophore and, together with flexible inter-domain linkers, block solvent access to the chromophore. Guided by the crystal structures, we engineered a series of GCaMP2 point mutants to probe the mechanism of GCaMP2 function and characterized one mutant with significantly improved signal-to-noise. The mutation is located at a domain interface and its effect on sensor function could not have been predicted in the absence of structural data.	[Rivera, Jonathan D. Velez; Malave, Elisa C. Alfaro; Schreiter, Eric R.] Univ Puerto Rico, Dept Chem, San Juan, PR 00931 USA; [Akerboom, Jasper; Tian, Lin; Hires, S. Andrew; Marvin, Jonathan S.; Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Guilbe, Maria M. Rodriguez] Univ Puerto Rico, Dept Biochem, San Juan, PR 00936 USA; [Hernandez, Hector H.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02142 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Howard Hughes Medical Institute; University of Puerto Rico; Massachusetts Institute of Technology (MIT)	Schreiter, ER (corresponding author), Univ Puerto Rico, Dept Chem, San Juan, PR 00931 USA.	eschreiter@vmail.uprrp.edu	Hernandez, Hector H./Q-4234-2019; Schreiter, Eric/B-2641-2009; Hires, Samuel/E-4717-2015	Hernandez, Hector H./0000-0001-7173-1829; Marvin, Jonathan/0000-0003-2294-4515; Schreiter, Eric/0000-0002-2864-7469; Tian, Lin/0000-0001-7012-6926	National Institutes of Health [5P20RR016439-05]; University of Puerto Rico, Rio Piedras Campus; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico, Rio Piedras Campus; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P20RR016439-05 to the UPR Protein Research Center. This work was also supported by the University of Puerto Rico, Rio Piedras Campus. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Elsliger MA, 1999, BIOCHEMISTRY-US, V38, P5296, DOI 10.1021/bi9902182; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guilbe MMR, 2008, ACTA CRYSTALLOGR F, V64, P629, DOI 10.1107/S1744309108016059; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Jung G, 2005, BIOPHYS J, V88, P1932, DOI 10.1529/biophysj.104.044412; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kummer AD, 2000, J PHYS CHEM B, V104, P4791, DOI 10.1021/jp9942522; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; NAUMANN EA, 2005, THESIS U KONSTANZ KO; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Souslova EA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-37; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; YASUDA R, 2004, SCI STKE, P15; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	37	173	182	1	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6455	6464		10.1074/jbc.M807657200	http://dx.doi.org/10.1074/jbc.M807657200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19098007	Green Published, hybrid			2022-12-27	WOS:000263742700048
J	Blackinton, J; Lakshminarasimhan, M; Thomas, KJ; Ahmad, R; Greggio, E; Raza, AS; Cookson, MR; Wilson, MA				Blackinton, Jeff; Lakshminarasimhan, Mahadevan; Thomas, Kelly J.; Ahmad, Rili; Greggio, Elisa; Raza, Ashraf S.; Cookson, Mark R.; Wilson, Mark A.			Formation of a Stabilized Cysteine Sulfinic Acid Is Critical for the Mitochondrial Function of the Parkinsonism Protein DJ-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURE; DISEASE GENE DJ-1; ALPHA-SYNUCLEIN; SACCHAROMYCES-CEREVISIAE; LOCALIZATION; SUPERFAMILY; MUTATIONS; OXIDATION; IDENTIFICATION; EVOLUTIONARY	The formation of cysteine-sulfinic acid has recently become appreciated as a modification that links protein function to cellular oxidative status. Human DJ-1, a protein associated with inherited parkinsonism, readily forms cysteine-sulfinic acid at a conserved cysteine residue (Cys(106) in human DJ-1). Mutation of Cys(106) causes the protein to lose its normal protective function in cell culture and model organisms. However, it is unknown whether the loss of DJ-1 protective function in these mutants is due to the absence of Cys(106) oxidation or the absence of the cysteine residue itself. To address this question, we designed a series of substitutions at a proximal glutamic acid residue (Glu(18)) in human DJ-1 that alter the oxidative propensity of Cys(106) through changes in hydrogen bonding. We show that two mutations, E18N and E18Q, allow Cys(106) to be oxidized to Cys(106)-sulfinic acid under mild conditions. In contrast, the E18D mutation stabilizes a cysteine-sulfenic acid that is readily reduced to the thiol in solution and in vivo. We show that E18N and E18Q can both partially substitute for wild-type DJ-1 using mitochondrial fission and cell viability assays. In contrast, the oxidatively impaired E18D mutant behaves as an inactive C106A mutant and fails to protect cells. We therefore conclude that formation of Cys(106)-sulfinic acid is a key modification that regulates the protective function of DJ-1.	[Blackinton, Jeff; Thomas, Kelly J.; Ahmad, Rili; Greggio, Elisa; Cookson, Mark R.] NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Bethesda, MD 20982 USA; [Lakshminarasimhan, Mahadevan; Raza, Ashraf S.; Wilson, Mark A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Lakshminarasimhan, Mahadevan; Raza, Ashraf S.; Wilson, Mark A.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Cookson, MR (corresponding author), NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Rm 1A116,MSC 3707,35 Convent Dr, Bethesda, MD 20982 USA.	cookson@mail.nih.gov; mwilson13@unl.edu	Greggio, Elisa/H-6119-2013; Raza, Faisal/AAG-4567-2021; Cookson, Mark/AAW-2516-2021	Greggio, Elisa/0000-0002-8172-3598; Raza, Faisal/0000-0001-5569-3535; Cookson, Mark/0000-0002-1058-3831; Lakshminarasimhan, Mahadevan/0000-0001-9475-4927	National Institutes of Health [P20RR17675]; National Institutes of Health, NIA [Z01-AG000953]; American Parkinson's Disease Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675, P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Parkinson's Disease Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR17675 (to M. A. W.) and by the Intramural Research Program of the National Institutes of Health, NIA, Project Z01-AG000953 (to M. R. C.). This work was also supported in part by the American Parkinson's Disease Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Annesi G, 2005, ANN NEUROL, V58, P803, DOI 10.1002/ana.20666; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chandran JS, 2008, NEUROBIOL DIS, V29, P505, DOI 10.1016/j.nbd.2007.11.011; Cheung ECC, 2007, APOPTOSIS, V12, P979, DOI 10.1007/s10495-007-0745-5; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Hod Y, 1999, J CELL BIOCHEM, V72, P435, DOI 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.3.CO;2-8; Holyoak T, 2003, ACTA CRYSTALLOGR D, V59, P2356, DOI 10.1107/S0907444903021784; Ito G, 2006, BIOCHEM BIOPH RES CO, V339, P667, DOI 10.1016/j.bbrc.2005.11.058; Jonsson TJ, 2005, BIOCHEMISTRY-US, V44, P8634, DOI 10.1021/bi050131i; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2004, P NATL ACAD SCI USA, V101, P1531, DOI 10.1073/pnas.0308089100; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	40	216	219	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6476	6485		10.1074/jbc.M806599200	http://dx.doi.org/10.1074/jbc.M806599200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124468	hybrid, Green Published			2022-12-27	WOS:000263742700050
J	Lamb, D; Mirsaliotis, A; Kelly, SM; Brighty, DW				Lamb, Daniel; Mirsaliotis, Antonis; Kelly, Sharon M.; Brighty, David W.			Basic Residues Are Critical to the Activity of Peptide Inhibitors of Human T Cell Leukemia Virus Type 1 Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; HIV-1 GP41; HTLV-I; TRANSMEMBRANE GLYCOPROTEIN; CIRCULAR-DICHROISM; SYNTHETIC PEPTIDES; PROTEIN EXPRESSION; COILED-COIL; IDENTIFICATION	A synthetic peptide based on the leash and alpha-helical region (LHR) of human T cell leukemia virus type 1 envelope is a potent inhibitor of viral entry into cells. The inhibitory peptide targets a triple-stranded coiled-coil motif of the fusion-active transmembrane glycoprotein and in a trans-dominant negative manner blocks resolution to the trimer-of-hairpins form. The LHR-mimetic is, therefore, functionally analogous to the C34/T20-type inhibitors of human immunodeficiency virus. Previous attempts to shorten the bioactive peptide produced peptides with severely attenuated activity. We now demonstrate that truncated peptides often suffer from poor solubility and impaired coiled coil binding properties, and we identify features that are critical to peptide function. In particular, the alpha-helical region of the LHR-mimetic is necessary but not sufficient for inhibitory activity. Moreover, two basic residues are crucial for coiled-coil binding and efficient inhibition of membrane fusion. By retaining these basic residues and a region of main chain peptide contacts with the coiled coil, a core LHR-mimetic was obtained that retains both the inhibitory properties and solubility profile of the parental peptide. Variants of the core peptide inhibit both membrane fusion and infection of cells by free viral particles, but unexpectedly, infection by virions was more susceptible to inhibition by low activity inhibitors than syncytium formation. The core inhibitor provides a valuable lead in the search for smaller more bio-available peptides and peptido-mimetics that possess anti-viral activity. Such molecules may be attractive candidates for therapeutic intervention in human T cell leukemia virus type 1 infections.	[Lamb, Daniel; Mirsaliotis, Antonis; Brighty, David W.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Kelly, Sharon M.] Univ Glasgow, Inst Biomed & Life Sci, Prot Characterizat Facil, Glasgow G12 8QQ, Lanark, Scotland	University of Dundee; University of Glasgow	Brighty, DW (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland.	d.w.brighty@dundee.ac.uk	Kelly, Sharon/K-4611-2013	Kelly, Sharon/0000-0002-3516-1387	The Leukemia Research Fund [LRF-354, LRF-05062]	The Leukemia Research Fund	The Leukemia Research Fund generously supported this work through Project Grants LRF-354 and LRF-05062 ( to D. W. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0; BLACKLOW SC, 1995, BIOCHEMISTRY-US, V34, P14955, DOI 10.1021/bi00046a001; Bossart KN, 2002, J VIROL, V76, P11186, DOI 10.1128/JVI.76.22.11186-11198.2002; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DOKHELAR MC, 1989, J ACQ IMMUN DEF SYND, V2, P431; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; GESSAIN A, 1985, LANCET, V2, P407; Hanon E, 2000, AIDS RES HUM RETROV, V16, P1711, DOI 10.1089/08892220050193191; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jassal SR, 2001, J VIROL, V75, P8317, DOI 10.1128/JVI.75.17.8317-8328.2001; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; Lamb D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-70; Liu SW, 2004, LANCET, V363, P938, DOI 10.1016/S0140-6736(04)15788-7; Lombardi S, 1996, VIROLOGY, V220, P274, DOI 10.1006/viro.1996.0315; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Maerz AL, 2000, J VIROL, V74, P6614, DOI 10.1128/JVI.74.14.6614-6621.2000; Majorovits E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002251; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Mirsaliotis A, 2008, J VIROL, V82, P4965, DOI 10.1128/JVI.02458-07; Mirsaliotis A, 2007, J GEN VIROL, V88, P660, DOI 10.1099/vir.0.82390-0; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; OSAME M, 1986, LANCET, V1, P1031; Pinon JD, 2003, J VIROL, V77, P3281, DOI 10.1128/JVI.77.5.3281-3290.2003; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; PRICE NC, 1996, DETERMINATION PROTEI, P34; Sagara Y, 1996, J VIROL, V70, P1564, DOI 10.1128/JVI.70.3.1564-1569.1996; Sjoberg M, 2008, J VIROL, V82, P2358, DOI 10.1128/JVI.01931-07; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; Yamano Y, 2002, BLOOD, V99, P88, DOI 10.1182/blood.V99.1.88	37	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6575	6584		10.1074/jbc.M806725200	http://dx.doi.org/10.1074/jbc.M806725200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19114713	hybrid			2022-12-27	WOS:000263742700060
J	Hallows, KR; Wang, HM; Edinger, RS; Butterworth, MB; Oyster, NM; Li, H; Buck, J; Levin, LR; Johnson, JP; Pastor-Soler, NM				Hallows, Kenneth R.; Wang, Huamin; Edinger, Robert S.; Butterworth, Michael B.; Oyster, Nicholas M.; Li, Hui; Buck, Jochen; Levin, Lonny R.; Johnson, John P.; Pastor-Soler, Nuria M.			Regulation of Epithelial Na+ Transport by Soluble Adenylyl Cyclase in Kidney Collecting Duct Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; V-ATPASE; SURFACE EXPRESSION; SODIUM-TRANSPORT; GAMMA-SUBUNIT; CYCLIC-AMP; K+-ATPASE; A6 CELLS; CAMP; CHANNEL	Alkalosis impairs the natriuretic response to diuretics, but the underlying mechanisms are unclear. The soluble adenylyl cyclase (sAC) is a chemosensor that mediates bicarbonate-dependent elevation of cAMP in intracellular microdomains. We hypothesized that sAC may be an important regulator of Na+ transport in the kidney. Confocal images of rat kidney revealed specific immunolocalization of sAC in collecting duct cells, and immunoblots confirmed sAC expression in mouse cortical collecting duct (mpkCCD(c14)) cells. These cells exhibit aldosterone-stimulated transepithelial Na+ currents that depend on both the apical epithelial Na+ channel (ENaC) and basolateral Na+, K+-ATPase. RNA interference-mediated 60-70% knockdown of sAC expression comparably inhibited basal transepithelial short circuit currents (I-sc) in mpkCCD(c14) cells. Moreover, the sAC inhibitors KH7 and 2-hydroxyestradiol reduced I-sc in these cells by 50-60% within 30 min. 8-Bromoadenosine-3',5'-cyclic-monophosphate substantially rescued the KH7 inhibition of transepithelial Na+ current. Aldosterone doubled ENaC-dependent Isc over 4 h, an effect that was abolished in the presence of KH7. The sAC contribution to Isc was unaffected with apical membrane nystatin-mediated permeabilization, whereas the sAC-dependent Na+ current was fully inhibited by basolateral ouabain treatment, suggesting that the Na+, K+-ATPase, rather than ENaC, is the relevant transporter target of sAC. Indeed, neither overexpression of sAC nor treatment with KH7 modulated ENaC currents in Xenopus oocytes. ATPase and biotinylation assays in mpkCCDc14 cells demonstrated that sAC inhibition decreases catalytic activity rather than surface expression of the Na+, K+-ATPase. In summary, these results suggest that sAC regulates both basal and agonist-stimulated Na+ reabsorption in the kidney collecting duct, acting to enhance Na+, K+-ATPase activity.	[Hallows, Kenneth R.; Wang, Huamin; Edinger, Robert S.; Oyster, Nicholas M.; Li, Hui; Johnson, John P.; Pastor-Soler, Nuria M.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Hallows, Kenneth R.; Butterworth, Michael B.; Johnson, John P.; Pastor-Soler, Nuria M.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Buck, Jochen; Levin, Lonny R.] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cornell University	Hallows, KR (corresponding author), Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, S976 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	hallows@pitt.edu		Levin, Lonny/0000-0002-5204-6356; Hallows, Kenneth/0000-0002-2964-2440	National Institutes of Health [R01 DK075048, K99 DK078917, R01 GM062328, K08 HD045524, R01 DK057718, DK047874]; American Diabetes Association; Hirschl Foundation; Cystic Fibrosis Foundation [HALLOW06P0, BUTTER06G0]; Cell Physiology and Morphology Cores of the Pittsburgh Center for Kidney Research [NIH P30 DK079307]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD045524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R01DK047874, R01DK057718, R01DK075048, R00DK078917, K99DK078917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Hirschl Foundation; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cell Physiology and Morphology Cores of the Pittsburgh Center for Kidney Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK075048 ( to K. R. H.), K99 DK078917 ( to M. B. B.), R01 GM062328 ( to J.B.), K08 HD045524 ( to N.M.P.S.), and R01 DK057718 and DK047874 ( to J.P.J.). This work was also supported by American Diabetes Association and Hirschl Foundation grants ( to L. R. L.) and by Cystic Fibrosis Foundation Grants HALLOW06P0 ( to K. R. H.) and BUTTER06G0 ( to M. B. B.). This work was also supported by the Cell Physiology and Morphology Cores of the Pittsburgh Center for Kidney Research (NIH P30 DK079307).	Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhalla V, 2006, AM J PHYSIOL-RENAL, V291, pF714, DOI 10.1152/ajprenal.00061.2006; BOSCH JP, 1977, AM J PHYSIOL, V232, pF397, DOI 10.1152/ajprenal.1977.232.5.F397; Breton S, 1998, AM J PHYSIOL-CELL PH, V275, pC1134, DOI 10.1152/ajpcell.1998.275.4.C1134; Breton S, 2000, AM J PHYSIOL-RENAL, V278, pF717, DOI 10.1152/ajprenal.2000.278.5.F717; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Bundey Richard A, 2004, Sci STKE, V2004, ppe19, DOI 10.1126/stke.2312004pe19; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; CASS A, 1970, J GEN PHYSIOL, V56, P100, DOI 10.1085/jgp.56.1.100; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC893, DOI 10.1152/ajpcell.1997.273.3.C893; Cortes VF, 2006, INT J BIOCHEM CELL B, V38, P1901, DOI 10.1016/j.biocel.2006.05.002; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Erlij D, 1999, PFLUG ARCH EUR J PHY, V438, P195, DOI 10.1007/s004240050898; Farrell J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003251; FORBUSH B, 1983, ANAL BIOCHEM, V128, P159, DOI 10.1016/0003-2697(83)90356-1; Franzin CM, 2007, J BIOENERG BIOMEMBR, V39, P379, DOI 10.1007/s10863-007-9105-y; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Gonin S, 2001, MOL BIOL CELL, V12, P255, DOI 10.1091/mbc.12.2.255; Harvey BJ, 2008, J STEROID BIOCHEM, V108, P310, DOI 10.1016/j.jsbmb.2007.09.005; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kleizen B, 2000, EUR J CELL BIOL, V79, P544, DOI 10.1078/0171-9335-00078; KLEYMAN TR, 1994, AM J PHYSIOL, V266, pF506, DOI 10.1152/ajprenal.1994.266.3.F506; LEWIS SA, 1977, J GEN PHYSIOL, V70, P427, DOI 10.1085/jgp.70.4.427; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Loon NR, 1998, CLIN SCI, V94, P287, DOI 10.1042/cs0940287; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; MITTAG TW, 1993, AM J PHYSIOL, V264, pF1060, DOI 10.1152/ajprenal.1993.264.6.F1060; Mohan S, 2004, J BIOL CHEM, V279, P32071, DOI 10.1074/jbc.M405091200; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; PALMER LG, 1985, J MEMBRANE BIOL, V83, P57, DOI 10.1007/BF01868738; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Pastor-Soler NM, 2008, AM J PHYSIOL-CELL PH, V294, pC488, DOI 10.1152/ajpcell.00537.2007; Paunescu TG, 2008, AM J PHYSIOL-RENAL, V294, pF130, DOI 10.1152/ajprenal.00406.2007; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Ramos LS, 2008, J GEN PHYSIOL, V132, P329, DOI 10.1085/jgp.200810044; Rokaw MD, 1996, J BIOL CHEM, V271, P32468, DOI 10.1074/jbc.271.50.32468; Schmid A, 2007, J GEN PHYSIOL, V130, P99, DOI 10.1085/jgp.200709784; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Stockand JD, 2000, NEWS PHYSIOL SCI, V15, P161; Summa V, 2004, J PHYSIOL-LONDON, V555, P355, DOI 10.1113/jphysiol.2003.054270; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; USSING HH, 1951, ACTA PHYSIOL SCAND, V23, P110, DOI 10.1111/j.1748-1716.1951.tb00800.x; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; Weber WM, 1999, PFLUG ARCH EUR J PHY, V438, P561, DOI 10.1007/s004240051076; WELLING PA, 1993, J BIOL CHEM, V268, P23469; Wetzel RK, 2001, AM J PHYSIOL-RENAL, V281, pF531, DOI 10.1152/ajprenal.2001.281.3.F531; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Young JJ, 2008, J NEUROSCI RES, V86, P118, DOI 10.1002/jnr.21458; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	59	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5774	5783		10.1074/jbc.M805501200	http://dx.doi.org/10.1074/jbc.M805501200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19126549	Green Published, hybrid			2022-12-27	WOS:000263560600041
J	Kongsuphol, P; Cassidy, D; Hieke, B; Treharne, KJ; Schreiber, R; Mehta, A; Kunzelmann, K				Kongsuphol, Patthara; Cassidy, Diane; Hieke, Bernhard; Treharne, Kate J.; Schreiber, Rainer; Mehta, Anil; Kunzelmann, Karl			Mechanistic Insight into Control of CFTR by AMPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TRANSMEMBRANE-CONDUCTANCE-REGULATOR; AIRWAY EPITHELIAL-CELLS; CYSTIC-FIBROSIS; APICAL MEMBRANE; R-DOMAIN; CHANNEL; CAMP; PHOSPHORYLATION; TRANSPORT	The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP and protein kinase A (PKA)-regulated Cl- channel in the apical membrane of epithelial cells. The metabolically regulated and adenosine monophosphate-stimulated kinase (AMPK) is colocalized with CFTR and attenuates its function. However, the sites for CFTR phosphorylation and the precise mechanism of inhibition of CFTR by AMPK remain obscure. We demonstrate that CFTR normally remains closed at baseline, but nevertheless, opens after inhibition of AMPK. AMPK phosphorylates CFTR in vitro at two essential serines (Ser(737) and Ser(768)) in the R domain, formerly identified as "inhibitory" PKA sites. Replacement of both serines by alanines (i) reduced phosphorylation of the R domain, with Ser768 having dramatically greater impact, (ii) produced CFTR channels that were partially open in the absence of any stimulation, (iii) significantly augmented their activation by IBMX/forskolin, and (iv) eliminated CFTR inhibition post AMPK activation. Attenuation of CFTR by AMPK activation was detectable in the absence of cAMP-dependent stimulation but disappeared in maximally stimulated oocytes. Our data also suggest that AMP is produced by local phosphodiesterases in close proximity to CFTR. Thus we propose that CFTR channels are kept closed in nonstimulated epithelia with high baseline AMPK activity but CFTR may be basally active in tissues with lowered endogenous AMPK activity.	[Kongsuphol, Patthara; Hieke, Bernhard; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Dept Physiol, D-93053 Regensburg, Germany; [Cassidy, Diane; Treharne, Kate J.; Mehta, Anil] Univ Dundee, TICH, Dundee DD195Y, Scotland	University of Regensburg; University of Dundee	Kunzelmann, K (corresponding author), Univ Regensburg, Dept Physiol, D-93053 Regensburg, Germany.	Karl.Kunzelmann@vkl.uni-regensburg.de		Kunzelmann, Karl/0000-0002-4583-7037	Deutsche Forschungsgemeinschaft [SFB699 A6, DFG KU756/8-1]; Wellcome Trust [079965/z/06/z, 075237/z/04/z]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB699 A6 and DFG KU756/8-1 and Wellcome Trust Grants 079965/z/06/z (to K.J.T.) and 075237/z/04/z (to D.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Dahan D, 2001, PFLUG ARCH EUR J PHY, V443, pS92, DOI 10.1007/s004240100652; Fraser S, 2005, AM J PHYSIOL-RENAL, V288, pF578, DOI 10.1152/ajprenal.00190.2004; Fraser SA, 2007, BIOCHEM J, V405, P85, DOI 10.1042/BJ20061850; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Guerra L, 2005, J BIOL CHEM, V280, P40925, DOI 10.1074/jbc.M505103200; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Guo X, 1997, J MEMBRANE BIOL, V155, P239, DOI 10.1007/s002329900176; Hallows KR, 2003, AM J PHYSIOL-CELL PH, V284, pC1297, DOI 10.1152/ajpcell.00227.2002; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; Hallows KR, 2005, CURR OPIN NEPHROL HY, V14, P464, DOI 10.1097/01.mnh.0000174145.14798.64; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Jarnaess E, 2007, BIOCHEM SOC T, V35, P931, DOI 10.1042/BST0350931; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; McAlroy HL, 2000, BRIT J PHARMACOL, V131, P1651, DOI 10.1038/sj.bjp.0703743; Mehta A, 2007, PFLUG ARCH EUR J PHY, V455, P215, DOI 10.1007/s00424-007-0290-7; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Quinton PM, 2007, PHYSIOLOGY, V22, P212, DOI 10.1152/physiol.00041.2006; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Treharne KJ, 2001, PFLUG ARCH EUR J PHY, V443, pS97; Walker J, 2003, AM J PHYSIOL-GASTR L, V285, pG850, DOI 10.1152/ajpgi.00077.2003; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Woollhead AM, 2005, J PHYSIOL-LONDON, V566, P781, DOI 10.1113/jphysiol.2005.088674	44	66	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5645	5653		10.1074/jbc.M806780200	http://dx.doi.org/10.1074/jbc.M806780200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19095655	Green Published, hybrid			2022-12-27	WOS:000263560600028
J	Portman, N; Lacomble, S; Thomas, B; McKean, PG; Gull, K				Portman, Neil; Lacomble, Sylvain; Thomas, Benjamin; McKean, Paul G.; Gull, Keith			Combining RNA Interference Mutants and Comparative Proteomics to Identify Protein Components and Dependences in a Eukaryotic Flagellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URCHIN SPERM FLAGELLA; PARAFLAGELLAR ROD; TRYPANOSOMA-BRUCEI; CHLAMYDOMONAS-FLAGELLA; ADENYLATE KINASE; BIOCHEMICAL-CHARACTERIZATION; POLYPEPTIDE COMPOSITION; VISCERAL LEISHMANIASIS; AFRICAN TRYPANOSOMES; CENTRAL APPARATUS	Eukaryotic flagella from organisms such as Trypanosoma brucei can be isolated and their protein components identified by mass spectrometry. Here we used a comparative approach utilizing two-dimensional difference gel electrophoresis and isobaric tags for relative and absolute quantitation to reveal protein components of flagellar structures via ablation by inducible RNA interference mutation. By this approach we identified 20 novel components of the paraflagellar rod (PFR). Using epitope tagging we validated a subset of these as being present within the PFR by immunofluorescence. Bioinformatic analysis of the PFR cohort reveals a likely calcium/calmodulin regulatory/signaling linkage between some components. We extended the RNA interference mutant/comparative proteomic analysis to individual novel components of our PFR proteome, showing that the approach has the power to reveal dependences between subgroups within the cohort.	[Portman, Neil; Lacomble, Sylvain; Thomas, Benjamin; Gull, Keith] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Portman, Neil; Lacomble, Sylvain; Thomas, Benjamin; Gull, Keith] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3RE, England; [McKean, Paul G.] Univ Lancaster, Sch Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YQ, England	University of Oxford; University of Oxford; Lancaster University	Gull, K (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	keith.gull@path.ox.ac.uk		Portman, Neil/0000-0003-0248-0258; McKean, Paul Gerard/0000-0002-0445-0741	Wellcome Trust; Human Frontier Science Program; EP Abraham Trust; Engineering and Physical Sciences Research Council ( EPSRC); Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [EGH17741] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program(Human Frontier Science Program); EP Abraham Trust; Engineering and Physical Sciences Research Council ( EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust, the Human Frontier Science Program, and the EP Abraham Trust ( to KG). This work was also supported by the Engineering and Physical Sciences Research Council ( EPSRC) and the Biotechnology and Biological Sciences Research Council ( BBSRC). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. Author's Choice-Final version full access.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; ADAMS GMW, 1981, J CELL BIOL, V91, P69, DOI 10.1083/jcb.91.1.69; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bannai H, 2000, J CELL SCI, V113, P831; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Bastin P, 1996, PARASITOL TODAY, V12, P302, DOI 10.1016/0169-4758(96)10031-4; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Bastin P, 2000, J CELL SCI, V113, P3321; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Berberich C, 1998, BBA-GENE STRUCT EXPR, V1442, P230, DOI 10.1016/S0167-4781(98)00176-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BESSEN M, 1980, J CELL BIOL, V86, P446, DOI 10.1083/jcb.86.2.446; BIRKETT CR, 1992, GENE, V110, P65, DOI 10.1016/0378-1119(92)90445-U; BONINI NM, 1991, ADV SEC MESS PHOSPH, V23, P227; BONINI NM, 1988, J CELL BIOL, V106, P1615, DOI 10.1083/jcb.106.5.1615; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BROKAW CJ, 1979, J CELL BIOL, V82, P401, DOI 10.1083/jcb.82.2.401; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; BRUN R, 1979, ACTA TROP, V36, P289; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; Carrillo E, 2008, VACCINE, V26, P1902, DOI 10.1016/j.vaccine.2008.01.042; Checchi F, 2008, BRIT MED J, V336, P679, DOI 10.1136/bmj.39505.490544.BE; Clark AK, 2005, PARASITOL RES, V96, P312, DOI 10.1007/s00436-005-1370-2; COSSON MP, 1983, J CELL SCI, V60, P231; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUNHA NL, 1984, J SUBMICR CYTOL PATH, V16, P705; de Souza W, 2007, MICROBES INFECT, V9, P544, DOI 10.1016/j.micinf.2006.12.014; DEFLORIN J, 1994, J BIOL CHEM, V269, P28745; Devaux S, 2007, MOL BIOL CELL, V18, P1293, DOI 10.1091/mbc.E06-09-0841; Dymek EE, 2007, J CELL BIOL, V179, P515, DOI 10.1083/jcb.200703107; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Elmendorf HG, 2003, INT J PARASITOL, V33, P3, DOI 10.1016/S0020-7519(02)00228-X; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fouts DL, 1998, J BIOL CHEM, V273, P21846, DOI 10.1074/jbc.273.34.21846; Gadelha C, 2007, CELL MOTIL CYTOSKEL, V64, P629, DOI 10.1002/cm.20210; Griffiths S, 2007, EUKARYOT CELL, V6, P1248, DOI 10.1128/EC.00110-07; HOLWILL MEJ, 1976, J EXP BIOL, V65, P229; HUANG B, 1979, J BIOL CHEM, V254, P3091; HYAMS JS, 1978, J CELL SCI, V33, P235; HYAMS JS, 1982, J CELL SCI, V55, P199; IMBODEN M, 1995, PARASITOLOGY, V110, P249, DOI 10.1017/S0031182000080835; Inoue Y, 2007, CELL MOTIL CYTOSKEL, V64, P690, DOI 10.1002/cm.20216; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; JOHNSON RE, 1979, BIOPHYS J, V25, P113, DOI 10.1016/S0006-3495(79)85281-9; KAMIYA R, 1984, J CELL BIOL, V98, P97, DOI 10.1083/jcb.98.1.97; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kinukawa M, 2007, J BIOCHEM, V142, P501, DOI 10.1093/jb/mvm154; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; Libusova L, 2004, EXP CELL RES, V295, P375, DOI 10.1016/j.yexcr.2004.01.009; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; LUCK D, 1977, P NATL ACAD SCI USA, V74, P3456, DOI 10.1073/pnas.74.8.3456; Maga JA, 1999, TRENDS CELL BIOL, V9, P409, DOI 10.1016/S0962-8924(99)01635-9; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; NAITOH Y, 1972, SCIENCE, V176, P523, DOI 10.1126/science.176.4034.523; Notari L, 2003, PHOTOCH PHOTOBIO SCI, V2, P1299, DOI 10.1039/b306774m; Notari L, 2001, BBA-BIOENERGETICS, V1504, P438, DOI 10.1016/S0005-2728(01)00160-8; Oberholzer M, 2007, TRENDS PARASITOL, V23, P71, DOI 10.1016/j.pt.2006.12.002; Oberholzer M, 2007, FASEB J, V21, P720, DOI 10.1096/fj.06-6818com; OKUNO M, 1979, J CELL SCI, V38, P105; OMOTO CK, 1985, CELL MOTIL CYTOSKEL, V5, P53, DOI 10.1002/cm.970050105; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; PIPERNO G, 1977, P NATL ACAD SCI USA, V74, P1600, DOI 10.1073/pnas.74.4.1600; Piperno G., 1982, Progress in Clinical and Biological Research, V80, P95; PIPERNO G, 1981, J CELL BIOL, V88, P73, DOI 10.1083/jcb.88.1.73; Pullen TJ, 2004, MOL BIOL CELL, V15, P3257, DOI 10.1091/mbc.E04-03-0217; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Ridgley E, 2000, MOL BIOCHEM PARASIT, V109, P195, DOI 10.1016/S0166-6851(00)00246-2; RUSSELL DG, 1983, EUR J CELL BIOL, V30, P137; SABORIO JL, 1989, J BIOL CHEM, V264, P4071; Santrich C, 1997, MOL BIOCHEM PARASIT, V90, P95, DOI 10.1016/S0166-6851(97)00149-7; Saravia NG, 2005, VACCINE, V23, P984, DOI 10.1016/j.vaccine.2004.07.044; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; Smith EF, 2002, MOL BIOL CELL, V13, P3303, DOI 10.1091/mbc.E02-04-0185; Smith JC, 2005, J PROTEOME RES, V4, P909, DOI 10.1021/pr050013h; STEBECK CE, 1995, MOL BIOCHEM PARASIT, V71, P1, DOI 10.1016/0166-6851(95)00022-S; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Wargo MJ, 2005, J CELL SCI, V118, P4655, DOI 10.1242/jcs.02585; Werner M, 2008, BIOL REV, V83, P191, DOI 10.1111/j.1469-185X.2008.00039.x; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirschell M, 2004, MOL BIOL CELL, V15, P2729, DOI 10.1091/mbc.E03-11-0820; WOODWARD R, 1994, MOL BIOCHEM PARASIT, V67, P31, DOI 10.1016/0166-6851(94)90093-0; WRIGHTSMAN RA, 1995, INFECT IMMUN, V63, P122, DOI 10.1128/IAI.63.1.122-125.1995; Yagi T, 2000, CELL STRUCT FUNCT, V25, P263, DOI 10.1247/csf.25.263; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811	92	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5610	5619		10.1074/jbc.M808859200	http://dx.doi.org/10.1074/jbc.M808859200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19074134	Green Published, hybrid			2022-12-27	WOS:000263560600024
J	Chen, X; Wang, KH; Chen, JN; Guo, JG; Yin, Y; Cai, X; Guo, X; Wang, GQ; Yang, R; Zhu, LY; Zhang, Y; Wang, J; Xiang, Y; Weng, CY; Zen, K; Zhang, JF; Zhang, CY				Chen, Xi; Wang, Kehui; Chen, Jiangning; Guo, Jigang; Yin, Yuan; Cai, Xing; Guo, Xing; Wang, Guoqiang; Yang, Rong; Zhu, Lingyun; Zhang, Yan; Wang, Jin; Xiang, Yang; Weng, Chunyue; Zen, Ke; Zhang, Junfeng; Zhang, Chen-Yu			In Vitro Evidence Suggests That miR-133a-mediated Regulation of Uncoupling Protein 2 (UCP2) Is an Indispensable Step in Myogenic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-HYPERTROPHY; ENERGY-METABOLISM; REDOX-REGULATION; MUSCLE-CELLS; MICRORNAS; TRANSCRIPTION; EXPRESSION; HEART; MODULATE; STRESS	UCP2 and UCP3, two novel uncoupling proteins, are important regulators of energy expenditure and thermogenesis in various organisms. The striking disparity between UCP2 mRNA and protein levels in muscle tissues prompted initial speculation that microRNAs are implicated in the regulatory pathway of UCP2. We found, for the first time, that the repression of UCP2 expression in cardiac and skeletal muscle resulted from its targeting by a muscle-specific microRNA, miR-133a. Moreover, our findings illustrate a novel function of UCP2 as a brake for muscle development. We also show that MyoD can remove the braking role of UCP2 via direct up-regulation of miR-133a during myogenic differentiation. Taken together, our current work delineates a novel regulatory network employing MyoD, microRNA, and uncoupling proteins to fine-tune the balance between muscle differentiation and proliferation during myogenesis.	[Chen, Xi; Wang, Kehui; Chen, Jiangning; Guo, Jigang; Yin, Yuan; Cai, Xing; Guo, Xing; Wang, Guoqiang; Yang, Rong; Zhu, Lingyun; Zhang, Yan; Wang, Jin; Xiang, Yang; Weng, Chunyue; Zen, Ke; Zhang, Junfeng; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, Jiangsu Diabet Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University	Zen, K (corresponding author), Nanjing Univ, Sch Life Sci, Jiangsu Diabet Ctr, State Key Lab Pharmaceut Biotechnol, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	kzen@nju.edu.cn; jfzhang@nju.edu.cn; cyzhang@nju.edu.cn	Yin, Yuan/AAG-1707-2020; 殷, 媛/GSE-4523-2022	/0000-0002-0420-4508	National Natural Science Foundation of China [90813035, 30890044, 30570731, 30771036]; National Basic Research Program of China [2006CB503908, 2006CB503909, 2004CB518603, 2003CB715905]; Natural Science Foundation of Jiangsu Province [BK2004082, BK2006714]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Natural Science Foundation of China ( Grants 90813035, 30890044, 30570731, and 30771036), the National Basic Research Program of China ( 973 Program) ( Grants 2006CB503908, 2006CB503909, 2004CB518603, and 2003CB715905), the "111" Project, and the Natural Science Foundation of Jiangsu Province ( Grants BK2004082 and BK2006714).	Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bodyak N, 2007, AM J PHYSIOL-HEART C, V293, pH829, DOI 10.1152/ajpheart.01409.2006; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Duval C, 2007, FEBS LETT, V581, P955, DOI 10.1016/j.febslet.2007.01.085; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Laloi C, 2004, CURR OPIN PLANT BIOL, V7, P323, DOI 10.1016/j.pbi.2004.03.005; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Murakami K, 2002, HYPERTENSION, V40, P251, DOI 10.1161/01.HYP.0000029094.85023.01; Murray AJ, 2004, LANCET, V364, P1786, DOI 10.1016/S0140-6736(04)17402-3; Neubauer S, 1997, CIRCULATION, V96, P2190; Noma T, 2001, FASEB J, V15, P1206, DOI 10.1096/fj.000569fje; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; OLSON EN, 1993, CIRC RES, V72, P1, DOI 10.1161/01.RES.72.1.1; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Piao YJ, 2005, FREE RADICAL BIO MED, V38, P989, DOI 10.1016/j.freeradbiomed.2004.11.011; Puceat M, 2005, ANTIOXID REDOX SIGN, V7, P1435, DOI 10.1089/ars.2005.7.1435; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Schrauwen P, 2002, J EXP BIOL, V205, P2275; Soulez M, 1996, MOL CELL BIOL, V16, P6065; Su B, 2001, CIRC RES, V89, P39, DOI 10.1161/hh1301.093615; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103	33	74	81	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5362	5369		10.1074/jbc.M807523200	http://dx.doi.org/10.1074/jbc.M807523200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19073597	hybrid			2022-12-27	WOS:000263416600066
J	Gould, CM; Kannan, N; Taylor, SS; Newton, AC				Gould, Christine M.; Kannan, Natarajan; Taylor, Susan S.; Newton, Alexandra C.			The Chaperones Hsp90 and Cdc37 Mediate the Maturation and Stabilization of Protein Kinase C through a Conserved PXXP Motif in the C-terminal Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE-DEPENDENT KINASE; PROLINE-RICH MOTIF; HYDROPHOBIC-MOTIF; TURN MOTIF; MOLECULAR CHAPERONES; PHOSPHORYLATION; AKT; PKC; DOMAIN; STABILITY	The life cycle of protein kinase C (PKC) is tightly controlled by mechanisms that mature the enzyme, sustain the activation-competent enzyme, and degrade the enzyme. Here we show that a conserved PXXP motif (Kannan, N., Haste, N., Taylor, S. S., and Neuwald, A. F. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 1272-1277), in the C-terminal tail of AGC (c-AMP-dependent protein kinase/protein kinase G/protein kinase C) kinases, controls the processing phosphorylation of conventional and novel PKC isozymes, a required step in the maturation of the enzyme into a signaling-competent species. Mutation of both Pro-616 and Pro-619 to Ala in the conventional PKC beta II abolishes the phosphorylation and activity of the kinase. Co-immunoprecipitation studies reveal that conventional and novel, but not atypical, PKC isozymes bind the chaperones Hsp90 and Cdc37 through a PXXP-dependent mechanism. Inhibitors of Hsp90 and Cdc37 significantly reduce the rate of processing phosphorylation of PKC. Of the two C-terminal sites processed by phosphorylation, the hydrophobic motif, but not the turn motif, is regulated by Hsp90. Overlay of purified Hsp90 onto a peptide array containing peptides covering the catalytic domain of PKC beta II identified regions surrounding the PXXP segment, but not the PXXP motif itself, as major binding determinants for Hsp90. These Hsp90-binding regions, however, are tethered to the C-terminal tail via a "molecular clamp" formed between the PXXP motif and a conserved Tyr (Tyr-446) in the alpha E-helix. Disruption of the clamp by mutation of the Tyr to Ala recapitulates the phosphorylation defect of mutating the PXXP motif. These data are consistent with a model in which a molecular clamp created by the PXXP motif in the C-terminal tail and determinants in the alpha E-helix of the catalytic domain allows the chaperones Hsp90 and Cdc37 to bind newly synthesized PKC, a required event in the processing of PKC by phosphorylation.	[Gould, Christine M.; Kannan, Natarajan; Taylor, Susan S.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92039 USA; [Gould, Christine M.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92039 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92039 USA.	anewton@ucsd.edu			National Institutes of Health [2T32 GM-07752, GM-43154, P01 DK54441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM043154, R37GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Grants 2T32 GM-07752 (to C. G.) and by National Institutes of Health Grants GM-43154 and P01 DK54441. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; Cameron AJ, 2008, INT J CANCER, V123, P769, DOI 10.1002/ijc.23560; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fields Alan P, 2003, Methods Mol Biol, V233, P519; Freeley M, 2005, BIOCHEM BIOPH RES CO, V334, P619, DOI 10.1016/j.bbrc.2005.06.136; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2006, J BIOL CHEM, V281, P32461, DOI 10.1074/jbc.M604076200; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; Gray PJ, 2007, CANCER RES, V67, P11942, DOI 10.1158/0008-5472.CAN-07-3162; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jane EP, 2008, CANCER LETT, V268, P46, DOI 10.1016/j.canlet.2008.03.039; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Kane LP, 2004, J IMMUNOL, V172, P5441, DOI 10.4049/jimmunol.172.9.5441; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KARNITZ LM, 2007, SCI STKE 2007, pE22; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McCarthy MM, 2008, ANN ONCOL, V19, P590, DOI 10.1093/annonc/mdm545; Moriwaki Y, 2008, NEUROSCI RES, V61, P43, DOI 10.1016/j.neures.2008.01.006; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; ORR JW, 1992, J BIOL CHEM, V267, P15263; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; REED SI, 1980, GENETICS, V95, P561; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200; Standaert ML, 2001, BIOCHEMISTRY-US, V40, P249, DOI 10.1021/bi0018234; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2002, CELL STRESS CHAPERON, V7, P91, DOI 10.1379/1466-1268(2002)007<0091:HNGRTI>2.0.CO;2; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yeong SS, 2006, J BIOL CHEM, V281, P30768, DOI 10.1074/jbc.M511278200; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Ziegler WH, 1999, CURR BIOL, V9, P522, DOI 10.1016/S0960-9822(99)80236-X	62	87	89	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4921	4935		10.1074/jbc.M808436200	http://dx.doi.org/10.1074/jbc.M808436200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19091746	Green Published, hybrid			2022-12-27	WOS:000263416600022
J	Ren, B; Duan, XW; Ding, HG				Ren, Binbin; Duan, Xuewu; Ding, Huangen			Redox Control of the DNA Damage-inducible Protein DinG Helicase Activity via Its Iron-Sulfur Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE PRODUCTION; ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; ENDONUCLEASE-III; REPAIR; DOMAIN; BACH1; SOXR; GENE; RNA	The Escherichia coli DNA damage-inducible protein DinG, a member of the superfamily 2 DNA helicases, has been implicated in the nucleotide excision repair and recombinational DNA repair pathways. Combining UV-visible absorption, EPR, and enzyme activity measurements, we demonstrate here that E. coli DinG contains a redox-active [4Fe-S-4] cluster with a midpoint redox potential (E-m) of -390 +/- 23 mV (pH 8.0) and that reduction of the [4Fe-4S] cluster reversibly switches off the DinG helicase activity. Unlike the [4Fe-4S] cluster in E. coli dihydroxyacid dehydratase, the DinG [4Fe-4S] cluster is stable, and the enzyme remains fully active after exposure to 100-fold excess of hydrogen peroxide, indicating that DinG could be functional under oxidative stress conditions. However, the DinG [4Fe-4S] cluster can be efficiently modified by nitric oxide (NO), forming the DinG-bound dinitrosyl iron complex with the concomitant inactivation of helicase activity in vitro and in vivo. Reassembly of the [4Fe-4S] cluster in NO-modified DinG restores helicase activity, indicating that the iron-sulfur cluster in DinG is the primary target of NO cytotoxicity. The results led us to propose that the iron-sulfur cluster in DinG may act as a sensor of intracellular redox potential to modulate its helicase activity and that modification of the iron-sulfur cluster in DinG and likely in other DNA repair enzymes by NO may contribute to NO-mediated genomic instability.	[Ren, Binbin; Duan, Xuewu; Ding, Huangen] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Ding, HG (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	hding@lsu.edu	Ding, Huangen/AAJ-8550-2020	Ding, Huangen/0000-0002-4815-7336	United States Public Health Service [RO1 CA107494]; National Science Foundation [MCB-0416537]; NATIONAL CANCER INSTITUTE [R01CA107494] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA107494 from the United States Public Health Service. This work was also supported by National Science Foundation Grant MCB-0416537 (to H. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agarwalla S, 2004, J BIOL CHEM, V279, P34123, DOI 10.1074/jbc.M405702200; Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; CIOFFI EA, 1980, ANAL BIOCHEM, V104, P485, DOI 10.1016/0003-2697(80)90104-9; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; COWART RE, 1993, ANAL BIOCHEM, V211, P151, DOI 10.1006/abio.1993.1246; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; Ding HG, 1996, J BIOL CHEM, V271, P33173, DOI 10.1074/jbc.271.52.33173; Drapier JC, 1997, METHODS, V11, P319, DOI 10.1006/meth.1996.0426; Dutton P L, 1978, Methods Enzymol, V54, P411; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; FLINT DH, 1993, J BIOL CHEM, V268, P14732; Foster HW, 1999, J AM CHEM SOC, V121, P4093; Gal A, 1996, P NATL ACAD SCI USA, V93, P15102, DOI 10.1073/pnas.93.26.15102; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Gobert AP, 2001, P NATL ACAD SCI USA, V98, P13844, DOI 10.1073/pnas.241443798; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Hinks JA, 2002, J BIOL CHEM, V277, P16936, DOI 10.1074/jbc.M200668200; Ignarro LJ, 1999, BIOSCIENCE REP, V19, P51, DOI 10.1023/A:1020150124721; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P1497, DOI 10.1093/nar/21.6.1497; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; LEWIS LK, 1992, J BACTERIOL, V174, P3377, DOI 10.1128/jb.174.10.3377-3385.1992; Li CQ, 2002, P NATL ACAD SCI USA, V99, P10364, DOI 10.1073/pnas.162356399; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; McDevitt CA, 2002, BIOCHEMISTRY-US, V41, P15234, DOI 10.1021/bi026221u; Mettert EL, 2007, J BACTERIOL, V189, P3036, DOI 10.1128/JB.00052-07; Paraskeva E, 1996, FEBS LETT, V389, P40, DOI 10.1016/0014-5793(96)00574-1; Porello SL, 1998, BIOCHEMISTRY-US, V37, P6465, DOI 10.1021/bi972433t; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Ren BB, 2008, MOL MICROBIOL, V70, P953, DOI 10.1111/j.1365-2958.2008.06464.x; Rogers PA, 2003, DNA REPAIR, V2, P809, DOI 10.1016/S1568-7864(03)00065-X; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; TAMIR S, 1993, CHEM RES TOXICOL, V6, P895, DOI 10.1021/tx00036a021; Van Dyk TK, 2001, J BACTERIOL, V183, P5496, DOI 10.1128/JB.183.19.5496-5505.2001; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Yang JJ, 2006, J BIOL CHEM, V281, P27956, DOI 10.1074/jbc.M601356200; Yang WY, 2002, J BIOL CHEM, V277, P12868, DOI 10.1074/jbc.M109485200	52	62	65	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4829	4835		10.1074/jbc.M807943200	http://dx.doi.org/10.1074/jbc.M807943200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19074432	Green Published, hybrid			2022-12-27	WOS:000263416600011
J	Csibi, A; Leibovitch, MP; Cornille, K; Tintignac, LA; Leibovitch, SA				Csibi, Alfredo; Leibovitch, Marie Pierre; Cornille, Karen; Tintignac, Lionel A.; Leibovitch, Serge A.			MAFbx/Atrogin-1 Controls the Activity of the Initiation Factor eIF3-f in Skeletal Muscle Atrophy by Targeting Multiple C-terminal Lysines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; FACTOR 3F; TRANSLATION; MTOR; EXPRESSION; ATROGIN-1; LIGASES; GROWTH; EIF4G	We recently presented evidence that the subunit eIF3-f of the eukaryotic initiation translation factor eIF3 that interacts with the E3-ligase Atrogin-1/muscle atrophy F-box (MAFbx) for polyubiquitination and proteasome-mediated degradation is a key target that accounts for MAFbx function during muscle atrophy. To understand this process, deletion analysis was used to identify the region of eIF3-f that is required for its proteolysis. Here, we report that the highly conserved C-terminal domain of eIF3-f is implicated for MAFbx-directed polyubiquitination and proteasomal degradation. Site-directed mutagenesis of eIF3-f revealed that the six lysine residues within this domain are required for full polyubiquitination and degradation by the proteasome. In addition, mutation of these six lysines (mutant K5-10R) displayed hypertrophic activity in cellulo and in vivo and was able to protect against starvation-induced muscle atrophy. Taken together, our data demonstrate that the C-terminal modifications, believed to be critical for proper eIF3-f regulation, are essential and contribute to a fine-tuning mechanism that plays an important role for eIF3-f function in skeletal muscle.	[Csibi, Alfredo; Leibovitch, Marie Pierre; Cornille, Karen; Tintignac, Lionel A.; Leibovitch, Serge A.] SupAgro Inst Natl Rech Agron, Lab Genom Fonct & Myogenese, Differenciat Cellulaire & Croissance UMR866, F-34060 Montpellier 1, France; [Csibi, Alfredo] Univ Montpellier Sud France, F-34060 Montpellier 1, France	INRAE; Institut Agro; Montpellier SupAgro	Leibovitch, SA (corresponding author), SupAgro Inst Natl Rech Agron, Lab Genom Fonct & Myogenese, Differenciat Cellulaire & Croissance UMR866, 2 Pl Pierre Viala, F-34060 Montpellier 1, France.	leibovs@supagro.inra.fr			"Association Francaise contre les Myopathies" (AFM); INRA; INSERM	"Association Francaise contre les Myopathies" (AFM)(Association Francaise contre les Myopathies); INRA; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from the "Association Francaise contre les Myopathies" (AFM), the department PHASE from INRA, and INSERM.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Csibi A, 2008, CELL CYCLE, V7, P1698, DOI 10.4161/cc.7.12.6090; Doldan A, 2008, MOL CARCINOGEN, V47, P806, DOI 10.1002/mc.20436; Doldan A, 2008, MOL CARCINOGEN, V47, P235, DOI 10.1002/mc.20379; Fraser CS, 2004, J BIOL CHEM, V279, P8946, DOI 10.1074/jbc.M312745200; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; GOLDSPINK DF, 1983, BIOCHEM J, V210, P89, DOI 10.1042/bj2100089; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tisdale Michael J, 2005, J Support Oncol, V3, P209; Xiao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001494; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	28	68	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4413	4421		10.1074/jbc.M807641200	http://dx.doi.org/10.1074/jbc.M807641200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19073596	Green Published, hybrid			2022-12-27	WOS:000263134400041
J	Rodriguez-Galan, O; Galindo, A; Hervas-Aguilar, A; Arst, HN; Penalva, MA				Rodriguez-Galan, Olga; Galindo, Antonio; Hervas-Aguilar, America; Arst, Herbert N., Jr.; Penalva, Miguel A.			Physiological Involvement in pH Signaling of Vps24-mediated Recruitment of Aspergillus PalB Cysteine Protease to ESCRT-III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER TRANSCRIPTION FACTOR; YEAST YARROWIA-LIPOLYTICA; AMBIENT PH; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; STRUCTURAL BASIS; PLASMA-MEMBRANE; RIM101 PATHWAY; UBIQUITIN ISOPEPTIDASE; ALKALINE PH	Activation of the Aspergillus nidulans transcription factor PacC, which mediates ambient pH regulation of gene expression and is recruited to ESCRT-III by the Vps32-interacting scaffold PalA, involves its ambient pH-dependent C-terminal proteolysis. This reaction is almost certainly catalyzed by the PalB calpain-like protease. Here we show that PalB associates with membranes and interacts specifically and directly with ESCRT-III Vps24. The PalB N-terminal MIT domain and the Vps24 C-terminal MIM motif are necessary and sufficient for this interaction. PalB(Delta MIT), a mutant PalB lacking the MIT domain is inefficiently recruited to membranes and impaired in PacC proteolytic processing. Notably, membrane recruitment is promoted and PacC processing largely restored by covalent attachment of Vps24 to mutant PalB(Delta MIT). This is the first reported evidence that calpain-like recruitment to ESCRT-III lattices plays a physiological role. It unambiguously positions the calpain-like protease PalB within the ESCRT-III-associated pH signaling complex, underlines the positive role of ESCRT-III in ambient pH signal transduction, and suggests a possible mechanism for PalB activation.	[Rodriguez-Galan, Olga; Galindo, Antonio; Hervas-Aguilar, America; Penalva, Miguel A.] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Arst, Herbert N., Jr.] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, London SW7 2AZ, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Imperial College London	Penalva, MA (corresponding author), CSIC, Ctr Invest Biol, Ramiro Maeztu 9, Madrid 28040, Spain.	penalva@cib.csic.es	Rodríguez-Galán, Olga/K-5580-2015; Galindo, Antonio/A-9991-2018; Penalva, Miguel A/G-2295-2015	Rodríguez-Galán, Olga/0000-0002-3137-8554; Galindo, Antonio/0000-0002-1108-652X; Penalva, Miguel A/0000-0002-3102-2806	DGICYT; Comunidad de Madrid [BIO2005-0556, S2006/SAL-024]; Wellcome Trust [067878, 084660]; BBSRC [BB/F01189X/1]	DGICYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by DGICYT and Comunidad de Madrid Grants BIO2005-0556 and S2006/SAL-024, respectively, (to M.A.P.) and by Wellcome Trust Grants 067878 and 084660 and BBSRC grant BB/F01189X/1 (to H.N.A.).	Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; Arst HN, 2003, TRENDS GENET, V19, P224, DOI 10.1016/S0168-9525(03)00052-0; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Blanchin-Roland S, 2005, MICROBIOL-SGM, V151, P3627, DOI 10.1099/mic.0.28196-0; Blanchin-Roland S, 2008, MICROBIOL-SGM, V154, P1668, DOI 10.1099/mic.0.2008/017046-0; Boysen JH, 2006, MOL BIOL CELL, V17, P1344, DOI 10.1091/mbc.e05-10-0949; Calcagno-Pizarelli AM, 2007, EUKARYOT CELL, V6, P2365, DOI 10.1128/EC.00275-07; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Cornet M, 2005, INFECT IMMUN, V73, P7977, DOI 10.1128/IAI.73.12.7977-7987.2005; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; DENISON SH, 1995, J BIOL CHEM, V270, P28519, DOI 10.1074/jbc.270.48.28519; Denison SH, 1998, MOL MICROBIOL, V30, P259, DOI 10.1046/j.1365-2958.1998.01058.x; Diez E, 2002, EMBO J, V21, P1350, DOI 10.1093/emboj/21.6.1350; Espeso EA, 1997, J MOL BIOL, V274, P466, DOI 10.1006/jmbi.1997.1428; Espeso EA, 2000, MOL CELL BIOL, V20, P3355, DOI 10.1128/MCB.20.10.3355-3363.2000; Espeso EA, 1996, J BIOL CHEM, V271, P28825, DOI 10.1074/jbc.271.46.28825; Futai E, 1999, MOL GEN GENET, V260, P559, DOI 10.1007/s004380050929; Futai E, 2001, BBA-GENE STRUCT EXPR, V1517, P316, DOI 10.1016/S0167-4781(00)00256-6; Galindo A, 2007, TRAFFIC, V8, P1346, DOI 10.1111/j.1600-0854.2007.00620.x; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Hervas-Aguilar A, 2007, J BIOL CHEM, V282, P34735, DOI 10.1074/jbc.M706723200; Howard TL, 2001, J CELL SCI, V114, P2395; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kullas AL, 2004, EUKARYOT CELL, V3, P1609, DOI 10.1128/EC.3.6.1609-1618.2004; Kyuuma M, 2006, CELL STRUCT FUNCT, V31, P159, DOI 10.1247/csf.06023; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Li WS, 1997, GENETICS, V145, P63; Ma YM, 2007, J BIOL CHEM, V282, P9805, DOI 10.1074/jbc.M611635200; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mingot JM, 1999, MOL CELL BIOL, V19, P1390; Mitchell AP, 2008, P NATL ACAD SCI USA, V105, P7111, DOI 10.1073/pnas.0803384105; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Negrete-Urtasun S, 1999, MOL MICROBIOL, V33, P994, DOI 10.1046/j.1365-2958.1999.01540.x; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; OREJAS M, 1995, GENE DEV, V9, P1622, DOI 10.1101/gad.9.13.1622; Osmani AH, 2006, NAT PROTOC, V1, P2517, DOI 10.1038/nprot.2006.406; OSMANI SA, 1988, CELL, V52, P241, DOI 10.1016/0092-8674(88)90513-2; Penalva MA, 2004, ANNU REV MICROBIOL, V58, P425, DOI 10.1146/annurev.micro.58.030603.123715; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Penas MM, 2007, EUKARYOT CELL, V6, P960, DOI 10.1128/EC.00047-07; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; RIEDER SE, 2001, CURR PROTOC CELL BIO; Rothfels K, 2005, MOL CELL BIOL, V25, P6772, DOI 10.1128/MCB.25.15.6772-6788.2005; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tatsumi A, 2007, BIOCHEM BIOPH RES CO, V362, P474, DOI 10.1016/j.bbrc.2007.08.027; Tatsumi A, 2006, BIOCHEM BIOPH RES CO, V347, P970, DOI 10.1016/j.bbrc.2006.06.183; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Tompa P, 2001, BIOCHEM BIOPH RES CO, V280, P1333, DOI 10.1006/bbrc.2001.4279; Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Xu WJ, 2001, J BACTERIOL, V183, P6917, DOI 10.1128/JB.183.23.6917-6923.2001; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666; Yorikawa C, 2008, J BIOCHEM, V143, P731, DOI 10.1093/jb/mvn030	74	46	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4404	4412		10.1074/jbc.M808645200	http://dx.doi.org/10.1074/jbc.M808645200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19056728	Green Published, hybrid			2022-12-27	WOS:000263134400040
J	Tsai, CM; Jankowska-Stephens, E; Mizanur, RM; Cipollo, JF				Tsai, Chao-Ming; Jankowska-Stephens, Ewa; Mizanur, Rahman M.; Cipollo, John F.			The Fine Structure of Neisseria meningitidis Lipooligosaccharide from the M986 Strain and Three of Its Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER-CORE LIPOPOLYSACCHARIDE; OUTER-MEMBRANE PROTEINS; GROUP-B; IMMUNOTYPE EPITOPES; SECONDARY RESPONSE; GROUP-A; OLIGOSACCHARIDE; PHOSPHOETHANOLAMINE; IMMUNORESPONSES; IDENTIFICATION	Neisseria meningitidis is a cause of fatal sepsis and epidemic meningitis. A major virulence factor is cell wall lipooligosaccharide (LOS). The M986 strain has been used extensively in immunological and vaccine research. Yet, the LOS repertoire of this strain is not known. Here we have investigated the LOS structures of M986 and three of its variants OP1, OP2-, and OP2+. This strain and its variants present a series of related LOS families that are increasingly truncated in their listed order. The major structural differences are seen in the lacto-N-neotetraose alpha-chain. The gamma-chain Hep II contains two phosphoethanolamine (PEA) substitutions at C3 and C6/7. These substitutions were seen in all strains except OP2+ where the canonical core Hep II is missing. The PEA disubstitution was present in nearly stoichiometric amounts with only minor amounts of monosubstitution observed, and no glycomers devoid of PEA were seen. This was also the case in LOS with a complete lacto-N-neotetraosyl alpha-chain even though previous reports suggested that the presence of an extended alpha-chain hinders C3 PEA substitution of Hep II. Approximately 50% of gamma-chain GlcNAc was present in its 3-OAc-substituted form. Because Hep II C3 PEA substitution and gamma-chain GlcNAc OAc addition have been reported to negatively interact, the co-existence of these two modifications in these strains is unique. The LOS structures of M986 and three of its variants have been determined, which better defines these strains as tools for immunological and vaccine research.	[Cipollo, John F.] NIH, Ctr Biol Evaluat & Res, US FDA, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA)	Cipollo, JF (corresponding author), NIH, Ctr Biol Evaluat & Res, US FDA, Bldg 29,Rm 126,8800 Rockville Pike, Bethesda, MD 20892 USA.	john.cipollo@fda.hhs.gov			Department of Energy [DE-FG09-93ER-20097]	Department of Energy(United States Department of Energy (DOE))	This work was supported by the Department of Energy-funded (Grant DE-FG09-93ER-20097) Center for Plant and Microbial Complex Carbohydrates. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASHTON FE, 1983, J MED MICROBIOL, V16, P443, DOI 10.1099/00222615-16-4-443; BANERJEEBHATNAGAR N, 1990, INFECT IMMUN, V58, P2875, DOI 10.1128/IAI.58.9.2875-2881.1990; Bayliss CD, 2008, INFECT IMMUN, V76, P5038, DOI 10.1128/IAI.00395-08; Cartwright Keith, 2001, Vaccine, V19, P4347, DOI 10.1016/S0264-410X(01)00205-5; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Cox AD, 2003, EUR J BIOCHEM, V270, P1759, DOI 10.1046/j.1432-1033.2003.03535.x; Cox AD, 2002, CARBOHYD RES, V337, P1435, DOI 10.1016/S0008-6215(02)00161-1; Cox AD, 2002, EUR J BIOCHEM, V269, P4169, DOI 10.1046/j.1432-1033.2002.03131.x; DEVI SJN, 1991, P NATL ACAD SCI USA, V88, P7175, DOI 10.1073/pnas.88.16.7175; DIFABIO JL, 1990, CAN J CHEM, V68, P1029, DOI 10.1139/v90-160; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; DYER DW, 1988, INFECT IMMUN, V56, P977, DOI 10.1128/IAI.56.4.977-983.1988; FARO J, 1987, MED MICROBIOL IMMUN, V176, P289; FARO J, 1986, INFECT IMMUN, V51, P224, DOI 10.1128/IAI.51.1.224-232.1986; FARO J, 1987, MED MICROBIOL IMMUN, V176, P131; FARO J, 1985, INFECT IMMUN, V48, P428, DOI 10.1128/IAI.48.2.428-432.1985; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GAMIAN A, 1992, J BIOL CHEM, V267, P922; GIBSON BW, 1993, J BACTERIOL, V175, P2702, DOI 10.1128/JB.175.9.2702-2712.1993; GU XX, 1991, ANAL BIOCHEM, V196, P311, DOI 10.1016/0003-2697(91)90472-6; HARDY MR, 1988, ANAL BIOCHEM, V170, P54, DOI 10.1016/0003-2697(88)90089-9; JENNINGS HJ, 1981, J IMMUNOL, V127, P1011; JENNINGS HJ, 1983, CARBOHYD RES, V121, P233, DOI 10.1016/0008-6215(83)84020-8; Kahler CM, 2006, J BIOL CHEM, V281, P19939, DOI 10.1074/jbc.M601308200; Kahler CM, 2005, GLYCOBIOLOGY, V15, P409, DOI 10.1093/glycob/cwi018; KAHLER CM, 2004, GLYCOBIOLOGY; KIM JJ, 1994, INFECT IMMUN, V62, P1566, DOI 10.1128/IAI.62.5.1566-1575.1994; Kogan G, 1997, CARBOHYD RES, V298, P191, DOI 10.1016/S0008-6215(96)00305-9; Mackinnon FG, 2002, MOL MICROBIOL, V43, P931, DOI 10.1046/j.1365-2958.2002.02754.x; MICHON F, 1990, J BIOL CHEM, V265, P7243; Minetti CASA, 1997, J BIOL CHEM, V272, P10710; O'Connor ET, 2006, J BACTERIOL, V188, P1039, DOI 10.1128/JB.188.3.1039-1048.2006; PAVLIAK V, 1993, J BIOL CHEM, V268, P14146; Plested JS, 2003, J INFECT DIS, V187, P1223, DOI 10.1086/368360; Quakyi EK, 1997, PATHOBIOLOGY, V65, P26, DOI 10.1159/000164100; Quakyi EK, 1999, J INFECT DIS, V180, P747, DOI 10.1086/314927; Quakyi EK, 1997, INFECT IMMUN, V65, P1972, DOI 10.1128/IAI.65.5.1972-1979.1997; Ram S, 2007, INFECT IMMUN, V75, P4071, DOI 10.1128/IAI.01109-06; SCHOLTEN RJPM, 1994, J MED MICROBIOL, V41, P236, DOI 10.1099/00222615-41-4-236; TSAI CM, 1980, J BACTERIOL, V141, P169, DOI 10.1128/JB.141.1.169-176.1980; Tsai CM, 2002, INFECT IMMUN, V70, P407, DOI 10.1128/IAI.70.1.407-411.2002; TSAI CM, 1987, INFECT IMMUN, V55, P1652, DOI 10.1128/IAI.55.7.1652-1656.1987; TSAI CM, 1983, J BACTERIOL, V155, P498, DOI 10.1128/JB.155.2.498-504.1983; Wright JC, 2004, J BACTERIOL, V186, P6970, DOI 10.1128/JB.186.20.6970-6982.2004	44	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4616	4625		10.1074/jbc.M808209200	http://dx.doi.org/10.1074/jbc.M808209200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19095648	hybrid			2022-12-27	WOS:000263134400061
J	Sampathi, S; Bhusari, A; Shen, BH; Chai, WH				Sampathi, Shilpa; Bhusari, Amruta; Shen, Binghui; Chai, Weihang			Human Flap Endonuclease I Is in Complex with Telomerase and Is Required for Telomerase-mediated Telomere Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CELLULAR SENESCENCE; CATALYTIC SUBUNIT; HUMAN-CHROMOSOMES; POLYMERASE ALPHA; END REPLICATION; STEM-CELLS; LENGTH	Studies from budding yeast and ciliates have suggested that telomerase extension of telomeres requires the conventional DNA replication machinery, yet little is known about how DNA replication proteins regulate telomerase action in higher eukaryotic cells. Here we investigate the role of one of the DNA replication factors, flap endonuclease I (FEN1), in regulating telomerase activity in mammalian cells. FEN1 is a nuclease that plays an important role in DNA replication, repair, and recombination. We show that FEN1 is in complex with telomerase in vivo via telomeric DNA. We further demonstrate that FEN1 deficiency in mouse embryonic fibroblasts leads to an increase in telomere end-to-end fusions. In cancer cells, FEN1 deficiency induces gradual shortening of telomeres but does not alter the single-stranded G-overhangs. This is, to our knowledge, the first evidence that FEN1 and telomerase physically co-exist as a complex and that FEN1 can regulate telomerase activity at telomeres in mammalian cells.	[Sampathi, Shilpa; Chai, Weihang] Washington State Univ, WWAMI Med Educ Program, Spokane, WA 99210 USA; [Sampathi, Shilpa; Chai, Weihang] Washington State Univ, Sch Mol Biosci, Spokane, WA 99210 USA; [Bhusari, Amruta] Texas Womans Univ, Dept Biol, Denton, TX 76204 USA; [Shen, Binghui] City Hope Natl Med Ctr, Dept Radiat Biol, Duarte, CA 91010 USA; [Shen, Binghui] Beckman Res Inst, Duarte, CA 91010 USA	Washington State University; Washington State University; Texas Womans University; City of Hope; City of Hope; Beckman Research Institute of City of Hope	Chai, WH (corresponding author), Washington State Univ, WWAMI Med Educ Program, Hlth Sci Bldg 320L,POB 1495, Spokane, WA 99210 USA.	wchai@wsu.edu	Chai, Weihang/AAG-5194-2021	Shen, Binghui/0000-0002-4408-407X	National Institutes of Health [R15CA132090, R01CA073764]; Texas Woman's University Research Enhancement Program; NATIONAL CANCER INSTITUTE [R01CA073764, R15CA132090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Woman's University Research Enhancement Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R15CA132090 (to W. C.) and R01CA073764 (to B. H. S.). This work was also supported by Texas Woman's University Research Enhancement Program (to W. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams AK, 1996, MOL CELL BIOL, V16, P4614; BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; CARSON MJ, 1985, CELL, V42, P249, DOI 10.1016/S0092-8674(85)80120-3; Chai WH, 2006, MOL CELL, V21, P427, DOI 10.1016/j.molcel.2005.12.004; Chai WH, 2005, MOL CELL BIOL, V25, P2158, DOI 10.1128/MCB.25.6.2158-2168.2005; Chai WH, 2002, J BIOL CHEM, V277, P47242, DOI 10.1074/jbc.M208542200; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Dahlen M, 2003, MOL CELL BIOL, V23, P3031, DOI 10.1128/MCB.23.9.3031-3042.2003; de Lange T, 2006, COLD SPRING HARB MON, V45, P387; Deng Z, 2007, CURR BIOL, V17, P1989, DOI 10.1016/j.cub.2007.10.054; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Fan XQ, 1997, MOL BIOL CELL, V8, P2145, DOI 10.1091/mbc.8.11.2145; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Herbert B-S, 2003, ANAL TELOMERES TELOM; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kikuchi K, 2005, MOL CELL BIOL, V25, P6948, DOI 10.1128/MCB.25.16.6948-6955.2005; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; Muftuoglu M, 2006, CANCER RES, V66, P113, DOI 10.1158/0008-5472.CAN-05-2742; Ohki R, 2001, MOL CELL BIOL, V21, P5753, DOI 10.1128/MCB.21.17.5753-5766.2001; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Parenteau J, 2002, GENETICS, V162, P1583; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Qi HY, 2000, GENE DEV, V14, P1777; Ray S, 2002, MOL CELL BIOL, V22, P5859, DOI 10.1128/MCB.22.16.5859-5868.2002; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; Sharma S, 2004, J BIOL CHEM, V279, P9847, DOI 10.1074/jbc.M309898200; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; Shay Jerry W., 1996, Current Opinion in Oncology, V8, P66, DOI 10.1097/00001622-199601000-00012; Shay JW, 2001, RADIAT RES, V155, P188, DOI 10.1667/0033-7587(2001)155[0188:TATIFC]2.0.CO;2; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; WRIGHT WE, 1989, MOL CELL BIOL, V9, P3088, DOI 10.1128/MCB.9.7.3088; Yago M, 2002, FEBS LETT, V520, P40, DOI 10.1016/S0014-5793(02)02757-6; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zou Y, 2004, P NATL ACAD SCI USA, V101, P12928, DOI 10.1073/pnas.0404106101; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207	53	26	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3682	3690		10.1074/jbc.M805362200	http://dx.doi.org/10.1074/jbc.M805362200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19068479	hybrid, Green Published			2022-12-27	WOS:000262872500036
J	Li, N; Wang, CM; Wu, YN; Liu, XG; Cao, XT				Li, Nan; Wang, Chunmei; Wu, Yanan; Liu, Xingguang; Cao, Xuetao			Ca2+/Calmodulin-dependent Protein Kinase II Promotes Cell Cycle Progression by Directly Activating MEK1 and Subsequently Modulating p27 Phosphorylation (Publication with Expression of Concern. See vol. 295, pg. 8879, 2020) (Withdrawn Publication. See vol. 296, 2021) (Withdrawn Publication. See vol. 296, 2021)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							DEPENDENT ACTIVATION; P27(KIP1); PATHWAY; CANCER; GROWTH; RAS; PROLIFERATION; CAMKII; ARREST; DEGRADATION	Cell proliferation is regulated by integration of multiple pathways, such as MAPK, phosphatidylinositol 3'-kinase, protein kinase C, and Ca2+/calmodulin-dependent protein kinase II (CaMKII) signaling, determining whether the cell proceeds into cell cycle progression. Recently, we have demonstrated that a novel endogenous CaMKII-inhibitory protein, hCaMKIIN alpha, suppresses tumor growth by inducing cell cycle arrest via p27 stabilization, accompanied by MEK/ERK deactivation. The data indicate a potential link between Ca2+/CaMKII and other signaling pathways, such as MAPK signaling. However, the detailed mechanisms of cross-talks between these important pathways on cell cycle regulation have not been specified. Here we report that CaMKII, in colon adenocarcinoma cells, activates MEK/ERK, which is responsible for the phosphorylation and subsequent proteasomal degradation of p27, thus causing the promotion of the S-G(2)/M transition of cell cycle progression. Importantly, we found that CaMKII can bind to MEK1 and that active CaMKII directly phosphorylates MEK1 in vitro, which could be abrogated by CaMKII inhibitor. Besides, ERK2 can directly interact with and phosphorylate p27. This is the first demonstration that CaMKII interplays with MEK1 and regulates p27 phosphorylation in the cell cycle progression. These findings provide mechanistic evidence for the cross-talk between CaMKII and MAPK signaling, which converges in MEK/ERK activation in the regulation of cell cycle progression.	[Li, Nan] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	Li, N (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China.	linan@immunol.org; caoxt@public3.sta.net.cn			Shanghai Committee of Science and Technology [06DJ14011]; National High Biotechnology Development Program of China [2006AA02A305]; National Natural Science Foundation of China [30570370, 30721091, 30772504]; New Century Excellent Talents in University	Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National High Biotechnology Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by Shanghai Committee of Science and Technology Grant 06DJ14011; National High Biotechnology Development Program of China Grant 2006AA02A305; National Natural Science Foundation of China Grants 30570370, 30721091, and 30772504; and the program for the New Century Excellent Talents in University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chen BC, 2001, BRIT J PHARMACOL, V134, P1055, DOI 10.1038/sj.bjp.0704334; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; Cuschieri J, 2005, SHOCK, V23, P99, DOI 10.1097/01.shk.0000148075.19190.db; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Gardoni F, 2007, J BIOL CHEM, V282, P28691, DOI 10.1074/jbc.M701899200; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; HAYCOCK JW, 1992, P NATL ACAD SCI USA, V89, P2365, DOI 10.1073/pnas.89.6.2365; Hershko DD, 2006, CANCER-AM CANCER SOC, V107, P668, DOI 10.1002/cncr.22073; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Illario M, 2005, J CLIN ENDOCR METAB, V90, P2865, DOI 10.1210/jc.2004-1520; Illario M, 2003, J BIOL CHEM, V278, P45101, DOI 10.1074/jbc.M305355200; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Jones SM, 2001, FEBS LETT, V490, P110, DOI 10.1016/S0014-5793(01)02113-5; Kawada M, 1997, ONCOGENE, V15, P629, DOI 10.1038/sj.onc.1201228; Lahlou H, 2003, J BIOL CHEM, V278, P39356, DOI 10.1074/jbc.M304524200; Levitt RJ, 2007, CANCER LETT, V255, P300, DOI 10.1016/j.canlet.2007.05.006; Maiti A, 2008, J BIOL CHEM, V283, P175, DOI 10.1074/jbc.M707269200; McCormick Frank, 1999, Trends in Cell Biology, V9, pM53, DOI 10.1016/S0962-8924(99)01668-2; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Morris TA, 1998, EXP CELL RES, V240, P218, DOI 10.1006/excr.1997.3925; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Schepers H, 2005, EXP HEMATOL, V33, P747, DOI 10.1016/j.exphem.2005.04.006; Shapira M, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1533; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; Wang CM, 2008, J BIOL CHEM, V283, P11565, DOI 10.1074/jbc.M800436200; Wolf G, 2003, DIABETOLOGIA, V46, P1090, DOI 10.1007/s00125-003-1163-z; Zhai H, 2005, EUR J PHARMACOL, V516, P112, DOI 10.1016/j.ejphar.2005.04.035	35	51	52	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3021	3027		10.1074/jbc.M805483200	http://dx.doi.org/10.1074/jbc.M805483200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19056740	hybrid			2022-12-27	WOS:000262700900046
J	Crow, A; Liu, YM; Moller, MC; Le Brun, NE; Hederstedt, L				Crow, Allister; Liu, Yiming; Moller, Mirja Carlsson; Le Brun, Nick E.; Hederstedt, Lars			Structure and Functional Properties of Bacillus subtilis Endospore Biogenesis Factor StoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; ESCHERICHIA-COLI THIOREDOXIN; CYTOCHROME-C MATURATION; ACTIVE-SITE; CYSTEINE RESIDUES; PK(A) VALUES; PROTEIN; RESA; MUTANTS; GENE	Bacillus subtilis StoA is an extracytoplasmic thiol-disulfide oxidoreductase (TDOR) important for the synthesis of the endospore peptidoglycan cortex protective layer. Here we demonstrate that StoA is membrane-associated in B. subtilis and report the crystal structure of the soluble protein lacking its membrane anchor. This showed that StoA adopts a thioredoxin-like fold with N-terminal and internal additions that are characteristic of extracytoplasmic TDORs. The CXXC active site of the crystallized protein was found to be in a mixture of oxidized and reduced states, illustrating that there is little conformational variation between redox states. The midpoint reduction potential was determined as -248 mV versus normal hydrogen electrode at pH 7 consistent with StoA fulfilling a reductive role in endospore biogenesis. pKa values of the active site cysteines, Cys-65 and Cys-68, were determined to be 5.5 and 7.8. Although Cys-68 is buried within the structure, both cysteines were found to be accessible to cysteine-specific alkylating reagents. In vivo studies of site-directed variants of StoA revealed that the active site cysteines are functionally important, as is Glu-71, which lies close to the active site and is conserved in many reducing extracytoplasmic TDORs. The structure and biophysical properties of StoA are very similar to those of ResA, a B. subtilis extracytoplasmic TDOR involved in cytochrome c maturation, raising important general questions about how these similar but non-redundant proteins achieve specificity. A detailed comparison of the two proteins demonstrates that relatively subtle differences, largely located around the active sites of the proteins, are sufficient to confer specificity.	[Crow, Allister; Le Brun, Nick E.] Univ E Anglia, Sch Chem Sci & Pharm, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Liu, Yiming; Moller, Mirja Carlsson; Hederstedt, Lars] Lund Univ, Dept Cell & Organism Biol, SE-22362 Lund, Sweden	University of East Anglia; Lund University	Le Brun, NE (corresponding author), Univ E Anglia, Sch Chem Sci & Pharm, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England.	n.le-brun@uea.ac.uk; Lars.Hederstedt@cob.lu.se	Crow, Allister/F-2147-2018	Crow, Allister/0000-0001-6856-5962; Carlsson Moller, Mirja/0000-0001-8695-6262; Hederstedt, Lars/0000-0002-6650-6296; Le Brun, Nick/0000-0001-9780-4061	Federation of European Microbiological Societies research fellowship; Swedish Research Council [6212007-6094]; Wellcome Trust Grant [076017/Z/04/Z]; Biotechnology and Biological Sciences Research Council [BB/C503597/1] Funding Source: researchfish	Federation of European Microbiological Societies research fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wellcome Trust Grant(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Federation of European Microbiological Societies research fellowship ( to M. C. M.), by Swedish Research Council Grant 6212007-6094, and by Wellcome Trust Grant 076017/Z/04/Z. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; Crow A, 2005, BIOCHEM SOC T, V33, P149, DOI 10.1042/BST0330149; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; DeLano W.L, PYMOL MOL GRAPHICS S; Edeling MA, 2002, STRUCTURE, V10, P973, DOI 10.1016/S0969-2126(02)00794-3; Erlendsson LS, 2004, J BACTERIOL, V186, P6230, DOI 10.1128/JB.186.18.6230-6238.2004; Erlendsson LS, 2003, J BIOL CHEM, V278, P17852, DOI 10.1074/jbc.M300103200; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FORTNAGEL P, 1968, J BACTERIOL, V95, P1431, DOI 10.1128/JB.95.4.1431-1438.1968; Goulding CW, 2004, J BIOL CHEM, V279, P3516, DOI 10.1074/jbc.M311833200; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; HAUGLAND RP, 2005, HDB GUIDE FLUORESCEN, pCH2; Hodson CTC, 2008, J BACTERIOL, V190, P4697, DOI 10.1128/JB.00145-08; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Imamura D, 2004, J BACTERIOL, V186, P5450, DOI 10.1128/JB.186.16.5450-5459.2004; JENG MF, 1995, BIOCHEMISTRY-US, V34, P10101, DOI 10.1021/bi00032a001; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KALLIS GB, 1980, J BIOL CHEM, V255, P261; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lewin A, 2008, BIOCHEM J, V414, P81, DOI 10.1042/BJ20080356; Lewin A, 2006, J BIOL CHEM, V281, P35467, DOI 10.1074/jbc.M607047200; LIN TY, 1989, BIOCHEMISTRY-US, V28, P5282, DOI 10.1021/bi00438a054; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; Moller M, 2006, ANTIOXID REDOX SIGN, V8, P823, DOI 10.1089/ars.2006.8.823; Moller MC, 2008, J BACTERIOL, V190, P4660, DOI 10.1128/JB.00252-08; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Nordstrand K, 1999, FEBS LETT, V449, P196, DOI 10.1016/S0014-5793(99)00401-9; Ouyang N, 2006, PROTEINS, V65, P1021, DOI 10.1002/prot.21184; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Raina S, 1997, ANNU REV MICROBIOL, V51, P179, DOI 10.1146/annurev.micro.51.1.179; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Schiott T, 2000, J BACTERIOL, V182, P2845, DOI 10.1128/JB.182.10.2845-2854.2000; Schiott T, 1997, J BACTERIOL, V179, P4523, DOI 10.1128/jb.179.14.4523-4529.1997; Schiott T, 1997, J BACTERIOL, V179, P1962, DOI 10.1128/jb.179.6.1962-1973.1997; Smits WK, 2005, J BACTERIOL, V187, P3921, DOI 10.1128/JB.187.12.3921-3930.2005; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; YAMANAKA H, 1994, J BACTERIOL, V176, P2906, DOI 10.1128/JB.176.10.2906-2913.1994	46	13	13	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10056	10066		10.1074/jbc.M809566200	http://dx.doi.org/10.1074/jbc.M809566200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19144642	Green Published, hybrid			2022-12-27	WOS:000264892900048
J	Ferry, C; Gianni, M; Lalevee, S; Bruck, N; Plassat, JL; Raska, I; Garattini, E; Rochette-Egly, C				Ferry, Christine; Gianni, Maurizio; Lalevee, Sebastien; Bruck, Nathalie; Plassat, Jean-Luc; Raska, Ivan, Jr.; Garattini, Enrico; Rochette-Egly, Cecile			SUG-1 Plays Proteolytic and Non-proteolytic Roles in the Control of Retinoic Acid Target Genes via Its Interaction with SRC-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; NUCLEAR RECEPTORS; MEDIATED TRANSCRIPTION; 26S PROTEASOME; ATPASE SUG1; RAR-ALPHA; PHOSPHORYLATION; RECRUITMENT; PROMOTER; COACTIVATORS	Nuclear retinoic acid receptor alpha (RAR alpha) activates gene expression through dynamic interactions with coregulatory protein complexes, the assembly of which is directed by the ligand and the AF-2 domain of RAR alpha. Then RAR alpha and its coactivator SRC-3 are degraded by the proteasome. Recently it has emerged that the proteasome also plays a key role in RAR alpha-mediated transcription. Here we show that SUG-1, one of the six ATPases of the 19 S regulatory complex of the 26 S proteasome, interacts with SRC-3, is recruited at the promoters of retinoic acid (RA) target genes, and thereby participates to their transcription. In addition, SUG-1 also mediates the proteasomal degradation of SRC-3. However, when present in excess amounts, SUG-1 blocks the activation of RAR alpha target genes and the degradation of RAR alpha that occurs in response to RA, via its ability to interfere with the recruitment of SRC-3 and other coregulators at the AF-2 domain of RAR alpha. We propose a model in which the ratio between SUG-1 and SRC-3 is crucial for the control of RAR alpha functioning. This study provides new insights into how SUG-1 has a unique role in linking the transcription and degradation processes via its ability to interact with SRC-3.	[Ferry, Christine; Lalevee, Sebastien; Bruck, Nathalie; Plassat, Jean-Luc; Rochette-Egly, Cecile] Univ Strasbourg 1, CNRS, INSERM,Unite Mixte Rech 7104, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, CU Strasbourg, France; [Gianni, Maurizio; Raska, Ivan, Jr.; Garattini, Enrico] Ist Ric Farmacol Mario Negri, Mol Biol Lab, I-20156 Milan, Italy	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Rochette-Egly, C (corresponding author), Univ Strasbourg 1, CNRS, INSERM,Unite Mixte Rech 7104, Inst Genet & Biol Mol & Cellulaire, Boite Postale 10142, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	cegly@igbmc.u-strasbg.fr	Raska, Ivan/E-9179-2017; Gianni, Maurizio/ABG-6322-2020; Garattini, Enrico/AAI-1998-2019	Raska, Ivan/0000-0003-3895-5286; Gianni, Maurizio/0000-0002-6945-708X; Garattini, Enrico/0000-0001-8983-886X	CNRS; INSERM; Agence Nationale pour la Recherche [ANR-05-BLAN-0390-02]; Institut National du Cancer [INCa PL06-095, PL07-96099]; Association pour la Recherche sur le Cancer [ARC A05/2/3139]; Associazione Italiana per la Ricerca contro il Cancro; Istituto Superiore di Sanita; Progetto Finalizzato Oncologia; Fondo D'Investimento per la Ricerca Biotecnologica	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Associazione Italiana per la Ricerca contro il Cancro(Fondazione AIRC per la ricerca sul cancro); Istituto Superiore di Sanita; Progetto Finalizzato Oncologia; Fondo D'Investimento per la Ricerca Biotecnologica	This work was supported in part by funds from CNRS, INSERM, the Agence Nationale pour la Recherche (ANR-05-BLAN-0390-02), the Institut National du Cancer (INCa PL06-095 and PL07-96099), the Association pour la Recherche sur le Cancer (ARC A05/2/3139), the Associazione Italiana per la Ricerca contro il Cancro, the Istituto Superiore di Sanita, the Progetto Finalizzato Oncologia (CNR and Ministero dell'Universita e della Ricerca Scientifica), and the Fondo D'Investimento per la Ricerca Biotecnologica.	Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Bour G, 2005, J BIOL CHEM, V280, P17027, DOI 10.1074/jbc.M501344200; Bour G, 2007, TRENDS CELL BIOL, V17, P302, DOI 10.1016/j.tcb.2007.04.003; Brown K, 2003, J BIOL CHEM, V278, P39402, DOI 10.1074/jbc.M307832200; Bruck N, 2009, EMBO J, V28, P34, DOI 10.1038/emboj.2008.256; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Das PM, 2004, BIOTECHNIQUES, V37, P961, DOI 10.2144/04376RV01; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Dennis AP, 2005, J STEROID BIOCHEM, V93, P139, DOI 10.1016/j.jsbmb.2004.12.015; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Gianni M, 2006, EMBO J, V25, P739, DOI 10.1038/sj.emboj.7600981; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Glass CK, 2000, GENE DEV, V14, P121; Kinyamu HK, 2005, J MOL ENDOCRINOL, V34, P281, DOI 10.1677/jme.1.01680; Kopf E, 2000, J BIOL CHEM, V275, P33280, DOI 10.1074/jbc.M002840200; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Laudet V., 2001, NUCL RECEPTOR FACTSB; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lefebvre P, 2005, VITAM HORM, V70, P199, DOI 10.1016/S0083-6729(05)70007-8; Lonard DM, 2005, TRENDS BIOCHEM SCI, V30, P126, DOI 10.1016/j.tibs.2005.01.001; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rasti M, 2006, EMBO J, V25, P2710, DOI 10.1038/sj.emboj.7601169; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Satoh K, 2001, BIOCHEMISTRY-US, V40, P314, DOI 10.1021/bi001815n; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Tansey WP, 2001, GENE DEV, V15, P1045, DOI 10.1101/gad.896501; VOM BE, 1996, EMBO J, V15, P110; Weeda G, 1997, NUCLEIC ACIDS RES, V25, P2274, DOI 10.1093/nar/25.12.2274; Widschwendter M, 2000, J NATL CANCER I, V92, P826, DOI 10.1093/jnci/92.10.826; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191; Zhu QZ, 2004, FEBS LETT, V556, P19, DOI 10.1016/S0014-5793(03)01347-4	47	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8127	8135		10.1074/jbc.M808815200	http://dx.doi.org/10.1074/jbc.M808815200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144644	hybrid, Green Published			2022-12-27	WOS:000264195600075
J	Irikura, D; Aritake, K; Nagata, N; Maruyama, T; Shimamoto, S; Urade, Y				Irikura, Daisuke; Aritake, Kosuke; Nagata, Nanae; Maruyama, Toshihiko; Shimamoto, Shigeru; Urade, Yoshihiro			Biochemical, Functional, and Pharmacological Characterization of AT-56, an Orally Active and Selective Inhibitor of Lipocalin-type Prostaglandin D Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CEREBROSPINAL-FLUID; EYE-MOVEMENT SLEEP; BETA-TRACE; SEMINAL PLASMA; D SYNTHETASE; RAT; CELLS; PURIFICATION; EXPRESSION; BINDING	We report here that 4-dibenzo[a,d] cyclohepten-5-ylidene-1[4-(2H-tetrazol-5-yl)-butyl]-piperidine (AT-56) is an orally active and selective inhibitor of lipocalin-type prostaglandin (PG) D synthase (L-PGDS). AT-56 inhibited human and mouse L-PGDSs in a concentration (3-250 mu M)-dependent manner but did not affect the activities of hematopoietic PGD synthase (H-PGDS), cyclooxygenase-1 and -2, and microsomal PGE synthase1. AT-56 inhibited the L-PGDS activity in a competitive manner against the substrate-PGH(2) (K-m = 14 mu M) with a K-i value of 75 mu M but did not inhibit the binding of 13-cis-retinoic acid, a nonsubstrate lipophilic ligand, to L-PGDS. NMR titration analysis revealed that AT-56 occupied the catalytic pocket, but not the retinoid-binding pocket, of L-PGDS. AT-56 inhibited the production of PGD(2) by L-PGDS-expressing human TE-671 cells after stimulation with Ca2+ ionophore (5 mu M A23187) with an IC50 value of about 3 mu M without affecting their production of PGE(2) and PGF(2 alpha) but had no effect on the PGD2 production by H-PGDS-expressing human megakaryocytes. Orally administered AT-56 (< 30 mg/ kg body weight) decreased the PGD2 production to 40% in the brain of H-PGDS-deficient mice after a stab wound injury in a dose-dependent manner without affecting the production of PGE2 and PGF(2 alpha) and also suppressed the accumulation of eosinophils and monocytes in the bronco-alveolar lavage fluid from the antigen-induced lung inflammation model of human L-PGDS-transgenic mice.	[Shimamoto, Shigeru] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Irikura, Daisuke; Aritake, Kosuke; Nagata, Nanae; Maruyama, Toshihiko; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Osaka 5650874, Japan	Osaka University	Urade, Y (corresponding author), Osaka Biosci Inst, Dept Mol Behav Biol, 6-2-4 Furuedai, Osaka 5650874, Japan.	uradey@obi.or.jp						Aritake K, 2006, J BIOL CHEM, V281, P15277, DOI 10.1074/jbc.M506431200; Beuckmann CT, 2000, J COMP NEUROL, V428, P62, DOI 10.1002/1096-9861(20001204)428:1<62::AID-CNE6>3.0.CO;2-E; Beuckmann CT, 1996, J NEUROSCI, V16, P6119; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; CHRISTHAZELHOF E, 1979, BIOCHIM BIOPHYS ACTA, V572, P43, DOI 10.1016/0005-2760(79)90198-X; CLAUSEN E, 1961, Ugeskr Laeger, V123, P620; Craik D J, 1997, Methods Mol Biol, V60, P195; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Eguchi Y, 1997, P NATL ACAD SCI USA, V94, P14689, DOI 10.1073/pnas.94.26.14689; Fujimori K, 2008, GENE, V426, P72, DOI 10.1016/j.gene.2008.08.023; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Fujitani Y, 2002, J IMMUNOL, V168, P443, DOI 10.4049/jimmunol.168.1.443; Gerena RL, 2000, J ANDROL, V21, P848; Gerena RL, 1998, BIOL REPROD, V58, P826, DOI 10.1095/biolreprod58.3.826; Hirai K, 2001, CURR TOP MICROBIOL, V255, P261; HIRATA M, 1994, P NATL ACAD SCI USA, V91, P11192, DOI 10.1073/pnas.91.23.11192; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; Inoue T, 2003, NAT STRUCT BIOL, V10, P291, DOI 10.1038/nsb907; Inui T, 2003, J BIOL CHEM, V278, P2845, DOI 10.1074/jbc.M209934200; Irikura D, 2003, J BIOCHEM, V133, P29, DOI 10.1093/jb/mvg006; ISLAM F, 1991, ARCH BIOCHEM BIOPHYS, V289, P161, DOI 10.1016/0003-9861(91)90456-S; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Lazarus M, 2002, ARCH BIOCHEM BIOPHYS, V397, P336, DOI 10.1006/abbi.2001.2614; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Mahmud I, 1997, J BIOL CHEM, V272, P28263, DOI 10.1074/jbc.272.45.28263; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; MATSUMURA H, 1991, P NATL ACAD SCI USA, V88, P9046, DOI 10.1073/pnas.88.20.9046; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Mizoguchi A, 2001, P NATL ACAD SCI USA, V98, P11674, DOI 10.1073/pnas.201398898; Mohri I, 2006, J NEUROCHEM, V97, P641, DOI 10.1111/j.1471-4159.2006.03753.x; NAGATA A, 1991, P NATL ACAD SCI USA, V88, P4020, DOI 10.1073/pnas.88.9.4020; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; PERVAIZ S, 1987, FASEB J, V1, P209, DOI 10.1096/fasebj.1.3.3622999; Pinzar E, 2000, P NATL ACAD SCI USA, V97, P4903, DOI 10.1073/pnas.090093997; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; Shimamoto S, 2007, J BIOL CHEM, V282, P31373, DOI 10.1074/jbc.M700123200; Tanaka R, 2009, BIOCHEM BIOPH RES CO, V378, P851, DOI 10.1016/j.bbrc.2008.11.152; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Tokugawa Y, 1998, BIOL REPROD, V58, P600, DOI 10.1095/biolreprod58.2.600; Trivedi SG, 2006, P NATL ACAD SCI USA, V103, P5179, DOI 10.1073/pnas.0507175103; UENO R, 1982, BIOCHEM BIOPH RES CO, V109, P576, DOI 10.1016/0006-291X(82)91760-0; UJIHARA M, 1988, ARCH BIOCHEM BIOPHYS, V264, P428, DOI 10.1016/0003-9861(88)90308-6; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; Urade Y, 2002, PROSTAG OTH LIPID M, V68-9, P375, DOI 10.1016/S0090-6980(02)00042-4; URADE Y, 1987, J BIOL CHEM, V262, P3820; URADE Y, 1985, J BIOL CHEM, V260, P2410; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; URADE Y, 2006, FUNCTIONAL STRUCTURA, P135; Urade Y., 2006, LIPOCALINS, V9, P99; WATANABE K, 1994, BIOCHEM BIOPH RES CO, V203, P1110, DOI 10.1006/bbrc.1994.2297; White DM, 1997, J BIOL CHEM, V272, P14387, DOI 10.1074/jbc.272.22.14387; YAMAMOTO S, 1982, METHOD ENZYMOL, V86, P55	54	35	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7623	7630		10.1074/jbc.M808593200	http://dx.doi.org/10.1074/jbc.M808593200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19131342	Green Published, hybrid			2022-12-27	WOS:000264195600024
J	Kular, RK; Cvetanovic, M; Siferd, S; Kini, AR; Opal, P				Kular, Rupinder K.; Cvetanovic, Marija; Siferd, Steve; Kini, Ameet R.; Opal, Puneet			Neuronal Differentiation Is Regulated by Leucine-rich Acidic Nuclear Protein (LANP), a Member of the Inhibitor of Histone Acetyltransferase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; RUBINSTEIN-TAYBI SYNDROME; GENE-EXPRESSION; PC12 CELLS; TRANSCRIPTIONAL REPRESSION; PHEOCHROMOCYTOMA CELLS; HIPPOCAMPAL-NEURONS; PC-12 CELLS; PP32; INHAT	Neuronal differentiation is a tightly regulated process characterized by temporal and spatial alterations in gene expression. A number of studies indicate a significant role for histone acetylation in the regulation of genes involved in development. Histone acetylation is regulated by histone deacetylases and histone acetyltransferases. Recent findings suggest that these catalytic activities, in turn, are modulated by yet another set of regulators. Of considerable interest in this context is the possible role of the INHAT (inhibitor of histone acetyltransferase) complex, comprised of a group of acidic proteins that suppress histone acetylation by a novel "histone-masking" mechanism. In this study, we specifically examined the role of the leucine-rich acidic nuclear protein (LANP), a defining member of the INHAT complex whose expression is tightly regulated in neuronal development. We report that depleting LANP in neuronal cell lines promotes neurite outgrowth by inducing changes in gene expression. In addition, we show that LANP directly regulates expression of the neurofilament light chain, an important neuron-specific cytoskeletal gene, by binding to the promoter of this gene and modulating histone acetylation levels. Finally, we corroborated our findings in vivo by demonstrating increased neurite outgrowth in primary neurons obtained from LANP null mice, which is also accompanied by increased histone acetylation at the NF-L promoter. Taken together, these results implicate INHATs as a distinct class of developmental regulators involved in the epigenetic modulation of neuronal differentiation.	[Kular, Rupinder K.; Cvetanovic, Marija; Opal, Puneet] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol, Chicago, IL 60611 USA; [Kular, Rupinder K.; Cvetanovic, Marija; Opal, Puneet] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Siferd, Steve] Express Anal Inc, Durham, NC 27713 USA; [Kini, Ameet R.] Loyola Univ, Stritch Sch Med, Dept Pathol, Maywood, IL 60302 USA; [Kini, Ameet R.] Loyola Univ, Stritch Sch Med, Cardinal Bernardin Canc Ctr, Maywood, IL 60302 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; Loyola University Chicago	Opal, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol, Chicago, IL 60611 USA.	p-opal@northwestern.edu	Cvetanovic, Marija/B-8907-2016	Siferd, Stephen/0000-0001-6870-984X	National Institutes of Health [K08 NS02246, K02 NS051340, R21 NS060080, 5T32 NS41234-01]; National Organization for Rare Disorders (NORD); National Ataxia Foundation, and the American Cancer Society, IL Division; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041234, K02NS051340, K08NS002246, R01NS082351, R21NS060080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Organization for Rare Disorders (NORD); National Ataxia Foundation, and the American Cancer Society, IL Division; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 NS02246, K02 NS051340, and R21 NS060080 (to P.O.) and Training Grant 5T32 NS41234-01 (to R. K.). This work was also supported by grants from the National Organization for Rare Disorders (NORD), the National Ataxia Foundation, and the American Cancer Society, IL Division (to P.O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Angelastro JM, 2000, P NATL ACAD SCI USA, V97, P10424, DOI 10.1073/pnas.97.19.10424; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Braveman Melissa W., 2004, V277, P261; Brody JR, 2007, MODERN PATHOL, V20, P1238, DOI 10.1038/modpathol.3800974; Brown AJH, 1999, MOL CELL NEUROSCI, V13, P119, DOI 10.1006/mcne.1999.0736; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Cvetanovic M, 2007, EMBO REP, V8, P671, DOI 10.1038/sj.embor.7400983; Dawson HN, 2001, J CELL SCI, V114, P1179; DIJKMANS TF, 2009, J NEUROCHEM IN PRESS; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Kadkol SS, 1998, PROSTATE, V34, P231, DOI 10.1002/(SICI)1097-0045(19980215)34:3<231::AID-PROS11>3.0.CO;2-F; Kadkol SS, 2001, BREAST CANCER RES TR, V68, P65, DOI 10.1023/A:1017919507109; Kutney SN, 2004, J BIOL CHEM, V279, P30850, DOI 10.1074/jbc.M404969200; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee KH, 2005, NEUROCHEM RES, V30, P533, DOI 10.1007/s11064-005-2688-y; LEE NH, 1995, P NATL ACAD SCI USA, V92, P8303, DOI 10.1073/pnas.92.18.8303; Lin WC, 2006, CURR OPIN GENET DEV, V16, P137, DOI 10.1016/j.gde.2006.02.002; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Marek L, 2004, J CELL PHYSIOL, V201, P459, DOI 10.1002/jcp.20087; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; MATSUOKA K, 1994, P NATL ACAD SCI USA, V91, P9670, DOI 10.1073/pnas.91.21.9670; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Opal P, 2004, MOL CELL BIOL, V24, P3140, DOI 10.1128/MCB.24.8.3140-3149.2004; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Schimmelpfeng J, 2004, J NEUROSCI METH, V139, P299, DOI 10.1016/j.jneumeth.2004.05.010; Schneider R, 2004, J BIOL CHEM, V279, P23859, DOI 10.1074/jbc.C400151200; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suzuki-Mizushima Y, 2002, BRAIN RES, V951, P209, DOI 10.1016/S0006-8993(02)03163-3; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Ulitzur N, 1997, J BIOL CHEM, V272, P30577, DOI 10.1074/jbc.272.48.30577; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vician L, 1997, J NEUROSCI RES, V50, P32, DOI 10.1002/(SICI)1097-4547(19971001)50:1<32::AID-JNR4>3.0.CO;2-M; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	40	30	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7783	7792		10.1074/jbc.M806150200	http://dx.doi.org/10.1074/jbc.M806150200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19136565	Green Published, hybrid			2022-12-27	WOS:000264195600040
J	Fu, JJ; Jiang, J; Li, JW; Wang, SS; Shi, G; Feng, Q; White, E; Qin, J; Wong, JM				Fu, Junjiang; Jiang, Jun; Li, Jiwen; Wang, Shanshan; Shi, Guang; Feng, Qin; White, Eileen; Qin, Jun; Wong, Jiemin			Deleted in Breast Cancer 1, a Novel Androgen Receptor (AR) Coactivator That Promotes AR DNA-binding Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; NUCLEAR-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; PROSTATE-CANCER; HISTONE ACETYLTRANSFERASE; MOLECULAR-BIOLOGY; COMPLEX; CHROMATIN; COREGULATORS; PROTEIN	Androgen receptor (AR) plays a critical role in development and maintenance of male reproductive functions and the etiology of prostate cancer. As a ligand-regulated transcription factor, identification and characterization of AR coregulators are essential for understanding the molecular mechanisms underlying its diverse biological functions. Here we reported the identification of a novel AR coactivator, deleted in breast cancer 1 (DBC1), through a biochemical approach. DBC1 interacts with AR in a ligand-stimulated manner and facilitates AR transcriptional activation in transfected cells as well as in Xenopus oocytes. In in vitro gel shift experiments, recombinant DBC1 drastically enhanced AR DNA-binding activity. Expression of DBC1 also enhanced the binding of AR to chromatinized template in vivo, whereas knockdown of DBC1 impaired the binding of AR to endogenous prostate-specific antigen (PSA) gene in the prostate cancer cell line LNCaP. Thus, our data identify DBC1 as a novel AR coactivator.	[Li, Jiwen; Wang, Shanshan; Shi, Guang; Wong, Jiemin] E China Normal Univ, Coll Life Sci, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Fu, Junjiang; Jiang, Jun; Feng, Qin; Qin, Jun] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Qin, Jun] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Fu, Junjiang] Cent S Univ, Xiangya Sch Med, Xiangya 410013, Peoples R China; [White, Eileen] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	East China Normal University; Baylor College of Medicine; Baylor College of Medicine; Central South University; Rutgers State University New Brunswick	Wong, JM (corresponding author), E China Normal Univ, Coll Life Sci, Inst Biomed Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	jmweng@bio.ecnu.edu.cn	White, Eileen/ABD-6745-2021	White, Eileen/0000-0003-2961-3065; Wong, Jiemin/0000-0002-5311-842X; Fu, Junjiang/0000-0002-0708-2200				ALMOUZNI G, 1993, GENE DEV, V7, P2033, DOI 10.1101/gad.7.10.2033; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Culig Z, 2003, UROLOGY, V62, P21, DOI 10.1016/S0090-4295(03)00698-8; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Fu JHJ, 2007, MOL CELL BIOL, V27, P4641, DOI 10.1128/MCB.00857-06; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Huang ZQ, 2002, MOL ENDOCRINOL, V16, P924, DOI 10.1210/me.16.5.924; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Lee HJ, 2003, CELL MOL LIFE SCI, V60, P1613, DOI 10.1007/s00018-003-2309-3; Leotoing L, 2008, ONCOGENE, V27, P2858, DOI 10.1038/sj.onc.1210942; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Li JW, 2006, MOL ENDOCRINOL, V20, P776, DOI 10.1210/me.2005-0298; Li JW, 2000, MOL CELL BIOL, V20, P2031, DOI 10.1128/MCB.20.6.2031-2042.2000; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; ONATE SA, 1995, SCIENCE, V270, P1354; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Qin J, 1997, ANAL CHEM, V69, P4002, DOI 10.1021/ac970489n; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sundararajan R, 2005, ONCOGENE, V24, P4908, DOI 10.1038/sj.onc.1208681; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Trauernicht AM, 2007, MOL ENDOCRINOL, V21, P1526, DOI 10.1210/me.2007-0064; Verrijdt G, 2002, BIOCHEM J, V361, P97, DOI 10.1042/0264-6021:3610097; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang L, 2005, PROSTATE, V63, P117, DOI 10.1002/pros.20170; WANG Q, 2002, J BIOL CHEM, V5, P5; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wolffe AP, 2000, VITAM HORM, V58, P449, DOI 10.1016/S0083-6729(00)58033-9; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Wong JM, 1997, EMBO J, V16, P3158, DOI 10.1093/emboj/16.11.3158; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	56	58	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6832	6840		10.1074/jbc.M808988200	http://dx.doi.org/10.1074/jbc.M808988200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19126541	hybrid, Green Published			2022-12-27	WOS:000263919000029
J	Unhavaithaya, Y; Hao, Y; Beyret, E; Yin, H; Kuramochi-Miyagawa, S; Nakano, T; Lin, HF				Unhavaithaya, Yingdee; Hao, Yi; Beyret, Ergin; Yin, Hang; Kuramochi-Miyagawa, Satomi; Nakano, Toru; Lin, Haifan			MILI, a PIWI-interacting RNA-binding Protein, Is Required for Germ Line Stem Cell Self-renewal and Appears to Positively Regulate Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERMATOGONIAL-DEPLETION JSD; UNDIFFERENTIATED SPERMATOGONIA; CAENORHABDITIS-ELEGANS; MESSENGER-RNAS; PIRNA COMPLEX; GENE ENCODES; DROSOPHILA; DIFFERENTIATION; INITIATION; MICRORNA	The Argonaute/PIWI protein family consists of Argonaute and PIWI subfamilies. Argonautes function in RNA interference and micro-RNA pathways; whereas PIWIs bind to PIWI-interacting RNAs and regulate germ line development, stem cell maintenance, epigenetic regulation, and transposition. However, the role of PIWIs in mammalian stem cells has not been demonstrated, and molecular mechanisms mediated by PIWIs remain elusive. Here we show that MILI, a murine PIWI protein, is expressed in the cytoplasm of testicular germ line stem cells, spermatogonia, and early spermatocytes, where it is enriched in chromatoid bodies. MILI is essential for the self-renewing division and differentiation of germ line stem cells but does not affect initial establishment of the germ line stem cell population at 7 days postpartum. Furthermore, MILI forms a stable RNA-independent complex with eIF3a and associates with the eIF4E- and eIF4G-containing m(7)G cap-binding complex. In isolated 7 days postpartum seminiferous tubules containing mostly germ line stem cells, the mili mutation has no effect on the cellular mRNA level yet significantly reduces the rate of protein synthesis. These observations indicate that MILI may positively regulate translation and that such regulation is required for germ line stem cell self-renewal.	[Unhavaithaya, Yingdee; Hao, Yi; Beyret, Ergin; Yin, Hang; Lin, Haifan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Beyret, Ergin; Yin, Hang; Lin, Haifan] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06511 USA; [Kuramochi-Miyagawa, Satomi; Nakano, Toru] Osaka Univ, Dept Mol Cell Biol, Suita, Osaka 5650871, Japan	Duke University; Yale University; Osaka University	Lin, HF (corresponding author), Yale Stem Cell Ctr, 10 Amistad St, New Haven, CT 06509 USA.	haifan.lin@yale.edu	Yin, Hang/J-3613-2019	Yin, Hang/0000-0002-9621-0138; BEYRET, ERGIN/0000-0003-1980-532X	National Institutes of Health [HD42012]; Connecticut Stem Cell Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Stem Cell Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD42012. This work was also supported by a grant from the Connecticut Stem Cell Research Foundation ( to H. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BEAMER WG, 1988, BIOL REPROD, V38, P899, DOI 10.1095/biolreprod38.4.899; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; Beyret E, 2008, MICRORNAS: FROM BASIC SCIENCE TO DISEASE BIOLOGY, P497; Bloch DB, 2006, RNA, V12, P707, DOI 10.1261/ rna.17406; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cataldo L, 1997, EXP CELL RES, V231, P206, DOI 10.1006/excr.1996.3447; Ciosk R, 2004, DEVELOPMENT, V131, P4831, DOI 10.1242/dev.01352; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; de Rooij DG, 1999, BIOL REPROD, V61, P842, DOI 10.1095/biolreprod61.3.842; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; Giorgini F, 2002, DEVELOPMENT, V129, P3669; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; GODCHAUX W, 1967, J MOL BIOL, V27, P57, DOI 10.1016/0022-2836(67)90351-8; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Harris AN, 2001, DEVELOPMENT, V128, P2823; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Johnson KR, 1997, J BIOL CHEM, V272, P7106, DOI 10.1074/jbc.272.11.7106; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; KLEENE KC, 1993, DEV BIOL, V159, P720, DOI 10.1006/dbio.1993.1277; KOSHIMIZU U, 1995, MOL REPROD DEV, V40, P221, DOI 10.1002/mrd.1080400211; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2006, J CELL SCI, V119, P2819, DOI 10.1242/jcs.03022; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; LIN H, 2004, STEM CELLS HDB, P57; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Morita S, 2007, GENOMICS, V89, P687, DOI 10.1016/j.ygeno.2007.01.004; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Ohta H, 2003, BIOL REPROD, V69, P1815, DOI 10.1095/biolreprod.103.019323; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Parisi M, 1999, GENETICS, V153, P235; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Rohozinski J, 2004, P NATL ACAD SCI USA, V101, P11695, DOI 10.1073/pnas.0401130101; Ross AJ, 2005, TRENDS ENDOCRIN MET, V16, P19, DOI 10.1016/j.tem.2004.11.004; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Shi HF, 2004, J BIOL CHEM, V279, P49889, DOI 10.1074/jbc.M409280200; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	69	160	176	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6507	6519		10.1074/jbc.M809104200	http://dx.doi.org/10.1074/jbc.M809104200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19114715	Green Published, hybrid			2022-12-27	WOS:000263742700053
J	Oresic, K; Ng, CL; Tortorella, D				Oresic, Kristina; Ng, Caroline L.; Tortorella, Domenico			TRAM1 Participates in Human Cytomegalovirus US2-and US11-mediated Dislocation of an Endoplasmic Reticulum Membrane Glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I HEAVY-CHAINS; PROTEIN INTEGRATION; MISFOLDED PROTEINS; SECRETORY PROTEIN; LIPID-BILAYER; DEGRADATION; ER; CYTOSOL; TRANSLOCATION; COMPLEX	The human cytomegalovirus proteins US2 and US11 have co-opted endoplasmic reticulum (ER) quality control to facilitate the destruction of major histocompatibility complex class I heavy chains. The class I heavy chains are dislocated from the ER to the cytosol, where they are deglycosylated and subsequently degraded by the proteasome. We examined the role of TRAM1 (translocating chain-associated membrane protein-1) in the dislocation of class I molecules using US2- and US11-expressing cells. TRAM1 is an ER protein initially characterized for its role in processing nascent polypeptides. Co-immunoprecipitation studies demonstrated that TRAM1 can complex with the wild type US2 and US11 proteins as well as deglycosylated and polyubiquitinated class I degradation intermediates. In studies using US2- and US11-TRAM1 knockdown cells, we observed an increase in levels of class I heavy chains. Strikingly, increased levels of glycosylated heavy chains were observed in TRAM1 knockdown cells when compared with control cells in a pulse-chase experiment. In fact, US11-mediated class I dislocation was more sensitive to the lack of TRAM1 than US2. These results provide further evidence that these viral proteins may utilize distinct complexes to facilitate class I dislocation. For example, US11-mediated class I heavy chain degradation requires Derlin-1 and SEL1L, whereas signal peptide peptidase is critical for US2-induced class I destabilization. In addition, TRAM1 can complex with the dislocation factors Derlin-1 and signal peptide peptidase. Collectively, the data support a model in which TRAM1 functions as a cofactor to promote efficient US2- and US11-dependent dislocation of major histocompatibility complex class I heavy chains.	[Oresic, Kristina; Ng, Caroline L.; Tortorella, Domenico] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Tortorella, D (corresponding author), Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl,Box 1124, New York, NY 10029 USA.	Domenico.Tortorella@mssm.edu		Tortorella, Domenico/0000-0003-0961-3535	National Institutes of Health [AI060905, U19 AI062623]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062623, R01AI060905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI060905 and U19 AI062623. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported in part by the Irma T. Hirschl Trust. To whom correspondence should be addressed: Dept. of Microbiology, Mount Sinai School of Medicine, One Gustave L. Levy Pl., Box 1124, New York, NY 10029. Tel.: 212-241-5447; Fax: 212-241-7336; E-mail:Domenico.Tortorella@mssm.edu.	Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; BEERSMA MFC, 1993, J IMMUNOL, V151, P4455; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HIGH S, 1993, J CELL BIOL, V121, P743, DOI 10.1083/jcb.121.4.743; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; JONES TR, 1995, J VIROL, V69, P4830, DOI 10.1128/JVI.69.8.4830-4841.1995; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Knight BC, 1998, BIOCHEM J, V331, P161, DOI 10.1042/bj3310161; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2003, MOL BIOL CELL, V14, P3690, DOI 10.1091/mbc.E03-03-0192; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Meacock SL, 2002, MOL BIOL CELL, V13, P4114, DOI 10.1091/mbc.E02-04-0198; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Noriega VM, 2008, J BIOL CHEM, V283, P4031, DOI 10.1074/jbc.M706283200; Oresic K, 2008, J GEN VIROL, V89, P1122, DOI 10.1099/vir.0.83516-0; Oresic K, 2006, J BIOL CHEM, V281, P19395, DOI 10.1074/jbc.M601026200; PARHAM P, 1979, J IMMUNOL, V123, P342; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; STAM NJ, 1986, J IMMUNOL, V137, P2299; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	49	14	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5905	5914		10.1074/jbc.M807568200	http://dx.doi.org/10.1074/jbc.M807568200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19121997	Green Published, hybrid			2022-12-27	WOS:000263560600054
J	Begle, A; Tryoen-Toth, P; de Barry, J; Bader, MF; Vitale, N				Begle, Aurelie; Tryoen-Toth, Petra; de Barry, Jean; Bader, Marie-France; Vitale, Nicolas			ARF6 Regulates the Synthesis of Fusogenic Lipids for Calcium-regulated Exocytosis in Neuroendocrine Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT MEMBRANE-FUSION; RIBOSYLATION FACTOR 6; DENSE-CORE VESICLES; PLASMA-MEMBRANE; CHROMAFFIN CELLS; PHOSPHOLIPASE-D; PHOSPHATIDIC-ACID; SECRETORY GRANULES; PORE FORMATION; PC12 CELLS	An important role for specific lipids in membrane fusion has recently emerged, but regulation of their biosynthesis remains poorly understood. Among fusogenic lipids, phosphatidic acid and phosphoinositol 4,5-bisphosphate (PIP2) have been proposed to act at various steps of neurotransmitter and hormone exocytosis. Using real time FRET (fluorescence resonance energy transfer) measurements, we show here that the GTPase ARF6, potentially involved in the synthesis of these lipids, is activated at the exocytotic sites in PC12 cells stimulated for secretion. Depletion of endogenous ARF6 by siRNA dramatically inhibited secretagogue-evoked exocytosis. ARF6-siRNA greatly reduced secretagogue-evoked phospholipase D (PLD) activation and phosphatidic acid formation at the plasma membrane and moderately reduced constitutive levels of PIP2 present at the plasma membrane in resting cells. Expression of an ARF6 insensitive to short interference RNA (siRNA) fully rescued secretion in ARF6-depleted cells. However, a mutated ARF6 protein specifically impaired in its ability to stimulate PLD had no effect. Finally, we show that the ARF6-siRNA-mediated inhibition of exocytosis could be rescued by an exogenous addition of lysophosphatidylcholine, a lipid that favors negative curvature on the inner leaflet of the plasma membrane. Altogether these data indicate that ARF6 is a critical upstream signaling element in the activation of PLD necessary to produce the fusogenic lipids required for exocytosis.	[Vitale, Nicolas] CNRS, UPR 3212, Inst Neurosci Cellulaires & Integrat, Dept Neurotransmiss & Secret, F-67084 Strasbourg, France; Univ Strasbourg, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vitale, N (corresponding author), CNRS, UPR 3212, Inst Neurosci Cellulaires & Integrat, Dept Neurotransmiss & Secret, 5 Rue Blaise Pascal, F-67084 Strasbourg, France.	vitalen@neurochem.u-strasbg.fr	Vitale, Nicolas/G-5967-2014; Bader, Marie-France/O-2098-2016	Vitale, Nicolas/0000-0002-4752-4907; Toth, Petra/0000-0003-4573-4705				Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Caumon AS, 2000, J BIOL CHEM, V275, P15637, DOI 10.1074/jbc.M908347199; Caumont AS, 1998, J BIOL CHEM, V273, P1373, DOI 10.1074/jbc.273.3.1373; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Choi WS, 2002, ANN NY ACAD SCI, V968, P198, DOI 10.1111/j.1749-6632.2002.tb04336.x; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de Barry J, 2006, J BIOL CHEM, V281, P18098, DOI 10.1074/jbc.M509842200; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Donaldson JG, 2005, BIOCHEM SOC T, V33, P1276, DOI 10.1042/BST0331276; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Hughes WE, 2004, J BIOL CHEM, V279, P27534, DOI 10.1074/jbc.M403012200; Humeau Y, 2001, P NATL ACAD SCI USA, V98, P15300, DOI 10.1073/pnas.261358698; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jones DH, 1999, BIOCHEM J, V341, P185, DOI 10.1042/0264-6021:3410185; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Kozlovsky Y, 2002, BIOPHYS J, V83, P2634, DOI 10.1016/S0006-3495(02)75274-0; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Liu LX, 2005, MOL BIOL CELL, V16, P4463, DOI 10.1091/mbc.E05-03-0231; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; Meyer MZ, 2006, J BIOL CHEM, V281, P7919, DOI 10.1074/jbc.M600081200; Millar CA, 1999, J BIOL CHEM, V274, P17619, DOI 10.1074/jbc.274.25.17619; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; MOUBOISSE F, 2009, J CELL SCI IN PRESS; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schweitzer JK, 2002, J BIOL CHEM, V277, P27210, DOI 10.1074/jbc.M201569200; Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Vitale N, 1996, EUR J NEUROSCI, V8, P1275, DOI 10.1111/j.1460-9568.1996.tb01296.x; Vitale N, 1998, J BIOL CHEM, V273, P2553, DOI 10.1074/jbc.273.5.2553; Vitale N, 2005, J BIOL CHEM, V280, P29921, DOI 10.1074/jbc.M413748200; Vitale N, 2002, ANN NY ACAD SCI, V971, P193, DOI 10.1111/j.1749-6632.2002.tb04463.x; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; VITALE N, 1993, J BIOL CHEM, V268, P14715; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Waselle L, 2005, MOL ENDOCRINOL, V19, P3097, DOI 10.1210/me.2004-0530; Yang CZ, 1999, J BIOL CHEM, V274, P25297, DOI 10.1074/jbc.274.36.25297; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhang Q, 1999, MOL CELL BIOL, V19, P8158	52	47	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4836	4845		10.1074/jbc.M806894200	http://dx.doi.org/10.1074/jbc.M806894200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19124467	hybrid			2022-12-27	WOS:000263416600012
J	Pittman, YR; Kandl, K; Lewis, M; Valente, L; Kinzy, TG				Pittman, Yvette R.; Kandl, Kimberly; Lewis, Marcus; Valente, Louis; Kinzy, Terri Goss			Coordination of Eukaryotic Translation Elongation Factor 1A (eEF1A) Function in Actin Organization and Translation Elongation by the Guanine Nucleotide Exchange Factor eEF1B alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; AMINOACYL-TRANSFER-RNA; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; BINDING SITE; FACTOR-I; F-ACTIN; EF-TU; COMPLEX; CYTOSKELETON	Eukaryotic translation elongation factor 1A (eEF1A) both shuttles aminoacyl-tRNA (aa-tRNA) to the ribosome and binds and bundles actin. A single domain of eEF1A is proposed to bind actin, aa-tRNA and the guanine nucleotide exchange factor eEF1B alpha. We show that eEF1B alpha has the ability to disrupt eEF1A-induced actin organization. Mutational analysis of eEF1B alpha F163, which binds in this domain, demonstrates effects on growth, eEF1A binding, nucleotide exchange activity, and cell morphology. These phenotypes can be partially restored by an intragenic W130A mutation. Furthermore, the combination of F163A with the lethal K205A mutation restores viability by drastically reducing eEF1B alpha affinity for eEF1A. This also results in a consistent increase in actin bundling and partially corrected morphology. The consequences of the overlapping functions in this eEF1A domain and its unique differences from the bacterial homologs provide a novel function for eEF1B alpha to balance the dual roles in actin bundling and protein synthesis.	[Pittman, Yvette R.; Lewis, Marcus; Valente, Louis; Kinzy, Terri Goss] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA; [Kandl, Kimberly] St Olaf Coll, Dept Biol, Northfield, MN 55057 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Saint Olaf College	Kinzy, TG (corresponding author), 675 Hoes Lane, Piscataway, NJ 08854 USA.	kinzytg@umdnj.edu			National Institutes of Health [R01 GM57483, F31 A126530]; NATIONAL CANCER INSTITUTE [F31CA126530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM57483 (to T. G. K.) and F31 A126530 (to Y. R. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anand M, 2001, COLD SPRING HARB SYM, V66, P439, DOI 10.1101/sqb.2001.66.439; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Burke D., 2000, METHODS YEAST GENETI; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; CARVALHO MDD, 1984, ARCH BIOCHEM BIOPHYS, V234, P603, DOI 10.1016/0003-9861(84)90310-2; DeLano WL, 2002, PYMOL USERS MANUAL; Dinman JD, 1997, RNA, V3, P870; Edmonds BT, 1998, J BIOL CHEM, V273, P10288, DOI 10.1074/jbc.273.17.10288; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; HONTS JE, 1994, J CELL BIOL, V126, P413, DOI 10.1083/jcb.126.2.413; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JANSSEN GMC, 1988, J BIOL CHEM, V263, P1773; Jeppesen MG, 2005, J BIOL CHEM, V280, P5071, DOI 10.1074/jbc.M411782200; JONES E W, 1991, P428; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; KINZY TG, 1992, J BIOL CHEM, V267, P1623; KINZY TG, 1994, NUCLEIC ACIDS RES, V22, P2703, DOI 10.1093/nar/22.13.2703; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Munshi R, 2001, GENETICS, V157, P1425; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Pittman YR, 2006, J BIOL CHEM, V281, P19457, DOI 10.1074/jbc.M601076200; SAHA SK, 1986, J BIOL CHEM, V261, P2599; SLOBIN LI, 1978, EUR J BIOCHEM, V84, P69, DOI 10.1111/j.1432-1033.1978.tb12142.x; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0	28	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4739	4747		10.1074/jbc.M807945200	http://dx.doi.org/10.1074/jbc.M807945200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19095653	Green Published, hybrid			2022-12-27	WOS:000263134400073
J	Hershko, A				Hershko, Avram			Some Lessons from My Work on the Biochemistry of the Ubiquitin System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DEPENDENT PROTEOLYTIC SYSTEM; PROTEIN LIGASE SYSTEM; DEGRADATION; ATP; RETICULOCYTES; POLYPEPTIDE; CONJUGATION; BREAKDOWN; P27		[Hershko, Avram] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Biochem Unit, IL-31096 Haifa, Israel; [Hershko, Avram] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Hershko, A (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Biochem Unit, POB 9649, IL-31096 Haifa, Israel.	hershko@tx.technion.ac.il						Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; ETLINGER JD, 1977, P NATL ACAD SCI USA, V74, P54, DOI 10.1073/pnas.74.1.54; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Hershko A, 1996, TRENDS BIOCHEM SCI, V21, P445, DOI 10.1016/S0968-0004(96)10054-2; HERSHKO A, 1971, J BIOL CHEM, V246, P710; HERSHKO A, 1986, J BIOL CHEM, V261, P1992; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; HERSHKO A, 1988, J BIOL CHEM, V263, P15237; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 2005, LES PRIX NOBEL 2004, P187; PERUTZ MF, 2003, I WISH I D MADE YOU, P412; SCHIMKE RT, 1970, ANNU REV BIOCHEM, V39, P929, DOI 10.1146/annurev.bi.39.070170.004433; SIMPSON MV, 1953, J BIOL CHEM, V201, P143; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529	19	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10291	10295		10.1074/jbc.X800016200	http://dx.doi.org/10.1074/jbc.X800016200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19075010	hybrid, Green Published			2022-12-27	WOS:000265104600002
J	Kleerekoper, QK; Putkey, JA				Kleerekoper, Quinn K.; Putkey, John A.			PEP-19, an Intrinsically Disordered Regulator of Calmodulin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; TARGET RECOGNITION; NMR CHARACTERIZATION; BINDING-PROTEIN; FOLDING PROBLEM; DYNAMICS; KINASE; EXPRESSION; SECONDARY; COMPLEX	PEP-19 is a small calmodulin (CaM)-binding protein that greatly increases the rates of association and dissociation of Ca2+ from the C-domain of CaM, an effect that is mediated by an acidic/IQ sequence in PEP-19. We show here using NMR that PEP-19 is an intrinsically disordered protein, but with residual structure localized to its acidic/IQ motif. We also show that the k(on) and k(off) rates for binding PEP-19 to apo-CaM are at least 50-fold slower than for binding to Ca2+-CaM. These data indicate that intrinsic disorder confers plasticity that allows PEP-19 to bind to either apo- or Ca2+-CaM via different structural modes, and that complex formation may be facilitated by conformational selection of residual structure in the acidic/IQ sequence.	[Putkey, John A.] Univ Texas, Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, Houston Med Sch, Struct Biol Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Putkey, JA (corresponding author), Univ Texas, Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	john.putkey@uth.tmc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038310] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM069611] Funding Source: Medline; NINDS NIH HHS [NS038310] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chen YG, 2007, J AM CHEM SOC, V129, P2414, DOI 10.1021/ja067791a; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; CRAESCU CT, 1995, J BIOL CHEM, V270, P7088, DOI 10.1074/jbc.270.13.7088; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2001, METHOD ENZYMOL, V339, P258; Erhardt JA, 2000, NEUROREPORT, V11, P3719, DOI 10.1097/00001756-200011270-00026; Evenas J, 2001, STRUCTURE, V9, P185, DOI 10.1016/S0969-2126(01)00575-5; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; Gerendasy D, 1999, J NEUROSCI RES, V58, P107, DOI 10.1002/(SICI)1097-4547(19991001)58:1<107::AID-JNR11>3.0.CO;2-G; GERENDASY DD, 1995, J BIOL CHEM, V270, P6741, DOI 10.1074/jbc.270.12.6741; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1990, FEBS LETT, V266, P155, DOI 10.1016/0014-5793(90)81528-V; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kanazawa Y, 2008, NEUROSCIENCE, V154, P473, DOI 10.1016/j.neuroscience.2008.03.044; Kranz JK, 2002, BIOCHEMISTRY-US, V41, P2599, DOI 10.1021/bi011818f; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; LOGAN TM, 1994, J MOL BIOL, V236, P637, DOI 10.1006/jmbi.1994.1173; Lundstrom P, 2005, P NATL ACAD SCI USA, V102, P16984, DOI 10.1073/pnas.0504361102; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320; Permyakov SE, 2003, PROTEINS, V53, P855, DOI 10.1002/prot.10481; PRECHEUR B, 1992, BIOCHEMISTRY-US, V31, P229, DOI 10.1021/bi00116a032; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Putkey JA, 2008, J BIOL CHEM, V283, P1401, DOI 10.1074/jbc.M703831200; Rabl CR, 2002, BIOPHYS CHEM, V101, P553, DOI 10.1016/S0301-4622(02)00150-3; Radivojac P, 2006, PROTEINS, V63, P398, DOI 10.1002/prot.20873; Ran XY, 2003, BIOCHEMISTRY-US, V42, P5143, DOI 10.1021/bi0271751; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; SEEHOLZER SH, 1986, P NATL ACAD SCI USA, V83, P3634, DOI 10.1073/pnas.83.11.3634; Shmukler BE, 2001, BBA-GENE STRUCT EXPR, V1518, P36, DOI 10.1016/S0167-4781(01)00166-X; Slemmon JR, 2000, MOL NEUROBIOL, V22, P99, DOI 10.1385/MN:22:1-3:099; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; Tapp H, 2005, J BIOL CHEM, V280, P9946, DOI 10.1074/jbc.M414614200; TSALKOVA TN, 1985, J MOL BIOL, V181, P533, DOI 10.1016/0022-2836(85)90425-5; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Xiao JG, 2008, MOL CELL BIOCHEM, V309, P143, DOI 10.1007/s11010-007-9652-x; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhou N, 1997, BIOCHEMISTRY-US, V36, P2817, DOI 10.1021/bi9625713	56	41	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7455	7464		10.1074/jbc.M808067200	http://dx.doi.org/10.1074/jbc.M808067200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19106096	hybrid, Green Published			2022-12-27	WOS:000264195600009
J	Taniguchi, Y; Ido, H; Sanzen, N; Hayashi, M; Sato-Nishiuchi, R; Futaki, S; Sekiguchi, K				Taniguchi, Yukimasa; Ido, Hiroyuki; Sanzen, Noriko; Hayashi, Maria; Sato-Nishiuchi, Ryoko; Futaki, Sugiko; Sekiguchi, Kiyotoshi			The C-terminal Region of Laminin beta Chains Modulates the Integrin Binding Affinities of Laminins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; GLUTAMIC-ACID RESIDUE; CELL-ADHESION; GLOBULAR DOMAIN; MICE LACKING; MUTANT MICE; NEUROMUSCULAR-JUNCTION; ALPHA-CHAINS; COILED COILS; RECOMBINANT	Laminins are major cell-adhesive proteins in basement membranes that are capable of binding to integrins. Laminins consist of three chains (alpha, beta, and gamma), in which three laminin globular modules in the alpha chain and the Glu residue in the C-terminal tail of the gamma chain have been shown to be prerequisites for binding to integrins. However, it remains unknown whether any part of the beta chain is involved in laminin-integrin interactions. We compared the binding affinities of pairs of laminin isoforms containing the beta 1 or beta 2 chain toward a panel of laminin-binding integrins, and we found that beta 2 chain-containing laminins (beta 2-laminins) bound more avidly to alpha 3 beta 1 and alpha 7X2 beta 1 integrins than beta 1 chain-containing laminins (beta 1-laminins), whereas alpha 6 beta 1, alpha 6 beta 4, and alpha 7X1 beta 1 integrins did not show any preference toward beta 2-laminins. Because alpha 3 beta 1 contains the "X2-type" variable region in the alpha 3 subunit and alpha 6 beta 1 and alpha 6 beta 4 contain the "X1-type" region in the alpha 6 subunit, we hypothesized that only integrins containing the X2-type region were capable of discriminating between beta 1-laminins and beta 2-laminins. In support of this possibility, a putative X2-type variant of alpha 6 beta 1 was produced and found to bind preferentially to beta 2-laminins. Production of a series of swap mutants between the beta 1 and beta 2 chains revealed that the C-terminal 20 amino acids in the coiled-coil domain were responsible for the enhanced integrin binding by beta 2-laminins. Taken together, the results provide evidence that the C-terminal region of beta chains is involved in laminin recognition by integrins and modulates the binding affinities of laminins toward X2-type integrins.	[Taniguchi, Yukimasa; Ido, Hiroyuki; Sanzen, Noriko; Hayashi, Maria; Sato-Nishiuchi, Ryoko; Futaki, Sugiko; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan	Osaka University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp		Sanzen, Noriko/0000-0001-6518-403X	Grants-in-aid for Scientific Research [17082005, 20370046]; New Energy and Industrial Technology Development Organization of Japan [06001294-0]	Grants-in-aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by Grants-in-aid for Scientific Research 17082005 and 20370046 (to K.S.) and Research Contract 06001294-0 with the New Energy and Industrial Technology Development Organization of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altroff H, 2003, J BIOL CHEM, V278, P491, DOI 10.1074/jbc.M209992200; AOTA S, 1994, J BIOL CHEM, V269, P24756; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; BROWN JC, 1994, J CELL SCI, V107, P329; Champliaud MF, 2000, EXP CELL RES, V259, P326, DOI 10.1006/excr.2000.4980; Champliaud MF, 1996, J CELL BIOL, V132, P1189, DOI 10.1083/jcb.132.6.1189; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; DELWEL GO, 1995, CELL ADHES COMMUN, V3, P143, DOI 10.3109/15419069509081283; DEUTZMANN R, 1990, EUR J BIOCHEM, V191, P513, DOI 10.1111/j.1432-1033.1990.tb19151.x; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; Hayashi Y, 2002, BIOCHEM BIOPH RES CO, V299, P498, DOI 10.1016/S0006-291X(02)02642-6; Hirosaki T, 2000, J BIOL CHEM, V275, P22495, DOI 10.1074/jbc.M001326200; Humphries MJ, 2002, ARTHRITIS RES THER, V4, pS69, DOI 10.1186/ar563; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; Ido H, 2006, MATRIX BIOL, V25, P112, DOI 10.1016/j.matbio.2005.10.003; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Ido H, 2008, J BIOL CHEM, V283, P28149, DOI 10.1074/jbc.M803553200; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Kikkawa Y, 2003, J CELL BIOL, V161, P187, DOI 10.1083/jcb.200211121; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kuang W, 1998, EXP CELL RES, V241, P117, DOI 10.1006/excr.1998.4025; Kunneken K, 2004, J BIOL CHEM, V279, P5184, DOI 10.1074/jbc.M310424200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; Miner JH, 2006, DEVELOPMENT, V133, P967, DOI 10.1242/dev.02270; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Miner JH, 2000, DEV BIOL, V217, P278, DOI 10.1006/dbio.1999.9546; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Nguyet NM, 2005, DEV BIOL, V282, P111, DOI 10.1016/j.ydbio.2005.02.031; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Nishiuchi R, 2003, J BIOCHEM, V134, P497, DOI 10.1093/jb/mvg185; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Sasaki T, 2002, EUR J BIOCHEM, V269, P431, DOI 10.1046/j.0014-2956.2001.02663.x; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Sterk LMT, 1998, CELL ADHES COMMUN, V5, P177; SUNG U, 1993, J CELL BIOL, V123, P1255, DOI 10.1083/jcb.123.5.1255; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Tunggal P, 2000, MICROSC RES TECHNIQ, V51, P214, DOI 10.1002/1097-0029(20001101)51:3<214::AID-JEMT2>3.0.CO;2-J; von der Mark H, 2007, J MOL BIOL, V371, P1188, DOI 10.1016/j.jmb.2007.05.074; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284; ZIOBER BL, 1993, J BIOL CHEM, V268, P26773	56	58	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7820	7831		10.1074/jbc.M809332200	http://dx.doi.org/10.1074/jbc.M809332200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147489	Green Published, hybrid			2022-12-27	WOS:000264195600044
J	Fagone, P; Gunter, C; Sage, CR; Gunn, KE; Brewer, JW; Jackowski, S				Fagone, Paolo; Gunter, Christopher; Sage, Christopher R.; Gunn, Kathryn E.; Brewer, Joseph W.; Jackowski, Suzanne			CTP:Phosphocholine Cytidylyltransferase alpha Is Required for B-cell Proliferation and Class Switch Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; PHOSPHOLIPID BIOSYNTHESIS; TARGETED DELETION; EXPRESSION; DIFFERENTIATION; GENE; XBP1	CTP:phosphocholine cytidylyltransferase (CCT) is a key rate-controlling enzyme in the biosynthetic pathway leading to the principle membrane phospholipid, phosphatidylcholine. CCT alpha is the predominant isoform expressed in mammalian cells. To investigate the role of CCT alpha in the development and function of B-lymphocytes, mice with B-lymphocytes that selectively lacked CCT alpha were derived using the CD19-driven Cre/loxP system. When challenged with a T-cell-dependent antigen, the animals harboring CCT alpha-deficient B-cells exhibited a hyper-IgM secretion phenotype coupled with a lack of IgG production. The inability of CCT alpha(-/-) B-cells to undergo class switch recombination correlated with a proliferation defect in vivo and in vitro in response to antigenic and mitogenic stimuli. Lipopolysaccharide stimulation of CCT alpha(-/-) B-cells resulted in an early trigger of the unfolded protein response-mediated splicing of Xbp-1 mRNA, and this was accompanied by accelerated kinetics of IgM secretion and higher incidence of IgM-secreting cells. Thus, the inability of stimulated B-cells to produce enough phosphatidylcholine prevents proliferation and class switch recombination but leads to unfolded protein response activation and a hyper-IgM secretion phenotype.	[Fagone, Paolo; Gunter, Christopher; Sage, Christopher R.; Jackowski, Suzanne] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Gunn, Kathryn E.] Mt St Marys Univ, Emmitsburg, MD 21727 USA; [Brewer, Joseph W.] Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA	St Jude Children's Research Hospital; University of South Alabama	Jackowski, S (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	suzanne.jackowski@stjude.org	Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429; Fagone, Paolo/0000-0002-0102-3701	National Institutes of Health [GM45737, GM61970, CA23944]; Cancer Center (CORE) [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, R25CA023944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061970, R01GM045737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center (CORE); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM45737 (to S.J.), GM61970 (to J.W.B.),CA23944 ( to C. S.), and Cancer Center (CORE) Support Grant CA21765. This work was also supported by the American Lebanese Syrian Associated Charities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Baburina I, 1998, J BIOL CHEM, V273, P2169, DOI 10.1074/jbc.273.4.2169; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; BOGGS KP, 1995, J BIOL CHEM, V270, P11612, DOI 10.1074/jbc.270.19.11612; Brewer JW, 2005, NAT IMMUNOL, V6, P23, DOI 10.1038/ni1149; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Clement JM, 1999, BIOCHEM BIOPH RES CO, V257, P643, DOI 10.1006/bbrc.1999.0512; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; ESKO JD, 1981, J BIOL CHEM, V256, P7388; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Gass JN, 2008, MOL IMMUNOL, V45, P1035, DOI 10.1016/j.molimm.2007.07.029; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Gunter C, 2007, BBA-MOL CELL BIOL L, V1771, P845, DOI 10.1016/j.bbalip.2007.04.015; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; KRUISBEEK AM, 2008, CURRENT PROTOCOLS IM; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Tian Y, 2008, J CELL BIOL, V181, P945, DOI 10.1083/jcb.200706152; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Van der Sanden MHM, 2003, BIOCHEM J, V369, P643, DOI 10.1042/BJ20020285; Waite KA, 2000, J BIOL CHEM, V275, P21197, DOI 10.1074/jbc.M003539200; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200	40	15	15	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6847	6854		10.1074/jbc.M807338200	http://dx.doi.org/10.1074/jbc.M807338200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139091	Green Published, hybrid			2022-12-27	WOS:000263919000031
J	Lapaque, N; Jahnke, M; Trowsdale, J; Kelly, AP				Lapaque, Nicolas; Jahnke, Martin; Trowsdale, John; Kelly, Adrian P.			The HLA-DR alpha Chain Is Modified by Polyubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; COMPLEX CLASS-II; DENDRITIC CELLS; ANTIGEN PRESENTATION; PLASMA-MEMBRANE; DOWN-REGULATION; PROTEIN; UBIQUITINATION; MOLECULES; PATHWAY	Ubiquitination plays a major role in regulating cell surface and intracellular localization of major histocompatibility complex class II molecules. Two E3 ligases, MARCH I and MARCH VIII, have been shown to polyubiquitinate lysine residue 225 in the cytoplasmic tail of I-A beta and HLA-DR beta. We show that lysine residue 219 in the cytoplasmic tail of DR alpha is also subject to polyubiquitination. Each chain of the HLA-DR heterodimer is independently recognized and ubiquitinated, but DR beta is more extensively modified. In the cytoplasmic tail of DR beta lysine, residue 225 is the only residue that is absolutely required for ubiquitination; all other residues can be deleted or substituted without loss of function. In contrast, although lysine 219 is absolutely required for modification of DR beta, other features of the DR beta tail act to limit the extent of ubiquitination.	[Lapaque, Nicolas; Jahnke, Martin; Trowsdale, John; Kelly, Adrian P.] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	University of Cambridge	Kelly, AP (corresponding author), Univ Cambridge, Dept Pathol, Div Immunol, Tennis Court Rd, Cambridge CB2 1QP, England.	apk23@mole.bio.cam.ac.uk	Lapaque, Nicolas/D-5377-2014; Lapaque, Nicolas/AAB-4530-2021	Lapaque, Nicolas/0000-0003-0824-0108; Lapaque, Nicolas/0000-0003-0824-0108	Medical Research Council [G9800943] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9800943] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; CRESSWELL P, 1992, CURR OPIN IMMUNOL, V4, P87, DOI 10.1016/0952-7915(92)90131-W; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Goto E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001490; Hiltbold EM, 2002, CURR OPIN IMMUNOL, V14, P30, DOI 10.1016/S0952-7915(01)00295-3; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Mukherjee K, 2000, J CELL BIOL, V148, P741, DOI 10.1083/jcb.148.4.741; Nakatsu F, 2000, J BIOL CHEM, V275, P26213, DOI 10.1074/jbc.M907720199; Neefjes J, 1999, EUR J IMMUNOL, V29, P1421, DOI 10.1002/(SICI)1521-4141(199905)29:05<1421::AID-IMMU1421>3.3.CO;2-3; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; van Lith M, 2001, J IMMUNOL, V167, P884, DOI 10.4049/jimmunol.167.2.884; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Watts C, 2004, NAT IMMUNOL, V5, P685, DOI 10.1038/ni1088; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	26	34	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7007	7016		10.1074/jbc.M805736200	http://dx.doi.org/10.1074/jbc.M805736200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19117940	hybrid, Green Published			2022-12-27	WOS:000263919000049
J	Appleby, JH; Zhou, KS; Volkmann, G; Liu, XQ				Appleby, Julia H.; Zhou, Kaisong; Volkmann, Gerrit; Liu, Xiang-Qin			Novel Split Intein for trans-Splicing Synthetic Peptide onto C Terminus of Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL MINI-INTEINS; CRYSTAL-STRUCTURE; TRICHODESMIUM-ERYTHRAEUM; HOMING ENDONUCLEASE; DNAB INTEIN; PCC6803; GENE; CYCLIZATION; DEFINITION; EVOLUTION	Conventional split inteins have been useful for trans-splicing between recombinant proteins, and an artificial S1 split intein is useful for adding synthetic peptide onto the N terminus of recombinant proteins. Here we have engineered a novel S11 split intein for trans-splicing synthetic peptide onto the C terminus of recombinant proteins. The C-intein of the S11 split intein is extremely small (6 amino acids (aa)); thus it can easily be produced together with a synthetic C-extein to be added to the C terminus of target proteins. The S11 intein was derived from the Ssp GyrB intein after deleting the homing endonuclease domain and splitting the remaining intein sequence near the C terminus, producing a 150-aa N-intein (I-N) and a 6-aa C-intein (I-C). Its trans-splicing activity was demonstrated first in Escherichia coli cells and then in vitro for trans-splicing between a synthetic peptide and a recombinant protein. The in vitro trans-splicing reaction exhibited a typical rate constant of (6.9 +/- 2.2) x 10(-5) s(-1) and reached a high efficiency of similar to 80%. This S-1 split intein can be useful for adding any desirable chemical groups to the C terminus of a protein of interest, which may include modified and unnatural amino acids, biotin and fluorescent labels, and even drug molecules.	[Appleby, Julia H.; Zhou, Kaisong; Volkmann, Gerrit; Liu, Xiang-Qin] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	Dalhousie University	Liu, XQ (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada.	Paul.Liu@Dal.Ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a research grant from the Canadian Institutes of Health Research.	Brenzel S, 2006, BIOCHEMISTRY-US, V45, P1571, DOI 10.1021/bi051697+; Caspi J, 2003, MOL MICROBIOL, V50, P1569, DOI 10.1046/j.1365-2958.2003.03825.x; Dalgaard JZ, 1997, J COMPUT BIOL, V4, P193, DOI 10.1089/cmb.1997.4.193; Derbyshire V, 1997, P NATL ACAD SCI USA, V94, P11466, DOI 10.1073/pnas.94.21.11466; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Duan XQ, 1997, CELL, V89, P555, DOI 10.1016/S0092-8674(00)80237-8; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; Ichiyanagi K, 2000, J MOL BIOL, V300, P889, DOI 10.1006/jmbi.2000.3873; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Liu XQ, 2004, FEBS LETT, V572, P46, DOI 10.1016/j.febslet.2004.07.016; Liu XQ, 2003, J BIOL CHEM, V278, P46826, DOI 10.1074/jbc.M309575200; Liu XQ, 2003, J BIOL CHEM, V278, P26315, DOI 10.1074/jbc.C300202200; Liu XQ, 2000, ANNU REV GENET, V34, P61, DOI 10.1146/annurev.genet.34.1.61; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; Mills KV, 1998, P NATL ACAD SCI USA, V95, P3543, DOI 10.1073/pnas.95.7.3543; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Pietrokovski S, 1998, PROTEIN SCI, V7, P64, DOI 10.1002/pro.5560070106; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Southworth MW, 1998, EMBO J, V17, P918, DOI 10.1093/emboj/17.4.918; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; Telenti A, 1997, J BACTERIOL, V179, P6378, DOI 10.1128/jb.179.20.6378-6382.1997; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Yang J, 2004, MOL MICROBIOL, V51, P1185, DOI 10.1046/j.1365-2958.2003.03902.x	28	42	47	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6194	6199		10.1074/jbc.M805474200	http://dx.doi.org/10.1074/jbc.M805474200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19136555	hybrid			2022-12-27	WOS:000263742700022
J	Oertel, BG; Kettner, M; Scholich, K; Renne, C; Roskam, B; Geisslinger, G; Schmidt, PH; Lotsch, J				Oertel, Bruno Georg; Kettner, Mattias; Scholich, Klaus; Renne, Christoph; Roskam, Bianca; Geisslinger, Gerd; Schmidt, Peter Harald; Loetsch, Joern			A Common Human mu-Opioid Receptor Genetic Variant Diminishes the Receptor Signaling Efficacy in Brain Regions Processing the Sensory Information of Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; G-PROTEIN ACTIVATION; POSTMORTEM HUMAN BRAIN; RESPIRATORY DEPRESSION; MORPHINE CONSUMPTION; HEALTHY-VOLUNTEERS; GENOTYPE AFFECTS; BINDING; A118G; ANALGESIA	The single nucleotide polymorphism 118A > G of the human mu-opioid receptor gene OPRM1, which leads to an exchange of the amino acid asparagine (N) to aspartic acid (D) at position 40 of the extracellular receptor region, alters the in vivo effects of opioids to different degrees in pain-processing brain regions. The most pronounced N40D effects were found in brain regions involved in the sensory processing of pain intensity. Using the mu-opioid receptor-specific agonist DAMGO, we analyzed the mu-opioid receptor signaling, expression, and binding affinity in human brain tissue sampled postmortem from the secondary somatosensory area (S-II) and from the ventral posterior part of the lateral thalamus, two regions involved in the sensory processing and transmission of nociceptive information. We show that the main effect of the N40D mu-opioid receptor variant is a reduction of the agonist-induced receptor signaling efficacy. In the S-II region of homo- and heterozygous carriers of the variant 118G allele (n = 18), DAMGO was only 62% as efficient (p = 0.002) as in homozygous carriers of the wild-type 118A allele (n = 15). In contrast, the number of [H-3] DAMGO binding sites was unaffected. Hence, the mu-opioid receptor G-protein coupling efficacy in SII of carriers of the 118G variant was only 58% as efficient as in homozygous carriers of the 118A allele (p < 0.001). The thalamus was unaffected by the OPRM1 118A > G SNP. In conclusion, we provide a molecular basis for the reduced clinical effects of opioid analgesics in carriers of mu-opioid receptor variant N40D.	[Oertel, Bruno Georg; Scholich, Klaus; Roskam, Bianca; Geisslinger, Gerd; Loetsch, Joern] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, D-60590 Frankfurt, Germany; [Kettner, Mattias; Schmidt, Peter Harald] Goethe Univ Frankfurt, Inst Forens Med, Frankfurt, Germany; [Renne, Christoph] Goethe Univ Frankfurt, Senckenberg Inst Pathol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Lotsch, J (corresponding author), Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de		Lotsch, Jorn/0000-0002-5818-6958				Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baumgartner U, 2006, NEUROIMAGE, V30, P692, DOI 10.1016/j.neuroimage.2005.10.033; Befort K, 2001, J BIOL CHEM, V276, P3130, DOI 10.1074/jbc.M006352200; Berthele A, 2005, NEUROIMAGE, V28, P185, DOI 10.1016/j.neuroimage.2005.05.030; Beyer A, 2004, J NEUROCHEM, V89, P553, DOI 10.1111/j.1471-4159.2004.02340.x; Bond C, 1998, P NATL ACAD SCI USA, V95, P9608, DOI 10.1073/pnas.95.16.9608; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campa D, 2008, CLIN PHARMACOL THER, V83, P559, DOI 10.1038/sj.clpt.6100385; CHAKRABARTI S, 1995, J NEUROCHEM, V64, P2534; Chou WY, 2006, ANESTHESIOLOGY, V105, P334, DOI 10.1097/00000542-200608000-00016; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; Gonzalez-Maeso J, 2000, EUR J PHARMACOL, V390, P25, DOI 10.1016/S0014-2999(99)00827-4; Klepstad P, 2004, ACTA ANAESTH SCAND, V48, P1232, DOI 10.1111/j.1399-6576.2004.00517.x; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; Ko MCH, 2003, J PHARMACOL EXP THER, V306, P179, DOI 10.1124/jpet.103.050625; Kroslak T, 2007, J NEUROCHEM, V103, P77, DOI 10.1111/j.1471-4159.2007.04738.x; Lotsch J, 2002, PHARMACOGENETICS, V12, P3, DOI 10.1097/00008571-200201000-00002; Maher CE, 2000, BIOCHEM PHARMACOL, V59, P1395, DOI 10.1016/S0006-2952(00)00272-0; Margas W, 2007, J NEUROPHYSIOL, V97, P1058, DOI 10.1152/jn.01007.2006; Neilan CL, 2003, J PHARMACOL EXP THER, V306, P430, DOI 10.1124/jpet.103.049742; Oertel BG, 2008, CLIN PHARMACOL THER, V83, P577, DOI 10.1038/sj.clpt.6100441; Oertel BG, 2006, PHARMACOGENET GENOM, V16, P625, DOI 10.1097/01.fpc.0000220566.90466.a2; Pan L, 2005, NEUROSCIENCE, V133, P209, DOI 10.1016/j.neuroscience.2004.12.033; Pan YX, 2003, BIOCHEM BIOPH RES CO, V301, P1057, DOI 10.1016/S0006-291X(03)00089-5; PILAPIL C, 1987, BRAIN RES BULL, V19, P611, DOI 10.1016/0361-9230(87)90080-3; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rodriguez-Puertas R, 2000, NEUROSCIENCE, V96, P169, DOI 10.1016/S0306-4522(99)00527-8; Romberg R, 2004, ANESTHESIOLOGY, V100, P120, DOI 10.1097/00000542-200401000-00021; Romberg RR, 2005, ANESTHESIOLOGY, V102, P522, DOI 10.1097/00000542-200503000-00008; Sia AT, 2008, ANESTHESIOLOGY, V109, P520, DOI 10.1097/ALN.0b013e318182af21; Sim LJ, 1996, EUR J PHARMACOL, V307, P97, DOI 10.1016/0014-2999(96)00211-7; Skarke C, 2003, CLIN PHARMACOL THER, V73, P107, DOI 10.1067/mcp.2003.5; Skarke C, 2004, CLIN CHEM, V50, P640, DOI 10.1373/clinchem.2003.027607; Zhang Y, 2005, J BIOL CHEM, V280, P32618, DOI 10.1074/jbc.M504942200; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	36	120	126	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6530	6535		10.1074/jbc.M807030200	http://dx.doi.org/10.1074/jbc.M807030200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19116204	hybrid			2022-12-27	WOS:000263742700055
J	Li, SY; Ouellet, H; Sherman, DH; Podust, LM				Li, Shengying; Ouellet, Hugues; Sherman, David H.; Podust, Larissa M.			Analysis of Transient and Catalytic Desosamine-binding Pockets in Cytochrome P-450 PikC from Streptomyces venezuelae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMBINATORIAL BIOSYNTHESIS; STRUCTURAL BASIS; CONSTRUCTION; ANTIBIOTICS; TELITHROMYCIN; HYDROXYLATION; SPECIFICITY; MACROLIDES; HYBRID; SYSTEM	The cytochrome P-450 PikC from Streptomyces venezuelae exhibits significant substrate tolerance and performs multiple hydroxylation reactions on structurally variant macrolides bearing the deoxyamino sugar desosamine. In previously determined co-crystal structures (Sherman, D. H., Li,S., Yermalitskaya, L.V., Kim, Y., Smith, J.A., Waterman, M.R., and Podust, L. M. (2006) J. Biol. Chem. 281, 26289-26297), the desosamine moiety of the native substrates YC-17 and narbomycin is bound in two distinct buried and surface-exposed binding pockets, mediated by specific interactions between the protonated dimethylamino group and the acidic amino acid residues Asp(50), Glu(85), and Glu(94). Although the Glu(85) and Glu(94) negative charges are essential for maximal catalytic activity of native enzyme, elimination of the surface-exposed negative charge at Asp(50) results in significantly enhanced catalytic activity. Nevertheless, the D50N substitution could not rescue catalytic activity of PikC(E94Q) based on lack of activity in the corresponding double mutant PikC(D50N/E94Q). To address the specific role for each desosamine-binding pocket, we analyzed the x-ray structures of the PikC(D50N) mutant co-crystallized with narbomycin (1.85 angstrom resolution) and YC-17 (3.2 angstrom resolution). In PikC(D50N), the desosamine moiety of both YC-17 and narbomycin was bound in a catalytically productive "buried site." This finding suggested a two-step substrate binding mechanism, whereby desosamine is recognized in the two subsites to allow the macrolide substrate to sequentially progress toward a catalytically favorable orientation. Collectively, the binding, mutagenesis, kinetic, and x-ray structural data suggest that enhancement of the catalytic activity of PikC(D50N) is due to the facilitated relocation of substrate to the buried site, which has higher binding affinity, as opposed to dissociation in solution from the transient "surface-exposed site."	[Ouellet, Hugues; Podust, Larissa M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Li, Shengying; Sherman, David H.] Univ Michigan, Dept Med Chem, Inst Life Sci, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Chem, Inst Life Sci, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Inst Life Sci, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Podust, LM (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA USA.	larissa.podust@ucsf.edu	Podust, Larissa/ABB-7940-2020	Podust, Larissa/0000-0002-8537-8760	National Institutes of Health [GM078553]; United States Dept. of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Dept. of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078553. This work was also supported by United States Dept. of Energy Contract DE-AC02-05CH11231.	Ackermann G, 2003, J ANTIMICROB CHEMOTH, V51, P497, DOI 10.1093/jac/dkg123; ANDERSEN JF, 1993, BIOCHEMISTRY-US, V32, P1905, DOI 10.1021/bi00059a004; Anzai Y, 2008, CHEM BIOL, V15, P950, DOI 10.1016/j.chembiol.2008.07.014; Auerbach T, 2004, TRENDS BIOTECHNOL, V22, P570, DOI 10.1016/j.tibtech.2004.09.006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blasi F, 2006, FUTURE MICROBIOL, V1, P7, DOI 10.2217/17460913.1.1.7; Borisova SA, 1999, ORG LETT, V1, P133, DOI 10.1021/ol9906007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchinson CR, 1998, CURR OPIN MICROBIOL, V1, P319, DOI 10.1016/S1369-5274(98)80036-2; Jenni S, 2003, CURR OPIN STRUC BIOL, V13, P212, DOI 10.1016/S0959-440X(03)00034-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khosla C, 1999, ANNU REV BIOCHEM, V68, P219, DOI 10.1146/annurev.biochem.68.1.219; LAMBALOT RH, 1995, BIOCHEMISTRY-US, V34, P1858, DOI 10.1021/bi00006a006; Li SY, 2007, J AM CHEM SOC, V129, P12940, DOI 10.1021/ja075842d; Ma Zhenkun, 2002, Current Medicinal Chemistry - Anti-Infective Agents, V1, P15, DOI 10.2174/1568012023355027; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nodate M, 2006, APPL MICROBIOL BIOT, V71, P455, DOI 10.1007/s00253-005-0147-y; Ogura H, 2004, BIOCHEMISTRY-US, V43, P14712, DOI 10.1021/bi048980d; OMURA T, 1964, J BIOL CHEM, V239, P2379; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Podust LM, 2004, PROTEIN SCI, V13, P255, DOI 10.1110/ps.03384804; Rix U, 2002, NAT PROD REP, V19, P542, DOI 10.1039/b103920m; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; Sherman DH, 2005, NAT BIOTECHNOL, V23, P1083, DOI 10.1038/nbt0905-1083; Srinivasan A, 2004, BIOTECHNOL BIOENG, V88, P528, DOI 10.1002/bit.20285; Tang L, 2001, CHEM BIOL, V8, P547, DOI 10.1016/S1074-5521(01)00032-1; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walsh CT, 2002, CHEMBIOCHEM, V3, P125; Xue YQ, 1998, CHEM BIOL, V5, P661, DOI 10.1016/S1074-5521(98)90293-9; Yoon YJ, 2002, CHEM BIOL, V9, P203, DOI 10.1016/S1074-5521(02)00095-9; Zhao LS, 1999, J AM CHEM SOC, V121, P9881, DOI 10.1021/ja992810k; Zhao LS, 1998, J AM CHEM SOC, V120, P10256, DOI 10.1021/ja981782n; Zhao LS, 1998, J AM CHEM SOC, V120, P12159, DOI 10.1021/ja982942y	38	40	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5723	5730		10.1074/jbc.M807592200	http://dx.doi.org/10.1074/jbc.M807592200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19124459	Green Published, hybrid			2022-12-27	WOS:000263560600036
J	Oslakovic, C; Krisinger, MJ; Andersson, A; Jauhiainen, M; Ehnholm, C; Dahlback, B				Oslakovic, Cecilia; Krisinger, Michael J.; Andersson, Astra; Jauhiainen, Matti; Ehnholm, Christian; Dahlback, Bjorn			Anionic Phospholipids Lose Their Procoagulant Properties When Incorporated into High Density Lipoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; ACTIVATED PROTEIN-C; CLOTTING FACTOR-X; PROTHROMBINASE COMPLEX; BLOOD-COAGULATION; FACTOR-VIII; MEMBRANE-BINDING; FACTOR-VA; PLASMA; ANTICOAGULANT	Blood coagulation involves a series of enzymatic protein complexes that assemble on the surface of anionic phospholipid. To investigate whether apolipoproteins affect coagulation reactions, they were included during the preparation of anionic phospholipid vesicles using a detergent solubilization-dialysis method. Apolipoprotein components of high density lipoproteins, especially apolipoprotein A-I, had a pronounced anticoagulant effect. The anionic phospholipids lost their procoagulant effect when the vesicle preparation method was performed in the presence of apolipoprotein A-I. The anionic phospholipid-apolipoprotein A-I particles were 8-10 nm in diameter and contained around 60-80 phospholipid molecules, depending on the phospholipid composition. The phospholipids of these particles were unable to support the activation of prothrombin by factor Xa in the presence of factor Va and unable to support binding of factor Va, whereas binding of prothrombin and factor Xa were efficient. Phospholipid transfer protein was shown to mediate transfer of phospholipids from liposomes to apolipoprotein A-I-containing reconstituted high density lipoprotein. In addition, serum was also shown to neutralize the procoagulant effect of anionic liposomes and to efficiently mediate transfer of phospholipids from liposomes to either apolipoprotein A-I-or apolipoprotein B-containing particles. In conclusion, apolipoprotein A-I was found to neutralize the procoagulant properties of anionic phospholipids by arranging the phospholipids in surface areas that are too small to accommodate the prothrombinase complex. This anionic phospholipid scavenger function may be an important mechanism to control the exposure of such phospholipids to circulating blood and thereby prevent inappropriate stimulation of blood coagulation.	[Oslakovic, Cecilia; Krisinger, Michael J.; Andersson, Astra; Dahlback, Bjorn] Lund Univ, Malmo Univ Hosp, Div Clin Chem, Dept Lab Med, SE-20502 Malmo, Sweden; [Jauhiainen, Matti; Ehnholm, Christian] Natl Publ Hlth Inst, FIN-00251 Helsinki, Finland; [Jauhiainen, Matti; Ehnholm, Christian] Finnish Inst Mol Med, FIN-00251 Helsinki, Finland	Lund University; Skane University Hospital; Finland National Institute for Health & Welfare	Dahlback, B (corresponding author), Lund Univ, Malmo Univ Hosp, Wallenberg Lab, Div Clin Chem,Dept Lab Med, Entrance 46,Floor 6, S-20502 Malmo, Sweden.	bjorn.dahlback@med.lu.se		Dahlback, Bjorn/0000-0003-1546-0328	Swedish Research Council [71430]; Swedish Heart-Lung Foundation; Soderberg Foundation; Pahlsson Foundation; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; University Hospital in Malmo	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Soderberg Foundation; Pahlsson Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; University Hospital in Malmo	This work was supported by Swedish Research Council Grant 71430; grants from the Swedish Heart-Lung Foundation, the Soderberg Foundation, the Pahlsson Foundation, the Sigrid Juselius Foundation, and the Finnish Foundation for Cardiovascular Research; and research funds from the University Hospital in Malmo. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Alder-Baerens N, 2005, J BIOL CHEM, V280, P26321, DOI 10.1074/jbc.M413993200; ARAI M, 1989, P NATL ACAD SCI USA, V86, P4277, DOI 10.1073/pnas.86.11.4277; Autin L, 2006, PROTEINS, V63, P440, DOI 10.1002/prot.20848; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Butenas S, 2002, BIOCHEMISTRY-MOSCOW+, V67, P3; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; Dahlback B, 2005, J INTERN MED, V257, P209, DOI 10.1111/j.1365-2796.2004.01444.x; DAHLBACK B, 1980, J CLIN INVEST, V66, P583, DOI 10.1172/JCI109890; DAHLBACK B, 1980, EUR J BIOCHEM, V104, P549, DOI 10.1111/j.1432-1033.1980.tb04458.x; Deguchi H, 2005, CIRCULATION, V112, P893, DOI 10.1161/CIRCULATIONAHA.104.521344; DELLANGELICA EC, 2000, CURRRENT PROTOCOLS C; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806; GALLAGHER SR, 2007, CURRENT PROTOCOLS CE; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON JI, 1983, J BIOL CHEM, V258, P4037; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Griffin JH, 1999, J CLIN INVEST, V103, P219, DOI 10.1172/JCI5006; GRIMSLEY GR, 2003, CURRENT PROTOCOLS PR; Hansson K, 2005, J THROMB HAEMOST, V3, P2633, DOI 10.1111/j.1538-7836.2005.01478.x; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Kjalke M, 2000, ARTERIOSCL THROM VAS, V20, P1835, DOI 10.1161/01.ATV.20.7.1835; Klein A, 2006, ARTERIOSCL THROM VAS, V26, P2160, DOI 10.1161/01.ATV.0000235699.98024.11; KRISHNASWAMY S, 1993, METHOD ENZYMOL, V222, P260; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; Lynch SF, 2007, BRIT J HAEMATOL, V137, P36, DOI 10.1111/j.1365-2141.2007.06514.x; Majumder R, 2008, BLOOD, V112, P2795, DOI 10.1182/blood-2008-02-138941; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; Moyer MP, 1998, ARTERIOSCL THROM VAS, V18, P458, DOI 10.1161/01.ATV.18.3.458; NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4164, DOI 10.1021/bi00638a005; NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4172, DOI 10.1021/bi00638a006; ORTEL TL, 1994, J BIOL CHEM, V269, P15898; Ortel TL, 1998, BLOOD, V91, P4188, DOI 10.1182/blood.V91.11.4188.411k33_4188_4196; ROSING J, 1993, J BIOL CHEM, V268, P21130; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Saenko EL, 1999, TRENDS CARDIOVAS MED, V9, P185, DOI 10.1016/S1050-1738(00)00019-0; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Shaw AW, 2007, J BIOL CHEM, V282, P6556, DOI 10.1074/jbc.M607973200; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; STENFLO J, 1974, P NATL ACAD SCI USA, V71, P2730, DOI 10.1073/pnas.71.7.2730; Stone MD, 2005, BIOCHEMISTRY-US, V44, P4037, DOI 10.1021/bi047655n; TAIT JF, 1992, ARCH BIOCHEM BIOPHYS, V298, P187, DOI 10.1016/0003-9861(92)90111-9; TANS G, 1991, BLOOD, V77, P2641; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vikstedt R, 2007, BIOCHEMISTRY-US, V46, P11979, DOI 10.1021/bi700833h; WILSCHUT J, 1985, BIOCHEMISTRY-US, V24, P8, DOI 10.1021/bi00322a002; YOKOYAMA WM, 2006, CURRENT PROTOCOLS IM	49	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5896	5904		10.1074/jbc.M807286200	http://dx.doi.org/10.1074/jbc.M807286200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19129179	hybrid, Green Submitted			2022-12-27	WOS:000263560600053
J	Strachan, RT; Sheffler, DJ; Willard, B; Kinter, M; Kiselar, JG; Roth, BL				Strachan, Ryan T.; Sheffler, Douglas J.; Willard, Belinda; Kinter, Michael; Kiselar, Janna G.; Roth, Bryan L.			Ribosomal S6 Kinase 2 Directly Phosphorylates the 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptor, Thereby Modulating 5-HT2A Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; 3RD INTRACELLULAR LOOP; IN-VIVO; CRYSTAL-STRUCTURE; PHOSPHOLIPASE-C; MESANGIAL CELLS; DESENSITIZATION; ACTIVATION; RHODOPSIN; AGONIST	The 5-hydroxytryptamine 2A (5-HT2A) receptor is a member of the G protein-coupled receptor superfamily (GPCR) and plays a key role in transducing a variety of cellular signals elicited by 5-hydroxytryptamine in both peripheral and central tissues. Despite its broad physiological importance, our current understanding of 5-HT2A receptor regulation is incomplete. We recently reported the novel finding that the multifunctional ERK effector ribosomal S6 kinase 2 (RSK2) physically interacts with the 5-HT2A receptor third intracellular (i3) loop and modulates receptor signaling (Sheffler, D.J., Kroeze, W.K., Garcia, B.G., Deutch, A.Y., Hufeisen, S.J., Leahy, P., Bruning, J.C., and Roth, B.L. (2006) Proc.Natl.Acad.Sci.U.S.A. 103, 4717-4722). We report here that RSK2 directly phosphorylates the 5-HT2A receptor i3 loop at the conserved residue Ser-314, thereby modulating 5-HT2A receptor signaling. Furthermore, these studies led to the discovery that RSK2 is required for epidermal growth factor-mediated heterologous desensitization of the 5-HT2A receptor. We arrived at these conclusions via multiple lines of evidence, including in vitro kinase experiments, tandem mass spectrometry, and site-directed mutagenesis. Our findings were further validated using phospho-specific Western blot analysis, metabolic labeling studies, and whole-cell signaling experiments. These results support a novel regulatory mechanism in which a downstream effector of the ERK/MAPK pathway directly interacts with, phosphorylates, and modulates signaling of the 5-HT2A serotonin receptor. To our knowledge, these findings are the first to demonstrate that a downstream member of the ERK/MAPK cascade phosphorylates a GPCR as well as mediates cross-talk between a growth factor and a GPCR.	[Roth, Bryan L.] Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27599 USA; [Strachan, Ryan T.; Roth, Bryan L.] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; [Sheffler, Douglas J.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Willard, Belinda; Kinter, Michael] Cleveland Clin Lerner Res Inst, Cleveland, OH 44195 USA; [Kiselar, Janna G.] Case Western Reserve Univ, Ctr Prote, Cleveland, OH 44106 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Case Western Reserve University; Vanderbilt University; Cleveland Clinic Foundation; Case Western Reserve University	Roth, BL (corresponding author), Univ N Carolina, Dept Pharmacol, Sch Med, 4009 Genet Med CB 7365, Chapel Hill, NC 27599 USA.	bryan_roth@med.unc.edu	Roth, Bryan/ABE-7032-2020; Roth, Bryan L/F-3928-2010	Roth, Bryan/0000-0002-0561-6520; Kinter, Michael/0000-0001-7409-8918	National Institutes of Health [RO1MH61887, NO1MH32004, U19MH82441]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061887, U19MH082441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1MH61887, NO1MH32004, and U19MH82441 (to B. L. R.).	Aghajanian GK, 1997, NEUROPHARMACOLOGY, V36, P589, DOI 10.1016/S0028-3908(97)00051-8; Allen JA, 2008, NEUROPHARMACOLOGY, V55, P961, DOI 10.1016/j.neuropharm.2008.06.048; Backstrom JR, 1997, J NEUROSCI METH, V77, P109, DOI 10.1016/S0165-0270(97)00102-7; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berg KA, 2001, J PHARMACOL EXP THER, V299, P593; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bourdon DM, 2006, METHOD ENZYMOL, V406, P489, DOI 10.1016/S0076-6879(06)06037-X; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruning JC, 2000, P NATL ACAD SCI USA, V97, P2462, DOI 10.1073/pnas.97.6.2462; Chrestensen CA, 2002, J BIOL CHEM, V277, P27733, DOI 10.1074/jbc.M202663200; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; DECLERCK F, 1982, AGENTS ACTIONS, V12, P388; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; DUERSON K, 1993, FEBS LETT, V324, P103, DOI 10.1016/0014-5793(93)81541-7; El Kouhen R, 2001, J BIOL CHEM, V276, P12774, DOI 10.1074/jbc.M009571200; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gavi S, 2006, TRENDS ENDOCRIN MET, V17, P46, DOI 10.1016/j.tem.2006.01.006; Gavi S, 2007, ENDOCRINOLOGY, V148, P2653, DOI 10.1210/en.2006-1569; Gelber EI, 1999, J NEUROCHEM, V72, P2206, DOI 10.1046/j.1471-4159.1999.0722206.x; Gooz M, 2006, J BIOL CHEM, V281, P21004, DOI 10.1074/jbc.M512096200; Gray JA, 2003, BIOCHEMISTRY-US, V42, P10853, DOI 10.1021/bi035061z; Gray JA, 2001, MOL PHARMACOL, V60, P1020, DOI 10.1124/mol.60.5.1020; Greene EL, 2000, AM J PHYSIOL-RENAL, V278, pF650, DOI 10.1152/ajprenal.2000.278.4.F650; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hanauer A, 2002, J MED GENET, V39, P705, DOI 10.1136/jmg.39.10.705; Hanley NRS, 2002, J PHARMACOL EXP THER, V300, P468, DOI 10.1124/jpet.300.2.468; Hanlon M, 2001, J BIOL CHEM, V276, P38449, DOI 10.1074/jbc.M102165200; January B, 1997, J BIOL CHEM, V272, P23871, DOI 10.1074/jbc.272.38.23871; KAGAYA A, 1990, J PHARMACOL EXP THER, V255, P305; Kang S, 2008, J BIOL CHEM, V283, P4652, DOI 10.1074/jbc.M709673200; Karoor V, 1996, J BIOL CHEM, V271, P29347, DOI 10.1074/jbc.271.46.29347; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; Maestri-El Kouhen O, 2000, J BIOL CHEM, V275, P36659, DOI 10.1074/jbc.M006788200; MAREK GJ, 1995, SYNAPSE, V21, P123, DOI 10.1002/syn.890210205; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; OKSENBERG D, 1995, J NEUROCHEM, V64, P1440; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Poteet-Smith CE, 1999, J BIOL CHEM, V274, P22135, DOI 10.1074/jbc.274.32.22135; Rahimian R, 1995, CAN J PHYSIOL PHARM, V73, P1686, DOI 10.1139/y95-731; RAHMAN S, 1995, NEUROSCIENCE, V66, P891, DOI 10.1016/0306-4522(95)00002-Z; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Roth B L, 1994, Ann Clin Psychiatry, V6, P67, DOI 10.3109/10401239409148985; ROTH BL, 1986, J PHARMACOL EXP THER, V238, P480; Roth BL, 1995, J PHARMACOL EXP THER, V275, P1638; Roth BL, 1998, PHARMACOL THERAPEUT, V79, P231, DOI 10.1016/S0163-7258(98)00019-9; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shapiro DA, 2002, J BIOL CHEM, V277, P11441, DOI 10.1074/jbc.M111675200; Sheffler DJ, 2006, P NATL ACAD SCI USA, V103, P4717, DOI 10.1073/pnas.0600585103; SIBLEY DR, 1986, P NATL ACAD SCI USA, V83, P9408, DOI 10.1073/pnas.83.24.9408; Smith JA, 2005, CANCER RES, V65, P1027; Soskic V, 1999, J BIOL CHEM, V274, P8539, DOI 10.1074/jbc.274.13.8539; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; VOURETCRAVIARI V, 1995, J BIOL CHEM, V270, P4813, DOI 10.1074/jbc.270.9.4813; Williams GV, 2002, J NEUROSCI, V22, P2843, DOI 10.1523/JNEUROSCI.22-07-02843.2002; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zhao Y, 1996, J BIOL CHEM, V271, P29773, DOI 10.1074/jbc.271.47.29773	75	32	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5557	5573		10.1074/jbc.M805705200	http://dx.doi.org/10.1074/jbc.M805705200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19103592	Green Published, hybrid			2022-12-27	WOS:000263560600019
J	Ackermann, S; Hiller, S; Osswald, H; Losle, M; Grenz, A; Hambrock, A				Ackermann, Stefanie; Hiller, Sabrina; Osswald, Hartmut; Loesle, Martina; Grenz, Almut; Hambrock, Annette			17 beta-Estradiol Modulates Apoptosis in Pancreatic beta-Cells by Specific Involvement of the Sulfonylurea Receptor (SUR) Isoform SUR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL OPENERS; PLASMA-LEVELS; INSULIN-RESISTANCE; ENDOCRINE PANCREAS; DIABETES-MELLITUS; ATP; ESTROGEN; ESTRADIOL; BINDING; MECHANISMS	Apoptosis of pancreatic beta-cells is an important factor in the pathophysiology of diabetes. Previously, we have shown that the "phytoestrogen" resveratrol can induce beta-cell apoptosis dependent on the expression of sulfonylurea receptor (SUR) 1, the regulatory subunit of pancreatic ATP-sensitive K+ channels. Here, we investigate whether 17 beta-estradiol also influences beta-cell apoptosis in a SUR1-dependent manner. Therefore, islets from wild type or SUR1 knock-out mice, clonal beta-cells, or HEK293 cells expressing different SUR forms were treated with 17 beta-estradiol or estrone. Different apoptotic parameters were determined and estrogen binding to SUR was analyzed. In murine islets, 17 beta-estradiol treatment resulted in significant apoptotic changes, which in their nature (either apoptotic or anti-apoptotic) were dependent on the age of the animal. These effects were not observed in SUR1 knock-out mice. Furthermore, 17 beta-estradiol, which specifically binds to SUR, induced enhanced apoptosis in SUR1-expressing HEK293 cells and clonal beta-cells, whereas apoptosis in recombinant cells expressing SUR2A or SUR2B (cardiac or vascular SUR-isoforms) or sham-transfected control cells was significantly lower. The apoptotic potency of 17 beta-estradiol was much higher than that of resveratrol or estrone. SUR1-specific 17 beta-estradiol-induced apoptosis was either abolished by the mutation M1289T in transmembrane helix 17 of SUR1 or clearly enhanced by two mutations in nucleotide binding fold 2 (R1379C, R1379L). In conclusion, 17 beta-estradiol treatment modulates beta-cell apoptosis under specific involvement of SUR1 in an age-dependent manner. 17 beta-Estradiol-induced apoptosis can be influenced by certain SUR1 mutations. These findings may contribute to the understanding of pathophysiological changes in beta-cell mass and could, for instance, provide interesting aspects concerning the etiology of gestational diabetes.	[Ackermann, Stefanie; Hiller, Sabrina; Osswald, Hartmut; Loesle, Martina; Grenz, Almut; Hambrock, Annette] Univ Tubingen, Fac Med, Dept Pharmacol & Toxicol, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Hambrock, A (corresponding author), Wilhelmstr 56, D-72074 Tubingen, Germany.	annette.hambrock@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [Ha 2711/2-1, Ha 2711/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Ha 2711/2-1 and Ha 2711/2-2 (to A. H. and S. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAM GE, 1972, J CLIN ENDOCR METAB, V34, P312, DOI 10.1210/jcem-34-2-312; Al-Majed HT, 2005, PANCREAS, V30, P307, DOI 10.1097/01.mpa.0000161886.17492.22; Ashcroft FM, 2007, AM J PHYSIOL-ENDOC M, V293, pE880, DOI 10.1152/ajpendo.00348.2007; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Baggio LL, 2006, ANNU REV MED, V57, P265, DOI 10.1146/annurev.med.57.110104.115624; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Buchanan TA, 2007, DIABETES CARE, V30, pS105, DOI 10.2337/dc07-s201; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Choi SB, 2005, ENDOCRINOLOGY, V146, P4786, DOI 10.1210/en.2004-1653; Contreras JL, 2002, TRANSPLANTATION, V74, P1252, DOI 10.1097/00007890-200211150-00010; de Koning EJP, 2008, TRENDS PHARMACOL SCI, V29, P218, DOI 10.1016/j.tips.2008.02.001; de Wet H, 2007, P NATL ACAD SCI USA, V104, P18988, DOI 10.1073/pnas.0707428104; DEHERTOGH R, 1975, J CLIN ENDOCR METAB, V40, P93, DOI 10.1210/jcem-40-1-93; Eckhoff DE, 2004, SURGERY, V136, P336, DOI 10.1016/j.surg.2004.05.009; Godsland IF, 2005, DIABETOLOGIA, V48, P2213, DOI 10.1007/s00125-005-1930-0; Gonzalez-Arenas A, 2006, MOL PHARMACOL, V70, P154, DOI 10.1124/mol.106.025064; Hambrock A, 2006, J PHARMACOL EXP THER, V316, P1031, DOI 10.1124/jpet.105.097501; Hambrock A, 2004, DIABETES, V53, pS128, DOI 10.2337/diabetes.53.suppl_3.S128; Hambrock A, 1999, MOL PHARMACOL, V55, P832; Hambrock A, 2001, MOL PHARMACOL, V60, P190, DOI 10.1124/mol.60.1.190; Hambrock A, 2007, J BIOL CHEM, V282, P3347, DOI 10.1074/jbc.M608216200; Hollander MH, 2007, OBSTET GYNECOL SURV, V62, P125, DOI 10.1097/01.ogx.0000253303.92229.59; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kim C, 2007, DIABETES CARE, V30, P1314, DOI 10.2337/dc06-2517; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; LINDBERG BS, 1974, ACTA OBSTET GYN SCAN, P21; LORIAUX DL, 1972, J CLIN ENDOCR METAB, V35, P887, DOI 10.1210/jcem-35-6-887; Luo Y, 2008, CELL BIOL INT, V32, P899, DOI 10.1016/j.cellbi.2008.03.023; Maedler K, 2006, DIABETES, V55, P2455, DOI 10.2337/db05-1586; MANLEY PW, 1993, J MED CHEM, V36, P2004, DOI 10.1021/jm00066a009; Moreau C, 2000, EMBO J, V19, P6644, DOI 10.1093/emboj/19.24.6644; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nadal A, 1998, FASEB J, V12, P1341, DOI 10.1096/fasebj.12.13.1341; Negulescu O, 2002, KIDNEY INT, V62, P1989, DOI 10.1046/j.1523-1755.2002.00679.x; Ripoll Cristina, 2008, Infectious Disorders - Drug Targets, V8, P61; Ropero AB, 2006, J STEROID BIOCHEM, V102, P163, DOI 10.1016/j.jsbmb.2006.09.019; Santen RJ, 2007, NAT CLIN PRACT ENDOC, V3, P496, DOI 10.1038/ncpendmet0535; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Soria B, 2004, DIABETES, V53, pS86, DOI 10.2337/diabetes.53.2007.S86; Stephan D, 2005, BRIT J PHARMACOL, V144, P1078, DOI 10.1038/sj.bjp.0706142; Tang WJ, 2006, J STEROID BIOCHEM, V100, P42, DOI 10.1016/j.jsbmb.2006.02.005; Van Pelt RE, 2008, J CLIN ENDOCR METAB, V93, P484, DOI 10.1210/jc.2007-1657; VANASSCHE FA, 1980, DIABETOLOGIA, V18, P487, DOI 10.1007/BF00261705; VANASSCHE FA, 1978, BRIT J OBSTET GYNAEC, V85, P818; Vaxillaire M, 2007, DIABETES, V56, P1737, DOI 10.2337/db06-1540; Zhang DW, 2003, BIOCHEMISTRY-US, V42, P9989, DOI 10.1021/bi034462b	51	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4905	4913		10.1074/jbc.M807638200	http://dx.doi.org/10.1074/jbc.M807638200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095654	hybrid			2022-12-27	WOS:000263416600020
J	Bonner, A; Almogren, A; Furtado, PB; Kerr, MA; Perkins, SJ				Bonner, Alexandra; Almogren, Adel; Furtado, Patricia B.; Kerr, Michael A.; Perkins, Stephen J.			The Nonplanar Secretory IgA2 and Near Planar Secretory IgA1 Solution Structures Rationalize Their Different Mucosal Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOCOCCAL POLYSACCHARIDE VACCINE; IMMUNOGLOBULIN-A IGA; AMINO-ACID-SEQUENCE; SUBCLASS DISTRIBUTION; NEUTRON-SCATTERING; X-RAY; ANALYTICAL ULTRACENTRIFUGATION; FC FRAGMENTS; COMPONENT; ANTIBODIES	Secretory IgA (SIgA) is the most prevalent human antibody and is central to mucosal immunity. It exists as two subclasses, SIgA1 and SIgA2, where SIgA2 has a shorter hinge joining the Fab and Fc regions. Both forms of SIgA are predominantly dimeric and contain an additional protein called the secretory component (SC) that is attached during the secretory process and is believed to protect SIgA in harsh mucosal conditions. Here we locate the five SC domains relative to dimeric IgA2 within SIgA2 using constrained scattering modeling. The x-ray and sedimentation parameters showed that SIgA2 has an extended solution structure. The constrained modeling of SIgA2 was initiated using two IgA2 monomers that were positioned according to our best fit solution structure for dimeric IgA1. SC was best located along the convex edge of the Fc-Fc region. The best fit models showed that SIgA2 is significantly nonplanar in its structure, in distinction to our previous near planar SIgA1 structure. Both the shorter IgA2 hinges and the presence of SC appear to displace the four Fab regions out of the Fc plane in SIgA2. This may explain the noncovalent binding of SC in some SIgA2 molecules. This nonplanar structure is predicted to result in specific immune properties for SIgA2 and SIgA1. It may explain differences observed between the SIgA1 and SIgA2 subclasses in terms of their interactions with antigens, susceptibility to proteases, effects on receptors, and distribution in different tissues. The different structures account for the prevalence of both forms in mucosal secretions.	[Bonner, Alexandra; Furtado, Patricia B.; Perkins, Stephen J.] UCL, Div Biosci, Inst Struct & Mol Biol, London WC1E 6BT, England; [Almogren, Adel] King Saud Univ, King Khalid Univ Hosp, Riyadh 11461, Saudi Arabia; [Almogren, Adel] King Saud Univ, Dept Pathol, Coll Med, Riyadh 11461, Saudi Arabia; [Kerr, Michael A.] Gen Infirm, Dept Clin Biochem & Immunol, Leeds LS1 3EX, W Yorkshire, England	University of London; Birkbeck University London; University College London; King Saud University; King Khalid University Hospital; King Saud University; Leeds General Infirmary	Perkins, SJ (corresponding author), UCL, Div Biosci, Inst Struct & Mol Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@medsch.ucl.ac.uk		Almogren, Ahmad/0000-0002-8253-9709	Biological and Biotechnology Sciences Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: researchfish; BBSRC [BB/E013104/1] Funding Source: UKRI	Biological and Biotechnology Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biological and Biotechnology Sciences Research Council and the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Almogren A, 2003, INFECT IMMUN, V71, P3349, DOI 10.1128/IAI.71.6.3349-3356.2003; Almogren A, 2008, MOL IMMUNOL, V45, P87, DOI 10.1016/j.molimm.2007.05.002; Almogren A, 2007, IMMUNOLOGY, V120, P273, DOI 10.1111/j.1365-2567.2006.02498.x; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; BEALE D, 1985, BIOCHEM J, V229, P759, DOI 10.1042/bj2290759; BLOTH B, 1971, J EXP MED, V133, P1035, DOI 10.1084/jem.133.5.1035; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; Bonner A, 2009, MUCOSAL IMMUNOL, V2, P74, DOI 10.1038/mi.2008.68; Bonner A, 2008, J IMMUNOL, V180, P1008, DOI 10.4049/jimmunol.180.2.1008; Bonner A, 2007, J BIOL CHEM, V282, P16969, DOI 10.1074/jbc.M701281200; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; BROWN TA, 1985, INFECT IMMUN, V49, P459, DOI 10.1128/IAI.49.2.459-462.1985; CHILDERS NK, 1989, ANNU REV MICROBIOL, V43, P503, DOI 10.1146/annurev.mi.43.100189.002443; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Crottet P, 1998, J IMMUNOL, V161, P5445; Crottet P, 1999, J BIOL CHEM, V274, P31456, DOI 10.1074/jbc.274.44.31456; FALLGREENGEBAUER E, 1993, BIOL CHEM H-S, V374, P1023, DOI 10.1515/bchm3.1993.374.7-12.1023; FITZSIMMONS SP, 1994, J PEDIATR-US, V124, P566, DOI 10.1016/S0022-3476(05)83135-X; Furtado PB, 2004, J MOL BIOL, V338, P921, DOI 10.1016/j.jmb.2004.03.007; GREY HM, 1968, J EXP MED, V128, P1223, DOI 10.1084/jem.128.6.1223; Hacsek G, 1996, J PEDIATR GASTR NUTR, V22, P307, DOI 10.1097/00005176-199604000-00014; HEREMANS JF, 1974, ANTIGENS, V2, P365; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; KETT K, 1986, J IMMUNOL, V136, P3631; Kilian M, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P291, DOI 10.1016/B978-012491543-5/50019-X; LADJEVA I, 1989, CLIN EXP IMMUNOL, V78, P85; LINDH E, 1975, J IMMUNOL, V114, P284; LUE C, 1988, J IMMUNOL, V140, P3793; MAZENGERA RL, 1990, BIOCHEM J, V272, P159, DOI 10.1042/bj2720159; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P153, DOI 10.1016/B978-012491543-5/50013-9; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Obaro SK, 2004, PEDIATR INFECT DIS J, V23, P1023, DOI 10.1097/01.inf.0000143651.54880.09; Osman AA, 1996, CLIN CHIM ACTA, V255, P145, DOI 10.1016/0009-8981(96)06401-7; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Pilette C, 2007, J IMMUNOL, V178, P4658, DOI 10.4049/jimmunol.178.7.4658; PRIGENTDELECOURT L, 1995, CLIN EXP IMMUNOL, V99, P221; PUTNAM FW, 1979, J BIOL CHEM, V254, P2865; Roux KH, 1998, J IMMUNOL, V161, P4083; Russell MW, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P267, DOI 10.1016/B978-012491543-5/50018-8; Schilling J, 2005, SCAND J IMMUNOL, V61, P207, DOI 10.1111/j.0300-9475.2005.01549.x; Simell B, 2006, CLIN EXP IMMUNOL, V143, P543, DOI 10.1111/j.1365-2249.2006.03009.x; STEWART WW, 1990, IMMUNOLOGY, V71, P328; Sumiyama K, 2002, MOL BIOL EVOL, V19, P1093, DOI 10.1093/oxfordjournals.molbev.a004167; SYKULEV YK, 1984, BIOFIZIKA+, V29, P744; Takeshita S, 2002, PEDIATR INT, V44, P5, DOI 10.1046/j.1442-200X.2002.01506.x; TORANO A, 1978, P NATL ACAD SCI USA, V75, P966, DOI 10.1073/pnas.75.2.966; Tregoat V, 2001, J CLIN LAB ANAL, V15, P55, DOI 10.1002/jcla.1; Woof JM, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P251, DOI 10.1016/B978-012491543-5/50017-6	51	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5077	5087		10.1074/jbc.M807529200	http://dx.doi.org/10.1074/jbc.M807529200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19109255	hybrid, Green Published			2022-12-27	WOS:000263416600038
J	Sharma, G; First, EA				Sharma, Gyanesh; First, Eric A.			Thermodynamic Analysis Reveals a Temperature-dependent Change in the Catalytic Mechanism of Bacillus stearothermophilus Tyrosyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTHALPY-ENTROPY COMPENSATION; RIBONUCLEIC-ACID SYNTHETASE; SITE-DIRECTED MUTAGENESIS; COGNATE TRANSFER-RNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; THERMUS-THERMOPHILUS; ADENYLATE FORMATION; TRANSITION-STATE; SIGNIFICANT DISCREPANCIES	Catalysis of tRNA(Tyr) aminoacylation by tyrosyl-tRNA synthetase can be divided into two steps. In the first step, tyrosine is activated by ATP to form the tyrosyl-adenylate intermediate. In the second step, the tyrosyl moiety is transferred to the 3' end of tRNA. To investigate the roles that enthalpic and entropic contributions play in catalysis by Bacillus stearothermophilus tyrosyl-tRNA synthetase (TyrRS), the temperature dependence for the activation of tyrosine and subsequent transfer to tRNA(Tyr) has been determined using single turnover kinetic methods. A van't Hoff plot for binding of ATP to the TyrRS center dot Tyr complex reveals three distinct regions. Particularly striking is the change occurring at 25 degrees C, where the values of Delta H-0 and Delta S-0 go from - 144 kJ/mol and - 438 J/mol K below 25 degrees C to + 137.9 kJ/mol and +507 J/mol K above 25 degrees C. Nonlinear Eyring and van't Hoff plots are also observed for formation of the TyrRS center dot[Tyr-ATP](double dagger) and TyrRS center dot Tyr- AMP complexes. Comparing the van't Hoff plots for the binding of ATP to tyrosyl-tRNA synthetase in the absence and presence of saturating tyrosine concentrations indicates that the temperature-dependent changes in Delta H-0 and Delta S-0 for the binding of ATP only occur when tyrosine is bound to the enzyme. Previous investigations revealed a similar synergistic interaction between the tyrosine and ATP substrates when the "KMSKS" signature sequence is deleted or replaced by a nonfunctional sequence. We propose that the temperature-dependent changes in Delta H0 and Delta S0 are because of the KMSKS signature sequence being conformationally constrained and unable to disrupt this synergistic interaction below 25 degrees C.	[Sharma, Gyanesh; First, Eric A.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	First, EA (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.	efirst@lsuhsc.edu	Sharma, Gyanesh/G-1210-2012		National Institutes of Health [GM68070]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68070 (NIGMS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARNEZ JG, 1995, EMBO J, V14, P4143, DOI 10.1002/j.1460-2075.1995.tb00088.x; Austin J, 2002, J BIOL CHEM, V277, P14812, DOI 10.1074/jbc.M103396200; AVIS JM, 1993, BIOCHEMISTRY-US, V32, P5312, DOI 10.1021/bi00071a005; BELRHALI H, 1995, STRUCTURE, V3, P341, DOI 10.1016/S0969-2126(01)00166-6; Berthet-Colominas C, 1998, EMBO J, V17, P2947, DOI 10.1093/emboj/17.10.2947; BHAT TN, 1982, J MOL BIOL, V158, P699, DOI 10.1016/0022-2836(82)90255-8; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; BRICK P, 1987, J MOL BIOL, V194, P287, DOI 10.1016/0022-2836(87)90376-7; BRUNIE S, 1990, J MOL BIOL, V216, P411, DOI 10.1016/S0022-2836(05)80331-6; Caprara MG, 1996, CELL, V87, P1135, DOI 10.1016/S0092-8674(00)81807-3; Caprara MG, 2001, J MOL BIOL, V308, P165, DOI 10.1006/jmbi.2001.4581; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2610, DOI 10.1021/bi00280a003; Case A, 2003, BIOCHEMISTRY-US, V42, P3335, DOI 10.1021/bi020668l; CHAN KW, 1995, FEBS LETT, V363, P33, DOI 10.1016/0014-5793(95)00274-D; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007; Demchenko A, 1997, COMMENTS MOL CELL BI, V9, P87; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P5, DOI 10.1021/bi00672a002; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P3350, DOI 10.1021/bi00686a010; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P13, DOI 10.1021/bi00672a003; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P8031, DOI 10.1021/bi00399a001; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13644, DOI 10.1021/bi00212a032; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13651, DOI 10.1021/bi00212a033; FIRST EA, 1995, BIOCHEMISTRY-US, V34, P5030, DOI 10.1021/bi00015a014; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13658, DOI 10.1021/bi00212a034; FREIST W, 1988, EUR J BIOCHEM, V177, P425, DOI 10.1111/j.1432-1033.1988.tb14392.x; Haldane JBS, 1930, ENZYMES, P74; Hall KB, 1995, METHOD ENZYMOL, V259, P261; HOUNTONDJI C, 1986, BIOCHEMISTRY-US, V25, P16, DOI 10.1021/bi00349a003; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ibba M, 1999, P NATL ACAD SCI USA, V96, P418, DOI 10.1073/pnas.96.2.418; JAKES R, 1975, BIOCHEMISTRY-US, V14, P3344, DOI 10.1021/bi00686a009; KERN D, 1979, BIOCHEMISTRY-US, V18, P5809, DOI 10.1021/bi00593a010; Kobayashi T, 2005, J MOL BIOL, V346, P105, DOI 10.1016/j.jmb.2004.11.034; KORNELYUK AI, 1995, BIOCHEM MOL BIOL INT, V35, P317; Kuratani M, 2006, J MOL BIOL, V355, P395, DOI 10.1016/j.jmb.2005.10.073; LANDES C, 1995, BIOCHIMIE, V77, P194, DOI 10.1016/0300-9084(96)88125-9; LEATHERBARROW RJ, 1987, BIOCHEMISTRY-US, V26, P8524, DOI 10.1021/bi00400a005; Li LW, 2008, CHEM BIOL DRUG DES, V71, P529, DOI 10.1111/j.1747-0285.2008.00661.x; Li T, 2008, EUR BIOPHYS J BIOPHY, V38, P25, DOI 10.1007/s00249-008-0350-8; Liu L, 2001, CHEM REV, V101, P673, DOI 10.1021/cr990416z; LIU YF, 1995, PROTEIN SCI, V4, P2559, DOI 10.1002/pro.5560041212; LOGAN DT, 1995, EMBO J, V14, P4156, DOI 10.1002/j.1460-2075.1995.tb00089.x; MECHULAM Y, 1991, J MOL BIOL, V217, P465, DOI 10.1016/0022-2836(91)90750-Z; MEHLER AH, 1967, J BIOL CHEM, V242, P5495; MOSYAK L, 1995, NAT STRUCT BIOL, V2, P537, DOI 10.1038/nsb0795-537; NAGHIBI H, 1995, P NATL ACAD SCI USA, V92, P5597, DOI 10.1073/pnas.92.12.5597; ONESTI S, 1995, STRUCTURE, V3, P163, DOI 10.1016/S0969-2126(01)00147-2; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; RAVEL JM, 1965, J BIOL CHEM, V240, P432; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; SANTI DV, 1971, FEBS LETT, V13, P157, DOI 10.1016/0014-5793(71)80224-7; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; SCHMITT E, 1994, J MOL BIOL, V242, P566, DOI 10.1006/jmbi.1994.1601; Segal I. H., 1976, BIOCH CALCULATIONS, P193; TINOCO IJ, 1978, PHYS CHEM PRINCIPLES, P253; Tsunoda M, 2007, NUCLEIC ACIDS RES, V35, P4289, DOI 10.1093/nar/gkm417; Uter NT, 2005, J BIOL CHEM, V280, P23966, DOI 10.1074/jbc.M414259200; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; WELLS TNC, 1991, BIOCHEMISTRY-US, V30, P5151, DOI 10.1021/bi00235a006; WELLS TNC, 1986, BIOCHEMISTRY-US, V25, P1881, DOI 10.1021/bi00356a007; WIESINGER H, 1980, H-S Z PHYSIOL CHEM, V361, P201; Xin Y, 2000, BIOCHEMISTRY-US, V39, P340, DOI 10.1021/bi991675l; Xin Y, 2000, J MOL BIOL, V303, P299, DOI 10.1006/jmbi.2000.4126; Yaremchuk A, 2000, EMBO J, V19, P4745, DOI 10.1093/emboj/19.17.4745; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373; ZELWER C, 1982, J MOL BIOL, V155, P63, DOI 10.1016/0022-2836(82)90492-2; Zhang Y, 2005, PROTEIN SCI, V14, P1340, DOI 10.1110/ps.041239305	75	14	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4179	4190		10.1074/jbc.M808500200	http://dx.doi.org/10.1074/jbc.M808500200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098308	Green Published, hybrid			2022-12-27	WOS:000263134400015
J	Heyes, DJ; Sakuma, M; de Visser, SP; Scrutton, NS				Heyes, Derren J.; Sakuma, Michiyo; de Visser, Sam P.; Scrutton, Nigel S.			Nuclear Quantum Tunneling in the Light-activated Enzyme Protochlorophyllide Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRODUCT RELEASE STEPS; DRIVEN ENZYME; CATALYTIC CYCLE; DYNAMICS; PROTEIN; PROTON; IDENTIFICATION; DEHYDROGENASE; PERSPECTIVE; MUTAGENESIS	In chlorophyll biosynthesis, the light-activated enzyme protochlorophyllide oxidoreductase catalyzes trans addition of hydrogen across the C-17-C-18 double bond of the chlorophyll precursor protochlorophyllide ( Pchlide). This unique light-driven reaction plays a key role in the assembly of the photosynthetic apparatus, but despite its biological importance, the mechanism of light-activated catalysis is unknown. In this study, we show that Pchlide reduction occurs by dynamically coupled nuclear quantum tunneling of a hydride anion followed by a proton on the microsecond time scale in the Pchlide excited and ground states, respectively. We demonstrate the need for fast dynamic searches to form degenerate "tunneling-ready" configurations within the lifetime of the Pchlide excited state from which hydride transfer occurs. Moreover, we have found a breakpoint at -27 degrees C in the temperature dependence of the hydride transfer rate, which suggests that motions/vibrations that are important for promoting light-activated hydride tunneling are quenched below -27 degrees C. We observed no such breakpoint for the proton-tunneling reaction, indicating a reliance on different promoting modes for this reaction in the enzyme-substrate complex. Our studies indicate that the overall photoreduction of Pchlide is endothermic and that rapid dynamic searches are required to form distinct tunneling-ready configurations within the lifetime of the photoexcited state. Consequently, we have established the first important link between photochemical and nuclear quantum tunneling reactions, linked to protein dynamics, in a biologically significant system.	[Heyes, Derren J.; Sakuma, Michiyo; Scrutton, Nigel S.] Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, Manchester M1 7DN, Lancs, England; [de Visser, Sam P.] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M1 7DN, Lancs, England	University of Manchester; University of Manchester	Heyes, DJ (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, 131 Princess St, Manchester M1 7DN, Lancs, England.	derren.heyes@manchester.ac.uk; sam.devisser@manchester.ac.uk; nigel.scrutton@manchester.ac.uk	de Visser, Samuel P/A-6960-2008	de Visser, Samuel P/0000-0002-2620-8788; Heyes, Derren/0000-0002-7453-1571	Biotechnology and Biological Sciences Research Council, United Kingdom; BBSRC [BB/D01963X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, United Kingdom. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aronsson H, 2003, PLANT MOL BIOL, V51, P1, DOI 10.1023/A:1020795415631; Basran J, 1999, BIOCHEMISTRY-US, V38, P3218, DOI 10.1021/bi982719d; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BEGLEY TP, 1989, J AM CHEM SOC, V111, P3095, DOI 10.1021/ja00190a071; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Benkovic SJ, 2006, SCIENCE, V312, P208, DOI 10.1126/science.1127654; Blomberg LM, 2004, J BIOL INORG CHEM, V9, P923, DOI 10.1007/s00775-004-0585-5; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; de Visser SP, 2007, INORG CHEM, V46, P4632, DOI 10.1021/ic700462h; de Visser SP, 2006, J AM CHEM SOC, V128, P9813, DOI 10.1021/ja061581g; de Visser SP, 2006, INORG CHEM, V45, P9551, DOI 10.1021/ic061019r; Dietzek B, 2006, J PHYS CHEM B, V110, P4399, DOI 10.1021/jp0556456; Frisch M.J., 2016, GAUSSIAN16 REV B01; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Heyes DJ, 2007, J BIOL CHEM, V282, P32015, DOI 10.1074/jbc.M706098200; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Johannissen LO, 2007, J PHYS CHEM B, V111, P2631, DOI 10.1021/jp066276w; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Knapp MJ, 2002, EUR J BIOCHEM, V269, P3113, DOI 10.1046/j.1432-1033.2002.03022.x; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Kuznetsov AM, 1999, CAN J CHEM, V77, P1085, DOI 10.1139/cjc-77-5-6-1085; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Masgrau L, 2004, ARCH BIOCHEM BIOPHYS, V428, P41, DOI 10.1016/j.abb.2004.03.013; Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002; Pudney CR, 2006, J AM CHEM SOC, V128, P14053, DOI 10.1021/ja0614619; *SCHR LLC, 2007, JAG 7 0; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; Sytina OA, 2008, NATURE, V456, P1001, DOI 10.1038/nature07354; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724; Zhao GJ, 2008, BIOPHYS J, V94, P38, DOI 10.1529/biophysj.107.113738	39	66	66	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3762	3767		10.1074/jbc.M808548200	http://dx.doi.org/10.1074/jbc.M808548200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073603	hybrid			2022-12-27	WOS:000262872500044
J	Schupp, M; Cristancho, AG; Lefterova, MI; Hanniman, EA; Briggs, ER; Steger, DJ; Qatanani, M; Curtin, JC; Schug, J; Ochsner, SA; McKenna, NJ; Lazar, MA				Schupp, Michael; Cristancho, Ana G.; Lefterova, Martina I.; Hanniman, Elyisha A.; Briggs, Erika R.; Steger, David J.; Qatanani, Mohammed; Curtin, Joshua C.; Schug, Jonathan; Ochsner, Scott A.; McKenna, Neil J.; Lazar, Mitchell A.			Re-expression of GATA2 Cooperates with Peroxisome Proliferator-activated Receptor-gamma Depletion to Revert the Adipocyte Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; TRANSCRIPTION FACTOR; ENERGY-BALANCE; DIFFERENTIATION; ADIPOGENESIS; EXPRESSION; TRIACYLGLYCEROL; SUPPRESSION; METABOLISM; REGULATOR	Nuclear peroxisome proliferator-activated receptor-gamma (PPAR gamma) is required for adipocyte differentiation, but its role in mature adipocytes is less clear. Here, we report that knockdown of PPAR gamma expression in 3T3-L1 adipocytes returned the expression of most adipocyte genes to preadipocyte levels. Consistently, down-regulated but not up-regulated genes showed strong enrichment of PPAR gamma binding. Surprisingly, not all adipocyte genes were reversed, and the adipocyte morphology was maintained for an extended period after PPAR gamma depletion. To explain this, we focused on transcriptional regulators whose adipogenic regulation was not reversed upon PPAR gamma depletion. We identified GATA2, a transcription factor whose down-regulation early in adipogenesis is required for preadipocyte differentiation and whose levels remain low after PPAR gamma knockdown. Forced expression of GATA2 in mature adipocytes complemented PPAR gamma depletion and impaired adipocyte functionality with a more preadipocyte-like gene expression profile. Ectopic expression of GATA2 in adipose tissue in vivo had a similar effect on adipogenic gene expression. These results suggest that PPAR gamma-independent down-regulation of GATA2 prevents reversion of mature adipocytes after PPAR gamma depletion.	[Schupp, Michael; Cristancho, Ana G.; Lefterova, Martina I.; Hanniman, Elyisha A.; Briggs, Erika R.; Steger, David J.; Qatanani, Mohammed; Curtin, Joshua C.; Lazar, Mitchell A.] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA; [Schupp, Michael; Cristancho, Ana G.; Lefterova, Martina I.; Hanniman, Elyisha A.; Briggs, Erika R.; Steger, David J.; Qatanani, Mohammed; Curtin, Joshua C.; Lazar, Mitchell A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Schug, Jonathan] Univ Penn, Sch Med, Dept Genet, Ctr Bioinformat, Philadelphia, PA 19104 USA; [Ochsner, Scott A.; McKenna, Neil J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Baylor College of Medicine	Lazar, MA (corresponding author), Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, 700 CRB,415 Curie Blvd, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019	Schupp, Michael/0000-0003-3720-1052; Ochsner, Scott/0000-0003-1099-7863; Cristancho, Ana/0000-0001-9250-8757; McKenna, Neil/0000-0001-6689-0104	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007314, U19DK062434, F32DK070405, R01DK049780] Funding Source: NIH RePORTER; NIDDK NIH HHS [U19DK62434, 5-F32-DK070405, T32-DK07314, R01 DK49780] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Dolinsky VW, 2003, BBA-MOL CELL BIOL L, V1635, P20, DOI 10.1016/j.bbalip.2003.09.007; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; IHAKA R, 1996, J GRAPH COMPUT STAT, V1, P299; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehner R, 1999, BIOCHEM J, V343, P1, DOI 10.1042/0264-6021:3430001; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Soni KG, 2004, J BIOL CHEM, V279, P40683, DOI 10.1074/jbc.M400541200; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wang F, 2008, AM J PHYSIOL-CELL PH, V295, pC213, DOI 10.1152/ajpcell.00422.2007; Wozniak RJ, 2008, CURR TOP DEV BIOL, V82, P55, DOI [10.1016/S0070-2153(07)00003-8, 10.1016/S0070-2153(67-)0000-3-8]; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105	28	50	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9458	9464		10.1074/jbc.M809498200	http://dx.doi.org/10.1074/jbc.M809498200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19136559	Green Published, hybrid			2022-12-27	WOS:000264669100052
J	Alvino, CL; McNeil, KA; Ong, SC; Delaine, C; Booker, GW; Wallace, JC; Whittaker, J; Forbes, BE				Alvino, Clair L.; McNeil, Kerrie A.; Ong, Shee Chee; Delaine, Carlie; Booker, Grant W.; Wallace, John C.; Whittaker, Jonathan; Forbes, Briony E.			A Novel Approach to Identify Two Distinct Receptor Binding Surfaces of Insulin-like Growth Factor II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-SCANNING MUTAGENESIS; CHAIN ALPHA-HELIX; LIGAND-BINDING; IGF-I; MONOCLONAL-ANTIBODIES; 6-PHOSPHATE RECEPTOR; BIOLOGICAL-ACTIVITY; SYNTHETIC PEPTIDE; HYBRID RECEPTORS; STRUCTURAL BASIS	Very little is known about the residues important for the interaction of insulin-like growth factor II (IGF-II) with the type 1 IGF receptor (IGF-1R) and the insulin receptor (IR). Insulin, to which IGF-II is homologous, is proposed to cross-link opposite halves of the IR dimer through two receptor binding surfaces, site 1 and site 2. In the present study we have analyzed the contribution of IGF-II residues equivalent to insulin's two binding surfaces toward the interaction of IGF-II with the IGF-1R and IR. Four "site 1" and six "site 2" analogues were produced and analyzed in terms of IGF-1R and IR binding and activation. The results show that Val(43), Phe(28), and Val(14) (equivalent to site 1) are critical to IGF-1R and IR binding, whereas mutation to alanine of Gln(18) affects only IGF-1R and not IR binding. Alanine substitutions at Glu(12), Asp(15), Phe(19), Leu(53), and Glu(57) analogues resulted in significant (>2-fold) decreases in affinity for both the IGF-1R and IR. Furthermore, taking a novel approach using a monomeric, single-chain minimized IGF-1R we have defined a distinct second binding surface formed by Glu(12), Phe(19), Leu(53), and Glu(57) that potentially engages the IGF-1R at one or more of the FnIII domains.	[Alvino, Clair L.; McNeil, Kerrie A.; Ong, Shee Chee; Delaine, Carlie; Booker, Grant W.; Wallace, John C.; Forbes, Briony E.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Whittaker, Jonathan] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Whittaker, Jonathan] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	University of Adelaide; Case Western Reserve University; Case Western Reserve University	Forbes, BE (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Gate 8,Victoria Dr, Adelaide, SA 5005, Australia.	briony.forbes@adelaide.edu.au	Forbes, Briony/R-1838-2019; , John/AAP-5150-2020	Forbes, Briony/0000-0003-4360-9927				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Bass J, 1996, J BIOL CHEM, V271, P19367, DOI 10.1074/jbc.271.32.19367; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; COOKE RM, 1991, BIOCHEMISTRY-US, V30, P5484, DOI 10.1021/bi00236a022; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2005, MOL ENDOCRINOL, V19, P711, DOI 10.1210/me.2004-0409; Denley A, 2003, HORM METAB RES, V35, P778; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; Epa VC, 2006, PROTEIN ENG DES SEL, V19, P377, DOI 10.1093/protein/gzl022; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Hao CL, 2006, BIOCHEM BIOPH RES CO, V347, P334, DOI 10.1016/j.bbrc.2006.06.089; HODGSON DR, 1995, EUR J BIOCHEM, V233, P299, DOI 10.1111/j.1432-1033.1995.299_1.x; HU SQ, 1993, J PROTEIN CHEM, V12, P741, DOI 10.1007/BF01024932; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Jansson M, 1997, BIOCHEMISTRY-US, V36, P4108, DOI 10.1021/bi961553i; Jensen M, 2000, THESIS U COPENHAGEN; Jensen M, 2008, BIOCHEM J, V412, P435, DOI 10.1042/BJ20080279; Jensen M, 2007, J BIOL CHEM, V282, P35179, DOI 10.1074/jbc.M704599200; KING R, 1992, J MOL ENDOCRINOL, V8, P29, DOI 10.1677/jme.0.0080029; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kristensen C, 1999, J BIOL CHEM, V274, P37351, DOI 10.1074/jbc.274.52.37351; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; Mynarcik DC, 1997, J BIOL CHEM, V272, P18650, DOI 10.1074/jbc.272.30.18650; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; SAKANO KI, 1991, J BIOL CHEM, V266, P20626; SATO A, 1993, INT J PEPT PROT RES, V41, P433; SCHAFFER L, 1993, BIOCHIM BIOPHYS ACTA, V1203, P205, DOI 10.1016/0167-4838(93)90084-5; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; SOOS MA, 1992, J BIOL CHEM, V267, P12955; SOOS MA, 1989, P NATL ACAD SCI USA, V86, P5217, DOI 10.1073/pnas.86.14.5217; Sorensen H, 2004, FEBS LETT, V565, P19, DOI 10.1016/j.febslet.2004.03.077; TERASAWA H, 1994, EMBO J, V13, P5590, DOI 10.1002/j.1460-2075.1994.tb06896.x; TORRES AM, 1995, J MOL BIOL, V248, P385, DOI 10.1006/jmbi.1995.0229; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Ward C, 2008, ACTA PHYSIOL, V192, P3, DOI 10.1111/j.1748-1716.2007.01781.x; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200	56	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7656	7664		10.1074/jbc.M808061200	http://dx.doi.org/10.1074/jbc.M808061200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19139090	hybrid, Green Published			2022-12-27	WOS:000264195600027
J	Matulova, P; Marini, V; Burgess, RC; Sisakova, A; Kwon, Y; Rothstein, R; Sung, P; Krejci, L				Matulova, Petra; Marini, Victoria; Burgess, Rebecca C.; Sisakova, Alexandra; Kwon, Youngho; Rothstein, Rodney; Sung, Patrick; Krejci, Lumir			Cooperativity of Mus81.Mms4 with Rad54 in the Resolution of Recombination and Replication Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MUS81-MMS4; HUMAN MUS81-EME1 ENDONUCLEASE; HOLLIDAY JUNCTION RESOLUTION; HOMOLOGOUS RECOMBINATION; HUMAN-CELLS; DNA-DAMAGE; BRANCH MIGRATION; MAMMALIAN-CELLS; BUDDING YEAST; PROTEIN	The Saccharomyces cerevisiae Mus81.Mms4 protein complex, a DNA structure-specific endonuclease, helps preserve genomic integrity by resolving pathological DNA structures that arise from damaged or aborted replication forks and may also play a role in the resolution of DNA intermediates arising through homologous recombination. Previous yeast two-hybrid studies have found an interaction of the Mus81 protein with Rad54, a Swi2/Snf2-like factor that serves multiple roles in homologous recombination processes. However, the functional significance of this novel interaction remains unknown. Here, using highly purified S. cerevisiae proteins, we show that Rad54 strongly stimulates the Mus81.Mms4 nuclease activity on a broad range of DNA substrates. This nuclease enhancement does not require ATP binding nor its hydrolysis by Rad54. We present evidence that Rad54 acts by targeting the Mus81.Mms4 complex to its DNA substrates. In addition, we demonstrate that the Rad54-mediated enhancement of the Mus81.Mms4 (Eme1) nuclease function is evolutionarily conserved. We propose that Mus81.Mms4 together with Rad54 efficiently process perturbed replication forks to promote recovery and may constitute an alternative mechanism to the resolution/dissolution of the recombination intermediates by Sgs1.Top3. These findings provide functional insights into the biological importance of the higher order complex of Mus81.Mms4 or its orthologue with Rad54.	[Matulova, Petra; Marini, Victoria; Sisakova, Alexandra; Krejci, Lumir] Masaryk Univ, Natl Ctr Biomol Res, Brno 62500, Czech Republic; [Kwon, Youngho; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Burgess, Rebecca C.; Rothstein, Rodney] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA	Masaryk University Brno; Yale University; Columbia University	Krejci, L (corresponding author), Masaryk Univ, Natl Ctr Biomol Res, Kamenice 5-A4, Brno 62500, Czech Republic.	lkrejci@chemi.muni.cz	Palomeque, María Victoria Marini/L-7480-2017; Krejci, Lumir/B-7842-2009	Krejci, Lumir/0000-0002-4732-1405; Rothstein, Rodney/0000-0002-4107-9654	National Institutes of Health [ES07061, GM57814, GM50237, GM67055, GM73567]; Wellcome International Senior Research Fellowship [WT076476]; EMBO/HHMI; Ministry of Education Youth and Sport of the Czech Republic [ME 888, MSM 0021622413, LC06030]; Grant Agency of Czech Republic [301/09/1917, 203/09/HO46]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067055, R01GM057814, R37GM050237, R01GM050237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome International Senior Research Fellowship; EMBO/HHMI(Howard Hughes Medical InstituteEuropean Molecular Biology Organization (EMBO)); Ministry of Education Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of Czech Republic(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES07061 (to P. S.), GM57814 (to P. S.), GM50237 (to R. R.), GM67055 (to R. R.), and GM73567 (to R. C. B.). This study was also supported by Wellcome International Senior Research Fellowship WT076476, EMBO/HHMI start up program, Ministry of Education Youth and Sport of the Czech Republic Grants ME 888, MSM 0021622413, and LC06030, and by the Grant Agency of Czech Republic Grants GACR 301/09/1917 and GACR 203/09/HO46. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abraham J, 2003, EMBO J, V22, P6137, DOI 10.1093/emboj/cdg580; Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Bastin-Shanower SA, 2003, MOL CELL BIOL, V23, P3487, DOI 10.1128/MCB.23.10.3487-3496.2003; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Clever B, 1997, EMBO J, V16, P2535, DOI 10.1093/emboj/16.9.2535; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; de los Santos T, 2003, GENETICS, V164, P81; de los Santos T, 2001, GENETICS, V159, P1511; Ehmsen KT, 2008, NUCLEIC ACIDS RES, V36, P2182, DOI 10.1093/nar/gkm1152; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fricke WM, 2005, DNA REPAIR, V4, P243, DOI 10.1016/j.dnarep.2004.10.001; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Gaskell LJ, 2007, EMBO J, V26, P1891, DOI 10.1038/sj.emboj.7601645; Haber JE, 2001, CELL, V107, P551, DOI 10.1016/S0092-8674(01)00593-1; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Hiyama T, 2006, NUCLEIC ACIDS RES, V34, P880, DOI 10.1093/nar/gkj495; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Kiianitsa K, 2006, P NATL ACAD SCI USA, V103, P9767, DOI 10.1073/pnas.0604240103; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Lehmann AR, 2003, CELL CYCLE, V2, P300, DOI 10.4161/cc.2.4.407; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Mazina OM, 2007, J BIOL CHEM, V282, P21068, DOI 10.1074/jbc.M701992200; Mazina OM, 2008, P NATL ACAD SCI USA, V105, P18249, DOI 10.1073/pnas.0807016105; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Mimida N, 2007, PLANT CELL PHYSIOL, V48, P648, DOI 10.1093/pcp/pcm029; Mullen JR, 2001, GENETICS, V157, P103; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Swagemakers SMA, 1998, J BIOL CHEM, V273, P28292, DOI 10.1074/jbc.273.43.28292; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Whitby MC, 2003, J BIOL CHEM, V278, P6928, DOI 10.1074/jbc.M210006200; Zhang R, 2005, CANCER RES, V65, P2526, DOI 10.1158/0008-5472.CAN-04-2421	57	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7733	7745		10.1074/jbc.M806192200	http://dx.doi.org/10.1074/jbc.M806192200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19129197	Green Published, hybrid			2022-12-27	WOS:000264195600035
J	Baron, RA; Tavare, R; Figueiredo, AC; Blazewska, KM; Kashemirov, BA; McKenna, CE; Ebetino, FH; Taylor, A; Rogers, MJ; Coxon, FP; Seabra, MC				Baron, Rudi A.; Tavare, Richard; Figueiredo, Ana C.; Blazewska, Katarzyna M.; Kashemirov, Boris A.; McKenna, Charles E.; Ebetino, Frank H.; Taylor, Adam; Rogers, Michael J.; Coxon, Fraser P.; Seabra, Miguel C.			Phosphonocarboxylates Inhibit the Second Geranylgeranyl Addition by Rab Geranylgeranyl Transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN FARNESYLTRANSFERASE; ESCORT PROTEIN; SMALL GTPASES; IN-VITRO; PRENYLATION; BISPHOSPHONATES; OSTEOCLASTS; RESOLUTION; COMPLEX; MOTIF	Rab geranylgeranyl transferase (RGGT) catalyzes the post-translational geranylgeranyl (GG) modification of (usually) two C-terminal cysteines in Rab GTPases. Here we studied the mechanism of the Rab geranylgeranylation reaction by bisphosphonate analogs in which one phosphonate group is replaced by a carboxylate (phosphonocarboxylate, PC). The phosphonocarboxylates used were 3-PEHPC, which was previously reported, and2-hydroxy-3-imidazo[1,2-a] pyridin-3-yl-2-phosphonopropionic acid ((+)-3-IPEHPC), a >25-fold more potent related compound as measured by both IC50 and Ki. (+)-3-IPEHPC behaves as a mixed-type inhibitor with respect to GG pyrophosphate ( GGPP) and an uncompetitive inhibitor with respect to Rab substrates. We propose that phosphonocarboxylates prevent only the second GG transfer onto Rabs based on the following evidence. First, geranylgeranylation of Rab proteins ending with a single cysteine motif such as CAAX, is not affected by the inhibitors, either in vitro or in vivo. Second, the addition of an -AAX sequence onto Rab-CC proteins protects the substrate from inhibition by the inhibitors. Third, we demonstrate directly that in the presence of (+)-3-IPEHPC, Rab-CC and Rab-CXC proteins are modified by only a single GG addition. The presence of (+)-3-IPEHPC resulted in a preference for the Rab N-terminal cysteine to be modified first, suggesting an order of cysteine geranylgeranylation in RGGT catalysis. Our results further suggest that the inhibitor binds to a site distinct from the GGPP-binding site on RGGT. We suggest that phosphonocarboxylate inhibitors bind to a GG-cysteine binding site adjacent to the active site, which is necessary to align the mono-GG-Rab for the second GG addition. These inhibitors may represent a novel therapeutic approach in Rab-mediated diseases.	[Baron, Rudi A.; Tavare, Richard; Figueiredo, Ana C.; Seabra, Miguel C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Blazewska, Katarzyna M.; Kashemirov, Boris A.; McKenna, Charles E.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Ebetino, Frank H.] Procter & Gamble Pharmaceut, Cincinnati, OH 45040 USA; [Taylor, Adam; Rogers, Michael J.; Coxon, Fraser P.] Univ Aberdeen, Inst Med Sci, Bone & Musculoskeletal Programme, Aberdeen AB25 2ZD, Scotland; [Seabra, Miguel C.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Seabra, Miguel C.] Univ Nova Lisboa, Fac Ciencias Med, P-1169056 Lisbon, Portugal	Imperial College London; University of Southern California; Procter & Gamble; University of Aberdeen; Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa	Seabra, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England.	m.seabra@imperial.ac.uk	Seabra, Miguel/AAC-3099-2019; Seabra, Miguel C/M-3280-2013; Figueiredo, Ana/K-1384-2013; Błażewska, Katarzyna/M-3722-2018	Seabra, Miguel C/0000-0002-6404-4892; Figueiredo, Ana/0000-0001-8386-8216; Błażewska, Katarzyna/0000-0002-1218-7111; Tavare, Richard/0000-0001-5150-5963; Rogers, Michael/0000-0002-1818-9249	Arthritis Research UK [17285] Funding Source: Medline; Versus Arthritis [17285] Funding Source: Medline; Wellcome Trust [075498] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission)		ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; ARMSTRONG SA, 1995, METHOD ENZYMOL, V257, P30; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Coxon FP, 2001, J BIOL CHEM, V276, P48213, DOI 10.1074/jbc.M106473200; Coxon FP, 2005, BONE, V37, P349, DOI 10.1016/j.bone.2005.04.021; Desnoyers L, 1998, P NATL ACAD SCI USA, V95, P12266, DOI 10.1073/pnas.95.21.12266; FARNSWORTH CC, 1994, P NATL ACAD SCI USA, V91, P11963, DOI 10.1073/pnas.91.25.11963; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Leung KF, 2007, J BIOL CHEM, V282, P1487, DOI 10.1074/jbc.M605557200; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Long SB, 2002, NATURE, V419, P645, DOI 10.1038/nature00986; Mazieres J, 2004, CANCER LETT, V206, P159, DOI 10.1016/j.canlet.2003.08.033; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Russell RGG, 2007, ANN NY ACAD SCI, V1117, P209, DOI 10.1196/annals.1402.089; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Seabra MC, 1998, METH MOL B, V84, P251; Shen F, 1996, J BIOL CHEM, V271, P3692; Taylor JS, 2003, EMBO J, V22, P5963, DOI 10.1093/emboj/cdg571; Thoma NH, 2000, BIOCHEMISTRY-US, V39, P12043, DOI 10.1021/bi000835m; van Beek E, 1999, BIOCHEM BIOPH RES CO, V255, P491, DOI 10.1006/bbrc.1999.0224; Watanabe M, 2008, J BIOL CHEM, V283, P9571, DOI 10.1074/jbc.M706229200; Wu YW, 2006, CHEMBIOCHEM, V7, P1859, DOI 10.1002/cbic.200600377; Zhang H, 2000, STRUCTURE, V8, P241, DOI 10.1016/S0969-2126(00)00102-7	27	47	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6861	6868		10.1074/jbc.M806952200	http://dx.doi.org/10.1074/jbc.M806952200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19074143	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000263919000033
J	Yang, J; Kennedy, EJ; Wu, J; Deal, MS; Pennypacker, J; Ghosh, G; Taylor, SS				Yang, Jie; Kennedy, Eileen J.; Wu, Jian; Deal, Michael S.; Pennypacker, Juniper; Ghosh, Gourisankar; Taylor, Susan S.			Contribution of Non-catalytic Core Residues to Activity and Regulation in Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; NUCLEOTIDE-BINDING; PKA; ADENOSINE; COMPLEX; COMMUNICATION; SPECIFICITY; MECHANISM; NETWORKS	Protein kinase A holoenzyme is comprised of two catalytic (C) and two regulatory (R) subunits which keep the enzyme in an inhibited state before activation by cyclic-AMP. The C-subunit folds into a conserved bi-lobal core flanked by N- and C-terminal tails. We report here characterization of a C-tail loss-of-function mutant, C-F327A, and a related suppressor mutant, C-F327A/K285P. Phe-327 is the only residue outside the kinase core that binds to the adenine ring of ATP, whereas Lys-285 is similar to 45 angstrom away and lies in an AGC kinase-specific insert. The two mutations were previously identified from a yeast genetic screen, where the F327A mutation was unable to complement cell growth but mutation of K285P in the same allele rescued cell viability. We show that C-F327A exhibits significant reduction in catalytic efficiency, which likely explains the observed loss-of-function phenotype. Interestingly, the additional K285P mutation does not restore kinase activity but reduces the inhibitory interaction of the double mutant with RII subunits. The additional K285P mutation, thus, helps to keep a low but uninhibited PKA activity that is sufficient for cell viability. The crystal structure of C-F327A/K285P further reveals that recruitment of Phe-327 to the ATP binding pocket not only contributes to the hydrophobic pocket, as previously thought, but also recruits its flanking C-tail region to the kinase core, thereby concertedly positioning the glycine-rich loop and ATP for phosphoryl transfer. The study exemplifies two different ways for regulating cAMP-dependent protein kinase activity through non-conserved residues and sheds light on the structural and functional diversity of the kinase family.	[Yang, Jie; Kennedy, Eileen J.; Wu, Jian; Deal, Michael S.; Pennypacker, Juniper; Ghosh, Gourisankar; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.			Kennedy, Eileen/0000-0001-5610-1677	National Institutes of Health [GM19301]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019301, R01GM019301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM19301. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Anand GS, 2007, J MOL BIOL, V374, P487, DOI 10.1016/j.jmb.2007.09.035; Andersen MD, 2001, J BIOL CHEM, V276, P14204, DOI 10.1074/jbc.M011543200; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CANNON JF, 1987, MOL CELL BIOL, V7, P2653, DOI 10.1128/MCB.7.8.2653; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Grant BD, 1996, PROTEIN SCI, V5, P1316, DOI 10.1002/pro.5560050710; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kennedy EJ, 2008, J BIOL CHEM, V283, P1084, DOI 10.1074/jbc.M704028200; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prowse CN, 2001, J BIOL CHEM, V276, P40817, DOI 10.1074/jbc.M105860200; Shi ZS, 2006, CURR OPIN STRUC BIOL, V16, P686, DOI 10.1016/j.sbi.2006.10.011; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Wong L, 2004, ACCOUNTS CHEM RES, V37, P304, DOI 10.1021/ar020128g; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; ZOLLER MJ, 1991, GENE, V99, P171, DOI 10.1016/0378-1119(91)90124-T	37	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6241	6248		10.1074/jbc.M805862200	http://dx.doi.org/10.1074/jbc.M805862200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19122195	Green Published, hybrid			2022-12-27	WOS:000263742700027
J	Cen, B; Li, HY; Weinstein, IB				Cen, Bo; Li, Haiyang; Weinstein, I. Bernard			Histidine Triad Nucleotide-binding Protein 1 Up-regulates Cellular Levels of p27(KIP1) by Targeting Scf(SKP2) Ubiquitin Ligase and Src	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; ACTIVATED MAST-CELLS; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL ACTIVITY; PROGNOSTIC-SIGNIFICANCE; TYROSINE KINASE; CDK INHIBITORS; HUMAN CANCER; CYCLIN; P27	The one or more underlying mechanisms of the tumor suppressing activity of the histidine triad nucleotide-binding protein 1 (HINT1) are not well defined. In this study we found that HINT1 regulates cellular levels of the cyclin-dependent kinase inhibitor p27(KIP1) through multiple mechanisms. Increased expression of HINT1 increases cellular levels of p27(KIP1), and HINT1 knockdown with small hairpin RNA leads to decreased cellular levels of p27(KIP1). HINT1 does not affect the transcription of p27(KIP1), but it does inhibit proteasomal degradation of the p27(KIP1) protein. HINT1 directly interacts with the SCFSKP2 ubiquitin ligase complex and inhibits the ubiquitylation of p27(KIP1). Src has been shown to phosphorylate p27(KIP1) and thus decrease its stability. We found that HINT1 is a negative regulator of Src transcription apparently by forming a complex with the transcription factor Sp1 on the promoter of Src. Taken together, our findings indicate that HINT1 up-regulates cellular levels of p27(KIP1) by two mechanisms: 1) it inhibits its ubiquitylation by targeting the SCFSKP2 ubiquitin ligase complex, and 2) it inhibits the phosphorylation of p27(KIP1) by Src via inhibiting Src expression.	[Cen, Bo; Li, Haiyang; Weinstein, I. Bernard] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Weinstein, I. Bernard] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Cen, B (corresponding author), Med Univ S Carolina, Hollings Canc Ctr, Dept Med, 86 Jonathan Lucas St, Charleston, SC 29425 USA.	cen@musc.edu			Environmental Protection Agency [X97279801-0]; T. J. Martell Foundation; National Foundation for Cancer Research; Entertainment Industry Foundation	Environmental Protection Agency(United States Environmental Protection Agency); T. J. Martell Foundation; National Foundation for Cancer Research; Entertainment Industry Foundation	This work was supported by the Environmental Protection Agency ( Grant X97279801-0 to H. L.), the T. J. Martell Foundation, the National Foundation for Cancer Research, and the Entertainment Industry Foundation ( to I.B.W.).	Ajit SK, 2007, CELL SIGNAL, V19, P723, DOI 10.1016/j.cellsig.2006.09.008; Avizienyte E, 2004, MOL BIOL CELL, V15, P2794, DOI 10.1091/mbc.E03-12-0879; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; BONHAM K, 1993, ONCOGENE, V8, P1973; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BRZOSKA PM, 1995, P NATL ACAD SCI USA, V92, P7824, DOI 10.1073/pnas.92.17.7824; Chen T, 2006, ANTI-CANCER DRUG, V17, P123, DOI 10.1097/00001813-200602000-00002; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Clurman BE, 1998, P NATL ACAD SCI USA, V95, P15158, DOI 10.1073/pnas.95.26.15158; Courtneidge SA, 2003, BIOCHEM SOC T, V31, P25, DOI 10.1042/bst0310025; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Guang W, 2004, MOL PHARMACOL, V66, P1285, DOI 10.1124/mol.66.5.; GUPTA SK, 1992, J BIOL CHEM, V267, P7987; Harper JW, 1999, NAT CELL BIOL, V1, pE5, DOI 10.1038/8952; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Klein MG, 1998, EXP CELL RES, V244, P26, DOI 10.1006/excr.1998.4153; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Korsisaari N, 2000, J BIOL CHEM, V275, P34837, DOI 10.1074/jbc.C000505200; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Lee YN, 2005, MOL CELL BIOL, V25, P8904, DOI 10.1128/MCB.25.20.8904-8912.2005; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Li H, 2006, ONCOGENE, V25, P713, DOI 10.1038/sj.onc.1209111; Lloyd RV, 1999, AM J PATHOL, V154, P313, DOI 10.1016/S0002-9440(10)65277-7; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Razin E, 1999, J BIOL CHEM, V274, P34272, DOI 10.1074/jbc.274.48.34272; Ritchie S, 2000, J BIOL CHEM, V275, P847, DOI 10.1074/jbc.275.2.847; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tsihlias J, 1999, ANNU REV MED, V50, P401; Wang L, 2007, CANCER RES, V67, P4700, DOI 10.1158/0008-5472.CAN-06-4645; Weiske J, 2006, J BIOL CHEM, V281, P27356, DOI 10.1074/jbc.M513452200; Zhou P, 1999, ANTICANCER RES, V19, P4935	51	23	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5265	5276		10.1074/jbc.M804531200	http://dx.doi.org/10.1074/jbc.M804531200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19112177	hybrid			2022-12-27	WOS:000263416600057
J	Izumi, K; Kodama, E; Shimura, K; Sakagami, Y; Watanabe, K; Ito, S; Watabe, T; Terakawa, Y; Nishikawa, H; Sarafianos, SG; Kitaura, K; Oishi, S; Fujii, N; Matsuoka, M				Izumi, Kazuki; Kodama, Eiichi; Shimura, Kazuya; Sakagami, Yasuko; Watanabe, Kentaro; Ito, Saori; Watabe, Tsuyoshi; Terakawa, Yukihiro; Nishikawa, Hiroki; Sarafianos, Stefan G.; Kitaura, Kazuo; Oishi, Shinya; Fujii, Nobutaka; Matsuoka, Masao			Design of Peptide-based Inhibitors for Human Immunodeficiency Virus Type 1 Strains Resistant to T-20	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 FUSION INHIBITOR; ENFUVIRTIDE RESISTANCE; ENVELOPE GLYCOPROTEIN; BH3 HELIX; GP41; MUTATIONS; EVOLUTION; VARIANT; BINDING; SENSITIVITY	Enfuvirtide (T-20) is a fusion inhibitor that suppresses replication of human immunodeficiency virus (HIV) variants with multi-drug resistance to reverse transcriptase and protease inhibitors. It is a peptide derived from the C-terminal heptad repeat (C-HR) of HIV-1 gp41, and it prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion. However, prolonged therapies with T-20 result in the emergence of T-20-resistant strains that contain primary mutations such as N43D in the N-HR of gp41 (where T-20 and C-HR bind) that help the virus escape at a fitness cost. Such variants often go on to acquire a secondary mutation, S138A, in the C-HR of gp41 region that corresponds to the sequence of T-20. We demonstrate here that the role of S138A is to compensate for the impaired fusion kinetics of HIV-1s carrying primary mutations that abrogate binding of T-20. To preempt this escape strategy, we designed a modified T-20 variant containing the S138A substitution and showed that it is a potent inhibitor of both T-20-sensitive and T-20-resistant viruses. Circular dichroism analysis revealed that the S138A provided increased stability of the 6-helix bundle. We validated our approach on another fusion inhibitor, C34. In this case, we designed a variant of C34 with the secondary escape mutation N126K and showed that it can effectively inhibit replication of C34-resistant HIV-1. These results prove that it is possible to design improved peptide-based fusion inhibitors that are efficient against a major mechanism of drug resistance.	[Izumi, Kazuki; Kodama, Eiichi; Shimura, Kazuya; Sakagami, Yasuko; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Watanabe, Kentaro; Ito, Saori; Watabe, Tsuyoshi; Terakawa, Yukihiro; Nishikawa, Hiroki; Kitaura, Kazuo; Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Sarafianos, Stefan G.] Univ Missouri, Sch Med, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA	Kyoto University; Kyoto University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kodama, E (corresponding author), Kyoto Univ, Inst Virus Res, 53 Kawaramachi, Kyoto 6068507, Japan.	ekodama@virus.kyoto-u.ac.jp	Oishi, Shinya/C-1350-2011; Kodama, Eiichi N/C-4032-2009	Oishi, Shinya/0000-0002-2833-2539; Kodama, Eiichi N/0000-0002-6622-2752; Sarafianos, Stefan G/0000-0002-5840-154X; SHIMURA, Kazuya/0000-0001-7819-5184; Matsuoka, Masao/0000-0002-0473-754X	National Institutes of Health [AI076119, AI079801, AI074389]; Ministry of Health and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Health Sciences Foundation; 21st Century COE program; Japan Society for the Promotion of Science research fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074389, R21AI079801, R33AI079801, R01AI076119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Health Sciences Foundation; 21st Century COE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science research fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by National Institutes of Health Grants AI076119, AI079801, and AI074389 (to S. G. S.). This work was also supported in part by grants from the Ministry of Health and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to E. K., S. O., and N. F.), the Japan Health Sciences Foundation (to E. K., S. O., N. F., and M. M.), the 21st Century COE program (to K. I., S. I., and H. N.), and a Japan Society for the Promotion of Science research fellowship (to H. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Armand-Ugon M, 2003, ANTIVIR RES, V59, P137, DOI 10.1016/S0166-3542(03)00071-8; Bai XF, 2008, BIOCHEMISTRY-US, V47, P6662, DOI 10.1021/bi702509d; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Baldwin C, 2008, J VIROL, V82, P7735, DOI 10.1128/JVI.02524-07; Baldwin CE, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-84; Cabrera C, 2006, AIDS, V20, P2075, DOI 10.1097/QAD.0b013e3280102377; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chinnadurai R, 2007, J VIROL, V81, P6563, DOI 10.1128/JVI.02546-06; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Labrosse B, 2006, J VIROL, V80, P8807, DOI 10.1128/JVI.02706-05; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Maeda Y, 1998, J INFECT DIS, V177, P1207, DOI 10.1086/515282; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nameki D, 2005, J VIROL, V79, P764, DOI 10.1128/JVI.79.2.764-770.2005; Nilsson I, 1998, J MOL BIOL, V284, P1165, DOI 10.1006/jmbi.1998.2217; Nishikawa H, 2009, INT J BIOCHEM CELL B, V41, P891, DOI 10.1016/j.biocel.2008.08.039; Nishitsuji H, 2006, J VIROL, V80, P7658, DOI 10.1128/JVI.00078-06; Oishi S, 2008, J MED CHEM, V51, P388, DOI 10.1021/jm701109d; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Perez-Alvarez L, 2006, J MED VIROL, V78, P141, DOI 10.1002/jmv.20520; Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; WATABE T, 2009, PEPTIDE SCI IN PRESS; Weiss Carol D, 2003, AIDS Rev, V5, P214; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005	38	38	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4914	4920		10.1074/jbc.M807169200	http://dx.doi.org/10.1074/jbc.M807169200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19073606	Green Published, hybrid			2022-12-27	WOS:000263416600021
J	Ramadan, O; Qu, YX; Wadgaonkar, R; Baroudi, G; Karnabi, E; Chahine, M; Boutjdir, M				Ramadan, Omar; Qu, Yongxia; Wadgaonkar, Raj; Baroudi, Ghayath; Karnabi, Eddy; Chahine, Mohamed; Boutjdir, Mohamed			Phosphorylation of the Consensus Sites of Protein Kinase A on alpha(1D) L-type Calcium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NULL MUTANT MICE; CA2+ CHANNELS; ATRIOVENTRICULAR-CONDUCTION; PACEMAKER ACTIVITY; CARDIAC MYOCYTES; FUNCTIONAL ROLES; SINOATRIAL NODE; EXPRESSION; ATRIAL; PHARMACOLOGY	The novel alpha(1D) L-type Ca2+ channel is expressed in supraventricular tissue and has been implicated in the pacemaker activity of the heart and in atrial fibrillation. We recently demonstrated that PKA activation led to increased alpha(1D) Ca2+ channel activity in tsA201 cells by phosphorylation of the channel protein. Here we sought to identify the phosphorylated PKA consensus sites on the alpha(1) subunit of the alpha(1D) Ca2+ channel by generating GST fusion proteins of the intracellular loops, N terminus, proximal and distal C termini of the alpha(1) subunit of alpha(1D) Ca2+ channel. An in vitro PKA kinase assay was performed for the GST fusion proteins, and their phosphorylation was assessed by Western blotting using either anti-PKA substrate or anti-phosphoserine antibodies. Western blotting showed that the N terminus and C terminus were phosphorylated. Serines 1743 and 1816, two PKA consensus sites, were phosphorylated by PKA and identified by mass spectrometry. Site directed mutagenesis and patch clamp studies revealed that serines 1743 and 1816 were major functional PKA consensus sites. Altogether, biochemical and functional data revealed that serines 1743 and 1816 are major functional PKA consensus sites on the alpha(1) subunit of alpha(1D) Ca2+ channel. These novel findings provide new insights into the autonomic regulation of the alpha(1D) Ca2+ channel in the heart.	[Ramadan, Omar; Qu, Yongxia; Wadgaonkar, Raj; Karnabi, Eddy; Boutjdir, Mohamed] VA New York Harbor Healthcare Syst, Brooklyn, NY 11209 USA; [Ramadan, Omar; Qu, Yongxia; Wadgaonkar, Raj; Karnabi, Eddy; Boutjdir, Mohamed] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Baroudi, Ghayath] Univ Montreal, Montreal, PQ H3C 3J7, Canada; [Chahine, Mohamed] Univ Laval Robert Giffard, Quebec City, PQ G1J 2G3, Canada; [Boutjdir, Mohamed] NYU, Sch Med, New York, NY 10016 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Universite de Montreal; Laval University; New York University	Boutjdir, M (corresponding author), VA New York Harbor Healthcare Syst, Res & Dev 151,800 Poly Pl, Brooklyn, NY 11209 USA.	Mohamed.boutjdir@med.va.gov		Boutjdir, Mohamed/0000-0002-6068-223X	NHLBI [HL 077494]; Veterans Administration Merit Grant Award; Veterans Administration MREP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077494] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Administration Merit Grant Award; Veterans Administration MREP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 077494 from the NHLBI. This work was also supported by Veterans Administration Merit Grant Award (to M. B.) and the Veterans Administration MREP Grant (to Y. Q.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Baroudi G, 2006, AM J PHYSIOL-HEART C, V291, pH1614, DOI 10.1152/ajpheart.00095.2006; Bell DC, 2001, J NEUROPHYSIOL, V85, P816, DOI 10.1152/jn.2001.85.2.816; Brette F, 2006, PROG BIOPHYS MOL BIO, V91, P1, DOI 10.1016/j.pbiomolbio.2005.01.001; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Matthes J, 2004, N-S ARCH PHARMACOL, V369, P554, DOI 10.1007/s00210-004-0940-7; Moosmang S, 2005, PHARMACOL THERAPEUT, V106, P347, DOI 10.1016/j.pharmthera.2004.12.003; Nargeot J, 1997, EUR HEART J, V18, pA15; OUADID H, 1992, MOL PHARMACOL, V41, P346; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Qu YX, 2005, CIRCULATION, V111, P3034, DOI 10.1161/CIRCULATIONAHA.104.517326; Qu YX, 2005, AM J PHYSIOL-HEART C, V288, pH2123, DOI 10.1152/ajpheart.01023.2004; RANDALL WC, 1984, J AUTONOM NERV SYST, V11, P145, DOI 10.1016/0165-1838(84)90072-9; REUTER H, 1984, ANNU REV PHYSIOL, V46, P473; STILES GL, 1984, ANNU REV MED, V35, P149, DOI 10.1146/annurev.me.35.020184.001053; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; Takimoto K, 1997, J MOL CELL CARDIOL, V29, P3035, DOI 10.1006/jmcc.1997.0532; Tellez JO, 2006, CIRC RES, V99, P1384, DOI 10.1161/01.RES.0000251717.98379.69; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang L, 2005, J BIOL CHEM, V280, P207, DOI 10.1074/jbc.M410509200; ZAMPONI G, 2005, VOLTAGE GATED CALCIU, P61; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070; Zhang Z, 2002, CIRC RES, V90, P981, DOI 10.1161/01.RES.0000018003.14304.E2	30	15	16	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5042	5049		10.1074/jbc.M809132200	http://dx.doi.org/10.1074/jbc.M809132200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19074150	Green Published, hybrid			2022-12-27	WOS:000263416600034
J	Ithychanda, SS; Das, M; Ma, YQ; Ding, KY; Wang, XX; Gupta, S; Wu, CY; Plow, EF; Qin, J				Ithychanda, Sujay Subbayya; Das, Mitali; Ma, Yan-Qing; Ding, Keyang; Wang, Xiaoxia; Gupta, Sudhiranjan; Wu, Chuanyue; Plow, Edward F.; Qin, Jun			Migfilin, a Molecular Switch in Regulation of Integrin Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; FILAMIN BINDING; PEPTIDES; ALPHA(IIB)BETA(3); LOCALIZATION; COMPETITION; MECHANICS; TRANSPORT; ADHESIONS; DOMAINS	The linkage of heterodimeric (alpha/beta) integrin receptors with their extracellular matrix ligands and intracellular actin cytoskeleton is a fundamental step for controlling cell adhesion and migration. Binding of the actin-linking protein, talin, to integrin beta cytoplasmic tails (CTs) induces high affinity ligand binding (integrin activation), whereas binding of another actin-linking protein, filamin, to the integrin beta CTs negatively regulates this process by blocking the talin-integrin interaction. Here we show structurally that migfilin, a novel cytoskeletal adaptor highly enriched in the integrin adhesion sites, strongly interacts with the same region in filamin where integrin beta CTs bind. We further demonstrate that the migfilin interaction dissociates filamin from integrin and promotes the talin/integrin binding and integrin activation. Migfilin thus acts as a molecular switch to disconnect filamin from integrin for regulating integrin activation and dynamics of extracellular matrix-actin linkage.	[Ithychanda, Sujay Subbayya; Das, Mitali; Ma, Yan-Qing; Ding, Keyang; Wang, Xiaoxia; Gupta, Sudhiranjan; Plow, Edward F.; Qin, Jun] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Plow, EF (corresponding author), Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, NB20,9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org; qinj@ccf.org	Qin, Jun/D-5559-2009; Ithychanda, Sujay Subbayya/C-7792-2011	Ithychanda, Sujay Subbayya/0000-0001-8979-246X; Qin, Jun/0000-0002-2647-9270	National Institutes of Health [GM62823, P01HL073311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62823 (to J. Q.) and P01HL073311 (to J. Q. and E. F. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akazawa H, 2004, J CELL BIOL, V164, P395, DOI 10.1083/jcb.200309159; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Chen L, 2001, CHEM BIOL, V8, P1123, DOI 10.1016/S1074-5521(01)00076-X; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; David T, 2006, J THROMB HAEMOST, V4, P2645, DOI 10.1111/j.1538-7836.2006.02198.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Goldmann WH, 2000, BIOCHEM BIOPH RES CO, V271, P553, DOI 10.1006/bbrc.2000.2653; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Klaile E, 2005, J CELL SCI, V118, P5513, DOI 10.1242/jcs.02660; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Martin K, 2003, J THROMB HAEMOST, V1, P2643, DOI 10.1046/j.1538-7836.2003.00478.x; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nelson AR, 2007, BIOCHEMISTRY-US, V46, P14771, DOI 10.1021/bi701295k; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Sjekloca L, 2007, J MOL BIOL, V368, P1011, DOI 10.1016/j.jmb.2007.02.018; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takafuta T, 2003, J BIOL CHEM, V278, P12175, DOI 10.1074/jbc.M209339200; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Trehin R, 2004, EUR J PHARM BIOPHARM, V58, P209, DOI 10.1016/j.ejpb.2004.02.018; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; UGAROVA TP, 1993, J BIOL CHEM, V268, P21080; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; Xu YZ, 2006, J BIOMOL NMR, V34, P41, DOI 10.1007/s10858-005-5358-0; Ye YP, 2006, J MED CHEM, V49, P2268, DOI 10.1021/jm050947h; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; ZHANG ZH, 1993, J CELL BIOL, V122, P235, DOI 10.1083/jcb.122.1.235	56	89	92	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4713	4722		10.1074/jbc.M807719200	http://dx.doi.org/10.1074/jbc.M807719200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074766	Green Published, hybrid			2022-12-27	WOS:000263134400071
J	Verselis, VK; Trelles, MP; Rubinos, C; Bargiello, TA; Srinivas, M				Verselis, Vytas K.; Trelles, Maria P.; Rubinos, Clio; Bargiello, Thaddeus A.; Srinivas, Miduturu			Loop Gating of Connexin Hemichannels Involves Movement of Pore-lining Residues in the First Extracellular Loop Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION HEMICHANNELS; SINGLE-CHANNEL SCAM; ATP RELEASE; METABOLIC INHIBITION; CX46 HEMICHANNELS; AMINO-TERMINUS; HEAVY-METALS; ION-CHANNEL; HELA-CELLS; SELECTIVITY	Unapposed connexin hemichannels exhibit robust closure in response to membrane hyperpolarization and extracellular calcium. This form of gating, termed "loop gating," is largely responsible for regulating hemichannel opening, thereby preventing cell damage through excessive flux of ions and metabolites. The molecular components and structural rearrangements underlying loop gating remain unknown. Here, using cysteine mutagenesis in Cx50, we demonstrate that residues at the TM1/E1 border undergo movement during loop gating. Replacement of Phe(43) in Cx50 with a cysteine resulted in small or no appreciable membrane currents. Bath application of dithiothreitol or TPEN (N,N,N',N'-tetrakis(2-pyridylmethyl) ethylenediamine), reagents that exhibit strong transition metal chelating activity, led to robust currents indicating that the F43C substitution impaired hemichannel function, producing "lock-up" in a closed or poorly functional state due to formation of metal bridges. In support, Cd2+ at submicromolar concentrations (50-100 nM) enhanced lock-up of F43C hemichannels. Moreover, lock-up occurred under conditions that favored closure, indicating that the sulfhydryl groups come close enough to each other or to other residues to coordinate metal ions with high affinity. In addition to F43C, metal binding was also found for G46C, and to a lesser extent, D51C substitutions, positions found to be pore-lining in the open state using the substituted-cysteine accessibility method, but not for A40C and A41C substitutions, which were not found to reside in the open pore. These results indicate that metal ions access the cysteine side chains through the open pore and that closure of the loop gate involves movement of the TM1/E1 region that results in local narrowing of the large aqueous connexin pore.	[Verselis, Vytas K.; Bargiello, Thaddeus A.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Trelles, Maria P.; Rubinos, Clio; Srinivas, Miduturu] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA	Yeshiva University; Albert Einstein College of Medicine; State University of New York (SUNY) System; SUNY Optometry	Verselis, VK (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	verselis@aecom.yu.edu; msrinivas@sunyopt.edu		Rubinos, Clio/0000-0002-1680-2302	National Institutes of Health Grants [GM54179, EY13869]; NATIONAL EYE INSTITUTE [R01EY013869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054179] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54179 (to V. K. V.) and EY13869 (to M. S.).	ARSLAN P, 1985, J BIOL CHEM, V260, P2719; Bao L, 2004, AM J PHYSIOL-CELL PH, V287, pC1389, DOI 10.1152/ajpcell.00220.2004; Beahm DL, 2002, BIOPHYS J, V82, P2016, DOI 10.1016/S0006-3495(02)75550-1; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; BUKAUSKAS FF, 1995, BIOPHYS J, V68, P2289, DOI 10.1016/S0006-3495(95)80411-X; Bukauskas FF, 2001, METH MOL B, V154, P379; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; Ebihara L, 2003, BIOPHYS J, V84, P277, DOI 10.1016/S0006-3495(03)74848-6; EBIHARA L, 1993, J GEN PHYSIOL, V102, P59, DOI 10.1085/jgp.102.1.59; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Krezel A, 2001, J INORG BIOCHEM, V84, P77, DOI 10.1016/S0162-0134(00)00212-9; Kronengold J, 2003, CELL COMMUN ADHES, V10, P193, DOI 10.1080/15419060390264325; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Oh S, 2000, J GEN PHYSIOL, V116, P13, DOI 10.1085/jgp.116.1.13; OSHIMA A, 2007, P NATL ACAD SCI US; Pfahnl A, 1998, BIOPHYS J, V75, P2323, DOI 10.1016/S0006-3495(98)77676-3; Puljung MC, 2004, J GEN PHYSIOL, V124, P587, DOI 10.1085/jgp.200409023; Purnick PEM, 2000, ARCH BIOCHEM BIOPHYS, V381, P181, DOI 10.1006/abbi.2000.1989; Purnick PEM, 2000, BIOPHYS J, V79, P2403, DOI 10.1016/S0006-3495(00)76485-X; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Ri Y, 1999, BIOPHYS J, V76, P2887, DOI 10.1016/S0006-3495(99)77444-8; Schock SC, 2008, BIOCHEM BIOPH RES CO, V368, P138, DOI 10.1016/j.bbrc.2008.01.054; Srinivas M, 2006, J GEN PHYSIOL, V127, P67, DOI 10.1085/jgp.200509397; Srinivas M, 2005, BIOPHYS J, V88, P1725, DOI 10.1529/biophysj.104.054023; Srinivas M, 2001, P NATL ACAD SCI USA, V98, P10942, DOI 10.1073/pnas.191206198; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Tong JJ, 2006, BIOPHYS J, V91, P2142, DOI 10.1529/biophysj.106.082859; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Valiunas V, 2000, PFLUG ARCH EUR J PHY, V440, P366, DOI 10.1007/s004240000294; Valiunas V, 2002, CIRC RES, V91, P104, DOI 10.1161/01.RES.0000025638.24255.AA; Verselis V.K., 2000, ADV MOL CEL, V30, P129; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Verselis VK, 2008, J GEN PHYSIOL, V132, P315, DOI 10.1085/jgp.200810029; Verselis Vytas K., 2009, P77, DOI 10.1007/978-1-59745-489-6_3; Wang HZ, 1997, J GEN PHYSIOL, V109, P491, DOI 10.1085/jgp.109.4.491; Zampighi GA, 1999, J GEN PHYSIOL, V113, P507, DOI 10.1085/jgp.113.4.507; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102	46	70	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4484	4493		10.1074/jbc.M807430200	http://dx.doi.org/10.1074/jbc.M807430200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074140	Green Published, hybrid			2022-12-27	WOS:000263134400048
J	Durr, KL; Tavraz, NN; Dempski, RE; Bamberg, E; Friedrich, T				Duerr, Katharina L.; Tavraz, Neslihan N.; Dempski, Robert E.; Bamberg, Ernst; Friedrich, Thomas			Functional Significance of E-2 State Stabilization by Specific alpha/beta-Subunit Interactions of Na,K- and H,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE-CLAMP FLUOROMETRY; NA,K-ATPASE BETA-SUBUNIT; ATP-ADP EXCHANGE; P-TYPE ATPASES; NA+/K+-ATPASE; INTRACELLULAR-TRANSPORT; GASTRIC H+,K+-ATPASE; XENOPUS OOCYTES; ACID-SECRETION; SODIUM-IONS	The beta-subunits of Na,K-ATPase and H,K-ATPase have important functions in maturation and plasma membrane targeting of the catalytic alpha-subunit but also modulate the transport activity of the holoenzymes. In this study, we show that tryptophan replacement of two highly conserved tyrosines in the transmembrane domain of both Na,K- and gastric H,K-ATPase beta-subunits resulted in considerable shifts of the voltage-dependent E1P/E2P distributions toward the E1P state as inferred from presteady-state current and voltage clamp fluorometric measurements of tetramethylrhodamine-6-maleimide-labeled ATPases. The shifts in conformational equilibria were accompanied by significant decreases in the apparent affinities for extracellular K+ that were moderate for the Na,K-ATPase beta-(Y39W,Y43W) mutation but much more pronounced for the corresponding H,K-ATPase beta-(Y44W,Y48W) variant. Moreover in the Na,K-ATPase beta-(Y39W,Y43W) mutant, the apparent rate constant for reverse binding of extracellular Na+ and the subsequent E2P-E1P conversion, as determined from transient current kinetics, was significantly accelerated, resulting in enhanced Na+ competition for extracellular K+ binding especially at extremely negative potentials. Analogously the reverse binding of extracellular protons and subsequent E2P-E1P conversion was accelerated by the H,K-ATPase beta-(Y44W,Y48W) mutation, and H+ secretion was strongly impaired. Remarkably tryptophan replacements of residues in the M7 segment of Na, K- and H,K-ATPase alpha-subunits, which are at interacting distance to the beta-tyrosines, resulted in similar E-1 shifts, indicating their participation in stabilization of E-2. Thus, interactions between selected residues within the transmembrane regions of alpha- and beta-subunits of P-2C-type ATPases exert an E-2-stabilizing effect, which is of particular importance for efficient H+ pumping by H,K-ATPase under in vivo conditions.	[Duerr, Katharina L.; Tavraz, Neslihan N.; Friedrich, Thomas] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [Dempski, Robert E.; Bamberg, Ernst] Max Planck Inst Biophys, Dept Biophys Chem, D-60438 Frankfurt, Germany; [Bamberg, Ernst] Goethe Univ Frankfurt, Chem & Pharmaceut Sci Dept, D-60439 Frankfurt, Germany	Technical University of Berlin; Max Planck Society; Goethe University Frankfurt	Durr, KL (corresponding author), Tech Univ Berlin, Inst Chem, PC 14,Str 17 Juni 135, D-10623 Berlin, Germany.	Katharina.Duerr@TU-Berlin.DE	Friedrich, Thomas/AAA-3418-2022; Duerr, Katharina/A-6975-2015	Duerr, Katharina/0000-0002-3245-4088	Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V; Deutsche Forschungsgemeinschaft [SFB 472, SFB 740]; Cluster of Excellence	Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence	This work was supported by the Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. and the Deutsche Forschungsgemeinschaft (Grants SFB 472 and SFB 740 and Cluster of Excellence "Unifying Concepts in Catalysis"). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abriel H, 1999, BBA-BIOMEMBRANES, V1418, P85, DOI 10.1016/S0005-2736(99)00025-5; Altendorf K, 1998, ACTA PHYSIOL SCAND, V163, P137; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; CHOW DC, 1993, AM J PHYSIOL, V265, pC1562, DOI 10.1152/ajpcell.1993.265.6.C1562; CHOW DC, 1992, AM J PHYSIOL, V263, pC39, DOI 10.1152/ajpcell.1992.263.1.C39; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Dempski RE, 2005, J GEN PHYSIOL, V125, P505, DOI 10.1085/jgp.200409186; Durr KL, 2008, BIOCHEMISTRY-US, V47, P4288, DOI 10.1021/bi800092k; EAKLE KA, 1994, J BIOL CHEM, V269, P6550; EAKLE KA, 1992, P NATL ACAD SCI USA, V89, P2834, DOI 10.1073/pnas.89.7.2834; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; Geibel S, 2003, ANN NY ACAD SCI, V986, P31, DOI 10.1111/j.1749-6632.2003.tb07136.x; Geibel S, 2003, P NATL ACAD SCI USA, V100, P964, DOI 10.1073/pnas.0337336100; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; Hasler U, 2001, J BIOL CHEM, V276, P16356, DOI 10.1074/jbc.M008778200; Hasler U, 2000, J BIOL CHEM, V275, P29011, DOI 10.1074/jbc.M002867200; Hasler U, 1998, J BIOL CHEM, V273, P30826, DOI 10.1074/jbc.273.46.30826; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; HELMICHDEJONG ML, 1985, BIOCHIM BIOPHYS ACTA, V821, P377, DOI 10.1016/0005-2736(85)90041-0; HORISBERGER JD, 1991, J BIOL CHEM, V266, P19131; Hu YK, 2000, J BIOL CHEM, V275, P19185, DOI 10.1074/jbc.M000641200; JAISSER F, 1994, J GEN PHYSIOL, V103, P605, DOI 10.1085/jgp.103.4.605; JAISSER F, 1993, J CELL BIOL, V123, P1421, DOI 10.1083/jcb.123.6.1421; JAUNIN P, 1993, J CELL BIOL, V123, P1751, DOI 10.1083/jcb.123.6.1751; Kamsteeg EJ, 2000, AM J PHYSIOL-RENAL, V279, pF778, DOI 10.1152/ajprenal.2000.279.4.F778; Kamsteeg EJ, 2001, BIOCHEM BIOPH RES CO, V282, P683, DOI 10.1006/bbrc.2001.4629; KAPLAN JH, 1982, J GEN PHYSIOL, V80, P915, DOI 10.1085/jgp.80.6.915; KAPLAN JH, 1980, NATURE, V288, P587, DOI 10.1038/288587a0; KAWAMURA M, 1985, BIOCHIM BIOPHYS ACTA, V821, P115, DOI 10.1016/0005-2736(85)90161-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORENTZON P, 1985, BIOCHIM BIOPHYS ACTA, V817, P25, DOI 10.1016/0005-2736(85)90064-1; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; MCDONOUGH AA, 1990, FASEB J, V4, P1598, DOI 10.1096/fasebj.4.6.2156741; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; NOGUCHI S, 1987, FEBS LETT, V225, P27, DOI 10.1016/0014-5793(87)81125-0; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; POLVANI C, 1989, J BIOL CHEM, V264, P17854; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; RABON EC, 1990, J BIOL CHEM, V265, P19594; RAKOWSKI RF, 1993, J GEN PHYSIOL, V101, P117, DOI 10.1085/jgp.101.1.117; RAY TK, 1985, FEBS LETT, V185, P24, DOI 10.1016/0014-5793(85)80733-X; Sachs G, 2007, J CLIN GASTROENTEROL, V41, pS226, DOI 10.1097/MCG.0b013e31803233b7; SAGAR A, 1994, J GEN PHYSIOL, V103, P869, DOI 10.1085/jgp.103.5.869; SHULL GE, 1986, J BIOL CHEM, V261, P6788; SWARTS HGP, 1995, J BIOL CHEM, V270, P7890, DOI 10.1074/jbc.270.14.7890; TUCHSEN E, 1987, BIOCHEMISTRY-US, V26, P1918, DOI 10.1021/bi00381a020; WALLMARK B, 1987, J BIOL CHEM, V262, P2077	53	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3842	3854		10.1074/jbc.M808101200	http://dx.doi.org/10.1074/jbc.M808101200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19064992	hybrid			2022-12-27	WOS:000262872500053
J	Karuri, NW; Lin, Z; Rye, HS; Schwarzbauer, JE				Karuri, Nancy W.; Lin, Zong; Rye, Hays S.; Schwarzbauer, Jean E.			Probing the Conformation of the Fibronectin III1-2 Domain by Fluorescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-ASSOCIATION; BINDING-SITE; MATRIX; PROTEIN; DYNAMICS; MODULES; GFP	Fibronectin (FN) matrix is crucial for cell and tissue functions during embryonic development, wound healing, and oncogenesis. Assembly of FN matrix fibrils requires FN domains that mediate interactions with integrin receptors and with other FN molecules. In addition, regulation of FN matrix assembly depends on the first two FN type III modules, III1 and III2, which harbor FN-binding sites. We propose that interactions between these two modules sequester FN-binding sites in soluble FN and that these sites become exposed by FN conformational changes during assembly. To test the idea that III1-2 has a compact conformation, we constructed CIIIY, a conformational sensor of III1-2 based on fluorescent resonance energy transfer between cyan and yellow fluorescent proteins conjugated at its N and C termini. We demonstrate energy transfer in CIIIY and show that fluorescent resonance energy transfer was eliminated by proteolysis and by treatment with mild denaturants that disrupted intramolecular interactions between the two modules. We also show that mutations of key charged residues resulted in conformational changes that exposed binding sites for the N-terminal 70-kDa FN fragment. Collectively, these results support a conformation-dependent mechanism for the regulation of FN matrix assembly by III1-2.	[Karuri, Nancy W.; Lin, Zong; Rye, Hays S.; Schwarzbauer, Jean E.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Schwarzbauer, JE (corresponding author), Princeton Univ, Dept Mol Biol, 315 Schultz Lab, Princeton, NJ 08544 USA.	jschwarz@princeton.edu		Schwarzbauer, Jean/0000-0003-1012-7593; Rye, Hays/0000-0002-9420-3137	National Institutes of Health Grants [CA044627, GM065421]; New Jersey Center for Biomaterials [T32EB005583]; NATIONAL CANCER INSTITUTE [R01CA044627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065421] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Center for Biomaterials; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA044627 (to J.E.S.) and GM065421 (to H. S. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the New Jersey Center for Biomaterials through NIBIB Training Program Grant T32EB005583 from the National Institutes of Health.	AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; ARGOS P, 1990, J MOL BIOL, V211, P943, DOI 10.1016/0022-2836(90)90085-Z; Briknarova K, 2003, J MOL BIOL, V332, P205, DOI 10.1016/S0022-2836(03)00890-8; CAMPBELL ID, 1994, STRUCTURE, V2, P333, DOI 10.1016/S0969-2126(00)00034-4; CHERNOUSOV MA, 1987, FEBS LETT, V217, P124, DOI 10.1016/0014-5793(87)81255-3; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; EPE B, 1983, P NATL ACAD SCI-BIOL, V80, P2579, DOI 10.1073/pnas.80.9.2579; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Ghosh K, 2006, TISSUE ENG, V12, P601, DOI 10.1089/ten.2006.12.601; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Honest H, 2002, BMJ-BRIT MED J, V325, P301, DOI 10.1136/bmj.325.7359.301; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; KHAN MY, 1990, BIOCHEM J, V270, P33, DOI 10.1042/bj2700033; Lakowicz J. R, 2006, PRINCIPLES FLUORESCE, DOI [DOI 10.1007/978-0-387-46312-4, 10.1007/978-0-387-46312-4_8, DOI 10.1007/978-0-387-46312-4_8, 10.1007/978-0-387-46312-4]; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Miyawaki A, 2003, NAT CELL BIOL, pS1, DOI 10.1038/ncb1031; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; Ohashi T, 1999, P NATL ACAD SCI USA, V96, P2153, DOI 10.1073/pnas.96.5.2153; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Prescott M, 1999, ANAL BIOCHEM, V273, P305, DOI 10.1006/abio.1999.4235; Santimaria M, 2003, CLIN CANCER RES, V9, P571; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsumoto K, 2003, BIOCHEM BIOPH RES CO, V312, P1383, DOI 10.1016/j.bbrc.2003.11.055; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Visser NV, 2002, FEBS LETT, V521, P31, DOI 10.1016/S0014-5793(02)02808-9; Zhang B, 2004, BIOCHEM BIOPH RES CO, V323, P674, DOI 10.1016/j.bbrc.2004.08.143; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	32	21	21	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3445	3452		10.1074/jbc.M805025200	http://dx.doi.org/10.1074/jbc.M805025200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19064996	Green Published, hybrid			2022-12-27	WOS:000262872500010
J	Sandwall, E; Bodevin, S; Nasser, NJ; Nevo, E; Avivi, A; Vlodavsky, I; Li, JP				Sandwall, Elina; Bodevin, Sabrina; Nasser, Nicola J.; Nevo, Eviatar; Avivi, Aaron; Vlodavsky, Israel; Li, Jin-Ping			Molecular Structure of Heparan Sulfate from Spalax IMPLICATIONS OF HEPARANASE AND HYPOXIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTERRANEAN MOLE-RAT; SUBSTRATE-SPECIFICITY; MAMMALIAN HEPARANASE; GENE CLONING; EXPRESSION; METASTASIS; TOLERANCE; IDENTIFICATION; ANGIOGENESIS; EVOLUTION	Spalax, a subterranean blind mole rat, is well adapted to live in an extreme hypoxic environment through up-regulated expression of growth factors and enzymes for ensuring sufficient oxygen supply. One of the overexpressed enzymes is heparanase, an endoglucuronidase that selectively cleaves heparan sulfate (HS) and is implicated in angiogenesis. To assess the implications of the heparanase in Spalax, we have characterized the structure of HS isolated from various organs of the animal. The oligosaccharides obtained after deaminative cleavage of HS samples from the tissues show an overall higher sulfation degree, distinct from that of murine tissues. Of particular significance was the appearance of a trisaccharide moiety in the tissues examined, apart of the even numbered oligosaccharide fractions typically found in HS from human and mouse tissues. The formation of this odd-numbered saccharide is a consequence of heparanase action, in agreement with the notion of high expression of the enzyme in this species. Analysis of HS extracted from human embryonic kidney cells (HEK293) after exposure to hypoxic condition revealed a structural change in the distribution of oligosaccharides similar to HS derived from Spalax organs. The alterations are likely due to up-regulated activity of heparanase, as real-time RT-PCR showed a 2-fold increase in heparanase mRNA expression in the hypoxia treated cells. HEK293 cells stably overexpressing Spalax heparanase produced HS sharing similarity with that from the Spalax organs, and exhibited enhanced MAPK activity in comparison with HEK293 cells, indicating a regulation role of the heparanase in the activity of growth factors.	[Sandwall, Elina; Bodevin, Sabrina; Li, Jin-Ping] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Nasser, Nicola J.; Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Nasser, Nicola J.; Nevo, Eviatar; Avivi, Aaron] Univ Haifa, Inst Evolut, IL-31905 Haifa, Israel	Uppsala University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Haifa	Li, JP (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden.	Jin-Ping.Li@imbim.uu.se			NCI; National Institutes of Health [R01-CA106456]; Swedish Research Council [32X-15023]; European Commission [QLK3-CT-2002-02049]; Polysackaridforskning AB (Uppsala, Sweden); United States-Israel Binational Science Foundation (BSF); Israel Cancer Research Fund (ICRF); NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Polysackaridforskning AB (Uppsala, Sweden); United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Cancer Research Fund (ICRF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant R01-CA106456 (to I. V.). This work was also supported by the Swedish Research Council (32X-15023), the European Commission (QLK3-CT-2002-02049), the Polysackaridforskning AB (Uppsala, Sweden), and by grants from the United States-Israel Binational Science Foundation (BSF), and the Israel Cancer Research Fund (ICRF). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ashur-Fabian C, 2004, P NATL ACAD SCI USA, V101, P12236, DOI 10.1073/pnas.0404998101; Avivi A, 2005, FASEB J, V19, P1314, DOI 10.1096/fj.04-3414fje; Avivi A, 1999, FEBS LETT, V452, P133, DOI 10.1016/S0014-5793(99)00584-0; Bengtsson J, 2003, BIOCHEMISTRY-US, V42, P2110, DOI 10.1021/bi026928g; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BIENKOWSKI MJ, 1985, SEMIN THROMB HEMOST, V11, P86, DOI 10.1055/s-2007-1004363; D'Souza SS, 2007, BIOL REPROD, V77, P433, DOI 10.1095/biolreprod.107.061317; EDOUTE Y, 1988, J COMP PHYSIOL B, V158, P575, DOI 10.1007/BF00692566; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; Gong F, 2003, J BIOL CHEM, V278, P35152, DOI 10.1074/jbc.M300925200; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He XT, 2004, CANCER RES, V64, P3928, DOI 10.1158/0008-5472.CAN-03-2718; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Li JP, 2008, ANTI-CANCER AGENT ME, V8, P64, DOI 10.2174/187152008783330824; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455; Nasser NJ, 2005, P NATL ACAD SCI USA, V102, P15161, DOI 10.1073/pnas.0507279102; Nevo, 1999, MOSAIC EVOLUTION SUB; NEVO E., 2001, ADAPTIVE RAD BLIND S; Okada Y, 2002, J BIOL CHEM, V277, P42488, DOI 10.1074/jbc.M206510200; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Shams I, 2004, P NATL ACAD SCI USA, V101, P9698, DOI 10.1073/pnas.0403540101; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3943, DOI 10.1021/bi00663a006; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200	35	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3814	3822		10.1074/jbc.M802196200	http://dx.doi.org/10.1074/jbc.M802196200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19068480	hybrid, Green Published			2022-12-27	WOS:000262872500050
J	Steirer, LM; Park, EI; Townsend, RR; Baenziger, JU				Steirer, Lindsay M.; Park, Eric I.; Townsend, R. Reid; Baenziger, Jacques U.			The Asialoglycoprotein Receptor Regulates Levels of Plasma Glycoproteins Terminating with Sialic Acid alpha 2,6-Galactose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; MICE LACKING; SUBUNIT; LECTIN; CELL; OLIGOSACCHARIDES; DETERMINANTS; SPECIFICITY; DEFICIENCY; EXPRESSION	The asialoglycoprotein receptor (ASGP-R) is an abundant, carbohydrate-specific, endocytic receptor expressed by parenchymal cells of the liver. We recently demonstrated that the ASGP-R mediates the clearance of glycoproteins bearing Sia alpha 2,6GalNAc as well as those bearing terminal Gal or GalNAc. We now report that glycoproteins such as haptoglobin, serum amyloid protein (SAP), and carboxylesterase that bear oligosaccharides with terminal Sia alpha 2,6Gal are elevated in the plasma of ASGP-R-deficient mice. Because of their abundance in plasma, glycoproteins bearing terminal Sia alpha 2,6Gal will saturate the ASGP-R and compete with each other on the basis of their relative affinities for the ASGP-R and their relative abundance. We propose that the ASGP-R mediates the clearance of glycoproteins that bear oligosaccharides terminating with Sia alpha 2,6Gal and thereby helps maintain the relative concentrations of these glycoproteins in the blood.	[Steirer, Lindsay M.; Park, Eric I.; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Townsend, R. Reid] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Steirer, Lindsay M.; Townsend, R. Reid; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Baenziger, JU (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	Baenziger@wustl.edu	Baenziger, Jacques U/E-9430-2012		National Institutes of Health [R37-CA21923]; National Centers of Research Resources [P41-RR00954]; Siteman Cancer Center; institutional resources to the Proteomics Center; NATIONAL CANCER INSTITUTE [R01CA021923, R37CA021923] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers of Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Siteman Cancer Center; institutional resources to the Proteomics Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant R37-CA21923 (to J. U. B.). This work was also supported by the National Centers of Research Resources P41-RR00954, the Siteman Cancer Center, and institutional resources to the Proteomics Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; BAENZIGER JU, 1980, CELL, V22, P611, DOI 10.1016/0092-8674(80)90371-2; BERGWERFF AA, 1995, EUR J BIOCHEM, V228, P1009; Braun JR, 1996, J BIOL CHEM, V271, P21160, DOI 10.1074/jbc.271.35.21160; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; HARTREE AS, 1992, BIOCHEM J, V287, P665, DOI 10.1042/bj2870665; HOOPER LV, 1995, J BIOL CHEM, V270, P5985, DOI 10.1074/jbc.270.11.5985; ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803; Kawada N, 1997, HISTOL HISTOPATHOL, V12, P1069; Kedderis GL, 1996, TOXICOL APPL PHARM, V140, P124, DOI 10.1006/taap.1996.0205; Manzella SM, 1997, J BIOL CHEM, V272, P4775, DOI 10.1074/jbc.272.8.4775; MENGELING BJ, 1991, ANAL BIOCHEM, V199, P286, DOI 10.1016/0003-2697(91)90103-Z; Mi YL, 2008, J CLIN INVEST, V118, P1815, DOI 10.1172/JCI32467; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Nyame AK, 1999, GLYCOBIOLOGY, V9, P1029, DOI 10.1093/glycob/9.10.1029; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Park EI, 2003, J BIOL CHEM, V278, P4597, DOI 10.1074/jbc.M210612200; SCHWARTZ AL, 1980, J BIOL CHEM, V255, P9033; SCHWARTZ AL, 1982, J BIOL CHEM, V257, P4230; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; TOLLESHAUG H, 1977, BIOCHIM BIOPHYS ACTA, V499, P73, DOI 10.1016/0304-4165(77)90230-6; Tozawa R, 2001, J BIOL CHEM, V276, P12624, DOI 10.1074/jbc.M011063200; Unverzagt C, 2002, J MED CHEM, V45, P478, DOI 10.1021/jm0110237; VanDamme EJM, 1996, EUR J BIOCHEM, V235, P128, DOI 10.1111/j.1432-1033.1996.00128.x; WEIGEL PH, 1980, J BIOL CHEM, V255, P6111	29	72	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3777	3783		10.1074/jbc.M808689200	http://dx.doi.org/10.1074/jbc.M808689200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19075021	Green Published, hybrid			2022-12-27	WOS:000262872500046
J	Rider, LW; Ottosen, MB; Gattis, SG; Palfey, BA				Rider, Lance W.; Ottosen, Mette B.; Gattis, Samuel G.; Palfey, Bruce A.			Mechanism of Dihydrouridine Synthase 2 from Yeast and the Importance of Modifications for Efficient tRNA Reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; BIOSYNTHESIS; TEMPERATURE; FAMILY	Dihydrouridinesynthases(DUSs) areflavin-dependent enzymes that catalyze site-specific reduction of uracils in tRNAs. The mechanism of DUS2 from Saccharomyces cerevisiae was studied. Previously published turnover rates for this DUS were very low. Our studies show that the catalytic cycle consists of reductive and oxidative half-reactions. The enzyme is reduced by NADPH rapidly but has a very slow oxidative half-reaction using in vitro transcribed tRNA substrates. Using tRNALeu purified from a DUS 2 knockout strain of yeast we obtained reaction rate enhancements of 600-fold over in vitro transcribed substrates, indicating that other RNA modifications are required for rapid uracil reduction. This demonstrates a previously unknown ordering of modifications and indicates that dihydrouridine formation is a later step in tRNA maturation. We also show that an active site cysteine is important for catalysis, likely in the protonation of uracil during tRNA reduction. Dihydrouridine of modified tRNA from Escherichia coli was also oxidized to uridine showing the reaction to be reversible.	[Rider, Lance W.; Ottosen, Mette B.; Gattis, Samuel G.; Palfey, Bruce A.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Palfey, BA (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	brupalf@umich.edu		Palfey, Bruce/0000-0001-5098-259X	National Institutes of Health [GM61087]; University of Michigan Biomedical Research Council [G001915]; NIGMS [GM08597]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061087, T32GM008597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Biomedical Research Council(University of Michigan System); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61087. This work was also supported by the University of Michigan Biomedical Research Council (Grant G001915). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by NIGMS Training Grant GM08597.	Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Bishop AC, 2002, J BIOL CHEM, V277, P25090, DOI 10.1074/jbc.M203208200; Cavaille J, 1999, RNA, V5, P66, DOI 10.1017/S1355838299981475; Dalluge JJ, 1996, NUCLEIC ACIDS RES, V24, P1073, DOI 10.1093/nar/24.6.1073; ENGEL PC, 1977, ANAL BIOCHEM, V82, P512, DOI 10.1016/0003-2697(77)90190-7; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; House CH, 1996, BIOCHEMISTRY-US, V35, P315, DOI 10.1021/bi951577+; HUNNINGHAKE D, 1966, ANAL BIOCHEM, V16, P200, DOI 10.1016/0003-2697(66)90147-3; Kallansrud G, 1996, ANAL BIOCHEM, V236, P134, DOI 10.1006/abio.1996.0141; Kato T, 2005, CANCER RES, V65, P5638, DOI 10.1158/0008-5472.CAN-05-0600; KUCHINO Y, 1978, NATURE, V271, P126, DOI 10.1038/271126a0; Noon KR, 2003, J BACTERIOL, V185, P5483, DOI 10.1128/JB.185.18.5483-5490.2003; OTTOLINA G, 1989, BIOCHIM BIOPHYS ACTA, V998, P173, DOI 10.1016/0167-4838(89)90270-7; Palfey B. A., 1998, COMPREHENSIVE BIOL C, VIII, P83; PALTEY BA, 2003, KINETIC ANAL MACROMO, P203; Park F, 2004, PROTEINS, V55, P772, DOI 10.1002/prot.20086; Savage DF, 2006, FEBS LETT, V580, P5198, DOI 10.1016/j.febslet.2006.08.062; Shigi N, 2006, J BIOL CHEM, V281, P2104, DOI 10.1074/jbc.M510771200; Sprinzl M, 1996, NUCLEIC ACIDS RES, V24, P68, DOI 10.1093/nar/24.1.68; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; Xing F, 2004, J BIOL CHEM, V279, P17850, DOI 10.1074/jbc.M401221200; Xing F, 2002, RNA, V8, P370, DOI 10.1017/S1355838202029825	24	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10324	10333		10.1074/jbc.M806137200	http://dx.doi.org/10.1074/jbc.M806137200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19139092	hybrid, Green Published			2022-12-27	WOS:000265104600006
J	Xie, Y; Ke, S; Ouyang, NT; He, JH; Xie, W; Bedford, MT; Tian, YN,				Xie, Ying; Ke, Sui; Ouyang, Nengtai; He, Jinhan; Xie, Wen; Bedford, Mark T.; Tian, Yanan			Epigenetic Regulation of Transcriptional Activity of Pregnane X Receptor by Protein Arginine Methyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; XENOBIOTIC RECEPTOR; HISTONE H4; IN-VIVO; METHYLATION; METABOLISM; ACTIVATION; PRMT1; COACTIVATOR; EXPRESSION	Pregnane X receptor (PXR) is a ligand-dependent transcription factor, regulating gene expression of enzymes and transporters involved in xenobiotic/drug metabolism. Here, we report that protein arginine methyltransferase 1 (PRMT1) is required for the transcriptional activity of PXR. PRMT1 regulates expression of numerous genes, including nuclear receptor-regulated transcription, through methylating histone and non-histone proteins. Co-immunoprecipitation and histone methyltransferase assays revealed that PRMT1 is a major histone methyltransferase associated with PXR. The PXR ligand-binding domain is responsible for PXR-PRMT1 interaction as determined by mammalian two-hybrid and glutathione S-transferase (GST) pull-down assays. The chromatin immunoprecipitation (ChIP) assay showed that PRMT1 was recruited to the regulatory region of the PXR target gene cytochrome P450 3A4 (CYP3A4), with a concomitant methylation of arginine 3 of histone H4, in response to the PXR agonist rifampicin. In mammalian cells, small interfering RNA (siRNA) knockdown and gene deletion of PRMT1 greatly diminished the transcriptional activity of PXR, suggesting an indispensable role of PRMT1 in PXR-regulated gene expression. Interestingly, PXR appears to have a reciprocal effect on the PRMT1 functions by regulating its cellular compartmentalization as well as its substrate specificity. Taken together, these results demonstrated mutual interactions and functional interplays between PXR and PRMT1, and this interaction may be important for the epigenetics of PXR-regulated gene expression.	[Xie, Ying; Ke, Sui; Ouyang, Nengtai; Tian, Yanan] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [He, Jinhan; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15213 USA; [He, Jinhan; Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15213 USA; [Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX 78957 USA	Texas A&M University System; Texas A&M University College Station; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; UTMD Anderson Cancer Center	Tian, YN, (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, Mail Stop 4466, College Stn, TX 77843 USA.	ytian@cvm.tamu.edu	Xie, Wen/M-1768-2016; Xie, Ying/AAX-4282-2020; Bedford, Mark T/E-7856-2011		NIEHS, National Institutes of Health [ES 09859, ES 09106]; American Heart Association [0355131Y]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009106, R01ES009859] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by NIEHS, National Institutes of Health Grants ES 09859 and ES 09106. This work was also supported by American Heart Association Grant 0355131Y.	Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; Dery U, 2008, MOL CELL BIOL, V28, P3058, DOI 10.1128/MCB.02025-07; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Gu XS, 2006, J BIOL CHEM, V281, P17882, DOI 10.1074/jbc.M601302200; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Huang S, 2007, MOL CELL BIOL, V27, P7991, DOI 10.1128/MCB.01326-07; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Kliewer SA, 2002, J LIPID RES, V43, P359; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200; Rizzo G, 2005, MOL PHARMACOL, V68, P551, DOI 10.1124/mol.105.012104; Robin-Lespinasse Y, 2007, J CELL SCI, V120, P638, DOI 10.1242/jcs.03357; Tan CP, 2006, MOL CELL BIOL, V26, P7224, DOI 10.1128/MCB.00473-06; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tian YA, 2009, BIOCHEM PHARMACOL, V77, P670, DOI 10.1016/j.bcp.2008.10.023; Tian YN, 2003, J BIOL CHEM, V278, P44041, DOI 10.1074/jbc.M306443200; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Xie W, 2006, CELL METAB, V4, P177, DOI 10.1016/j.cmet.2006.08.004	30	53	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9199	9205		10.1074/jbc.M806193200	http://dx.doi.org/10.1074/jbc.M806193200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19144646	hybrid, Green Published			2022-12-27	WOS:000264669100026
J	Killock, DJ; Parsons, M; Zarrouk, M; Ameer-Beg, SM; Ridley, AJ; Haskard, DO; Zvelebil, M; Ivetic, A				Killock, David J.; Parsons, Maddy; Zarrouk, Marouan; Ameer-Beg, Simon M.; Ridley, Anne J.; Haskard, Dorian O.; Zvelebil, Marketa; Ivetic, Aleksandar			In Vitro and in Vivo Characterization of Molecular Interactions between Calmodulin, Ezrin/Radixin/Moesin, and L-selectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; ERM PROTEINS; CYTOPLASMIC DOMAIN; CRYSTAL-STRUCTURE; ACTIN-BINDING; FERM DOMAIN; ADHESION; RECRUITMENT; ACTIVATION; TAIL	L-selectin is a cell adhesion molecule that tethers leukocytes to the luminal walls of venules during inflammation and enables them to roll under the force of blood flow. Clustering of L-selectin during rolling is thought to promote outside-in signals that lead to integrin activation and chemokine receptor expression, ultimately contributing to leukocyte arrest. Several studies have underscored the importance of the L-selectin cytoplasmic tail in functionally regulating adhesion and signaling. Interestingly, the L-selectin tail comprises only 17 amino acids, and yet it is thought to bind simultaneously to several proteins. For example, constitutive association of calmodulin (CaM) and ezrin/radixin/moesin (ERM) to L-selectin confers resistance to proteolysis and microvillar positioning, respectively. In this report we found that recombinant purified CaM and ERM bound noncompetitively to the same tail of L-selectin. Furthermore, molecular modeling supported the possibility that CaM, L-selectin, and moesin could form a heterotrimeric complex. Finally, using fluorescence lifetime imaging microscopy to measure fluorescence resonance energy transfer, it was shown that CaM, L-selectin, and ERM could interact simultaneously in vivo. Moreover, L-selectin clustering promoted CaM/ERM interaction in cis (i.e. derived from neighboring L-selectin tails). These results highlight a novel intracellular event that occurs as a consequence of L-selectin clustering, which could participate in transducing signals that promote the transition from rolling to arrest.	[Haskard, Dorian O.; Ivetic, Aleksandar] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Cardiovasc Sci Unit, London W12 0NN, England; [Parsons, Maddy; Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Ameer-Beg, Simon M.] Kings Coll London, Richard Dimbleby Dept Canc Res, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Ameer-Beg, Simon M.] Kings Coll London, Richard Dimbleby Dept Canc Res, Div Canc Studies, London SE1 1UL, England; [Zvelebil, Marketa] Breakthrough Breast Canc Res Ctr, Inst Canc Res, London SW3 6JB, England	Imperial College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Ivetic, A (corresponding author), Kings Coll London, James Black Ctr, Div Cardiovasc, 125 Coldharbour Lane, London SE5 9NU, England.	alex.ivetic@kcl.ac.uk	Parsons, Maddy/B-2203-2013; Zarrouk, Marouan/K-7541-2019	Parsons, Maddy/0000-0002-2021-8379; Zvelebil, Marketa/0000-0001-8018-5591; Ivetic, Aleksandar/0000-0001-9844-6518; Ameer-Beg, Simon/0000-0001-5227-575X; Zarrouk, Marouan/0000-0002-3259-6123; Killock, David/0000-0002-3267-8284; Ridley, Anne/0000-0001-8186-5708	Wellcome Trust; Ludwig Institute for Cancer Research;  [FP6 contract LHSG-CT-2003-502935]	Wellcome Trust(Wellcome Trust); Ludwig Institute for Cancer Research; 	This work was supported in part by the Wellcome Trust, the Ludwig Institute for Cancer Research, and the European Union (FP6 contract LHSG-CT-2003-502935). All the authors declare that they have no financially competing interests. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Brenner B, 1996, P NATL ACAD SCI USA, V93, P15376, DOI 10.1073/pnas.93.26.15376; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Canutescu AA, 2005, BIOINFORMATICS, V21, P2914, DOI 10.1093/bioinformatics/bti438; Chen CX, 2006, J BIOCHEM, V140, P229, DOI 10.1093/jb/mvj149; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Ding ZQ, 2003, BLOOD, V101, P4245, DOI 10.1182/blood-2002-06-1782; Dwir O, 2002, J BIOL CHEM, V277, P21130, DOI 10.1074/jbc.M201999200; Dwir O, 2001, J CELL BIOL, V155, P145, DOI 10.1083/jcb.200103042; Edwards SD, 2001, BIOCHEMISTRY-US, V40, P7061, DOI 10.1021/bi010419h; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; ERLANDSEN SL, 1993, J HISTOCHEM CYTOCHEM, V41, P327, DOI 10.1177/41.3.7679125; Evans SS, 1999, J IMMUNOL, V162, P3615; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Giblin PA, 1997, J IMMUNOL, V159, P3498; Gonzalez-Amaro R, 1999, CRIT REV IMMUNOL, V19, P389; Green CE, 2004, J IMMUNOL, V172, P7780, DOI 10.4049/jimmunol.172.12.7780; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hao JJ, 2008, J PROTEOME RES, V7, P2911, DOI 10.1021/pr800016a; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Hishiya A, 1999, J BIOL CHEM, V274, P26705, DOI 10.1074/jbc.274.38.26705; Hwang ST, 1996, J EXP MED, V184, P1343, DOI 10.1084/jem.184.4.1343; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Ivetic A, 2004, BIOCHEM SOC T, V32, P1118, DOI 10.1042/BST0321118; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; Kilian K, 2004, J BIOL CHEM, V279, P34472, DOI 10.1074/jbc.M405916200; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger Elmar, 2003, Methods Biochem Anal, V44, P509; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Mattila PE, 2005, AM J PHYSIOL-CELL PH, V289, pC323, DOI 10.1152/ajpcell.00603.2004; Nunomura W, 2000, J BIOL CHEM, V275, P6360, DOI 10.1074/jbc.275.9.6360; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Parsons M, 2005, MOL CELL BIOL, V25, P1680, DOI 10.1128/MCB.25.5.1680-1695.2005; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; PAVALKO FM, 1995, J CELL BIOL, V129, P1155, DOI 10.1083/jcb.129.4.1155; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Renkonen J, 2002, AM J PATHOL, V161, P543, DOI 10.1016/S0002-9440(10)64210-1; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Takai Y, 2008, J MOL BIOL, V381, P634, DOI 10.1016/j.jmb.2008.05.085; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Zarbock A, 2008, AM J PATHOL, V172, P1, DOI 10.2353/ajpath.2008.070502	51	41	42	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8824	8836		10.1074/jbc.M806983200	http://dx.doi.org/10.1074/jbc.M806983200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19129194	Green Published, hybrid			2022-12-27	WOS:000264397800066
J	Lee, CC; Kuo, CJ; Ko, TP; Hsu, MF; Tsui, YC; Chang, SC; Yang, S; Chen, SJ; Chen, HC; Hsu, MC; Shih, SR; Liang, PH; Wang, AHJ				Lee, Cheng-Chung; Kuo, Chih-Jung; Ko, Tzu-Ping; Hsu, Min-Feng; Tsui, Yao-Chen; Chang, Shih-Cheng; Yang, Syaulan; Chen, Shu-Jen; Chen, Hua-Chien; Hsu, Ming-Chu; Shih, Shin-Ru; Liang, Po-Huang; Wang, Andrew H. -J.			Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE RESPIRATORY SYNDROME; ANTIVIRAL ACTIVITY; SARS-COV; IRREVERSIBLE INHIBITORS; CRYSTAL-STRUCTURE; MAIN PROTEASE; CORONAVIRUS; VIRUS; DESIGN; PROTEINASE	Human coxsackievirus (CV) belongs to the picornavirus family, which consists of over 200 medically relevant viruses. In picornavirus, a chymotrypsin-like protease (3C(pro)) is required for viral replication by processing the polyproteins, and thus it is regarded as an antiviral drug target. A 3C-like protease (3CL(pro)) also exists in human coronaviruses (CoV) such as 229E and the one causing severe acute respiratory syndrome (SARS). To combat SARS, we previously had developed peptidomimetic and zinc-coordinating inhibitors of 3CL(pro). As shown in the present study, some of these compounds were also found to be active against 3C(pro) of CV strain B3 (CVB3). Several crystal structures of 3C(pro) from CVB3 and 3CLpro from CoV-229E and SARS-CoV in complex with the inhibitors were solved. The zinc-coordinating inhibitor is tetrahedrally coordinated to the His(40)-Cys(147) catalytic dyad of CVB3 3C(pro). The presence of specific binding pockets for the residues of peptidomimetic inhibitors explains the binding specificity. Our results provide a structural basis for inhibitor optimization and development of potential drugs for antiviral therapies.	[Lee, Cheng-Chung; Kuo, Chih-Jung; Ko, Tzu-Ping; Hsu, Min-Feng; Tsui, Yao-Chen; Liang, Po-Huang; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Lee, Cheng-Chung; Ko, Tzu-Ping; Hsu, Min-Feng; Liang, Po-Huang; Wang, Andrew H. -J.] Acad Sinica, Natl Core Facil High Throughput Prot Crystallog, Taipei 11529, Taiwan; [Kuo, Chih-Jung; Liang, Po-Huang; Wang, Andrew H. -J.] Acad Sinica, Taiwan Int Grad Program, Taipei 11529, Taiwan; [Lee, Cheng-Chung; Wang, Andrew H. -J.] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Struct Biol Program, Taipei 11221, Taiwan; [Tsui, Yao-Chen; Liang, Po-Huang; Wang, Andrew H. -J.] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan; [Chang, Shih-Cheng; Shih, Shin-Ru] Chang Gung Mem Hosp, Dept Clin Pathol, Clin Virol Lab, Tao Yuan 333, Taiwan; [Chang, Shih-Cheng; Shih, Shin-Ru] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan; [Yang, Syaulan; Chen, Shu-Jen; Chen, Hua-Chien; Hsu, Ming-Chu] TaiGen Biotechnol, Taipei 114, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University	Liang, PH (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.	phliang@gate.sinica.edu.tw; ahjwang@gate.sinica.edu.tw	Liang, Po-Huang/H-6610-2015; Shih, Shin-Ru/M-9711-2016	Liang, Po-Huang/0000-0003-1207-5256; Kuo, Chih-Jung/0000-0002-4988-5124; Shih, Shin-Ru/0000-0003-4874-401X	Academia Sinica; National Science Council, Taiwan [NSC-95-3112-B-001-015-Y]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Academia Sinica and the National Science Council, Taiwan (NSC-95-3112-B-001-015-Y to A.H.-J.W.) for the National Core Facility of High-Throughput Protein Crystallography at Academia Sinica, Taiwan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Binford SL, 2005, ANTIMICROB AGENTS CH, V49, P619, DOI 10.1128/AAC.49.2.619-626.2005; Birtley JR, 2005, J BIOL CHEM, V280, P11520, DOI 10.1074/jbc.M413254200; BRADBURNE AF, 1967, BMJ-BRIT MED J, V3, P767, DOI 10.1136/bmj.3.5568.767; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAVID MK, 2007, FIELDS VIROLOGY, P795; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Hsu JTA, 2004, FEBS LETT, V574, P116, DOI 10.1016/j.febslet.2004.08.015; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Johnson TO, 2002, J MED CHEM, V45, P2016, DOI 10.1021/jm010435c; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P392; Kuo CJ, 2004, BIOCHEM BIOPH RES CO, V318, P862, DOI 10.1016/j.bbrc.2004.04.098; Lee CC, 2007, FEBS LETT, V581, P5454, DOI 10.1016/j.febslet.2007.10.048; Liang PH, 2006, CURR TOP MED CHEM, V6, P361, DOI 10.2174/156802606776287090; Matthews DA, 1999, P NATL ACAD SCI USA, V96, P11000, DOI 10.1073/pnas.96.20.11000; MAZE SS, 1990, CLIN CARDIOL, V13, P69, DOI 10.1002/clc.4960130203; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Monpoeho S, 2000, BIOTECHNIQUES, V29, P88, DOI 10.2144/00291st03; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; PORTER AG, 1993, J VIROL, V67, P6917, DOI 10.1128/JVI.67.12.6917-6921.1993; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Shie JJ, 2005, BIOORGAN MED CHEM, V13, P5240, DOI 10.1016/j.bmc.2005.05.065; Shih SR, 2004, J BIOMED SCI, V11, P239, DOI 10.1159/000076036; van der Hoek L, 2006, FEMS MICROBIOL REV, V30, P760, DOI 10.1111/j.1574-6976.2006.00032.x; Wang HM, 2007, EXPERT OPIN THER PAT, V17, P533, DOI 10.1517/13543776.17.5.533; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yang S, 2006, J MED CHEM, V49, P4971, DOI 10.1021/jm0603926	33	86	95	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7646	7655		10.1074/jbc.M807947200	http://dx.doi.org/10.1074/jbc.M807947200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144641	hybrid, Green Published			2022-12-27	WOS:000264195600026
J	Motani, A; Wang, ZL; Conn, M; Siegler, K; Zhang, Y; Liu, QX; Johnstone, S; Xu, HD; Thibault, S; Wang, YC; Fan, PC; Connors, R; Le, H; Xu, GF; Walker, N; Shan, B; Coward, P				Motani, Alykhan; Wang, Zhulun; Conn, Marion; Siegler, Karen; Zhang, Ying; Liu, Qingxiang; Johnstone, Sheree; Xu, Haoda; Thibault, Steve; Wang, Yingcai; Fan, Pingchen; Connors, Richard; Le, Hoa; Xu, Guifen; Walker, Nigel; Shan, Bei; Coward, Peter			Identification and Characterization of a Non-retinoid Ligand for Retinol-binding Protein 4 Which Lowers Serum Retinol-binding Protein 4 Levels in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA RETINOL; INSULIN-RESISTANCE; METABOLIC SYNDROME; CRYSTAL-STRUCTURE; CANCER-PATIENTS; RETINOL-BINDING-PROTEIN-4; TRANSTHYRETIN; REFINEMENT; RESOLUTION; COMPLEX	Retinol-binding protein 4 (RBP4) transports retinol from the liver to extrahepatic tissues, and RBP4 lowering is reported to improve insulin sensitivity in mice. We have identified A1120, a high affinity (K-i = 8.3 nM) non-retinoid ligand for RBP4, which disrupts the interaction between RBP4 and its binding partner transthyretin. Analysis of the RBP4-A1120 co-crystal structure reveals that A1120 induces critical conformational changes at the RBP4-transthyretin interface. Administration of A1120 to mice lowers serum RBP4 and retinol levels but, unexpectedly, does not improve insulin sensitivity. In addition, we show that Rpb4(-/-) mice display normal insulin sensitivity and are not protected from high fat diet-induced insulin resistance. We conclude that lowering RBP4 levels does not improve insulin sensitivity in mice. Therefore, RBP4 lowering may not be an effective strategy for treating diabetes.	[Motani, Alykhan; Conn, Marion; Siegler, Karen; Zhang, Ying; Liu, Qingxiang; Shan, Bei; Coward, Peter] Amgen Inc, Dept Metab Disorders, San Francisco, CA 94080 USA; [Wang, Zhulun; Johnstone, Sheree; Xu, Haoda; Thibault, Steve; Walker, Nigel] Amgen Inc, Dept Mol Struct, San Francisco, CA 94080 USA; [Wang, Yingcai; Fan, Pingchen; Connors, Richard] Amgen Inc, Dept Chem, San Francisco, CA 94080 USA; [Le, Hoa; Xu, Guifen] Amgen Inc, Dept Pharmacokinet & Drug Metab, San Francisco, CA 94080 USA	Amgen; Amgen; Amgen; Amgen	Coward, P (corresponding author), Amgen Inc, Dept Metab Disorders, 1120 Vet Blvd, San Francisco, CA 94080 USA.	pcoward@amgen.com		Siegler, Karen/0000-0002-1945-7559; Wang, Yingcai/0000-0001-5555-8712				Balagopal P, 2007, J CLIN ENDOCR METAB, V92, P1971, DOI 10.1210/jc.2006-2712; BERNI R, 1992, FEBS LETT, V308, P43, DOI 10.1016/0014-5793(92)81046-O; BERNI R, 1993, FASEB J, V7, P1179, DOI 10.1096/fasebj.7.12.8375617; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; Coward P, 2009, ANAL BIOCHEM, V384, P312, DOI 10.1016/j.ab.2008.09.051; Fanjul AN, 1996, J BIOL CHEM, V271, P22441, DOI 10.1074/jbc.271.37.22441; FORMELLI F, 1989, CANCER RES, V49, P6149; Goodman DS, 1984, RETINOIDS, P41, DOI DOI 10.1016/B978-0-12-658102-7.50008-7; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Greene LH, 2001, PROTEIN SCI, V10, P2301, DOI 10.1110/ps.22901; Henze A, 2008, DIABETES, V57, P3323, DOI 10.2337/db08-0866; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lewis JG, 2008, CLIN BIOCHEM, V41, P1034, DOI 10.1016/j.clinbiochem.2008.06.002; MAKOVER A, 1989, J LIPID RES, V30, P171; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naylor HM, 1999, BIOCHEMISTRY-US, V38, P2647, DOI 10.1021/bi982291i; NEWCOMER ME, 1984, EMBO J, V3, P1451, DOI 10.1002/j.1460-2075.1984.tb01995.x; PENG YM, 1989, INT J CANCER, V43, P22, DOI 10.1002/ijc.2910430106; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Promintzer M, 2007, J CLIN ENDOCR METAB, V92, P4306, DOI 10.1210/jc.2006-2522; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; ZANOTTI G, 1993, J MOL BIOL, V230, P613, DOI 10.1006/jmbi.1993.1173; ZANOTTI G, 1994, J BIOL CHEM, V269, P29613; ZANOTTI G, 1993, J BIOL CHEM, V268, P24873	34	60	74	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7673	7680		10.1074/jbc.M809654200	http://dx.doi.org/10.1074/jbc.M809654200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147488	Green Published, hybrid			2022-12-27	WOS:000264195600029
J	Morales, J; Mogi, T; Mineki, S; Takashima, E; Mineki, R; Hirawake, H; Sakamoto, K; Omura, S; Kita, K				Morales, Jorge; Mogi, Tatsushi; Mineki, Shigeru; Takashima, Eizo; Mineki, Reiko; Hirawake, Hiroko; Sakamoto, Kimitoshi; Omura, Satoshi; Kita, Kiyoshi			Novel Mitochondrial Complex II Isolated from Trypanosoma cruzi Is Composed of 12 Peptides Including a Heterodimeric Ip Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUCCINATE-UBIQUINONE OXIDOREDUCTASE; QUINONE-BINDING-SITE; ELECTRON-TRANSFER COMPLEXES; FUMARATE REDUCTASE; ESCHERICHIA-COLI; PARASITIC NEMATODE; ENERGY-METABOLISM; AMINO-ACIDS; DEHYDROGENASE; HEME	Mitochondrial respiratory enzymes play a central role in energy production in aerobic organisms. They differentiated from the alpha-proteobacteria-derived ancestors by adding noncatalytic subunits. An exception is Complex II (succinate: ubiquinone reductase), which is composed of four alpha-proteobacteria-derived catalytic subunits (SDH1-SDH4). Complex II often plays a pivotal role in adaptation of parasites in host organisms and would be a potential target for new drugs. We purified Complex II from the parasitic protist Trypanosoma cruzi and obtained the unexpected result that it consists of six hydrophilic (SDH1, SDH2(N), SDH2(C), and SDH5-SDH7) and six hydrophobic (SDH3, SDH4, and SDH8-SDH11) nucleus-encoded subunits. Orthologous genes for each subunit were identified in Trypanosoma brucei and Leishmania major. Notably, the iron-sulfur subunit was heterodimeric; SDH2(N) and SDH2(C) contain the plant-type ferredoxin domain in the N-terminal half and the bacterial ferredoxin domain in the C-terminal half, respectively. Catalytic subunits (SDH1, SDH2(N) plus SDH2(C), SDH3, and SDH4) contain all key residues for binding of dicarboxylates and quinones, but the enzyme showed the lower affinity for both substrates and inhibitors than mammalian enzymes. In addition, the enzyme binds protoheme IX, but SDH3 lacks a ligand histidine. These unusual features are unique in the Trypanosomatida and make their Complex II a target for new chemotherapeutic agents.	[Morales, Jorge; Mogi, Tatsushi; Takashima, Eizo; Hirawake, Hiroko; Sakamoto, Kimitoshi; Kita, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Omura, Satoshi] Kitasato Univ, Grad Sch Infect Control Sci, Minato Ku, Tokyo 1088641, Japan; [Omura, Satoshi] Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, Tokyo 1088641, Japan; [Mineki, Reiko] Juntendo Univ, Grad Sch Med, Div Proteom & Biomol Sci, Bunkyo Ku, Tokyo 1138421, Japan; [Mineki, Shigeru] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Chiba 2788510, Japan	University of Tokyo; Kitasato University; Kitasato University; Juntendo University; Tokyo University of Science	Mogi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, Tokyo 1130033, Japan.	tmogi@m.u-tokyo.ac.jp; kitak@m.u-tokyo.ac.jp	Morales, Jorge/E-9916-2013; Morales, Jorge/AAJ-9381-2020; Sakamoto, Kimitoshi/G-4539-2014	Morales, Jorge/0000-0002-2828-1567; Kita, Kiyoshi/0000-0002-0426-4308; Takashima, Eizo/0000-0001-9070-8499	Japanese Society for the Promotion of Science [20570124, 18GS0314, 18073004]; Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT)	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research 20570124 (to T. M.), Creative Scientific Research Grant 18GS0314 (to K. K.), Grant-in-aid for Scientific Research on Priority Areas 18073004 (to K. K.) from the Japanese Society for the Promotion of Science, and Targeted Proteins Research Program (to K. K.) from the Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT).	Adams KL, 2001, GENETICS, V158, P1289; Allen JWA, 2004, BIOCHEM J, V383, P537, DOI 10.1042/BJ20040832; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Besteiro S, 2005, TRENDS PARASITOL, V21, P185, DOI 10.1016/j.pt.2005.02.008; Bourguignon SC, 2006, ACTA TROP, V98, P103, DOI 10.1016/j.actatropica.2006.02.006; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; BRUSCA JS, 1994, METHOD ENZYMOL, V228, P182; CAZZULO JJ, 1994, J BIOENERG BIOMEMBR, V26, P157, DOI 10.1007/BF00763064; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Concepcion JL, 1999, COMP BIOCHEM PHYS B, V122, P211, DOI 10.1016/S0305-0491(99)00002-4; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010; Funes S, 2002, SCIENCE, V298, P2155, DOI 10.1126/science.1076003; GRIVENNIKOVA VG, 1993, BIOCHIM BIOPHYS ACTA, V1140, P282, DOI 10.1016/0005-2728(93)90067-P; HARINGTON JS, 1961, PARASITOLOGY, V51, P309, DOI 10.1017/S0031182000070554; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; KITA K, 1989, J BIOL CHEM, V264, P2672; Kita K, 2002, ADV PARASIT, V51, P95, DOI 10.1016/S0065-308X(02)51004-6; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Maklashina E, 2001, J BIOL CHEM, V276, P18968, DOI 10.1074/jbc.M011270200; Marande W, 2007, SCIENCE, V318, P415, DOI 10.1126/science.1148033; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Millar AH, 2004, PLANT MOL BIOL, V56, P77, DOI 10.1007/s11103-004-2316-2; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Miyadera H, 2003, EUR J BIOCHEM, V270, P1863, DOI 10.1046/j.1432-1033.2003.03553.x; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Nelson RE, 2004, MOL BIOCHEM PARASIT, V135, P219, DOI 10.1016/j.molbiopara.2004.02.003; Oyedotun KS, 2007, BBA-BIOENERGETICS, V1767, P1436, DOI 10.1016/j.bbabio.2007.09.008; ROOS MH, 1994, MOL BIOCHEM PARASIT, V66, P273, DOI 10.1016/0166-6851(94)90154-6; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; SARUTA F, 1995, J BIOL CHEM, V270, P928, DOI 10.1074/jbc.270.2.928; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; TAKAMIYA S, 1986, BIOCHIM BIOPHYS ACTA, V848, P99, DOI 10.1016/0005-2728(86)90165-9; Takashima E, 2002, MOL BIOCHEM PARASIT, V122, P189, DOI 10.1016/S0166-6851(02)00100-7; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; Tran QM, 2007, P NATL ACAD SCI USA, V104, P18007, DOI 10.1073/pnas.0707732104; Tran QM, 2006, J BIOL CHEM, V281, P32310, DOI 10.1074/jbc.M607476200; TUSHURASHVILI PR, 1985, BIOCHIM BIOPHYS ACTA, V809, P145, DOI 10.1016/0005-2728(85)90057-X; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; Waller RF, 2006, GENE, V383, P33, DOI 10.1016/j.gene.2006.07.003; WHO Expert Committee on Problems Related to Alcohol Consumption, 2007, World Health Organ Tech Rep Ser, P1; WILLIAMS N, 1990, MOL BIOCHEM PARASIT, V43, P125, DOI 10.1016/0166-6851(90)90137-B; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yang XD, 1998, J BIOL CHEM, V273, P31916, DOI 10.1074/jbc.273.48.31916; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	53	44	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7255	7263		10.1074/jbc.M806623200	http://dx.doi.org/10.1074/jbc.M806623200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19122194	Green Published, hybrid			2022-12-27	WOS:000263919000072
J	Zhao, XB; Yu, SW; Ranguelova, K; Suarez, J; Metlitsky, L; Schelvis, JPM; Magliozzo, RS				Zhao, Xiangbo; Yu, Shengwei; Ranguelova, Kalina; Suarez, Javier; Metlitsky, Leonid; Schelvis, Johannes P. M.; Magliozzo, Richard S.			Role of the Oxyferrous Heme Intermediate and Distal Side Adduct Radical in the Catalase Activity of Mycobacterium tuberculosis KatG Revealed by the W107F Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ELECTRON-PARAMAGNETIC-RESONANCE; NADH OXIDASE ACTIVITY; TRP CROSS-LINK; PEROXIDASE KATG; ISONIAZID ACTIVATION; BURKHOLDERIA-PSEUDOMALLEI; HYDROGEN-PEROXIDE; HORSERADISH-PEROXIDASE; CRYSTAL-STRUCTURE	Catalase-peroxidase (KatG) is essential in Mycobacterium tuberculosis for oxidative stress management and activation of the antitubercular pro-drug isoniazid. The role of a unique distal side adduct found in KatG enzymes, involving linked side chains of residues Met(255), Tyr(229), and Trp(107) (MYW), in the unusual catalase activity of KatG is addressed here and in our companion paper (Suarez, J., Ranguelova, K., Jarzecki, A. A., Manzerova, J., Krymov, V., Zhao, X., Yu, S., Metlitsky, L., Gerfen, G. J., and Magliozzo, R. S. (2009) J. Biol. Chem. 284, in press). The KatG[W107F] mutant exhibited severely reduced catalase activity yet normal peroxidase activity, and as isolated contains more abundant 6-coordinate heme in high spin and low spin forms compared with the wild-type enzyme. Most interestingly, oxyferrous heme is also found in the purified enzyme. Oxyferrous KatG[W107F] was prepared by photolysis in air of the carbonyl enzyme or was generated using hydrogen peroxide decayed with a t(1/2) of 2 days compared with 6 min for wild-type protein. The stability of oxyenyzme was modestly enhanced in KatG[Y229F] but was not affected in KatG[M255A]. Optical stopped-flow experiments showed rapid formation of Compound I in KatG[W107F] and facile formation of oxyferrous heme in the presence of micromolar hydrogen peroxide. An analysis of the relationships between catalase activity, stability of oxyferrous enzyme, and a proposed MYW adduct radical is presented. The loss of catalase function is assigned to the loss of the MYW adduct radical and structural changes that lead to greatly enhanced stability of oxyenzyme, an intermediate of the catalase cycle of native enzyme.	[Zhao, Xiangbo; Yu, Shengwei; Ranguelova, Kalina; Suarez, Javier; Metlitsky, Leonid; Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Suarez, Javier; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Chem, New York, NY 10016 USA; [Suarez, Javier; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Biochem, New York, NY 10016 USA; [Schelvis, Johannes P. M.] NYU, Dept Chem, New York, NY 10003 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; New York University	Magliozzo, RS (corresponding author), CUNY Brooklyn Coll, Dept Chem, 2900 Bedford Ave, Brooklyn, NY 11210 USA.	rmaglioz@brooklyn.cuny.edu			National Institutes of Health [AI-43582, AI-060014]; National Science Foundation; Heiser Program for Research in Leprosy and Tuberculosis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043582, R56AI060014, R01AI060014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Heiser Program for Research in Leprosy and Tuberculosis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-43582 and AI-060014 (NIAID) (to R. S. M.). This work was also supported by National Science Foundation grant (to J. P. M. S.) and the Heiser Program for Research in Leprosy and Tuberculosis (to S. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANTONINI E, 1971, HEMOGLOBIN MYOGLOBIN, P44; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; BLUMBERG WE, 1968, J BIOL CHEM, V243, P1854; Carpena X, 2006, BIOCHEMISTRY-US, V45, P5171, DOI 10.1021/bi060017f; Carpena X, 2003, J MOL BIOL, V327, P475, DOI 10.1016/S0022-2836(03)00122-0; Chouchane S, 2003, J BIOL CHEM, V278, P8154, DOI 10.1074/jbc.M208256200; Chouchane S, 2000, BIOCHEMISTRY-US, V39, P9975, DOI 10.1021/bi0005815; Deemagarn T, 2007, PROTEINS, V66, P219, DOI 10.1002/prot.21209; DeLano WL, 2004, PYMOL MOL GRAPHICS S; DUNFORD HB, 1999, HEME PEROXIDASES, P276; Ghiladi RA, 2005, BIOCHEMISTRY-US, V44, P15093, DOI 10.1021/bi051463q; Ghiladi RA, 2005, J BIOL CHEM, V280, P22651, DOI 10.1074/jbc.M502486200; GonzalezFlecha B, 1997, J BACTERIOL, V179, P382, DOI 10.1128/jb.179.2.382-388.1997; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; IKEDASAITO M, 1992, J BIOL CHEM, V267, P22843; Ivancich A, 2003, J AM CHEM SOC, V125, P14093, DOI 10.1021/ja035582+; Jakopitsch C, 2005, J BIOL CHEM, V280, P9037, DOI 10.1074/jbc.M413317200; Jakopitsch C, 2005, J BIOL CHEM, V280, P42411, DOI 10.1074/jbc.M508009200; Jakopitsch C, 2003, EUR J BIOCHEM, V270, P1006, DOI 10.1046/j.1432-1033.2003.03476.x; Jakopitsch C, 2001, BIOCHEM BIOPH RES CO, V287, P682, DOI 10.1006/bbrc.2001.5616; Jakopitsch C, 2004, J BIOL CHEM, V279, P46082, DOI 10.1074/jbc.M408399200; Jakopitsch C, 2003, J BIOL CHEM, V278, P20185, DOI 10.1074/jbc.M211625200; Jakopitsch C, 2007, BIOCHEMISTRY-US, V46, P1183, DOI 10.1021/bi062266+; JOHNSSON K, 1994, J AM CHEM SOC, V116, P7425, DOI 10.1021/ja00095a063; Kapetanaki S, 2003, BIOCHEMISTRY-US, V42, P3835, DOI 10.1021/bi026992y; Magliozzo RS, 1996, J AM CHEM SOC, V118, P11303, DOI 10.1021/ja962047j; MARCINKEVICIENE JA, 1995, J BIOL CHEM, V270, P22290, DOI 10.1074/jbc.270.38.22290; Metcalfe C, 2008, J BIOL CHEM, V283, P6193, DOI 10.1074/jbc.M707412200; MILLER MA, 1992, BIOCHEMISTRY-US, V31, P2789, DOI 10.1021/bi00125a020; MILLER MA, 1994, NAT STRUCT BIOL, V1, P524, DOI 10.1038/nsb0894-524; PEISACH J, 1971, P 1 INT AM S HEM, P199; Pierattelli R, 2004, J BIOL CHEM, V279, P39000, DOI 10.1074/jbc.M402384200; Ranguelova K, 2008, BIOCHEMISTRY-US, V47, P12583, DOI 10.1021/bi801511u; Ranguelova K, 2007, J BIOL CHEM, V282, P6255, DOI 10.1074/jbc.M607309200; Regelsberger G, 2000, J BIOL CHEM, V275, P22854, DOI 10.1074/jbc.M002371200; Regelsberger G, 2001, BIOCHEM SOC T, V29, P99; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Saint-Joanis B, 1999, BIOCHEM J, V338, P753, DOI 10.1042/0264-6021:3380753; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Singh R, 2004, J BIOL CHEM, V279, P43098, DOI 10.1074/jbc.M406374200; Suarez J, 2009, J BIOL CHEM, V284, P7017, DOI 10.1074/jbc.M808106200; Svistunenko DA, 2000, BIOCHEM J, V351, P595, DOI 10.1042/0264-6021:3510595; Vlasits J, 2007, FEBS LETT, V581, P320, DOI 10.1016/j.febslet.2006.12.037; Wengenack NL, 1998, BIOCHEMISTRY-US, V37, P15825, DOI 10.1021/bi982023k; WITTENBE.BA, 1967, BIOCHEMISTRY-US, V6, P1970, DOI 10.1021/bi00859a013; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834; Yu SW, 2003, J BIOL CHEM, V278, P44121, DOI 10.1074/jbc.M304757200; ZHANG Y, 1993, RES MICROBIOL, V144, P143, DOI 10.1016/0923-2508(93)90029-2; Zhao XB, 2006, BIOCHEMISTRY-US, V45, P4131, DOI 10.1021/bi051967o; Zhao XB, 2007, BIOCHEMISTRY-US, V46, P3161, DOI 10.1021/bi062218p	51	16	16	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7030	7037		10.1074/jbc.M808107200	http://dx.doi.org/10.1074/jbc.M808107200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139098	hybrid, Green Published			2022-12-27	WOS:000263919000051
J	Guo, P; Dong, XY; Zhang, XH; Zhao, KW; Sun, XD; Li, QN; Dong, JT				Guo, Peng; Dong, Xue-Yuan; Zhang, Xiaohui; Zhao, Ke-Wen; Sun, Xiaodong; Li, Qunna; Dong, Jin-Tang			Pro-proliferative Factor KLF5 Becomes Anti-proliferative in Epithelial Homeostasis upon Signaling-mediated Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CDK INHIBITOR P15(INK4B); HUMAN PROSTATE-CANCER; KRUPPEL-LIKE FACTOR-5; TRANSCRIPTION FACTOR; TGF-BETA; STEM-CELLS; TUMOR PROGRESSION; HUMAN SKIN; PROMOTER	During epithelial homeostasis, stem cells divide to produce progenitor cells, which not only proliferate to generate the cell mass but also respond to cellular signaling to transition from a proliferative state to a differentiation state. Such a transition involves functional alterations of transcriptional factors, yet the underlying molecular mechanisms are poorly understood. Recent studies have implicated Kruppel-like factors (KLFs) including KLF5 in the renewal and maintenance of stem/progenitor cells. Here we demonstrate that the pro-proliferative factor KLF5 becomes anti-proliferative upon TGF beta-mediated acetylation in an in vitro model of epithelial homeostasis. In the HaCaT epidermal cell line treated with or without TGF beta, we found that KLF5 was not only essential for cell proliferation, it was also indispensable for TGF beta-induced anti-proliferation in these cells. KLF5 inhibited the expression of p15 (CDKN2B), a cell cycle inhibitor, without TGF beta, but became a coactivator in TGF beta-induced p15 expression in the same cells. Mechanistically, TGF beta recruited acetylase p300 to acetylate KLF5, and acetylation in turn altered the binding of KLF5 to p15 promoter, resulting in the reversal of KLF5 function. These studies not only demonstrate that a basic transcription factor can be both pro-proliferation and anti-proliferation in epithelial homeostasis, they also present a unique mechanism for how transcriptional regulation changes during the transition from proliferation to inhibition of proliferation. Furthermore, they establish KLF5 as an essential cofactor for TGF beta signaling.	[Guo, Peng; Dong, Xue-Yuan; Zhang, Xiaohui; Zhao, Ke-Wen; Sun, Xiaodong; Li, Qunna; Dong, Jin-Tang] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University	Dong, JT (corresponding author), 1365-C Clifton Rd, Atlanta, GA 30322 USA.	jdong2@emory.edu	guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022	Guo, Peng/0000-0002-4575-8443; Dong, Jin-Tang/0000-0003-2349-5782	NCI [Grant R01CA87921]; National Institutes of Health; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [R01CA087921] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Grant R01CA87921 from the NCI, National Institutes of Health. This work was also supported by the Georgia Cancer Coalition.	Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; Chanchevalap S, 2004, FEBS LETT, V578, P99, DOI 10.1016/j.febslet.2004.10.079; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; Grabbe J, 1996, J INVEST DERMATOL, V107, P219, DOI 10.1111/1523-1747.ep12329664; Greiff AH, 2002, CLIN EXP METASTAS, V19, P727, DOI 10.1023/A:1021304700234; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Lemaitre G, 2005, PROTEOMICS, V5, P3637, DOI 10.1002/pmic.200401224; LI JM, 1995, J BIOL CHEM, V270, P26750, DOI 10.1074/jbc.270.45.26750; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park BJ, 2000, CANCER RES, V60, P3031; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Roberts A, 2005, ONCOGENE, V24, P5667, DOI 10.1038/sj.onc.1208915; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sandhu C, 1997, MOL CELL BIOL, V17, P2458, DOI 10.1128/MCB.17.5.2458; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shi HP, 1999, NUCLEIC ACIDS RES, V27, P4807, DOI 10.1093/nar/27.24.4807; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sur I, 2002, EUR J CELL BIOL, V81, P323, DOI 10.1078/0171-9335-00257; Sur I, 2006, J CELL SCI, V119, P3593, DOI 10.1242/jcs.03070; Wakefield LM, 2007, CANCER CELL, V12, P293, DOI 10.1016/j.ccr.2007.10.002; Wan H, 2007, STEM CELLS, V25, P1286, DOI 10.1634/stemcells.2006-0304; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Zhang ZP, 2003, NUCLEIC ACIDS RES, V31, P2196, DOI 10.1093/nar/gkg310	40	62	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6071	6078		10.1074/jbc.M806270200	http://dx.doi.org/10.1074/jbc.M806270200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19056724	Green Published, hybrid			2022-12-27	WOS:000263742700009
J	Soderhall, I; Wu, CL; Novotny, M; Lee, BL; Soderhall, K				Soderhall, Irene; Wu, Chenglin; Novotny, Marian; Lee, Bok Luel; Soderhall, Kenneth			A Novel Protein Acts as a Negative Regulator of Prophenoloxidase Activation and Melanization in the Freshwater Crayfish Pacifastacus leniusculus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; PHENOLOXIDASE; DEFENSE; TRYPSINOGEN; INHIBITOR; COMPONENT; CLONING; SYSTEM	Melanization is an important immune component of the innate immune system of invertebrates and is vital for defense as well as for wound healing. In most invertebrates melanin synthesis is achieved by the prophenoloxidase-activating system, a proteolytic cascade similar to vertebrate complement. Even though melanin formation is necessary for host defense in crustaceans and insects, the process needs to be tightly regulated because of the hazard to the animal of unwanted production of quinone intermediates and melanization in places where it is not suitable. In the present study we have identified a new melanization inhibition protein (MIP) from the hemolymph of the crayfish, Pacifastacus leniusculus. Crayfish MIP has a similar function as the insect MIP molecule we recently discovered in the beetle Tenebrio molitor but interestingly has a completely different sequence. Crayfish MIP as well as Tenebrio MIP do not affect phenoloxidase activity in itself but instead interfere with the melanization reaction from quinone compounds to melanin. Importantly, crayfish MIP in contrast to Tenebrio MIP contains a fibrinogen-like domain, most similar to the substrate recognition domain of vertebrate L-ficolins. Surprisingly, an Asp-rich region similar to that found in ficolins that is likely to be involved in Ca2+ binding is present in crayfish MIP. However, crayfish MIP did not show any hemagglutinating activity as is common for the vertebrate ficolins. A mutant form of MIP with a deletion lacking four Asp amino acids from the Asp-rich region lost most of its activity, implicating that this part of the protein is involved in regulating the prophenoloxidase activating cascade. Overall, a new negative regulator of melanization was identified in freshwater crayfish that shows interesting parallels with proteins (i.e. ficolins) involved in vertebrate immune response.	[Soderhall, Irene; Wu, Chenglin; Soderhall, Kenneth] Uppsala Univ, Dept Comparat Physiol, S-75236 Uppsala, Sweden; [Novotny, Marian] Charles Univ Prague, Dept Cell Biol, Fac Nat Sci, Prague 12843, Czech Republic; [Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea	Uppsala University; Charles University Prague; Pusan National University	Soderhall, I (corresponding author), Uppsala Univ, Dept Comparat Physiol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	Irene.Soderhall@ebc.uu.se	Novotny, Marian/B-7036-2008; Soderhall, Irene/AAS-5433-2020	Novotny, Marian/0000-0001-8788-3202; 	Swedish Science Research Council; Swedish Research Council Formas	Swedish Science Research Council; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Swedish Science Research Council and The Swedish Research Council Formas. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ashida Masaaki, 1998, P135; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; HOPP TP, 1981, P NATL ACAD SCI USA, V86, P152; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang ZC, 1997, P NATL ACAD SCI USA, V94, P6682, DOI 10.1073/pnas.94.13.6682; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Lu ZQ, 2007, INSECT BIOCHEM MOLEC, V37, P478, DOI 10.1016/j.ibmb.2007.02.004; Nemoda Z, 2005, J BIOL CHEM, V280, P29645, DOI 10.1074/jbc.M505661200; Okino N, 1995, J BIOL CHEM, V270, P31008, DOI 10.1074/jbc.270.52.31008; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; RADHAKRI.TM, 1969, BIOCHEMISTRY-US, V8, P4020, DOI 10.1021/bi00838a019; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi L, 2006, INSECT MOL BIOL, V15, P313, DOI 10.1111/j.1365-2583.2006.00643.x; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Wang RG, 2001, EUR J BIOCHEM, V268, P895, DOI 10.1046/j.1432-1327.2001.01945.x; Zhao MY, 2005, J BIOL CHEM, V280, P24744, DOI 10.1074/jbc.M504173200	29	67	68	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6301	6310		10.1074/jbc.M806764200	http://dx.doi.org/10.1074/jbc.M806764200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129195	hybrid			2022-12-27	WOS:000263742700033
J	Wu, WH; Wu, CH; Ladurner, A; Mizuguchi, G; Wei, D; Xiao, H; Luk, E; Ranjan, A; Wu, C				Wu, Wei-Hua; Wu, Chwen-Huey; Ladurner, Andreas; Mizuguchi, Gaku; Wei, Debbie; Xiao, Hua; Luk, Ed; Ranjan, Anand; Wu, Carl			N Terminus of Swr1 Binds to Histone H2AZ and Provides a Platform for Subunit Assembly in the Chromatin Remodeling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; ACTIN-RELATED PROTEINS; VARIANT H2A.Z; HETEROCHROMATIN BOUNDARIES; H4 ACETYLATION; HSA DOMAIN; NUA4; HTZ1; NUCLEOSOME; EXCHANGE	Variant histone H2AZ-containing nucleosomes are involved in the regulation of gene expression. In Saccharomyces cerevisiae, chromatin deposition of histone H2AZ is mediated by the fourteen-subunit SWR1 complex, which catalyzes ATP-dependent exchange of nucleosomal histone H2A for H2AZ. Previous work defined the role of seven SWR1 subunits (Swr1 ATPase, Swc2, Swc3, Arp6, Swc5, Yaf9, and Swc6) in maintaining complex integrity and H2AZ histone replacement activity. Here we examined the function of three additional SWR1 subunits, bromodomain containing Bdf1, actin-related protein Arp4 and Swc7, by analyzing affinity-purified mutant SWR1 complexes. We observed that depletion of Arp4 (arp4-td) substantially impaired the association of Bdf1, Yaf9, and Swc4. In contrast, loss of either Bdf1 or Swc7 had minimal effects on overall complex integrity. Furthermore, the basic H2AZ histone replacement activity of SWR1 in vitro required Arp4, but not Bdf1 or Swc7. Thus, three out of fourteen SWR1 subunits, Bdf1, Swc7, and previously noted Swc3, appear to have roles auxiliary to the basic histone replacement activity. The N-terminal region of the Swr1 ATPase subunit is necessary and sufficient to direct association of Bdf1 and Swc7, as well as Arp4, Act1, Yaf9 and Swc4. This same region contains an additional H2AZ-H2B specific binding site, distinct from the previously identified Swc2 subunit. These findings suggest that one SWR1 enzyme might be capable of binding two H2AZ-H2B dimers, and provide further insight on the hierarchy and interdependency of molecular interactions within the SWR1 complex.	[Wu, Wei-Hua; Wu, Chwen-Huey; Mizuguchi, Gaku; Wei, Debbie; Xiao, Hua; Luk, Ed; Ranjan, Anand; Wu, Carl] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Ladurner, Andreas] European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); European Molecular Biology Laboratory (EMBL)	Wu, WH (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bldg 37,Rm 6066, Bethesda, MD 20892 USA.	wuwe@mail.nih.gov; carlwu@helix.nih.gov		Ladurner, Andreas/0000-0003-3835-232X; Luk, Ed/0000-0002-6619-2258	NCI; National Institutes of Health; NATIONAL CANCER INSTITUTE [Z01BC005263, ZIABC005263] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the intramural research program of the NCI, National Institutes of Health.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bittner CB, 2004, EUKARYOT CELL, V3, P976, DOI 10.1128/EC.3.4.976-983.2004; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Choi K, 2007, DEVELOPMENT, V134, P1931, DOI 10.1242/dev.001891; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Dohmen RJ, 2005, METHOD ENZYMOL, V399, P799, DOI 10.1016/S0076-6879(05)99052-6; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Durant M, 2007, MOL CELL BIOL, V27, P5327, DOI 10.1128/MCB.00468-07; Eirin-Lopez JM, 2007, CURR GENOMICS, V8, P59, DOI 10.2174/138920207780076965; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gligoris T, 2007, MOL CELL BIOL, V27, P4198, DOI 10.1128/MCB.00238-07; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kasten M, 2004, EMBO J, V23, P1348, DOI 10.1038/sj.emboj.7600143; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Kusch Thomas, 2007, Subcell Biochem, V41, P91; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Matangkasombut O, 2000, GENE DEV, V14, P951; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2004, METHOD ENZYMOL, V377, P401; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Sunada R, 2005, YEAST, V22, P753, DOI 10.1002/yea.1239; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Trotter KW, 2008, MOL CELL BIOL, V28, P1413, DOI 10.1128/MCB.01301-07; Wong MM, 2007, J BIOL CHEM, V282, P26132, DOI 10.1074/jbc.M703418200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004	53	78	79	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6200	6207		10.1074/jbc.M808830200	http://dx.doi.org/10.1074/jbc.M808830200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19088068	Green Published, hybrid			2022-12-27	WOS:000263742700023
J	Zhang, LJ; Liu, X; Gafken, PR; Kioussi, C; Leid, M				Zhang, Ling-juan; Liu, Xiao; Gafken, Philip R.; Kioussi, Chrissa; Leid, Mark			A Chicken Ovalbumin Upstream Promoter Transcription Factor I (COUP-TFI) Complex Represses Expression of the Gene Encoding Tumor Necrosis Factor alpha-induced Protein 8 (TNFAIP8)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR COREPRESSOR COMPLEX; DEATH EFFECTOR DOMAIN; NUCLEAR RECEPTORS; N-COR; DEACETYLASE SIRT1; PURIFICATION; ACTIVATION; INTERACTS; MEMBERS; DIFFERENTIATION	The orphan nuclear receptor chicken ovalbumin upstream promoter transcription factor I (COUP-TFI) plays key roles in development and homeostasis. A tandem affinity purification procedure revealed that COUP-TFI associated with a number of transcriptional regulatory proteins in HeLa S3 cells, including the nuclear receptor corepressor (NCoR), TIF1 beta/KAP-1, HDAC1, and the SWI/SNF family member Brahma. The proapoptotic protein DBC1 was also identified in COUP-TFI complexes. In vitro experiments revealed that COUP-TFI interacted directly with NCoR but in a manner different from that of other nuclear receptors. DBC1 stabilized the interaction between COUP-TFI and NCoR by interacting directly with both proteins. The gene encoding the anti-apoptotic protein TNFAIP8 (tumor necrosis factor alpha(TNF alpha)-induced protein 8) was identified as being repressed by COUP-TFI in a manner that required several of the component proteins of the COUP-TFI complex. Finally, our studies highlight a central role for COUP-TFI in the induction of the TNFAIP8 promoter by TNF alpha. Together, these studies identify a novel COUP-TFI complex that functions as a repressor of transcription and may play a role in the TNF alpha signaling pathways.	[Zhang, Ling-juan; Liu, Xiao; Kioussi, Chrissa; Leid, Mark] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Gafken, Philip R.] Fred Hutchinson Canc Res Ctr, Prote Facil, Seattle, WA 98109 USA	Oregon State University; Fred Hutchinson Cancer Center	Leid, M (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	Mark.Leid@oregonstate.edu	Zhang, Lingjuan/K-3080-2017; Zhang, Ling-juan/V-6141-2019	Zhang, Lingjuan/0000-0001-6937-4578; Zhang, Ling-juan/0000-0001-6937-4578; Kioussi, Chrissa/0000-0001-8226-9908	National Institutes of Health [GM60852]; Oregon State University College of Pharmacy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon State University College of Pharmacy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60852 to M. L.). This work was also supported by the Oregon State University College of Pharmacy.	Avram D, 1999, J BIOL CHEM, V274, P14331, DOI 10.1074/jbc.274.20.14331; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; Dressel U, 1999, MOL CELL BIOL, V19, P3383; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Gay F, 2002, MOL ENDOCRINOL, V16, P1332, DOI 10.1210/me.16.6.1332; Glass CK, 2000, GENE DEV, V14, P121; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Huggins GS, 2001, J BIOL CHEM, V276, P28029, DOI 10.1074/jbc.M103577200; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kane CD, 2000, EMBO J, V19, P691, DOI 10.1093/emboj/19.4.691; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kobayashi S, 2004, J MOL ENDOCRINOL, V32, P69, DOI 10.1677/jme.0.0320069; Kumar D, 2004, ONCOGENE, V23, P612, DOI 10.1038/sj.onc.1207123; Kumar D, 2000, J BIOL CHEM, V275, P2973, DOI 10.1074/jbc.275.4.2973; Kurihara I, 2005, J BIOL CHEM, V280, P6721, DOI 10.1074/jbc.M411820200; Kurihara I, 2002, ENDOCR RES, V28, P581, DOI 10.1081/ERC-120016845; Lee CT, 2004, MOL CELL BIOL, V24, P10835, DOI 10.1128/MCB.24.24.10835-10843.2004; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marcus SL, 1996, J BIOL CHEM, V271, P27197, DOI 10.1074/jbc.271.44.27197; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Rohr O, 2000, J BIOL CHEM, V275, P2654, DOI 10.1074/jbc.275.4.2654; Rohr O, 1997, J BIOL CHEM, V272, P31149, DOI 10.1074/jbc.272.49.31149; SAGAMI I, 1986, MOL CELL BIOL, V6, P4259, DOI 10.1128/MCB.6.12.4259; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Seol W, 1996, MOL ENDOCRINOL, V10, P1646, DOI 10.1210/me.10.12.1646; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shibata H, 2003, HORM RES, V59, P85, DOI 10.1159/000067830; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Stroup D, 1997, J BIOL CHEM, V272, P9833; Studer M, 2005, BRAIN RES BULL, V66, P394, DOI 10.1016/j.brainresbull.2004.11.027; Sundararajan R, 2005, ONCOGENE, V24, P4908, DOI 10.1038/sj.onc.1208681; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; Toulouse A, 2003, GENOMICS, V82, P162, DOI 10.1016/S0888-7543(03)00101-0; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; WANG LH, 1987, J BIOL CHEM, V262, P16080; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Warnecke M, 2005, GENE DEV, V19, P614, DOI 10.1101/gad.317905; Yi EC, 2003, RAPID COMMUN MASS SP, V17, P2093, DOI 10.1002/rcm.1150; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; You ZB, 2001, J BIOL CHEM, V276, P26398, DOI 10.1074/jbc.M102464200; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang Y, 2003, MOL CELL BIOL, V23, P6958, DOI 10.1128/MCB.23.19.6958-6972.2003; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6; Zhu NL, 2007, GENE, V393, P70, DOI 10.1016/j.gene.2007.01.016	65	35	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6156	6168		10.1074/jbc.M807713200	http://dx.doi.org/10.1074/jbc.M807713200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19112178	Green Published, hybrid			2022-12-27	WOS:000263742700018
J	Asada, K; Kurokawa, J; Furukawa, T				Asada, Ken; Kurokawa, Junko; Furukawa, Tetsushi			Redox- and Calmodulin-dependent S-Nitrosylation of the KCNQ1 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CURRENT; DENSITY PROTEIN PSD-95; LONG-QT SYNDROME; NITRIC-OXIDE; GUINEA-PIG; CARDIAC REPOLARIZATION; RECEPTOR MODULATION; POTASSIUM CHANNELS; CYSTEINE; NO	Nitric oxide (NO) is a gaseous signal mediator showing numerous important biological effects. NO has been shown in many instances to exhibit its action via the protein S-nitrosylation mechanism, in which binding of NO to Cys residues regulate protein function independently of activation of soluble guanylate cyclase. The direct link between protein S-nitrosylation and functional modulation, however, has been demonstrated only in limited examples. Furthermore, although most proteins have more than one Cys residue, the mechanism by which a certain Cys becomes a specific target residue of S-nitrosylation is poorly understood. We have previously reported that NO regulates currents through the cardiac slowly activating delayed rectifier potassium channel (I-Ks) irrespective of soluble guanylate cyclase activation. Here we demonstrate using a biotin-switch assay that NO induced S-nitrosylation of the alpha-subunit of the IKs channel, KCNQ1, at Cys(445) in the C terminus. A redox motif flanking Cys(445) and the interaction of KCNQ1 with calmodulin are required for preferential S-nitrosylation of Cys(445). A patch clamp experiment shows that S-nitrosylation of Cys(445) modulates the KCNQ1/KCNE1 channel function. Our data provide a molecular basis of NO-mediated regulation of the I-Ks channel. This novel regulatory mechanism of the I-Ks channel may play a role in previously demonstrated NO-mediated phenomenon in cardiac electrophysiology, including shortening in action potential duration in response to intracellular Ca2+ or sex hormones.	[Asada, Ken; Kurokawa, Junko; Furukawa, Tetsushi] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat Pharmacol, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU)	Furukawa, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat Pharmacol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	t_furukawa.bip@mri.tmd.ac.jp	Kurokawa, Junko/ABF-7557-2021; furukawa, tetsushi/ABD-3178-2020; Kurokawa, Junko/Q-6287-2017; Asada, Ken/AAP-6668-2020	Kurokawa, Junko/0000-0002-9098-0908; Kurokawa, Junko/0000-0002-9098-0908; Asada, Ken/0000-0003-0548-4449	Ministry of Education, Science, Culture, Sports and Technology of Japan [17081007, 18659066, 19689006]; Vehicle Racing Commemorative Foundation; Kanae Foundation for the promotion of medical science; Suzuken Memorial Foundation; Naito Foundation	Ministry of Education, Science, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Kanae Foundation for the promotion of medical science; Suzuken Memorial Foundation; Naito Foundation(Naito Memorial Foundation)	This work was supported by Grant-in-aid for Scientific Research on Priority Areas 17081007 (to T. F.); Grants 18659066 (to T. F.) and 19689006 (to J.K.) from the Ministry of Education, Science, Culture, Sports and Technology of Japan; a research grant (to T. F.) from The Vehicle Racing Commemorative Foundation; and research grants (to J.K.) from the Kanae Foundation for the promotion of medical science, Suzuken Memorial Foundation, and Naito Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bai CX, 2005, CIRCULATION, V112, P1701, DOI 10.1161/CIRCULATIONAHA.104.523217; Bai CX, 2005, CIRC RES, V96, P64, DOI 10.1161/01.RES.0000151846.19788.E0; Bai CX, 2004, BRIT J PHARMACOL, V142, P567, DOI 10.1038/sj.bjp.0705814; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Broillet MC, 2000, J BIOL CHEM, V275, P15135, DOI 10.1074/jbc.275.20.15135; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Clancy CE, 2003, ANNU REV PHARMACOL, V43, P441, DOI 10.1146/annurev.pharmtox.43.100901.140245; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dilly KW, 2004, J BIOL CHEM, V279, P40778, DOI 10.1074/jbc.M406010200; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hess DT, 2001, NAT CELL BIOL, V3, pE46, DOI 10.1038/35055152; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kurokawa J, 2008, J PHYSIOL-LONDON, V586, P2961, DOI 10.1113/jphysiol.2007.150367; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Nakamura H, 2007, CIRCULATION, V116, P2913, DOI 10.1161/CIRCULATIONAHA.107.702407; Nedospasov A, 2000, P NATL ACAD SCI USA, V97, P13543, DOI 10.1073/pnas.250398197; NITTA J, 1994, CIRC RES, V74, P96, DOI 10.1161/01.RES.74.1.96; Perez-Mato I, 1999, J BIOL CHEM, V274, P17075, DOI 10.1074/jbc.274.24.17075; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; TOHSE N, 1990, AM J PHYSIOL, V258, pH1200, DOI 10.1152/ajpheart.1990.258.4.H1200; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200	33	51	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					6014	6020		10.1074/jbc.M807158200	http://dx.doi.org/10.1074/jbc.M807158200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19124472	hybrid			2022-12-27	WOS:000263560600065
J	Wu, JJ; Weis, MA; Kim, LS; Carter, BG; Eyre, DR				Wu, Jiann-Jiu; Weis, Mary Ann; Kim, Lammy S.; Carter, Bryan G.; Eyre, David R.			Differences in Chain Usage and Cross-linking Specificities of Cartilage Type V/XI Collagen Isoforms with Age and Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IX COLLAGEN; XI COLLAGEN; EXTRACELLULAR-MATRIX; INTERVERTEBRAL DISC; II COLLAGEN; V COLLAGEN; IDENTIFICATION; FIBRILS; HETEROGENEITY; DOMAINS	Collagen type V/XI is a minor but essential component of collagen fibrils in vertebrates. We here report on age-and tissue-related variations in isoform usage in cartilages. With maturation of articular cartilage, the alpha 1(V) chain progressively replaced the alpha 2(XI) chain. A mix of the molecular isoforms, alpha 1(XI) alpha 1(V) alpha 3(XI) and alpha 1(XI) alpha 2(XI) alpha 3(XI), best explained this finding. A prominence of alpha 1(V) chains is therefore characteristic and a potential biomarker of mature mammalian articular cartilage. Analysis of cross-linked peptides showed that the alpha 1(V) chains were primarily cross-linked to alpha 1(XI) chains in the tissue and hence an integral component of the V/XI polymer. From nucleus pulposus of the intervertebral disc (in which the bulk collagen monomer is type II as in articular cartilage), type V/XI collagen consisted of a mix of five genetically distinct chains, alpha 1(XI), alpha 2(XI), alpha 3(XI), alpha 1(V), and alpha 2(V). These presumably were derived from several different molecular isoforms, including alpha 1(XI) alpha 2(XI) alpha 3(XI), (alpha 1(XI))(2) alpha 2(V), and others. Meniscal fibrocartilage shows yet another V/XI phenotype. The findings support and extend the concept that the clade B subfamily of COL5 and COL11 gene products should be considered members of the same collagen subfamily, from which, in combination with clade A gene products (COL2A1 or COL5A2), a range of molecular isoforms has evolved into tissue-dependent usage. We propose an evolving role for collagen V/XI isoforms as an adaptable polymeric template of fibril macro-architecture.	[Wu, Jiann-Jiu; Weis, Mary Ann; Kim, Lammy S.; Carter, Bryan G.; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wu, JJ (corresponding author), 1959 NE Pacific St,HSB BB1052, Seattle, WA 98195 USA.	wujj@u.washington.edu			National Institutes of Health [AR37318, AR36794]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037318, R37AR037318, R37AR036794, R01AR036794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR37318 and AR36794.	AYAD S, 1989, BIOCHEM J, V262, P753, DOI 10.1042/bj2620753; BISHOP PN, 1994, BIOCHEM J, V299, P497, DOI 10.1042/bj2990497; Boot-Handford RP, 2003, J BIOL CHEM, V278, P31067, DOI 10.1074/jbc.M212889200; BURGESON RE, 1979, BIOCHEM BIOPH RES CO, V87, P1124, DOI 10.1016/S0006-291X(79)80024-8; Eyre D, 1987, STRUCTURE FUNCTION C, P261; EYRE D R, 1990, P188; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; EYRE DR, 1987, FEBS LETT, V220, P337, DOI 10.1016/0014-5793(87)80842-6; Eyre DR, 2002, BIOCHEM SOC T, V30, P844; EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267; EYRE DR, 1983, FEBS LETT, V158, P265, DOI 10.1016/0014-5793(83)80592-4; Huxley-Jones J, 2007, MATRIX BIOL, V26, P2, DOI 10.1016/j.matbio.2006.09.008; Kinter M, 2000, PROTEIN SEQUENCING I, V1st, P152; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE JM, 1975, ARTHRITIS RHEUM-US, V18, P553, DOI 10.1002/art.1780180605; Malone JP, 2005, BIOCHEMISTRY-US, V44, P15269, DOI 10.1021/bi0508338; MAYNE R, 1993, J BIOL CHEM, V268, P9381; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MORRIS NP, 1987, J BIOL CHEM, V262, P11345; MULLERGLAUSER W, 1986, J CELL BIOL, V102, P1931, DOI 10.1083/jcb.102.5.1931; NIYIBIZI C, 1994, EUR J BIOCHEM, V224, P943, DOI 10.1111/j.1432-1033.1994.00943.x; NIYIBIZI C, 1989, FEBS LETT, V242, P314, DOI 10.1016/0014-5793(89)80492-2; Oegema TR, 2002, BIOCHEM SOC T, V30, P839, DOI 10.1042/bst0300839; Poole CA, 1997, OSTEOARTHR CARTILAGE, V5, P191, DOI 10.1016/S1063-4584(97)80014-3; SNOWDEN JM, 1980, INVEST OPHTH VIS SCI, V19, P610; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; WU JJ, 1995, J BIOL CHEM, V270, P18865, DOI 10.1074/jbc.270.32.18865; WU JJ, 1992, J BIOL CHEM, V267, P23007; Wu JJ, 2003, J BIOL CHEM, V278, P24521, DOI 10.1074/jbc.M302431200; WU JJ, 1984, BIOCHEM BIOPH RES CO, V123, P1033, DOI 10.1016/S0006-291X(84)80237-5	31	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5539	5545		10.1074/jbc.M806369200	http://dx.doi.org/10.1074/jbc.M806369200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19103590	Green Published, hybrid			2022-12-27	WOS:000263560600017
J	Fahling, M; Mrowka, R; Steege, A; Kirschner, KM; Benko, E; Forstera, B; Persson, PB; Thiele, BJ; Meier, JC; Scholz, H				Faehling, Michael; Mrowka, Ralf; Steege, Andreas; Kirschner, Karin M.; Benko, Edgar; Foerstera, Benjamin; Persson, Pontus B.; Thiele, Bernd J.; Meier, Jochen C.; Scholz, Holger			Translational Regulation of the Human Achaete-scute Homologue-1 by Fragile X Mental Retardation Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; HIPPOCAMPAL-NEURONS; CGG REPEAT; FMR1 GENE; CELL DIFFERENTIATION; BINDING PROTEIN; MASH1; BRAIN; EXPRESSION; POLYRIBOSOMES	Fragile X syndrome is a common inherited cause of mental retardation that results from loss or mutation of the fragile X mental retardation protein (FMRP). In this study, we identified the mRNA of the basic helix-loop-helix transcription factor human achaete-scute homologue-1 (hASH1 or ASCL1), which is required for normal development of the nervous system and has been implicated in the formation of neuroendocrine tumors, as a new FMRP target. Using a double-immunofluorescent staining technique we detected an overlapping pattern of both proteins in the hippocampus, temporal cortex, subventricular zone, and cerebellum of newborn rats. Forced expression of FMRP and gene silencing by small interference RNA transfection revealed a positive correlation between the cellular protein levels of FMRP and hASH1. A luciferase reporter construct containing the 5 '-untranslated region of hASH1 mRNA was activated by the full-length FMRP, but not by naturally occurring truncated FMR proteins, in transient co-transfections. The responsible cis-element was mapped by UV-cross-linking experiments and reporter mutagenesis assays to a (U) 10 sequence located in the 5 '-untranslated region of the hASH1 mRNA. Sucrose density gradient centrifugation revealed that hASH1 transcripts were translocated into a translationally active polysomal fraction upon transient transfection of HEK293 cells with FMRP, thus indicating translational activation of hASH1 mRNA. In conclusion, we identified hASH1 as a novel downstream target of FMRP. Improved translation efficiency of hASH1 mRNA by FMRP may represent an important regulatory switch in neuronal differentiation.	[Faehling, Michael; Mrowka, Ralf; Steege, Andreas; Kirschner, Karin M.; Benko, Edgar; Persson, Pontus B.; Thiele, Bernd J.; Scholz, Holger] Univ Med Berlin, Inst Vegetat Physiol, Charite, D-10117 Berlin, Germany; [Benko, Edgar] Tech Univ Berlin, Inst Biotechnol, D-13355 Berlin, Germany; [Foerstera, Benjamin; Meier, Jochen C.] Max Delbruck Ctr Mol Med, RNA Editing & Hyperexcitabil Disorders Helmholtz, D-13092 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Fahling, M (corresponding author), Univ Med Berlin, Inst Vegetat Physiol, Charite, Tucholskystr 2, D-10117 Berlin, Germany.	michael.faehling@charite.de	Fähling, Michael/E-5018-2011; Mrowka, Ralf/AAW-1480-2021; Steege, Andreas/F-3885-2010	Mrowka, Ralf/0000-0002-0991-3418; Meier, Jochen/0000-0001-5574-3336; Fahling, Michael/0000-0003-1079-5049; Kirschner, Karin/0000-0003-0226-8636; Persson, Pontus/0000-0003-0926-2878	Deutsche Forschungsgemeinschaft [FA845/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG, Grant FA845/2-1). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; BAKKER CE, 1994, CELL, V78, P23; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bittel DC, 2007, GENET MED, V9, P464, DOI 10.1097/GIM.0b013e3180ca9a9a; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Casarosa S, 1999, DEVELOPMENT, V126, P525; Castella P, 1999, J NEUROSCI RES, V56, P229, DOI 10.1002/(SICI)1097-4547(19990501)56:3<229::AID-JNR2>3.0.CO;2-Z; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; EICHLER EE, 1993, HUM MOL GENET, V2, P1147, DOI 10.1093/hmg/2.8.1147; Eichler SA, 2008, J CELL MOL MED, V12, P2848, DOI 10.1111/j.1582-4934.2008.00357.x; Fahling M, 2009, ACTA PHYSIOL, V195, P205, DOI 10.1111/j.1748-1716.2008.01894.x; Fahling M, 2006, J BIOL CHEM, V281, P26089, DOI 10.1074/jbc.M604939200; Fahling M, 2006, J BIOL CHEM, V281, P9279, DOI 10.1074/jbc.M510925200; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gabus C, 2004, NUCLEIC ACIDS RES, V32, P2129, DOI 10.1093/nar/gkh535; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; Grynfeld A, 2000, INT J CANCER, V88, P401, DOI 10.1002/1097-0215(20001101)88:3<401::AID-IJC12>3.3.CO;2-M; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HIRST M, 1995, AM J HUM GENET, V56, P67; Horton S, 1999, MOL CELL NEUROSCI, V14, P355, DOI 10.1006/mcne.1999.0791; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Jo AY, 2007, EXP CELL RES, V313, P4066, DOI 10.1016/j.yexcr.2007.08.026; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; Kokubu H, 2008, GENES CELLS, V13, P41, DOI 10.1111/j.1365-2443.2007.01146.x; Koukoui SD, 2007, BRAIN RES REV, V53, P27, DOI 10.1016/j.brainresrev.2006.06.001; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Lim JH, 2005, J CELL PHYSIOL, V205, P170, DOI 10.1002/jcp.20401; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; MEIJER H, 1994, HUM MOL GENET, V3, P615; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Mrowka R, 2007, NUCLEIC ACIDS RES, V35, P5120, DOI 10.1093/nar/gkm535; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; Sugimori M, 2008, DEVELOPMENT, V135, P1271, DOI 10.1242/dev.015370; Sung YJ, 2000, BIOCHEM BIOPH RES CO, V275, P973, DOI 10.1006/bbrc.2000.3405; Torii MA, 1999, DEVELOPMENT, V126, P443; Ufer C, 2008, GENE DEV, V22, P1838, DOI 10.1101/gad.466308; VERKERK AJMH, 1993, HUM MOL GENET, V2, P399, DOI 10.1093/hmg/2.4.399; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wagner N, 2005, DEVELOPMENT, V132, P1327, DOI 10.1242/dev.01682; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Willemsen R, 2004, MENT RETARD DEV D R, V10, P60, DOI 10.1002/mrdd.20010; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Zhong N, 1999, AM J MED GENET, V84, P268, DOI 10.1002/(SICI)1096-8628(19990528)84:3<268::AID-AJMG20>3.0.CO;2-#	70	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4255	4266		10.1074/jbc.M807354200	http://dx.doi.org/10.1074/jbc.M807354200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19097999	hybrid			2022-12-27	WOS:000263134400023
J	Jeong, YI; Kim, SW; Jung, ID; Lee, JS; Chang, JH; Lee, CM; Chun, SH; Yoon, MS; Kim, GT; Ryu, SW; Kim, JS; Shin, YK; Lee, WS; Shin, HK; Lee, JD; Park, YM				Jeong, Young-Il; Kim, Sang Woo; Jung, In Duk; Lee, Jun Sik; Chang, Jeong Hyun; Lee, Chang-Min; Chun, Sung Hak; Yoon, Man-Soo; Kim, Geun Tae; Ryu, Seok Woo; Kim, Jong-Suk; Shin, Yong Kyoo; Lee, Won Suk; Shin, Hwa Kyoung; Lee, Jae-Dong; Park, Yeong-Min			Curcumin Suppresses the Induction of Indoleamine 2,3-Dioxygenase by Blocking the Janus-activated Kinase-Protein Kinase C delta-STAT1 Signaling Pathway in Interferon-gamma-stimulated Murine Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRYPTOPHAN CATABOLISM; IN-VIVO; SERINE PHOSPHORYLATION; POTENTIAL TARGETS; GENE PROMOTER; COLON-CANCER; EXPRESSION; TOLERANCE; IDO	Indoleamine 2,3-dioxygenase (IDO) catalyzes the initial and rate-limiting step in the degradation of tryptophan and is strongly induced in interferon-gamma (IFN gamma)-stimulated dendritic cells (DCs). IDO has recently been established as a key enzyme in T-cell suppression-mediated immune tolerance to tumors. STAT1 phosphorylation appears to play an important role in the control of IDO expression by IFN gamma, but the precise regulatory mechanism remains obscure. Here we present a novel mechanism of IFN gamma-induced IDO expression in bone marrow-derived dendritic cells. In addition, we demonstrate that curcumin, an active component of turmeric, significantly inhibited the induction of IDO expression and activity by IFN gamma. We found that curcumin suppressed STAT1 activation by directly inhibiting Janus-activated kinase 1/2 and protein kinase C delta phosphorylation in bone marrow-derived DCs, suppressing the subsequent translocation and binding of STAT1 to the GAS element of the IRF-1 promoter. Coincident with these inhibitory effects on IFN gamma-induced IDO expression, curcumin reversed IDO-mediated suppression of T-cell responses. Our results, thus, suggest that down-regulation of IDO in DCs is an important immunomodulatory property of curcumin that may be exploited therapeutically in the control of cancers.	[Jung, In Duk; Lee, Jun Sik; Lee, Chang-Min; Chun, Sung Hak; Park, Yeong-Min] Pusan Natl Univ, Dept Microbiol & Immunol, Pusan 602739, South Korea; [Jeong, Young-Il; Lee, Jae-Dong] Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, Pusan 609735, South Korea; [Kim, Sang Woo; Yoon, Man-Soo] Pusan Natl Univ, Dept Obstet & Gynecol, Pusan 602739, South Korea; [Jung, In Duk; Lee, Jun Sik; Lee, Chang-Min; Chun, Sung Hak; Park, Yeong-Min] Pusan Natl Univ, Natl Res Lab Dendrit Cell Differentiat & Regulat, Med Res Inst, Pusan 602739, South Korea; [Lee, Won Suk; Shin, Hwa Kyoung] Pusan Natl Univ, Dept Pharmacol, Coll Med, Pusan 602739, South Korea; [Chang, Jeong Hyun] Daegu Haany Univ, Coll Hlth & Therapy, Dept Clin Lab Sci, Gyeongsangbuk Do 712715, Gyeongsan, South Korea; [Kim, Geun Tae] Busan Med Ctr, Dept Internal Med, Pusan 611072, South Korea; [Ryu, Seok Woo] Busan Med Ctr, Dept Family Med, Pusan 611072, South Korea; [Kim, Jong-Suk] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561180, South Korea; [Shin, Yong Kyoo] Chung Ang Univ, Coll Med, Dept Pharmacol, Seoul 156756, South Korea	Pusan National University; Pusan National University; Pusan National University; Pusan National University; Pusan National University; Daegu Haany University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Jeonbuk National University; Chung Ang University; Chung Ang University Hospital	Park, YM (corresponding author), Pusan Natl Univ, Dept Microbiol & Immunol, Ami Dong 1-10, Pusan 602739, South Korea.	immunpym@pusan.ac.kr			Korea Science and Engineering Foundation [R0A-2005-000-10008-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by the Korea Science and Engineering Foundation through National Research Laboratory Program Grant R0A-2005-000-10008-0. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aggarwal BB, 2005, CLIN CANCER RES, V11, P7490, DOI 10.1158/1078-0432.CCR-05-1192; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; BURKE F, 1995, INT J CANCER, V60, P115, DOI 10.1002/ijc.2910600117; Chon SY, 1996, J BIOL CHEM, V271, P17247, DOI 10.1074/jbc.271.29.17247; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Granucci F, 2003, EMBO J, V22, P2546, DOI 10.1093/emboj/cdg261; Grohmann U, 2000, J IMMUNOL, V165, P1357, DOI 10.4049/jimmunol.165.3.1357; Grohmann U, 2001, J IMMUNOL, V167, P708, DOI 10.4049/jimmunol.167.2.708; Grohmann U, 2001, J IMMUNOL, V166, P277, DOI 10.4049/jimmunol.166.1.277; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ireson C, 2001, CANCER RES, V61, P1058; Jeong YI, 2007, BIOCHEM BIOPH RES CO, V354, P1004, DOI 10.1016/j.bbrc.2007.01.076; Johnson JJ, 2007, CANCER LETT, V255, P170, DOI 10.1016/j.canlet.2007.03.005; Jung ID, 2007, FEBS LETT, V581, P1449, DOI 10.1016/j.febslet.2007.02.073; Kawamori T, 1999, CANCER RES, V59, P597; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Kim SI, 2007, INT IMMUNOPHARMACOL, V7, P805, DOI 10.1016/j.intimp.2007.01.020; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lee HJ, 2007, BIOCHEM PHARMACOL, V73, P1412, DOI 10.1016/j.bcp.2006.12.018; LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; Matthews SA, 2006, CURR OPIN IMMUNOL, V18, P314, DOI 10.1016/j.coi.2006.03.006; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; Mellor AL, 2004, INT IMMUNOL, V16, P1391, DOI 10.1093/intimm/dxh140; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077; Ozawa H, 1996, EUR J IMMUNOL, V26, P648, DOI 10.1002/eji.1830260321; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J; Stan SD, 2008, J CELL BIOCHEM, V104, P339, DOI 10.1002/jcb.21623; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tas SW, 2007, BLOOD, V110, P1540, DOI 10.1182/blood-2006-11-056010; Thomas SR, 2001, J IMMUNOL, V166, P6332, DOI 10.4049/jimmunol.166.10.6332; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Williams CA, 2008, IMMUNOLOGY, V124, P89, DOI 10.1111/j.1365-2567.2007.02743.x; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	50	86	91	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3700	3708		10.1074/jbc.M807328200	http://dx.doi.org/10.1074/jbc.M807328200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19075017	hybrid			2022-12-27	WOS:000262872500038
J	Beckwith, J				Beckwith, Jon			Genetic Suppressors and Recovery of Repressed Biochemical Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DISULFIDE BOND FORMATION; SIGNAL-SEQUENCE MUTATIONS; ESCHERICHIA-COLI; BIOLOGICAL CHLORINATION; DNA-REPLICATION; PROTEIN; MEMBRANE; GLUTAREDOXINS; BIOSYNTHESIS; THIOREDOXIN		Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Beckwith, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	jbeckwith@hms.harvard.edu						BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; BASSFORD PJ, 1979, J BACTERIOL, V139, P19, DOI 10.1128/JB.139.1.19-31.1979; BECKWITH J, 1963, BIOCHIM BIOPHYS ACTA, V76, P162; BECKWITH J, 1972, J MOL BIOL, V69, P155, DOI 10.1016/0022-2836(72)90031-9; BECKWITH JR, 1963, J BIOL CHEM, V238, P3091; BECKWITH JR, 1963, J BIOL CHEM, V238, P3086; BECKWITH JR, 1961, J ORG CHEM, V26, P5206, DOI 10.1021/jo01070a515; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; BRENNER S, 1965, J MOL BIOL, V13, P629, DOI 10.1016/S0022-2836(65)80131-0; BRENNER S, 1965, NATURE, V206, P994, DOI 10.1038/206994a0; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; COCKS GT, 1974, J BACTERIOL, V118, P83, DOI 10.1128/JB.118.1.83-88.1974; CUNNINGHAM K, 1989, EMBO J, V8, P955, DOI 10.1002/j.1460-2075.1989.tb03457.x; DERMAN AI, 1991, J BACTERIOL, V173, P7719, DOI 10.1128/jb.173.23.7719-7722.1991; DERMAN AI, 1993, SCIENCE, V262, P1744, DOI 10.1126/science.8259521; EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5; Faulkner MJ, 2008, P NATL ACAD SCI USA, V105, P6735, DOI 10.1073/pnas.0801986105; FERRONOVICK S, 1984, CELL, V38, P211, DOI 10.1016/0092-8674(84)90542-7; Fomenko DE, 2003, BIOCHEMISTRY-US, V42, P11214, DOI 10.1021/bi034459s; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; GARDEL C, 1990, EMBO J, V9, P3209, DOI 10.1002/j.1460-2075.1990.tb07519.x; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; HAGER LP, 1953, J AM CHEM SOC, V75, P5767, DOI 10.1021/ja01118a533; JACOB F, 1960, CR HEBD ACAD SCI, V250, P1727; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; KUMAMOTO CA, 1983, J BACTERIOL, V154, P253, DOI 10.1128/JB.154.1.253-260.1983; LEE CA, 1986, J BACTERIOL, V166, P878, DOI 10.1128/jb.166.3.878-883.1986; MICHAELIS S, 1986, J BACTERIOL, V167, P160, DOI 10.1128/jb.167.1.160-167.1986; Ortenberg R, 2004, P NATL ACAD SCI USA, V101, P7439, DOI 10.1073/pnas.0401965101; PARDEE AB, 1959, J MOL BIOL, V1, P165, DOI 10.1016/S0022-2836(59)80045-0; PARDEE AB, 1962, BIOCHIM BIOPHYS ACTA, V60, P452, DOI 10.1016/0006-3002(62)90435-3; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Porras P, 2002, BIOCHEM BIOPH RES CO, V295, P1046, DOI 10.1016/S0006-291X(02)00771-4; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; RICHARDSON JP, 1975, P NATL ACAD SCI USA, V72, P1725, DOI 10.1073/pnas.72.5.1725; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; RIGGS PD, 1988, GENETICS, V118, P571; Ritz D, 2001, SCIENCE, V294, P158, DOI 10.1126/science.1063143; SCAIFE J, 1966, COLD SPRING HARB SYM, V31, P403, DOI 10.1101/SQB.1966.031.01.052; SHAW PD, 1959, J BIOL CHEM, V234, P2565; SILHAVY TJ, 1977, P NATL ACAD SCI USA, V74, P5411, DOI 10.1073/pnas.74.12.5411; STADER J, 1989, GENE DEV, V3, P1045, DOI 10.1101/gad.3.7.1045; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Tian HP, 2000, P NATL ACAD SCI USA, V97, P4730, DOI 10.1073/pnas.090087297; Yamamoto Y, 2008, MOL CELL, V29, P36, DOI 10.1016/j.molcel.2007.11.029	48	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12585	12592		10.1074/jbc.X800017200	http://dx.doi.org/10.1074/jbc.X800017200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19129182	hybrid, Green Published			2022-12-27	WOS:000265688300001
J	Zhang, G; Chen, S; Goldoni, S; Calder, BW; Simpson, HC; Owens, RT; McQuillan, DJ; Young, MF; Iozzo, RV; Birk, DE				Zhang, Guiyun; Chen, Shoujun; Goldoni, Silvia; Calder, Bennett W.; Simpson, Holly C.; Owens, Rick T.; McQuillan, David J.; Young, Marian F.; Iozzo, Renato V.; Birk, David E.			Genetic Evidence for the Coordinated Regulation of Collagen Fibrillogenesis in the Cornea by Decorin and Biglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; LEUCINE-RICH PROTEOGLYCANS; DEFICIENT MICE; FIBRIL SEGMENTS; LUMICAN-DEFICIENT; IN-SITU; EXTRACELLULAR COMPARTMENTS; TARGETED DISRUPTION; SKIN FRAGILITY; LATERAL GROWTH	Decorin and biglycan are class I small leucine-rich proteoglycans (SLRPs) involved in regulation of collagen fibril and matrix assembly. We hypothesize that tissue-specific matrix assembly, such as in the cornea, requires a coordinate regulation involving multiple SLRPs. To this end, we investigated the expression of decorin and biglycan in the cornea of mice deficient in either SLRP gene and in double-mutant mice. Decorin and biglycan exhibited overlapping spatial expression patterns throughout the corneal stroma with differential temporal expression. Whereas decorin was expressed at relatively high levels in all developmental stages, biglycan expression was high early, decreased during development, and was present at very low levels in the mature cornea. Ultrastructural analyses demonstrated comparable fibril structure in the decorin-and biglycan-null corneas compared with wild-type controls. We found a compensatory up-regulation of biglycan gene expression in the decorin-deficient mice, but not the reverse. Notably, the corneas of compound decorin/biglycan-null mice showed severe disruption in fibril structure and organization, especially affecting the posterior corneal regions, corroborating the idea that biglycan compensates for the loss of decorin. Fibrillogenesis assays using recombinant decorin and biglycan confirmed a functional compensation, with both having similar effects at high SLRP/collagen ratios. However, at low ratios decorin was a more efficient regulator. The use of proteoglycan or protein core yielded comparable results. These findings provide firm genetic evidence for an interaction of decorin and biglycan during corneal development and further suggest that decorin has a primary role in regulating fibril assembly, a function that can be fine-tuned by biglycan during early development.	[Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Owens, Rick T.; McQuillan, David J.] LifeCell Corp, Branchburg, NJ 08876 USA; [Young, Marian F.] NIDCR, NIH, Bethesda, MD 20892 USA; [Chen, Shoujun; Birk, David E.] Univ S Florida, Dept Pathol & Cell Biol, Coll Med, Tampa, FL 33612 USA	Jefferson University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); State University System of Florida; University of South Florida	Birk, DE (corresponding author), 12901 Bruce B Downs Blvd,MDC11, Tampa, FL 33612 USA.	dbirk@health.usf.edu	Birk, David/I-4072-2012; Iozzo, Renato/AAS-1980-2020	Birk, David/0000-0002-4865-9088; Iozzo, Renato/0000-0002-5908-5112; Young, Marian F/0000-0003-0929-8854	National Institutes of Health NEI [EY005129]; Intramural Research Program, NIDCR; NATIONAL CANCER INSTITUTE [R01CA039481] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000379] Funding Source: NIH RePORTER	National Institutes of Health NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural Research Program, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health NEI Grant EY005129 (to D.E.B.) and support from the Intramural Research Program, NIDCR (to M.F.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Birk DE, 2005, TOP CURR CHEM, V247, P185, DOI 10.1007/b103823; BIRK DE, 1984, ARCH BIOCHEM BIOPHYS, V235, P178, DOI 10.1016/0003-9861(84)90266-2; BIRK DE, 1995, DEV DYNAM, V202, P229, DOI 10.1002/aja.1002020303; BIRK DE, 1994, J ANAT, V184, P457; Birk DE, 1997, DEV DYNAM, V208, P291; Birk DE, 1996, MATRIX BIOL, V15, P111, DOI 10.1016/S0945-053X(96)90152-3; BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024; BIRK DE, 1989, P NATL ACAD SCI USA, V86, P4549, DOI 10.1073/pnas.86.12.4549; BIRK DE, 1990, ANN NY ACAD SCI, V580, P176, DOI 10.1111/j.1749-6632.1990.tb17928.x; Birk DE., 1991, MATRIX ASSEMBLY, P221; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P20613; Bredrup C, 2005, INVEST OPHTH VIS SCI, V46, P420, DOI 10.1167/iovs.04-0804; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Carlson EC, 2003, BIOCHEM J, V369, P461, DOI 10.1042/BJ20020593; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chakravarti S, 2006, DEV DYNAM, V235, P2493, DOI 10.1002/dvdy.20868; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dunlevy JR, 2000, EXP EYE RES, V70, P349, DOI 10.1006/exer.1999.0789; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; Quantock AJ, 2001, INVEST OPHTH VIS SCI, V42, P1750; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Rodahl E, 2006, AM J OPHTHALMOL, V142, P520, DOI 10.1016/j.ajo.2006.03.064; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776; SCHONHERR E, 1995, J BIOL CHEM, V270, P8877, DOI 10.1074/jbc.270.15.8877; Schonherr E, 2004, J VASC RES, V41, P499, DOI 10.1159/000081806; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Tasheva ES, 2002, MOL VIS, V8, P407; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Zhang CM, 2005, CHINESE J ASTRON AST, V5, P21, DOI 10.1088/1009-9271/5/S1/21; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	48	157	162	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8888	8897		10.1074/jbc.M806590200	http://dx.doi.org/10.1074/jbc.M806590200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19136671	Green Published, hybrid			2022-12-27	WOS:000264397800071
J	Balcazar, N; Sathyamurthy, A; Elghazi, L; Gould, A; Weiss, A; Shiojima, I; Walsh, K; Bernal-Mizrachi, E				Balcazar, Norman; Sathyamurthy, Aruna; Elghazi, Lynda; Gould, Aaron; Weiss, Aaron; Shiojima, Ichiro; Walsh, Kenneth; Bernal-Mizrachi, Ernesto			mTORC1 Activation Regulates beta-Cell Mass and Proliferation by Modulation of Cyclin D2 Synthesis and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX-2; DEPENDENT KINASE-4; DIRECT TARGET; GROWTH; AKT; PHOSPHORYLATION; DEGRADATION; TSC2; D1; DISRUPTION	Growth factors, insulin signaling, and nutrients are important regulators of beta-cell mass and function. The events linking these signals to the regulation of beta-cell mass are not completely understood. The mTOR pathway integrates signals from growth factors and nutrients. Here, we evaluated the role of the mTOR/raptor (mTORC1) signaling in proliferative conditions induced by controlled activation of Akt signaling. These experiments show that the mTORC1 is a major regulator of beta-cell cycle progression by modulation of cyclin D2, D3, and Cdk4 activity. The regulation of cell cycle progression by mTORC1 signaling resulted from modulation of the synthesis and stability of cyclin D2, a critical regulator of beta-cell cycle, proliferation, and mass. These studies provide novel insights into the regulation of cell cycle by the mTORC1, provide a mechanism for the antiproliferative effects of rapamycin, and imply that the use of rapamycin could negatively impact the success of islet transplantation and the adaptation of beta-cells to insulin resistance.	[Balcazar, Norman; Sathyamurthy, Aruna; Elghazi, Lynda; Gould, Aaron; Weiss, Aaron; Bernal-Mizrachi, Ernesto] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Shiojima, Ichiro; Walsh, Kenneth] Boston Univ, Sch Med, Mol Cardiol Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Washington University (WUSTL); Boston University	Bernal-Mizrachi, E (corresponding author), Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, 660 S Euclid Ave,Campus Box 8127, St Louis, MO 63110 USA.	ebernal@wustl.edu		Elghazi, Lynda/0000-0003-1755-9217	National Institutes of Health [R01DK073716-01]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK073716-01 (to E.B.-M.). This work was also supported by a Career Development Award from the American Diabetes Association (to E.B.-M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bernal-Mizrachi E, 2000, J BIOL CHEM, V275, P25681, DOI 10.1074/jbc.M003424200; Bonner-Weir S, 2000, J MOL ENDOCRINOL, V24, P297, DOI 10.1677/jme.0.0240297; Casanovas O, 2004, ONCOGENE, V23, P7537, DOI 10.1038/sj.onc.1208040; Cozar-Castellano I, 2004, DIABETES, V53, P149, DOI 10.2337/diabetes.53.1.149; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Girish V, 2004, Indian J Cancer, V41, P47; HARRIS TE, 2003, SCI STKE, V212, P1; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Kwon G, 2006, J BIOL CHEM, V281, P3261, DOI 10.1074/jbc.M508821200; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Milo-Landesman D, 2001, CELL TRANSPLANT, V10, P645; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Naderi S, 2004, J CELL SCI, V117, P3769, DOI 10.1242/jcs.01210; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Rachdi L, 2008, P NATL ACAD SCI USA, V105, P9250, DOI 10.1073/pnas.0803047105; Rane SG, 2000, FRONT BIOSCI, V5, pD1, DOI 10.2741/Rane; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zhang N, 2006, DIABETES, V55, P2429, DOI 10.2337/db06-0173; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	44	86	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7832	7842		10.1074/jbc.M807458200	http://dx.doi.org/10.1074/jbc.M807458200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144649	Green Published, hybrid			2022-12-27	WOS:000264195600045
J	Beazely, MA; Lim, AN; Li, HB; Trepanier, C; Chen, XM; Sidhu, B; MacDonald, JF				Beazely, Michael A.; Lim, Aeni; Li, Hongbin; Trepanier, Catherine; Chen, XuanMao; Sidhu, Bikram; MacDonald, John F.			Platelet-derived Growth Factor Selectively Inhibits NR2B-containing N-Methyl-D-aspartate Receptors in CA1 Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRASYNAPTIC NMDA RECEPTORS; MEDIATED SYNAPTIC-TRANSMISSION; FACTOR-B-CHAIN; SUBUNIT COMPOSITION; DIFFERENTIAL ROLES; KAINATE RECEPTORS; AMPA RECEPTORS; PROTEIN-KINASE; CREB SHUTOFF; CELL-DEATH	Platelet-derived growth factor (PDGF) beta receptor activation inhibits N-methyl-D-aspartate (NMDA)-evoked currents in hippocampal and cortical neurons via the activation of phospholipase C gamma, PKC, the release of intracellular calcium, and a rearrangement of the actin cytoskeleton. In the hippocampus, the majority of NMDA receptors are heteromeric; most are composed of 2 NR1 subunits and 2 NR2A or 2 NR2B subunits. Using NR2B- and NR2A-specific antagonists, we demonstrate that PDGF-BB treatment preferentially inhibits NR2B-containing NMDA receptor currents in CA1 hippocampal neurons and enhances long-term depression in an NR2B subunit-dependent manner. Furthermore, treatment of hippocampal slices or cultures with PDGF-BB decreases the surface localization of NR2B but not of NR2A subunits. PDGF beta receptors colocalize to a higher degree with NR2B subunits than with NR2A subunits. After neuronal injury, PDGF beta receptors and PDGF-BB are upregulated and PDGF beta receptor activation is neuroprotective against glutamate-induced neuronal damage in cultured neurons. We demonstrate that the neuroprotective effects of PDGF-BB are occluded by the NR2B antagonist, Ro25-6981, and that PDGF-BB promotes NMDA signaling to CREB and ERK1/2. We conclude that PDGF beta R signaling, by preferentially targeting NR2B receptors, provides an important mechanism for neuroprotection by growth factors in the central nervous system.	[Beazely, Michael A.; Lim, Aeni; Li, Hongbin; Chen, XuanMao; Sidhu, Bikram; MacDonald, John F.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Trepanier, Catherine; MacDonald, John F.] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	MacDonald, JF (corresponding author), Univ Toronto, Dept Physiol, Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	j.macdonald@utoronto.ca	chen, xuanmao/I-7576-2013; Sidhu, Bikrampal/ABB-1367-2020	Beazely, Michael/0000-0002-8722-460X; Chen, Xuanmao/0000-0002-0057-8510	Canadian Institutes of Health Research [15514]; postdoctoral award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); postdoctoral award	This work was supported by Canadian Institutes of Health Research Grant 15514 (to J. F. M.) and a postdoctoral award (to M. A. B.).	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Arancio O, 2007, CURR OPIN NEUROBIOL, V17, P325, DOI 10.1016/j.conb.2007.03.013; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; Beazely MA, 2006, J NEUROCHEM, V98, P1657, DOI 10.1111/j.1471-4159.2006.04064.x; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Carrier RL, 2006, J NEUROSCI METH, V154, P239, DOI 10.1016/j.jneumeth.2005.12.030; Chen WS, 2007, NEUROPHARMACOLOGY, V52, P200, DOI 10.1016/j.neuropharm.2006.07.003; Egawa-Tsuzuki T, 2004, EXP NEUROL, V186, P89, DOI 10.1016/j.expneurol.2003.11.001; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Groc L, 2007, J NEUROSCI, V27, P10165, DOI 10.1523/JNEUROSCI.1772-07.2007; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Hardingham GE, 2006, BIOCHEM SOC T, V34, P936, DOI 10.1042/BST0340936; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Hendricson AW, 2002, J PHARMACOL EXP THER, V301, P938, DOI 10.1124/jpet.301.3.938; IIHARA K, 1994, J CEREBR BLOOD F MET, V14, P818, DOI 10.1038/jcbfm.1994.102; Ishii Y, 2006, J NEUROCHEM, V98, P588, DOI 10.1111/j.1471-4159.2006.03922.x; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Jackson MF, 2003, MOL PHARMACOL, V64, P395, DOI 10.1124/mol.64.2.395; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Kotecha SA, 2002, NEURON, V35, P1111, DOI 10.1016/S0896-6273(02)00859-0; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lei SB, 1999, J BIOL CHEM, V274, P30617, DOI 10.1074/jbc.274.43.30617; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MANDERS EMM, 1992, J CELL SCI, V103, P857; Marini AM, 2007, AMINO ACIDS, V32, P299, DOI 10.1007/s00726-006-0414-y; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Ohi Y, 2007, BRAIN RES, V1159, P77, DOI 10.1016/j.brainres.2007.05.037; Ohno M, 1999, NEUROSCIENCE, V90, P643, DOI 10.1016/S0306-4522(98)00593-4; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Philpot BD, 2003, J NEUROSCI, V23, P5583; Pokorska A, 2003, J NEUROCHEM, V84, P447, DOI 10.1046/j.1471-4159.2003.01504.x; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; Tovar KR, 2002, NEURON, V34, P253; Tseng HC, 2005, NEUROBIOL DIS, V19, P77, DOI 10.1016/j.nbd.2004.11.007; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Valenzuela CF, 1997, BRAIN RES REV, V24, P77; Valenzuela CF, 1996, J BIOL CHEM, V271, P16151, DOI 10.1074/jbc.271.27.16151; Vanhoutte P, 2003, CURR OPIN NEUROBIOL, V13, P366, DOI 10.1016/S0959-4388(03)00073-4; von Engelhardt J, 2007, NEUROPHARMACOLOGY, V53, P10, DOI 10.1016/j.neuropharm.2007.04.015; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WANG LY, 1994, J PHYSIOL-LONDON, V475, P431, DOI 10.1113/jphysiol.1994.sp020083; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Xu F, 2006, BRAIN RES, V1121, P22, DOI 10.1016/j.brainres.2006.08.129; YEH HJ, 1993, P NATL ACAD SCI USA, V90, P1952, DOI 10.1073/pnas.90.5.1952; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008; Zhou MJ, 1997, ANAL BIOCHEM, V253, P169, DOI 10.1006/abio.1997.2392; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	66	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8054	8063		10.1074/jbc.M805384200	http://dx.doi.org/10.1074/jbc.M805384200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19106110	hybrid, Green Published			2022-12-27	WOS:000264195600068
J	Leonhardt, K; Gebhardt, R; Mossner, J; Lutsenko, S; Huster, D				Leonhardt, Karoline; Gebhardt, Rolf; Moessner, Joachim; Lutsenko, Svetlana; Huster, Dominik			Functional Interactions of Cu-ATPase ATP7B with Cisplatin and the Role of ATP7B in the Resistance of Cells to the Drug	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-TRIPHOSPHATASE ATP7B; WILSONS-DISEASE PROTEIN; COPPER TRANSPORTERS; HEPATOCELLULAR-CARCINOMA; CELLULAR PHARMACOLOGY; BINDING SITES; EFFLUX; TRAFFICKING; EXPRESSION; PLATINUM	Cisplatin is a widely used chemotherapeutic agent for treatment of ovarian, testicular, lung, and stomach cancers. The initial response to the drug is robust; however, tumor cells commonly develop resistance to cisplatin, which complicates treatment. Recently, overexpression of the Cu-ATPase ATP7B in ovary cells was linked to the increased cellular resistance to cisplatin; and the role for Cu-ATPases in the export of cisplatin from cells was proposed. Our results support functional interactions between cisplatin and ATP7B but argue against the active transport through the copper translocation pathway as a mechanism of drug resistance. In hepatocytes, we observed no correlation between the levels of endogenous ATP7B and the resistance of cells to cisplatin. Unlike copper, cisplatin does not induce trafficking of ATP7B in hepatoma cells, neither does it compete with copper in a transport assay. However, cisplatin binds to ATP7B and stimulates catalytic phosphorylation with EC50 similar to that of copper. Mutations of the first five N-terminal copper-binding sites of ATP7B do not inhibit the cisplatin-induced phosphorylation of ATP7B. In contrast, the deletion of the first four copper-binding sites abolishes the effect of cisplatin on the ATP7B activity. Thus, cisplatin binding to ATP7B and/or general changes in cellular copper homeostasis are likely contributors to the increased resistance to the drug. The link between changes in copper homeostasis and cisplatin resistance was confirmed by treating the Huh7 cells with copper chelator and increasing their resistance to cisplatin.	[Lutsenko, Svetlana] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Leonhardt, Karoline; Moessner, Joachim; Huster, Dominik] Univ Leipzig, Dept Med 2, D-04103 Leipzig, Germany; [Gebhardt, Rolf] Univ Leipzig, Dept Biochem, D-04103 Leipzig, Germany; [Huster, Dominik] Otto VonGuericke Univ Magdegurg, Dept Gastroenterol Hepatol & Infect Dis, D-39120 Magdeburg, Germany	Oregon Health & Science University; Leipzig University; Leipzig University; Otto von Guericke University	Lutsenko, S (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	lutsenko@ohsu.edu; dominik.huster@med.ovgu.de			National Institutes of Health [R01 DK071865]; German Research Foundation [HU 932/3-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK071865 (to S. L.). This work was also supported by German Research Foundation Grant HU 932/3-1 (to D. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama S, 1999, ANTI-CANCER DRUG DES, V14, P143; ANDREWS PA, 1990, CANCER COMMUN-US, V2, P93, DOI 10.3727/095535490820874641; Barocas DA, 2008, CURR OPIN ONCOL, V20, P307, DOI 10.1097/CCO.0b013e3282f8b03e; Bartee MY, 2007, BIOMETALS, V20, P627, DOI 10.1007/s10534-006-9074-3; BIER H, 1988, ARCH OTO-RHINO-LARYN, V245, P166, DOI 10.1007/BF00464020; Brozovic A, 2004, INT J CANCER, V112, P974, DOI 10.1002/ijc.20522; Buiakova OI, 1999, HUM MOL GENET, V8, P1665, DOI 10.1093/hmg/8.9.1665; Cater MA, 2006, GASTROENTEROLOGY, V130, P493, DOI 10.1053/j.gastro.2005.10.054; Cater MA, 2007, BIOCHEM J, V401, P143, DOI 10.1042/BJ20061055; DiDonato M, 1997, J BIOL CHEM, V272, P33279, DOI 10.1074/jbc.272.52.33279; Dolgova NV, 2009, BIOCHEM J, V419, P51, DOI 10.1042/BJ20081359; Ferraldeschi R, 2007, DRUGS, V67, P2135, DOI 10.2165/00003495-200767150-00003; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; Forbes JR, 2000, HUM MOL GENET, V9, P1927, DOI 10.1093/hmg/9.13.1927; GEBHARDT R, 1982, EUR J CELL BIOL, V29, P68; GMAJ P, 1983, EUR J BIOCHEM, V136, P71, DOI 10.1111/j.1432-1033.1983.tb07706.x; HAMILTON TC, 1985, BIOCHEM PHARMACOL, V34, P2583, DOI 10.1016/0006-2952(85)90551-9; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; Hatori Y, 2007, J BIOL CHEM, V282, P25213, DOI 10.1074/jbc.M703520200; Higashimoto M, 2003, INT J MOL MED, V11, P337; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Jordan P, 2000, CELL MOL LIFE SCI, V57, P1229, DOI 10.1007/PL00000762; Kanzaki A, 2002, JPN J CANCER RES, V93, P70, DOI 10.1111/j.1349-7006.2002.tb01202.x; Katano K, 2004, CLIN CANCER RES, V10, P4578, DOI 10.1158/1078-0432.CCR-03-0689; Katano K, 2002, CANCER RES, V62, P6559; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Komatsu M, 2000, CANCER RES, V60, P1312; Kruger N J, 1994, Methods Mol Biol, V32, P9; Kuo MT, 2007, CANCER METAST REV, V26, P71, DOI 10.1007/s10555-007-9045-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mathurin P, 1998, ALIMENT PHARM THERAP, V12, P111; Moehler M, 2007, BEST PRACT RES CL GA, V21, P965, DOI 10.1016/j.bpg.2007.10.003; Mukai M, 2002, ONCOL REP, V9, P839; Ohbu M, 2003, CANCER LETT, V189, P33, DOI 10.1016/S0304-3835(02)00462-7; Petris MJ, 2002, J BIOL CHEM, V277, P46736, DOI 10.1074/jbc.M208864200; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Safaei R, 2006, CANCER LETT, V234, P34, DOI 10.1016/j.canlet.2005.07.046; Safaei R, 2004, CANCER CHEMOTH PHARM, V53, P239, DOI 10.1007/s00280-003-0736-3; Safaei R, 2005, CRIT REV ONCOL HEMAT, V53, P13, DOI 10.1016/j.critrevonc.2004.09.007; Safaei R, 2008, MOL PHARMACOL, V73, P461, DOI 10.1124/mol.107.040980; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Uthus EO, 2007, J NUTR, V137, P1370, DOI 10.1093/jn/137.6.1370; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Wakamatsu T, 2007, INT J ONCOL, V31, P1465; Wong E, 1999, CHEM REV, V99, P2451, DOI 10.1021/cr980420v; Yoshizawa K, 2007, ONCOL REP, V18, P987; Yuan JN, 2008, MED ONCOL, V25, P201, DOI 10.1007/s12032-007-9013-3; ZELAZOWSKI AJ, 1984, ARCH BIOCHEM BIOPHYS, V229, P246; Zisowsky J, 2007, BIOCHEM PHARMACOL, V73, P298, DOI 10.1016/j.bcp.2006.10.003	55	53	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7793	7802		10.1074/jbc.M805145200	http://dx.doi.org/10.1074/jbc.M805145200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19141620	Green Published, hybrid			2022-12-27	WOS:000264195600041
J	Dubini, A; Mus, F; Seibert, M; Grossman, AR; Posewitz, MC				Dubini, Alexandra; Mus, Florence; Seibert, Michael; Grossman, Arthur R.; Posewitz, Matthew C.			Flexibility in Anaerobic Metabolism as Revealed in a Mutant of Chlamydomonas reinhardtii Lacking Hydrogenase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE FORMATE-LYASE; GENE-EXPRESSION; SUCCINIC ACID; SULFATE RESPIRATION; H-2 PRODUCTION; ATP SYNTHESIS; GREEN-ALGAE; EVOLUTION; PATHWAYS; INSIGHTS	The green alga Chlamydomonas reinhardtii has a network of fermentation pathways that become active when cells acclimate to anoxia. Hydrogenase activity is an important component of this metabolism, and we have compared metabolic and regulatory responses that accompany anaerobiosis in wild-type C. reinhardtii cells and a null mutant strain for the HYDEF gene (hydEF-1 mutant), which encodes an [FeFe] hydrogenase maturation protein. This mutant has no hydrogenase activity and exhibits elevated accumulation of succinate and diminished production of CO2 relative to the parental strain during dark, anaerobic metabolism. In the absence of hydrogenase activity, increased succinate accumulation suggests that the cells activate alternative pathways for pyruvate metabolism, which contribute to NAD(P)H reoxidation, and continued glycolysis and fermentation in the absence of O-2. Fermentative succinate production potentially proceeds via the formation of malate, and increases in the abundance of mRNAs encoding two malate-forming enzymes, pyruvate carboxylase and malic enzyme, are observed in the mutant relative to the parental strain following transfer of cells from oxic to anoxic conditions. Although C. reinhardtii has a single gene encoding pyruvate carboxylase, it has six genes encoding putative malic enzymes. Only one of the malic enzyme genes, MME4, shows a dramatic increase in expression (mRNA abundance) in the hydEF-1 mutant during anaerobiosis. Furthermore, there are marked increases in transcripts encoding fumarase and fumarate reductase, enzymes putatively required to convert malate to succinate. These results illustrate the marked metabolic flexibility of C. reinhardtii and contribute to the development of an informed model of anaerobic metabolism in this and potentially other algae.	[Dubini, Alexandra; Seibert, Michael; Posewitz, Matthew C.] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Dubini, Alexandra] Colorado Sch Mines, Environm Sci & Engn Div, Golden, CO 80401 USA; [Posewitz, Matthew C.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA; [Mus, Florence; Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines; Colorado School of Mines; Carnegie Institution for Science	Posewitz, MC (corresponding author), Natl Renewable Energy Lab, Golden, CO 80401 USA.	matthew_posewitz@nrel.gov	dubini, alexandra/A-7252-2016; dubini, alexandra/Q-6277-2019	dubini, alexandra/0000-0001-8825-3915; dubini, alexandra/0000-0001-8825-3915; Mus, Florence/0000-0002-1655-1267	Office of Biological and Environmental Research; GTL; Office of Science; United States Department of Energy; National Science Foundation [MCB 0235878]; Air Force Office of Scientific Research [FA9550-05-1-0365]	Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GTL; Office of Science(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the Office of Biological and Environmental Research, GTL Program, Office of Science, United States Department of Energy (to A. R. G., M. C. P., and M. S.), by National Science Foundation Grant MCB 0235878 (to A. R. G.), and by Air Force Office of Scientific Research Grant FA9550-05-1-0365 (to M. C. P.).	Allmer J, 2006, PROTEOMICS, V6, P6207, DOI 10.1002/pmic.200600208; APARICIO PJ, 1985, PLANT PHYSIOL, V78, P803, DOI 10.1104/pp.78.4.803; Arp DJ, 2007, ANNU REV MICROBIOL, V61, P503, DOI 10.1146/annurev.micro.61.080706.093449; Atteia A, 2006, J BIOL CHEM, V281, P9909, DOI 10.1074/jbc.M507862200; BHANDARI B, 1984, FEBS LETT, V168, P321, DOI 10.1016/0014-5793(84)80271-9; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Bologna FP, 2007, J BACTERIOL, V189, P5937, DOI 10.1128/JB.00428-07; Eberhard S, 2006, CURR GENET, V49, P106, DOI 10.1007/s00294-005-0041-2; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; GFELLER RP, 1984, PLANT PHYSIOL, V75, P212, DOI 10.1104/pp.75.1.212; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Ghirardi ML, 2005, BIOCHEM SOC T, V33, P70, DOI 10.1042/BST0330070; Ghirardi ML, 1997, APPL BIOCHEM BIOTECH, V63-5, P141, DOI 10.1007/BF02920420; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; Hankamer B, 2007, PHYSIOL PLANTARUM, V131, P10, DOI 10.1111/j.1399-3054.2007.00924.x; HAPPE T, 1994, EUR J BIOCHEM, V222, P769, DOI 10.1111/j.1432-1033.1994.tb18923.x; Happe T, 2002, EUR J BIOCHEM, V269, P1022, DOI 10.1046/j.0014-2956.2001.02743.x; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P780; Hemschemeier A, 2005, BIOCHEM SOC T, V33, P39, DOI 10.1042/BST0330039; Hemschemeier A, 2008, EUKARYOT CELL, V7, P518, DOI 10.1128/EC.00368-07; HODSON RC, 1971, PLANT PHYSIOL, V47, P296, DOI 10.1104/pp.47.2.296; Im CS, 2003, PHOTOSYNTH RES, V75, P111, DOI 10.1023/A:1022800630430; Kosourov S, 2003, PLANT CELL PHYSIOL, V44, P146, DOI 10.1093/pcp/pcg020; KREUZBERG K, 1984, PHYSIOL PLANTARUM, V61, P87, DOI 10.1111/j.1399-3054.1984.tb06105.x; Kruse O, 2005, PHOTOCH PHOTOBIO SCI, V4, P957, DOI 10.1039/b506923h; Kruse O, 2005, J BIOL CHEM, V280, P34170, DOI 10.1074/jbc.M503840200; Lee SJ, 2006, APPL ENVIRON MICROB, V72, P1939, DOI 10.1128/AEM.72.3.1939-1948.2006; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Li Y, 2008, BIOTECHNOL PROGR, V24, P815, DOI 10.1021/bp070371k; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matias PM, 2005, PROG BIOPHYS MOL BIO, V89, P292, DOI 10.1016/j.pbiomolbio.2004.11.003; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Melis A, 2007, ADV EXP MED BIOL, V616, P108; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Millard CS, 1996, APPL ENVIRON MICROB, V62, P1808, DOI 10.1128/AEM.62.5.1808-1810.1996; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Nagy LE, 2007, BIOTECHNOL LETT, V29, P421, DOI 10.1007/s10529-006-9254-9; OHTA S, 1987, PLANT PHYSIOL, V83, P1022, DOI 10.1104/pp.83.4.1022; Ozawa K, 2000, J BACTERIOL, V182, P2200, DOI 10.1128/JB.182.8.2200-2206.2000; Posewitz M., 2008, CURR CHEM BIOL, V2, P178, DOI DOI 10.2174/187231308784220527; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Posewitz MC, 2005, BIOCHEM SOC T, V33, P102, DOI 10.1042/BST0330102; Quinn JM, 2002, PLANT PHYSIOL, V128, P463, DOI 10.1104/pp.010694; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P165, DOI 10.1007/PL00000845; Rochaix JD, 2002, FEBS LETT, V529, P34, DOI 10.1016/S0014-5793(02)03181-2; ROESSLER PG, 1984, PLANT PHYSIOL, V75, P705, DOI 10.1104/pp.75.3.705; Seibert M, 2008, BIOENERGY, P273; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Stoimenova M, 2007, PLANTA, V226, P465, DOI 10.1007/s00425-007-0496-0; Stols L, 1997, APPL ENVIRON MICROB, V63, P2695, DOI 10.1128/AEM.63.7.2695-2701.1997; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Wagner V, 2006, EUKARYOT CELL, V5, P457, DOI 10.1128/EC.5.3.457-468.2006; WEAVER PF, 1980, SOL ENERGY, V24, P3, DOI 10.1016/0038-092X(80)90018-3	57	85	86	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7201	7213		10.1074/jbc.M803917200	http://dx.doi.org/10.1074/jbc.M803917200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19117946	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000263919000067
J	Ros, S; Garcia-Rocha, M; Dominguez, J; Ferrer, JC; Guinovart, JJ				Ros, Susana; Garcia-Rocha, Mar; Dominguez, Jorge; Ferrer, Juan C.; Guinovart, Joan J.			Control of Liver Glycogen Synthase Activity and Intracellular Distribution by Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; PHOSPHOSERINE RESIDUES INVIVO; RAT HEPATOCYTES; MOLECULAR-MECHANISM; COS CELLS; GLUCOSE; ACTIVATION; GLUCOSE-6-PHOSPHATE; GLUCOKINASE; SITES	Eukaryotic glycogen synthase activity is regulated by reversible phosphorylation at multiple sites. Of the two GS isoforms found in mammals, the muscle enzyme (muscle glycogen synthase) has received more attention and the relative importance of every known phosphorylation site in the control of its activity and intracellular distribution has been previously addressed. We have analyzed the impact of the dephosphorylation at the homologous sites of the glycogen synthase liver (LGS) isoform. Serine residues at these sites were replaced by non-phosphorylatable alanine residues, singly or in pairs, and the resultant LGS variants were expressed in cultured cells using adenoviral vectors. The sole mutation at site 2 (Ser(7)) yielded an enzyme that was almost fully active and able to induce glycogen deposition in primary hepatocytes incubated in the absence of glucose and in FTO2B cells, a cell line that does not normally synthesize glycogen. Mutation at site 2 was also sufficient to trigger the aggregation and translocation of LGS from the cytoplasm to the hepatocyte cell cortex in the absence of glucose. However, this redistribution was not observed in hepatocytes incubated without glucose when an additional mutation (E509A), which renders the enzyme inactive, was introduced. This result suggests that LGS translocation is strictly dependent on glycogen synthesis.	[Ros, Susana; Garcia-Rocha, Mar; Dominguez, Jorge; Guinovart, Joan J.] Univ Barcelona, IRB Barcelona, E-08028 Barcelona, Spain; [Ros, Susana; Garcia-Rocha, Mar; Dominguez, Jorge; Guinovart, Joan J.] Univ Barcelona, CIBERDEM, E-08028 Barcelona, Spain; [Ros, Susana; Garcia-Rocha, Mar; Dominguez, Jorge; Ferrer, Juan C.; Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; University of Barcelona	Guinovart, JJ (corresponding author), Univ Barcelona, IRB Barcelona, Baldiri Reixac 10, E-08028 Barcelona, Spain.	guinovart@irbbarcelona.org	Ferrer, Joan C./AAP-2145-2021; Ros, Susana/B-6350-2019	Ros, Susana/0000-0002-5451-1880; Garcia-Rocha, Mar/0000-0003-2467-2090; Ferrer, Joan C./0000-0003-1212-5161	Ministry of Education and Science, Spain [BFU2005-02253, SAF2007-64722]; Autonomous Government of Catalonia [2005-SGR-00570]; Fundacion Marcelino Botin, CIBER de Diabetes y Enfermedades Metabolicas Asociadas, an ISCIII project	Ministry of Education and Science, Spain(Spanish Government); Autonomous Government of Catalonia(Generalitat de Catalunya); Fundacion Marcelino Botin, CIBER de Diabetes y Enfermedades Metabolicas Asociadas, an ISCIII project	This work was supported in part by Grants BFU2005-02253 and SAF2007-64722 from the Ministry of Education and Science, Spain, Grant 2005-SGR-00570 from the Autonomous Government of Catalonia, and the Fundacion Marcelino Botin, CIBER de Diabetes y Enfermedades Metabolicas Asociadas, an ISCIII project. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARINO J, 1984, FEBS LETT, V170, P310, DOI 10.1016/0014-5793(84)81334-4; ARINO J, 1986, BIOCHEM BIOPH RES CO, V134, P113, DOI 10.1016/0006-291X(86)90534-6; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; BAI G, 1990, J BIOL CHEM, V265, P7843; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; BOSCH F, 1986, J BIOL CHEM, V261, P6927; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Cid E, 2005, FEBS J, V272, P3197, DOI 10.1111/j.1742-4658.2005.04738.x; CIUDAD CJ, 1988, ARCH BIOCHEM BIOPHYS, V264, P30, DOI 10.1016/0003-9861(88)90566-8; DEWULF H, 1967, EUR J BIOCHEM, V2, P50; DEWULF H, 1970, EUR J BIOCHEM, V15, P1; Fernandez-Novell JM, 2002, FEBS LETT, V531, P222, DOI 10.1016/S0014-5793(02)03506-8; FernandezNovell JM, 1997, BIOCHEM J, V321, P227, DOI 10.1042/bj3210227; Ferrer JC, 1997, FEBS LETT, V415, P249, DOI 10.1016/S0014-5793(97)01136-8; Garcia-Rocha M, 2001, BIOCHEM J, V357, P17, DOI 10.1042/0264-6021:3570017; Gomis RR, 2002, J BIOL CHEM, V277, P23246, DOI 10.1074/jbc.M111208200; Gomis RR, 2000, BIOCHEM J, V351, P811, DOI 10.1042/0264-6021:3510811; Hanashiro I, 2002, ARCH BIOCHEM BIOPHYS, V397, P286, DOI 10.1006/abbi.2001.2623; Kadotani A, 2007, ARCH BIOCHEM BIOPHYS, V466, P283, DOI 10.1016/j.abb.2007.08.006; KATZ J, 1979, BIOCHEM J, V180, P389, DOI 10.1042/bj1800389; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; MASSAGUE J, 1977, FEBS LETT, V82, P317, DOI 10.1016/0014-5793(77)80610-8; NAKIELNY S, 1991, EUR J BIOCHEM, V199, P713, DOI 10.1111/j.1432-1033.1991.tb16175.x; NEWGARD CB, 1983, J BIOL CHEM, V258, P8046; O'Doherty RM, 2000, J CLIN INVEST, V105, P479, DOI 10.1172/JCI8673; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; PARKER PJ, 1982, EUR J BIOCHEM, V124, P47, DOI 10.1111/j.1432-1033.1982.tb05904.x; PICTON C, 1982, FEBS LETT, V150, P191, DOI 10.1016/0014-5793(82)81332-X; POULTER L, 1988, EUR J BIOCHEM, V175, P497, DOI 10.1111/j.1432-1033.1988.tb14222.x; Roach P. J., 1986, ENZYMES, VXVII, P499; Roach Peter J., 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P139; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; Seoane J, 1996, J BIOL CHEM, V271, P23756, DOI 10.1074/jbc.271.39.23756; SKURAT AV, 1994, J BIOL CHEM, V269, P25534; Skurat AV, 1996, BIOCHEM J, V313, P45, DOI 10.1042/bj3130045; SKURAT AV, 1995, J BIOL CHEM, V270, P12491, DOI 10.1074/jbc.270.21.12491; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; VALERA A, 1994, EUR J BIOCHEM, V222, P533, DOI 10.1111/j.1432-1033.1994.tb18895.x; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Wilson WA, 2005, P NATL ACAD SCI USA, V102, P16596, DOI 10.1073/pnas.0508481102; Zvibel I, 1998, DIFFERENTIATION, V63, P215, DOI 10.1111/j.1432-0436.1998.00215.x	43	43	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6370	6378		10.1074/jbc.M808576200	http://dx.doi.org/10.1074/jbc.M808576200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124463	hybrid			2022-12-27	WOS:000263742700040
J	Pascreau, G; Eckerdt, F; Lewellyn, AL; Prigent, C; Maller, JL				Pascreau, Gaetan; Eckerdt, Frank; Lewellyn, Andrea L.; Prigent, Claude; Maller, James L.			Phosphorylation of p53 Is Regulated by TPX2-Aurora A in Xenopus Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-A KINASE; CENTROSOME AMPLIFICATION; MITOTIC KINASE; GENETIC INSTABILITY; SIGNALING PATHWAY; TARGETING PROTEIN; STRUCTURAL BASIS; CELL-LINES; ACTIVATION; SPINDLE	p53 is an important tumor suppressor regulating the cell cycle at multiple stages in higher vertebrates. The p53 gene is frequently deleted or mutated in human cancers, resulting in loss of p53 activity. This leads to centrosome amplification, aneuploidy, and tumorigenesis, three phenotypes also observed after overexpression of the oncogenic kinase Aurora A. Accordingly, recent studies have focused on the relationship between these two proteins. p53 and Aurora A have been reported to interact in mammalian cells, but the function of this interaction remains unclear. We recently reported that Xenopus p53 can inhibit Aurora A activity in vitro but only in the absence of TPX2. Here we investigate the interplay between Xenopus Aurora A, TPX2, and p53 and show that newly synthesized TPX2 is required for nearly all Aurora A activation and for full p53 synthesis and phosphorylation in vivo during oocyte maturation. In vitro, phosphorylation mediated by Aurora A targets serines 129 and 190 within the DNA binding domain of p53. Glutathione S-transferase pull-down studies indicate that the interaction occurs via the p53 transactivation domain and the Aurora A catalytic domain around the T-loop. Our studies suggest that targeting of TPX2 might be an effective strategy for specifically inhibiting the phosphorylation of Aurora A substrates, including p53.	[Pascreau, Gaetan; Eckerdt, Frank; Lewellyn, Andrea L.; Maller, James L.] Univ Colorado, Sch Med, Howard Hughes Med Inst, Aurora, CO 80045 USA; [Pascreau, Gaetan; Eckerdt, Frank; Lewellyn, Andrea L.; Maller, James L.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Prigent, Claude] Univ Rennes 1, CNRS, F-35043 Rennes, France	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Maller, JL (corresponding author), 12801 E 17th Ave,POB 6511,MS 8303, Aurora, CO 80045 USA.	jim.maller@ucdenver.edu		Pascreau, Gaetan/0000-0002-1654-4032	Howard Hughes Medical Institute; CNRS; Union Internationale Contre le Cancer	Howard Hughes Medical Institute(Howard Hughes Medical Institute); CNRS(Centre National de la Recherche Scientifique (CNRS)); Union Internationale Contre le Cancer	This work was supported by the Howard Hughes Medical Institute and by grants from the CNRS and the Union Internationale Contre le Cancer (to C. P.).	Amariglio F, 1997, ONCOGENE, V15, P2191, DOI 10.1038/sj.onc.1201395; Anderson JA, 1997, MOL BIOL CELL, V8, P1195, DOI 10.1091/mbc.8.7.1195; Anderson K, 2007, BIOCHEMISTRY-US, V46, P10287, DOI 10.1021/bi7011355; Andresson T, 1998, EMBO J, V17, P5627, DOI 10.1093/emboj/17.19.5627; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bayliss R, 2004, CELL CYCLE, V3, P404; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; BROWN CR, 1994, J CELL PHYSIOL, V160, P47, DOI 10.1002/jcp.1041600107; Castro A, 2003, J BIOL CHEM, V278, P2236, DOI 10.1074/jbc.M207894200; Chen SS, 2002, EMBO J, V21, P4491, DOI 10.1093/emboj/cdf409; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Frank-Vaillant M, 2000, J CELL SCI, V113, P1127; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Gadea BB, 2005, MOL BIOL CELL, V16, P1305, DOI 10.1091/mbc.E04-10-0891; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Giet R, 1999, J CELL SCI, V112, P3591; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kaustov L, 2006, CELL CYCLE, V5, P489, DOI 10.4161/cc.5.5.2489; Keady BT, 2007, J CELL SCI, V120, P1093, DOI 10.1242/jcs.03416; Kiat LS, 2002, J BIOL CHEM, V277, P45558, DOI 10.1074/jbc.M206820200; Krams M, 2003, J CLIN ONCOL, V21, P1810, DOI 10.1200/JCO.2003.05.076; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Ma Y, 2006, CLIN CANCER RES, V12, P1121, DOI 10.1158/1078-0432.CCR-05-1766; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Morris VB, 2000, EXP CELL RES, V256, P122, DOI 10.1006/excr.2000.4800; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; Pascreau G, 2005, J BIOL CHEM, V280, P13415, DOI 10.1074/jbc.M410584200; Pascreau G, 2008, DEV BIOL, V317, P523, DOI 10.1016/j.ydbio.2008.02.053; Pihan GA, 1998, CANCER RES, V58, P3974; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; REMPEL RE, 1995, J BIOL CHEM, V270, P6843, DOI 10.1074/jbc.270.12.6843; Satinover DL, 2004, P NATL ACAD SCI USA, V101, P8625, DOI 10.1073/pnas.0402966101; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Scoumanne A, 2005, CANCER BIOL THER, V4, P1178, DOI 10.4161/cbt.4.11.2254; Shinmura K, 2007, ONCOGENE, V26, P2939, DOI 10.1038/sj.onc.1210085; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Tatsuka M, 1998, CANCER RES, V58, P4811; Tchang F, 1999, EXP CELL RES, V251, P46, DOI 10.1006/excr.1999.4570; TCHANG F, 1993, DEV BIOL, V159, P163, DOI 10.1006/dbio.1993.1230; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Tritarelli A, 2004, MOL BIOL CELL, V15, P3751, DOI 10.1091/mbc.E03-12-0900; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; VERNOS I, 1995, TRENDS CELL BIOL, V5, P297, DOI 10.1016/S0962-8924(00)89045-5; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Xu Y, 2008, ONCOGENE, V27, P3501, DOI 10.1038/sj.onc.1211023; Yamamoto TM, 2008, MOL CELL BIOL, V28, P4196, DOI 10.1128/MCB.00169-08; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411; ZAJDEL MEB, 1988, ONCOGENE, V2, P579; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	68	23	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5497	5505		10.1074/jbc.M805959200	http://dx.doi.org/10.1074/jbc.M805959200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19121998	hybrid, Green Published			2022-12-27	WOS:000263560600012
J	Dancho, B; McKenzie, MO; Connor, JH; Lyles, DS				Dancho, Brooke; McKenzie, Margie O.; Connor, John H.; Lyles, Douglas S.			Vesicular Stomatitis Virus Matrix Protein Mutations That Affect Association with Host Membranes and Viral Nucleocapsids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; INFECTED-CELLS; MUTANTS; COMPLEMENTATION; MICRODOMAINS; LIPOSOMES; SEQUENCES; SEPARATE; VIRIONS; DOMAINS	Viral matrix (M) proteins bind the nucleoprotein core (nucleocapsid) to host membranes during the process of virus assembly by budding. Previous studies using truncated M proteins had implicated the N-terminal 50 amino acids of the vesicular stomatitis virus M protein in binding both membranes and nucleocapsids and a sequence from amino acids 75-106 as an additional membrane binding region. Structure-based mutations were introduced into these two regions, and their effects on membrane association and incorporation into nucleocapsid-M protein complexes were determined using quantitative assays. The results confirmed that the N terminus of M protein is involved in association with plasma membranes as well as nucleocapsids, although these two activities were differentially affected by individual mutations. Mutations in the 75-106 region affected incorporation into nucleocapsid-M complexes but had only minor effects on association with membranes. The ability of site-specific mutant M proteins to complement growth of temperature-sensitive M mutant virus did not correlate well with the ability to associate with membranes or nucleocapsids, suggesting that complementation involves an additional activity of M protein. Mutants with similar abilities to associate with membranes and nucleocapsids but differing in complementation activity were incorporated into infectious cDNA clones. Infectious virus was repeatedly recovered containing mutant M proteins capable of complementation but was never recovered with mutant M proteins that lacked complementation activity, providing further evidence for a separate activity of M protein that is essential for virus replication.	[Dancho, Brooke; McKenzie, Margie O.; Lyles, Douglas S.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Connor, John H.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	Wake Forest University; Boston University	Lyles, DS (corresponding author), Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.	dlyles@wfubmc.edu		Connor, John/0000-0002-8867-7256; Lyles, Douglas/0000-0002-8401-3073	National Institutes of Health [AI15892]; NIAID; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015892, R55AI015892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15892 (a Public Health Service grant from the NIAID).	Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; BARGE A, 1993, J VIROL, V67, P7246, DOI 10.1128/JVI.67.12.7246-7253.1993; BLACK BL, 1993, J VIROL, V67, P4814, DOI 10.1128/JVI.67.8.4814-4821.1993; Brown EL, 2003, J VIROL, V77, P3985, DOI 10.1128/JVI.77.7.3985-3992.2003; CHONG LD, 1993, J VIROL, V67, P407, DOI 10.1128/JVI.67.1.407-414.1993; Connor JH, 2006, J VIROL, V80, P3701, DOI 10.1128/JVI.80.8.3701-3711.2006; Flood EA, 2000, VIROLOGY, V278, P520, DOI 10.1006/viro.2000.0675; Flood EA, 1999, VIROLOGY, V261, P295, DOI 10.1006/viro.1999.9856; Gaudier M, 2002, EMBO J, V21, P2886, DOI 10.1093/emboj/cdf284; Gaudier M, 2001, VIROLOGY, V288, P308, DOI 10.1006/viro.2001.1062; GOPALAKRISHNA Y, 1985, J VIROL, V56, P655, DOI 10.1128/JVI.56.3.655-659.1985; Irie T, 2004, J VIROL, V78, P7823, DOI 10.1128/JVI.78.14.7823-7827.2004; Jayakar HR, 2004, VIRUS RES, V106, P117, DOI 10.1016/j.virusres.2004.08.009; KAPTUR PE, 1991, J VIROL, V65, P1057, DOI 10.1128/JVI.65.3.1057-1065.1991; KNIPE DM, 1977, J VIROL, V21, P1128, DOI 10.1128/JVI.21.3.1128-1139.1977; Kopecky SA, 2001, J VIROL, V75, P12169, DOI 10.1128/JVI.75.24.12169-12181.2001; LENARD J, 1990, J VIROL, V64, P3486, DOI 10.1128/JVI.64.7.3486-3491.1990; Lenard J, 1996, VIROLOGY, V216, P289, DOI 10.1006/viro.1996.0064; LI Y, 1993, J VIROL, V67, P4415, DOI 10.1128/JVI.67.7.4415-4420.1993; LYLES DS, 1988, J VIROL, V62, P4387, DOI 10.1128/JVI.62.11.4387-4392.1988; Lyles DS, 1996, VIROLOGY, V217, P76, DOI 10.1006/viro.1996.0095; Lyles DS, 1998, BIOCHEMISTRY-US, V37, P439, DOI 10.1021/bi971812j; MCCREEDY BJ, 1989, VIRUS RES, V14, P189, DOI 10.1016/0168-1702(89)90001-4; MCCREEDY BJ, 1990, J VIROL, V64, P902, DOI 10.1128/JVI.64.2.902-906.1990; MORITA K, 1987, J VIROL, V61, P256, DOI 10.1128/JVI.61.2.256-263.1987; NEWCOMB WW, 1982, J VIROL, V41, P1055, DOI 10.1128/JVI.41.3.1055-1062.1982; NEWCOMB WW, 1981, J VIROL, V39, P295, DOI 10.1128/JVI.39.1.295-299.1981; OGDEN JR, 1986, J VIROL, V58, P860, DOI 10.1128/JVI.58.3.860-868.1986; ONO K, 1987, J VIROL, V61, P1332, DOI 10.1128/JVI.61.5.1332-1341.1987; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; Swinteck BD, 2008, J VIROL, V82, P5536, DOI 10.1128/JVI.02407-07; THOMAS D, 1985, J VIROL, V54, P598, DOI 10.1128/JVI.54.2.598-607.1985; Timmins J, 2004, FEMS MICROBIOL LETT, V233, P179, DOI [10.1111/j.1574-6968.2004.tb09480.x, 10.1016/j.femsle.2004.03.002]; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; YE ZP, 1994, J VIROL, V68, P7386, DOI 10.1128/JVI.68.11.7386-7396.1994	35	22	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4500	4509		10.1074/jbc.M808136200	http://dx.doi.org/10.1074/jbc.M808136200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088071	hybrid, Green Published			2022-12-27	WOS:000263134400050
J	Mitra, S; Tsvetkov, AS; Finkbeiner, S				Mitra, Siddhartha; Tsvetkov, Andrey S.; Finkbeiner, Steven			Single Neuron Ubiquitin-Proteasome Dynamics Accompanying Inclusion Body Formation in Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYGLUTAMINE PROTEINS; FLUORESCENT PROTEIN; POLYUBIQUITIN GENE; MUTANT HUNTINGTIN; SYSTEM; DEGRADATION; AUTOPHAGY; CELLS; MICE; NEURODEGENERATION	The accumulation of mutant protein in intracellular aggregates is a common feature of neurodegenerative disease. In Huntington disease, mutant huntingtin leads to inclusion body (IB) formation and neuronal toxicity. Impairment of the ubiquitin-proteasome system (UPS) has been implicated in IB formation and Huntington disease pathogenesis. However, IBs form asynchronously in only a subset of cells with mutant huntingtin, and the relationship between IB formation and UPS function has been difficult to elucidate. Here, we applied single-cell longitudinal acquisition and analysis to monitor mutant huntingtin IB formation, UPS function, and neuronal toxicity. We found that proteasome inhibition is toxic to striatal neurons in a dose-dependent fashion. Before IB formation, the UPS is more impaired in neurons that go on to form IBs than in those that do not. After forming IBs, impairment is lower in neurons with IBs than in those without. These findings suggest IBs are a protective cellular response to mutant protein mediated in part by improving intracellular protein degradation.	[Mitra, Siddhartha; Tsvetkov, Andrey S.; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Mitra, Siddhartha; Finkbeiner, Steven] Univ Calif San Francisco, Program Biomed Sci, Med Scientist Training Program, San Francisco, CA 94143 USA; [Tsvetkov, Andrey S.; Finkbeiner, Steven] Univ Calif San Francisco, Neurosci Program, Dept Neurol, San Francisco, CA 94143 USA; [Tsvetkov, Andrey S.; Finkbeiner, Steven] Univ Calif San Francisco, Neurosci Program, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	sfinkbeiner@gladstone.ucsf.edu			National Institutes of Health [R01 2NS039074, R01 NS045191]; NINDS; NIA [P01 AG022074]; Taube Family Foundation Program in Huntington Disease; Gladstone Institutes; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045191, R01NS039074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Taube Family Foundation Program in Huntington Disease; Gladstone Institutes(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 2NS039074 and R01 NS045191 from the NINDS (to S. F.) and Grant P01 AG022074 from the NIA. This work was also supported by the Taube Family Foundation Program in Huntington Disease, and the Gladstone Institutes (to S. F.).	Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bett JS, 2006, HUM MOL GENET, V15, P33, DOI 10.1093/hmg/ddi423; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Ding QX, 2002, J BIOL CHEM, V277, P13935, DOI 10.1074/jbc.M107706200; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Michalik A, 2004, NEUROBIOL DIS, V16, P202, DOI 10.1016/j.nbd.2003.12.020; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rusmini P, 2007, NEUROBIOL AGING, V28, P1099, DOI 10.1016/j.neurobiolaging.2006.05.015; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Ryu KY, 2008, MOL CELL BIOL, V28, P1136, DOI 10.1128/MCB.01566-07; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Stangl K, 2002, BIOCHEM BIOPH RES CO, V291, P542, DOI 10.1006/bbrc.2002.6476; Stenoien DL, 2002, NAT CELL BIOL, V4, P806, DOI 10.1038/ncb859; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	41	74	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4398	4403		10.1074/jbc.M806269200	http://dx.doi.org/10.1074/jbc.M806269200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074152	Green Published, hybrid			2022-12-27	WOS:000263134400039
J	Sum, CS; Tikhonova, IG; Costanzi, S; Gershengorn, MC				Sum, Chi Shing; Tikhonova, Irina G.; Costanzi, Stefano; Gershengorn, Marvin C.			Two Arginine-Glutamate Ionic Locks Near the Extracellular Surface of FFAR1 Gate Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; THYROTROPIN-RELEASING-HORMONE; A(2A) ADENOSINE RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; DRUG DISCOVERY; AGONIST RECOGNITION; LIGAND RECOGNITION; INSULIN-SECRETION; CRYSTAL-STRUCTURE; BINDING	Activation of a number of class A G protein-coupled receptors (GPCRs) is thought to involve two molecular switches, a rotamer toggle switch within the transmembrane domain and an ionic lock at the cytoplasmic surface of the receptor; however, the mechanism by which agonist binding changes these molecular interactions is not understood. Importantly, 80% of GPCRs including free fatty acid receptor 1 (FFAR1) lack the complement of amino acid residues implicated in either or both of these two switches; the mechanism of activation of these GPCRs is therefore less clear. By homology modeling, we identified two Glu residues (Glu-145 and Glu-172) in the second extracellular loop of FFAR1 that form putative interactions individually with two transmembrane Arg residues (Arg-183(5.39) and Arg-258(7.35)) to create two ionic locks. Molecular dynamics simulations showed that binding of agonists to FFAR1 leads to breakage of these Glu-Arg interactions. In mutagenesis experiments, breakage of these two putative interactions by substituting Ala for Glu-145 and Glu-172 caused constitutive receptor activation. Our results therefore reveal a molecular switch for receptor activation present on the extracellular surface of FFAR1 that is broken by agonist binding. Similar ionic locks between the transmembrane domains and the extracellular loops may constitute a mechanism common to other class A GPCRs also.	[Sum, Chi Shing; Gershengorn, Marvin C.] NIDDK, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA; [Tikhonova, Irina G.; Costanzi, Stefano] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gershengorn, MC (corresponding author), 50 South Dr,Rm 4134, Bethesda, MD 20892 USA.	marving@intra.niddk.nih.gov	Costanzi, Stefano/G-8990-2013	Costanzi, Stefano/0000-0003-3183-7332	Intramural Research Program; NIDDK; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK013025, ZIADK013025, ZIADK011006, Z01DK011006] Funding Source: NIH RePORTER	Intramural Research Program; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program, NIDDK, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Ballesteros J.A., 1995, METHODS NEUROSCIENCE; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brown AJ, 2005, DNA CELL BIOL, V24, P54, DOI 10.1089/dna.2005.24.54; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Colson AO, 1998, BIOPHYS J, V74, P1087, DOI 10.1016/S0006-3495(98)77827-0; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; Costanzi S, 2005, J MED CHEM, V48, P8108, DOI 10.1021/jm050911p; Costanzi S, 2004, J MED CHEM, V47, P5393, DOI 10.1021/jm049914c; Costanzi S, 2008, J BIOL CHEM, V283, P16269, DOI 10.1074/jbc.R800014200; Costanzi S, 2008, J MED CHEM, V51, P2907, DOI 10.1021/jm800044k; Cristalli G, 2008, CURR PHARM DESIGN, V14, P1525, DOI 10.2174/138161208784480081; Foucaud M, 2006, MOL PHARMACOL, V69, P680, DOI 10.1124/mol.105.019992; Garrido DM, 2006, BIOORG MED CHEM LETT, V16, P1840, DOI 10.1016/j.bmcl.2006.01.007; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; Huang W, 2005, BIOCHEMISTRY-US, V44, P2419, DOI 10.1021/bi048808+; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Kim JH, 1996, MOL PHARMACOL, V49, P683; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Moro S, 1999, BIOCHEMISTRY-US, V38, P3498, DOI 10.1021/bi982369v; OLAH ME, 1994, J BIOL CHEM, V269, P24692; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perlman JH, 1997, BIOCHEMISTRY-US, V36, P15670, DOI 10.1021/bi9713310; Robbins AK, 1998, BIOTECHNIQUES, V25, P240, DOI 10.2144/98252st04; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Shapiro DA, 2002, J BIOL CHEM, V277, P11441, DOI 10.1074/jbc.M111675200; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Song FB, 2007, J MED CHEM, V50, P2807, DOI 10.1021/jm070130j; Stoddart LA, 2007, MOL PHARMACOL, V71, P994, DOI 10.1124/mol.106.031534; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Tan ES, 2008, CHEM BIOL, V15, P343, DOI 10.1016/j.chembiol.2008.03.004; Tikhonova IG, 2008, J MED CHEM, V51, P625, DOI 10.1021/jm7012425; Tikhonova IG, 2007, J MED CHEM, V50, P2981, DOI 10.1021/jm0614782; Winzell MS, 2007, PHARMACOL THERAPEUT, V116, P437, DOI 10.1016/j.pharmthera.2007.08.002	44	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3529	3536		10.1074/jbc.M806987200	http://dx.doi.org/10.1074/jbc.M806987200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19068482	Green Published, hybrid			2022-12-27	WOS:000262872500020
J	Yanagimoto, S; Tatsuno, K; Okugawa, S; Kitazawa, T; Tsukada, K; Koike, K; Kodama, T; Kimura, S; Shibasaki, Y; Ota, Y				Yanagimoto, Shintaro; Tatsuno, Keita; Okugawa, Shu; Kitazawa, Takatoshi; Tsukada, Kunihisa; Koike, Kazuhiko; Kodama, Tatsuhiko; Kimura, Satoshi; Shibasaki, Yoshikazu; Ota, Yasuo			A Single Amino Acid of Toll-like Receptor 4 That Is Pivotal for Its Signal Transduction and Subcellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; ENDOPLASMIC-RETICULUM; CONTAINING ADAPTER; CUTTING EDGE; TLR4; MD-2; MOLECULE; PROTEIN; MUTATIONS; CD14	Toll-like receptor 4 (TLR4) is essential for recognizing a Gram-negative bacterial component, lipopolysaccharide (LPS). A single amino acid mutation at position 712 of murine TLR4 leads to hyporesponsiveness to LPS. In this study we determined that an amino acid, a leucine at position 815 of human TLR4, is also pivotal for LPS responsiveness and subcellular distribution. By replacing the leucine with alanine, the mutant TLR4 lost responsiveness to LPS and did not localize on the plasma membrane. In addition, it does not coprecipitate with myeloid differentiation-2, an accessory protein that is necessary for TLR4 to recognize LPS. These results suggest that the leucine at position 815 is required for the normal maturation of TLR4 and for formation of the TLR4.MD-2 complex.	[Ota, Yasuo] Teikyo Univ, Sch Med, Dept Med, Itabashi Ku, Tokyo 1738605, Japan; [Yanagimoto, Shintaro; Shibasaki, Yoshikazu] Univ Tokyo, Grad Sch Arts & Sci, Ctr Structuring Life Sci, Meguro Ku, Tokyo 1538903, Japan; [Yanagimoto, Shintaro; Tatsuno, Keita; Okugawa, Shu; Kitazawa, Takatoshi; Tsukada, Kunihisa; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Infect Dis, Bunkyo Ku, Tokyo 1138655, Japan; [Yanagimoto, Shintaro; Kodama, Tatsuhiko] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Kimura, Satoshi] Tokyo Teishin Hosp, Chiyoda Ku, Tokyo 1028798, Japan	Teikyo University; University of Tokyo; University of Tokyo; University of Tokyo	Ota, Y (corresponding author), Teikyo Univ, Sch Med, Dept Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	yasuota-tky@umin.ac.jp		Okugawa, Shu/0000-0003-3455-8291	National Institute of Biomedical Innovation; New Energy and Industrial Technology Development Organization; Special Coordination Fund for Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology; Ministry of Education, Culture, Sports, Science and Technology	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Special Coordination Fund for Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by the Program of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, by the Focus 21 project of the New Energy and Industrial Technology Development Organization, and by the Special Coordination Fund for Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology. This study was also partly supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (to Y.O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Akashi S, 2000, BIOCHEM BIOPH RES CO, V268, P172, DOI 10.1006/bbrc.2000.2089; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Correia JD, 2002, J BIOL CHEM, V277, P1845, DOI 10.1074/jbc.M109910200; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Espevik T, 2003, SCAND J INFECT DIS, V35, P660, DOI 10.1080/00365540310016493; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Konno K, 2006, BIOCHEM BIOPH RES CO, V339, P1076, DOI 10.1016/j.bbrc.2005.11.123; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Muta T, 2001, EUR J BIOCHEM, V268, P4580, DOI 10.1046/j.1432-1327.2001.02385.x; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nishitani C, 2006, J BIOL CHEM, V281, P38322, DOI 10.1074/jbc.M606904200; Nishitania C, 2005, BIOCHEM BIOPH RES CO, V328, P586, DOI 10.1016/j.bbrc.2005.01.021; Nufer O, 2003, CURR BIOL, V13, pR391, DOI 10.1016/S0960-9822(03)00318-X; Ohnishi T, 2003, CLIN DIAGN LAB IMMUN, V10, P405, DOI 10.1128/CDLI.10.3.405-410.2003; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Wakabayashi Y, 2006, J IMMUNOL, V177, P1772, DOI 10.4049/jimmunol.177.3.1772; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	33	8	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3513	3520		10.1074/jbc.M803086200	http://dx.doi.org/10.1074/jbc.M803086200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19064998	hybrid			2022-12-27	WOS:000262872500018
J	Juanes, ME; Elvira, G; Garcia-Grande, A; Calero, M; Gasset, M				Juanes, Maria E.; Elvira, Gema; Garcia-Grande, Aranzazu; Calero, Miguel; Gasset, Maria			RETRACTED: Biosynthesis of Prion Protein Nucleocytoplasmic Isoforms by Alternative Initiation of Translation (Retracted article. See vol. 292, pg. 20044, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							ENDOPLASMIC-RETICULUM; SIGNAL SEQUENCE; CYTOSOLIC PRP; TRANSMEMBRANE; CELLS; FORM; NEURODEGENERATION; PROLIFERATION; NEUROTOXICITY; ACCUMULATION	The cellular prion protein PrPC is synthesized as a family of four distinct forms. Of these, (PrP)-Pr-Cyt is a minor member that segregates outside of the secretory route and can generate cytotoxic forms. Using signal sequence mutants, we found that (PrP)-Pr-Cyt is translated from a downstream AUG (coding for Met-8 in human PrP or Met-15 in Syrian hamster PrP). Shortening of the signal sequence dictated the spillage of this isoform into the cytosol, from where it accessed the nucleus or formed insoluble cytosolic aggregates if the proteasome is inhibited. The PrP isoform isolated from the nuclear fractions of cell and brain homogenates was partially SUMO-1-conjugated. Expression of HaPrP(M15) in cells caused an antiproliferative phenotype due to a cell cycle arrest at the G(0)/G(1) phase. The identification of this PrP isoform and its properties provides novel insight into PrPC physiological and pathological functions.	[Juanes, Maria E.; Elvira, Gema; Gasset, Maria] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Garcia-Grande, Aranzazu] Ctr Nacl Invest Oncol, Madrid 28029, Spain; [Calero, Miguel] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid 28220, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Gasset, M (corresponding author), CSIC, Inst Quim Fis Rocasolano, Serrano 119, E-28006 Madrid, Spain.	mgasset@iqfr.csic.es	Gasset, Maria/K-4339-2012; Gasset, Maria/I-2050-2014; Calero, Miguel/H-5691-2015	Gasset, Maria/0000-0001-6436-4055; Gasset, Maria/0000-0001-6436-4055; Calero, Miguel/0000-0001-5366-3324	Ministerio de Ciencia e Innovacion [SAF2006-00418, PI050912]; European Union [FOOD-CT-2004506579]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Union(European Commission)	This work was supported by Grants SAF2006-00418 (to M. G.) and FIS PI050912 (to M. C.) from the Ministerio de Ciencia e Innovacion (to M. G.) and Grant FOOD-CT-2004506579 (M. G.) from the European Union. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chang KJ, 2006, J BIOL CHEM, V281, P7775, DOI 10.1074/jbc.M511265200; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Crozet C, 2006, MOL CELL NEUROSCI, V32, P315, DOI 10.1016/j.mcn.2006.05.004; Derrington E, 2002, CR BIOL, V325, P17, DOI 10.1016/S1631-0691(02)01388-4; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Gonzalez-Iglesias R, 2002, J MOL BIOL, V319, P527, DOI 10.1016/S0022-2836(02)00341-8; Hegde RS, 2003, TRENDS NEUROSCI, V26, P337, DOI 10.1016/S0166-2236(03)00143-7; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hegde RS, 1996, CELL, V85, P217, DOI 10.1016/S0092-8674(00)81098-3; Holscher C, 2001, J BIOL CHEM, V276, P13388, DOI 10.1074/jbc.M007331200; Hosokawa T, 2008, BIOCHEM BIOPH RES CO, V366, P657, DOI 10.1016/j.bbrc.2007.11.163; Kim SJ, 2001, J BIOL CHEM, V276, P26132, DOI 10.1074/jbc.M101638200; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; Liang J, 2007, FASEB J, V21, P2247, DOI 10.1096/fj.06-7799com; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; MEHDI H, 1990, GENE, V91, P173, DOI 10.1016/0378-1119(90)90085-6; Mironov A, 2003, J NEUROSCI, V23, P7183, DOI 10.1523/JNEUROSCI.23-18-07183.2003; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Ott CM, 2004, BIOCHEMISTRY-US, V43, P11973, DOI 10.1021/bi049156s; Rambold AS, 2006, MOL BIOL CELL, V17, P3356, DOI 10.1091/mbc.E06-01-0083; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Rogers GW, 2004, P NATL ACAD SCI USA, V101, P2794, DOI 10.1073/pnas.0308576101; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Say YH, 2007, PROTEOMICS, V7, P1059, DOI 10.1002/pmic.200600849; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Wang XH, 2006, J BIOL CHEM, V281, P13559, DOI 10.1074/jbc.M512306200; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383	40	21	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2787	2794		10.1074/jbc.M804051200	http://dx.doi.org/10.1074/jbc.M804051200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19059915	Green Submitted, hybrid			2022-12-27	WOS:000262700900021
J	Raaijmakers, JH; Bos, JL				Raaijmakers, Judith H.; Bos, Johannes L.			Specificity in Ras and Rap Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NUCLEOTIDE EXCHANGE FACTOR; PHOSPHOLIPASE-C-EPSILON; MEDIATES RAP1-INDUCED ADHESION; CELL-CELL JUNCTIONS; CYCLIC-AMP; INTEGRIN ACTIVATION; CRUCIAL ROLE; PATHWAY; GTPASES; DOMAIN	Ras and Rap proteins are closely related small GTPases. Whereas Ras is known for its role in cell proliferation and survival, Rap1 is predominantly involved in cell adhesion and cell junction formation. Ras and Rap are regulated by different sets of guanine nucleotide exchange factors and GTPase-activating proteins, determining one level of specificity. In addition, although the effector domains are highly similar, Rap and Ras interact with largely different sets of effectors, providing a second level of specificity. In this review, we discuss the regulatory proteins and effectors of Ras and Rap, with a focus on those of Rap.	[Bos, Johannes L.] Univ Med Ctr Utrecht, Ctr Biomed Genet, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Univ Med Ctr Utrecht, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Bos, JL (corresponding author), Univ Med Ctr Utrecht, Ctr Biomed Genet, Dept Physiol Chem, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	j.l.bos@umcutrecht.nl			Dutch Cancer Society; Netherlands Genomics Initiative through the Cancer Genomics Centre	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Genomics Initiative through the Cancer Genomics Centre	This work was supported by the Dutch Cancer Society (to J. H. R.) and by the Netherlands Genomics Initiative through the Cancer Genomics Centre (to J. L. B.). This is the first article of three in the Thematic Minireview Series on Novel Ras Effectors. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Beraud-Dufour S, 2007, FEBS J, V274, P5518, DOI 10.1111/j.1742-4658.2007.06068.x; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Christian SL, 2003, J BIOL CHEM, V278, P41756, DOI 10.1074/jbc.M303180200; Dube N, 2008, CELL SIGNAL, V20, P1608, DOI 10.1016/j.cellsig.2008.05.006; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Krugmann S, 2006, J CELL SCI, V119, P425, DOI 10.1242/jcs.02755; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Li Y, 2006, J BIOL CHEM, V281, P2506, DOI 10.1074/jbc.M508165200; Liao YH, 2001, J BIOL CHEM, V276, P28478, DOI 10.1074/jbc.M101737200; Lorger M, 2006, J CELL SCI, V119, P3385, DOI 10.1242/jcs.03027; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Medeiros RB, 2005, IMMUNITY, V23, P213, DOI 10.1016/j.immuni.2005.07.006; Menasche G, 2007, MOL CELL BIOL, V27, P4070, DOI 10.1128/MCB.02011-06; Miertzschke M, 2007, J BIOL CHEM, V282, P30629, DOI 10.1074/jbc.M704361200; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Sato T, 2005, CANCER SCI, V96, P578, DOI 10.1111/j.1349-7006.2005.00087.x; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yoshikawa Y, 2007, MOL BIOL CELL, V18, P2949, DOI 10.1091/mbc.E07-03-0250; Zaldua N, 2007, FEBS LETT, V581, P5814, DOI 10.1016/j.febslet.2007.11.053; Zhang ZC, 2005, J BIOL CHEM, V280, P33200, DOI 10.1074/jbc.M505057200	50	144	150	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					10995	10999		10.1074/jbc.R800061200	http://dx.doi.org/10.1074/jbc.R800061200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19091745	Green Published, hybrid			2022-12-27	WOS:000265494500002
J	Nomura, M				Nomura, Masayasu			Switching from Prokaryotic Molecular Biology to Eukaryotic Molecular Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-PROTEIN GENES; RNA-POLYMERASE-I; E-COLI RIBOSOMES; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; RIBONUCLEIC-ACID; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; CONDITIONAL EXPRESSION; FEEDBACK-REGULATION		Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Nomura, M (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	mnomura@uci.edu			National Institutes of Health [GM35949]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035949, R01GM035949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I acknowledge continued grant support from the National Institutes of Health ( from 1961 to the present; the current grant is GM35949) and the National Science Foundation ( from 1964 to 1995). Quite a few of the early-day molecular biologists, whose names I have given in this article, are gone by now. They include my postdoctoral-time mentors, Sol Spiegelman and Seymour Benzer, and other teachers, colleagues, and friends: Francis Crick, Max Delbruck, Salvador Luria, George Streisinger, Ole Maaloe, Niels Ole Kjeldgaard, Rudy Planta, and Gunther Stent. Other notable early-day molecular biologists mentioned, Jacques Monod, John Kendrew, and Max Perutz, also have passed away. I miss them and cherish my memories of these early-day molecular biologists. Ira Herskowitz, who was much younger than I, also passed away prematurely. I dedicate this article to these people. I would also like to thank my former graduate students, postdoctoral fellows, and other staff scientists for their dedicated participation in research in my laboratory throughout my career. Finally, I thank James F. Crow, Melanie Oakes, Suzanne Sandmeyer, Robert Steele, Millard Susman, and Marian Waterman for their reading of the drafts of this article and for their useful suggestions and comments and Melanie Oakes and Catherine Cao for their help in the preparation of this article.	BEGGS JD, 1978, NATURE, V275, P104, DOI 10.1038/275104a0; Botstein David, 1993, P361; BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0; Cote CA, 2002, RNA, V8, P786, DOI 10.1017/S1355838202023063; ELBARADI TTAL, 1986, CURR GENET, V10, P733, DOI 10.1007/BF00405095; ELLWOOD M, 1980, J BACTERIOL, V143, P1077, DOI 10.1128/JB.143.2.1077-1080.1980; FALLON AM, 1979, P NATL ACAD SCI USA, V76, P3411, DOI 10.1073/pnas.76.7.3411; GOURSE RL, 1985, P NATL ACAD SCI USA, V82, P1069, DOI 10.1073/pnas.82.4.1069; GROS F, 1961, NATURE, V190, P581, DOI 10.1038/190581a0; GUTHRIE C, 1969, P NATL ACAD SCI USA, V63, P384, DOI 10.1073/pnas.63.2.384; GUTHRIE C, 1968, NATURE, V219, P232, DOI 10.1038/219232a0; HARTWELL LH, 1970, MOL GEN GENET, V109, P42, DOI 10.1007/BF00334045; HENRY Y, 1994, EMBO J, V13, P2452, DOI 10.1002/j.1460-2075.1994.tb06530.x; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; JASKUNAS SR, 1975, NATURE, V256, P183, DOI 10.1038/256183a0; JASKUNAS SR, 1975, P NATL ACAD SCI USA, V72, P6, DOI 10.1073/pnas.72.1.6; JINKSROBERTSON S, 1983, CELL, V33, P865, DOI 10.1016/0092-8674(83)90029-6; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; KENERLEY ME, 1977, J BACTERIOL, V132, P931, DOI 10.1128/JB.132.3.931-949.1977; KRANZ JE, 1990, P NATL ACAD SCI USA, V87, P6629, DOI 10.1073/pnas.87.17.6629; LURIA SE, 1984, SLOT MACHINE BROKEN, P103; MaalOe O, 1966, CONTROL MACROMOLECUL; Maaloe O, 1969, DEVELOP BIOL       S, V3, P33; MAICAS E, 1988, MOL CELL BIOL, V8, P169, DOI 10.1128/MCB.8.1.169; MARCKER K, 1964, J MOL BIOL, V8, P835, DOI 10.1016/S0022-2836(64)80164-9; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P7026, DOI 10.1073/pnas.88.16.7026; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; NOMURA M, 1967, P NATL ACAD SCI USA, V58, P946, DOI 10.1073/pnas.58.3.946; NOMURA M, 1961, J MOL BIOL, V3, P684, DOI 10.1016/S0022-2836(61)80031-4; NOMURA M, 1970, NATURE, V228, P744, DOI 10.1038/228744a0; NOMURA M, 1960, J MOL BIOL, V2, P306, DOI 10.1016/S0022-2836(60)80027-7; Nomura M, 2004, MOL BIOL INTELL UNIT, P128; NOMURA M, 1963, COLD SPRING HARB SYM, V28, P315, DOI 10.1101/SQB.1963.028.01.046; NOMURA M, 1988, TRANSCRIPTION RIBOSO, P155; NOMURA M, 1981, SCI SCI ESSAYS BIOCH, P133; NOMURA M, 1953, J AGR CHEM SOC JPN, V27, P46; Oakes M, 1998, J CELL BIOL, V143, P23, DOI 10.1083/jcb.143.1.23; Oakes ML, 2006, MOL CELL BIOL, V26, P3889, DOI 10.1128/MCB.26.10.3889-3901.2006; OZAKI M, 1969, NATURE, V222, P333, DOI 10.1038/222333a0; PETES TD, 1977, P NATL ACAD SCI USA, V74, P5091, DOI 10.1073/pnas.74.11.5091; RIGGS DL, 1990, J BIOL CHEM, V265, P7596; ROSBASH M, 1981, CELL, V24, P679, DOI 10.1016/0092-8674(81)90094-5; SAITO K, 1994, J MOL BIOL, V235, P125, DOI 10.1016/S0022-2836(05)80021-X; SAITO K, 1994, J MOL BIOL, V235, P111, DOI 10.1016/S0022-2836(05)80020-8; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; SMITH AE, 1970, NATURE, V226, P607, DOI 10.1038/226607a0; Stent G. S., 1969, COMING GOLDEN AGE VI; STENT GS, 1968, SCIENCE, V160, P390, DOI 10.1126/science.160.3826.390; STREISINGER G, 1992, PHAGES ORIGINS MOL B, P335; TRAUB P, 1968, P NATL ACAD SCI USA, V59, P777, DOI 10.1073/pnas.59.3.777; TSAY YF, 1988, GENE DEV, V2, P664, DOI 10.1101/gad.2.6.664; VOLKIN E, 1956, VIROLOGY, V2, P149, DOI 10.1016/0042-6822(56)90016-2; WARNER JR, 1985, MOL CELL BIOL, V5, P1512, DOI 10.1128/MCB.5.6.1512; WITTEKIND M, 1990, MOL CELL BIOL, V10, P2049, DOI 10.1128/MCB.10.5.2049; YAMAGISHI M, 1988, CURR GENET, V13, P305, DOI 10.1007/BF00424424; YATES JL, 1980, P NATL ACAD SCI-BIOL, V77, P1837, DOI 10.1073/pnas.77.4.1837; [No title captured]	59	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9625	9635		10.1074/jbc.X800014200	http://dx.doi.org/10.1074/jbc.X800014200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19074426	Green Published, hybrid			2022-12-27	WOS:000264892900001
J	Dalal, K; Nguyen, N; Alami, M; Tan, J; Moraes, TF; Lee, WC; Maurus, R; Sligar, SS; Brayer, GD; Duong, F				Dalal, Kush; Nguyen, Nham; Alami, Meriem; Tan, Jennifer; Moraes, Trevor F.; Lee, Woo Cheol; Maurus, Robert; Sligar, Stephen S.; Brayer, Gary D.; Duong, Franck			Structure, Binding, and Activity of Syd, a SecY-interacting Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PREPROTEIN TRANSLOCASE; TRANSMEMBRANE STRETCHES; CONDUCTING CHANNEL; GENETIC-ANALYSIS; RIBOSOME; SUBUNIT; COMPLEX; DOMAIN; MOTOR	The Syd protein has been implicated in the Sec-dependent transport of polypeptides across the bacterial inner membrane. Using Nanodiscs, we here provide direct evidence that Syd binds the SecY complex, and we demonstrate that interaction involves the two electropositive and cytosolic loops of the SecY subunit. We solve the crystal structure of Syd and together with cysteine cross-link analysis, we show that a conserved concave and electronegative groove constitutes the SecY-binding site. At the membrane, Syd decreases the activity of the translocon containing loosely associated SecY-SecE subunits, whereas in detergent solution Syd disrupts the SecYEG heterotrimeric associations. These results support the role of Syd in proofreading the SecY complex biogenesis and point to the electrostatic nature of the Sec channel interaction with its cytosolic partners.	[Dalal, Kush; Nguyen, Nham; Alami, Meriem; Tan, Jennifer; Moraes, Trevor F.; Maurus, Robert; Brayer, Gary D.; Duong, Franck] Univ British Columbia, Dept Biochem & Mol Biol, Fac Med, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Lee, Woo Cheol] Univ British Columbia, Dept Microbiol & Immunol, Fac Med, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Sligar, Stephen S.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of British Columbia; University of British Columbia; University of Illinois System; University of Illinois Urbana-Champaign	Duong, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Fac Med, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	FDuong@interchange.ubc.ca		Duong Van Hoa, Franck/0000-0001-7328-6124	Canadian Institutes of Health Research; Pacific Century Graduate Scholarship from the British Columbia provincial government; Natural Sciences and Engineering Research Council; Canada Research Chair program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pacific Century Graduate Scholarship from the British Columbia provincial government; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs)	This work was supported by the Canadian Institutes of Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.; Supported by the Pacific Century Graduate Scholarship from the British Columbia provincial government.; Supported by the Natural Sciences and Engineering Research Council.; Supported by the Canada Research Chair program.	Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bessonneau P, 2002, EMBO J, V21, P995, DOI 10.1093/emboj/21.5.995; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Karamanou S, 2008, MOL MICROBIOL, V70, P311, DOI 10.1111/j.1365-2958.2008.06402.x; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; Matsuo E, 1998, J BIOL CHEM, V273, P18835, DOI 10.1074/jbc.273.30.18835; Matsuo E, 1998, MOL GEN GENET, V258, P240, DOI 10.1007/s004380050728; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Nishiyama K, 2000, BIOSCI BIOTECH BIOCH, V64, P2121, DOI 10.1271/bbb.64.2121; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; SCHATZ PJ, 1991, EMBO J, V10, P1749, DOI 10.1002/j.1460-2075.1991.tb07699.x; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SHIMOIKE T, 1995, J BIOL CHEM, V270, P5519, DOI 10.1074/jbc.270.10.5519; TAURA T, 1994, MOL GEN GENET, V243, P261, DOI 10.1007/BF00301061; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218	29	25	25	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7897	7902		10.1074/jbc.M808305200	http://dx.doi.org/10.1074/jbc.M808305200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19139097	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000264195600051
J	Raj, DK; Mu, JB; Jiang, HY; Kabat, J; Singh, S; Sullivan, M; Fay, MP; McCutchan, TF; Su, XZ				Raj, Dipak Kumar; Mu, Jianbing; Jiang, Hongying; Kabat, Juraj; Singh, Subash; Sullivan, Margery; Fay, Michael P.; McCutchan, Thomas F.; Su, Xin-zhuan			Disruption of a Plasmodium falciparum Multidrug Resistance-associated Protein (PfMRP) Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTERS; CHLOROQUINE RESISTANCE; MALARIA PARASITES; ABC TRANSPORTERS; QUININE RESISTANCE; DIGESTIVE VACUOLE; P-GLYCOPROTEIN; PFMDR1 GENE; SENSITIVITY; MEFLOQUINE	ATP-binding cassette transporters play an important role in drug resistance and nutrient transport. In the human malaria parasite Plasmodium falciparum, a homolog of the human p-glycoprotein (PfPgh-1) was shown to be involved in resistance to several drugs. More recently, many transporters were associated with higher IC50 levels in responses to chloroquine (CQ) and quinine (QN) in field isolates. Subsequent studies, however, could not confirm the associations, although inaccuracy in drug tests in the later studies could contribute to the lack of associations. Here we disrupted a gene encoding a putative multidrug resistance-associated protein (PfMRP) that was previously shown to be associated with P. falciparum responses to CQ and QN. Parasites with disrupted PfMRP (W2/MRP Delta) could not grow to a parasitemia higher than 5% under normal culture conditions, possibly because of lower efficiency in removing toxic metabolites. The W2/MRP Delta parasite also accumulated more radioactive glutathione, CQ, and QN and became more sensitive to multiple antimalarial drugs, including CQ, QN, artemisinin, piperaquine, and primaquine. PfMRP was localized on the parasite surface membrane, within membrane-bound vesicles, and along the straight side of the D-shaped stage II gametocytes. The results suggest that PfMRP plays a role in the efflux of glutathione, CQ, and QN and contributes to parasite responses to multiple antimalarial drugs, possibly by pumping drugs outside the parasite.	[Raj, Dipak Kumar; Mu, Jianbing; Jiang, Hongying; Singh, Subash; Sullivan, Margery; McCutchan, Thomas F.; Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Kabat, Juraj] NIAID, Res Technol Branch, NIH, Rockville, MD 20852 USA; [Fay, Michael P.] NIAID, Biostat Res Branch, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Su, XZ (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 12735 Twinbrook Pkwy,Rm 3E-24B, Rockville, MD 20852 USA.	xsu@niaid.nih.gov	Fay, Michael P/A-2974-2008	Fay, Michael P/0000-0002-8643-9625; Su, Xinzhuan/0000-0003-3246-3248	Division of Intramural Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892, Z01AI000892, Z01AI000208, ZIAAI000208] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the Division of Intramural Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Allen JD, 2000, CANCER RES, V60, P5761; Anderson TJC, 2005, ANTIMICROB AGENTS CH, V49, P2180, DOI 10.1128/AAC.49.6.2180-2188.2005; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cervenak J, 2006, CANCER LETT, V234, P62, DOI 10.1016/j.canlet.2005.01.061; Chakraborti PK, 1999, BIOSCIENCE REP, V19, P293, DOI 10.1023/A:1020598324663; Cojean S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-24; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Duraisingh MT, 2000, MOL MICROBIOL, V36, P955, DOI 10.1046/j.1365-2958.2000.01914.x; Duraisingh MT, 2000, PARASITOLOGY, V121, P1, DOI 10.1017/S0031182099006022; Dyer M, 2000, PARASITOL TODAY, V16, P102, DOI 10.1016/S0169-4758(99)01608-7; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; Ferdig MT, 2004, MOL MICROBIOL, V52, P985, DOI 10.1111/j.1365-2958.2004.04035.x; Fernandez V, 1998, INFECT IMMUN, V66, P2969, DOI 10.1128/IAI.66.6.2969-2975.1998; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; Furuya T, 2005, P NATL ACAD SCI USA, V102, P16813, DOI 10.1073/pnas.0501858102; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ginsburg H, 2003, REDOX REP, V8, P276, DOI 10.1179/135100003225002907; Ginsburg H, 1998, BIOCHEM PHARMACOL, V56, P1305, DOI 10.1016/S0006-2952(98)00184-1; Igarashi Y, 2004, MOL BIOL EVOL, V21, P2149, DOI 10.1093/molbev/msh226; Jungwirth H, 2006, FEBS LETT, V580, P1131, DOI 10.1016/j.febslet.2005.12.050; Kawazu SI, 2008, PARASITOL INT, V57, P1, DOI 10.1016/j.parint.2007.08.001; Klokouzas A, 2004, BIOCHEM BIOPH RES CO, V321, P197, DOI 10.1016/j.bbrc.2004.06.135; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Liang XJ, 2006, CURR DRUG TARGETS, V7, P911, DOI 10.2174/138945006778019264; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Oliveira F, 2006, VACCINE, V24, P374, DOI 10.1016/j.vaccine.2005.07.085; Ouellette Marc, 1994, Trends in Microbiology, V2, P407, DOI 10.1016/0966-842X(94)90620-3; Peklak-Scott C, 2005, BIOCHEMISTRY-US, V44, P4426, DOI 10.1021/bi047810y; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Rebbeor JF, 2002, BBA-BIOMEMBRANES, V1559, P171, DOI 10.1016/S0005-2736(01)00454-0; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rosenberg E, 2006, J BIOL CHEM, V281, P27039, DOI 10.1074/jbc.M601686200; RUBIO JP, 1994, EXP PARASITOL, V79, P137, DOI 10.1006/expr.1994.1073; Rychlik B, 2000, ACTA BIOCHIM POL, V47, P763, DOI 10.18388/abp.2000_3994; Sanchez CP, 2008, MOL MICROBIOL, V70, P786, DOI 10.1111/j.1365-2958.2008.06413.x; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sinden RE, 1998, MALARIA PARASITE BIO; Singh S, 2007, P NATL ACAD SCI USA, V104, P20043, DOI 10.1073/pnas.0709999104; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Stefkova J, 2004, PHYSIOL RES, V53, P235; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; Su XZ, 1998, EXP PARASITOL, V89, P262, DOI 10.1006/expr.1998.4299; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Team RC., 2022, LANG ENV STAT COMP; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007	61	107	112	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7687	7696		10.1074/jbc.M806944200	http://dx.doi.org/10.1074/jbc.M806944200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19117944	Green Published, hybrid			2022-12-27	WOS:000264195600031
J	Davis, L; Abdi, K; Machius, M; Brautigam, C; Tomchick, DR; Bennett, V; Michaely, P				Davis, Lydia; Abdi, Khadar; Machius, Mischa; Brautigam, Chad; Tomchick, Diana R.; Bennett, Vann; Michaely, Peter			Localization and Structure of the Ankyrin-binding Site on beta(2)-Spectrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE SPECTRIN; MOLECULAR-STRUCTURE; MEMBRANE; PROTEINS; PATHWAYS; REPEATS; MODEL; DEFECTS; CELLS; HELIX	Spectrins are tetrameric actin-cross-linking proteins that form an elastic network, termed the membrane skeleton, on the cytoplasmic surface of cellular membranes. At the plasma membrane, the membrane skeleton provides essential support, preventing loss of membrane material to environmental shear stresses. The skeleton also controls the location, abundance, and activity of membrane proteins that are critical to cell and tissue function. The ability of the skeleton to modulate membrane stability and function requires adaptor proteins that bind the skeleton to membranes. The principal adaptors are the ankyrin proteins, which bind to the beta-subunit of spectrin and to the cytoplasmic domains of numerous integral membrane proteins. Here, we present the crystal structure of the ankyrin-binding domain of human beta(2)-spectrin at 1.95 A resolution together with mutagenesis data identifying the binding surface for ankyrins on beta(2)-spectrin.	[Michaely, Peter] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Davis, Lydia; Abdi, Khadar; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Davis, Lydia; Abdi, Khadar; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Machius, Mischa; Brautigam, Chad; Tomchick, Diana R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University; Duke University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Michaely, P (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Peter.Michaely@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022	Brautigam, Chad/0000-0001-6563-1338; Tomchick, Diana/0000-0002-7529-4643	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL085218, HL085218] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085218] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altmann SM, 2002, STRUCTURE, V10, P1085, DOI 10.1016/S0969-2126(02)00808-0; Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1982, NATURE, V299, P126, DOI 10.1038/299126a0; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; BURRIDGE K, 1982, J CELL BIOL, V95, P478, DOI 10.1083/jcb.95.2.478; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DISCHER DE, 1994, SCIENCE, V266, P1032, DOI 10.1126/science.7973655; Dubreuil RR, 2006, J MEMBRANE BIOL, V211, P151, DOI 10.1007/s00232-006-0863-y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallagher PG, 1998, BLOOD CELL MOL DIS, V24, P539, DOI 10.1006/bcmd.1998.0217; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HARTWIG JH, 1995, PROTEIN PROFILE, V2, P703; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KENNEDY SP, 1991, J CELL BIOL, V115, P267, DOI 10.1083/jcb.115.1.267; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MOHANDAS N, 1983, SEMIN HEMATOL, V20, P225; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; Mohler PJ, 2005, FRONT BIOSCI, V10, P2832, DOI 10.2741/1739; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1991, P CCP4 STUD WEEK IS, P80; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SHOTTON DM, 1979, J MOL BIOL, V131, P303, DOI 10.1016/0022-2836(79)90078-0; Stabach PR, 2000, J BIOL CHEM, V275, P21385, DOI 10.1074/jbc.C000159200	29	54	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6982	6987		10.1074/jbc.M809245200	http://dx.doi.org/10.1074/jbc.M809245200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19098307	Green Published, hybrid			2022-12-27	WOS:000263919000046
J	Rausch, JW; Chelico, L; Goodman, MF; Le Grice, SFJ				Rausch, Jason W.; Chelico, Linda; Goodman, Myron F.; Le Grice, Stuart F. J.			Dissecting APOBEC3G Substrate Specificity by Nucleoside Analog Interference	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV REVERSE-TRANSCRIPTASE; DNA DEAMINASE DOMAIN; SINGLE-STRANDED-DNA; CYTIDINE DEAMINASE; VIF PROTEIN; CRYSTAL-STRUCTURE; FUNCTIONAL IMPLICATIONS; RETROVIRAL INFECTION; ANTIVIRAL ACTIVITY; VIRUS INFECTIVITY	The apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC) cytidine deaminase genes encode a set of enzymes including APOBEC1(A1), APOBEC2(A2), APOBEC4 (A4), and APOBEC3A-H (A3A-H). Although each possesses one or more zinc binding motifs conserved among enzymes catalyzing C -> U conversion, the functions and substrate specificities of these gene products vary considerably. For example, although two closely related enzymes, A3F and A3G, both restrict HIV-1 infection in strains deficient in virus infectivity factor (vif), A3F selectively deaminates cytosine within 5'-TTCA-3' motifs in single stranded DNA, whereas A3G targets 5'-CCCA-3' sequences. In the present study we have used nucleoside analog interference mapping to probe A3G-DNA interactions throughout the enzyme-substrate complex as well as to determine which DNA structural features determine substrate specificity. Our results indicate that multiple components of nucleosides within the consensus sequence are important for substrate recognition by A3G (with base moieties being most critical), whereas deamination interference by analog substitution outside this region is minimal. Furthermore, exocyclic groups in pyrimidines 1-2 nucleotides 5' of the target cytosine were shown to dictate substrate recognition by A3G, with chemical composition at ring positions 3 and 4 found to be more important than at ring position 5. Taken together, these results provide insights into how the enzyme selects A3G hotspot motifs for deamination as well as which approaches might be best suited for forming a stable, catalytically competent crosslinked A3G-DNA complex for future structural studies.	[Chelico, Linda; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Mol & Computat Sect, Los Angeles, CA 90089 USA; [Rausch, Jason W.; Le Grice, Stuart F. J.] NCI Frederick, Retroviral Replicat Lab, HIV Drug Resistance Program, Natl Inst Hlth, Ft Detrick, MD 21702 USA	University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Le Grice, SFJ (corresponding author), 1050 Boyles St, Frederick, MD 21702 USA.	slegrice@ncifcrf.gov		Chelico, Linda/0000-0003-4673-8978	National Institutes of Health staff; NATIONAL CANCER INSTITUTE [ZIABC010495] Funding Source: NIH RePORTER	National Institutes of Health staff(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was authored, in whole or in part, by National Institutes of Health staff. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; BHATTACHARYA S, 1994, TRENDS BIOCHEM SCI, V19, P105, DOI 10.1016/0968-0004(94)90200-3; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Goncalves J, 1996, J VIROL, V70, P8701, DOI 10.1128/JVI.70.12.8701-8709.1996; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Hakata Y, 2006, J BIOL CHEM, V281, P36624, DOI 10.1074/jbc.M604980200; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Huang HF, 2000, CHEM BIOL, V7, P355, DOI 10.1016/S1074-5521(00)00113-7; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Opi S, 2006, J VIROL, V80, P4673, DOI 10.1128/JVI.80.10.4673-4682.2006; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang L, 2008, VIROLOGY, V370, P113, DOI 10.1016/j.virol.2007.08.027; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	49	40	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7047	7058		10.1074/jbc.M807258200	http://dx.doi.org/10.1074/jbc.M807258200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136562	hybrid, Green Published			2022-12-27	WOS:000263919000053
J	Bederman, IR; Foy, S; Chandramouli, V; Alexander, JC; Previs, SF				Bederman, Ilya R.; Foy, Steven; Chandramouli, Visvanathan; Alexander, James C.; Previs, Stephen F.			Triglyceride Synthesis in Epididymal Adipose Tissue CONTRIBUTION OF GLUCOSE AND NON-GLUCOSE CARBON SOURCES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS ISOTOPOMER ANALYSIS; CARBOHYDRATE-FREE DIET; IN-VIVO; FATTY-ACIDS; PHOSPHOENOLPYRUVATE CARBOXYKINASE; CHOLESTEROL-SYNTHESIS; GLYCERIDE-GLYCEROL; PLASMA-GLUCOSE; HIGH-PROTEIN; GLYCERONEOGENESIS	The obesity epidemic has generated interest in determining the contribution of various pathways to triglyceride synthesis, including an elucidation of the origin of triglyceride fatty acids and triglyceride glycerol. We hypothesized that a dietary intervention would demonstrate the importance of using glucose versus non-glucose carbon sources to synthesize triglycerides in white adipose tissue. C57BL/6J mice were fed either a low fat, high carbohydrate (HC) diet or a high fat, carbohydrate-free (CF) diet and maintained on (H2O)-H-2 (to determine total triglyceride dynamics) or infused with [6,6-H-2] glucose (to quantify the contribution of glucose to triglyceride glycerol). The (H2O)-H-2 labeling data demonstrate that although de novo lipogenesis contributed similar to 80% versus similar to 5% to the pool of triglyceride palmitate in HC-versus CF-fed mice, the epididymal adipose tissue synthesized similar to 1.5-fold more triglyceride in CF-versus HC-fed mice, i.e. 37 +/- 5 versus 25 +/- 3 mu mol x day(-1). The [6,6-H-2] glucose labeling data demonstrate that similar to 69 and similar to 28% of triglyceride glycerol is synthesized from glucose in HC-versus CF-fed mice, respectively. Although these data are consistent with the notion that non-glucose carbon sources (e. g. glyceroneogenesis) can make substantial contributions to the synthesis of triglyceride glycerol (i.e. the absolute synthesis of triglyceride glycerol from non-glucose substrates increased from similar to 8 to similar to 26 mu mol x day(-1) in HC-versus CF-fed mice), these observations suggest (i) the importance of nutritional status in affecting flux rates and (ii) the operation of a glycerol-glucose cycle.	[Previs, Stephen F.] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Chandramouli, Visvanathan; Previs, Stephen F.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Alexander, James C.] Case Western Reserve Univ, Dept Math, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Previs, SF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, Rm WG 48,10900 Euclid Ave, Cleveland, OH 44106 USA.	stephen.previs@case.edu			National Institutes of Health Metabolomics Roadmap Initiative [R33DK070291]; American Diabetes Association [1-04-JF-40]; Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER	National Institutes of Health Metabolomics Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Metabolomics Roadmap Initiative Grant R33DK070291. This work was also supported by grants from the American Diabetes Association (Grant 1-04-JF-40) and the Mt. Sinai Health Care Foundation (Cleveland, OH).	BAKER N, 1972, J LIPID RES, V13, P716; BALLARD FJ, 1967, J BIOL CHEM, V242, P2746; BEALE EG, 2003, BIOCHEM SOC T, V31, P1125; Bederman IR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1048, DOI 10.1152/ajpendo.00340.2005; Behn A, 2006, CURR OPIN CARDIOL, V21, P353, DOI 10.1097/01.hco.0000231406.84554.96; Bessesen DH, 2000, AM J PHYSIOL-ENDOC M, V278, pE1124, DOI 10.1152/ajpendo.2000.278.6.E1124; Botion LM, 1998, METABOLISM, V47, P1217, DOI 10.1016/S0026-0495(98)90326-2; Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Brito SC, 2006, METABOLISM, V55, P84, DOI 10.1016/j.metabol.2005.07.010; Brunengraber DZ, 2003, AM J PHYSIOL-ENDOC M, V285, pE917, DOI 10.1152/ajpendo.00128.2003; Burgess SC, 2003, ANAL BIOCHEM, V318, P321, DOI 10.1016/S0003-2697(03)00158-1; Burgess SC, 2008, J APPL PHYSIOL, V104, P1852, DOI 10.1152/japplphysiol.90406.2008; Cadoudal T, 2008, DIABETES, V57, P2272, DOI 10.2337/db08-0477; Chacko SK, 2008, J APPL PHYSIOL, V104, P944, DOI 10.1152/japplphysiol.00752.2007; Chen JL, 2005, J BIOL CHEM, V280, P25396, DOI 10.1074/jbc.M413948200; Daniels SR, 2006, FUTURE CHILD, V16, P47, DOI 10.1353/foc.2006.0004; Dietz WH, 2004, NEW ENGL J MED, V350, P855, DOI 10.1056/NEJMp048008; Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2; Forest C, 2003, BIOCHEM SOC T, V31, P1125; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Jones JG, 2002, MAGNET RESON MED, V48, P535, DOI 10.1002/mrm.10234; KNEER P, 1968, J BIOL CHEM, V243, P2863; LEE WNP, 1994, AM J PHYSIOL, V266, pE699, DOI 10.1152/ajpendo.1994.266.5.E699; LEE WNP, 1994, AM J PHYSIOL, V266, pE372, DOI 10.1152/ajpendo.1994.266.3.E372; Leroyer SN, 2006, J BIOL CHEM, V281, P13141, DOI 10.1074/jbc.M512943200; NURJHAN N, 1986, DIABETES, V35, P1326, DOI 10.2337/diabetes.35.12.1326; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; ROGNSTAD R, 1974, EUR J BIOCHEM, V47, P383, DOI 10.1111/j.1432-1033.1974.tb03703.x; Schoenheimer R, 1936, J BIOL CHEM, V114, P381; Siler SQ, 1998, AM J PHYSIOL-ENDOC M, V275, pE897, DOI 10.1152/ajpendo.1998.275.5.E897; Summers LKM, 2000, AM J CLIN NUTR, V71, P1470; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Turner SM, 2003, AM J PHYSIOL-ENDOC M, V285, pE790, DOI 10.1152/ajpendo.00402.2002; WHITE LW, 1968, ARCH BIOCHEM BIOPHYS, V126, P552, DOI 10.1016/0003-9861(68)90441-4; Wolfe RR, 2004, ISOTOPE TRACERS META; Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200; Yang DW, 1998, ANAL BIOCHEM, V258, P315, DOI 10.1006/abio.1998.2632	38	67	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6101	6108		10.1074/jbc.M808668200	http://dx.doi.org/10.1074/jbc.M808668200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19114707	Green Published, hybrid			2022-12-27	WOS:000263742700012
J	Herz, K; Rimon, A; Jeschke, G; Padan, E				Herz, Katia; Rimon, Abraham; Jeschke, Gunnar; Padan, Etana			beta-Sheet-dependent Dimerization Is Essential for the Stability of NhaA Na+/H+ Antiporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; LOOP-VIII-IX; ESCHERICHIA-COLI; TRANSPORT PROTEIN; CONFORMATIONAL-CHANGE; ION-TRANSPORT; CROSS-LINKING; ALKALINE PH; MEMBRANE; ANT	A structural model of the NhaA dimer showed that a beta-hairpin of each monomer combines to form a beta-sheet at the periplasmic side of the membrane. By Cys scanning the entire beta-hairpin and testing each Cys replacement for functionality and intermolecular cross-linking, we found that Gln(47) and Arg(49) are critical for the NhaA dimer and that K57C causes an acidic shift of 1 pH unit to the pH dependence of NhaA. Comparing the growth of the NhaA variants with the previously isolated beta-hairpin deleted mutant (triangle(P45- N58)) and the wild type validated that NhaA dimers have an advantage over monomers in growth under extreme stress conditions and unraveled that during this growth the apparent K-m for Na+ of triangle( P45- N58) was increased 50-fold as compared with the wild type. Remarkably, the effect of the extreme stress on the NhaA variants is reversible. Testing the temperature stability (4-55 degrees C) of the NhaA variants in dodecyl maltoside micells showed that the mutants impaired in dimerization were much less temperature-stable than the wild type. We suggest that NhaA dimers are crucial for the stability of the antiporter under extreme stress conditions.	[Herz, Katia; Rimon, Abraham; Padan, Etana] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Jeschke, Gunnar] ETH, Dept Phys Chem, CH-8093 Zurich, Switzerland	Hebrew University of Jerusalem; Swiss Federal Institutes of Technology Domain; ETH Zurich	Padan, E (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	etana@vms.huji.ac.il		Jeschke, Gunnar/0000-0001-6853-8585	United States-Israel Binational Science Foundation [501/03-16.2]; European Drug Initiative on Channels and Transporters [EU FP 7]	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); European Drug Initiative on Channels and Transporters	This work was supported by United States-Israel Binational Science Foundation Grant 501/03-16.2 and European Drug Initiative on Channels and Transporters Grant EU FP 7. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; CASEY JR, 1991, J BIOL CHEM, V266, P15726; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; GERCHMAN Y, 1993, P NATL ACAD SCI USA, V90, P1212, DOI 10.1073/pnas.90.4.1212; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Hilger D, 2007, BIOPHYS J, V93, P3675, DOI 10.1529/biophysj.107.109769; Hilger D, 2005, BIOPHYS J, V89, P1328, DOI 10.1529/biophysj.105.062232; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; KARPEL R, 1988, J BIOL CHEM, V263, P10408; Maris AE, 2005, J MOL BIOL, V350, P843, DOI 10.1016/j.jmb.2005.05.057; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Olkhova E., 2006, P NATL ACAD SCI US; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PADAN E, 1989, J BIOL CHEM, V264, P20297; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; PINNER E, 1993, J BIOL CHEM, V268, P1729; Rimon A, 2002, BIOCHEMISTRY-US, V41, P14897, DOI 10.1021/bi0261342; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Schagger H., 2003, PRACTICAL GUIDE MEMB, P105; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Screpanti E, 2006, J MOL BIOL, V362, P192, DOI 10.1016/j.jmb.2006.07.019; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Tsuboi Y, 2003, J BIOL CHEM, V278, P21467, DOI 10.1074/jbc.M301932200; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; Veenhoff LM, 2001, EMBO J, V20, P3056, DOI 10.1093/emboj/20.12.3056; Venturi M, 2000, J BIOL CHEM, V275, P4734, DOI 10.1074/jbc.275.7.4734; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558; Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534	43	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6337	6347		10.1074/jbc.M807720200	http://dx.doi.org/10.1074/jbc.M807720200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129192	hybrid			2022-12-27	WOS:000263742700037
J	Veyron-Churlet, R; Molle, V; Taylor, RC; Brown, AK; Besra, GS; Zanella-Cleon, I; Futterer, K; Kremer, L				Veyron-Churlet, Romain; Molle, Virginie; Taylor, Rebecca C.; Brown, Alistair K.; Besra, Gurdyal S.; Zanella-Cleon, Isabelle; Fuetterer, Klaus; Kremer, Laurent			The Mycobacterium tuberculosis beta-Ketoacyl-Acyl Carrier Protein Synthase III Activity Is Inhibited by Phosphorylation on a Single Threonine Residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; SERINE/THREONINE KINASE; CELL-DIVISION; CRYSTAL-STRUCTURE; FAS-II; SUBSTRATE-SPECIFICITY; SER/THR KINASE; IN-VIVO; BIOSYNTHESIS; IDENTIFICATION	Mycolic acids are hallmark features of the Mycobacterium tuberculosis cell wall. They are synthesized by the condensation of two fatty acids, a C56-64-meromycolyl chain and a C24-26-fatty acyl chain. Meromycolates are produced via the combination of type I and type II fatty acid synthases (FAS-I and FAS-II). The beta-ketoacyl-acyl carrier protein (ACP) synthase III ( mtFabH) links FAS-I and FAS-II, catalyzing the condensation of FAS-I-derived acyl-CoAs with malonyl-ACP. Because mtFabH represents a potential regulatory key point of the mycolic acid pathway, we investigated the hypothesis that phosphorylation of mtFabH controls its activity. Phosphorylation of proteins by Ser/Thr protein kinases (STPKs) has recently emerged as a major physiological mechanism of regulation in prokaryotes. We demonstrate here that mtFabH was efficiently phosphorylated in vitro by several mycobacterial STPKs, particularly by PknF and PknA, as well as in vivo in mycobacteria. Analysis of the phosphoamino acid content indicated that mtFabH was phosphorylated exclusively on threonine residues. Mass spectrometry analyses using liquid chromatography-electrospray ionization/tandem mass spectrometry identified Thr(45) as the unique phosphoacceptor. This was further supported by complete loss of PknF- or PknA-dependent phosphorylation of a mtFabH mutant. Mapping Thr(45) on the crystal structure of mtFabH illustrates that this residue is located at the entrance of the substrate channel, suggesting that the phosphate group may alter accessibility of the substrate and thus affect mtFabH enzymatic activity. A T45D mutant of mtFabH, designed to mimic constitutive phosphorylation, exhibited markedly decreased transacylation, malonyl-AcpM decarboxylation, and condensing activities compared with the wild-type protein or the T45A mutant. Together, these findings not only represent the first demonstration of phosphorylation of a beta-ketoacyl-ACP synthase III enzyme but also indicate that phosphorylation of mtFabH inhibits its enzymatic activity, which may have important consequences in regulating mycolic acid biosynthesis.	[Molle, Virginie; Zanella-Cleon, Isabelle] Univ Lyon 1, CNRS, IBCP, UMR 5086,IFR128 BioSci, F-69367 Lyon 07, France; [Veyron-Churlet, Romain; Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Veyron-Churlet, Romain; Kremer, Laurent] Univ Montpellier I, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Kremer, Laurent] INSERM, F-34095 Montpellier 05, France; [Taylor, Rebecca C.; Brown, Alistair K.; Besra, Gurdyal S.; Fuetterer, Klaus] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Birmingham	Molle, V (corresponding author), Univ Lyon 1, CNRS, IBCP, UMR 5086,IFR128 BioSci, 7 Passage Vercors, F-69367 Lyon 07, France.	vmolle@ibcp.fr; laurent.kremer@univ-montp2.fr	MOLLE, Virginie/D-4050-2019; Kremer, Laurent/M-4935-2017; Veyron-Churlet, Romain/J-4254-2019	MOLLE, Virginie/0000-0002-6573-3411; Kremer, Laurent/0000-0002-6604-4458; Veyron-Churlet, Romain/0000-0001-6902-5917; Brown, Alistair/0000-0003-0479-8294; Futterer, Klaus/0000-0001-7445-5372; Besra, Gurdyal/0000-0002-5605-0395	National Research Agency [ANR-06-MIME-027-01]; MRC [G0500590] Funding Source: UKRI; Medical Research Council [G0500590] Funding Source: researchfish	National Research Agency(French National Research Agency (ANR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Research Agency Grant ANR-06-MIME-027-01 (to V. M. and L. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alhamadsheh MM, 2007, CHEM BIOL, V14, P513, DOI 10.1016/j.chembiol.2007.03.013; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Banerjee A, 1998, MICROBIOL-SGM, V144, P2697, DOI 10.1099/00221287-144-10-2697; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bhatt A, 2008, CHEM BIOL, V15, P930, DOI 10.1016/j.chembiol.2008.07.007; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Brown AK, 2005, J BIOL CHEM, V280, P32539, DOI 10.1074/jbc.M413216200; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Canova MJ, 2008, PROTEOMICS, V8, P521, DOI 10.1002/pmic.200700442; Choi KH, 2000, J BIOL CHEM, V275, P28201; Cohen-Gonsaud M, 2004, J BIOMOL NMR, V30, P373, DOI 10.1007/s10858-004-3466-x; Cohen-Gonsaud M, 2002, J MOL BIOL, V320, P249, DOI 10.1016/S0022-2836(02)00463-1; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cottin V, 1999, J BIOL CHEM, V274, P32975, DOI 10.1074/jbc.274.46.32975; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Kruh NA, 2008, J BIOL CHEM, V283, P31719, DOI 10.1074/jbc.M802169200; Marrakchi H, 2002, MICROBIOL-SGM, V148, P951, DOI 10.1099/00221287-148-4-951; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Musayev F, 2005, J MOL BIOL, V346, P1313, DOI 10.1016/j.jmb.2004.12.044; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Peirs P, 1997, EUR J BIOCHEM, V244, P604, DOI 10.1111/j.1432-1033.1997.00604.x; Perez J, 2006, BIOCHEM BIOPH RES CO, V348, P6, DOI 10.1016/j.bbrc.2006.06.164; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Qiu XY, 2001, J MOL BIOL, V307, P341, DOI 10.1006/jmbi.2000.4457; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Scarsdale JN, 2001, J BIOL CHEM, V276, P20516, DOI 10.1074/jbc.M010762200; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Shorrosh BS, 1996, PLANT J, V10, P261, DOI 10.1046/j.1365-313X.1996.10020261.x; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Zheng XJ, 2007, BIOCHEM BIOPH RES CO, V355, P162, DOI 10.1016/j.bbrc.2007.01.122	58	57	58	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6414	6424		10.1074/jbc.M806537200	http://dx.doi.org/10.1074/jbc.M806537200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19074144	Green Published, hybrid			2022-12-27	WOS:000263742700044
J	Tisdale, EJ; Azizi, F; Artalejo, CR				Tisdale, Ellen J.; Azizi, Fouad; Artalejo, Cristina R.			Rab2 Utilizes Glyceraldehyde-3-phosphate Dehydrogenase and Protein Kinase C iota to Associate with Microtubules and to Recruit Dynein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; APKC-IOTA/LAMBDA; PKC-IOTA/LAMBDA; CARGO TRANSPORT; GOLGI; TUBULIN; ER; KINESIN	Rab2 requires glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and atypical protein kinase C iota(aPKC iota) for retrograde vesicle formation from vesicular tubular clusters that sort secretory cargo from recycling proteins returned to the endoplasmic reticulum. However, the precise role of GAPDH and aPKC iota in the early secretory pathway is unclear. GAPDH was the first glycolytic enzyme reported to co-purify with microtubules (MTs). Similarly, aPKC associates directly with MTs. To learn whether Rab2 also binds directly to MTs, a MT binding assay was performed. Purified Rab2 was found in a MT-enriched pellet only when both GAPDH and aPKC iota were present, and Rab2-MT binding could be prevented by a recombinant fragment made to the Rab2 amino terminus (residues 2-70), which directly interacts with GAPDH and aPKC iota. Because GAPDH binds to the carboxyl terminus of alpha-tubulin, we characterized the distribution of tyrosinated/detyrosinated alpha-tubulin that is recruited by Rab2 in a quantitative membrane binding assay. Rab2-treated membranes contained predominantly tyrosinated alpha-tubulin; however, aPKC iota was the limiting and essential factor. Tyrosination/detyrosination influences MT motor protein binding; therefore, we determined whether Rab2 stimulated kinesin or dynein membrane binding. Although kinesin was not detected on membranes incubated with Rab2, dynein was recruited in a dose-dependent manner, and binding was aPKC iota-dependent. These combined results suggest a mechanism by which Rab2 controls MT and motor recruitment to vesicular tubular clusters.	[Tisdale, Ellen J.; Azizi, Fouad; Artalejo, Cristina R.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Wayne State University	Tisdale, EJ (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, 540 E Canfield Ave,6374 Scott Hall, Detroit, MI 48201 USA.	etisdale@med.wayne.edu			National Institutes of Health [GM068813]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068813 (to E. J. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; ARCE CA, 1985, BIOCHEM J, V226, P311, DOI 10.1042/bj2260311; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Barroso MR, 1996, J BIOL CHEM, V271, P10183, DOI 10.1074/jbc.271.17.10183; Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; Bielli A, 2001, BIOCHEM BIOPH RES CO, V281, P1141, DOI 10.1006/bbrc.2001.4468; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Cueille N, 2007, J PROTEOME RES, V6, P2640, DOI 10.1021/pr070081z; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; GarciaRocha M, 1997, EXP CELL RES, V230, P1, DOI 10.1006/excr.1996.3364; Glaser PE, 2002, P NATL ACAD SCI USA, V99, P14104, DOI 10.1073/pnas.222542999; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; HAMMOND J, 2007, CURR OPIN CELL BIOL, V19, P1; Harris TJC, 2007, DEV CELL, V12, P727, DOI 10.1016/j.devcel.2007.02.011; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Idriss HT, 2000, CELL MOTIL CYTOSKEL, V45, P173, DOI 10.1002/(SICI)1097-0169(200003)45:3<173::AID-CM1>3.0.CO;2-O; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; LIPPINCOTTSCHWARTZ J, 1995, J CELL BIOL, V128, P293, DOI 10.1083/jcb.128.3.293; MACRAE TH, 1992, BIOCHIM BIOPHYS ACTA, V1160, P145, DOI 10.1016/0167-4838(92)90001-T; McCaffrey MW, 2001, FEBS LETT, V495, P21, DOI 10.1016/S0014-5793(01)02359-6; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Roghi C, 1999, J CELL SCI, V112, P4673; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Seibenhener M L, 1999, Mol Cell Biol Res Commun, V2, P28, DOI 10.1006/mcbr.1999.0140; Shao CY, 2006, J NEUROPATH EXP NEUR, V65, P327, DOI 10.1097/01.jnen.0000218441.00040.82; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Sironi JJ, 1997, MOL CELL BIOCHEM, V170, P9, DOI 10.1023/A:1006846828547; SOMERS M, 1990, EUR J BIOCHEM, V193, P437, DOI 10.1111/j.1432-1033.1990.tb19357.x; Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060; Tisdale EJ, 2006, J BIOL CHEM, V281, P8436, DOI 10.1074/jbc.M513031200; Tisdale EJ, 1999, MOL BIOL CELL, V10, P1837, DOI 10.1091/mbc.10.6.1837; Tisdale EJ, 2000, TRAFFIC, V1, P702, DOI 10.1034/j.1600-0854.2000.010903.x; Tisdale EJ, 1996, J BIOL CHEM, V271, P29372, DOI 10.1074/jbc.271.46.29372; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; Tisdale EJ, 2003, J BIOL CHEM, V278, P52524, DOI 10.1074/jbc.M309343200; Tisdale EJ, 1997, J CELL BIOL, V137, P581, DOI 10.1083/jcb.137.3.581; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Tisdale EJ, 1998, J BIOL CHEM, V273, P17269, DOI 10.1074/jbc.273.27.17269; Tisdale EJ, 2007, TRAFFIC, V8, P733, DOI 10.1111/j.1600-0854.2007.00569.x; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Volker KW, 1997, ARCH BIOCHEM BIOPHYS, V338, P237, DOI 10.1006/abbi.1996.9819; VOLKER KW, 1995, COMP BIOCHEM PHYS B, V112, P503, DOI 10.1016/0305-0491(95)00096-8; Wade Richard H, 2007, Methods Mol Med, V137, P1, DOI 10.1007/978-1-59745-442-1_1; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Wanschers B, 2008, CELL MOTIL CYTOSKEL, V65, P183, DOI 10.1002/cm.20254; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yoshiyama Y, 2003, J NEUROSCI, V23, P10662	66	55	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5876	5884		10.1074/jbc.M807756200	http://dx.doi.org/10.1074/jbc.M807756200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106097	Green Published, hybrid			2022-12-27	WOS:000263560600051
J	Wei, HJ; Gan, BY; Wu, XY; Guan, JL				Wei, Huijun; Gan, Boyi; Wu, Xiaoyang; Guan, Jun-Lin			Inactivation of FIP200 Leads to Inflammatory Skin Disorder, but Not Tumorigenesis, in Conditional Knock-out Mouse Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FOCAL ADHESION KINASE; CELL-CYCLE REGULATION; HUMAN BREAST-CANCER; TRANSGENIC MICE; TRANSCRIPTIONAL ACTIVITY; SIGNALING PATHWAYS; IMMUNE-SYSTEM; IFN-GAMMA; TNF-ALPHA	FIP200 (focal adhesion kinase family interacting protein of 200 kDa) has been shown to interact with other proteins to regulate several intracellular signaling pathways. To study a potential role of FIP200 in tumorigenesis and possibly other disease processes in vivo, we created and analyzed murine mammary tumor virus-Cre-mediated FIP200 conditional knock-out (CKO) mice. We found that deletion of FIP200 in mammary epithelial cells did not result in spontaneous development of breast cancer. Moreover, deletion of FIP200 did not further accelerate or inhibit lymphomagenesis induced by inactivation of p53 in mice. Interestingly, however, FIP200 and p53 double conditional knock-out (dCKO) mice exhibited significant hyperplasia of epidermis (acanthosis), thickening of the cornified layer (hyperkeratosis), and increased vascularity in the dermis. FIP200 CKO mice also showed similar, although less severe, skin defects as dCKO mice. Analyses of primary keratinocytes isolated from dCKO mice did not detect increased proliferation of these cells in vitro, suggesting that epidermis hyperproliferation is not epidermal cell-autonomous but may be a consequence of increased inflammation triggered by immune cells in vivo. Consistent with this possibility, we found infiltration of leukocytes including T cells, macrophages, and granulocytes into the dermis and epidermis, associated with activation of NF-kappa B and increased expression of several proinflammatory cytokines and chemokines in skin of the dCKO mice. We further found that cultured FIP200 KO keratinocytes showed reduced NF-kappa B phosphorylation in response to tumor necrosis factor alpha stimulation, suggesting a paracrine regulation of aberrant NF-kappa B activation in the skin microenviroment of dCKO and FIP200 CKO mice. Together, these results demonstrate that ablation of FIP200, although not promoting tumorigenesis, can lead to skin inflammatory disorders, suggesting a novel function of FIP200 in the maintenance of normal skin homeostasis in vivo.	[Wei, Huijun; Gan, Boyi; Wu, Xiaoyang; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Gan, Boyi/HDM-4206-2022		National Institutes of Health [GM52890]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52890 (to J.-L.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Bamba N, 2004, INT J MOL MED, V14, P583; Carroll JM, 1997, J INVEST DERMATOL, V108, P412, DOI 10.1111/1523-1747.ep12289702; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chano T, 2006, INT J MOL MED, V18, P425; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Gudjonsson JE, 2007, J INVEST DERMATOL, V127, P1292, DOI 10.1038/sj.jid.5700807; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Leung DYM, 1999, J ALLERGY CLIN IMMUN, V104, pS99, DOI 10.1016/S0091-6749(99)70051-5; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Martin N, 2008, MOL CELL BIOL, V28, P2771, DOI 10.1128/MCB.01210-07; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Nickoloff BJ, 1999, J CLIN INVEST, V104, P1161, DOI 10.1172/JCI8633; Nickoloff BJ, 1997, NAT MED, V3, P475, DOI 10.1038/nm0597-475b; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Peng X, 2006, J CLIN INVEST, V116, P217, DOI 10.1172/JCI24497; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Rebholz B, 2007, IMMUNITY, V27, P296, DOI 10.1016/j.immuni.2007.05.024; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904	43	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					6004	6013		10.1074/jbc.M806375200	http://dx.doi.org/10.1074/jbc.M806375200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106106	Green Published, hybrid			2022-12-27	WOS:000263560600064
J	Mukherjee, S; Partch, CL; Lehotzky, RE; Whitham, CV; Chu, HT; Bevins, CL; Gardner, KH; Hooper, LV				Mukherjee, Sohini; Partch, Carrie L.; Lehotzky, Rebecca E.; Whitham, Cecilia V.; Chu, Hiutung; Bevins, Charles L.; Gardner, Kevin H.; Hooper, Lora V.			Regulation of C-type Lectin Antimicrobial Activity by a Flexible N-terminal Prosegment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERICIDAL LECTIN; ALPHA-DEFENSINS; ACTIVATION; PROTEINS; EXPRESSION; BINDING; HIP/PAP; ENZYME; DOMAIN; MICE	Members of the RegIII family of intestinal C-type lectins are directly antibacterial proteins that play a vital role in maintaining host-bacterial homeostasis in the mammalian gut, yet little is known about the mechanisms that regulate their biological activity. Here we show that the antibacterial activities of mouse RegIII gamma and its human ortholog, HIP/PAP, are tightly controlled by an inhibitory N-terminal prosegment that is removed by trypsin in vivo. NMR spectroscopy revealed a high degree of conformational flexibility in the HIP/PAP inhibitory prosegment, and mutation of either acidic prosegment residues or basic core protein residues disrupted prosegment inhibitory activity. NMR analyses of pro-HIP/PAP variants revealed distinctive colinear backbone amide chemical shift changes that correlated with antibacterial activity, suggesting that prosegment-HIP/PAP interactions are linked to a two-state conformational switch between biologically active and inactive protein states. These findings reveal a novel regulatory mechanism governing C-type lectin biological function and yield new insight into the control of intestinal innate immunity.	[Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Mukherjee, Sohini; Lehotzky, Rebecca E.; Whitham, Cecilia V.; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Partch, Carrie L.; Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chu, Hiutung; Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Davis	Gardner, KH (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kevin.gardner@utsouthwestern.edu; lora.hooper@utsouthwestern.edu	Gardner, Kevin H./K-7802-2012; Gardner, Kevin/K-5493-2019; Bevins, Charles L/P-4438-2015	Gardner, Kevin H./0000-0002-8671-2556; Bevins, Charles L/0000-0003-2725-2622; Chu, Hiutung/0000-0001-7489-0446	National Institutes of Health [DK070855, GM081875, CA130441]; Burroughs Wellcome Foundation; Robert A. Welch Foundation [1-1659]; NATIONAL CANCER INSTITUTE [F32CA130441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738, R01AI050843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK070855 (to L. V. H.), GM081875 (to K. H. G.), and CA130441 (to C. L. P.). This work was also supported by the Burroughs Wellcome Foundation (New Investigators in the Pathogenesis of Infectious Diseases Award (to L. V. H.), and the Robert A. Welch Foundation (1-1659, to L. V. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abergel C, 1999, ACTA CRYSTALLOGR D, V55, P1487, DOI 10.1107/S0907444999007969; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cash HL, 2006, PROTEIN EXPRES PURIF, V48, P151, DOI 10.1016/j.pep.2006.01.014; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Christa L, 1996, AM J PHYSIOL-GASTR L, V271, pG993, DOI 10.1152/ajpgi.1996.271.6.G993; Clayberger C, 2003, CURR OPIN IMMUNOL, V15, P560, DOI 10.1016/S0952-7915(03)00097-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Graf R, 2001, J BIOL CHEM, V276, P21028, DOI 10.1074/jbc.M010717200; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Mukherjee S, 2008, CELL MOL LIFE SCI, V65, P3019, DOI 10.1007/s00018-008-8182-3; Ogawa H, 2000, AM J PHYSIOL-GASTR L, V279, pG492, DOI 10.1152/ajpgi.2000.279.3.G492; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	27	59	63	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4881	4888		10.1074/jbc.M808077200	http://dx.doi.org/10.1074/jbc.M808077200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095652	Green Published, hybrid			2022-12-27	WOS:000263416600017
J	Li, YD; Ye, BQ; Zheng, SX; Wang, JT; Wang, JG; Chen, M; Liu, JG; Pei, XH; Wang, LJ; Lin, ZX; Gupta, K; Mackman, N; Slungaard, A; Key, NS; Geng, JG				Li, Yi-Dan; Ye, Bu-Qing; Zheng, Sheng-Xi; Wang, Jin-Tao; Wang, Jian-Guo; Chen, Ming; Liu, Ji-Guo; Pei, Xin-Hui; Wang, Li-Jing; Lin, Zhi-Xin; Gupta, Kalpna; Mackman, Nigel; Slungaard, Arne; Key, Nigel S.; Geng, Jian-Guo			NF-kappa B Transcription Factor p50 Critically Regulates Tissue Factor in Deep Vein Thrombosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; CELL-ADHESION; VENOUS THROMBOSIS; FACTOR GENE; ENDOTHELIAL-CELLS; MONOCYTIC CELLS; DEFICIENT MICE; CANCER GROWTH; BONE-MARROW; ACTIVATION	NF-kappa B transcription factors regulate the expression of tissue factor (TF), a principal initiator of the coagulation cascade. Dominant among them is the p50/p65 heterodimer. Here we report that Andrographolide (Andro; a p50 inhibitor) and genetic deletion of p50 attenuated TF activity in stimulated endothelial cells and monocytes/macrophages. Results of the electrophoretic mobility "supershift" assay and chromatin immunoprecipitation demonstrated the direct interaction of the p50/p65 heterodimer with the NF-kappa B site of the human TF promoter. Andro-treated and p50 null mice both exhibited blunted TF expression and reduced venous thrombosis, which were recapitulated by an anti-murine TF antibody in vivo. Our findings thus indicate that regulation of TF by NF-kappa B transcription factor p50 is essential for the pathogenesis of deep vein thrombosis and suggest that specific inhibitors of p50, such as Andro, may be therapeutically valuable for preventing and perhaps treating venous thrombosis.	[Li, Yi-Dan; Ye, Bu-Qing; Zheng, Sheng-Xi; Wang, Jin-Tao; Chen, Ming; Liu, Ji-Guo; Pei, Xin-Hui; Geng, Jian-Guo] Chinese Acad Sci, Grad Sch, Mol Cell Biol Lab, Inst Biochem & Cell Biol,Shangai Inst Biol Sci, Shanghai 200031, Peoples R China; [Wang, Jian-Guo; Mackman, Nigel; Key, Nigel S.] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27599 USA; [Pei, Xin-Hui; Lin, Zhi-Xin] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Wang, Li-Jing] Guangdong Pharmaceut Univ, Inst Basic Med Sci, Guangzhou 510006, Guangdong, Peoples R China; [Gupta, Kalpna; Slungaard, Arne; Geng, Jian-Guo] Univ Minnesota, Sch Med, Vasc Biol Ctr, Minneapolis, MN 55455 USA; [Gupta, Kalpna; Slungaard, Arne; Geng, Jian-Guo] Univ Minnesota, Sch Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of North Carolina; University of North Carolina Chapel Hill; Shanghai Jiao Tong University; Guangdong Pharmaceutical University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Geng, JG (corresponding author), MMC 480,420 Delaware St SE, Minneapolis, MN 55455 USA.	genglab@gmail.com	Xiao, Yang/B-5668-2012		Asia-Pacific International Molecular Biology Network and Institute of Biochemistry and Cell Biology professorship; National Science Foundation of China [30721065, 30623003, 30700409, 30771960, 30630036]; Ministry of Science and Technology of China [2006CB943902, 2006AA02Z169, 2007CB947102, 2007CB914501]; Chinese Academy of Sciences [KSCX2-YW-R-67, KJCX2-YW-H08]; Shanghai Municipal Commission for Science and Technology [06DZ22032, 058014578]; Shanghai Institutes for Biological Sciences [2007KIP203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064743] Funding Source: NIH RePORTER	Asia-Pacific International Molecular Biology Network and Institute of Biochemistry and Cell Biology professorship; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Commission for Science and Technology; Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AI064743. This work was also supported by an Asia-Pacific International Molecular Biology Network and Institute of Biochemistry and Cell Biology professorship, National Science Foundation of China Grants 30721065, 30623003, 30700409, 30771960, and 30630036, Ministry of Science and Technology of China Grants 2006CB943902, 2006AA02Z169, 2007CB947102, and 2007CB914501, Chinese Academy of Sciences Grants KSCX2-YW-R-67 and KJCX2-YW-H08, Shanghai Municipal Commission for Science and Technology Grants 06DZ22032 and 058014578, Shanghai Institutes for Biological Sciences Grant 2007KIP203.	ANDREWS BS, 1991, GENE, V98, P265, DOI 10.1016/0378-1119(91)90184-D; Atarashi K, 2005, J IMMUNOL, V174, P1424, DOI 10.4049/jimmunol.174.3.1424; Campbell IK, 2000, J CLIN INVEST, V105, P1799, DOI 10.1172/JCI8298; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Furie B, 2001, THROMB HAEMOSTASIS, V86, P214, DOI 10.1055/s-0037-1616219; Geng JG, 2004, CURR MED CHEM, V11, P2153, DOI 10.2174/0929867043364720; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Henke PK, 2001, J SURG RES, V99, P84, DOI 10.1006/jsre.2001.6122; Hilliard B, 1999, J IMMUNOL, V163, P2937; JANSON TL, 1984, HAEMOSTASIS, V14, P440; Key NS, 2001, THROMB HAEMOSTASIS, V85, P375; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Ma YQ, 2004, BLOOD, V104, P2549, DOI 10.1182/blood-2004-03-1108; Mack KD, 1998, J IMMUNOL METHODS, V211, P79, DOI 10.1016/S0022-1759(97)00194-4; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; MERCURIO AM, 1984, J EXP MED, V160, P1114, DOI 10.1084/jem.160.4.1114; Modarai B, 2005, THROMB HAEMOSTASIS, V93, P801, DOI 10.1160/TH04-09-0596; Modarai B, 2005, CIRCULATION, V111, P2645, DOI 10.1161/CIRCULATIONAHA.104.492678; Morrissey JH, 2003, J THROMB HAEMOST, V1, P878, DOI 10.1046/j.1538-7836.2003.00219.x; Myers D, 2002, J SURG RES, V108, P212, DOI 10.1006/jsre.2002.6552; Myers DD, 2003, J VASC SURG, V38, P1075, DOI 10.1016/S0741-5214(03)01033-4; Nandiwada SL, 2006, J IMMUNOL, V177, P401, DOI 10.4049/jimmunol.177.1.401; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; Oeth P, 1997, ARTERIOSCL THROM VAS, V17, P365, DOI 10.1161/01.ATV.17.2.365; OETH PA, 1994, MOL CELL BIOL, V14, P3772, DOI 10.1128/MCB.14.6.3772; Ozcan M, 2001, THROMB HAEMOSTASIS, V85, P250, DOI 10.1055/s-0037-1615705; PARRY GCN, 1994, J BIOL CHEM, V269, P20823; Polgar J, 2005, J THROMB HAEMOST, V3, P1590, DOI 10.1111/j.1538-7836.2005.01373.x; SHU HB, 1993, MOL CELL BIOL, V13, P6283, DOI 10.1128/MCB.13.10.6283; Singh I, 2003, CIRCULATION, V107, P869, DOI 10.1161/01.CIR.0000050149.22928.39; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Sullivan VV, 2003, J SURG RES, V109, P1, DOI 10.1016/S0022-4804(02)00041-0; Tilley R, 2006, SEMIN THROMB HEMOST, V32, P5, DOI 10.1055/s-2006-933335; Viles-Gonzalez JF, 2005, AM HEART J, V149, pS19, DOI 10.1016/j.ahj.2004.10.019; Wakefield T W, 1997, Cardiovasc Surg, V5, P6, DOI 10.1016/S0967-2109(96)00083-X; Wakefield Thomas W, 2005, Semin Vasc Surg, V18, P118, DOI 10.1053/j.semvascsurg.2005.05.003; Wakefield TW, 1999, J VASC SURG, V30, P885, DOI 10.1016/S0741-5214(99)70013-3; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang JG, 2006, BLOOD, V107, P558, DOI 10.1182/blood-2005-05-2152; Wang YJ, 2007, CELL RES, V17, P933, DOI 10.1038/cr.2007.89; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; Woollard KJ, 2006, CIRC RES, V98, P149, DOI 10.1161/01.RES.0000199295.14073.69; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739	50	72	86	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4473	4483		10.1074/jbc.M806010200	http://dx.doi.org/10.1074/jbc.M806010200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19095643	Green Published, hybrid			2022-12-27	WOS:000263134400047
J	van Brummelen, AC; Olszewski, KL; Wilinski, D; Llinas, M; Louw, AI; Birkholtz, LM				van Brummelen, Anna C.; Olszewski, Kellen L.; Wilinski, Daniel; Llinas, Manuel; Louw, Abraham I.; Birkholtz, Lyn-Marie			Co-inhibition of Plasmodium falciparum S-Adenosylmethionine Decarboxylase/Ornithine Decarboxylase Reveals Perturbation-specific Compensatory Mechanisms by Transcriptome, Proteome, and Metabolome Analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUCEI-RHODESIENSE INFECTIONS; HUMAN MALARIA; GENE-EXPRESSION; ORNITHINE-DECARBOXYLASE; LYSINE DECARBOXYLASE; BIOSYNTHETIC-ENZYMES; HUMAN-ERYTHROCYTES; CELL-GROWTH; IN-VITRO; POLYAMINES	Polyamines are ubiquitous components of all living cells, and their depletion usually causes cytostasis, a strategy employed for treatment of West African trypanosomiasis. To evaluate polyamine depletion as an anti-malarial strategy, cytostasis caused by the co-inhibition of S-adenosylmethionine decarboxylase/ ornithine decarboxylase in Plasmodium falciparum was studied with a comprehensive transcriptome, proteome, and metabolome investigation. Highly synchronized cultures were sampled just before and during cytostasis, and a novel zero time point definition was used to enable interpretation of results in lieu of the developmentally regulated control of gene expression in P. falciparum. Transcriptome analysis revealed the occurrence of a generalized transcriptional arrest just prior to the growth arrest due to polyamine depletion. However, the abundance of 538 transcripts was differentially affected and included three perturbation-specific compensatory transcriptional responses as follows: the increased abundance of the transcripts for lysine decarboxylase and ornithine aminotransferase and the decreased abundance of that for S-adenosylmethionine synthetase. Moreover, the latter two compensatory mechanisms were confirmed on both protein and metabolite levels confirming their biological relevance. In contrast with previous reports, the results provide evidence that P. falciparum responds to alleviate the detrimental effects of polyamine depletion via regulation of its transcriptome and subsequently the proteome and metabolome.	[van Brummelen, Anna C.; Louw, Abraham I.; Birkholtz, Lyn-Marie] Univ Pretoria, Dept Biochem, ZA-0002 Gauteng, South Africa; [Olszewski, Kellen L.; Wilinski, Daniel; Llinas, Manuel] Princeton Univ, Dept Mol Biol, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA	University of Pretoria; Princeton University	Birkholtz, LM (corresponding author), Univ Pretoria, Dept Biochem, Lynwood Rd, ZA-0002 Pretoria, South Africa.	lbirkholtz@up.ac.za	Louw, Abraham I/A-5726-2008; Birkholtz, Lyn-Marie/E-2939-2010; Birkholtz, Lyn-Marie/AAF-8481-2019	Birkholtz, Lyn-Marie/0000-0001-5888-2905; Birkholtz, Lyn-Marie/0000-0001-5888-2905; Louw, Abraham/0000-0002-8036-1513	National Research Foundation [FA2004051300055, TTK2006061500031]; Prestigious Bursary; South African Malaria Initiative; University of Pretoria; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	National Research Foundation; Prestigious Bursary; South African Malaria Initiative; University of Pretoria; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Research Foundation Grant FA2004051300055, Thuthuka TTK2006061500031, and Prestigious Bursary (to A. C. v. B.), the South African Malaria Initiative, and the University of Pretoria. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alm K, 1999, J CELL BIOCHEM, V75, P46, DOI 10.1002/(SICI)1097-4644(19991001)75:1<46::AID-JCB5>3.3.CO;2-E; ASSARAF YG, 1984, BIOCHEM J, V222, P815, DOI 10.1042/bj2220815; ASSARAF YG, 1987, PARASITOL RES, V73, P313, DOI 10.1007/BF00531084; BACCHI CJ, 1992, ANTIMICROB AGENTS CH, V36, P2736, DOI 10.1128/AAC.36.12.2736; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Birkholtz L, 2008, ACTA TROP, V105, P113, DOI 10.1016/j.actatropica.2007.10.013; BITONTI AJ, 1987, EXP PARASITOL, V64, P237, DOI 10.1016/0014-4894(87)90148-2; BITONTI AJ, 1989, P NATL ACAD SCI USA, V86, P651, DOI 10.1073/pnas.86.2.651; BITONTI AJ, 1990, ANTIMICROB AGENTS CH, V34, P1485, DOI 10.1128/AAC.34.8.1485; Boshoff HIM, 2006, MICROBES INFECT, V8, P1654, DOI 10.1016/j.micinf.2005.11.018; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; BYERS TL, 1991, BIOCHEM J, V274, P527, DOI 10.1042/bj2740527; Clark K, 2008, BIOL CHEM, V389, P111, DOI 10.1515/BC.2008.014; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Cui L, 2008, EUKARYOT CELL, V7, P1200, DOI 10.1128/EC.00063-08; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; Das Gupta R, 2005, ANTIMICROB AGENTS CH, V49, P2857, DOI 10.1128/AAC.49.7.2857-2864.2005; Date SV, 2006, GENOME RES, V16, P542, DOI 10.1101/gr.4573206; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Deitsch K, 2007, AM J TROP MED HYG, V77, P201; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efferth T, 2006, MOL CANCER THER, V5, P1986, DOI 10.1158/1535-7163.MCT-06-0086; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang J, 2004, MOL BIOCHEM PARASIT, V133, P125, DOI 10.1016/j.molbiopara.2003.09.004; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gunasekera AM, 2003, MOL MICROBIOL, V50, P1229, DOI 10.1046/j.1365-2958.2003.03787.x; Gunasekera AM, 2007, EXP PARASITOL, V117, P87, DOI 10.1016/j.exppara.2007.03.001; Haider N, 2005, MOL BIOCHEM PARASIT, V142, P224, DOI 10.1016/j.molbiopara.2005.04.004; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; ICEKSON I, 1986, PLANT PHYSIOL, V82, P607, DOI 10.1104/pp.82.2.607; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Johnsson A, 2005, ANTICANCER RES, V25, P2661; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch K, 2005, MOLECULAR APPROACHES TO MALARIA, P68; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lu WY, 2006, J AM SOC MASS SPECTR, V17, P37, DOI 10.1016/j.jasms.2005.09.001; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Makanga M, 2005, PROTEOMICS, V5, P1849, DOI 10.1002/pmic.200401076; Muller IB, 2008, MOL BIOCHEM PARASIT, V160, P1, DOI 10.1016/j.molbiopara.2008.03.008; Muller S, 2000, J BIOL CHEM, V275, P8097, DOI 10.1074/jbc.275.11.8097; MUSCARI C, 1995, MOL CELL BIOCHEM, V144, P125, DOI 10.1007/BF00944391; Natalang O, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-388; Nemoto T, 2001, BIOCHEM BIOPH RES CO, V280, P848, DOI 10.1006/bbrc.2000.4227; Nirmalan N, 2004, MOL MICROBIOL, V52, P1187, DOI 10.1111/j.1365-2958.2004.04049.x; Nirmalan N, 2002, MOL MICROBIOL, V46, P179, DOI 10.1046/j.1365-2958.2002.03148.x; Oakley MSM, 2007, INFECT IMMUN, V75, P2012, DOI 10.1128/IAI.01236-06; ODEN KL, 1983, BIOCHEMISTRY-US, V22, P2978, DOI 10.1021/bi00281a030; Reguera RM, 2005, COMP BIOCHEM PHYS C, V140, P151, DOI 10.1016/j.cca.2005.02.006; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; Seiler N, 2005, J CELL MOL MED, V9, P623, DOI 10.1111/j.1582-4934.2005.tb00493.x; Seiler N, 2003, CURR DRUG TARGETS, V4, P537, DOI 10.2174/1389450033490885; SHAPIRO T, 2006, GOODMAN GILMANS PHAR, P1053; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stoeckert CJ, 2006, TRENDS PARASITOL, V22, P543, DOI 10.1016/j.pt.2006.09.005; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TADOLINI B, 1988, BIOCHEM J, V249, P33, DOI 10.1042/bj2490033; Takatsuka Y, 2000, J BACTERIOL, V182, P6732, DOI 10.1128/JB.182.23.6732-6741.2000; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Tkachenko AG, 2003, BIOCHEMISTRY-MOSCOW+, V68, P850, DOI 10.1023/A:1025790729797; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Ueda M, 1998, INVEST OPHTH VIS SCI, V39, P820; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; WRIGHT PS, 1991, BIOCHEM PHARMACOL, V41, P1713, DOI 10.1016/0006-2952(91)90174-4; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yang YH, 2005, STAT BIOL HEALTH, P49; Yeh I, 2006, MINI-REV MED CHEM, V6, P177, DOI 10.2174/138955706775475957; Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200; Young JA, 2005, PHARMACOGENOMICS, V6, P17, DOI 10.1517/14622416.6.1.17	75	53	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4635	4646		10.1074/jbc.M807085200	http://dx.doi.org/10.1074/jbc.M807085200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19073607	Green Published, hybrid			2022-12-27	WOS:000263134400063
J	Zong, HH; Bastie, CC; Xu, J; Fassler, R; Campbell, KP; Kurland, IJ; Pessin, JE				Zong, Haihong; Bastie, Claire C.; Xu, Jun; Fassler, Reinhard; Campbell, Kevin P.; Kurland, Irwin J.; Pessin, Jeffrey E.			Insulin Resistance in Striated Muscle-specific Integrin Receptor beta 1-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; HUMAN SKELETAL-MUSCLE; PROTEIN-KINASE; LINKED KINASE; GLYCOGEN-SYNTHASE; SUBSTRATE-1 PHOSPHORYLATION; CELL-ADHESION; BETA-1-INTEGRIN; ACTIVATION	Integrin receptor plays key roles in mediating both inside-out and outside-in signaling between cells and the extracellular matrix. We have observed that the tissue-specific loss of the integrin beta 1 subunit in striated muscle results in a near complete loss of integrin beta 1 subunit protein expression concomitant with a loss of talin and to a lesser extent, a reduction in F-actin content. Muscle-specific integrin beta 1-deficient mice had no significant difference in food intake, weight gain, fasting glucose, and insulin levels with their littermate controls. However, dynamic analysis of glucose homeostasis using euglycemic- hyperinsulinemic clamps demonstrated a 44 and 48% reduction of insulin-stimulated glucose infusion rate and glucose clearance, respectively. The whole body insulin resistance resulted from a specific inhibition of skeletal muscle glucose uptake and glycogen synthesis without any significant effect on the insulin suppression of hepatic glucose output or insulin-stimulated glucose uptake in adipose tissue. The reduction in skeletal muscle insulin responsiveness occurred without any change in GLUT4 protein expression levels but was associated with an impairment of the insulin-stimulated protein kinase B/Akt serine 473 phosphorylation but not threonine 308. The inhibition of insulin-stimulated serine 473 phosphorylation occurred concomitantly with a decrease in integrin-linked kinase expression but with no change in the mTOR.Rictor.LST8 complex (mTORC2). These data demonstrate an in vivo crucial role of integrin beta 1 signaling events in mediating cross-talk to that of insulin action.	[Zong, Haihong; Bastie, Claire C.; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Zong, Haihong; Bastie, Claire C.; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Xu, Jun; Kurland, Irwin J.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Fassler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82151 Martinsried, Germany; [Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA; [Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA; [Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Max Planck Society; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Pessin, JE (corresponding author), Albert Einstein Coll Med, Dept Med, 1301 Morris Pk Ave, Bronx, NY 10461 USA.	jpessin@aecom.yu.edu		Campbell, Kevin/0000-0003-2066-5889; Bastie, Claire/0000-0001-8178-4748	National Institutes of Health [DK55811, DK33823, DK20541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055811, P30DK020541, R01DK058132, P60DK020541, R37DK033823, R01DK033823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK55811, DK33823, and DK20541. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama S K, 1996, Hum Cell, V9, P181; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bjornholm M, 1997, DIABETES, V46, P524, DOI 10.2337/diabetes.46.3.524; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; CARO JF, 1987, J CLIN INVEST, V79, P1330, DOI 10.1172/JCI112958; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; DAMSBO P, 1991, DIABETOLOGIA, V34, P239, DOI 10.1007/BF00405082; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dormond O, 2007, J BIOL CHEM, V282, P23679, DOI 10.1074/jbc.M700563200; Gary DS, 2001, J NEUROCHEM, V76, P1485, DOI 10.1046/j.1471-4159.2001.00173.x; Gauthier R, 2001, AM J PHYSIOL-CELL PH, V280, pC1540, DOI 10.1152/ajpcell.2001.280.6.C1540; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GINSBERG MH, 1983, J CELL BIOL, V97, P571, DOI 10.1083/jcb.97.2.571; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Guilherme A, 1998, J BIOL CHEM, V273, P33119, DOI 10.1074/jbc.273.50.33119; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang DS, 2006, ENDOCRINOLOGY, V147, P3333, DOI 10.1210/en.2005-0382; Huang DS, 2002, J BIOL CHEM, V277, P18151, DOI 10.1074/jbc.M104252200; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; JOHNSON AB, 1991, METABOLISM, V40, P252, DOI 10.1016/0026-0495(91)90106-7; Joy AM, 2003, J CELL SCI, V116, P4409, DOI 10.1242/jcs.00712; Kanagawa M, 2005, FEBS LETT, V579, P4792, DOI 10.1016/j.febslet.2005.07.059; Kanzaki M, 2006, ENDOCR J, V53, P267, DOI 10.1507/endocrj.KR-65; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Kim JK, 1996, DIABETES, V45, P651, DOI 10.2337/diabetes.45.5.651; Kim YB, 2005, MOL CELL BIOL, V25, P9713, DOI 10.1128/MCB.25.21.9713-9723.2005; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kuppuswamy D, 2002, CIRC RES, V90, P1240, DOI 10.1161/01.RES.0000025080.78636.23; Li FG, 1999, J CELL SCI, V112, P4589; Mandarino LJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE463, DOI 10.1152/ajpendo.1996.270.3.E463; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; OHSHIMA K, 1984, AM J PHYSIOL, V246, pE193, DOI 10.1152/ajpendo.1984.246.2.E193; Oshikawa J, 2004, P NATL ACAD SCI USA, V101, P12670, DOI 10.1073/pnas.0402053101; Pasquet JM, 2002, THROMB HAEMOSTASIS, V88, P115; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pencek RR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1124, DOI 10.1152/ajpendo.00598.2004; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Ren JH, 1997, BIOCHEMISTRY-US, V36, P10213, DOI 10.1021/bi9709295; Ryder JW, 2001, FRONT BIOSCI-LANDMRK, V6, pD154, DOI 10.2741/Ryder; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Shai SY, 2002, GENET ENG P, V24, P87; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Tai YT, 2003, CANCER RES, V63, P5850; Tomas E, 2002, ANN NY ACAD SCI, V967, P43; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang HV, 2008, J CELL BIOL, V180, P1037, DOI 10.1083/jcb.200707175; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamaji S, 2002, BIOCHEM BIOPH RES CO, V297, P1324, DOI 10.1016/S0006-291X(02)02381-1; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Yujiri T, 2003, J BIOL CHEM, V278, P3846, DOI 10.1074/jbc.M206087200; Zierath JR, 1998, MOL CELL BIOCHEM, V182, P153, DOI 10.1023/A:1006861628496; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	66	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4679	4688		10.1074/jbc.M807408200	http://dx.doi.org/10.1074/jbc.M807408200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19064993	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000263134400067
J	Ramseger, R; White, R; Kroger, S				Ramseger, Rene; White, Robin; Kroeger, Stephan			Transmembrane Form Agrin-induced Process Formation Requires Lipid Rafts and the Activation of Fyn and MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS; NICOTINIC ACETYLCHOLINE-RECEPTOR; CULTURED HIPPOCAMPAL-NEURONS; SIGNAL-TRANSDUCTION; CORTICAL-NEURONS; TYROSINE KINASE; DEFICIENT MICE; NEUROMUSCULAR-JUNCTION; DENDRITIC FILOPODIA	Overexpression or clustering of the transmembrane form of the extracellular matrix heparan sulfate proteoglycan agrin (TM-agrin) induces the formation of highly dynamic filopodia-like processes on axons and dendrites from central and peripheral nervous system-derived neurons. Here we show that the formation of these processes is paralleled by a partitioning of TM-agrin into lipid rafts, that lipid rafts and transmembrane-agrin colocalize on the processes, that extraction of lipid rafts with methyl-beta-cyclodextrin leads to a dose-dependent reduction of process formation, that inhibition of lipid raft synthesis prevents process formation, and that the continuous presence of lipid rafts is required for the maintenance of the processes. Association of TM-agrin with lipid rafts results in the phosphorylation and activation of the Src family kinase Fyn and subsequently in the phosphorylation and activation of MAPK. Inhibition of Fyn or MAPK activation inhibits process formation. These results demonstrate that the formation of filopodia-like processes by TM-agrin is the result of the activation of a complex intracellular signaling cascade, supporting the hypothesis that TM-agrin is a receptor or coreceptor on neurons.	[Ramseger, Rene] Johannes Gutenberg Univ Mainz, Dept Physiol Chem, D-55128 Mainz, Germany; [White, Robin; Kroeger, Stephan] Johannes Gutenberg Univ Mainz, Dept Biol, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Kroger, S (corresponding author), Univ Munich, Dept Physiol, Schillerstr 46, D-80336 Munich, Germany.	skroeger@lmu.de		Kroger, Stephan/0000-0002-4626-1690	Deutsche Forschungsgemeinschaft [Kr1039/7]; Deutsche Forschungsgemeinschaft Priority Program 1086 [Kr1039/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft Priority Program 1086(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft Grant Kr1039/7 and Deutsche Forschungsgemeinschaft Priority Program 1086 Grant Kr1039/9.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Annies M, 2006, MOL CELL NEUROSCI, V31, P515, DOI 10.1016/j.mcn.2005.11.005; Annies M, 2002, MOL CELL NEUROSCI, V20, P525, DOI 10.1006/mcne.2002.1125; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bose CM, 2000, J NEUROSCI, V20, P9086; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41; Campagna JA, 2006, NEUROSCIENCE, V138, P123, DOI 10.1016/j.neuroscience.2005.11.019; Chen L, 2006, J BIOL CHEM, V281, P24575, DOI 10.1074/jbc.M604147200; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ferreira A, 1999, J CELL SCI, V112, P4729; Fiala JC, 1998, J NEUROSCI, V18, P8900; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; HALFTER W, 1987, J NEUROSCI, V7, P3712; Halfter W, 1997, J COMP NEUROL, V383, P1; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Hering H, 2003, J NEUROSCI, V23, P3262; Hilgenberg LGW, 1999, J NEUROSCI, V19, P7384, DOI 10.1523/JNEUROSCI.19-17-07384.1999; Hilgenberg LGW, 2004, J NEUROBIOL, V61, P289, DOI 10.1002/neu.20049; INOKUCHI J, 1987, CANCER LETT, V38, P23, DOI 10.1016/0304-3835(87)90196-0; Iwase T, 2005, J NEUROCHEM, V94, P1488, DOI 10.1111/j.1471-4159.2005.03290.x; Kammerer RA, 1999, EMBO J, V18, P6762, DOI 10.1093/emboj/18.23.6762; Karasewski L, 2003, J NEUROBIOL, V55, P14, DOI 10.1002/neu.10197; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kim MJ, 2007, GLYCOBIOLOGY, V17, P231, DOI 10.1093/glycob/cwl069; Kim MJ, 2003, J NEUROBIOL, V55, P261, DOI 10.1002/neu.10213; Kolkova K, 2000, J NEUROSCI, V20, P2238; Kovacic B, 1998, J BIOL CHEM, V273, P35185; Kroger S, 2002, NEWS PHYSIOL SCI, V17, P207, DOI 10.1152/01390.2002; Kroger S, 1996, J NEUROBIOL, V29, P165; Kroger S, 1997, MOL CELL NEUROSCI, V10, P149, DOI 10.1006/mcne.1997.0651; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; Li WJ, 2005, J BIOL CHEM, V280, P6036, DOI 10.1074/jbc.M406546200; Li Z, 1999, J NEUROBIOL, V39, P547, DOI 10.1002/(SICI)1097-4695(19990615)39:4<547::AID-NEU8>3.0.CO;2-C; Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008; Ma L, 2003, J NEUROSCI, V23, P3164; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mantych KB, 2001, J NEUROSCI, V21, P6802, DOI 10.1523/JNEUROSCI.21-17-06802.2001; Marta CB, 2003, J NEUROSCI, V23, P5461; Mayer BJ, 2001, J CELL SCI, V114, P1253; McCroskery S, 2006, MOL CELL NEUROSCI, V33, P15, DOI 10.1016/j.mcn.2006.06.004; Nagafuku M, 2003, J BIOL CHEM, V278, P51920, DOI 10.1074/jbc.M307674200; Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932; Parnass Z, 2000, HIPPOCAMPUS, V10, P561, DOI 10.1002/1098-1063(2000)10:5<561::AID-HIPO6>3.3.CO;2-O; PLEIMAN CM, 1993, MOL CELL BIOL, V13, P5877, DOI 10.1128/MCB.13.9.5877; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SCHON A, 1989, BIOCHEMISTRY-US, V28, P5019, DOI 10.1021/bi00438a017; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Szczur K, 2006, BLOOD, V108, P4205, DOI 10.1182/blood-2006-03-013789; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Tatton L, 2003, J BIOL CHEM, V278, P4847, DOI 10.1074/jbc.M209321200; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; Uhm CS, 2001, J NEUROSCI, V21, P9678, DOI 10.1523/JNEUROSCI.21-24-09678.2001; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Wu CC, 1999, NEUROSCIENCE, V92, P665, DOI 10.1016/S0306-4522(99)00018-4; Zhu D, 2006, J NEUROSCI, V26, P4841, DOI 10.1523/JNEUROSCI.2807-05.2006; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	74	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7697	7705		10.1074/jbc.M806719200	http://dx.doi.org/10.1074/jbc.M806719200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19139104	hybrid, Green Published			2022-12-27	WOS:000264195600032
J	Gao, Y; Howard, A; Ban, K; Chandra, J				Gao, Yin; Howard, Adrienne; Ban, Kechen; Chandra, Joya			Oxidative Stress Promotes Transcriptional Up-regulation of Fyn in BCR-ABL1-expressing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASES; SRC-FAMILY KINASES; PHILADELPHIA-CHROMOSOME; ROS PRODUCTION; DNA-DAMAGE; GC BOXES; BCR/ABL; GENE; ACTIVATION; REGION	Signaling initiated by the BCR-ABL1 kinase causes chronic myelogenous leukemia (CML). Recently, we reported that expression of Fyn, a Src kinase, is heightened in CML cells and patient specimens and confers in vitro and in vivo proliferative advantages. Fyn is regulated by redox, and because BCR-ABL1 raises intracellular oxidant levels, which have been implicated in CML progression, we explored the molecular regulation of Fyn. Here we identify the transcription factors that drive redox- and BCR-ABL1-dependent Fyn expression. Promoter deletion analysis in 293T, BaF3, BaF3-p210, and K562 cells identified the region essential for basal transcriptional activity. Mutation of Sp1 and Egr1 binding sites within the essential region diminished Fyn promoter activity and identified Egr1 as conferring redox sensitivity. Gel shift and chromatin immunoprecipitation assays confirmed the binding of Sp1 and Egr1 to the promoter fragments. Importantly, knockdown of Sp1 or Egr1 with small interference RNA or inhibition of Sp1 binding by mithramycin A repressed Fyn protein expression. Our work is the first to define transcription factors that are responsible for endogenous, oxidative stress-dependent and BCR-ABL1-dependent Fyn expression.	[Gao, Yin; Howard, Adrienne; Ban, Kechen; Chandra, Joya] Univ Texas MD Anderson Canc Ctr, Childrens Canc Hosp MD Anderson, Dept Pediat Res, Unit 853, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chandra, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Box 853,1515 Holcombe Blvd, Houston, TX 77030 USA.	jchandra@mdanderson.org	Chandra, Joya/ABC-7869-2021	Chandra, Joya/0000-0002-2077-9715	National Institutes of Health [RO1 CA 115811]; NATIONAL CANCER INSTITUTE [R01CA115811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA 115811 (to J.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe J, 1999, J BIOL CHEM, V274, P21003, DOI 10.1074/jbc.274.30.21003; Albertini V, 2006, NUCLEIC ACIDS RES, V34, P1721, DOI 10.1093/nar/gkl063; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Arlinghaus Ralph, 2004, Cancer Treat Res, V119, P239; Ban KC, 2008, BLOOD, V111, P2904, DOI 10.1182/blood-2007-05-091769; Berwanger B, 2002, CANCER CELL, V2, P377, DOI 10.1016/S1535-6108(02)00179-4; BONHAM K, 1993, ONCOGENE, V8, P1973; Chandra J, 1998, BLOOD, V92, P4220, DOI 10.1182/blood.V92.11.4220.423k49_4220_4229; Chang IS, 2007, BLOOD, V110, P994, DOI 10.1182/blood-2007-03-078303; COURTNEIDGE SA, 1993, DEVELOPMENT, P57; Dang CV, 2005, CELL CYCLE, V4, P1465, DOI 10.4161/cc.4.11.2121; DATTA R, 1993, P NATL ACAD SCI USA, V90, P2419, DOI 10.1073/pnas.90.6.2419; Deininger MWN, 2007, EXP HEMATOL, V35, P144, DOI 10.1016/j.exphem.2007.01.023; Doggrell SA, 2005, EXPERT OPIN INV DRUG, V14, P89, DOI 10.1517/13543784.14.1.89; Eiring AM, 2008, BLOOD, V111, P816, DOI 10.1182/blood-2007-05-090472; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fukada T, 2001, J BIOL CHEM, V276, P25512, DOI 10.1074/jbc.M101354200; Furumoto Y, 2004, IMMUNOL RES, V30, P241, DOI 10.1385/IR:30:2:241; Guerzoni C, 2006, BLOOD, V107, P4080, DOI 10.1182/blood-2005-08-3181; Hauses M, 1998, J BIOL CHEM, V273, P31844, DOI 10.1074/jbc.273.48.31844; Hochhaus A, 2007, SEMIN HEMATOL, V44, pS15, DOI 10.1053/j.seminhematol.2006.12.002; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Juric D, 2007, J CLIN ONCOL, V25, P1341, DOI 10.1200/JCO.2006.09.3534; Kamath AV, 2008, CANCER CHEMOTH PHARM, V61, P365, DOI 10.1007/s00280-007-0478-8; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Lee J, 2006, FASEB J, V20, P2375, DOI 10.1096/fj.06-5957fje; Legros L, 2004, BLOOD, V104, P495, DOI 10.1182/blood-2003-08-2695; Long J, 2007, CANCER CHEMOTH PHARM, V59, P527, DOI 10.1007/s00280-006-0295-5; Masutani H, 2000, INT J HEMATOL, V71, P25; MATSUZAWA Y, 1991, ONCOGENE, V6, P1561; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Nowell PC, 2007, J CLIN INVEST, V117, P2033, DOI 10.1172/JCI31771; Nowicki MO, 2004, BLOOD, V104, P3746, DOI 10.1182/blood-2004-05-1941; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Penserga ETP, 2007, ONCOGENE, V26, P11, DOI 10.1038/sj.onc.1209756; Ritchie S, 2000, J BIOL CHEM, V275, P847, DOI 10.1074/jbc.275.2.847; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sanguinetti AR, 2003, BIOCHEM J, V376, P159, DOI 10.1042/BJ20030336; Sattler M, 2003, SEMIN HEMATOL, V40, P4, DOI 10.1053/shem.2003.50034; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Shah NP, 2003, ONCOGENE, V22, P7389, DOI 10.1038/sj.onc.1206942; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Sorensen KD, 2008, INT J CANCER, V122, P509, DOI 10.1002/ijc.23136; Stuart JR, 2005, ONCOGENE, V24, P8085, DOI 10.1038/sj.onc.1208953; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; UCHIUMI F, 1992, MOL CELL BIOL, V12, P3784, DOI 10.1128/MCB.12.9.3784	50	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7114	7125		10.1074/jbc.M804801200	http://dx.doi.org/10.1074/jbc.M804801200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131339	hybrid, Green Published			2022-12-27	WOS:000263919000059
J	Berdyshev, EV; Gorshkova, I; Skobeleva, A; Bittman, R; Lu, XQ; Dudek, SM; Mirzapoiazova, T; Garcia, JGN; Natarajan, V				Berdyshev, Evgeny V.; Gorshkova, Irina; Skobeleva, Anastasia; Bittman, Robert; Lu, Xuequan; Dudek, Steven M.; Mirzapoiazova, Tamara; Garcia, Joe G. N.; Natarajan, Viswanathan			FTY720 Inhibits Ceramide Synthases and Up-regulates Dihydrosphingosine 1-Phosphate Formation in Human Lung Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE KINASE; IMMUNOSUPPRESSANT FTY720; DRUG FTY720; SPHINGOSINE-1-PHOSPHATE; APOPTOSIS; MODULATION; GENERATION; PHOSPHORYLATION; HEPATOTOXICITY; ACCUMULATION	Novel immunomodulatory molecule FTY720 is a synthetic analog of myriocin, but unlike myriocin FTY720 does not inhibit serine palmitoyltransferase. Although many of the effects of FTY720 are ascribed to its phosphorylation and subsequent sphingosine 1-phosphate (S1P)-like action through S1P(1,3-5) receptors, studies on modulation of intracellular balance of signaling sphingolipids by FTY720 are limited. In this study, we used stable isotope pulse labeling of human pulmonary artery endothelial cells with L-[U-C-13,N-15] serine as well as in vitro enzymatic assays and liquid chromatography-tandem mass spectrometry methodology to characterize FTY720 interference with sphingolipid de novo biosynthesis. In human pulmonary artery endothelial cells, FTY720 inhibited ceramide synthases, resulting in decreased cellular levels of dihydroceramides, ceramides, sphingosine, and S1P but increased levels of dihydrosphingosine and dihydrosphingosine 1-phosphate (DHS1P). The FTY720-induced modulation of sphingolipid de novo biosynthesis was similar to that of fumonisin B1, a classical inhibitor of ceramide synthases, but differed in the efficiency to inhibit biosynthesis of short-chain versus long-chain ceramides. In vitro kinetic studies revealed that FTY720 is a competitive inhibitor of ceramide synthase 2 toward dihydrosphingosine with an apparent K-i of 2.15 mu M. FTY720-induced up-regulation of DHS1P level was mediated by sphingosine kinase (SphK) 1, but not SphK2, as confirmed by experiments using SphK1/2 silencing with small interfering RNA. Our data demonstrate for the first time the ability of FTY720 to inhibit ceramide synthases and modulate the intracellular balance of signaling sphingolipids. These findings open a novel direction for therapeutic applications of FTY720 that focuses on inhibition of ceramide biosynthesis, ceramide-dependent signaling, and the up-regulation of DHS1P generation in cells.	[Natarajan, Viswanathan] Univ Chicago, Dept Med, Div Biol Sci, GCIS, Chicago, IL 60637 USA; [Bittman, Robert; Lu, Xuequan] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	University of Chicago; City University of New York (CUNY) System; Queens College NY (CUNY)	Natarajan, V (corresponding author), Univ Chicago, Dept Med, Div Biol Sci, GCIS, 929 E 57th St, Chicago, IL 60637 USA.	eberdysh@medicine.bsd.uchicago.edu	Garcia, Joe GN/E-8862-2010		National Institutes of Health [HL-079396, HL-083187]; Lipidomics Facility of the Department of Medicine at the University of Chicago; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187, R37HL079396, R01HL079396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lipidomics Facility of the Department of Medicine at the University of Chicago(University of Chicago); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-079396 (to V. N.) and HL-083187 (to R. B.). This work was also supported by the Lipidomics Facility of the Department of Medicine at the University of Chicago.	Bandhuvula P, 2005, J BIOL CHEM, V280, P33697, DOI 10.1074/jbc.C500294200; Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Desai K, 2002, BBA-MOL CELL BIOL L, V1585, P188, DOI 10.1016/S1388-1981(02)00340-2; Eto M, 2006, INT J UROL, V13, P148, DOI 10.1111/j.1442-2042.2006.01249.x; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; He QR, 2006, TOXICOL SCI, V94, P388, DOI 10.1093/toxsci/kfl102; Hiestand Peter C., 2008, V66; Huwiler A, 2006, CURR PHARM DESIGN, V12, P4625, DOI 10.2174/138161206779010422; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Kim DH, 2007, ARCH PHARM RES, V30, P962, DOI 10.1007/BF02993964; Kim DH, 2006, J TOXICOL ENV HEAL A, V69, P2071, DOI 10.1080/15287390600746215; Kiuchi M, 2000, J MED CHEM, V43, P2946, DOI 10.1021/jm000173z; LaMontagne K, 2006, CANCER RES, V66, P221, DOI 10.1158/0008-5472.CAN-05-2001; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Le Stunff H, 2002, J BIOL CHEM, V277, P8920, DOI 10.1074/jbc.M109968200; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lu XQ, 2006, TETRAHEDRON LETT, V47, P825, DOI 10.1016/j.tetlet.2005.11.092; Mansoor M, 2008, REV RECENT CLIN TRIA, V3, P62, DOI 10.2174/157488708783330486; Merrill AH, 1996, ADV EXP MED BIOL, V392, P297; Merrill AH, 2000, METHOD ENZYMOL, V312, P3; Morales A, 2007, MINI-REV MED CHEM, V7, P371, DOI 10.2174/138955707780363792; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Panjarian S, 2008, PROSTAG OTH LIPID M, V86, P41, DOI 10.1016/j.prostaglandins.2008.02.004; Paugh SW, 2006, MOL PHARMACOL, V70, P41, DOI 10.1124/mol.105.020552; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Payne SG, 2007, BLOOD, V109, P1077, DOI 10.1182/blood-2006-03-011437; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Salm P, 2006, J CHROMATOGR B, V843, P157, DOI 10.1016/j.jchromb.2006.05.026; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Schmid G, 2005, TRANSPL P, V37, P110, DOI 10.1016/j.transproceed.2004.12.278; Schmid G, 2007, J CELL BIOCHEM, V101, P259, DOI 10.1002/jcb.21181; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Seumois G, 2007, J LEUKOCYTE BIOL, V81, P1477, DOI 10.1189/jlb.0806529; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Suzuki H, 2007, TOXICOLOGY, V229, P42, DOI 10.1016/j.tox.2006.09.010; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Thevissen K, 2006, MINI-REV MED CHEM, V6, P699, DOI 10.2174/138955706777435643; VASKOVSKY VE, 1975, J CHROMATOGR, V114, P129, DOI 10.1016/S0021-9673(00)85249-8; Vessey DA, 2007, J BIOCHEM MOL TOXIC, V21, P273, DOI 10.1002/jbt.20193; Yamaji-Hasegawa A, 2005, BIOCHEMISTRY-US, V44, P268, DOI 10.1021/bi048605l; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628; Zhang Z, 2007, MINI-REV MED CHEM, V7, P845; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	53	128	131	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5467	5477		10.1074/jbc.M805186200	http://dx.doi.org/10.1074/jbc.M805186200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19119142	Green Published, hybrid			2022-12-27	WOS:000263560600009
J	Shaik, SS; Soltau, TD; Chaturvedi, G; Totapally, B; Hagood, JS; Andrews, WW; Athar, M; Voitenok, NN; Killingsworth, CR; Patel, RP; Fallon, MB; Maheshwari, A				Shaik, Sadiq S.; Soltau, Thomas D.; Chaturvedi, Gaurav; Totapally, Balagangadhar; Hagood, James S.; Andrews, William W.; Athar, Mohammad; Voitenok, Nikolai N.; Killingsworth, Cheryl R.; Patel, Rakesh P.; Fallon, Michael B.; Maheshwari, Akhil			Low Intensity Shear Stress Increases Endothelial ELR+ CXC Chemokine Production via a Focal Adhesion Kinase-p38 beta MAPK-NF-kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; NITRIC-OXIDE SYNTHASE; POLYMORPHONUCLEAR LEUKOCYTES; TRANSCRIPTIONAL ACTIVATION; SIGNALING PATHWAY; SKELETAL-MUSCLE; GENE-EXPRESSION; MOLECULAR-BASIS; CELLS; FLOW	CXC chemokines with a glutamate-leucine-arginine (ELR) tripeptide motif (ELR+ CXC chemokines) play an important role in leukocyte trafficking into the tissues. For reasons that are not well elucidated, circulating leukocytes are recruited into the tissues mainly in small vessels such as capillaries and venules. Because ELR+ CXC chemokines are important mediators of endothelial-leukocyte interaction, we compared chemokine expression by microvascular and aortic endothelium to investigate whether differences in chemokine expression by various endothelial types could, at least partially, explain the microvascular localization of endothelial-leukocyte interaction. Both in vitro and in vivo models indicate that ELR+ CXC chemokine expression is higher in microvascular endothelium than in aortic endothelial cells. These differences can be explained on the basis of the preferential activation of endothelial chemokine production by low intensity shear stress. Low shear activated endothelial ELR+ CXC chemokine production via cell surface heparan sulfates, beta(3)-integrins, focal adhesion kinase, the mitogen-activated protein kinase p38 beta, mitogen-and stress-associated protein kinase-1, and the transcription factor.	[Hagood, James S.; Maheshwari, Akhil] Univ Alabama, Dept Pediat, Translat Res Normal & Disordered Dev Program, Birmingham, AL 35233 USA; [Hagood, James S.; Maheshwari, Akhil] Univ Alabama, Dept Cell Biol, Birmingham, AL 35233 USA; [Andrews, William W.] Univ Alabama, Dept Obstet & Gynecol, Birmingham, AL 35233 USA; [Athar, Mohammad] Univ Alabama, Dept Dermatol, Birmingham, AL 35233 USA; [Killingsworth, Cheryl R.] Univ Alabama, Dept Internal Med, Birmingham, AL 35233 USA; [Patel, Rakesh P.; Maheshwari, Akhil] Univ Alabama, Dept Pathol, Birmingham, AL 35233 USA; [Fallon, Michael B.] Vet Affairs Hosp, Birmingham, AL 35233 USA; [Voitenok, Nikolai N.; Fallon, Michael B.] Fund Mol Hematol & Immunol, Moscow, Russia; [Chaturvedi, Gaurav] Univ Kansas, Med Ctr, Ctr Reprod Sci, Kansas City, KS 66160 USA; [Totapally, Balagangadhar] Miami Childrens Hosp, Dept Pediat, Miami, FL 33155 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Kansas; University of Kansas Medical Center	Maheshwari, A (corresponding author), NHB 525,619 19th St S, Birmingham, AL 35233 USA.	akhil@peds.uab.edu		Patel, Rakesh/0000-0002-1526-4303	National Institutes of Health [K12HD043397, RHD059142, HL082818, ES015323, DK056804]; American Heart Association [0665155B]; American Gastroenterological Association Research Scholar Award; American Heart Association Award [0655312B]; National Center for Research Resources [C06 RR 15490]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059142, K12HD043397] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015490] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Gastroenterological Association Research Scholar Award; American Heart Association Award(American Heart Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K12HD043397 and RHD059142 (to A. M.), HL082818 (to J. S. H.), ES015323 (to M. A.), and DK056804 (to M. B. F.). This work was also supported by American Heart Association Grant 0665155B, an American Gastroenterological Association Research Scholar Award, American Heart Association Award 0655312B (to R. P. P.). The work was made possible in part by Research Facilities Improvement Program Grant C06 RR 15490 from the National Center for Research Resources. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ATHERTON A, 1972, J PHYSIOL-LONDON, V222, P447, DOI 10.1113/jphysiol.1972.sp009808; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Benjamin JT, 2007, AM J PHYSIOL-LUNG C, V292, pL550, DOI 10.1152/ajplung.00329.2006; BOYLE J, 1988, J THEOR BIOL, V131, P223, DOI 10.1016/S0022-5193(88)80238-8; Chen HQ, 2003, BIORHEOLOGY, V40, P53; Chen ZY, 2001, PROSTAG LEUKOTR ESS, V64, P67, DOI 10.1054/plef.2000.0239; Cheng C, 2007, J CLIN INVEST, V117, P616, DOI 10.1172/JCI28180; Cheng M, 2007, ENDOTHELIUM-J ENDOTH, V14, P265, DOI 10.1080/10623320701678169; Chung BJ, 2003, COMPUT STRUCT, V81, P535, DOI 10.1016/S0045-7949(02)00416-9; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656, DOI 10.1161/01.ATV.19.3.656; Doerschuk CM, 1999, AM J RESP CRIT CARE, V159, P1693; Fox SE, 2005, CYTOKINE, V29, P135, DOI 10.1016/j.cyto.2004.10.007; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; Gerna G, 2000, J VIROL, V74, P5629, DOI 10.1128/JVI.74.12.5629-5638.2000; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662; Hale KK, 1999, J IMMUNOL, V162, P4246; Hay DC, 2003, BBA-MOL CELL RES, V1642, P33, DOI 10.1016/S0167-4889(03)00084-3; Hippenstiel S, 2000, BLOOD, V95, P3044; Ho RC, 2005, AM J PHYSIOL-CELL PH, V289, pC794, DOI 10.1152/ajpcell.00632.2004; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Iivanainen E, 2003, MICROSC RES TECHNIQ, V60, P13, DOI 10.1002/jemt.10238; Illi B, 2003, CIRC RES, V93, P155, DOI 10.1161/01.RES.0000080933.82105.29; Jana M, 2005, FREE RADICAL BIO MED, V38, P655, DOI 10.1016/j.freeradbiomed.2004.11.021; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kato H, 2001, BIORHEOLOGY, V38, P347; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Luscinskas FW, 2002, SEMIN IMMUNOL, V14, P105, DOI 10.1006/smim.2001.0347; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Maheshwari A, 2005, PEDIATR RES, V57, P438, DOI 10.1203/01.PDR.0000151317.08180.7E; Maheshwari A, 2003, CYTOKINE, V24, P91, DOI 10.1016/j.cyto.2003.07.002; Maheshwari A, 2006, J LEUKOCYTE BIOL, V80, P1111, DOI 10.1189/jlb.0306230; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Meyer T, 1998, BRIT J CANCER, V77, P530, DOI 10.1038/bjc.1998.86; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Mohan S, 2007, AM J PHYSIOL-CELL PH, V292, pC362, DOI 10.1152/ajpcell.00535.2005; Moon JJ, 2005, J CELL PHYSIOL, V203, P166, DOI 10.1002/jcp.20220; Mukaida N, 1995, Cancer Treat Res, V80, P261; Nolan K, 1999, MOL CELL BIOL, V19, P6120; Partridge J, 2007, FASEB J, V21, P3553, DOI 10.1096/fj.06-8059com; Pries AR, 2003, CLIN HEMORHEOL MICRO, V29, P143; RESNICK N, 1995, FASEB J, V9, P874, DOI 10.1096/fasebj.9.10.7615157; SDOUGOS HP, 1984, J FLUID MECH, V138, P379, DOI 10.1017/S0022112084000161; Sheikh S, 2003, BLOOD, V102, P2828, DOI 10.1182/blood-2003-01-0080; Shin WS, 2002, ATHEROSCLEROSIS, V160, P91, DOI 10.1016/S0021-9150(01)00571-8; SKALAK R, 1989, ANNU REV FLUID MECH, V21, P167; Smythies LE, 2006, J LEUKOCYTE BIOL, V80, P492, DOI 10.1189/jlb.1005566; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; SRIRAMARAO P, 1993, J BIOL CHEM, V268, P22036; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; WIGGS BR, 1994, J APPL PHYSIOL, V77, P463, DOI 10.1152/jappl.1994.77.1.463; Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290	58	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5945	5955		10.1074/jbc.M807205200	http://dx.doi.org/10.1074/jbc.M807205200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117939	Green Published, hybrid			2022-12-27	WOS:000263560600058
J	Wang, YQ; Liao, MX; Hoe, N; Acharya, P; Deng, CH; Krutchinsky, AN; Correia, MA				Wang, YongQiang; Liao, Mingxiang; Hoe, Nicholas; Acharya, Poulomi; Deng, Changhui; Krutchinsky, Andrew N.; Correia, Maria Almira			A Role for Protein Phosphorylation in Cytochrome P450 3A4 Ubiquitin-dependent Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; ETHANOL-INDUCIBLE CYTOCHROME-P-450; RETICULUM-ASSOCIATED DEGRADATION; SITE-SPECIFIC PHOSPHORYLATION; METAL-CATALYZED OXIDATION; ER-ASSOCIATED DEGRADATION; ISOLATED RAT HEPATOCYTES; SACCHAROMYCES-CEREVISIAE; POSTTRANSLATIONAL MODIFICATION; MICROSOMAL CYTOCHROME-P-450	Cytochromes P450 (P450s) incur phosphorylation. Although the precise role of this post-translational modification is unclear, marking P450s for degradation is plausible. Indeed, we have found that after structural inactivation, CYP3A4, the major human liver P450, and its rat orthologs are phosphorylated during their ubiquitin-dependent proteasomal degradation. Peptide mapping coupled with mass spectrometric analyses of CYP3A4 phosphorylated in vitro by protein kinase C (PKC) previously identified two target sites, Thr264 and Ser420. We now document that liver cytosolic kinases additionally target Ser478 as a major site. To determine whether such phosphorylation is relevant to in vivo CYP3A4 degradation, wild type and CYP3A4 with single, double, or triple Ala mutations of these residues were heterologously expressed in Saccharomyces cerevisiae pep4 Delta strains. We found that relative to CYP3A4wt, its S478A mutant was significantly stabilized in these yeast, and this was greatly to markedly enhanced for its S478A/T264A, S478A/S420A, and S478A/T264A/S420A double and triple mutants. Similar relative S478A/T264A/S420A mutant stabilization was also observed in HEK293T cells. To determine whether phosphorylation enhances CYP3A4 degradation by enhancing its ubiquitination, CYP3A4 ubiquitination was examined in an in vitro UBC7/gp78-reconstituted system with and without cAMP-dependent protein kinase A and PKC, two liver cytosolic kinases involved in CYP3A4 phosphorylation. cAMP-dependent protein kinase A/PKC-mediated phosphorylation of CYP3A4wt but not its S478A/T264A/S420A mutant enhanced its ubiquitination in this system. Together, these findings indicate that phosphorylation of CYP3A4 Ser478, Thr264, and Ser420 residues by cytosolic kinases is important both for its ubiquitination and proteasomal degradation and suggest a direct link between P450 phosphorylation, ubiquitination, and degradation.	[Wang, YongQiang; Liao, Mingxiang; Hoe, Nicholas; Acharya, Poulomi; Correia, Maria Almira] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Deng, Changhui; Krutchinsky, Andrew N.; Correia, Maria Almira] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Correia, Maria Almira] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94158 USA; [Correia, Maria Almira] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Correia, MA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Mission Bay Campus,Genentech Hall,N572F,Box 2280,, San Francisco, CA 94158 USA.	almira.correia@ucsf.edu	Deng, Changhui/A-1010-2012		National Institutes of Health [GM44037, DK26506, R21 RR023120]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR023120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026506, R56DK026506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants GM44037 and DK26506 (to M.A.C.) and R21 RR023120 (to A.N.K.). The costs of publication of this article were defrayed in part by the payment of page charges.	Aguiar M, 2005, DRUG METAB REV, V37, P379, DOI 10.1081/DMR-200046136; Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; AMICI A, 1989, J BIOL CHEM, V264, P3341; Annan RS, 1996, ANAL CHEM, V68, P3413, DOI 10.1021/ac960221g; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bardag-Gorce F, 2002, FREE RADICAL BIO MED, V32, P17, DOI 10.1016/S0891-5849(01)00768-7; Blethrow JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000358; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; CALLEN DF, 1977, MUTAT RES, V45, P309, DOI 10.1016/0027-5107(77)90141-5; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Choi BK, 2003, PROTEOMICS, V3, P1955, DOI 10.1002/pmic.200300558; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Correia MA, 2007, EXPERT OPIN DRUG MET, V3, P33, DOI 10.1517/17425255.3.1.33; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; CORREIA MA, 1987, ARCH BIOCHEM BIOPHYS, V258, P436, DOI 10.1016/0003-9861(87)90365-1; CORREIA MA, 1992, ARCH BIOCHEM BIOPHYS, V297, P228, DOI 10.1016/0003-9861(92)90666-K; CORREIA MA, 1989, DRUG METAB REV, V20, P615, DOI 10.3109/03602538909103565; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; DAI Y, 1993, BIOCHEMISTRY-US, V32, P6928, DOI 10.1021/bi00078a017; Denisov IG, 2007, J BIOL CHEM, V282, P26865, DOI 10.1074/jbc.M704747200; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9; ELIASSON E, 1990, P NATL ACAD SCI USA, V87, P3225, DOI 10.1073/pnas.87.8.3225; ELIASSON E, 1988, BIOCHEM BIOPH RES CO, V150, P436, DOI 10.1016/0006-291X(88)90539-6; ELIASSON E, 1992, J BIOL CHEM, V267, P15765; ELIASSON E, 1994, J BIOL CHEM, V269, P18378; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Faouzi S, 2007, BIOCHEMISTRY-US, V46, P7793, DOI 10.1021/bi700340n; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; FREEMAN JE, 1994, BIOCHEMISTRY-US, V33, P13963, DOI 10.1021/bi00251a002; Goasduff T, 1999, ARCH BIOCHEM BIOPHYS, V370, P258, DOI 10.1006/abbi.1999.1399; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; GUENGERICH FP, 1986, BIOCHEM BIOPH RES CO, V138, P193, DOI 10.1016/0006-291X(86)90265-2; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; He K, 1998, BIOCHEMISTRY-US, V37, P17448, DOI 10.1021/bi9808464; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; JANSSON I, 1990, ARCH BIOCHEM BIOPHYS, V283, P285, DOI 10.1016/0003-9861(90)90644-E; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; KOCH JA, 1989, BIOCHEMISTRY-US, V28, P3145, DOI 10.1021/bi00434a005; Kornitzer D, 2002, METHOD ENZYMOL, V351, P639; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Liao M, 2006, MOL PHARMACOL, V69, P1897, DOI 10.1124/mol.105.021816; Lohr JB, 1997, BIOCHEM BIOPH RES CO, V231, P403, DOI 10.1006/bbrc.1997.6113; MENEZ JF, 1993, ALCOHOL ALCOHOLISM, V28, P445; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P12740, DOI 10.1073/pnas.91.26.12740; MULLER R, 1985, FEBS LETT, V187, P21, DOI 10.1016/0014-5793(85)81205-9; Murray BP, 2001, ARCH BIOCHEM BIOPHYS, V393, P106, DOI 10.1006/abbi.2001.2482; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Oesch-Bartlomowicz B, 2005, BIOCHEM BIOPH RES CO, V338, P446, DOI 10.1016/j.bbrc.2005.08.092; Oesch-Bartlomowicz B, 1998, EXP CELL RES, V242, P294, DOI 10.1006/excr.1998.4120; Oesch-Bartlomowicz B, 2003, ARCH BIOCHEM BIOPHYS, V409, P228, DOI 10.1016/S0003-9861(02)00558-1; OPRIAN DD, 1983, J BIOL CHEM, V258, P8684; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; PYERIN W, 1983, CARCINOGENESIS, V4, P573, DOI 10.1093/carcin/4.5.573; PYERIN W, 1987, BIOCHEM BIOPH RES CO, V142, P885, DOI 10.1016/0006-291X(87)91496-3; PYERIN W, 1989, EMBO J, V8, P3003, DOI 10.1002/j.1460-2075.1989.tb08450.x; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; RIDDICK DS, 1990, BIOCHEM PHARMACOL, V40, P1915, DOI 10.1016/0006-2952(90)90374-T; ROBERTS BJ, 1995, J BIOL CHEM, V270, P29632; SCHAEFER WH, 1985, BIOCHEMISTRY-US, V24, P3254, DOI 10.1021/bi00334a027; Sepuri NBV, 2007, FEBS J, V274, P4615, DOI 10.1111/j.1742-4658.2007.05990.x; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; TANIGUCHI H, 1985, BIOCHEM PHARMACOL, V34, P1835, DOI 10.1016/0006-2952(85)90657-4; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; VILGRAIN I, 1984, BIOCHEM BIOPH RES CO, V125, P554, DOI 10.1016/0006-291X(84)90575-8; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wang HF, 1998, BIOCHEMISTRY-US, V37, P12536, DOI 10.1021/bi980895g; Wang HF, 1999, ARCH BIOCHEM BIOPHYS, V365, P45, DOI 10.1006/abbi.1999.1139; Wang XY, 2001, BIOCHEMISTRY-US, V40, P11318, DOI 10.1021/bi010690z; WATKINS PB, 1986, J BIOL CHEM, V261, P6264; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zhukov A, 1999, BIOCHEM J, V340, P453, DOI 10.1042/0264-6021:3400453; ZHUKOV A, 1993, BIOCHEM BIOPH RES CO, V197, P221, DOI 10.1006/bbrc.1993.2464	88	41	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5671	5684		10.1074/jbc.M806104200	http://dx.doi.org/10.1074/jbc.M806104200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19095658	Green Published, hybrid			2022-12-27	WOS:000263560600031
J	Cohn, MA; Kee, Y; Haas, W; Gygi, SP; D'Andrea, AD				Cohn, Martin A.; Kee, Younghoon; Haas, Wilhelm; Gygi, Steven P.; D'Andrea, Alan D.			UAF1 Is a Subunit of Multiple Deubiquitinating Enzyme Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; FANCONI-ANEMIA PATHWAY; PROTEIN COMPLEXES; PROTEASOME; UBIQUITIN; REPAIR; UCH37	A balance between ubiquitination and deubiquitination regulates numerous cellular processes and pathways, and specific deubiquitinating enzymes often play the decisive role of controlling this balance. We recently reported that the USP1 deubiquitinating enzyme, which regulates the Fanconi anemia pathway by deubiquitinating the central player of the pathway, FANCD2, is activated by the WD40-repeat containing UAF1 protein through formation of a stable USP1/UAF1 protein complex. Here we present the isolation of two novel multisubunit deubiquitinating enzyme complexes containing USP12 and USP46, respectively. Both complexes contain the UAF1 protein as a bona fide subunit. Interestingly, UAF1 regulates the enzymatic activity of both enzyme complexes, suggesting that this activator protein may regulate a subclass of human deubiquitinating enzymes. We postulate that additional WD40-containing proteins may also form complexes with other human deubiquitinating enzymes and thereby regulate their activity and substrate specificity.	[Cohn, Martin A.; Kee, Younghoon; D'Andrea, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Haas, Wilhelm; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	D'Andrea, AD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, 44 Binney St, Boston, MA 02115 USA.	alan_dandrea@dfci.harvard.edu	Classen, Scott/AAY-8176-2020; Kee, Younghoon/J-4107-2019	Cohn, Martin/0000-0002-2988-3009	National Institutes of Health [5P01CA092584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P01CA092584.	Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Harlow E., 1988, ANTIBODIES LAB MANUA; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Maniatis T., 1989, MOL CLONING LAB MAN; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Yang XH, 2007, P NATL ACAD SCI USA, V104, P20645, DOI 10.1073/pnas.0710916105; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015	30	132	141	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5343	5351		10.1074/jbc.M808430200	http://dx.doi.org/10.1074/jbc.M808430200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19075014	Green Published, hybrid			2022-12-27	WOS:000263416600064
J	Zhang, LL; Lai, E; Teodoro, T; Volchuk, A				Zhang, Liling; Lai, Elida; Teodoro, Tracy; Volchuk, Allen			GRP78, but Not Protein-disulfide Isomerase, Partially Reverses Hyperglycemia-induced Inhibition of Insulin Synthesis and Secretion in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CHRONIC OXIDATIVE STRESS; MESSENGER-RNA; ER STRESS; CHEMICAL CHAPERONES; GLUCOSE-HOMEOSTASIS; GENE-TRANSCRIPTION; FATTY-ACIDS; ACTIVATION; TRANSLATION	Chronic hyperglycemia contributes to pancreatic beta-cell dysfunction during the development of type 2 diabetes. Treatment of pancreatic beta-cells with prolonged high glucose concentrations has been shown to reduce insulin promoter activity and insulin gene expression. Here, we examined the effect of high glucose on endoplasmic reticulum (ER) stress pathway activation and insulin production in INS-1 832/13 pancreatic beta-cells. Treatment of cells with 25 mM glucose for 24-48 h decreased insulin mRNA and protein levels and reduced the proinsulin translation rate, which was accompanied by enhanced unfolded protein response pathway activation (XBP-1 mRNA splicing and increased phospho-eIF2 alpha, CHOP, and active ATF6 levels). Overexpressing the ER chaperone GRP78 partially rescued high glucose-induced suppression of proinsulin levels and improved glucose-stimulated insulin secretion with no effect on insulin 2 mRNA levels. Under these conditions, there was little effect of GRP78 overexpression on ER stress markers. Knockdown of GRP78 expression under basal glucose conditions reduced cellular insulin levels and glucose-stimulated insulin secretion. Thus, GRP78is essential for insulin biosynthesis, and enhancing chaperone capacity can improve beta-cell function in the presence of prolonged hyperglycemia. In contrast, overexpression of the ER chaperone and oxidoreductase protein-disulfide isomerase (PDI) reduced glucose-stimulated insulin secretion and induced ER stress resulting from the accumulation of proinsulin in the ER. These results suggest a role for both GRP78 and PDI in insulin biosynthesis, although an excess of PDI disrupts normal proinsulin processing.	[Zhang, Liling; Lai, Elida; Teodoro, Tracy; Volchuk, Allen] Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada; [Lai, Elida; Teodoro, Tracy; Volchuk, Allen] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Volchuk, Allen] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Volchuk, A (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, 101 Coll St,TMDT 10-707, Toronto, ON M5G 1L7, Canada.	avolchuk@uhnres.utoronto.ca			Canadian Diabetes Association Operating [GA-2-06-2138-AV]; Canadian Foundation for Innovation and the Ontario Innovation Trust	Canadian Diabetes Association Operating; Canadian Foundation for Innovation and the Ontario Innovation Trust	This work was supported, in part, by Canadian Diabetes Association Operating Grant GA-2-06-2138-AV ( to A. V.). Infrastructure support for laboratory of A. V. was provided by funding from the Canadian Foundation for Innovation and the Ontario Innovation Trust.	Choi SE, 2008, ARCH BIOCHEM BIOPHYS, V475, P109, DOI 10.1016/j.abb.2008.04.015; Davis R, 2000, BIOTECHNOL PROGR, V16, P736, DOI 10.1021/bp000107q; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dowling P, 2006, PROTEOMICS, V6, P6578, DOI 10.1002/pmic.200600298; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Maeda R, 2007, BBA-PROTEINS PROTEOM, V1774, P1619, DOI 10.1016/j.bbapap.2007.08.016; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Olson LK, 1998, MOL ENDOCRINOL, V12, P207, DOI 10.1210/me.12.2.207; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Pirot P, 2007, DIABETOLOGIA, V50, P1006, DOI 10.1007/s00125-007-0609-0; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; REN J, 2007, J TRANSL MED; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; Seo HY, 2008, ENDOCRINOLOGY, V149, P3832, DOI 10.1210/en.2008-0015; SERVIER CS, 2002, NAT REV MOL CELL BIO, V3, P836; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Shalev A, 2002, ENDOCRINOLOGY, V143, P2541, DOI 10.1210/en.143.7.2541; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wang M, 2007, INT J BIOCHEM CELL B, V39, P2076, DOI 10.1016/j.biocel.2007.05.022; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Wicksteed B, 2007, CELL METAB, V5, P221, DOI 10.1016/j.cmet.2007.02.007; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Wiseman RL, 2007, CURR OPIN CELL BIOL, V19, P359, DOI 10.1016/j.ceb.2007.05.005; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	44	81	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5289	5298		10.1074/jbc.M805477200	http://dx.doi.org/10.1074/jbc.M805477200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103594	hybrid			2022-12-27	WOS:000263416600059
J	Duby, G; Poreba, W; Piotrowiak, D; Bobik, K; Derua, R; Waelkens, E; Boutry, M				Duby, Geoffrey; Poreba, Wojciech; Piotrowiak, Dominik; Bobik, Krzysztof; Derua, Rita; Waelkens, Etienne; Boutry, Marc			Activation of Plant Plasma Membrane H+-ATPase by 14-3-3 Proteins Is Negatively Controlled by Two Phosphorylation Sites within the H+-ATPase C-terminal Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-POINT MUTATIONS; FUNGAL PATHOGENS; DEFENSE RESPONSE; BINDING-SITE; PROTON PUMP; GUARD-CELLS; BLUE-LIGHT; YEAST; ARABIDOPSIS; FUSICOCCIN	The proton pump ATPase (H+-ATPase) of the plant plasma membrane is regulated by an autoinhibitory C-terminal domain, which can be displaced by phosphorylation of the penultimate Thr residue and the subsequent binding of 14-3-3 proteins. We performed a mass spectrometric analysis of PMA2 (plasma membrane H+-ATPase isoform 2) isolated from Nicotiana tabacum suspension cells and identified two new phosphorylated residues in the enzyme 14-3-3 protein binding site: Thr(931) and Ser(938). When PMA2 was expressed in Saccharomyces cerevisiae, mutagenesis of each of these two residues into Asp prevented growth of a yeast strain devoid of its own H+-ATPases. When the Asp mutations were individually introduced in a constitutively activated mutant of PMA2(E14D), they still allowed yeast growth but at a reduced rate. Purification of His-tagged PMA2 showed that the T931D or S938D mutation prevented 14-3-3 protein binding, although the penultimate Thr(955) was still phosphorylated, indicating that Thr(955) phosphorylation is not sufficient for full enzyme activation. Expression of PMA2 in an N. tabacum cell line also showed an absence of 14-3-3 protein binding resulting from the T931D or S938D mutation. Together, the data show that activation of H+-ATPase by the binding of 14-3-3 proteins is negatively controlled by phosphorylation of two residues in the H+-ATPase 14-3-3 protein binding site. The data also show that phosphorylation of the penultimate Thr and 14- 3- 3 binding each contribute in part to H+-ATPase activation.	[Duby, Geoffrey; Poreba, Wojciech; Piotrowiak, Dominik; Bobik, Krzysztof; Boutry, Marc] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium; [Derua, Rita; Waelkens, Etienne] Katholieke Univ Leuven, Fac Geneeskunde, Afdeling Biochem, B-3000 Louvain, Belgium	Universite Catholique Louvain; KU Leuven	Duby, G (corresponding author), Catholic Univ Louvain, Inst Sci Vie, Croix Sud 5-15, B-1348 Louvain, Belgium.	geoffrey.duby@uclouvain.be		Boutry, Marc/0000-0002-2315-6900	Interuniversity Poles of Attraction Program; Belgian National Fund for Scientific Research	Interuniversity Poles of Attraction Program; Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the Interuniversity Poles of Attraction Program ( Belgian State, Scientific, Technical, and Cultural Services) and the Belgian National Fund for Scientific Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arango M, 2003, PLANTA, V216, P355, DOI 10.1007/s00425-002-0856-8; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Buch-Pedersen MJ, 2006, J BIOL CHEM, V281, P38285, DOI 10.1074/jbc.M604781200; Camoni L, 2000, J BIOL CHEM, V275, P9919, DOI 10.1074/jbc.275.14.9919; Camoni L, 2006, PLANT CELL PHYSIOL, V47, P743, DOI 10.1093/pcp/pcj046; Dambly S, 2001, J BIOL CHEM, V276, P7017, DOI 10.1074/jbc.M007740200; Desbrosses G, 1998, EUR J BIOCHEM, V251, P496, DOI 10.1046/j.1432-1327.1998.2510496.x; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; DUBY G, 2008, PFLUG ARCH IN PRESS; Emi T, 2001, PLANT PHYSIOL, V125, P1115, DOI 10.1104/pp.125.2.1115; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Fuglsang AT, 2003, J BIOL CHEM, V278, P42266, DOI 10.1074/jbc.M306707200; Fullone MR, 1998, J BIOL CHEM, V273, P7698, DOI 10.1074/jbc.273.13.7698; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Kanczewska J, 2005, P NATL ACAD SCI USA, V102, P11675, DOI 10.1073/pnas.0504498102; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; Lino B, 1998, PLANTA, V204, P352, DOI 10.1007/s004250050266; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; Ookura T, 2005, JARQ-JPN AGR RES Q, V39, P99, DOI 10.6090/jarq.39.99; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Schaller A, 1999, PLANT CELL, V11, P263, DOI 10.1105/tpc.11.2.263; SCHALLER GE, 1988, PLANT PHYSIOL, V86, P512, DOI 10.1104/pp.86.2.512; Sondergaard TE, 2004, PLANT PHYSIOL, V136, P2475, DOI 10.1104/pp.104.048231; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; SUZUKI YS, 1992, PLANT PHYSIOL, V99, P1314, DOI 10.1104/pp.99.4.1314; Svennelid F, 1999, PLANT CELL, V11, P2379, DOI 10.1105/tpc.11.12.2379; Treco D. A., 2001, CURRENT PROTOCOLS MO; van der Fits L, 2000, PLANT MOL BIOL, V43, P495, DOI 10.1023/A:1006440221718; VERAESTRELLA R, 1994, PLANT PHYSIOL, V104, P209, DOI 10.1104/pp.104.1.209; WACH A, 1990, EUR J BIOCHEM, V189, P675, DOI 10.1111/j.1432-1033.1990.tb15536.x; Woloszynska M, 2003, ANN NY ACAD SCI, V986, P198, DOI 10.1111/j.1749-6632.2003.tb07160.x; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Xing T, 1996, PLANT CELL, V8, P555, DOI 10.2307/3870332; Zhao RM, 1999, PLANT SCI, V149, P157, DOI 10.1016/S0168-9452(99)00155-7	44	46	49	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4213	4221		10.1074/jbc.M807311200	http://dx.doi.org/10.1074/jbc.M807311200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088078	hybrid			2022-12-27	WOS:000263134400018
J	Bansal, PK; Nourse, A; Abdulle, R; Kitagawa, K				Bansal, Parmil K.; Nourse, Amanda; Abdulle, Rashid; Kitagawa, Katsumi			Sgt1 Dimerization Is Required for Yeast Kinetochore Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE KINETOCHORE; CENTROMERE-BINDING PROTEIN; SIZE-DISTRIBUTION ANALYSIS; BUDDING YEAST; CHROMOSOME SEGREGATION; ESSENTIAL COMPONENT; CELL-CYCLE; COMPLEX; HSP90; DNA	The kinetochore, which consists of DNA sequence elements and structural proteins, is essential for high-fidelity chromosome transmission during cell division. In budding yeast, Sgt1 and Hsp90 help assemble the core kinetochore complex CBF3 by activating the CBF3 components Skp1 and Ctf13. In this study, we show that Sgt1 forms homodimers by performing in vitro and in vivo immunoprecipitation and analytical ultracentrifugation analyses. Analyses of the dimerization of Sgt1 deletion proteins showed that the Skp1-binding domain (amino acids 1-211) contains the Sgt1 homodimerization domain. Also, the Sgt1 mutant proteins that were unable to dimerize also did not bind Skp1, suggesting that Sgt1 dimerization is important for Sgt1-Skp1 binding. Restoring dimerization activity of a dimerization-deficient sgt1 mutant (sgt1-L31P) by using the CENP-B (centromere protein-B) dimerization domain suppressed the temperature sensitivity, the benomyl sensitivity, and the chromosome missegregation phenotype of sgt1-L31P. These results strongly suggest that Sgt1 dimerization is required for kinetochore assembly.	[Bansal, Parmil K.; Abdulle, Rashid; Kitagawa, Katsumi] St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; [Nourse, Amanda] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kitagawa, K (corresponding author), St Jude Childrens Hosp, Dept Mol Pharmacol, MS 230,262 Danny Thomas Pl, Memphis, TN 38105 USA.	katsumi.kitagawa@stjude.org		Nourse, Amanda/0000-0003-4595-5321	National Institutes of Health [GM68418]; NCI [CA21765]; American Lebanese Syrian Association Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Association Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68418 and Cancer Center Support Grant CA21765 from NCI. This work was also supported by the American Lebanese Syrian Association Charities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; BAKER RE, 1990, MOL CELL BIOL, V10, P2458, DOI 10.1128/MCB.10.6.2458; Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; CAI MJ, 1989, MOL CELL BIOL, V9, P2544, DOI 10.1128/MCB.9.6.2544; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Dubacq C, 2002, EUKARYOT CELL, V1, P568, DOI 10.1128/EC.1.4.568-582.2002; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; HEGEMANN JH, 1988, MOL CELL BIOL, V8, P2523, DOI 10.1128/MCB.8.6.2523; HIETER P, 1985, CELL, V42, P913, DOI 10.1016/0092-8674(85)90287-9; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JIANG WD, 1993, J CELL BIOL, V121, P513, DOI 10.1083/jcb.121.3.513; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Kitagawa K, 2003, MOL CELL, V11, P1201, DOI 10.1016/S1097-2765(03)00145-X; KITAGAWA K, 1995, MOL CELL BIOL, V15, P1602; Kitagawa K, 2002, BIOTECHNIQUES, V33, P288, DOI 10.2144/02332bm07; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; LECHNER J, 1994, EMBO J, V13, P5203, DOI 10.1002/j.1460-2075.1994.tb06851.x; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Niikura Y, 2006, ONCOGENE, V25, P4133, DOI 10.1038/sj.onc.1209461; Nyarko A, 2007, BIOCHEMISTRY-US, V46, P11331, DOI 10.1021/bi700735t; Rose MD., 1990, METHODS YEAST GENETI; Russell ID, 1999, J CELL BIOL, V145, P933, DOI 10.1083/jcb.145.5.933; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P26; Sorger PK, 1995, P NATL ACAD SCI USA, V92, P12026, DOI 10.1073/pnas.92.26.12026; Steensgaard P, 2004, EMBO REP, V5, P626, DOI 10.1038/sj.embor.7400154; Stemmann O, 1996, EMBO J, V15, P3611, DOI 10.1002/j.1460-2075.1996.tb00730.x; Stemmann O, 2002, P NATL ACAD SCI USA, V99, P8585, DOI 10.1073/pnas.082223899; STRUNNIKOV AV, 1995, J CELL BIOL, V128, P749, DOI 10.1083/jcb.128.5.749; Sudakin V, 2007, BIODRUGS, V21, P225, DOI 10.2165/00063030-200721040-00003; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607	44	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3586	3592		10.1074/jbc.M806281200	http://dx.doi.org/10.1074/jbc.M806281200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073600	Green Published, hybrid			2022-12-27	WOS:000262872500026
J	Zuckerman, V; Lenos, K; Popowicz, GM; Silberman, I; Grossman, T; Marine, JC; Holak, TA; Jochemsen, AG; Haupt, Y				Zuckerman, Valentina; Lenos, Kristiaan; Popowicz, Grzegorz M.; Silberman, Isabelle; Grossman, Tamar; Marine, Jean-Christophe; Holak, Tad A.; Jochemsen, Aart G.; Haupt, Ygal			c-Abl Phosphorylates Hdmx and Regulates Its Interaction with p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; TYROSINE KINASE; MDMX; ACTIVATION; STABILIZATION; DEGRADATION; PATHWAY; STRESS; ATM; UBIQUITINATION	Upon exposure to DNA damage the p53 tumor suppressor is accumulated and activated to stall cellular growth. For this to occur, p53 must be relieved from its major inhibitors, Mdm2 (Hdm2 in humans) and Mdmx (Mdm4; Hdmx in humans). A key mechanism controlling this relief is the post-translational modifications of p53 and its inhibitors. We have previously demonstrated that the stress-activated tyrosine kinase, c-Abl, contributes to the relief of p53 from Hdm2. Because Hdmx is the major inhibitor of p53 activity, the additional possibility that c-Abl protects p53 through targeting Hdmx was explored in this study. c-Abl was found to interact with and to phosphorylate Hdmx. This phosphorylation was enhanced in response to DNA damage. Importantly, we mapped the sites of phosphorylation to the p53 binding domain of Hdmx. One of these phosphorylations, on tyrosine 99, inhibited Hdmx interaction with p53. This inhibition is consistent with the predicted role of this residue in the interaction with p53 based on the crystal structure of the interaction site. Our results show that c-Abl not only targets Hdm2, but also Hdmx, which together contribute to p53 activation in response to DNA damage.	[Zuckerman, Valentina; Silberman, Isabelle; Grossman, Tamar; Haupt, Ygal] Hebrew Univ Jerusalem, Sch Med, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel; [Lenos, Kristiaan; Jochemsen, Aart G.] Leiden Univ, Med Ctr, Dept Mol & Cell Biol, NL-2300 RA Leiden, Netherlands; [Popowicz, Grzegorz M.; Holak, Tad A.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Marine, Jean-Christophe] Univ Ghent, Lab Mol Canc Biol, VIB, B-9052 Ghent, Belgium	Hebrew University of Jerusalem; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society; Flanders Institute for Biotechnology (VIB); Ghent University	Haupt, Y (corresponding author), Peter MacCallum Canc Ctr, Div Res, St Andrews Pl, Melbourne, Vic 3002, Australia.	Ygal.Haupt@petermac.org	Popowicz, Grzegorz/G-4769-2017; Grossman, Tamar/CAI-8262-2022; Marine, Jean Christophe/J-2237-2015; Marine, Jean-Christophe/K-3292-2016	Popowicz, Grzegorz/0000-0003-2818-7498; Grossman, Tamar/0000-0001-6301-1696; Marine, Jean-Christophe/0000-0003-2433-9837; Haupt, Ygal/0000-0001-5925-0096	Israel Science Foundation [1341/05]; Association for International Cancer Research; Dutch Cancer Society [UL 2006-3595]; Deutsche Krebshilfe [108354]; European Community [503576]	Israel Science Foundation(Israel Science Foundation); Association for International Cancer Research; Dutch Cancer Society(KWF Kankerbestrijding); Deutsche Krebshilfe(Deutsche Krebshilfe); European Community(European Commission)	This work was supported by Israel Science Foundation Grant 1341/05, the Association for International Cancer Research, the Dutch Cancer Society Grant UL 2006-3595, the Deutsche Krebshilfe Grant 108354, and by European Community FP6 funding of European Commission Contract 503576. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Dias SS, 2006, ONCOGENE, V25, P6666, DOI 10.1038/sj.onc.1209671; Gilkes DM, 2007, CELL CYCLE, V6, P151, DOI 10.4161/cc.6.2.3719; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Haupt Y, 1996, EMBO J, V15, P1596, DOI 10.1002/j.1460-2075.1996.tb00504.x; Jing Y, 2007, J BIOCHEM, V141, P621, DOI 10.1093/jb/mvm068; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Levav-Cohen Y, 2005, BIOCHEM BIOPH RES CO, V331, P737, DOI 10.1016/j.bbrc.2005.03.152; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li CG, 2002, MOL CELL BIOL, V22, P7562, DOI 10.1128/MCB.22.21.7562-7571.2002; Lopez-Pajares V, 2008, J BIOL CHEM, V283, P13707, DOI 10.1074/jbc.M710030200; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Meek DW, 2003, MOL CANCER RES, V1, P1017; Meulmeester E, 2005, CELL CYCLE, V4, P1166, DOI 10.4161/cc.4.9.1981; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Prodosmo A, 2008, J MOL MED-JMM, V86, P585, DOI 10.1007/s00109-008-0322-6; Ramos YFM, 2001, CANCER RES, V61, P1839; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Sionov RV, 2001, MOL CELL BIOL, V21, P5869; Sionov RV, 1999, J BIOL CHEM, V274, P8371, DOI 10.1074/jbc.274.13.8371; Stad R, 2000, J BIOL CHEM, V275, P28039; Sun XG, 2000, J BIOL CHEM, V275, P17237, DOI 10.1074/jbc.C000099200; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wei G, 2005, J BIOL CHEM, V280, P12271, DOI 10.1074/jbc.M409522200; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; Zhu JY, 2004, CURR TOP DEV BIOL, V59, P165, DOI 10.1016/S0070-2153(04)59007-5	46	52	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					4031	4039		10.1074/jbc.M809211200	http://dx.doi.org/10.1074/jbc.M809211200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19075013	hybrid			2022-12-27	WOS:000262872500071
J	Bogdanov, M; Xie, J; Dowhan, W				Bogdanov, Mikhail; Xie, Jun; Dowhan, William			Lipid-Protein Interactions Drive Membrane Protein Topogenesis in Accordance with the Positive Inside Rule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LACTOSE PERMEASE; ESCHERICHIA-COLI; TOPOLOGICAL ORGANIZATION; PHOSPHOLIPID-COMPOSITION; TRANSMEMBRANE HELICES; ENDOPLASMIC-RETICULUM; PHOSPHATIDYLETHANOLAMINE; TRANSLOCATION; DETERMINANTS; RECOGNITION	Transmembrane domain orientation within some membrane proteins is dependent on membrane lipid composition. Initial orientation occurs within the translocon, but final orientation is determined after membrane insertion by interactions within the protein and between lipid headgroups and protein extramembrane domains. Positively and negatively charged amino acids in extramembrane domains represent cytoplasmic retention and membrane translocation forces, respectively, which are determinants of protein orientation. Lipids with no net charge dampen the translocation potential of negative residues working in opposition to cytoplasmic retention of positive residues, thus allowing the functional presence of negative residues in cytoplasmic domains without affecting protein topology.	[Bogdanov, Mikhail; Xie, Jun; Dowhan, William] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Bogdanov, M (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	mikhail.v.bogdanov@uth.tmc.edu; william.dowhan@uth.tmc.edu	Bogdanov, Mikhail/J-3695-2017	Xie, Jun/0000-0001-6943-0330	National Institutes of Health [GM R37-20478]; John S. Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John S. Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM R37-20478 ( to W. D.). This work was also supported by the John S. Dunn Research Foundation ( to W. D.). This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bogdanov Mikhail, 2008, V49, P197, DOI 10.1007/978-1-4020-8831-5_8; Conover GM, 2008, CELL MICROBIOL, V10, P514, DOI 10.1111/j.1462-5822.2007.01066.x; Delgado-Partin VM, 1998, J BIOL CHEM, V273, P9927, DOI 10.1074/jbc.273.16.9927; DOWHAN W, 2009, ANN REV BIO IN PRESS, V78; DOWHAN W, 2009, J LIPID RES IN PRESS, V50; Dowhan W, 2008, N COMP BIOC, P1, DOI 10.1016/B978-044453219-0.50003-9; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Nagahama H, 2006, J GEN APPL MICROBIOL, V52, P91, DOI 10.2323/jgam.52.91; Nagamori S, 2003, J BIOL CHEM, V278, P14820, DOI 10.1074/jbc.M300332200; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rutz C, 1999, J BIOL CHEM, V274, P33757, DOI 10.1074/jbc.274.47.33757; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; White SH, 2005, BIOCHEM SOC T, V33, P1012, DOI 10.1042/BST0331012; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; Xie J, 2006, J BIOL CHEM, V281, P19172, DOI 10.1074/jbc.M602565200; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200	29	58	60	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9637	9641		10.1074/jbc.R800081200	http://dx.doi.org/10.1074/jbc.R800081200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19074771	Green Published, hybrid			2022-12-27	WOS:000264892900002
J	Contreras, L; Satrustegui, J				Contreras, Laura; Satrustegui, Jorgina			Calcium Signaling in Brain Mitochondria INTERPLAY OF MALATE ASPARTATE NADH SHUTTLE AND CALCIUM UNIPORTER/MITOCHONDRIAL DEHYDROGENASE PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; ALPHA-KETOGLUTARATE DEHYDROGENASE; GLYCEROL-PHOSPHATE DEHYDROGENASE; PERMEABILITY TRANSITION; OXIDATIVE-METABOLISM; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; GLUTAMATE-DEHYDROGENASE; REDUCING EQUIVALENTS; GLUCOSE CONSUMPTION; SENSORY STIMULATION	Ca2+ signaling in mitochondria has been mainly attributed to Ca2+ entry to the matrix through the Ca2+ uniporter and activation of mitochondrial matrix dehydrogenases. However, mitochondria can also sense increases in cytosolic Ca2+ through a mechanism that involves the aspartate-glutamate carriers, extramitochondrial Ca2+ activation of the NADH malate-aspartate shuttle (MAS). Both pathways are linked through the shared substrate alpha-ketoglutarate (alpha KG). Here we have studied the interplay between the two pathways under conditions of Ca2+ activation. We show that alpha KG becomes limiting when Ca2+ enters in brain or heart mitochondria, but not liver mitochondria, resulting in a drop in alpha KG efflux through the oxoglutarate carrier and in a drop in MAS activity. Inhibition of alpha KG efflux and MAS activity by matrix Ca2+ in brain mitochondria was fully reversible upon Ca2+ efflux. Because of their differences in cytosolic calcium concentration requirements, the MAS and Ca2+ uniporter-mitochondrial dehydrogenase pathways are probably sequentially activated during a Ca2+ transient, and the inhibition of MAS at the center of the transient may provide an explanation for part of the increase in lactate observed in the stimulated brain in vivo.	[Satrustegui, Jorgina] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; CIBER Enfermedades Raras, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Satrustegui, J (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, CSIC, C Nicolas Cabrera 1,Campus Cantoblanco, E-28049 Madrid, Spain.	jsatrustegui@cbm.uam.es	Contreras, Laura/A-2296-2015; Contreras, Laura/ABG-7620-2021; Satrustegui, Jorgina/R-6732-2019	Contreras, Laura/0000-0003-1157-4942; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667	Ministerio de Educacion y Ciencia [BFU2005-C02-01, BFU2008-04084/BMC]; Comunidad de Madrid [S-GEN-0269-2006]; European Union [LSHM-CT-2006-518153]	Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); European Union(European Commission)	This work was supported by Ministerio de Educacion y Ciencia Grants BFU2005-C02-01 and BFU2008-04084/BMC, Comunidad de Madrid Grant S-GEN-0269-2006 MITOLAB-CM, and European Union Grant LSHM-CT-2006-518153. The costs of publication of this article were defrayed in part by the payment of page charges.	Atlante A, 1999, J NEUROCHEM, V73, P237, DOI 10.1046/j.1471-4159.1999.0730237.x; Bak LK, 2006, J CEREBR BLOOD F MET, V26, P1285, DOI 10.1038/sj.jcbfm.9600281; Begum L, 2002, BBA-GENE STRUCT EXPR, V1574, P283, DOI 10.1016/S0167-4781(01)00376-1; Berkich DA, 2007, J NEUROSCI RES, V85, P3367, DOI 10.1002/jnr.21500; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; BERNARDI P, 1990, EUR J BIOCHEM, V188, P91, DOI 10.1111/j.1432-1033.1990.tb15375.x; Bernardinelli Y, 2006, GLIA, V54, P460, DOI 10.1002/glia.20387; Caesar K, 2008, J PHYSIOL-LONDON, V586, P1337, DOI 10.1113/jphysiol.2007.144154; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Carobbio S, 2009, J BIOL CHEM, V284, P921, DOI 10.1074/jbc.M806295200; CEDERBAU.AI, 1973, ARCH BIOCHEM BIOPHYS, V158, P763, DOI 10.1016/0003-9861(73)90571-7; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; CHEESEMAN AJ, 1988, J NEUROCHEM, V50, P1559, DOI 10.1111/j.1471-4159.1988.tb03044.x; Contreras L, 2007, J BIOL CHEM, V282, P7098, DOI 10.1074/jbc.M610491200; Cruz NF, 2007, J NEUROSCI RES, V85, P3254, DOI 10.1002/jnr.21193; DAWSON AG, 1978, FEBS LETT, V91, P169, DOI 10.1016/0014-5793(78)81164-8; de Bari L, 2002, BIOCHEM J, V365, P391, DOI 10.1042/BJ20020139; del Arco A, 2002, EUR J BIOCHEM, V269, P3313, DOI 10.1046/j.1432-1033.2002.03018.x; Dienel GA, 2002, J CEREBR BLOOD F MET, V22, P1490, DOI 10.1097/01.WCB.0000034363.37277.89; Erakovic V, 2001, EPILEPSIA, V42, P181, DOI 10.1046/j.1528-1157.2001.4220181.x; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; Gellerich FN, 2008, J BIOL CHEM, V283, P30715, DOI 10.1074/jbc.M709555200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Hernandez-SanMiguel E, 2006, CELL CALCIUM, V40, P53, DOI 10.1016/j.ceca.2006.03.009; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kasischke KA, 2008, J PHYSIOL-LONDON, V586, P1207, DOI 10.1113/jphysiol.2008.151373; LANOUE KF, 1974, J BIOL CHEM, V249, P7522; LANOUE KF, 1974, J BIOL CHEM, V249, P7514; LANOUE KF, 1974, ARCH BIOCHEM BIOPHYS, V161, P544, DOI 10.1016/0003-9861(74)90337-3; Lasorsa FM, 2003, J BIOL CHEM, V278, P38686, DOI 10.1074/jbc.M304988200; LEVEILLE PJ, 1980, BRAIN RES, V196, P287, DOI 10.1016/0006-8993(80)90397-2; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; MacDonald MJ, 1996, ARCH BIOCHEM BIOPHYS, V326, P79, DOI 10.1006/abbi.1996.0049; Madsen PL, 1999, J CEREBR BLOOD F MET, V19, P393, DOI 10.1097/00004647-199904000-00005; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Mangia S, 2007, J CEREBR BLOOD F MET, V27, P1055, DOI 10.1038/sj.jcbfm.9600401; Marmol P, 2009, J BIOL CHEM, V284, P515, DOI 10.1074/jbc.M806729200; MARTINEZ A, 1988, NEUROSCI LETT, V88, P336, DOI 10.1016/0304-3940(88)90234-0; MARTINEZSERRANO A, 1992, MOL BIOL CELL, V3, P235, DOI 10.1091/mbc.3.2.235; McCormack JG, 1999, CALCIUM AS A CELLULAR REGULATOR, P529; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MCCORMACK JG, 1979, BIOCHEM J, V180, P533, DOI 10.1042/bj1800533; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Monteith GR, 1999, AM J PHYSIOL-CELL PH, V276, pC1193, DOI 10.1152/ajpcell.1999.276.5.C1193; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Nehlig A, 2007, GLIA, V55, P1238, DOI 10.1002/glia.20376; Nguyen NHT, 2003, J NEUROCHEM, V85, P831, DOI 10.1046/j.1471-4159.2003.01762.x; NICHOLLS DG, 1980, BIOCHEM J, V186, P833, DOI 10.1042/bj1860833; NICHOLLS DG, 1978, BIOCHEM J, V170, P511, DOI 10.1042/bj1700511; NICHOLS BJ, 1995, MOL CELL BIOCHEM, V149, P203, DOI 10.1007/BF01076578; O'Donnell JM, 2004, AM J PHYSIOL-HEART C, V286, pH2237, DOI 10.1152/ajpheart.01113.2003; O'Donnell JM, 1998, AM J PHYSIOL-HEART C, V274, pH467, DOI 10.1152/ajpheart.1998.274.2.H467; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; Pardo B, 2006, J BIOL CHEM, V281, P1039, DOI 10.1074/jbc.M507270200; Patel AB, 2005, J NEUROSCI RES, V79, P128, DOI 10.1002/jnr.20311; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Ramos M, 2003, DEV BRAIN RES, V143, P33, DOI 10.1016/S0165-3806(03)00097-X; ROBERT R, 1983, METHODS ENZYMATIC AN, V3; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; RUNSWICK MJ, 1990, BIOCHEMISTRY-US, V29, P11033, DOI 10.1021/bi00502a004; RUTTER GA, 1992, BIOCHIM BIOPHYS ACTA, V1175, P107, DOI 10.1016/0167-4889(92)90016-5; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Scholz TD, 1997, J MOL CELL CARDIOL, V29, P1605, DOI 10.1006/jmcc.1997.0394; SCHOLZ TD, 1995, PEDIATR RES, V38, P221, DOI 10.1203/00006450-199508000-00015; SLUSE FE, 1973, EUR J BIOCHEM, V32, P283, DOI 10.1111/j.1432-1033.1973.tb02609.x; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Tretter L, 2000, J NEUROSCI, V20, P8972; Villa A, 1998, BBA-BIOMEMBRANES, V1373, P347, DOI 10.1016/S0005-2736(98)00120-5; VITORICA J, 1985, BIOCHEM J, V225, P41, DOI 10.1042/bj2250041; Waagepetersen HS, 2008, NEUROCHEM RES, V33, P1610, DOI 10.1007/s11064-008-9695-8; WAN B, 1989, J BIOL CHEM, V264, P13430; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Watkins J, 2008, J PROTEOME RES, V7, P328, DOI 10.1021/pr070300g; WERNETTE ME, 1981, J BIOL CHEM, V256, P2767; Xu Y, 2007, J NEUROCHEM, V101, P120, DOI 10.1111/j.1471-4159.2006.04349.x; Yang SJ, 2003, BIOCHIMIE, V85, P581, DOI 10.1016/S0300-9084(03)00092-0	87	69	74	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7091	7099		10.1074/jbc.M808066200	http://dx.doi.org/10.1074/jbc.M808066200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129175	hybrid, Green Published			2022-12-27	WOS:000263919000057
J	Gupta, SS; Borin, BN; Cover, TL; Krezel, AM				Gupta, Shobhana S.; Borin, Brendan N.; Cover, Timothy L.; Krezel, Andrzej M.			Structural Analysis of the DNA-binding Domain of the Helicobacter pylori Response Regulator ArsR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HP0165-HP0166 2-COMPONENT SYSTEM; GENE-EXPRESSION; PROTEIN; PHOSPHORYLATION; OMPR; ACTIVATION; INFECTION; SEQUENCE; KINASE; PHOB	The Helicobacter pylori ArsS-ArsR two-component signal transduction system, comprised of a sensor histidine kinase (ArsS) and a response regulator (ArsR), allows the bacteria to regulate gene expression in response to acidic pH. We expressed and purified the full-length ArsR protein and the DNA-binding domain of ArsR (ArsR-DBD), and we analyzed the tertiary structure of the ArsR-DBD using solution nuclear magnetic resonance (NMR) methods. Both the full-length ArsR and the ArsR-DBD behaved as monomers in size exclusion chromatography experiments. The structure of ArsR-DBD consists of an N-terminal four-stranded beta-sheet, a helical core, and a C-terminal beta-hairpin. The overall tertiary fold of the ArsR-DBD is most closely related to DBD structures of the OmpR/PhoB subfamily of bacterial response regulators. However, the orientation of the N-terminal beta-sheet with respect to the rest of the DNA-binding domain is substantially different in ArsR compared with the orientation in related response regulators. Molecular modeling of an ArsR-DBD-DNA complex permits identification of protein elements that are predicted to bind target DNA sequences and thereby regulate gene transcription in H. pylori.	[Krezel, Andrzej M.] Vanderbilt Univ, Struct Biol Ctr, Dept Biol Sci, Nashville, TN 37232 USA; [Gupta, Shobhana S.; Cover, Timothy L.] Vanderbilt Univ, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Cover, Timothy L.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Cover, Timothy L.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Krezel, AM (corresponding author), Vanderbilt Univ, Struct Biol Ctr, Dept Biol Sci, 465 21st Ave,MRBIII 5270A, Nashville, TN 37232 USA.	andrzej.m.krezel@vanderbilt.edu	Cover, Timothy/I-3814-2015	Cover, Timothy/0000-0001-8503-002X	National Institutes of Health [R01 AI39657]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI39657. This work was also supported by the Department of Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AIBA H, 1989, J BIOCHEM-TOKYO, V106, P5, DOI 10.1093/oxfordjournals.jbchem.a122817; Ang S, 2001, INFECT IMMUN, V69, P1679, DOI 10.1128/IAI.69.3.1679-1686.2001; Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; Beier D, 2000, J BACTERIOL, V182, P2068, DOI 10.1128/JB.182.8.2068-2076.2000; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Bury-Mone S, 2004, MOL MICROBIOL, V53, P623, DOI 10.1111/j.1365-2958.2004.04137.x; CASE DA, 2004, AMBER, V9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dietz P, 2002, J BACTERIOL, V184, P350, DOI 10.1128/JB.184.2.350-362.2002; Eguchi Y, 2005, TRENDS BIOCHEM SCI, V30, P70, DOI 10.1016/j.tibs.2004.12.003; FIEDLER U, 1995, EMBO J, V14, P3696, DOI 10.1002/j.1460-2075.1995.tb00039.x; Forsyth MH, 2002, J BACTERIOL, V184, P4630, DOI 10.1128/JB.184.16.4630-4635.2002; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HALL MN, 1981, J MOL BIOL, V146, P23, DOI 10.1016/0022-2836(81)90364-8; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hong E, 2007, J BIOL CHEM, V282, P20667, DOI 10.1074/jbc.M609104200; JO YL, 1986, J BIOL CHEM, V261, P5252; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Loh JT, 2006, INFECT IMMUN, V74, P3052, DOI 10.1128/IAI.74.5.3052-3059.2006; MARSHALL BJ, 1984, LANCET, V1, P1311; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; McCleary WR, 1996, MOL MICROBIOL, V20, P1155, DOI 10.1111/j.1365-2958.1996.tb02636.x; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; Mueller A, 2005, CANCER EPIDEM BIOMAR, V14, P1859, DOI 10.1158/1055-9965.EPI-04-0820; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Panthel K, 2003, INFECT IMMUN, V71, P5381, DOI 10.1128/IAI.71.9.5381-5385.2003; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; PETERSON WL, 1991, NEW ENGL J MED, V324, P1043, DOI 10.1056/NEJM199104113241507; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflock M, 2005, INFECT IMMUN, V73, P6437, DOI 10.1128/IAI.73.10.6437-6445.2005; Pflock M, 2004, FEMS MICROBIOL LETT, V234, P51, DOI 10.1016/j.femsle.2004.03.023; Pflock M, 2006, J BIOTECHNOL, V126, P52, DOI 10.1016/j.jbiotec.2006.03.045; Pflock M, 2006, J BACTERIOL, V188, P3449, DOI 10.1128/JB.188.10.3449-3462.2006; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHADE C, 1994, GASTROENTEROLOGY, V107, P180, DOI 10.1016/0016-5085(94)90075-2; Schar J, 2005, J BACTERIOL, V187, P3100, DOI 10.1128/JB.187.9.3100-3109.2005; Scott DR, 2007, P NATL ACAD SCI USA, V104, P7235, DOI 10.1073/pnas.0702300104; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wen Y, 2006, J BACTERIOL, V188, P1750, DOI 10.1128/JB.188.5.1750-1761.2006; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Wen Y, 2007, J BACTERIOL, V189, P2426, DOI 10.1128/JB.01492-06; WISHART DS, 1994, METHOD ENZYMOL, V239, P363	52	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6536	6545		10.1074/jbc.M804592200	http://dx.doi.org/10.1074/jbc.M804592200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19117956	Green Published, hybrid			2022-12-27	WOS:000263742700056
J	Hora, R; Bridges, DJ; Craig, A; Sharma, A				Hora, Rachna; Bridges, Daniel J.; Craig, Alister; Sharma, Amit			Erythrocytic Casein Kinase II Regulates Cytoadherence of Plasmodium falciparum-infected Red Blood Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE-RICH PROTEIN; MEMBRANE PROTEIN-1; SUBCELLULAR-LOCALIZATION; PHOSPHORYLATION; MALARIA; PFEMP1; LIGAND; SPECTRIN; PARASITE; RECEPTOR	Plasmodium falciparum malaria is a major human health scourge and a key cause of mortality. Its pathogenicity partly results from the phenomenon of "cytoadherence" mediated by the PfEMP1 (Plasmodium falciparum erythrocyte membrane protein 1) family. Extracellular domains of PfEMP1s are variable and bind various host endothelial receptors, whereas their cytoplasmic domains (VARCs) are relatively conserved. VARCs affix PfEMP1s in the human erythrocyte membrane by interacting with host cytoskeleton proteins and exported parasite proteins. Here, we provide in vitro and in vivo evidence for PfEMP1 phosphorylation (on VARC) and propose an important function for this modification. Specific inhibitors and enhancers have been used to identify erythrocytic casein kinase II (CKII) as the enzyme responsible for VARC modification activity. We have also delineated probable CKII target residues on VARC, which mainly reside in an N-terminal acidic cluster. Our data show that VARC phosphorylation alters its binding to parasite encoded knob-associated histidine-rich protein (KAHRP). Finally, we demonstrate reduced cytoadherence of infected RBCs to endothelial receptors like ICAM-1 and CSA (these contribute to cerebral and placental malaria, respectively) in response to their CKII inhibition. Collectively, this study furthers our understanding of VARC function, underscores the importance of erythrocytic CKII in cytoadherence, and suggests a possible new target for anti-cytoadherence molecules.	[Hora, Rachna; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India; [Bridges, Daniel J.; Craig, Alister] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Liverpool School of Tropical Medicine; University of Liverpool	Sharma, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India.	amit.icgeb@gmail.com		Hora, Rachna/0000-0002-6085-8389; Craig, Alister/0000-0003-0914-6164	MRC [G0400417] Funding Source: UKRI; Medical Research Council [G0400417] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ASSARAF YG, 1984, BIOCHEM J, V222, P815, DOI 10.1042/bj2220815; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Barragan A, 1999, BIOCHEM SOC T, V27, P487, DOI 10.1042/bst0270487; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BERENDT AR, 1994, PARASITOLOGY, V108, P19; Brunati AM, 2000, BLOOD, V96, P1550, DOI 10.1182/blood.V96.4.1550.h8001550_1550_1557; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; CULVENOR JG, 1987, EXP PARASITOL, V63, P58, DOI 10.1016/0014-4894(87)90078-6; Dondorp AM, 2000, PARASITOL TODAY, V16, P228, DOI 10.1016/S0169-4758(00)01666-5; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Ghosh S, 2002, J CELL SCI, V115, P4107, DOI 10.1242/jcs.00102; Glenister FK, 2002, BLOOD, V99, P1060, DOI 10.1182/blood.V99.3.1060; HATHAWAY GM, 1984, J BIOL CHEM, V259, P7011; HATHAWAY GM, 1980, J BIOL CHEM, V255, P8038; Horrocks P, 2005, J CELL SCI, V118, P2507, DOI 10.1242/jcs.02381; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; Lechuga MT, 2006, ACTA PSYCHOL, V123, P279, DOI 10.1016/j.actpsy.2006.01.006; LING E, 1988, J BIOL CHEM, V263, P2209; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; PATEL VP, 1981, J CELL BIOL, V88, P430, DOI 10.1083/jcb.88.2.430; Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200; POLOGE LG, 1987, P NATL ACAD SCI USA, V84, P7139, DOI 10.1073/pnas.84.20.7139; Raha T, 2000, PROTEIN ENG, V13, P437, DOI 10.1093/protein/13.6.437; Ramya TNC, 2006, BIOCHEM BIOPH RES CO, V348, P579, DOI 10.1016/j.bbrc.2006.07.127; RUANGJIRACHUPORN W, 1991, PARASITOLOGY, V102, P325, DOI 10.1017/S003118200006426X; Sarno S, 2005, BBA-PROTEINS PROTEOM, V1754, P263, DOI 10.1016/j.bbapap.2005.07.043; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Voigt S, 2000, MOL BIOCHEM PARASIT, V110, P423, DOI 10.1016/S0166-6851(00)00281-4; Wagner LM, 2002, MOL VIS, V8, P394; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Waller KL, 2002, MOL BIOCHEM PARASIT, V119, P125, DOI 10.1016/S0166-6851(01)00395-4	37	32	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6260	6269		10.1074/jbc.M809756200	http://dx.doi.org/10.1074/jbc.M809756200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19131328	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000263742700029
J	Suthammarak, W; Yang, YY; Morgan, PG; Sedensky, MM				Suthammarak, Wichit; Yang, Yu-Ying; Morgan, Phil G.; Sedensky, Margaret M.			Complex I Function Is Defective in Complex IV-deficient Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; RESPIRATORY-CHAIN SUPERCOMPLEXES; MITOCHONDRIAL ELECTRON-TRANSPORT; MAMMALIAN MITOCHONDRIA; LIVER-MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; PARKINSONS-DISEASE; NADH DEHYDROGENASE; NDUFS4 GENE; SUBUNIT-IV	Cytochrome c oxidase (COX) is hypothesized to be an important regulator of oxidative phosphorylation. However, no animal phenotypes have been described due to genetic defects in nuclear-encoded subunits of COX. We knocked down predicted homologues of COX IV and COX Va in the nematode Caenorhabditis elegans. Animals treated with W09C5.8 (COX IV) or Y37D8A.14 (COX Va) RNA interference had shortened lifespans and severe defects in mitochondrial respiratory chain function. Amount and activity of complex IV, as well as super-complexes that included complex IV, were decreased in COX-deficient worms. The formation of supercomplex I:III was not dependent on COX. We found that COX deficiencies decreased intrinsic complex I enzymatic activity, as well as complex I-III enzymatic activity. However, overall amounts of complex I were not decreased in these animals. Surprisingly, intrinsic complex I enzymatic activity is dependent on the presence of complex IV, despite no overall decrease in the amount of complex I. Presumably the association of complex I with complex IV within the supercomplex I:III:IV enhances electron flow through complex I. Our results indicate that reduction of a single subunit within the electron transport chain can affect multiple enzymatic steps of electron transfer, including movement within a different protein complex. Patients presenting with multiple defects of electron transport may, in fact, harbor a single genetic defect.	[Morgan, Phil G.; Sedensky, Margaret M.] Childrens Res Inst, Seattle, WA 98101 USA; [Suthammarak, Wichit; Yang, Yu-Ying; Morgan, Phil G.; Sedensky, Margaret M.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Suthammarak, Wichit; Morgan, Phil G.; Sedensky, Margaret M.] Univ Hosp, Dept Anesthesiol, Cleveland, OH 44106 USA; [Morgan, Phil G.; Sedensky, Margaret M.] Univ Washington, Dept Anesthesiol, Seattle, WA 98101 USA; [Suthammarak, Wichit] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10700, Thailand	Case Western Reserve University; University Hospitals of Cleveland; University of Washington; University of Washington Seattle; Mahidol University	Sedensky, MM (corresponding author), Childrens Res Inst, 1900 9th Ave, Seattle, WA 98101 USA.	margaret.sedensky@seattlechildrens.org			National Institutes of Health [GM58881, AG026273]; Royal Thai Government, Science and Technology Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Thai Government, Science and Technology Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM58881 and AG026273 (to M.M.S., Y.-Y.Y., and P.G.M.) and by the Royal Thai Government, Science and Technology Scholarship (W.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Arnold S, 1998, EUR J BIOCHEM, V252, P325, DOI 10.1046/j.1432-1327.1998.2520325.x; BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451; Bianchi C, 2004, J BIOL CHEM, V279, P36562, DOI 10.1074/jbc.M405135200; Brass EP, 2001, AM J PHYSIOL-HEART C, V280, pH603, DOI 10.1152/ajpheart.2001.280.2.H603; Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257; CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258; Cardol P, 2008, BBA-BIOENERGETICS, V1777, P388, DOI 10.1016/j.bbabio.2008.01.001; CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0; CHAZOTTE B, 1988, J BIOL CHEM, V263, P14359; Conway JP, 2005, MOL CELL PROTEOMICS, V4, P1522, DOI 10.1074/mcp.M500111-MCP200; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; Genova Maria Luisa, 2003, Ital J Biochem, V52, P58; Grad LI, 2006, BBA-BIOENERGETICS, V1757, P115, DOI 10.1016/j.bbabio.2005.11.009; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; Hatefi Y, 1978, Methods Enzymol, V53, P11; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; HOPPEL C, 1969, ARCH BIOCHEM BIOPHYS, V135, P173, DOI 10.1016/0003-9861(69)90528-1; Kadenbach B, 1997, MOL CELL BIOCHEM, V174, P131, DOI 10.1023/A:1006819416358; Kayser EB, 2004, MECH AGEING DEV, V125, P455, DOI 10.1016/j.mad.2004.04.002; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; KORENKE GC, 1990, EUR J PEDIATR, V150, P104, DOI 10.1007/BF02072049; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; Krause F, 2005, BIOCHEM BIOPH RES CO, V329, P583, DOI 10.1016/j.bbrc.2005.02.010; LAZAROU M, 2008, BIOCHIM BIOPHYS ACTA, V1793, P78; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022; MORGAN PG, 1988, ANESTHESIOLOGY, V69, P246, DOI 10.1097/00000542-198808000-00015; Napiwotzki J, 1997, BIOL CHEM, V378, P1013, DOI 10.1515/bchm.1997.378.9.1013; Napiwotzki J, 1998, BIOL CHEM, V379, P335, DOI 10.1515/bchm.1998.379.3.335; Scacco S, 2003, J BIOL CHEM, V278, P44161, DOI 10.1074/jbc.M307615200; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 1996, Methods Enzymol, V264, P555, DOI 10.1016/S0076-6879(96)64048-8; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; Schagger H, 2001, J BIOL CHEM, V276, P37861; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; van Straaten HLM, 2005, NEUROPEDIATRICS, V36, P193, DOI 10.1055/s-2005-865713; von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6; VONCK J, 2008, BIOCHIM BIOPHYS ACTA, V1793, P117; Yoshikawa S, 1997, CURR OPIN STRUC BIOL, V7, P574, DOI 10.1016/S0959-440X(97)80124-8	51	62	64	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6425	6435		10.1074/jbc.M805733200	http://dx.doi.org/10.1074/jbc.M805733200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19074434	hybrid, Green Published			2022-12-27	WOS:000263742700045
J	Truty, MJ; Lomberk, G; Fernandez-Zapico, ME; Urrutia, R				Truty, Mark J.; Lomberk, Gwen; Fernandez-Zapico, Martin E.; Urrutia, Raul			Silencing of the Transforming Growth Factor-beta (TGF beta) Receptor II by Kruppel-like Factor 14 Underscores the Importance of a Negative Feedback Mechanism in TGF beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-CANCER CELLS; TRANSCRIPTION FACTORS; SP1-LIKE PROTEIN; GENE PROMOTER; SP1; EXPRESSION; FAMILY; DEACETYLASE; REPRESSORS; MEMBERS	The role of non-Smad proteins in the regulation of transforming growth factor-beta (TGF beta) signaling is an emerging line of active investigation. Here, we characterize the role of KLF14, as a TGF beta-inducible, non-Smad protein that silences the TGF beta receptor II ( TGF beta RII) promoter. Together with endocytosis, transcriptional silencing is a critical mechanism for down-regulating TGF beta receptors at the cell surface. However, the mechanisms underlying transcriptional repression of these receptors remain poorly understood. KLF14 has been chosen from a comprehensive screen of 24 members of the Sp/KLF family due to its TGF beta inducibility, its ability to regulate the TGF beta RII promoter, and the fact that this protein had yet to be functionally characterized. We find that KLF14 represses the TGF beta RII, a function that is augmented by TGF beta treatment. Mapping of the TGF beta RII promoter, in combination with site-directed mutagenesis, electromobility shift, and chromatin immunoprecipitation assays, have identified distinct GC-rich sequences used by KLF14 to regulate this promoter. Mechanistically, KLF14 represses the TGF beta RII promoter via a co-repressor complex containing mSin3A and HDAC2. Furthermore, the TGF beta pathway activation leads to recruitment of a KLF14-mSin3A-HDAC2 repressor complex to the TGF beta RII promoter, as well as the remodeling of chromatin to increase histone marks that associate with transcriptional silencing. Thus, these results describe a novel negative-feedback mechanism by which TGF beta RII activation at the cell surface induces the expression of KLF14 to ultimately silence the TGF beta RII and further expand the network of non-Smad transcription factors that participate in the TGF beta pathway.	[Truty, Mark J.] Mayo Clin, Dept Surg, Clinician Investigator Training Program, Rochester, MN 55905 USA; [Truty, Mark J.; Lomberk, Gwen; Fernandez-Zapico, Martin E.; Urrutia, Raul] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Truty, Mark J.; Lomberk, Gwen; Fernandez-Zapico, Martin E.; Urrutia, Raul] Mayo Clin, Dept Physiol & Biophys, Gastroenterol Res Unit, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Urrutia, R (corresponding author), Mayo Clin, GI Res Unit, 200 1st St SW,Guggenheim 10, Rochester, MN 55905 USA.	urrutia.raul@mayo.edu	Lomberk, Gwen/AAL-8490-2020	Lomberk, Gwen/0000-0001-5463-789X	National Institutes of Health [DK 52913]; Mayo Clinic Pancreatic SPORE [P50 CA102701]; NATIONAL CANCER INSTITUTE [R03CA125127, P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, R56DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Pancreatic SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 52913. This work was also supported by Mayo Clinic Pancreatic SPORE (Grant P50 CA102701 to R. U.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; We dedicate this manuscript to the memory of Kazimierz Truty and to all the other patients who have succumbed to pancreatic cancer.	Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; BAE HW, 1995, J BIOL CHEM, V270, P29460, DOI 10.1074/jbc.270.49.29460; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Cook T, 2000, AM J PHYSIOL-GASTR L, V278, pG513, DOI 10.1152/ajpgi.2000.278.4.G513; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Ellenrieder V, 2001, CURR OPIN GASTROEN, V17, P434, DOI 10.1097/00001574-200109000-00006; GAZIT D, 1993, MOL ENDOCRINOL, V7, P189, DOI 10.1210/me.7.2.189; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Itman C, 2006, REPRODUCTION, V132, P233, DOI 10.1530/rep.1.01075; Jennings R, 2001, ONCOGENE, V20, P6899, DOI 10.1038/sj.onc.1204808; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaczynski J, 2001, J BIOL CHEM, V276, P36749, DOI 10.1074/jbc.M105831200; Kaczynski JA, 2002, BIOCHEM J, V366, P873, DOI 10.1042/BJ20020388; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Koli KM, 1997, J BIOL CHEM, V272, P6423, DOI 10.1074/jbc.272.10.6423; Koutsodontis G, 2002, BIOCHEMISTRY-US, V41, P12771, DOI 10.1021/bi026141q; Lee BI, 2001, CANCER RES, V61, P931; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Natesampillai S, 2006, J BIOL CHEM, V281, P3040, DOI 10.1074/jbc.M509417200; Nishikawa Y, 1998, J CELL PHYSIOL, V176, P612, DOI 10.1002/(SICI)1097-4652(199809)176:3<612::AID-JCP18>3.0.CO;2-0; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Park SH, 2002, J BIOL CHEM, V277, P5168, DOI 10.1074/jbc.M106451200; Parker-Katiraee L, 2007, PLOS GENET, V3, P665, DOI 10.1371/journal.pgen.0030065; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Schneider D, 2002, BBA-MOL BASIS DIS, V1588, P1, DOI 10.1016/S0925-4439(02)00052-2; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Venkatasubbarao K, 2001, CANCER RES, V61, P6239; WOODWARD TL, 1995, J CELL PHYSIOL, V165, P339, DOI 10.1002/jcp.1041650215; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001; Zhao SJ, 2003, CANCER RES, V63, P2624	36	47	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6291	6300		10.1074/jbc.M807791200	http://dx.doi.org/10.1074/jbc.M807791200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19088080	Green Published, hybrid			2022-12-27	WOS:000263742700032
J	Housley, MP; Udeshi, ND; Rodgers, JT; Shabanowitz, J; Puigserver, P; Hunt, DF; Hart, GW				Housley, Michael P.; Udeshi, Namrata D.; Rodgers, Joseph T.; Shabanowitz, Jeffrey; Puigserver, Pere; Hunt, Donald F.; Hart, Gerald W.			A PGC-1 alpha-O-GlcNAc Transferase Complex Regulates FoxO Transcription Factor Activity in Response to Glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLCNAC TRANSFERASE; LINKED N-ACETYLGLUCOSAMINE; PPAR-GAMMA COACTIVATOR-1; ACTIVATED RECEPTOR-GAMMA; RNA-POLYMERASE-II; INSULIN-RESISTANCE; MASS-SPECTROMETRY; NUCLEOCYTOPLASMIC GLYCOSYLATION; HEPATIC GLUCONEOGENESIS; HEXOSAMINE BIOSYNTHESIS	Metabolic and stress response gene regulation is crucial for the survival of an organism to a changing environment. Three key molecules that sense nutrients and broadly affect gene expression are the FoxO transcription factors, the transcriptional co-activator PGC-1 alpha, and the dynamic post-translational modification, O-linked beta-N-acetylglucosamine (O-GlcNAc). Here we identify novel post-translational modifications of PGC-1 alpha, including O-GlcNAc, and describe a novel mechanism for how PGC-1 alpha co-activates transcription by FoxOs. In liver, in cultured cells, and in vitro with recombinant proteins, PGC-1 alpha binds to O-GlcNAc transferase and targets the enzyme to FoxOs, resulting in their increased GlcNAcylation and increased transcriptional activity. Furthermore, glucose-enhanced activation of FoxO1 occurs via this PGC-1 alpha-O-GlcNAc transferase-mediated GlcNAcylation. Therefore, one mechanism by which PGC-1 alpha can serve as a co-activator of transcription is by targeting the O-GlcNAc transferase to increase GlcNAcylation of specific transcription factors important to nutrient/stress sensing and energy metabolism.	[Housley, Michael P.; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Udeshi, Namrata D.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA; [Rodgers, Joseph T.; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Rodgers, Joseph T.; Puigserver, Pere] Dana Farber Canc Inst, Dept Cell Biol, Boston, MA 02115 USA	Johns Hopkins University; University of Virginia; University of Virginia; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368; Hart, Gerald/0000-0001-7812-4351; Rodgers, Joseph/0000-0002-6598-5520	National Institutes of Health [DK61671, HD13563, GM37537]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD013563, R01HD013563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61671 and HD13563 (to G. W. H.) and GM37537 (to D. F. H.). G. W. H. receives a share of royalties on university sales of the CTD110.6 antibody. Arrangement managed by The Johns Hopkins University School conflict of interest policies. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Birnbaum MJ, 2008, SCIENCE, V319, P1348, DOI 10.1126/science.1155915; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; CHEUNG WD, 2008, J BIOL CHEM; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Mikesh LM, 2006, BBA-PROTEINS PROTEOM, V1764, P1811, DOI 10.1016/j.bbapap.2006.10.003; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; MONSIGNY M, 1980, EUR J BIOCHEM, V104, P147, DOI 10.1111/j.1432-1033.1980.tb04410.x; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sano M, 2004, EMBO J, V23, P3559, DOI 10.1038/sj.emboj.7600351; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	56	145	152	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5148	5157		10.1074/jbc.M808890200	http://dx.doi.org/10.1074/jbc.M808890200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103600	hybrid, Green Published			2022-12-27	WOS:000263416600045
J	Miraoui, H; Oudina, K; Petite, H; Tanimoto, Y; Moriyama, K; Marie, PJ				Miraoui, Hichem; Oudina, Karim; Petite, Herve; Tanimoto, Yukiho; Moriyama, Keiji; Marie, Pierre J.			Fibroblast Growth Factor Receptor 2 Promotes Osteogenic Differentiation in Mesenchymal Cells via ERK1/2 and Protein Kinase C Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; OSTEOBLAST DIFFERENTIATION; APERT-SYNDROME; STEM-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATED KINASE; STROMAL CELLS; N-CADHERIN; MARROW; EXPRESSION	Mesenchymal stem cells (MSCs) are able to differentiate into several lineages including osteoblasts. The signaling mechanisms involved in the osteogenic differentiation of MSCs are however not fully understood. We investigated the role of fibroblast growth factor receptor 2 (FGFR2) in osteoblast committment and differentiation of murine mesenchymal C3H10T1/2 cells stably transfected with wild type (WT) or activated FGFR2 due to Apert S252W geneticmutation(MT). WTFGFR2 slightly increased, whereas MT FGFR2 strongly increased, FGFR2 tyrosine phosphorylation, indicating activation of the receptor. WT and MT FGFR2 increased C3H10T1/2 cell proliferation but not survival. Both WT and MT FGFR2 increased early and late osteoblast gene expression and matrix mineralization. Forced expression of WT and MT FGFR2 also increased osteoblast gene expression in MC3T3-E1 calvaria osteoblasts. In both cell types, MTFGFR2 was more effective than WTFGFR2. In contrast, WT and MTFGFR2 decreased adipocyte differentiation of C3H10T1/2 cells. WT and MT FGFR2 induced ERK1/2 but not JNK or PI3K/AKT phosphorylation. MT, but not WT, also increased protein kinase C (PKC) activity. Pharmacological inhibition of ERK1/2 prevented cell proliferation induced by WT and MT FGFR2. Using dominant-negative ERK and PKC alpha vectors, we demonstrated that WT and MT FGFR2 promoted osteoblast gene expression through ERK1/2 and PKC alpha signaling, respectively. This study identifies FGFR2 as a novel regulatory molecule that promotes osteogenic differentiation in murine MSCs. The promoting effect of WT and MT FGFR2 is mediated by ERK1/2 and PKC alpha pathways that play essential and distinct roles in FGFR2-induced osteogenic differentiation of mesenchymal cells.	[Marie, Pierre J.] Hop Lariboisiere, INSERM, U606, F-75475 Paris 10, France; [Miraoui, Hichem; Oudina, Karim; Petite, Herve; Marie, Pierre J.] Univ Paris 07, Paris 10, France; [Oudina, Karim; Petite, Herve] CNRS, UMR 7052, Paris 10, France; [Tanimoto, Yukiho; Moriyama, Keiji] Tokyo Med & Dent Univ, Grad Sch, Dept Maxillofacial Orthognath, Tokyo 1138549, Japan	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Tokyo Medical & Dental University (TMDU)	Marie, PJ (corresponding author), Hop Lariboisiere, INSERM, U606, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	pierre.marie@inserm.fr	Petite, Herve/E-3478-2016; Moriyama, Keiji/AAC-3193-2019	Petite, Herve/0000-0003-1694-5060; Moriyama, Keiji/0000-0003-0580-4510				Ahdjoudj S, 2001, J CELL BIOCHEM, V81, P23, DOI 10.1002/1097-4644(20010401)81:1<23::AID-JCB1021>3.0.CO;2-H; Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; AUBIN JE, 2002, PRINCIPLES BONE BIOL, V1, P59; Baroni T, 2005, J CELL PHYSIOL, V202, P524, DOI 10.1002/jcp.20148; Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Debiais F, 2004, EXP CELL RES, V297, P235, DOI 10.1016/j.yexcr.2004.03.032; Debiais F, 2001, J CELL BIOCHEM, V81, P68, DOI 10.1002/1097-4644(20010401)81:1<68::AID-JCB1024>3.0.CO;2-S; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fragale A, 1999, AM J PATHOL, V154, P1465, DOI 10.1016/S0002-9440(10)65401-6; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Gatesman A, 2004, MOL CELL BIOL, V24, P7578, DOI 10.1128/MCB.24.17.7578-7597.2004; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gori F, 1999, J BONE MINER RES, V14, P1522, DOI 10.1359/jbmr.1999.14.9.1522; Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kaabeche K, 2004, J BIOL CHEM, V279, P36259, DOI 10.1074/jbc.M402469200; Karsenty G, 2000, SEMIN CELL DEV BIOL, V11, P343, DOI 10.1006/scdb.2000.0188; Kim BG, 2006, PROTEOMICS, V6, P1166, DOI 10.1002/pmic.200500289; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; LAUGHTON C, 1986, ANAL BIOCHEM, V156, P307, DOI 10.1016/0003-2697(86)90258-7; Lemonnier J, 2001, AM J PATHOL, V158, P1833, DOI 10.1016/S0002-9440(10)64139-9; Lemonnier J, 2001, J BONE MINER RES, V16, P832, DOI 10.1359/jbmr.2001.16.5.832; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Ling L, 2006, J CELL PHYSIOL, V209, P811, DOI 10.1002/jcp.20760; Lomri A, 1998, J CLIN INVEST, V101, P1310; Longo M, 2004, BONE, V34, P100, DOI 10.1016/j.bone.2003.09.007; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Ng KW, 2007, STEM CELLS DEV, V16, P305, DOI 10.1089/scd.2006.0044; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; OWEN M, 2002, CELL SCI S, V10, P63; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Pratap J, 2003, CANCER RES, V63, P5357; Pri-Chen S, 1998, BONE, V23, P111, DOI 10.1016/S8756-3282(98)00087-8; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Richardson JA, 2007, J CELL BIOCHEM, V100, P1131, DOI 10.1002/jcb.21112; Rios H. F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P325; Rucci N, 2005, J CELL SCI, V118, P3263, DOI 10.1242/jcs.02436; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Tang CH, 2007, J CELL PHYSIOL, V211, P45, DOI 10.1002/jcp.20896; Tanimoto Y, 2004, J BIOL CHEM, V279, P45926, DOI 10.1074/jbc.M404824200; Wang YL, 2005, DEVELOPMENT, V132, P3537, DOI 10.1242/dev.01914; Wilkie AOM, 2002, AM J MED GENET, V112, P266, DOI 10.1002/ajmg.10775; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Yin L, 2008, BONE, V42, P631, DOI 10.1016/j.bone.2007.11.019	69	116	122	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4897	4904		10.1074/jbc.M805432200	http://dx.doi.org/10.1074/jbc.M805432200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19117954	hybrid			2022-12-27	WOS:000263416600019
J	Tai, DJC; Su, CC; Ma, YL; Lee, EHY				Tai, Derek J. C.; Su, Chia-Chen; Ma, Yun-Li; Lee, Eminy H. Y.			SGK1 Phosphorylation of I kappa B Kinase alpha and p300 Up-regulates NF-kappa B Activity and Increases N-Methyl-D-aspartate Receptor NR2A and NR2B Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID-INDUCIBLE KINASE; SPATIAL MEMORY FORMATION; CELL-SURVIVAL RESPONSE; INDUCED PROTEIN-KINASE; TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; EPITHELIAL-CELLS; GENE-EXPRESSION; NMDA RECEPTOR	Serum- and glucocorticoid-inducible kinase 1 (SGK1) is a downstream target of phosphatidylinositol 3-kinase signaling, and it regulates various cellular and physiological functions, but the SGK1 substrate proteins and genes regulated by SGK1 are less known. Here we have identified I kappa B kinase alpha (IKK alpha) as a novel substrate of SGK1 by using biochemical and bioinformatic approaches. SGK1 directly phosphorylates IKK alpha at Thr-23 and indirectly activates IKK alpha at Ser-180. Furthermore, SGK1 enhanced nuclear factor kappa B (NF-kappa B) activity and up-regulated N-methyl-D-aspartate receptor NR2A and NR2B expression through activation of IKK alpha at Thr-23 and Ser-180, and these two residues play an equally important role in mediating these effects of SGK1. Although SGK1 does not phosphorylate IKK beta, IKK beta activity is still required for IKK complex activation and for SGK1 phosphorylation and activation of NF-kappa B. In addition, SGK1 increased the acetylation of NF-kappa B through phosphorylation of p300 at Ser-1834, and this also leads to NF-kappa B activation and NR2A and NR2B expression. Moreover, an endogenous stimulus of SGK1, insulin, increased IKK alpha and NF-kappa B phosphorylation as well as NF-kappa B acetylation and NF-kappa B activity, but SGK1 small interfering RNA transfection blocked these effects of insulin. In examination of the functional significance of the SGK1-IKK alpha-NF-kappa B signaling pathway, we found that transfection of the IKK alpha double mutant (IKK alpha T23A/S180A) to rat hippocampus antagonized SGK-1-mediated spatial memory facilitation. Our results together demonstrated novel substrate proteins of SGK1 and novel SGK1 signaling pathways. Activation of these signaling pathways enhances NR2A and NR2B expression that is implicated in neuronal plasticity.	[Tai, Derek J. C.] Acad Sinica, Grad Inst Life Sci, Natl Def Med Ctr, Taipei 115, Taiwan; [Su, Chia-Chen; Ma, Yun-Li; Lee, Eminy H. Y.] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; Academia Sinica - Taiwan	Lee, EHY (corresponding author), 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	eminy@gate.sinica.edu.tw	Lee, Eminy H.Y./S-7014-2018	Lee, Eminy/0000-0001-6342-0940; Ma, Yun Li/0000-0002-6321-8889	National Science Council of Taiwan [NSC96-2321-B-001-001, NSC97-2321-B-001-003]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grants NSC96-2321-B-001-001 and NSC97-2321-B-001-003 from the National Science Council of Taiwan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdallah B, 1996, HUM GENE THER, V7, P1947, DOI 10.1089/hum.1996.7.16-1947; Benoliel AM, 1997, J CELL SCI, V110, P2089; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chao CC, 2007, J NEUROSCI, V27, P6243, DOI 10.1523/JNEUROSCI.1531-07.2007; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chetty A, 2006, PEDIATR RES, V60, P389, DOI 10.1203/01.pdr.0000238257.15502.f4; Hayashi M, 2001, J BIOL CHEM, V276, P8631, DOI 10.1074/jbc.C000838200; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lee CT, 2006, EUR J NEUROSCI, V23, P1311, DOI 10.1111/j.1460-9568.2006.04650.x; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Liu AG, 2004, J BIOL CHEM, V279, P17449, DOI 10.1074/jbc.M311267200; Liu BH, 2004, GENE THER, V11, P52, DOI 10.1038/sj.gt.3302126; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YL, 2006, LEARN MEMORY, V13, P114, DOI 10.1101/lm.179206; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Meng FM, 2005, AM J PHYSIOL-CELL PH, V289, pC971, DOI 10.1152/ajpcell.00081.2005; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; Oliveira AMM, 2007, LEARN MEMORY, V14, P564, DOI 10.1101/lm.656907; Ozes ON, 1999, NATURE, V401, P82; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Perrotti N, 2001, J BIOL CHEM, V276, P9406, DOI 10.1074/jbc.M007052200; Rajamanickam J, 2007, J NEUROCHEM, V102, P858, DOI 10.1111/j.1471-4159.2007.04585.x; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Schoenebeck B, 2005, MOL CELL NEUROSCI, V30, P249, DOI 10.1016/j.mcn.2005.07.017; Strutz-Seebohm N, 2005, J PHYSIOL-LONDON, V565, P391, DOI 10.1113/jphysiol.2004.079624; Sun LX, 2000, SYNAPSE, V35, P212, DOI 10.1002/(SICI)1098-2396(20000301)35:3<212::AID-SYN6>3.0.CO;2-O; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang YC, 2006, MOL CELL BIOL, V26, P8357, DOI 10.1128/MCB.01017-06; Zhang LP, 2005, CANCER RES, V65, P457	43	72	75	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4073	4089		10.1074/jbc.M805055200	http://dx.doi.org/10.1074/jbc.M805055200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088076	hybrid			2022-12-27	WOS:000263134400005
J	Jung-Hynes, B; Nihal, M; Zhong, WX; Ahmad, N				Jung-Hynes, Brittney; Nihal, Minakshi; Zhong, Weixiong; Ahmad, Nihal			Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer A TARGET FOR PROSTATE CANCER MANAGEMENT VIA ITS INHIBITION?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; CELL-SURVIVAL; LIFE-SPAN; FORKHEAD; EXPRESSION; LONGEVITY; GROWTH; GENE; PROTEIN; ACETYLATION	Prostate cancer (PCa) is a major age-related malignancy, and according to estimates from the American Cancer Society, a man's chance of developing this cancer significantly increases with increasing age, from 1 in 10,149 by age 39 to 1 in 38 by age 59 to 1 in 7 by age 70. Therefore, it is important to identify the causal connection between mechanisms of aging and PCa. Employing in vitro and in vivo approaches, in this study, we tested the hypothesis that SIRT1, which belongs to the Sir2 (silent information regulator 2) family of sirtuin class III histone deacetylases, is overexpressed in PCa, and its inhibition will have antiproliferative effects in human PCa cells. Our data demonstrated that SIRT1 was significantly overexpressed in human PCa cells (DU145, LNCaP, 22Rv1, and PC3) compared with normal prostate epithelial cells (PrEC) at protein, mRNA, and enzymatic activity levels. SIRT1 was also found to be overexpressed in human PCa tissues compared with adjacent normal prostate tissue. Interestingly, our data demonstrated that SIRT1 inhibition via nicotinamide and sirtinol (at the activity level) as well as via short hairpin RNA-mediated RNA interference (at the genetic level) resulted in a significant inhibition in the growth and viability of human PCa cells while having no effect on normal prostate epithelial cells. Further, we found that inhibition of SIRT1 caused an increase in FOXO1 acetylation and transcriptional activation in PCa cells. Our data suggested that SIRT1, via inhibiting FOXO1 activation, could contribute to the development of PCa. We suggest that SIRT1 could serve as a target toward developing novel strategies for PCa management.	[Ahmad, Nihal] Univ Wisconsin, Med Sci Ctr, Dept Dermatol, Madison, WI 53706 USA; [Jung-Hynes, Brittney; Ahmad, Nihal] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA; [Nihal, Minakshi; Zhong, Weixiong] Univ Wisconsin, William S Middleton Mem Vet Hosp, Madison, WI 53706 USA; [Zhong, Weixiong] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Zhong, Weixiong; Ahmad, Nihal] Univ Wisconsin, Ctr Comprehens Canc, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ahmad, N (corresponding author), Univ Wisconsin, Med Sci Ctr, Dept Dermatol, 1300 Univ Ave, Madison, WI 53706 USA.	nahmad@wisc.edu	Ahmad, Nihal/AAR-4249-2021	Ahmad, Nihal/0000-0002-4239-9887	National Institutes of Health; NIEHS; Molecular and Environmental Toxicology Center Training [T32ES007015]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Molecular and Environmental Toxicology Center Training; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NIEHS, Molecular and Environmental Toxicology Center Training Grant T32ES007015 (predoctoral traineeship to B.J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Balestrieri ML, 2008, BBA-PROTEINS PROTEOM, V1784, P936, DOI 10.1016/j.bbapap.2008.03.004; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Dai JM, 2007, J CELL PHYSIOL, V210, P161, DOI 10.1002/jcp.20831; Dai Y, 2007, MOL ENDOCRINOL, V21, P1807, DOI 10.1210/me.2006-0467; Deng XQ, 2007, LIVER INT, V27, P708, DOI 10.1111/j.1478-3231.2007.01497.x; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fraga MF, 2007, ANN NY ACAD SCI, V1100, P60, DOI 10.1196/annals.1395.005; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Jarrard DF, 1999, CANCER RES, V59, P2957; Jeong J, 2007, EXP MOL MED, V39, P8, DOI 10.1038/emm.2007.2; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kamel C, 2006, AGING CELL, V5, P81, DOI 10.1111/j.1474-9726.2006.00191.x; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Li H, 2002, BIOGERONTOLOGY, V3, P107, DOI 10.1023/A:1015232102470; Li R, 2007, HUM PATHOL, V38, P1501, DOI 10.1016/j.humpath.2007.02.016; Liang XJ, 2008, MOL CANCER RES, V6, P1499, DOI 10.1158/1541-7786.MCR-07-2130; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Marmorstein R, 2004, BIOCHEM SOC T, V32, P904, DOI 10.1042/BST0320904; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Morris BJ, 2005, J HYPERTENS, V23, P1285, DOI 10.1097/01.hjh.0000173509.45363.dd; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; PARRY P, 1994, GENE CHROMOSOME CANC, V11, P79, DOI 10.1002/gcc.2870110203; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; REZNIKOFF CA, 1987, J CELL PHYSIOL, V131, P285, DOI 10.1002/jcp.1041310302; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Tikoo K, 2007, FEBS LETT, V581, P1071, DOI 10.1016/j.febslet.2007.02.006; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang C, 2005, J PHARMACOL SCI, V97, P494, DOI 10.1254/jphs.FPJ04055X; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Ying WH, 2006, FRONT BIOSCI-LANDMRK, V11, P3129, DOI 10.2741/2038	62	141	148	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3823	3832		10.1074/jbc.M807869200	http://dx.doi.org/10.1074/jbc.M807869200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19075016	Green Published, hybrid			2022-12-27	WOS:000262872500051
J	Makise, M; Takehara, M; Kuniyasu, A; Matsui, N; Nakayama, H; Mizushima, T				Makise, Masaki; Takehara, Masaya; Kuniyasu, Akihiko; Matsui, Nanako; Nakayama, Hitoshi; Mizushima, Tohru			Linkage between Phosphorylation of the Origin Recognition Complex and Its ATP Binding Activity in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; CHROMOSOMAL DNA-REPLICATION; CELL-CYCLE; IN-VIVO; RE-REPLICATION; MCM PROTEINS; CDC6P; ORC; INITIATOR; PROTEOLYSIS	The initiation of chromosomal DNA replication is tightly regulated to achieve genome replication just once per cell cycle and cyclin-dependent kinase (CDK) plays an important role in this process. Adenine nucleotides that bind to the origin recognition complex (ORC) are also suggested to be involved in this process. Of the six subunits of the Saccharomyces cerevisiae ORC(Orc1-6p), both Orc1p and Orc5p have ATP binding activity, and both Orc2p and Orc6p are phosphorylated by CDK in cells. In this study we constructed a series of yeast strains expressing phospho-mimetic mutants of Orc2p or Orc6p and found that expression of a Ser-188 mutant of Orc2p (Orc2-5Dp) delays G(1)-S transition and S phase progression and causes the accumulation of cells with 2C DNA content. Using antibody that specifically recognizes Ser-188-phosphorylated Orc2p, we showed that Ser-188 is phosphorylated by CDK in a cell cycle-regulated manner. Expression of Orc2-5Dp caused phosphorylation of Rad53p and inefficient loading of the six minichromosome maintenance proteins. These results suggest that the accumulation of cells with 2C DNA content is due to inefficient origin firing and induction of the cell cycle checkpoint response and that dephosphorylation of Ser-188 of Orc2p in late M or G(1) phase may be involved in pre-RC formation. In vitro, a purified mutant ORC containing Orc2-5Dp lost Orc5p ATP binding activity. This is the first demonstration of a link between phosphorylation of the ORC and its ability to bind ATP, which may be important for the cell cycle-regulated initiation of DNA replication.	[Makise, Masaki; Takehara, Masaya; Kuniyasu, Akihiko; Matsui, Nanako; Nakayama, Hitoshi; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan	Kumamoto University	Mizushima, T (corresponding author), 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp			Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Archambault V, 2005, MOL CELL BIOL, V25, P6707, DOI 10.1128/MCB.25.15.6707-6721.2005; Asano T, 2007, FEMS YEAST RES, V7, P1256, DOI 10.1111/j.1567-1364.2007.00299.x; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Branzei D, 2006, EXP CELL RES, V312, P2654, DOI 10.1016/j.yexcr.2006.06.012; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Garber PM, 2002, GENETICS, V161, P521; Gibson DG, 2006, GENES CELLS, V11, P557, DOI 10.1111/j.1365-2443.2006.00967.x; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Kuniyasu A, 2003, FEBS LETT, V552, P259, DOI 10.1016/S0014-5793(03)00936-0; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Lee JR, 2002, BIOCHEM J, V362, P395, DOI 10.1042/bj3620395; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Liku ME, 2005, MOL BIOL CELL, V16, P5026, DOI 10.1091/mbc.E05-05-0412; Makise M, 2003, J BIOL CHEM, V278, P46440, DOI 10.1074/jbc.M307392200; Makise M, 2008, J BIOCHEM, V143, P455, DOI 10.1093/jb/mvn005; Makise M, 2007, BIOCHEM J, V402, P397, DOI 10.1042/BJ20060841; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Matsuda K, 2007, FEMS YEAST RES, V7, P1263, DOI 10.1111/j.1567-1364.2007.00298.x; Mimura S, 2004, NATURE, V431, P1118, DOI 10.1038/nature03024; Mizushima T, 2000, GENE DEV, V14, P1631; Mizushima T, 1997, EMBO J, V16, P3724, DOI 10.1093/emboj/16.12.3724; Mizushima T, 1998, J BIOL CHEM, V273, P20847, DOI 10.1074/jbc.273.33.20847; Mizushima T, 1996, J BIOL CHEM, V271, P25178, DOI 10.1074/jbc.271.41.25178; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Radichev I, 2006, J BIOL CHEM, V281, P23264, DOI 10.1074/jbc.M603873200; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; Sanchez M, 1999, J BIOL CHEM, V274, P9092, DOI 10.1074/jbc.274.13.9092; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Shimada K, 2007, CELL, V128, P85, DOI 10.1016/j.cell.2006.11.045; SIKORSKI RS, 1989, GENETICS, V122, P19; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Takahashi N, 2004, J BIOL CHEM, V279, P8469, DOI 10.1074/jbc.M305531200; Takahashi N, 2002, J BIOL CHEM, V277, P16033, DOI 10.1074/jbc.M108615200; Takenaka H, 2004, J MOL BIOL, V340, P29, DOI 10.1016/j.jmb.2004.04.045; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Watanabe K, 2002, EUKARYOT CELL, V1, P200, DOI 10.1128/EC.1.2.200-212.2002; Weinreich M, 2001, P NATL ACAD SCI USA, V98, P11211, DOI 10.1073/pnas.201387198; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304	57	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3396	3407		10.1074/jbc.M804293200	http://dx.doi.org/10.1074/jbc.M804293200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19068484	hybrid			2022-12-27	WOS:000262872500005
J	Xiao, LP; Liu, P; Li, XF; Doetschman, T; Coffin, JD; Drissi, H; Hurley, MM				Xiao, Liping; Liu, Peng; Li, Xiaofeng; Doetschman, Thomas; Coffin, J. Douglas; Drissi, Hicham; Hurley, Marja M.			Exported 18-kDa Isoform of Fibroblast Growth Factor-2 Is a Critical Determinant of Bone Mass in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRIZZLED-RELATED PROTEIN-1; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; TRABECULAR BONE; GENE; CBFA1; EXPRESSION; OSTEOPENIA; MINERALIZATION; DISRUPTION	The role of the 18-kDa isoform of fibroblast growth factor-2 (FGF2) in the maintenance of bone mass was examined in Col3.6-18-kDa FGF2-IRES-GFPsaph transgenic (18-kDa TgFGF2) mice in which a 3.6-kb fragment of the type I collagen 5'-regulatory region (Col3.6) drives the expression of only the 18-kDa isoform of FGF2 with green fluorescent protein-sapphire (GFPsaph). Vector only transgenic mice (Col3.6-IRES-GFPsaph, VTg) were also developed as a control, and mice specifically deficient in 18-kDa FGF2 (FGF2(lmw-/-)) were also examined. Bone mineral density, femoral bone volume, trabecular thickness, and cortical bone area and thickness were significantly increased in 18-kDa TgFGF2 mice compared with VTg. Bone marrow cultures (BMSC) from 18-kDa TgFGF2 mice produced more mineralized nodules than VTg. Increased bone formation was associated with reduced expression of the Wnt antagonist secreted frizzled receptor 1 (sFRP-1). In contrast to 18-kDa TgFGF2 mice, FGF2(lmw-/-) mice have significantly reduced bone mineral density and fewer mineralized nodules, coincident with increased expression of sFRP-1 in bones and BMSC. Moreover, silencing of sFRP-1 in BMSC from FGF2(lmw-/-) mice reversed the decrease in beta-catenin and Runx2 mRNA. Assay of Wnt/beta-catenin-mediated transcription showed increased and decreased TCF-luciferase activity in BMSC from 18-kDa TgFGF2 and FGF2(lmw-/-) mice, respectively. Collectively, these results demonstrate that the 18-kDa FGF2 isoform is a critical determinant of bone mass in mice by modulation of the Wnt signaling pathway.	[Hurley, Marja M.] Univ Connecticut, Sch Med, Div Endocrinol & Metab, Ctr Hlth,Dept Med, Farmington, CT 06030 USA; [Liu, Peng] Univ Connecticut, Dept Reconstruct Sci, Farmington, CT 06030 USA; [Li, Xiaofeng] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Doetschman, Thomas] Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA; [Coffin, J. Douglas] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Drissi, Hicham] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA; Univ Arizona, Inst BIO5, Tucson, AZ 85724 USA	University of Connecticut; University of Connecticut; Yale University; University of Arizona; University of Montana System; University of Montana; University of Connecticut; University of Arizona	Hurley, MM (corresponding author), Univ Connecticut, Sch Med, Div Endocrinol & Metab, Ctr Hlth,Dept Med, 263 Farmington Ave, Farmington, CT 06030 USA.	hurley@exchange.uchc.edu	Liu, Peng/AAH-5688-2020	drissi, hicham/0000-0002-3322-281X	National Institutes of Health [AG021189-05A1]; NATIONAL INSTITUTE ON AGING [R01AG021189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021189-05A1 ( to M. M. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Church VL, 2002, INT J DEV BIOL, V46, P927; COTTIN JDG, 1995, MOL BIOL CELL, V6, P1861; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; Dougall WC, 2006, CANCER METAST REV, V25, P541, DOI 10.1007/s10555-006-9021-3; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; FLORKIEWICZ RZ, 1991, ANN NY ACAD SCI, V638, P109, DOI 10.1111/j.1749-6632.1991.tb49022.x; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; Friedenstein A., 1990, BONE MINERAL RES, P243, DOI DOI 10.1016/B978-0-444-81371-8.50012-1; Garmy-Susini B, 2004, CIRC RES, V94, P1301, DOI 10.1161/01.RES.0000127719.13255.81; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539, DOI 10.1210/endo-124-3-1539; Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; HURLEY MM, 2002, PRINCIPLES BONE BIOL, P825; Iseki S, 1999, DEVELOPMENT, V126, P5611; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; MAZUE G, 1993, TOXICOL PATHOL, V21, P490, DOI 10.1177/019262339302100508; Millar JBA, 2002, GENOME BIOL, V3; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Naganawa T, 2006, BIOCHEM BIOPH RES CO, V339, P490, DOI 10.1016/j.bbrc.2005.10.215; Nakagawa N, 1999, BIOCHEM BIOPH RES CO, V265, P158, DOI 10.1006/bbrc.1999.1601; NAKAMURA T, 1995, ENDOCRINOLOGY, V136, P1276, DOI 10.1210/en.136.3.1276; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096; Patel MS, 2002, NEW ENGL J MED, V346, P1572, DOI 10.1056/NEJM200205163462011; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006; Sobue T, 2005, J CELL BIOCHEM, V95, P83, DOI 10.1002/jcb.20389; STACHOWIAK MK, 1994, J CELL BIOL, V127, P203, DOI 10.1083/jcb.127.1.203; Valverde-Franco G, 2004, HUM MOL GENET, V13, P271, DOI 10.1093/hmg/ddh034; Wamsley HL, 2005, TOXICOL PATHOL, V33, P577, DOI 10.1080/01926230500243060; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao L, 2003, J CELL BIOCHEM, V89, P1291, DOI 10.1002/jcb.10589; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; ZHANG X, 2005, BIOCHEM BIOPH RES CO, V290, P526; Zhong XT, 2007, J BIOL CHEM, V282, P20523, DOI 10.1074/jbc.M609096200	49	49	52	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3170	3182		10.1074/jbc.M804900200	http://dx.doi.org/10.1074/jbc.M804900200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19056741	Green Published, hybrid			2022-12-27	WOS:000262700900061
J	Hanover, JA; Love, DC; Prinz, WA				Hanover, John A.; Love, Dona C.; Prinz, William A.			Calmodulin-driven Nuclear Entry: Trigger for Sex Determination and Terminal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN IMPORT; LOCALIZATION SIGNALS; CALCIUM/CALMODULIN INHIBITION; CALCIUM REGULATION; BINDING-PROTEIN; PORE COMPLEX; DNA-BINDING; SRY; TRANSPORT; REVERSAL	We originally proposed that Ca2+-calmodulin mediates a novel nuclear entry pathway distinct from the canonic Ran-dependent pathway (Sweitzer, T. D., and Hanover, J. A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 14574-14579). Although seemingly redundant, Ca2+-calmodulin-driven nuclear entry is now known to facilitate nuclear delivery of architectural transcription factors to chromatin. Intriguingly, defects in calmodulin-driven nuclear import of the transcription factors SRY and SOX9 in Sertoli cells lead to human sex reversal diseases with altered male gonad development. Calmodulin-triggered nuclear entry is an evolutionarily ancient feature of eukaryotes observed from yeast to man. Ca2+-calmodulin-triggered nuclear entry of key architectural transcription factors is a potentially key epigenetic regulator of terminal differentiation in response to cell signaling.	[Hanover, John A.; Love, Dona C.; Prinz, William A.] NIDDK, Lab Cell Biochem & Biol, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hanover, JA (corresponding author), NIDDK, Lab Cell Biochem & Biol, Natl Inst Hlth, Bethesda, MD 20892 USA.	jah@helix.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK060106, ZIADK060102, ZIADK060106] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAM SA, 1992, METHOD ENZYMOL, V219, P97; ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; Antonsson A, 2003, MOL CELL BIOL, V23, P1418, DOI 10.1128/MCB.23.4.1418-1427.2003; Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Brini M, 2000, CELL MOL LIFE SCI, V57, P354, DOI 10.1007/PL00000698; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Corbett A, 1996, EXP CELL RES, V229, P212, DOI 10.1006/excr.1996.0362; CORBETT AH, 1995, J CELL BIOL, V130, P1017, DOI 10.1083/jcb.130.5.1017; Corbett AH, 1996, J BIOL CHEM, V271, P18477, DOI 10.1074/jbc.271.31.18477; CORNELIUSSEN B, 1994, NATURE, V368, P760, DOI 10.1038/368760a0; DOYE V, 1995, TRENDS GENET, V11, P235, DOI 10.1016/S0168-9525(00)89057-5; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Guth SIE, 2008, CELL MOL LIFE SCI, V65, P3000, DOI 10.1007/s00018-008-8138-7; Hanover JA, 2007, J BIOL CHEM, V282, P33743, DOI 10.1074/jbc.M705875200; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; Harley VR, 2002, NOVART FDN SYMP, V244, P57; Harley VR, 1996, FEBS LETT, V391, P24, DOI 10.1016/0014-5793(96)00694-1; Hartman H, 2002, P NATL ACAD SCI USA, V99, P1420, DOI 10.1073/pnas.032658599; Hauser J, 2008, MOL BIOL CELL, V19, P2509, DOI 10.1091/mbc.E07-09-0886; Hermann S, 1998, CELL CALCIUM, V23, P135, DOI 10.1016/S0143-4160(98)90112-9; JAGER RJ, 1992, HUM GENET, V90, P350; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Koopman P, 2003, NATURE, V426, P241, DOI 10.1038/426241a; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Larsson G, 2005, BIOPHYS J, V89, P1214, DOI 10.1529/biophysj.104.055780; Larsson G, 2001, PROTEIN SCI, V10, P169, DOI 10.1110/ps.28401; Li BR, 2001, J BIOL CHEM, V276, P46480, DOI 10.1074/jbc.C100388200; LOEB JDJ, 1995, P NATL ACAD SCI USA, V92, P7647, DOI 10.1073/pnas.92.17.7647; Luz H, 2006, BIOINFORMATICS, V22, P1166, DOI 10.1093/bioinformatics/btl073; Melchior F, 1995, COLD SPRING HARB SYM, V60, P707, DOI 10.1101/SQB.1995.060.01.077; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; Onions J, 1997, J BIOL CHEM, V272, P23930, DOI 10.1074/jbc.272.38.23930; Onions J, 2000, BIOCHEMISTRY-US, V39, P4366, DOI 10.1021/bi992533u; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Polanco JC, 2007, DEV BIOL, V302, P13, DOI 10.1016/j.ydbio.2006.08.049; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Preiss S, 2001, J BIOL CHEM, V276, P27864, DOI 10.1074/jbc.M101278200; PRUSCHY M, 1994, J CELL BIOL, V127, P1527, DOI 10.1083/jcb.127.6.1527; Saarikettu J, 2004, J BIOL CHEM, V279, P41004, DOI 10.1074/jbc.M408120200; SCHLENSTEDT G, 1993, J CELL BIOL, V123, P785, DOI 10.1083/jcb.123.4.785; SCHLENSTEDT G, 1995, EMBO J, V14, P5367, DOI 10.1002/j.1460-2075.1995.tb00221.x; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; Sim H, 2005, MOL ENDOCRINOL, V19, P1884, DOI 10.1210/me.2004-0334; Smith JM, 2004, TRENDS GENET, V20, P4, DOI 10.1016/j.tig.2003.11.007; STARR CM, 1991, BIOESSAYS, V13, P145, DOI 10.1002/bies.950130309; STARR CM, 1990, J CELL BIOL, V110, P1861, DOI 10.1083/jcb.110.6.1861; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Stochaj U, 1999, BIOESSAYS, V21, P579, DOI 10.1002/(SICI)1521-1878(199907)21:7<579::AID-BIES6>3.0.CO;2-E; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Sweitzer TD, 1996, P NATL ACAD SCI USA, V93, P14574, DOI 10.1073/pnas.93.25.14574; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156	63	41	42	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12593	12597		10.1074/jbc.R800076200	http://dx.doi.org/10.1074/jbc.R800076200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19126540	Green Published, hybrid			2022-12-27	WOS:000265688300002
J	Long, P; Mercer, A; Begum, R; Stephens, GJ; Sihra, TS; Jovanovic, JN				Long, Philip; Mercer, Audrey; Begum, Rahima; Stephens, Gary J.; Sihra, Talvinder S.; Jovanovic, Jasmina N.			Nerve Terminal GABA(A) Receptors Activate Ca2+/Calmodulin-dependent Signaling to Inhibit Voltage-gated Ca2+ Influx and Glutamate Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESYNAPTIC IONOTROPIC RECEPTORS; CALCIUM-CHANNELS; TRANSMITTER RELEASE; PROTEIN-KINASE; SYNAPSIN-I; CALMODULIN ANTAGONISTS; CHLORIDE CONCENTRATION; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; CA(V)2.1 CHANNELS	gamma-Aminobutyric acid type A (GABA(A)) receptors, a family of Cl--permeable ion channels, mediate fast synaptic inhibition as postsynaptically enriched receptors for gamma-aminobutyric acid at GABAergic synapses. Here we describe an alternative type of inhibition mediated by GABA(A) receptors present on neocortical glutamatergic nerve terminals and examine the underlying signaling mechanism(s). By monitoring the activity of the presynaptic CaM kinase II/synapsin I signaling pathway in isolated nerve terminals, we demonstrate that GABAA receptor activation correlated with an increase in basal intraterminal [Ca2+](i). Interestingly, this activation of GABAA receptors resulted in a reduction of subsequent depolarization-evoked Ca2+ influx, which thereby led to an inhibition of glutamate release. To investigate how the observed GABAA receptor-mediated modulation operates, we determined the sensitivity of this process to the Na-K-2Cl cotransporter 1 antagonist bumetanide, as well as substitution of Ca2+ with Ba2+, or Ca2+/calmodulin inhibition by W7. All of these treatments abolished the modulation by GABAA receptors. Application of selective antagonists of voltage-gated Ca2+ channels (VGCCs) revealed that the GABA(A) receptor-mediated modulation of glutamate release required the specific activity of L- and R-type VGCCs. Crucially, the inhibition of release by these receptors was abolished in terminals isolated from R-type VGCC knock-out mice. Together, our results indicate that a functional coupling between nerve terminal GABA(A) receptors and L- or R-type VGCCs is mediated by Ca2+/calmodulin-dependent signaling. This mechanism provides a GABA-mediated control of glutamatergic synaptic activity by a direct inhibition of glutamate release.	[Long, Philip; Mercer, Audrey; Begum, Rahima; Jovanovic, Jasmina N.] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Stephens, Gary J.] Univ Reading, Sch Pharm, Dept Pharmacol, Reading RG6 6AP, Berks, England; [Sihra, Talvinder S.] UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London School of Pharmacy; University of Reading; University of London; University College London	Jovanovic, JN (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England.	jasmina.jovanovic@pharmacy.ac.uk	Stephens, Gary/J-3578-2014; Sihra, Talvinder S/A-4581-2009	Stephens, Gary/0000-0002-8966-4238; Mercer, Audrey/0000-0002-5086-2560	Royal Society UK and Biotechnology and Biological Sciences Research Council UK project; School of Pharmacy studentship; MRC [G0800498] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C507237/1] Funding Source: researchfish; Medical Research Council [G0800498] Funding Source: researchfish	Royal Society UK and Biotechnology and Biological Sciences Research Council UK project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); School of Pharmacy studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Royal Society UK and Biotechnology and Biological Sciences Research Council UK project grants (to J.N.J.) and a School of Pharmacy studentship (to P.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AUGUSTINE GJ, 1984, J PHYSIOL-LONDON, V346, P257, DOI 10.1113/jphysiol.1984.sp015020; Axmacher N, 2004, NEUROREPORT, V15, P329, DOI 10.1097/00001756-200402090-00024; Axmacher N, 2004, NEUROIMAGE, V22, P1014, DOI 10.1016/j.neuroimage.2004.02.009; Belenky MA, 2003, NEUROSCIENCE, V118, P909, DOI 10.1016/S0306-4522(03)00062-9; Bencsits E, 1999, J BIOL CHEM, V274, P19613, DOI 10.1074/jbc.274.28.19613; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; Billups D, 2002, J PHYSIOL-LONDON, V545, P183, DOI 10.1113/jphysiol.2002.024877; BONANNO G, 1987, SYNAPSE, V1, P254, DOI 10.1002/syn.890010306; CARBONE E, 1989, PROG BIOPHYS MOL BIO, V54, P31, DOI 10.1016/0079-6107(89)90008-4; CHAO SH, 1984, MOL PHARMACOL, V26, P75; CZERNIK AJ, 1991, METHOD ENZYMOL B, V201, P264; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; DEUCHARS J, 1994, J PHYSIOL-LONDON, V478, P423, DOI 10.1113/jphysiol.1994.sp020262; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P543, DOI 10.1113/jphysiol.1961.sp006646; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; ECCLES J. C., 1964, PROGR BRAIN RES, V12, P65, DOI 10.1016/S0079-6123(08)60618-4; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; ECCLES JC, 1962, J PHYSIOL-LONDON, V160, P62, DOI 10.1113/jphysiol.1962.sp006835; ECCLES JC, 1961, J PHYSIOL-LONDON, V159, P147, DOI 10.1113/jphysiol.1961.sp006798; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Fassio A, 1999, J NEUROSCI RES, V57, P324, DOI 10.1002/(SICI)1097-4547(19990801)57:3<324::AID-JNR4>3.0.CO;2-Z; FUNG SC, 1983, NEUROSCI LETT, V42, P61, DOI 10.1016/0304-3940(83)90422-6; Gasparini S, 2001, J NEUROSCI, V21, P8715, DOI 10.1523/JNEUROSCI.21-22-08715.2001; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HIDAKA H, 1981, MOL PHARMACOL, V20, P571; HIDAKA H, 1983, METHOD ENZYMOL, V102, P185; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; HOPKINS MH, 1992, J ENZYM INHIB, V6, P125, DOI 10.3109/14756369209040743; Hughes DI, 2000, J NEUROSCI METH, V101, P107, DOI 10.1016/S0165-0270(00)00254-5; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jang IS, 2006, NEUROSCIENCE, V138, P25, DOI 10.1016/j.neuroscience.2005.11.001; Jang IS, 2005, NEUROSCIENCE, V135, P737, DOI 10.1016/j.neuroscience.2005.06.030; Jang IS, 2001, J NEUROSCI, V21, P5962, DOI 10.1523/JNEUROSCI.21-16-05962.2001; Jensen K, 1999, J NEUROPHYSIOL, V81, P1225, DOI 10.1152/jn.1999.81.3.1225; Jovanovic JN, 2001, J NEUROSCI, V21, P7944, DOI 10.1523/JNEUROSCI.21-20-07944.2001; Koga H, 2005, BRAIN RES, V1046, P24, DOI 10.1016/j.brainres.2005.03.026; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; MCMAHON HT, 1991, J NEUROCHEM, V56, P86, DOI 10.1111/j.1471-4159.1991.tb02566.x; Menegon A, 2000, J CELL SCI, V113, P3573; Millan C, 2002, NEUROSCI LETT, V330, P29, DOI 10.1016/S0304-3940(02)00719-X; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MITCHELL PR, 1978, NATURE, V274, P904, DOI 10.1038/274904a0; Mody I, 2001, NEUROCHEM RES, V26, P907, DOI 10.1023/A:1012376215967; Mohler H, 2007, J NEUROCHEM, V102, P1, DOI 10.1111/j.1471-4159.2007.04454.x; NACHSHEN DA, 1982, J GEN PHYSIOL, V79, P1065, DOI 10.1085/jgp.79.6.1065; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; OLSEN RW, 1986, LIFE SCI, V39, P1969, DOI 10.1016/0024-3205(86)90320-6; PEARCE BR, 1982, EUR J PHARMACOL, V82, P131, DOI 10.1016/0014-2999(82)90501-5; Pereverzev A, 2002, MOL ENDOCRINOL, V16, P884, DOI 10.1210/me.16.4.884; Perkinton MS, 1998, J NEUROCHEM, V70, P1513; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pouzat C, 1999, J NEUROSCI, V19, P1675; Price GD, 2006, J NEUROSCI, V26, P11432, DOI 10.1523/JNEUROSCI.1660-06.2006; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; Rhee JS, 1999, J NEUROCHEM, V72, P800, DOI 10.1046/j.1471-4159.1999.0720800.x; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Ruiz A, 2003, NEURON, V39, P961, DOI 10.1016/S0896-6273(03)00559-2; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Sieghart W, 2006, ADV PHARMACOL, V54, P231, DOI 10.1016/S1054-3589(06)54010-4; SIHRA TS, 1987, J NEUROCHEM, V49, P261, DOI 10.1111/j.1471-4159.1987.tb03424.x; SIHRA TS, 1992, J BIOL CHEM, V267, P1983; SIHRA TS, 1993, J NEUROCHEM, V61, P1220, DOI 10.1111/j.1471-4159.1993.tb13612.x; SIHRA TS, 1996, POSTTRANSLATIONAL MO, P67; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; Stell BM, 2007, J NEUROSCI, V27, P9022, DOI 10.1523/JNEUROSCI.1954-07.2007; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tokunaga T, 2004, HIPPOCAMPUS, V14, P570, DOI 10.1002/hipo.10202; TOSELLI M, 1992, PFLUG ARCH EUR J PHY, V421, P59, DOI 10.1007/BF00374734; Trigo FF, 2007, J NEUROSCI, V27, P12452, DOI 10.1523/JNEUROSCI.3413-07.2007; Turecek R, 2002, P NATL ACAD SCI USA, V99, P13884, DOI 10.1073/pnas.212419699; Vazquez E, 1997, EUR J NEUROSCI, V9, P2009, DOI 10.1111/j.1460-9568.1997.tb01369.x; Wang G, 1999, J NEUROSCI, V19, P9235; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; Whiting PJ, 1999, NEUROCHEM INT, V34, P387, DOI 10.1016/S0197-0186(99)00048-0; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Xiao C, 2007, J PHYSIOL-LONDON, V580, P731, DOI 10.1113/jphysiol.2006.124099; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; ZHANG SLJ, 1993, SCIENCE, V259, P531, DOI 10.1126/science.8380942; ZHANG SLJ, 1995, J PHYSIOL-LONDON, V483, P583, DOI 10.1113/jphysiol.1995.sp020608	90	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8717	8728		10.1074/jbc.M805322200	http://dx.doi.org/10.1074/jbc.M805322200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19141616	Green Published, hybrid			2022-12-27	WOS:000264397800056
J	Pauff, JM; Cao, H; Hille, R				Pauff, James M.; Cao, Hongnan; Hille, Russ			Substrate Orientation and Catalysis at the Molybdenum Site in Xanthine Oxidase CRYSTAL STRUCTURES IN COMPLEX WITH XANTHINE AND LUMAZINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; MACROMOLECULAR STRUCTURES; MECHANISM; DEHYDROGENASE; SPECIFICITY; REFINEMENT; RESIDUES	Xanthine oxidoreductase is a ubiquitous cytoplasmic protein that catalyzes the final two steps in purine catabolism. We have previously investigated the catalytic mechanism of the enzyme by rapid reaction kinetics and x-ray crystallography using the poor substrate 2-hydroxy-6-methylpurine, focusing our attention on the orientation of substrate in the active site and the role of Arg-880 in catalysis. Here we report additional crystal structures of as-isolated, functional xanthine oxidase in the course of reaction with the pterin substrate lumazine at 2.2 angstrom resolution and of the nonfunctional desulfo form of the enzyme in complex with xanthine at 2.6 angstrom resolution. In both cases the orientation of substrate is such that the pyrimidine subnucleus is oriented opposite to that seen with the slow substrate 2-hydroxy-6-methylpurine. The mechanistic implications as to how the ensemble of active site functional groups in the active site work to accelerate reaction rate are discussed.	[Pauff, James M.; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; Ohio State Univ, Med Scientist Program, Columbus, OH 43210 USA	University of California System; University of California Riverside; University System of Ohio; Ohio State University	Pauff, JM (corresponding author), Univ Calif Riverside, Dept Biochem, 1463 Boyce Hall, Riverside, CA 92521 USA.	russ.hille@ucr.edu	Cao, Hongnan/M-2047-2014	Cao, Hongnan/0000-0002-9808-3240; Cao, Hongnan/0000-0003-2496-1298	National Institutes of Health [GM 075036]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; SGX Pharmaceuticals, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); SGX Pharmaceuticals, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 075036 (to R. H.). This work was also supported in part by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357 and by SGX Pharmaceuticals, Inc. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRY CE, 2004, J PHYSL, V3, P589; BRAY RC, 1988, Q REV BIOPHYS, V21, P299, DOI 10.1017/S0033583500004479; BRAY RC, 1969, BIOCHEM J, V114, P725, DOI 10.1042/bj1140725; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Doonan CJ, 2005, J AM CHEM SOC, V127, P4518, DOI 10.1021/ja042500o; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; HILLE R, 1995, FASEB J, V9, P995, DOI 10.1096/fasebj.9.11.7649415; Hille R, 2006, EUR J INORG CHEM, P1913, DOI 10.1002/ejic.200600087; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; Ilich P, 1997, INORG CHIM ACTA, V263, P87, DOI 10.1016/S0020-1693(97)05654-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leimkuhler S, 2004, J BIOL CHEM, V279, P40437, DOI 10.1074/jbc.M405778200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MASSEY V, 1970, J BIOL CHEM, V245, P6595; MASSEY V, 1969, J BIOL CHEM, V244, P1682; MURSHUDOV G, 1996, P DAR STUD WEEK DAR; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishino T, 2005, J BIOL CHEM, V280, P24888, DOI 10.1074/jbc.M501830200; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Pauff JM, 2008, J BIOL CHEM, V283, P4818, DOI 10.1074/jbc.M707918200; Pauff JM, 2007, J BIOL CHEM, V282, P12785, DOI 10.1074/jbc.M700364200; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	33	70	72	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8751	8758		10.1074/jbc.M804517200	http://dx.doi.org/10.1074/jbc.M804517200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19109252	Green Published, hybrid			2022-12-27	WOS:000264397800059
J	Saramaki, A; Diermeier, S; Kellner, R; Laitinen, H; Vaisanen, S; Carlberg, C				Saramaki, Anna; Diermeier, Sarah; Kellner, Ruth; Laitinen, Heidi; Vaisanen, Sami; Carlberg, Carsten			Cyclical Chromatin Looping and Transcription Factor Association on the Regulatory Regions of the p21 (CDKN1A) Gene in Response to 1 alpha,25-Dihydroxyvitamin D-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D; BREAST-CANCER; HISTONE ACETYLATION; RECRUITMENT; EXPRESSION; BINDING; ACTIVATION; PROMOTER; DISTINCT; CELLS	The nuclear receptor vitamin D receptor (VDR) is known to associate with three vitamin D response element (VDREs)-containing regions within the CDKN1A (p21) gene region. Here we show in MDA-MB453 breast cancer cells that the natural VDR ligand 1 alpha,25-dihydroxyvitamin D-3 causes cyclical transcription factor binding and chromatin looping of distal VDREs to the transcription start site (TSS) of the p21 gene, leading to cyclical accumulation of the p21 mRNA. At the chromatin level, association of the mediator protein MED1 precedes both the peaks of VDR binding to VDREs and phosphorylated RNA polymerase (p-Pol II) to the TSS. The loss of co-repressor NCoR1-histone deacetylase (HDAC) 3 complex and inhibitory chromatin looping from VDREs to the TSS are also initial events followed by increased acetylation of histone 3 at lysine 9 at the TSS prior to initiation of transcription. Simultaneous to VDR and p-Pol II peaks, chromatin loops between VDREs and the TSS are formed, and the lysine demethylase LSD1 and the histone acetyltransferase CBP are enriched in both regions. This is followed by a moderate peak in p21 transcript accumulation, repeated in cycles of 45-60 min. The transcript accumulation pattern is disturbed by siRNA inhibition of the mediator protein MED1, LSD1, NCoR1, or various HDACs, whereas CBP appears unnecessary for the response. Inhibition of MED1, HDAC4, or LSD1 by siRNA also attenuates ligand-induced chromatin looping. In conclusion, 1 alpha,25-dihydroxyvitamin D3 regulates p21 transcription by inducing cyclical chromatin looping that depends on both histone deacetylation and demethylation.	[Carlberg, Carsten] Univ Luxembourg, Life Sci Res Unit, L-1511 Luxembourg, Luxembourg; [Saramaki, Anna; Diermeier, Sarah; Kellner, Ruth; Laitinen, Heidi; Vaisanen, Sami; Carlberg, Carsten] Univ Kuopio, Dept Biosci, FIN-70210 Kuopio, Finland	University of Luxembourg; University of Eastern Finland	Carlberg, C (corresponding author), Univ Luxembourg, Life Sci Res Unit, 162A Ave Faiencerie, L-1511 Luxembourg, Luxembourg.	carsten.carlberg@uni.lu	Diermeier, Sarah/H-8024-2019; Carlberg, Carsten/C-9075-2011; Vähärautio, Anna/K-4279-2015	Diermeier, Sarah/0000-0002-6120-2744; Carlberg, Carsten/0000-0003-2633-0684; Vähärautio, Anna/0000-0003-4721-3954	Academy of Finland; Finnish Cancer Organization; Juselius Foundation	Academy of Finland(Academy of Finland); Finnish Cancer Organization; Juselius Foundation	This work was supported by grants from the Academy of Finland, the Finnish Cancer Organization, and the Juselius Foundation.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Banwell CM, 2006, CLIN CANCER RES, V12, P2004, DOI 10.1158/1078-0432.CCR-05-1218; Barnett DH, 2008, CANCER RES, V68, P3505, DOI 10.1158/0008-5472.CAN-07-6151; Carlberg C, 1998, CRIT REV EUKAR GENE, V8, P19, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.20; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Esposito F, 1997, EUR J BIOCHEM, V245, P730, DOI 10.1111/j.1432-1033.1997.00730.x; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Ingraham BA, 2008, CURR MED RES OPIN, V24, P139, DOI 10.1185/030079907X253519; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Liu J, 2000, J BIOL CHEM, V275, P11846, DOI 10.1074/jbc.275.16.11846; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Malinen M, 2008, NUCLEIC ACIDS RES, V36, P121, DOI 10.1093/nar/gkm913; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; Turunen MM, 2007, NUCLEIC ACIDS RES, V35, P2734, DOI 10.1093/nar/gkm179; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	26	86	89	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8073	8082		10.1074/jbc.M808090200	http://dx.doi.org/10.1074/jbc.M808090200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19122196	Green Published, hybrid			2022-12-27	WOS:000264195600070
J	Du, M; Keeling, KM; Fan, LM; Liu, XL; Bedwell, DM				Du, Ming; Keeling, Kim M.; Fan, Liming; Liu, Xiaoli; Bedwell, David M.			Poly-L-aspartic Acid Enhances and Prolongs Gentamicin-mediated Suppression of the CFTR-G542X Mutation in a Cystic Fibrosis Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREMATURE STOP MUTATIONS; AMINOGLYCOSIDE ANTIBIOTICS; LYSOSOMAL PHOSPHOLIPIDOSIS; CFTR FUNCTION; INHIBITION; PROTECTION; MECHANISM; AMIKACIN	Aminoglycosides such as gentamicin have the ability to suppress translation termination at premature stop mutations, leading to a partial restoration of protein expression and function. This observation led to studies showing that this approach may provide a viable treatment for patients with genetic diseases such as cystic fibrosis that are caused by premature stop mutations. Although aminoglycoside treatment is sometimes associated with harmful side effects, several studies have shown that the co-administration of polyanions such as poly-L-aspartic acid (PAA) can both reduce toxicity and increase the intracellular aminoglycoside concentration. In the current study we examined how the co-administration of gentamicin with PAA influenced the readthrough of premature stop codons in cultured cells and a cystic fibrosis mouse model. Using a dual luciferase readthrough reporter system in cultured cells, we found that the co-administration of gentamicin with PAA increased readthrough 20-40% relative to cells treated with the same concentration of gentamicin alone. Using a Cftr(-/-) hCFTR-G542X mouse model, we found that PAA also increased the in vivo nonsense suppression induced by gentamicin. Following the withdrawal of gentamicin, PAA significantly prolonged the time interval during which readthrough could be detected, as shown by short circuit current measurements and immunofluorescence. Because the use of gentamicin to suppress disease-causing nonsense mutations will require their long term administration, the ability of PAA to reduce toxicity and increase both the level and duration of readthrough has important implications for this promising therapeutic approach.	[Bedwell, David M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bedwell, DM (corresponding author), Univ Alabama Birmingham, Dept Microbiol, BBRB 432,Box 8,1530 3rd Ave S, Birmingham, AL 35294 USA.	dbedwell@uab.edu	Liu, Xiaoli/HGE-7614-2022	Bedwell, David/0000-0002-6605-818X	NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK053090] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA13148] Funding Source: Medline; NIDDK NIH HHS [P50 DK53090] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; BEAUCHAMP D, 1990, J PHARMACOL EXP THER, V255, P858; Bedwell DM, 1997, NAT MED, V3, P1280, DOI 10.1038/nm1197-1280; BROWN SA, 1988, ANTIMICROB AGENTS CH, V32, P595, DOI 10.1128/AAC.32.4.595; CARLIER MB, 1983, ANTIMICROB AGENTS CH, V23, P440, DOI 10.1128/AAC.23.3.440; Clancy JP, 2007, AM J RESP CELL MOL, V37, P57, DOI 10.1165/rcmb.2006-0173OC; Clancy JP, 2001, AM J RESP CRIT CARE, V163, P1683, DOI 10.1164/ajrccm.163.7.2004001; DEBROE ME, 1984, KIDNEY INT, V25, P643, DOI 10.1038/ki.1984.69; Du M, 2002, J MOL MED, V80, P595, DOI 10.1007/s00109-002-0363-1; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Du M, 2006, J MOL MED, V84, P573, DOI 10.1007/s00109-006-0045-5; Fan-Minogue H, 2008, RNA, V14, P148, DOI 10.1261/rna.805208; GILBERT DN, 1989, J INFECT DIS, V159, P945, DOI 10.1093/infdis/159.5.945; Grentzmann G, 1998, RNA, V4, P479; Howard M, 1996, NAT MED, V2, P467, DOI 10.1038/nm0496-467; Howard MT, 2004, ANN NEUROL, V55, P422, DOI 10.1002/ana.20052; HULKA GF, 1993, AM J OTOL, V14, P352; HUTCHIN T, 1994, ANTIMICROB AGENTS CH, V38, P2517, DOI 10.1128/AAC.38.11.2517; Keeling K. M., 2005, Current Pharmacogenomics, V3, P259, DOI 10.2174/157016005774913149; Keeling KM, 2002, J MOL MED-JMM, V80, P367, DOI 10.1007/s00109-001-0317-z; Keeling KM, 2001, HUM MOL GENET, V10, P291, DOI 10.1093/hmg/10.3.291; Kerem E, 2004, CURR OPIN PULM MED, V10, P547, DOI 10.1097/01.mcp.0000141247.22078.46; KISHORE BK, 1992, J PHARMACOL EXP THER, V262, P424; LAURENT G, 1982, BIOCHEM PHARMACOL, V31, P3861, DOI 10.1016/0006-2952(82)90303-3; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003, DOI 10.1128/AAC.43.5.1003; MOESTRUP SK, 1995, J CLIN INVEST, V96, P1404, DOI 10.1172/JCI118176; Politano L, 2003, Acta Myol, V22, P15; RAMSAMMY L, 1990, AM J PHYSIOL, V258, pC1141, DOI 10.1152/ajpcell.1990.258.6.C1141; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; Sandoval RM, 2004, AM J PHYSIOL-RENAL, V286, pF617, DOI 10.1152/ajprenal.00130.2003; Schmitz C, 2002, J BIOL CHEM, V277, P618, DOI 10.1074/jbc.M109959200; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Wagner KR, 2001, ANN NEUROL, V49, P706, DOI 10.1002/ana.1023.abs; WILLIAMS PD, 1986, J PHARMACOL EXP THER, V237, P919; Wilschanski M, 2000, AM J RESP CRIT CARE, V161, P860, DOI 10.1164/ajrccm.161.3.9904116; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170	36	35	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6885	6892		10.1074/jbc.M806728200	http://dx.doi.org/10.1074/jbc.M806728200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136563	hybrid, Green Published			2022-12-27	WOS:000263919000036
J	Gupta, KK; Paulson, BA; Folker, ES; Charlebois, B; Hunt, AJ; Goodson, HV				Gupta, Kamlesh K.; Paulson, Benjamin A.; Folker, Eric S.; Charlebois, Blake; Hunt, Alan J.; Goodson, Holly V.			Minimal Plus-end Tracking Unit of the Cytoplasmic Linker Protein CLIP-170	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE DYNAMICS; STRUCTURAL BASIS; IN-VIVO; EB1; CYTOSKELETON; TUBULIN; BINDING; P150(GLUED); MECHANISMS; DYNACTIN	Cytoplasmic linker protein 170 (CLIP-170) is the prototype microtubule (MT) plus-end tracking protein (+TIP) and is involved in regulating MT dynamics. A comprehensive understanding of the process by which CLIP-170 tracks MT plus ends would provide insight into its function. However, the precise molecular mechanism of CLIP-170 +TIP behavior is unknown, and many potential models have been presented. Here, by separating the two CLIP-170 CAP-Gly domains and their adjacent serine-rich regions into fragments of varied size, we have characterized the minimal plus-end tracking unit of CLIP-170 in vivo. Each CLIP-170 fragment was also characterized for its tubulin polymerization activity in vitro. We found that the two CAP-Gly domains have different activities, whereas CAP-Gly-1 appears incompetent to mediate either +TIP behavior or MT nucleation, a CLIP-170 fragment consisting of the second CAP-Gly domain and its adjacent serine-rich region can both track MT plus ends in vivo and induce tubulin polymerization in vitro. These observations complement recent work on CLIP-170 fragments, demonstrate that CAP-Gly motifs do not require dimerization for +TIP and polymerization-promoting activities, and provide insight into CLIP-170 function and mechanism.	[Gupta, Kamlesh K.; Paulson, Benjamin A.; Goodson, Holly V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Folker, Eric S.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 11032 USA; [Charlebois, Blake; Hunt, Alan J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Notre Dame; Columbia University; University of Michigan System; University of Michigan	Goodson, HV (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 439 Stepan Hall Chem & Biochem, Notre Dame, IN 46556 USA.	hgoodson@nd.edu	Goodson, Holly/AAE-6079-2022	Folker, Eric/0000-0003-1619-7330; Goodson, Holly/0000-0001-7942-8349	National Institutes of Health [R01 GM065420, R01 GM076177]; American Heart Association [0825871G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076177, R01GM065420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM065420 ( to H. V. G.) and R01 GM076177 ( to A. J. H.). This work was also supported by American Heart Association Postdoctoral Fellowship 0825871G ( to K. K. G.).	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Bartolini F, 2005, J CELL SCI, V118, P1197, DOI 10.1242/jcs.01719; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Goodson HV, 2003, CELL MOTIL CYTOSKEL, V55, P156, DOI 10.1002/cm.10114; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Hayashi I, 2007, NAT STRUCT MOL BIOL, V14, P980, DOI 10.1038/nsmb1299; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Hoogenraad CC, 2000, J CELL SCI, V113, P2285; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Lallemand-Breitenbach V, 2004, J BIOL CHEM, V279, P41168, DOI 10.1074/jbc.M406482200; Li SL, 2002, J BIOL CHEM, V277, P48596, DOI 10.1074/jbc.M208512200; Ligon LA, 2006, FEBS LETT, V580, P1327, DOI 10.1016/j.febslet.2006.01.050; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Miller RK, 2006, CURR TOP DEV BIOL, V76, P49, DOI 10.1016/S0070-2153(06)76002-1; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PIERRE P, 1994, J CELL SCI, V107, P1909; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; RIEHEMANN K, 1993, TRENDS BIOCHEM SCI, V18, P82, DOI 10.1016/0968-0004(93)90159-K; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Scheel J, 1999, J BIOL CHEM, V274, P25883, DOI 10.1074/jbc.274.36.25883; Sharp DJ, 2005, CELL CYCLE, V4, P1482, DOI 10.4161/cc.4.11.2116; Sim KL, 2002, MOL CELL PROTEOMICS, V1, P983, DOI 10.1074/mcp.M200032-MCP200; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Walczak CE, 2000, CURR OPIN CELL BIOL, V12, P52, DOI 10.1016/S0955-0674(99)00056-3; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291	42	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6735	6742		10.1074/jbc.M807675200	http://dx.doi.org/10.1074/jbc.M807675200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19074770	hybrid, Green Published			2022-12-27	WOS:000263919000018
J	Jenei, ZA; Borthwick, K; Zammit, VA; Dixon, AM				Jenei, Zsuzsanna A.; Borthwick, Karen; Zammit, Victor A.; Dixon, Ann M.			Self-association of Transmembrane Domain 2 (TM2), but Not TM1, in Carnitine Palmitoyltransferase 1A ROLE OF GXXXG(A) MOTIFS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; RAT-LIVER MITOCHONDRIA; MALONYL-COA SENSITIVITY; FATTY-ACID OXIDATION; HELIX ASSOCIATION; CELL-FUNCTION; CPT-I; TOPOLOGY; DIMERIZATION; CARNITINE-PALMITOYLTRANSFERASE-1	Carnitine palmitoyltransferase 1 (CPT1) controls the rate of entry of long-chain fatty acids into the mitochondrial matrix for beta-oxidation and has been reported to exist as an oligomer. We have investigated the in vivo oligomerization of full-length rat CPT1A (rCPT1A) along with those of the N-terminal truncation/deletion mutants Delta(1-82), Delta(1-18), and Delta(19-30) expressed in yeast mitochondria. The data indicate that in liver mitochondria in vivo CPT1A exists as a hexamer but that during preparation and storage of mitochondria the order of oligomerization is rapidly reduced to the trimer, such that a mixture of hexamer and trimer is observed in isolated mitochondria in vitro. Mutants bearing deletions of different segments of the N terminus (including the more N-terminal of the two transmembrane domains) have the same pattern of oligomerization when expressed in yeast mitochondria. The self-association of the individual rCPT1A transmembrane (TM) domains (TM1, TM2) was also studied using the TOXCAT assay (which measures TM self-association in the Escherichia coli inner membrane). There was minimal self-association of the sequence corresponding to TM1 but significant self-association of TM2 in TOXCAT. Chemical cross-linking and analytical ultracentrifugation of a TM2-derived synthetic peptide showed oligomerization with a similar trimer/hexamer equilibrium to that observed for native rCPT1A in isolated mitochondria. Therefore, there was a correlation between the oligomerization behavior of TM2 peptide and that of the full-length protein. In silico molecular modeling of rCPT1A TM2 highlighted the favorable orientation of GXXXG and GXXXA motifs in the formation of the TM2 hexamer.	[Jenei, Zsuzsanna A.; Dixon, Ann M.] Univ Warwick, Warwick Med Sch, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Borthwick, Karen; Zammit, Victor A.] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Dixon, AM (corresponding author), Univ Warwick, Warwick Med Sch, Dept Chem, Coventry CV4 7AL, W Midlands, England.	ann.dixon@warwick.ac.uk	Jenei, Zsuzsanna/F-2028-2011; Dixon, Ann M/I-3696-2012	Dixon, Ann M/0000-0002-5261-304X	Diabetes UK; Warwick University Postgraduate Research Fellowship	Diabetes UK(Diabetes UK); Warwick University Postgraduate Research Fellowship	This work was supported by a Diabetes UK grant (to V.A.Z. and A. M. D.) and by a Warwick University Postgraduate Research Fellowship (to Z.J.). The costs of publication of this article were defrayed in part by the payment of page charges.	Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN HF, 1995, J BIOL CHEM, V270, P14115, DOI 10.1074/jbc.270.23.14115; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Ding FX, 2001, BIOCHEMISTRY-US, V40, P8945, DOI 10.1021/bi010394m; Drynan L, 1996, BIOCHEM J, V317, P791, DOI 10.1042/bj3170791; Faye A, 2005, BIOCHEM J, V387, P67, DOI 10.1042/BJ20041533; Faye A, 2007, J BIOL CHEM, V282, P26908, DOI 10.1074/jbc.M705418200; Fisher LE, 1999, J MOL BIOL, V293, P639, DOI 10.1006/jmbi.1999.3126; Fraser F, 1997, BIOCHEM J, V323, P711, DOI 10.1042/bj3230711; Fraser F, 1998, BIOCHEM J, V329, P225, DOI 10.1042/bj3290225; Jackson VN, 2000, J BIOL CHEM, V275, P38410, DOI 10.1074/jbc.M007722200; KOLODZIEJ MP, 1990, BIOCHEM J, V272, P421, DOI 10.1042/bj2720421; KOLODZIEJ MP, 1992, BIOCHEM J, V282, P415, DOI 10.1042/bj2820415; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; Lazarova T, 2004, BIOCHEMISTRY-US, V43, P12945, DOI 10.1021/bi0492051; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Lopez-Vinas E, 2007, J BIOL CHEM, V282, P18212, DOI 10.1074/jbc.M700885200; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Melnyk RA, 2003, BIOPOLYMERS, V71, P675, DOI 10.1002/bip.10595; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008; Turkaly P, 1999, FEBS LETT, V460, P241, DOI 10.1016/S0014-5793(99)01354-X; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; ZAMMIT VA, 1989, BIOCHEM J, V263, P89, DOI 10.1042/bj2630089; Zammit VA, 1999, PROG LIPID RES, V38, P199, DOI 10.1016/S0163-7827(99)00002-8; Zammit VA, 1998, LIPIDS, V33, P371, DOI 10.1007/s11745-998-0217-7; Zammit VA, 1999, BIOCHEM J, V343, P505, DOI 10.1042/0264-6021:3430505; Zammit VA, 1997, ADV ENZYME REGUL, V37, P295, DOI 10.1016/S0065-2571(96)00015-5; Zammit VA, 2008, IUBMB LIFE, V60, P347, DOI 10.1002/iub.78	43	26	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6988	6997		10.1074/jbc.M808487200	http://dx.doi.org/10.1074/jbc.M808487200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136561	Green Published, hybrid			2022-12-27	WOS:000263919000047
J	Arnold, T; Zeth, K; Linke, D				Arnold, Thomas; Zeth, Kornelius; Linke, Dirk			Structure and Function of Colicin S4, a Colicin with a Duplicated Receptor-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING COLICINS; MEMBRANE PROTEIN OMPW; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSLOCATION DOMAIN; CELL ENTRY; MODEL; MECHANISM; INSERTION; RECRUITMENT	Colicins are plasmid-encoded toxic proteins produced by Escherichia coli strains to kill other E. coli strains that lack the corresponding immunity protein. Colicins intrude into the host cell by exploiting existing transport, diffusion, or efflux systems. We have traced the way colicin S4 takes to execute its function and show that it interacts specifically with OmpW, OmpF, and the Tol system before it inserts its pore-forming domain into the cytoplasmic membrane. The common structural architecture of colicins comprises a translocation, a receptor-binding, and an activity domain. We have solved the crystal structure of colicin S4 to a resolution of 2.5 A, which shows a remarkably compact domain arrangement of four independent domains, including a unique domain duplication of the receptor-binding domain. Finally, we have determined the residues responsible for binding to the receptor OmpW by mutating exposed charged residues in one or both receptor-binding domains.	[Arnold, Thomas; Zeth, Kornelius; Linke, Dirk] Max Planck Inst Dev Biol, Dept 1, D-72076 Tubingen, Germany	Max Planck Society	Zeth, K (corresponding author), Max Planck Inst Dev Biol, Dept 1, Spemannstr 35, D-72076 Tubingen, Germany.	kornelius.zeth@tuebingen.mpg.de; dirk.linke@tuebingen.mpg.de	Linke, Dirk/F-9147-2010	Linke, Dirk/0000-0003-3150-6752	Max Planck Society; German Science Foundation [SFB766/B4]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation(German Research Foundation (DFG))	This work was supported by the Max Planck Society and by German Science Foundation Grant SFB766/B4. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albrecht R, 2006, ACTA CRYSTALLOGR F, V62, P415, DOI 10.1107/S1744309106010190; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Braun V, 2006, ACS CHEM BIOL, V1, P352, DOI 10.1021/cb600256k; Cao Z, 2002, BIOCHIMIE, V84, P399, DOI 10.1016/S0300-9084(02)01455-4; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CAVARD D, 1991, J BACTERIOL, V173, P191, DOI 10.1128/jb.173.1.191-196.1991; CAVARD D, 1990, J BACTERIOL, V172, P648, DOI 10.1128/jb.172.2.648-652.1990; Cheng YS, 2006, J MOL BIOL, V356, P22, DOI 10.1016/j.jmb.2005.11.056; Clavel T, 1998, MOL MICROBIOL, V29, P359, DOI 10.1046/j.1365-2958.1998.00945.x; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; COLLARINI M, 1987, EUR BIOPHYS J BIOPHY, V14, P147, DOI 10.1007/BF00253839; Collins ES, 2002, J MOL BIOL, V318, P787, DOI 10.1016/S0022-2836(02)00036-0; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAVIDSON VL, 1984, J MEMBRANE BIOL, V79, P105, DOI 10.1007/BF01872115; de Zamaroczy M, 2002, BIOCHIMIE, V84, P423, DOI 10.1016/S0300-9084(02)01426-8; Delcour AH, 2003, FRONT BIOSCI-LANDMRK, V8, pD1055, DOI 10.2741/1132; Deprez C, 2002, BIOCHEMISTRY-US, V41, P2589, DOI 10.1021/bi0157262; Duche D, 2002, BIOCHIMIE, V84, P455, DOI 10.1016/S0300-9084(02)01424-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gillor O, 2008, MICROBIOL-SGM, V154, P1783, DOI 10.1099/mic.0.2007/016139-0; Gratia A, 1925, CR SOC BIOL, V93, P1040; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kienker PK, 1997, J MEMBRANE BIOL, V157, P27, DOI 10.1007/s002329900213; Kleanthous C, 1998, MOL MICROBIOL, V28, P227, DOI 10.1046/j.1365-2958.1998.00811.x; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; Lakey JH, 2001, CURR TOP MICROBIOL, V257, P131; Lazzaroni JC, 2002, BIOCHIMIE, V84, P391, DOI 10.1016/S0300-9084(02)01419-0; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; Loftus SR, 2006, P NATL ACAD SCI USA, V103, P12353, DOI 10.1073/pnas.0603433103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pilsl H, 1999, J BACTERIOL, V181, P3578, DOI 10.1128/JB.181.11.3578-3581.1999; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; RILEY MA, 1993, MOL BIOL EVOL, V10, P1048; Soding J, 2003, BIOESSAYS, V25, P837, DOI 10.1002/bies.10321; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; SONG HY, 1991, J BACTERIOL, V173, P2927, DOI 10.1128/JB.173.9.2927-2934.1991; SUN TP, 1986, J BACTERIOL, V165, P107, DOI 10.1128/jb.165.1.107-115.1986; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Vetter IR, 1998, STRUCTURE, V6, P863, DOI 10.1016/S0969-2126(98)00088-4; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zakharov SD, 2004, BIOPHYS J, V87, P3901, DOI 10.1529/biophysj.104.046151; Zakharov SD, 2004, FRONT BIOSCI-LANDMRK, V9, P1311, DOI 10.2741/1334; Zakharov SD, 2002, BBA-BIOMEMBRANES, V1565, P333, DOI 10.1016/S0005-2736(02)00579-5; Zakharov SD, 2002, BIOCHIMIE, V84, P465, DOI 10.1016/S0300-9084(02)01453-0; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200	58	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6403	6413		10.1074/jbc.M808504200	http://dx.doi.org/10.1074/jbc.M808504200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19056731	Green Published, hybrid			2022-12-27	WOS:000263742700043
J	Brown, JR; Yang, F; Sinha, A; Ramakrishnan, B; Tor, Y; Qasba, PK; Esko, JD				Brown, Jillian R.; Yang, Feng; Sinha, Anjana; Ramakrishnan, Boopathy; Tor, Yitzhak; Qasba, Pradman K.; Esko, Jeffrey D.			Deoxygenated Disaccharide Analogs as Specific Inhibitors of beta 1-4-Galactosyltransferase 1 and Selectin-mediated Tumor Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALYL-LEWIS-X; CRYSTAL-STRUCTURE; ACCEPTOR SPECIFICITY; LACTOSE SYNTHASE; CELL-ADHESION; UDP-GAL; BETA-1,4-GALACTOSYLTRANSFERASE; GLYCOSYLATION; COMPLEX; MICE	The disaccharide peracetylated GlcNAc beta 1-3Gal beta-O-naphthalenemethanol (disaccharide 1) diminishes the formation of the glycan sialyl Lewis X (Neu5Ac alpha 2-3Gal beta 1-4(Fuc alpha 1-3)Glc-NAc; sLe(X)) in tumor cells. Previous studies showed that the mechanism of action of disaccharide 1 involves three steps: (i) deacetylation by carboxyesterases, (ii) action as a biosynthetic intermediate for downstream enzymes involved in sLe(X) assembly, and (iii) generation of several glycans related to sLe(X). In this report, we show that GlcNAc beta 1-3Gal beta-O-naphthalenemethanol binds to the acceptor site of human beta 1-4-galactosyltransferase much like the acceptor trisaccharide, GlcNAc beta 1-2Man beta 1-6Man, which is present on N-linked glycans. The 4'-deoxy analog, in which the acceptor hydroxyl group was replaced by -H, did not act as a substrate but instead acted as a competitive inhibitor of the enzyme. The acetylated form of this compound inhibited sLe(X) formation in U937 monocytic leukemia cells, suggesting that it had inhibitory activity in vivo as well. A series of synthetic acetylated analogs of 1 containing -H, -F, -N-3, -NH2, or -OCH3 instead of the hydroxyl groups at C-3'- and C-4'-positions of the terminal N-acetylglucosamine residue also blocked sLe(X) formation in cells. The reduction of sLe(X) by the 4'-deoxy analog also diminished experimental tumor metastasis by Lewis lung carcinoma in vivo. These data suggest that nonsubstrate disaccharides have therapeutic potential through their ability to bind to glycosyltransferases in vivo and to alter glycan-dependent pathologic processes.	[Brown, Jillian R.; Yang, Feng; Sinha, Anjana; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Tor, Yitzhak] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ramakrishnan, Boopathy] Nanobiol Program, Struct Glycobiol Sect, Frederick, MD 21702 USA; [Ramakrishnan, Boopathy] NCI, Basic Res Program, SAIC Frederick Inc, Ctr Canc Res,NIH, Frederick, MD 21702 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	jesko@ucsd.edu			National Institutes of Health [CA46462, CA112278, N01-CO-12400]; Intramural Research Program of the National Institutes of Health; NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA046462, R01CA112278, ZIABC010041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA46462 and CA112278 (to J. D. E.) and by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research. The crystallographic part of this project has been funded, in whole or in part, with federal funds from NCI, National Institutes of Health, under Contract N01-CO-12400. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Asano M, 2003, BLOOD, V102, P1678, DOI 10.1182/blood-2003-03-0836; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Brockhausen I, 2006, GLYCOCONJUGATE J, V23, P525, DOI 10.1007/s10719-006-7153-x; Brown JR, 2007, CRIT REV BIOCHEM MOL, V42, P481, DOI 10.1080/10409230701751611; Brown JR, 2006, CLIN CANCER RES, V12, P2894, DOI 10.1158/1078-0432.CCR-05-2745; Brown JR, 2003, J BIOL CHEM, V278, P23352, DOI 10.1074/jbc.M303093200; BROWN JR, 2003, CARBOHYDRATE BASED D, P883; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chhabra SR, 2003, MINI-REV MED CHEM, V3, P679, DOI 10.2174/1389557033487791; Chung SJ, 1998, BIOORG MED CHEM LETT, V8, P3359, DOI 10.1016/S0960-894X(98)00618-0; DeLano W.L, PYMOL MOL GRAPHICS S; ESKO JD, 1987, J BIOL CHEM, V262, P12189; Foster MM, 2003, CANCER RES, V63, P2775; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; HINDSGAUL O, 1991, J BIOL CHEM, V266, P17858; HUANG J, 1992, ONCOL RES, V4, P507; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAJIHARA Y, 1992, CARBOHYD RES, V229, pC5, DOI 10.1016/S0008-6215(00)90494-4; Kajihara Y, 1998, CARBOHYD RES, V306, P361, DOI 10.1016/S0008-6215(97)10093-3; Kavarana MJ, 1999, J MED CHEM, V42, P221, DOI 10.1021/jm9708036; KOJIMA N, 1992, BIOCHEM BIOPH RES CO, V182, P1288, DOI 10.1016/0006-291X(92)91872-N; Morton CL, 2000, CANCER RES, V60, P4206; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ramakrishnan B, 2004, BIOCHEMISTRY-US, V43, P12513, DOI 10.1021/bi049007+; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Ramasamy V, 2005, J MOL BIOL, V353, P53, DOI 10.1016/j.jmb.2005.07.050; Saotome C, 2000, BIOORGAN MED CHEM, V8, P2249, DOI 10.1016/S0968-0896(00)00170-X; Sarkar AK, 1997, J BIOL CHEM, V272, P25608, DOI 10.1074/jbc.272.41.25608; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Sarkar AK, 2000, CARBOHYD RES, V329, P287, DOI 10.1016/S0008-6215(00)00200-7; SINHA SK, 1980, CARBOHYD RES, V81, P239, DOI 10.1016/S0008-6215(00)85655-4; SOARES ER, 1979, BIOCHEM GENET, V17, P577, DOI 10.1007/BF00502119; Witz IP, 2008, CANCER METAST REV, V27, P19, DOI 10.1007/s10555-007-9101-z; WONG CH, 1991, J AM CHEM SOC, V113, P8137, DOI 10.1021/ja00021a045	36	33	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4952	4959		10.1074/jbc.M805782200	http://dx.doi.org/10.1074/jbc.M805782200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106107	Green Published, hybrid			2022-12-27	WOS:000263416600025
J	Claxton, HB; Akey, DL; Silver, MK; Admiraal, SJ; Smith, JL				Claxton, Heather B.; Akey, David L.; Silver, Monica K.; Admiraal, Suzanne J.; Smith, Janet L.			Structure and Functional Analysis of RifR, the Type II Thioesterase from the Rifamycin Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYKETIDE SYNTHASE; STREPTOMYCES-VENEZUELAE; PEPTIDE SYNTHETASES; GENE-CLUSTER; SURFACTIN; DOMAINS; ENZYME; ARCHITECTURE; SPECIFICITY; SELECTIVITY	Two thioesterases are commonly found in natural product biosynthetic clusters, a type I thioesterase that is responsible for removing the final product from the biosynthetic complex and a type II thioesterase that is believed to perform housekeeping functions such as removing aberrant units from carrier domains. We present the crystal structure and the kinetic analysis of RifR, a type II thioesterase from the hybrid nonribosomal peptide synthetases/polyketide synthase rifamycin biosynthetic cluster of Amycolatopsis mediterranei. Steady-state kinetics show that RifR has a preference for the hydrolysis of acyl units from the phosphopantetheinyl arm of the acyl carrier domain over the hydrolysis of acyl units from the phosphopantetheinyl arm of acyl-CoAs as well as a modest preference for the decarboxylated substrate mimics acetyl-CoA and propionyl-CoA over malonyl-CoA and methylmalonyl-CoA. Multiple RifR conformations and structural similarities to other thioesterases suggest that movement of a helical lid controls access of substrates to the active site of RifR.	[Claxton, Heather B.; Akey, David L.; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Claxton, Heather B.; Silver, Monica K.; Admiraal, Suzanne J.; Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Smith, JL (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	JanetSmith@umich.edu		Silver, Monica K./0000-0002-5920-6906; Admiraal, Suzanne/0000-0003-3334-2499	National Institutes of Health [DK42303]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042303, R01DK042303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK42303 (to J. L. S.). This work was also supported by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (to S. J. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akey DL, 2006, NAT CHEM BIOL, V2, P537, DOI 10.1038/nchembio824; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Butler AR, 1999, CHEM BIOL, V6, P287, DOI 10.1016/S1074-5521(99)80074-X; Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen HW, 2001, CHEM BIOL, V8, P301, DOI 10.1016/S1074-5521(01)00009-6; Chen S, 2001, GENE, V263, P255, DOI 10.1016/S0378-1119(00)00560-6; COSMINA P, 1993, MOL MICROBIOL, V8, P821, DOI 10.1111/j.1365-2958.1993.tb01629.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deutsch J, 2002, NEUROCHEM RES, V27, P1577, DOI 10.1023/A:1021614422668; Doi-Katayama Y, 2000, J ANTIBIOT, V53, P484, DOI 10.7164/antibiotics.53.484; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Fujimori DG, 2007, P NATL ACAD SCI USA, V104, P16498, DOI 10.1073/pnas.0708242104; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geoffroy VA, 2000, INFECT IMMUN, V68, P4452, DOI 10.1128/IAI.68.8.4452-4461.2000; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Hu ZH, 2003, MICROBIOL-SGM, V149, P2213, DOI 10.1099/mic.0.26015-0; Hutchinson CR, 2003, P NATL ACAD SCI USA, V100, P3010, DOI 10.1073/pnas.0730689100; Kim BS, 2002, J BIOL CHEM, V277, P48028, DOI 10.1074/jbc.M207770200; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Kotowska M, 2002, MICROBIOL-SGM, V148, P1777, DOI 10.1099/00221287-148-6-1777; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LIBERTINI LJ, 1978, J BIOL CHEM, V253, P1393; Linne U, 2004, EUR J BIOCHEM, V271, P1536, DOI 10.1111/j.1432-1033.2004.04063.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Patel J, 1998, TETRAHEDRON, V54, P15927, DOI 10.1016/S0040-4020(98)01002-3; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Reimmann C, 2004, J BACTERIOL, V186, P6367, DOI 10.1128/JB.186.19.6367-6373.2004; ROBERTS GA, 1993, EUR J BIOCHEM, V214, P305, DOI 10.1111/j.1432-1033.1993.tb17925.x; Roongsawang N, 2007, CHEMBIOCHEM, V8, P501, DOI 10.1002/cbic.200600465; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; Schneider A, 1998, ARCH MICROBIOL, V169, P404, DOI 10.1007/s002030050590; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Tang Y, 2004, BIOCHEMISTRY-US, V43, P9546, DOI 10.1021/bi049157k; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Tsai SC, 2002, BIOCHEMISTRY-US, V41, P12598, DOI 10.1021/bi0260177; Tsuji SY, 2001, BIOCHEMISTRY-US, V40, P2326, DOI 10.1021/bi002463n; Weissman KJ, 2004, PHILOS T R SOC A, V362, P2671, DOI 10.1098/rsta.2004.1470; Wertheimer AM, 1999, INFECT IMMUN, V67, P6496; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111; Yeh E, 2004, CHEMBIOCHEM, V5, P1290, DOI 10.1002/cbic.200400077; Yu FM, 2006, APPL BIOCHEM BIOTECH, V135, P145, DOI 10.1385/ABAB:135:2:145; Yu TW, 1999, P NATL ACAD SCI USA, V96, P9051, DOI 10.1073/pnas.96.16.9051	56	57	59	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5021	5029		10.1074/jbc.M808604200	http://dx.doi.org/10.1074/jbc.M808604200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103602	Green Published, hybrid			2022-12-27	WOS:000263416600032
J	Gao, XS; Campian, JL; Qian, MW; Sun, XF; Eaton, JW				Gao, Xueshan; Campian, Jian Li; Qian, Mingwei; Sun, Xiao-Feng; Eaton, John W.			Mitochondrial DNA Damage in Iron Overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED-MAMMALIAN-CELLS; RESPIRATORY-CHAIN; HEART-MITOCHONDRIA; SKELETAL-MUSCLE; SERUM IRON; CARDIOMYOPATHY; REPAIR; AGE; HEMOCHROMATOSIS; INHIBITION	Chronic iron overload has slow and insidious effects on heart, liver, and other organs. Because iron-driven oxidation of most biologic materials (such as lipids and proteins) is readily repaired, this slow progression of organ damage implies some kind of biological "memory." We hypothesized that cumulative iron-catalyzed oxidant damage to mtDNA might occur in iron overload, perhaps explaining the often lethal cardiac dysfunction. Real time PCR was used to examine the " intactness" of mttDNA in cultured H9c2 rat cardiac myocytes. After 3 -5 days exposure to high iron, these cells exhibited damage to mtDNA reflected by diminished amounts of near full-length 15.9-kb PCR product with no change in the amounts of a 16.1-kb product from a nuclear gene. With the loss of intact mtDNA, cellular respiration declined and mRNAs for three electron transport chain subunits and 16 S rRNA encoded by mtDNA decreased, whereas no decrements were found in four subunits encoded by nuclear DNA. To examine the importance of the interactions of iron with metabolically generated reactive oxygen species, we compared the toxic effects of iron in wild-type and rhoo cells. In wild-type cells, elevated iron caused increased production of reactive oxygen species, cytostasis, and cell death, whereas the rhoo cells were unaffected. We conclude that long-term damage to cells and organs in iron-overload disorders involves interactions between iron and mitochondrial reactive oxygen species resulting in cumulative damage to mtDNA, impaired synthesis of respiratory chain subunits, and respiratory dysfunction.	[Gao, Xueshan; Campian, Jian Li; Qian, Mingwei; Sun, Xiao-Feng; Eaton, John W.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Eaton, John W.] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA; [Gao, Xueshan; Sun, Xiao-Feng; Eaton, John W.] Linkoping Univ, Dept Oncol, S-58185 Linkoping, Sweden	University of Louisville; University of Louisville; Linkoping University	Eaton, JW (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, 580 S Preston St,Baxter Res Bldg 2,Rm 210, Louisville, KY 40202 USA.	EatonRedox@aol.com			National Institutes of Health [RO1 DK073586]; Commonwealth of Kentucky Research Challenge Trust Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Kentucky Research Challenge Trust Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK073586 (to J. W. E.). This work was also supported by the Commonwealth of Kentucky Research Challenge Trust Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; ALDOURI MA, 1990, ACTA HAEMATOL-BASEL, V84, P113; ALTMAN SA, 1995, FREE RADICAL BIO MED, V19, P897, DOI 10.1016/0891-5849(95)00095-F; ARTISS JD, 1981, CLIN BIOCHEM, V14, P311, DOI 10.1016/S0009-9120(81)91065-1; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; Bejma J, 1999, J APPL PHYSIOL, V87, P465, DOI 10.1152/jappl.1999.87.1.465; BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2; Bouaziz N, 2002, EUR J PHARMACOL, V441, P35, DOI 10.1016/S0014-2999(02)01490-5; Brunk UT, 2001, REDOX REP, V6, P91, DOI 10.1179/135100001101536094; CARMICHAEL PL, 1995, MUTAT RES-FUND MOL M, V326, P235, DOI 10.1016/0027-5107(94)00177-7; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; ESKELINEN S, 1983, SCAND J CLIN LAB INV, V43, P453; Fuller KM, 2002, ELECTROPHORESIS, V23, P1571, DOI 10.1002/1522-2683(200206)23:11<1571::AID-ELPS1571>3.0.CO;2-3; GABUTTI V, 1994, BAIL CL HAE, V7, P919, DOI 10.1016/S0950-3536(05)80131-3; GRAF E, 1984, J BIOL CHEM, V259, P3620; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002; JACKSON JH, 1987, J CLIN INVEST, V80, P1090, DOI 10.1172/JCI113165; Jarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0; Kruidering M, 1997, J PHARMACOL EXP THER, V280, P638; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LINK G, 1993, J LAB CLIN MED, V121, P127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4; LUO YZ, 1994, P NATL ACAD SCI USA, V91, P12438, DOI 10.1073/pnas.91.26.12438; Persson HL, 2003, FREE RADICAL BIO MED, V34, P1295, DOI 10.1016/S0891-5849(03)00106-0; PETERS TJ, 1986, FREE RADICALS LIVER, P107; QIAN MW, 1989, ARCH BIOCHEM BIOPHYS, V275, P280, DOI 10.1016/0003-9861(89)90374-3; Quinlan GJ, 2002, FREE RADICAL BIO MED, V33, P1306, DOI 10.1016/S0891-5849(02)00903-6; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; RYAN TP, 1992, CRIT REV TOXICOL, V22, P119, DOI 10.3109/10408449209146308; SCHRAUFSTATTER I, 1988, J CLIN INVEST, V82, P1040, DOI 10.1172/JCI113660; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; STAL P, 1990, J HEPATOL, V11, P172, DOI 10.1016/0168-8278(90)90109-5; Tolentino JH, 2008, NUCLEIC ACIDS RES, V36, P1300, DOI 10.1093/nar/gkm1157; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; VACA CE, 1989, BIOCHIM BIOPHYS ACTA, V1001, P35, DOI 10.1016/0005-2760(89)90304-4; Williams AJ, 1998, ANAL BIOCHEM, V259, P176, DOI 10.1006/abio.1998.2624; Wood JC, 2005, CIRCULATION, V112, P535, DOI 10.1161/CIRCULATIONAHA.104.504415; Yaffee M, 1996, P NATL ACAD SCI USA, V93, P5341, DOI 10.1073/pnas.93.11.5341; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yang JL, 2008, DNA REPAIR, V7, P1110, DOI 10.1016/j.dnarep.2008.03.012; Yu ZQ, 2003, FREE RADICAL BIO MED, V34, P1243, DOI 10.1016/S0891-5849(03)00109-6; ZASTAWNY TH, 1995, FREE RADICAL BIO MED, V18, P1013, DOI 10.1016/0891-5849(94)00241-B	44	91	100	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4767	4775		10.1074/jbc.M806235200	http://dx.doi.org/10.1074/jbc.M806235200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095657	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000263416600004
J	Sreeramulu, S; Jonker, HRA; Langer, T; Richter, C; Lancaster, CRD; Schwalbe, H				Sreeramulu, Sridhar; Jonker, Hendrik R. A.; Langer, Thomas; Richter, Christian; Lancaster, C. Roy D.; Schwalbe, Harald			The Human Cdc37 center dot Hsp90 Complex Studied by Heteronuclear NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPOLAR COUPLINGS; BINDING DOMAIN; CO-CHAPERONE; HSP90; CDC37; HEAT-SHOCK-PROTEIN-90; EXPRESSION; PROTEINS; PHOSPHORYLATION; ASSIGNMENT	The cell division cycle protein 37 (Cdc37) and the 90-kDa heat shock protein (Hsp90) are molecular chaperones, which are crucial elements in the protein signaling pathway. The largest class of client proteins for Cdc37 and Hsp90 are protein kinases. The catalytic domains of these kinases are stabilized by Cdc37, and their proper folding and functioning is dependent on Hsp90. Here, we present the x-ray crystal structure of the 16-kDa middle domain of human Cdc37 at 1.88 angstrom resolution and the structure of this domain in complex with the 23-kDa N-terminal domain of human Hsp90 based on heteronuclear solution state NMR data and docking. Our results demonstrate that the middle domain of Cdc37 exists as a monomer. NMR and mutagenesis experiments reveal Leu-205 in Cdc37 as a key residue enabling complex formation. These findings can be very useful in the development of small molecule inhibitors against cancer.	[Sreeramulu, Sridhar; Jonker, Hendrik R. A.; Langer, Thomas; Richter, Christian; Schwalbe, Harald] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Organ Chem & Chem Biol, D-60438 Frankfurt, Germany; [Lancaster, C. Roy D.] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany; [Lancaster, C. Roy D.] Univ Saarland, Fac Med, Dept Biol Struct, D-66421 Homburg, Germany	Goethe University Frankfurt; Max Planck Society; Saarland University	Schwalbe, H (corresponding author), Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Organ Chem & Chem Biol, Max von Laue Str 7, D-60438 Frankfurt, Germany.	schwalbe@nmr.uni-frankfurt.de	Schwalbe, Harald J/F-9023-2010; Lancaster, C. Roy/E-4313-2010; Langer, Thomas/AAB-7609-2020; Schwalbe, Harald/AAB-3143-2020	Schwalbe, Harald J/0000-0001-5693-7909; Schwalbe, Harald/0000-0001-5693-7909; Lancaster, C. Roy D./0000-0002-2814-0051	European commission; Deutsche Forschungsgemeinschaft	European commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the SPINE (Structural Proteomics in Europe) project of the European commission and by the Cluster of Excellence: Macromolecular Complexes (Deutsche Forschungsgemeinschaft). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; GARCIA MMT, 1990, INT J BIOL MACROMOL, V12, P19; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; HONIG B, 1993, J PHYS CHEM-US, V97, P1101, DOI 10.1021/j100108a002; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Jacobs DM, 2006, J BIOMOL NMR, V36, P52, DOI 10.1007/s10858-006-9030-0; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Keller R., 2004, COMPUTER AIDED RESON, V1; Lamphere L, 1997, ONCOGENE, V14, P1999, DOI 10.1038/sj.onc.1201036; Lee P, 2002, J CELL BIOL, V159, P1051, DOI 10.1083/jcb.200210121; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Matts Robert, 2007, V2, P331, DOI 10.1007/978-1-4020-6401-2_16; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Mort-Bontemps-Soret M, 2002, MOL GENET GENOMICS, V267, P447, DOI 10.1007/s00438-002-0676-3; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Ramanathan RK, 2005, CLIN CANCER RES, V11, P3385, DOI 10.1158/1078-0432.CCR-04-2322; REED SI, 1985, COLD SPRING HARB SYM, V50, P627, DOI 10.1101/SQB.1985.050.01.076; REED SI, 1980, GENETICS, V95, P561; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Scholz G, 2000, MOL CELL BIOL, V20, P6984, DOI 10.1128/MCB.20.18.6984-6995.2000; Schwarze SR, 2003, CANCER RES, V63, P4614; Shao J, 2001, J BIOL CHEM, V276, P206, DOI 10.1074/jbc.M007583200; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Sreeramulu S, 2005, J BIOMOL NMR, V32, P262, DOI 10.1007/s10858-005-8529-0; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stepanova L, 2000, ONCOGENE, V19, P2186, DOI 10.1038/sj.onc.1203561; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wang YX, 1998, J AM CHEM SOC, V120, P7385, DOI 10.1021/ja980862o; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; WHITELAW ML, 1991, J BIOL CHEM, V266, P16436; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; YUFU Y, 1992, LEUKEMIA RES, V16, P597, DOI 10.1016/0145-2126(92)90008-U; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	57	58	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3885	3896		10.1074/jbc.M806715200	http://dx.doi.org/10.1074/jbc.M806715200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073599	hybrid			2022-12-27	WOS:000262872500057
J	Urtishak, KA; Smith, KD; Chanoux, RA; Greenberg, RA; Johnson, FB; Brown, EJ				Urtishak, Karen A.; Smith, Kevin D.; Chanoux, Rebecca A.; Greenberg, Roger A.; Johnson, F. Brad; Brown, Eric J.			Timeless Maintains Genomic Stability and Suppresses Sister Chromatid Exchange during Unperturbed DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; BLOOMS-SYNDROME GENE; CHROMOSOME FRAGILE SITES; S-PHASE ARREST; HOMOLOGOUS RECOMBINATION; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; INTERACTING PROTEIN; SYNDROME HELICASE; VERTEBRATE CELLS	Genome integrity is maintained during DNA replication by coordination of various replisome-regulated processes. Although it is known that Timeless (Tim) is a replisome component that participates in replication checkpoint responses to genotoxic stress, its importance for genome maintenance during normal DNA synthesis has not been reported. Here we demonstrate that Tim reduction leads to genomic instability during unperturbed DNA replication, culminating in increased chromatid breaks and translocations (triradials, quadriradials, and fusions). Tim deficiency led to increased H2AX phosphorylation and Rad51 and Rad52 foci formation selectively during DNA synthesis and caused a 3-4-fold increase in sister chromatid exchange. The sister chromatid exchange events stimulated by Tim reduction were largely mediated via a Brca2/Rad51-dependent mechanism and were additively increased by deletion of the Blm helicase. Therefore, Tim deficiency leads to an increased reliance on homologous recombination for proper continuation of DNA synthesis. Together, these results indicate a pivotal role for Tim in maintaining genome stability throughout normal DNA replication.	[Brown, Eric J.] Univ Penn, Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Greenberg, Roger A.; Johnson, F. Brad] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Brown, EJ (corresponding author), 421 Curie Blvd,514 BRB 2-3, Philadelphia, PA 19104 USA.	brownej@mail.med.upenn.edu			W.W. Smith Charitable Trust; American Cancer Society Institutional Grant [IRG 78-002-29]; Abramson Family Cancer Research Institute	W.W. Smith Charitable Trust; American Cancer Society Institutional Grant(American Cancer Society); Abramson Family Cancer Research Institute	This work was supported by the W.W. Smith Charitable Trust, American Cancer Society Institutional Grant IRG 78-002-29, and the Abramson Family Cancer Research Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Amor-Gueret M, 2006, CANCER LETT, V236, P1, DOI 10.1016/j.canlet.2005.04.023; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Chester N, 1998, GENE DEV, V12, P3382, DOI 10.1101/gad.12.21.3382; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Davies SL, 2004, MOL CELL BIOL, V24, P1279, DOI 10.1128/MCB.24.3.1279-1291.2004; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; Fujimori A, 2001, EMBO J, V20, P5513, DOI 10.1093/emboj/20.19.5513; Goss KH, 2002, SCIENCE, V297, P2051, DOI 10.1126/science.1074340; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Henry-Mowatt J, 2003, MOL CELL, V11, P1109, DOI 10.1016/S1097-2765(03)00132-1; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; KUHN EM, 1986, CANCER GENET CYTOGEN, V22, P1, DOI 10.1016/0165-4608(86)90132-9; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Liu YL, 2000, EMBO REP, V1, P85, DOI 10.1093/embo-reports/kvd002; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; McDaniel LD, 2003, DNA REPAIR, V2, P1387, DOI 10.1016/j.dnarep.2003.08.006; Mcllwraith MJ, 2008, MOL CELL, V29, P510, DOI 10.1016/j.molcel.2007.11.037; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Mimura S, 2000, GENES CELLS, V5, P439, DOI 10.1046/j.1365-2443.2000.00340.x; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Mohanty BK, 2006, P NATL ACAD SCI USA, V103, P897, DOI 10.1073/pnas.0506540103; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Nedelcheva-Veleva MN, 2006, NUCLEIC ACIDS RES, V34, P4138, DOI 10.1093/nar/gkl528; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Sommariva E, 2005, MOL CELL BIOL, V25, P2770, DOI 10.1128/MCB.25.7.2770-2784.2005; Thorpe PH, 2006, MOL CELL BIOL, V26, P3752, DOI 10.1128/MCB.26.10.3752-3763.2006; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wilson DM, 2007, MUTAT RES-FUND MOL M, V616, P11, DOI 10.1016/j.mrfmmm.2006.11.017; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xiao J, 2003, DEV DYNAM, V228, P82, DOI 10.1002/dvdy.10346; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Yu YJ, 2002, J VIROL, V76, P3731, DOI 10.1128/JVI.76.8.3731-3738.2002; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	62	27	27	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8768	8776		10.1074/jbc.M806103200	http://dx.doi.org/10.1074/jbc.M806103200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19112184	Green Published, hybrid			2022-12-27	WOS:000264397800061
J	Aziz, A; Hess, JF; Budamagunta, MS; FitzGerald, PG; Voss, JC				Aziz, Atya; Hess, John F.; Budamagunta, Madhu S.; FitzGerald, Paul G.; Voss, John C.			Head and Rod 1 Interactions in Vimentin IDENTIFICATION OF CONTACT SITES, STRUCTURE, AND CHANGES WITH PHOSPHORYLATION USING SITE-DIRECTED SPIN LABELING AND ELECTRON PARAMAGNETIC RESONANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT STRUCTURE; EPIDERMOLYSIS-BULLOSA SIMPLEX; PREDICTING COILED COILS; IN-VITRO; PARAMAGNETIC-RESONANCE; ASSEMBLY PROPERTIES; CIRCULAR-DICHROISM; CROSS-LINKING; AMNION CELLS; PROTEINS	We have used site-directed spin labeling (SDSL) and electron paramagnetic resonance (EPR) to identify residues 17 and 137 as sites of interaction between the head domain and rod domain 1A of the intermediate filament protein vimentin. This interaction was maximal when compared with the spin labels placed at up- and downstream positions in both head and rod regions, indicating that residues 17 and 137 were the closest point of interaction in this region. SDSL EPR characterization of residues 120-145, which includes the site of head contact with rod 1A, reveals that this region exhibits the heptad repeat pattern indicative of alpha-helical coiled-coil structure, but that this heptad repeat pattern begins to decay near residue 139, suggesting a transition out of coiled-coil structure. By monitoring the spectra of spin labels placed at the 17 and 137 residues during in vitro assembly, we show that 17-137 interaction occurs early in the assembly process. We also explored the effect of phosphorylation on the 17-137 interaction and found that phosphorylation-induced changes affected the head-head interaction (17-17) in the dimer, without significantly influencing the rod-rod (137-137) and head-rod (17-137) interactions in the dimer. These data provide the first direct evidence for, and location of, head-rod interactions in assembled intermediate filaments, as well as direct evidence of coiled-coil structure in rod 1A. Finally, the data identify changes in the structure in this region following in vitro phosphorylation.	[Aziz, Atya; Hess, John F.; FitzGerald, Paul G.; Voss, John C.] Univ Calif Davis, Dept Cell Biol & Human Anat, Sch Med, Davis, CA 95616 USA; [Budamagunta, Madhu S.; Voss, John C.] Univ Calif Davis, Dept Biochem & Mol Med, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Voss, JC (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, Sch Med, Davis, CA 95616 USA.	pgfitzgerald@ucdavis.edu	Budamagunta, Madhu S/C-4628-2011	Voss, John/0000-0001-9279-209X	National Institutes of Health [EY017575, P30 EY012576, AG029246]; National Center for Research Resources, National Institutes of Health [C06 RR-12088-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants EY017575 ( to P. G. F.) and P30 EY012576 and AG029246 (to J. C. V.). Work was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR-12088-01 from the National Center for Research Resources, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALBERS K, 1992, INT REV CYTOL, V134, P243, DOI 10.1016/S0074-7696(08)62030-6; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; BEUTTENMULLER M, 1994, EXP CELL RES, V213, P128, DOI 10.1006/excr.1994.1182; CARTER JM, 1995, EXP EYE RES, V60, P181, DOI 10.1016/S0014-4835(95)80009-3; CELIS JE, 1983, J CELL BIOL, V97, P1429, DOI 10.1083/jcb.97.5.1429; Chomiki N, 2001, EUR J BIOCHEM, V268, P903, DOI 10.1046/j.1432-1327.2001.01946.x; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3; COULOMBE PA, 1991, J CELL BIOL, V115, P1661, DOI 10.1083/jcb.115.6.1661; COULOMBE PA, 1993, SEMIN DERMATOL, V12, P173; DELACOURTE A, 1982, BIOCHIM BIOPHYS ACTA, V709, P99, DOI 10.1016/0167-4838(82)90426-5; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; EVANS RM, 1982, CELL, V29, P43, DOI 10.1016/0092-8674(82)90088-5; FEY SJ, 1983, FEBS LETT, V157, P165, DOI 10.1016/0014-5793(83)81138-7; FUCHS E, 1994, J CELL BIOL, V125, P511, DOI 10.1083/jcb.125.3.511; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; FUCHS E, 1983, CELL, V34, P332, DOI 10.1016/0092-8674(83)90367-7; FUCHS E, 1994, J INVEST DERMATOL, V103, P25; GEISLER N, 1993, J STRUCT BIOL, V110, P205, DOI 10.1006/jsbi.1993.1023; Gohara R, 2001, FEBS LETT, V489, P182, DOI 10.1016/S0014-5793(01)02108-1; Goldie KN, 2007, J STRUCT BIOL, V158, P378, DOI 10.1016/j.jsb.2006.12.007; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X; HERRMANN H, 1998, INTERMEDIATE FILAMEN; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Hess JF, 2005, J BIOL CHEM, V280, P2141, DOI 10.1074/jbc.M412254200; Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200; Hess JF, 2002, J BIOL CHEM, V277, P35516, DOI 10.1074/jbc.M206500200; Hess JF, 2006, BIOCHEMISTRY-US, V45, P11737, DOI 10.1021/bi060741y; HUBBELL WL, 1987, REV SCI INSTRUM, V58, P1879, DOI 10.1063/1.1139536; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; KAUFMANN E, 1985, J MOL BIOL, V185, P733, DOI 10.1016/0022-2836(85)90058-0; LIKHTENSHTEIN GI, 1993, BIOPHYSICAL LABELING, P57; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; OMARY MB, 2004, INTERMEDIATE FILAMEN; Oshima RG, 2007, EXP CELL RES, V313, P1981, DOI 10.1016/j.yexcr.2007.04.007; PARRY D, 1985, CELLULAR MOL BIOL IN; PARRY D A D, 1992, Current Opinion in Cell Biology, V4, P94, DOI 10.1016/0955-0674(92)90064-J; PARRY DAD, 1985, BIOCHEM BIOPH RES CO, V127, P1012, DOI 10.1016/S0006-291X(85)80045-0; PARRY DAD, 1995, INTERMEDIATE FILAMEN; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Pittenger JT, 2008, BIOCHEMISTRY-US, V47, P10863, DOI 10.1021/bi801137m; QUINLAN RA, 1983, EUR J BIOCHEM, V132, P477, DOI 10.1111/j.1432-1033.1983.tb07386.x; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2004, METHOD CELL BIOL, V78, P25; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442; TRAUB P, 1993, J MOL BIOL, V230, P837, DOI 10.1006/jmbi.1993.1205; TRAUB P, 1992, J CELL SCI, V101, P363; TRAUB P, 1983, J CELL SCI, V63, P43; Wang H, 2000, J CELL BIOL, V151, P1459, DOI 10.1083/jcb.151.7.1459	57	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7330	7338		10.1074/jbc.M809029200	http://dx.doi.org/10.1074/jbc.M809029200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19117942	Green Published, hybrid			2022-12-27	WOS:000263919000079
J	Kovacs, WJ; Tape, KN; Shackelford, JE; Wikander, TM; Richards, MJ; Fliesler, SJ; Krisans, SK; Faust, PL				Kovacs, Werner J.; Tape, Khanichi N.; Shackelford, Janis E.; Wikander, Thomas M.; Richards, Michael J.; Fliesler, Steven J.; Krisans, Skaidrite K.; Faust, Phyllis L.			Peroxisome Deficiency Causes a Complex Phenotype because of Hepatic SREBP/Insig Dysregulation Associated with Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; CHOLESTEROL HOMEOSTASIS; ZELLWEGER-SYNDROME; LIVER DYSFUNCTION; STEROL RESISTANCE; GENE-EXPRESSION; KNOCKOUT MOUSE; MESSENGER-RNA; PROTEIN; ACTIVATION	Regulation of hepatic cholesterol biosynthesis, lipogenesis, and insulin signaling intersect at the transcriptional level by control of SREBP and Insig genes. We previously demonstrated that peroxisome-deficient PEX2(-/-) mice activate SREBP-2 pathways but are unable to maintain normal cholesterol homeostasis. In this study, we demonstrate that oral bile acid treatment normalized hepatic and plasma cholesterol levels and hepatic cholesterol synthesis in early postnatal PEX2 mutants, but SREBP-2 and its target gene expressions remained increased. SREBP-2 pathway induction was also observed in neonatal and longer surviving PEX2 mutants, where hepatic cholesterol levels were normal. Abnormal expression patterns for SREBP-1c and Insig-2a, and novel regulation of Insig-2b, further demonstrate that peroxisome deficiency widely affects the regulation of related metabolic pathways. We have provided the first demonstration that peroxisome deficiency activates hepatic endoplasmic reticulum (ER) stress pathways, especially the integrated stress response mediated by PERK and ATF4 signaling. Our studies suggest a mechanism whereby ER stress leads to dysregulation of the endogenous sterol response mechanism and concordantly activates oxidative stress pathways. Several metabolic derangements in peroxisome-deficient PEX2(-/-) liver are likely to trigger ER stress, including perturbed flux of mevalonate metabolites, altered bile acid homeostasis, changes in fatty acid levels and composition, and oxidative stress.	[Kovacs, Werner J.] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Kovacs, Werner J.; Tape, Khanichi N.; Shackelford, Janis E.; Krisans, Skaidrite K.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Wikander, Thomas M.; Faust, Phyllis L.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Richards, Michael J.; Fliesler, Steven J.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Richards, Michael J.; Fliesler, Steven J.] St Louis Univ, Inst Eye, Dept Ophthalmol, St Louis, MO 63104 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; California State University System; San Diego State University; Columbia University; Saint Louis University; Saint Louis University	Kovacs, WJ (corresponding author), ETH Honggerberg, Inst Cell Biol, Schafmattstr 18,HPM F39-2, CH-8093 Zurich, Switzerland.	werner.kovacs@cell.biol.ethz.ch	Kovacs, Werner/AAD-1107-2019; Fliesler, Steven J./AAE-9243-2020	Kovacs, Werner/0000-0002-4440-4344; Fliesler, Steven/0000-0002-2557-142X	National Institutes of Health [DK58238, DK58040, HD36807, NS050602, EY007361]; Research to Prevent Blindness; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036807] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058040, R01DK058238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK58238 and DK58040 (to S. K. K.), HD36807 and NS050602 (to P. L. F.), and EY007361 (to S. J. F.). This work was also supported by an unrestricted departmental grant from Research to Prevent Blindness (to S. J. F.).	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Allen-Jennings AE, 2002, J BIOL CHEM, V277, P20020, DOI 10.1074/jbc.M200727200; Allen-Jennings AE, 2001, J BIOL CHEM, V276, P29507, DOI 10.1074/jbc.M100986200; Alvarez C, 1999, EUR J CELL BIOL, V78, P1; Baes M, 2006, BBA-MOL CELL RES, V1763, P1785, DOI 10.1016/j.bbamcr.2006.08.018; Baumgart E, 2001, AM J PATHOL, V159, P1477, DOI 10.1016/S0002-9440(10)62534-5; Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dirkx R, 2005, HEPATOLOGY, V41, P868, DOI 10.1002/hep.20628; Faust PL, 2003, J COMP NEUROL, V461, P394, DOI 10.1002/cne.10699; Faust PL, 1997, J CELL BIOL, V139, P1293, DOI 10.1083/jcb.139.5.1293; Faust PL, 2001, J MOL NEUROSCI, V16, P289, DOI 10.1385/JMN:16:2-3:289; FLIESLER SJ, 2002, STEROLS OXYSTEROLS C; Flowers MT, 2008, PHYSIOL GENOMICS, V33, P361, DOI 10.1152/physiolgenomics.00139.2007; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Harding HP, 2005, CELL METAB, V2, P361, DOI 10.1016/j.cmet.2005.11.005; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Iovanna JL, 2002, J GASTROINTEST CANC, V31, P89; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Janowski BA, 2002, P NATL ACAD SCI USA, V99, P12675, DOI 10.1073/pnas.202471599; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Keane MH, 2007, HEPATOLOGY, V45, P982, DOI 10.1002/hep.21532; Kovacs WJ, 2007, HISTOCHEM CELL BIOL, V127, P273, DOI 10.1007/s00418-006-0254-6; Kovacs WJ, 2004, MOL CELL BIOL, V24, P1, DOI 10.1128/MCB.24.1.1-13.2004; Kovacs WJ, 2002, PROG LIPID RES, V41, P369, DOI 10.1016/S0163-7827(02)00002-4; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Lee PCW, 2007, J LIPID RES, V48, P1944, DOI 10.1194/jlr.M700225-JLR200; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Niknejad N, 2007, J BIOL CHEM, V282, P29748, DOI 10.1074/jbc.M705859200; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Palmeira CM, 2004, TOXICOLOGY, V203, P1, DOI 10.1016/j.tox.2004.06.001; Passe CMM, 2006, ENDOCRINE, V30, P81, DOI 10.1385/ENDO:30:1:81; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Schwarz M, 2001, J LIPID RES, V42, P1594; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Wanders RJA, 1998, MOL ASPECTS MED, V19, P71, DOI 10.1016/S0098-2997(98)00003-X; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yeagle PL., 1988, BIOL CHOLESTEROL	64	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7232	7245		10.1074/jbc.M809064200	http://dx.doi.org/10.1074/jbc.M809064200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19110480	hybrid, Green Published			2022-12-27	WOS:000263919000070
J	Legesse-Miller, A; Elemento, O; Pfau, SJ; Forman, JJ; Tavazoie, S; Coller, HA				Legesse-Miller, Aster; Elemento, Olivier; Pfau, Sarah J.; Forman, Joshua J.; Tavazoie, Saeed; Coller, Hilary A.			let-7 Overexpression Leads to an Increased Fraction of Cells in G(2)/M, Direct Down-regulation of Cdc34, and Stabilization of Wee1 Kinase in Primary Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELLS; MICRORNAS; TRANSFORMATION; PROLIFERATION; EXPRESSION; PROGNOSIS; PATHWAYS; TARGETS; GROWTH; GENES	microRNAs play a critically important role in a wide array of biological processes including those implicated in cancer, neuro-degenerative and metabolic disorders, and viral infection. Although we have begun to understand microRNA biogenesis and function, experimental demonstration of their functional effects and the molecular mechanisms by which they function remains a challenge. Members of the let-7/miR-98 family play a critical role in cell cycle control with respect to differentiation and tumorigenesis. In this study, we show that exogenous addition of pre-let-7 in primary human fibroblasts results in a decrease in cell number and an increased fraction of cells in the G(2)/M cell cycle phase. Combining microarray techniques with DNA sequence analysis to identify potential let-7 targets, we discovered 838 genes with a let-7 binding site in their 3'-untranslated region that were down-regulated upon overexpression of let-7b. Among these genes is cdc34, the ubiquitin-conjugating enzyme of the Skp1/cullin/F-box (SCF) complex. Cdc34 protein levels are strongly down-regulated by let-7 overexpression. Reporter assays demonstrated direct regulation of the cdc34 3'-untranslated region by let-7. We hypothesized that low Cdc34 levels would result in decreased SCF activity, stabilization of the SCF target Wee1, and G(2)/M accumulation. Consistent with this hypothesis, small interfering RNA-mediated down-regulation of Wee1 reversed the G(2)/M phenotype induced by let-7 overexpression. We conclude that Cdc34 is a functional target of let-7 and that let-7 induces down-regulation of Cdc34, stabilization of the Wee1 kinase, and an increased fraction of cells in G(2)/M in primary fibroblasts.	[Legesse-Miller, Aster; Elemento, Olivier; Pfau, Sarah J.; Forman, Joshua J.; Tavazoie, Saeed; Coller, Hilary A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Elemento, Olivier; Tavazoie, Saeed] Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA	Princeton University; Princeton University	Coller, HA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hcoller@princeton.edu		Forman, Joshua/0000-0001-7762-0062; Pfau, Sarah/0000-0001-7528-0666	National Institutes of Health [R01 GM081686]; PhRMA Foundation [2007RSGl9572]; NIGMS Center of Excellence [P50 GM071508]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086465, P50GM071508, R01GM081686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation; NIGMS Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 GM081686. This work was also supported in part by Grant 2007RSGl9572 from the PhRMA Foundation ( to H. A. C.) and by National Institutes of Health Grant P50 GM071508 from the NIGMS Center of Excellence ( to H. A. C., A. L. and S. T.). The costs of publication of this article were defrayed in part by the payment of page charges.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Inamura K, 2007, LUNG CANCER, V58, P392, DOI 10.1016/j.lungcan.2007.07.013; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	23	91	95	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6605	6609		10.1074/jbc.C900002200	http://dx.doi.org/10.1074/jbc.C900002200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19126550	Green Published, hybrid			2022-12-27	WOS:000263919000004
J	Perlmutter, JD; Braun, AR; Sachs, JN				Perlmutter, Jason D.; Braun, Anthony R.; Sachs, Jonathan N.			Curvature Dynamics of alpha-Synuclein Familial Parkinson Disease Mutants MOLECULAR SIMULATIONS OF THE MICELLE- AND BILAYER-BOUND FORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA COMPONENT; LIPID-BILAYERS; SECONDARY STRUCTURE; MEMBRANE-BINDING; LINKED MUTATIONS; FIBRIL FORMATION; PROTEIN; HELIX; PATHOGENESIS; AGGREGATION	alpha-Synuclein remains a protein of interest due to its propensity to form fibrillar aggregates in neurodegenerative disease and its putative function in synaptic vesicle regulation. Herein, we present a series of atomistic molecular dynamics simulations of wild-type alpha-synuclein and three Parkinson disease familial mutants (A30P, A53T, and E46K) in two distinct environments. First, in order to match recent NMR experiments, we have simulated each protein bound to an SDS detergent micelle. Second, in order to connect more closely to the true biological environment, we have simulated the proteins bound to a 1,2-dioleoyl-sn-glycero-3-phosphoserine lipid bilayer. In the micelle-bound case, we find that the wild type and all of the variants of alpha-synuclein flatten the underlying micelle, decreasing its surface area. A30P is known to lessen alpha-synuclein/membrane affinity and, consistent with experiment, destabilizes the simulated secondary structure. In the case of A53T, our simulations reveal a range of stabilizing hydrogen bonds that form with the threonine. In both environments, the E46K mutation, which is known to increase bilayer affinity, leads to an additional hydrogen bond between the protein and either the detergent or lipid. Simulations indicate that alpha S and its variants are less dynamic in the bilayer than in the micelle. Furthermore, the simulations of the mutants suggest how changes in the structure and dynamics of alpha-synuclein may affect its biological role.	[Perlmutter, Jason D.; Braun, Anthony R.; Sachs, Jonathan N.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Sachs, JN (corresponding author), 312 Church St SE,7-126 Hasselmo Hall, Minneapolis, MN 55455 USA.	jnsachs@umn.edu		Perlmutter, Jason/0000-0003-2855-2360; Braun, Anthony/0000-0002-9942-3390				Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Garg G, 2005, J PHYS CHEM B, V109, P1340, DOI 10.1021/jp0472663; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; IWAI A, 1995, BIOCHEMISTRY-US, V34, P10139, DOI 10.1021/bi00032a006; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Kucerka N, 2008, BIOPHYS J, V95, P2792, DOI 10.1529/biophysj.107.122465; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Leontiadou H, 2004, BIOPHYS J, V86, P2156, DOI 10.1016/S0006-3495(04)74275-7; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mihajlovic M, 2008, PROTEINS, V70, P761, DOI 10.1002/prot.21558; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Narayanan V, 2001, BIOCHEMISTRY-US, V40, P9927, DOI 10.1021/bi002952n; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Ohkubo YZ, 2008, STRUCTURE, V16, P72, DOI 10.1016/j.str.2007.10.021; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Pitman MC, 2004, BIOCHEMISTRY-US, V43, P15318, DOI 10.1021/bi048231w; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; Sachs JN, 2003, CHEM PHYS LIPIDS, V126, P211, DOI 10.1016/j.chemphyslip.2003.08.001; Sachs JN, 2006, ANNU REV BIOCHEM, V75, P707, DOI 10.1146/annurev.biochem.75.110105.142336; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tarek M, 2005, BIOPHYS J, V88, P4045, DOI 10.1529/biophysj.104.050617; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	65	81	81	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7177	7189		10.1074/jbc.M808895200	http://dx.doi.org/10.1074/jbc.M808895200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19126542	Green Published, hybrid			2022-12-27	WOS:000263919000065
J	Kaminska, M; Havrylenko, S; Decottignies, P; Gillet, S; Le Marechal, P; Negrutskii, B; Mirande, M				Kaminska, Monika; Havrylenko, Svitlana; Decottignies, Paulette; Gillet, Sylvie; Le Marechal, Pierre; Negrutskii, Boris; Mirande, Marc			Dissection of the Structural Organization of the Aminoacyl-tRNA Synthetase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; MACROMOLECULAR COMPLEXES; POLYPEPTIDE COMPONENTS; P43 COMPONENT; PURIFICATION; RABBIT; SHEEP; IDENTIFICATION; ASSEMBLAGE; LIVER	The spatio-temporal organization of proteins within the cytoplasm of eukaryotic cells rests in part on the assembly of stable and transient multiprotein complexes. Here we examined the assembly of the multiaminoacyl-tRNA synthetase complex (MARS) in human cells. This complex contains nine aminoacyl-tRNA synthetases and three auxiliary proteins and is a hallmark of metazoan species. Isolation of the complexes has been performed by tandem affinity purification from human cells in culture. To understand the rules of assembly of this particle, expression of the three nonsynthetase components of MARS, p18, p38, and p43, was blocked by stable small interfering RNA silencing. The lack of these components was not lethal for the cells, but cell growth was slightly reduced. The residual complexes that could form in vivo in the absence of the auxiliary proteins were isolated by tandem affinity purification. From the repertoire of the subcomplexes that could be isolated, a comprehensive map of protein-protein interactions mediating complex assembly is deduced. The data are consistent with a structural role of the three nonsynthetase components of MARS, with p38 connecting two subcomplexes that may form in the absence of p38.	[Kaminska, Monika; Havrylenko, Svitlana; Mirande, Marc] CNRS, Lab Enzymol & Biochim Struct, F-91190 Gif Sur Yvette, France; [Havrylenko, Svitlana; Negrutskii, Boris] Inst Mol Biol & Genet, UA-03143 Kiev, Ukraine; [Decottignies, Paulette; Gillet, Sylvie; Le Marechal, Pierre] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, CNRS, UMR 8619, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Mirande, M (corresponding author), CNRS, Lab Enzymol & Biochim Struct, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	Mirande@lebs.cnrs-gif.fr	Gillet, Sylvie/A-3227-2017; Negrutskii, Boris/G-6439-2016	Gillet, Sylvie/0000-0002-3732-4696; Negrutskii, Boris/0000-0001-5974-1629	CNRS; Association pour la Recherche sur le Cancer; La Ligue	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); La Ligue	This work was supported by grants from the CNRS, the Association pour la Recherche sur le Cancer, and "La Ligue."	Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; BEC G, 1989, J BIOL CHEM, V264, P21131; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; CIRAKOGLU B, 1985, EUR J BIOCHEM, V151, P101, DOI 10.1111/j.1432-1033.1985.tb09074.x; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Han JM, 2006, J BIOL CHEM, V281, P38663, DOI 10.1074/jbc.M605211200; Jiang SL, 2005, FEBS LETT, V579, P6049, DOI 10.1016/j.febslet.2005.09.062; JOHNSON DL, 1981, P NATL ACAD SCI-BIOL, V78, P4059, DOI 10.1073/pnas.78.7.4059; JOHNSON DL, 1980, J BIOL CHEM, V255, P4362; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; KAO J, 1994, J BIOL CHEM, V269, P9774; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Kunst CB, 1997, NAT GENET, V15, P91, DOI 10.1038/ng0197-91; KUSTER B, 2002, NATURE, V415, P141; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Mansilla F, 2002, BIOCHEM J, V365, P669, DOI 10.1042/BJ20011681; MIRANDE M, 1982, J BIOL CHEM, V257, P1056; MIRANDE M, 1982, J BIOL CHEM, V257, P1049; MIRANDE M, 2005, AMINOACYL TRNA SYNTH, P298; MOTORIN YA, 1988, FEBS LETT, V238, P262, DOI 10.1016/0014-5793(88)80492-7; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; Norcum MT, 1998, PROTEIN SCI, V7, P79, DOI 10.1002/pro.5560070108; NORCUM MT, 1991, J BIOL CHEM, V266, P15398; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shalak V, 2007, J BIOL CHEM, V282, P10935, DOI 10.1074/jbc.M611737200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIHAG RK, 1983, J BIOL CHEM, V258, P1846; Wolfe CL, 2005, J BIOL CHEM, V280, P38870, DOI 10.1074/jbc.M502759200	39	51	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6053	6060		10.1074/jbc.M809636200	http://dx.doi.org/10.1074/jbc.M809636200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19131329	hybrid			2022-12-27	WOS:000263742700007
J	Tomaru, T; Steger, DJ; Lefterova, MI; Schupp, M; Lazar, MA				Tomaru, Takuya; Steger, David J.; Lefterova, Martina I.; Schupp, Michael; Lazar, Mitchell A.			Adipocyte-specific Expression of Murine Resistin Is Mediated by Synergism between Peroxisome Proliferator-activated Receptor gamma and CCAAT/Enhancer-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; RNA-POLYMERASE-II; PPAR-GAMMA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; 3T3-L1 ADIPOCYTES; C/EBP-ALPHA; TRANSCRIPTIONAL REGULATION; GLUCOSE-HOMEOSTASIS; HUMAN GENOME	Resistin antagonizes insulin action in mouse, making it a potential therapeutic target for treating metabolic diseases such as diabetes. To better understand how mouse resistin gene (Retn) expression is restricted to fat tissue, we identified an adipocyte-specific enhancer located similar to 8.8-kb upstream of the transcription start site. This region contains a binding site for the master adipogenic regulator peroxisome proliferator-activated receptor gamma (PPAR gamma), and binds endogenous PPAR gamma together with its partner retinoid-X receptor alpha(RXR alpha). It also contains three binding sites for CCAAT/enhancer-binding protein (C/EBP), and is bound by endogenous C/EBP alpha and C/EBP beta in adipocytes. Exogenous expression of PPAR gamma/RXR alpha and C/EBP alpha in non-adipocyte cells synergistically drives robust expression from the enhancer. Although PPAR gamma ligands repress Retn transcription in adipocytes, rosiglitazone paradoxically stimulates the enhancer activity, suggesting that the enhancer is not directly involved in negative regulation. Unlike expression of Retn in mouse, human resistin (RETN) is expressed primarily in macrophages. Interestingly, the region homologous to the mouse Retn enhancer in the human gene contains all three C/EBP elements, but is not conserved for the sequence bound by PPAR gamma. Furthermore, it displays little or no binding by PPAR gamma in vitro. Taken together, the data suggest that a composite enhancer binding both PPAR gamma and C/EBP factors confers adipocyte-specific expression to Retn in mouse, and its absence from the human gene may explain the lack of adipocyte expression in humans.	[Lazar, Mitchell A.] Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, 700 CRB,415 Curie Blvd, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019	Schupp, Michael/0000-0003-3720-1052	National Institutes of Health [P01 DK49210]; Picower Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Picower Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK P01 DK49210 ( to M. A. L.). This work was also supported by the Picower Foundation.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHAWLA A, 1993, J BIOL CHEM, V268, P16265; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Chung SS, 2006, BIOCHEM BIOPH RES CO, V348, P253, DOI 10.1016/j.bbrc.2006.07.048; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Conneely KN, 2004, DIABETOLOGIA, V47, P1782, DOI 10.1007/s00125-004-1537-x; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Hartman HB, 2002, J BIOL CHEM, V277, P19754, DOI 10.1074/jbc.M201451200; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873; Jonke J, 2002, OBES RES, V10, P1; Jung HS, 2005, METABOLISM, V54, P314, DOI 10.1016/j.metabol.2004.05.019; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kamin D, 2005, J CLIN ENDOCR METAB, V90, P3423, DOI 10.1210/jc.2005-0287; Kielstein JT, 2003, AM J KIDNEY DIS, V42, P62, DOI 10.1016/S0272-6386(03)00409-8; LAUER MN, 2002, J CLIN ENDOCR METAB, V87, P2407; Lazar MA, 2007, HORM METAB RES, V39, P710, DOI 10.1055/s-2007-985897; Lee JH, 2003, J CLIN ENDOCR METAB, V88, P4848, DOI 10.1210/jc.2003-030519; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Li Y, 2002, MOL ENDOCRINOL, V16, P1040, DOI 10.1210/me.16.5.1040; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MACDOUGALD OA, 1994, J BIOL CHEM, V269, P19041; MACDOUGALD OA, 1995, J BIOL CHEM, V270, P647, DOI 10.1074/jbc.270.2.647; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; McTernan PG, 2002, J CLIN ENDOCR METAB, V87, P2407, DOI 10.1210/jc.87.5.2407; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; Osawa H, 2004, AM J HUM GENET, V75, P678, DOI 10.1086/424761; Osawa H, 2005, BIOCHEM BIOPH RES CO, V335, P596, DOI 10.1016/j.bbrc.2005.07.122; Osawa H, 2008, CLIN ENDOCRINOL, V69, P74, DOI 10.1111/j.1365-2265.2007.03154.x; Osawa H, 2007, DIABETES CARE, V30, P1501, DOI 10.2337/dc06-1936; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Rajala MW, 2002, MOL ENDOCRINOL, V16, P1920, DOI 10.1210/me.2002-0048; Rangwala SM, 2004, DIABETES, V53, P1937, DOI 10.2337/diabetes.53.8.1937; Reaven G, 2004, RECENT PROG HORM RES, V59, P207, DOI 10.1210/rp.59.1.207; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seo JB, 2003, MOL ENDOCRINOL, V17, P1522, DOI 10.1210/me.2003-0028; Smith SR, 2003, DIABETES, V52, P1611, DOI 10.2337/diabetes.52.7.1611; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Vidal-Puig A, 2001, CLIN ENDOCRINOL, V55, P437, DOI 10.1046/j.1365-2265.2001.01377.x; Wang H, 2002, J CLIN ENDOCR METAB, V87, P2520, DOI 10.1210/jc.87.6.2520; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Yang RZ, 2003, BIOCHEM BIOPH RES CO, V310, P927, DOI 10.1016/j.bbrc.2003.09.093; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	73	55	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6116	6125		10.1074/jbc.M808407200	http://dx.doi.org/10.1074/jbc.M808407200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19126543	Green Published, hybrid			2022-12-27	WOS:000263742700014
J	Ogusucu, R; Rettori, D; Netto, LES; Augusto, O				Ogusucu, Renata; Rettori, Daniel; Netto, Luis E. S.; Augusto, Ohara			Superoxide Dismutase 1-mediated Production of Ethanol- and DNA-derived Radicals in Yeasts Challenged with Hydrogen Peroxide MOLECULAR INSIGHTS INTO THE GENOME INSTABILITY OF PEROXIREDOXIN-NULL STRAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; OXIDATIVE STRESS-RESPONSE; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; OXYGEN-METABOLISM; CELL-DEATH; COPPER; ANION; DECOMPOSITION; MECHANISMS	Peroxiredoxins are receiving increasing attention as defenders against oxidative damage and sensors of hydrogen peroxide-mediated signaling events. In the yeast Saccharomyces cerevisiae, deletion of one or more isoforms of the peroxiredoxins is not lethal but compromises genome stability by mechanisms that remain under scrutiny. Here, we show that cytosolic peroxiredoxin-null cells (tsa1 Delta tsa2 Delta) are more resistant to hydrogen peroxide than wildtype (WT) cells and consume it faster under fermentative conditions. Also, tsa1 Delta tsa2 Delta cells produced higher yields of the 1-hydroxyethyl radical from oxidation of the glucose metabolite ethanol, as proved by spin-trapping experiments. A major role for Fenton chemistry in radical formation was excluded by comparing WT and tsa1 Delta tsa2 Delta cells with respect to their levels of total and chelatable metal ions and of radical produced in the presence of chelators. The main route for 1-hydroxyethyl radical formation was ascribed to the peroxidase activity of Cu, Zn-superoxide dismutase (Sod1), whose expression and activity increased similar to 5- and 2-fold, respectively, in tsa1 Delta tsa2 Delta compared with WT cells. Accordingly, overexpression of human Sod1 in WT yeasts led to increased 1-hydroxyethyl radical production. Relevantly, tsa1 Delta tsa2 Delta cells challenged with hydrogen peroxide contained higher levels of DNA-derived radicals and adducts as monitored by immuno-spin trapping and incorporation of C-14 from glucose into DNA, respectively. The results indicate that part of hydrogen peroxide consumption by tsa1 Delta tsa2 Delta cells is mediated by induced Sod1, which oxidizes ethanol to the 1-hydroxyethyl radical, which, in turn, leads to increased DNA damage. Overall, our studies provide a pathway to account for the hypermutability of peroxiredoxin-null strains.	[Ogusucu, Renata; Rettori, Daniel; Augusto, Ohara] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil; [Netto, Luis E. S.] Univ Sao Paulo, Dept Biol, Inst Biociencias, BR-05513970 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Augusto, O (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Caixa Postal 26077, BR-05513970 Sao Paulo, Brazil.	oaugusto@iq.usp.br	Rettori, Daniel/F-4596-2012; Netto, Luis/A-3783-2008; Augusto, Ohara/D-3839-2012	Netto, Luis/0000-0002-4250-9177; Augusto, Ohara/0000-0002-7220-4286	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Projeto Milenio Redoxoma)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Projeto Milenio Redoxoma)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Projeto Milenio Redoxoma).	AUGUSTO O, 1993, FREE RADICAL BIO MED, V15, P329, DOI 10.1016/0891-5849(93)90079-A; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bonatto D, 2007, FREE RADICAL BIO MED, V43, P557, DOI 10.1016/j.freeradbiomed.2007.05.013; Chen L, 2007, CHEM RES TOXICOL, V20, P108, DOI 10.1021/tx060232x; Claiborne A., 1985, CRC HDB METHODS OXYG, P283; Demasi APD, 2006, FEBS J, V273, P805, DOI 10.1111/j.1742-4658.2006.05116.x; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; GRALLA EB, 1991, P NATL ACAD SCI USA, V88, P8558, DOI 10.1073/pnas.88.19.8558; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; Halliwell B., 2007, FREE RADICAL BIO MED, P79; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Iraqui I, 2008, CANCER RES, V68, P1055, DOI 10.1158/0008-5472.CAN-07-2683; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Joffe A, 2003, CHEM RES TOXICOL, V16, P1528, DOI 10.1021/tx034142t; Karanjawala ZE, 2003, DNA REPAIR, V2, P285, DOI 10.1016/S1568-7864(02)00218-5; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; KNECHT KT, 1993, ARCH BIOCHEM BIOPHYS, V303, P339, DOI 10.1006/abbi.1993.1293; Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Lee YA, 2007, CHEM-EUR J, V13, P4571, DOI 10.1002/chem.200601434; Linares E, 2003, FREE RADICAL BIO MED, V34, P766, DOI 10.1016/S0891-5849(02)01424-7; Liochev SI, 2004, P NATL ACAD SCI USA, V101, P743, DOI 10.1073/pnas.0307635100; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; Matsuda T, 2007, CARCINOGENESIS, V28, P2363, DOI 10.1093/carcin/bgm057; Matter B, 2007, CHEM RES TOXICOL, V20, P1379, DOI 10.1021/tx7001146; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Medinas DB, 2007, IUBMB LIFE, V59, P255, DOI 10.1080/15216540701230511; MISRA HP, 1979, J BIOL CHEM, V254, P1623; Monje-Casas F, 2004, BIOCHEM J, V383, P139, DOI 10.1042/BJ20040851; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Munhoz DC, 2004, J BIOL CHEM, V279, P35219, DOI 10.1074/jbc.M313773200; Nakao LS, 1998, CHEM RES TOXICOL, V11, P888, DOI 10.1021/tx9800351; Nakao LS, 2002, CHEM RES TOXICOL, V15, P1248, DOI 10.1021/tx0255166; Naozuka J, 2007, J BRAZIL CHEM SOC, V18, P1547, DOI 10.1590/S0103-50532007000800015; Oberley L.W., 1985, HDB METHODS OXYGEN R, P217; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; PACKER JE, 1981, INT J RADIAT BIOL, V39, P135, DOI 10.1080/09553008114550151; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Peter Y, 2001, EMBO J, V20, P1538, DOI 10.1093/emboj/20.7.1538; PHILIPPSEN P, 1991, METHOD ENZYMOL, V194, P169; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; RAEM TD, 1999, SCIENCE, V284, P805; Ragu S, 2007, P NATL ACAD SCI USA, V104, P9747, DOI 10.1073/pnas.0703192104; Ramirez DC, 2007, NAT PROTOC, V2, P512, DOI 10.1038/nprot.2007.5; Ramirez DC, 2005, FREE RADICAL BIO MED, V38, P201, DOI 10.1016/j.freeradbiomed.2004.10.008; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Roe JA, 2002, FREE RADICAL BIO MED, V32, P169, DOI 10.1016/S0891-5849(01)00778-X; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Salmon JM, 2000, FOOD CHEM, V71, P519, DOI 10.1016/S0308-8146(00)00204-1; Seitz HK, 2007, ALCOHOL RES HEALTH, V30, P38; SENTANDREU R, 1969, BIOCHEM J, V115, P231, DOI 10.1042/bj1150231; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Srinivasan C, 2000, J BIOL CHEM, V275, P29187, DOI 10.1074/jbc.M004239200; Trujillo Madia, 2007, V44, P83; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; Wong CM, 2002, J BIOL CHEM, V277, P5385, DOI 10.1074/jbc.M106846200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; YEGOROV DY, 1993, FREE RADICAL BIO MED, V15, P565, DOI 10.1016/0891-5849(93)90158-Q; YIM MB, 1993, J BIOL CHEM, V268, P4099; ZAMOCKY M, 1995, FEBS LETT, V367, P241, DOI 10.1016/0014-5793(95)00568-T; Zhang H, 2000, J BIOL CHEM, V275, P14038, DOI 10.1074/jbc.275.19.14038	69	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5546	5556		10.1074/jbc.M805526200	http://dx.doi.org/10.1074/jbc.M805526200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106092	hybrid			2022-12-27	WOS:000263560600018
J	Webster, RJ; Giles, KM; Price, KJ; Zhang, PM; Mattick, JS; Leedman, PJ				Webster, Rebecca J.; Giles, Keith M.; Price, Karina J.; Zhang, Priscilla M.; Mattick, John S.; Leedman, Peter J.			Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; 3'-UNTRANSLATED REGION; TYROSINE KINASE; EXPRESSION; TARGET; EGFR; IDENTIFICATION; STIMULATION; INVOLVEMENT; MICROARRAY	The epidermal growth factor receptor (EGFR) is frequently overexpressed in cancer and is an important therapeutic target. Aberrant expression and function of microRNAs have been associated with tumorigenesis. Bioinformatic predictions suggest that the human EGFR mRNA 3'-untranslated region contains three microRNA-7 (miR-7) target sites, which are not conserved across mammals. We found that miR-7 down-regulates EGFR mRNA and protein expression in cancer cell lines (lung, breast, and glioblastoma) via two of the three sites, inducing cell cycle arrest and cell death. Because miR-7 was shown to decrease EGFR mRNA expression, we used microarray analysis to identify additional mRNA targets of miR-7. These included Raf1 and multiple other genes involved in EGFR signaling and tumorigenesis. Furthermore, miR-7 attenuated activation of protein kinase B (Akt) and extracellular signal-regulated kinase 1/2, two critical effectors of EGFR signaling, in different cancer cell lines. These data establish an important role for miR-7 in controlling mRNA expression and indicate that miR-7 has the ability to coordinately regulate EGFR signaling in multiple human cancer cell types.	[Webster, Rebecca J.; Giles, Keith M.; Price, Karina J.; Zhang, Priscilla M.; Leedman, Peter J.] Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Lab Canc Med, Perth, WA 6000, Australia; [Webster, Rebecca J.; Price, Karina J.; Leedman, Peter J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6000, Australia; [Mattick, John S.] Univ Queensland, Australian Res Council, Special Res Ctr Funct & Appl Genom, Inst Mol Biosci, Brisbane, Qld 4000, Australia	University of Western Australia; University of Western Australia; University of Queensland	Leedman, PJ (corresponding author), Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Lab Canc Med, Level 6,MRF Bldg,Rear 50 Murray St, Perth, WA 6000, Australia.	peterl@waimr.uwa.edu.au	Mattick, John/ABH-6130-2020; Mattick, John S/I-7789-2012; Leedman, Peter J/O-4044-2014	Mattick, John/0000-0002-7680-7527; Mattick, John S/0000-0002-7680-7527; 	National Health and Medical Research Council of Australia; The Office of Innovation; Industry at the University of Western Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); The Office of Innovation; Industry at the University of Western Australia	This work was supported by the National Health and Medical Research Council of Australia and the The Office of Innovation and Industry at the University of Western Australia co-funded the PCT application on miR-7 (lodged August 28, 2007).	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Aoki H, 2007, CLIN CANCER RES, V13, P6603, DOI 10.1158/1078-0432.CCR-07-0145; Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Balmer LA, 2001, MOL CELL BIOL, V21, P2070, DOI 10.1128/MCB.21.6.2070-2084.2001; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianco R, 2005, ENDOCR-RELAT CANCER, V12, pS159, DOI 10.1677/erc.1.00999; Bottoni A, 2007, J CELL PHYSIOL, V210, P370, DOI 10.1002/jcp.20832; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haisenleder DJ, 2003, ENDOCRINOLOGY, V144, P2768, DOI 10.1210/en.2002-0168; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kim SW, 2003, J BIOL CHEM, V278, P2661, DOI 10.1074/jbc.M205819200; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee HJ, 2006, P NATL ACAD SCI USA, V103, P15669, DOI 10.1073/pnas.0605781103; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Ritter CA, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50027; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tripp SR, 2005, ANAL QUANT CYTOL, V27, P71; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Yano S, 2003, ANTICANCER RES, V23, P3639; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	51	347	388	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5731	5741		10.1074/jbc.M804280200	http://dx.doi.org/10.1074/jbc.M804280200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19073608	hybrid			2022-12-27	WOS:000263560600037
J	Oliveira, JMA; Goncalves, J				Oliveira, Jorge M. A.; Goncalves, Jorge			In Situ Mitochondrial Ca2+ Buffering Differences of Intact Neurons and Astrocytes from Cortex and Striatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED PERMEABILITY TRANSITION; HUNTINGTONS-DISEASE; CYCLOSPORINE-A; BRAIN MITOCHONDRIA; NEURODEGENERATIVE DISEASE; SYNAPTIC MITOCHONDRIA; CALCIUM INFLUX; CYCLOPHILIN-D; GLIAL-CELLS; HETEROGENEITY	The striatum is particularly vulnerable to neurological disorders, such as Huntington disease. Previous studies, with nonsynaptic mitochondria isolated from cortical and striatal homogenates, suggest that striatal mitochondria are highly vulnerable to Ca2+ loads, possibly influencing striatal vulnerability. However, whether and how neuronal and glial mitochondria from cortex and striatum differ in Ca2+ vulnerability remains unknown. We test this hypothesis using a novel strategy allowing comparisons of mitochondrial Ca2+ buffering capacity in cortical and striatal neuron-astrocyte co-cultures. We provide original evidence that mitochondria not only in neurons but also in astrocytes from striatal origin exhibit a decreased Ca2+ buffering capacity when compared with cortical counterparts. The decreased mitochondrial Ca2+ buffering capacity in striatal versus cortical astrocytes does not stem from variation in mitochondrial concentration or in the rate of intracellular Ca2+ elevation, being mechanistically linked to an increased propensity to undergo cyclosporin A (CsA)-sensitive permeability transition. Indeed, 1 mu M CsA selectively increased the mitochondrial Ca2+ buffering capacity of striatal astrocytes, without modifying that of neurons or cortical astrocytes. Neither thapsigargin nor FK506 modified mitochondrial Ca2+ buffering differences between cell types, excluding a predominant contribution of endoplasmic reticulum or calcineurin. These results provide additional insight into the mechanisms of striatal vulnerability, showing that the increased Ca2+ vulnerability of striatal versus cortical mitochondria resides in both intact neurons and astrocytes, thus positioning the striatum at greater risk for disturbed neuron-astrocyte interactions. Also, the selective effect of CsA over striatal astrocytes suggests that in vivo neuronal sheltering with this compound may indirectly result from astrocytic protection.	[Oliveira, Jorge M. A.; Goncalves, Jorge] Univ Porto, Fac Farm, Serv Farmacol, REQUIMTE, P-4050047 Oporto, Portugal	Universidade do Porto	Oliveira, JMA (corresponding author), Univ Porto, Fac Farm, Serv Farmacol, REQUIMTE, Rua Anibal Cunha 164, P-4050047 Oporto, Portugal.	jorgemao@ff.up.pt	Goncalves, Jorge MM/X-4629-2018; Gonçalves, Jorge/E-1726-2013; REQUIMTE, PHYTO/M-4633-2013; Oliveira, Jorge M. A./D-4787-2013	Goncalves, Jorge MM/0000-0002-3045-2150; Gonçalves, Jorge/0000-0002-3045-2150; Oliveira, Jorge M. A./0000-0002-6040-5355				Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bambrick L, 2004, NEUROCHEM RES, V29, P601, DOI 10.1023/B:NERE.0000014830.06376.e6; Bambrick LL, 2006, J BIOENERG BIOMEMBR, V38, P43, DOI 10.1007/s10863-006-9004-7; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Brustovetsky N, 2003, J NEUROSCI, V23, P4858; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Calabresi P, 2000, NEUROLOGY, V55, P1249, DOI 10.1212/WNL.55.9.1249; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; Cho JH, 1997, BIOCHEM J, V324, P971, DOI 10.1042/bj3240971; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Dienel GA, 2005, GLIA, V50, P362, DOI 10.1002/glia.20157; Eliseev RA, 2007, NEUROBIOL AGING, V28, P1532, DOI 10.1016/j.neurobiolaging.2006.06.022; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; HAUGLAND RP, 2002, HDB FLUORESCENT PROB, P776; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Krieger C, 2002, EUR J PHARMACOL, V447, P177, DOI 10.1016/S0014-2999(02)01842-3; Kristian T, 2006, J NEUROSCI METH, V152, P136, DOI 10.1016/j.jneumeth.2005.08.018; Kristian T, 2002, J NEUROCHEM, V83, P1297, DOI 10.1046/j.1471-4159.2002.01238.x; Leventhal L, 2000, J COMP NEUROL, V425, P471, DOI 10.1002/1096-9861(20001002)425:4<471::AID-CNE1>3.0.CO;2-U; Li LJ, 2003, NEUROBIOL AGING, V24, P1113, DOI 10.1016/j.neurobiolaging.2003.04.003; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Makowska A, 2000, EUR J BIOCHEM, V267, P877, DOI 10.1046/j.1432-1327.2000.01066.x; McDonald JW, 1996, ANN NEUROL, V40, P750, DOI 10.1002/ana.410400511; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x; Oliveira JMA, 2006, J NEUROSCI, V26, P11174, DOI 10.1523/JNEUROSCI.3004-06.2006; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Smith R, 2005, CELL MOL LIFE SCI, V62, P1901, DOI 10.1007/s00018-005-5084-5; Sonnewald U, 1998, J CEREBR BLOOD F MET, V18, P231, DOI 10.1097/00004647-199803000-00001; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Ward MW, 2000, J NEUROSCI, V20, P7208; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Wokosin DL, 2004, BIOPHYS J, V86, P1726, DOI 10.1016/S0006-3495(04)74241-1	47	32	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5010	5020		10.1074/jbc.M807459200	http://dx.doi.org/10.1074/jbc.M807459200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106091	Green Published, hybrid			2022-12-27	WOS:000263416600031
J	Ray, S; Dutta, D; Rumi, MAK; Kent, LN; Soares, MJ; Paul, S				Ray, Soma; Dutta, Debasree; Rumi, M. A. Karim; Kent, Lindsey N.; Soares, Michael J.; Paul, Soumen			Context-dependent Function of Regulatory Elements and a Switch in Chromatin Occupancy between GATA3 and GATA2 Regulate Gata2 Transcription during Trophoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING PROTEIN; CELL-DIFFERENTIATION; GENE-EXPRESSION; STEM-CELLS; ERYTHROID-DIFFERENTIATION; PROLACTIN FAMILY; FACTOR INTERPLAY; THYROID-HORMONE; NERVOUS-SYSTEM; MICE LACKING	GATA transcription factors are important regulators of tissue-specific gene expression during development. GATA2 and GATA3 have been implicated in the regulation of trophoblast-specific genes. However, the regulatory mechanisms of GATA2 expression in trophoblast cells are poorly understood. In this study, we demonstrate that Gata2 is transcriptionally induced during trophoblast giant cell-specific differentiation. Transcriptional induction is associated with displacement of GATA3-dependent nucleoprotein complexes by GATA2-dependent nucleoprotein complexes at two regulatory regions, the -3.9- and +9.5-kb regions, of the mouse Gata2 locus. Analyses with reporter genes showed that, in trophoblast cells, -3.9- and +9.5-kb regions function as transcriptional enhancers in GATA motif independent and dependent fashions, respectively. We also found that knockdown of GATA3 by RNA interference induces GATA2 in undifferentiated trophoblast cells. Interestingly, three other known GATA motif-dependent Gata2 regulatory elements, the -1.8-, -2.8-, and -77-kb regions, which are important to regulate Gata2 in hematopoietic cells are not occupied by GATA factors in trophoblast cells. These elements do not show any enhancer activity and also possess inaccessible chromatin structure in trophoblast cells indicating a context-dependent function. Our results indicate that GATA3 directly represses Gata2 in undifferentiated trophoblast cells, and a switch in chromatin occupancy between GATA3 and GATA2 (GATA3/GATA2 switch) induces transcription during trophoblast differentiation. We predict that this GATA3/GATA2 switch is an important mechanism for the transcriptional regulation of other trophoblast-specific genes.	[Paul, Soumen] Univ Kansas, Med Ctr, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Div Canc & Dev Biol, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Paul, S (corresponding author), Univ Kansas, Med Ctr, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA.	spaul2@kumc.edu		Kent, Lindsey N./0000-0003-4990-8477	National Institutes of Health [P20 RRO24214, HD20676]; NIH/Kansas INBRE [P20 RRO16475]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD020676] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR024214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/Kansas INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants COBRE P20 RRO24214 and HD20676. This work was also supported by NIH/Kansas INBRE Grant P20 RRO16475. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ain R, 2003, DEV BIOL, V260, P176, DOI 10.1016/S0012-1606(03)00210-0; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Bresnick EH, 2005, J CELL PHYSIOL, V205, P1, DOI 10.1002/jcp.20393; Cheng YH, 2005, BIOL REPROD, V73, P500, DOI 10.1095/biolreprod.105.039941; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Cross JC, 2003, PLACENTA, V24, P123, DOI 10.1053/plac.2002.0887; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; FARIA TN, 1991, ENDOCRINOLOGY, V129, P2895, DOI 10.1210/endo-129-6-2895; Flavell RA, 1999, COLD SPRING HARB SYM, V64, P563, DOI 10.1101/sqb.1999.64.563; Follows GA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm108; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Gordon DF, 2006, MOL ENDOCRINOL, V20, P1073, DOI 10.1210/me.2005-0115; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Im Hogune, 2004, Methods Mol Biol, V284, P129; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; Kobayashi-Osaki M, 2005, MOL CELL BIOL, V25, P7005, DOI 10.1128/MCB.25.16.7005-7020.2005; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kurata H, 2002, J IMMUNOL, V168, P4538, DOI 10.4049/jimmunol.168.9.4538; Landles C, 2003, MOL ENDOCRINOL, V17, P2418, DOI 10.1210/me.2003-0097; Ma GT, 1997, DEVELOPMENT, V124, P907; Ma GT, 2000, BIOL REPROD, V63, P570, DOI 10.1095/biolreprod63.2.570; Martindill DMJ, 2007, NAT CELL BIOL, V9, P1131, DOI 10.1038/ncb1633; Martowicz ML, 2005, J BIOL CHEM, V280, P1724, DOI 10.1074/jbc.M406038200; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Minegishi N, 1999, BLOOD, V93, P4196, DOI 10.1182/blood.V93.12.4196.412k23_4196_4207; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Molkentin JD, 2000, MOL CELL BIOL, V20, P5256, DOI 10.1128/MCB.20.14.5256-5260.2000; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; NG YK, 1994, DEVELOPMENT, V120, P3257; ORLIC D, 1995, P NATL ACAD SCI USA, V92, P4601, DOI 10.1073/pnas.92.10.4601; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Peng LH, 2004, MOL ENDOCRINOL, V18, P2049, DOI 10.1210/me.2004-0028; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Sahgal N, 2006, METH MOLEC MED, V121, P159; Sahgal N, 2005, DIFFERENTIATION, V73, P452, DOI 10.1111/j.1432-0436.2005.00044.x; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Soares MJ, 2007, TRENDS ENDOCRIN MET, V18, P114, DOI 10.1016/j.tem.2007.02.005; STEGER DJ, 1994, MOL CELL BIOL, V14, P5592, DOI 10.1128/MCB.14.8.5592; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wiemers DO, 2003, ENDOCRINOLOGY, V144, P313, DOI 10.1210/en.2002-220724; Wozniak RJ, 2008, MOL CELL BIOL, V28, P6681, DOI 10.1128/MCB.01061-08; Wozniak RJ, 2007, J BIOL CHEM, V282, P14665, DOI 10.1074/jbc.M700792200; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200	58	54	55	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4978	4988		10.1074/jbc.M807329200	http://dx.doi.org/10.1074/jbc.M807329200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106099	hybrid, Green Published			2022-12-27	WOS:000263416600028
J	Huang, S; Ryan, RM; Vandenberg, RJ				Huang, Shiwei; Ryan, Renae M.; Vandenberg, Robert J.			The Role of Cation Binding in Determining Substrate Selectivity of Glutamate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; EXTRACELLULAR GATE; CHLORIDE CONDUCTANCE; HIGH-AFFINITY; ION; SODIUM; CHANNELS; HOMOLOG; FLUXES; EAAC1	Glutamate transport is coupled to the co-transport of 3Na(+) and 1H(+) and the countertransport of 1K(+). However, the mechanism of how this process occurs is not well understood. The crystal structure of an archaeal homolog of the human glutamate transporters, Glt(Ph), has provided the framework to begin to understand the mechanism of transport. The glutamate transporter EAAT2 is different from other subtypes in two respects. First, Li+ cannot support transport by EAAT2, whereas it can support transport by the other excitatory amino acid transporters, and second, EAAT2 is sensitive to a wider range of blockers than other subtypes. We have investigated the relationship between the cation driving transport and whether the glutamate analogues, L-anti-endo-3,4-methanopyrrolidine-dicarboxylic acid (MPDC) and (2S,4R)-4-methylglutamate (4MG), are substrates or blockers of transport. We have also investigated the molecular basis for these differences. EAAT2 has a Ser residue at position 441 with hairpin loop 2, whereas the corresponding residue in EAAT1 is a Gly residue. We demonstrate that if the transporter has a Ser residue at this position, then 4MG and MPDC are poor substrates in Na+, and Li+ cannot support transport of any substrate. Conversely, if the transporter has a Gly residue at this position, then in Na+ 4MG and MPDC are substrates with efficacy comparable with glutamate, but in Li+ 4MG and MPDC are poor substrates relative to glutamate. This Ser/Gly residue is located between the bound substrate and one of the cation binding sites, which provides an explanation for the coupling of substrate and cation binding.	[Huang, Shiwei; Ryan, Renae M.; Vandenberg, Robert J.] Univ Sydney, Transporter Biol Grp, Discipline Pharmacol, Sch Med Sci,Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney	Huang, S (corresponding author), Univ Sydney, Transporter Biol Grp, Discipline Pharmacol, Sch Med Sci,Bosch Inst, Sydney, NSW 2006, Australia.		Vandenberg, Robert John/E-6018-2016; Ryan, Renae/AAC-3540-2021	Vandenberg, Robert John/0000-0003-1523-4814; Ryan, Renae/0000-0002-8680-4610	Australian National Health and Medical Research Council (NHMRC); University of Sydney; NHMRC	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian National Health and Medical Research Council (NHMRC) project grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a University of Sydney postgraduate award.; Supported by an NHMRC C. J. Martin Fellowship.; Supported by an NHMRC Senior Research Fellowship.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Bridges RJ, 1999, CURR PHARM DESIGN, V5, P363; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Shimamoto K, 2007, MOL PHARMACOL, V71, P294, DOI 10.1124/mol.106.027250; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Vandenberg RJ, 1997, MOL PHARMACOL, V51, P809, DOI 10.1124/mol.51.5.809; Vandenberg RJ, 1998, BRIT J PHARMACOL, V123, P1593, DOI 10.1038/sj.bjp.0701776; Vandenberg RJ, 2008, CHANNELS, V2, P51, DOI 10.4161/chan.2.1.6047; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	25	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4510	4515		10.1074/jbc.M808495200	http://dx.doi.org/10.1074/jbc.M808495200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074430	hybrid			2022-12-27	WOS:000263134400051
J	Shi, L; Jian, K; Ko, ML; Trump, D; Ko, GYP				Shi, Liheng; Jian, Kuihuan; Ko, Michael L.; Trump, Dorothy; Ko, Gladys Y. -P.			Retinoschisin, a New Binding Partner for L-type Voltage-gated Calcium Channels in the Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED RETINOSCHISIS; ARYLALKYLAMINE N-ACETYLTRANSFERASE; STATIONARY NIGHT BLINDNESS; CIRCADIAN REGULATION; CA2+ CHANNEL; JUVENILE RETINOSCHISIS; DEPENDENT FACILITATION; CONE PHOTORECEPTORS; CALMODULIN KINASE; BIPOLAR CELLS	The L-type voltage-gated calcium channels (L-VGCCs) are activated under high depolarization voltages. They are vital for diverse biological events, including cell excitability, differentiation, and synaptic transmission. In retinal photoreceptors, L-VGCCs are responsible for neurotransmitter release and are under circadian influences. However, the mechanism of L-VGCC regulation in photoreceptors is not fully understood. Here, we show that retinoschisin, a highly conserved extracellular protein, interacts with the L-VGCC alpha 1D subunit and regulates its activities in a circadian manner. Mutations in the gene encoding retinoschisin (RS1) cause retinal disorganization that leads to early onset of macular degeneration. Since ion channel activities can be modulated through interactions with extracellular proteins, disruption of these interactions can alter physiology and be the root cause of disease states. Co-immunoprecipitation and mammalian two-hybrid assays showed that retinoschisin and the N-terminal fragment of the L-VGCC alpha 1D subunit physically interacted with one another. The expression and secretion of retinoschisin are under circadian regulation with a peak at night and nadir during the day. Inhibition of L-type VGCCs decreased membrane-bound retinoschisin at night. Overexpression of a missense RS1 mutant gene, R141G, into chicken cone photoreceptors caused a decrease of L-type VGCC currents at night. Our findings demonstrate a novel bidirectional relationship between an ion channel and an extracellular protein; L-type VGCCs regulate the circadian rhythm of retinoschisin secretion, whereas secreted retinoschisin feeds back to regulate L-type VGCCs. Therefore, physical interactions between L-VGCC alpha 1D subunits and retinoschisin play an important role in the membrane retention of L-VGCC alpha 1D subunits and photoreceptor-bipolar synaptic transmission.	[Shi, Liheng; Jian, Kuihuan; Ko, Michael L.; Ko, Gladys Y. -P.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Trump, Dorothy] Univ Manchester, Fac Med & Hlth Sci, Med Genet Res Grp, Manchester M13 9PT, Lancs, England; [Trump, Dorothy] Univ Manchester, Fac Med & Hlth Sci, Ctr Mol Med, Manchester M13 9PT, Lancs, England	Texas A&M University System; Texas A&M University College Station; University of Manchester; University of Manchester	Ko, GYP (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, Mail Stop 4458, College Stn, TX 77843 USA.	gko@cvm.tamu.edu	Tuluc, Petronel/C-2527-2011; Jian, Kuihuan/C-3646-2012		National Institutes of Health [NIHRO1EY017452, S10RR022532, P42ES004917, P30ES009106]; Department of Veterinary Integrative Bioscience Programmatic Development Minigrant; Texas AM University; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022532] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004917, P30ES009106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterinary Integrative Bioscience Programmatic Development Minigrant; Texas AM University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NEI Grant NIHRO1EY017452 (to G.Y.-P.K.). This work was also supported by a Department of Veterinary Integrative Bioscience Programmatic Development Minigrant (to G.Y.-P.K.) and the start-up fund from Texas A&M University (to G.Y.-P.K.). The Image Analysis Laboratory has been supported in part by National Institutes of Health Grants S10RR022532, P42ES004917, and P30ES009106. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Bradshaw K, 2004, DOC OPHTHALMOL, V108, P135, DOI 10.1023/B:DOOP.0000036786.22179.44; CAHILL GM, 1995, PROG RETIN EYE RES, V14, P267, DOI 10.1016/1350-9462(94)00001-Y; Chae KS, 2005, J NEUROCHEM, V94, P367, DOI 10.1111/j.1471-4159.2005.03201.x; Dzhura I, 2003, J PHYSIOL-LONDON, V550, P731, DOI 10.1113/jphysiol.2003.043778; Dzhura I, 2002, J PHYSIOL-LONDON, V545, P399, DOI 10.1113/jphysiol.2002.021881; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Evers MR, 2002, J NEUROSCI, V22, P7177; Gehrig A, 1999, J MED GENET, V36, P932; GLEASON E, 1992, VISUAL NEUROSCI, V8, P315, DOI 10.1017/S0952523800005058; Grayson C, 2000, HUM MOL GENET, V9, P1873, DOI 10.1093/hmg/9.12.1873; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Gui PC, 2006, J BIOL CHEM, V281, P14015, DOI 10.1074/jbc.M600433200; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hull C, 2006, J NEUROPHYSIOL, V96, P2025, DOI 10.1152/jn.00364.2006; Ivanova TN, 2003, BRAIN RES, V973, P56, DOI 10.1016/S0006-8993(03)02540-X; Ivanova TN, 2003, BRAIN RES, V991, P96, DOI 10.1016/j.brainres.2003.08.003; Ko GYP, 2004, BRAIN RES, V1021, P277, DOI 10.1016/j.brainres.2004.05.072; Ko GYP, 2004, J NEUROSCI, V24, P1296, DOI 10.1523/JNEUROSCI.3560-03.2004; Ko GYP, 2003, J NEUROSCI, V23, P3145; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; Ko ML, 2008, INVEST OPHTH VIS SCI, V49, P1615, DOI 10.1167/iovs.07-1189; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; Molday LL, 2007, J BIOL CHEM, V282, P32792, DOI 10.1074/jbc.M706321200; Molday LL, 2001, INVEST OPHTH VIS SCI, V42, P816; Molday RS, 2007, EXP EYE RES, V84, P227, DOI 10.1016/j.exer.2005.12.013; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Norris CM, 2002, NEUROSCIENCE, V110, P213, DOI 10.1016/S0306-4522(01)00574-7; Reid SNM, 1999, GENE, V227, P257, DOI 10.1016/S0378-1119(98)00578-2; Reid SNM, 2005, GLIA, V49, P397, DOI 10.1002/glia.20131; Reid SNM, 2003, J NEUROSCI, V23, P6030, DOI 10.1523/JNEUROSCI.23-14-06030.2003; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Takada Y, 2004, INVEST OPHTH VIS SCI, V45, P3302, DOI 10.1167/iovs.04-0156; Takada Y, 2006, MOL VIS, V12, P1108; Tantri A, 2004, SURV OPHTHALMOL, V49, P214, DOI 10.1016/j.survophthal.2003.12.007; Waitkus-Edwards KR, 2002, CIRC RES, V90, P473, DOI 10.1161/hh0402.105899; Wang T, 2006, BRIT J OPHTHALMOL, V90, P81, DOI 10.1136/bjo.2005.078048; Wang T, 2002, HUM MOL GENET, V11, P3097, DOI 10.1093/hmg/11.24.3097; Wu WWH, 2005, J BIOL CHEM, V280, P10721, DOI 10.1074/jbc.M413117200; Wu X, 2001, J BIOL CHEM, V276, P30285, DOI 10.1074/jbc.M102436200; Zeng Y, 2004, INVEST OPHTH VIS SCI, V45, P3279, DOI 10.1167/iovs.04-0576	45	38	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3966	3975		10.1074/jbc.M806333200	http://dx.doi.org/10.1074/jbc.M806333200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074145	hybrid, Green Published			2022-12-27	WOS:000262872500065
J	Meyer, D; Seth, S; Albrecht, J; Maier, MK; du Pasquier, L; Ravens, I; Dreyer, L; Burger, R; Gramatzki, M; Schwinzer, R; Kremmer, E; Foerster, R; Bernhardt, G				Meyer, Dorothee; Seth, Sebastian; Albrecht, Jana; Maier, Michael K.; du Pasquier, Louis; Ravens, Inga; Dreyer, Lutz; Burger, Renate; Gramatzki, Martin; Schwinzer, Reinhard; Kremmer, Elisabeth; Foerster, Reinhold; Bernhardt, Guenter			CD96 Interaction with CD155 via Its First Ig-like Domain Is Modulated by Alternative Splicing or Mutations in Distal Ig-like Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; CELL-ADHESION; IMMUNOGLOBULIN SUPERFAMILY; POLIOVIRUS RECEPTOR; MOLECULAR-CLONING; IDENTIFICATION; MEMBER; EXPRESSION; MIGRATION	The adhesion receptor CD96 (TACTILE) is a transmembrane glycoprotein possessing three extracellular immunoglobulin-like domains. Among peripheral blood cells, CD96 is expressed on T cells as well as NK cells and a subpopulation of B cells. A possible function of this receptor in NK cell-mediated killing activities was suggested recently. Moreover, CD96 was described as a tumor marker for T-cell acute lymphoblastic leukemia and acute myeloid leukemia. CD96 binds to CD155 (poliovirus receptor) and nectin-1, an adhesion receptor related to CD155. Here we report that human but not mouse CD96 is expressed in two splice variants possessing either an I-like (variant 1) or V-like (variant 2) second domain. With the notable exception of an AML tumor sample, variant 2 predominates in all the CD96-expressing cell types and tissues examined. Using chimeric human/murine CD96 receptors, we show that the interaction with its ligands is mediated via the outermost V-like domain. In contrast to mouse, however, the binding of human CD96 to CD155 is sensitive to the characteristics of the two downstream domains. This is illustrated by a significantly weaker CD96/CD155 interaction mediated by variant 1 when compared with variant 2. Moreover, recent evidence suggested that mutations in human CD96 correlate with the occurrence of a rare form of trigonocephaly. One such mutation causing a single amino acid exchange in the third domain of human CD96 decreased the capacity of both variants to bind to CD155 considerably, suggesting that a CD96-driven adhesion to CD155 may be crucial in developmental processes.	[Meyer, Dorothee; Seth, Sebastian; Albrecht, Jana; Maier, Michael K.; Ravens, Inga; Dreyer, Lutz; Foerster, Reinhold; Bernhardt, Guenter] Hannover Med Sch, Inst Immunol, Dept Visceral & Transplantat Surg, D-30625 Hannover, Germany; [Schwinzer, Reinhard] Hannover Med Sch, Transplantat Lab, Dept Visceral & Transplantat Surg, D-30625 Hannover, Germany; [du Pasquier, Louis] Univ Basel, Inst Zool & Evolutionary Biol, CH-4051 Basel, Switzerland; [Burger, Renate; Gramatzki, Martin] Univ Med Ctr SH Campus Kiel, Div Stem Cell Transplantat & Immunotherapy, Dept Med 2, D-24105 Kiel, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	Hannover Medical School; Hannover Medical School; University of Basel; University of Kiel; Schleswig Holstein University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Bernhardt, G (corresponding author), Hannover Med Sch, Inst Immunol, Dept Visceral & Transplantat Surg, Carl Neuberg Str 1, D-30625 Hannover, Germany.	bernhardt.guenter@mh-hannover.de	Bernhardt, Günter/F-6946-2012; Gramatzki, Martin/A-9533-2010; Burger, Renate/A-9615-2010; Förster, Reinhold/D-6770-2011	Bernhardt, Günter/0000-0002-0510-2853; Forster, Reinhold/0000-0001-6190-7923; Dreyer, Lutz/0000-0003-4380-890X	Deutsche Forschungsgemeinschaft [BE1886/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft Grant BE1886/2-1 (to G. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BERNHARDT G, 1994, VIROLOGY, V203, P344, DOI 10.1006/viro.1994.1493; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Cannon JP, 2004, CURR BIOL, V14, pR465, DOI 10.1016/j.cub.2004.06.009; Cario G, 2007, J CLIN ONCOL, V25, P4813, DOI 10.1200/JCO.2007.11.8166; Chambers CA, 2001, TRENDS IMMUNOL, V22, P217, DOI 10.1016/S1471-4906(01)01868-3; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Du Pasquier L, 2004, IMMUNOL REV, V198, P233, DOI 10.1111/j.0105-2896.2004.00122.x; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Gramatzki M, 1998, EXP HEMATOL, V26, P1209; Hollyoake M, 2005, MOL BIOL EVOL, V22, P1661, DOI 10.1093/molbev/msi162; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Inagaki M, 2005, DEVELOPMENT, V132, P1525, DOI 10.1242/dev.01697; Kaname T, 2007, AM J HUM GENET, V81, P835, DOI 10.1086/522014; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Neville MJ, 1999, J IMMUNOL, V162, P4745; NOBIS P, 1985, J GEN VIROL, V66, P2563, DOI 10.1099/0022-1317-66-12-2563; Ravens I, 2003, BIOCHEM BIOPH RES CO, V312, P1364, DOI 10.1016/j.bbrc.2003.11.067; Rozsnyay Z, 1999, IMMUNOL LETT, V68, P101, DOI 10.1016/S0165-2478(99)00037-1; Seth S, 2007, BIOCHEM BIOPH RES CO, V364, P959, DOI 10.1016/j.bbrc.2007.10.102; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; WANG PL, 1992, J IMMUNOL, V148, P2600; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887	26	52	57	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2235	2244		10.1074/jbc.M807698200	http://dx.doi.org/10.1074/jbc.M807698200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19056733	hybrid			2022-12-27	WOS:000262545600033
J	Sussman, R				Sussman, Raquel			Serendipity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							STRAND BINDING-PROTEIN; PHAGE LAMBDA-REPRESSOR; CELLULAR SLIME MOULD; ESCHERICHIA-COLI; RECA-PROTEIN; BACTERIOPHAGE-LAMBDA; DICTYOSTELIUM-DISCOIDEUM; DEOXYRIBONUCLEIC-ACID; PROTEOLYTIC CLEAVAGE; DNA		Univ Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sussman, R (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	rsussman@mbl.edu						BALUCH J, 1980, MOL GEN GENET, V178, P317, DOI 10.1007/BF00270478; BALUCH J, 1980, J BACTERIOL, V144, P489, DOI 10.1128/JB.144.2.489-498.1980; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; COHEN SP, 1983, J MOL BIOL, V167, P901, DOI 10.1016/S0022-2836(83)80119-3; GILLESPIE D, 1965, J MOL BIOL, V12, P829, DOI 10.1016/S0022-2836(65)80331-X; HERSHEY AD, 1949, GENETICS, V34, P44; HERSHEY AD, 1948, P NATL ACAD SCI USA, V34, P89, DOI 10.1073/pnas.34.3.89; JACOB F, 1962, CR HEBD ACAD SCI, V254, P4214; KAPLAN JC, 1969, P NATL ACAD SCI USA, V63, P144, DOI 10.1073/pnas.63.1.144; KIHO Y, 1964, P NATL ACAD SCI USA, V51, P111, DOI 10.1073/pnas.51.1.111; KRAMER FR, 1974, J MOL BIOL, V89, P719, DOI 10.1016/0022-2836(74)90047-3; Luria SE, 1943, GENETICS, V28, P491; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; PHILLIPS WD, 1964, BIOCHIM BIOPHYS ACTA, V80, P508, DOI 10.1016/0926-6550(64)90155-0; PTASHNE M, 1967, P NATL ACAD SCI USA, V57, P306, DOI 10.1073/pnas.57.2.306; RESNICK J, 1982, NUCLEIC ACIDS RES, V10, P5239, DOI 10.1093/nar/10.17.5239; RESNICK J, 1982, P NATL ACAD SCI-BIOL, V79, P2832, DOI 10.1073/pnas.79.9.2832; ROBERTS JW, 1977, P NATL ACAD SCI USA, V74, P2283, DOI 10.1073/pnas.74.6.2283; ROTMAN R, 1944, THESIS U CHILE; SATO G, 1957, SCIENCE, V126, P961, DOI 10.1126/science.126.3280.961; SPIEGELMAN S, 1950, P NATL ACAD SCI USA, V36, P591, DOI 10.1073/pnas.36.11.591; STANLEY W. M., 1935, SCIENCE, V81, P644, DOI 10.1126/science.81.2113.644; SUSSMAN M, 1955, J GEN MICROBIOL, V13, P295, DOI 10.1099/00221287-13-2-295; SUSSMAN M, 1954, J GEN MICROBIOL, V10, P110, DOI 10.1099/00221287-10-1-110; SUSSMAN M, 1966, P NATL ACAD SCI USA, V55, P813, DOI 10.1073/pnas.55.4.813; SUSSMAN M., 1961, EXPTL CELL RES SUPPL, V8, P91, DOI 10.1016/0014-4827(61)90342-1; SUSSMAN M, 1951, J EXP ZOOL, V118, P407, DOI 10.1002/jez.1401180303; SUSSMAN M, 1956, 14TH GROWTH S, P125; SUSSMAN R, 1978, P NATL ACAD SCI USA, V75, P5817, DOI 10.1073/pnas.75.12.5817; SUSSMAN R, 1975, P NATL ACAD SCI USA, V72, P1973, DOI 10.1073/pnas.72.5.1973; SUSSMAN R, 1962, CR HEBD ACAD SCI, V254, P1517; SUSSMAN R, 1962, J GEN MICROBIOL, V30, P349; SUSSMAN R, 1961, EXP CELL RES, V23, P154; Sussman R, 2008, CELL CYCLE, V7, P89, DOI 10.4161/cc.7.1.5109; SUSSMAN RR, 1953, ANN NY ACAD SCI, V56, P949, DOI 10.1111/j.1749-6632.1953.tb30274.x; SUSSMAN RR, 1960, DEV BIOL, V2, P367, DOI 10.1016/0012-1606(60)90022-1; SUSSMAN RR, 1960, J GEN MICROBIOL, V23, P287, DOI 10.1099/00221287-23-2-287; SUSSMAN RR, 1967, BIOCHIM BIOPHYS ACTA, V149, P407, DOI 10.1016/0005-2787(67)90169-4; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984; WINGE O., 1948, COMPT REND TRAV LAB CARLSBERG [COPENHAGEN SER PHYSIOL], V24, P263; WITKIN EM, 1967, P NATL ACAD SCI USA, V57, P1275, DOI 10.1073/pnas.57.5.1275; Yano KI, 1997, P NATL ACAD SCI USA, V94, P1721, DOI 10.1073/pnas.94.5.1721	42	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10285	10290		10.1074/jbc.X800013200	http://dx.doi.org/10.1074/jbc.X800013200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19075011	hybrid, Green Published			2022-12-27	WOS:000265104600001
J	Duan, XY; Yang, Y; Chen, YH; Arenz, J; Rangi, GK; Zhao, XL; Ye, H				Duan, Xinyuan; Yang, Yan; Chen, Yu-Hung; Arenz, Jacqueline; Rangi, Gurdish K.; Zhao, Xiaolan; Ye, Hong			Architecture of the Smc5/6 Complex of Saccharomyces cerevisiae Reveals a Unique Interaction between the Nse5-6 Subcomplex and the Hinge Regions of Smc5 and Smc6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; DNA-REPAIR COMPLEX; SUMO LIGASE; YEAST; CHROMOSOME; PROTEINS; DAMAGE; SEGREGATION; COMPONENT; KLEISIN	The evolutionarily conserved structural maintenance of chromosome (SMC) proteins forms the core structures of three multisubunit complexes as follows: cohesin, condensin, and the Smc5/6 complex. These complexes play crucial roles in different aspects of chromosomal organization, duplication, and segregation. Although the architectures of cohesin and condensin are better understood, that of the more recently identified Smc5/6 complex remains to be elucidated. We have previously shown that the Smc5/6 complex of Saccharomyces cerevisiae contains Smc5, Smc6, and six non-SMC elements (Nse1-6). In this study, we investigated the architecture of the budding yeast Smc5/6 complex employing the yeast two-hybrid assay as well as in vitro biochemical approaches using purified recombinant proteins. These analyses revealed that Smc5 and Smc6 associate with each other at their hinge regions and constitute the backbone of the complex, whereas the Nse1-6 subunits form three distinct subcomplexes/entities that interact with different regions of Smc5 and Smc6. The Nse1, -3, and -4 subunits form a stable subcomplex that binds to the head and the adjacent coiled-coil region of Smc5. Nse2 binds to the middle of the coiled-coil region of Smc5. Nse5 and Nse6 interact with each other and, as a heterodimer, bind to the hinge regions of Smc5 and Smc6. These findings provide new insights into the structures of the Smc5/6 complex and lay the foundation for further investigations into the mechanism of its functions.	[Yang, Yan; Chen, Yu-Hung; Arenz, Jacqueline; Zhao, Xiaolan] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Duan, Xinyuan; Rangi, Gurdish K.; Ye, Hong] Univ Louisville, James Graham Brown Canc Ctr, Sch Med, Louisville, KY 40202 USA; [Chen, Yu-Hung] Cornell Univ, Grad Sch Med Sci, Program Biochem, New York, NY 10021 USA; [Chen, Yu-Hung] Cornell Univ, Grad Sch Med Sci, Program Cell, New York, NY 10021 USA; [Chen, Yu-Hung] Cornell Univ, Grad Sch Med Sci, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; University of Louisville; Cornell University; Cornell University; Cornell University	Zhao, XL (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA.	zhaox1@mskcc.org; hong.ye@louisville.edu		Zhao, Xiaolan/0000-0002-8302-6905	National Institutes of Health [R01GM079516, R01GM080670]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080670, R01GM079516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM079516 (toH.Y.), R01GM080670 (to X.Z.), and 5P20 RR 018733 ( Center of Biomedical Research Excellence in Molecular Targets grant to the James Graham Brown Cancer Center at the University of Louisville in Kentucky). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Beasley M, 2002, GENOME RES, V12, P1201, DOI 10.1101/gr107302; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Cobbe N, 2004, MOL BIOL EVOL, V21, P332, DOI 10.1093/molbev/msh023; Cost GJ, 2006, GENETICS, V172, P2185, DOI 10.1534/genetics.105.053876; Golemis E A, 1997, Methods Mol Biol, V63, P197; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hu B, 2005, MOL MICROBIOL, V55, P1735, DOI 10.1111/j.1365-2958.2005.04531.x; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Lee KM, 2006, DNA REPAIR, V5, P138, DOI 10.1016/j.dnarep.2005.08.003; Lehmann AR, 2005, DNA REPAIR, V4, P309, DOI 10.1016/j.dnarep.2004.07.009; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Palecek J, 2006, J BIOL CHEM, V281, P36952, DOI 10.1074/jbc.M608004200; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; Strom L, 2007, CURR OPIN CELL BIOL, V19, P344, DOI 10.1016/j.ceb.2007.04.003; Taylor EM, 2008, MOL CELL BIOL, V28, P1197, DOI 10.1128/MCB.00767-07; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	30	67	67	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8507	8515		10.1074/jbc.M809139200	http://dx.doi.org/10.1074/jbc.M809139200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19141609	hybrid, Green Published			2022-12-27	WOS:000264397800035
J	Hou, R; Sibinga, NES				Hou, Rong; Sibinga, Nicholas E. S.			Atrophin Proteins Interact with the Fat1 Cadherin and Regulate Migration and Orientation in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PATHWAY; HISTONE DEACETYLASE; PROTOCADHERIN FAT1; ACTIN DYNAMICS; GENE FAT; DROSOPHILA; GROWTH; TRANSCRIPTION; MORPHOGENESIS; PROLIFERATION	Fat1, an atypical cadherin induced robustly after arterial injury, has significant effects on mammalian vascular smooth muscle cell (VSMC) growth and migration. The related Drosophila protein Fat interacts genetically and physically with Atrophin, a protein essential for development and control of cell polarity. We hypothesized that interactions between Fat1 and mammalian Atrophin (Atr) proteins might contribute to Fat1 effects on VSMCs. Like Fat1, mammalian Atr expression increased after arterial injury and in VSMCs stimulated with growth and chemotactic factors including angiotensin II, basic fibroblast growth factor, and platelet-derived growth factor BB. Two distinct Atr2 transcripts, atr2L and atr2S, were identified by Northern analysis; in VSMCs, atr2S mRNA expression was more responsive to stimuli. By immunocytochemistry, Fat1 and Atrs colocalized at cell-cell junctions, in the perinuclear area, and in the nucleus. In coimmunoprecipitation studies, Fat1 interacted with both Atr1 and Atr2; these interactions required Fat1 amino acids 4300-4400 and an intact Atro-box in the Atrs. Knock-down of Atrs by small interfering RNA did not affect VSMC growth but had complex effects on migration, which was impaired by Atr1 knockdown, enhanced by Atr2 L knockdown, and unchanged when both Atr2S and Atr2L were depleted. Enhanced migration caused by Atr2L knockdown required Fat1 expression. Similarly, orientation of cells after monolayer denudation was impaired in cells with Atr1 knockdown but enhanced in cells selectively depleted of Atr2L. Together these findings suggest that Fat1 and Atrs act in concert after vascular injury but show further that distinct Atr isoforms have disparate effects on VSMC directional migration.	[Sibinga, Nicholas E. S.] Albert Einstein Coll Med, Dept Med, Div Cardiovasc, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Sibinga, NES (corresponding author), Albert Einstein Coll Med, Dept Med, Div Cardiovasc, Forchheimer G46,1300 Morris Pk Ave, Bronx, NY 10461 USA.	nsibinga@aecom.yu.edu	Sibinga, Nicholas/GOJ-8544-2022	Sibinga, Nicholas/0000-0003-4838-910X	NATIONAL CANCER INSTITUTE [R01CA086289] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088104, R01HL067944] Funding Source: NIH RePORTER; NCI NIH HHS [CA086289] Funding Source: Medline; NHLBI NIH HHS [R01 HL088104, HL67944] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Braun GS, 2007, J BIOL CHEM, V282, P22823, DOI 10.1074/jbc.M701758200; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Castillejo-Lopez C, 2004, J BIOL CHEM, V279, P24034, DOI 10.1074/jbc.M313878200; Charroux B, 2006, DEV BIOL, V291, P278, DOI 10.1016/j.ydbio.2005.12.012; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Erkner A, 2002, DEVELOPMENT, V129, P1119; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Khan FA, 1996, NEUROBIOL DIS, V3, P121, DOI 10.1006/nbdi.1996.0012; Magg T, 2005, EXP CELL RES, V307, P100, DOI 10.1016/j.yexcr.2005.03.006; MAJESKY MW, 1992, CIRC RES, V71, P759, DOI 10.1161/01.RES.71.4.759; Matsui S, 2008, J DERMATOL SCI, V51, P207, DOI 10.1016/j.jdermsci.2008.04.006; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; Plaster N, 2007, DEV DYNAM, V236, P1891, DOI 10.1002/dvdy.21196; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; Shen YG, 2007, J BIOL CHEM, V282, P5037, DOI 10.1074/jbc.M610274200; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Tanoue T, 2005, J CELL SCI, V118, P2347, DOI 10.1242/jcs.02398; Tanoue T, 2004, J CELL BIOL, V165, P517, DOI 10.1083/jcb.200403006; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Tyler DM, 2007, DEV BIOL, V305, P187, DOI 10.1016/j.ydbio.2007.02.004; Waerner T, 2001, CELL GROWTH DIFFER, V12, P201; Wang L, 2006, GENE DEV, V20, P525, DOI 10.1101/gad.1393506; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Wood JD, 2000, J CELL BIOL, V150, P939, DOI 10.1083/jcb.150.5.939; Zhang CL, 2006, GENE DEV, V20, P1308, DOI 10.1101/gad.1413606; Zhang S, 2002, CELL, V108, P45, DOI 10.1016/S0092-8674(01)00630-4; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	37	33	40	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6955	6965		10.1074/jbc.M809333200	http://dx.doi.org/10.1074/jbc.M809333200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131340	Green Published, hybrid			2022-12-27	WOS:000263919000043
J	Lichti-Kaiser, K; Xu, CS; Staudinger, JL				Lichti-Kaiser, Kristin; Xu, Chenshu; Staudinger, Jeff L.			Cyclic AMP-dependent Protein Kinase Signaling Modulates Pregnane x Receptor Activity in a Species-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE-ANDROSTANE RECEPTOR; CYP3A4 GENE-EXPRESSION; NUCLEAR RECEPTORS; CROSS-TALK; MEDIATED INDUCTION; DRUG-INTERACTIONS; METABOLISM; PATHWAYS; MOUSE; CAMP	Pregnane x receptor is a ligand-activated transcription factor that regulates drug-inducible expression of several key cytochrome P450 enzymes and drug transporter proteins in liver and intestine in a species-specific manner. Activation of this receptor modulates several key biochemical pathways, including gluconeogenesis, beta-oxidation of fatty acids, fatty acid uptake, cholesterol homeostasis, and lipogenesis. It is of current interest to determine whether the interaction between pregnane x receptor and these key biochemical pathways is evolutionarily conserved. We show here that activation of the cyclic AMP-dependent protein kinase signaling pathway synergizes with pregnane x receptor-mediated gene activation in mouse hepatocytes. Conversely, cyclic AMP-dependent protein kinase signaling has a repressive effect upon pregnane x receptor-mediated gene activation in rat and human hepatocytes. We show that the human pregnane x receptor protein can serve as an effective substrate for catalytically active cyclic AMP-dependent protein kinase in vitro. Metabolic labeling of the protein in vivo indicates that human pregnane x receptor exists as a phosphoprotein and that activation of cyclic AMP-dependent protein kinase signaling modulates the phosphorylation status of pregnane x receptor. Activation of cyclic AMP-dependent protein kinase signaling also modulates the interactions of pregnane x receptor with protein cofactors. Our results define the species-specific impact of cyclic AMP-dependent protein kinase signaling on pregnane x receptor and provide a molecular explanation of cyclic AMP-dependent protein kinase-mediated repression of human pregnane x receptor activity. Taken together, our results identify a novel mode of regulation of pregnane x receptor activity and highlight prominent functional differences in the process across species.	[Lichti-Kaiser, Kristin; Xu, Chenshu; Staudinger, Jeff L.] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA	University of Kansas	Staudinger, JL (corresponding author), Univ Kansas, Dept Pharmacol & Toxicol, 1251Wescoe Hall Dr,5044 Malott Hall, Lawrence, KS 66045 USA.	stauding@ku.edu	Xu, Chenshu/F-7864-2014		National Institutes of Health [R01-DK068443]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK068443.	Aitken AE, 2006, ANNU REV PHARMACOL, V46, P123, DOI 10.1146/annurev.pharmtox.46.120604.141059; BEAVO JA, 1974, P NATL ACAD SCI USA, V71, P3580, DOI 10.1073/pnas.71.9.3580; Brobst DE, 2004, J PHARMACOL EXP THER, V310, P528, DOI 10.1124/jpet.103.064329; Ding XS, 2005, BIOCHEM PHARMACOL, V69, P867, DOI 10.1016/j.bcp.2004.11.025; Ding XS, 2005, J PHARMACOL EXP THER, V312, P849, DOI 10.1124/jpet.104.076331; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Dowless MS, 2005, EUR J PHARMACOL, V512, P9, DOI 10.1016/j.ejphar.2005.02.022; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Galisteo M, 1999, J PHARMACOL EXP THER, V290, P1270; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Goodwin B, 2002, ANNU REV PHARMACOL, V42, P1, DOI 10.1146/annurev.pharmtox.42.111901.111051; Kim SK, 2007, PHARMACOL THERAPEUT, V113, P88, DOI 10.1016/j.pharmthera.2006.07.004; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Kodama S, 2006, DRUG METAB REV, V38, P75, DOI 10.1080/03602530600569851; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lichti-Kaiser K, 2008, DRUG METAB DISPOS, V36, P1538, DOI 10.1124/dmd.108.021774; Lin WW, 2008, J BIOL CHEM, V283, P30650, DOI 10.1074/jbc.M806132200; Ma X, 2007, DRUG METAB DISPOS, V35, P194, DOI 10.1124/dmd.106.012831; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Marc N, 2000, EUR J BIOCHEM, V267, P963, DOI 10.1046/j.1432-1327.2000.01083.x; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Moore LB, 2002, MOL ENDOCRINOL, V16, P977, DOI 10.1210/me.16.5.977; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Scheer N, 2008, J CLIN INVEST, V118, P3228, DOI 10.1172/JCI35483; SIDHU JS, 1995, J BIOL CHEM, V270, P12762, DOI 10.1074/jbc.270.21.12762; Sidhu JS, 1996, J PHARMACOL EXP THER, V276, P238; Staudinger JL, 2008, MOL PHARMACEUT, V5, P17, DOI 10.1021/mp700098c; Staudinger JL, 2003, DRUG METAB DISPOS, V31, P523, DOI 10.1124/dmd.31.5.523; Teng S, 2005, J PHARMACOL EXP THER, V312, P841, DOI 10.1124/jpet.104.076141; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	36	45	46	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6639	6649		10.1074/jbc.M807426200	http://dx.doi.org/10.1074/jbc.M807426200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19141612	Green Published, hybrid			2022-12-27	WOS:000263919000008
J	Pan, W; da Graca, LS; Shao, YF; Yin, Q; Wu, H; Jiang, XJ				Pan, Wei; da Graca, Li S.; Shao, Yufang; Yin, Qian; Wu, Hao; Jiang, Xuejun			PHAPI/pp32 Suppresses Tumorigenesis by Stimulating Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACIDIC NUCLEAR-PROTEIN; HISTONE ACETYLATION; NUCLEOTIDE EXCHANGE; CASPASE ACTIVATION; SERINE-PROTEASE; BCL-2 FAMILY; CELL-DEATH; PP32; IAP; INHIBITOR	PHAPI/pp32 is a tumor suppressor whose expression is altered in various human cancers. Although PHAPI possesses multiple biochemical activities, the molecular basis for its tumor-suppressive function has remained obscure. Recently we identified PHAPI as an apoptotic enhancer that stimulates apoptosome-mediated caspase activation. In this study, we defined the structural requirement for its activity to stimulate caspase activation using a series of truncation mutants of PHAPI. Further, utilizing these mutants, we provide evidence to support the model that the apoptotic activity of PHAPI is required for its tumor-suppressive capability. Consistently, pp32R1, a close homolog of PHAPI and yet an oncoprotein, is not able to stimulate caspase activation. Ahighly discrete region between these two proteins localizes to an essential caspase activation motif of PHAPI. Additionally, PHAPI is predominantly a nuclear protein, and it can translocate to the cytoplasm during apoptosis. Disruption of the nuclear localization signal of PHAPI caused a modest decrease of its tumor-suppressive function, indicating that nuclear localization of PHAPI contributes to, but is not essential for, tumor suppression.	[Pan, Wei; da Graca, Li S.; Shao, Yufang; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Yin, Qian; Wu, Hao; Jiang, Xuejun] Cornell Univ, Grad Sch Biomed Sci, Weill Med Coll, New York, NY 10021 USA; [Yin, Qian; Wu, Hao] Cornell Univ, Dept Biochem, Weill Med Coll, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 522, New York, NY 10021 USA.	jiangx@mskcc.org			NATIONAL CANCER INSTITUTE [R01CA113890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045937] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA113890] Funding Source: Medline; NIAID NIH HHS [R01 AI045937] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Adler HT, 1997, J BIOL CHEM, V272, P28407, DOI 10.1074/jbc.272.45.28407; Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Brody JR, 2007, MODERN PATHOL, V20, P1238, DOI 10.1038/modpathol.3800974; Brody JR, 1999, J BIOL CHEM, V274, P20053, DOI 10.1074/jbc.274.29.20053; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Fukukawa C, 2005, INT J ONCOL, V26, P751; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Hoffarth S, 2008, CELL DEATH DIFFER, V15, P161, DOI 10.1038/sj.cdd.4402256; Horvitz HR, 1999, CANCER RES, V59, p1701S; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Kadkol SS, 1999, NAT MED, V5, P275, DOI 10.1038/6488; Kadkol SS, 2001, BREAST CANCER RES TR, V68, P65, DOI 10.1023/A:1017919507109; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kim HE, 2008, MOL CELL, V30, P239, DOI 10.1016/j.molcel.2008.03.014; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Schafer ZT, 2006, CANCER RES, V66, P2210, DOI 10.1158/0008-5472.CAN-05-3923; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Ulitzur N, 1997, J BIOL CHEM, V272, P30577, DOI 10.1074/jbc.272.48.30577; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200	39	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6946	6954		10.1074/jbc.M805801200	http://dx.doi.org/10.1074/jbc.M805801200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19121999	Green Published, hybrid			2022-12-27	WOS:000263919000042
J	Cheng, HT; Megha; London, E				Cheng, Hui-Ting; Megha; London, Erwin			Preparation and Properties of Asymmetric Vesicles That Mimic Cell Membranes EFFECT UPON LIPID RAFT FORMATION AND TRANSMEMBRANE HELIX ORIENTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIQUID-ORDERED DOMAINS; GPI-ANCHORED PROTEINS; DETERGENT-RESISTANT; PHASE-TRANSITIONS; MODEL MEMBRANES; PHOSPHATIDYLCHOLINE VESICLES; FLUORESCENCE CORRELATION; TRANSBILAYER MOVEMENT; CHOLESTEROL; BILAYERS	A methyl-beta-cyclodextrin-induced lipid exchange technique was devised to prepare small unilamellar vesicles with stable asymmetric lipid compositions. Asymmetric vesicles that mimic biological membranes were prepared with sphingomyelin (SM) or SM mixed with 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) as the predominant lipids in the outer leaflet and dioleoylphosphatidylcholine (DOPC), POPC, 1-palmitoyl-2-oleoylphosphatidyl- L-serine (POPS), or POPS mixed with 1-palmitoyl2- oleoyl-phosphatidylethanolamine (POPE) in the inner leaflet. Fluorescence-based assays were developed to confirm lipid asymmetry. Cholesterol was introduced into these vesicles using a second methyl-beta-cyclodextrin exchange step. In asymmetric vesicles composed of SM outside, DOPC inside (SMo/DOPCi) or SM outside, 2:1 mol:mol POPE:POPS inside (SMo/2:1 POPE:POPSi) the outer leaflet SM formed an ordered state with a thermal stability similar to that in pure SM vesicles and significantly greater than that in symmetric vesicles with the same overall lipid composition. Analogous behavior was observed in vesicles containing cholesterol. This shows that an asymmetric lipid distribution like that in eukaryotic plasma membranes can be conducive to ordered domain (raft) formation. Furthermore asymmetric vesicles containing similar to 25 mol % cholesterol formed ordered domains more thermally stable than those in asymmetric vesicles lacking cholesterol, showing that the crucial ability of cholesterol to stabilize ordered domain formation is likely to contribute to ordered domain formation in cell membranes. Additional studies demonstrated that hydrophobic helix orientation is affected by lipid asymmetry with asymmetry favoring formation of the transmembrane configuration. The ability to form asymmetric vesicles represents an important improvement in model membrane studies and should find many applications in the future.	[Cheng, Hui-Ting; Megha; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Erwin.London@stonybrook.edu			National Institutes of Health [GM48596]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM48596. The costs of publication of this article were defrayed in part by the payment of page charges.	Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Anderson TG, 2004, BIOCHEMISTRY-US, V43, P2251, DOI 10.1021/bi0358869; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Ayuyan AG, 2008, BIOPHYS J, V94, P2654, DOI 10.1529/biophysj.107.118596; Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967; Bakht Omar, 2007, V398, P29, DOI 10.1007/978-1-59745-513-8_4; BARSUKOV LI, 1980, BIOCHIM BIOPHYS ACTA, V598, P153, DOI 10.1016/0005-2736(80)90273-4; BECK A, 1993, CHEM PHYS LIPIDS, V66, P135, DOI 10.1016/0009-3084(93)90038-5; Bjorkqvist YJE, 2005, BIOPHYS J, V88, P4054, DOI 10.1529/biophysj.104.054718; BLOJ B, 1981, MOL CELL BIOCHEM, V40, P163; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3275, DOI 10.1021/bi026697d; Chiantia S, 2006, CHEMPHYSCHEM, V7, P2409, DOI 10.1002/cphc.200600464; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; Collins MD, 2008, P NATL ACAD SCI USA, V105, P124, DOI 10.1073/pnas.0702970105; Crane JM, 2005, LANGMUIR, V21, P1377, DOI 10.1021/la047654w; Crane JM, 2004, BIOPHYS J, V86, P2965, DOI 10.1016/S0006-3495(04)74347-7; DAWIDOWICZ EA, 1976, BIOCHIM BIOPHYS ACTA, V455, P621, DOI 10.1016/0005-2736(76)90036-5; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Du H, 1998, PHOTOCHEM PHOTOBIOL, V68, P141, DOI 10.1562/0031-8655(1998)068<0141:PACADA>2.3.CO;2; EASTMAN SJ, 1991, BIOCHEMISTRY-US, V30, P1740, DOI 10.1021/bi00221a002; EVERETT J, 1986, J BIOL CHEM, V261, P6725; Fastenberg ME, 2003, BIOCHEMISTRY-US, V42, P12376, DOI 10.1021/bi034718d; Feigenson GW, 2001, BIOPHYS J, V80, P2775, DOI 10.1016/S0006-3495(01)76245-5; Fidorra M, 2006, BIOPHYS J, V90, P4437, DOI 10.1529/biophysj.105.077107; Fujita K, 2007, BIOCHEMISTRY-US, V46, P5185, DOI 10.1021/bi6024758; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7; HOPE MJ, 1989, BIOCHEMISTRY-US, V28, P4181, DOI 10.1021/bi00436a009; HUANG C, 1978, P NATL ACAD SCI USA, V75, P308, DOI 10.1073/pnas.75.1.308; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; Johnston I, 2008, BBA-BIOMEMBRANES, V1778, P185, DOI 10.1016/j.bbamem.2007.09.021; Kahya N, 2006, MOL MEMBR BIOL, V23, P29, DOI 10.1080/09687860500489099; Kaiser RD, 1998, BIOCHEMISTRY-US, V37, P8180, DOI 10.1021/bi980064a; Kiessling V, 2006, BIOPHYS J, V91, P3313, DOI 10.1529/biophysj.106.091421; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; KOYNOVA R, 1995, BBA-LIPID LIPID MET, V1255, P213, DOI 10.1016/0005-2760(94)00202-A; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; KOYNOVA R, 1994, CHEM PHYS LIPIDS, V69, P1, DOI 10.1016/0009-3084(94)90024-8; Krishnakumar SS, 2007, J MOL BIOL, V374, P671, DOI 10.1016/j.jmb.2007.09.037; Krishnakumar SS, 2007, J MOL BIOL, V374, P1251, DOI 10.1016/j.jmb.2007.10.032; LACOWICZ J, 1999, PRINCIPLES FLUORESCE, P298; LENTZ BR, 1976, BIOCHEMISTRY-US, V15, P4521, DOI 10.1021/bi00665a029; Lerch-Bader M, 2008, P NATL ACAD SCI USA, V105, P4127, DOI 10.1073/pnas.0711580105; Leventis R, 2001, BIOPHYS J, V81, P2257, DOI 10.1016/S0006-3495(01)75873-0; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; LONDON E, 1981, BIOCHIM BIOPHYS ACTA, V649, P89, DOI 10.1016/0005-2736(81)90012-2; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; LONDON E, 1978, ANAL BIOCHEM, V88, P203, DOI 10.1016/0003-2697(78)90412-8; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Malewicz B, 2005, BIOPHYS J, V88, P2670, DOI 10.1529/biophysj.104.057059; Megha M, 2006, J BIOL CHEM, V281, P21903, DOI 10.1074/jbc.M600395200; Nybond S, 2005, BBA-BIOMEMBRANES, V1718, P61, DOI 10.1016/j.bbamem.2005.10.009; Ottico E, 2003, J LIPID RES, V44, P2142, DOI 10.1194/jlr.M300247-JLR200; Pautot S, 2003, P NATL ACAD SCI USA, V100, P10718, DOI 10.1073/pnas.1931005100; PRENDERGAST FG, 1981, BIOCHEMISTRY-US, V20, P7333, DOI 10.1021/bi00529a002; Ramstedt B, 1999, EUR J BIOCHEM, V266, P997, DOI 10.1046/j.1432-1327.1999.00938.x; Ramstedt B, 2006, BBA-BIOMEMBRANES, V1758, P1945, DOI 10.1016/j.bbamem.2006.05.020; Ren JH, 1997, BIOCHEMISTRY-US, V36, P10213, DOI 10.1021/bi9709295; Rinia HA, 2001, FEBS LETT, V501, P92, DOI 10.1016/S0014-5793(01)02636-9; Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHMIDT CF, 1978, NATURE, V271, P775, DOI 10.1038/271775a0; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Shahidullah K, 2008, J MOL BIOL, V379, P704, DOI 10.1016/j.jmb.2008.04.026; Shaikh SR, 2004, BIOPHYS J, V87, P1752, DOI 10.1529/biophysj.104.044552; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Shogomori H, 2003, BIOL CHEM, V384, P1259, DOI 10.1515/BC.2003.139; Sohn HW, 2008, J IMMUNOL, V180, P793, DOI 10.4049/jimmunol.180.2.793; Sohn HW, 2006, P NATL ACAD SCI USA, V103, P8143, DOI 10.1073/pnas.0509858103; Sot J, 2006, BIOPHYS J, V90, P903, DOI 10.1529/biophysj.105.067710; SRIPADA PK, 1987, J LIPID RES, V28, P710; Tanhuanpaa K, 1999, J BIOL CHEM, V274, P35359, DOI 10.1074/jbc.274.50.35359; UNTRACHT SH, 1977, J BIOL CHEM, V252, P4449; Veatch SL, 2007, P NATL ACAD SCI USA, V104, P17650, DOI 10.1073/pnas.0703513104; Veatch SL, 2006, BIOPHYS J, V90, P4428, DOI 10.1529/biophysj.105.080283; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; Wang JW, 2004, BIOCHEMISTRY-US, V43, P1010, DOI 10.1021/bi035696y; Wang TY, 2000, BIOPHYS J, V79, P919, DOI 10.1016/S0006-3495(00)76347-8; Wang TY, 2001, BIOCHEMISTRY-US, V40, P13031, DOI 10.1021/bi0112311; Wang TY, 2001, BIOPHYS J, V81, P2762, DOI 10.1016/S0006-3495(01)75919-X; Wenz JJ, 2003, BIOCHEMISTRY-US, V42, P14267, DOI 10.1021/bi035759c; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200	90	130	130	2	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6079	6092		10.1074/jbc.M806077200	http://dx.doi.org/10.1074/jbc.M806077200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129198	hybrid, Green Published			2022-12-27	WOS:000263742700010
J	Deakin, JA; Blaum, BRRS; Gallagher, JT; Uhrin, D; Lyon, M				Deakin, Jon A.; Blaum, Baerbel S.; Gallagher, John T.; Uhrin, Dusan; Lyon, Malcolm			The Binding Properties of Minimal Oligosaccharides Reveal a Common Heparan Sulfate/Dermatan Sulfate-binding Site in Hepatocyte Growth Factor/Scatter Factor That Can Accommodate a Wide Variety of Sulfation Patterns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR SCATTER FACTOR; C-MET; FACTOR RECEPTOR; GLYCOSAMINOGLYCANS; DISTINCT; HGF/SF; DOMAIN; CELLS; NK1; PROLIFERATION	Heparan sulfate (HS)/heparin and dermatan sulfate (DS) both bind with high affinity to hepatocyte growth factor/scatter factor (HGF/SF) and function as necessary co-factors in vitro. How both these two structurally distinct glycosaminoglycans (GAGs) are recognized has remained unclear. We have now reconciled this issue using a panel of minimal tri- and tetrasaccharide sequences of variable but well defined sulfation patterns in combination with further development of the gel mobility shift assay to allow simultaneous comparisons of relative protein affinities/selectivities for different oligosaccharides. From this approach it would seem that a minimum binding sequence is a disulfated trisaccharide comprised of an internal iduronate flanked by monosulfated hexosamine residues and that additional sulfation further enhances affinity. However, the similarity in recognition of HS/heparin and DS seems to arise primarily from a lack of any apparent positional requirement for sulfation. Thus, isomers of HS/heparin tetrasaccharides containing only two sulfates irrespective of whether they are purely N-, 2-O-, or 6-O-sulfates bind with equivalent apparent affinity as a disulfated DS tetrasaccharide. In addition, the NMR chemical shifts induced in NK1 (the truncated variant of HGF/SF comprised of the N- terminal and first Kringle domains) by titration with either heparin or DS oligosaccharides strongly indicate that both bind to essentially the same site. Together, these observations reveal an unexpected degree of flexibility in the GAG-HGF/SF interface, allowing a single binding site in the protein to accommodate iduronate-containing sequences of variable sulfation pattern and/or density from different GAGs.	[Deakin, Jon A.; Gallagher, John T.; Lyon, Malcolm] Univ Manchester, Paterson Inst Canc Res, Sch Canc & Imaging Sci, Canc Res UK Glycooncol Grp, Manchester M20 4BX, Lancs, England; [Blaum, Baerbel S.; Uhrin, Dusan] Univ Edinburgh, Sch Chem, Edinburgh Biomol NMR Unit, Edinburgh EH9 3JJ, Midlothian, Scotland	Paterson Institute for Cancer Research; University of Manchester; University of Edinburgh	Lyon, M (corresponding author), Univ Manchester, Paterson Inst Canc Res, Sch Canc & Imaging Sci, Canc Res UK Glycooncol Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	MLyon@picr.man.ac.uk		Lyon, Malcolm/0000-0001-9575-6879; Blaum, Baerbel/0000-0003-4312-8912	Cancer Research UK Programme; EaStCHEM Studentship	Cancer Research UK Programme(Cancer Research UK); EaStCHEM Studentship	This work was supported by a Cancer Research UK Programme Grant (to J.A.D.,J.T.G., and M. L.) and an EaStCHEM Studentship (to B. S. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Bechard D, 2001, J BIOL CHEM, V276, P48341, DOI 10.1074/jbc.M108395200; Bevan D, 2004, J PATHOL, V203, P831, DOI 10.1002/path.1578; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; CASU B, 1988, TRENDS BIOCHEM SCI, V13, P221, DOI 10.1016/0968-0004(88)90088-6; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Deakin JA, 1999, J CELL SCI, V112, P1999; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Delehedde M, 2002, J BIOL CHEM, V277, P12456, DOI 10.1074/jbc.M111345200; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Gherardi E, 2003, P NATL ACAD SCI USA, V100, P12039, DOI 10.1073/pnas.2034936100; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Harris EN, 2008, GLYCOBIOLOGY, V18, P638, DOI 10.1093/glycob/cwn045; Hartmann G, 1998, CURR BIOL, V8, P125, DOI 10.1016/S0960-9822(98)70059-4; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; Jin L, 2005, PHYS CHEM CHEM PHYS, V7, P3464, DOI 10.1039/b508644b; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lietha D, 2001, EMBO J, V20, P5543, DOI 10.1093/emboj/20.20.5543; LUDWIGS U, 1987, BIOCHEM J, V245, P795, DOI 10.1042/bj2450795; Lyon M, 2004, J BIOL CHEM, V279, P43560, DOI 10.1074/jbc.M408510200; LYON M, 1994, J BIOL CHEM, V269, P11216; Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271; Lyon M, 2002, J BIOL CHEM, V277, P1040, DOI 10.1074/jbc.M107506200; LYON M, 2007, NEW DEV THERAPEUTIC, P317; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; MARK MR, 1992, J BIOL CHEM, V267, P26166; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; MIZUNO K, 1994, J BIOL CHEM, V269, P1131; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Rahmoune H, 1998, BIOCHEMISTRY-US, V37, P6003, DOI 10.1021/bi972468t; Raiber EA, 2007, BIOORG MED CHEM LETT, V17, P6321, DOI 10.1016/j.bmcl.2007.08.074; Raman R, 2003, P NATL ACAD SCI USA, V100, P2357, DOI 10.1073/pnas.0437842100; Rubin JS, 2001, J BIOL CHEM, V276, P32977, DOI 10.1074/jbc.M105486200; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Sergeant N, 2000, J BIOL CHEM, V275, P17094, DOI 10.1074/jbc.M000237200; THUNBERG L, 1982, CARBOHYD RES, V100, P393, DOI 10.1016/S0008-6215(00)81050-2; Tolbert WD, 2007, P NATL ACAD SCI USA, V104, P14592, DOI 10.1073/pnas.0704290104; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; van der Voort R, 1999, J BIOL CHEM, V274, P6499, DOI 10.1074/jbc.274.10.6499; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Zhou HJ, 1999, BIOCHEMISTRY-US, V38, P14793, DOI 10.1021/bi9908641	51	46	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6311	6321		10.1074/jbc.M807671200	http://dx.doi.org/10.1074/jbc.M807671200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19114710	hybrid			2022-12-27	WOS:000263742700034
J	Carta, L; Smaldone, S; Zilberberg, L; Loch, D; Dietz, HC; Rifkin, DB; Ramirez, F				Carta, Luca; Smaldone, Silvia; Zilberberg, Lior; Loch, David; Dietz, Harry C.; Rifkin, Daniel B.; Ramirez, Francesco			p38 MAPK Is an Early Determinant of Promiscuous Smad2/3 Signaling in the Aortas of Fibrillin-1 (Fbn1)-null Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES LATENT TGF-BETA-1; FACTOR-BETA ACTIVATION; SMOOTH-MUSCLE CELLS; TGF-BETA; MARFAN-SYNDROME; MOUSE MODEL; ANEURYSM; RECEPTOR; BINDING; MICROFIBRILS	Excessive transforming growth factor-beta(TGF-beta) signaling characterizes the progression of aortic aneurysm in mouse models of Marfan syndrome, a systemic disorder of the connective tissue that is caused by mutations in the gene encoding the extracellular matrix protein fibrillin-1. Fibrillin-1 mutations are believed to promote abnormal Smad2/3 signaling by impairing the sequestration of latent TGF-beta complexes into the extracellular matrix. Here we report that promiscuous Smad2/3 signaling is the cell-autonomous phenotype of primary cultures of vascular smooth muscle cells (VSMC) explanted from the thoracic aortas of Fbn1 mutant mice with either neonatal onset or progressively severe aortic aneurysm. This cellular phenotype was characterized in VSMC isolated from Fbn1-null (mgN/mgN) mice, which recapitulate the most severe form of Marfan syndrome. We found that loss of fibrillin-1 deposition promotes the production of intracellular reactive oxygen species and abnormal accumulation of phosphorylated TGF-beta-activated kinase 1 and p38 MAPK, in addition to increasing the levels of endogenous phospho-Smad2. We showed that improper Smad2/3 signaling in Fbn1-null VSMC is in part stimulated by phospho-p38 MAPK, which is in turn activated in response to signals other than those mediated by the kinase activity of the ALK5 receptor. Consistent with these cell culture data, in vivo analyses documented that phospho-p38 MAPK accumulates earlier than phospho-Smad2 in the aortic wall of mgN/mgN mice and that systemic inhibition of phospho-p38 MAPK activity lowers the levels of phospho-Smad2 in this tissue. Collectively, these findings indicate that improper activation of p38 MAPK is a precursor of constitutive Smad2/3 signaling in the aortic wall of a mouse model of neonatal lethal Marfan syndrome.	[Carta, Luca; Smaldone, Silvia; Ramirez, Francesco] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Carta, Luca; Smaldone, Silvia; Ramirez, Francesco] Mt Sinai Sch Med, Cardiovasc Inst, New York, NY 10029 USA; [Loch, David; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Loch, David; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Loch, David; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Loch, David; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Zilberberg, Lior; Rifkin, Daniel B.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; New York University	Ramirez, F (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave L Levy Pl,Box 1603, New York, NY 10029 USA.	francesco.ramirez@mssm.edu			National Institutes of Health [AR049698]; Howard Hughes Medical Institute; William S. Smilow Center for Marfan Syndrome Research; National Marfan Foundation; James Elster Research Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); William S. Smilow Center for Marfan Syndrome Research; National Marfan Foundation; James Elster Research Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR049698, the Howard Hughes Medical Institute, the William S. Smilow Center for Marfan Syndrome Research, the National Marfan Foundation, and the Drs. Amy and James Elster Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BASS DA, 1983, J IMMUNOL, V130, P1910; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Chung AWY, 2008, CIRC RES, V102, pE73, DOI 10.1161/CIRCRESAHA.108.174367; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; Jovanovic J, 2007, J BIOL CHEM, V282, P6743, DOI 10.1074/jbc.M607008200; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kielty CM, 2002, J CELL SCI, V115, P2817; Koli K, 2008, ANTIOXID REDOX SIGN, V10, P333, DOI 10.1089/ars.2007.1914; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; OHASHI N, 2000, ARTERIOSCL THROM VAS, V20, P166; OHBA M, 1994, J CELL BIOL, V126, P1079, DOI 10.1083/jcb.126.4.1079; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Ramirez F, 2004, PHYSIOL GENOMICS, V19, P151, DOI 10.1152/physiolgenomics.00092.2004; Ramirez F, 2007, CURR OPIN GENET DEV, V17, P252, DOI 10.1016/j.gde.2007.04.006; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; SPRAGUE EA, 1983, EXP MOL PATHOL, V37, P48; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; TRAVO P, 1980, BLOOD VESSELS, V17, P110; Watkins SJ, 2006, CARDIOVASC RES, V69, P432, DOI 10.1016/j.cardiores.2005.11.007; Winter-Vann AM, 2007, J CELL BIOCHEM, V102, P848, DOI 10.1002/jcb.21522; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xiong W, 2008, J VASC SURG, V47, P166, DOI 10.1016/j.jvs.2007.09.016; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200	39	78	81	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5630	5636		10.1074/jbc.M806962200	http://dx.doi.org/10.1074/jbc.M806962200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19109253	Green Published, hybrid			2022-12-27	WOS:000263560600026
J	Hart, EJ; Powers-Lee, SG				Hart, Emily J.; Powers-Lee, Susan G.			Role of Cys-1327 and Cys-1337 in Redox Sensitivity and Allosteric Monitoring in Human Carbamoyl Phosphate Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; ACETYL-L-GLUTAMATE; N-ACETYLGLUTAMATE; ESCHERICHIA-COLI; SITE; IDENTIFICATION; EVOLUTION; RESIDUES; LOCATION; AMMONIA	Human carbamoyl phosphate synthetase (hCPS) has evolved critical features that allow it to remove excess and potentially neurotoxic ammonia via the urea cycle, including use of only free ammonia as a nitrogen donor, a Km for ammonia 100-fold lower than for CPSs that also use glutamine as a nitrogen donor, and required allosteric activation by N-acetylglutamate (AGA), a sensor of excess amino acids. The recent availability of a Schizosaccharomyces pombe expression system for hCPS allowed us to utilize protein engineering approaches to elucidate the distinctive hCPS properties. Although the site of AGA interaction is not defined, it is known that the binding of AGA to CPS leads to a conformational change in which a pair of cysteine side chains become proximate and can then be selectively induced to undergo disulfide bonding. We analyzed the response of hCPS cysteine mutants to thiol-specific reagents and identified Cys-1327 and Cys-1337 as the AGA-responsive proximate cysteines. Possibly two of the features unique to urea-specific CPSs, relative to other CPSs (the conserved Cys-1327/Cys-1337 pair and the occurrence at very high concentrations in the liver mitochondrial matrix) co-evolved to provide buffering against reactive oxygen species. Reciprocal mutation analysis of Escherichia coli CPS (eCPS), creating P909C and G919C and establishing the ability of these engineered cysteine residues to share a disulfide bond, indicated an eCPS conformational change at least partly similar to the hCPS conformational change induced by AGA. These findings strongly suggested an alternative eCPS conformation relative to the single crystal conformation thus far identified.	[Hart, Emily J.; Powers-Lee, Susan G.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Northeastern University	Powers-Lee, SG (corresponding author), Northeastern Univ, Dept Biol, 360 Huntington Ave, Boston, MA 02115 USA.	spl@neu.edu			National Institutes of Health [DK54423]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54423. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abyzov A, 2005, BIOINFORMATICS, V21, P3677, DOI 10.1093/bioinformatics/bti602; Ahuja V, 2008, J INHERIT METAB DIS, V31, P481, DOI 10.1007/s10545-008-0913-y; Anderson PM, 1995, MOL ASPECTS CARBAMOY, P33; Belay ED, 1999, NEW ENGL J MED, V340, P1377, DOI 10.1056/NEJM199905063401801; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; CLARKE S, 1976, J BIOL CHEM, V251, P950; COHEN NS, 1985, BIOCHEM J, V229, P205, DOI 10.1042/bj2290205; Corvi MM, 2001, J BIOL CHEM, V276, P45704, DOI 10.1074/jbc.M102766200; Finckh U, 1998, HUM MUTAT, V12, P206, DOI 10.1002/(SICI)1098-1004(1998)12:3<206::AID-HUMU8>3.3.CO;2-K; GAUTIER C, 1984, CR ACAD SCI III-VIE, V299, P849; GESCHWILL K, 1989, BIOCHEM J, V260, P573, DOI 10.1042/bj2600573; HARAGUCHI Y, 1991, GENE, V107, P335; Kim J, 2004, ARCH BIOCHEM BIOPHYS, V425, P33, DOI 10.1016/j.abb.2004.02.031; Kim J, 2001, BIOCHEMISTRY-US, V40, P11030, DOI 10.1021/bi011121u; Kothe M, 2004, PROTEIN SCI, V13, P466, DOI 10.1110/ps.03416804; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUSTY CJ, 1981, BIOCHEMISTRY-US, V20, P3665, DOI 10.1021/bi00516a001; MARSHALL M, 1985, ARCH BIOCHEM BIOPHYS, V241, P200, DOI 10.1016/0003-9861(85)90376-5; McCudden CR, 1996, J BIOL CHEM, V271, P18285, DOI 10.1074/jbc.271.30.18285; MCGIVAN JD, 1976, BIOCHEM J, V154, P415, DOI 10.1042/bj1540415; Miles BW, 2000, BIOCHEMISTRY-US, V39, P5051, DOI 10.1021/bi992772h; MOMMSEN TP, 1989, SCIENCE, V243, P72, DOI 10.1126/science.2563172; NYUNOYA H, 1983, P NATL ACAD SCI-BIOL, V80, P4629, DOI 10.1073/pnas.80.15.4629; PAULUS H, 1983, CURR TOP CELL REGUL, V22, P177; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POTTER MD, 1992, J BIOL CHEM, V267, P2023; RODRIGUEZAPARICIO LB, 1989, BIOCHEMISTRY-US, V28, P3070, DOI 10.1021/bi00433a050; RUBINO SD, 1986, J BIOL CHEM, V261, P1320; Saeed-Kothe A, 2002, J BIOL CHEM, V277, P7231, DOI 10.1074/jbc.M110926200; Sambrook J., 2001, MOL CLONING LAB MANU; Thoden JB, 1999, ACTA CRYSTALLOGR D, V55, P8, DOI 10.1107/S0907444998006234	31	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5977	5985		10.1074/jbc.M808702200	http://dx.doi.org/10.1074/jbc.M808702200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106093	Green Published, hybrid			2022-12-27	WOS:000263560600061
J	Wang, HX; Sugiyama, Y; Hikima, T; Sugano, E; Tomita, H; Takahashi, T; Ishizuka, T; Yawo, H				Wang, Hongxia; Sugiyama, Yuka; Hikima, Takuya; Sugano, Eriko; Tomita, Hiroshi; Takahashi, Tetsuo; Ishizuka, Toru; Yawo, Hiromu			Molecular Determinants Differentiating Photocurrent Properties of Two Channelrhodopsins from Chlamydomonas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY RHODOPSIN-II; HUMAN COLOR-VISION; GREEN-ALGAE; VISUAL PIGMENTS; GATED CHANNELS; LIGHT; ACTIVATION; RESPONSES; MICE; DEGENERATION	A light signal is converted into an electrical one in a single molecule named channelrhodopsin, one of the archaea-type rhodopsins in unicellular green algae. Although highly homologous, two molecules of this family, channelrhodopsin-1 (ChR1) and -2 (ChR2), are distinct in photocurrent properties such as the wavelength sensitivity, desensitization, and turning-on and -off kinetics. However, the structures regulating these properties have not been completely identified. Photocurrents were analyzed for several chimera molecules made by replacing N-terminal segments of ChR2 with the homologous counterparts of ChR1. We found that the wavelength sensitivity of the photocurrent was red-shifted with negligible desensitization and slowed turning-on and -off kinetics when replacement was made with the segment containing the fifth transmembrane helix of ChR1. Therefore, this segment is involved in the determination of photocurrent properties, the wavelength sensitivity, and the kinetics characterizing ChR1 and ChR2. Eight amino acid residues differentiating this segment were exchanged one-by-one, and the photocurrent properties of each targeted mutant ChR2 were further analyzed. Among them, position Tyr226(ChR1)/Asn187(ChR2) is one of the molecular determinants involved in the wavelength sensitivity, desensitization, and turning-on and -off kinetics. It is suggested that these amino acid residues directly or indirectly interact with the chromophore as well as with the protein structure determining the photocurrent kinetics. Some of the chimera channelrhodopsins are suggested to have several advantages over the wild-type ChR2 in the introduction of light-induced membrane depolarization for the purpose of artificial stimulation of neurons in vivo and visual prosthesis for photoreceptor degeneration.	[Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Sugiyama, Yuka; Yawo, Hiromu] Tohoku Univ, Sch Med, Dept Physiol & Pharmacol, Sendai, Miyagi 9808575, Japan; [Wang, Hongxia; Sugiyama, Yuka; Hikima, Takuya; Yawo, Hiromu] Tohoku Univ, Basic & Translat Res Ctr Global Brain Sci, Sendai, Miyagi 9808575, Japan; [Sugano, Eriko; Tomita, Hiroshi] Tohoku Univ, Int Adv Res & Educ Org, Sendai, Miyagi 9808575, Japan; [Takahashi, Tetsuo] Toho Univ, Fac Pharmaceut Sci, Chiba 2748510, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Toho University	Yawo, H (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	yawo@mail.tains.tohoku.ac.jp	Ishizuka, Toru/L-8191-2017; Tomita, Hiroshi/O-2135-2018; Yawo, Hiromu/I-4871-2015	Ishizuka, Toru/0000-0003-4405-8792; Tomita, Hiroshi/0000-0003-1051-2301; Yawo, Hiromu/0000-0002-4299-3288	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Suzuken Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Suzuken Memorial Foundation	This work was supported by grants-in-aid for scientific research, Global COE Program (Basic and Translational Research Center for Global Brain Science) and Strategic Research Program for Brain Sciences (SRPBS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and Suzuken Memorial Foundation.	Adamian L, 2006, PHOTOCHEM PHOTOBIOL, V82, P1426, DOI 10.1562/2006-02-14-RA-802; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bradley J, 2005, CURR OPIN NEUROBIOL, V15, P343, DOI 10.1016/j.conb.2005.05.014; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; HEGEMANN P, 2008, REV PLANT BIOL, V59, P167; Herlitze S, 2007, CURR OPIN NEUROBIOL, V17, P87, DOI 10.1016/j.conb.2006.12.002; Hillebrecht JR, 2006, BIOCHEMISTRY-US, V45, P1579, DOI 10.1021/bi051851s; Hoffmann M, 2006, J AM CHEM SOC, V128, P10808, DOI 10.1021/ja062082i; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kateriya S, 2004, NEWS PHYSIOL SCI, V19, P133, DOI 10.1152/nips.01517.2004; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kloppmann E, 2005, PROTEINS, V61, P953, DOI 10.1002/prot.20744; Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; MELKONIAN M, 1980, J ULTRA MOL STRUCT R, V72, P90, DOI 10.1016/S0022-5320(80)90138-0; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Pebay-Peyroula E, 2002, BBA-BIOMEMBRANES, V1565, P196, DOI 10.1016/S0005-2736(02)00569-2; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Sambrook J., 2001, MOL CLONING LAB MANU; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120	41	128	170	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5685	5696		10.1074/jbc.M807632200	http://dx.doi.org/10.1074/jbc.M807632200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19103605	hybrid			2022-12-27	WOS:000263560600032
J	Giussani, P; Brioschi, L; Bassi, R; Riboni, L; Viani, P				Giussani, Paola; Brioschi, Loredana; Bassi, Rosaria; Riboni, Laura; Viani, Paola			Phosphatidylinositol 3-Kinase/AKT Pathway Regulates the Endoplasmic Reticulum to Golgi Traffic of Ceramide in Glioma Cells A LINK BETWEEN LIPID SIGNALING PATHWAYS INVOLVED IN THE CONTROL OF CELL SURVIVAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANNABINOID-INDUCED APOPTOSIS; ELEMENT-BINDING PROTEIN; GLIOBLASTOMA-MULTIFORME; CLINICAL-OUTCOMES; NERVOUS-SYSTEM; KINASE-B; DEATH; PTEN; INHIBITION; TRANSPORT	Different lines of evidence indicate that both aberrant activation of the phosphatidylinositol 3-OH kinase (PI3K)/Akt survival pathway and down-regulation of the death mediator ceramide play a critical role in the aggressive behavior, apoptosis resistance, and adverse clinical outcome of glioblastoma multi-forme. Furthermore, the inhibition of the PI3K/Akt pathway and the up-regulation of ceramide have been found functional to the activity of many cytotoxic treatments against glioma cell lines and glioblastomas as well. A reciprocal control between PI3K/Akt and ceramide signaling in glioma cell survival/death is suggested by data demonstrating a protective role of PI3K/Akt on ceramide-induced cell death in glial cells. In this study we investigated the role of the PI3K/Akt pathway in the regulation of the ceramide metabolism in C6 glioma cells, a cell line in which the PI3K/Akt pathway is constitutively activated. Metabolic experiments performed with different radioactive metabolic precursors of sphingolipids and microscopy studies with fluorescent ceramides demonstrated that the chemical inhibition of PI3K and the transfection with a dominant negative Akt strongly inhibited ceramide utilization for the biosynthesis of complex sphingolipids by controlling the endoplasmic reticulum (ER) to Golgi vesicular transport of ceramide. These findings constitute the first evidence for a PI3K/Akt-dependent regulation of vesicle-mediated movements of ceramide in the ER-Golgi district. Moreover, the findings also suggest the activation of the PI3K/Akt pathway as crucial to coordinate the biosynthesis of membrane complex sphingolipids with cell proliferation and growth and/or to maintain low ceramide levels, especially as concerns those treatments that promote ceramide biosynthesis in the ER.	[Giussani, Paola; Brioschi, Loredana; Bassi, Rosaria; Riboni, Laura; Viani, Paola] Univ Milan, Dept Med Chem Biochem & Biotechnol, LITA, I-20090 Milan, Italy	University of Milan	Viani, P (corresponding author), Univ Milan, Dept Med Chem Biochem & Biotechnol, LITA, Via Flli Cervi 93, I-20090 Milan, Italy.	paola.viani@unimi.it	VIANI, PAOLA/Q-5955-2017; Giussani, Paola/R-4268-2017; Riboni, Laura/R-4281-2017	VIANI, PAOLA/0000-0002-5728-6631; Giussani, Paola/0000-0002-7793-1757; Riboni, Laura/0000-0002-4149-8226; BASSI, ROSARIA/0000-0001-7409-4730	University of Milan	University of Milan	This work was supported by grants from the University of Milan (to P. G., L. R., and P. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Bijl N, 2008, J PHARMACOL EXP THER, V326, P849, DOI 10.1124/jpet.108.139394; Blazquez C, 2000, FASEB J, V14, P2315, DOI 10.1096/fj.00-0122com; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Cockcroft S, 2001, J MEMBRANE BIOL, V180, P187, DOI 10.1007/s002320010069; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Davis F G, 2001, Expert Rev Anticancer Ther, V1, P395, DOI 10.1586/14737140.1.3.395; del Pulgar TG, 2002, J BIOL CHEM, V277, P36527, DOI 10.1074/jbc.M205797200; del Pulgar TG, 2002, BIOCHEM J, V363, P183, DOI 10.1042/0264-6021:3630183; Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Ermoian RP, 2002, CLIN CANCER RES, V8, P1100; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Giussani P, 2008, BBA-MOL CELL BIOL L, V1781, P40, DOI 10.1016/j.bbalip.2007.11.002; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Guha A, 2004, CURR OPIN NEUROL, V17, P655, DOI 10.1097/00019052-200412000-00004; Guzman M, 2005, HANDB EXP PHARMACOL, V168, P627; Hara S, 2004, CELL DEATH DIFFER, V11, P853, DOI 10.1038/sj.cdd.4401428; Hartmann C, 2005, ACTA NEUROPATHOL, V109, P639, DOI 10.1007/s00401-005-1000-1; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Hinz B, 2004, MOL PHARMACOL, V66, P1643, DOI 10.1124/mol.104.002618; Kim WH, 2005, NEUROCHEM RES, V30, P969, DOI 10.1007/s11064-005-6223-y; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Knobbe CB, 2005, NEUROPATH APPL NEURO, V31, P486, DOI 10.1111/j.1365-2990.2005.00660.x; Knobbe CB, 2002, NEURO-ONCOLOGY, V4, P196; Kondo T, 2006, EUR J CANCER, V42, P1237, DOI 10.1016/j.ejca.2006.01.038; Kubiatowski T, 2001, J NEUROSURG, V95, P480, DOI 10.3171/jns.2001.95.3.0480; LOU HOC, 1965, J NEUROCHEM, V12, P619; Mochizuki T, 2002, J BIOL CHEM, V277, P2790, DOI 10.1074/jbc.M106361200; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Noda S, 2001, J NEURO-ONCOL, V52, P11, DOI 10.1023/A:1010624823158; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Pahan K, 2000, J NEUROCHEM, V75, P576, DOI 10.1046/j.1471-4159.2000.0750576.x; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; Rao RD, 2004, SEMIN ONCOL, V31, P595, DOI 10.1053/j.seminoncol.2004.07.002; Rasheed BKA, 1997, CANCER RES, V57, P4187; Riboni L, 2000, METHOD ENZYMOL, V311, P656; Riboni L, 2002, GLIA, V39, P105, DOI 10.1002/glia.10087; Riboni L, 2001, J BIOL CHEM, V276, P12797, DOI 10.1074/jbc.M011570200; Sawada M, 2004, CELL DEATH DIFFER, V11, P997, DOI 10.1038/sj.cdd.4401438; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Scheek S, 1997, P NATL ACAD SCI USA, V94, P11179, DOI 10.1073/pnas.94.21.11179; Sekulic A, 2000, CANCER RES, V60, P3504; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Sullards MC, 2003, CELL MOL BIOL, V49, P789; Testai FD, 2004, J NEUROCHEM, V89, P636, DOI 10.1046/j.1471-4159.2004.02374.x; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Viani P, 2003, J BIOL CHEM, V278, P9592, DOI 10.1074/jbc.M207729200; Vogt PK, 2001, TRENDS MOL MED, V7, P482, DOI 10.1016/S1471-4914(01)02161-X; Wong MLH, 2007, J CLIN NEUROSCI, V14, P301, DOI 10.1016/j.jocn.2006.11.005; Worgall TS, 2004, ARTERIOSCL THROM VAS, V24, P943, DOI 10.1161/01.ATV.0000125703.20434.4d; Zinda MJ, 2001, BIOCHEM BIOPH RES CO, V280, P1107, DOI 10.1006/bbrc.2000.4248	61	32	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5088	5096		10.1074/jbc.M808934200	http://dx.doi.org/10.1074/jbc.M808934200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103588	Green Published, hybrid			2022-12-27	WOS:000263416600039
J	Liang, P; Wang, HY; Chen, H; Cui, YY; Gu, LC; Chai, JJ; Wang, KW				Liang, Ping; Wang, Huayi; Chen, Hao; Cui, Yuanyuan; Gu, Lichuan; Chai, Jijie; Wang, KeWei			Structural Insights into KChIP4a Modulation of Kv4.3 Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL-INTERACTING PROTEINS; CLOSED-STATE INACTIVATION; A-TYPE; K+ CHANNELS; POTASSIUM CHANNELS; FUNCTIONAL INTERACTION; I-TO; SUBUNIT; EXPRESSION; CALCIUM	Dynamic inactivation in Kv4 A-type K+ current plays a critical role in regulating neuronal excitability by shaping action potential waveform and duration. Multifunctional auxiliary KChIP1-4 subunits, which share a high homology in their C-terminal core regions, exhibit distinctive modulation of inactivation and surface expression of pore-forming Kv4 subunits. However, the structural differences that underlie the functional diversity of Kv channel-interacting proteins (KChIPs) remain undetermined. Here we have described the crystal structure of KChIP4a at 3.0 angstrom resolution, which shows distinct N-terminal alpha-helices that differentiate it from other KChIPs. Biochemical experiments showed that competitive binding of the Kv4.3 N-terminal peptide to the hydrophobic groove of the core of KChIP4a causes the release of the KChIP4a N terminus that suppresses the inactivation of Kv4.3 channels. Electrophysiology experiments confirmed that the first N-terminal alpha-helix peptide (residues 1-34) of KChIP4a, either by itself or fused to N-terminal truncated Kv4.3, can confer slow inactivation. We propose that N-terminal binding of Kv4.3 to the core of KChIP4a mobilizes the KChIP4a N terminus, which serves as the slow inactivation gate.	[Liang, Ping; Chen, Hao; Cui, Yuanyuan; Wang, KeWei] Peking Univ, Ctr Prot Sci, Dept Neurobiol, Neurosci Res Inst,Key Lab Neurosci,Minist Educ, Beijing 100083, Peoples R China; [Wang, Huayi; Chai, Jijie] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Gu, Lichuan] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Peking University; National Institute of Biological Sciences, Beijing; Shandong University	Wang, KW (corresponding author), Peking Univ, Ctr Prot Sci, Dept Neurobiol, Neurosci Res Inst,Key Lab Neurosci,Minist Educ, 38 Xueyuan Rd, Beijing 100083, Peoples R China.	wangkw@bjmu.edu.cn	Cui, Yuanyuan/G-1899-2015	Chai, Jijie/0000-0001-7591-3873	Chinese Ministry of Science and Technology [2003-AA210090]; National Science Foundation of China [30630017]; Ministry of Science Technology of China [2006AA02Z183, 2007CB512100]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science Technology of China(Ministry of Science and Technology, China)	This work was supported by "863" Grant 2003-AA210090 from the Chinese Ministry of Science and Technology (to J.C.) and Research Grants 30630017 from the National Science Foundation of China and 2006AA02Z183 and 2007CB512100 from the Ministry of Science Technology of China (to K.W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Beck EJ, 2001, BIOPHYS J, V81, P867, DOI 10.1016/S0006-3495(01)75747-5; Borek D, 2003, ACTA CRYSTALLOGR D, V59, P2031, DOI 10.1107/S0907444903020924; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CP, 2006, PROTEIN J, V25, P345, DOI 10.1007/s10930-006-9020-9; Cui YY, 2008, NEUROCHEM RES, V33, P2078, DOI 10.1007/s11064-008-9688-7; Deng XY, 2005, ACTA BIOCH BIOPH SIN, V37, P241, DOI 10.1111/j.1745-7270.2005.00034.x; Deschenes I, 2002, CIRCULATION, V106, P423, DOI 10.1161/01.CIR.0000025417.65658.B6; Dougherty K, 2008, J GEN PHYSIOL, V131, P257, DOI 10.1085/jgp.200709938; Falk T, 2003, NEUROSCIENCE, V120, P387, DOI 10.1016/S0306-4522(03)00044-7; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Guo WN, 2002, CIRC RES, V90, P586, DOI 10.1161/01.RES.0000012664.05949.E0; Hatano N, 2002, PFLUG ARCH EUR J PHY, V444, P80, DOI 10.1007/s00424-002-0798-9; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; Holmqvist MH, 2001, J NEUROSCI, V21, P4154, DOI 10.1523/JNEUROSCI.21-12-04154.2001; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Hu HJ, 2003, J NEUROPHYSIOL, V90, P1671, DOI 10.1152/jn.00340.2003; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jow F, 2004, P NATL ACAD SCI USA, V101, P15535, DOI 10.1073/pnas.0402081101; Kaulin YA, 2008, BIOPHYS J, V94, P1241, DOI 10.1529/biophysj.107.117796; Kunjilwar K, 2004, J BIOL CHEM, V279, P54542, DOI 10.1074/jbc.M409721200; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Nadal MS, 2001, J PHYSIOL-LONDON, V537, P801; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Olschewski A, 2001, ANESTHESIOLOGY, V94, P280, DOI 10.1097/00000542-200102000-00018; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Schwenk J, 2008, J BIOL CHEM, V283, P18937, DOI 10.1074/jbc.M800976200; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Shibata R, 2000, J NEUROSCI, V20, P4145; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Wang GY, 2006, J GEN PHYSIOL, V127, P391, DOI 10.1085/jgp.200509442; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Xiong H, 2004, MOL BRAIN RES, V128, P103, DOI 10.1016/j.molbrainres.2004.06.024; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5	45	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4960	4967		10.1074/jbc.M807704200	http://dx.doi.org/10.1074/jbc.M807704200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19109250	hybrid			2022-12-27	WOS:000263416600026
J	Mason, AC; Haring, SJ; Pryor, JM; Staloch, CA; Gan, TF; Wold, MS				Mason, Aaron C.; Haring, Stuart J.; Pryor, John M.; Staloch, Cathy A.; Gan, Tze Fei; Wold, Marc S.			An Alternative Form of Replication Protein A Prevents Viral Replication in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; BINDING-PROTEIN; COMPLEX-FORMATION; POLYMERASE-DELTA; T-ANTIGEN; RPA; SUBUNIT; INITIATION; CANCER; ELONGATION	Replication protein A (RPA), the eukaryotic single-stranded DNA-binding complex, is essential for multiple processes in cellular DNA metabolism. The "canonical" RPA is composed of three subunits (RPA1, RPA2, and RPA3); however, there is a human homolog to the RPA2 subunit, called RPA4, that can substitute for RPA2 in complex formation. We demonstrate that the resulting "alternative" RPA (aRPA) complex has solution and DNA binding properties indistinguishable from the canonical RPA complex; however, aRPA is unable to support DNA replication and inhibits canonical RPA function. Two regions of RPA4, the putative L34 loop and the C terminus, are responsible for inhibiting SV40 DNA replication. Given that aRPA inhibits canonical RPA function in vitro and is found in nonproliferative tissues, these studies indicate that RPA4 expression may prevent cellular proliferation via replication inhibition while playing a role in maintaining the viability of quiescent cells.	[Mason, Aaron C.; Haring, Stuart J.; Pryor, John M.; Staloch, Cathy A.; Gan, Tze Fei; Wold, Marc S.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Wold, MS (corresponding author), Univ Iowa, Carver Coll Med, Dept Biochem, 375 Newton Rd,3107 MERF, Iowa City, IA 52242 USA.	marc-wold@uiowa.edu	Haring, Stuart/E-7481-2012; Wold, Marc/F-5806-2010	Wold, Marc/0000-0002-4580-1624; Pryor, John/0000-0001-7000-9383	National Institutes of Health [GM44721]; Center for Aging and Cancer at the University of Iowa [CA103672]; NATIONAL CANCER INSTITUTE [P20CA103672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Aging and Cancer at the University of Iowa; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant ( GM44721). This work was also supported by grants from the Center for Aging and Cancer at the University of Iowa ( CA103672).	Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Braun KA, 1997, BIOCHEMISTRY-US, V36, P8443, DOI 10.1021/bi970473r; Brush GS, 1995, METHOD ENZYMOL, V262, P522; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; Deng XY, 2007, J MOL BIOL, V374, P865, DOI 10.1016/j.jmb.2007.09.074; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Givalos N, 2007, MODERN PATHOL, V20, P159, DOI 10.1038/modpathol.3800719; Gomes XV, 1996, BIOCHEMISTRY-US, V35, P10558, DOI 10.1021/bi9607517; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Ishibashi T, 2006, J BIOCHEM, V139, P99, DOI 10.1093/jb/mvj014; KELLY TJ, 1988, J BIOL CHEM, V263, P17889; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; KESHAV KF, 1995, MOL CELL BIOL, V15, P3119; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; MELENDY T, 1993, J BIOL CHEM, V268, P3389; MURAKAMI Y, 1992, P NATL ACAD SCI USA, V89, P952, DOI 10.1073/pnas.89.3.952; Philipova D, 1996, GENE DEV, V10, P2222, DOI 10.1101/gad.10.17.2222; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Rider SD, 2005, J BIOL CHEM, V280, P31460, DOI 10.1074/jbc.M504466200; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Simmons DT, 2004, NUCLEIC ACIDS RES, V32, P1103, DOI 10.1093/nar/gkh236; Tomkiel JE, 2002, CLIN CANCER RES, V8, P752; Walther AP, 1999, BIOCHEMISTRY-US, V38, P3963, DOI 10.1021/bi982370u; Walther AP, 1999, NUCLEIC ACIDS RES, V27, P656, DOI 10.1093/nar/27.2.656; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; Zhang D, 1998, NUCLEIC ACIDS RES, V26, P631, DOI 10.1093/nar/26.2.631	33	17	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5324	5331		10.1074/jbc.M808963200	http://dx.doi.org/10.1074/jbc.M808963200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19116208	Green Published, hybrid			2022-12-27	WOS:000263416600062
J	Ohnishi, A; Hashimoto, K; Imai, K; Matsumoto, S				Ohnishi, Atsushi; Hashimoto, Kana; Imai, Kiyohiro; Matsumoto, Shogo			Functional Characterization of the Bombyx mori Fatty Acid Transport Protein (BmFATP) within the Silkmoth Pheromone Gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA-BINDING PROTEIN; BIOSYNTHESIS ACTIVATING NEUROPEPTIDE; CYTOPLASMIC LIPID DROPLETS; ACYL-COA; SILKWORM; IDENTIFICATION; RECEPTOR; CLONING; CELLS; ACBP	Fatty acid transport protein (FATP) is an evolutionarily conserved membrane-bound protein that facilitates the uptake of extracellular long chain fatty acids. In humans and mice, six FATP isoforms have been identified and their tissue-specific distributions suggest that each plays a discrete role in lipid metabolism in association with fatty acid uptake. While the presence of FATP homologs in insects has been demonstrated, their functional role remains to be characterized. Pheromonogenesis is defined as the dynamic period in which all machinery required for sex pheromone biosynthesis is generated and organized within the pheromone gland (PG) cells. By exploiting this unique system in the PG of the silkmoth, Bombyx mori, we found that BmFATP is predominantly expressed in the PG and undergoes up-regulation 1 day prior to eclosion. Before eclosion, B. mori PG cells accumulate cytoplasmic lipid droplets (LDs), which play a role in storing the pheromone (bombykol) precursor fatty acid in the form of triacylglycerol. RNAi-mediated gene silencing of BmFATP in vivo significantly suppressed LD accumulation by preventing the synthesis of triacylglycerols and resulted in a significant reduction in bombykol production. These results, in conjunction with the findings that BmFATP stimulates the uptake of extracellular long-chain fatty acids and BmFATP knockdown reduces cellular long-chain acyl-CoA synthetase activity, suggest that BmFATP plays an essential role in bombykol biosynthesis by stimulating both LD accumulation and triacylglycerol synthesis via a process called vectorial acylation that couples the uptake of extracellular fatty acids with activation to CoA thioesters during pheromonogenesis.	[Ohnishi, Atsushi; Hashimoto, Kana; Matsumoto, Shogo] RIKEN, Adv Sci Inst, Mol Entomol Lab, Wako, Saitama 3510198, Japan; [Hashimoto, Kana; Imai, Kiyohiro] Hosei Univ, Dept Chem Mat, Koganei, Tokyo 1848584, Japan	RIKEN; Hosei University	Matsumoto, S (corresponding author), RIKEN, Adv Sci Inst, Mol Entomol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	smatsu@riken.jp		Ohnishi, Atsushi/0000-0003-1213-4439	RIKEN; Targeted Proteins Research Program (TPRP); Ministry of Education, Culture, Sports, Science and Technology of Japan [20380040, 19580061]	RIKEN; Targeted Proteins Research Program (TPRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Bioarchitect Research Program from RIKEN and the Targeted Proteins Research Program (TPRP), Grants-in-Aid for Scientific Research (B) 20380040, and (C) 19580061 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ANDO T, 1988, AGR BIOL CHEM TOKYO, V52, P141; Choi MY, 2003, P NATL ACAD SCI USA, V100, P9721, DOI 10.1073/pnas.1632485100; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DiRusso CC, 2000, EUR J BIOCHEM, V267, P4422, DOI 10.1046/j.1432-1327.2000.01489.x; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fonagy A, 2000, J INSECT PHYSIOL, V46, P735, DOI 10.1016/S0022-1910(99)00162-6; Fonagy A, 2001, ARTHROPOD STRUCT DEV, V30, P113, DOI 10.1016/S1467-8039(01)00027-5; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Hull JJ, 2004, J BIOL CHEM, V279, P51500, DOI 10.1074/jbc.M408142200; Jurenka R.A., 2003, P53, DOI 10.1016/B978-012107151-6/50005-0; Kim YJ, 2008, PEPTIDES, V29, P268, DOI 10.1016/j.peptides.2007.12.001; Lewis SE, 2001, J BIOL CHEM, V276, P37042, DOI 10.1074/jbc.M105556200; MATSUMOTO S, 1990, J INSECT PHYSIOL, V36, P427, DOI 10.1016/0022-1910(90)90060-S; Matsumoto S, 2002, INSECT BIOCHEM MOLEC, V32, P1447, DOI 10.1016/S0965-1748(02)00065-6; Matsumoto S, 2001, INSECT BIOCHEM MOLEC, V31, P603, DOI 10.1016/S0965-1748(00)00165-X; MATUMOTO S, 2007, J INSECT PHYSL, V53, P752; MOGENSEN IB, 1987, BIOCHEM J, V241, P189, DOI 10.1042/bj2410189; Moto K, 2004, P NATL ACAD SCI USA, V101, P8631, DOI 10.1073/pnas.0402056101; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Obermeyer T, 2007, J LIPID RES, V48, P2354, DOI 10.1194/jlr.M700300-JLR200; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Ozawa R, 1996, INSECT BIOCHEM MOLEC, V26, P259, DOI 10.1016/0965-1748(95)00088-7; Rafaeli A, 2002, INT REV CYTOL, V213, P49; Rafaeli Ada, 2003, P107, DOI 10.1016/B978-012107151-6/50007-4; RASMUSSEN JT, 1994, BIOCHEM J, V299, P165, DOI 10.1042/bj2990165; RASMUSSEN JT, 1993, BIOCHEM J, V292, P907, DOI 10.1042/bj2920907; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; STANLEYSAMUELSON DW, 1988, ARCH INSECT BIOCHEM, V9, P1, DOI 10.1002/arch.940090102; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Yoshiga T, 2000, GENE, V246, P339, DOI 10.1016/S0378-1119(00)00047-0; Zou ZY, 2002, J BIOL CHEM, V277, P31062, DOI 10.1074/jbc.M205034200	35	41	43	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5128	5136		10.1074/jbc.M806072200	http://dx.doi.org/10.1074/jbc.M806072200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19112106	hybrid			2022-12-27	WOS:000263416600043
J	Darna, M; Schmutz, I; Richter, K; Yelamanchili, SV; Pendyala, G; Holtje, M; Albrecht, U; Ahnert-Hilger, G				Darna, Mahesh; Schmutz, Isabelle; Richter, Karin; Yelamanchili, Sowmya V.; Pendyala, Gurudutt; Hoeltje, Markus; Albrecht, Urs; Ahnert-Hilger, Gudrun			Time of Day-dependent Sorting of the Vesicular Glutamate Transporter to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTOPHYSIN-SYNAPTOBREVIN COMPLEX; MECHANISM; GABA	Neurotransmitters are concentrated into synaptic vesicles by VGLUT (vesicular glutamate transporter) or VGAT (vesicular GABA transporter). The number of VGLUTs per vesicle determines the amount of stored neurotransmitter, thereby influencing postsynaptic response. Recently, we described a strong diurnal cycling of the amount of VGLUT1 on synaptic vesicles prepared from whole mouse brain at different times of the day (Yelamanchili, S. V., Pendyala, G., Brunk, I., Darna, M., Albrecht, U., and Ahnert-Hilger, G. (2006) J. Biol. Chem. 281, 15671 15679). To analyze whether and how much VGLUT resides in cellular versus vesicular membranes, we developed a Pronase assay. We found that VGLUT and synaptotagmin are highly accessible to proteolytic cleavage in rat and mouse synaptosomal preparations, indicating considerable amounts of these vesicular proteins at the plasma membrane, whereas only minor amounts of synaptophysin and Rab3 are digested. Sucrose stimulation increases digestion of VGLUT, synaptotagmin, and synaptophysin due to membrane fusion that exposes the lumen-facing peptides to the extracellular space. Digestion of mouse synaptosomes prepared at different times of the day revealed a diurnal cycling of VGLUT to the plasma membrane. More VGLUT is digested at noon (Zeitgeber time 6) compared with the start of the light period (Zeitgeber time 0), whereas digestion of synaptophysin and synaptotagmin is independent of diurnal cycling. In contrast to VGLUT, the amount of VGAT appears not to vary diurnally but is decreased in membrane preparations from animals kept under constant darkness. We conclude that VGLUTs are sorted diurnally to the plasma membrane to modulate glutamate transmission during a day/night cycle, whereas VGAT expression is not oscillating but is increased in the presence of a light/dark cycle.	[Darna, Mahesh; Richter, Karin; Yelamanchili, Sowmya V.; Hoeltje, Markus; Ahnert-Hilger, Gudrun] Charite Ctr 2 Basic Med, AG Funct Cell Biol, Inst Integrat Neuroanat, D-10115 Berlin, Germany; [Schmutz, Isabelle; Pendyala, Gurudutt; Albrecht, Urs] Univ Fribourg, Dept Med, Div Biochem, CH-1700 Fribourg, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Fribourg	Ahnert-Hilger, G (corresponding author), Charite Ctr 2 Basic Med, AG Funct Cell Biol, Inst Integrat Neuroanat, Philippstr 12, D-10115 Berlin, Germany.	gudrun.ahnert@charite.de	Albrecht, Urs/A-9831-2011	Albrecht, Urs/0000-0002-0663-8676; Holtje, Markus/0000-0003-3193-4140	German Research Foundation [AH 67/5]; Graduierten Kolleg 1123; Swiss National Science Foundation; State of Fribourg; European Community Grant EUCLOCK	German Research Foundation(German Research Foundation (DFG)); Graduierten Kolleg 1123; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State of Fribourg; European Community Grant EUCLOCK(European Commission)	This work was supported by German Research Foundation Grant AH 67/5 (to G. A.- H.), Graduierten Kolleg 1123 (to M. D.), and the Swiss National Science Foundation, the State of Fribourg, and European Community Grant EUCLOCK (to U. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; Albrecht U, 2002, METHODS, V28, P465, DOI 10.1016/S1046-2023(02)00266-9; Becher A, 1999, J NEUROSCI, V19, P1922; Brunk I, 2006, J BIOL CHEM, V281, P33373, DOI 10.1074/jbc.M603204200; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Grosse G, 2003, MOL CELL NEUROSCI, V24, P709, DOI 10.1016/S1044-7431(03)00234-3; Hinz B, 2001, EUR J CELL BIOL, V80, P615, DOI 10.1078/0171-9335-00196; Holtje M, 2008, J BIOL CHEM, V283, P9289, DOI 10.1074/jbc.M706499200; Iwamoto H, 2006, J NEUROSCI, V26, P9851, DOI 10.1523/JNEUROSCI.1862-06.2006; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Moriyama Y, 2004, J BIOCHEM, V135, P155, DOI 10.1093/jb/mvh018; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Steiner JA, 2008, TRAFFIC, V9, P1393, DOI 10.1111/j.1600-0854.2008.00757.x; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Yelamanchili SV, 2006, J BIOL CHEM, V281, P15671, DOI 10.1074/jbc.M600378200; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	27	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4300	4307		10.1074/jbc.M805480200	http://dx.doi.org/10.1074/jbc.M805480200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19103593	Green Submitted, hybrid			2022-12-27	WOS:000263134400028
J	Wu, XB; Sinani, D; Kim, H; Lee, J				Wu, Xiaobin; Sinani, Devis; Kim, Heejeong; Lee, Jaekwon			Copper Transport Activity of Yeast Ctr1 Is Down-regulated via Its C Terminus in Response to Excess Copper	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BIOCHEMICAL-CHARACTERIZATION; STIMULATED ENDOCYTOSIS; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; DEGRADATION; UBIQUITIN; TRAFFICKING; MECHANISMS; EXPRESSION	Copper is an essential yet toxic trace element. The Ctr1 family of proteins plays a critical role for copper uptake in eukaryotes. However, the mechanisms of action of Ctr1 are largely unknown. Our previous data demonstrated that copper transport induces conformational changes in the cytosolic C terminus of the yeast Saccharomyces cerevisiae Ctr1. To define the physiological significance of this molecular event and gain better insights into the mechanism of Ctr1-mediated copper uptake, we have characterized the functional roles of the Ctr1 C terminus. A Ctr1 mutant lacking the entire C-terminal cytosolic tail is functional in high affinity copper uptake; however, yeast cells expressing this mutant are extremely sensitive to excess copper. Toxic copper uptake is not attributed to elevated expression or distinct subcellular localization of this mutant as compared with wild type Ctr1. Further characterization of the function of Ctr1 containing deletions or site-directed mutations at the C terminus indicates a structural role for the C terminus in controlling Ctr1 activities. In response to excess copper, Ctr1-mediated copper transport is rapidly blocked in a C terminus-dependent mechanism associated with direct binding of copper. We propose that conformational changes in the cytosolic tail of yeast Ctr1 by copper sensing within this domain lead to the inhibition of Ctr1-mediated copper transport. These data suggest a new regulatory mechanism by which yeast cells maintain homeostatic copper acquisition.	[Wu, Xiaobin; Sinani, Devis; Kim, Heejeong; Lee, Jaekwon] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Lee, J (corresponding author), Univ Nebraska, Dept Biochem, Redox Biol Ctr, N210 Beadle Ctr, Lincoln, NE 68588 USA.	jlee7@unlnotes.unl.edu		Wu, Xiaobin/0000-0001-5479-8597	National Institutes of Health [DK79209, P20-RR-17675]; Nutricia Foundation Fellowship; Hatch Act in the University of Nebraska Agricultural Research Division; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutricia Foundation Fellowship(Danone Nutricia); Hatch Act in the University of Nebraska Agricultural Research Division; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK79209 ( to J. L.) and P20-RR-17675 ( to the Nebraska Redox Biology Center). This work was also supported by a Nutricia Foundation Fellowship ( to D. S.), and funds provided through the Hatch Act in the University of Nebraska Agricultural Research Division. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Ausubel F.M., 1987, CURRENT PROTOCOL MOL; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gitlin JD, 2003, GASTROENTEROLOGY, V125, P1868, DOI 10.1053/j.gastro.2003.05.010; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; Katzmann DJ, 1999, MOL CELL BIOL, V19, P2998; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2006, TOP CURR GENET, V14, P1; Linder M, 1991, BIOCH COPPER; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NEBOT C, 1993, ANAL BIOCHEM, V214, P442, DOI 10.1006/abio.1993.1521; Nies DH, 2007, SCIENCE, V317, P1695, DOI 10.1126/science.1149048; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Overton MC, 2002, J BIOL CHEM, V277, P41463, DOI 10.1074/jbc.M205368200; OYANAGUI Y, 1984, ANAL BIOCHEM, V142, P290; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Prohaska JR, 2000, NUTRITION, V16, P502, DOI 10.1016/S0899-9007(00)00308-7; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; Sinani D, 2007, J BIOL CHEM, V282, P26775, DOI 10.1074/jbc.M703973200; TAN PK, 1993, J CELL BIOL, V123, P1707, DOI 10.1083/jcb.123.6.1707; Uauy R, 1998, AM J CLIN NUTR, V67, p952S, DOI 10.1093/ajcn/67.5.952S; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711	48	61	67	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4112	4122		10.1074/jbc.M807909200	http://dx.doi.org/10.1074/jbc.M807909200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088072	Green Published, hybrid			2022-12-27	WOS:000263134400008
J	Davis, BN; Hilyard, AC; Nguyen, PH; Lagna, G; Hata, A				Davis, Brandi N.; Hilyard, Aaron C.; Nguyen, Peter H.; Lagna, Giorgio; Hata, Akiko			Induction of MicroRNA-221 by Platelet-derived Growth Factor Signaling Is Critical for Modulation of Vascular Smooth Muscle Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; POSTTRANSCRIPTIONAL REGULATION; PULMONARY-HYPERTENSION; BREAST-CANCER; C-KIT; MYOCARDIN; EXPRESSION; MIR-221; TUMORS; CELLS	The platelet-derived growth factor (PDGF) signaling pathway is a critical regulator of animal development and homeostasis. Activation of the PDGF pathway leads to neointimal proliferative responses to artery injury; it promotes a switch of vascular smooth muscle cells (vSMC) to a less contractile phenotype by inhibiting the SMC-specific gene expression and increasing the rate of proliferation and migration. The molecular mechanism for these pleiotropic effects of PDGFs has not been fully described. Here, we identify the microRNA-221 (miR-221), a small noncoding RNA, as a modulator of the phenotypic change of vSMCs in response to PDGF signaling. We demonstrate that miR-221 is transcriptionally induced upon PDGF treatment in primary vSMCs, leading to down-regulation of the targets c-Kit and p27Kip1. Down-regulation of p27Kip1 by miR-221 is critical for PDGF-mediated induction of cell proliferation. Additionally, decreased c-Kit causes inhibition of SMC-specific contractile gene transcription by reducing the expression of Myocardin (Myocd), a potent SMC-specific nuclear coactivator. Our study demonstrates that PDGF signaling, by modulating the expression of miR-221, regulates two critical determinants of the vSMC phenotype; they are SMC gene expression and cell proliferation.	[Davis, Brandi N.; Hilyard, Aaron C.; Nguyen, Peter H.; Lagna, Giorgio; Hata, Akiko] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Davis, Brandi N.; Nguyen, Peter H.; Hata, Akiko] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Hata, A (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, 800 Washington St,Box 8486, Boston, MA 02111 USA.	akiko.hata@tufts.edu	Davis-Dusenbery, Brandi/N-2798-2013	Davis-Dusenbery, Brandi/0000-0001-7811-8613	National Institutes of Health [HL082854, HL086572]; NIHLB; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL086572, R01HL082854, R01HL093154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHLB; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082854 (to A. Hata) and HL086572 (to G. L.) (NIHLB). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adnot S, 2005, J CLIN INVEST, V115, P1461, DOI 10.1172/JCI25399; Ali S, 2007, GENE, V401, P38, DOI 10.1016/j.gene.2007.06.017; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Chen DH, 1997, J CLIN INVEST, V99, P2334, DOI 10.1172/JCI119414; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Ghofrani HA, 2005, NEW ENGL J MED, V353, P1412, DOI 10.1056/NEJMc051946; Gross DJ, 2006, ENDOCR-RELAT CANCER, V13, P535, DOI 10.1677/erc.1.01124; Hammond SM, 2006, CANCER CHEMOTH PHARM, V58, pS63, DOI 10.1007/s00280-006-0318-2; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Hinson JS, 2008, AM J PHYSIOL-HEART C, V295, pH1067, DOI 10.1152/ajpheart.91421.2007; Hollenbeck ST, 2004, J SURG RES, V120, P288, DOI 10.1016/j.jss.2004.01.005; Kent D, 2008, CLIN CANCER RES, V14, P1926, DOI 10.1158/1078-0432.CCR-07-5134; Kim HJ, 2008, J NUCL MED, V49, P1686, DOI 10.2967/jnumed.108.052894; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Koff A, 2006, CANCER CELL, V9, P75, DOI 10.1016/j.ccr.2006.01.020; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Mann DL, 2007, NEW ENGL J MED, V356, P2644, DOI 10.1056/NEJMcibr072068; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; McNamara CA, 1996, SEMIN THROMB HEMOST, V22, P139, DOI 10.1055/s-2007-999001; Miano JM, 2004, CIRC RES, V95, P340, DOI 10.1161/01.RES.0000140893.16465.2d; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Morrell Nicholas W, 2006, Proc Am Thorac Soc, V3, P680, DOI 10.1513/pats.200605-118SF; Naeije R, 2004, Bull Mem Acad R Med Belg, V159, P219; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Sanders KM, 2007, J PHYSIOL-LONDON, V578, P33, DOI 10.1113/jphysiol.2006.122473; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Torrado M, 2003, J MOL MED, V81, P566, DOI 10.1007/s00109-003-0470-7; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Weiner JA, 2000, BIOCHEM J, V345, P225, DOI 10.1042/0264-6021:3450225; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yang ZJ, 2007, DNA CELL BIOL, V26, P257, DOI 10.1089/dna.2006.0548; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	67	270	291	0	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3728	3738		10.1074/jbc.M808788200	http://dx.doi.org/10.1074/jbc.M808788200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19088079	Green Published, hybrid			2022-12-27	WOS:000262872500041
J	Wang, C; Chen, TY; Zhang, N; Yang, MJ; Li, B; Lu, X; Cao, XT; Ling, CQ				Wang, Chen; Chen, Taoyong; Zhang, Ning; Yang, Mingjin; Li, Bai; Lu, Xiang; Cao, Xuetao; Ling, Changquan			Melittin, a Major Component of Bee Venom, Sensitizes Human Hepatocellular Carcinoma Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Activating CaMKII-TAK1-JNK/p38 and Inhibiting I kappa B alpha Kinase-NF kappa B (Publication with Expression of Concern. See vol. 295, pg. 8880, 2020) (Withdrawn Publication. See vol. 296, 2021)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							TRAIL-INDUCED APOPTOSIS; HEPATOMA-CELLS; TUMORICIDAL ACTIVITY; MEDIATED APOPTOSIS; DOMAIN PROTEIN; RECEPTOR; TAK1; EXPRESSION; CALCIUM; FAMILY	Promoting apoptosis is a strategy for cancer drug discovery. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in a wide range of malignant cells. However, several cancers, including human hepatocellular carcinoma (HCC), exhibit a major resistance to TRAIL-induced cell death. Melittin, a water-soluble 26-amino acid peptide derived from bee venom of Apis mellifera, can exert toxic or inhibitory effects on many types of tumor cells. Here we report that melittin can induce apoptosis of HCC cells by activating Ca2+/calmodulin-dependent protein kinase, transforming growth factor-beta-activated kinase 1 (TAK1), and JNK/p38 MAPK. We show that melittin-induced apoptosis can be inhibited by calcium chelator, by inhibitors for Ca2+/calmodulin-dependent protein kinase, JNK and p38, and by dominant negative TAK1. In the presence of melittin, TRAIL-induced apoptosis is significantly increased in TRAIL-resistant HCC cells, which may be attributed to melittin-induced TAK1-JNK/p38 activation and melittin-mediated inhibition of I kappa B alpha kinase-NF kappa B. Our data suggest that melittin can synergize with TRAIL in the induction of HCC cell apoptosis by activating the TAK1-JNK/p38 pathway but inhibiting the I kappa B alpha kinase-NF kappa B pathway. Therefore, the combination of melittin with TRAIL may be a promising therapeutic approach in the treatment of TRAIL-resistant human cancer.	[Wang, Chen; Zhang, Ning; Li, Bai; Lu, Xiang; Ling, Changquan] Second Mil Med Univ, Changhai Hosp, Dept Integrat Med, Shanghai 200433, Peoples R China; [Wang, Chen; Chen, Taoyong; Yang, Mingjin; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Wang, Chen; Chen, Taoyong; Yang, Mingjin; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Ling, CQ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Integrat Med, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	lingchangquan@hotmail.com	li, bz/GVR-7133-2022; Ling, Changquan/J-2108-2016	Ling, Changquan/0000-0003-3476-6445; Ling, Changquan/0000-0002-0037-4059	Ministry of Science and Technology of China [2006BAI04A06]; Shanghai Municipal Health Bureau [97BR044-2]; National Natural Science Foundation [30572122]; National Outstanding Doctor Academic Degree Thesis Foundation of China [200775]; National 115 Key Project of Liver Cancer [2008ZX10002-023]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Municipal Health Bureau; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Outstanding Doctor Academic Degree Thesis Foundation of China; National 115 Key Project of Liver Cancer	This work was supported by National Key Project of Scientific and Technical Supporting Programs Grant 2006BAI04A06 provided by the Ministry of Science and Technology of China, 100 Talents Programme Grant 97BR044-2 provided by the Shanghai Municipal Health Bureau, National Natural Science Foundation of Grant 30572122, National Outstanding Doctor Academic Degree Thesis Foundation of China Grant 200775, and National 115 Key Project of Liver Cancer Grant 2008ZX10002-023. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Bouchier-Hayes L, 2001, J BIOL CHEM, V276, P44069, DOI 10.1074/jbc.M107373200; BULLOUGH DA, 1989, BIOCHIM BIOPHYS ACTA, V975, P377, DOI 10.1016/S0005-2728(89)80346-9; Carlo-Stella C, 2007, CLIN CANCER RES, V13, P2313, DOI 10.1158/1078-0432.CCR-06-2774; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen TY, 2004, BLOOD, V103, P413, DOI 10.1182/blood-2003-07-2412; Choo MK, 2006, MOL CANCER THER, V5, P2970, DOI 10.1158/1535-7163.MCT-06-0379; Chu ST, 2007, LIFE SCI, V80, P364, DOI 10.1016/j.lfs.2006.09.024; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; DUKE RC, 1994, FASEB J, V8, P237, DOI 10.1096/fasebj.8.2.8119494; Ganten TM, 2005, HEPATOLOGY, V42, P588, DOI 10.1002/hep.20807; He SG, 2007, CANCER BIOL THER, V6, P1247; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Kim YS, 2002, HEPATOLOGY, V36, P1498, DOI 10.1053/jhep.2002.36942; Li B, 2006, ONKOLOGIE, V29, P367, DOI 10.1159/000094711; Li HZ, 2007, J BIOL CHEM, V282, P4943, DOI 10.1074/jbc.M609494200; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Liu SJ, 2008, HEPATOLOGY, V47, P1964, DOI 10.1002/hep.22240; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; MIX LL, 1984, BIOCHEM BIOPH RES CO, V119, P69, DOI 10.1016/0006-291X(84)91619-X; OKAMOTO T, 1995, TOXICOL APPL PHARM, V133, P150, DOI 10.1006/taap.1995.1136; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1998, FEBS LETT, V424, P41, DOI 10.1016/S0014-5793(98)00135-5; Park HJ, 2007, BIOCHEM PHARMACOL, V73, P237, DOI 10.1016/j.bcp.2006.09.023; Pathil A, 2006, HEPATOLOGY, V43, P425, DOI 10.1002/hep.21054; Raghuraman H, 2007, BIOSCIENCE REP, V27, P189, DOI 10.1007/s10540-006-9030-z; Saini SS, 1999, TOXICON, V37, P1605, DOI 10.1016/S0041-0101(99)00110-5; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Schuchmann M, 2006, ONCOL REP, V15, P227; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Shigeno M, 2003, ONCOGENE, V22, P1653, DOI 10.1038/sj.onc.1206139; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Stuhlmeier KM, 2007, J IMMUNOL, V179, P655, DOI 10.4049/jimmunol.179.1.655; Suliman A, 2001, ONCOGENE, V20, P2122, DOI 10.1038/sj.onc.1204282; Thiefes A, 2005, J BIOL CHEM, V280, P27728, DOI 10.1074/jbc.M411657200; Wajant H, 2000, J BIOL CHEM, V275, P24357, DOI 10.1074/jbc.M000811200; Walczak H, 2000, CANCER RES, V60, P3051; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Wirth T, 2005, CANCER RES, V65, P7393, DOI 10.1158/0008-5472.CAN-04-3664; Yamaguchi Y, 2005, ONCOL REP, V14, P1311; Yamanaka T, 2000, HEPATOLOGY, V32, P482, DOI 10.1053/jhep.2000.16266; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhang YX, 2007, INT J CONTROL AUTOM, V5, P559	48	150	166	1	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3804	3813		10.1074/jbc.M807191200	http://dx.doi.org/10.1074/jbc.M807191200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074436	hybrid			2022-12-27	WOS:000262872500049
J	Kyriakis, JM				Kyriakis, John M.			Thinking Outside the Box about Ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CANCER; ONCOGENES; GTPASES; KINASE		Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA	Tufts Medical Center	Kyriakis, JM (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA.	jkyriakis@tuftsmedicalcenter.org						Bernards A, 2007, GROWTH FACTORS, V25, P355, DOI 10.1080/08977190701830375; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; BOLLAG G, 1998, SEMIN CANCER BIOL, V3, P199; BOS JL, 1989, CANCER RES, V49, P4682; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Dasgupta B, 2003, CURR OPIN GENET DEV, V13, P20, DOI 10.1016/S0959-437X(02)00015-1; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Downward J, 1997, ADV SEC MESS PHOSPH, V31, P1; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Magee T, 1999, CELL, V98, P9, DOI 10.1016/S0092-8674(00)80601-7; McCormick F, 1996, CURR OPIN BIOTECH, V7, P449, DOI 10.1016/S0958-1669(96)80123-6; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; Rodriguez-Viciana P, 2005, COLD SH Q B, V70, P461, DOI 10.1101/sqb.2005.70.044; RodriguezViciana P, 1996, PHILOS T ROY SOC B, V351, P225, DOI 10.1098/rstb.1996.0020; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	22	17	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					10993	10994		10.1074/jbc.R800085200	http://dx.doi.org/10.1074/jbc.R800085200			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19091742	Green Published, hybrid			2022-12-27	WOS:000265494500001
J	Matheny, SA; White, MA				Matheny, Sharon A.; White, Michael A.			Signaling Threshold Regulation by the Ras Effector IMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CELL-CYCLE ARREST; KINASE-ACTIVITY; UBIQUITIN LIGASE; CARCINOMA CELLS; MAPK SCAFFOLD; GROWTH-FACTOR; ZINC-FINGER; T-CELLS; B-RAF; PROTEIN	The Ras effector and E3 ligase family member IMP (impedes mitogenic signal propagation) acts as a steady-state resistor within the Raf-MEK-ERK kinase module. IMP concentrations are directly regulated by Ras, through induction of autoubiquitination, to permit productive Raf-MEK complex assembly. Inhibition of Raf-MEK pathway activation by IMP occurs through the inactivation of KSR, a scaffold/adapter protein that couples activated Raf to its substrate MEK1. The capacity of IMP to inhibit signal propagation through Raf to MEK is, in part, a consequence of disrupting KSR1 homo-oligomerization and c-Raf-B-Raf hetero-oligomerization. These observations suggest that IMP functions as a threshold modulator, controlling sensitivity of the cascade to stimulus by directly limiting the assembly of functional KSR1-dependent Raf-MEK complexes.	[White, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Matheny, Sharon A.] Zimmer Biol, Austin, TX 78729 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	White, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu			National Institutes of Health [CA71443]; Robert Welch Foundation [I-1414]; NATIONAL CANCER INSTITUTE [R01CA071443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA71443. This work was also supported by Robert Welch Foundation Grant I-1414. This is the third article of three in the Thematic Minireview Series on Novel Ras Effectors. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Brennan JA, 2002, J BIOL CHEM, V277, P5369, DOI 10.1074/jbc.M109875200; Bumeister R, 2004, CURR BIOL, V14, P439, DOI 10.1016/j.cub.2004.02.037; Chen C, 2008, J BIOL CHEM, V283, P12789, DOI 10.1074/jbc.M709305200; Cichowski K, 2003, GENE DEV, V17, P449, DOI 10.1101/gad.1054703; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Czyzyk J, 2008, J BIOL CHEM, V283, P23004, DOI 10.1074/jbc.M804084200; Edin ML, 2005, MOL CELL BIOL, V25, P4466, DOI 10.1128/MCB.25.11.4466-4475.2005; Esch RK, 2002, P NATL ACAD SCI USA, V99, P9160, DOI 10.1073/pnas.142034399; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Harbers M, 2001, J BIOL CHEM, V276, P48596, DOI 10.1074/jbc.M108077200; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Janes KA, 2008, CELL, V135, P343, DOI 10.1016/j.cell.2008.08.034; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Lovatt M, 2006, MOL CELL BIOL, V26, P8655, DOI 10.1128/MCB.00168-06; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Luo ZJ, 1997, MOL CELL BIOL, V17, P46, DOI 10.1128/MCB.17.1.46; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Morrison DK, 2001, J CELL SCI, V114, P1609; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Persons DL, 1999, CLIN CANCER RES, V5, P1007; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Razidlo GL, 2004, J BIOL CHEM, V279, P47808, DOI 10.1074/jbc.M406395200; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Roy S, 1997, J BIOL CHEM, V272, P20139, DOI 10.1074/jbc.272.32.20139; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Sobko A, 2002, DEV CELL, V2, P745, DOI 10.1016/S1534-5807(02)00186-7; Stewart S, 1999, MOL CELL BIOL, V19, P5523; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vial E, 2003, J CELL SCI, V116, P4957, DOI 10.1242/jcs.00812; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Wang YQ, 2002, J BIOL CHEM, V277, P15766, DOI 10.1074/jbc.M111733200; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yazlovitskaya EM, 1999, MOL CARCINOGEN, V25, P14, DOI 10.1002/(SICI)1098-2744(199905)25:1<14::AID-MC2>3.0.CO;2-V	49	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11007	11011		10.1074/jbc.R800082200	http://dx.doi.org/10.1074/jbc.R800082200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19091743	hybrid, Green Published			2022-12-27	WOS:000265494500004
J	Varmeh, S; Manfredi, JJ				Varmeh, Shohreh; Manfredi, James J.			Inappropriate Activation of Cyclin-dependent Kinases by the Phosphatase Cdc25b Results in Premature Mitotic Entry and Triggers a p53-dependent Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE RESPONSE; CELL-CYCLE; TUMOR-SUPPRESSOR; AURORA-A; MITOSIS; PHOSPHORYLATION; TRANSITION; P53; PROTEIN	The dual specificity phosphatase Cdc25B is capable of inhibiting cellular proliferation, and this occurs in a manner dependent upon its catalytic activity. Here it is shown that this is accompanied by inappropriate cyclin-dependent kinase activation and premature mitotic entry, leading to both p53-dependent and independent checkpoints. Forced expression of Cdc25B inappropriately upregulated the activity of Cdk1 and Cdk2, by reducing levels of inhibitory phosphorylation. In cells lacking p14ARF, p53 is induced, and components of the ATM and ATR pathways are activated. Cdc25B triggers cell cycle arrest in the G1 and G2 phases that is p53- and p21-dependent and is inhibited by caffeine. Cdc25B also causes cells with an S phase DNA content to enter mitosis prematurely in a p53- independent manner. Synchronization of cells with aphidicolin results in these cells undergoing apoptosis. Thus, inappropriate cell cycle progression and premature mitotic entry via dysregulation of cyclin-dependent kinases results in activation of both p53 dependent and independent responses. Because Cdc25B is known to have oncogenic activity, this provides insight into the multistep nature of cancer development and why there is p53 loss during tumorigenesis.	[Varmeh, Shohreh; Manfredi, James J.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Manfredi, JJ (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, Box 1130, New York, NY 10029 USA.	james.manfredi@mssm.edu			NCI [R01 CA86001]; Dept. of Defense Breast Cancer Research Program [W81XWH-05-1-0305]; NATIONAL CANCER INSTITUTE [R01CA086001] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dept. of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA86001 from the NCI. This work was also supported by Dept. of Defense Breast Cancer Research Program Grant W81XWH-05-1-0305. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Cazales M, 2005, CELL CYCLE, V4, P1233, DOI 10.4161/cc.4.9.1964; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Gabrielli BG, 1997, J BIOL CHEM, V272, P28607, DOI 10.1074/jbc.272.45.28607; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; GALAKTIONOV K, 1995, GENE DEV, V9, P1046, DOI 10.1101/gad.9.9.1046; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Goldstone S, 2001, ONCOGENE, V20, P921, DOI 10.1038/sj.onc.1204177; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Guadagno TM, 1996, CELL, V84, P73, DOI 10.1016/S0092-8674(00)80994-0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Kudo Y, 1997, JPN J CANCER RES, V88, P947, DOI 10.1111/j.1349-7006.1997.tb00313.x; Lammer C, 1998, J CELL SCI, V111, P2445; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Lowe SW, 1999, ENDOCR-RELAT CANCER, V6, P45, DOI 10.1677/erc.0.0060045; Ma ZQ, 1999, ONCOGENE, V18, P4564, DOI 10.1038/sj.onc.1202809; MEIJER L, 1991, EMBO J, V10, P1545, DOI 10.1002/j.1460-2075.1991.tb07674.x; MILLAR JBA, 1991, P NATL ACAD SCI USA, V88, P10500, DOI 10.1073/pnas.88.23.10500; Miyata H, 2000, CLIN CANCER RES, V6, P4859; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nishijima H, 1997, J CELL BIOL, V138, P1105, DOI 10.1083/jcb.138.5.1105; Royds JA, 2006, CELL DEATH DIFFER, V13, P1017, DOI 10.1038/sj.cdd.4401913; Sambrook J., 2001, MOL CLONING LAB MANU; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; Varmeh-Ziaie S, 2007, J BIOL CHEM, V282, P24633, DOI 10.1074/jbc.M703105200; Wilborn M, 2001, BIOCHEMISTRY-US, V40, P14200, DOI 10.1021/bi015638h; Xu X, 1996, J BIOL CHEM, V271, P5118; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	53	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9475	9488		10.1074/jbc.M900037200	http://dx.doi.org/10.1074/jbc.M900037200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19136558	Green Published, hybrid			2022-12-27	WOS:000264669100054
J	Deevska, GM; Rozenova, KA; Giltiay, NV; Chambers, MA; White, J; Boyanovsky, BB; Wei, J; Daugherty, A; Smart, EJ; Reid, MB; Merrill, AH; Nikolova-Karakashian, M				Deevska, Gergana M.; Rozenova, Krassimira A.; Giltiay, Natalia V.; Chambers, Melissa A.; White, James; Boyanovsky, Boris B.; Wei, Jia; Daugherty, Alan; Smart, Eric J.; Reid, Michael B.; Merrill, Alfred H., Jr.; Nikolova-Karakashian, Mariana			Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE CELLS; NIEMANN-PICK DISEASE; METABOLIC SYNDROME; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID METABOLISM; CERAMIDE SYNTHESIS; INHIBITION; OBESITY; LIVER	Acid sphingomyelinase plays important roles in ceramide homeostasis, which has been proposed to be linked to insulin resistance. To test this association in vivo, acid sphingomyelinase deletion (asm(-/-)) was transferred to mice lacking the low density lipoprotein receptor (ldlr(-/-)), and then offsprings were placed on control or modified (enriched in saturated fat and cholesterol) diets for 10 weeks. The modified diet caused hypercholesterolemia in all genotypes; however, in contrast to asm(-/-) / ldlr(-/-), the acid sphingomyelinase-deficient littermates did not display hepatic triacylglyceride accumulation, although sphingomyelin and other sphingolipids were substantially elevated, and the liver was enlarged. asm(-/-) / ldlr(-/-) mice on a modified diet did not accumulate body fat and were protected against diet-induced hyperglycemia and insulin resistance. Experiments with hepatocytes revealed that acid sphingomyelinase regulates the partitioning of the major fatty acid in the modified diet, palmitate, into two competitive and inversely related pools, triacylglycerides and sphingolipids, apparently via modulation of serine palmitoyltransferase, a rate-limiting enzyme in de novo sphingolipid synthesis. These studies provide evidence that acid sphingomyelinase activity plays an essential role in the regulation of glucose metabolism by regulating the hepatic accumulation of triacylglycerides and sphingolipids during consumption of a diet rich in saturated fats.	[Nikolova-Karakashian, Mariana] Univ Kentucky, Coll Med, Albert B Chandler Med Ctr, Dept Physiol, Lexington, KY 40536 USA; [White, James; Smart, Eric J.] Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY 40536 USA; [Daugherty, Alan] Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY 40536 USA; [Wei, Jia; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Dept Mol Cell Biol, Atlanta, GA 30332 USA; [Wei, Jia; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University of Kentucky; University of Kentucky; University of Kentucky; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Nikolova-Karakashian, M (corresponding author), Univ Kentucky, Coll Med, Albert B Chandler Med Ctr, Dept Physiol, 800 Rose St, Lexington, KY 40536 USA.	mnikolo@uky.edu	Daugherty, Alan/C-8282-2009; Boyanovsky, Boris/AAQ-5194-2021; Giltiay, Natalia/AAH-2130-2019; Giltiay, Natalia V./H-8655-2019	Daugherty, Alan/0000-0003-2093-3775; Giltiay, Natalia/0000-0001-7284-514X; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [R01 AG 19223]; American Heart Association Scientist Development [0130238N, P20RR15592]; LIPID MAPS Consortium [GM069338]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019223, R01AG026711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development(American Heart Association); LIPID MAPS Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG 19223 (NIA to M. N. K.). This work was also supported by American Heart Association Scientist Development Grants 0130238N (to N. K.) and P20RR15592 (to E. J. S.) and LIPID MAPS Consortium Grant GM069338 (to A. H. M.).	Bagnato C, 2003, J BIOL CHEM, V278, P52203, DOI 10.1074/jbc.M305760200; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; CROCKER AC, 1958, MEDICINE, V37, P1, DOI 10.1097/00005792-195802000-00001; den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e; Dickson RC, 2000, METHOD ENZYMOL, V311, P3; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Ghosh N, 2007, ENDOCRINOLOGY, V148, P1359, DOI 10.1210/en.2006-0750; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; JeBailey L, 2007, DIABETES, V56, P394, DOI 10.2337/db06-0823; KAHOVCOVA J, 1969, J CHROMATOGR, V40, P90, DOI 10.1016/S0021-9673(01)96622-1; KOVAL M, 1990, J CELL BIOL, V111, P429, DOI 10.1083/jcb.111.2.429; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Leventhal AR, 2001, J BIOL CHEM, V276, P44976, DOI 10.1074/jbc.M106455200; MacDonald MLE, 2008, J LIPID RES, V49, P217, DOI 10.1194/jlr.M700478-JLR200; Marathe S, 1999, ARTERIOSCL THROM VAS, V19, P2648, DOI 10.1161/01.ATV.19.11.2648; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MERRILL AH, 1995, J BIOL CHEM, V270, P13834, DOI 10.1074/jbc.270.23.13834; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Reynoso R, 2003, MOL CELL BIOCHEM, V246, P155, DOI 10.1023/A:1023423005187; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Turpin SM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1341, DOI 10.1152/ajpendo.00095.2006; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; Worgall TS, 2002, J BIOL CHEM, V277, P3878, DOI 10.1074/jbc.M102393200; Wu L, 2006, J LIPID RES, V47, P2215, DOI 10.1194/jlr.M600146-JLR200; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	36	66	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8359	8368		10.1074/jbc.M807800200	http://dx.doi.org/10.1074/jbc.M807800200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19074137	Green Published, hybrid			2022-12-27	WOS:000264397800020
J	Wies, E; Hahn, AS; Schmidt, K; Viebahn, C; Rohland, N; Lux, A; Schellhorn, T; Holzer, A; Jung, JU; Neipel, F				Wies, Effi; Hahn, Alexander S.; Schmidt, Katharina; Viebahn, Cornelia; Rohland, Nadine; Lux, Anja; Schellhorn, Tim; Holzer, Angela; Jung, Jae U.; Neipel, Frank			The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR; EPSTEIN-BARR-VIRUS; HHV8 ASSOCIATED DISEASES; TRANSCRIPTION FACTOR; EFFUSION LYMPHOMA; DNA-SEQUENCES; SIGNAL-TRANSDUCTION; CASTLEMANS-DISEASE; INDUCED APOPTOSIS; VIRAL-INFECTION	Kaposi's sarcoma-associated herpesvirus encodes four genes with homology to the family of interferon regulatory factors (IRFs). At least one of these viral IRFs, vIRF-3, is expressed in latently Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma (PEL) cells and is essential for the survival of PEL cells. We now report that vIRF-3 interacts with cellular IRF-5, thereby inhibiting binding of IRF-5 to interferon-responsive promoter elements. Consequently, vIRF-3 blocked IRF-5-mediated promoter activation. A central double helix motif present in vIRF-3 was sufficient to abrogate both DNA binding and transcriptional transactivation by IRF-5. Upon DNA damage or activation of the interferon or Toll-like receptor pathways, cytoplasmic IRF-5 has been reported to be translocated to the nucleus, which results in induction of both p53-independent apoptosis and p21-mediated cell cycle arrest. We report here that IRF-5 is present in the nuclei of PEL cells without interferon stimulation. Silencing of vIRF-3 expression in PEL cells was accompanied by increased sensitivity to interferon-mediated apoptosis and up-regulation of IRF-5 target genes. In addition, vIRF-3 antagonized IRF-5-mediated activation of the p21 promoter. The data presented here indicate that vIRF-3 contributes to immune evasion and sustained proliferation of PEL cells by releasing IRF-5 from transcription complexes.	[Schellhorn, Tim; Holzer, Angela; Neipel, Frank] Univ Klinikum Erlangen, Inst Virol, D-91054 Erlangen, Germany; [Jung, Jae U.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA USA	University of Erlangen Nuremberg; University of Southern California	Neipel, F (corresponding author), Univ Klinikum Erlangen, Inst Virol, Schlossgarten 4, D-91054 Erlangen, Germany.	Frank.Neipel@viro.med.uni-erlangen.de	Hahn, Alexander/ABE-5642-2021	Hahn, Alexander/0000-0003-4171-2744; Schmidt, Katharina/0000-0003-2797-9952; Lux, Anja/0000-0001-9475-2147	Deutsche Forschungsgemeinschaft [SFB 643]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 643 and Graduate School 1071, " Viruses of the Immune System," the IZKF Erlangen, the European Community research project TargetHerpes, and the Mainzer Akademie der Wissenschaften und der Literatur. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arvanitakis L, 1996, BLOOD, V88, P2648, DOI 10.1182/blood.V88.7.2648.bloodjournal8872648; Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Birkmann A, 2001, J VIROL, V75, P11583, DOI 10.1128/JVI.75.23.11583-11593.2001; Cannon JS, 2000, J VIROL, V74, P10187, DOI 10.1128/JVI.74.21.10187-10193.2000; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Cheng TF, 2006, J IMMUNOL, V176, P7462, DOI 10.4049/jimmunol.176.12.7462; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Cunningham C, 2003, J GEN VIROL, V84, P1471, DOI 10.1099/vir.0.19015-0; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Esteban M, 2003, J GEN VIROL, V84, P1463, DOI 10.1099/vir.0.19014-0; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Harada H, 1998, BIOCHIMIE, V80, P641, DOI 10.1016/S0300-9084(99)80017-0; Hengge UR, 2002, LANCET INFECT DIS, V2, P281, DOI 10.1016/S1473-3099(02)00263-3; Hengge UR, 2002, LANCET INFECT DIS, V2, P344, DOI 10.1016/S1473-3099(02)00288-8; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Hu GD, 2006, EXPERT REV ANTICANC, V6, P775, DOI 10.1586/14737140.6.5.775; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; Kliche S, 2001, MOL CELL, V7, P833, DOI 10.1016/S1097-2765(01)00227-1; Kovaleva M, 2006, J VIROL, V80, P8510, DOI 10.1128/JVI.00420-06; Lee H, 1998, NAT MED, V4, P435, DOI 10.1038/nm0498-435; Lin RT, 2005, J BIOL CHEM, V280, P3088, DOI 10.1074/jbc.M408452200; Lubyova B, 2004, J BIOL CHEM, V279, P7643, DOI 10.1074/jbc.M309485200; Lubyova B, 2007, J BIOL CHEM, V282, P31944, DOI 10.1074/jbc.M706430200; MANCL ME, 2005, J BIOL CHEM, P21090; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Moore PS, 2003, ANNU REV MICROBIOL, V57, P609, DOI 10.1146/annurev.micro.57.030502.090824; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Munoz-Fontela C, 2007, J VIROL, V81, P1511, DOI 10.1128/JVI.01816-06; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Rivas C, 2001, J VIROL, V75, P429, DOI 10.1128/JVI.75.1.429-438.2001; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Schulz TF, 2006, J PATHOL, V208, P187, DOI 10.1002/path.1904; Seo T, 2004, ONCOGENE, V23, P6146, DOI 10.1038/sj.onc.1207807; Shin YC, 2006, J VIROL, V80, P2257, DOI 10.1128/JVI.80.5.2257-2266.2006; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Swanton C, 1997, NATURE, V390, P184, DOI 10.1038/36606; Szremska AP, 2003, BLOOD, V102, P4159, DOI 10.1182/blood-2003-03-0915; TAKAOKA A, 2008, CANC SCI; Wessely R, 2003, HUM MOL GENET, V12, P177, DOI 10.1093/hmg/ddg018; Wies E, 2008, BLOOD, V111, P320, DOI 10.1182/blood-2007-05-092288; Xu DS, 2008, J VIROL, V82, P6251, DOI 10.1128/JVI.00163-08; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhang LW, 2001, SEMIN CANCER BIOL, V11, P445, DOI 10.1006/scbi.2001.0411; Zimring JC, 1998, J VIROL, V72, P701, DOI 10.1128/JVI.72.1.701-707.1998	54	58	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8525	8538		10.1074/jbc.M809252200	http://dx.doi.org/10.1074/jbc.M809252200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19129183	hybrid, Green Published			2022-12-27	WOS:000264397800037
J	Anyatonwu, G; Joseph, SK				Anyatonwu, Georgia; Joseph, Suresh K.			Surface Accessibility and Conformational Changes in the N-terminal Domain of Type I Inositol Trisphosphate Receptors STUDIES USING CYSTEINE SUBSTITUTION MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING SITE; 1,4,5-TRISPHOSPHATE RECEPTOR; FUNCTIONAL-PROPERTIES; ANION CHANNEL; IP3 RECEPTORS; PORE; PHOSPHORYLATION; ORGANIZATION; EXPRESSION; LOCATION	To identify surface-accessible residues and monitor conformational changes of the type I inositol 1,4,5-trisphosphate receptor protein in membranes, we have introduced 10 cysteine substitutions into the N-terminal ligand-binding domain. The reactivity of these mutants with progressively larger maleimide-polyethylene glycol derivatives (MPEG) was measured using a gel shift assay of tryptic fragments. The results indicate that the mutations fall into four categories as follows: sites that are highly accessible based on reactivity with the largest 20-kDa MPEG (S2C); sites that are moderately accessible based on reactivity only with 5-kDa MPEG (S6C, S7C, A189C, and S277C); sites whose accessibility is markedly enhanced by Ca2+ (S171C, S277C, and A575C); and sites that are inaccessible irrespective of incubation conditions (S217C, A245C, and S436C). The stimulation of accessibility induced by Ca2+ at the S277C site occurred with an EC50 of 0.8 mu M and was mimicked by Sr2+ but not Ba2+. Inositol 1,4,5-trisphosphate alone did not affect reactivity of any of the mutants in the presence or absence of Ca2+. The data are interpreted using crystal structures and EM reconstructions of the receptor. Our data identify N-terminal regions of the protein that become exposed upon Ca2+ binding and suggest possible orientations of the suppressor and ligand-binding domains that have implications for the mechanism of gating of the channel.	[Anyatonwu, Georgia; Joseph, Suresh K.] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA	Jefferson University	Joseph, SK (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Rm 230A JAH,1020 Locust St, Philadelphia, PA 19107 USA.	suresh.joseph@efferson.edu			National Institutes of Health [DK34804, T32-AA07463]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK34804 (to S. K. J.) and T32-AA07463 (training grant to G. A.). The costs of publication of this article were defrayed in part by the payment of page charges.	Bai GR, 2006, BIOCHEM BIOPH RES CO, V348, P1319, DOI 10.1016/j.bbrc.2006.07.208; Bauer PJ, 2005, BIOCHEMISTRY-US, V44, P1624, DOI 10.1021/bi0478749; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Chan J, 2007, J MOL BIOL, V373, P1269, DOI 10.1016/j.jmb.2007.08.057; da Fonseca PCA, 2003, P NATL ACAD SCI USA, V100, P3936, DOI 10.1073/pnas.0536251100; Desai SA, 1997, P NATL ACAD SCI USA, V94, P2045, DOI 10.1073/pnas.94.5.2045; Fernandez-Cobo M, 1999, CYTOKINE, V11, P216, DOI 10.1006/cyto.1998.0422; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Guo ZY, 2005, BIOCHEMISTRY-US, V44, P6537, DOI 10.1021/bi047409b; Hamada K, 2003, J BIOL CHEM, V278, P52881, DOI 10.1074/jbc.M309743200; Hamada K, 2002, J BIOL CHEM, V277, P21115, DOI 10.1074/jbc.C200244200; Howorka S, 2000, J BIOL CHEM, V275, P37876, DOI 10.1074/jbc.M003838200; Howorka S, 2000, J AM CHEM SOC, V122, P2411, DOI 10.1021/ja993221h; Jiang QX, 2002, EMBO J, V21, P3575, DOI 10.1093/emboj/cdf380; Joseph SK, 2006, BIOCHEM J, V393, P575, DOI 10.1042/BJ20050889; Joseph SK, 2005, CELL CALCIUM, V38, P539, DOI 10.1016/j.ceca.2005.07.007; Joseph SK, 1997, J BIOL CHEM, V272, P1579, DOI 10.1074/jbc.272.3.1579; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; Kasri NN, 2004, MOL PHARMACOL, V66, P276, DOI 10.1124/mol.66.2.276; Khan MT, 2007, J BIOL CHEM, V282, P32983, DOI 10.1074/jbc.M705183200; Lee B, 2006, DEVELOPMENT, V133, P4355, DOI 10.1242/dev.02624; LIN JK, 1987, BIOTECHNOL BIOENG, V29, P976, DOI 10.1002/bit.260290809; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; MARSHALL ICB, 1994, BIOCHEM J, V301, P591, DOI 10.1042/bj3010591; Merzlyak PG, 1999, BIOPHYS J, V77, P3023, DOI 10.1016/S0006-3495(99)77133-X; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Movileanu L, 2001, J GEN PHYSIOL, V117, P239, DOI 10.1085/jgp.117.3.239; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Peyronnet O, 2002, BBA-BIOMEMBRANES, V1567, P113, DOI 10.1016/S0005-2736(02)00605-3; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Ramos-Franco J, 1998, BIOPHYS J, V75, P834, DOI 10.1016/S0006-3495(98)77572-1; Riley AM, 2002, J BIOL CHEM, V277, P40290, DOI 10.1074/jbc.M206925200; Sabirov RZ, 2004, BIOPHYS J, V87, P1672, DOI 10.1529/biophysj.104.043174; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Serysheva II, 2003, J BIOL CHEM, V278, P21319, DOI 10.1074/jbc.C300148200; Srikanth S, 2004, BIOPHYS J, V86, P3634, DOI 10.1529/biophysj.104.040121; Tanimura A, 2004, J BIOL CHEM, V279, P38095, DOI 10.1074/jbc.C400312200; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Ternovsky VI, 2004, FEBS LETT, V576, P433, DOI 10.1016/j.febslet.2004.09.051; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316	52	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8093	8102		10.1074/jbc.M806932200	http://dx.doi.org/10.1074/jbc.M806932200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19141613	hybrid, Green Published			2022-12-27	WOS:000264195600072
J	Bailey, MJ; Coon, SL; Carter, DA; Humphries, A; Kim, JS; Shi, Q; Gaildrat, P; Morin, F; Ganguly, S; Hogenesch, JB; Weller, JL; Rath, MF; Moller, M; Baler, R; Sugden, D; Rangel, ZG; Munson, PJ; Klein, DC				Bailey, Michael J.; Coon, Steven L.; Carter, David A.; Humphries, Ann; Kim, Jong-So; Shi, Qiong; Gaildrat, Pascaline; Morin, Fabrice; Ganguly, Surajit; Hogenesch, John B.; Weller, Joan L.; Rath, Martin F.; Moller, Morten; Baler, Ruben; Sugden, David; Rangel, Zoila G.; Munson, Peter J.; Klein, David C.			Night/Day Changes in Pineal Expression of > 600 Genes CENTRAL ROLE OF ADRENERGIC/cAMP SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ARYLALKYLAMINE-N-ACETYLTRANSFERASE; O-METHYLTRANSFERASE ACTIVITY; OTX2 HOMEOBOX GENE; RAT PINEAL; MELATONIN SYNTHESIS; THYROID-HORMONE; MESSENGER-RNA; E-BOX; CIRCADIAN CLOCK; DAILY RHYTHM	The pineal gland plays an essential role in vertebrate chronobiology by converting time into a hormonal signal, melatonin, which is always elevated at night. Here we have analyzed the rodent pineal transcriptome using Affymetrix GeneChip (R) technology to obtain a more complete description of pineal cell biology. The effort revealed that 604 genes (1,268 probe sets) with Entrez Gene identifiers are differentially expressed greater than 2-fold between midnight and mid-day (false discovery rate <0.20). Expression is greater at night in similar to 70%. These findings were supported by the results of radiochemical in situ hybridization histology and quantitative real time-PCR studies. We also found that the regulatory mechanism controlling the night/day changes in the expression of most genes involves norepinephrine-cyclic AMP signaling. Comparison of the pineal gene expression profile with that in other tissues identified 334 genes (496 probe sets) that are expressed greater than 8-fold higher in the pineal gland relative to other tissues. Of these genes, 17% are expressed at similar levels in the retina, consistent with a common evolutionary origin of these tissues. Functional categorization of the highly expressed and/or night/day differentially expressed genes identified clusters that are markers of specialized functions, including the immune/inflammation response, melatonin synthesis, photodetection, thyroid hormone signaling, and diverse aspects of cellular signaling and cell biology. These studies produce a paradigm shift in our understanding of the 24-h dynamics of the pineal gland from one focused on melatonin synthesis to one including many cellular processes.	[Bailey, Michael J.; Coon, Steven L.; Kim, Jong-So; Shi, Qiong; Gaildrat, Pascaline; Morin, Fabrice; Ganguly, Surajit; Weller, Joan L.; Klein, David C.] NICHD, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Carter, David A.; Humphries, Ann] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Hogenesch, John B.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Rath, Martin F.; Moller, Morten] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Baler, Ruben] NIMH, Unit Temporal Gene Express, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA; [Sugden, David] Kings Coll London, Sch Biomed & Hlth Sci, Div Reprod & Endocrinol, London SE1 1UL, England; [Rangel, Zoila G.; Munson, Peter J.] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cardiff University; Novartis; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of London; King's College London; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Klein, DC (corresponding author), 49 Convent Dr,Bldg 49,Rm 6A82, Bethesda, MD 20892 USA.	kleind@mail.nih.gov	Carter, David/A-4479-2010; Rath, Martin/AAL-9732-2021	Carter, David/0000-0002-8419-3975; Morin, Fabrice/0000-0001-6785-1967; Klein, David/0000-0002-1792-5806; Moller, Morten/0000-0002-3263-7482; Rath, Martin/0000-0002-4047-6324; Ganguly, Surajit/0000-0002-1876-9147	CENTER FOR INFORMATION TECHNOLOGY [ZIACT000266] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008838, ZIAHD008837, ZIAHD008836] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIMH NIH HHS [P50 MH074924] Funding Source: Medline; NINDS NIH HHS [R01 NS054794] Funding Source: Medline; Wellcome Trust Funding Source: Medline	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALTSHULER D, 1993, DEVELOPMENT, V119, P1317; Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Appelbaum L, 2006, J MOL ENDOCRINOL, V36, P337, DOI 10.1677/jme.1.01893; Appelbaum L, 2005, J BIOL CHEM, V280, P11544, DOI 10.1074/jbc.M412935200; Appelbaum L, 2004, MOL ENDOCRINOL, V18, P1210, DOI 10.1210/me.2003-0439; Appelbaum L, 2006, MOL CELL ENDOCRINOL, V252, P27, DOI 10.1016/j.mce.2006.03.021; ARAKI M, 1990, CELL DIFFER DEV, V31, P129, DOI 10.1016/0922-3371(90)90016-P; ARAKI M, 1992, DEV BIOL, V149, P440, DOI 10.1016/0012-1606(92)90298-U; ARENDT J, 1994, MELATONIN MAMMALIAN, P1; AUERBACH DA, 1981, ENDOCRINOLOGY, V108, P559, DOI 10.1210/endo-108-2-559; Auerbach G, 2000, P NATL ACAD SCI USA, V97, P13567, DOI 10.1073/pnas.240463497; Bai L, 2008, BRAIN RES, V1203, P89, DOI 10.1016/j.brainres.2008.01.073; Bajic Vladimir B., 2004, In Silico Biology, V4, P109; BALER R, 1995, J BIOL CHEM, V270, P27319, DOI 10.1074/jbc.270.45.27319; Baler R, 1997, J BIOL CHEM, V272, P6979, DOI 10.1074/jbc.272.11.6979; Baler R, 1996, BIOCHEM BIOPH RES CO, V220, P975, DOI 10.1006/bbrc.1996.0517; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard M, 1996, J NEUROCHEM, V67, P1032; Bernard M, 1997, J NEUROCHEM, V68, P213; Bernard M, 2001, J NEUROCHEM, V79, P248, DOI 10.1046/j.1471-4159.2001.00555.x; Borjigin J, 1999, J NEUROSCI, V19, P1018; Borjigin J, 1999, J BIOL CHEM, V274, P35012, DOI 10.1074/jbc.274.49.35012; Borjigin J, 2003, J BIOL CHEM, V278, P16315, DOI 10.1074/jbc.M300828200; Ceinos RM, 2004, NEUROSIGNALS, V13, P308, DOI 10.1159/000081966; Chen W, 2000, MOL BRAIN RES, V81, P43, DOI 10.1016/S0169-328X(00)00160-1; Chik CL, 2007, ENDOCRINOLOGY, V148, P1465, DOI 10.1210/en.2006-1454; CHIK CL, 1988, ENDOCRINOLOGY, V122, P702, DOI 10.1210/endo-122-2-702; Coon SL, 1997, MOL PHARMACOL, V51, P551, DOI 10.1124/mol.51.4.551; Davies JS, 2006, MOL CELL ENDOCRINOL, V252, P19, DOI 10.1016/j.mce.2006.03.020; Dinet V, 2006, EXP EYE RES, V83, P276, DOI 10.1016/j.exer.2005.12.011; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Estivill-Torrus G, 2001, MECH DEVELOP, V109, P215, DOI 10.1016/S0925-4773(01)00527-5; Falcon J, 2003, J NEUROENDOCRINOL, V15, P378, DOI 10.1046/j.1365-2826.2003.00993.x; FALCON J, 1989, J NEUROSCI, V9, P1943; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Foulkes NS, 1996, NATURE, V381, P83, DOI 10.1038/381083a0; Fukada Y, 2002, MOL NEUROBIOL, V25, P19, DOI 10.1385/MN:25:1:019; Fukuhara C, 2004, J NEUROSCI, V24, P1803, DOI 10.1523/JNEUROSCI.4988-03.2004; Fukuhara C, 2003, J PINEAL RES, V35, P196, DOI 10.1034/j.1600-079X.2003.00078.x; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gaildrat P, 2005, J BIOL CHEM, V280, P16851, DOI 10.1074/jbc.M414587200; Ganguly S, 2007, J BIOL CHEM, V282, P32758, DOI 10.1074/jbc.M705950200; Gehring WJ, 2002, INT J DEV BIOL, V46, P65; Gothilf Y, 2002, DEV DYNAM, V225, P241, DOI 10.1002/dvdy.10152; Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895; HADA T, 1994, BBA-LIPID LIPID MET, V1211, P221, DOI 10.1016/0005-2760(94)90272-0; Harpavat S, 2003, THYROID, V13, P1013, DOI 10.1089/105072503770867183; Ho AK, 2007, ENDOCRINOLOGY, V148, P4592, DOI 10.1210/en.2007-0578; Ho AK, 2007, ENDOCRINOLOGY, V148, P743, DOI 10.1210/en.2006-1154; HO AK, 1988, J PINEAL RES, V5, P553, DOI 10.1111/j.1600-079X.1988.tb00798.x; HO AK, 1987, J BIOL CHEM, V262, P11764; HO AK, 1987, J NEUROCHEM, V48, P1033, DOI 10.1111/j.1471-4159.1987.tb05622.x; Humphries A, 2002, J NEUROENDOCRINOL, V14, P101, DOI 10.1046/j.0007-1331.2001.00738.x; Humphries A, 2007, MOL CELL ENDOCRINOL, V270, P43, DOI 10.1016/j.mce.2007.02.003; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Iuvone PM, 1997, BIOL SIGNAL, V6, P217; Karolczak M, 2004, EUR J NEUROSCI, V19, P3382, DOI 10.1111/j.0953-816X.2004.03444.x; Kim JS, 2007, ENDOCRINOLOGY, V148, P1475, DOI 10.1210/en.2006-1420; Kim JS, 2005, J BIOL CHEM, V280, P677, DOI 10.1074/jbc.M408438200; Kimura A, 2000, J BIOL CHEM, V275, P1152, DOI 10.1074/jbc.275.2.1152; Klein D C, 1983, Prog Clin Biol Res, V125, P169; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Klein DC, 2006, CHRONOBIOL INT, V23, P5, DOI 10.1080/07420520500545839; KLEIN DC, 1985, CIBA F SYMP, V117, P38; Klein DC, 2004, J BIOL RHYTHM, V19, P264, DOI 10.1177/0748730404267340; KLEIN DC, 1983, P NATL ACAD SCI-BIOL, V80, P599, DOI 10.1073/pnas.80.2.599; Kofler B, 2002, HISTOCHEM J, V34, P167, DOI 10.1023/A:1020946631937; Kohrle J, 2005, THYROID, V15, P841, DOI 10.1089/thy.2005.15.841; LAITINEN JT, 1995, CELL MOL NEUROBIOL, V15, P177, DOI 10.1007/BF02073327; Li AM, 2003, INVEST OPHTH VIS SCI, V44, P996, DOI 10.1167/iovs.02-0434; Li XD, 1998, P NATL ACAD SCI USA, V95, P1876, DOI 10.1073/pnas.95.4.1876; Lincoln GA, 2006, CHRONOBIOL INT, V23, P301, DOI 10.1080/07420520500464452; Mani SS, 1999, J BIOL CHEM, V274, P15590, DOI 10.1074/jbc.274.22.15590; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; Maronde E, 2007, TRENDS ENDOCRIN MET, V18, P142, DOI 10.1016/j.tem.2007.03.001; McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; Moller M, 2006, CHRONOBIOL INT, V23, P393, DOI 10.1080/07420520500521855; Moller M, 1997, CELL TISSUE RES, V288, P279, DOI 10.1007/s004410050813; Munoz EM, 2007, J NEUROCHEM, V102, P887, DOI 10.1111/j.1471-4159.2007.04605.x; MURAKAMI M, 1989, LIFE SCI, V44, P425, DOI 10.1016/0024-3205(89)90267-1; Namihira M, 1999, NEUROSCI LETT, V267, P69, DOI 10.1016/S0304-3940(99)00324-9; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; NIR I, 1978, J NEURAL TRANSM, V42, P117, DOI 10.1007/BF01675350; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; PACEASCIAK CR, 1993, BIOCHEM BIOPH RES CO, V197, P869, DOI 10.1006/bbrc.1993.2559; PACEASCIAK CR, 1995, J LIPID MEDIAT CELL, V12, P307, DOI 10.1016/0929-7855(95)00036-P; PARFITT A, 1976, NEUROPHARMACOLOGY, V15, P353, DOI 10.1016/0028-3908(76)90083-6; RATH M, 2009, ENDOCRINOLO IN PRESS; Rath MF, 2006, J NEUROCHEM, V97, P556, DOI 10.1111/j.1471-4159.2006.03773.x; Ren J, 2005, J BIOL CHEM, V280, P36912, DOI 10.1074/jbc.M507725200; Reynaud D, 1997, BBA-LIPID LIPID MET, V1346, P305, DOI 10.1016/S0005-2760(97)00041-6; REYNAUD D, 1994, J BIOL CHEM, V269, P23976; REYNAUD D, 1994, J NEUROCHEM, V62, P126; REYNAUD D, 1995, ADV PROSTAG THROMB L, V23, P183; Ribelayga C, 1997, BRAIN RES, V777, P247, DOI 10.1016/S0006-8993(97)01231-6; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; ROSEBOOM PH, 1995, MOL PHARMACOL, V47, P439; Scheetz TE, 2006, P NATL ACAD SCI USA, V103, P14429, DOI 10.1073/pnas.0602562103; Schomerus C, 1999, REPROD NUTR DEV, V39, P305, DOI 10.1051/rnd:19990303; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; Simonneaux V, 2004, MOL BRAIN RES, V120, P164, DOI 10.1016/j.molbrainres.2003.10.019; Smith SB, 1999, MOL CELL BIOL, V19, P8272; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; SUGDEN AL, 1986, J BIOL CHEM, V261, P1608; SUGDEN D, 1984, ENDOCRINOLOGY, V114, P435, DOI 10.1210/endo-114-2-435; Sugden D, 1996, BRIT J PHARMACOL, V118, P1246, DOI 10.1111/j.1476-5381.1996.tb15530.x; SUGDEN LA, 1987, J BIOL CHEM, V262, P741; TANAKA K, 1987, ENDOCRINOLOGY, V121, P74, DOI 10.1210/endo-121-1-74; Tosini G, 2006, CHRONOBIOL INT, V23, P381, DOI 10.1080/07420520500482066; Tosini G, 2000, P NATL ACAD SCI USA, V97, P11540, DOI 10.1073/pnas.210248297; Van Loo P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r66; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANECEK J, 1985, ENDOCRINOLOGY, V116, P2167, DOI 10.1210/endo-116-6-2167; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Wang X, 1996, MOL BRAIN RES, V41, P269, DOI 10.1016/0169-328X(96)00107-6; Wang X, 1997, J NEUROSCI METH, V73, P187, DOI 10.1016/S0165-0270(97)02237-1; Yamada H, 1998, J NEUROSCI, V18, P4946; Yeh JJ, 2001, J NEUROCHEM, V77, P336, DOI 10.1046/j.1471-4159.2001.00259.x; Young JE, 2007, GENOMICS, V90, P236, DOI 10.1016/j.ygeno.2007.03.004; Yu AM, 2003, PHARMACOGENETICS, V13, P173, DOI 10.1097/00008571-200303000-00007	124	115	123	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7606	7622		10.1074/jbc.M808394200	http://dx.doi.org/10.1074/jbc.M808394200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19103603	Green Published, hybrid			2022-12-27	WOS:000264195600023
J	Green, JA; Berrier, AL; Pankov, R; Yamada, KM				Green, J. Angelo; Berrier, Allison L.; Pankov, Roumen; Yamada, Kenneth M.			beta(1) Integrin Cytoplasmic Domain Residues Selectively Modulate Fibronectin Matrix Assembly and Cell Spreading through Talin and Akt-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; FOCAL ADHESIONS; BETA-1 SUBUNIT; ACTIVATION; BINDING; BETA-1-INTEGRIN; PHOSPHORYLATION; FIBRILLOGENESIS; IDENTIFICATION; LAMININ-10/11	The integrin beta(1) cytoplasmic domain (tail) serves as a scaffold for numerous intracellular proteins. The mechanisms by which the tail coordinates these proteins to facilitate extracellular matrix assembly and cell spreading are not clear. This study demonstrates that the beta(1) cytoplasmic domain can regulate cell spreading on fibronectin and fibronectin matrix assembly through Akt- and talin-dependent mechanisms, respectively. To identify these mechanisms, we characterized GD25 cells expressing the beta(1) integrin cytoplasmic domain mutants W775A and R760A. Although cell spreading appears normal in R760A mutant-integrin cells compared with wild type, it is inhibited in W775A mutant cells. In contrast, both mutant cell lines show defective fibronectin matrix assembly. Inhibition of cell spreading, but not matrix assembly, in the W775A mutant cells is due to a specific defect in Akt-1 activation. In addition, we find that both W775A and R760A mutant integrins have reduced surface expression of the 9EG7 epitope that correlates with reduced recruitment of talin to beta(1) integrin cytoplasmic complexes. Down-regulation of talin with small interfering RNA or expression of green fluorescent protein-talin head domain inhibits matrix assembly in beta(1) wild-type cells, mimicking the defect seen with the W775A and R760A mutant cells. These results demonstrate distinct mechanisms by which integrins regulate cell spreading and matrix assembly through the beta(1) integrin cytoplasmic tail.	[Green, J. Angelo; Berrier, Allison L.; Pankov, Roumen; Yamada, Kenneth M.] NIDCR, NIH, Lab Cell & Dev Biol, Bethesda, MD 20892 USA; [Berrier, Allison L.] Louisiana State Univ, Hlth Sci Ctr, Sch Dent, Dept Oral & Craniofacial Biol, New Orleans, LA 70119 USA; [Pankov, Roumen] Sofia Univ St Kliment Ohridski, Fac Biol, Dept Cytol Histol & Embryol, Sofia 1164, Bulgaria	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Sofia	Green, JA (corresponding author), NIDCR, NIH, Lab Cell & Dev Biol, Bethesda, MD 20892 USA.	angelo.green@nih.gov; kenneth.yamada@nih.gov	Pankov, Roumen G/B-3284-2014; Pankov, Roumen/AAK-3205-2021	Pankov, Roumen G/0000-0002-3157-3659; Pankov, Roumen/0000-0002-3157-3659; Yamada, Kenneth/0000-0003-1512-6805	NIDCR; National Institutes of Health; National Center on Minority Health and Health Disparities; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000718] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program of the NIDCR, National Institutes of Health, and the National Center on Minority Health and Health Disparities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bodeau AL, 2001, J CELL SCI, V114, P2795; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Delcommenne M, 1999, METH MOL B, V129, P19; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; HAYASHI Y, 1990, J CELL BIOL, V110, P175, DOI 10.1083/jcb.110.1.175; Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822; Humphries MJ, 2004, BIOCHEM SOC T, V32, P407, DOI 10.1042/BST0320407; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kaapa A, 1999, EXP CELL RES, V250, P524, DOI 10.1006/excr.1999.4533; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; LEWIS JM, 1995, MOL BIOL CELL, V6, P151, DOI 10.1091/mbc.6.2.151; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; Retta SF, 1998, MOL BIOL CELL, V9, P715, DOI 10.1091/mbc.9.4.715; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Sondermann H, 1999, CELL ADHES COMMUN, V7, P43, DOI 10.3109/15419069909034391; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tran H, 2002, J CELL SCI, V115, P2031; Vignoud L, 1997, J CELL SCI, V110, P1421; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Wennerberg K, 1998, J CELL SCI, V111, P1117; YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 1999, J CELL SCI, V112, P1655; Zhang QH, 1999, J BIOL CHEM, V274, P368, DOI 10.1074/jbc.274.1.368; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	45	27	28	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8148	8159		10.1074/jbc.M805934200	http://dx.doi.org/10.1074/jbc.M805934200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144637	Green Published, hybrid			2022-12-27	WOS:000264195600077
J	Chen, YL; Chen, YH; Lin, YC; Tsai, KC; Chiu, HT				Chen, Yi-Lin; Chen, Yi-Hsine; Lin, Yu-Chin; Tsai, Kuo-Chung; Chiu, Hsien-Tai			Functional Characterization and Substrate Specificity of Spinosyn Rhamnosyltransferase by in Vitro Reconstitution of Spinosyn Biosynthetic Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DTDP-GLUCOSE 4,6-DEHYDRATASE; ENTERICA SEROVAR TYPHIMURIUM; L-RHAMNOSE BIOSYNTHESIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SACCHAROPOLYSPORA-SPINOSA; SALMONELLA-ENTERICA; MANNOSE 4,6-DEHYDRATASE; GENE-CLUSTER; GLYCOSYLTRANSFERASES	Spinosyn, a potent insecticide, is a novel tetracyclic polyketide decorated with D-forosamine and tri-O-methyl-L-rhamnose. Spinosyn rhamnosyltransferase (SpnG) is a key biocatalyst with unique sequence identity and controls the biosynthetic maturation of spinosyn. The rhamnose is critical for the spinosyn insecticidal activity and cell wall biosynthesis of the spinosyn producer, Saccharopolyspora spinosa. In this study, we have functionally expressed and characterized SpnG and the three enzymes, Gdh, Epi, and Kre, responsible for dTDP-L-rhamnose biosynthesis in S. spinosa by purified enzymes from Escherichia coli. Most notably, the substrate specificity of SpnG was thoroughly characterized by kinetic and inhibition experiments using various NDP sugar analogs made by an in situ combination of NDP-sugar-modifying enzymes. SpnG was found to exhibit striking substrate promiscuity, yielding corresponding glycosylated variants. Moreover, the critical residues presumably involved in catalytic mechanism of Gdh and SpnG were functionally evaluated by site-directed mutagenesis. The information gained from this study has provided important insight into molecular recognition and mechanism of the enzymes, especially SpnG. The results have made possible the structure-activity characterization of SpnG, as well as the use of SpnG or its engineered form to serve as a combinatorial tool to make spinosyn analogs with altered biological activities and potency.	[Chen, Yi-Lin; Chen, Yi-Hsine; Lin, Yu-Chin; Tsai, Kuo-Chung; Chiu, Hsien-Tai] Natl Tsing Hua Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan	National Tsing Hua University	Chiu, HT (corresponding author), Natl Tsing Hua Univ, Dept Biol Sci & Technol, 75 Po Ai St, Hsinchu 300, Taiwan.	chiu@mail.nctu.edu.tw			National Science Council, Taiwan [NSC90-2113-M-009-014, NSC89-2113-M-009-036]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Taiwan, Grants NSC90-2113-M-009-014 and NSC89-2113-M-009-036 ( to H.- T. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALEX T, 2005, Patent No. 2005044979; Allard STM, 2004, J BIOL CHEM, V279, P2211, DOI 10.1074/jbc.M310134200; Allard STM, 2001, J MOL BIOL, V307, P283, DOI 10.1006/jmbi.2000.4470; Baltz RH, 2006, NAT BIOTECHNOL, V24, P1533, DOI 10.1038/nbt1265; Bode HB, 2007, ANGEW CHEM INT EDIT, V46, P2147, DOI 10.1002/anie.200604671; Bolam DN, 2007, P NATL ACAD SCI USA, V104, P5336, DOI 10.1073/pnas.0607897104; Borisova SA, 2004, J AM CHEM SOC, V126, P6534, DOI 10.1021/ja049967j; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Creemer LC, 1998, J ANTIBIOT, V51, P795, DOI 10.7164/antibiotics.51.795; Gerratana B, 2001, BIOCHEMISTRY-US, V40, P9187, DOI 10.1021/bi0108249; Graninger M, 2002, APPL ENVIRON MICROB, V68, P3708, DOI 10.1128/AEM.68.8.3708-3715.2002; Graninger M, 1999, J BIOL CHEM, V274, P25069, DOI 10.1074/jbc.274.35.25069; Gross JW, 2000, BIOCHEMISTRY-US, V39, P13633, DOI 10.1021/bi001963d; Gross JW, 2001, BIOCHEMISTRY-US, V40, P12497, DOI 10.1021/bi011138c; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kirst Herbert A., 2002, Current Topics in Medicinal Chemistry, V2, P675, DOI 10.2174/1568026023393615; KISER T, 2000, PRACTICAL STREPTOMYC, P117; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lopez O, 2005, GREEN CHEM, V7, P431, DOI 10.1039/b500733j; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu W, 2005, CHEM BIOL, V12, P527, DOI 10.1016/j.chembiol.2005.02.016; Madduri K, 2001, J IND MICROBIOL BIOT, V27, P399, DOI 10.1038/sj.jim.7000180; Madduri K, 2001, J BACTERIOL, V183, P5632, DOI 10.1128/JB.183.19.5632-5638.2001; Martin CJ, 2003, ORG BIOMOL CHEM, V1, P4144, DOI 10.1039/b310740j; Meyers CLF, 2004, BIOCHEMISTRY-US, V43, P15022, DOI 10.1021/bi048457z; Minami A, 2007, J AM CHEM SOC, V129, P5102, DOI 10.1021/ja0685250; Mittler M, 2007, J MOL BIOL, V372, P67, DOI 10.1016/j.jmb.2007.06.005; Mulichak AM, 2004, BIOCHEMISTRY-US, V43, P5170, DOI 10.1021/bi036130c; Mulichak AM, 2003, P NATL ACAD SCI USA, V100, P9238, DOI 10.1073/pnas.1233577100; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Naundorf A, 1996, CARBOHYD RES, V285, P141, DOI 10.1016/S0008-6215(96)90180-9; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Sambrook J., 2001, MOL CLONING LAB MANU; Somoza JR, 2000, STRUCTURE, V8, P123, DOI 10.1016/S0969-2126(00)00088-5; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Thoden JB, 2002, J BIOL CHEM, V277, P27528, DOI 10.1074/jbc.M204413200; Waldron C, 2001, CHEM BIOL, V8, P487, DOI 10.1016/S1074-5521(01)00029-1; Walsh CT, 2006, NATURE, V443, P285, DOI 10.1038/443285a; Wu BY, 2001, BIOCHEM BIOPH RES CO, V285, P364, DOI 10.1006/bbrc.2001.5137; Yuan YQ, 2005, J AM CHEM SOC, V127, P14128, DOI 10.1021/ja053704n; Zhang CS, 2006, SCIENCE, V313, P1291, DOI 10.1126/science.1130028	43	35	37	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7352	7363		10.1074/jbc.M808441200	http://dx.doi.org/10.1074/jbc.M808441200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19126547	Green Published, hybrid			2022-12-27	WOS:000263919000081
J	Huergo, LF; Merrick, M; Monteiro, RA; Chubatsu, LS; Steffens, MBR; Pedrosa, FO; Souza, EM				Huergo, Luciano F.; Merrick, Mike; Monteiro, Rose A.; Chubatsu, Leda S.; Steffens, Maria B. R.; Pedrosa, Fabio O.; Souza, Emanuel M.			In Vitro Interactions between the P-II Proteins and the Nitrogenase Regulatory Enzymes Dinitrogenase Reductase ADP-ribosyltransferase (DraT) and Dinitrogenase Reductase-activating Glycohydrolase (DraG) in Azospirillum brasilense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PROTEIN; BACTERIUM RHODOBACTER-CAPSULATUS; ADENYLATE ENERGY-CHARGE; AMTB-GLNK COMPLEX; RHODOSPIRILLUM-RUBRUM; ESCHERICHIA-COLI; MEMBRANE SEQUESTRATION; POSTTRANSLATIONAL REGULATION; ACETYLGLUTAMATE-KINASE; CRYSTAL-STRUCTURE	The activity of the nitrogenase enzyme in the diazotroph Azospirillum brasilense is reversibly inactivated by ammonium through ADP-ribosylation of the nitrogenase NifH subunit. This process is catalyzed by DraT and is reversed by DraG, and the activities of both enzymes are regulated according to the levels of ammonium through direct interactions with the P-II proteins GlnB and GlnZ. We have previously shown that DraG interacts with GlnZ both in vivo and in vitro and that DraT interacts with GlnB in vivo. We have now characterized the influence of P-II uridylylation status and the P-II effectors (ATP, ADP, and 2-oxoglutarate) on the in vitro formation of DraT-GlnB and DraG-GlnZ complexes. We observed that both interactions are maximized when P-II proteins are de-uridylylated and when ADP is present. The DraT-GlnB complex formed in vivo was purified to homogeneity in the presence of ADP. The stoichiometry of the DraT-GlnB complex was determined by three independent approaches, all of which indicated a 1: 1 stoichiometry (DraT monomer: GlnB trimer). Our results suggest that the intracellular fluctuation of the P-II ligands ATP, ADP, and 2-oxoglutarate play a key role in the post-translational regulation of nitrogenase activity.	[Huergo, Luciano F.; Monteiro, Rose A.; Chubatsu, Leda S.; Steffens, Maria B. R.; Pedrosa, Fabio O.; Souza, Emanuel M.] Univ Fed Parana, Dept Biochem & Mol Biol, BR-81531900 Curitiba, Parana, Brazil; [Merrick, Mike] John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England	Universidade Federal do Parana; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Huergo, LF (corresponding author), Univ Fed Parana, Dept Biochem & Mol Biol, CP 19046, BR-81531900 Curitiba, Parana, Brazil.	huergo@ufpr.br	de Souza, Emanuel Maltempi/C-1920-2013; Pedrosa, Fabio 0/C-1938-2013; Chubatsu, Leda S./H-2603-2012	de Souza, Emanuel Maltempi/0000-0003-1546-9218; Chubatsu, Leda S./0000-0002-8687-2816; Huergo, Luciano/0000-0002-7587-9510; Monteiro, Rose Adele/0000-0001-8226-0700	CNPq; Fundacao Araucaria; Biotechnology and Biological Sciences Research Council (UK)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by CNPq and Fundacao Araucaria.; Supported by a PDJ fellowship from the CNPq-Brazil.; Received support from the Biotechnology and Biological Sciences Research Council (UK).	Araujo LM, 2008, BRAZ J MED BIOL RES, V41, P289, DOI 10.1590/S0100-879X2008000400006; Araujo MS, 2004, PROTEIN EXPRES PURIF, V33, P19, DOI 10.1016/j.pep.2003.08.024; ATKINSON MR, 1994, J BIOL CHEM, V269, P28288; BURRIS RH, 1991, J BIOL CHEM, V266, P9339; Carr PD, 1996, ACTA CRYSTALLOGR D, V52, P93, DOI 10.1107/S0907444995007293; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; de Zamaroczy M, 1998, MOL MICROBIOL, V29, P449, DOI 10.1046/j.1365-2958.1998.00938.x; deZamaroczy M, 1996, J BACTERIOL, V178, P4143, DOI 10.1128/jb.178.14.4143-4149.1996; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Durand A, 2006, J BIOL CHEM, V281, P29558, DOI 10.1074/jbc.M602477200; Espinosa J, 2006, MOL MICROBIOL, V61, P457, DOI 10.1111/j.1365-2958.2006.05231.x; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Forchhammer K, 1999, MOL MICROBIOL, V33, P338, DOI 10.1046/j.1365-2958.1999.01477.x; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Huergo LF, 2006, MOL MICROBIOL, V59, P326, DOI 10.1111/j.1365-2958.2005.04944.x; Huergo LF, 2005, FEMS MICROBIOL LETT, V253, P47, DOI 10.1016/j.femsle.2005.09.026; Huergo LF, 2005, ARCH MICROBIOL, V183, P209, DOI 10.1007/s00203-005-0763-z; Huergo LF, 2007, MOL MICROBIOL, V66, P1523, DOI 10.1111/j.1365-2958.2007.06016.x; Huergo LF, 2006, FEBS LETT, V580, P5232, DOI 10.1016/j.febslet.2006.08.054; Jiang P, 1998, BIOCHEMISTRY-US, V37, P12782, DOI 10.1021/bi980667m; Jiang P, 2007, BIOCHEMISTRY-US, V46, P12979, DOI 10.1021/bi701062t; Jiang P, 2007, BIOCHEMISTRY-US, V46, P4117, DOI 10.1021/bi0620508; KAMBEROV ES, 1995, J BIOL CHEM, V270, P17797, DOI 10.1074/jbc.270.30.17797; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; LI J, 1987, J BACTERIOL, V169, P231, DOI 10.1128/jb.169.1.231-237.1987; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; LOWERY RG, 1988, J BIOL CHEM, V263, P16714; Mizuno Y, 2007, J BIOL CHEM, V282, P35733, DOI 10.1074/jbc.M707127200; Nordlund S, 2000, PROKARYOTIC NITROGEN FIXATION, P149; PAUL TD, 1984, BIOCHEM J, V224, P961, DOI 10.1042/bj2240961; Pawlowski A, 2003, J BACTERIOL, V185, P5240, DOI 10.1128/JB.185.17.5240-5247.2003; Ponnuraj RK, 2005, FEBS LETT, V579, P5751, DOI 10.1016/j.febslet.2005.09.057; SAARI LL, 1984, J BIOL CHEM, V259, P5502; SENIOR PJ, 1975, J BACTERIOL, V123, P407, DOI 10.1128/JB.123.2.407-418.1975; Strosser J, 2004, MOL MICROBIOL, V54, P132, DOI 10.1111/j.1365-2958.2004.04247.x; Teixeira PF, 2008, MICROBIOL-SGM, V154, P2336, DOI 10.1099/mic.0.2008/017533-0; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; Tremblay PL, 2008, J BACTERIOL, V190, P1588, DOI 10.1128/JB.01643-07; Tremblay PL, 2007, J BACTERIOL, V189, P5850, DOI 10.1128/JB.00680-07; UPCHURCH RG, 1980, J BACTERIOL, V143, P274, DOI 10.1128/JB.143.1.274-284.1980; Van Dommelen A, 2002, MOL GENET GENOMICS, V266, P813, DOI 10.1007/s00438-001-0598-5; Wang H, 2005, FEMS MICROBIOL LETT, V253, P273, DOI 10.1016/j.femsle.2005.09.049; Wolfe DM, 2007, J BACTERIOL, V189, P6861, DOI 10.1128/JB.00759-07; Xu YB, 1998, J MOL BIOL, V282, P149, DOI 10.1006/jmbi.1998.1979; Xu YB, 2001, EUR J BIOCHEM, V268, P2028, DOI 10.1046/j.1432-1327.2001.02074.x; Yildiz O, 2007, EMBO J, V26, P589, DOI 10.1038/sj.emboj.7601492; Zhang YP, 2006, MICROBIOL-SGM, V152, P2075, DOI 10.1099/mic.0.28903-0; Zhang YP, 1997, FEMS MICROBIOL LETT, V152, P195, DOI 10.1111/j.1574-6968.1997.tb10428.x; Zhu Y, 2006, J BACTERIOL, V188, P1866, DOI 10.1128/JB.188.5.1866-1874.2006	50	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6674	6682		10.1074/jbc.M807378200	http://dx.doi.org/10.1074/jbc.M807378200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131333	Green Published, hybrid			2022-12-27	WOS:000263919000011
J	Wu, CL; Kim, PY; Manuel, R; Seto, M; Whitlow, M; Nagashima, M; Morser, J; Gils, A; Declerck, P; Nesheim, ME				Wu, Chengliang; Kim, Paul Y.; Manuel, Reg; Seto, Marian; Whitlow, Marc; Nagashima, Mariko; Morser, John; Gils, Ann; Declerck, Paul; Nesheim, Michael E.			The Roles of Selected Arginine and Lysine Residues of TAFI (Pro-CPU) in Its Activation to TAFIa by the Thrombin-Thrombomodulin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVABLE FIBRINOLYSIS INHIBITOR; PLASMA PROCARBOXYPEPTIDASE B; PROTEIN-C; PROTEOLYTIC CLEAVAGE; CATALYZED ACTIVATION; CARBOXYPEPTIDASE-B; THERMAL-STABILITY; STRUCTURAL BASIS; INACTIVATION; THROMBOLYSIS	Thrombomodulin (TM) increases the catalytic efficiency of thrombin (IIa)-mediated activation of thrombin-activable fibrinolysis inhibitor (TAFI) 1250-fold. Negatively charged residues of the C-loop of TM-EGF-like domain 3 are required for TAFI activation. Molecular models suggested several positively charged residues of TAFI with which the C-loop residues could interact. Seven TAFI mutants were constructed to determine if these residues are required for efficient TAFI activation. TAFI wild-type or mutants were activated in the presence or absence of TM and the kinetic parameters of TAFI activation were determined. When the three consecutive lysine residues in the activation peptide of TAFI were substituted with alanine (K42/43/44A), the catalytic efficiencies for TAFI activation with TM decreased 8-fold. When other positively charged surface residues of TAFI (Lys-133, Lys-211, Lys-212, Arg-220, Lys-240, or Arg-275) were mutated to alanine, the catalytic efficiencies for TAFI activation with TM decreased by 1.7-2.7-fold. All decreases were highly statistically significant. In the absence of TM, catalytic efficiencies ranged from 2.8-fold lower to 1.24-fold higher than wild-type. None of these, except the 2.8-fold lower value, was statistically significant. The average half-life of the TAFIa mutants was 8.1 +/- 0.6 min, and that of wild type was 8.4 +/- 0.3 min at 37 degrees C. Our data show that these residues are important in the activation of TAFI by IIa, especially in the presence of TM. Whether the mutated residues promote a TAFI-TM or TAFI-IIa interaction remains to be determined. In addition, these residues do not influence spontaneous inactivation of TAFIa.	[Wu, Chengliang; Kim, Paul Y.; Manuel, Reg; Nesheim, Michael E.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Nesheim, Michael E.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Gils, Ann; Declerck, Paul] Katholieke Univ Leuven, Fac Pharmaceut Sci, Lab Pharmaceut Biol, B-3000 Louvain, Belgium; [Seto, Marian; Whitlow, Marc; Nagashima, Mariko; Morser, John] Berlex Biosci, Richmond, CA 94804 USA	Queens University - Canada; Queens University - Canada; KU Leuven	Nesheim, ME (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	nesheimm@queensu.ca	Kim, Paul/GYV-3258-2022; Declerck, Paul J/A-2330-2017	Kim, Paul/0000-0003-0943-4924; Declerck, Paul J/0000-0003-1259-9105	National Institutes of Health [5 P01 HL046703]; CIHR [MT-9781]; Heart and Stroke Foundation of Ontario [T5575]; Heart and Stroke Foundation of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 P01 HL046703 (to M. E. N.). This work was also supported by CIHR Grant MT-9781 (to M. E. N.), as well as Heart and Stroke Foundation of Ontario Grant T5575 (to M. E. N.). This study was also supported by the Heart and Stroke Foundation of Canada Doctoral Research Award (to P. Y. K.). The costs of publication of this article were defrayed in part by the payment of page charges.	Anand K, 2008, J BIOL CHEM, V283, P29416, DOI 10.1074/jbc.M804003200; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Bajzar L, 1996, BLOOD, V88, P2093, DOI 10.1182/blood.V88.6.2093.bloodjournal8862093; Boffa MB, 1998, J BIOL CHEM, V273, P2127, DOI 10.1074/jbc.273.4.2127; Boffa MB, 2000, J BIOL CHEM, V275, P12868, DOI 10.1074/jbc.275.17.12868; BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497; CAMPBELL W, 1989, BIOCHEM BIOPH RES CO, V162, P933, DOI 10.1016/0006-291X(89)90762-6; Campbell WD, 2002, MICROBIOL IMMUNOL, V46, P131, DOI 10.1111/j.1348-0421.2002.tb02669.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; EATON DL, 1991, J BIOL CHEM, V266, P21833; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; ESMON CT, 1982, J BIOL CHEM, V257, P7944; ESMON CT, 1991, ANN NY ACAD SCI, V614, P30; ESMON NL, 1982, J BIOL CHEM, V257, P859; FAN BQ, 1993, J BIOL CHEM, V268, P17588; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; Gils A, 2005, J THROMB HAEMOST, V3, P2745, DOI 10.1111/j.1538-7836.2005.01629.x; Gils A, 2003, ARTERIOSCL THROM VAS, V23, P1122, DOI 10.1161/01.ATV.0000074145.58172.BD; GOMISRUTH FX, 1995, EMBO J, V14, P4387, DOI 10.1002/j.1460-2075.1995.tb00117.x; Hall SW, 1999, J BIOL CHEM, V274, P25510, DOI 10.1074/jbc.274.36.25510; Klement P, 1999, BLOOD, V94, P2735, DOI 10.1182/blood.V94.8.2735.420k30_2735_2743; Kokame K, 1998, J BIOL CHEM, V273, P12135, DOI 10.1074/jbc.273.20.12135; Mao SS, 1999, J BIOL CHEM, V274, P35046, DOI 10.1074/jbc.274.49.35046; Marx PF, 2008, BLOOD, V112, P2803, DOI 10.1182/blood-2008-03-146001; Marx PF, 2000, J BIOL CHEM, V275, P12410, DOI 10.1074/jbc.275.17.12410; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Nagashima M, 2000, THROMB RES, V98, P333, DOI 10.1016/S0049-3848(00)00184-5; Nesheim ME, 1999, FIBRINOLYSIS PROTEOL, V13, P72, DOI 10.1016/S0268-9499(99)90082-6; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; PARKINSON JF, 1992, BIOCHEM BIOPH RES CO, V185, P567, DOI 10.1016/0006-291X(92)91662-A; Refino CJ, 2000, FIBRINOLYSIS PROTEOL, V14, P305, DOI 10.1054/fipr.2000.0087; SADLER JE, 1993, HAEMOSTASIS, V23, P183; Schneider M, 2002, J BIOL CHEM, V277, P1021, DOI 10.1074/jbc.M104444200; Schneider M, 2002, J BIOL CHEM, V277, P9944, DOI 10.1074/jbc.M111685200; SHINOHARA T, 1994, INT ARCH ALLERGY IMM, V103, P400, DOI 10.1159/000236661; TAN AK, 1995, BIOCHEMISTRY-US, V34, P5811, DOI 10.1021/bi00017a012; TSIANG M, 1992, J BIOL CHEM, V267, P6164; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; Wang W, 1998, J BIOL CHEM, V273, P27176, DOI 10.1074/jbc.273.42.27176; WANG W, 1994, J BIOL CHEM, V269, P15937; Wang W, 2000, J BIOL CHEM, V275, P22942, DOI 10.1074/jbc.M001760200; Wu CL, 2003, THROMB HAEMOSTASIS, V90, P414, DOI 10.1160/TH02-09-0104; Wu CL, 2003, J BIOL CHEM, V278, P25847, DOI 10.1074/jbc.M301223200	44	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7059	7067		10.1074/jbc.M804745200	http://dx.doi.org/10.1074/jbc.M804745200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19074424	hybrid, Green Published			2022-12-27	WOS:000263919000054
J	Nijstad, N; Wiersma, H; Gautier, T; van der Giet, M; Maugeais, C; Tietge, UJF				Nijstad, Niels; Wiersma, Harmen; Gautier, Thomas; van der Giet, Markus; Maugeais, Cyrille; Tietge, Uwe J. F.			Scavenger Receptor BI-mediated Selective Uptake Is Required for the Remodeling of High Density Lipoprotein by Endothelial Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; PHOSPHOLIPASE A(2); SR-BI; CHOLESTERYL ESTER; HDL CHOLESTEROL; TARGETED MUTATION; APOA-I; METABOLISM; MICE; ATHEROSCLEROSIS	Endothelial lipase (EL) is a negative regulator of high density lipoprotein (HDL) cholesterol plasma levels, and scavenger receptor BI (SR-BI) is involved in remodeling of HDL. The present study investigates the requirement of SR-BI for the effects of EL- mediated phospholipid hydrolysis on HDL metabolism in vivo. In vitro, selective uptake from EL- modified HDL was 129% higher than selective uptake from control HDL in SR-BI-overexpressing cells (p = 0.01). In vivo overexpression of human EL by means of recombinant adenovirus decreased HDL plasma levels significantly (p < 0.01). Fast protein liquid chromatography analysis and agarose gel electrophoresis revealed that EL expression resulted in the generation of small pre-beta HDL particles in wild-type mice, whereas in SR-BI-/- mice small HDL were preferentially removed. In kinetic experiments the fractional catabolic rate (FCR) of HDL cholesteryl ester increased by 110% (p < 0.001), and the FCR of HDL apolipoproteins increased by 64% (p < 0.001) in response to EL overexpression in wild-type mice. In SR-BI-/- mice a similar increase in the HDL apolipoprotein FCR occurred (p < 0.001); however, there was no further increase in HDL cholesteryl ester catabolism. The apparent whole body selective uptake was increased 3-fold by EL in wild-type mice (p < 0.001), whereas there was no selective uptake in SR-BI knock-out mice. EL overexpression increased hepatic selective uptake as well as holoparticle uptake (each p < 0.01) in wild-typemice, whereas in SR-BI knock-out mice only holoparticle uptake increased (p < 0.01). Our results indicate that SR-BI-mediated selective uptake of HDL cholesteryl ester is essential for the remodeling of large alpha-migrating HDL particles by EL.	[Nijstad, Niels; Wiersma, Harmen; Gautier, Thomas; Tietge, Uwe J. F.] Univ Groningen, Univ Med Ctr Groningen, Pediat Lab, Ctr Liver Digest & Metab Dis, NL-9713 GZ Groningen, Netherlands; [van der Giet, Markus] Charite, Med Klin 4, D-12203 Berlin, Germany; [Maugeais, Cyrille] Roche Pharmaceut, CH-4070 Basel, Switzerland	University of Groningen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Roche Holding	Tietge, UJF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Pediat Lab, Ctr Liver Digest & Metab Dis, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	u_tietge@yahoo.com	Gautier, Thomas/Q-5371-2018	Gautier, Thomas/0000-0003-1119-7382; van der Giet, Markus/0000-0003-3590-5451	Netherlands Organization for Scientific Research [917-56-358]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Organization for Scientific Research VIDI Grant 917-56-358 ( to U. J. F. T.). The costs of publication of this article were defrayed in part by the payment of page charges.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Brundert M, 2005, ARTERIOSCL THROM VAS, V25, P143, DOI 10.1161/01.ATV.0000149381.16166.c6; Caiazza D, 2004, BIOCHEMISTRY-US, V43, P11898, DOI 10.1021/bi049776t; GLASS C, 1985, J BIOL CHEM, V260, P744; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Hurt-Camejo E, 2001, CIRC RES, V89, P298, DOI 10.1161/hh1601.095598; Ishida T, 2003, J CLIN INVEST, V111, P347, DOI [10.1172/JCI200316306, 10.1172/JCI16306]; Jacquet S, 2005, CELL MOL LIFE SCI, V62, P2508, DOI 10.1007/s00018-005-5194-0; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Ma K, 2003, P NATL ACAD SCI USA, V100, P2748, DOI 10.1073/pnas.0438039100; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Maugeais C, 2003, CIRCULATION, V108, P2121, DOI 10.1161/01.CIR.0000092889.24713.DC; McCoy MG, 2002, J LIPID RES, V43, P921; Out R, 2004, J LIPID RES, V45, P2088, DOI 10.1194/jlr.M400191-JLR200; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; RADER DJ, 2002, ARTERIOSCLER THROMB, V22, P1213; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rosengren B, 2006, ARTERIOSCL THROM VAS, V26, P1579, DOI 10.1161/01.ATV.0000221231.56617.67; Skropeta D, 2007, J LIPID RES, V48, P2047, DOI 10.1194/jlr.M700248-JLR200; Tietge UJF, 2000, J BIOL CHEM, V275, P10077, DOI 10.1074/jbc.275.14.10077; Tietge UJF, 2003, AM J PHYSIOL-ENDOC M, V285, pE403, DOI 10.1152/ajpendo.00576.2002; Tietge UJF, 2002, ARTERIOSCL THROM VAS, V22, P1213, DOI 10.1161/01.ATV.0000023228.90866.29; Tietge UJF, 2008, J LIPID RES, V49, P563, DOI 10.1194/jlr.M700276-JLR200; Trigatti BL, 2003, ARTERIOSCL THROM VAS, V23, P1732, DOI 10.1161/01.ATV.0000091363.28501.84; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Vassiliou G, 2004, ARTERIOSCL THROM VAS, V24, P1669, DOI 10.1161/01.ATV.0000134295.09932.60; Webb NR, 2005, CURR OPIN LIPIDOL, V16, P341, DOI 10.1097/01.mol.0000169355.20395.55; Webb NR, 2004, J LIPID RES, V45, P1666, DOI 10.1194/jlr.M400026-JLR200	33	50	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6093	6100		10.1074/jbc.M807683200	http://dx.doi.org/10.1074/jbc.M807683200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19136670	hybrid			2022-12-27	WOS:000263742700011
J	Harada, H; Itasaka, S; Kizaka-Kondoh, S; Shibuya, K; Morinibu, A; Shinomiya, K; Hiraoka, M				Harada, Hiroshi; Itasaka, Satoshi; Kizaka-Kondoh, Shinae; Shibuya, Keiko; Morinibu, Akiyo; Shinomiya, Kazumi; Hiraoka, Masahiro			The Akt/mTOR Pathway Assures the Synthesis of HIF-1 alpha Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; GROWTH-FACTOR EXPRESSION; COLON-CANCER CELLS; GENE-EXPRESSION; FACTOR-I; OXYGEN; HIF-1; RADIOTHERAPY; RADIATION; RADIOSENSITIVITY	Transcriptional activity of HIF-1 (hypoxia-inducible factor-1) has been reported to be up-regulated in solid tumors after ionizing radiation; however, the molecular mechanism underlying the response remains to be elucidated. In the present study, we performed a series of molecular imaging experiments using a HIF-1-dependent reporter gene, 5HREp-ODD-luc, and found an essential role of the Akt/mTOR pathway. Hypoxic tumor cells distant from blood vessels were dramatically reoxygenated at 24 h postirradiation, and HIF-1 activity increased as HIF-1 alpha accumulated in the reoxygenated regions. The accumulation was inhibited with a nonmetabolizable glucose analog, 2-deoxy-D- glucose, through the suppression of radiation-induced phosphorylation of Akt in the reoxygenated regions. Akt knockdown and an mTOR inhibitor revealed the importance of the Akt/mTOR pathway in the postirradiation accumulation of HIF-1 alpha. In vitro experiments confirmed that an increase in glucose availability induced Akt phosphorylation under reoxygenated conditions and consequently up-regulated HIF-1 alpha translation. Moreover, both the accelerated translation and the previously reported reactive oxygen species-mediated stabilization of HIF-1 alpha protein were essential to the activation of HIF-1. All of these results indicate that Akt/mTOR- dependent translation of HIF-1 alpha plays a critical role in the postirradiation up-regulation of intratumoral HIF-1 activity in response to radiation-induced alterations of glucose and oxygen availability in a solid tumor.	[Harada, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Sakyo Ku, Kyoto 6068507, Japan; [Harada, Hiroshi; Hiraoka, Masahiro] Kyoto Univ, Grad Sch Med, Nanomed Merger Educ Unit, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Harada, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	hharada@kuhp.kyoto-u.ac.jp	Kondoh, Shinae/C-6937-2015; Kondoh, Shinae/AAF-8745-2020	Kondoh, Shinae/0000-0003-3085-5782; Kondoh, Shinae/0000-0003-3085-5782	New Energy and Industrial Technology Development Organization (NEDO) Japan; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology, Japan	New Energy and Industrial Technology Development Organization (NEDO) Japan(New Energy and Industrial Technology Development Organization (NEDO)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was part of the programs "R&D of Molecular Imaging Equipment for Malignant Tumor Therapy Support" supported by New Energy and Industrial Technology Development Organization (NEDO) Japan and "Research for Promoting Technological Seeds" supported by the Japan Science and Technology Agency. This study was supported by Grants-in-aid for Scientific Research on Priority Areas (Cancer Research) and for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Aebersold DM, 2001, CANCER RES, V61, P2911; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; DORIE MJ, 1984, INT J RADIAT ONCOL, V10, P687, DOI 10.1016/0360-3016(84)90300-6; Ettinger SN, 2001, CANCER RES, V61, P7964; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; FOWLER JF, 1991, RADIOTHER ONCOL, V22, P156, DOI 10.1016/0167-8140(91)90017-B; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Fukuda R, 2003, CANCER RES, V63, P2330; Gorski DH, 1999, CANCER RES, V59, P3374; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Harada H, 2002, CANCER RES, V62, P2013; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; Harada H, 2005, MOL IMAGING, V4, P182; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kennedy AS, 1997, INT J RADIAT ONCOL, V37, P897, DOI 10.1016/S0360-3016(96)00539-1; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; KUBOTA R, 1992, J NUCL MED, V33, P1972; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; MUELLERKLIESER W, 1993, HISTOCHEM J, V25, P407, DOI 10.1007/BF00157805; Murata R, 1996, INT J RADIAT ONCOL, V34, P859, DOI 10.1016/0360-3016(95)02155-8; NORRIS ML, 1995, J BIOL CHEM, V270, P23774, DOI 10.1074/jbc.270.40.23774; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Shibata T, 2000, GENE THER, V7, P493, DOI 10.1038/sj.gt.3301124; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; VAUPEL P, 1989, CANCER RES, V49, P6449; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zeng LH, 2008, CANCER SCI, V99, P2327, DOI 10.1111/j.1349-7006.2008.00943.x; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	35	133	139	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5332	5342		10.1074/jbc.M806653200	http://dx.doi.org/10.1074/jbc.M806653200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098000	hybrid			2022-12-27	WOS:000263416600063
J	Bhalla, AD; Gudikote, JP; Wang, J; Chan, WK; Chang, YF; Olivas, OR; Wilkinson, MF				Bhalla, Angela D.; Gudikote, Jayanthi P.; Wang, Jun; Chan, Wai-Kin; Chang, Yao-Fu; Olivas, O. Renee; Wilkinson, Miles F.			Nonsense Codons Trigger an RNA Partitioning Shift	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXON-JUNCTION COMPLEX; CELL-RECEPTOR TRANSCRIPTS; ISOMERASE MESSENGER-RNA; MEDIATED DECAY; TRANSLATION TERMINATION; REGULATORY MECHANISM; NUCLEAR TRANSLATION; PROTEIN-SYNTHESIS; SURVEILLANCE; GENE	T-cell receptor-beta (TCR beta) genes naturally acquire premature termination codons (PTCs) as a result of programmed gene rearrangements. PTC-bearing TCR beta transcripts are dramatically down-regulated to protect T-cells from the deleterious effects of the truncated proteins that would otherwise be produced. Here we provide evidence that two responses collaborate to elicit this dramatic down-regulation. One is rapid mRNA decay triggered by the nonsense-mediated decay (NMD) RNA surveillance pathway. We demonstrate that this occurs in highly purified nuclei lacking detectable levels of three different cytoplasmic markers, but containing an outer nuclear membrane marker, suggesting that decay occurs either in the nucleoplasm or at the outer nuclear membrane. The second response is a dramatic partitioning shift in the nuclear fraction-to-cytoplasmic fraction mRNA ratio that results in few TCR beta transcripts escaping to the cytoplasmic fraction of cells. Analysis of TCR beta mRNA kinetics after either transcriptional repression or induction suggested that this nonsense codon-induced partitioning shift ( NIPS) response is not the result of cytoplasmic NMD but instead reflects retention of PTC+ TCR beta mRNA in the nuclear fraction of cells. We identified TCR beta sequences crucial for NIPS but found that NIPS is not exclusively a property of TCR beta transcripts, and we identified non-TCR beta sequences that elicit NIPS. RNA interference experiments indicated that NIPS depends on the NMD factors UPF1 and eIF4AIII but not the NMD factor UPF3B. We propose that NIPS collaborates with NMD to retain and degrade a subset of PTC+ transcripts at the outer nuclear membrane and/or within the nucleoplasm.	[Bhalla, Angela D.; Gudikote, Jayanthi P.; Wang, Jun; Chan, Wai-Kin; Chang, Yao-Fu; Olivas, O. Renee; Wilkinson, Miles F.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Bhalla, Angela D.] Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wilkinson, MF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, 1515 Holcombe Blvd,Unit 1000, Houston, TX 77030 USA.	mwilkins@mdanderson.org	Chan, Waikin/AAI-4995-2020		National Institutes of Health [GM058595]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM058595. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Brogna S, 2002, MOL CELL, V10, P93, DOI 10.1016/S1097-2765(02)00565-8; Buhler M, 2005, MOL CELL, V18, P307, DOI 10.1016/j.molcel.2005.03.030; Buhler M, 2002, EMBO REP, V3, P646, DOI 10.1093/embo-reports/kvf129; Caputi M, 2002, GENE DEV, V16, P1754, DOI 10.1101/gad.997502; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Chang YF, 2007, J BIOL CHEM, V282, P29738, DOI 10.1074/jbc.M704372200; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; Clement JQ, 2001, J BIOL CHEM, V276, P16919, DOI 10.1074/jbc.M005104200; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; Dahlberg JE, 2003, RNA, V9, P1, DOI 10.1261/rna.2121703; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gudikote JP, 2002, EMBO J, V21, P125, DOI 10.1093/emboj/21.1.125; Gudikote JP, 2005, NAT STRUCT MOL BIOL, V12, P801, DOI 10.1038/nsmb980; GUDIKOTE JP, 2006, NONSENSE MEDIATED MR, P71; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hilleren P, 1999, RNA, V5, P711, DOI 10.1017/S1355838299990519; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; Jacobson A, 2000, COLD SPRING HARBOR M, V39, P827; Kessler O, 1996, MOL CELL BIOL, V16, P4426; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Li SL, 1997, J EXP MED, V185, P985, DOI 10.1084/jem.185.6.985; LOZANO F, 1994, EMBO J, V13, P4617, DOI 10.1002/j.1460-2075.1994.tb06783.x; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Lytle JR, 2004, RNA, V10, P657, DOI 10.1261/rna.5241404; MacLean JA, 2005, CELL, V120, P369, DOI 10.1016/j.cell.2004.12.022; Mangiarotti G, 1999, BIOCHEMISTRY-US, V38, P3996, DOI 10.1021/bi9822022; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Muhlemann O, 2001, MOL CELL, V8, P33, DOI 10.1016/S1097-2765(01)00288-X; Nathanson L, 2003, RNA, V9, P9, DOI 10.1261/rna.2990203; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Rodriguez AJ, 2007, SEMIN CELL DEV BIOL, V18, P202, DOI 10.1016/j.semcdb.2007.02.002; Schell T, 2002, GENOME BIOL, V3; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Wagner E, 2002, J CELL SCI, V115, P3033; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wang J, 2002, J BIOL CHEM, V277, P18489, DOI 10.1074/jbc.M111781200; Wang J, 2002, SCIENCE, V297, P108, DOI 10.1126/science.1069757; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; WILKINSON M, 2000, ESSENTIAL MOL BIOL, P69; Wilkinson MF, 2005, TRENDS GENET, V21, P143, DOI 10.1016/j.tig.2005.01.007; Wilkinson MF, 2002, NAT CELL BIOL, V4, pE144, DOI 10.1038/ncb0602-e144; Wilusz CJ, 2001, GENE DEV, V15, P2781; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826; Zhang SA, 1997, RNA, V3, P234	68	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4062	4072		10.1074/jbc.M805193200	http://dx.doi.org/10.1074/jbc.M805193200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19091751	Green Published, hybrid			2022-12-27	WOS:000263134400004
J	Etxebarria, A; Terrones, O; Yamaguchi, H; Landajuela, A; Landeta, O; Antonsson, B; Wang, HG; Basanez, G				Etxebarria, Aitor; Terrones, Oihana; Yamaguchi, Hirohito; Landajuela, Ane; Landeta, Olatz; Antonsson, Bruno; Wang, Hong-Gang; Basanez, Gorka			Endophilin B1/Bif-1 Stimulates BAX Activation Independently from Its Capacity to Produce Large Scale Membrane Morphological Rearrangements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; MOLECULAR-DYNAMICS SIMULATIONS; POLYMORPHIC PHASE-BEHAVIOR; X-RAY-DIFFRACTION; CELL-DEATH; PROTEIN FAMILY; CYTOCHROME-C; APOPTOSIS; DOMAIN; CURVATURE	Endophilin B1/BAX-interacting factor 1 (Bif-1) is a protein that cooperates with dynamin-like protein 1 (DLP1/Drp1) to maintain normal mitochondrial outer membrane (MOM) dynamics in healthy cells and also contributes to BAX-driven MOM permeabilization ( MOMP), the irreversible commitment point to cell death for the majority of apoptotic stimuli. However, despite its importance, exactly how Bif-1 fulfils its proapoptotic role is unknown. Here, we demonstrate that the stimulatory effect of Bif-1 on BAX-driven MOMP and on BAX conformational activation observed in intact cells during apoptosis can be recapitulated in a simplified system consisting of purified proteins and MOM-like liposomes. In this reconstituted model system the N-BAR domain of Bif-1 reproduced the stimulatory effect of Bif-1 on functional BAX activation. This process was dependent on physical interaction between Bif-1 N-BAR and BAX as well as on the presence of the mitochondrion-specific lipid cardiolipin. Despite that Bif-1 N-BAR produced large scale morphological rearrangements in MOM-like liposomes, this phenomenon could be separated from functional BAX activation. Furthermore, DLP1 also caused global morphological changes in MOM-like liposomes, but DLP1 did not stimulate BAX-permeabilizing function in the absence or presence of Bif-1. Taken together, our findings not only provide direct evidence for a functional interplay between Bif-1, BAX, and cardiolipin during MOMP but also add significantly to the growing body of evidence indicating that components of the mitochondrial morphogenesis machinery possess proapoptotic functions that are independent from their recognized roles in normal mitochondrial dynamics.	[Etxebarria, Aitor; Terrones, Oihana; Landajuela, Ane; Landeta, Olatz; Basanez, Gorka] Univ Basque Country, EHU, Ctr Mixto,CSIC, Unidad Biofis, E-48080 Bilbao, Spain; [Yamaguchi, Hirohito] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Antonsson, Bruno] Merck Serono Int SA, CH-1202 Geneva, Switzerland; [Wang, Hong-Gang] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Texas System; UTMD Anderson Cancer Center; Merck & Company; Serono International S.A.; Merck KGaA; EMD Serono Inc.; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Basanez, G (corresponding author), EHU, CSIC UPV, Unidad Biofis, Barrio Sarriena S-N, Leioa 48940, Spain.	gbzbaasg@lg.ehu.es	Terrones, Oihana/AAA-8903-2019; Basanez, Gorka/L-9509-2014; Wang, Hong-Gang/A-3018-2015; Terrones, Oihana/I-4023-2015	Basanez, Gorka/0000-0002-7475-7861; Wang, Hong-Gang/0000-0003-0551-0571; Terrones, Oihana/0000-0001-7421-6486; Landeta, Olatz/0000-0002-5494-0271	Ministerio de Ciencia e Innovacion [BFU2008-01637, CA82197-09]; NATIONAL CANCER INSTITUTE [R01CA082197] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Ministerio de Ciencia e Innovacion Grants BFU2008-01637 ( to G. B.) and CA82197-09 ( to H.-G. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alirol E, 2006, MOL BIOL CELL, V17, P4593, DOI 10.1091/mbc.E06-05-0377; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Basanez G, 2002, CELL MOL LIFE SCI, V59, P1478, DOI 10.1007/s00018-002-8523-6; Basanez G, 2008, PLOS BIOL, V6, P1148, DOI 10.1371/journal.pbio.0060154; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Blood PD, 2008, BIOPHYS J, V95, P1866, DOI 10.1529/biophysj.107.121160; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Dahlberg M, 2007, J PHYS CHEM B, V111, P7194, DOI 10.1021/jp071954f; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; FROLOV VA, 2008, J CELL, V132, P727; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; James DI, 2008, DEV CELL, V15, P341, DOI 10.1016/j.devcel.2008.08.011; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lewis RNAH, 2007, BIOPHYS J, V92, P3166, DOI 10.1529/biophysj.106.094003; Liu JH, 2003, MOL CANCER RES, V1, P892; Liu JH, 2008, BIOCHEMISTRY-US, V47, P4518, DOI 10.1021/bi701962c; Low C, 2008, BIOPHYS J, V95, P4315, DOI 10.1529/biophysj.108.134155; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; MARSH D, 1996, BIOCHIM BIOPHYS ACTA, V1286, P182; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Modregger J, 2003, J BIOL CHEM, V278, P4160, DOI 10.1074/jbc.M208568200; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; POWELL GL, 1985, BIOCHEMISTRY-US, V24, P2902, DOI 10.1021/bi00333a013; REICHERT AS, 2002, BIOCHIM BIOPHYS ACTA, V1542, P41; Scorrano L, 2008, J CELL BIOL, V183, P579, DOI 10.1083/jcb.200810125; Sheridan C, 2008, TRENDS CELL BIOL, V18, P353, DOI 10.1016/j.tcb.2008.06.002; Solary E, 2008, NAT GENET, V40, P379, DOI 10.1038/ng0408-379; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Terrones O, 2008, J BIOL CHEM, V283, P7790, DOI 10.1074/jbc.M708814200; VANDENBRINKVAND.E, 2006, BIOCHIM BIOPHYS ACTA, V1666, P275; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wells RC, 2007, J BIOL CHEM, V282, P33769, DOI 10.1074/jbc.M700807200; Yamaguchi H, 2008, J BIOL CHEM, V283, P19112, DOI 10.1074/jbc.M709882200; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	57	47	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4200	4212		10.1074/jbc.M808050200	http://dx.doi.org/10.1074/jbc.M808050200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074440	hybrid, Green Published			2022-12-27	WOS:000263134400017
J	Besnard, V; Wert, SE; Stahlman, MT; Postle, AD; Xu, Y; Ikegami, M; Whitsett, JA				Besnard, Valerie; Wert, Susan E.; Stahlman, Mildred T.; Postle, Anthony D.; Xu, Yan; Ikegami, Machiko; Whitsett, Jeffrey A.			Deletion of Scap in Alveolar Type II Cells Influences Lung Lipid Homeostasis and Identifies a Compensatory Role for Pulmonary Lipofibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; ENDOPLASMIC-RETICULUM STRESS; ELEMENT-BINDING PROTEIN; FATTY-ACID SYNTHESIS; ACTIVATING TRANSCRIPTION FACTOR-3; KERATINOCYTE GROWTH-FACTOR; PROBE LEVEL DATA; GENE-EXPRESSION; RESPIRATORY EPITHELIUM; C/EBP-ALPHA	Pulmonary function after birth is dependent upon surfactant lipids that reduce surface tension in the alveoli. The sterol-responsive element-binding proteins (SREBPs) are transcription factors regulating expression of genes controlling lipid homeostasis in many tissues. To identify the role of SREBPs in the lung, we conditionally deleted the SREBP cleavage-activating protein gene, Scap, in respiratory epithelial cells (Scap(Delta/Delta)) in vivo. Prior to birth (E18.5), deletion of Scap decreased the expression of both SREBPs and a number of genes regulating fatty acid and cholesterol metabolism. Nevertheless, Scap(Delta/Delta) mice survived postnatally, surfactant and lung tissue lipids being substantially normalized in adult Scap(Delta/Delta) mice. Although phospholipid synthesis was decreased in type II cells from adult Scap(Delta/Delta) mice, lipid storage, synthesis, and transfer by lung lipofibroblasts were increased. mRNA microarray data indicated that SCAP influenced two major gene networks, one regulating lipid metabolism and the other stress-related responses. Deletion of the SCAP/SREBP pathway in respiratory epithelial cells altered lung lipid homeostasis and induced compensatory lipid accumulation and synthesis in lung lipofibroblasts.	[Whitsett, Jeffrey A.] Univ Cincinnati, Coll Med, Dept Pediat,Sect Neonatol Perinatal & Pulm Biol, Cincinnati Childrens Hosp Med Ctr,Div Pulm Biol, Cincinnati, OH 45229 USA; [Stahlman, Mildred T.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Postle, Anthony D.] Univ Southampton, Sch Med, Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Vanderbilt University; University of Southampton	Whitsett, JA (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat,Sect Neonatol Perinatal & Pulm Biol, Cincinnati Childrens Hosp Med Ctr,Div Pulm Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	jeff.whitsett@cchmc.org		, Yan/0000-0003-2025-027X; Postle, Anthony/0000-0001-7361-0756; Besnard, Valerie/0000-0002-2614-629X	National Institutes of Health [HL-85610, HL-90156]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105433, R01HL090156, R01HL085610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-85610 and HL-90156 (to J. A. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Barbosa-Tessmann IP, 1999, J BIOL CHEM, V274, P31139, DOI 10.1074/jbc.274.44.31139; BARTLETT GR, 1959, J BIOL CHEM, V234, P468; Besnard V, 2005, AM J PHYSIOL-LUNG C, V289, pL750, DOI 10.1152/ajplung.00151.2005; Besnard V, 2007, AM J PHYSIOL-LUNG C, V293, pL1395, DOI 10.1152/ajplung.00275.2007; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLENDER RP, 1993, AM J PHYSIOL, V265, pL521, DOI 10.1152/ajplung.1993.265.6.L521; Chang YS, 2006, AM J RESP CELL MOL, V35, P268, DOI 10.1165/rcmb.2006-0037OC; Chang YS, 2005, J LIPID RES, V46, P2624, DOI 10.1194/jlr.M500154-JLR200; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Edvardsson U, 2006, J LIPID RES, V47, P329, DOI 10.1194/jlr.M500203-JLR200; Felder TK, 2005, BBA-GENE STRUCT EXPR, V1731, P41, DOI 10.1016/j.bbaexp.2005.08.004; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fitzgerald ML, 2007, J LIPID RES, V48, P621, DOI 10.1194/jlr.M600449-JLR200; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; Flowers MT, 2008, PHYSIOL GENOMICS, V33, P361, DOI 10.1152/physiolgenomics.00139.2007; Garmany TH, 2006, PEDIATR RES, V59, P801, DOI 10.1203/01.pdr.0000219311.14291.df; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Harding HP, 2005, CELL METAB, V2, P361, DOI 10.1016/j.cmet.2005.11.005; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iwamoto N, 2006, J LIPID RES, V47, P1915, DOI 10.1194/jlr.M600127-JLR200; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kilberg M, 2002, J NUTR, V132, P1801, DOI 10.1093/jn/132.7.1801; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Magra AL, 2006, J LIPID RES, V47, P2367, DOI 10.1194/jlr.M600157-JLR200; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Mason RJ, 2003, J CLIN INVEST, V112, P244, DOI 10.1172/JCI200316793; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Okamoto K, 2006, BRAIN RES, V1081, P19, DOI 10.1016/j.brainres.2006.01.081; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Pascual M, 2008, DRUG METAB DISPOS, V36, P1063, DOI 10.1124/dmd.107.019380; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Postle AD, 2006, J LIPID RES, V47, P1322, DOI 10.1194/jlr.M600054-JLR200; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; RUGH R, 1993, MOUSE ITS REPROD DEV, P299; Schultz CJ, 2002, AM J PHYSIOL-LUNG C, V283, pL288, DOI 10.1152/ajplung.00204.2001; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; TORDAY J, 1995, BBA-LIPID LIPID MET, V1254, P198, DOI 10.1016/0005-2760(94)00184-Z; Torday JS, 2002, AM J PHYSIOL-LUNG C, V282, pL405, DOI 10.1152/ajplung.2002.282.3.L405; Torday JS, 2002, AM J PHYSIOL-LUNG C, V283, pL130, DOI 10.1152/ajplung.00380.2001; Van Dyck F, 2007, CELL METAB, V6, P406, DOI 10.1016/j.cmet.2007.09.010; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Weinhofer I, 2005, J BIOL CHEM, V280, P41243, DOI 10.1074/jbc.M509450200; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Whitsett JA, 2006, PAEDIATR RESPIR REV, V7, pS240, DOI 10.1016/j.prrv.2006.04.191; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Yang MCW, 2005, AM J RESP CELL MOL, V32, P35, DOI 10.1165/rcmb.2003-0422OC; Zeng LF, 2004, J BIOL CHEM, V279, P48801, DOI 10.1074/jbc.M407817200; Zhang FJ, 2004, AM J RESP CELL MOL, V30, P174, DOI 10.1165/rcmb.2003-0235OC; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zhou L, 1997, DEV DYNAM, V210, P305, DOI 10.1002/(SICI)1097-0177(199711)210:3<305::AID-AJA10>3.0.CO;2-9	73	48	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					4018	4030		10.1074/jbc.M805388200	http://dx.doi.org/10.1074/jbc.M805388200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074148	Green Published, hybrid			2022-12-27	WOS:000262872500070
J	Dubeykovskaya, Z; Dubeykovskiy, A; Solal-Cohen, J; Wang, TC				Dubeykovskaya, Zinaida; Dubeykovskiy, Alexander; Solal-Cohen, Joel; Wang, Timothy C.			Secreted Trefoil Factor 2 Activates the CXCR4 Receptor in Epithelial and Lymphocytic Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; PANCREATIC SPASMOLYTIC POLYPEPTIDE; SIGNAL-REGULATED KINASES-1/2; INDUCED GASTRIC INJURY; CHEMOKINE RECEPTOR; FACTOR-I; BREAST-CANCER; EXPERIMENTAL COLITIS; FUNCTIONAL CXCR4; IMMUNE-RESPONSE	The secreted trefoil factor family 2 (TFF2) protein contributes to the protection of the gastrointestinal mucosa from injury by strengthening and stabilizing mucin gels, stimulating epithelial restitution, and restraining the associated inflammation. Although trefoil factors have been shown to activate signaling pathways, no cell surface receptor has been directly linked to trefoil peptide signaling. Here we demonstrate the ability of TFF2 peptide to activate signaling via the CXCR4 chemokine receptor in cancer cell lines. We found that both mouse and human TFF2 proteins (at similar to 0.5 mu M) activate Ca2+ signaling in lymphoblastic Jurkat cells that could be abrogated by receptor desensitization (with SDF-1 alpha) or pretreatment with the specific antagonist AMD3100 or an anti-CXCR4 antibody. TFF2 pretreatment of Jurkat cells decreased Ca2+ rise and chemotactic response to SDF-1 alpha. In addition, the CXCR4-negative gastric epithelial cell line AGS became highly responsive to TFF2 treatment upon expression of the CXCR4 receptor. TFF2-induced activation of mitogen-activated protein kinases in gastric and pancreatic cancer cells, KATO III and AsPC-1, respectively, was also dependent on the presence of the CXCR4 receptor. Finally we demonstrate a distinct proliferative effect of TFF2 protein on an AGS gastric cancer cell line that expresses CXCR4. Overall these data identify CXCR4 as a bona fide signaling receptor for TFF2 and suggest a mechanism through which TFF2 may modulate immune and tumorigenic responses in vivo.	[Dubeykovskaya, Zinaida; Dubeykovskiy, Alexander; Wang, Timothy C.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Solal-Cohen, Joel] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University; Columbia University	Wang, TC (corresponding author), Columbia Univ, Med Ctr, Dept Med, 1130 St Nicholas Ave,Rm 925, New York, NY 10032 USA.	tcw21@columbia.edu		Wang, Timothy/0000-0001-5730-3019	National Institutes of Health [2RO1DK060758]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 2RO1DK060758 (to T. C. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akimoto M, 2002, CLIN SCI, V103, p450S, DOI 10.1042/CS103S450S; ALISON MR, 1995, J PATHOL, V175, P405, DOI 10.1002/path.1711750408; Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P489, DOI 10.1053/gast.1996.v110.pm8566596; Bajetto A, 2001, J NEUROCHEM, V77, P1226, DOI 10.1046/j.1471-4159.2001.00350.x; Bajetto A, 2006, NEUROCHEM INT, V49, P423, DOI 10.1016/j.neuint.2006.03.003; Banisadr G, 2000, J NEUROIMMUNOL, V110, P151, DOI 10.1016/S0165-5728(00)00338-6; Barbero S, 2003, CANCER RES, V63, P1969; Baus-Loncar M, 2005, CELL MOL LIFE SCI, V62, P2947, DOI 10.1007/s00018-005-5483-7; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Blades MC, 2002, ARTHRITIS RHEUM, V46, P824, DOI 10.1002/art.10102; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; CARR MD, 1994, P NATL ACAD SCI USA, V91, P2206, DOI 10.1073/pnas.91.6.2206; Cherla RP, 2001, J IMMUNOL, V166, P3067, DOI 10.4049/jimmunol.166.5.3067; CHINERY R, 1995, PEPTIDES, V16, P749, DOI 10.1016/0196-9781(95)00045-L; Christine R, 2005, CANCER RES, V65, P195; Cook GA, 1998, J GASTROEN HEPATOL, V13, P363, DOI 10.1111/j.1440-1746.1998.tb00647.x; Cook GA, 1999, FEBS LETT, V456, P155, DOI 10.1016/S0014-5793(99)00940-0; DE A, 1994, P NATL ACAD SCI USA, V91, P1084, DOI 10.1073/pnas.91.3.1084; Dewan MZ, 2006, BIOMED PHARMACOTHER, V60, P273, DOI 10.1016/j.biopha.2006.06.004; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Dwinell MB, 1999, GASTROENTEROLOGY, V117, P359, DOI 10.1053/gast.1999.0029900359; Eddleston J, 2002, J IMMUNOL, V169, P6445, DOI 10.4049/jimmunol.169.11.6445; Emami S, 2004, PEPTIDES, V25, P885, DOI 10.1016/j.peptides.2003.10.019; Farrell JJ, 2002, J CLIN INVEST, V109, P193, DOI 10.1172/JCI200212529; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; Forster R, 1998, J IMMUNOL, V160, P1522; Fox JG, 2007, AM J PATHOL, V171, P1520, DOI 10.2353/ajpath.2007.070249; FRANDSEN EK, 1988, REGUL PEPTIDES, V20, P45, DOI 10.1016/0167-0115(88)90056-0; FRANDSEN EK, 1986, REGUL PEPTIDES, V16, P291, DOI 10.1016/0167-0115(86)90028-5; Graness A, 2002, J BIOL CHEM, V277, P18440, DOI 10.1074/jbc.M200468200; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Hoffmann W, 2002, INT REV CYTOL, V213, P147; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; JEFFREY GP, 1994, GASTROENTEROLOGY, V106, P336, DOI 10.1016/0016-5085(94)90590-8; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Jordan NJ, 1999, J CLIN INVEST, V104, P1061, DOI 10.1172/JCI6685; Kalinkovich A, 2006, CANCER RES, V66, P11013, DOI 10.1158/0008-5472.CAN-06-2006; Kanbe K, 2002, ARTHRITIS RHEUM-US, V46, P130, DOI 10.1002/1529-0131(200201)46:1<130::AID-ART10020>3.0.CO;2-D; Kjellev S, 2007, PEPTIDES, V28, P1197, DOI 10.1016/j.peptides.2007.03.016; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Kurt-Jones EA, 2007, INFECT IMMUN, V75, P471, DOI 10.1128/IAI.02039-05; Lalani EN, 1999, LAB INVEST, V79, P537; Liu D, 1997, LAB INVEST, V77, P557; LOETSCHER M, 1994, J BIOL CHEM, V269, P232; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; Majka M, 2000, EUR J HAEMATOL, V64, P164, DOI 10.1034/j.1600-0609.2000.90112.x; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; May FEB, 2004, PEPTIDES, V25, P865, DOI 10.1016/j.peptides.2003.12.024; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Norsett KG, 2005, PHYSIOL GENOMICS, V22, P24, DOI 10.1152/physiolgenomics.00245.2004; Oertel M, 2001, AM J RESP CELL MOL, V25, P418, DOI 10.1165/ajrcmb.25.4.4429; Otto WR, 2006, PROTEOMICS, V6, P4235, DOI 10.1002/pmic.200500911; Pannequin J, 2004, J ENDOCRINOL, V181, P315, DOI 10.1677/joe.0.1810315; Petty JM, 2007, J IMMUNOL, V178, P8148, DOI 10.4049/jimmunol.178.12.8148; PLAYFORD RJ, 1995, GASTROENTEROLOGY, V108, P92, DOI 10.1016/0016-5085(95)90012-8; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Poulsen SS, 2005, REGUL PEPTIDES, V126, P163, DOI 10.1016/j.regpep.2004.09.007; Poulsen SS, 2003, REGUL PEPTIDES, V115, P91, DOI 10.1016/S0167-0115(03)00145-9; Poulsen SS, 1998, GUT, V43, P240, DOI 10.1136/gut.43.2.240; Quintana A, 2005, PFLUG ARCH EUR J PHY, V450, P1, DOI 10.1007/s00424-004-1364-4; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Soriano-Izquierdo A, 2004, J LEUKOCYTE BIOL, V75, P214, DOI 10.1189/jlb.0803396; Storesund T, 2008, EUR J ORAL SCI, V116, P135, DOI 10.1111/j.1600-0722.2007.00516.x; Tan XD, 1997, BIOCHEM BIOPH RES CO, V237, P673, DOI 10.1006/bbrc.1997.7144; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Thim L, 2000, REGUL PEPTIDES, V90, P61, DOI 10.1016/S0167-0115(00)00110-5; Tran CP, 1999, GUT, V44, P636, DOI 10.1136/gut.44.5.636; Tu SP, 2007, AM J PHYSIOL-GASTR L, V292, pG1726, DOI 10.1152/ajpgi.00348.2006; Ueda Y, 2006, CANCER RES, V66, P5665, DOI 10.1158/0008-5472.CAN-05-3579; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Weber KSC, 2001, MOL BIOL CELL, V12, P3074, DOI 10.1091/mbc.12.10.3074; Zhao M, 2008, BREAST CANCER RES TR, V110, P211, DOI 10.1007/s10549-007-9712-7	76	69	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3650	3662		10.1074/jbc.M804935200	http://dx.doi.org/10.1074/jbc.M804935200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19064997	Green Published, hybrid			2022-12-27	WOS:000262872500033
J	Kaneko, O; Gong, L; Zhang, JL; Hansen, JK; Hassan, R; Lee, B; Ho, M				Kaneko, Osamu; Gong, Lucy; Zhang, Jingli; Hansen, Johanna K.; Hassan, Raffit; Lee, Byungkook; Ho, Mitchell			A Binding Domain on Mesothelin for CA125/MUC16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER ANTIGEN; MONOCLONAL-ANTIBODY; MOLECULAR-CLONING; EXTRACELLULAR SUPERSTRUCTURE; MALIGNANT MESOTHELIOMA; CELL-ADHESION; HIGH-AFFINITY; TUMOR-CELLS; CA-125 GENE; EXPRESSION	Ovarian cancer and malignant mesothelioma frequently express both mesothelin and CA125 (also known as MUC16) at high levels on the cell surface. The interaction between mesothelin and CA125 may facilitate the implantation and peritoneal spread of tumors by cell adhesion, whereas the detailed nature of this interaction is still unknown. Here, we used truncated mutagenesis and alanine replacement techniques to identify a binding site on mesothelin for CA125. We examined the molecular interaction by Western blot overlay assays and further quantitatively analyzed by enzyme-linked immunosorbent assay. We also evaluated the binding on cancer cells by flow cytometry. We identified the region (296-359) consisting of 64 amino acids at the N-terminal of cell surface mesothelin as the minimum fragment for complete binding activity to CA125. We found that substitution of tyrosine 318 with an alanine abolished CA125 binding. Replacement of tryptophan 321 and glutamic acid 324 with alanine could partially decrease binding to CA125, whereas mutation of histidine 354 had no effect. These results indicate that a conformation-sensitive structure of the region (296 359) is required and sufficient for the binding of mesothelin to CA125. In addition, we have shown that a single chain monoclonal antibody (SS1) recognizes this CA125-binding domain and blocks the mesothelin-CA125 interaction on cancer cells. The identified CA125-binding domain significantly inhibits cancer cell adhesion and merits evaluation as a new therapeutic agent for preventing or treating peritoneal malignant tumors.	[Ho, Mitchell] NCI, Antibody Therapy Unit, Mol Biol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ho, M (corresponding author), NCI, Antibody Therapy Unit, Mol Biol Lab, Ctr Canc Res,NIH, 37 Convent Dr,Rm 5002C, Bethesda, MD 20892 USA.	homi@mail.nih.gov	Ho, Mitchell/F-5059-2015	Ho, Mitchell/0000-0002-9152-5405	National Institutes of Health Intramural Research Program of the NCI; Center for Cancer Research; Ovarian Cancer Research Fund Individual Investigator Award; Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE [ZIABC010891, ZIABC011013, Z01BC011013, Z01BC010891] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund Individual Investigator Award; Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NCI, Center for Cancer Research. This work was also supported in part by a Ovarian Cancer Research Fund Individual Investigator Award (M. H.) and an Mesothelioma Applied Research Foundation Grant in Honor of Craig Kozicki (M. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Attanoos RL, 2002, HISTOPATHOLOGY, V40, P237, DOI 10.1046/j.1365-2559.2002.01352.x; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Bateman AC, 1997, HISTOPATHOLOGY, V30, P49, DOI 10.1046/j.1365-2559.1996.d01-562.x; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Desseyn JL, 2008, GENE, V410, P215, DOI 10.1016/j.gene.2007.12.014; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Hassan Raffit, 2007, Cancer Immun, V7, P20; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hellstrom I, 2008, CANCER EPIDEM BIOMAR, V17, P1520, DOI 10.1158/1055-9965.EPI-08-0039; Hellstrom I, 2006, CANCER EPIDEM BIOMAR, V15, P1014, DOI 10.1158/1055-9965.EPI-05-0334; Ho M, 2005, CLIN CANCER RES, V11, P3814, DOI 10.1158/1078-0432.CCR-04-2304; Ho M, 2005, J BIOL CHEM, V280, P607, DOI 10.1074/jbc.M409783200; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Ho M, 2006, CANCER EPIDEM BIOMAR, V15, P1751, DOI 10.1158/1055-9965.EPI-06-0479; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; KOJIMA T, 1995, J BIOL CHEM, V270, P21984, DOI 10.1074/jbc.270.37.21984; Maeda T, 2004, J BIOL CHEM, V279, P13174, DOI 10.1074/jbc.M309417200; McGregor DP, 2008, CURR OPIN PHARMACOL, V8, P616, DOI 10.1016/j.coph.2008.06.002; Miettinen M, 2003, AM J SURG PATHOL, V27, P150, DOI 10.1097/00000478-200302000-00002; O'Brien TJ, 2002, TUMOR BIOL, V23, P154, DOI 10.1159/000064032; O'Brien TJ, 2001, TUMOR BIOL, V22, P348, DOI 10.1159/000050638; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1418, DOI 10.1097/00000478-200311000-00003; Palumbo C, 2008, CURR MED CHEM, V15, P855, DOI 10.2174/092986708783955446; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Runowicz CD, 2008, CANCER J, V14, P7, DOI 10.1097/PPO.0b013e318163c2e0; Scholler N, 2007, CANCER LETT, V247, P130, DOI 10.1016/j.canlet.2006.03.029; Sterman DH, 2007, CLIN CANCER RES, V13, P4456, DOI 10.1158/1078-0432.CCR-07-0403; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200	32	114	127	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3739	3749		10.1074/jbc.M806776200	http://dx.doi.org/10.1074/jbc.M806776200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19075018	Green Published, hybrid			2022-12-27	WOS:000262872500042
J	Armishaw, C; Jensen, AA; Balle, T; Clark, RJ; Harpsoe, K; Skonberg, C; Liljefors, T; Stromgaard, K				Armishaw, Christopher; Jensen, Anders A.; Balle, Thomas; Clark, Richard J.; Harpsoe, Kasper; Skonberg, Christian; Liljefors, Tommy; Stromgaard, Kristian			Rational Design of alpha-Conotoxin Analogues Targeting alpha 7 Nicotinic Acetylcholine Receptors IMPROVED ANTAGONISTIC ACTIVITY BY INCORPORATION OF PROLINE DERIVATIVES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING PROTEIN; LIGAND-BINDING; PEPTIDE ANTAGONIST; CONUS-GEOGRAPHUS; ACCURATE DOCKING; IMI; NMR; REVEALS; SUBTYPE	Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that belong to the superfamily of Cys loop receptors. Valuable insight into the orthosteric ligand binding to nAChRs in recent years has been obtained from the crystal structures of acetylcholine-binding proteins (AChBPs) that share significant sequence homology with the aminoterminal domains of the nAChRs. alpha-Conotoxins, which are isolated from the venom of carnivorous marine snails, selectively inhibit the signaling of neuronal nAChR subtypes. Co-crystal structures of alpha-conotoxins in complex with AChBP show that the side chain of a highly conserved proline residue in these toxins is oriented toward the hydrophobic binding pocket in the AChBP but does not have direct interactions with this pocket. In this study, we have designed and synthesized analogues of alpha-conotoxins ImI and PnIA[A10L], by introducing a range of substituents on the Pro6 residue in these toxins to probe the importance of this residue for their binding to the nAChRs. Pharmacological characterization of the toxin analogues at the alpha(7) nAChR shows that although polar and charged groups on Pro6 result in analogues with significantly reduced antagonistic activities, analogues with aromatic and hydrophobic substituents in the Pro6 position exhibit moderate activity at the receptor. Interestingly, introduction of a 5-(R)-phenyl substituent at Pro6 in alpha-conotoxin ImI gives rise to a conotoxin analogue with a significantly higher binding affinity and antagonistic activity at the alpha(7) nAChR than those exhibited by the native conotoxin.	[Armishaw, Christopher; Jensen, Anders A.; Balle, Thomas; Harpsoe, Kasper; Liljefors, Tommy; Stromgaard, Kristian] Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen O, Denmark; [Skonberg, Christian] Univ Copenhagen, Dept Pharmaceut & Analyt Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen O, Denmark; [Clark, Richard J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Copenhagen; University of Copenhagen; University of Queensland	Jensen, AA (corresponding author), Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, Univ Sparken 2, DK-2100 Copenhagen O, Denmark.	aaj@farma.ku.dk; krst@farma.ku.dk	Jensen, Anders/AAJ-3335-2020; Stromgaard, Kristian/E-3380-2010; Clark, Richard J/G-8848-2012; Harpsøe, Kasper/V-6870-2018; Skonberg, Christian/D-2381-2010	Jensen, Anders/0000-0002-7927-5052; Clark, Richard J/0000-0002-6807-5426; Harpsøe, Kasper/0000-0002-9326-9644; Balle, Thomas/0000-0002-0233-8350; Stromgaard, Kristian/0000-0003-2206-4737	Drug Research Academy; Faculty of Pharmaceutical Sciences, University of Copenhagen	Drug Research Academy; Faculty of Pharmaceutical Sciences, University of Copenhagen	This work was supported in part by post-doctoral grants from the Drug Research Academy, Faculty of Pharmaceutical Sciences, University of Copenhagen (to C. A. and K. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Armishaw CJ, 2006, J BIOL CHEM, V281, P14136, DOI 10.1074/jbc.M512419200; Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Boulegue C, 2006, J MOL BIOL, V358, P846, DOI 10.1016/j.jmb.2006.02.031; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dowell C, 2003, J NEUROSCI, V23, P8445; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Dutertre S, 2006, BIOCHEM PHARMACOL, V72, P661, DOI 10.1016/j.bcp.2006.03.027; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Ellison M, 2004, BIOCHEMISTRY-US, V43, P16019, DOI 10.1021/bi048918g; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; Everhart D, 2004, BIOCHEMISTRY-US, V43, P2732, DOI 10.1021/bi036180h; FAINZILBER M, 1994, BIOCHEMISTRY-US, V33, P9523, DOI 10.1021/bi00198a018; Feuerbach D, 2005, NEUROPHARMACOLOGY, V48, P215, DOI 10.1016/j.neuropharm.2004.10.003; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gehrmann J, 1999, J MED CHEM, V42, P2364, DOI 10.1021/jm990114p; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; GRAY WR, 1981, J BIOL CHEM, V256, P4734; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; Hogg RC, 2003, J BIOL CHEM, V278, P26908, DOI 10.1074/jbc.M212628200; Hogg RC, 1999, J BIOL CHEM, V274, P36559, DOI 10.1074/jbc.274.51.36559; Hu SH, 1996, STRUCTURE, V4, P417, DOI 10.1016/S0969-2126(96)00047-0; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jacobsen RB, 1999, BIOCHEMISTRY-US, V38, P13310, DOI 10.1021/bi9907476; Jensen AA, 2003, MOL PHARMACOL, V64, P865, DOI 10.1124/mol.64.4.865; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; JOHNSON DS, 1995, MOL PHARMACOL, V48, P194; Kang TS, 2007, BIOCHEMISTRY-US, V46, P3338, DOI 10.1021/bi061969o; Kasheverov IE, 2006, FEBS J, V273, P4470, DOI 10.1111/j.1742-4658.2006.05453.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lamthanh H, 1999, FEBS LETT, V454, P293, DOI 10.1016/S0014-5793(99)00831-5; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laube B, 2002, TRENDS PHARMACOL SCI, V23, P519, DOI 10.1016/S0165-6147(02)02138-7; Livett BG, 2006, TOXICON, V48, P810, DOI 10.1016/j.toxicon.2006.07.023; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Loughnan M, 1998, J BIOL CHEM, V273, P15667, DOI 10.1074/jbc.273.25.15667; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Luo SQ, 1998, J NEUROSCI, V18, P8571; Maslennikov IV, 1999, FEBS LETT, V444, P275, DOI 10.1016/S0014-5793(99)00069-1; McIntosh JM, 2002, J BIOL CHEM, V277, P33610, DOI 10.1074/jbc.M205102200; MCINTOSH JM, 1994, J BIOL CHEM, V269, P16733; MCINTOSH M, 1982, ARCH BIOCHEM BIOPHYS, V218, P329, DOI 10.1016/0003-9861(82)90351-4; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; MYERS RA, 1991, BIOCHEMISTRY-US, V30, P9370, DOI 10.1021/bi00102a034; Nicke A, 2003, J BIOL CHEM, V278, P3137, DOI 10.1074/jbc.M210280200; O'Mara M, 2005, BIOPHYS J, V88, P3286, DOI 10.1529/biophysj.104.051664; Quiram PA, 1998, J BIOL CHEM, V273, P11001, DOI 10.1074/jbc.273.18.11001; Quiram PA, 2000, J BIOL CHEM, V275, P4889, DOI 10.1074/jbc.275.7.4889; Quiram PA, 1998, J BIOL CHEM, V273, P11007, DOI 10.1074/jbc.273.18.11007; Reeves DC, 2002, MOL MEMBR BIOL, V19, P11, DOI 10.1080/09687680110110048; Rogers JP, 1999, BIOCHEMISTRY-US, V38, P3874, DOI 10.1021/bi9826254; Sabey K, 1999, MOL PHARMACOL, V55, P58, DOI 10.1124/mol.55.1.58; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Schrodinger L., 2008, MAESTRO VERSION 8 5; SCHRODINGER LLC, 2008, PRIME VERSION 2 0; SCHRODINGER LLC, 2008, MACROMODEL VERSION 9; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sher E, 2004, CURR TOP MED CHEM, V4, P283, DOI 10.2174/1568026043451393; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Tamaki M, 2001, J ORG CHEM, V66, P3593, DOI 10.1021/jo005625u; Tamamura H, 2005, J MED CHEM, V48, P3280, DOI 10.1021/jm050009h; Trudell JR, 2002, BBA-BIOMEMBRANES, V1565, P91, DOI 10.1016/S0005-2736(02)00512-6; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Xiao YX, 2004, BIOORG MED CHEM LETT, V14, P1845, DOI 10.1016/j.bmcl.2003.09.105; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Xiao YX, 1998, MOL PHARMACOL, V54, P322, DOI 10.1124/mol.54.2.322	88	42	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9498	9512		10.1074/jbc.M806136200	http://dx.doi.org/10.1074/jbc.M806136200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19131337	hybrid, Green Published			2022-12-27	WOS:000264669100056
J	Maron, BA; Zhang, YY; Handy, DE; Beuve, A; Tang, SS; Loscalzo, J; Leopold, JA				Maron, Bradley A.; Zhang, Ying-Yi; Handy, Diane E.; Beuve, Annie; Tang, Shiow-Shih; Loscalzo, Joseph; Leopold, Jane A.			Aldosterone Increases Oxidant Stress to Impair Guanylyl Cyclase Activity by Cysteinyl Thiol Oxidation in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; NITRIC-OXIDE; HEART-FAILURE; VASODILATOR DYSFUNCTION; SULFENIC ACID; ACTIVATION; EXPRESSION; NO; SUPEROXIDE; PEROXYNITRITE	Hyperaldosteronism is associated with impaired endothelium-dependent vascular reactivity owing to increased reactive oxygen species and decreased bioavailable nitric oxide (NO center dot); however, the effects of aldosterone on vasodilatory signaling pathways in vascular smooth muscle cells (VSMC) remain unknown. Soluble guanylyl cyclase (GC) is a heterodimer that is activated by NO center dot to convert cytosolic GTP to cGMP, a second messenger required for normal VSMC relaxation. Here, we show that aldosterone (10(-9)-10(-7) mol/liter) diminishes GC activity by activating NADPH oxidase in bovine aortic VSMC to increase reactive oxygen species levels and induce oxidative posttranslational modification(s) of Cys-122, a beta(1)-subunit cysteinyl residue demonstrated previously to modulate NO center dot sensing by GC. In VSMC treated with aldosterone, Western immunoblotting detected evidence of GC beta(1)-subunit disulfide bonding, whereas mass spectrometry analysis of a homologous peptide containing the Cys-122-bearing sequence exposed to conditions of increased oxidant stress confirmed cysteinyl sulfinic acid (m/z 435), sulfonic acid (m/z 443), and disulfide (m/z 836) bond formation. The functional effect of these modifications was examined by transfecting COS-7 cells with wild-type GC or mutant GC containing an alanine substitution at Cys-122 (C122A). Exposure to aldosterone or hydrogen peroxide (H2O2) significantly decreased cGMP levels in cells expressing wild-type GC. In contrast, aldosterone or H2O2 did not influence cGMP levels in cells expressing the mutant C122A GC, confirming that oxidative modification of Cys-122 specifically impairs GC activity. These findings demonstrate that pathophysiologically relevant concentrations of aldosterone increase oxidant stress to convert GC to an NO center dot-insensitive state, resulting in disruption of normal vasodilatory signaling pathways in VSMC.	[Maron, Bradley A.; Zhang, Ying-Yi; Handy, Diane E.; Tang, Shiow-Shih; Loscalzo, Joseph; Leopold, Jane A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02115 USA; [Beuve, Annie] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center	Leopold, JA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, 77 Ave Louis Pasteur,NRB 0630K, Boston, MA 02115 USA.	jleopold@partners.org	Loscalzo, Joseph/ABD-8980-2021	Handy, Diane/0000-0002-4310-8527	National Institutes of Health [HL089771, HL61795, NO1HV28178, HL5897, PO1HL815876, HL081110]; American Heart Association grant-in-aid; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089771, K02HL081110, R01HL061795, R01HL058976, P01HL081587, R37HL061795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grant-in-aid(American Heart Association); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089771 (to A.B.), HL61795, NO1HV28178, HL58976, and PO1HL81587 (to J.L.), and HL081110 (to J.A.L.). This work was also supported by an American Heart Association grant-in-aid (to J.A.L.) The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ahokas RA, 2005, CIRCULATION, V111, P51, DOI 10.1161/01.CIR.0000151516.84238.37; Bauersachs J, 1998, CARDIOVASC RES, V37, P772, DOI 10.1016/S0008-6363(97)00250-2; BRANDWEIN HJ, 1981, J BIOL CHEM, V256, P2958; Duprez DA, 1998, EUR HEART J, V19, P1371, DOI 10.1053/euhj.1998.1099; Farquharson CAJ, 2000, CIRCULATION, V101, P594, DOI 10.1161/01.CIR.101.6.594; Friebe A, 1997, BIOCHEMISTRY-US, V36, P1194, DOI 10.1021/bi962047w; Gerassimou C, 2007, BRIT J PHARMACOL, V150, P1084, DOI 10.1038/sj.bjp.0707179; Gladwin MT, 2006, J CLIN INVEST, V116, P2330, DOI 10.1172/JCI29807; Goldstein S, 2005, CHEM REV, V105, P2457, DOI 10.1021/cr0307087; Handy DE, 2005, J BIOL CHEM, V280, P15518, DOI 10.1074/jbc.M501452200; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; IGNARRO LJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P49, DOI 10.1016/0304-4165(82)90008-3; Jiang BB, 1999, HYPERTENSION, V34, P574, DOI 10.1161/01.HYP.34.4.574; Kloss S, 2000, HYPERTENSION, V35, P43; Koesling D, 1999, METHODS, V19, P485, DOI 10.1006/meth.1999.0891; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Mastroberardino PG, 2008, FREE RADICAL BIO MED, V45, P971, DOI 10.1016/j.freeradbiomed.2008.06.018; Melichar VO, 2004, P NATL ACAD SCI USA, V101, P16671, DOI 10.1073/pnas.0405509101; Mingone CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL337, DOI 10.1152/ajplung.00482.2005; Mulsch A, 1997, BRIT J PHARMACOL, V120, P681, DOI 10.1038/sj.bjp.0700982; MULSCH A, 1989, N-S ARCH PHARMACOL, V339, P568, DOI 10.1007/BF00167263; Munzel T, 2005, ARTERIOSCL THROM VAS, V25, P1551, DOI 10.1161/01.ATV.0000168896.64927.bb; MURAD F, 1981, ADV CYCL NUCL RES<D>, V14, P229; RADI R, 1991, J BIOL CHEM, V266, P4244; Ruetten H, 1999, CIRC RES, V85, P534, DOI 10.1161/01.RES.85.6.534; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Shetty V, 2007, J AM SOC MASS SPECTR, V18, P1544, DOI 10.1016/j.jasms.2007.05.013; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SIMONS JM, 1990, FREE RADICAL BIO MED, V8, P251, DOI 10.1016/0891-5849(90)90070-Y; Srikanth R, 2007, J AM SOC MASS SPECTR, V18, P1499, DOI 10.1016/j.jasms.2007.05.011; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Struthers AD, 2004, MOL CELL ENDOCRINOL, V217, P239, DOI 10.1016/j.mce.2003.10.024; Sun Y, 2002, AM J PATHOL, V161, P1773, DOI 10.1016/S0002-9440(10)64454-9; SWEDBERG K, 1990, CIRCULATION, V82, P1730, DOI 10.1161/01.CIR.82.5.1730; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; WALDMAN SA, 1991, METHODS ENZYMOL, V195, P391; Walford GA, 2004, J BIOL CHEM, V279, P4425, DOI 10.1074/jbc.M310582200; Weber KT, 2003, J LAB CLIN MED, V142, P71, DOI 10.1016/S0022-2143(03)00062-3; Weber KT, 2001, NEW ENGL J MED, V345, P1689, DOI 10.1056/NEJMra000050; Weber M, 2001, FREE RADICAL BIO MED, V31, P1360, DOI 10.1016/S0891-5849(01)00706-7; Welch GN, 1998, P ASSOC AM PHYSICIAN, V110, P22	43	75	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7665	7672		10.1074/jbc.M809460200	http://dx.doi.org/10.1074/jbc.M809460200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19141618	Green Published, hybrid			2022-12-27	WOS:000264195600028
J	Baltus, GA; Kowalski, MP; Tutter, AV; Kadam, S				Baltus, Gretchen A.; Kowalski, Michael P.; Tutter, Antonin V.; Kadam, Shilpa			A Positive Regulatory Role for the mSin3A-HDAC Complex in Pluripotency through Nanog and Sox2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; HISTONE DEACETYLASE; GENE-EXPRESSION; DIFFERENTIATION; ACETYLATION; NETWORK; OCT4	Large networks of proteins govern embryonic stem (ES) cell pluripotency. Recent analysis of the critical pluripotency factors Oct4 and Nanog has identified their interaction with multiple transcriptional repression complexes, including members of the mSin3A-HDAC complex, suggesting that these factors could be involved in the regulation of Oct4/Nanog function. mSin3A is critical for embryonic development, but the mechanism by which the mSin3A-HDAC complex is able to regulate ES cell pluripotency is undefined. Herein we show that the mSin3A-HDAC complex positively regulates Nanog expression in ES cells through Sox2, a critical ES cell transcription factor and regulator of Nanog. We have identified the mSin3A-HDAC complex to be present at the Nanog promoter only under proliferating conditions concurrent with histone acetylation. We find that Sox2 associates with mSin3A-HDAC complex members both in vitro and in vivo, similar to the interactions found between Oct4/Nanog and the mSin3A-HDAC complex. Knockdown of mSin3A-HDAC complex members or HDAC inhibitor treatment reduces Nanog expression, and overexpression of mSin3A-HDAC complex subunits stimulates Nanog expression. Our data demonstrate that the mSin3A-HDAC complex can positively regulate Nanog expression under proliferating conditions and that this activity is complementary to mSin3A-mediated p53-dependent silencing of Nanog during differentiation.	[Baltus, Gretchen A.; Kowalski, Michael P.; Tutter, Antonin V.; Kadam, Shilpa] Novartis Inst Biomed Res, Dept Dev & Mol Pathways, Cambridge, MA 02139 USA	Novartis	Kadam, S (corresponding author), Novartis Inst Biomed Res, Dept Dev & Mol Pathways, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	shilpa.kadam@novartis.com						Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Imai Y, 2004, MOL CELL BIOL, V24, P1033, DOI 10.1128/MCB.24.3.1033-1043.2004; Johnson BV, 2006, CURR OPIN GENET DEV, V16, P447, DOI 10.1016/j.gde.2006.08.012; KAESER MD, 2006, CURR OPIN GENE DEV, V5, P508; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kasler Herbert G., 2006, P129; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McCool KW, 2007, J BIOL CHEM, V282, P6696, DOI 10.1074/jbc.M609519200; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Thevenet L, 2004, EMBO J, V23, P3336, DOI 10.1038/sj.emboj.7600352; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001	34	51	53	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6998	7006		10.1074/jbc.M807670200	http://dx.doi.org/10.1074/jbc.M807670200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139101	hybrid, Green Published			2022-12-27	WOS:000263919000048
J	Gong, ZH; Cho, YW; Kim, JE; Ge, K; Chen, JJ				Gong, Zihua; Cho, Young-Wook; Kim, Ja-Eun; Ge, Kai; Chen, Junjie			Accumulation of Pax2 Transactivation Domain Interaction Protein (PTIP) at Sites of DNA Breaks via RNF8-dependent Pathway Is Required for Cell Survival after DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRCT-DOMAIN; BINDING; MDC1; PHOSPHORYLATION; REPAIR; P53	Genomic stability in eukaryotic cells is maintained by the coordination of multiple cellular events including cell cycle checkpoint, DNA repair, transcription, and apoptosis after DNA damage. Pax2 transactivation domain interaction protein (PTIP), a protein that contains six BRCT domains, has been implicated in DNA damage response. In this study we showed that recruitment of PTIP to damaged chromatin depends on DNA damage signaling proteins gamma H2AX center dot MDC1 center dot RNF8, which in turn facilitates sustained localization of PA1 (PTIP-associated protein 1) to sites of DNA break. Similar to PTIP, depletion of PA1 increases cellular sensitivity to ionizing radiation. Furthermore, we demonstrated that the N-terminal PA1 binding domain and the C-terminal focus-localization domain of PTIP are critical for PTIP function in DNA damage repair. Interestingly, although PTIP and PA1 associate with MLL (mixed lineage leukemia) complexes and participate in transcriptional regulation, this function of PTIP center dot PA1 in DNA damage response is likely to be independent of the MLL complexes. Taken together, we propose that a subset of PTIP center dot PA1 complex is recruited to DNA damage sites via the RNF8-dependent pathway and is required for cell survival in response to DNA damage.	[Gong, Zihua; Kim, Ja-Eun; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Cho, Young-Wook; Ge, Kai] NIDDK, Nucl Receptor Biol Sect, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA; [Kim, Ja-Eun] Kyung Hee Univ, Sch Med, Dept Pharmacol, Seoul 130701, South Korea	Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Kyung Hee University	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA.	Junjie.chen@yale.edu	Kim, Ja-Eun/AAI-1896-2020; Ge, Kai/H-2810-2019; Cho, Young-Wook/F-8269-2011	Kim, Ja-Eun/0000-0002-9132-1277; Ge, Kai/0000-0002-7442-5138; 	National Institutes of Health [CA089239, CA092312, CA100109]; NATIONAL CANCER INSTITUTE [R01CA100109, R01CA092312, R01CA089239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075017, ZIADK047055, ZIADK075003, Z01DK047055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.).	Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; Cho EA, 2003, MOL CELL BIOL, V23, P1666, DOI 10.1128/MCB.23.5.1666-1673.2003; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	26	62	68	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7284	7293		10.1074/jbc.M809158200	http://dx.doi.org/10.1074/jbc.M809158200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19124460	Green Published, hybrid			2022-12-27	WOS:000263919000075
J	Gropler, MC; Harris, TE; Hall, AM; Wolins, NE; Gross, RW; Han, XL; Chen, ZJ; Finck, BN				Gropler, Matthew C.; Harris, Thurl E.; Hall, Angela M.; Wolins, Nathan E.; Gross, Richard W.; Han, Xianlin; Chen, Zhouji; Finck, Brian N.			Lipin 2 Is a Liver-enriched Phosphatidate Phosphohydrolase Enzyme That Is Dynamically Regulated by Fasting and Obesity in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE-METABOLISM; HEPATIC GLUCONEOGENESIS; BIOLOGICAL SAMPLES; MASS-SPECTROMETRY; COACTIVATOR PGC-1; MAJEED-SYNDROME; MUTANT MOUSE; MUTATION; EXPRESSION; LPIN2	Lipin 1 is a bifunctional intracellular protein that regulates fatty acid metabolism in the nucleus via interactions with DNA-bound transcription factors and at the endoplasmic reticulum as a phosphatidic acid phosphohydrolase enzyme (PAP-1) to catalyze the penultimate step in triglyceride synthesis. However, livers of 8-day-old mice lacking lipin 1 (fld mice) exhibited normal PAP-1 activity and a 20-fold increase in triglyceride levels. We sought to further analyze the hepatic lipid profile of these mice by electrospray ionization mass spectrometry. Surprisingly, hepatic content of phosphatidate, the substrate of PAP-1 enzymes, was markedly diminished in fld mice. Similarly, other phospholipids derived from phosphatidate, phosphatidylglycerol and cardiolipin, were also depleted. Another member of the lipin family (lipin 2) is enriched in liver, and hepatic lipin 2 protein content was markedly increased by lipin 1 deficiency, food deprivation, and obesity, often independent of changes in steady-state mRNA levels. Importantly, RNAi against lipin 2 markedly reduced PAP-1 activity in hepatocytes from both wild type and fld mice and suppressed triglyceride synthesis under conditions of high fatty acid availability. Collectively, these data suggest that lipin 2 plays an important role as a hepatic PAP-1 enzyme.	[Gropler, Matthew C.; Hall, Angela M.; Wolins, Nathan E.; Gross, Richard W.; Han, Xianlin; Chen, Zhouji; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Harris, Thurl E.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	Washington University (WUSTL); University of Virginia	Finck, BN (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave,Box 8031, St Louis, MO 63110 USA.	bfinck@wustl.edu		Hall, Angela Marie/0000-0003-0006-7910; Finck, Brian/0000-0001-5411-3674	National Institutes of Health [R01 DK078187, R01 HL73939, R01 DK52753, R01 DK28312, P01 HL57278]; Digestive Diseases Research Core Center (National Institutes of Health) [P30 DK52574]; Clinical Nutrition Research Unit Core Center (National Institutes of Health) [P30 DK56341]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278, R01HL073939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078187, R01DK028312, P30DK056341, P30DK052574, R01DK052753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Core Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Nutrition Research Unit Core Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK078187 ( to B. N. F.), R01 HL73939 ( to Z. C.), R01s DK52753 and DK28312 ( to J. C. Lawrence, Jr. ( deceased)), and P01 HL57278 ( to R. W. G. and X. H.). This work was also supported, in part, by the Digestive Diseases Research Core Center ( National Institutes of Health Grant P30 DK52574) and the Clinical Nutrition Research Unit Core Center (National Institutes of Health Grant P30 DK56341) at the Washington University School of Medicine.	Al-Mosawi ZS, 2007, ARTHRITIS RHEUM, V56, P960, DOI 10.1002/art.22431; Aulchenko YS, 2007, DIABETES, V56, P3020, DOI 10.2337/db07-0338; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Gonzalez-Baro MR, 2007, AM J PHYSIOL-GASTR L, V292, pG1195, DOI 10.1152/ajpgi.00553.2006; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han XL, 2001, ANAL BIOCHEM, V295, P88, DOI 10.1006/abio.2001.5178; Han XL, 2004, ANAL BIOCHEM, V330, P317, DOI 10.1016/j.ab.2004.04.004; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200; Mileykovskaya E, 2005, BIOCHEMISTRY-MOSCOW+, V70, P154, DOI 10.1007/s10541-005-0095-2; MOSTAFA N, 1993, BIOCHIM BIOPHYS ACTA, V1169, P189, DOI 10.1016/0005-2760(93)90205-N; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Rehnmark S, 1998, J LIPID RES, V39, P2209; Reue K, 1996, J LIPID RES, V37, P1387; Reue K, 2000, J LIPID RES, V41, P1067; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	31	55	59	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6763	6772		10.1074/jbc.M807882200	http://dx.doi.org/10.1074/jbc.M807882200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136718	Green Published, hybrid			2022-12-27	WOS:000263919000021
J	Martin, D; Galisteo, R; Gutkind, JS				Martin, Daniel; Galisteo, Rebeca; Gutkind, J. Silvio			CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NF kappa B through the CBM (Carma3/Bcl10/Malt1) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELLS; ANGIOGENESIS; INTERLEUKIN-8; HYPOXIA; SECRETION; PERMEABILITY; HIF-1-ALPHA; PATHWAYS; GENE	Vascular endothelial growth factor (VEGF) is a potent mitogen and permeability factor for endothelial cells that plays a central role in angiogenesis, vascular maintenance, inflammation, and cancer. VEGF also mediates the homeostatic adaptation to hypoxic conditions by promoting an increase in vascular density to compensate for decreased oxygenation. This process is triggered by an oxygen-sensitive transcription factor, hypoxia-inducible factor-1 (HIF1 alpha), which becomes active in hypoxic tissues, leading to the synthesis and secretion of VEGF. The role of HIF1 alpha in other processes that involve angiogenesis such as in inflammation is less clear. Of interest, endothelial cells not only respond to but also store and secrete VEGF, which is required for the maintenance of the integrity of the vascular system. How this intracellular pool of VEGF is regulated is still not understood. Here, we found that CXCL8/IL8, a potent proangiogenic and inflammatory chemokine, up-regulates VEGF mRNA and protein levels in endothelial cells by acting on its cognate receptor, CXCR2, and that this results in the autocrine activation of VEGFR2. Surprisingly, this process does not involve HIFI alpha but instead requires the activation of the transcription factor NF kappa B. Furthermore, we identified the components of the CBM complex, Carma3, Bcl10, and Malt1, as key mediators of the CXCL8/IL8-induced NF kappa B activation and VEGF up-regulation. Together, these findings support the existence of an NF kappa B-mediated pathway by which the proinflammatory chemokine CXCL8/IL8 controls the expression of VEGF in endothelial cells, thereby promoting the activation of VEGF receptors in an autocrine fashion.	[Martin, Daniel; Galisteo, Rebeca; Gutkind, J. Silvio] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Gutkind, JS (corresponding author), NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	sg39v@nih.gov	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482; Martin Izquierdo, Daniel/0000-0002-8880-9087	National Institutes of Health Intramural AIDS Targeted Antiviral Program; NIDCR (National Institutes of Health); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER	National Institutes of Health Intramural AIDS Targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by a National Institutes of Health Intramural AIDS Targeted Antiviral Program and by the a grant from the NIDCR (National Institutes of Health).	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang S, 2000, CANCER RES, V60, P5334; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Koehne P, 2000, AM J PHYSIOL-HEART C, V279, pH817, DOI 10.1152/ajpheart.2000.279.2.H817; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Nathan AT, 1999, BRIT MED BULL, V55, P96, DOI 10.1258/0007142991902312; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Shibata A, 2002, BREAST CANCER RES TR, V73, P237, DOI 10.1023/A:1015872531675; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Sodhi A, 2000, CANCER RES, V60, P4873; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; Weibel ER, 1984, PATHWAY OXYGEN STRUC	25	296	309	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6038	6042		10.1074/jbc.C800207200	http://dx.doi.org/10.1074/jbc.C800207200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19112107	Green Published, hybrid			2022-12-27	WOS:000263742700004
J	Peng, H; Vijayakumar, S; Schiene-Fischer, C; Li, H; Purkerson, JM; Malesevic, M; Liebscher, J; Al-Awqati, Q; Schwartz, GJ				Peng, Hu; Vijayakumar, Soundarapandian; Schiene-Fischer, Cordelia; Li, Hui; Purkerson, Jeffrey M.; Malesevic, Miroslav; Liebscher, Juergen; Al-Awqati, Qais; Schwartz, George J.			Secreted Cyclophilin A, a Peptidylprolyl cis-trans Isomerase, Mediates Matrix Assembly of Hensin, a Protein Implicated in Epithelial Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; PROLYL ISOMERASE; EXTRACELLULAR-MATRIX; PEPTIDE ARRAYS; SPOT SYNTHESIS; POLARITY; CELLS; DMBT1; POLYMERIZATION; REVERSES	Hensin is a rabbit ortholog of DMBT1, a multifunctional, multidomain protein implicated in the regulation of epithelial differentiation, innate immunity, and tumorigenesis. Hensin in the extracellular matrix (ECM) induced morphological changes characteristic of terminal differentiation in a clonal cell line (clone C) of rabbit kidney intercalated cells. Although hensin is secreted in monomeric and various oligomeric forms, only the polymerized ECM form is able to induce these phenotypic changes. Here we report that hensin secretion and matrix assembly were inhibited by the peptidylprolyl cis-trans isomerase (PPIase) inhibitors cyclosporin A (CsA) and a derivative of cyclosporin A with modifications in the D-Ser side chain (Cs9) but not by the calcineurin pathway inhibitor FK506. PPIase inhibition led to failure of hensin polymerization in the medium and ECM, plus the loss of apical cytoskeleton, apical microvilli, and the columnar epithelial shape of clone C cells. Cyclophilin A was produced and secreted into the media to a much greater extent than cyclophilins B and C. Our results also identified the direct CsA-sensitive interaction of cyclophilin A with hensin, suggesting that cyclophilin A is the PPIase that mediates the polymerization and matrix assembly of hensin. These results are significant because this is the first time a direct role of peptidylprolyl cis-trans isomerase activity has been implicated in the process of epithelial differentiation.	[Schwartz, George J.] Univ Rochester, Med Ctr, Sch Med, Dept Pediat, Rochester, NY 14642 USA; [Schiene-Fischer, Cordelia; Malesevic, Miroslav] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany; [Liebscher, Juergen] Humboldt Univ, Dept Chem, D-10115 Berlin, Germany; [Al-Awqati, Qais] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA	University of Rochester; Max Planck Society; Humboldt University of Berlin; Columbia University	Schwartz, GJ (corresponding author), Univ Rochester, Med Ctr, Sch Med, Dept Pediat, Box 777,601 Elmwood Ave, Rochester, NY 14642 USA.	George_Schwartz@urmc.rochester.edu	Al-Awqati, Qais/B-2465-2009; Liebscher, Jürgen/A-8964-2012; Liebscher, Jürgen/R-1689-2019; Malesevic, Miroslav/D-8128-2012; vijayakumar, soundarapandian/B-4539-2010	Liebscher, Jürgen/0000-0002-1802-5543; Liebscher, Jürgen/0000-0002-1802-5543; Malesevic, Miroslav/0000-0002-1484-3709; Al-Awqati, Qais/0000-0001-7141-1040	National Institutes of Health [DK-20999, DK-50603]; American Heart Association [0150138N]; Deutsche Forschungsgemeinschaft [GK1026]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK020999, R01DK050603, R01DK020999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-20999 (to Q. AI-A.) and DK-50603 (to G.J.S.). This work was also supported by Grant-in-aid 0150138N from the American Heart Association (to G.J.S.) and by Deutsche Forschungsgemeinschaft Grant GK1026 (to C.S.- F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BILLICH A, 1995, J VIROL, V69, P2451, DOI 10.1128/JVI.69.4.2451-2461.1995; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Bukrinsky MI, 2002, TRENDS IMMUNOL, V23, P323, DOI 10.1016/S1471-4906(02)02237-8; Dornan J, 2003, CURR TOP MED CHEM, V3, P1392, DOI 10.2174/1568026033451899; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; FRIEDMAN J, 1994, AM J PATHOL, V144, P1247; Hikita C, 2000, J CELL BIOL, V151, P1235, DOI 10.1083/jcb.151.6.1235; Hikita C, 1999, J BIOL CHEM, V274, P17671, DOI 10.1074/jbc.274.25.17671; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kang WQ, 2003, FEBS LETT, V540, P21, DOI 10.1016/S0014-5793(03)00217-5; Mi ZY, 2007, CANCER RES, V67, P4088, DOI 10.1158/0008-5472.CAN-06-4066; Mollenhauer J, 2000, CANCER RES, V60, P1704; Mollenhauer J, 2002, GENE CHROMOSOME CANC, V35, P242, DOI 10.1002/gcc.10115; Obama K, 2006, CLIN CANCER RES, V12, P70, DOI 10.1158/1078-0432.CCR-05-0588; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Schwartz GJ, 2002, J CLIN INVEST, V109, P89, DOI 10.1172/JCI13292; Takito J, 1999, AM J PHYSIOL-RENAL, V277, pF277, DOI 10.1152/ajprenal.1999.277.2.F277; Takito J, 1996, J CLIN INVEST, V98, P2324, DOI 10.1172/JCI119044; Takito J, 2004, J CELL BIOL, V166, P1093, DOI 10.1083/jcb.200405159; Tsuruoka S, 2003, J PHARMACOL EXP THER, V305, P840, DOI 10.1124/jpet.102.048207; VANADELSBERG J, 1989, AM J PHYSIOL, V256, pC1004, DOI 10.1152/ajpcell.1989.256.5.C1004; VANADELSBERG J, 1994, CELL, V76, P1053, DOI 10.1016/0092-8674(94)90382-4; Vijayakumar S, 1999, J CELL BIOL, V144, P1057, DOI 10.1083/jcb.144.5.1057; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Watanabe S, 2005, AM J PHYSIOL-RENAL, V288, pF40, DOI 10.1152/ajprenal.00218.2004; Wulf G, 2003, BREAST CANCER RES, V5, P76, DOI 10.1186/bcr572; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yang H, 2005, J SURG RES, V123, P312, DOI 10.1016/j.jss.2004.08.026; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200; Zhang YX, 2005, J BIOL CHEM, V280, P4842, DOI 10.1074/jbc.M409178200	35	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6465	6475		10.1074/jbc.M808964200	http://dx.doi.org/10.1074/jbc.M808964200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19112104	hybrid, Green Published			2022-12-27	WOS:000263742700049
J	Mines, MA; Goodwin, JS; Limbird, LE; Cui, FF; Fan, GH				Mines, Marjelo A.; Goodwin, J. Shawn; Limbird, Lee E.; Cui, Fei-Fei; Fan, Guo-Huang			Deubiquitination of CXCR4 by USP14 Is Critical for Both CXCL12-induced CXCR4 Degradation and Chemotaxis but Not ERK Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; PROTEIN-COUPLED RECEPTOR; REGULATED KINASE ACTIVATION; LUNG-CANCER CELLS; NUCLEAR TRANSLOCATION; EXTRACELLULAR SIGNAL; PROGENITOR CELLS; BREAST-CANCER; TUMOR-CELLS; BONE-MARROW	The chemokine receptor CXCR4 plays important roles in the immune and nervous systems. Abnormal expression of CXCR4 contributes to cancer and inflammatory and neurodegenerative disorders. Although ligand-dependent CXCR4 ubiquitination is known to accelerate CXCR4 degradation, little is known about counter mechanisms for receptor deubiquitination. CXCL12, a CXCR4 agonist, induces a time-dependent association of USP14 with CXCR4, or its C terminus, that is not mimicked by USP2A, USP4, or USP7, other members of the deubiquitination catalytic family. Co-localization of CXCR4 and USP14 also is time-dependent following CXCL12 stimulation. The physical interaction of CXCR4 and USP14 is paralleled by USP14-catalyzed deubiquitination of the receptor; knockdown of endogenous USP14 by RNA interference (RNAi) blocks CXCR4 deubiquitination, whereas overexpression of USP14 promotes CXCR4 deubiquitination. We also observed that ubiquitination of CXCR4 facilitated receptor degradation, whereas overexpression of USP14 or RNAi-induced knockdown of USP14 blocked CXCL12-mediated CXCR4 degradation. Most interestingly, CXCR4-mediated chemotactic cell migration was blocked by either overexpression or RNAi-mediated knockdown of USP14, implying that a CXCR4-ubiquitin cycle on the receptor, rather than a particular ubiquitinated state of the receptor, is critical for the ligand gradient sensing and directed motility required for chemokine-mediated chemotaxis. Our observation that a mutant of CXCR4, HA-3K/R CXCR4, which cannot be ubiquitinated and does not mediate a chemotactic response to CXCL12, indicates the importance of this covalent modification not only in marking receptors for degradation but also for permitting CXCR4-mediated signaling. Finally, the indistinguishable activation of ERK by wild type- or 3K/R-CXCR4 suggests that chemotaxis in response to CXCL12 may be independent of the ERK cascade.	[Limbird, Lee E.] Meharry Med Coll, Dept Cardiovasc Biol, Nashville, TN 37208 USA; [Mines, Marjelo A.; Fan, Guo-Huang] Meharry Med Coll, Dept Neurobiol & Neurotoxicol, Nashville, TN 37208 USA; [Goodwin, J. Shawn] Meharry Med Coll, Dept Canc Biol, Nashville, TN 37208 USA; [Cui, Fei-Fei] Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Cui, Fei-Fei] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200031, Peoples R China; [Fan, Guo-Huang] Tennessee Healthcare Syst, Dept Vet Affairs, Nashville, TN 37212 USA	Meharry Medical College; Meharry Medical College; Meharry Medical College; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Limbird, LE (corresponding author), Meharry Med Coll, Dept Cardiovasc Biol, Nashville, TN 37208 USA.	llimbird@mmc.edu			National Institutes of Health [U54NS41071, RR0303-19]; Veterans Affairs Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health grants and Grants U54NS41071 (NINDS) and RR0303-19. This work was also supported by a career investigator award from the Veterans Affairs Hospital (to G.-H.F.).	Abu El-Asrar AM, 2001, BRIT J OPHTHALMOL, V85, P1357; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Brady AE, 2005, MOL PHARMACOL, V67, P1690, DOI 10.1124/mol.104.005215; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burger M, 2003, ONCOGENE, V22, P8093, DOI 10.1038/sj.onc.1207097; Cabioglu N, 2005, CLIN EXP METASTAS, V22, P39, DOI 10.1007/s10585-005-3222-y; Cook LB, 2003, MOL ENDOCRINOL, V17, P1777, DOI 10.1210/me.2003-0073; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Ding Y, 2006, MOL PHARMACOL, V69, P1269, DOI 10.1124/mol.105.020271; Ding Y, 2008, EXP CELL RES, V314, P590, DOI 10.1016/j.yexcr.2007.10.032; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hong X, 2006, CANCER LETT, V236, P39, DOI 10.1016/j.canlet.2005.05.011; Kang H, 2005, BREAST, V14, P360, DOI 10.1016/j.breast.2004.12.007; Li RS, 2006, J BIOL CHEM, V281, P37616, DOI 10.1074/jbc.M607266200; Luo C, 2006, J BIOL CHEM, V281, P30081, DOI 10.1074/jbc.M605837200; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Mines M, 2007, CURR MED CHEM, V14, P2456, DOI 10.2174/092986707782023686; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Oh JW, 2001, J IMMUNOL, V166, P2695, DOI 10.4049/jimmunol.166.4.2695; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; Peng SB, 2005, MOL CANCER RES, V3, P227; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Rauer M, 2002, J NEUROVIROL, V8, P168, DOI 10.1080/13550280290049741; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Su LP, 2005, CLIN CANCER RES, V11, P8273, DOI 10.1158/1078-0432.CCR-05-0537; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wang ZQ, 2008, J BIOL CHEM, V283, P3951, DOI 10.1074/jbc.M706848200; WILSON SM, 2000, EMBO J, V20, P5187; Woerner BM, 2005, CANCER RES, V65, P11392, DOI 10.1158/0008-5472.CAN-05-0847; Wysoczynski M, 2005, BLOOD, V105, P40, DOI 10.1182/blood-2004-04-1430; Xia MQ, 1999, J NEUROVIROL, V5, P32, DOI 10.3109/13550289909029743; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	45	74	78	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5742	5752		10.1074/jbc.M808507200	http://dx.doi.org/10.1074/jbc.M808507200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106094	hybrid, Green Published			2022-12-27	WOS:000263560600038
J	Dayal, S; Sparks, A; Jacob, J; Allende-Vega, N; Lane, DP; Saville, MK				Dayal, Saurabh; Sparks, Alison; Jacob, Jimmy; Allende-Vega, Nerea; Lane, David P.; Saville, Mark K.			Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME INHIBITOR BORTEZOMIB; UBIQUITIN-CONJUGATING ENZYMES; PROTEIN-DEGRADATION; TUMOR-CELLS; MDM2; CHAINS; ISOPEPTIDASE; BINDING; SUBUNIT; SYSTEM	Both p53 and its repressor Mdm2 are subject to ubiquitination and proteasomal degradation. We show that knockdown of the deubiquitinating enzyme USP5 (isopeptidase T) results in an increase in the level and transcriptional activity of p53. Suppression of USP5 stabilizes p53, whereas it has little or no effect on the stability of Mdm2. This provides a mechanism for transcriptional activation of p53. USP5 knockdown interferes with the degradation of ubiquitinated p53 rather than attenuating p53 ubiquitination. In vitro studies have shown that a preferred substrate for USP5 is unanchored polyubiquitin. Consistent with this, we observed for the first time in a mammalian system that USP5 makes a major contribution to Lys-48-linked polyubiquitin disassembly and that suppression of USP5 results in the accumulation of unanchored polyubiquitin chains. Ectopic expression of a C-terminal mutant of ubiquitin (G75A/G76A), which also causes the accumulation of free polyubiquitin, recapitulates the effects of USP5 knockdown on the p53 pathway. We propose a model in which p53 is selectively stabilized because the unanchored polyubiquitin that accumulates after USP5 knockdown is able to compete with ubiquitinated p53 but not with Mdm2 for proteasomal recognition. This raises the possibility that there are significant differences in proteasomal recognition of p53 and Mdm2. These differences could be exploited therapeutically. Our study reveals a novel mechanism for regulation of p53 and identifies USP5 as a potential target for p53 activating therapeutic agents for the treatment of cancer.	[Dayal, Saurabh; Sparks, Alison; Jacob, Jimmy; Allende-Vega, Nerea; Lane, David P.; Saville, Mark K.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, CR UK Cell Transformat Res Grp, Dundee DD1 9SY, Scotland	University of Dundee	Saville, MK (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, CR UK Cell Transformat Res Grp, Dundee DD1 9SY, Scotland.	m.k.saville@dundee.ac.uk	高, 雨莉/HGU-8187-2022	Lane, David/0000-0003-0551-3545; Allende-Vega, Nerea/0000-0001-5569-6461	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amerik AY, 1997, EMBO J, V16, P4826; Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Blaydes JP, 1998, ONCOGENE, V17, P1045, DOI 10.1038/sj.onc.1202014; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Brignone C, 2004, ONCOGENE, V23, P4121, DOI 10.1038/sj.onc.1207540; Brooks CL, 2004, CELL CYCLE, V3, P895; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cheok CF, 2007, MOL CANCER RES, V5, P1133, DOI 10.1158/1541-7786.MCR-07-0161; Ciechanover A, 2006, EXP BIOL MED, V231, P1197; Concannon CG, 2007, ONCOGENE, V26, P1681, DOI 10.1038/sj.onc.1209974; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dey A, 2008, BRIT J CANCER, V98, P4, DOI 10.1038/sj.bjc.6604098; Dicato M, 2006, ONCOLOGY-BASEL, V70, P474, DOI 10.1159/000099284; Dierssen U, 2007, HEPATOLOGY, V46, p780A; Doelling JH, 2001, PLANT J, V27, P393, DOI 10.1046/j.1365-313X.2001.01106.x; Eisele F, 2006, BIOCHEM BIOPH RES CO, V350, P329, DOI 10.1016/j.bbrc.2006.09.041; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; FALQUET L, 1995, FEBS LETT, V359, P73, DOI 10.1016/0014-5793(94)01451-6; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fujimuro M, 1997, EUR J BIOCHEM, V249, P427, DOI 10.1111/j.1432-1033.1997.00427.x; Gabriel JM, 2002, BIOCHEMISTRY-US, V41, P13755, DOI 10.1021/bi026096m; Glockzin S, 2003, MOL CELL BIOL, V23, P8960, DOI 10.1128/MCB.23.24.8960-8969.2003; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; HADARI T, 1992, J BIOL CHEM, V267, P719; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Hishiya A, 2006, EMBO J, V25, P554, DOI 10.1038/sj.emboj.7600945; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Lindsey DF, 1998, J BIOL CHEM, V273, P29178, DOI 10.1074/jbc.273.44.29178; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; Martinez LA, 2002, P NATL ACAD SCI USA, V99, P14849, DOI 10.1073/pnas.222406899; Mayor T, 2007, MOL CELL PROTEOMICS, V6, P1885, DOI 10.1074/mcp.M700264-MCP200; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Nair VD, 2006, J BIOL CHEM, V281, P39550, DOI 10.1074/jbc.M603950200; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Shabek N, 2007, BIOCHEM BIOPH RES CO, V363, P425, DOI 10.1016/j.bbrc.2007.08.185; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; STEIN RL, 1995, BIOCHEMISTRY-US, V34, P12616, DOI 10.1021/bi00039a017; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wilkinson KD, 2005, EMBO REP, V6, P815, DOI 10.1038/sj.embor.7400506; Williams SA, 2003, CANCER RES, V63, P7338; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Woods Yvonne L, 2003, Hematol J, V4, P233, DOI 10.1038/sj.thj.6200260; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Xu Q, 2004, MOL CANCER THER, V3, P1263; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191; Zhu QZ, 2001, J BIOL CHEM, V276, P29695, DOI 10.1074/jbc.M102634200	81	145	151	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5030	5041		10.1074/jbc.M805871200	http://dx.doi.org/10.1074/jbc.M805871200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098288	hybrid, Green Accepted			2022-12-27	WOS:000263416600033
J	Lee, HS; Lim, CJ; Puzon-McLaughlin, W; Shattil, SJ; Ginsberg, MH				Lee, Ho-Sup; Lim, Chinten James; Puzon-McLaughlin, Wilma; Shattil, Sanford J.; Ginsberg, Mark H.			RIAM Activates Integrins by Linking Talin to Ras GTPase Membrane-targeting Sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATES RAP1-INDUCED ADHESION; HUMAN-PLATELETS; CELL-ADHESION; RAP1; BINDING; LIGAND; ALPHA(IIB)BETA(3); ALPHA-IIB-BETA-3; HEMOSTASIS; INHIBITION	Rap1 small GTPases interact with Rap1-GTP-interacting adaptor molecule (RIAM), a member of the MRL (Mig-10/RIAM/Lamellipodin) protein family, to promote talin-dependent integrin activation. Here, we show that MRL proteins function as scaffolds that connect the membrane targeting sequences in Ras GTPases to talin, thereby recruiting talin to the plasma membrane and activating integrins. The MRL proteins bound directly to talin via short, N-terminal sequences predicted to form amphipathic helices. RIAM-induced integrin activation required both its capacity to bind to Rap1 and to talin. Moreover, we constructed a minimized 50-residue Rap-RIAM module containing the talin binding site of RIAM joined to the membrane-targeting sequence of Rap1A. This minimized Rap-RIAM module was sufficient to target talin to the plasma membrane and to mediate integrin activation, even in the absence of Rap1 activity. We identified a short talin binding sequence in Lamellipodin (Lpd), another MRL protein; talin binding Lpd sequence joined to a Rap1 membrane-targeting sequence is sufficient to recruit talin and activate integrins. These data establish the mechanism whereby MRL proteins interact with both talin and Ras GTPases to activate integrins.	[Lee, Ho-Sup; Lim, Chinten James; Puzon-McLaughlin, Wilma; Shattil, Sanford J.; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ginsberg, MH (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr,Mail Code 0726, La Jolla, CA 92093 USA.	mhginsberg@ucsd.edu	Lim, Chinten James/G-3777-2013	Lim, Chinten James/0000-0001-6381-7585	National Institutes of Health [HL 078784, AR27214, HL 31950]; Cell Migration Consortium [U54 GM06434]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950, P01HL078784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027214, R37AR027214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Migration Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 078784, AR27214, and HL 31950. This work was also supported by Cell Migration Consortium Grant U54 GM06434. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BECKERLE MC, 1989, J CELL BIOL, V109, P3333, DOI 10.1083/jcb.109.6.3333; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Franke B, 2000, MOL CELL BIOL, V20, P779, DOI 10.1128/MCB.20.3.779-785.2000; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; KOVACSOVICS TJ, 1995, J BIOL CHEM, V270, P11358, DOI 10.1074/jbc.270.19.11358; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Quinn CC, 2006, CURR BIOL, V16, P845, DOI 10.1016/j.cub.2006.03.025; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; SHADLE PJ, 1984, J CELL BIOL, V99, P2056, DOI 10.1083/jcb.99.6.2056; SHATTIL SJ, 1987, BLOOD, V70, P307; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Zhang ZC, 2005, J BIOL CHEM, V280, P33200, DOI 10.1074/jbc.M505057200	34	225	228	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5119	5127		10.1074/jbc.M807117200	http://dx.doi.org/10.1074/jbc.M807117200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098287	Green Published, hybrid			2022-12-27	WOS:000263416600042
J	Rosker, C; Meur, G; Taylor, EJA; Taylor, CW				Rosker, Christian; Meur, Gargi; Taylor, Emily J. A.; Taylor, Colin W.			Functional Ryanodine Receptors in the Plasma Membrane of RINm5F Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MUSCLE SARCOPLASMIC-RETICULUM; NONSELECTIVE CATION CHANNEL; CA2+-INDUCED CA2+ RELEASE; PROTEIN-KINASE-A; INSULIN-SECRETION; INTRACELLULAR CALCIUM; TRISPHOSPHATE RECEPTORS; SIGNAL-TRANSDUCTION	Ryanodine receptors (RyR) are Ca2+ channels that mediate Ca2+ release from intracellular stores in response to diverse intracellular signals. In RINm5F insulinoma cells, caffeine, and 4-chloro-m-cresol (4CmC), agonists of RyR, stimulated Ca2+ entry that was independent of store-operated Ca2+ entry, and blocked by prior incubation with a concentration of ryanodine that inactivates RyR. Patch-clamp recording identified small numbers of large-conductance (gamma(K) = 169 pS) cation channels that were activated by caffeine, 4CmC or low concentrations of ryanodine. Similar channels were detected in rat pancreatic beta-cells. InRINm5Fcells, the channels were blocked by cytosolic, but not extracellular, ruthenium red. Subcellular fractionation showed that type 3 IP3 receptors (IP3R3) were expressed predominantly in endoplasmic reticulum, whereas RyR2 were present also in plasma membrane fractions. Using RNAi selectively to reduce expression of RyR1, RyR2, or IP3R3, we showed that RyR2 mediates both the Ca2+ entry and the plasma membrane currents evoked by agonists of RyR. We conclude that small numbers of RyR2 are selectively expressed in the plasma membrane of RINm5F pancreatic beta-cells, where they mediate Ca2+ entry.	[Rosker, Christian; Meur, Gargi; Taylor, Emily J. A.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	Taylor, Colin/G-2447-2010	Taylor, Colin/0000-0001-7771-1044; Meur, Gargi/0000-0002-8466-2997; Taylor, Emily/0000-0001-7974-1538	Wellcome Trust; Biotechnology and Biological Sciences Research Council (UK); Biotechnology and Biological Sciences Research Council [BB/E004660/1] Funding Source: researchfish; BBSRC [BB/E004660/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust and the Biotechnology and Biological Sciences Research Council (UK). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Barrera NP, 2007, BIOCHEM BIOPH RES CO, V364, P815, DOI 10.1016/j.bbrc.2007.10.104; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; BLONDEL O, 1994, J BIOL CHEM, V269, P27167; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; BOKVIST K, 1995, EMBO J, V14, P50, DOI 10.1002/j.1460-2075.1995.tb06974.x; Dellis O, 2008, J BIOL CHEM, V283, P751, DOI 10.1074/jbc.M706960200; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dyachok O, 2004, J BIOL CHEM, V279, P45455, DOI 10.1074/jbc.M407673200; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; FADOOL DA, 1992, NEURON, V9, P907, DOI 10.1016/0896-6273(92)90243-7; Fessenden JD, 2003, J BIOL CHEM, V278, P28727, DOI 10.1074/jbc.M303821200; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gillespie D, 2008, BIOPHYS J, V95, P3706, DOI 10.1529/biophysj.108.131987; GROMADA J, 1995, DIABETES, V44, P767, DOI 10.2337/diabetes.44.7.767; GUERRERO A, 1994, J GEN PHYSIOL, V104, P375, DOI 10.1085/jgp.104.2.375; Gustafsson AJ, 2004, FASEB J, V18, P301, DOI 10.1096/fj.04-2621fje; Hamilton SL, 2005, CELL CALCIUM, V38, P253, DOI 10.1016/j.ceca.2005.06.037; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; Huang CLH, 2007, ANN NY ACAD SCI, V1116, P255, DOI 10.1196/annals.1402.064; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kermode H, 1998, BIOPHYS J, V74, P1296, DOI 10.1016/S0006-3495(98)77843-9; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lee B, 1998, J MOL ENDOCRINOL, V21, P31, DOI 10.1677/jme.0.0210031; LINDSAY ARG, 1991, J PHYSIOL-LONDON, V439, P463, DOI 10.1113/jphysiol.1991.sp018676; Liu YJ, 1997, CELL CALCIUM, V22, P277, DOI 10.1016/S0143-4160(97)90066-X; LOIRAND G, 1991, J PHYSIOL-LONDON, V437, P461, DOI 10.1113/jphysiol.1991.sp018606; MacDonald PE, 2007, PHYSIOLOGY, V22, P113, DOI 10.1152/physiol.00047.2006; Mears D, 1999, CELL CALCIUM, V25, P59, DOI 10.1054/ceca.1998.0007; MEISSNER G, 1989, J BIOL CHEM, V264, P1715; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Mitchell KJ, 2001, J CELL BIOL, V155, P41, DOI 10.1083/jcb.200103145; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Penfornis A, 2006, DIABETES METAB, V32, P539, DOI 10.1016/S1262-3636(06)72809-9; PRENTKI M, 1984, NATURE, V309, P562, DOI 10.1038/309562a0; Ravazzola M, 1996, P NATL ACAD SCI USA, V93, P2745, DOI 10.1073/pnas.93.7.2745; ROJAS E, 1994, ENDOCRINOLOGY, V134, P1771, DOI 10.1210/en.134.4.1771; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Santonastasi M, 2007, ACTA PHARMACOL SIN, V28, P937, DOI 10.1111/j.1745-7254.2007.00582.x; Shigeto M, 2007, J PHARMACOL EXP THER, V322, P1, DOI 10.1124/jpet.107.120592; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; Swatton JE, 1999, BIOCHEM J, V344, P55, DOI 10.1042/0264-6021:3440055; Szaszak M, 2008, CELL SIGNAL, V20, P590, DOI 10.1016/j.cellsig.2007.10.020; Takasawa S, 1998, J BIOL CHEM, V273, P2497, DOI 10.1074/jbc.273.5.2497; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Tian M, 2006, BRIT J PHARMACOL, V147, P289, DOI 10.1038/sj.bjp.0706590; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Warton K, 2004, GENE, V342, P85, DOI 10.1016/j.gene.2004.07.027; Welker S, 1997, N-S ARCH PHARMACOL, V356, P543, DOI 10.1007/PL00005089; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Williams AJ, 2001, Q REV BIOPHYS, V34, P61, DOI 10.1017/S0033583501003675; Willmann MR, 2002, TRENDS PLANT SCI, V7, P8, DOI 10.1016/S1360-1385(01)02218-X; Woolcott OO, 2006, CELL CALCIUM, V39, P529, DOI 10.1016/j.ceca.2006.02.003; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zhan X, 2008, EUR BIOPHYS J BIOPHY, V37, P773, DOI 10.1007/s00249-008-0269-0; Zhang YA, 2007, AM J PHYSIOL-HEART C, V293, pH2448, DOI 10.1152/ajpheart.00032.2007	66	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5186	5194		10.1074/jbc.M805587200	http://dx.doi.org/10.1074/jbc.M805587200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19116207	Green Published, hybrid			2022-12-27	WOS:000263416600049
J	Stowell, SR; Cho, MJ; Feasley, CL; Arthur, CM; Song, XZ; Colucci, JK; Karmakar, S; Mehta, P; Dias-Baruffi, M; McEver, RP; Cummings, RD				Stowell, Sean R.; Cho, Moonjae; Feasley, Christa L.; Arthur, Connie M.; Song, Xuezheng; Colucci, Jennifer K.; Karmakar, Sougata; Mehta, Padmaja; Dias-Baruffi, Marcelo; McEver, Rodger P.; Cummings, Richard D.			Ligand Reduces Galectin-1 Sensitivity to Oxidative Inactivation by Enhancing Dimer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSIDE-BINDING LECTIN; PROMOTES AXONAL REGENERATION; HAMSTER OVARY CELLS; T-CELLS; PHOSPHATIDYLSERINE EXTERNALIZATION; ELECTROPHORUS-ELECTRICUS; OXIDIZED GALECTIN-1; SECONDARY STRUCTURE; SURFACE EXPOSURE; GLYCAN ARRAY	Galectin-1 (Gal-1) regulates leukocyte turnover by inducing the cell surface exposure of phosphatidylserine (PS), a ligand that targets cells for phagocytic removal, in the absence of apoptosis. Gal-1 monomer- dimer equilibrium appears to modulate Gal-1-induced PS exposure, although the mechanism underlying this regulation remains unclear. Here we show that monomer- dimer equilibrium regulates Gal-1 sensitivity to oxidation. A mutant form of Gal-1, containing C2S and V5D mutations (mGal-1), exhibits impaired dimerization and fails to induce cell surface PS exposure while retaining the ability to recognize carbohydrates and signal Ca2+ flux in leukocytes. mGal-1 also displayed enhanced sensitivity to oxidation, whereas ligand, which partially protected Gal-1 from oxidation, enhanced Gal-1 dimerization. Continual incubation of leukocytes with Gal-1 resulted in gradual oxidative inactivation with concomitant loss of cell surface PS, whereas rapid oxidation prevented mGal-1 from inducing PS exposure. Stabilization of Gal-1 or mGal-1 with iodoacetamide fully protected Gal-1 and mGal-1 from oxidation. Alkylation-induced stabilization allowed Gal-1 to signal sustained PS exposure in leukocytes and mGal-1 to signal both Ca2+ flux and PS exposure. Taken together, these results demonstrate that monomer-dimer equilibrium regulates Gal-1 sensitivity to oxidative inactivation and provides a mechanism whereby ligand partially protects Gal-1 from oxidation.	[Stowell, Sean R.; Arthur, Connie M.; Song, Xuezheng; Colucci, Jennifer K.; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Cho, Moonjae] Cheju Natl Univ, Sch Med, Cheju 690756, South Korea; [Feasley, Christa L.; McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem, Norman, OK 73019 USA; [Feasley, Christa L.; McEver, Rodger P.] Oklahoma Med Res Fdn, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA; [Karmakar, Sougata; Mehta, Padmaja; McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Dias-Baruffi, Marcelo] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, SP, Brazil	Emory University; Jeju National University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Norman; Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; Universidade de Sao Paulo	Cummings, RD (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	rdcummi@emory.edu	Baruffi, Marcelo D/I-7199-2015	Baruffi, Marcelo D/0000-0002-2039-1884	National Institutes of Health [HL085607]; NIGMS [GM62116]; Consortium for Functional Glycomics (CoreDand Core H); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054502, P01HL085607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169, U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Consortium for Functional Glycomics (CoreDand Core H); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL085607 and NIGMS Grant GM62116. This work was also supported by the Consortium for Functional Glycomics (CoreDand Core H). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Andre S, 2005, INT J CANCER, V114, P46, DOI 10.1002/ijc.20699; BARONDES SH, 1984, SCIENCE, V223, P1259, DOI 10.1126/science.6367039; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; BOURNE Y, 1994, NAT STRUCT BIOL, V1, P863, DOI 10.1038/nsb1294-863; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Carden DL, 1996, AM J PHYSIOL-HEART C, V271, pH1947, DOI 10.1152/ajpheart.1996.271.5.H1947; Carlow DA, 2003, J IMMUNOL, V171, P5100, DOI 10.4049/jimmunol.171.10.5100; Cerri DG, 2008, GLYCOBIOLOGY, V18, P842, DOI 10.1093/glycob/cwn079; CHO MJ, 1995, J BIOL CHEM, V270, P5198, DOI 10.1074/jbc.270.10.5198; CHO MJ, 1995, J BIOL CHEM, V270, P5207, DOI 10.1074/jbc.270.10.5207; CLERCH LB, 1988, BIOCHEMISTRY-US, V27, P692, DOI 10.1021/bi00402a030; Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dias-Baruffi M, 2003, J BIOL CHEM, V278, P41282, DOI 10.1074/jbc.M306624200; GALTON MM, 1965, APPL MICROBIOL, V13, P81, DOI 10.1128/AEM.13.1.81-85.1965; GIBBONS RJ, 1969, J BACTERIOL, V98, P341, DOI 10.1128/JB.98.2.341-346.1969; GIUDICELLI V, 1997, GLYCOBIOLOGY, V7, pR7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; He LZ, 2003, BIOPHYS J, V85, P511, DOI 10.1016/S0006-3495(03)74496-8; HIRABAYASHI J, 1991, J BIOL CHEM, V266, P23648; Horie H, 2005, CURR DRUG TARGETS, V6, P385, DOI 10.2174/1389450054021954; Iglesias MM, 2003, BBA-PROTEINS PROTEOM, V1648, P164, DOI 10.1016/S1570-9639(03)00119-5; Inagaki Y, 2000, EUR J BIOCHEM, V267, P2955, DOI 10.1046/j.1432-1033.2000.01311.x; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; KAKIMOTO K, 1995, CELL IMMUNOL, V165, P26, DOI 10.1006/cimm.1995.1183; Kaltner H, 2002, CELL TISSUE RES, V307, P35, DOI 10.1007/s004410100457; Karmakar S, 2005, J BIOL CHEM, V280, P28623, DOI 10.1074/jbc.M414140200; Kopcow HD, 2008, P NATL ACAD SCI USA, V105, P18472, DOI 10.1073/pnas.0809233105; La M, 2003, AM J PATHOL, V163, P1505, DOI 10.1016/S0002-9440(10)63507-9; LEVI G, 1981, J BIOL CHEM, V256, P5735; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; Miura T, 2004, CELL DEATH DIFFER, V11, P1076, DOI 10.1038/sj.cdd.4401462; Nam HJ, 2006, J BIOL CHEM, V281, P25670, DOI 10.1074/jbc.M604421200; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Pande AH, 2003, PROTEIN PEPTIDE LETT, V10, P265, DOI 10.2174/0929866033478960; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; POWELL JT, 1988, BIOCHEM J, V252, P447, DOI 10.1042/bj2520447; POWELL JT, 1984, BIOCHEM J, V223, P769, DOI 10.1042/bj2230769; Shahwan M, 2004, BIOCHEMISTRY-MOSCOW+, V69, P506, DOI 10.1023/B:BIRY.0000029848.01019.de; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Smrz D, 2008, J BIOL CHEM, V283, P10904, DOI 10.1074/jbc.M710386200; Smrz D, 2007, J BIOL CHEM, V282, P10487, DOI 10.1074/jbc.M611090200; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Stowell SR, 2004, GLYCOBIOLOGY, V14, P157, DOI 10.1093/glycob/cwh018; Tartier L, 2000, CELL DEATH DIFFER, V7, P1002, DOI 10.1038/sj.cdd.4400726; Teichberg V I, 1978, Methods Enzymol, V50, P291; TEICHBERG VI, 1975, P NATL ACAD SCI USA, V72, P1383, DOI 10.1073/pnas.72.4.1383; Than NG, 2008, P NATL ACAD SCI USA, V105, P15819, DOI 10.1073/pnas.0807606105; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; TRACEY BM, 1992, J BIOL CHEM, V267, P10342; van den Brule F, 2003, LAB INVEST, V83, P377, DOI 10.1097/01.LAB.0000059949.01480.40; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; Wasano K, 1997, J HISTOCHEM CYTOCHEM, V45, P275, DOI 10.1177/002215549704500212; WHITNEY PL, 1986, BIOCHEM J, V238, P683, DOI 10.1042/bj2380683	61	63	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4989	4999		10.1074/jbc.M808925200	http://dx.doi.org/10.1074/jbc.M808925200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103599	Green Published, hybrid			2022-12-27	WOS:000263416600029
J	Suzuki, N; Tsumoto, K; Hajicek, N; Daigo, K; Tokita, R; Minami, S; Kodama, T; Hamakubo, T; Kozasa, T				Suzuki, Nobuchika; Tsumoto, Kouhei; Hajicek, Nicole; Daigo, Kenji; Tokita, Reiko; Minami, Shiro; Kodama, Tatsuhiko; Hamakubo, Takao; Kozasa, Tohru			Activation of Leukemia-associated RhoGEF by G alpha(13) with Significant Conformational Rearrangements in the Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; HETEROTRIMERIC G-PROTEINS; ISOTHERMAL TITRATION CALORIMETRY; P115 RHOGEF; STRUCTURAL DETERMINANTS; GTPASE; P115RHOGEF; RGS; IDENTIFICATION; MECHANISMS	The transient protein-protein interactions induced by guanine nucleotide-dependent conformational changes of G proteins play central roles in G protein-coupled receptor-mediated signaling systems. Leukemia-associated RhoGEF (LARG), a guanine nucleotide exchange factor for Rho, contains an RGS homology (RH) domain and Dbl homology/pleckstrin homology (DH/PH) domains and acts both as a GTPase-activating protein (GAP) and an effector for G alpha(13). However, the molecular mechanism of LARG activation upon G alpha(13) binding is not yet well understood. In this study, we analyzed the G alpha(13)-LARG interaction using cellular and biochemical methods, including a surface plasmon resonance (SPR) analysis. The results obtained using various LARG fragments demonstrated that active G alpha(13) interacts with LARG through the RH domain, DH/PH domains, and C-terminal region. However, an alanine substitution at the RH domain contact position in G alpha(13) resulted in a large decrease in affinity. Thermodynamic analysis revealed that binding of G alpha(13) proceeds with a large negative heat capacity change (Delta Cp degrees), accompanied by a positive entropy change (Delta S degrees). These results likely indicate that the binding of G alpha(13) with the RH domain triggers conformational rearrangements between G alpha(13) and LARG burying an exposed hydrophobic surface to create a large complementary interface, which facilitates complex formation through both GAP and effector interfaces, and activates the RhoGEF. We propose that LARG activation	[Suzuki, Nobuchika; Daigo, Kenji; Kodama, Tatsuhiko; Hamakubo, Takao; Kozasa, Tohru] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Tokyo 1538904, Japan; [Suzuki, Nobuchika; Tokita, Reiko; Minami, Shiro] Univ Tokyo, Dept Bioregulat, Nippon Med Sch, Tokyo 2778562, Japan; [Tsumoto, Kouhei] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Tokyo 2778562, Japan; [Hajicek, Nicole; Kozasa, Tohru] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University of Tokyo; Nippon Medical School; University of Tokyo; University of Tokyo; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kozasa, T (corresponding author), 835 S Wolcott Ave, Chicago, IL 60612 USA.	tkozas@uic.edu	Daigo, Kenji/S-8915-2016	Daigo, Kenji/0000-0001-6398-3356	National Institutes of Health [GM61454]; American Heart Association; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Biomedical Innovation in Japan; New Energy and Industrial Technology Development Organization in Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation in Japan(National Institute of Biomedical Innovation); New Energy and Industrial Technology Development Organization in Japan(New Energy and Industrial Technology Development Organization (NEDO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61454 (to T. K.). This work was also supported by the American Heart Association (to T. K.), by Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the Program of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation in Japan, and by the NFAT project of the New Energy and Industrial Technology Development Organization in Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ARAGAY AM, 1995, J BIOL CHEM, V270, P20073, DOI 10.1074/jbc.270.34.20073; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bhattacharyya R, 2003, BIOCHEM J, V371, P709, DOI 10.1042/BJ20021897; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Eisenhaure TM, 2003, J BIOL CHEM, V278, P30975, DOI 10.1074/jbc.M303277200; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; Grabocka E, 2007, MOL PHARMACOL, V72, P993, DOI 10.1124/mol.107.035162; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Horn JR, 2001, BIOCHEMISTRY-US, V40, P1774, DOI 10.1021/bi002408e; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Kreutz B, 2007, CELL SIGNAL, V19, P1681, DOI 10.1016/j.cellsig.2007.03.004; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; McEntaffer RL, 1999, BIOCHEMISTRY-US, V38, P4931, DOI 10.1021/bi982636x; MURPHY KP, 1992, J MOL BIOL, V227, P293, DOI 10.1016/0022-2836(92)90699-K; Nakamura S, 2004, MOL PHARMACOL, V66, P1029, DOI 10.1124/mol.104.002287; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Roos H, 1998, J MOL RECOGNIT, V11, P204, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<204::AID-JMR424>3.0.CO;2-T; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; Scott JK, 2001, EMBO J, V20, P767, DOI 10.1093/emboj/20.4.767; SINGER WD, 1994, J BIOL CHEM, V269, P19796; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Sowa ME, 2000, P NATL ACAD SCI USA, V97, P1483, DOI 10.1073/pnas.030409597; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Tanabe S, 2004, METHOD ENZYMOL, V390, P285; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Wear MA, 2006, ANAL BIOCHEM, V359, P285, DOI 10.1016/j.ab.2006.08.038; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Zerangue N, 1998, CURR BIOL, V8, pR313, DOI 10.1016/S0960-9822(98)70196-4	47	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5000	5009		10.1074/jbc.M804073200	http://dx.doi.org/10.1074/jbc.M804073200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19074425	Green Published, hybrid			2022-12-27	WOS:000263416600030
J	Kayed, R; Pensalfini, A; Margol, L; Sokolov, Y; Sarsoza, F; Head, E; Hall, J; Glabe, C				Kayed, Rakez; Pensalfini, Anna; Margol, Larry; Sokolov, Yuri; Sarsoza, Floyd; Head, Elizabeth; Hall, James; Glabe, Charles			Annular Protofibrils Are a Structurally and Functionally Distinct Type of Amyloid Oligomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; ALPHA-SYNUCLEIN; NEURODEGENERATIVE DISEASE; PROTEIN AGGREGATION; ALZHEIMER-DISEASE; COMMON MECHANISM; IN-VITRO; PEPTIDE; TOXICITY; FIBRILS	Amyloid oligomers are believed to play causal roles in several types of amyloid-related neurodegenerative diseases. Several different types of amyloid oligomers have been reported that differ in morphology, size, or toxicity, raising the question of the pathological significance and structural relationships between different amyloid oligomers. Annular protofibrils (APFs) have been described in oligomer preparations of many different amyloidogenic proteins and peptides as ring-shaped or pore-like structures. They are interesting because their pore-like morphology is consistent with numerous reports of membrane-permeabilizing activity of amyloid oligomers. Here we report the preparation of relatively homogeneous preparations of APFs and an antiserum selective for APFs (alpha APF) compared with pre-fibrillar oligomers (PFOs) and fibrils. PFOs appear to be precursors for APF formation, which form in high yield after exposure to a hydrophobic-hydrophilic interface. Surprisingly, preformed APFs do not permeabilize lipid bilayers, unlike the precursor PFOs. APFs display a conformation-dependent, generic epitope that is distinct from that of PFOs and amyloid fibrils. Incubation of PFOs with phospholipids vesicles results in a loss of PFO immunoreactivity with a corresponding increase in alpha APF immunoreactivity, suggesting that lipid vesicles catalyze the conversion of PFOs into APFs. The annular anti-protofibril antibody also recognizes heptameric alpha-hemolysin pores, but not monomers, suggesting that the antibody recognizes an epitope that is specific for a beta barrel structural motif.	[Kayed, Rakez; Pensalfini, Anna; Margol, Larry; Glabe, Charles] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Sarsoza, Floyd; Head, Elizabeth] Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92697 USA; [Sarsoza, Floyd; Head, Elizabeth] Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA; [Sokolov, Yuri; Hall, James] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Kayed, R (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	cglabe@uci.edu	Pensalfini, Anna/X-5563-2019		National Institutes of Health [NS31230, AG16573, AG00538]; Cure Alzheimer Fund; Larry L. Hillblom Foundation; NATIONAL INSTITUTE ON AGING [P01AG000538, P50AG016573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer Fund; Larry L. Hillblom Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS31230, AG16573, and AG00538. This work was also supported by the Cure Alzheimer Fund and The Larry L. Hillblom Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BURDICK D, 1992, J BIOL CHEM, V267, P546; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362; FUSSLE R, 1981, J CELL BIOL, V91, P83, DOI 10.1083/jcb.91.1.83; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Hafner JH, 2001, PROG BIOPHYS MOL BIO, V77, P73, DOI 10.1016/S0079-6107(01)00011-6; Hardy J, 2005, BIOCHEM SOC T, V33, P578, DOI 10.1042/BST0330578; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; Hrncic R, 2000, AM J PATHOL, V157, P1239, DOI 10.1016/S0002-9440(10)64639-1; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Lal R, 2007, BBA-BIOMEMBRANES, V1768, P1966, DOI 10.1016/j.bbamem.2007.04.021; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Montoya M, 2003, BBA-BIOMEMBRANES, V1609, P19, DOI 10.1016/S0005-2736(02)00663-6; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Yoshiike Y, 2007, NEUROMOL MED, V9, P270, DOI 10.1007/s12017-007-0003-6	45	249	257	1	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4230	4237		10.1074/jbc.M808591200	http://dx.doi.org/10.1074/jbc.M808591200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098006	Green Published, hybrid			2022-12-27	WOS:000263134400020
J	Kenneth, NS; Mudie, S; van Uden, P; Rocha, S				Kenneth, Niall S.; Mudie, Sharon; van Uden, Patrick; Rocha, Sonia			SWI/SNF Regulates the Cellular Response to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CHROMATIN-REMODELING COMPLEX; ARF TUMOR-SUPPRESSOR; GENE-EXPRESSION; INDUCIBLE FACTOR-1-ALPHA; PROTEASOMAL DEGRADATION; VASCULAR DEVELOPMENT; HIF-1-ALPHA; SUBUNIT; IDENTIFICATION	Hypoxia induces a variety of cellular responses such as cell cycle arrest, apoptosis, and autophagy. Most of these responses are mediated by the hypoxia-inducible factor-1 alpha. To induce target genes, hypoxia-inducible factor-1 alpha requires a chromatin environment conducive to allow binding to specific sequences. Here, we have studied the role of the chromatin-remodeling complex SWI/SNF in the cellular response to hypoxia. We find that SWI/SNF is required for several of the cellular responses induced by hypoxia. Surprisingly, hypoxia-inducible factor-1 alpha is a direct target of the SWI/SNF chromatin-remodeling complex. SWI/SNF components are found associated with the hypoxia-inducible factor-1 alpha promoter and modulation of SWI/SNF levels results in pronounced changes in hypoxia-inducible factor-1 alpha expression and its ability to transactivate target genes. Furthermore, impairment of SWI/SNF function renders cells resistant to hypoxia-induced cell cycle arrest. These results reveal a previously uncharacterized dependence of hypoxia signaling on the SWI/SNF complex and demonstrate a new level of control over the hypoxia-inducible factor-1 alpha system.	[Kenneth, Niall S.; Mudie, Sharon; van Uden, Patrick; Rocha, Sonia] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland	University of Dundee	Rocha, S (corresponding author), Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, MSI-WTB-JBC Complex, Dundee DD1 5EH, Scotland.	s.rocha@dundee.ac.uk		KENNETH, NIALL/0000-0001-8528-1021; Rocha, Sonia/0000-0002-2413-4981	Royal Society research; MRC [G0601098] Funding Source: UKRI; Medical Research Council [G0601098] Funding Source: researchfish	Royal Society research(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Royal Society research grant and a Tenovus Scotland small grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbott BD, 2000, DEV DYNAM, V219, P526, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1080>3.0.CO;2-N; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Bardos JI, 2004, MOL CELL BIOL, V24, P2905, DOI 10.1128/MCB.24.7.2905-2914.2004; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruegge K, 2007, CURR MED CHEM, V14, P1853; Chau NM, 2005, CANCER RES, V65, P4918, DOI 10.1158/0008-5472.CAN-04-4453; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Fandrey J, 2006, CARDIOVASC RES, V71, P642, DOI 10.1016/j.cardiores.2006.05.005; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Gorlach Agnes, 2008, Biochem J, V412, pe17, DOI 10.1042/BJ20080920; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Han D, 2008, DEV BIOL, V315, P136, DOI 10.1016/j.ydbio.2007.12.024; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hassan AH, 2007, BIOCHEM J, V402, P125, DOI 10.1042/BJ20060907; Heeboll S, 2008, HISTOL HISTOPATHOL, V23, P1069, DOI 10.14670/HH-23.1069; Heimeier RA, 2008, MOL ENDOCRINOL, V22, P1065, DOI 10.1210/me.2007-0492; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; PAPANDREOU I, 2008, CELL DEATH DIFFER, V28, P7212; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Roche KC, 2004, ONCOGENE, V23, P8185, DOI 10.1038/sj.onc.1208025; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Shadeo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-64; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Singh M, 2007, CHEMBIOCHEM, V8, P1308, DOI 10.1002/cbic.200600562; Sohn DH, 2007, J BIOL CHEM, V282, P10614, DOI 10.1074/jbc.M610563200; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Varga-Weisz PD, 2006, CURR OPIN GENET DEV, V16, P151, DOI 10.1016/j.gde.2006.02.006; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	48	84	87	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4123	4131		10.1074/jbc.M808491200	http://dx.doi.org/10.1074/jbc.M808491200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19097995	hybrid			2022-12-27	WOS:000263134400009
J	Thakur, JK; Arthanari, H; Yang, FJ; Chau, KH; Wagner, G; Naar, AM				Thakur, Jitendra K.; Arthanari, Haribabu; Yang, Fajun; Chau, Katherine H.; Wagner, Gerhard; Naeaer, Anders M.			Mediator Subunit Gal11p/MED15 Is Required for Fatty Acid-dependent Gene Activation by Yeast Transcription Factor Oaf1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCODING PEROXISOMAL PROTEINS; NUCLEAR RECEPTOR SUPERFAMILY; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; BETA-OXIDATION; TRANSACTIVATION DOMAIN; X-RECEPTOR; METABOLISM; INDUCTION; COMPLEX	The yeast zinc cluster transcription factor Oaf1p activates transcription of target genes in response to direct binding of fatty acids in a manner analogous to the vertebrate nuclear receptor peroxisome proliferator-activated receptor alpha(PPAR alpha). PPARs and other metazoan nuclear receptors productively engage several distinct LXXLL motif-containing co-activators, including p160 family members and the TRAP220/MED1 subunit of the Mediator coactivator, to promote ligand-dependent gene activation. Yeast, however, does not appear to harbor LXXLL motif co-activators, and the mechanism of fatty acid-dependent gene activation by the yeast PPAR alpha analog Oaf1p is unknown. Here we show that the yeast Mediator subunit Gal11p/MED15 and its activator-targeted KIX domain plays a critical role in fatty acid-dependent transcriptional regulation of fatty acid beta-oxidation and peroxisomal genes by Oaf1p and for the ability of yeast to utilize fatty acids as a sole carbon source. Moreover, structural studies by NMR spectroscopy reveal that the Oaf1p activation domain interacts with the Gal11p/MED15 KIX domain in a manner similar to the yeast zinc cluster family member and xenobiotic receptor Pdr1p, revealing that the Gal11p/MED15 KIX domain is a key target of several ligand-dependent transcription factors in yeast. Together with previous work showing that the Caenorhabditis elegans Gal11p/MED15 homolog MDT-15 plays a critical role in regulation of fatty acid metabolism by the nematode PPAR-like nuclear receptor NHR-49, the findings presented here provide evidence for an ancient and essential role of a Mediator co-activator subunit in regulation of fatty acid metabolism by nuclear receptor-like transcription factors in eukaryotes.	[Thakur, Jitendra K.; Yang, Fajun; Naeaer, Anders M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Thakur, Jitendra K.; Yang, Fajun; Naeaer, Anders M.] Harvard Univ, Sch Med, Dept Cell Biol, Charlestown, MA 02129 USA; [Arthanari, Haribabu; Chau, Katherine H.; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School	Naar, AM (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Rm 7407,Bldg 149,13th St, Charlestown, MA 02129 USA.	naar@helix.mgh.harvard.edu	Thakur, Jitendra/AAN-8674-2021	Thakur, Jitendra Kumar/0000-0001-7874-1923; Arthanari, Haribabu/0000-0002-7281-1289	NCI NIH HHS [R01 CA127990] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA127990] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baumgartner U, 1999, J BIOL CHEM, V274, P22208, DOI 10.1074/jbc.274.32.22208; Bertrand W, 2004, MOL BIOL EVOL, V21, P1923, DOI 10.1093/molbev/msh200; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Escriva H, 2004, ESSAYS BIOCHEM, V40, P11, DOI 10.1042/bse0400011; Escriva H, 2000, BIOESSAYS, V22, P717; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Glass CK, 2000, GENE DEV, V14, P121; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Handschin C, 2005, ARCH BIOCHEM BIOPHYS, V433, P387, DOI 10.1016/j.abb.2004.08.030; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; Karpichev IV, 1997, MOL CELL BIOL, V17, P69, DOI 10.1128/MCB.17.1.69; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lee YC, 1999, MOL CELL BIOL, V19, P2967; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Phelps C, 2006, P NATL ACAD SCI USA, V103, P7077, DOI 10.1073/pnas.0510080103; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Rottensteiner H, 1997, EUR J BIOCHEM, V247, P776, DOI 10.1111/j.1432-1033.1997.00776.x; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Taubert S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000021; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942	33	73	76	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4422	4428		10.1074/jbc.M808263200	http://dx.doi.org/10.1074/jbc.M808263200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19056732	Green Published, hybrid			2022-12-27	WOS:000263134400042
J	Atanassov, II; Pittman, JK; Turner, SR				Atanassov, Ivan I.; Pittman, Jon K.; Turner, Simon R.			Elucidating the Mechanisms of Assembly and Subunit Interaction of the Cellulose Synthase Complex of Arabidopsis Secondary Cell Walls	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNITS; PROTEIN COMPLEXES; PLASMA-MEMBRANE; BIOSYNTHESIS; PURIFICATION; TAG; DEPOSITION; DEFICIENT; ROSETTES; MUTANTS	Cellulose is the most abundant biopolymer in nature; however, questions relating to the biochemistry of its synthesis including the structure of the cellulose synthase complex (CSC) can only be answered by the purification of a fully functional complex. Despite its importance, this goal remains elusive. The work described here utilizes epitope tagging of cellulose synthase A (CESA) proteins that are known components of the CSC. To avoid problems associated with preferential purification of CESA monomers, we developed a strategy based on dual epitope tagging of the CESA7 protein to select for CESA multimers. With this approach, we used a two-step purification that preferentially selected for larger CESA oligomers. These preparations consisted solely of the three known secondary cell wall CESA proteins CESA4, CESA7, and CESA8. No additional CESA isoforms or other proteins were identified. The data are consistent with a model in which CESA protein homodimerization occurs prior to formation of larger CESA oligomers. This suggests that the three different CESA proteins undergo dimerization independently, but the presence of all three subunits is required for higher order oligomerization. Analysis of purified CESA complex and crude extracts suggests that disulfide bonds and noncovalent interactions contribute to the stability of the CESA subunit interactions. These results demonstrate that this approach will provide an excellent framework for future detailed analysis of the CSC.	[Atanassov, Ivan I.; Pittman, Jon K.; Turner, Simon R.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Turner, SR (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	simon.turner@manchester.ac.uk	Turner, Simon/K-7580-2012	Pittman, Jon/0000-0001-7197-1494; Atanassov, Ivan/0000-0002-7771-3629; Turner, Simon/0000-0003-4859-1068	Biotechnology and Biological Sciences Research Council [P19340]; Biotechnology and Biological Sciences Research Council [BB/C511064/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant P19340. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Cano-Delgado AI, 2000, DEVELOPMENT, V127, P3395; Chang IF, 2006, PROTEOMICS, V6, P6158, DOI 10.1002/pmic.200600225; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Gardiner JC, 2003, PLANT CELL, V15, P1740, DOI 10.1105/tpc.012815; HAIGLER CH, 1986, PROTOPLASMA, V134, P111, DOI 10.1007/BF01275709; Joshi CP, 2007, CURR OPIN PLANT BIOL, V10, P220, DOI 10.1016/j.pbi.2007.04.013; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Kimura S, 1999, PLANT CELL, V11, P2075, DOI 10.1105/tpc.11.11.2075; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; Kudlicka K, 1997, PLANT PHYSIOL, V115, P643, DOI 10.1104/pp.115.2.643; Kurek I, 2002, P NATL ACAD SCI USA, V99, P11109, DOI 10.1073/pnas.162077099; Lai-Kee-Him J, 2002, J BIOL CHEM, V277, P36931, DOI 10.1074/jbc.M203530200; MUELLER SC, 1980, J CELL BIOL, V84, P315, DOI 10.1083/jcb.84.2.315; Mutwil M, 2008, CURR OPIN PLANT BIOL, V11, P252, DOI 10.1016/j.pbi.2008.03.007; Nomura E, 2004, J MASS SPECTROM, V39, P202, DOI 10.1002/jms.578; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; Schafer PH, 1998, J IMMUNOL, V161, P2307; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; SCHNEIDER B, 1986, PROTOPLASMA, V131, P142, DOI 10.1007/BF01285036; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; Taylor NG, 2008, NEW PHYTOL, V178, P239, DOI 10.1111/j.1469-8137.2008.02385.x; Taylor NG, 2004, CELLULOSE, V11, P329, DOI 10.1023/B:CELL.0000046405.11326.a8; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; Wang J, 2008, J EXP BOT, V59, P2627, DOI 10.1093/jxb/ern125; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zolotarjova NI, 2001, J BIOL CHEM, V276, P17063, DOI 10.1074/jbc.M009627200	41	87	95	6	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3833	3841		10.1074/jbc.M807456200	http://dx.doi.org/10.1074/jbc.M807456200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19056734	hybrid			2022-12-27	WOS:000262872500052
J	Bovenschen, N; Quadir, R; van den Berg, AL; Brenkman, AB; Vandenberghe, I; Devreese, B; Joore, J; Kummer, JA				Bovenschen, Niels; Quadir, Razi; van den Berg, A. Lotte; Brenkman, Arjan B.; Vandenberghe, Isabel; Devreese, Bart; Joore, Jos; Kummer, J. Alain			Granzyme K Displays Highly Restricted Substrate Specificity That Only Partially Overlaps with Granzyme A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY PROTEIN SET; HNRNP-K; LYMPHOCYTE PROTEASE; CRYSTAL-STRUCTURE; SERINE PROTEASES; POTENTIAL TARGET; ALPHA-TUBULIN; A-DEFICIENT; IDENTIFICATION; CYTOTOXICITY	Granzymes are serine proteases stored in cytolytic granules of cytotoxic lymphocytes that eliminate virus-infected and tumor cells. Little is known about the molecular mechanism and function of granzyme (Gr) K. GrK is similar to GrA in that they are the only granzymes that display tryptase-like activity. Both granzymes induce cell death by single-stranded nicking of the chromosomal DNA by cleaving the same components of the endoplasmic reticulum-associated SET complex. Therefore, GrK may provide a backup and failsafe mechanism for GrA with redundant specificity. In the present study, we addressed the question of whether GrK displays identical substrate specificity as GrA. In peptide- and protease-proteomic screens, GrK and GrA displayed highly restricted substrate specificities that overlapped only partially. Whereas GrK and GrA cleave SET with similar efficiencies likely at the same sites, both granzymes cleaved the pre-mRNA-binding protein heterogeneous ribonuclear protein K with different kinetics at distinct sites. GrK was markedly more efficient in cleaving heterogeneous ribonuclear protein K than GrA. GrK, but not GrA, cleaved the microtubule network protein beta-tubulin after two distinct Arg residues. Neither GrK cleavage sites in beta-tubulin nor a peptidebased proteomic screen revealed a clear GrK consensus sequence around the P1 residue, suggesting that GrK specificity depends on electrostatic interactions between exosites of the substrate and the enzyme. We hypothesize that GrK not only constitutes a redundant functional backup mechanism that assists GrA-induced cell death but that it also displays a unique function by cleaving its own specific substrates.	[Bovenschen, Niels; Quadir, Razi; van den Berg, A. Lotte; Kummer, J. Alain] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [Brenkman, Arjan B.] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, NL-3584 CX Utrecht, Netherlands; [Vandenberghe, Isabel; Devreese, Bart] Univ Ghent, Dept Biochem Physiol & Microbiol, Lab Prot Biochem & Biomol Engn, B-9000 Ghent, Belgium; [Joore, Jos] Pepscan, NL-8219 PK Lelystad, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Ghent University	Bovenschen, N (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	n.bovenschen@umcutrecht.nl	Devreese, Bart/B-2011-2009; Devreese, Bart/K-2841-2019	Devreese, Bart/0000-0002-9764-2581; Devreese, Bart/0000-0002-9764-2581; Joore, Jos/0000-0002-2744-4862	Netherlands Organization for Scientific Research Grant [916.66.044]; Dutch Cancer Society Grant [UMCU-2004-3047]	Netherlands Organization for Scientific Research Grant(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society Grant(KWF Kankerbestrijding)	This work was supported by Netherlands Organization for Scientific Research Grant 916.66.044 (to N. B.) and Dutch Cancer Society Grant UMCU-2004-3047 (to J.A.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adrain C, 2006, J BIOL CHEM, V281, P8118, DOI 10.1074/jbc.M509361200; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Bell JK, 2003, NAT STRUCT BIOL, V10, P527, DOI 10.1038/nsb944; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bovenschen N, 2008, J IMMUNOL, V180, P8184, DOI 10.4049/jimmunol.180.12.8184; Carter CRD, 1996, CELL IMMUNOL, V172, P235, DOI 10.1006/cimm.1996.0238; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Davis JE, 2001, EUR J IMMUNOL, V31, P39, DOI 10.1002/1521-4141(200101)31:1<39::AID-IMMU39>3.0.CO;2-1; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Goping IS, 2006, J CELL SCI, V119, P858, DOI 10.1242/jcs.02791; Hink-Schauer C, 2003, NAT STRUCT BIOL, V10, P535, DOI 10.1038/nsb945; Hink-Schauer C, 2002, J BIOL CHEM, V277, P50923, DOI 10.1074/jbc.M207962200; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Jackson DS, 1998, J MED CHEM, V41, P2289, DOI 10.1021/jm970543s; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kam CM, 2000, BBA-PROTEIN STRUCT M, V1477, P307, DOI 10.1016/S0167-4838(99)00282-4; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Mahrus S, 2005, CHEM BIOL, V12, P567, DOI 10.1016/j.chembiol.2005.03.006; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Ng LFP, 2005, PLOS MED, V2, P673, DOI 10.1371/journal.pmed.0020163; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; Shresta S, 1997, J BIOL CHEM, V272, P20236, DOI 10.1074/jbc.272.32.20236; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Zhao T, 2007, CELL DEATH DIFFER, V14, P489, DOI 10.1038/sj.cdd.4402040; Zhao TB, 2007, J BIOL CHEM, V282, P12104, DOI 10.1074/jbc.M611006200; Zhu PC, 2006, EMBO REP, V7, P431, DOI 10.1038/sj.embor.7400622	34	68	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3504	3512		10.1074/jbc.M806716200	http://dx.doi.org/10.1074/jbc.M806716200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19059912	hybrid			2022-12-27	WOS:000262872500017
J	Pautz, A; Linker, K; Altenhofer, S; Heil, S; Schmidt, N; Art, J; Knauer, S; Stauber, R; Sadri, N; Pont, A; Schneider, RJ; Kleinert, H				Pautz, Andrea; Linker, Katrin; Altenhoefer, Sebastian; Heil, Sebastian; Schmidt, Nadine; Art, Julia; Knauer, Shirley; Stauber, Roland; Sadri, Navid; Pont, Adam; Schneider, Robert J.; Kleinert, Hartmut			Similar Regulation of Human Inducible Nitric-oxide Synthase Expression by Different Isoforms of the RNA-binding Protein AUF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INOS-EXPRESSION; ALPHA MESSENGER-RNA; GENE-EXPRESSION; RICH ELEMENT; 3'-UNTRANSLATED REGION; POSTTRANSCRIPTIONAL REGULATION; HUR; STABILITY; TURNOVER; DISEASE	The ARE/poly-(U) binding factor 1 (AUF1), a protein family consisting of four isoforms, is believed to mediate mRNA degradation by binding to AU-rich elements (ARE). However, evidence exists that individual AUF1 isoforms may stabilize ARE-containing mRNAs. The 3'-untranslated region of the human inducible nitric-oxide synthase (iNOS) contains five AREs, which promote RNA degradation. We have recently shown that the RNA-binding protein KSRP is critically involved in the decay of the iNOS mRNA. In this study we examined the effects of the individual AUF1 isoforms on iNOS expression. Overexpression of each AUF1 isoform reduces iNOS expression on mRNA and protein levels to the same extent by modulation of mRNA stability. Accordingly, knockdown of all or individual AUF1 isoforms by an RNA interference approach enhances iNOS expression. The AUF1 effect on iNOS expression is dependent on the iNOS 3'-untranslated region sequence, as demonstrated in transfection experiments with a reporter mRNA. Binding studies showed that all AUF1 isoforms interact with the same AU-rich region in the iNOS-3'-untranslated region. Cytokine stimulation altered intracellular AUF1 binding activities. These data demonstrate that AUF1 is an important factor that promotes iNOS mRNA degradation. Furthermore, all individual AUF1 isoforms act in a similar manner.	[Pautz, Andrea; Linker, Katrin; Altenhoefer, Sebastian; Heil, Sebastian; Schmidt, Nadine; Art, Julia; Kleinert, Hartmut] Johannes Gutenberg Univ Mainz, Dept Pharmacol, D-55101 Mainz, Germany; [Knauer, Shirley; Stauber, Roland] Univ Hosp Mainz, D-55101 Mainz, Germany; [Sadri, Navid; Pont, Adam; Schneider, Robert J.] NYU, Sch Med, Dept Microbiol, New York, NY 10003 USA	Johannes Gutenberg University of Mainz; University Hospital Mainz; New York University	Kleinert, H (corresponding author), Johannes Gutenberg Univ Mainz, Dept Pharmacol, Obere Zahlbacher Str 67, D-55101 Mainz, Germany.	kleinert@mail.uni-mainz.de	Knauer, Shirley K/E-7931-2012; Kleinert, Hartmut/M-2988-2018	Knauer, Shirley K/0000-0003-4321-0924; Kleinert, Hartmut/0000-0003-2202-3548; sadri, navid/0000-0001-5051-717X; Stauber, Roland/0000-0002-1341-4523; Schneider, Robert/0000-0001-5807-5564	Innovation Foundation of the State of Rhineland-Palatinate [8312-386261/322a]; Collaborative Research Center [SFB 553]; Deutsche Forschungsgemeinschaft [LI 1759/1-1]	Innovation Foundation of the State of Rhineland-Palatinate; Collaborative Research Center; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant 8312-386261/322a and -b from the Innovation Foundation of the State of Rhineland-Palatinate, by the Collaborative Research Center SFB 553 (Project A7 (to H. K.), and by the Deutsche Forschungsgemeinschaft Grant LI 1759/1-1. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Benjamin D, 2007, EXPERT OPIN BIOL TH, V7, P1515, DOI 10.1517/14712598.7.10.1515; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; Bros M, 2006, GENOMICS, V87, P463, DOI 10.1016/j.ygeno.2005.11.013; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Dobi A, 2006, J BIOL CHEM, V281, P28889, DOI 10.1074/jbc.M511858200; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002; Espel E, 2005, SEMIN CELL DEV BIOL, V16, P59, DOI 10.1016/j.semcdb.2004.11.008; Fechir M, 2005, MOL PHARMACOL, V67, P2148, DOI 10.1124/mol.104.008763; Fechir M, 2003, N-S ARCH PHARMACOL, V367, pR41; Fuentes-Panana EM, 2000, J VIROL, V74, P8166, DOI 10.1128/JVI.74.17.8166-8175.2000; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Ing NH, 2008, J BIOL CHEM, V283, P1764, DOI 10.1074/jbc.M704745200; Jiao RQ, 2006, J CELL BIOCHEM, V98, P1257, DOI 10.1002/jcb.20843; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lee C, 2008, CEREB CORTEX, V18, P2909, DOI 10.1093/cercor/bhn051; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; MAZANMAMCZARZ K, 2008, NUCL ACIDS IN PRESS; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Palanisamy V, 2008, J DENT RES, V87, P772, DOI 10.1177/154405910808700803; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; SADRI N, 2008, J INVESTIG IN PRESS; Sagliocco F, 2006, BIOCHEM J, V400, P337, DOI 10.1042/BJ20060328; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Sarkar S, 2008, J INTERF CYTOK RES, V28, P679, DOI 10.1089/jir.2008.0028; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Sobue S, 2008, ONCOGENE, V27, P6023, DOI 10.1038/onc.2008.198; Soderberg M, 2007, MOL IMMUNOL, V44, P434, DOI 10.1016/j.molimm.2006.02.019; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Torrisani J, 2007, MOL CELL BIOL, V27, P395, DOI 10.1128/MCB.01236-06; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	55	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2755	2766		10.1074/jbc.M809314200	http://dx.doi.org/10.1074/jbc.M809314200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19074427	hybrid			2022-12-27	WOS:000262700900018
J	Hill, R; Wu, H				Hill, Reginald; Wu, Hong			PTEN, Stem Cells, and Cancer Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							IN-VIVO; CONDITIONAL LOSS; PROSTATE-CANCER; SELF-RENEWAL; LEUKEMIA; TUMORIGENESIS; LEADS; RESISTANCE; DELETION; NOTCH1	Like normal stem cells, "cancer stem cells" have the capacity for indefinite proliferation and generation of new cancerous tissues through self-renewal and differentiation. Among the major intracellular signaling pathways, WNT, SHH, and NOTCH are known to be important in regulating normal stem cell activities, and their alterations are associated with tumorigenesis. It has become clear recently that PTEN (phosphatase and tensin homologue) is also critical for stem cell maintenance and that PTEN loss can cause the development of cancer stem cells and ultimately tumorigenesis.	[Hill, Reginald; Wu, Hong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Hill, R (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	rhill@mednet.ucla.edu	Hill, Reginald/D-2270-2016		National Institutes of Health [UO1 CA84128-06, P50 CA092131]; NCI [RO1 CA107166]; Prostate Cancer Foundation [DOD PC031130]; Damon Runyon Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA092131, U01CA084128, R01CA107166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; Damon Runyon Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants UO1 CA84128-06, P50 CA092131, and RO1 CA107166 from NCI (to H. W.). This work was also supported by Prostate Cancer Foundation Grant DOD PC031130 and a Damon Runyon Cancer Foundation fellowship award (to R. H.). This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Fukuda R, 2005, P NATL ACAD SCI USA, V102, P15213, DOI 10.1073/pnas.0507184102; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Inoue-Narita T, 2008, CANCER RES, V68, P5760, DOI 10.1158/0008-5472.CAN-08-0889; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li G, 2002, DEVELOPMENT, V129, P4159; Li Y, 2001, BMC Mol Biol, V2, P2, DOI 10.1186/1471-2199-2-2; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Palomero T, 2008, CLIN CANCER RES, V14, P5314, DOI 10.1158/1078-0432.CCR-07-4864; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Stambolic V, 2000, CANCER RES, V60, P3605; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Suzuki A, 2003, CANCER RES, V63, P674; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	50	112	118	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11755	11759		10.1074/jbc.R800071200	http://dx.doi.org/10.1074/jbc.R800071200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19117948	Green Published, hybrid			2022-12-27	WOS:000265494600005
J	Hoegg, MB; Browman, DT; Resek, ME; Robbins, SM				Hoegg, Maja B.; Browman, Duncan T.; Resek, Mary E.; Robbins, Stephen M.			Distinct Regions within the Erlins Are Required for Oligomerization and Association with High Molecular Weight Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE MICRODOMAINS; SPFH DOMAIN; REGGIE/FLOTILLIN PROTEINS; ENDOPLASMIC-RETICULUM; RAFT ASSOCIATION; MAMMALIAN-CELLS; CHOLESTEROL; FAMILY; PALMITOYLATION; MYRISTOYLATION	The group of stomatin/prohibitin/flotillin/HflK/C (SPFH) domain-containing proteins comprise members of diverse subcellular localization and function. Association with detergent-resistant membranes (DRMs) and the propensity to form oligomers are two common properties of SPFH domain proteins and likely important for the function of these proteins. Our laboratory recently discovered two novel members of this protein group, which, based on their endoplasmic reticulum (ER) localization and association with DRMs, were named ER lipid raft-associated protein (erlin)-1 and -2. Here we characterized erlin oligomerization and identified domains within the erlins responsible for oligomerization and DRM association. Using co-immunoprecipitation and sucrose density gradient centrifugation approaches on endogenous and ectopically expressed erlin proteins, we found that they formed homo- and hetero-oligomers and were part of large multimeric complexes. These properties were independent of their DRM association. By analyzing truncation and point mutants of erlin-2 we discovered that interaction between erlin monomers (oligomerization) and association with high molecular weight complexes require distinct regions within the protein. Although oligomerization and DRM association were mediated by a region immediately downstream of the SPFH domain (residues 228-300), integration into high molecular weight complexes was absolutely dependent on a phenylalanine residue C-terminal of this region (Phe-305), which lies within a short stretch of hydrophobic residues. Our data demonstrate that lower order oligomerization and incorporation into multimeric complexes are two separate biochemical properties of the erlins, because they are mediated by distinct regions.	[Hoegg, Maja B.; Browman, Duncan T.; Resek, Mary E.; Robbins, Stephen M.] Univ Calgary, So Alberta Canc Res Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Resek, Mary E.; Robbins, Stephen M.] Univ Calgary, So Alberta Canc Res Inst, Dept Oncol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Robbins, SM (corresponding author), Hlth Res Innovat Ctr, Room 2AA22,3330 Hosp Dr,NW, Calgary, AB T2N 4N1, Canada.	srobbins@ucalgary.ca		Robbins, Stephen/0000-0001-7475-1665	Canadian Institutes of Health Research; Alberta Cancer Foundation Legacy Funds	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation Legacy Funds	This work was supported in part by grants from the Canadian Institutes of Health Research and the Alberta Cancer Foundation Legacy Funds. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Christis C, 2008, FEBS J, V275, P4700, DOI 10.1111/j.1742-4658.2008.06590.x; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Ikegawa S, 1999, CYTOGENET CELL GENET, V85, P227, DOI 10.1159/000015298; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kokubo H, 2003, BRAIN RES, V965, P83, DOI 10.1016/S0006-8993(02)04140-9; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Li N, 2000, BIOCHEM BIOPH RES CO, V279, P487, DOI 10.1006/bbrc.2000.3935; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Polyak MJ, 2002, BLOOD, V99, P3256, DOI 10.1182/blood.V99.9.3256; Rivera-Milla E, 2006, CELL MOL LIFE SCI, V63, P343, DOI 10.1007/s00018-005-5434-3; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Sprenger RR, 2006, BIOCHEM J, V400, P401, DOI 10.1042/BJ20060355; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200	24	23	24	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7766	7776		10.1074/jbc.M809127200	http://dx.doi.org/10.1074/jbc.M809127200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19131330	Green Published, hybrid			2022-12-27	WOS:000264195600038
J	Hornakova, T; Staerk, J; Royer, Y; Flex, E; Tartaglia, M; Constantinescu, SN; Knoops, L; Renauld, JC				Hornakova, Tekla; Staerk, Judith; Royer, Yohan; Flex, Elisabetta; Tartaglia, Marco; Constantinescu, Stefan N.; Knoops, Laurent; Renauld, Jean-Christophe			Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor alpha Homodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL LEUKEMIA; TYROSINE KINASE; POLYCYTHEMIA-VERA; CYTOKINE RECEPTOR; THYMIC LYMPHOMAS; GAMMA-CHAIN; MYELOPROLIFERATIVE DISORDERS; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; EXPRESSION	Activating mutations in JAK1 have been reported in acute lymphoblastic leukemias, but little is known about the mechanisms involved in their constitutive activation. Here, we studied the ability of JAK1 V658F and A634D to activate the Janus kinase (JAK)/STAT pathway upon ectopic expression in HEK293 cells alone or together with the other components of the interleukin-9 receptor complex (IL-9R alpha, gamma c, and JAK3). Expression of JAK1 mutants alone failed to trigger STAT activation, but co-expression of the IL-9R alpha chain promoted JAK1 mutant phosphorylation and STAT activation. Mutation of the FERM domain of JAK1, which is critical for cytokine receptor association, or of the single tyrosine of IL-9R alpha involved in STAT recruitment abolished this activity, indicating that JAK1 mutants need to associate with a functional IL-9R alpha to activate STAT factors. Several lines of evidence indicated that IL-9R alpha homodimerization was involved in this process. IL-9R alpha variants with mutations of the JAK-interacting BOX1 region not only failed to promote JAK1 activation but also acted as dominant negative forms reverting the effect of wild-type IL-9R alpha. Coimmunoprecipitation experiments also showed the formation of IL-9R alpha homodimers. Interestingly, STAT activation was partially inhibited by expression of gamma c, suggesting that overlapping residues are involved in IL-9R alpha homodimerization and IL-9R alpha/gamma c heterodimerization. Co-expression of wild-type JAK3 partially reverted the inhibition by gamma c, indicating that JAK3 cooperates with JAK1 mutants within the IL-9 receptor complex. Similar results were observed with IL-2R beta. Taken together, our results show that IL-9R alpha and IL-2R beta homodimers efficiently mediate constitutive activation of ALL-associated JAK1 mutants.	[Hornakova, Tekla; Staerk, Judith; Royer, Yohan; Constantinescu, Stefan N.; Knoops, Laurent; Renauld, Jean-Christophe] Univ Catholique Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; [Hornakova, Tekla; Staerk, Judith; Royer, Yohan; Constantinescu, Stefan N.; Knoops, Laurent; Renauld, Jean-Christophe] Univ Catholique Louvain, Duve Inst, B-1200 Brussels, Belgium; [Flex, Elisabetta; Tartaglia, Marco] Ist Super Sanita, I-00161 Rome, Italy; [Knoops, Laurent] Clin Univ St Luc, Div Hematol, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Istituto Superiore di Sanita (ISS); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Renauld, JC (corresponding author), Univ Catholique Louvain, Ludwig Inst Canc Res, Brussels Branch, Ave Hippocrate 74, B-1200 Brussels, Belgium.	renauld@bru.licr.org	Tartaglia, Marco/K-2955-2018; Constantinescu, Stefan N/E-5277-2012; Flex, Elisabetta/A-5958-2017; Renauld, Jean-Christophe/B-7268-2012	Tartaglia, Marco/0000-0001-7736-9672; Flex, Elisabetta/0000-0002-6802-1356; Constantinescu, Stefan N./0000-0002-8599-2699; Renauld, Jean-Christophe/0000-0003-1736-2131; Staerk, Judith/0000-0001-8698-6998	Belgian State, Prime Minister's Office, Science Policy Programming; Actions de Recherche Concertees of the Communaute Francaise de Belgique; Foundation Salus Sanguinis; Atlantic Philanthropies/Ludwig Institute for Cancer Research Ltd. Clinical Discovery Program; operation Televie	Belgian State, Prime Minister's Office, Science Policy Programming; Actions de Recherche Concertees of the Communaute Francaise de Belgique; Foundation Salus Sanguinis; Atlantic Philanthropies/Ludwig Institute for Cancer Research Ltd. Clinical Discovery Program; operation Televie	This work was supported in part by the Belgian Programme on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming, by the Actions de Recherche Concertees of the Communaute Francaise de Belgique, by Foundation Salus Sanguinis, Atlantic Philanthropies/Ludwig Institute for Cancer Research Ltd. Clinical Discovery Program, and the operation Televie.	Baba H, 2002, EUR J HAEMATOL, V68, P362, DOI 10.1034/j.1600-0609.2002.00653.x; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Demoulin JB, 2000, CANCER RES, V60, P3971; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; DRUEZ C, 1990, J IMMUNOL, V145, P2494; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Fischer M, 2003, LEUKEMIA, V17, P2513, DOI 10.1038/sj.leu.2403123; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Gerland K, 2000, MOL CELL ENDOCRINOL, V168, P1, DOI 10.1016/S0303-7207(00)00314-2; Haan C, 2001, J BIOL CHEM, V276, P37451, DOI 10.1074/jbc.M106135200; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jeong EG, 2008, CLIN CANCER RES, V14, P3716, DOI 10.1158/1078-0432.CCR-07-4839; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; KELLEHER K, 1991, BLOOD, V77, P1436; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Malka Y, 2008, J BIOL CHEM, V283, P33569, DOI 10.1074/jbc.M803125200; MERZ H, 1991, BLOOD, V78, P1311; NAKARAI T, 1994, J EXP MED, V180, P241, DOI 10.1084/jem.180.1.241; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Peelman F, 2006, J BIOL CHEM, V281, P15496, DOI 10.1074/jbc.M512622200; RENAULD JC, 1992, P NATL ACAD SCI USA, V89, P5690, DOI 10.1073/pnas.89.12.5690; RENAULD JC, 1994, ONCOGENE, V9, P1327; RENAULD JC, 1995, BLOOD, V85, P1300, DOI 10.1182/blood.V85.5.1300.bloodjournal8551300; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; UYTTENHOVE C, 1991, J EXP MED, V173, P519, DOI 10.1084/jem.173.2.519; Vainchenker William, 2005, Hematology Am Soc Hematol Educ Program, P195; VINK A, 1993, EUR J IMMUNOL, V23, P1134, DOI 10.1002/eji.1830230523; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186	41	57	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6773	6781		10.1074/jbc.M807531200	http://dx.doi.org/10.1074/jbc.M807531200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139102	hybrid, Green Published			2022-12-27	WOS:000263919000022
J	Zhang, Y; Inouye, M				Zhang, Yonglong; Inouye, Masayori			The Inhibitory Mechanism of Protein Synthesis by YoeB, an Escherichia coli Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; TRANSLATION INITIATION; RIBONUCLEIC ACID; STRUCTURAL BASIS; TOLUENE; SITE; RIBOSOMES; CLEAVAGE; BACTERIA; BINDING	YoeB is a toxin encoded by the yefM-yoeB antitoxin-toxin operon in the Escherichia coli genome. Here we show that YoeB, a highly potent protein synthesis inhibitor, specifically blocks translation initiation. In in vivo primer extension experiments using two different mRNAs, a major band was detected after YoeB induction at three bases downstream of the initiation codon at 2.5 min. An identical band was also detected in in vitro toeprinting experiments after the addition of YoeB to the reaction mixtures containing 70 S ribosomes and the same mRNAs, even in the absence of tRNA(f)(Met). Notably, this band was not detected in the presence of YoeB alone, indicating that YoeB by itself does not have endoribonuclease activity under the conditions used. The 70 S ribosomes increased upon YoeB induction, and YoeB was found to be specifically associated with 50 S subunits. Using tetracycline and hygromycin B, we demonstrated that YoeB binds to the 50 S ribosomal subunit in 70 S ribosomes and interacts with the A site leading to mRNA cleavage at this site. As a result, the 3'-end portion of the mRNA was released from ribosomes, and translation initiation was effectively inhibited. These results demonstrate that YoeB primarily inhibits translation initiation.	[Zhang, Yonglong; Inouye, Masayori] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	inouye@umdnj.edu			National Institutes of Health [RO1GM081567]; Takara Bio Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takara Bio Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1GM081567 and by a grant from Takara Bio Inc.	Aoki H, 2002, ANTIMICROB AGENTS CH, V46, P1080, DOI 10.1128/AAC.46.4.1080-1085.2002; Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Brandi L, 2006, P NATL ACAD SCI USA, V103, P39, DOI 10.1073/pnas.0507740102; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Cherny I, 2004, J BIOL CHEM, V279, P8252, DOI 10.1074/jbc.M308263200; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Du HS, 1998, J BIOL CHEM, V273, P20494, DOI 10.1074/jbc.273.32.20494; HALEGOUA S, 1976, EUR J BIOCHEM, V69, P163, DOI 10.1111/j.1432-1033.1976.tb10869.x; HALEGOUA S, 1976, J BACTERIOL, V126, P183, DOI 10.1128/JB.126.1.183-191.1976; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hesterkamp T, 1997, J BIOL CHEM, V272, P21865, DOI 10.1074/jbc.272.35.21865; Moll I, 2002, BIOCHEM BIOPH RES CO, V297, P1021, DOI 10.1016/S0006-291X(02)02333-1; MOSES RE, 1970, P NATL ACAD SCI USA, V67, P674, DOI 10.1073/pnas.67.2.674; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; PETERSON RL, 1971, J BACTERIOL, V107, P585, DOI 10.1128/JB.107.2.585-588.1971; RAJBHANDARY UL, 1969, J BIOL CHEM, V244, P1104; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; Swaney SM, 1998, ANTIMICROB AGENTS CH, V42, P3251, DOI 10.1128/AAC.42.12.3251; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	24	80	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6627	6638		10.1074/jbc.M808779200	http://dx.doi.org/10.1074/jbc.M808779200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19124462	hybrid, Green Published			2022-12-27	WOS:000263919000007
J	Mukherjee, A; Morosky, SA; Shen, L; Weber, CR; Turner, JR; Kim, KS; Wang, TY; Coyne, CB				Mukherjee, Amitava; Morosky, Stefanie A.; Shen, Le; Weber, Christopher R.; Turner, Jerrold R.; Kim, Kwang Sik; Wang, Tianyi; Coyne, Carolyn B.			Retinoic Acid-induced Gene-1 (RIG-I) Associates with the Actin Cytoskeleton via Caspase Activation and Recruitment Domain-dependent Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; RECEPTOR-RELATED PROTEIN-1; HEPATITIS-C VIRUS; TIGHT JUNCTIONS; POLIOVIRUS RECEPTOR; ADAPTER PROTEIN; ENTRY; RECOGNITION; MEDIATOR	The actin cytoskeleton serves as a barrier that protects mammalian cells from environmental pathogens such as bacteria, fungi, and viruses. Several components of antimicrobial signaling pathways have been shown to associate directly with the actin cytoskeleton, indicating that the cytoskeleton may also serve as a platform for immune-associated molecules. Here we report that retinoic acid-induced gene-I (RIG-I), an important viral RNA recognition molecule, is associated with the actin cytoskeleton and localizes predominantly to actin-enriched membrane ruffles in non-polarized epithelial cells. Subcellular localization and fractionation experiments revealed that the association between RIG-I and the actin cytoskeleton was mediated by its N-terminal caspase activation and recruitment domains (CARDs), which were necessary and sufficient to induce cytoskeletal association. We also show that RIG-I plays a role in cellular migration, as ectopic expression of RIG-I enhanced cellular migration in a wound healing assay and depletion of endogenous RIG-I significantly reduced wound healing. We further show that in both cultured intestinal epithelial cells (IEC) and human colon and small intestine biopsies, RIG-I is enriched at apico-lateral cell junctions and colocalizes with markers of the tight junction. Depolymerization of the actin cytoskeleton in polarized IEC led to the rapid relocalization of RIG-I and to the induction of type I interferon signaling. These data provide evidence that RIG-I is associated with the actin cytoskeleton in non-polarized epithelial cells and with the junctional complex in polarized IECs and human intestine and colon biopsies and may point to a physiological role for RIG-I in the regulation of cellular migration.	[Mukherjee, Amitava; Morosky, Stefanie A.; Coyne, Carolyn B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Wang, Tianyi] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Shen, Le; Weber, Christopher R.; Turner, Jerrold R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Kim, Kwang Sik] Johns Hopkins Univ, Sch Med, Div Pediat Infect Dis, Baltimore, MD 21287 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago; Johns Hopkins University	Coyne, CB (corresponding author), S313 Biomed Sci Tower,3500 Terrace St, Pittsburgh, PA 15261 USA.	coynec2@pitt.edu	Turner, Jerrold/H-1502-2019; Mukherjee, Amitava/AAK-4002-2020; Shen, Le/E-7866-2010; Turner, Jerrold R/A-6895-2009	Mukherjee, Amitava/0000-0001-5603-5147; Turner, Jerrold R/0000-0003-0627-9455; Weber, Christopher/0000-0002-2117-3184	University of Pittsburgh School of Medicine, Dept. of Cell Biology and Physiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK067887, R01DK061931, R56DK094954, R01DK068271] Funding Source: NIH RePORTER	University of Pittsburgh School of Medicine, Dept. of Cell Biology and Physiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by faculty development funding from the University of Pittsburgh School of Medicine, Dept. of Cell Biology and Physiology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Are AF, 2000, EXP CELL RES, V256, P533, DOI 10.1006/excr.2000.4830; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hershberg RM, 2002, AM J PHYSIOL-GASTR L, V283, pG833, DOI 10.1152/ajpgi.00208.2002; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Krummenacher C, 1998, J VIROL, V72, P7064, DOI 10.1128/JVI.72.9.7064-7074.1998; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; Li JY, 2008, J CELL BIOL, V181, P321, DOI 10.1083/jcb.200711082; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; MCNEIL PL, 2001, TURR PROTOC CELL BIO; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang NN, 2008, P NATL ACAD SCI USA, V105, P10553, DOI 10.1073/pnas.0804895105	35	42	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6486	6494		10.1074/jbc.M807547200	http://dx.doi.org/10.1074/jbc.M807547200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19122199	hybrid, Green Published			2022-12-27	WOS:000263742700051
J	Neppl, RL; Lubomirov, LT; Momotani, K; Pfitzer, G; Eto, M; Somlyo, AV				Neppl, Ronald L.; Lubomirov, Lubomir T.; Momotani, Ko; Pfitzer, Gabriele; Eto, Masumi; Somlyo, Avril V.			Thromboxane A(2)-induced Bi-directional Regulation of Cerebral Arterial Tone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; LIGHT-CHAIN PHOSPHATASE; VASCULAR SMOOTH-MUSCLE; VASODILATOR-STIMULATED PHOSPHOPROTEIN; PORCINE CORONARY-ARTERY; MYOSIN-BINDING SUBUNIT; RHO-ASSOCIATED KINASE; NITRIC-OXIDE; CA2+ SENSITIZATION; SIGNAL-TRANSDUCTION	Myosin light chain phosphatase plays a critical role in modulating smooth muscle contraction in response to a variety of physiologic stimuli. A downstream target of the RhoA/Rho-kinase and nitric oxide (NO)/cGMP/cyclic GMP-dependent kinase (cGKI) pathways, myosin light chain phosphatase activity reflects the sum of both calcium sensitization and desensitization pathways through phosphorylation and dephosphorylation of the myosin phosphatase targeting subunit (MYPT1). As cerebral blood flow is highly spatio-temporally modulated under normal physiologic conditions, severe perturbations in normal cerebral blood flow, such as in cerebral vasospasm, can induce neurological deficits. In nonpermeabilized cerebral vessels stimulated with U-46619, a stable mimetic of endogenous thromboxane A(2) implicated in the etiology of cerebral vasospasm, we observed significant increases in contractile force, RhoA activation, regulatory light chain phosphorylation, as well as phosphorylation of MYPT1 at Thr-696, Thr-853, and surprisingly Ser-695. Inhibition of nitric oxide signaling completely abrogated basal MYPT1 Ser-695 phosphorylation and significantly increased and potentiated U-46619-induced MYPT1 Thr-853 phosphorylation and contractile force, indicating that NO/cGMP/cGKI signaling maintains basal vascular tone through active inhibition of calcium sensitization. Surprisingly, a fall in Ser-695 phosphorylation did not result in an increase in phosphorylation of the Thr-696 site. Although activation of cGKI with exogenous cyclic nucleotides inhibited thromboxane A(2)-induced MYPT1 membrane association, RhoA activation, contractile force, and regulatory light chain phosphorylation, the anticipated decreases in MYPT1 phosphorylation at Thr-696/Thr-853 were not observed, indicating that the vasorelaxant effects of cGKI are not through dephosphorylation of MYPT1. Thus, thromboxane A2 signaling within the intact cerebral vasculature induces "buffered" vasoconstrictions, in which both the RhoA/Rho-kinase calcium-sensitizing and the NO/cGMP/cGKI calcium-desensitizing pathways are activated.	[Neppl, Ronald L.; Momotani, Ko; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Neppl, Ronald L.; Somlyo, Avril V.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Lubomirov, Lubomir T.; Pfitzer, Gabriele] Univ Cologne, Inst Vegetat Physiol, D-50931 Cologne, Germany; [Eto, Masumi] Thomas Jefferson Univ, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA	University of Virginia; University of Virginia; University of Cologne; Jefferson University	Somlyo, AV (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, POB 800736, Charlottesville, VA 22908 USA.	avs5u@virginia.edu	Neppl, Ronald L/AAW-1257-2020; Eto, Masumi/ABE-4700-2020	Neppl, Ronald L/0000-0003-1497-6058; Eto, Masumi/0000-0002-0651-5836	National Institutes of Health [PO1 HL19242, PO1 HL48807, RO1 HL83261]; Pennsylvania Department of Health CURE; medical faculty of the University of Cologne; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048807, R01HL083261, P01HL019242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health CURE; medical faculty of the University of Cologne; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL19242, PO1 HL48807 ( to A. V. S.), RO1 HL83261, and PO1 HL48807. This work was also supported by a Pennsylvania Department of Health CURE Grant ( to M. E.) and grants from the medical faculty of the University of Cologne ( to G. P. and L. T. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Bolz SS, 2003, CIRCULATION, V107, P3081, DOI 10.1161/01.CIR.0000074202.19612.8C; BOULANGER CM, 1995, HYPERTENSION, V26, P752, DOI 10.1161/01.HYP.26.5.752; BRADLEY AB, 1987, J PHYSIOL-LONDON, V385, P437, DOI 10.1113/jphysiol.1987.sp016500; BUTT E, 1994, J BIOL CHEM, V269, P14509; Choudhury N, 2004, J MUSCLE RES CELL M, V25, P657, DOI 10.1007/s10974-004-7807-x; Davidge ST, 2001, CIRC RES, V89, P650, DOI 10.1161/hh2001.098351; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; ELLIS EF, 1976, SCIENCE, V193, P1135, DOI 10.1126/science.959827; Eto M, 2007, STRUCTURE, V15, P1591, DOI 10.1016/j.str.2007.10.014; Etter EF, 2001, J BIOL CHEM, V276, P34681, DOI 10.1074/jbc.M104737200; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fritsch RM, 2004, J BIOL CHEM, V279, P12551, DOI 10.1074/jbc.M313365200; Gong MC, 1997, J BIOL CHEM, V272, P10704; GRAY DW, 1992, BRIT J PHARMACOL, V107, P691, DOI 10.1111/j.1476-5381.1992.tb14508.x; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Hansen-Schwartz J, 2007, TRENDS PHARMACOL SCI, V28, P252, DOI 10.1016/j.tips.2007.04.002; HIMPENS B, 1990, PFLUG ARCH EUR J PHY, V417, P21, DOI 10.1007/BF00370764; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hou X, 2000, STROKE, V31, P516, DOI 10.1161/01.STR.31.2.516; Huang JS, 2004, CELL SIGNAL, V16, P521, DOI 10.1016/j.cellsig.2003.10.008; Ibarra-Alvarado C, 2002, MOL PHARMACOL, V61, P312, DOI 10.1124/mol.61.2.312; Ito M, 1997, BIOCHEMISTRY-US, V36, P7607, DOI 10.1021/bi9702647; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Khromov AS, 2006, P NATL ACAD SCI USA, V103, P2440, DOI 10.1073/pnas.0508566103; KITAZAWA T, 1991, J BIOL CHEM, V266, P1708; Koga Y, 2005, J BIOL CHEM, V280, P4983, DOI 10.1074/jbc.M410909200; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Lontay B, 2005, CELL SIGNAL, V17, P1265, DOI 10.1016/j.cellsig.2005.01.008; Lubomirov LT, 2006, CIRC RES, V98, P1159, DOI 10.1161/01.RES.0000219904.43852.3e; MacDonald JA, 2000, FEBS LETT, V479, P83, DOI 10.1016/S0014-5793(00)01884-6; Maguire JJ, 2005, TRENDS PHARMACOL SCI, V26, P448, DOI 10.1016/j.tips.2005.07.007; Manganello JM, 2003, J BIOL CHEM, V278, P124, DOI 10.1074/jbc.M209219200; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Miyamoto A, 2007, VASC PHARMACOL, V46, P85, DOI 10.1016/j.vph.2006.06.018; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Muranyi A, 2001, FEBS LETT, V493, P80, DOI 10.1016/S0014-5793(01)02283-9; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Nishizawa S, 2005, TRENDS CARDIOVAS MED, V15, P24, DOI 10.1016/j.tcm.2004.12.002; Nobe K, 2001, CIRC RES, V88, P1283, DOI 10.1161/hh1201.092035; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; OKUBO S, 1994, BIOCHEM BIOPH RES CO, V200, P429, DOI 10.1006/bbrc.1994.1467; Reid HM, 2003, J BIOL CHEM, V278, P51190, DOI 10.1074/jbc.M309314200; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XD, 2004, J CELL SCI, V117, P3511, DOI 10.1242/jcs.01205; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Sausbier M, 2000, CIRC RES, V87, P825, DOI 10.1161/01.RES.87.9.825; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schnackenberg CG, 2000, AM J PHYSIOL-RENAL, V279, pF302, DOI 10.1152/ajprenal.2000.279.2.F302; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Senba S, 1999, J BIOCHEM-TOKYO, V125, P354, DOI 10.1093/oxfordjournals.jbchem.a022294; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; SHIRAHASE H, 1987, BLOOD VESSELS, V24, P117; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; SOMLYO AV, 1992, J BIOL CHEM, V267, P22316; Surks HK, 2003, J BIOL CHEM, V278, P51484, DOI 10.1074/jbc.M305622200; Surks HK, 2003, CELL SIGNAL, V15, P937, DOI 10.1016/S0898-6568(03)00057-3; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Suzuki H, 2006, ENDOCRINOLOGY, V147, P5914, DOI 10.1210/en.2006-0834; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; UHLER MD, 1993, J BIOL CHEM, V268, P13586; van Lieshout JJ, 2003, J APPL PHYSIOL, V94, P833, DOI 10.1152/japplphysiol.00260.2002; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Walker LA, 2001, J BIOL CHEM, V276, P24519, DOI 10.1074/jbc.M103560200; Wilson DP, 2005, BIOCHEM J, V389, P763, DOI 10.1042/BJ20050237; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wooldridge AA, 2008, J BIOL CHEM, V283, P11850, DOI 10.1074/jbc.M708628200; Worner R, 2007, AM J PHYSIOL-HEART C, V292, pH237, DOI 10.1152/ajpheart.00079.2006; Wu XQ, 1998, J BIOL CHEM, V273, P11362, DOI 10.1074/jbc.273.18.11362	80	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6348	6360		10.1074/jbc.M807040200	http://dx.doi.org/10.1074/jbc.M807040200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19095646	Green Published, hybrid			2022-12-27	WOS:000263742700038
J	Fenske, SA; Yesilaltay, A; Pal, R; Daniels, K; Barker, C; Quinones, V; Rigotti, A; Krieger, M; Kocher, O				Fenske, Sara A.; Yesilaltay, Ayce; Pal, Rinku; Daniels, Kathleen; Barker, Caroline; Quinones, Veronica; Rigotti, Attilio; Krieger, Monty; Kocher, Olivier			Normal Hepatic Cell Surface Localization of the High Density Lipoprotein Receptor, Scavenger Receptor Class B, Type I, Depends on All Four PDZ Domains of PDZK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SR-BI; CHYLOMICRON METABOLISM; TARGETED DISRUPTION; CHOLESTEROL EFFLUX; CONTAINING PROTEIN; LIPID-METABOLISM; APOLIPOPROTEIN-E; EXPRESSION; MICE; LIVER	PDZK1 is a four PDZ domain-containing scaffold protein that binds to scavenger receptor class B, type I (SR-BI), the high density lipoprotein receptor, by its first PDZ domain (PDZ1). PDZK1 knock-out mice exhibit a >95% decrease in hepatic SR-BI protein and consequently an similar to 70% increase in plasma cholesterol in abnormally large high density lipoprotein particles. These defects are corrected by hepatic overexpression of full-length PDZK1 but not the PDZ1 domain alone, which partially restores SR-BI protein abundance but not cell surface expression or function. We have generated PDZK1 knock-out mice with hepatic expression of four PDZK1 transgenes encoding proteins with nested C-terminal truncations: pTEM, which lacks the three C-terminal residues (putative PDZ-binding motif), and PDZ1.2, PDZ1.2.3, or PDZ1.2.3.4, which contain only the first two, three, or four N-terminalPDZ domains, respectively, but not the remaining C-terminal sequences. Hepatic overexpression of pTEM restored normal hepatic SR-BI abundance, localization, and function. Hepatic overexpression of PDZ1.2 or PDZ1.2.3 partially restored SR-BI abundance (similar to 12 or similar to 30% of wild type, respectively) but did not (PDZ1.2) or only slightly (PDZ1.2.3) restored hepatic SR-BI cell surface localization and function. Hepatic overexpression of PDZ1.2.3.4 completely restored SR-BI protein abundance, cell surface expression, and function (normalization of plasma cholesterol levels). Thus, all four PDZ domains in PDZK1, but not PDZ1-3 alone, are sufficient for its normal control of the abundance, localization, and therefore function of hepatic SR-BI, whereas the residues C-terminal to the PDZ4 domain, including the C-terminal putative PDZ-binding domain, are not required.	[Fenske, Sara A.; Yesilaltay, Ayce; Barker, Caroline; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA; [Pal, Rinku; Daniels, Kathleen; Kocher, Olivier] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Pal, Rinku; Daniels, Kathleen; Kocher, Olivier] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Quinones, Veronica; Rigotti, Attilio] Pontificia Univ Catolica Chile, Dept Gastroenterol, Fac Med, Santiago 8330024, Chile	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Pontificia Universidad Catolica de Chile	Krieger, M (corresponding author), MIT, Dept Biol, Rm 68-483,77 Massachusetts Ave, Cambridge, MA 02139 USA.	krieger@mit.edu			National Institutes of Health [HL077780]; Clinical Translational Science Award [1UL1RR025758-01]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1070634];  [HL64737];  [HL52212];  [HL66105]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052212, R01HL077780, P01HL066105, R01HL064737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Translational Science Award; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL077780 (to O.K.); Grants HL64737, HL52212, and HL66105 (to M. K.); and Clinical Translational Science Award Grant 1UL1RR025758-01 (to the Massachusetts Institute of Technology). This work was also supported by4Grant 1070634 (to A.R.).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Eckhardt ERM, 2006, J BIOL CHEM, V281, P4348, DOI 10.1074/jbc.M513154200; Eckhardt ERM, 2004, J BIOL CHEM, V279, P14372, DOI 10.1074/jbc.M313793200; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Fu T, 2003, J BIOL CHEM, V278, P52559, DOI 10.1074/jbc.M310892200; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 1999, LAB INVEST, V79, P1161; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; Out R, 2005, J LIPID RES, V46, P1172, DOI 10.1194/jlr.M400361-JLR200; Out R, 2004, J BIOL CHEM, V279, P18401, DOI 10.1074/jbc.M401170200; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; REAVEN E, 1984, J CLIN INVEST, V74, P1384, DOI 10.1172/JCI111549; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; STEIN Y, 1983, BIOCHIM BIOPHYS ACTA, V752, P98, DOI 10.1016/0005-2760(83)90237-0; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Van Eck M, 2008, J LIPID RES, V49, P136, DOI 10.1194/jlr.M700355-JLR200; Wang PJ, 2005, J BIOL CHEM, V280, P30143, DOI 10.1074/jbc.M503969200; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241; Webb NR, 1997, J LIPID RES, V38, P1490; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; Zhang XH, 2007, ENDOCRINOLOGY, V148, P5295, DOI 10.1210/en.2007-0376	39	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5797	5806		10.1074/jbc.M808211200	http://dx.doi.org/10.1074/jbc.M808211200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19116202	Green Published, hybrid			2022-12-27	WOS:000263560600043
J	Tvorogov, D; Sundvall, M; Kurppa, K; Hollmen, M; Repo, S; Johnson, MS; Elenius, K				Tvorogov, Denis; Sundvall, Maria; Kurppa, Kari; Hollmen, Maija; Repo, Susanna; Johnson, Mark S.; Elenius, Klaus			Somatic Mutations of ErbB4 SELECTIVE LOSS-OF-FUNCTION PHENOTYPE AFFECTING SIGNAL TRANSDUCTION PATHWAYS IN CANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE DOMAIN; LUNG-CANCER; INTRACELLULAR DOMAIN; RECEPTOR; GROWTH; ACTIVATION; EGFR; MECHANISM; ISOFORM; PHOSPHORYLATION	Cancer drugs targeting ErbB receptors, such as epidermal growth factor receptor and ErbB2, are currently in clinical use. However, the role of ErbB4 as a potential cancer drug target has remained controversial. Recently, somatic mutations altering the coding region of ErbB4 were described in patients with breast, gastric, colorectal, or non-small cell lung cancer, but the functional significance of these mutations is unknown. Here we demonstrate that 2 of 10 of the cancer-associated mutations of ErbB4 lead to loss of ErbB4 kinase activity due to disruption of functionally important structural features. Interestingly, the kinase-dead ErbB4 mutants were as efficient as wild-type ErbB4 in forming a heterodimeric neuregulin receptor with ErbB2 and promoting phosphorylation of Erk1/2 and Akt in an ErbB2 kinase-dependent manner. However, the mutant ErbB4 receptors failed to phosphorylate STAT5 and suppressed differentiation of MDA-MB-468 mammary carcinoma cells. These findings suggest that the somatic ErbB4 mutations have functional consequences and lead to selective changes in ErbB4 signaling.	[Tvorogov, Denis; Sundvall, Maria; Kurppa, Kari; Hollmen, Maija; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, FIN-20520 Turku, Finland; [Tvorogov, Denis; Sundvall, Maria; Kurppa, Kari; Hollmen, Maija; Elenius, Klaus] Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland; [Repo, Susanna; Johnson, Mark S.] Abo Akad Univ, Dept Biochem & Pharm, Struct Bioinformat Lab, FIN-20520 Turku, Finland; [Hollmen, Maija] Turku Grad Sch Biomed Sci, FIN-20520 Turku, Finland; [Elenius, Klaus] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland	University of Turku; University of Turku; Abo Akademi University; University of Turku; University of Turku	Elenius, K (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinanmyllynkatu 10, FIN-20520 Turku, Finland.	klaus.elenius@utu.fi	Hollmén, Maija/B-5831-2017; Elenius, Klaus/AAI-7594-2021	Hollmén, Maija/0000-0002-3250-7653; Elenius, Klaus/0000-0001-5700-0827; Sundvall, Maria H/0000-0002-0494-2965; Kurppa, Kari/0000-0001-8286-2429; Tvorogov, Denis/0000-0002-2009-1347; Susanna, Repo/0000-0003-3488-4767	Academy of Finland,; Finnish Cancer Organizations; Finnish Cultural Foundation; Foundation for the Finnish Cancer Institute; Foundation of Abo Akademi University; Oscar Oflund's Foundation; Tor, Joe and Pentti Borg's Memorial Fund; Sigrid Juselius Foundation; TEKES National Agency for Technology; Turku University Central Hospital	Academy of Finland,(Academy of FinlandEuropean Commission); Finnish Cancer Organizations; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Foundation for the Finnish Cancer Institute; Foundation of Abo Akademi University; Oscar Oflund's Foundation; Tor, Joe and Pentti Borg's Memorial Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation); TEKES National Agency for Technology(Finnish Funding Agency for Technology & Innovation (TEKES)); Turku University Central Hospital	This work was supported by the Academy of Finland, Finnish Cancer Organizations, Finnish Cultural Foundation, Foundation for the Finnish Cancer Institute, Foundation of Abo Akademi University ( Center of Excellence Program in Cell Stress), Oscar Oflund's Foundation, Tor, Joe and Pentti Borg's Memorial Fund, Sigrid Juselius Foundation, TEKES National Agency for Technology, and Turku University Central Hospital. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brignola PS, 2002, J BIOL CHEM, V277, P1576, DOI 10.1074/jbc.M105907200; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DeLano W. L., 2007, PYMOL MOL GRAPHICS S; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Du X, 2004, GENETICS, V166, P331, DOI 10.1534/genetics.166.1.331; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gullick WJ, 2003, J PATHOL, V200, P279, DOI 10.1002/path.1335; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Johnson M. S., 2000, BIOINFORMATICS SEQUE, P15; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Linggi B, 2006, J BIOL CHEM, V281, P25373, DOI 10.1074/jbc.M603998200; Liu B, 2006, PROTEINS, V65, P331, DOI 10.1002/prot.21111; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Muraoka-Cook RS, 2006, MOL BIOL CELL, V17, P4118, DOI 10.1091/mbc.E06-02-0101; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Pircher TJ, 1997, MOL CELL ENDOCRINOL, V133, P169, DOI 10.1016/S0303-7207(97)00164-0; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; TIMMS JF, 1995, BIOCHEM J, V308, P219, DOI 10.1042/bj3080219; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang Q, 2007, NAT MED, V13, P1341, DOI 10.1038/nm1659; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	49	51	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5582	5591		10.1074/jbc.M805438200	http://dx.doi.org/10.1074/jbc.M805438200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19098003	hybrid			2022-12-27	WOS:000263560600021
J	Darbellay, B; Arnaudeau, S; Konig, S; Jousset, H; Bader, C; Demaurex, N; Bernheim, L				Darbellay, Basile; Arnaudeau, Serge; Koenig, Stephane; Jousset, Helene; Bader, Charles; Demaurex, Nicolas; Bernheim, Laurent			STIM1-and Orai1-dependent Store-operated Calcium Entry Regulates Human Myoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNELS; PORE SUBUNIT; MICE LACKING; CRAC CHANNEL; K+ CURRENT; T-CELLS; HYPERPOLARIZATION; ACTIVATION; FUSION; SENSOR	Our previous work on human myoblasts suggested that a hyperpolarization followed by a rise in [Ca2(+)](in) involving store-operated Ca2+ entry (SOCE) channels induced myoblast differentiation. Advances in the understanding of the SOCE pathway led us to examine more precisely its role in post-natal human myoblast differentiation. We found that SOCE orchestrated by STIM1, the endoplasmic reticulum Ca2+ sensor activating Orai Ca2+ channels, is crucial. Silencing STIM1, Orai1, or Orai3 reduced SOCE amplitude and myoblast differentiation, whereas Orai2 knockdown had no effect. Conversely, overexpression of STIM1 with Orai1 increased SOCE and accelerated myoblast differentiation. STIM1 or Orai1 silencing decreased resting [Ca2+](in) and intracellular Ca2+ store content, but correction of these parameters did not rescue myoblast differentiation. Remarkably, SOCE amplitude correlated linearly with the expression of two early markers of myoblast differentiation, MEF2 and myogenin, regardless of the STIM1 or Orai isoform that was silenced. Unexpectedly, we found that the hyperpolarization also depends on SOCE, placing SOCE upstream of K+ channel activation in the signaling cascade that controls myoblast differentiation. These findings indicate that STIM1 and Orai1 are key molecules for the induction of human myoblast differentiation.	[Arnaudeau, Serge; Koenig, Stephane; Bernheim, Laurent] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland; [Darbellay, Basile; Bader, Charles] Univ Geneva, Fac Med, Dept Clin Neurosci, CH-1211 Geneva 4, Switzerland; [Arnaudeau, Serge; Jousset, Helene; Demaurex, Nicolas] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Geneva	Bernheim, L (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	laurent.bernheim@unige.ch	Darbellay, Basile/B-1708-2018	Demaurex, Nicolas/0000-0002-9933-6772; Koenig, Stephane/0000-0002-0801-279X	Fonds National Suisse pour la Recherche Scientifique [3100A0-105331, 3100A0-118393]; Fondation Suisse pour la Recherche sur les Maladies Musculaires; Association Francaise contre les Myopathies; Fondation Marcel Levaillant	Fonds National Suisse pour la Recherche Scientifique; Fondation Suisse pour la Recherche sur les Maladies Musculaires; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation Marcel Levaillant	This work was supported by Fonds National Suisse pour la Recherche Scientifique Grants 3100A0-105331 ( to L. B.) and 3100A0-118393 ( to N.D.), the Fondation Suisse pour la Recherche sur les Maladies Musculaires, the Association Francaise contre les Myopathies, and the Fondation Marcel Levaillant.	Arnaudeau S, 2006, J CELL PHYSIOL, V208, P435, DOI 10.1002/jcp.20679; Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; BAROFFIO A, 1993, MUSCLE NERVE, V16, P498, DOI 10.1002/mus.880160511; Bijlenga P, 1998, J PHYSIOL-LONDON, V512, P317, DOI 10.1111/j.1469-7793.1998.317be.x; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Demaurex N, 2005, CELL CALCIUM, V38, P213, DOI 10.1016/j.ceca.2005.06.026; Demaurex N, 2003, CELL CALCIUM, V34, P109, DOI 10.1016/S0143-4160(03)00081-2; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Espinos E, 2001, NEUROMUSCULAR DISORD, V11, P341, DOI 10.1016/S0960-8966(00)00204-2; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fischer-Lougheed J, 2001, J CELL BIOL, V153, P677, DOI 10.1083/jcb.153.4.677; Grosse J, 2007, J CLIN INVEST, V117, P3540, DOI 10.1172/JCI32312; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HAMANN M, 1994, J PHYSIOL-LONDON, V475, P305, DOI 10.1113/jphysiol.1994.sp020071; Hinard V, 2008, DEVELOPMENT, V135, P859, DOI 10.1242/dev.011387; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Konig S, 2004, J BIOL CHEM, V279, P28187, DOI 10.1074/jbc.M313932200; Konig S, 2006, DEVELOPMENT, V133, P3107, DOI 10.1242/dev.02479; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Liu JH, 1998, J PHYSIOL-LONDON, V510, P467, DOI 10.1111/j.1469-7793.1998.467bk.x; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2007, CELL CALCIUM, V42, P157, DOI 10.1016/j.ceca.2007.03.008; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	49	111	112	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5370	5380		10.1074/jbc.M806726200	http://dx.doi.org/10.1074/jbc.M806726200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19088073	hybrid			2022-12-27	WOS:000263416600067
J	Lauer, ME; Fulop, C; Mukhopadhyay, D; Comhair, S; Erzurum, SC; Hascall, VC				Lauer, Mark E.; Fulop, Csaba; Mukhopadhyay, Durba; Comhair, Suzy; Erzurum, Serpil C.; Hascall, Vincent C.			Airway Smooth Muscle Cells Synthesize Hyaluronan Cable Structures Independent of Inter-alpha-inhibitor Heavy Chain Attachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRYPSIN INHIBITOR; EXTRACELLULAR-MATRIX; LEUKOCYTE ADHESION; EPITHELIAL-CELLS; VIRUS-INFECTION; SHAP; COMPLEX; PROTEIN; SERUM	The covalent association of inter-alpha-inhibitor-derived heavy chains (HCs) with hyaluronan was first described in synovial fluid from arthritic patients and later described as a structural and functional component of hyaluronan "cable" structures produced by many different cells and stimuli. HC transfer has been shown to be mediated by the protein product of TSG-6 (tumor necrosis factor-stimulated gene 6). Considering the accumulation of hyaluronan in airways following asthmatic attacks and the subsequent infiltration of leukocytes, we sought to characterize HC substitution of hyaluronan "cables" in primary mouse airway smooth muscle cells (MASM) and primary human airway smooth muscle cells (HASM). We found that cells derived from mice lacking TSG-6 had no defect in hyaluronan production or hyaluronan-mediated leukocyte adhesion when treated with the viral mimic poly(I,C). Functional hyaluronan cables were induced by cycloheximide in the confirmed absence of protein synthesis, with or without simultaneous treatment with poly(I, C). We characterized the species specificity of the antibody other investigators used to describe the HC-hyaluronan complex of hyaluronan cables and found minimal affinity to bovine-derived HCs in contrast to HCs from mouse and human sera. Thus, we cultured MASM and HASM cells in serum from these three sources and analyzed hyaluronan extracts for HCs and other hyaluronan-binding proteins, using parallel cumulus cell-oocyte complex (COC) extracts as positive controls. We conclude that, if hyaluronan cables derived from MASM and HASM cells are substituted with HCs, the amount of substitution is significantly below the limit of detection when compared with COC extracts of similar hyaluronan mass.	[Lauer, Mark E.; Fulop, Csaba; Mukhopadhyay, Durba; Hascall, Vincent C.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Comhair, Suzy; Erzurum, Serpil C.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hascall, VC (corresponding author), Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA.	hascalv@ccf.org			National Institutes of Health [PO1 HL081064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 HL081064 ( Pathology of Asthma).	Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Cowman MK, 2005, CARBOHYD RES, V340, P791, DOI 10.1016/j.carres.2005.01.022; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DELAMOTTE CA, 2000, HYALURONAN 2000, P381; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fries E, 2003, ACTA BIOCHIM POL, V50, P735; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; HUANG L, 1993, J BIOL CHEM, V268, P26725; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Kida D, 1999, J RHEUMATOL, V26, P1230; Kishida T, 2008, CONNECT TISSUE RES, V49, P105, DOI 10.1080/03008200701818629; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Obayashi Y, 2008, ONCOL REP, V19, P1245; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2004, J AM SOC NEPHROL, V15, P1199, DOI 10.1097/01.ASN.0000125619.27422.8E; Shen L, 2006, HEPATOL RES, V34, P178, DOI 10.1016/j.hepres.2005.12.008; Shi T, 2006, MOL PHARMACOL, V70, P129, DOI 10.1124/mol.105.020735; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	30	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5313	5323		10.1074/jbc.M807979200	http://dx.doi.org/10.1074/jbc.M807979200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19075022	Green Published, hybrid			2022-12-27	WOS:000263416600061
J	Hirschler-Laszkiewicz, I; Tong, Q; Conrad, K; Zhang, WY; Flint, WW; Barber, AJ; Barber, DL; Cheung, JY; Miller, BA				Hirschler-Laszkiewicz, Iwona; Tong, Qin; Conrad, Kathleen; Zhang, Wenyi; Flint, Wesley W.; Barber, Alistair J.; Barber, Dwayne L.; Cheung, Joseph Y.; Miller, Barbara A.			TRPC3 Activation by Erythropoietin Is Modulated by TRPC6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ERYTHROID PRECURSORS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; CA2+-PERMEABLE CATION CHANNEL; MURINE ERYTHROLEUKEMIA-CELLS; FREE CALCIUM-CONCENTRATION; PLASMA-MEMBRANE; LIVING CELLS; FUNCTIONAL-CHARACTERIZATION; PHYSIOLOGICAL RELEVANCE; SIGNAL-TRANSDUCTION	Regulation of intracellular calcium ([Ca2+](i)) by erythropoietin (Epo) is an essential part of signaling pathways controlling proliferation and differentiation of erythroid progenitors, but regulatory mechanisms are largely unknown. TRPC3 and the homologous TRPC6 are two members of the transient receptor potential channel (TRPC) superfamily that are expressed on normal human erythroid precursors. Here we show that TRPC3 expression increases but TRPC6 decreases during erythroid differentiation. This is associated with a significantly greater increase in [Ca2+](i) in response to Epo stimulation, suggesting that the ratio of TRPC3/TRPC6 is physiologically important. In HEK 293T cells heterologously expressing TRPC and erythropoietin receptor (Epo-R), Epo stimulated an increase in [Ca2+](i) through TRPC3 but not TRPC6. Replacement of the C terminus of TRPC3 with the TRPC6 C terminus (TRPC3-C6C) resulted in loss of activation by Epo. In contrast, substitution of the C terminus of TRPC6 with that of TRPC3 (TRPC6-C3C) resulted in an increase in [Ca2+](i) in response to Epo. Substitution of the N termini had no effect. Domains in the TRPC3 C terminus between amino acids 671 and 746 are critical for the response to Epo. Epo-R and phospholipase C gamma associated with TRPC3, and these interactions were significantly reduced with TRPC6 and TRPC3-C6C chimeras. TRPC3 and TRPC6 form heterotetramers. Coexpression of TRPC6 or C3/C6 chimeras with TRPC3 and Epo-R inhibited the Epo-stimulated increase in [Ca2+](i). In a heterologous expression system, Epo stimulation increased cell surface expression of TRPC3, which was inhibited by TRPC6. However, in primary erythroblasts, an increase in TRPC3 cell surface expression was not observed in erythroblasts in which Epo stimulated an increase in [Ca2+](i), demonstrating that increased membrane insertion of TRPC3 is not required. These data demonstrate that TRPC6 regulates TRPC3 activation by Epo. Endogenously, regulation of TRPC3 by TRPC6 may primarily be through modulation of signaling mechanisms, including reduced interaction of TRPC6 with phospholipase C gamma and Epo-R.	[Miller, Barbara A.] Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, Coll Med, Hershey, PA 17033 USA; [Barber, Alistair J.] Penn State Univ, Dept Ophthalmol, Coll Med, Hershey, PA 17033 USA; [Miller, Barbara A.] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA; [Barber, Dwayne L.] Ontario Canc Inst, Div Stem Cells & Dev Biol, Toronto, ON M5G 2M9, Canada; [Cheung, Joseph Y.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Jefferson University	Miller, BA (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, Coll Med, POB 850, Hershey, PA 17033 USA.	bmiller3@psu.edu		Barber, Alistair/0000-0003-4235-2293; Barber, Dwayne/0000-0001-5528-8150	National Institutes of Health [R01 DK46778, R01 HL58672, R01 HL74854]; Four Diamonds Fund of the Pennsylvania State University College of Medicine; Canadian Institute for Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074854, R01HL058672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Four Diamonds Fund of the Pennsylvania State University College of Medicine; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK46778 (to B. A. M.) and R01 HL58672 and R01 HL74854 (to J.Y.C.). This work was also supported by the Four Diamonds Fund of the Pennsylvania State University College of Medicine and by the Canadian Institute for Health Research (to D. L. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bogoyevitch MA, 2004, CARDIOVASC RES, V63, P208, DOI 10.1016/j.cardiores.2004.03.017; Bony V, 1999, BRIT J HAEMATOL, V107, P263, DOI 10.1046/j.1365-2141.1999.01721.x; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Cheung JY, 1997, BLOOD, V89, P92, DOI 10.1182/blood.V89.1.92.92_92_100; CHEUNG JY, 1992, J CLIN INVEST, V90, P1850, DOI 10.1172/JCI116061; Chu X, 2004, J BIOL CHEM, V279, P10514, DOI 10.1074/jbc.M308478200; Chu X, 2002, J BIOL CHEM, V277, P34375, DOI 10.1074/jbc.M205541200; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Dietrich A, 2005, N-S ARCH PHARMACOL, V371, P257, DOI 10.1007/s00210-005-1052-8; Eder P., 2007, V179, P77; FRASER JK, 1989, EXP HEMATOL, V17, P10; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GILLO B, 1993, BLOOD, V81, P783; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Goel M, 2007, AM J PHYSIOL-RENAL, V293, pF1476, DOI 10.1152/ajprenal.00186.2007; Gomez CY, 2006, J VIROL, V80, P8796, DOI 10.1128/JVI.02159-05; Hasselblatt M, 2006, J NEUROSURG ANESTH, V18, P132, DOI 10.1097/00008506-200604000-00007; HENSOLD JO, 1991, BLOOD, V77, P1362; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang WC, 2007, CELL CALCIUM, V42, P1, DOI 10.1016/j.ceca.2006.11.002; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Kawasaki BT, 2006, P NATL ACAD SCI USA, V103, P335, DOI 10.1073/pnas.0508030102; KUREBAYASHI N, 1993, BIOPHYS J, V64, P1934, DOI 10.1016/S0006-3495(93)81564-9; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; LEVENSON R, 1980, P NATL ACAD SCI-BIOL, V77, P5948, DOI 10.1073/pnas.77.10.5948; Liu DY, 2007, J HYPERTENS, V25, P799, DOI 10.1097/HJH.0b013e32803cae2b; Manolis Antonis S., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P355, DOI 10.2174/156800605774370326; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; MASUDA S, 1993, J BIOL CHEM, V268, P11208; May KA, 2008, CANCER RES, V68, P4013, DOI 10.1158/0008-5472.CAN-07-3324; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; MILLER BA, 1989, BLOOD, V73, P1188; Miller BA, 1999, J BIOL CHEM, V274, P20465, DOI 10.1074/jbc.274.29.20465; MILLER BA, 1988, J CLIN INVEST, V82, P309, DOI 10.1172/JCI113588; Miller BA, 1996, J CLIN INVEST, V98, P1728, DOI 10.1172/JCI118971; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; MISITI J, 1979, J CLIN INVEST, V64, P1573, DOI 10.1172/JCI109618; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; Peppiatt-Wildman CM, 2007, J PHYSIOL-LONDON, V580, P755, DOI 10.1113/jphysiol.2006.126656; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Pope SH, 2000, EUR J HAEMATOL, V64, P292, DOI 10.1034/j.1600-0609.2000.90032.x; Reaves BJ, 2007, BIOCHEM SOC T, V35, P77, DOI 10.1042/BST0350077; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Rossert J, 2005, NEPHROL DIAL TRANSPL, V20, P1025, DOI 10.1093/ndt/gfh800; SAWYER ST, 1989, BLOOD, V74, P103; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tong Q, 2008, J BIOL CHEM, V283, P10385, DOI 10.1074/jbc.M710231200; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1232, DOI 10.1016/j.bbrc.2005.01.086; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Vazquez E, 2006, SEMIN CELL DEV BIOL, V17, P607, DOI 10.1016/j.semcdb.2006.11.004; Vazquez G, 2003, J BIOL CHEM, V278, P21649, DOI 10.1074/jbc.M302162200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; WAKAO H, 1995, EMBO J, V14, P2527, DOI 10.1002/j.1460-2075.1995.tb07250.x; Wu YM, 1997, AM J PHYSIOL-HEART C, V273, pH2161, DOI 10.1152/ajpheart.1997.273.5.H2161; YELAMARTY RV, 1990, J CLIN INVEST, V85, P1799, DOI 10.1172/JCI114638; Zhang MY, 1998, BLOOD, V92, P1225, DOI 10.1182/blood.V92.4.1225.416k20_1225_1234; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698	72	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4567	4581		10.1074/jbc.M804734200	http://dx.doi.org/10.1074/jbc.M804734200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074769	Green Published, hybrid			2022-12-27	WOS:000263134400057
J	Li, YL; Gao, XF; Chen, LL				Li, Yali; Gao, Xinfeng; Chen, Lingling			GroEL Recognizes an Amphipathic Helix and Binds to the Hydrophobic Side	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; 2.8 ANGSTROM RESOLUTION; CHAPERONIN GROEL; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; POLYPEPTIDE; COMPLEX; RHODANESE; IDENTIFICATION; CONFORMATIONS	GroEL is an essential Escherichia coli molecular chaperon that uses ATP to facilitate correct folding of a range of proteins in a cell. Central to the GroEL substrate diversity is how GroEL recognizes the substrates. The interaction between GroEL and substrate has been proposed to be largely hydrophobic because GroEL interacts with proteins in non-native conformations but not in native forms. Analysis of GroEL substrate proteins reveals that one of its main substrates are proteins with alpha beta folding domains, suggesting that GroEL may stabilize the collapsed alpha beta core by binding to hydrophobic surfaces that are usually buried between the alpha and beta elements. In this study, we characterize the interaction between GroEL and a peptide derived from our previous selection via a phage display method. NMR studies map the peptide-binding site to the region containing Helices H and I, which is consistent with evidence that this region comprises the primary substrate-binding site. The peptide is largely unstructured in solution but adopts a helical conformation when bound to the GroEL apical domain with a moderate affinity (K-d = 17.1 +/- 2.5 mu M). The helical conformation aligns residues to form an amphipathic structure, and the hydrophobic side of this amphipathic helix interacts with GroEL as suggested by fluorescence quenching studies. Together with previous structural studies on the GroEL-peptide complexes, our work supports the notion that the amphipathic secondary elements in the substrate proteins may be the structural motif recognized by GroEL.	[Li, Yali; Chen, Lingling] Indiana Univ, Interdisciplinary Biochem Program, Bloomington, IN 47405 USA; [Gao, Xinfeng] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Chen, Lingling] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Chen, LL (corresponding author), Indiana Univ, Dept Biol, 212 S Hawthorne Dr, Bloomington, IN 47405 USA.	linchen@indiana.edu	Chen, Ling-Ling/AAY-3547-2021		National Institutes of Health [GM065260-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065260-01A1 (to L. C.).	*ACC, 1996, DISC US GUID; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1995, NAT STRUCT BIOL, V2, P1083, DOI 10.1038/nsb1295-1083; Buckle AM, 1997, P NATL ACAD SCI USA, V94, P3571, DOI 10.1073/pnas.94.8.3571; CAMPBELL AP, 1993, ANNU REV BIOPH BIOM, V22, P99, DOI 10.1146/annurev.bb.22.060193.000531; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Goddard T.D., 2004, SPARKY 3; HAYERHARTL MK, 1994, EMBO J, V13, P3192, DOI 10.1002/j.1460-2075.1994.tb06618.x; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Horst R, 2007, P NATL ACAD SCI USA, V104, P20788, DOI 10.1073/pnas.0710042105; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Kobayashi N, 1999, J MOL BIOL, V292, P181, DOI 10.1006/jmbi.1999.3042; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LANDRY SJ, 1991, BIOCHEMISTRY-US, V30, P7359, DOI 10.1021/bi00244a001; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; LIPPENS G, 1995, J BIOMOL NMR, V5, P327, DOI 10.1007/BF00211762; Mande SC, 1996, SCIENCE, V271, P203, DOI 10.1126/science.271.5246.203; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MENDOZA JA, 1992, J BIOL CHEM, V267, P24648; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; PARDI A, 1984, J MOL BIOL, V180, P741, DOI 10.1016/0022-2836(84)90035-4; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Preuss M, 1999, BIOCHEMISTRY-US, V38, P10272, DOI 10.1021/bi990342l; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Thiyagarajan P, 1996, STRUCTURE, V4, P79, DOI 10.1016/S0969-2126(96)00011-1; Wang JM, 2003, J MOL BIOL, V334, P489, DOI 10.1016/j.jmb.2003.09.074; Wang ZL, 1999, BIOCHEMISTRY-US, V38, P12537, DOI 10.1021/bi991070p; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; ZAHN R, 1994, NATURE, V368, P261, DOI 10.1038/368261a0	43	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4324	4331		10.1074/jbc.M804818200	http://dx.doi.org/10.1074/jbc.M804818200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074438	hybrid, Green Published			2022-12-27	WOS:000263134400031
J	Xu, ZQ; Hurchla, MA; Deng, HJ; Uluckan, O; Bu, F; Berdy, A; Eagleton, MC; Heller, EA; Floyd, DH; Dirksen, WP; Shu, S; Tanaka, Y; Fernandez, SA; Rosol, TJ; Weilbaecher, KN				Xu, Zhiqiang; Hurchla, Michelle A.; Deng, Hongju; Uluckan, Oezge; Bu, Fang; Berdy, Andrew; Eagleton, Mark C.; Heller, Emanuela A.; Floyd, Desiree H.; Dirksen, Wessel P.; Shu, Sherry; Tanaka, Yuetsu; Fernandez, Soledad A.; Rosol, Thomas J.; Weilbaecher, Katherine N.			Interferon-gamma Targets Cancer Cells and Osteoclasts to Prevent Tumor-associated Bone Loss and Bone Metastases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; VIRUS TYPE-I; IFN-GAMMA; CARCINOMA-CELLS; INHIBITS GROWTH; DEFICIENT MICE; INDUCTION; APOPTOSIS; ACTIVATION; EXPRESSION	Interferon-gamma (IFN-gamma) has been shown to enhance anti-tumor immunity and inhibit the formation of bone-resorbing osteoclasts. We evaluated the role of IFN-gamma in bone metastases, tumor-associated bone destruction, and hypercalcemia in human T cell lymphotrophic virus type 1-Tax transgenic mice. Compared with Tax(+)IFN-gamma(+/+) mice, Tax(+)IFN-gamma(-/-) mice developed increased osteolytic bone lesions and soft tissue tumors, as well as increased osteoclast formation and activity. In vivo administration of IFN-gamma to tumor-bearing Tax(+)IFN-gamma(-/-) mice prevented new tumor development and resulted in decreased bromodeoxyuridine uptake by established tumors. Invitro, IFN-gamma directly decreased the viability of Tax(+) tumor cells through inhibition of proliferation, suppression of ERK phosphorylation, and induction of apoptosis and caspase 3 cleavage. IFN-gamma also inhibited macrophage colony-stimulating factor-mediated proliferation and survival of osteoclast progenitors in vitro. Administration of IFN-gamma to C57BL/6 mice decreased Tax(+) tumor growth and prevented tumor-associated bone loss and hypercalcemia. In contrast, IFN-gamma treatment failed to protect IFN-gamma R1(-/-) mice from Tax(+) tumor-induced skeletal complications, despite decreasing tumor growth. These data demonstrate that IFN-gamma suppressed tumor-induced bone loss and hypercalcemia in Tax(+) mice by inhibiting both Tax(+) tumor cell growth and host-induced osteolysis. These data suggest a protective role for IFN-gamma in patients with bone metastases and hypercalcemia of malignancy.	[Xu, Zhiqiang; Hurchla, Michelle A.; Deng, Hongju; Uluckan, Oezge; Bu, Fang; Berdy, Andrew; Eagleton, Mark C.; Heller, Emanuela A.; Floyd, Desiree H.; Weilbaecher, Katherine N.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Dirksen, Wessel P.; Shu, Sherry; Rosol, Thomas J.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Tanaka, Yuetsu] Univ Ryukyus, Dept Immunol, Grad Sch, Okinawa 9030213, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Fac Med, Okinawa 9030213, Japan; [Fernandez, Soledad A.] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	Washington University (WUSTL); University System of Ohio; Ohio State University; University of the Ryukyus; University of the Ryukyus; University System of Ohio; Ohio State University	Weilbaecher, KN (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, 660 S Euclid Ave,Campus Box 8069, St Louis, MO 63110 USA.	kweilbae@dom.wustl.edu	Uluckan, Ozge/H-6912-2015; Rosol, Thomas/G-9585-2011	Uluckan, Ozge/0000-0001-9468-1211; Rosol, Thomas/0000-0003-3737-1190	National Institutes of Health [CA100730, R01 CA 097250, T32 CA09547, RO1 CA100730]; St. Louis Men's Club Against Cancer; NATIONAL CANCER INSTITUTE [P01CA100730, R01CA097250, P50CA094056, T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Louis Men's Club Against Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants PPG CA100730 and R01 CA 097250 (to Z. X., M. H., H. D., M. C. E., D. H. F., E. A. H., and K. N. W.), Grant T32 CA09547 (cancer biology training grant to O. U. and M. H.), and Grant RO1 CA100730 (to T. J. R. and W. P. D. and NCRR to S. S.), as well as by the St. Louis Men's Club Against Cancer (to K. N. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bakewell SJ, 2003, P NATL ACAD SCI USA, V100, P14205, DOI 10.1073/pnas.2234372100; Chu CQ, 2003, ANN RHEUM DIS, V62, P983, DOI 10.1136/ard.62.10.983; COCHRAN AJ, 1989, ANTICANCER RES, V9, P859; De Klerck B, 2004, ARTHRITIS RES THER, V6, pR220, DOI 10.1186/ar1167; Detjen KM, 2002, INT J ONCOL, V21, P1133; Detjen KM, 2001, GUT, V49, P251, DOI 10.1136/gut.49.2.251; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2005, CANCER RES, V65, P3447, DOI 10.1158/0008-5472.CAN-04-4316; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; Fox SW, 2000, BIOCHEM BIOPH RES CO, V276, P868, DOI 10.1006/bbrc.2000.3577; Gao L, 2005, BLOOD, V106, P4294, DOI 10.1182/blood-2005-04-1730; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Hirbe AC, 2007, P NATL ACAD SCI USA, V104, P14062, DOI 10.1073/pnas.0705203104; Hirbe AC, 2007, BLOOD, V109, P3424, DOI 10.1182/blood-2006-09-048686; HOCHMAN N, 1991, CELL IMMUNOL, V137, P14, DOI 10.1016/0008-8749(91)90052-D; Huang W, 2003, ARTHRITIS RES THER, V5, pR49, DOI 10.1186/ar612; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Kakuta S, 2002, IMMUNOLOGY, V105, P92, DOI 10.1046/j.0019-2805.2001.01342.x; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; KEY LL, 1995, NEW ENGL J MED, V332, P1594, DOI 10.1056/NEJM199506153322402; Kim EJ, 2002, J CELL BIOCHEM, V85, P369, DOI 10.1002/jcb.10142; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Lee KY, 2008, ONCOGENE, V27, P5267, DOI 10.1038/onc.2008.147; Madyastha PR, 2000, J INTERF CYTOK RES, V20, P645, DOI 10.1089/107999000414826; Merchant MS, 2007, CANCER IMMUNOL IMMUN, V56, P1037, DOI 10.1007/s00262-006-0257-0; Mitra-Kaushik S, 2004, BLOOD, V104, P3305, DOI 10.1182/blood-2004-01-0266; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Natasha T, 2006, AM J PATHOL, V168, P551, DOI 10.2353/ajpath.2006.050480; TAKAHASHI N, 1986, J CLIN INVEST, V78, P894, DOI 10.1172/JCI112677; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; TANAKA Y, 1990, JPN J CANCER RES, V81, P225, DOI 10.1111/j.1349-7006.1990.tb02554.x; Tannir N, 2006, CANCER-AM CANCER SOC, V107, P497, DOI 10.1002/cncr.22038; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Tintut Y, 2002, J BIOL CHEM, V277, P14221, DOI 10.1074/jbc.M111551200; Toh ML, 2007, CURR OPIN RHEUMATOL, V19, P284, DOI 10.1097/BOR.0b013e32805e87e0; Tomita M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-22; Vermeire K, 1997, J IMMUNOL, V158, P5507; Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844; Weissglas M, 2007, BJU INT, V99, P1530, DOI 10.1111/j.1464-410X.2007.06862.x; Xaus J, 1999, IMMUNITY, V11, P103, DOI 10.1016/S1074-7613(00)80085-0; Zhao HB, 2005, J BONE MINER RES, V20, P2116, DOI 10.1359/JBMR.050724; ZHU L, 2006, J IMMUNOL, V177, P8844	44	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4658	4666		10.1074/jbc.M804812200	http://dx.doi.org/10.1074/jbc.M804812200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19059914	hybrid, Green Published			2022-12-27	WOS:000263134400065
J	Zhao, J; Shigaki, T; Mei, H; Guo, YQ; Cheng, NH; Hirschi, KD				Zhao, Jian; Shigaki, Toshiro; Mei, Hui; Guo, Ying-qing; Cheng, Ning-Hui; Hirschi, Kendal D.			Interaction between Arabidopsis Ca2(+)/H+ Exchangers CAX1 and CAX3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CA2+/H+ ANTIPORTER; H+/CA2+ ANTIPORTER; ION HOMEOSTASIS; SALT TOLERANCE; CROSS-TALK; TRANSPORT; YEAST; EXPRESSION; IDENTIFICATION	In plants, high capacity tonoplast cation/H+ antiport is mediated in part by a family of CAX (cation exchanger) transporters. Functional association between CAX1 and CAX3 has previously been inferred; however, the nature of this interaction has not been established. Here we analyze the formation of "hetero-CAX" complexes and their transport properties. Co-expressing both CAX1 and CAX3 mediated lithium and salt tolerance in yeast, and these phenotypes could not be recapitulated by expression of deregulated versions of either transporter. Coincident expression of Arabidopsis CAX1 and CAX3 occurs during particular stress responses, flowering, and seedling growth. Analysis of cax1, cax3, and cax1/3 seedlings demonstrated similar stress sensitivities. When plants expressed high levels of both CAXs, alterations in transport properties were evident that could not be recapitulated by high level expression of either transporter individually. In planta coimmunoprecipitation suggested that a protein-protein interaction occurred between CAX1 and CAX3. In vivo interaction between the CAX proteins was shown using a split ubiquitin yeast two-hybrid system and gel shift assays. These findings demonstrate cation exchange plasticity through hetero-CAX interactions.	[Zhao, Jian; Shigaki, Toshiro; Guo, Ying-qing; Cheng, Ning-Hui; Hirschi, Kendal D.] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Mei, Hui; Hirschi, Kendal D.] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, College Stn, TX 77845 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station	Hirschi, KD (corresponding author), Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, 1100 Bates St,Suite 9018,Campus Mail Stop BCM 320, Houston, TX 77030 USA.	kendalh@bcm.edu	Zhao, Jian/Q-8591-2019; hirschi, kendal/GNP-0351-2022	Zhao, Jian/0000-0002-4416-7334; Guo, Yingqing/0000-0002-9527-6119	United States Department of Agriculture/Agricultural Research Service [58-6250-6001]; National Science Foundation [90344350]; United States Department of Agriculture [2005-34402-17121]	United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture/Agricultural Research Service under Cooperative Agreement 58-6250-6001, National Science Foundation Grant 90344350, and United States Department of Agriculture Grant 2005-34402-17121, Designing Foods for Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Catala R, 2003, PLANT CELL, V15, P2940, DOI 10.1105/tpc.015248; Cheng NH, 2005, PLANT PHYSIOL, V138, P2048, DOI 10.1104/pp.105.061218; Cheng NH, 2003, PLANT CELL, V15, P347, DOI 10.1105/tpc.007385; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; Hirschi KD, 2004, PLANT PHYSIOL, V136, P2438, DOI 10.1104/pp.104.046490; Hirschi KD, 1999, PLANT CELL, V11, P2113, DOI 10.1105/tpc.11.11.2113; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Liang F, 1997, P NATL ACAD SCI USA, V94, P8579, DOI 10.1073/pnas.94.16.8579; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Luo GZ, 2005, PLANT MOL BIOL, V59, P809, DOI 10.1007/s11103-005-1386-0; Marini AM, 2000, MOL MICROBIOL, V35, P378, DOI 10.1046/j.1365-2958.2000.01704.x; Marty F, 1999, PLANT CELL, V11, P587, DOI 10.1105/tpc.11.4.587; Mei H, 2007, J EXP BOT, V58, P3419, DOI 10.1093/jxb/erm190; Mitsui K, 2005, BBA-BIOMEMBRANES, V1720, P125, DOI 10.1016/j.bbamem.2005.11.005; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Reinders A, 2002, PLANT CELL, V14, P1567, DOI 10.1105/tpc.002428; RODRIGUEZNAVARRO A, 1984, J BACTERIOL, V159, P940; Ros R, 1998, J BACTERIOL, V180, P3131, DOI 10.1128/JB.180.12.3131-3136.1998; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schulz B, 2004, SCIENCE, V306, P622, DOI 10.1126/science.1105227; SCHUMAKER KS, 1986, J BIOL CHEM, V261, P2172; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shigaki T, 2006, PLANT BIOLOGY, V8, P419, DOI 10.1055/s-2006-923950; Shigaki T, 2005, J BIOL CHEM, V280, P30136, DOI 10.1074/jbc.M503610200; Shigaki T, 2001, J BIOL CHEM, V276, P43152, DOI 10.1074/jbc.M106637200; Shigaki T, 2000, GENE, V257, P291, DOI 10.1016/S0378-1119(00)00390-5; Suga S, 2004, PLANT CELL PHYSIOL, V45, P823, DOI 10.1093/pcp/pch120; Sze H, 2000, ANNU REV PLANT PHYS, V51, P433, DOI 10.1146/annurev.arplant.51.1.433; Ueoka-Nakanishi H, 2000, EUR J BIOCHEM, V267, P3090, DOI 10.1046/j.1432-1033.2000.01343.x; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; WARD JM, 1992, PLANT PHYSIOL, V99, P161, DOI 10.1104/pp.99.1.161; Zhao J, 2008, PLANTA, V227, P659, DOI 10.1007/s00425-007-0648-2; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	48	44	48	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4605	4615		10.1074/jbc.M804462200	http://dx.doi.org/10.1074/jbc.M804462200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098009	hybrid			2022-12-27	WOS:000263134400060
J	Ansorge, HL; Meng, XM; Zhang, GY; Veit, G; Sun, M; Klement, JF; Beason, DP; Soslowsky, LJ; Koch, M; Birk, DE				Ansorge, Heather L.; Meng, Xianmin; Zhang, Guiyun; Veit, Guido; Sun, Mei; Klement, John F.; Beason, David P.; Soslowsky, Louis J.; Koch, Manuel; Birk, David E.			Type XIV Collagen Regulates Fibrillogenesis PREMATURE COLLAGEN FIBRIL GROWTH AND TISSUE DYSFUNCTION IN NULL MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-6 KNOCKOUT MICE; FETAL BOVINE SKIN; DIFFERENTIAL EXPRESSION; MECHANICAL-PROPERTIES; CONNECTIVE TISSUES; MESSENGER-RNA; TENDON; LUMICAN; MODEL; DECORIN	Type XIV collagen is a fibril-associated collagen with an interrupted triple helix. This collagen interacts with the fibril surface and has been implicated as a regulator of fibrillogenesis; however, a specific role has not been elucidated. Functional roles for type XIV collagen were defined utilizing a new type XIV collagen-deficient mouse line. This line was produced using a conventional targeted knock-out approach. Col14a1(-/-) mice were devoid of type XIV collagen, whereas heterozygous mice had reduced synthesis. Both mutant Col14a1 genotypes were viable with a grossly normal phenotype; however, mature skin exhibited altered mechanical properties. Prior to evaluating tendon fibrillogenesis in type XIV collagen-deficient mice, the developmental expression patterns were analyzed in wild-type flexor digitorum longus (FDL) tendons. Analyses of mRNA and protein expression indicated tissue-specific temporal expression that was associated with the early stages in fibrillogenesis. Ultrastructural analyses of wild-type and null tendons demonstrated premature fibril growth and larger fibril diameters in tendons from null mice at postnatal day 4 (P4). However, fibril structure in mature tendons was normal. Biomechanical studies established a direct structure/function relationship with reduced strength in P7-null tendons. However, the biomechanical properties in P60 tendons were comparable in null and wild-type mice. Our results indicate a regulatory function for type XIV collagen in early stages of collagen fibrillogenesis with tissue differences.	[Sun, Mei; Birk, David E.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Ansorge, Heather L.; Beason, David P.; Soslowsky, Louis J.] Univ Penn, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA; [Meng, Xianmin; Zhang, Guiyun] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA; [Meng, Xianmin; Zhang, Guiyun] Thomas Jefferson Univ, Dept Anat & Cell Biol, Philadelphia, PA 19107 USA; [Klement, John F.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Veit, Guido; Koch, Manuel] Univ Cologne, Fac Med, Ctr Biochem, D-50923 Cologne, Germany; [Koch, Manuel] Univ Cologne, Fac Med, Dept Dermatol, D-50923 Cologne, Germany; [Koch, Manuel] Univ Cologne, Fac Med, Ctr Mol Med Cologne, D-50923 Cologne, Germany	State University System of Florida; University of South Florida; University of Pennsylvania; Jefferson University; Jefferson University; Jefferson University; University of Cologne; University of Cologne; University of Cologne	Birk, DE (corresponding author), Univ S Florida, Coll Med, Dept Pathol & Cell Biol, 12901 Bruce B Downs Blvd,MDC11, Tampa, FL 33612 USA.	dbirk@health.usf.edu	Koch, Manuel/AAG-9914-2021; Veit, Guido/C-9596-2009; Birk, David/I-4072-2012	Koch, Manuel/0000-0002-2962-7814; Veit, Guido/0000-0002-6758-2696; Birk, David/0000-0002-4865-9088	National Institutes of Health [AR044745]; NEI [EY05129]; NIAMS [AR050950]; NATIONAL EYE INSTITUTE [R01EY005129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950, R01AR044745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR044745 from NIAMS, Grant EY05129 from NEI, and Grant AR050950 from NIAMS, supporting the Penn Center for Musculoskeletal Disorders. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berthod F, 1997, J INVEST DERMATOL, V108, P737, DOI 10.1111/1523-1747.ep12292122; Birk DE, 2005, TOP CURR CHEM, V247, P185, DOI 10.1007/b103823; BIRK DE, 1995, DEV DYNAM, V202, P229, DOI 10.1002/aja.1002020303; Birk DE, 1997, EUR J CELL BIOL, V72, P352; BIRK DE, 1986, J CELL BIOL, V103, P231, DOI 10.1083/jcb.103.1.231; BROWN JC, 1993, J CELL BIOL, V120, P557, DOI 10.1083/jcb.120.2.557; CASTAGNOLA P, 1992, EUR J CELL BIOL, V59, P340; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Christner PJ, 2006, J INVEST DERMATOL, V126, P595, DOI 10.1038/sj.jid.5700100; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DERWIN KA, 1994, J BIOMECH, V27, P1277, DOI 10.1016/0021-9290(94)90281-X; Derwin KA, 1999, J BIOMECH ENG-T ASME, V121, P598, DOI 10.1115/1.2800859; DUBLET B, 1991, J BIOL CHEM, V266, P6853; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Favata M, 2006, SCARLESS HEALING FET; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Gerecke DR, 2004, MATRIX BIOL, V22, P593, DOI 10.1016/j.matbio.2003.11.004; Goh KL, 2005, BBA-GEN SUBJECTS, V1722, P183, DOI 10.1016/j.bbagen.2004.12.004; Gordon MK, 1990, CURR OPIN CELL BIOL, V2, P833, DOI 10.1016/0955-0674(90)90080-X; Gordon MK, 1996, DEV DYNAM, V206, P49, DOI 10.1002/(SICI)1097-0177(199605)206:1<49::AID-AJA5>3.3.CO;2-T; Grant ME, 2002, COLLAGEN FAMILY STRU, P159, DOI DOI 10.1002/0471221929.CH2; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; KEENE DR, 1991, J CELL BIOL, V113, P971, DOI 10.1083/jcb.113.4.971; KOCH M, 1995, J CELL BIOL, V130, P1005, DOI 10.1083/jcb.130.4.1005; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; LETHIAS C, 1993, J INVEST DERMATOL, V101, P92, DOI 10.1111/1523-1747.ep12360433; Lin TW, 2006, J BIOMECH, V39, P61, DOI 10.1016/j.jbiomech.2004.11.009; Lin TW, 2005, J BIOMECH, V38, P99, DOI 10.1016/j.jbiomech.2004.03.008; LUNSTRUM GP, 1991, J CELL BIOL, V113, P963, DOI 10.1083/jcb.113.4.963; Meng XM, 2003, J INVEST DERMATOL, V121, P720, DOI 10.1046/j.1523-1747.2003.12515.x; NISHIYAMA T, 1994, J BIOL CHEM, V269, P28193; Niyibizi C, 1995, MATRIX BIOL, V14, P743, DOI 10.1016/S0945-053X(05)80017-4; Nurminskaya MV, 1998, ARCH BIOCHEM BIOPHYS, V350, P1, DOI 10.1006/abbi.1997.0498; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; Robinson PS, 2004, ANN BIOMED ENG, V32, P924, DOI 10.1023/B:ABME.0000032455.78459.56; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; Veit G, 2006, J BIOL CHEM, V281, P27461, DOI 10.1074/jbc.M603147200; WALCHLI C, 1994, J CELL SCI, V107, P669; WALCHLI C, 1993, EUR J BIOCHEM, V212, P483, DOI 10.1111/j.1432-1033.1993.tb17685.x; Young BB, 2000, DEV DYNAM, V217, P430, DOI 10.1002/(SICI)1097-0177(200004)217:4<430::AID-DVDY10>3.0.CO;2-5; Young BB, 2002, J CELL BIOCHEM, V87, P208, DOI 10.1002/jcb.10290; Zhang CM, 2005, CHINESE J ASTRON AST, V5, P21, DOI 10.1088/1009-9271/5/S1/21; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang GY, 2003, J ANAT, V202, P411, DOI 10.1046/j.1469-7580.2003.00174.x	48	116	121	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8427	8438		10.1074/jbc.M805582200	http://dx.doi.org/10.1074/jbc.M805582200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19136672	Green Published, hybrid			2022-12-27	WOS:000264397800027
J	Carrithers, MD; Chatterjee, G; Carrithers, LM; Offoha, R; Iheagwara, U; Rahner, C; Graham, M; Waxman, SG				Carrithers, Michael D.; Chatterjee, Gouri; Carrithers, Lisette M.; Offoha, Roosevelt; Iheagwara, Uzoma; Rahner, Christoph; Graham, Morven; Waxman, Stephen G.			Regulation of Podosome Formation in Macrophages by a Splice Variant of the Sodium Channel SCN8A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS; CALCIUM; RELEASE; COMPLEX; DYNAMIN; PROTEIN; PROTRUSIONS; EXPRESSION; PHENYTOIN; MIGRATION	Voltage-gated sodium channels initiate electrical signaling in excitable cells such as muscle and neurons. They also are expressed in non-excitable cells such as macrophages and neoplastic cells. Previously, in macrophages, we demonstrated expression of SCN8A, the gene that encodes the channel NaV1.6, and intracellular localization of NaV1.6 to regions near F-actin bundles, particularly at areas of cell attachment. Here we show that a splice variant of NaV1.6 regulates cellular invasion through its effects on podosome and invadopodia formation in macrophages and melanoma cells. cDNA sequence analysis of SCN8A from THP-1 cells, a human monocyte-macrophage cell line, confirmed the expression of a full-length splice variant that lacks exon 18. Immunoelectron microscopy demonstrated NaV1.6-positive staining within the electron dense podosome rosette structure. Pharmacologic antagonism with tetrodotoxin (TTX) in differentiated THP-1 cells or absence of functional NaV1.6 through a naturally occurring mutation (med) in mouse peritoneal macrophages inhibited podosome formation. Agonist-mediated activation of the channel with veratridine caused release of sodium from cationic vesicular compartments, uptake by mitochondria, and mitochondrial calcium release through the Na/Ca exchanger. Invasion by differentiated THP-1 and HTB-66 cells, an invasive melanoma cell line, through extracellular matrix was inhibited by TTX. THP-1 invasion also was inhibited by small hairpin RNA knockdown of SCN8A. These results demonstrate that a variant of NaV1.6 participates in the control of podosome and invadopodia formation and suggest that intracellular sodium release mediated by NaV1.6 may regulate cellular invasion of macrophages and melanoma cells.	[Carrithers, Michael D.; Chatterjee, Gouri; Carrithers, Lisette M.; Offoha, Roosevelt; Iheagwara, Uzoma; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Rahner, Christoph; Graham, Morven] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell Biol, Madison, WI 53792 USA; [Carrithers, Michael D.] Univ Wisconsin, Sch Med & Publ Hlth, Program Human & Translat Immunol, Madison, WI 53792 USA; [Waxman, Stephen G.] Vet Adm Connecticut Healthcare, Ctr Neurosci & Neuroregenerat Res, Hamden, CT 06518 USA	Yale University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carrithers, MD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, 600 N Highland Ave, Madison, WI 53792 USA.	carrithers@neurology.wisc.edu	Waxman, Stephen/Z-2507-2019	Waxman, Stephen/0000-0001-5718-7177	National Institutes of Health; National Multiple Sclerosis Society; Nancy Davis Foundation; Dana Foundation award in Clinical Hypotheses in Neuroimmunology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS047457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Nancy Davis Foundation; Dana Foundation award in Clinical Hypotheses in Neuroimmunology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institutes of Health. This work was also supported by the National Multiple Sclerosis Society, the Nancy Davis Foundation, and a Dana Foundation award in Clinical Hypotheses in Neuroimmunology (to M. D. C.).	BAKER PF, 1971, J PHYSIOL-LONDON, V218, P709, DOI 10.1113/jphysiol.1971.sp009641; Bechtold DA, 2004, ANN NEUROL, V55, P607, DOI 10.1002/ana.20045; Black JA, 2007, ANN NEUROL, V62, P21, DOI 10.1002/ana.21172; Blumenstein Y, 2004, J PHYSIOL-LONDON, V556, P121, DOI 10.1113/jphysiol.2003.056168; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; Craner MJ, 2005, GLIA, V49, P220, DOI 10.1002/glia.20112; Evans JG, 2006, EUR J CELL BIOL, V85, P145, DOI 10.1016/j.ejcb.2005.08.006; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; Fraser SP, 2003, J CELL PHYSIOL, V195, P479, DOI 10.1002/jcp.10312; GAVAZZI I, 1989, J CELL SCI, V94, P85; Ghersi G, 2006, CANCER RES, V66, P4652, DOI 10.1158/0008-5472.CAN-05-1245; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; LEBLANC N, 1990, SCIENCE, V248, P372, DOI 10.1126/science.2158146; Lo AC, 2003, J NEUROPHYSIOL, V90, P3566, DOI 10.1152/jn.00434.2003; LOWE DA, 1976, NATURE, V260, P337, DOI 10.1038/260337a0; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; MIYAUCHI A, 1990, J CELL BIOL, V111, P2543, DOI 10.1083/jcb.111.6.2543; Nikolaeva MA, 2005, J NEUROSCI, V25, P9960, DOI 10.1523/JNEUROSCI.2003-05.2005; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Oh Y, 1998, NEUROREPORT, V9, P1267, DOI 10.1097/00001756-199805110-00002; Plummer NW, 1997, J BIOL CHEM, V272, P24008, DOI 10.1074/jbc.272.38.24008; Smith KJ, 2007, BRAIN PATHOL, V17, P230, DOI 10.1111/j.1750-3639.2007.00066.x; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Tsuboi S, 2007, J IMMUNOL, V178, P2987, DOI 10.4049/jimmunol.178.5.2987; Waxman SG, 2008, NAT CLIN PRACT NEURO, V4, P159, DOI 10.1038/ncpneuro0735; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823	34	87	96	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8114	8126		10.1074/jbc.M801892200	http://dx.doi.org/10.1074/jbc.M801892200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19136557	hybrid, Green Published			2022-12-27	WOS:000264195600074
J	Burgess, STG; Shen, C; Ferguson, LA; O'Neill, GT; Docherty, K; Hunter, N; Goldmann, W				Burgess, Stewart T. G.; Shen, Cuicui; Ferguson, Laura A.; O'Neill, Gerard T.; Docherty, Kevin; Hunter, Nora; Goldmann, Wilfred			Identification of Adjacent Binding Sites for the YY1 and E4BP4 Transcription Factors in the Ovine PrP (Prion) Gene Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN GENE; MESSENGER-RNA; EXPRESSION; POLYMORPHISMS; ACCUMULATION; ACTIVATION; REGULATOR; SURVIVAL; ELEMENT	The PrP gene encodes the cellular isoform of the prion protein (PrPc) which has been shown to be crucial to the development of transmissible spongiform encephalopathies (TSEs). PrP knock-out mice, which do not express endogenous PrPc, exhibit resistance to TSE disease. The regulation of PrP gene expression represents, therefore, a crucial factor in the development of TSEs. Two sequence motifs in the PrP promoter (positions -287 to -263 from transcriptional start) were previously reported as being highly conserved, and it was suggested that they represent binding sites for as yet unidentified transcription factors. To test this hypothesis, binding of nuclear proteins was analyzed by electrophoretic mobility shift assays using ovine or murine cells and tissues with radiolabeled DNA probes containing the conserved motif sequences. Specific binding was observed to both motifs, and polymorphic variants of these motifs exhibited differential binding. Two proteins bound to these motifs were identified as the Yin Yang 1 (YY1) (motif 1) and E4BP4 (motif 2) transcription factors. Functional promoter analysis of four different promoter variants revealed that motif 1 (YY1) was associated with inhibitory activity in the context of the PrP promoter, whereas motif 2 (E4BP4) was linked to a slight enhancing activity. This represents the first demonstration of binding of nuclear factors to two highly conserved DNA sequence motifs within mammalian PrP promoters. The action of these factors on the PrP promoter is haplotype-specific, leading us to propose that the prion protein expression pattern and, with it, the distribution of TSE infectivity may be associated with PrP promoter genotype.	[Burgess, Stewart T. G.; Shen, Cuicui; O'Neill, Gerard T.; Hunter, Nora; Goldmann, Wilfred] Univ Edinburgh, Neuropathogenesis Div, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Ferguson, Laura A.; Docherty, Kevin] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Shen, Cuicui] China Agr Univ, Coll Vet Med, Natl Inst Anim TSEs, Beijing 100094, Peoples R China; [Burgess, Stewart T. G.; Shen, Cuicui; O'Neill, Gerard T.; Hunter, Nora; Goldmann, Wilfred] Univ Edinburgh, Neuropathogenesis Div, RDSVS, Roslin EH25 9PS, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Aberdeen; China Agricultural University; University of Edinburgh	Goldmann, W (corresponding author), Univ Edinburgh, Neuropathogenesis Div, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland.	wilfred.goldmann@roslin.ed.ac.uk		Docherty, Kevin/0000-0001-6765-2060; burgess, stewart/0000-0002-9268-7641	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [00A1D06533, CPA1741]; BBSRC [BBS/E/D/05241340, BBS/E/A/00001651] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/A/00001651, BBS/E/D/05241340] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) Grant 00A1D06533, Roslin ISPG Programme 3 "The Biology of Neurodegenerative Disease," and BBSRC China Partnering Award CPA1741.	Baier M, 2008, INT J DEV NEUROSCI, V26, P821, DOI 10.1016/j.ijdevneu.2008.07.001; Cagampang FRA, 1999, NEUROSCIENCE, V91, P1201, DOI 10.1016/S0306-4522(99)00092-5; Cowell IG, 2002, BIOESSAYS, V24, P1023, DOI 10.1002/bies.10176; Dupre SM, 2008, ENDOCRINOLOGY, V149, P5527, DOI 10.1210/en.2008-0834; Dyer KD, 2001, LIFE SCI, V69, P201, DOI 10.1016/S0024-3205(01)01104-3; Ericsson J, 1999, J BIOL CHEM, V274, P14508, DOI 10.1074/jbc.274.20.14508; Freshney RI., 1987, CULTURE ANIMAL CELLS; GAMBETTI P, 1993, BRIT MED BULL, V49, P980, DOI 10.1093/oxfordjournals.bmb.a072657; Haigh CL, 2007, J MOL BIOL, V368, P915, DOI 10.1016/j.jmb.2007.02.086; Hu W, 2007, ACTA NEUROL SCAND, V116, P75, DOI 10.1111/j.1600-0404.2007.00868.x; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; Inoue S, 1997, J VET MED SCI, V59, P175, DOI 10.1292/jvms.59.175; Jamieson E, 2001, NEUROREPORT, V12, P3567, DOI 10.1097/00001756-200111160-00039; Johansson E, 1998, J BIOL CHEM, V273, P29816, DOI 10.1074/jbc.273.45.29816; JOHN HA, 1994, HUM GENE THER, V5, P283, DOI 10.1089/hum.1994.5.3-283; Johnson RT, 2005, LANCET NEUROL, V4, P635, DOI 10.1016/S1474-4422(05)70192-7; Kretzschmar HA, 1997, J NEURAL TRANSM-SUPP, P191; MANSON JC, 1994, NEURODEGENERATION, V3, P331; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; MCKNIGHT SL, 1991, SCI AM, V264, P54, DOI 10.1038/scientificamerican0491-54; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Montagna P, 2005, SLEEP MED REV, V9, P339, DOI 10.1016/j.smrv.2005.02.001; Nishimura Y, 2001, J BIOL CHEM, V276, P19921, DOI 10.1074/jbc.M010332200; NOVAK K, 2006, J NEUROCHEM, V96, P1696; O'Neill GT, 2005, J ANIM BREED GENET, V122, P86, DOI 10.1111/j.1439-0388.2005.00520.x; O'Neill GT, 2003, J ANIM BREED GENET, V120, P114, DOI 10.1046/j.1439-0388.2003.00381.x; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Premzl M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-1; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Romey MC, 2000, J BIOL CHEM, V275, P3561, DOI 10.1074/jbc.275.5.3561; Saeki K, 1996, BIOCHEM BIOPH RES CO, V219, P47, DOI 10.1006/bbrc.1996.0179; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Schneider K, 2007, J ENDODONT, V33, P110, DOI 10.1016/j.joen.2006.11.010; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; WEISSMANN C, 2003, BRIT MED B SERIES EX, P321; WESTAWAY D, 1994, P NATL ACAD SCI USA, V91, P6418, DOI 10.1073/pnas.91.14.6418; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yu YL, 2002, J BIOL CHEM, V277, P27144, DOI 10.1074/jbc.M200924200; Zambrano N, 1997, BIOCHEM J, V328, P293, DOI 10.1042/bj3280293; Zomosa-Signoret V, 2008, VET RES, V39, DOI 10.1051/vetres:2007048	45	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6716	6724		10.1074/jbc.M807065200	http://dx.doi.org/10.1074/jbc.M807065200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129193	hybrid, Green Published			2022-12-27	WOS:000263919000016
J	Cormier, A; Clement, MJ; Knossow, M; Lachkar, S; Savarin, P; Toma, F; Sobel, A; Gigant, B; Curmi, PA				Cormier, Anthony; Clement, Marie-Jeanne; Knossow, Marcel; Lachkar, Sylvie; Savarin, Philippe; Toma, Flavio; Sobel, Andre; Gigant, Benoit; Curmi, Patrick A.			The PN2-3 Domain of Centrosomal P4.1-associated Protein Implements a Novel Mechanism for Tubulin Sequestration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; SECONDARY STRUCTURE PREDICTION; STATHMIN FAMILY PROTEINS; NMR-SPECTROSCOPY; CIRCULAR-DICHROISM; GTPASE ACTIVITY; CHEMICAL-SHIFT; BINDING; COMPLEX; CPAP	Microtubules are cytoskeletal components involved in multiple cell functions such as mitosis, motility, or intracellular traffic. In vivo, these polymers made of alpha beta-tubulin nucleate mostly from the centrosome to establish the interphasic microtubule network or, during mitosis, the mitotic spindle. Centrosomal P4.1-associated protein (CPAP; also named CENPJ) is a centrosomal protein involved in the assembly of centrioles and important for the centrosome function. This protein contains a microtubule-destabilizing region referred to as PN2-3. Here we decrypt the microtubule destabilization activity of PN2-3 at the molecular level and show that it results from the sequestration of tubulin by PN2-3 in a non-polymerizable 1: 1 complex. We also map the tubulin/PN2-3 interaction both on the PN2-3 sequence and on the tubulin surface. NMR and CD data on free PN2-3 in solution show that this is an intrinsically unstructured protein that comprises a 23-amino acid residue alpha-helix. This helix is embedded in a 76-residue region that interacts strongly with tubulin. The interference of PN2-3 with well characterized tubulin properties, namely GTPase activity, nucleotide exchange, vinblastine-induced self-assembly, and stathmin family protein binding, highlights the beta subunit surface located at the intermolecular longitudinal interface when tubulin is embedded in a microtubule as a tubulin/PN2-3 interaction area. These findings characterize the PN2-3 fragment of CPAP as a protein with an unprecedented tubulin sequestering mechanism distinct from that of stathmin family proteins.	[Cormier, Anthony; Knossow, Marcel; Gigant, Benoit] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Clement, Marie-Jeanne; Savarin, Philippe; Toma, Flavio; Curmi, Patrick A.] Univ Evry Val DEssonne, INSERM, UMR829, Lab Struct Activite Biomol Normales & Pathol, F-91025 Evry, France; [Lachkar, Sylvie; Sobel, Andre] Univ Paris 06, Inst Fer Moulin, INSERM, UMR839, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Gigant, B (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Batiment 34,1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	gigant@lebs.cnrs-gif.fr; pcurmi@univ-evry.fr	CURMI, Patrick/G-4036-2013	CURMI, Patrick A./0000-0001-5045-8501; Gigant, Benoit/0000-0002-5946-6759	INSERM; CNRS; Association pour la Recherche sur le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by INSERM, CNRS, Association pour la Recherche sur le Cancer (to P.A.C. and A.S.), and Association Francaise contre les Myopathies (to A.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Amayed P, 2000, BIOCHEMISTRY-US, V39, P12295, DOI 10.1021/bi000279w; BAI R, 1990, J BIOL CHEM, V265, P17141; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bevington PR, 1992, DATA REDUCTION ERROR; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPLOW M, 1980, ARCH BIOCHEM BIOPHYS, V203, P404, DOI 10.1016/0003-9861(80)90193-9; CARLIER MF, 1987, BIOCHEMISTRY-US, V26, P4428, DOI 10.1021/bi00388a036; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cho JH, 2006, BIOCHEM BIOPH RES CO, V339, P742, DOI 10.1016/j.bbrc.2005.11.074; Clement MJ, 2008, BIOMOL NMR ASSIGN, V2, P115, DOI 10.1007/s12104-008-9099-3; Clement MJ, 2005, BIOCHEMISTRY-US, V44, P14616, DOI 10.1021/bi0512492; Cormier A, 2008, EMBO REP, V9, P1101, DOI 10.1038/embor.2008.171; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAVIDPFEUTY T, 1979, J BIOL CHEM, V254, P1696; DETRICH HW, 1978, BIOCHEMISTRY-US, V17, P3900, DOI 10.1021/bi00612a002; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Jourdain I, 2004, BIOCHEM J, V378, P877, DOI 10.1042/BJ20031413; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Martin SR, 2008, METHOD CELL BIOL, V84, P263, DOI 10.1016/S009l-679X(07)84010-6; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Sambrook J., 1989, MOL CLONING LAB MANU; Schiebel E, 2000, CURR OPIN CELL BIOL, V12, P113, DOI 10.1016/S0955-0674(99)00064-2; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; STULTZ CM, 1993, PROTEIN SCI, V2, P305; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Wang CG, 2007, BIOCHEMISTRY-US, V46, P10595, DOI 10.1021/bi701147f; WEISENBE.RC, 1970, BIOCHEMISTRY-US, V9, P4110, DOI 10.1021/bi00823a012; WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	47	39	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6909	6917		10.1074/jbc.M808249200	http://dx.doi.org/10.1074/jbc.M808249200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131341	Green Published, hybrid			2022-12-27	WOS:000263919000038
J	Halle, M; Gomez, MA; Stuible, M; Shimizu, H; McMaster, WR; Olivier, M; Tremblay, ML				Halle, Maxime; Gomez, Maria Adelaida; Stuible, Matthew; Shimizu, Hidehisa; McMaster, W. Robert; Olivier, Martin; Tremblay, Michel L.			The Leishmania Surface Protease GP63 Cleaves Multiple Intracellular Proteins and Actively Participates in p38 Mitogen-activated Protein Kinase Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE-1/2; TYROSINE-PHOSPHATASE-PEST; TARGETED GENE DELETION; NF-KAPPA-B; PTP-PEST; DONOVANI PROMASTIGOTES; AMAZONENSIS PROMASTIGOTES; EXTRACELLULAR RELEASE; PARASITIC PROTOZOAN; ACTIN CYTOSKELETON	The Leishmania parasite is a widespread disease threat in tropical areas, causing symptoms ranging from skin lesions to death. Leishmania parasites typically invade macrophages but are also capable of infecting fibroblasts, which may serve as a reservoir for recurrent infection. Invasion by intracellular pathogens often involves exploitation of the host cell cytoskeletal and signaling machinery. Here we have observed a dramatic rearrangement of the actin cytoskeleton and marked modifications in the profile of protein tyrosine phosphorylation in fibroblasts infected with Leishmania major. Correspondingly, exposure to L. major resulted in degradation of the phosphorylated adaptor protein p130Cas and the protein-tyrosine phosphatase-PEST. Cellular and in vitro assays using pharmacological protease inhibitors, recombinant enzyme, and genetically modified strains of L. major identified the parasite protease GP63 as the principal catalyst of proteolysis during infection. A number of additional signaling proteins were screened for degradation during L. major infection as follows: a small subset was cleaved, including cortactin, T-cell protein-tyrosine phosphatase, and caspase-3, but the majority remained unaffected. Protein degradation occurred in cells incubated with Leishmania extracts in the absence of intact parasites, suggesting a mechanism permitting transfer of functional GP63 into the intracellular space. Finally, we evaluated the impact of Leishmania on MAPK signaling; unlike p44/42 and JNK, p38 was in activated upon infection in a GP63 and protein degradation-dependent manner, which likely involves cleavage of the upstream adaptor TAB1. Our results establish that GP63 plays a central role in a number of host cell molecular events that likely contribute to the infectivity of Leishmania.	[Gomez, Maria Adelaida; Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Halle, Maxime; Stuible, Matthew; Shimizu, Hidehisa; Tremblay, Michel L.] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Halle, Maxime; Stuible, Matthew; Shimizu, Hidehisa; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [McMaster, W. Robert] Univ British Columbia, Dept Med Genet, Jack Bell Res Ctr, Vancouver, BC V6H 3Z6, Canada; [McMaster, W. Robert] Vancouver Hosp, Immun & Infect Res Ctr, Vancouver, BC V6H 3Z6, Canada	McGill University; McGill University; McGill University; University of British Columbia; University of British Columbia	Olivier, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg,3775 Univ St,Rm 600, Montreal, PQ H3A 2B4, Canada.	martin.olivier@mcgill.ca; michel.tremblay@mcgill.ca		Gomez, Maria Adelaida/0000-0001-8792-1563; Shimizu, Hidehisa/0000-0002-0939-0098				Aga E, 2002, J IMMUNOL, V169, P898, DOI 10.4049/jimmunol.169.2.898; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Awasthi A, 2003, J EXP MED, V197, P1037, DOI 10.1084/jem.20022033; Balaraman S, 2005, MOL BIOCHEM PARASIT, V139, P117, DOI 10.1016/j.molbiopara.2004.10.006; BELLE E A, 1958, Can Med Assoc J, V79, P726; Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Bogdan C, 2000, J EXP MED, V191, P2121, DOI 10.1084/jem.191.12.2121; BOUVIER J, 1985, J BIOL CHEM, V260, P5504; Brittingham A, 1999, INFECT IMMUN, V67, P4477, DOI 10.1128/IAI.67.9.4477-4484.1999; BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102; BUTTON LL, 1993, GENE, V134, P75, DOI 10.1016/0378-1119(93)90176-4; CAMPBELL DA, 1992, FEMS MICROBIOL LETT, V96, P89, DOI 10.1111/j.1574-6968.1992.tb05398.x; Carmen JC, 2007, MOL MICROBIOL, V64, P904, DOI 10.1111/j.1365-2958.2007.05714.x; CHAUDHURI G, 1988, MOL BIOCHEM PARASIT, V27, P43, DOI 10.1016/0166-6851(88)90023-0; CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483; Chen DQ, 2000, INFECT IMMUN, V68, P80, DOI 10.1128/IAI.68.1.80-86.2000; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; COOL DE, 1990, P NATL ACAD SCI USA, V87, P7280, DOI 10.1073/pnas.87.18.7280; Corradin S, 1999, J BIOL CHEM, V274, P25411, DOI 10.1074/jbc.274.36.25411; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Cote JF, 1998, BIOCHEMISTRY-US, V37, P13128, DOI 10.1021/bi981259l; Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Ellis M, 2002, J BIOL CHEM, V277, P27968, DOI 10.1074/jbc.M202047200; Garton AJ, 1999, J BIOL CHEM, V274, P3811, DOI 10.1074/jbc.274.6.3811; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Ghosh D, 2002, BIOSCIENCE REP, V22, P395, DOI 10.1023/A:1020914024544; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Gregory DJ, 2008, EUR J IMMUNOL, V38, P1071, DOI 10.1002/eji.200737586; Halle M, 2007, CELL CYCLE, V6, P2773, DOI 10.4161/cc.6.22.4926; Halle M, 2007, MOL CELL BIOL, V27, P1172, DOI 10.1128/MCB.02462-05; Hao LN, 1997, J BIOL CHEM, V272, P29322, DOI 10.1074/jbc.272.46.29322; Hepburn NC, 2000, CLIN EXP DERMATOL, V25, P363, DOI 10.1046/j.1365-2230.2000.00664.x; Hespanhol RC, 2005, J HISTOCHEM CYTOCHEM, V53, P35, DOI 10.1369/jhc.4A6384.2005; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hsiao CHC, 2008, MOL BIOCHEM PARASIT, V157, P148, DOI 10.1016/j.molbiopara.2007.10.008; Ibarra-Sanchez MD, 2001, ONCOGENE, V20, P4728, DOI 10.1038/sj.onc.1204648; Jaffe CL, 2003, PARASITOL RES, V91, P229, DOI 10.1007/s00436-003-0960-0; Jamieson JS, 2005, J CELL SCI, V118, P5835, DOI 10.1242/jcs.02693; Joshi PB, 1998, MOL MICROBIOL, V27, P519, DOI 10.1046/j.1365-2958.1998.00689.x; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Junghae M, 2002, INFECT IMMUN, V70, P5026, DOI 10.1128/IAI.70.9.5026-5035.2002; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; Kima PE, 2007, INT J PARASITOL, V37, P1087, DOI 10.1016/j.ijpara.2007.04.007; Kook S, 2000, MOL BIOL CELL, V11, P929, DOI 10.1091/mbc.11.3.929; Kulkarni MM, 2008, INFECT IMMUN, V76, P1738, DOI 10.1128/IAI.01274-07; Kulkarni MM, 2006, MOL MICROBIOL, V62, P1484, DOI 10.1111/j.1365-2958.2006.05459.x; Kyaw M, 2004, MOL PHARMACOL, V65, P832, DOI 10.1124/mol.65.4.832; Lerm M, 2006, INFECT IMMUN, V74, P2613, DOI 10.1128/IAI.74.5.2613-2618.2006; Liu LM, 2006, PARASITOL RES, V99, P189, DOI 10.1007/s00436-006-0168-1; Lodge R, 2005, CELL MICROBIOL, V7, P1647, DOI 10.1111/j.1462-5822.2005.00582.x; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; McGwire BS, 2003, INFECT IMMUN, V71, P1008, DOI 10.1128/IAI.71.2.1008-1010.2003; McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Morehead J, 2002, INFECT IMMUN, V70, P4571, DOI 10.1128/IAI.70.8.4571-4580.2002; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Oliveira SHP, 1998, PARASITE IMMUNOL, V20, P405, DOI 10.1046/j.1365-3024.1998.00159.x; Prive C, 2000, EUR J IMMUNOL, V30, P2235, DOI 10.1002/1521-4141(2000)30:8&lt;2235::AID-IMMU2235&gt;3.0.CO;2-9; RIZVI FS, 1988, EUR J IMMUNOL, V18, P473, DOI 10.1002/eji.1830180323; ROBERTS LS, 2000, GD SCHMIDT LS ROBERT, P61; Rottner K, 2004, J PATHOL, V204, P396, DOI 10.1002/path.1638; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Seay MB, 1996, INFECT IMMUN, V64, P5129, DOI 10.1128/IAI.64.12.5129-5137.1996; Selbach M, 2005, TRENDS MICROBIOL, V13, P181, DOI 10.1016/j.tim.2005.02.007; Shi J, 2006, MOL BIOL CELL, V17, P4698, DOI 10.1091/mbc.E06-06-0492; Shim SR, 2001, BIOCHEM BIOPH RES CO, V286, P601, DOI 10.1006/bbrc.2001.5441; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Stuart LM, 2007, J BIOL CHEM, V282, P27392, DOI 10.1074/jbc.M702887200; Thiakaki M, 2006, MICROBES INFECT, V8, P1455, DOI 10.1016/j.micinf.2006.01.006; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; Victoir K, 2005, PARASITOLOGY, V131, P207, DOI 10.1017/S0031182005007535; Voth BR, 1998, MOL BIOCHEM PARASIT, V93, P31, DOI 10.1016/S0166-6851(98)00013-9; Woelbing F, 2006, J EXP MED, V203, P177, DOI 10.1084/jem.20052288; Yao CQ, 2007, EUKARYOT CELL, V6, P1905, DOI 10.1128/EC.00073-07; Yao CQ, 2004, MOL BIOCHEM PARASIT, V135, P171, DOI 10.1016/j.molbiopara.2004.03.010; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Yao CQ, 2002, MOL BIOCHEM PARASIT, V121, P119, DOI 10.1016/S0166-6851(02)00030-0; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; ZHAO ZZ, 1992, ANAL BIOCHEM, V202, P361, DOI 10.1016/0003-2697(92)90119-R	87	89	92	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6893	6908		10.1074/jbc.M805861200	http://dx.doi.org/10.1074/jbc.M805861200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19064994	Green Published, hybrid			2022-12-27	WOS:000263919000037
J	Larue, K; Kimber, MS; Ford, R; Whitfield, C				Larue, Kane; Kimber, Matthew S.; Ford, Robert; Whitfield, Chris			Biochemical and Structural Analysis of Bacterial O-antigen Chain Length Regulator Proteins Reveals a Conserved Quaternary Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL REGIONS; GROUP-1 CAPSULAR POLYSACCHARIDES; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; SHIGELLA-FLEXNERI; PSEUDOMONAS-AERUGINOSA; CONFORMATIONAL FLEXIBILITY; 3-DIMENSIONAL STRUCTURE; ALTERNATIVE PATHWAY; POLYACRYLAMIDE GELS	Lipopolysaccharide (LPS) is a major component of the Gram-negative outer membrane and is an important virulence determinant. The O-antigen polysaccharide of the LPS molecule provides protection from host defenses, and the length of O-antigen chains plays a pivotal role. In the Wzy-dependent O-antigen biosynthesis pathway, the integral inner membrane protein Wzz determines the O-antigen chain length. How these proteins function is currently unknown, but the hypothesis includes activities such as a "molecular ruler" or a "molecular stopwatch," and other possibilities may exist. Wzz homologs are membrane proteins with two transmembrane helices that flank a large periplasmic domain. Recent x-ray crystallographic studies of the periplasmic portions of Wzz proteins found multiple oligomeric forms, with quaternary structures favoring the "molecular ruler" interpretation. Here, we have studied full-length Wzz proteins with the transmembrane portions embedded in lipid membranes. Using electron microscopy and image analysis we find a unique hexameric state rather than differing oligomeric forms. The data suggest that in vivo Wzz proteins determine O-antigen chain length via subtle structure-function relationships at the level of primary, secondary, or tertiary structure within the context of a hexameric complex.	[Larue, Kane; Kimber, Matthew S.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Ford, Robert] Univ Manchester, Fac Life Sci, Manchester M60 1QD, Lancs, England	University of Guelph; University of Manchester	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Kimber, Matthew/0000-0001-9454-5586; Ford, Robert/0000-0002-0958-1505	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Amer AO, 2001, MICROBIOL-SGM, V147, P3015, DOI 10.1099/00221287-147-11-3015; Amor PA, 1997, MOL MICROBIOL, V26, P145, DOI 10.1046/j.1365-2958.1997.5631930.x; AMOS LA, 1983, PROG BIOPHYS MOL BIO, V39, P183, DOI 10.1016/0079-6107(83)90017-2; Anderson MS, 2000, FEMS MICROBIOL LETT, V191, P169, DOI 10.1111/j.1574-6968.2000.tb09335.x; BASTIN DA, 1993, MOL MICROBIOL, V7, P725, DOI 10.1111/j.1365-2958.1993.tb01163.x; BATCHELOR RA, 1992, J BACTERIOL, V174, P5228, DOI 10.1128/JB.174.16.5228-5236.1992; BATCHELOR RA, 1991, J BACTERIOL, V173, P5699, DOI 10.1128/jb.173.18.5699-5704.1991; Becker A, 1998, J BACTERIOL, V180, P395, DOI 10.1128/JB.180.2.395-399.1998; BINOTTO J, 1991, CAN J MICROBIOL, V37, P474, DOI 10.1139/m91-078; Collins RF, 2006, J BIOL CHEM, V281, P2144, DOI 10.1074/jbc.M508078200; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Daniels C, 2002, ENVIRON MICROBIOL, V4, P883, DOI 10.1046/j.1462-2920.2002.00288.x; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dodgson C, 1996, J BACTERIOL, V178, P1895, DOI 10.1128/jb.178.7.1895-1902.1996; Doublet P, 2002, J BIOL CHEM, V277, P37339, DOI 10.1074/jbc.M204465200; Franco AV, 1998, J BACTERIOL, V180, P2670, DOI 10.1128/JB.180.10.2670-2675.1998; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; Guo H, 2006, PROTEIN EXPRES PURIF, V48, P49, DOI 10.1016/j.pep.2006.01.015; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; JOINER KA, 1988, ANNU REV MICROBIOL, V42, P201, DOI 10.1146/annurev.mi.42.100188.001221; KASTOWSKY M, 1992, J BACTERIOL, V174, P4798, DOI 10.1128/JB.174.14.4798-4806.1992; Klee SR, 1997, J BACTERIOL, V179, P2421, DOI 10.1128/jb.179.7.2421-2425.1997; LAM JS, 1992, J BACTERIOL, V174, P7159, DOI 10.1128/jb.174.22.7159-7167.1992; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Ludtke SJ, 2001, J MOL BIOL, V314, P253, DOI 10.1006/jmbi.2001.5133; Marolda CL, 2008, J BACTERIOL, V190, P2128, DOI 10.1128/JB.01746-07; Marolda CL, 2006, J BACTERIOL, V188, P5124, DOI 10.1128/JB.00461-06; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Morona R, 2000, MICROBIOL-UK, V146, P1, DOI 10.1099/00221287-146-1-1; Mosser G, 2001, MICRON, V32, P517, DOI 10.1016/S0968-4328(00)00047-0; MUNFORD RS, 1980, J BACTERIOL, V144, P630, DOI 10.1128/JB.144.2.630-640.1980; Murray GL, 2006, J BACTERIOL, V188, P2735, DOI 10.1128/JB.188.7.2735-2739.2006; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; PALVA ET, 1980, EUR J BIOCHEM, V107, P137, DOI 10.1111/j.1432-1033.1980.tb04634.x; PANGBURN MK, 1989, J IMMUNOL, V142, P2766; PANGBURN MK, 1989, J IMMUNOL, V142, P2759; Price NP, 2005, GLYCOBIOLOGY, V15, p29R, DOI 10.1093/glycob/cwi065; Purins L, 2008, MICROBIOL-SGM, V154, P1104, DOI 10.1099/mic.0.2007/014225-0; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Saldias MS, 2008, MICROBIOL-SGM, V154, P440, DOI 10.1099/mic.0.2007/013136-0; Tang KH, 2007, BIOCHEMISTRY-US, V46, P11744, DOI 10.1021/bi701181r; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Wang L, 1996, J BACTERIOL, V178, P2598, DOI 10.1128/jb.178.9.2598-2604.1996; WANG L, 1994, J BACTERIOL, V176, P4348, DOI 10.1128/jb.176.14.4348-4356.1994; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Yeager M, 1999, Methods Enzymol, V294, P135; Zgurskaya HI, 2000, J BACTERIOL, V182, P4264, DOI 10.1128/JB.182.15.4264-4267.2000; Zgurskaya HI, 1999, J MOL BIOL, V285, P409, DOI 10.1006/jmbi.1998.2313	61	56	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7395	7403		10.1074/jbc.M809068200	http://dx.doi.org/10.1074/jbc.M809068200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129185	Green Published, hybrid			2022-12-27	WOS:000263919000085
J	Mirnikjoo, B; Balasubramanian, K; Schroit, AJ				Mirnikjoo, Banafsheh; Balasubramanian, Krishnakumar; Schroit, Alan J.			Mobilization of Lysosomal Calcium Regulates the Externalization of Phosphatidylserine during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; FREE CA2+; CELLS; MITOCHONDRIAL; EXPOSURE; TRANSLOCATION; INTRANUCLEAR; PLATELETS; INCREASE; SURFACE	A hallmark of apoptotic cells is the Ca2+ dependent appearance of phosphatidylserine (PS) at the cell surface as a result of its redistribution from the inner-to-outer plasma membrane leaflet. Although endoplasmic reticulum and mitochondrial Ca2+ are known to participate in apoptosis, their role in PS externalization has not been established. In this study, several organelle-specific fluorescent markers and Ca2+-sensitive probes were used to identify the source of Ca2+ critical to PS externalization. By employing Rhod-2AM, fluorescein-labeled high molecular weight dextran, and Calcium Green 1, we provide evidence that lysosomes respond to apoptotic stimuli by releasing their luminal Ca2+ to the cytosol. Cells treated with the cytosolic phospholipase A(2) inhibitor, cPLA2 alpha, had no effect on caspase activation but exhibited a significant decrease in lysosomal Ca2+ release and externalization of PS in response to apoptotic stimuli. Similarly, cells depleted of lysosomal Ca2+ underwent programmed cell death yet failed to externalize PS. These data indicate that although Ca2+ release from other intracellular organelles to the cytosol is adequate for apoptosis, the release of Ca2+ from lysosomes is critical for PS externalization.	[Mirnikjoo, Banafsheh; Balasubramanian, Krishnakumar; Schroit, Alan J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Schroit, AJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	aschroit@mdanderson.org			National Institutes of Health [CA-98527]; Foundation and by Department of Defense Breast Cancer Research Program [W81XWH-06-1-0347]; NATIONAL CANCER INSTITUTE [R01CA098527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation and by Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-98527 (to A.J.S.). This work was also supported in part by a grant from the John Q. Gaines Foundation and by Department of Defense Breast Cancer Research Program Grant W81XWH-06-1-0347 ( to B. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; BELLOMO G, 1992, CANCER RES, V52, P1342; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Burlando B, 2002, AM J PHYSIOL-CELL PH, V283, pC1461, DOI 10.1152/ajpcell.00429.2001; Castedo M, 1996, J IMMUNOL, V157, P512; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Draper DW, 2004, J IMMUNOL, V172, P2416, DOI 10.4049/jimmunol.172.4.2416; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Hallett MB, 1999, J IMMUNOL METHODS, V232, P77, DOI 10.1016/S0022-1759(99)00167-2; Hampton MB, 1996, FEBS LETT, V399, P277, DOI 10.1016/S0014-5793(96)01341-5; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; Keij JF, 2000, CYTOMETRY, V39, P203, DOI 10.1002/(SICI)1097-0320(20000301)39:3<203::AID-CYTO5>3.0.CO;2-Z; Kong SK, 1997, ONCOLOGY-BASEL, V54, P55; Marchi B, 2004, AQUAT TOXICOL, V66, P197, DOI 10.1016/j.aquatox.2003.09.003; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Sims PJ, 2001, THROMB HAEMOSTASIS, V86, P266; SMEETS EF, 1994, BBA-BIOMEMBRANES, V1195, P281, DOI 10.1016/0005-2736(94)90268-2; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; WILLIAMSON P, 1992, BIOCHEMISTRY-US, V31, P6355, DOI 10.1021/bi00142a027; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; Zunkler BJ, 2004, BIOCHEM PHARMACOL, V67, P1437, DOI 10.1016/j.bcp.2003.12.011	30	34	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6918	6923		10.1074/jbc.M805288200	http://dx.doi.org/10.1074/jbc.M805288200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19126538	Green Published, hybrid			2022-12-27	WOS:000263919000039
J	Nogami, K; Nishiya, K; Saenko, EL; Takeyama, M; Ogiwara, K; Yoshioka, A; Shima, M				Nogami, Keiji; Nishiya, Katsumi; Saenko, Evgueni L.; Takeyama, Masahiro; Ogiwara, Kenichi; Yoshioka, Akira; Shima, Midori			Identification of Plasmin-interactive Sites in the Light Chain of Factor VIII Responsible for Proteolytic Cleavage at Lys(36)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-VIII; ACTIVATED PROTEIN-C; FACTOR-IXA; A1 SUBUNIT; FACTOR XA; HEAVY-CHAIN; CATALYZED CLEAVAGE; A2 SUBUNITS; FACTOR-VA; INACTIVATION	We have recently reported that plasmin likely associates with the factor VIII light chain to proteolyze at Lys(36) within the A1 domain. In this study, we determined that the rate of plasmin-catalyzed inactivation on the forms of factor VIIIa containing A1-(1-336) and (1722)A3C1C2, reflecting Lys36 cleavage, was reduced by similar to 60%, compared with those containing (1649)A3C1C2 and (1690)A3C1C2. SDS-PAGE analysis revealed that Lys36 cleavage of factor VIIIa with (1722)A3C1C2 was markedly slower than those with (1649)A3C1C2 and (1690)A3C1C2. Surface plasmon resonance-based assays, using active site-modified anhydro-plasmin (Ah-plasmin) showed that (1722)A3C1C2 bound to Ah-plasmin with an similar to 3-fold lower affinity than (1649)A3C1C2 or (1690)A3C1C2 (K-d, 176, 68.2, and 60.3 nM, respectively). Recombinant A3 bound to Ah-plasmin (K-d, 44.2 nM), whereas C2 failed to bind, confirming the presence of a plasmin-binding site within N terminus of A3. Furthermore, the Glu-Gly-Arg active sitem-odified factor IXa also blocked (1722)A3C1C2 binding to Ah-plasmin by similar to 95%, supporting the presence of another plasmin-binding site overlapping the factor IXa-binding site in A3. In keeping with a major contribution of the lysine-binding sites in plasmin for interaction with the factor VIII light chain, analysis of the A3 sequence revealed two regions involving clustered lysine residues in 1690-1705 and 1804-1818. Two peptides based on these regions blocked (1649)A3C1C2 binding to Ah-plasmin by similar to 60% and plasmin-catalyzed Lys36 cleavage of factor VIIIa with A1-(1-336) by similar to 80%. Our findings indicate that an extended surface, centered on residues 1690-1705 and 1804 1818 within the A3 domain, contributes to a unique plasmin-interactive site that promotes plasmin docking during cofactor inactivation by cleavage at Lys(36).	[Nogami, Keiji; Nishiya, Katsumi; Takeyama, Masahiro; Ogiwara, Kenichi; Yoshioka, Akira; Shima, Midori] Nara Med Univ, Dept Pediat, Nara 6348522, Japan; [Saenko, Evgueni L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Nara Medical University; University System of Maryland; University of Maryland Baltimore	Nogami, K (corresponding author), Nara Med Univ, Dept Pediat, 840 Shijo Cho, Nara 6348522, Japan.	roc-noga@naramed-u.ac.jp	Ogiwara, Kenichi/ABD-7067-2021	Ogiwara, Kenichi/0000-0002-3046-6915				BACHMANN F, 2000, HEMOSTASIS THROMBOSI, P275; Bovenschen N, 2003, J BIOL CHEM, V278, P9370, DOI 10.1074/jbc.M212053200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DONATH MJSH, 1995, J BIOL CHEM, V270, P3648, DOI 10.1074/jbc.270.8.3648; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Fay PJ, 2001, J BIOL CHEM, V276, P12434, DOI 10.1074/jbc.M009539200; Jenkins PV, 2004, BIOCHEMISTRY-US, V43, P5094, DOI 10.1021/bi036289p; Kalafatis M, 2001, J BIOL CHEM, V276, P18614, DOI 10.1074/jbc.M007134200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPHEAR BJ, 1992, BLOOD, V80, P3120; Lapan KA, 1997, J BIOL CHEM, V272, P2082; Lenting PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/jbc.271.4.1935; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; MANN KG, 1990, BLOOD, V76, P1; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Nogami K, 2003, J BIOL CHEM, V278, P1634, DOI 10.1074/jbc.M209811200; Nogami K, 2004, J BIOL CHEM, V279, P15763, DOI 10.1074/jbc.M400568200; Nogami K, 2003, J BIOL CHEM, V278, P16502, DOI 10.1074/jbc.M213044200; Nogami K, 2008, BBA-PROTEINS PROTEOM, V1784, P753, DOI 10.1016/j.bbapap.2008.01.019; Nogami K, 2007, J BIOL CHEM, V282, P5287, DOI 10.1074/jbc.M607816200; O'Brien LM, 2000, BLOOD, V95, P1714, DOI 10.1182/blood.V95.5.1714.005k40_1714_1720; OBrien LM, 1997, BLOOD, V90, P3943, DOI 10.1182/blood.V90.10.3943; OMAR MN, 1987, J BIOL CHEM, V262, P9750; Pemberton S, 1997, BLOOD, V89, P2413, DOI 10.1182/blood.V89.7.2413; Pipe SW, 1997, P NATL ACAD SCI USA, V94, P11851, DOI 10.1073/pnas.94.22.11851; Pryzdial ELG, 1999, J BIOL CHEM, V274, P8500, DOI 10.1074/jbc.274.13.8500; RAMAKRISHNAN V, 1991, BIOCHEMISTRY-US, V30, P3963, DOI 10.1021/bi00230a023; REGAN LM, 1995, J BIOL CHEM, V270, P8546, DOI 10.1074/jbc.270.15.8546; REGAN LM, 1994, J BIOL CHEM, V269, P9445; Rosenblum MEK, 2002, J BIOL CHEM, V277, P11664, DOI 10.1074/jbc.M200037200; Samis JA, 2000, BLOOD, V95, P943, DOI 10.1182/blood.V95.3.943.003k34_943_951; SHIMA M, 1993, THROMB HAEMOSTASIS, V69, P240; Takeshima K, 2003, THROMB HAEMOSTASIS, V89, P788, DOI 10.1055/s-0037-1613463; TULINSKY A, 1988, PROTEINS, V3, P85, DOI 10.1002/prot.340030203; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; WU TP, 1991, BIOCHEMISTRY-US, V30, P10589, DOI 10.1021/bi00107a030; Zhong DG, 1998, BLOOD, V92, P136, DOI 10.1182/blood.V92.1.136.413k35_136_142	41	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6934	6945		10.1074/jbc.M802224200	http://dx.doi.org/10.1074/jbc.M802224200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19126539	Green Published, hybrid			2022-12-27	WOS:000263919000041
J	Zartler, ER; Porambo, RJ; Anderson, CL; Chen, LH; Yu, JG; Nahm, MH				Zartler, Edward R.; Porambo, Richard J.; Anderson, Carrie L.; Chen, Lorenzo H.; Yu, Jigui; Nahm, Moon H.			Structure of the Capsular Polysaccharide of Pneumococcal Serotype 11A Reveals a Novel Acetylglycerol That Is the Structural Basis for 11A Subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGLE-SPINNING NMR; GENETIC-BASIS; ASSIGNMENT; RESOLUTION; H-1; SENSITIVITY; ANTIBODIES; HSQC; 15B	We have undertaken a structural assessment of Streptococcus pneumoniae 11A polysaccharide as well as two clinical isolates related to 11A. The clinical isolates were labeled 11A alpha and 11A beta. The result of our experiments is a revision to the old structure for S. pneumoniae 11A polysaccharide. The new structure differs from the old structure in both the primary connectivities and acetylation pattern. We also show that 11A contains an acetylglycerol-PO4 moiety, a substitution that is heretofore unknown in the bacterial polysaccharide literature. The two clinical isolates were also structurally characterized. 11A alpha was determined to be identical to 11A. 11A beta is a new serotype, which differs from 11A in the absence of the acetylation of the glycerol-PO4 moiety and a different acetylation pattern of the saccharides. Thus, we propose that the acetylglycerol is the structural basis for 11A alpha and 11A beta subtypes.	[Zartler, Edward R.; Porambo, Richard J.; Anderson, Carrie L.; Chen, Lorenzo H.] Merck & Co Inc, Merck Res Labs, Bioproc Analyt & Formulat Sci, West Point, PA 19486 USA; [Yu, Jigui; Nahm, Moon H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35249 USA	Merck & Company; University of Alabama System; University of Alabama Birmingham	Zartler, ER (corresponding author), 770 Sumneytown Pike,WP42A-20, West Point, PA 19486 USA.	edward_zartler@merck.com		Nahm, Moon/0000-0002-6922-1042	National Institutes of Health [AI-30021]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant AI-30021 (to M. H. N.).	Abeygunawardana C, 2000, ANAL BIOCHEM, V279, P226, DOI 10.1006/abio.1999.4470; AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; BAX A, 1986, J MAGN RESON, V67, P565, DOI 10.1016/0022-2364(86)90395-1; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Cerda-Garcia-Rojas CM, 2000, MAGN RESON CHEM, V38, P494; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; Gasmi G, 1996, MAGN RESON CHEM, V34, P185, DOI 10.1002/(SICI)1097-458X(199603)34:3<185::AID-OMR866>3.3.CO;2-Y; Gudlavalleti SK, 2006, CARBOHYD RES, V341, P557, DOI 10.1016/j.carres.2005.11.036; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Kamerling JP., 2000, STREPTOCOCCUS PNEUMO, P81; KENNEDY DA, 1969, BIOCHEM J, V115, P37, DOI 10.1042/bj1150037; Kim JS, 2006, ANAL BIOCHEM, V358, P136, DOI 10.1016/j.ab.2006.08.016; Kim JS, 2005, ANAL BIOCHEM, V347, P262, DOI 10.1016/j.ab.2005.09.022; Kotsubo V, 1996, ADV CRYOG ENG, P1857; Li W, 2005, ANAL CHEM, V77, P5785, DOI 10.1021/ac050906t; McNeely TB, 1998, INFECT IMMUN, V66, P3705, DOI 10.1128/IAI.66.8.3705-3710.1998; MERCHANT TE, 1990, J LIPID RES, V31, P479; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; OTTER A, 1995, J MAGN RESON SER B, V109, P194, DOI 10.1006/jmrb.1995.0009; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Rajam G, 2007, CLIN VACCINE IMMUNOL, V14, P1223, DOI 10.1128/CVI.00184-07; Reynolds WF, 1997, MAGN RESON CHEM, V35, P455, DOI 10.1002/(SICI)1097-458X(199707)35:7<455::AID-OMR116>3.0.CO;2-6; RICHARDS JC, 1985, CAN J BIOCHEM CELL B, V63, P953, DOI 10.1139/o85-118; RICHARDS JC, 1988, ADV EXP MED BIOL, V228, P595; Russell DJ, 2000, J NAT PROD, V63, P1047, DOI 10.1021/np0003140; SUMMERS MF, 1986, J AM CHEM SOC, V108, P4285, DOI 10.1021/ja00275a008; Tezuka Y, 1997, CARBOHYD RES, V305, P155, DOI 10.1016/S0008-6215(97)10036-2; Vammen B, 1939, J IMMUNOL, V37, P359; van Selm S, 2003, INFECT IMMUN, V71, P6192, DOI 10.1128/IAI.71.11.6192-6198.2003; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Xu QW, 2005, ANAL BIOCHEM, V336, P262, DOI 10.1016/j.ab.2004.10.019; Yu F, 2006, BIOPHYS J, V91, P1952, DOI 10.1529/biophysj.105.079913; Yu J, 2008, J MED MICROBIOL, V57, P171, DOI 10.1099/jmm.0.47549-0	34	27	27	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7318	7329		10.1074/jbc.M807952200	http://dx.doi.org/10.1074/jbc.M807952200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19114709	hybrid, Green Published			2022-12-27	WOS:000263919000078
J	Huang, JN; Ren, T; Guan, H; Jiang, YX; Cheng, H				Huang, Jiannan; Ren, Tong; Guan, Hui; Jiang, Yixing; Cheng, Hua			HTLV-1 Tax Is a Critical Lipid Raft Modulator That Hijacks I kappa B Kinases to the Microdomains for Persistent Activation of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA-VIRUS TYPE-1; T-CELL-ACTIVATION; LYMPHOTROPIC-VIRUS; C-THETA; IKK-ALPHA; IMMUNOLOGICAL SYNAPSE; PHYSICAL ASSOCIATION; TRANSFORMING PROTEIN; MEMBRANE RAFTS; PKC-THETA	Upon T cell activation, I kappa B kinases (IKKs) are transiently recruited to the plasma membrane-associated lipid raft microdomains for activation of NF-kappa B in promoting T cell proliferation. Retroviral Tax proteins from human T cell leukemia virus type 1 and type 2 (HTLV-1 and -2) are capable of activating IKK, yet only HTLV-1 infection causes T cell leukemia, which correlates with persistent activation of NF-kappa B induced by Tax1. Here, we show that the Tax proteins exhibit differential modes of IKK activation. The subunits of IKK are constitutively present in lipid rafts in activated forms in HTLV-1-infected T cells that express Tax. Disruption of lipid rafts impairs I kappa B kinase activation by Tax1. We also show that the cytoplasmic Tax1 protein persistently resides in the Golgi-associated lipid raft microdomains. Tax1 directs lipid raft translocation of IKK through selective interaction with IKK gamma and accordingly, depletion of IKK gamma impairs Tax1-directed lipid raft recruitment of IKK alpha and IKK beta. In contrast, Tax2 activates NF-kappa B in a manner independent of lipid raft recruitment of IKK. These findings indicate that Tax1 actively recruits IKK to the lipid raft microdomains for persistent activation of NF-kappa B, thereby contributing to HTLV-1 oncogenesis.	[Huang, Jiannan; Ren, Tong; Guan, Hui; Jiang, Yixing; Cheng, Hua] Penn State Univ, Coll Med, Penn State Canc Inst, Hershey, PA 17033 USA; [Jiang, Yixing; Cheng, Hua] Penn State Univ, Coll Med, Dept Med, Hershey, PA 17033 USA; [Cheng, Hua] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cheng, H (corresponding author), C6818,500 Univ Dr, Hershey, PA 17033 USA.	hcheng@hmc.psu.edu			Penn State Hershey Cancer Institute	Penn State Hershey Cancer Institute	This work was supported by the Penn State Hershey Cancer Institute. The costs of publication of this article were defrayed in part by the payment of page charges.	Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Burton M, 2000, J VIROL, V74, P2351, DOI 10.1128/JVI.74.5.2351-2364.2000; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Chu ZL, 1999, J BIOL CHEM, V274, P15297, DOI 10.1074/jbc.274.22.15297; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074/jbc.273.26.15891; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Demarchi F, 1996, J VIROL, V70, P4427, DOI 10.1128/JVI.70.7.4427-4437.1996; Drevot P, 2002, EMBO J, V21, P1899, DOI 10.1093/emboj/21.8.1899; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Fenard D, 2005, J IMMUNOL, V175, P6050, DOI 10.4049/jimmunol.175.9.6050; Feng X, 2003, J VIROL, V77, P13389, DOI 10.1128/JVI.77.24.13389-13395.2003; Feuer G, 2005, ONCOGENE, V24, P5996, DOI 10.1038/sj.onc.1208971; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Harhaj NS, 2007, J BIOL CHEM, V282, P4185, DOI 10.1074/jbc.M611031200; He HT, 2008, EMBO REP, V9, P525, DOI 10.1038/embor.2008.78; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; KIYOKAWA T, 1985, VIROLOGY, V147, P462, DOI 10.1016/0042-6822(85)90149-7; Krautkramer E, 2004, J VIROL, V78, P4085, DOI 10.1128/JVI.78.8.4085-4097.2004; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Li XH, 1999, J BIOL CHEM, V274, P34417, DOI 10.1074/jbc.274.48.34417; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Lindwasser OW, 2002, P NATL ACAD SCI USA, V99, P13037, DOI 10.1073/pnas.212409999; Luftig M, 2004, P NATL ACAD SCI USA, V101, P141, DOI 10.1073/pnas.2237183100; Manna SK, 2000, J IMMUNOL, V164, P5156, DOI 10.4049/jimmunol.164.10.5156; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Meertens L, 2004, J BIOL CHEM, V279, P43307, DOI 10.1074/jbc.M400497200; Nejmeddine M, 2005, J BIOL CHEM, V280, P29653, DOI 10.1074/jbc.M502639200; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Pise-Masison CA, 1998, J VIROL, V72, P1165, DOI 10.1128/JVI.72.2.1165-1170.1998; Richard V, 2001, AM J PATHOL, V158, P2219, DOI 10.1016/S0002-9440(10)64694-9; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rousso I, 2000, P NATL ACAD SCI USA, V97, P13523, DOI 10.1073/pnas.240459697; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; SALGHETTI S, 1995, P NATL ACAD SCI USA, V92, P349, DOI 10.1073/pnas.92.2.349; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Uhlik M, 1998, J BIOL CHEM, V273, P21132, DOI 10.1074/jbc.273.33.21132; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; Wu XF, 2007, EMBO REP, V8, P510, DOI 10.1038/sj.embor.7400931; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; Zheng YH, 2001, CURR BIOL, V11, P875, DOI 10.1016/S0960-9822(01)00237-8; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	59	47	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6208	6217		10.1074/jbc.M806390200	http://dx.doi.org/10.1074/jbc.M806390200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129196	hybrid			2022-12-27	WOS:000263742700024
J	Lei, H; Kazlauskas, A				Lei, Hetian; Kazlauskas, Andrius			Growth Factors Outside of the Platelet-derived Growth Factor (PDGF) Family Employ Reactive Oxygen Species/Src Family Kinases to Activate PDGF Receptor alpha and Thereby Promote Proliferation and Survival of Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FACTOR-BETA RECEPTOR; RETINAL-DETACHMENT; SIGNAL-TRANSDUCTION; C-SRC; TYROSINE KINASES; OXIDATIVE STRESS; CLINICAL FACTORS; ANGIOTENSIN-II; PROTEIN-KINASE	The vitreous contains a plethora of growth factors that are strongly implicated in the formation of fibroproliferative diseases such as proliferative vitreoretinopathy. Although platelet-derived growth factors (PDGFs) are present in the vitreous, vitreal growth factors outside of the PDGF family activated the PDGF alpha receptor (PDGFR alpha) and promoted disease progression in a rabbit model of proliferative vitreoretinopathy (H. Lei, G. Velez, P. Hovland, T. Hirose, D. Gilbertson, and A. Kazlauskas (2008) submitted for publication.) In this report we investigated the mechanism by which non-PDGFs activated PDGFR alpha. We found that non-PDGFs increased the cellular level of reactive oxygen species (ROS) and that this event was necessary and sufficient for phosphorylation of PDGFR alpha. We speculated that the underlying mechanism was ROS-mediated inhibition of phosphotyrosine phosphatases, which antagonize receptor autophosphorylation. However, this did not appear to be the case. Non-PDGFs promoted tyrosine phosphorylation of catalytically inactive PDGFR alpha, and thereby indicated that at least one additional tyrosine kinase was involved. Indeed, preventing expression or blocking the kinase activity of Src family kinases suppressed non-PDGF-dependent tyrosine phosphorylation of PDGFR alpha. Thus non-PDGFs increased the level of ROS, which activated Src family kinases and resulted in phosphorylation of PDGFR alpha. Finally, although non-PDGFs induced only modest phosphorylation of PDGFR alpha, proliferation and survival of cells in response to non-PDGFs was significantly enhanced by expression of PDGFR alpha. These studies reveal a novel mechanism for activation of PDGFR alpha that appears capable of enhancing the responsiveness of cells to growth factors outside of the PDGF family.	[Lei, Hetian; Kazlauskas, Andrius] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute	Kazlauskas, A (corresponding author), 20 Staniford St, Boston, MA 02114 USA.	ak@eri.harvard.edu		Lei, Hetian/0000-0003-4091-1936	National Institutes of Health [EY012509]; NATIONAL EYE INSTITUTE [R01EY012509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY012509 (to A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Andrews A, 1999, INVEST OPHTH VIS SCI, V40, P2683; Asaria RHY, 2004, BRIT J OPHTHALMOL, V88, P1439, DOI 10.1136/bjo.2003.040402; Avrov K, 2003, EXP CELL RES, V291, P426, DOI 10.1016/j.yexcr.2003.08.001; Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Banerjee S, 2007, INVEST OPHTH VIS SCI, V48, P2203, DOI 10.1167/iovs.06-1358; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; Campochiaro PA, 1997, ARCH OPHTHALMOL-CHIC, V115, P237, DOI 10.1001/archopht.1997.01100150239014; Campochiaro PA, 1996, PROG RETIN EYE RES, V15, P547, DOI 10.1016/1350-9462(96)00012-2; CUI J, 2008, EXP EYE RES IN PRESS; Cui JZ, 2007, EYE, V21, P200, DOI 10.1038/sj.eye.6702169; Dieudonne SC, 2004, INVEST OPHTH VIS SCI, V45, P4113, DOI 10.1167/iovs.04-0643; Dolloff NG, 2007, CANCER RES, V67, P555, DOI 10.1158/0008-5472.CAN-06-2593; Emaduddin M, 2008, P NATL ACAD SCI USA, V105, P2358, DOI 10.1073/pnas.0712176105; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Gelderloos JA, 1998, J BIOL CHEM, V273, P5908, DOI 10.1074/jbc.273.10.5908; GLASER BM, 1987, OPHTHALMOLOGY, V94, P327; Hansen K, 1996, EMBO J, V15, P5299, DOI 10.1002/j.1460-2075.1996.tb00915.x; Harada C, 2006, PROG RETIN EYE RES, V25, P149, DOI 10.1016/j.preteyeres.2005.09.001; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Ikuno Y, 2000, INVEST OPHTH VIS SCI, V41, P3107; Ikuno Y, 2002, INVEST OPHTH VIS SCI, V43, P483; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kita T, 2007, DIABETES, V56, P1421, DOI 10.2337/db06-1644; KLINGHOFFER AR, 1995, J BIOL CHEM, V270, P22208; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; La Heij EC, 2002, AM J OPHTHALMOL, V134, P367, DOI 10.1016/S0002-9394(02)01536-2; LAQUA H, 1975, AM J OPHTHALMOL, V80, P602, DOI 10.1016/0002-9394(75)90390-6; Lashkari K, 1999, INVEST OPHTH VIS SCI, V40, P149; Lei HT, 2007, INVEST OPHTH VIS SCI, V48, P2335, DOI 10.1167/iovs.06-0965; Lei HT, 2004, CIRC RES, V94, P902, DOI 10.1161/01.RES.0000124979.46214.E3; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563, DOI 10.1074/jbc.270.21.12563; Liou G, 2002, MOL VIS, V8, P494; Liu YL, 2007, FASEB J, V21, P2725, DOI 10.1096/fj.06-8058com; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; Matsuoka H, 2004, J BIOL CHEM, V279, P5975, DOI 10.1074/jbc.M311278200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mukherjee S, 2007, INVEST OPHTH VIS SCI, V48, P1892, DOI 10.1167/iovs.06-1095; NAGASAKI H, 1991, RETINA-J RET VIT DIS, V11, P204, DOI 10.1097/00006982-199111020-00002; NAKAGAWA M, 1995, INVEST OPHTH VIS SCI, V36, P2388; Oshima Y, 2002, GENE THER, V9, P1214, DOI 10.1038/sj.gt.3301789; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3649; Rosenkranz S, 1999, GROWTH FACTORS, V16, P201, DOI 10.3109/08977199909002130; RYAN SJ, 1993, AM J OPHTHALMOL, V115, P1; Siegbahn A, 2008, ARTERIOSCL THROM VAS, V28, P135, DOI 10.1161/ATVBAHA.107.155754; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Veracini L, 2006, J CELL SCI, V119, P2921, DOI 10.1242/jcs.03015; Wan XS, 2003, RADIAT RES, V160, P622, DOI 10.1667/3099; YOSHINO Y, 1989, RETINA-J RET VIT DIS, V9, P97, DOI 10.1097/00006982-198909020-00004; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zheng YP, 2003, JPN J OPHTHALMOL, V47, P158, DOI 10.1016/S0021-5155(02)00698-6	64	76	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6329	6336		10.1074/jbc.M808426200	http://dx.doi.org/10.1074/jbc.M808426200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19126548	Green Published, hybrid			2022-12-27	WOS:000263742700036
J	Cunningham, F; Rath, A; Johnson, RM; Deber, CM				Cunningham, Fiona; Rath, Arianna; Johnson, Rachel M.; Deber, Charles M.			Distinctions between Hydrophobic Helices in Globular Proteins and Transmembrane Segments as Factors in Protein Sorting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; K+ CHANNEL; MEMBRANE; RECOGNITION; PREDICTION; PEPTIDES; OLIGOMERIZATION; ENVIRONMENTS; ASSOCIATION; TRANSLOCON	Transmembrane (TM) segments in proteins can be distinguished in amino acid sequences as continuous stretches of hydrophobic residues. However, examination of a data base of helical water-soluble (globular) proteins revealed that nearly one-third contained helices of sufficient length to span a bilayer (>= 19 residues) that had mean hydrophobicity >= actual TM segments. We now report that synthetic peptides corresponding to these globular protein sequences, which we termed "delta-helices," behave like native TM sequences and readily insert into membrane mimetic environments in helical conformations. As well, certain delta-helix sequences can integrate into the membrane bilayer when placed into a membrane-targeted chimeric protein. We establish that delta-helices can be distinguished computationally from bona fide TM segments by the decreased frequency of occurrence of Ile/Val residues and by their relatively decreased solvent accessibilities (versus other globular helices) within tertiary structure. The further observations that (i) delta-helices generally contain three or more charged residues and (ii) delta-helices display relatively even distribution of these charged residues along their lengths, rather than concentration near their N and C termini as observed for TM segments, may constitute key recognition factors in diverting delta-helices from the membrane in vivo. Although a discrete biological role for delta-helices remains to be pinpointed, our overall results suggest that such segments may be required for globular protein folding and identify additional factors that may be important in the correct selection of TM segments by the cellular machinery.	[Deber, Charles M.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Deber, CM (corresponding author), Hosp Sick Children, Res Inst, Div Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	deber@sickkids.ca			Natural Sciences and Engineering Research Council of Canada [A-2807]; Canadian Institutes of Health Research [5810]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported, in part, by grants ( to C. M. D.) from the Natural Sciences and Engineering Research Council of Canada ( NSERC Discovery Grant A-2807) and Canadian Institutes of Health Research ( Grant FRN-5810).	CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; Cuthbertson JM, 2006, BIOCHEMISTRY-US, V45, P14298, DOI 10.1021/bi0610911; Deber CM, 2001, PROTEIN SCI, V10, P212, DOI 10.1110/ps.30301; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Galdiero S, 2007, CURR PROTEIN PEPT SC, V8, P63, DOI 10.2174/138920307779941541; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hubbard ST, 1993, NACCESS; IMAMURA T, 2006, ENCY SURFACE COLLOID, V7, P5251; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Johnson RM, 2006, BIOCHEMISTRY-US, V45, P8507, DOI 10.1021/bi060063f; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liu LP, 1999, BIOORGAN MED CHEM, V7, P1, DOI 10.1016/S0968-0896(98)00233-8; Liu LP, 1996, BIOPOLYMERS, V39, P465, DOI 10.1002/(SICI)1097-0282(199609)39:3<465::AID-BIP17>3.0.CO;2-A; Liu LP, 1998, J BIOL CHEM, V273, P23645, DOI 10.1074/jbc.273.37.23645; Lu LP, 1998, BIOPOLYMERS, V47, P41, DOI 10.1002/(SICI)1097-0282(1998)47:1<41::AID-BIP6>3.0.CO;2-X; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Melnyk RA, 2003, BIOPOLYMERS, V71, P675, DOI 10.1002/bip.10595; Melnyk RA, 2001, BIOCHEMISTRY-US, V40, P11106, DOI 10.1021/bi010642e; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Netz DJA, 2002, APPL ENVIRON MICROB, V68, P5274, DOI 10.1128/AEM.68.11.5274-5280.2002; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rath A, 2008, PROTEINS, V70, P786, DOI 10.1002/prot.21569; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Wang C, 2000, PEPTIDES FOR THE NEW MILLENNIUM, P367; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104; Zhao G, 2006, PROTEIN SCI, V15, P1987, DOI 10.1110/ps.062286306	34	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5395	5402		10.1074/jbc.M809017200	http://dx.doi.org/10.1074/jbc.M809017200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095650	hybrid			2022-12-27	WOS:000263416600069
J	Millard, EL; Nevin, ST; Loughnan, ML; Nicke, A; Clark, RJ; Alewood, PF; Lewis, RJ; Adams, DJ; Craik, DJ; Daly, NL				Millard, Emma L.; Nevin, Simon T.; Loughnan, Marion L.; Nicke, Annette; Clark, Richard J.; Alewood, Paul F.; Lewis, Richard J.; Adams, David J.; Craik, David J.; Daly, Norelle L.			Inhibition of Neuronal Nicotinic Acetylcholine Receptor Subtypes by alpha-Conotoxin GID and Analogues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE CALCULATION; TORSION ANGLE DYNAMICS; XENOPUS-LAEVIS OOCYTES; CRYSTAL-STRUCTURE; HOMOLOG ACHBP; ANTAGONISTS; BINDING; DETERMINANTS; CARCINOMA; PROTEINS	alpha-Conotoxins are small disulfide-rich peptides from the venom of the Conus species that target the nicotinic acetylcholine receptor (nAChR). They are valuable pharmacological tools and also have potential therapeutic applications particularly for the treatment of chronic pain. alpha-Conotoxin GID is isolated from the venom of Conus geographus and has an unusual N-terminal tail sequence that has been shown to be important for binding to the alpha 4 beta 2 subtype of the nAChR. To date, only four conotoxins that inhibit the alpha 4 beta 2 subtype have been characterized, but they are of considerable interest as it is the most abundant nAChR subtype in the mammalian brain and has been implicated in a range of diseases. In this study, analysis of alaninescan and truncation mutants of GID reveals that a conserved proline in alpha-conotoxins is important for activity at the alpha 7, alpha 3 beta 2, and alpha 4 beta 2 subtypes. Although the proline residue was the most critical residue for activity at the alpha 3 beta 2 subtype, Asp3, Arg12, and Asn14 are also critical at the alpha 7 subtype. Interestingly, very few of the mutations tested retained activity at the alpha 4 beta 2 subtype indicating a tightly defined binding site. This lack of tolerance to sequence variation may explain the lack of selective ligands discovered for the alpha 4 beta 2 subtype to date. Overall, our findings contribute to the understanding of the structureactivity relationships of alpha-conotoxins and may be beneficial for the ongoing attempts to exploit modulators of the neuronal nAChRs as therapeutic agents.	[Millard, Emma L.; Loughnan, Marion L.; Clark, Richard J.; Alewood, Paul F.; Lewis, Richard J.; Craik, David J.; Daly, Norelle L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Millard, Emma L.; Nevin, Simon T.; Adams, David J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Nicke, Annette] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany	University of Queensland; University of Queensland; University of Queensland; Max Planck Society	Daly, NL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	n.daly@imb.uq.edu.au	Daly, Norelle L/D-4302-2013; Clark, Richard J/G-8848-2012; Alewood, Paul F/J-2412-2014; Loughnan, Marion/B-4508-2009; Nevin, Simon/B-2663-2014; Craik, David/B-1695-2010; Lewis, Richard J/E-8674-2013; Adams, David John/K-3578-2019; Lewis, Richard/T-8763-2019	Daly, Norelle L/0000-0002-4697-6602; Clark, Richard J/0000-0002-6807-5426; Craik, David/0000-0003-0007-6796; Lewis, Richard J/0000-0003-3470-923X; Adams, David John/0000-0002-7030-2288; Lewis, Richard/0000-0003-3470-923X; Nicke, Annette/0000-0001-6798-505X; Alewood, Paul/0000-0001-7454-6522	Australian Research Council; Deutsche Forschungsgemeinschaft [NI 592/3]; National Health and Medical Research Council	Australian Research Council(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian Research Council (to D. J.A., R.J.L., P.F.A., and D.J.C.), Deutsche Forschungsgemeinschaft Grant NI 592/3 (to A. N.), and the National Health and Medical Research Council (to N.L.D. and R.J.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Codignola A, 1996, NEUROSCI LETT, V206, P53, DOI 10.1016/0304-3940(96)12423-X; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutertre S, 2004, EUR J BIOCHEM, V271, P2327, DOI 10.1111/j.1432-1033.2004.04147.x; Dutertre S, 2006, BIOCHEM PHARMACOL, V72, P661, DOI 10.1016/j.bcp.2006.03.027; Dutton JL, 2001, CURR MED CHEM, V8, P327, DOI 10.2174/0929867013373453; Dwoskin LP, 2001, J PHARMACOL EXP THER, V298, P395; ECCLES C, 1991, Journal of Biomolecular NMR, V1, P111, DOI 10.1007/BF01877224; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; Everhart D, 2004, BIOCHEMISTRY-US, V43, P2732, DOI 10.1021/bi036180h; FAINZILBER M, 1994, BIOCHEMISTRY-US, V33, P9523, DOI 10.1021/bi00198a018; Geerts H, 2002, J NEURAL TRANSM-SUPP, P203; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; GLOOR S, 1995, GENE, V160, P213, DOI 10.1016/0378-1119(95)00226-V; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hill JM, 1998, BIOCHEMISTRY-US, V37, P15621, DOI 10.1021/bi981535w; Hu SH, 1997, BIOCHEMISTRY-US, V36, P11323, DOI 10.1021/bi9713052; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jin AH, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-28; Kang TS, 2005, ANGEW CHEM INT EDIT, V44, P6333, DOI 10.1002/anie.200502300; Lam Sum, 2007, Cardiol Rev, V15, P154, DOI 10.1097/01.crd.0000260270.12829.45; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; McIntosh JM, 1999, ANNU REV BIOCHEM, V68, P59, DOI 10.1146/annurev.biochem.68.1.59; Meyer EM, 1998, J PHARMACOL EXP THER, V287, P918; Millard EL, 2004, EUR J BIOCHEM, V271, P2320, DOI 10.1111/j.1432-1033.2004.04148.x; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; Nicke A, 2003, J BIOL CHEM, V278, P3137, DOI 10.1074/jbc.M210280200; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; O'Neill MJ, 2002, CNS NEUROL DISORD-DR, V1, P399, DOI 10.2174/1568007023339166; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Sciamanna MA, 1997, J NEUROCHEM, V69, P2302; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; VIBAT CRT, 1995, CELL MOL NEUROBIOL, V15, P411, DOI 10.1007/BF02071877; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117	39	34	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4944	4951		10.1074/jbc.M804950200	http://dx.doi.org/10.1074/jbc.M804950200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098004	hybrid			2022-12-27	WOS:000263416600024
J	Desplats, C; Mus, F; Cuine, S; Billon, E; Cournac, L; Peltier, G				Desplats, Carine; Mus, Florence; Cuine, Stephan; Billon, Emmanuelle; Cournac, Laurent; Peltier, Gilles			Characterization of Nda2, a Plastoquinone-reducing Type II NAD(P)H Dehydrogenase in Chlamydomonas Chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH DEHYDROGENASE; RESPIRATORY-CHAIN; ACIDIANUS-AMBIVALENS; HYDROGEN-PRODUCTION; ARABIDOPSIS; REINHARDTII; IDENTIFICATION; REDUCTASE; PROTEINS; MITOCHONDRIA	Electron transfer pathways associated to oxygenic photosynthesis, including cyclic electron flow around photosystem I and chlororespiration, rely on non-photochemical reduction of plastoquinones (PQs). In higher plant chloroplasts, a bacterial-like NDH complex homologous to complex I is involved in PQ reduction, but such a complex is absent from Chlamydomonas plastids where a type II NAD(P) H dehydrogenase activity has been proposed to operate. With the aim to elucidate the nature of the enzyme-supporting non-photochemical reduction of PQs, one of the type II NAD( P) H dehydrogenases identified in the Chlamydomonas reinhardtii genome (Nda2) was produced as a recombinant protein in Escherichia coli and further characterized. As many type II NAD( P) H dehydrogenases, Nda2 uses NADH as a preferential substrate, but in contrast to the eukaryotic enzymes described so far, contains non-covalently bound FMN as a cofactor. When expressed at a low level, Nda2 complements growth of an E. coli lacking both NDH-1 and NDH-2, but is toxic at high expression levels. Using an antibody raised against the recombinant protein and based on its mass spectrometric identification, we show that Nda2 is localized in thylakoid membranes. Chlorophyll fluorescence measurements performed on thylakoid membranes show that Nda2 is able to interact with thylakoid membranes of C. reinhardtii by reducing PQs from exogenous NADH or NADPH. We discuss the possible involvement of Nda2 in cyclic electron flow around PSI, chlororespiration, and hydrogen production.	[Desplats, Carine; Mus, Florence; Cuine, Stephan; Billon, Emmanuelle; Cournac, Laurent; Peltier, Gilles] Aix Marseille Univ,CEA,CEA Cadarache, Direct Sci Vivant,UMR Biol Vegetale & Microbiol E, Lab Bioenerget & Biotechnol Bacteries & Microalgu, Inst Biol Environm & Biotechnol,CNRS, F-13108 St Paul Les Durance, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Peltier, G (corresponding author), Aix Marseille Univ,CEA,CEA Cadarache, Direct Sci Vivant,UMR Biol Vegetale & Microbiol E, Lab Bioenerget & Biotechnol Bacteries & Microalgu, Inst Biol Environm & Biotechnol,CNRS, Batiment 161, F-13108 St Paul Les Durance, France.	gilles.peltier@cea.fr	PELTIER, Gilles/ABD-4484-2021; Cournac, Laurent/G-2564-2010	PELTIER, Gilles/0000-0002-2226-3931; Mus, Florence/0000-0002-1655-1267; Cournac, Laurent/0000-0003-0371-938X	French "Agence Nationale pour la Recherche"; European FP7-Energy-RTD program [212508]	French "Agence Nationale pour la Recherche"(French National Research Agency (ANR)); European FP7-Energy-RTD program	This work was supported by the French "Agence Nationale pour la Recherche" (PHOTOBIOH2 project) and by the European FP7-Energy-RTD program (SOLARH2 project n degrees 212508). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Atteia A, 2006, J BIOL CHEM, V281, P9909, DOI 10.1074/jbc.M507862200; ATTEIA A, 1992, J BIOL CHEM, V267, P226; Bandeiras TM, 2003, BBA-BIOENERGETICS, V1557, P13, DOI 10.1016/S0005-2728(02)00374-2; Bandeiras TM, 2002, FEBS LETT, V531, P273, DOI 10.1016/S0014-5793(02)03514-7; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; Bernard L, 2006, FEBS J, V273, P3625, DOI 10.1111/j.1742-4658.2006.05370.x; Birch OM, 2000, J BIOL CHEM, V275, P32277, DOI 10.1074/jbc.M004497200; Bollivar DW, 1996, PLANT PHYSIOL, V112, P105, DOI 10.1104/pp.112.1.105; Brito JA, 2006, BBA-PROTEINS PROTEOM, V1764, P842, DOI 10.1016/j.bbapap.2005.09.015; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Cardol P, 2005, PLANT PHYSIOL, V137, P447, DOI 10.1104/pp.104.054148; Carneiro P, 2004, BBA-BIOENERGETICS, V1608, P45, DOI 10.1016/j.bbabio.2003.10.004; Carrie C, 2008, FEBS LETT, V582, P3073, DOI 10.1016/j.febslet.2008.07.061; Chen HC, 2004, PLANTA, V220, P198, DOI 10.1007/s00425-004-1331-5; CORRELL CC, 1993, PROTEIN SCI, V2, P2112, DOI 10.1002/pro.5560021212; Cournac L, 2002, INT J HYDROGEN ENERG, V27, P1229, DOI 10.1016/S0360-3199(02)00105-2; Dai SD, 1996, J MOL BIOL, V264, P1044, DOI 10.1006/jmbi.1996.0695; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Desplats C, 2007, FEBS LETT, V581, P4017, DOI 10.1016/j.febslet.2007.07.035; Dos Santos CV, 2005, PLANT PHYSIOL, V138, P909, DOI 10.1104/pp.105.062430; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Elhafez D, 2006, PLANT CELL PHYSIOL, V47, P43, DOI 10.1093/pcp/pci221; ERIKSSON M, 1995, PLANT PHYSIOL, V107, P479, DOI 10.1104/pp.107.2.479; Fang J, 2002, BIOCHEMISTRY-US, V41, P3065, DOI 10.1021/bi015989w; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fouchard S, 2005, APPL ENVIRON MICROB, V71, P6199, DOI 10.1128/AEM.71.10.6199-6205.2005; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P219, DOI 10.1085/jgp.26.2.219; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GANS P, 1990, BIOCHIM BIOPHYS ACTA, V1015, P150, DOI 10.1016/0005-2728(90)90226-T; Geisler DA, 2007, J BIOL CHEM, V282, P28455, DOI 10.1074/jbc.M704674200; GODDE D, 1980, ARCH MICROBIOL, V127, P245, DOI 10.1007/BF00427200; Gomes CM, 2001, J BIOENERG BIOMEMBR, V33, P1, DOI 10.1023/A:1005630221892; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mechin V, 2003, PROTEOMICS, V3, P1299, DOI 10.1002/pmic.200300450; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Melis A, 2007, PLANTA, V226, P1075, DOI 10.1007/s00425-007-0609-9; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Melo AMP, 2001, J BIOL CHEM, V276, P3947, DOI 10.1074/jbc.M008199200; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Michalecka AM, 2004, PLANT J, V37, P415, DOI 10.1046/j.1365-313X.2003.01970.x; Michalecka AM, 2003, PLANT PHYSIOL, V133, P642, DOI 10.1104/pp.103.024208; Mus F, 2005, BBA-BIOENERGETICS, V1708, P322, DOI 10.1016/j.bbabio.2005.05.003; PATEL AM, 1995, J BACTERIOL, V177, P3917, DOI 10.1128/jb.177.14.3917-3922.1995; PELTIER G, 1991, P NATL ACAD SCI USA, V88, P4791, DOI 10.1073/pnas.88.11.4791; PELTIER G, 1987, BIOCHIM BIOPHYS ACTA, V893, P83, DOI 10.1016/0005-2728(87)90151-4; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Rasmusson AG, 1999, PLANT J, V20, P79, DOI 10.1046/j.1365-313X.1999.00576.x; RAVENEL J, 1994, PLANTA, V193, P251; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarrio N, 2006, BBA-BIOENERGETICS, V1757, P1476, DOI 10.1016/j.bbabio.2006.09.002; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Wagner V, 2008, PLANT PHYSIOL, V146, P772, DOI 10.1104/pp.107.109645; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083	59	111	114	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4148	4157		10.1074/jbc.M804546200	http://dx.doi.org/10.1074/jbc.M804546200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19056727	hybrid			2022-12-27	WOS:000263134400012
J	Mikami, T; Yasunaga, D; Kitagawa, H				Mikami, Tadahisa; Yasunaga, Daiki; Kitagawa, Hiroshi			Contactin-1 Is a Functional Receptor for Neuroregulatory Chondroitin Sulfate-E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTES NEURITE OUTGROWTH; TYROSINE-PHOSPHATASE ALPHA; E-DISACCHARIDE EXPRESSION; NEURONAL CELL-ADHESION; HIPPOCAMPAL-NEURONS; DERMATAN SULFATE; GROWTH-FACTORS; KINASE FYN; BINDING; MOLECULE	Chondroitin sulfate (CS) plays critical roles in central nervous system development and regeneration, and individual modifications of CS form a "sulfation code" that regulates growth factor signaling or neuronal growth. Although we have shown that CS-E polysaccharide, but not CS-A or -C polysaccharide, has an inherent ability to promote neurite outgrowth toward primary neurons, its molecular mechanism remains elusive. Here, we show the involvement of a plasma membrane-tethered cell adhesion molecule, contactin-1 (CNTN-1), in CS-E-mediated neurite extension in a mouse neuroblastoma cell line and primary hippocampal neurons. CS-E, but not CS-A, -C, or heparan sulfate, engaged CNTN-1 with significant affinity and induced intracellular signaling downstream of CNTN-1, indicating that CS-E is a selective ligand for a potential CS receptor, CNTN-1, leading to neurite outgrowth. Our data provide the first evidence that biological functions of CS are exerted through the CS receptor-mediated signaling pathway(s).	[Mikami, Tadahisa; Yasunaga, Daiki; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Kitagawa, Hiroshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Kobe Pharmaceutical University; Japan Science & Technology Agency (JST)	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Japan Private School Promotion Foundation [19390025]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20790080, 18790073]; Ministry of Health, Labour, and Welfare	Japan Private School Promotion Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by the scientific promotion fund from the Japan Private School Promotion Foundation, Grants-in-aid for Scientific Research-B # 19390025 (to H. K.) and Encouragement of Young Scientists # 20790080 and # 18790073 (to T. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and a grant-in-aid for research on psychiatric and neurological diseases and mental health (to H. K.) from the Ministry of Health, Labour, and Welfare.	Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Brackenbury WJ, 2008, J NEUROSCI, V28, P3246, DOI 10.1523/JNEUROSCI.5446-07.2008; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Carulli D, 2005, CURR OPIN NEUROBIOL, V15, P252, DOI 10.1016/j.conb.2005.03.018; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Falk J, 2002, BIOL CELL, V94, P327, DOI 10.1016/S0248-4900(02)00006-0; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Revest JM, 1999, EUR J NEUROSCI, V11, P1134, DOI 10.1046/j.1460-9568.1999.00521.x; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Tully SE, 2004, J AM CHEM SOC, V126, P7736, DOI 10.1021/ja0484045; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; ZISCH AH, 1995, MOL CELL NEUROSCI, V6, P263, DOI 10.1006/mcne.1995.1021	28	93	96	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4494	4499		10.1074/jbc.M809227200	http://dx.doi.org/10.1074/jbc.M809227200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19075012	hybrid			2022-12-27	WOS:000263134400049
J	Struchholz, S; Elfrink, K; Pieper, U; Kalhammer, G; Honnert, U; Gruetzner, A; Linke, WA; Liao, WQ; Bahler, M				Struchholz, Sandra; Elfrink, Kerstin; Pieper, Uwe; Kalhammer, Georg; Honnert, Ulrike; Gruetzner, Anika; Linke, Wolfgang A.; Liao, Wanqin; Baehler, Martin			Functional Role of the Extended Loop 2 in the Myosin 9b Head for Binding F-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTOMYOSIN ADENOSINE-TRIPHOSPHATASE; MAXIMUM ATPASE ACTIVITY; PROCESSIVE MOVEMENT; ELECTRON CRYOMICROSCOPY; MOTOR DOMAIN; PROTEIN; MECHANISM; MUSCLE; IXB; AFFINITY	The mammalian class IX myosin Myo9b can move considerable distances along actin filaments before it dissociates. This is remarkable, because it is single headed and because the rate-limiting step in its ATPase cycle is ATP hydrolysis. Thus, it spends most of its cycling time in the ATP-bound state that has a weak affinity for F-actin in other myosins. It has been speculated that the very extended loop 2 in the Myo9b head domain comprises an additional actin-binding site that prevents it from dissociation in the weak binding states. Here we show that two regions in the loop 2 determine the F-actin concentrations needed to maximally activate the steady-state ATPase activity. Together these two regions regulate the amount capable of binding F-actin and the affinity of the nucleotide-free state. The isolated loop 2 behaved like an entropic spring and bound stoichiometrically and with high affinity to F-actin. Subfragment 1 from skeletal muscle myosin II bound to F-actin simultaneously with the isolated loop 2 of Myo9b and could not displace it. Furthermore, the present results imply also a regulatory role for the tail region. Taken together, the results demonstrate that the extended loop 2 in Myo9b binds F-actin and influences the binding of the conventional stereo-specific actin-binding site.	[Struchholz, Sandra; Elfrink, Kerstin; Pieper, Uwe; Kalhammer, Georg; Honnert, Ulrike; Gruetzner, Anika; Linke, Wolfgang A.; Liao, Wanqin; Baehler, Martin] Univ Munster, Inst Allgemeine Zool & Genet, D-48149 Munster, Germany	University of Munster	Bahler, M (corresponding author), Univ Munster, Inst Allgemeine Zool & Genet, Schlosspl 5, D-48149 Munster, Germany.	baehler@uni-muenster.de	Linke, Wolfgang A/E-8662-2012	Linke, Wolfgang/0000-0003-0801-3773	Deutsche Forschungsgemeinschaft [BA 1354/9-1, SFB 629]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants BA 1354/9-1 and SFB 629. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALISSANO P, 1978, P NATL ACAD SCI USA, V75, P2210, DOI 10.1073/pnas.75.5.2210; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; FOWLER WE, 1982, J CELL BIOL, V93, P452, DOI 10.1083/jcb.93.2.452; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; GOA J, 1953, SCAND J CLIN LAB INV, V5, P218, DOI 10.3109/00365515309094189; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Inoue A, 2002, NAT CELL BIOL, V4, P302, DOI 10.1038/ncb774; JAHN R, 1984, P NATL ACAD SCI-BIOL, V81, P1684, DOI 10.1073/pnas.81.6.1684; Joel PB, 2003, BIOCHEMISTRY-US, V42, P9160, DOI 10.1021/bi034415j; Kambara T, 2006, J BIOL CHEM, V281, P4949, DOI 10.1074/jbc.M509141200; Kempler K, 2007, BIOCHEMISTRY-US, V46, P4280, DOI 10.1021/bi062112u; Krementsova EB, 2006, J BIOL CHEM, V281, P6079, DOI 10.1074/jbc.M510041200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKATOS S, 1991, J BIOL CHEM, V266, P18707; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Linke WA, 2008, PFLUG ARCH EUR J PHY, V456, P101, DOI 10.1007/s00424-007-0389-x; MAGRI E, 1978, BIOCHEM BIOPH RES CO, V82, P1207, DOI 10.1016/0006-291X(78)90315-7; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; Murphy CT, 1999, BIOCHEMISTRY-US, V38, P3785, DOI 10.1021/bi9826815; Nalavadi V, 2005, J BIOL CHEM, V280, P38957, DOI 10.1074/jbc.M507161200; Nishikawa M, 2006, BIOCHEM BIOPH RES CO, V343, P1159, DOI 10.1016/j.bbrc.2006.03.057; OKAMOTO Y, 1985, J BIOCHEM-TOKYO, V98, P1143, DOI 10.1093/oxfordjournals.jbchem.a135365; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Post PL, 2002, J BIOL CHEM, V277, P11679, DOI 10.1074/jbc.M111173200; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; REINHARD J, 1995, EMBO J, V14, P697, DOI 10.1002/j.1460-2075.1995.tb07048.x; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Sweeney HL, 2007, EMBO J, V26, P2682, DOI 10.1038/sj.emboj.7601720; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v	40	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3663	3671		10.1074/jbc.M808338200	http://dx.doi.org/10.1074/jbc.M808338200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19059909	hybrid			2022-12-27	WOS:000262872500034
J	Zen, K; Liu, DQ; Li, LM; Chen, CXJ; Guo, YL; Ha, B; Chen, X; Zhang, CY; Liu, Y				Zen, Ke; Liu, Dan-Qing; Li, Li-Min; Chen, Celia X. -J.; Guo, Ya-Lan; Ha, Bihn; Chen, Xi; Zhang, Chen-Yu; Liu, Yuan			The Heparan Sulfate Proteoglycan Form of Epithelial CD44v3 Serves as a CD11b/CD18 Counter-receptor during Polymorphonuclear Leukocyte Transepithelial Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN MAC-1 CD11B/CD18; INFLAMMATORY-BOWEL-DISEASE; NEUTROPHIL TRANSMIGRATION; INTESTINAL EPITHELIUM; ULCERATIVE-COLITIS; ADHESION RECEPTOR; INTERFERON-GAMMA; CROHNS-DISEASE; EXPRESSION; LIGAND	Leukocyte beta(2)-integrin CD11b/CD18 mediates the firm adhesion and subsequent transepithelial migration of polymorphonuclear leukocytes, but the identity of its counter-receptor(s) on epithelia remains elusive. Here we identified a monoclonal antibody, clone C3H7, which strongly bound to the basolateral membranes of epithelial cells and inhibited both the adhesion of epithelial cells to immobilized CD11b/CD8 and the transepithelial migration of PMNs in a physiologically relevant basolateral-to-apical direction. C3H7 antigen expression in epithelial monolayers was significantly increased by treatment with pro-inflammatory cytokine interferon-gamma or a combination of interferon-gamma and tumor necrosis factor-alpha. Up-regulation of C3H7 antigen was also observed in the epithelium of inflamed human colon tissues. Microsequencing and Western blotting of the purified antigen showed it to be CD44 variant 3 (CD44v3), a similar to 160-kDa membrane glycoprotein. Further studies demonstrated that this epithelial CD44v3 specifically binds to CD11b/CD18 through its heparan sulfate moieties. In summary, our study demonstrates for the first time that the heparan sulfate proteoglycan form of epithelial CD44v3 plays a critical role in facilitating PMN recruitment during inflammatory episodes via directly binding to CD11b/CD18.	[Zen, Ke; Liu, Dan-Qing; Li, Li-Min; Guo, Ya-Lan; Chen, Xi; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Res Ctr, Nanjing 210093, Jiangsu, Peoples R China; [Zen, Ke; Chen, Celia X. -J.; Guo, Ya-Lan; Ha, Bihn; Liu, Yuan] Georgia State Univ, Dept Biol, Program Mol Biol & Physiol, Atlanta, GA 30303 USA	Nanjing University; University System of Georgia; Georgia State University	Zen, K (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Res Ctr, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	kzen@nju.edu.cn			National Institutes of Health [R21 AI073622]; American Heart Association [0535263N]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 AI073622. This work was also supported by Scientist Development Grant 0535263N from the American Heart Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; Cai TQ, 1996, J EXP MED, V184, P1213, DOI 10.1084/jem.184.4.1213; Camacho FI, 1999, HISTOPATHOLOGY, V35, P144, DOI 10.1046/j.1365-2559.1999.00712.x; Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098; Colgan Sean P, 2002, ScientificWorldJournal, V2, P76; COLGAN SP, 1995, J BIOL CHEM, V270, P10531, DOI 10.1074/jbc.270.18.10531; COLGAN SP, 1994, AM J PHYSIOL, V267, pC402, DOI 10.1152/ajpcell.1994.267.2.C402; DANA N, 1991, P NATL ACAD SCI USA, V88, P3106, DOI 10.1073/pnas.88.8.3106; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; Frick C, 2005, EUR J IMMUNOL, V35, P3610, DOI 10.1002/eji.200425914; HAWKER PC, 1980, GASTROENTEROLOGY, V79, P508; Huang GTJ, 1996, J CLIN INVEST, V98, P572, DOI 10.1172/JCI118825; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Lawrence DW, 2003, J EXP MED, V198, P999, DOI 10.1084/jem.20030380; Leir SH, 2000, AM J PHYSIOL-LUNG C, V278, pL1129, DOI 10.1152/ajplung.2000.278.6.L1129; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Macdonald DC, 2003, EUR J GASTROEN HEPAT, V15, P1101, DOI 10.1097/00042737-200310000-00007; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Parkos CA, 1996, J CELL BIOL, V132, P437, DOI 10.1083/jcb.132.3.437; PARKOS CA, 1991, J CLIN INVEST, V88, P1605, DOI 10.1172/JCI115473; Peter K, 1999, CIRCULATION, V100, P1533, DOI 10.1161/01.CIR.100.14.1533; Pituch-Noworolska A, 1998, ANTICANCER RES, V18, P3747; Reaves TA, 2001, AM J PHYSIOL-GASTR L, V280, pG746, DOI 10.1152/ajpgi.2001.280.4.G746; Reinisch W, 1998, GUT, V43, P375, DOI 10.1136/gut.43.3.375; ROSENBERG WMC, 1995, LANCET, V345, P1205, DOI 10.1016/S0140-6736(95)91991-0; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Schenauer MR, 2007, J BIOL CHEM, V282, P25182, DOI 10.1074/jbc.M703387200; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; SMITH CW, 1988, J CLIN INVEST, V82, P1746, DOI 10.1172/JCI113788; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; Trejdosiewicz LK, 1998, CYTOKINE, V10, P756, DOI 10.1006/cyto.1998.0361; UNDERHILL C, 1992, J CELL SCI, V103, P293; Vachon E, 2007, BLOOD, V110, P4492, DOI 10.1182/blood-2007-02-076539; WALZOG B, 1995, EXP CELL RES, V218, P28, DOI 10.1006/excr.1995.1127; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weg-Remers S, 1998, AM J GASTROENTEROL, V93, P790; WEILAND JE, 1986, AM REV RESPIR DIS, V133, P218; Wittig B, 1999, LAB INVEST, V79, P747; Yan Y, 2007, AM J PHYSIOL-GASTR L, V292, pG535, DOI 10.1152/ajpgi.00385.2006; Zen K, 2004, MOL BIOL CELL, V15, P3926, DOI 10.1091/mbc.E04-04-0317; Zen K, 2002, J IMMUNOL, V169, P5270, DOI 10.4049/jimmunol.169.9.5270	50	24	26	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3768	3776		10.1074/jbc.M807805200	http://dx.doi.org/10.1074/jbc.M807805200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073595	hybrid, Green Published			2022-12-27	WOS:000262872500045
J	Chen, T; Li, M; Ding, Y; Zhang, LS; Xi, Y; Pan, WJ; Tao, DL; Wang, JY; Li, L				Chen, Ting; Li, Meng; Ding, Yu; Zhang, Le-shuai; Xi, Ying; Pan, Wei-jun; Tao, Dong-lei; Wang, Ji-yong; Li, Lin			Identification of Zinc-finger BED Domain-containing 3 (Zbed3) as a Novel Axin-interacting Protein That Activates Wnt/beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-KINASE MECHANISM; BETA-CATENIN; NEGATIVE REGULATOR; WNT; PATHWAY; PHOSPHORYLATION; COMPLEX; TRANSDUCTION; EXPRESSION; STABILITY	Axin, a key modulator of the Wnt/beta-catenin pathway, acts as a scaffold protein in phosphorylating and degrading cytoplasmic beta-catenin. Canonical Wnt proteins appear to stabilize beta-catenin by inducing the interaction of LRP5/6 with Axin. This interaction requires the phosphorylation of the Ser or Thr residues in the PPPP(S/T)PX(T/S) motifs at the intracellular domain of LRP5/6. In this work, we identified a novel Axin-interacting protein, zinc-finger BED domain-containing 3 (Zbed3), by yeast two-hybrid screening. The interaction was confirmed in co-immunoprecipitation experiment in mammalian cells and in vitro pulldown assays. Moreover, we found Zbed3 also contains a PPPPSPT motif, which is crucial to its binding to Axin. The Ser and Thr residues in the motif appear to be also phosphorylated by glycogen synthase kinase 3 beta (GSK3 beta) and the CKI family kinases, as GSK3 beta and CKI epsilon could enhance the interaction of Zbed3 with Axin. Mutation of the Ser (SA) or Thr (TA) residue to Ala in the motif markedly impaired its ability to interact with Axin. Expressing Zbed3, but not these mutants, led to inhibition of GSK3 beta-mediated beta-catenin phosphorylation, cytoplasmic beta-catenin accumulation, and activation of lymphoid enhancer binding factor-1-dependent reporter gene transcription. Furthermore, knockdown of Zbed3 with RNA interference attenuated Wnt-induced beta-catenin accumulation, lymphoid enhancer binding factor-1-dependent luciferase reporter activity, and the Wnt target gene expression. These results together indicate that Zbed3 is a novel Axin-binding protein that is involved in Wnt/beta-catenin signaling modulation.	[Chen, Ting; Li, Meng; Ding, Yu; Zhang, Le-shuai; Xi, Ying; Pan, Wei-jun; Tao, Dong-lei; Wang, Ji-yong; Li, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	lli@sibs.ac.cn	Zhang, Leshuai/C-8077-2012; Ding, Yu/A-2949-2013; li, li/HII-4157-2022; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022	Le, Shuai/0000-0003-3748-5454	Ministry of Science and Technology of China [2007CB914500 and 2007CB947100]; Natural Science Foundation of China [30821065, 30600305]; Science and Technology Commission of Shanghai Municipality; Chinese Academy of Sciences	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology of China Grants 2007CB914500 and 2007CB947100, by Natural Science Foundation of China Grants 30821065 ( to L. L.) and 30600305 ( to J. W.), and by Science and Technology Commission of Shanghai Municipality and Chinese Academy of Sciences grants.	Baig-Lewis S, 2007, DEV BIOL, V306, P94, DOI 10.1016/j.ydbio.2007.03.005; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Chia IV, 2005, MOL CELL BIOL, V25, P4371, DOI 10.1128/MCB.25.11.4371-4376.2005; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Dahmen RP, 2001, CANCER RES, V61, P7039; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kusano S, 2002, MOL CELL BIOL, V22, P6393, DOI 10.1128/MCB.22.18.6393-6405.2002; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PLATT T, 1972, EXPT MOL GENETICS, P352; Polakis P, 2000, GENE DEV, V14, P1837; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Shiomi K, 2003, CURR BIOL, V13, P73, DOI 10.1016/S0960-9822(02)01398-2; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	39	35	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6683	6689		10.1074/jbc.M807753200	http://dx.doi.org/10.1074/jbc.M807753200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19141611	Green Published, hybrid			2022-12-27	WOS:000263919000012
J	Morgan, B; Ang, SK; Yan, GH; Lu, H				Morgan, Bruce; Ang, Swee Kim; Yan, Guanhua; Lu, Hui			Zinc Can Play Chaperone-like and Inhibitor Roles during Import of Mitochondrial Small Tim Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE RELAY SYSTEM; INTERMEMBRANE SPACE; BINDING; MIA40; OXIDATION; FINGERS; BIOLOGY; MOTIF	Zinc is an essential cofactor required for the function of similar to 8% of the yeast and 10% of the human proteome. All of the "small Tim" proteins of the mitochondrial intermembrane space contain a strictly conserved "twin CX3C" zinc finger motif, which can bind zinc ions in the Cys-reduced form. We have shown previously that although disulfide bond formation is essential for the function of these proteins in mitochondria, only reduced proteins can be imported into mitochondria (Lu, H., Allen, S., Wardleworth, L., Savory, P., and Tokatlidis, K. (2004) J. Biol. Chem. 279, 18952-18958 and Morgan, B., and Lu, H. (2008) Biochem. J. 411, 115-122). However, the role of zinc during the import of these proteins is unclear. This study shows that the function of zinc is complex. It can play a thiol stabilizer role preventing oxidative folding of the small Tim proteins and maintaining the proteins in an import-competent form. On the other hand, zinc-bound forms cannot be imported into mitochondria efficiently. Furthermore, our results show that zinc is a powerful inhibitor of Erv1, an essential component of the import pathway used by the small Tim proteins. We propose that zinc plays a chaperone-like role in the cytosol during biogenesis of the small Tim proteins and that the proteins are imported into mitochondria through the apo-forms.	[Morgan, Bruce; Ang, Swee Kim; Yan, Guanhua; Lu, Hui] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Lu, H (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	hui.lu@manchester.ac.uk	Lu, Hui/AAB-5476-2021	Lu, Hui/0000-0002-7029-2681; Ang, Swee Kim/0000-0003-3058-6105; Morgan, Bruce/0000-0001-9393-1071	Biotechnology and Biological Sciences Research Council [BB/C514323, BB/C514323/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Curran SP, 2004, J BIOL CHEM, V279, P43744, DOI 10.1074/jbc.M404878200; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; FRAUSTO JJR, 2001, BIOL CHEM ELEMENTS, P315; HAASE H, 2006, BIOGERONTOLOGY, V28, P1; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Ivanova E, 2008, J MOL BIOL, V375, P229, DOI 10.1016/j.jmb.2007.10.037; Ivanova E, 2008, PROTEINS, V71, P467, DOI 10.1002/prot.21713; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Krezel A, 2003, INORG CHEM, V42, P1994, DOI 10.1021/ic025969y; Leuenberger D, 2003, TRAFFIC, V4, P144, DOI 10.1034/j.1600-0854.2003.00095.x; Li W, 2003, J MOL BIOL, V333, P461, DOI 10.1016/j.jmb.2003.08.038; Lu H, 2005, J MOL BIOL, V353, P897, DOI 10.1016/j.jmb.2005.09.002; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Lu H, 2004, J BIOL CHEM, V279, P18959, DOI 10.1074/jbc.M313046200; Maret W, 2005, J TRACE ELEM MED BIO, V19, P7, DOI 10.1016/j.jtemb.2005.02.003; Maret W, 2004, BIOCHEMISTRY-US, V43, P3301, DOI 10.1021/bi036340p; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mesecke N, 2008, EMBO REP, V9, P1107, DOI 10.1038/embor.2008.173; Morgan B, 2008, BIOCHEM J, V411, P115, DOI 10.1042/BJ20071476; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1997, J NEUROSCI, V17, P9554; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Tang W, 2001, BIOCHEMISTRY-US, V40, P14985, DOI 10.1021/bi0107593; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Vallee B L, 1995, EXS, V73, P259; Wang WZ, 2007, BIOCHEMISTRY-US, V46, P3246, DOI 10.1021/bi602499t; WILLIAMS RJP, 1984, ENDEAVOUR, V8, P65, DOI 10.1016/0160-9327(84)90040-1	35	30	32	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6818	6825		10.1074/jbc.M808691200	http://dx.doi.org/10.1074/jbc.M808691200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19117943	hybrid, Green Published			2022-12-27	WOS:000263919000027
J	Park, EY; Sung, YH; Yang, MH; Noh, JY; Park, SY; Lee, TY; Yook, YJ; Yoo, KH; Roh, KJ; Kim, I; Hwang, YH; Oh, GT; Seong, JK; Ahn, C; Lee, HW; Park, JH				Park, Eun Young; Sung, Young Hoon; Yang, Moon Hee; Noh, Ji Yeun; Park, So Young; Lee, Tae Young; Yook, Yeon Joo; Yoo, Kyung Hyun; Roh, Kyung Jin; Kim, Ingyu; Hwang, Young-Hwan; Oh, Goo Taeg; Seong, Je Kyung; Ahn, Curie; Lee, Han-Woong; Park, Jong Hoon			Cyst Formation in Kidney via B-Raf Signaling in the PKD2 Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIN-2 INTERACTS; EPITHELIAL-CELLS; REGULATED KINASE; DISEASE; GENE; CHANNEL; PROTEIN; CYSTOGENESIS; PATHOGENESIS; MUTATIONS	The pathogenic mechanisms of human autosomal dominant polycystic kidney disease (ADPKD) have been well known to include the mutational inactivation of PKD2. Although haploinsufficiency and loss of heterozygosity at the Pkd2 locus can cause cyst formation in mice, polycystin-2 is frequently expressed in the renal cyst of human ADPKD, raising the possibility that deregulated activation of PKD2 may be associated with the cystogenesis of human ADPKD. To determine whether increased PKD2 expression is physiologically pathogenic, we generated PKD2-overexpressing transgenic mice. These mice developed typical renal cysts and an increase of proliferation and apoptosis, which are reflective of the human ADPKD phenotype. These manifestations were first observed at six months, and progressed with age. In addition, we found that ERK activation was induced by PKD2 overexpression via B-Raf signaling, providing a possible molecular mechanism of cystogenesis. In PKD2 transgenic mice, B-Raf/MEK/ERK sequential signaling was up-regulated. Additionally, the transgenic human polycystin-2 partially rescues the lethality of Pkd2 knock-out mice and therefore demonstrates that the transgene generated a functional product. Functional strengthening or deregulated activation of PKD2 may be a direct cause of ADPKD. The present study provides evidence for an in vivo role of overexpressed PKD2 in cyst formation. This transgenic mouse model should provide new insights into the pathogenic mechanism of human ADPKD.	[Sung, Young Hoon; Lee, Han-Woong] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Park, Eun Young; Yang, Moon Hee; Noh, Ji Yeun; Park, So Young; Lee, Tae Young; Yook, Yeon Joo; Yoo, Kyung Hyun; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea; [Ahn, Curie] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea; [Oh, Goo Taeg] Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; [Oh, Goo Taeg] Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea; [Hwang, Young-Hwan] Eulji Med Ctr, Dept Internal Med, Seoul 139711, South Korea; [Kim, Ingyu] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Roh, Kyung Jin; Seong, Je Kyung] Seoul Natl Univ, Coll Vet Med, Lab Dev Biol & Genom, Seoul 151742, South Korea	Yonsei University; Sookmyung Women's University; Seoul National University (SNU); Ewha Womans University; Ewha Womans University; Vanderbilt University; Seoul National University (SNU)	Lee, HW (corresponding author), Yonsei Univ, Dept Biochem, Seoul 120749, South Korea.	hwl@yonsei.ac.kr; parkjh@sookmyung.ac.kr	Ahn, Curie/J-5527-2012; Oh, Goo Taeg/AAQ-9995-2021	Seong, Je Kyung/0000-0003-1177-6958; Hwang, Young-Hwan/0000-0001-8935-2659	National Research Laboratory [R0A-2005-000-10101-0]; KOSEF grant funded by MEST (Research Center for Women's Disease); MEST [M106KB010014-07K0201-01410, M103KV010025-07K2201-02510]	National Research Laboratory(Korea Science and Engineering Foundation); KOSEF grant funded by MEST (Research Center for Women's Disease)(Korea Science and Engineering Foundation); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Laboratory Grant R0A-2005-000-10101-0, the SRC/ERC program of the KOSEF grant funded by MEST (Research Center for Women's Disease), and 21C Frontier Projects (Functional Human Genome Project, M106KB010014-07K0201-01410 and Brain Research Center, M103KV010025-07K2201-02510) from the MEST.	Arnaout MA, 2001, ANNU REV MED, V52, P93, DOI 10.1146/annurev.med.52.1.93; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; Burtey S, 2008, CELL BIOL INT, V32, P1193, DOI 10.1016/j.cellbi.2008.07.021; Burtey S, 2008, NEPHROL DIAL TRANSPL, V23, P1157, DOI 10.1093/ndt/gfm763; CARONE FA, 1996, ETIOLOGY PATHOGENESI, P111; Chang FM, 2003, INT J ONCOL, V22, P469; Chang MY, 2006, NEPHROL DIAL TRANSPL, V21, P2078, DOI 10.1093/ndt/gfl150; DAGATI V, 1992, J AM SOC NEPHROL, V3, P975; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Grantham JJ, 1996, AM J KIDNEY DIS, V28, P788, DOI 10.1016/S0272-6386(96)90378-9; Grimm DH, 2003, J BIOL CHEM, V278, P36786, DOI 10.1074/jbc.M306536200; Hidaka S, 2004, J BIOL CHEM, V279, P35009, DOI 10.1074/jbc.M314206200; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Lehtonen S, 2000, J BIOL CHEM, V275, P32888, DOI 10.1074/jbc.M006624200; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Li Q, 2003, J MOL BIOL, V325, P949, DOI 10.1016/S0022-2836(02)01333-5; Li Q, 2003, BIOCHEMISTRY-US, V42, P450, DOI 10.1021/bi0267792; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; NADASDY T, 1995, J AM SOC NEPHROL, V5, P1462; Nagao S, 2003, KIDNEY INT, V63, P427, DOI 10.1046/j.1523-1755.2003.00755.x; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Pei Y, 1998, J AM SOC NEPHROL, V9, P1853; Pei Y, 2001, TRENDS MOL MED, V7, P151, DOI 10.1016/S1471-4914(01)01953-0; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; Pritchard L, 2000, HUM MOL GENET, V9, P2617, DOI 10.1093/hmg/9.18.2617; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; ROSCOE JM, 1993, KIDNEY INT, V44, P1101, DOI 10.1038/ki.1993.355; Rundle DR, 2004, J BIOL CHEM, V279, P29728, DOI 10.1074/jbc.M400544200; Somlo S, 2001, CURR BIOL, V11, pR356, DOI 10.1016/S0960-9822(01)00193-2; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; Torra R, 1999, AM J HUM GENET, V65, P345, DOI 10.1086/302501; Torra R, 1996, J AM SOC NEPHROL, V7, P2142; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Tsiokas L, 2007, CELL SIGNAL, V19, P444, DOI 10.1016/j.cellsig.2006.09.005; Veldhuisen B, 1997, AM J HUM GENET, V61, P547, DOI 10.1086/515497; Viribay M, 1997, HUM GENET, V101, P229, DOI 10.1007/s004390050621; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; WRIGHT AF, 1993, HUM GENET, V90, P569, DOI 10.1007/BF00217461; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Xenophontos S, 1997, HUM MOL GENET, V6, P949, DOI 10.1093/hmg/6.6.949; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; Zhou XJ, 1998, DIAGN MOL PATHOL, V7, P65, DOI 10.1097/00019606-199804000-00001	53	64	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7214	7222		10.1074/jbc.M805890200	http://dx.doi.org/10.1074/jbc.M805890200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19098310	Green Published, hybrid			2022-12-27	WOS:000263919000068
J	Song, WF; Liu, G; Bosworth, CA; Walker, JR; Megaw, GA; Lazrak, A; Abraham, E; Sullender, WM; Matalon, S				Song, Weifeng; Liu, Gang; Bosworth, Charles A.; Walker, John R.; Megaw, George A.; Lazrak, Ahmed; Abraham, Edward; Sullender, Wayne M.; Matalon, Sadis			Respiratory Syncytial Virus Inhibits Lung Epithelial Na+ Channels by Up-regulating Inducible Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALVEOLAR MACROPHAGES; BIOPHYSICAL PROPERTIES; SODIUM-CHANNELS; PROTEIN; GENE; EXPRESSION; INFECTION; CELL; ACTIVATION	Respiratory syncytial virus (RSV) infection has been shown to reduce Na+-driven alveolar fluid clearance in BALB/ c mice in vivo. To investigate the cellular mechanisms by which RSV inhibits amiloride-sensitive epithelial Na+ channels (ENaC), the main pathways through which Na+ ions enter lung epithelial cells, we infected human Clara-like lung (H441) cells with RSV that expresses green fluorescent protein (rRA2). 3-6 days later patch clamp recordings showed that infected cells (i.e. cells expressing green fluorescence; GFP(+)) had significantly lower whole-cell amiloride-sensitive currents and single channel activity (NPo) as compared with non-infected (GFP(-)), non-inoculated, or cells infected with UV-inactivated RSV. Both alpha and beta ENaC mRNA levels were significantly reduced in GFP(+) cells as measured by real-time reverse transcription-PCR. Infection with RSV increased expression of the inducible nitric-oxide synthase (iNOS) and nitrite concentration in the culture medium; nuclear translocation of NF-kappa B p65 subunit and NF-kappa B activation were also up-regulated. iNOS up-regulation in GFP(+) cells was prevented by knocking down I kappa B kinase gamma before infection. Furthermore, pretreatment of H441 cells with the specific iNOS inhibitor 1400W (1 mu M) resulted in a doubling of the amiloride-sensitive Na+ current in GFP(+) cells. Additionally, preincubation of H441 cells with A77-1726 (20 mu M), a de novo UTP synthesis inhibitor, and 1400W completely reversed the RSV inhibition of amiloride-sensitive currents in GFP(+) cells. Thus, both UTP- and iNOS-generated reactive species contribute to ENaC down-regulation in RSV-infected airway epithelial cells.	[Song, Weifeng; Bosworth, Charles A.; Walker, John R.; Lazrak, Ahmed; Matalon, Sadis] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35233 USA; [Liu, Gang; Abraham, Edward] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35233 USA; [Megaw, George A.; Sullender, Wayne M.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35233 USA; [Sullender, Wayne M.; Matalon, Sadis] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35233 USA; [Matalon, Sadis] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35233 USA; [Bosworth, Charles A.; Lazrak, Ahmed; Matalon, Sadis] Univ Alabama Birmingham, Ctr Free Radical Biol, Birmingham, AL 35233 USA; [Matalon, Sadis] Univ Alabama Birmingham, Ctr Lung Injury & Repair, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Matalon, S (corresponding author), Univ Alabama Birmingham, Dept Anesthesiol, 224 BMR 2,901 19th St S, Birmingham, AL 35205 USA.	sadis@uab.edu		, Gang/0000-0002-6999-7633; Liu, Gang/0000-0003-2615-131X; Lazrak, Ahmed/0000-0002-4127-1937	National Institutes of Health [HL-31197, HL-51173]; NIEHS, Public Health Service [U01ES015676, 1U54NS063739]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL031197, R01HL051173, R01HL031197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)United States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-31197 and HL- 51173 and Grants U01ES015676 and 1U54NS063739 (NIEHS, Public Health Service). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bebok Z, 2002, J BIOL CHEM, V277, P43041, DOI 10.1074/jbc.M203154200; Burnstock G, 2000, J PHARMACOL EXP THER, V295, P862; Campbell DL, 1996, J GEN PHYSIOL, V108, P277, DOI 10.1085/jgp.108.4.277; Cartee TL, 2003, J VIROL, V77, P7352, DOI 10.1128/JVI.77.13.7352-7360.2003; Chen L, 2006, J BIOL CHEM, V281, P9190, DOI 10.1074/jbc.M513231200; CHEN L, 2008, AM J RESP C IN PRESS; Chen L, 2008, AM J RESP CELL MOL, V39, P150, DOI 10.1165/rcmb.2008-0005OC; Chen XJ, 2004, AM J PHYSIOL-LUNG C, V287, pL366, DOI 10.1152/ajplung.00011.2004; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Davis IC, 2007, AM J RESP CELL MOL, V37, P379, DOI 10.1165/rcmb.2007-0142OC; Davis IC, 2007, AM J PHYSIOL-LUNG C, V293, pL281, DOI 10.1152/ajplung.00458.2006; Davis IC, 2006, AM J RESP CRIT CARE, V173, P673, DOI 10.1164/rccm.200508-1200OC; Davis IC, 2004, AM J PHYSIOL-LUNG C, V286, pL112, DOI 10.1152/ajplung.00218.2003; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Eckardt-Michel J, 2008, J VIROL, V82, P3236, DOI 10.1128/JVI.01887-07; Eu JP, 1999, BIOCHEM PHARMACOL, V57, P1079, DOI 10.1016/S0006-2952(98)00360-8; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Fuentes S, 2007, J VIROL, V81, P8361, DOI 10.1128/JVI.02717-06; Guo Y, 1998, AM J PHYSIOL-LUNG C, V274, pL369, DOI 10.1152/ajplung.1998.274.3.L369; Guo Z, 2007, FASEB J, V21, P535, DOI 10.1096/fj.06-6739com; Haeberle HA, 2002, J INFECT DIS, V186, P1199, DOI 10.1086/344644; Hammer J, 1997, PEDIATR PULM, V23, P176, DOI 10.1002/(SICI)1099-0496(199703)23:3<176::AID-PPUL2>3.0.CO;2-M; Hardy RW, 1999, J VIROL, V73, P170, DOI 10.1128/JVI.73.1.170-176.1999; Hardy RW, 1998, J VIROL, V72, P520, DOI 10.1128/JVI.72.1.520-526.1998; Hickman-Davis J, 1999, P NATL ACAD SCI USA, V96, P4953, DOI 10.1073/pnas.96.9.4953; Jain L, 1998, AM J PHYSIOL-LUNG C, V274, pL475, DOI 10.1152/ajplung.1998.274.4.L475; Janssen R, 2007, J VIROL, V81, P5958, DOI 10.1128/JVI.02220-06; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; Kochva U, 2003, PROTEIN SCI, V12, P2668, DOI 10.1110/ps.03151103; Kulaksiz H, 2002, P NATL ACAD SCI USA, V99, P6796, DOI 10.1073/pnas.102171199; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Kunzelmann K, 2004, J BIOL CHEM, V279, P48760, DOI 10.1074/jbc.M409747200; Kunzelmann K, 2007, J VIROL, V81, P3714, DOI 10.1128/JVI.02621-06; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lazrak A, 2000, AM J PHYSIOL-CELL PH, V279, pC762, DOI 10.1152/ajpcell.2000.279.3.C762; Lazrak A, 2003, AM J PHYSIOL-LUNG C, V285, pL443, DOI 10.1152/ajplung.00412.2002; Lazrak A, 2002, AM J PHYSIOL-LUNG C, V282, pL650, DOI 10.1152/ajplung.00370.2001; Lazrak A, 2000, AM J PHYSIOL-LUNG C, V278, pL848, DOI 10.1152/ajplung.2000.278.4.L848; Lindell DM, 2008, EUR J IMMUNOL, V38, P2168, DOI 10.1002/eji.200838155; LING BN, 1989, AM J PHYSIOL, V256, pF1094, DOI 10.1152/ajprenal.1989.256.6.F1094; Liu G, 2008, FASEB J, V22, P2285, DOI 10.1096/fj.07-101816; Liu G, 2007, J IMMUNOL, V179, P4125, DOI 10.4049/jimmunol.179.6.4125; Matalon S, 2002, J APPL PHYSIOL, V93, P1852, DOI 10.1152/japplphysiol.01241.2001; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; MBIGUINO A, 1991, J VIROL METHODS, V31, P161, DOI 10.1016/0166-0934(91)90154-R; Nara M, 2000, AM J PHYSIOL-CELL PH, V279, pC1938, DOI 10.1152/ajpcell.2000.279.6.C1938; Nifli AP, 2005, J DAIRY RES, V72, P44, DOI 10.1017/S0022029905001172; PATTNAIK AK, 1992, CELL, V69, P1011, DOI 10.1016/0092-8674(92)90619-N; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; ROBERTS SR, 1995, J VIROL, V69, P2667, DOI 10.1128/JVI.69.4.2667-2673.1995; Shijubo N, 2000, ANN NY ACAD SCI, V923, P268; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Stockando JD, 2000, J BIOL CHEM, V275, P25760, DOI 10.1074/jbc.M003615200; SULLENDER WM, 1990, VIROLOGY, V178, P195, DOI 10.1016/0042-6822(90)90394-7; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; Tsutsumi H, 1999, J LEUKOCYTE BIOL, V66, P99, DOI 10.1002/jlb.66.1.99; Whitehead SS, 1999, J VIROL, V73, P3438, DOI 10.1128/JVI.73.4.3438-3442.1999; XIE QW, 1994, J BIOL CHEM, V269, P4705; YU QZ, 1995, J VIROL, V69, P2412, DOI 10.1128/JVI.69.4.2412-2419.1995; Zaman K, 2006, MOL PHARMACOL, V70, P1435, DOI 10.1124/mol.106.023242; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002; Zhang YH, 2003, J VIROL, V77, P5933, DOI 10.1128/JVI.77.10.5933-5947.2003; Zhang YH, 2001, J VIROL, V75, P9044, DOI 10.1128/JVI.75.19.9044-9058.2001	65	42	44	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7294	7306		10.1074/jbc.M806816200	http://dx.doi.org/10.1074/jbc.M806816200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131335	hybrid, Green Published			2022-12-27	WOS:000263919000076
J	Miloushev, VZ; Levine, JA; Arbing, MA; Hunt, JF; Pitt, GS; Palmer, AG				Miloushev, Vesselin Z.; Levine, Joshua A.; Arbing, Mark A.; Hunt, John F.; Pitt, Geoffrey S.; Palmer, Arthur G., III			Solution Structure of the Na(V)1.2 C-terminal EF-hand Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL INACTIVATION; MOLECULAR-STRUCTURE DETERMINATION; PROTEIN-STRUCTURE DETERMINATION; CALCIUM-FREE CALMODULIN; TONIC-CLONIC SEIZURES; LONG-QT SYNDROME; SLOW INACTIVATION; DIPOLAR COUPLINGS; RESONANCE ASSIGNMENTS; CARDIAC EXCITABILITY	Voltage-gated sodium channels initiate the rapid upstroke of action potentials in many excitable tissues. Mutations within intracellular C-terminal sequences of specific channels underlie a diverse set of channelopathies, including cardiac arrhythmias and epilepsy syndromes. The three-dimensional structure of the C-terminal residues 1777-1882 of the human Na(V)1.2 voltage-gated sodium channel has been determined in solution by NMR spectroscopy at pH 7.4 and 290.5 K. The ordered structure extends from residues Leu-1790 to Glu-1868 and is composed of four alpha-helices separated by two short anti-parallel beta-strands; a less well defined helical region extends from residue Ser-1869 to Arg-1882, and a disordered N-terminal region encompasses residues 1777-1789. Although the structure has the overall architecture of a paired EF-hand domain, the Na(V)1.2 C-terminal domain does not bind Ca2+ through the canonical EF-hand loops, as evidenced by monitoring H-1, N-15 chemical shifts during a Ca2+ titration. Backbone chemical shift resonance assignments and Ca2+ titration also were performed for the Na(V)1.5 (1773-1878) isoform, demonstrating similar secondary structure architecture and the absence of Ca2+ binding by the EF-hand loops. Clinically significant mutations identified in the C-terminal region of Na(V)1 sodium channels cluster in the helix I-IV interface and the helix II-III interhelical segment or in helices III and IV of the Na(V)1.2 (1777-1882) structure.	[Miloushev, Vesselin Z.; Palmer, Arthur G., III] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Levine, Joshua A.] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Arbing, Mark A.; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Pitt, Geoffrey S.] Duke Univ, Div Cardiol, Dept Med, Med Ctr, Durham, NC 27710 USA	Columbia University; Columbia University; Columbia University; Duke University	Palmer, AG (corresponding author), 701 West 168th St,Box 36, New York, NY 10032 USA.	agp6@columbia.edu	Pitt, Geoffrey/L-4927-2019	Pitt, Geoffrey/0000-0003-2246-0289	National Institutes of Health [R01 HL71165, MSTP 5T32 GM07367, R01 GM59273]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059273, U54GM074958, T32GM007367, P50GM062413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL71165 (to G. S. P.), MSTP 5T32 GM07367 (to V.Z.M.), and R01 GM59273 (to A. G. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abriel H, 2000, CIRCULATION, V102, P921; Abriel H, 2005, TRENDS CARDIOVAS MED, V15, P35, DOI 10.1016/j.tcm.2005.01.001; Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; Alekov AK, 2001, EUR J NEUROSCI, V13, P2171, DOI 10.1046/j.0953-816x.2001.01590.x; An RH, 1998, CIRC RES, V83, P141, DOI 10.1161/01.RES.83.2.141; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; BABITCH JA, 1987, J THEOR BIOL, V127, P451, DOI 10.1016/S0022-5193(87)80142-X; Bezzina C, 1999, CIRC RES, V85, P1206; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; Biswas S, 2008, J GEN PHYSIOL, V131, P197, DOI 10.1085/jgp.200709863; Brugada J, 1999, EUROPACE, V1, P156, DOI 10.1053/eupc.1999.0033; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Casini S, 2007, CARDIOVASC RES, V76, P418, DOI 10.1016/j.cardiores.2007.08.005; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chou JJ, 2000, J BIOMOL NMR, V18, P101, DOI 10.1023/A:1008358318863; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; Cicero DO, 2006, J MAGN RESON, V180, P222, DOI 10.1016/j.jmr.2006.02.016; Cormier JW, 2002, J BIOL CHEM, V277, P9233, DOI 10.1074/jbc.M110204200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deschenes I, 1999, CIRCULATION, V100, P278; Doreleijers JF, 1999, J BIOMOL NMR, V14, P123, DOI 10.1023/A:1008335423527; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Fletcher CM, 1996, J BIOMOL NMR, V8, P292, DOI 10.1007/BF00410328; Fujiwara T, 2003, BRAIN, V126, P531, DOI 10.1093/brain/awg053; GAO ZH, 1993, J BIOL CHEM, V268, P20096; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Glaaser IW, 2006, J BIOL CHEM, V281, P24015, DOI 10.1074/jbc.M605473200; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Hilber K, 2001, J BIOL CHEM, V276, P27831, DOI 10.1074/jbc.M101933200; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Makita N, 2002, CIRCULATION, V106, P1269, DOI 10.1161/01.CIR.0000027139.42087.B6; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Mumenthaler C, 1997, J BIOMOL NMR, V10, P351, DOI 10.1023/A:1018383106236; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Permi P, 2000, J BIOMOL NMR, V17, P43, DOI 10.1023/A:1008372624615; Pitt B, 2007, CIRCULATION, V115, P2976, DOI 10.1161/CIRCULATIONAHA.106.670109; Pitt GS, 2007, CARDIOVASC RES, V73, P641, DOI 10.1016/j.cardiores.2006.10.019; QU YS, 1995, J BIOL CHEM, V270, P25696, DOI 10.1074/jbc.270.43.25696; Rhodes TH, 2005, J PHYSIOL-LONDON, V569, P433, DOI 10.1113/jphysiol.2005.094326; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rivolta I, 2001, J BIOL CHEM, V276, P30623, DOI 10.1074/jbc.M104471200; Rohl CA, 1999, BIOCHEMISTRY-US, V38, P855, DOI 10.1021/bi9823380; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Tateyama M, 2004, BIOPHYS J, V86, P1843, DOI 10.1016/S0006-3495(04)74251-4; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Terrenoire C, 2007, J CARDIOVASC ELECTR, V18, P900, DOI 10.1111/j.1540-8167.2007.00838.x; The YK, 2006, BIOPHYS J, V90, P3511, DOI 10.1529/biophysj.105.073072; Tikhonov DB, 2007, BIOPHYS J, V93, P1557, DOI 10.1529/biophysj.106.100248; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Vilin YY, 1999, BIOPHYS J, V77, P1384, DOI 10.1016/S0006-3495(99)76987-0; Wang DW, 2000, CIRC RES, V87, pE37, DOI 10.1161/01.RES.87.8.e37; WILMOT CM, 1990, PROTEIN ENG, V3, P479, DOI 10.1093/protein/3.6.479; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xu XP, 2002, BIOPOLYMERS, V65, P408, DOI 10.1002/bip.10276; Young KA, 2005, J PHYSIOL-LONDON, V565, P349, DOI 10.1113/jphysiol.2004.081422; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	82	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6446	6454		10.1074/jbc.M807401200	http://dx.doi.org/10.1074/jbc.M807401200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129176	hybrid, Green Published			2022-12-27	WOS:000263742700047
J	Barone, S; Fussell, SL; Singh, AK; Lucas, F; Xu, J; Kim, C; Wu, XD; Yu, YL; Amlal, H; Seidler, U; Zuo, J; Soleimani, M				Barone, Sharon; Fussell, Stacey L.; Singh, Anurag Kumar; Lucas, Fred; Xu, Jie; Kim, Charles; Wu, Xudong; Yu, Yiling; Amlal, Hassane; Seidler, Ursula; Zuo, Jian; Soleimani, Manoocher			Slc2a5 (Glut5) Is Essential for the Absorption of Fructose in the Intestine and Generation of Fructose-induced Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC SYNDROME; FUNCTIONAL-CHARACTERIZATION; BASOLATERAL MEMBRANES; INSULIN-RESISTANCE; TRANSPORTER GLUT5; DIETARY FRUCTOSE; PARIETAL-CELLS; EXCHANGER; CHLORIDE; DISEASE	The identity of the transporter responsible for fructose absorption in the intestine in vivo and its potential role in fructose-induced hypertension remain speculative. Here we demonstrate that Glut5 (Slc2a5) deletion reduced fructose absorption by similar to 75% in the jejunum and decreased the concentration of serum fructose by similar to 90% relative to wild-type mice on increased dietary fructose. When fed a control (60% starch) diet, Glut5(-/-) mice had normal blood pressure and displayed normal weight gain. However, whereas Glut5(-/-) mice showed enhanced salt absorption in their jejuna in response to luminal fructose and developed systemic hypertension when fed a high fructose (60% fructose) diet for 14 weeks, Glut5(-/-) mice did not display fructose-stimulated salt absorption in their jejuna, and they experienced a significant impairment of nutrient absorption in their intestine with accompanying hypotension as early as 3-5 days after the start of a high fructose diet. Examination of the intestinal tract of Glut5(-/-) mice fed a high fructose diet revealed massive dilatation of the caecum and colon, consistent with severe malabsorption, along with a unique adaptive up-regulation of ion transporters. In contrast to the malabsorption of fructose, Glut5(-/-) mice did not exhibit an absorption defect when fed a high glucose (60% glucose) diet. We conclude that Glut5 is essential for the absorption of fructose in the intestine and plays a fundamental role in the generation of fructose-induced hypertension. Deletion of Glut5 results in a serious nutrient-absorptive defect and volume depletion only when the animals are fed a high fructose diet and is associated with compensatory adaptive up-regulation of ion-absorbing transporters in the colon.	[Soleimani, Manoocher] Univ Cincinnati, Dept Internal Med, Ctr Genet Transport & Epithelial Biol, Cincinnati, OH 45267 USA; [Barone, Sharon; Fussell, Stacey L.; Xu, Jie; Amlal, Hassane; Soleimani, Manoocher] Univ Cincinnati, Dept Med, Cincinnati, OH 45267 USA; [Lucas, Fred] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45267 USA; [Singh, Anurag Kumar; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Wu, Xudong; Yu, Yiling; Zuo, Jian] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Soleimani, Manoocher] Vet Adm Med Ctr, Res Serv, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Hannover Medical School; St Jude Children's Research Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Soleimani, M (corresponding author), Univ Cincinnati, Dept Internal Med, Ctr Genet Transport & Epithelial Biol, 231 Albert Sabin Way,MSB G259, Cincinnati, OH 45267 USA.	manoocher.soleimani@uc.edu	Seidler, Ursula/HII-8049-2022	Seidler, Ursula/0000-0002-9600-2769; Singh, Anurag Kumar/0000-0003-0818-0993	National Institutes of Health [DK 62809]; Merit Review Award [DC06471, CA21765]; ALSAC; Deutsche Forschungsgemeinschaft [460/9-5]; Hartwell Foundation; DCI, Inc.; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062809, R01DK062809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review Award(US Department of Veterans Affairs); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hartwell Foundation; DCI, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 62809 and a Merit Review Award (to M. S.) and Grants DC06471, CA21765, and ALSAC (to J. Z.). This work was also supported by the Deutsche Forschungsgemeinschaft (Grant Se 460/9-5 to U.S.) and research funds from the Hartwell Foundation (to J. Z.) and DCI, Inc. (to M. S. and H. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Batsis JA, 2007, CLIN PHARMACOL THER, V82, P509, DOI 10.1038/sj.clpt.6100355; Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019; Campbell JA, 1999, J SCI FOOD AGR, V79, P232, DOI [10.1002/(SICI)1097-0010(199902)79:2<232::AID-JSFA176>3.3.CO;2-M, 10.1002/(SICI)1097-0010(199902)79:2&lt;232::AID-JSFA176&gt;3.0.CO;2-V]; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Corpe CP, 1996, PFLUG ARCH EUR J PHY, V432, P192, DOI 10.1007/s004240050124; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; HALLFRISCH J, 1990, FASEB J, V4, P2652, DOI 10.1096/fasebj.4.9.2189777; Helliwell PA, 2000, BIOCHEM J, V350, P149, DOI 10.1042/0264-6021:3500149; Higashiura K, 1999, AM J HYPERTENS, V12, P596, DOI 10.1016/S0895-7061(99)00025-4; Hirabayashi J, 1996, Q REV BIOL, V71, P365, DOI 10.1086/419443; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; KAYANO T, 1990, J BIOL CHEM, V265, P13276; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee DH, 2001, METABOLISM, V50, P74, DOI 10.1053/meta.2001.19527; Macdonald IA, 1999, EUR J CLIN NUTR, V53, pS101, DOI 10.1038/sj.ejcn.1600750; Mayes Peter A., 1993, American Journal of Clinical Nutrition, V58, p754S, DOI 10.1093/ajcn/58.5.754S; Merediz EFC, 2004, EQUINE VET J, V36, P532, DOI 10.2746/0425164044877378; Miller A, 2008, CURR OPIN GASTROEN, V24, P204, DOI 10.1097/MOG.0b013e3282f3f4c4; Nagai Y, 2002, AM J PHYSIOL-ENDOC M, V282, pE1180, DOI 10.1152/ajpendo.00471.2001; Obunai K, 2007, MED CLIN N AM, V91, P1169, DOI 10.1016/j.mcna.2007.06.003; Petrovic S, 2003, AM J PHYSIOL-GASTR L, V284, pG1093, DOI 10.1152/ajpgi.00454.2002; Petrovic S, 2002, AM J PHYSIOL-GASTR L, V283, pG1207, DOI 10.1152/ajpgi.00137.2002; RAND EB, 1993, AM J PHYSIOL, V264, pG1169, DOI 10.1152/ajpgi.1993.264.6.G1169; RUMESSEN JJ, 1992, SCAND J GASTROENTERO, V27, P819, DOI 10.3109/00365529209000148; Sacks FM, 2004, J CLIN PSYCHIAT, V65, P3; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF423, DOI 10.1152/ajprenal.00124.2006; Schurmann A, 2008, AM J PHYSIOL-ENDOC M, V295, pE225, DOI 10.1152/ajpendo.90406.2008; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Schweinfest CW, 2006, J BIOL CHEM, V281, P37962, DOI 10.1074/jbc.M607527200; Shu R, 1997, AM J PHYSIOL-GASTR L, V272, pG446, DOI 10.1152/ajpgi.1997.272.3.G446; Singh AK, 2008, KIDNEY INT, V74, P438, DOI 10.1038/ki.2008.184; SOLEIMANI M, 1994, CIRC RES, V74, P48, DOI 10.1161/01.RES.74.1.48; SOLEIMANI M, 1991, J CLIN INVEST, V88, P1135, DOI 10.1172/JCI115413; vandenBerghe G, 1996, J INHERIT METAB DIS, V19, P470, DOI 10.1007/BF01799108; VANDENBERGHE G, 1994, ANNU REV NUTR, V14, P41, DOI 10.1146/annurev.nu.14.070194.000353; VANDENBERGHE N, 1991, BIOCHEM J, V278, P565, DOI 10.1042/bj2780565; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Wu XD, 2008, BRAIN RES, V1210, P20, DOI 10.1016/j.brainres.2008.02.094; Wu XD, 2007, DEV NEUROBIOL, V67, P483, DOI 10.1002/dneu.20357	43	159	171	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5056	5066		10.1074/jbc.M808128200	http://dx.doi.org/10.1074/jbc.M808128200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19091748	Green Published, hybrid			2022-12-27	WOS:000263416600036
J	Lauer, ME; Mukhopadhyay, D; Fulop, C; de la Motte, CA; Majors, AK; Hascall, VC				Lauer, Mark E.; Mukhopadhyay, Durba; Fulop, Csaba; de la Motte, Carol A.; Majors, Alana K.; Hascall, Vincent C.			Primary Murine Airway Smooth Muscle Cells Exposed to Poly(I,C) or Tunicamycin Synthesize a Leukocyte-adhesive Hyaluronan Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEPENDENT PROTEIN-KINASE; TUBULAR EPITHELIAL-CELLS; ALPHA-TRYPSIN INHIBITOR; DOUBLE-STRANDED-RNA; EXTRACELLULAR-MATRIX; ATOPIC ASTHMA; INFLAMMATION; CD44; MUCOSAL	Asthmatic attacks often follow viral infections with subsequent airway smooth muscle cell proliferation and the formation of an abnormal hyaluronan extracellular matrix with infiltrated leukocytes. In this study, we show that murine airway smooth muscle cells (MASM) treated with polyinosinic acid-polycytidylic acid (poly(I,C)), a double-stranded RNA that simulates a viral infection, synthesize an abnormal hyaluronan matrix that binds leukocytes (U937 cells). Synthesis of this matrix is initiated rapidly and accumulates linearly for 10 h, reaching a plateau level similar to 7-fold higher than control cultures. MASM cells treated with tunicamycin, to induce endoplasmic reticulum stress, also rapidly initiate synthesis of the abnormal hyaluronan matrix with linear accumulation for similar to 10 h, but only reach a plateau level similar to 2-fold higher than control cultures. In contrast to poly(I,C), the response to tunicamycin depends on cell density, with pre-confluent cells producing more abnormal matrix per cell. Furthermore, U937 cell adhesion per hyaluronan content is higher in the sparse matrix produced in response to tunicamycin, suggesting that the structure in the poly(I,C)induced matrix masks potential binding sites. When MASM cells were exposed to tunicamycin and poly(I,C) at the same time, U937 cell adhesion was partially additive, implying that these two toxins stimulate hyaluronan synthesis through two different pathways. We also characterized the size of hyaluronan produced by MASM cells, in response to poly(I,C) and tunicamycin, and we found that it ranges from 1500 to 4000 kDa, the majority of which was similar to 4000 kDa and not different in size than hyaluronan made by untreated cells.	[Lauer, Mark E.; Mukhopadhyay, Durba; Fulop, Csaba; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; [de la Motte, Carol A.; Majors, Alana K.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [de la Motte, Carol A.; Majors, Alana K.] Cleveland Clin, Dept Colorectal Surg, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hascall, VC (corresponding author), Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA.	hascalv@ccf.org			National Institutes of Health [P11 HL081064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P11 HL081064 ( Pathology of Asthma). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alcorn JF, 2007, AM J RESP CRIT CARE, V176, P974, DOI 10.1164/rccm.200702-334OC; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; BOUSQUET J, 1991, J ALLERGY CLIN IMMUN, V88, P649, DOI 10.1016/0091-6749(91)90159-L; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Braunstahl GJ, 2003, CLIN EXP ALLERGY, V33, P579, DOI 10.1046/j.1365-2222.2003.01652.x; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Coyle AJ, 1996, ANN NY ACAD SCI, V796, P97, DOI 10.1111/j.1749-6632.1996.tb32571.x; Day AJ, 1999, BIOCHEM SOC T, V27, P115, DOI 10.1042/bst0270115; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Ehlenfield DR, 2000, PEDIATRICS, V105, P79, DOI 10.1542/peds.105.1.79; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; Grissell TV, 2005, AM J RESP CRIT CARE, V172, P433, DOI 10.1164/rccm.200412-1621OC; Hakonarson H, 1998, J CLIN INVEST, V102, P1732, DOI 10.1172/JCI4141; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HASCALL VC, 1997, SCI HYALURONAN TODAY; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Homer RJ, 2000, CLIN CHEST MED, V21, P331, DOI 10.1016/S0272-5231(05)70270-7; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; LAURENT UBG, 1991, EXP PHYSIOL, V76, P695, DOI 10.1113/expphysiol.1991.sp003536; LAURENT UBG, 1992, MATRIX, V12, P130, DOI 10.1016/S0934-8832(11)80054-5; LAZAAR AL, 1994, J EXP MED, V180, P807, DOI 10.1084/jem.180.3.807; Lee ES, 2007, FEBS LETT, V581, P4325, DOI 10.1016/j.febslet.2007.08.001; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Ludwig MS, 2007, J APPL PHYSIOL, V103, P735, DOI 10.1152/japplphysiol.00751.2007; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Milinkovic M, 2004, BLOOD, V103, P740, DOI 10.1182/blood-2003-05-1500; Mukhopadhyay D, 2006, MATRIX BIOL, V25, pS94, DOI 10.1016/j.matbio.2006.08.257; Mulvey M, 2006, J VIROL, V80, P7354, DOI 10.1128/JVI.00479-06; Nag SS, 2003, J ALLERGY CLIN IMMUN, V111, P558, DOI 10.1067/mai.2003.131; Niimi K, 2007, J IMMUNOL, V178, P489, DOI 10.4049/jimmunol.178.1.489; Oliver BGG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-71; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Park JW, 2004, AM J RESP CELL MOL, V30, P830, DOI 10.1165/rcmb.2003-0373OC; Phipps S, 2004, AM J RESP CELL MOL, V31, P626, DOI 10.1165/rcmb.2004-0193OC; Roberts C R, 1998, Can Respir J, V5, P48; ROBERTS CR, 1995, CHEST, V107, pS111, DOI 10.1378/chest.107.3_Supplement.111S; Robinson DS, 1999, INT ARCH ALLERGY IMM, V118, P98, DOI 10.1159/000024039; Robinson DS, 2004, J ALLERGY CLIN IMMUN, V114, P58, DOI 10.1016/j.jaci.2004.03.034; Saavalainen K, 2007, J BIOL CHEM, V282, P11530, DOI 10.1074/jbc.M607871200; SAHU S, 1978, BIOCHEM J, V173, P565, DOI 10.1042/bj1730565; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Shimazawa M, 2007, INVEST OPHTH VIS SCI, V48, P3729, DOI 10.1167/iovs.06-1122; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657	59	66	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5299	5312		10.1074/jbc.M807965200	http://dx.doi.org/10.1074/jbc.M807965200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19088077	hybrid, Green Published			2022-12-27	WOS:000263416600060
J	Schroeder, S; Lawernce, AD; Biedendieck, R; Rose, RS; Deery, E; Graham, RM; McLean, KJ; Munro, AW; Rigby, SEJ; Warren, MJ				Schroeder, Susanne; Lawernce, Andrew D.; Biedendieck, Rebekka; Rose, Ruth-Sarah; Deery, Evelyne; Graham, Ross M.; McLean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.; Warren, Martin J.			Demonstration That CobG, the Monooxygenase Associated with the Ring Contraction Process of the Aerobic Cobalamin (Vitamin B-12) Biosynthetic Pathway, Contains an Fe-S Center and a Mononuclear Non-heme Iron Center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; COLI SULFITE REDUCTASE; PERNICIOUS-ANEMIA; OXYGEN; MECHANISM; MOSSBAUER; EVOLUTION; SUBSTRATE; INSIGHTS; SIROHEME	The ring contraction process that occurs during cobalamin (vitamin B-12) biosynthesis is mediated via the action of two enzymes, CobG and CobJ. The first of these generates a tertiary alcohol at the C-20 position of precorrin-3A by functioning as a monooxygenase, a reaction that also forms a gamma lactone with the acetic acid side chain on ring A. The product, precorrin-3B, is then acted upon by CobJ, which methylates at the C-17 position and promotes ring contraction of the macrocycle by catalyzing a masked pinacol rearrangement. Here, we report the characterization of CobG enzymes from Pseudomonas denitrificans and Brucella melitensis. We show that both contain a [4Fe-4S] center as well as a mononuclear non-heme iron. Although both enzymes are active in vivo, the P. denitrificans enzyme was found to be inactive in vitro. Further analysis of this enzyme revealed that the mononuclear non-heme iron was not reducible, and it was concluded that it is rapidly inactivated once it is released from the bacterial cell. In contrast, the B. melitensis enzyme was found to be fully active in vitro and the mononuclear non-heme iron was reducible by dithionite. The reduced mononuclear non-heme was able to react with the oxygen analogue NO, but only in the presence of the substrate precorrin-3A. The cysteine residues responsible for binding the Fe-S center were identified by site-directed mutagenesis. A mechanism for CobG is presented.	[Schroeder, Susanne; Lawernce, Andrew D.; Biedendieck, Rebekka; Deery, Evelyne; Warren, Martin J.] Univ Kent, Dept Biosci, Prot Sci Grp, Canterbury CT2 7NJ, Kent, England; [Graham, Ross M.] Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol M704, Fremantle, WA 6160, Australia; [McLean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University of Kent; University of Western Australia; University of Manchester	Warren, MJ (corresponding author), Univ Kent, Dept Biosci, Prot Sci Grp, Canterbury CT2 7NJ, Kent, England.	m.j.warren@kent.ac.uk	Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022; Rose, Ruth/AAW-3844-2020	Munro, Andrew/0000-0002-4642-180X; Rose, Ruth/0000-0001-6406-137X; Schroeder, Susanne/0000-0003-1703-9158; Warren, Martin/0000-0002-6028-6456; Biedendieck, Rebekka/0000-0002-3567-6196; McLean, Kirsty/0000-0002-7193-5044	Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/D003997/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D003997/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARCIERO DM, 1983, J BIOL CHEM, V258, P4981; Bartlett GJ, 2003, J MOL BIOL, V331, P829, DOI 10.1016/S0022-2836(03)00734-4; BATTERSBY AR, 1994, SCIENCE, V264, P1551, DOI 10.1126/science.8202709; BERTINI I, 1995, STRUCT BOND, V83, P1; BERTRAND P, 1982, J CHEM PHYS, V76, P4715, DOI 10.1063/1.442788; Bian SM, 1999, COORDIN CHEM REV, V190, P1049, DOI 10.1016/S0010-8545(99)00157-5; BLANCHE F, 1993, ANGEW CHEM INT EDIT, V32, P1651, DOI 10.1002/anie.199316511; BURGER RM, 1981, J BIOL CHEM, V256, P1636; CHEN VJ, 1989, J BIOL CHEM, V264, P21677; CHRISTNER JA, 1981, J BIOL CHEM, V256, P2098; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; CRANE BR, 1995, SCIENCE, V270, P59, DOI 10.1126/science.270.5233.59; DEBUSSCHE L, 1993, J CHEM SOC CHEM COMM, P1100, DOI 10.1039/c39930001100; DEBUSSCHE L, 1993, J BACTERIOL, V175, P7430, DOI 10.1128/JB.175.22.7430-7440.1993; Dutton P L, 1978, Methods Enzymol, V54, P411; ESCHENMOSER A, 1988, ANGEW CHEM INT EDIT, V27, P5, DOI 10.1002/anie.198800051; Gaffney BJ, 1996, ANNU REV BIOPH BIOM, V25, P431, DOI 10.1146/annurev.bb.25.060196.002243; Girerd JJ, 2000, STRUCT BOND, V97, P145; HODGKIN DC, 1955, NATURE, V176, P325, DOI 10.1038/176325a0; Jackson TA, 2003, J AM CHEM SOC, V125, P8348, DOI 10.1021/ja029523s; JANICK PA, 1982, BIOCHEMISTRY-US, V21, P3538, DOI 10.1021/bi00258a003; Johnson MK, 1999, ADV INORG CHEM, V47, P1, DOI 10.1016/S0898-8838(08)60076-8; Leech HK, 2003, J BIOL CHEM, V278, P41900, DOI 10.1074/jbc.M306112200; LOVENBERG W, 1973, IRON SULPHUR PROTEIN, V2, P195; McGoldrick HM, 2005, J BIOL CHEM, V280, P1086, DOI 10.1074/jbc.M411884200; MINOT GR, 1983, JAMA-J AM MED ASSOC, V250, P3328, DOI 10.1001/jama.250.24.3328; Mouesca JM, 1998, COORDIN CHEM REV, V178, P1573, DOI 10.1016/S0010-8545(98)00155-6; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Neidig ML, 2005, CHEM COMMUN, P5843, DOI 10.1039/b510233m; NELSON MJ, 1987, J BIOL CHEM, V262, P12137; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Raux E, 1999, BIOORG CHEM, V27, P100, DOI 10.1006/bioo.1998.1125; Raux E, 1996, J BACTERIOL, V178, P753, DOI 10.1128/jb.178.3.753-767.1996; RICKES EL, 1948, SCIENCE, V107, P396, DOI 10.1126/science.107.2781.396; Roessner CA, 2001, VITAM HORM, V61, P267; Ryle MJ, 2002, CURR OPIN CHEM BIOL, V6, P193, DOI 10.1016/S1367-5931(02)00302-2; SCOTT AI, 1993, FEBS LETT, V331, P105, DOI 10.1016/0014-5793(93)80306-F; SCOTT AI, 1994, HETEROCYCLES, V39, P471; Simaan AJ, 1999, EUR J INORG CHEM, P993; Simaan AJ, 2001, INORG CHEM, V40, P6538, DOI 10.1021/ic010635e; SMITH EL, 1948, NATURE, V161, P638, DOI 10.1038/161638a0; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; SPENCER JB, 1993, J AM CHEM SOC, V115, P11610, DOI 10.1021/ja00077a075; SPENCER JB, 1994, J AM CHEM SOC, V116, P4991, DOI 10.1021/ja00090a056; Stolowich NJ, 1996, J AM CHEM SOC, V118, P1657, DOI 10.1021/ja952739s; SWEENEY WV, 1980, ANNU REV BIOCHEM, V49, P139, DOI 10.1146/annurev.bi.49.070180.001035; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F	48	10	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4796	4805		10.1074/jbc.M807184200	http://dx.doi.org/10.1074/jbc.M807184200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19068481	hybrid			2022-12-27	WOS:000263416600007
J	Tachibana, T; Okazaki, S; Murayama, A; Naganuma, A; Nomoto, A; Kuge, S				Tachibana, Tsuyoshi; Okazaki, Shoko; Murayama, Asako; Naganuma, Akira; Nomoto, Akio; Kuge, Shusuke			A Major Peroxiredoxin-induced Activation of Yap1 Transcription Factor Is Mediated by Reduction-sensitive Disulfide Bonds and Reveals a Low Level of Transcriptional Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXIDE-INDUCED OXIDATION; CYSTEINE-SULFINIC ACID; SACCHAROMYCES-CEREVISIAE; HYDROGEN-PEROXIDE; 2-CYS PEROXIREDOXIN; REDOX REGULATION; NUCLEAR EXPORT; BUDDING YEAST; STRESS; H2O2	Redox reactions involving cysteine thiol-disulfide exchange are crucial for the intracellular monitoring of hydrogen peroxide (H2O2). Yap1, the master transcription factor for the oxidative stress response in budding yeast, is activated by the formation of disulfide bonds in response to H2O2. Gpx3 (glutathione peroxidase-like protein 3) acts as a receptor for H2O2, and Ybp1 (Yap1-binding protein 1) is crucial for Gpx3-dependent disulfide bond formation in Yap1. We previously reported that Tsa1, a major peroxiredoxin in yeast cells, is required for activation of Yap1 in a widely used yeast strain, W303-1b, carrying the ybp1-1 mutant allele encoding a truncated Ybp1 protein. In the present study, we show that Tsa1 can interact with Yap1 via disulfide linkages and induce the formation of intramolecular disulfide bonds in Yap1 in ybp1-1 cells. The results provide evidence that Prx can have intrinsic activity as an H2O2 receptor and can relay H2O2 as a signal to the Prx target proteins in terms of formation of disulfide linkage. Furthermore, our data reveal that there is more of the reduction-resistant active form of Yap1 (i.e. Yap1 (oxII)) when it is partnered with Gpx3 than with Tsa1. These data support our hypothesis that changes in the redox status of Yap1 to reduction-resistant forms by multiple disulfide bond formation are important for determining the level and duration of Yap1 activity in the dynamic equilibrium of redox reactions in cells exposed to H2O2.	[Tachibana, Tsuyoshi; Okazaki, Shoko; Naganuma, Akira; Kuge, Shusuke] Tohoku Univ, Lab Mol & Biochem Toxicol, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9800861, Japan; [Murayama, Asako; Nomoto, Akio] Univ Tokyo, Dept Microbiol, Grad Sch Med, Minato Ku, Tokyo 1130033, Japan	Tohoku University; University of Tokyo	Kuge, S (corresponding author), 6-3 Azaaoba,Aoba Ku, Sendai, Miyagi 9800861, Japan.	skuge@mail.pharm.tohoku.ac.jp	NAGANUMA, AKIRA/V-2918-2019		Ministry of Education, Culture, Sports, Science, and Technology (Japan); "Program for Promotion of Fundamental Studies in Health Sciences" of the National Institute of Biomedical Innovation	Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Program for Promotion of Fundamental Studies in Health Sciences" of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by grants-in-aid for exploratory research and a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology (Japan) and by the "Program for Promotion of Fundamental Studies in Health Sciences" of the National Institute of Biomedical Innovation.	Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; DUNN B, 1997, CURRENT PROTOCOLS MO; Frankel EN, 1996, J AGR FOOD CHEM, V44, P131, DOI 10.1021/jf950374p; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Izawa S, 1999, J BIOL CHEM, V274, P28459, DOI 10.1074/jbc.274.40.28459; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Kuge S, 2001, MOL CELL BIOL, V21, P6139, DOI 10.1128/MCB.21.18.6139-6150.2001; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lee SY, 2008, BIOCHEM BIOPH RES CO, V367, P67, DOI 10.1016/j.bbrc.2007.12.105; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; Okazaki S, 2005, ANTIOXID REDOX SIGN, V7, P327, DOI 10.1089/ars.2005.7.327; Okazaki S, 2007, MOL CELL, V27, P675, DOI 10.1016/j.molcel.2007.06.035; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Tanaka T, 2005, J BIOL CHEM, V280, P42078, DOI 10.1074/jbc.M508622200; Tao K, 1999, FEBS LETT, V457, P90, DOI 10.1016/S0014-5793(99)01013-3; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790; Wood MJ, 2003, BIOCHEMISTRY-US, V42, P11982, DOI 10.1021/bi035003d; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	36	56	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4464	4472		10.1074/jbc.M807583200	http://dx.doi.org/10.1074/jbc.M807583200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19106090	hybrid			2022-12-27	WOS:000263134400046
J	Chen, W; Chen, Y; Xu, BE; Juang, YC; Stippec, S; Zhao, YM; Cobb, MH				Chen, Wei; Chen, Yue; Xu, Bing-e; Juang, Yu-Chi; Stippec, Steve; Zhao, Yingming; Cobb, Melanie H.			Regulation of a Third Conserved Phosphorylation Site in SGK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; WNK1 ACTIVATES SGK1; TURN MOTIF; SERUM; IDENTIFICATION; DEGRADATION; MECHANISM; RAPAMYCIN; P70(S6K); TERMINUS	SGK1 (serum- and glucocorticoid-induced kinase 1) is a member of the AGC branch of the protein kinase family. Among well described functions of SGK1 is the regulation of epithelial transport through phosphorylation of the ubiquitin protein ligase Nedd4-2 (neuronal precursor cell expressed developmentally down-regulated 4-2). The activation of SGK1 has been widely accepted to be dependent on the phosphorylation of Thr(256) in the activation loop and Ser(422) in the hydrophobic motif near the C terminus. Here, we report the identification of two additional phosphorylation sites, Ser(397) and Ser(401). Both are required for maximum SGK1 activity induced by extracellular agents or by coexpression with other protein kinases, with the largest loss of activity from mutation of Ser(397). Coexpression with active Akt1 increased the phosphorylation of Ser(397) and thereby SGK1 kinase activity. SGK1 activation was further augmented by coexpression with the protein kinase WNK1(with no lysine kinase 1). These findings reveal further complexity underlying the regulation of SGK1 activity.	[Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Melanie.Cobb@UTSouthwestern.edu		Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health Grant [GM53032]; Innovative Technologies for the Molecular Analysis of Cancer [CA107943]; Welch Foundation Grant [I1243]; NATIONAL CANCER INSTITUTE [R33CA107943, R21CA107943] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Technologies for the Molecular Analysis of Cancer; Welch Foundation Grant(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53032 (to M. H. C.) and "Innovative Technologies for the Molecular Analysis of Cancer" Program Grant CA107943 from NCI (to Y.Z.). This work was also supported by Welch Foundation Grant I1243 (to M. H. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Brickley DR, 2002, J BIOL CHEM, V277, P43064, DOI 10.1074/jbc.M207604200; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Moser BA, 1997, MOL CELL BIOL, V17, P5648, DOI 10.1128/MCB.17.9.5648; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Pao AC, 2007, AM J PHYSIOL-RENAL, V292, pF1741, DOI 10.1152/ajprenal.00027.2007; Parekh D, 1999, J BIOL CHEM, V274, P34758, DOI 10.1074/jbc.274.49.34758; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Saitoh M, 2002, J BIOL CHEM, V277, P20104, DOI 10.1074/jbc.M201745200; Shu HJ, 2004, MOL CELL PROTEOMICS, V3, P279, DOI 10.1074/mcp.D300003-MCP200; Tessier M, 2006, J CELL BIOCHEM, V98, P1391, DOI 10.1002/jcb.20894; Vallon V, 2005, AM J PHYSIOL-REG I, V289, pR395, DOI 10.1152/ajpregu.00731.2004; Vitari AC, 2004, BIOCHEM J, V378, P257, DOI 10.1042/BJ20031692; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Xu BE, 2005, J BIOL CHEM, V280, P34218, DOI 10.1074/jbc.M505735200; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zhao B, 2007, PROTEIN SCI, V16, P2761, DOI 10.1110/ps.073161707	35	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3453	3460		10.1074/jbc.M807502200	http://dx.doi.org/10.1074/jbc.M807502200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19068477	hybrid, Green Published			2022-12-27	WOS:000262872500011
J	Wang, W; Fridman, A; Blackledge, W; Connelly, S; Wilson, IA; Pilz, RB; Boss, GR				Wang, Wei; Fridman, Alla; Blackledge, William; Connelly, Stephen; Wilson, Ian A.; Pilz, Renate B.; Boss, Gerry R.			The Phosphatidylinositol 3-Kinase/Akt Cassette Regulates Purine Nucleotide Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID STARVATION; HUMAN-LYMPHOBLASTS; PROTEIN-KINASE; PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE; GLUCOSE-METABOLISM; MAMMALIAN TARGET; BIOSYNTHESIS; CELLS; MECHANISM; GROWTH	The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is highly conserved throughout evolution and regulates cell size and survival and cell cycle progression. It regulates the latter by stimulating procession through G(1) and the G(1)/S phase transition. Entry into S phase requires an abundant supply of purine nucleotides, but the effect of the PI3K/Akt pathway on purine synthesis has not been studied. We now show that the PI3K/Akt cassette regulates both de novo and salvage purine nucleotide synthesis in insulin-responsive mouse mesenchymal cells. We found that serum and insulin stimulated de novo purine synthesis in serum-starved cells largely through PI3K/Akt signaling, and pharmacologic and genetic inhibition of PI3K/Akt reduced de novo synthesis by 75% in logarithmically growing cells. PI3K/Akt regulated early steps of de novo synthesis by modulating phosphoribosylpyrophosphate production by the non-oxidative pentose phosphate pathway and late steps by modulating activity of the bifunctional enzyme aminoimidazole-carboxamide ribonucleotide transformylase IMP cyclohydrolase, an enzyme not previously known to be regulated. The effects of PI3K/Akt on purine nucleotide salvage were likely through regulating phosphoribosylpyrophosphate availability. These studies define a new mechanism whereby the PI3K/Akt cassette functions as a master regulator of cellular metabolism and a key player in oncogenesis.	[Wang, Wei; Fridman, Alla; Blackledge, William; Pilz, Renate B.; Boss, Gerry R.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Wang, Wei; Fridman, Alla; Blackledge, William; Pilz, Renate B.; Boss, Gerry R.] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; [Connelly, Stephen; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Connelly, Stephen; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute	Boss, GR (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gboss@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	National Institutes of Health [NS58030, AI42266, DK69263]; Skaggs Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042266, R01AI042266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK069263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS58030 (to G. R. B.) and AI42266 (to I. A. W. and S. C.) and Training Grant DK69263 (to W. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported in part by the Skaggs Institute.	Becker MA, 2001, PROG NUCLEIC ACID RE, V69, P115, DOI 10.1016/S0079-6603(01)69046-9; Boros LG, 2001, PANCREAS, V22, P1, DOI 10.1097/00006676-200101000-00001; Boros LG, 1997, CANCER RES, V57, P4242; BOSS GR, 1984, J BIOL CHEM, V259, P2936; BOSS GR, 1985, J BIOL CHEM, V260, P6054; BOSS GR, 1987, BIOCHEM J, V242, P425, DOI 10.1042/bj2420425; BOSS GR, 1980, J IMMUNOL, V125, P679; BOSS GR, 1982, J BIOL CHEM, V257, P4242; BOYLE JA, 1972, BIOCHIM BIOPHYS ACTA, V269, P179, DOI 10.1016/0005-2787(72)90424-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coffer PJ, 1998, BIOCHEM J, V335, P1; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Gassmann MG, 1999, ONCOGENE, V18, P6667, DOI 10.1038/sj.onc.1203120; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HENDERSON JF, 1968, CAN J BIOCHEM CELL B, V46, P703, DOI 10.1139/o68-108; HENDERSON JF, 1962, J BIOL CHEM, V237, P2631; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; HERSHFIELD MS, 1976, J BIOL CHEM, V251, P7348; HOLMES EW, 1973, J BIOL CHEM, V248, P6035; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; KRENITSKY TA, 1969, J BIOL CHEM, V244, P1263; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marie S, 2004, AM J HUM GENET, V74, P1276, DOI 10.1086/421475; MARTIN DW, 1972, J BIOL CHEM, V247, P5477; MUELLER WT, 1981, BIOCHEMISTRY-US, V20, P337, DOI 10.1021/bi00505a017; PILZ RB, 1984, J BIOL CHEM, V259, P2927; RABINOWITZ JC, 1963, METHOD ENZYMOL, V6, P814, DOI 10.1016/0076-6879(63)06256-X; RAIVIO KO, 1981, BIOCHIM BIOPHYS ACTA, V678, P51, DOI 10.1016/0304-4165(81)90046-5; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; SCHEELE JS, 1994, J BIOL CHEM, V269, P18599; SIDI Y, 1985, J CLIN INVEST, V76, P2416, DOI 10.1172/JCI112255; Torres RJ, 1996, CLIN CHIM ACTA, V245, P105, DOI 10.1016/0009-8981(95)06178-9; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wolan DW, 2002, BIOCHEMISTRY-US, V41, P15505, DOI 10.1021/bi020505x; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	39	43	44	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3521	3528		10.1074/jbc.M806707200	http://dx.doi.org/10.1074/jbc.M806707200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19068483	Green Published, hybrid			2022-12-27	WOS:000262872500019
J	Zhang, HD; Eoff, RL; Kozekov, ID; Rizzo, CJ; Egli, M; Guengerich, FP				Zhang, Huidong; Eoff, Robert L.; Kozekov, Ivan D.; Rizzo, Carmelo J.; Egli, Martin; Guengerich, F. Peter			Versatility of Y-family Sulfolobus solfataricus DNA Polymerase Dpo4 in Translesion Synthesis Past Bulky N-2-Alkylguanine Adducts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; NUCLEOTIDE INCORPORATION OPPOSITE; ERROR-FREE BYPASS; TANDEM MASS-SPECTROMETRY; INTERSTRAND CROSS-LINKS; STEADY-STATE KINETICS; RAY-DIFFRACTION DATA; REPLICATION FIDELITY; LESION-BYPASS; ELECTROSPRAY-IONIZATION	In contrast to replicative DNA polymerases, Sulfolobus solfataricus Dpo4 showed a limited decrease in catalytic efficiency (k(cat)/K-m) for insertion of dCTP opposite a series of N-2-alkylguanine templates of increasing size from (methyl (Me) to (9-anthracenyl)-Me (Anth)). Fidelity was maintained with increasing size up to (2-naphthyl)-Me (Naph). The catalytic efficiency increased slightly going from the N-2-NaphG to the N-2-AnthG substrate, at the cost of fidelity. Pre-steady-state kinetic bursts were observed for dCTP incorporation throughout the series (N-2-MeG to N-2-AnthG), with a decrease in the burst amplitude and k(pol), the rate of single-turnover incorporation. The pre-steady-state kinetic courses with G and all of the six N-2-alkyl G adducts could be fit to a general DNA polymerase scheme to which was added an inactive complex in equilibrium with the active ternary Dpo4.DNA.dNTP complex, and only the rates of equilibrium with the inactive complex and phosphodiester bond formation were altered. Two crystal structures of Dpo4 with a template N-2-NaphG (in a post-insertion register opposite a 3'-terminal C in the primer) were solved. One showed N-2-NaphG in a syn conformation, with the naphthyl group located between the template and the Dpo4 "little finger" domain. The Hoogsteen face was within hydrogen bonding distance of the N4 atoms of the cytosine opposite N-2-NaphG and the cytosine at the -2 position. The second structure showed N-2-Naph G in an anti conformation with the primer terminus largely disordered. Collectively these results explain the versatility of Dpo4 in bypassing bulky G lesions.	[Zhang, Huidong; Eoff, Robert L.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Zhang, Huidong; Eoff, Robert L.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Kozekov, Ivan D.; Rizzo, Carmelo J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Kozekov, Ivan D.; Rizzo, Carmelo J.] Vanderbilt Univ, Ctr Mol Toxicol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Zhang, Huidong/0000-0001-7845-3331	National Institutes of Health Grants [R01 ES010375, F32 CA119776, P01 ES05355, P30 ES000267]; U. S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [F32CA119776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005355, R01ES010375, P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 (to F. P. G.), F32 CA119776 (to R. L. E.), P01 ES05355 (to I. D. K., C. J. R., a nd M. E.), and P30 ES000267 (to F. P. G., C. J. R., and M. E.). Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-Eng-38. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bauer J, 2007, P NATL ACAD SCI USA, V104, P14905, DOI 10.1073/pnas.0700717104; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; BORER PN, 1975, HDB BIOCH MOL BIOL, P589; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHENG SC, 1989, CHEM RES TOXICOL, V2, P334, DOI 10.1021/tx00011a011; Cheng TF, 2008, J BIOL CHEM, V283, P27820, DOI 10.1074/jbc.M804086200; Choi JY, 2008, J BIOL CHEM, V283, P23645, DOI 10.1074/jbc.M801686200; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Choi JY, 2004, J BIOL CHEM, V279, P19217, DOI 10.1074/jbc.M313759200; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; EOFF RL, 2009, CHEM BIOL DNA DAMAGE; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; FANG JL, 1997, CARCINOGENESIS, V18, P632; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2116, DOI 10.1021/bi035746z; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Forgacs E, 1997, J BIOL CHEM, V272, P8525, DOI 10.1074/jbc.272.13.8525; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; Jia L, 2008, NUCLEIC ACIDS RES, V36, P6571, DOI 10.1093/nar/gkn719; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kornberg A., 1992, DNA REPLICATION; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lao YB, 2007, CHEM RES TOXICOL, V20, P246, DOI 10.1021/tx060208j; Lao YB, 2005, CHEM RES TOXICOL, V18, P711, DOI 10.1021/tx0497292; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Lee HR, 2007, J BIOL CHEM, V282, P31982, DOI 10.1074/jbc.M705392200; Lemee F, 2007, ONCOGENE, V26, P3387, DOI 10.1038/sj.onc.1210116; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Liu X, 2006, BIOCHEMISTRY-US, V45, P12898, DOI 10.1021/bi060792v; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Matsuda T, 1999, BIOCHEMISTRY-US, V38, P929, DOI 10.1021/bi982134j; MEEHAN T, 1979, NATURE, V277, P410, DOI 10.1038/277410a0; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Ni JS, 1996, ANAL CHEM, V68, P1989, DOI 10.1021/ac960270t; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Perlow-Poehnelt RA, 2004, J BIOL CHEM, V279, P36951, DOI 10.1074/jbc.M404332200; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Searle C. F., 1984, CHEM CARCINOGENS; TAN HB, 1994, BIOCHEMISTRY-US, V33, P5335, DOI 10.1021/bi00183a042; Terashima I, 2001, BIOCHEMISTRY-US, V40, P4106, DOI 10.1021/bi002719p; Tissier A, 2000, GENE DEV, V14, P1642; Trincao J, 2004, NAT STRUCT MOL BIOL, V11, P457, DOI 10.1038/nsmb755; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; TURESKY RJ, 1992, CHEM RES TOXICOL, V5, P479, DOI 10.1021/tx00028a005; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Vellieux FMD, 1997, J APPL CRYSTALLOGR, V30, P396, DOI 10.1107/S0021889896012551; Wang MY, 2007, CHEM RES TOXICOL, V20, P625, DOI 10.1021/tx600332p; Wang MY, 1997, CHEM RES TOXICOL, V10, P772, DOI 10.1021/tx960193x; Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; Yasui M, 2001, NUCLEIC ACIDS RES, V29, P1994, DOI 10.1093/nar/29.9.1994; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zang H, 2005, CHEM RES TOXICOL, V18, P389, DOI 10.1021/tx049683c; Zang H, 2005, J BIOL CHEM, V280, P1165, DOI 10.1074/jbc.M405996200; Zhang S, 2006, CHEM RES TOXICOL, V19, P1386, DOI 10.1021/tx060154d	82	53	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3563	3576		10.1074/jbc.M807778200	http://dx.doi.org/10.1074/jbc.M807778200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19059910	hybrid, Green Published			2022-12-27	WOS:000262872500024
J	Fontanini, A; Foti, C; Potu, H; Crivellato, E; Maestro, R; Bernardi, P; Demarchi, F; Brancolini, C				Fontanini, Alessandra; Foti, Carmela; Potu, Harish; Crivellato, Enrico; Maestro, Roberta; Bernardi, Paolo; Demarchi, Francesca; Brancolini, Claudio			The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis A COMPARATIVE STUDY WITH THE PROTEASOME INHIBITOR BORTEZOMIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; RECEPTOR-INTERACTING PROTEIN; CYCLOPHILIN-D; CYCLOSPORINE-A; NECROSIS; ACTIVATION; AUTOPHAGY; UBIQUITIN; TARGET; BAX	Inhibitors of the ubiquitin-proteasome system (UPSIs) promote apoptosis of cancer cells and show encouraging anti-tumor activities in vivo. In this study, we evaluated the death activities of two different UPSIs: bortezomib and the isopeptidase inhibitor G5. To unveil whether these compounds elicit different types of death, we compared their effect both on apoptosis-proficient wild type mouse embryo fibroblasts and on cells defective for apoptosis(double- deficient Bax/Bak mouse embryo fibroblasts) (double knockout; DKO). We have discovered that (i) both inhibitors induce apoptosis in a Bax and Bak-dependent manner, (ii) both inhibitors elicit autophagy in WT and DKO cells, and (iii) only G5 can kill apoptosis-resistant DKO cells by activating a necrotic response. The induction of necrosis was confirmed by different experimental approaches, including time lapse analysis, HMGB1 release, and electron microscopy studies. Neither treatment with antinecrotic agents, such as antioxidants, poly(ADP-ribose) polymerase and JNK inhibitors, necrostatin, and the intracellular Ca2+ chelator, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester, nor overexpression of Bcl-2 and Bcl-xL prevented necrosis induced by G5. This necrotic death is characterized by the absence of protein oxidation and by the rapid cyclosporin A-independent dissipation of the mitochondrial membrane potential. Notably, a peculiar feature of the G5-induced necrosis is an early and dramatic reorganization of the actin cytoskeleton, coupled to an alteration of cell adhesion. The importance of cell adhesion impairment in the G5-induced necrotic death of DKO cells was confirmed by the antagonist effect of the extracellular matrix-adhesive components, collagen and fibronectin.	[Fontanini, Alessandra; Foti, Carmela; Potu, Harish; Brancolini, Claudio] Univ Udine, Sez Biol, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy; [Fontanini, Alessandra; Foti, Carmela; Potu, Harish; Brancolini, Claudio] Univ Udine, MATI Ctr Excellence, I-33100 Udine, Italy; [Crivellato, Enrico] Univ Udine, Dipartimento Ric Med & Morfol, I-33100 Udine, Italy; [Maestro, Roberta] Natl Canc Inst, Inst Ricovero Cura Carattere Sci, Unit Immunol Oncol 1, Ctr Riferimento Oncol, I-33081 Aviano, PN, Italy; [Bernardi, Paolo] Univ Padua, Dipartimento Sci Biomed, I-35121 Padua, Italy; [Demarchi, Francesca] Area Sci Pk, Lab Nazl Consorzio Interuniv Bio, I-34142 Trieste, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine; University of Udine; University of Udine; IRCCS Aviano (CRO); University of Padua	Brancolini, C (corresponding author), Univ Udine, Sez Biol, Dipartimento Sci & Tecnol Biomed, Ple Kolbe 4, I-33100 Udine, Italy.	claudio.brancolini@uniud.it	Maestro, Roberta/M-1846-2015; Bernardi, Paolo/C-3656-2008; Maestro, Roberta/P-9748-2019	Maestro, Roberta/0000-0002-6642-5592; Bernardi, Paolo/0000-0001-9187-3736; Maestro, Roberta/0000-0002-6642-5592; BRANCOLINI, Claudio/0000-0002-6597-5373; Demarchi, Francesca/0000-0003-1565-3162	Associazione Italiana Ricerca sul Cancro; Regione Friuli-Venezia Giulia; Ministero della Salute; Ministero dell'Universita e Ricerca	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Regione Friuli-Venezia Giulia(Regione Friuli Venezia Giulia); Ministero della Salute(Ministry of Health, Italy); Ministero dell'Universita e Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro, Regione Friuli-Venezia Giulia ( Progetto AITT), and Ministero della Salute ( to C. B. and R. M.) and Ministero dell'Universita e Ricerca ( to C. B.).	Aleo E, 2006, CANCER RES, V66, P9235, DOI 10.1158/0008-5472.CAN-06-0702; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Brancolini Claudio, 2008, Curr Mol Pharmacol, V1, P24; Bras M, 2007, MOL CELL BIOL, V27, P7073, DOI 10.1128/MCB.02116-06; Brustovetsky N, 2000, J NEUROSCI, V20, P103, DOI 10.1523/JNEUROSCI.20-01-00103.2000; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Demarchi F, 2005, DRUG RESIST UPDATE, V8, P359, DOI 10.1016/j.drup.2005.12.001; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; Ditsworth D, 2007, J BIOL CHEM, V282, P17845, DOI 10.1074/jbc.M701465200; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Henderson C, 2003, J BIOL CHEM, V278, P12579, DOI 10.1074/jbc.M213093200; Henderson CJ, 2005, CELL DEATH DIFFER, V12, P1240, DOI 10.1038/sj.cdd.4401729; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Li ZM, 2004, BIOCHEM BIOPH RES CO, V319, P1171, DOI 10.1016/j.bbrc.2004.05.098; Lindsten T, 2006, CELL DEATH DIFFER, V13, P1272, DOI 10.1038/sj.cdd.4401953; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Malkevitch NV, 1997, FEBS LETT, V412, P173, DOI 10.1016/S0014-5793(97)00666-2; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; Marques-Santos LF, 2006, CELL BIOL INT, V30, P197, DOI 10.1016/j.cellbi.2005.10.021; Milano A, 2007, EUR J CANCER, V43, P1125, DOI 10.1016/j.ejca.2007.01.038; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicholson B, 2008, PROTEIN SCI, V17, P1035, DOI 10.1110/ps.083450408; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Paroni G, 2004, MOL BIOL CELL, V15, P2804, DOI 10.1091/mbc.E03-08-0624; Paroni G, 2001, J BIOL CHEM, V276, P21907, DOI 10.1074/jbc.M011565200; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Rodriguez-Nieto S, 2006, CURR PHARM DESIGN, V12, P4411, DOI 10.2174/138161206779010495; Ruiz-Vela A, 2005, EMBO REP, V6, P379, DOI 10.1038/sj.embor.7400375; Sardao VA, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-11; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Xu Y, 2006, J BIOL CHEM, V281, P8788, DOI 10.1074/jbc.M508135200; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	54	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8369	8381		10.1074/jbc.M806113200	http://dx.doi.org/10.1074/jbc.M806113200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19139105	Green Published, hybrid			2022-12-27	WOS:000264397800021
J	Garapaty, S; Xu, CF; Trojer, P; Mahajan, MA; Neubert, TA; Samuels, HH				Garapaty, Shivani; Xu, Chong-Feng; Trojer, Patrick; Mahajan, Muktar A.; Neubert, Thomas A.; Samuels, Herbert H.			Identification and Characterization of a Novel Nuclear Protein Complex Involved in Nuclear Hormone Receptor-mediated Gene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE-4 METHYLTRANSFERASE COMPLEX; ACTIVATING SIGNAL COINTEGRATOR-2; RETINOIC ACID; IN-VIVO; TRANSCRIPTIONAL REGULATION; HISTONE METHYLTRANSFERASE; INTERACTING PROTEIN; COACTIVATOR ASC-2; BINDING PROTEIN; CARCINOMA-CELLS	NRC/NCoA6 plays an important role in mediating the effects of ligand-bound nuclear hormone receptors as well as other transcription factors. NRC interacting factor 1 (NIF-1) was cloned as a novel factor that interacts in vivo with NRC. Although NIF-1 does not directly interact with nuclear hormone receptors, it enhances activation by nuclear hormone receptors presumably through its interaction with NRC. To further understand the cellular and biological function of NIF-1, we identified NIF-1-associated proteins by in-solution proteolysis followed by mass spectrometry. The identified components revealed factors involved in histone methylation and cell cycle control and include Ash2L, RbBP5, WDR5, HCF-1, DBC-1, and EMSY. Although the NIF-1 complex contains Ash2L, RbBP5, and WDR5, suggesting that the complex might methylate histone H3-Lys-4, we found that the complex contains a H3 methyltransferase activity that modifies a residue other than H3-Lys-4. The identified components form at least two distinctly sized NIF-1 complexes. DBC-1 and EMSY were identified as integral components of an NIF-1 complex of similar to 1.5 MDa and were found to play an important role in the regulation of nuclear receptor-mediated transcription. Stimulation of the Sox9 and HoxA1 genes by retinoic acid receptor-alpha was found to require both DBC-1 andEMSYin addition to NIF-1 for maximal transcriptional activation. Interestingly, NRC was not identified as a component of the NIF-1 complex, suggesting that NIF-1 and NRC do not exist as stable in vitro purified complexes, although the separate NIF-1 and NRC complexes appear to functionally interact in the cell.	[Garapaty, Shivani; Xu, Chong-Feng; Mahajan, Muktar A.; Neubert, Thomas A.; Samuels, Herbert H.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Trojer, Patrick] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University; New York University	Samuels, HH (corresponding author), NYU, Sch Med, Dept Pharmacol, MSB 424,550 1st Ave, New York, NY 10016 USA.	herbert.samuels@nyumc.org		Mahajan, Muktar/0000-0003-1024-6808	NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK016636, R01DK016636, R37DK016636] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA016087-239025] Funding Source: Medline; NCRR NIH HHS [1S10 RR017990-01] Funding Source: Medline; NIDDK NIH HHS [DK16636] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Afonja O, 2002, ONCOGENE, V21, P7850, DOI 10.1038/sj.onc.1205985; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Antonson P, 2003, MOL CELL BIOL, V23, P1260, DOI 10.1128/MCB.23.4.1260-1268.2003; Belakavadi M, 2006, REV PHYSIOL BIOCH P, V156, P23, DOI 10.1007/s10254-005-0002-7; Caira F, 2000, J BIOL CHEM, V275, P5308, DOI 10.1074/jbc.275.8.5308; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Chen YH, 2006, CANCER RES, V66, P8749, DOI 10.1158/0008-5472.CAN-06-0581; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Crawford BD, 2006, ACS CHEM BIOL, V1, P495, DOI 10.1021/cb600367v; DeCerbo J, 2005, CURR OPIN CELL BIOL, V17, P302, DOI 10.1016/j.ceb.2005.04.008; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Garapaty S, 2008, J BIOL CHEM, V283, P6806, DOI 10.1074/jbc.M706986200; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Haber DA, 2003, CELL, V115, P507, DOI 10.1016/S0092-8674(03)00933-4; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Hong SH, 2004, J BIOL CHEM, V279, P16996, DOI 10.1074/jbc.M311752200; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KRISTIE TM, 1993, J BIOL CHEM, V268, P6525; Lee HI, 2008, BIOCHEM BIOPH RES CO, V368, P298, DOI 10.1016/j.bbrc.2008.01.082; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu ZR, 2002, MOL CELL BIOL, V22, P5443, DOI 10.1128/MCB.22.15.5443-5450.2002; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Mahajan MA, 2005, ENDOCR REV, V26, P583, DOI 10.1210/er.2004-0012; Mahajan MA, 2004, MOL CELL BIOL, V24, P4994, DOI 10.1128/MCB.24.11.4994-5004.2004; Mahajan MA, 2002, MOL CELL BIOL, V22, P6883, DOI 10.1128/MCB.22.19.6883-6894.2002; Mahajan MA, 2000, MOL CELL BIOL, V20, P5048, DOI 10.1128/MCB.20.14.5048-5063.2000; Mahajan Muktar A, 2008, Nucl Recept Signal, V6, pe002, DOI 10.1621/nrs.06002; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Qi C, 2004, J BIOL CHEM, V279, P33696, DOI 10.1074/jbc.M401266200; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Trauernicht AM, 2007, MOL ENDOCRINOL, V21, P1526, DOI 10.1210/me.2007-0064; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; Tsai CC, 2004, VITAM HORM, V68, P93; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Yeom SY, 2006, MOL CELL BIOL, V26, P4553, DOI 10.1128/MCB.01412-05; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhu YJ, 2000, J BIOL CHEM, V275, P13510, DOI 10.1074/jbc.275.18.13510	62	63	75	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7542	7552		10.1074/jbc.M805872200	http://dx.doi.org/10.1074/jbc.M805872200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19131338	Green Published, hybrid			2022-12-27	WOS:000264195600017
J	MacKinnon, MA; Curwin, AJ; Gaspard, GJ; Suraci, AB; Fernandez-Murray, JP; McMaster, CR				MacKinnon, Melissa A.; Curwin, Amy J.; Gaspard, Gerard J.; Suraci, Alison B.; Fernandez-Murray, J. Pedro; McMaster, Christopher R.			The Kap60-Kap95 Karyopherin Complex Directly Regulates Phosphatidylcholine Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; EARLY EMBRYONIC LETHALITY; SACCHAROMYCES-CEREVISIAE; CHOLINE-KINASE; NUCLEAR-LOCALIZATION; MEMBRANE-BINDING; ALPHA; GENE; EXPRESSION; YEAST	Phosphatidylcholine is the major phospholipid in eukaryotic cells. There are two main pathways for the synthesis of phosphatidylcholine: the CDP-choline pathway present in all eukaryotes and the phosphatidylethanolamine methylation pathway present in mammalian hepatocytes and some single celled eukaryotes, including the yeast Saccharomyces cerevisiae. In S. cerevisiae, the rate-determining step in the synthesis of phosphatidylcholine via the CDP-choline pathway is catalyzed by Pct1. Pct1 converts phosphocholine and CTP to CDP-choline and pyrophosphate. In this study, we determined that Pct1 is in the nucleoplasm and at endoplasmic reticulum and nuclear membranes. Pct1 directly interacts with the alpha-importin Kap60 via a bipartite basic region in Pct1, and this region of Pct1 was required for its entry into the nucleus. Pct1 also interacted with the beta-importin Kap95 in cell extracts, implying a model whereby Pct1 interacts with Kap60 and Kap95 with this tripartite complex transiting the nuclear pore. Exclusion of Pct1 from the nucleus by elimination of its nuclear localization signal or by decreasing Kap60 function did not affect the level of phosphatidylcholine synthesis. Diminution of Kap95 function resulted in almost complete ablation of phosphatidylcholine synthesis under conditions where Pct1 was extranuclear. The beta-importin Kap95 is a direct regulator membrane synthesis.	[McMaster, Christopher R.] Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada.	christopher.mcmaster@dal.ca	Curwin, Amy/O-8816-2015	Curwin, Amy/0000-0003-1086-2483; McMaster, Christopher/0000-0003-0822-5776	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes for Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrews BJ, 2003, NAT BIOTECHNOL, V21, P1297, DOI 10.1038/nbt1103-1297; Aoyama C, 2000, J LIPID RES, V41, P452; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; Bai C, 1997, METHOD ENZYMOL, V283, P141; Banchio C, 2003, J BIOL CHEM, V278, P32457, DOI 10.1074/jbc.M304810200; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; BOURMANN HA, 2003, BIOCHEMISTRY-US, V42, P3054; BOURMANN HA, 2006, MOL BIOL CELL, V17, P1006; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Friesen JA, 2001, PROTEIN EXPRES PURIF, V21, P141, DOI 10.1006/prep.2000.1354; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Henneberry AL, 1999, BIOCHEM J, V339, P291, DOI 10.1042/0264-6021:3390291; Henneberry AL, 2000, J BIOL CHEM, V275, P29808, DOI 10.1074/jbc.M005786200; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Henneberry AL, 2001, MOL BIOL CELL, V12, P511, DOI 10.1091/mbc.12.3.511; Howe AG, 2002, J BIOL CHEM, V277, P44100, DOI 10.1074/jbc.M206643200; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Kim KH, 1999, J BIOL CHEM, V274, P9531, DOI 10.1074/jbc.274.14.9531; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Lagace TA, 2005, BIOCHEM J, V392, P449, DOI 10.1042/BJ20051021; Lagace TA, 2005, MOL BIOL CELL, V16, P1120, DOI 10.1091/mbc.E04-10-0874; Lagace TA, 2002, MOL CELL BIOL, V22, P4851, DOI 10.1128/MCB.22.13.4851-4862.2002; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; McMaster CR, 2004, TOP CURR GENET, V6, P5; Newton AC, 2004, TRENDS PHARMACOL SCI, V25, P175, DOI 10.1016/j.tips.2004.02.010; Northwood IC, 1999, J BIOL CHEM, V274, P26240, DOI 10.1074/jbc.274.37.26240; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; Soto A, 2008, J BIOL CHEM, V283, P10079, DOI 10.1074/jbc.M800502200; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Stevens SY, 2001, NAT STRUCT BIOL, V8, P947, DOI 10.1038/nsb1101-947; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Taneva SG, 2005, BIOCHEMISTRY-US, V44, P9382, DOI 10.1021/bi050679p; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WANG YL, 1993, J BIOL CHEM, V268, P5899; WANG YL, 1995, J BIOL CHEM, V270, P354, DOI 10.1074/jbc.270.1.354; Williams JG, 1998, J BIOL CHEM, V273, P13482, DOI 10.1074/jbc.273.22.13482; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; Yu Y, 2002, J BIOL CHEM, V277, P34978, DOI 10.1074/jbc.M205316200	51	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7376	7384		10.1074/jbc.M809117200	http://dx.doi.org/10.1074/jbc.M809117200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19141610	Green Published, hybrid			2022-12-27	WOS:000263919000083
J	Pamuklar, Z; Federico, L; Liu, SY; Umezu-Goto, M; Dong, AP; Panchatcharam, M; Fulerson, Z; Berdyshev, E; Natarajan, V; Fang, XJ; Van Meeteren, LA; Moolenaar, WH; Mills, GB; Morris, AJ; Smyth, SS				Pamuklar, Zehra; Federico, Lorenzo; Liu, Shuying; Umezu-Goto, Makiko; Dong, Anping; Panchatcharam, Manikandan; Fulerson, Zachary; Berdyshev, Evgeny; Natarajan, Viswanathan; Fang, Xianjun; Van Meeteren, Laurens A.; Moolenaar, Wouter H.; Mills, Gordon B.; Morris, Andrew J.; Smyth, Susan S.			Autotaxin/Lysopholipase D and Lysophosphatidic Acid Regulate Murine Hemostasis and Thrombosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; PLATELET SHAPE CHANGE; MYOSIN LIGHT-CHAIN; GLANZMANN THROMBASTHENIA; LYSOPHOSPHOLIPASE-D; AUTOTAXIN; ACTIVATION; RECEPTORS; KINASE; BLOOD	The lipid mediator lysophosphatidic acid (LPA) is a potent regulator of vascular cell function in vitro, but its physiologic role in the cardiovasculature is largely unexplored. To address the role of LPA in regulating platelet function and thrombosis, we investigated the effects of LPA on isolated murine platelets. Although LPA activates platelets from the majority of human donors, we found that treatment of isolated murine platelets with physiologic concentrations of LPA attenuated agonist-induced aggregation. Transgenic overexpression of autotaxin/lysophospholipase D (Enpp2), the enzyme necessary for production of the bulk of biologically active LPA in plasma, elevated circulating LPA levels and induced a bleeding diathesis and attenuation of thrombosis in mice. Intravascular administration of exogenous LPA recapitulated the prolonged bleeding time observed in Enpp2-Tg mice. Enpp2(+/-) mice, which have similar to 50% normal plasma LPA levels, were more prone to thrombosis. Plasma autotaxin associated with platelets during aggregation and concentrated in arterial thrombus, and activated but not resting platelets bound recombinant autotaxin/lysoPLD in an integrin-dependent manner. These results identify a novel pathway in which LPA production by autotaxin/lysoPLD regulates murine hemostasis and thrombosis and suggest that binding of autotaxin/lysoPLD to activated platelets may provide a mechanism to localize LPA production.	[Pamuklar, Zehra; Federico, Lorenzo; Dong, Anping; Panchatcharam, Manikandan; Fulerson, Zachary; Morris, Andrew J.; Smyth, Susan S.] Gill Heart Inst, Div Cardiovasc Med, Lexington, KY USA; [Federico, Lorenzo; Smyth, Susan S.] Univ Kentucky, Dept Pharmacol, Lexington, KY 40536 USA; [Morris, Andrew J.] Univ Kentucky, Dept Biochem, Lexington, KY 40536 USA; [Liu, Shuying; Umezu-Goto, Makiko; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Berdyshev, Evgeny; Natarajan, Viswanathan] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Fang, Xianjun] Virginia Commonwealth Univ, Sch Med, Dept Biochem, Richmond, VA 23298 USA; [Van Meeteren, Laurens A.; Moolenaar, Wouter H.] Netherlands Canc Inst, Div Cellular Biochem, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Smyth, Susan S.] US Dept Vet Affairs, Med Ctr, Lexington, KY 40511 USA	University of Kentucky; University of Kentucky; University of Texas System; UTMD Anderson Cancer Center; University of Chicago; Virginia Commonwealth University; Netherlands Cancer Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Smyth, SS (corresponding author), Gill Heart Inst, Div Cardiovasc Med, 900 S Limestone St,326 CTW Bldg, Lexington, KY USA.	SusanSmyth@uky.edu	Van Meeteren, Laurens A./AGQ-6139-2022; Morris, Andrew/B-7869-2010; van Meeteren, Laurens/A-9890-2008	van Meeteren, Laurens/0000-0001-9885-0668; Panchatcharam, Manikandan/0000-0002-7691-8948	National Institutes of Health [HL070304, HL078663, HL074219, CA096496, GM050388, HL79396, P30 CA16672, PO1 CA64602]; NATIONAL CANCER INSTITUTE [P50CA098258, P01CA064602, R01CA096496, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL079396, R01HL078663, R01HL074219, R01HL079396, K08HL070304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL070304, HL078663, and HL074219 ( to S. S. S.), CA096496 and GM050388 to A. J. M.), HL79396 ( to V. N.), and P30 CA16672 and PO1 CA64602 ( to G. B. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amisten S, 2008, THROMB RES, V122, P47, DOI 10.1016/j.thromres.2007.08.014; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Blue R, 2008, BLOOD, V111, P1248, DOI 10.1182/blood-2007-08-105544; Borna C, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-10; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Chen X, 2003, SCAND J CLIN LAB INV, V63, P497, DOI 10.1080/00365510310003265; Choi JW, 2008, BBA-MOL CELL BIOL L, V1781, P531, DOI 10.1016/j.bbalip.2008.03.004; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Cimpean A, 2004, BIOCHEM J, V381, P71, DOI 10.1042/BJ20040465; COLLER BS, 1991, BLOOD, V78, P2603; DEJANA E, 1979, THROMB RES, V15, P191, DOI 10.1016/0049-3848(79)90064-1; Denis CV, 2007, ARTERIOSCL THROM VAS, V27, P728, DOI 10.1161/01.ATV.0000259359.52265.62; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Emeis JJ, 2007, J THROMB HAEMOST, V5, P670, DOI 10.1111/j.1538-7836.2007.02408.x; Georas SN, 2007, CLIN EXP ALLERGY, V37, P311, DOI 10.1111/j.1365-2222.2006.02626.x; GERRARD JM, 1979, AM J PATHOL, V96, P423; GERRARD JM, 1984, BIOCHIM BIOPHYS ACTA, V795, P487, DOI 10.1016/0005-2760(84)90177-2; Guieu R, 2001, J INVEST MED, V49, P56, DOI 10.2310/6650.2001.34091; Haseruck N, 2004, BLOOD, V103, P2585, DOI 10.1182/blood-2003-04-1127; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Lee Z, 2008, MOL BIOL CELL, V19, P5435, DOI 10.1091/mbc.E08-03-0316; Li ZY, 2003, BLOOD, V101, P4423, DOI 10.1182/blood-2002-10-3210; Maddux BA, 2006, AM J PHYSIOL-ENDOC M, V290, pE746, DOI 10.1152/ajpendo.00298.2005; Maschberger P, 2000, J BIOL CHEM, V275, P19159, DOI 10.1074/jbc.M910257199; MOOLENAAR WH, 1992, COLD SPRING HARB SYM, V57, P163, DOI 10.1101/SQB.1992.057.01.021; Morris AJ, 2007, METHOD ENZYMOL, V434, P89, DOI 10.1016/S0076-6879(07)34005-6; Nylander S, 2006, THROMB RES, V117, P543, DOI 10.1016/j.thromres.2005.04.026; Olorundare OE, 2001, BLOOD, V98, P117, DOI 10.1182/blood.V98.1.117; Pamuklar Z, 2008, ARTERIOSCL THROM VAS, V28, P555, DOI 10.1161/ATVBAHA.107.151837; Pandey D, 2007, BLOOD CELL MOL DIS, V38, P269, DOI 10.1016/j.bcmd.2007.01.002; Retzer M, 2000, CELL SIGNAL, V12, P645, DOI 10.1016/S0898-6568(00)00108-X; Retzer M, 2000, FEBS LETT, V466, P70, DOI 10.1016/S0014-5793(99)01762-7; Rother E, 2003, CIRCULATION, V108, P741, DOI 10.1161/01.CIR.0000083715.37658.C4; SCHUMACHER KA, 1972, N-S ARCH PHARMACOL, V275, P373, DOI 10.1007/BF00501126; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Siess W, 2004, J CELL BIOCHEM, V92, P1086, DOI 10.1002/jcb.20108; Smyth SS, 2000, THROMB HAEMOSTASIS, V84, P1103; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, BIOCHEM J, V365, P617, DOI 10.1042/BJ20020348; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2005, J BIOL CHEM, V280, P21155, DOI 10.1074/jbc.M413183200; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Wang X, 2005, J THROMB HAEMOST, V3, P695, DOI 10.1111/j.1538-7836.2005.01236.x; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Westrick RJ, 2007, ARTERIOSCL THROM VAS, V27, P2079, DOI 10.1161/ATVBAHA.107.142810	48	106	111	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7385	7394		10.1074/jbc.M807820200	http://dx.doi.org/10.1074/jbc.M807820200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139100	hybrid, Green Published			2022-12-27	WOS:000263919000084
J	Thompson, JL; Mignen, O; Shuttleworth, TJ				Thompson, Jill L.; Mignen, Olivier; Shuttleworth, Trevor J.			The Orai1 Severe Combined Immune Deficiency Mutation and Calcium Release-activated Ca2+ Channel Function in the Heterozygous Condition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-SELECTIVE ARC CHANNELS; CRAC CHANNEL; STORE DEPLETION; PLASMA-MEMBRANE; T-LYMPHOCYTES; MIC CHANNELS; STIM1; IMMUNODEFICIENCY; INFLUX; SENSOR	Homozygous expression of Orai1 bearing the R91W mutation results in the complete abrogation of currents through the store-operated Ca2+ release-activated Ca2+ (CRAC) channels, resulting in a form of hereditary severe combined immune deficiency(SCID) syndrome (Feske, S., Gwack, Y., Prakriya, M., Srikanth, S., Puppel, S. H., Tanasa, B., Hogan, P. G., Lewis, R. S., Daly, M., and Rao, A. (2006) Nature 441, 179-185). Although heterozygous carriers of the mutation show no clinical symptoms of immunodeficiency, store-operated Ca2+ entry in their T cells is impaired, suggesting a gene-dosage effect of the mutation. We have recently demonstrated that the functional CRAC channel pore is composed of a tetrameric assembly of Orai1 subunits (Mignen, O., Thompson, J. L., and Shuttleworth, T. J. (2008) J. Physiol. 586, 419-425). Therefore, to directly quantify the effect of the SCID mutant in the heterozygous situation, we generated a series of concatenated tetramers of Orai1 that included different numbers and arrangements of the R91W Orai1 subunits. The data obtained show that inclusion of increasing numbers of mutant subunits results in a graded reduction in CRAC channel currents and that this effect is independent of the spatial arrangement or order of the mutant subunits in the tetramer. Macroscopic biophysical properties of the channels were unchanged by inclusion of the mutant subunits, although the rate at which the current activates on store depletion was slowed. We conclude that incorporation of R91W mutant Orai1 subunits in the CRAC channel pore affects the overall magnitude of its conductance and that this effect is related solely to the number of mutant subunits incorporated. Predictions based on the tetrameric channel structure indicate that the graded effect of incorporation of SCID mutant subunits into such an assembly is quantitatively consistent with the previously demonstrated impaired effects on Ca2+ entry recorded in the heterozygous carriers.	[Thompson, Jill L.; Mignen, Olivier; Shuttleworth, Trevor J.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Mignen, Olivier] Univ Paris Sud, Hop Marie Lannelongue, CNRS, UMR 8062, F-92350 Le Plessis Robinson, France	University of Rochester; Centre National de la Recherche Scientifique (CNRS); Hopital Marie Lannelongue; UDICE-French Research Universities; Universite Paris Saclay	Shuttleworth, TJ (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	trevor_shuttleworth@urmc.rochester.edu	MIGNEN, Olivier/M-3258-2019	MIGNEN, Olivier/0000-0001-7913-6119	National Institutes of Health [GM040457]; Alfred and Eleanor Wedd Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred and Eleanor Wedd Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM040457 (to T. J. S.).; Supported in part by funds from the Alfred and Eleanor Wedd Endowment.	Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; LEDEIST F, 1995, BLOOD, V85, P1053, DOI 10.1182/blood.V85.4.1053.bloodjournal8541053; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2000, J BIOL CHEM, V275, P9114, DOI 10.1074/jbc.275.13.9114; Mignen O, 2008, J PHYSIOL-LONDON, V586, P185, DOI 10.1113/jphysiol.2007.146258; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	35	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6620	6626		10.1074/jbc.M808346200	http://dx.doi.org/10.1074/jbc.M808346200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19075015	Green Published, hybrid			2022-12-27	WOS:000263919000006
J	Tsai, AG; Engelhart, AE; Hatmal, MM; Houston, SI; Hud, NV; Haworth, IS; Lieber, MR				Tsai, Albert G.; Engelhart, Aaron E.; Hatmal, Ma'mon M.; Houston, Sabrina I.; Hud, Nicholas V.; Haworth, Ian S.; Lieber, Michael R.			Conformational Variants of Duplex DNA Correlated with Cytosine-rich Chromosomal Fragile Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR BREAKPOINT REGION; B-DNA; RAG COMPLEX; CRYSTALLOGRAPHIC MAP; A-DNA; BISULFITE; MOTIFS; TRANSLOCATIONS; ELECTROSTATICS; DEAMINATION	We found that several major chromosomal fragile sites in human lymphomas, including the bcl-2 major breakpoint region, bcl-1 major translocation cluster, and c-Myc exon 1-intron 1 boundary, contain distinctive sequences of consecutive cytosines exhibiting a high degree of reactivity with the structure-specific chemical probe bisulfite. To assess the inherent structural variability of duplex DNA in these regions and to determine the range of structures reactive to bisulfite, we have performed bisulfite probing on genomic DNA in vitro and in situ; on duplex DNA in supercoiled and linearized plasmids; and on oligonucleotide DNA/DNA and DNA/2'-O-methyl RNA duplexes. Bisulfite is significantly more reactive at the frayed ends of DNA duplexes, which is expected given that bisulfite is an established probe of single-stranded DNA. We observed that bisulfite also distinguishes between more subtle sequence/structural differences in duplex DNA. Supercoiled plasmids are more reactive than linear DNA; and sequences containing consecutive cytosines, namely GGGCCC, are more reactive than those with alternating guanine and cytosine, namely GCGCGC. Circular dichroism and x-ray crystallography show that the GGGCCC sequence forms an intermediate B/A structure. Molecular dynamics simulations also predict an intermediate B/A structure for this sequence, and probe calculations suggest greater bisulfite accessibility of cytosine bases in the intermediate B/A structure over canonical B- or A-form DNA. Electrostatic calculations reveal that consecutive cytosine bases create electropositive patches in the major groove, predicting enhanced localization of the bisulfite anion at homo-C tracts over alternating G/C sequences. These characteristics of homo-C tracts in duplex DNA may be associated with DNA-protein interactions in vivo that predispose certain genomic regions to chromosomal fragility.	[Engelhart, Aaron E.; Hud, Nicholas V.] Georgia Inst Technol, Dept Chem & Biochem, Atlanta, GA 30332 USA; [Lieber, Michael R.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Hatmal, Ma'mon M.; Houston, Sabrina I.; Haworth, Ian S.; Lieber, Michael R.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem, Los Angeles, CA 90089 USA; [Hatmal, Ma'mon M.; Haworth, Ian S.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA	University System of Georgia; Georgia Institute of Technology; University of Southern California; University of Southern California; University of Southern California	Hud, NV (corresponding author), Georgia Inst Technol, Dept Chem & Biochem, Atlanta, GA 30332 USA.	hud@chemistry.gatech.edu; ihaworth@usc.edu; lieber@usc.edu	Hud, Nicholas V/T-7017-2017; Hatmal, Ma'mon M./AAF-7164-2020	Lieber, Michael/0000-0003-3700-6345; Hud, Nicholas/0000-0001-7711-6472; Tsai, Albert/0000-0002-6607-3347; Engelhart, Aaron/0000-0002-1849-7700; M. Hatmal, Ma'mon/0000-0003-1745-8985; Lieber, Michael/0000-0001-8809-0909	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health grants (to M. R. L. and N. V. H. laboratories). The costs of publication of this article were defrayed in part by the payment of page charges.	Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bertoni F, 2004, BRIT J HAEMATOL, V124, P130, DOI 10.1046/j.1365-2141.2003.04761.x; Busch K, 2007, LEUKEMIA, V21, P1739, DOI 10.1038/sj.leu.2404753; Calladine C. R., 2004, UNDERSTANDING DNA MO; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dornberger U, 1999, J BIOL CHEM, V274, P6957, DOI 10.1074/jbc.274.11.6957; GOUGH GW, 1986, EMBO J, V5, P191, DOI 10.1002/j.1460-2075.1986.tb04195.x; Greenbaum JA, 2007, GENOME RES, V17, P940, DOI 10.1101/gr.5602807; Hays FA, 2005, P NATL ACAD SCI USA, V102, P7157, DOI 10.1073/pnas.0409455102; Hud NV, 2003, BIOPOLYMERS, V69, P144, DOI 10.1002/bip.10364; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; Lamm G, 2003, REV COMP CH, V19, P147, DOI 10.1002/0471466638.ch4; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Ng HL, 2000, P NATL ACAD SCI USA, V97, P2035, DOI 10.1073/pnas.040571197; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Raghavan SC, 2007, DNA REPAIR, V6, P751, DOI 10.1016/j.dnarep.2006.12.016; Raghavan SC, 2005, MOL CELL BIOL, V25, P5904, DOI 10.1128/MCB.25.14.5904-5919.2005; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; RAIZIS AM, 1995, ANAL BIOCHEM, V226, P161, DOI 10.1006/abio.1995.1204; Saenger W., 1984, PRINCIPLES NUCL ACID; SHAPIRO R, 1974, J AM CHEM SOC, V96, P906, DOI 10.1021/ja00810a043; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; SONO M, 1973, J AM CHEM SOC, V95, P4745, DOI 10.1021/ja00795a044; Svozil D, 2008, NUCLEIC ACIDS RES, V36, P3690, DOI 10.1093/nar/gkn260; Vargason JM, 2001, P NATL ACAD SCI USA, V98, P7265, DOI 10.1073/pnas.121176898; Wahl MC, 1997, BIOPOLYMERS, V44, P45, DOI 10.1002/(SICI)1097-0282(1997)44:1<45::AID-BIP4>3.0.CO;2-#; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	33	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7157	7164		10.1074/jbc.M806866200	http://dx.doi.org/10.1074/jbc.M806866200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19106104	Green Published, hybrid			2022-12-27	WOS:000263919000063
J	Deshpande, AM; Dai, YS; Kim, Y; Kim, J; Kimlin, L; Gao, K; Wong, DT				Deshpande, Amit M.; Dai, Yan-Shan; Kim, Yong; Kim, Jeffrey; Kimlin, Lauren; Gao, Kai; Wong, David T.			Cdk2ap1 Is Required for Epigenetic Silencing of Oct4 during Murine Embryonic Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; TUMOR-SUPPRESSOR GENE; SELF-RENEWAL; DNA METHYLATION; MOUSE EMBRYO; PLURIPOTENCY; EXPRESSION; NURD; COMPONENT; NETWORK	Oct4 is a known master regulator of stem cell renewal and differentiation. Expression of Oct4 during differentiation is regulated by promoter methylation by the nucleosome remodeling and histone deacetylation (NuRD) complex. Here, we show that Cdk2ap1, a negative regulator of Cdk2 function and cell cycle, promotes Oct4 promoter methylation during murine embryonic stem cell differentiation to down-regulate Oct4 expression. We further show that this repressor function of Cdk2ap1 is dependent on its physical interaction with the methyl DNA-binding protein, Mbd3. Our data support a potential molecular link between the known differentiation promoters, including bone morphogenetic proteins and transforming growth factor signaling, and embryonic stem cell differentiation.	[Deshpande, Amit M.; Dai, Yan-Shan; Kim, Yong; Kim, Jeffrey; Kimlin, Lauren; Gao, Kai; Wong, David T.] Univ Calif Los Angeles, Sch Dent, Dent Res Inst, Los Angeles, CA 90025 USA	University of California System; University of California Los Angeles	Deshpande, AM (corresponding author), 10833 Conte Ave,CHS 73-017, Los Angeles, CA 90095 USA.	adeshpan@ucla.edu; dtww@ucla.edu	Dai, Yanshan/B-8577-2009; Kumar, Rajesh/E-7957-2010	Dai, Yanshan/0000-0001-5048-7417	National Institutes of Health [DE014857]; National Institutes of Health T32 grant [DE07296]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007296, R01DE014857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health T32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE014857 and by a National Institutes of Health T32 grant ( Grant DE07296 to Y. K.).	Buitrago W, 2007, J INVEST DERMATOL, V127, P260, DOI 10.1038/sj.jid.5700654; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Crook JM, 2006, NAT CELL BIOL, V8, P212, DOI 10.1038/ncb0306-212; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; GOUGH NM, 1989, CANCER CELL-MON REV, V1, P77; GOUGH NM, 1989, REPROD FERT DEVELOP, V1, P281, DOI 10.1071/RD9890281; Gu PL, 2006, MOL CELL BIOL, V26, P9471, DOI 10.1128/MCB.00898-06; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hu MG, 2004, CANCER RES, V64, P490, DOI 10.1158/0008-5472.CAN-03-2284; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kim Y, 2005, ONCOGENE, V24, P407, DOI 10.1038/sj.onc.1208222; Lan ZJ, 2002, J BIOL CHEM, V277, P50660, DOI 10.1074/jbc.M209586200; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Mullen EM, 2007, PPAR RES, V2007, DOI 10.1155/2007/61563; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Rao S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-230; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Temple S, 2003, CELL, V115, P247, DOI 10.1016/S0092-8674(03)00853-5; TODD R, 1995, FASEB J, V9, P1362, DOI 10.1096/fasebj.9.13.7557027; Tsuji T, 1998, J BIOL CHEM, V273, P6704, DOI 10.1074/jbc.273.12.6704; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Watabe Tetsuro, 2006, V330, P341; Watson CM, 2001, CELL STRUCT FUNCT, V26, P123; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009	38	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6043	6047		10.1074/jbc.C800158200	http://dx.doi.org/10.1074/jbc.C800158200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19117947	Green Published, hybrid			2022-12-27	WOS:000263742700005
J	Nakano, A; Koinuma, D; Miyazawa, K; Uchida, T; Saitoh, M; Kawabata, M; Hanai, J; Akiyama, H; Abe, M; Miyazono, K; Matsumoto, T; Imamura, T				Nakano, Ayako; Koinuma, Daizo; Miyazawa, Keiji; Uchida, Takafumi; Saitoh, Masao; Kawabata, Masahiro; Hanai, Jun-ichi; Akiyama, Hirotada; Abe, Masahiro; Miyazono, Kohei; Matsumoto, Toshio; Imamura, Takeshi			Pin1 Down-regulates Transforming Growth Factor-beta (TGF-beta) Signaling by Inducing Degradation of Smad Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; BREAST-CANCER; DEPENDENT DEGRADATION; CELL-MEMBRANE; I RECEPTOR; PATHWAYS; PHOSPHORYLATION; SMURF2; MECHANISM; BMP	Transforming growth factor-beta (TGF-beta) is crucial in numerous cellular processes, such as proliferation, differentiation, migration, and apoptosis. TGF-beta signaling is transduced by intracellular Smad proteins that are regulated by the ubiquitin-proteasome system. Smad ubiquitin regulatory factor 2 (Smurf2) prevents TGF-beta and bone morphogenetic protein signaling by interacting with Smads and inducing their ubiquitin-mediated degradation. Here we identified Pin1, a peptidylprolyl cis-trans isomerase, as a novel protein binding Smads. Pin1 interacted with Smad2 and Smad3 but not Smad4; this interaction was enhanced by the phosphorylation of (S/T) P motifs in the Smad linker region. (S/T) P motif phosphorylation also enhanced the interaction of Smad2/3 with Smurf2. Pin1 reduced Smad2/3 protein levels in a manner dependent on its peptidyl-prolyl cis-trans isomerase activity. Knockdown of Pin1 increased the protein levels of endogenous Smad2/3. In addition, Pin1 both enhanced the interaction of Smurf2 with Smads and enhanced Smad ubiquitination. Pin1 inhibited TGF-beta-induced transcription and gene expression, suggesting that Pin1 negatively regulates TGF-beta signaling by down-regulating Smad2/3 protein levels via induction of Smurf2-mediated ubiquitin-proteasomal degradation.	[Nakano, Ayako; Koinuma, Daizo; Kawabata, Masahiro; Hanai, Jun-ichi; Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Div Biochem, Tokyo 1358550, Japan; [Nakano, Ayako; Abe, Masahiro; Matsumoto, Toshio] Univ Tokushima, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Tokushima 7708503, Japan; [Miyazawa, Keiji; Saitoh, Masao; Miyazono, Kohei] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Tokyo 1130033, Japan; [Uchida, Takafumi; Akiyama, Hirotada] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan	Japanese Foundation for Cancer Research; Tokushima University; University of Tokyo; Tohoku University	Imamura, T (corresponding author), Japanese Fdn Canc Res, Inst Canc, Div Biochem, Tokyo 1358550, Japan.	timamura-ind@umin.ac.jp	Koinuma, Daizo/Y-8716-2018; MIYAZAWA, KEIJI/I-9713-2014	Koinuma, Daizo/0000-0001-5611-2122; Uchida, Takafumi/0000-0003-3665-4906	KAKENHI; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science Forum	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Forum	This research was supported by KAKENHI (grants-in-aid for scientific research) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This study was carried out as a part of "Ground Research Announcement for Space Utilization" promoted by the Japan Science Forum.	Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Chen SY, 2006, MOL CELL BIOL, V26, P929, DOI 10.1128/MCB.26.3.929-939.2006; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Grimm OH, 2002, NAT CELL BIOL, V4, P519, DOI 10.1038/ncb812; Hayashi M, 2008, J BIOL CHEM, V283, P565, DOI 10.1074/jbc.M708154200; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Nishihara A, 1998, GENES CELLS, V3, P613, DOI 10.1046/j.1365-2443.1998.00217.x; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	37	87	90	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6109	6115		10.1074/jbc.M804659200	http://dx.doi.org/10.1074/jbc.M804659200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19122240	hybrid			2022-12-27	WOS:000263742700013
J	Liu, Y; Veena, CK; Morgan, JB; Mohammed, KA; Jekabsons, MB; Nagle, DG; Zhou, YD				Liu, Yang; Veena, Coothan K.; Morgan, J. Brian; Mohammed, Kaleem A.; Jekabsons, Mika B.; Nagle, Dale G.; Zhou, Yu-Dong			Methylalpinumisoflavone Inhibits Hypoxia-inducible Factor-1 (HIF-1) Activation by Simultaneously Targeting Multiple Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; MITOCHONDRIAL COMPLEX-III; FACTOR 1-ALPHA; PROTEIN-KINASE; IDENTIFICATION; CANCER; FACTOR-1-ALPHA; HIF-1-ALPHA; ALPHA; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA	Hypoxia is a common feature of solid tumors, and the extent of tumor hypoxia correlates with advanced disease stages and treatment resistance. The transcription factor hypoxia-inducible factor-1 (HIF-1) represents an important tumor-selective molecular target for anticancer drug discovery directed at tumor hypoxia. A natural product chemistry-based approach was employed to discover small molecule inhibitors of HIF-1. Bioassay-guided isolation of an active lipid extract of the tropical legumaceous plant Lonchocarpus glabrescens and structure elucidation afforded two new HIF-1 inhibitors: alpinumisoflavone (compound 1) and 4'-O-methylalpinumisoflavone (compound 2). In human breast tumor T47D cells, compounds 1 and 2 inhibited hypoxia-induced HIF-1 activation with IC50 values of 5 and 0.6 mu M, respectively. At the concentrations that inhibited HIF-1 activation, compound 2 inhibited hypoxic induction of HIF-1 target genes (CDKN1A, GLUT-1, and VEGF), tumor angiogenesis in vitro, cell migration, and chemotaxis. Compound 2 inhibits HIF-1 activation by blocking the induction of nuclear HIF-1 alpha protein, the oxygen-regulated subunit that controls HIF-1 activity. Mechanistic studies indicate that, unlike rotenone and other mitochondrial inhibitors, compound 2 represents the first small molecule that inhibits HIF-1 activation by simultaneously suppressing mitochondrial respiration and disrupting protein translation in vitro. This unique mechanism distinguishes compound 2 from other small molecule HIF-1 inhibitors that are simple mitochondrial inhibitors or flavanoid-based protein kinase inhibitors.	[Liu, Yang; Veena, Coothan K.; Morgan, J. Brian; Mohammed, Kaleem A.; Nagle, Dale G.; Zhou, Yu-Dong] Univ Mississippi, Dept Pharmacognosy, University, MS 38677 USA; [Nagle, Dale G.] Univ Mississippi, Res Inst Pharmaceut Sci, Sch Pharm, University, MS 38677 USA; [Jekabsons, Mika B.] Univ Mississippi, Dept Biol, University, MS 38677 USA	University of Mississippi; University of Mississippi; University of Mississippi	Nagle, DG (corresponding author), Univ Mississippi, Dept Pharmacognosy, University, MS 38677 USA.	dnagle@olemiss.edu; ydzhou@olemiss.edu	Liu, Yang/G-7780-2011	Nagle, Dale/0000-0001-7883-2673; Liu, Yang/0000-0002-0413-5637	National Institutes of Health [CA98787 and P20RR021929]; National Institutes of Health Research Facilities Improvement [C06 RR-14503-01]; National Oceanic and Atmospheric Administration/National Institute of Undersea Science and Technology [NA16RU1496]; NATIONAL CANCER INSTITUTE [R56CA098787, R01CA098787] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014503, P20RR021929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Research Facilities Improvement(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Oceanic and Atmospheric Administration/National Institute of Undersea Science and Technology(National Oceanic Atmospheric Admin (NOAA) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98787 and P20RR021929 and conducted in a facility constructed with National Institutes of Health Research Facilities Improvement Grant C06 RR-14503-01. This work was also supported by National Oceanic and Atmospheric Administration/National Institute of Undersea Science and Technology Grant NA16RU1496.	Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Birner P, 2000, CANCER RES, V60, P4693; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chau NM, 2005, CANCER RES, V65, P4918, DOI 10.1158/0008-5472.CAN-04-4453; Dewhirst MW, 1998, SEMIN RADIAT ONCOL, V8, P143, DOI 10.1016/S1053-4296(98)80040-4; Fang NB, 1999, J AGR FOOD CHEM, V47, P2130, DOI 10.1021/jf981188x; Gong YQ, 2005, AM J PHYSIOL-CELL PH, V288, pC1023, DOI 10.1152/ajpcell.00443.2004; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Han XH, 2005, ARCH PHARM RES, V28, P1324, DOI 10.1007/BF02977895; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hodges TW, 2004, J NAT PROD, V67, P767, DOI 10.1021/np030514m; Hossain CF, 2005, BIOCHEM BIOPH RES CO, V333, P1026, DOI 10.1016/j.bbrc.2005.05.191; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JACKSON B, 1971, J CHEM SOC C, P3389, DOI 10.1039/j39710003389; Jones DT, 2006, MOL CANCER THER, V5, P2193, DOI 10.1158/1535-7163.MCT-05-0443; Kingsford-Adaboh R, 2006, ACTA CRYSTALLOGR B, V62, P843, DOI 10.1107/S0108768106019616; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Le QT, 2004, CANCER METAST REV, V23, P293, DOI 10.1023/B:CANC.0000031768.89246.d7; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Lin X, 2008, P NATL ACAD SCI USA, V105, P174, DOI 10.1073/pnas.0706585104; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Na M, 2006, J NAT PROD, V69, P1572, DOI 10.1021/np0601861; Nagle DG, 2006, CURR DRUG TARGETS, V7, P355, DOI 10.2174/138945006776054979; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Rapisarda A, 2002, CANCER RES, V62, P4316; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Rucci N, 2008, ANTI-CANCER AGENT ME, V8, P342, DOI 10.2174/187152008783961905; Ryan HE, 2000, CANCER RES, V60, P4010; Schroedl C, 2002, AM J PHYSIOL-LUNG C, V283, pL922, DOI 10.1152/ajplung.00014.2002; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Simon MC, 2006, ADV EXP MED BIOL, V588, P165; Tan C, 2005, CANCER RES, V65, P605; Tatum JL, 2006, INT J RADIAT BIOL, V82, P699, DOI 10.1080/09553000601002324; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vaux EC, 2001, BLOOD, V98, P296, DOI 10.1182/blood.V98.2.296; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, BIOCHEM BIOPH RES CO, V216, P669, DOI 10.1006/bbrc.1995.2674; Zhong H, 1999, CANCER RES, V59, P5830; Zhou YD, 2005, J NAT PROD, V68, P947, DOI 10.1021/np050029m	50	53	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5859	5868		10.1074/jbc.M806744200	http://dx.doi.org/10.1074/jbc.M806744200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19091749	Green Published, hybrid			2022-12-27	WOS:000263560600049
J	Preston, RJS; Tran, S; Johnson, JA; Ainle, FN; Harmon, S; White, B; Smith, OP; Jenkins, PV; Dahlback, B; O'Donnell, JS				Preston, Roger J. S.; Tran, Sinh; Johnson, Jennifer A.; Ainle, Fionnuala Ni; Harmon, Shona; White, Barry; Smith, Owen P.; Jenkins, P. Vince; Dahlback, Bjorn; O'Donnell, James S.			Platelet Factor 4 Impairs the Anticoagulant Activity of Activated Protein C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BRAIN ENDOTHELIUM; FACTOR-VA; MEDIATED CLEAVAGES; BINDING-PROPERTIES; COFACTOR ACTIVITY; S DEFICIENCY; GLA DOMAIN; IN-VIVO; INACTIVATION; RECEPTOR	Platelet factor 4 (PF4) is an abundant platelet alpha-granule chemokine released following platelet activation. PF4 interacts with thrombomodulin and the gamma-carboxyglutamic acid (Gla) domain of protein C, thereby enhancing activated protein C (APC) generation by the thrombin-thrombomodulin complex. However, the protein C Gla domain not only mediates protein C activation in vivo, but also plays a critical role in modulating the diverse functional properties of APC once generated. In this study we demonstrate that PF4 significantly inhibits APC anticoagulant activity. PF4 inhibited both protein S-dependentAPC anticoagulant function in plasma and protein S-dependent factor Va (FVa) proteolysis 3- to 5-fold, demonstrating that PF4 impairs protein S cofactor enhancement of APC anticoagulant function. Using recombinant factor Va variants FVa-R506Q/R679Q and FVa-R306Q/R679Q, PF4 was shown to impair APC proteolysis of FVa at position Arg(306) by 3-fold both in the presence and absence of protein S. These data suggest that PF4 contributes to the poorly understood APC resistance phenotype associated with activated platelets. Finally, despite PF4 binding to the APC Gla domain, we show that APC in the presence of PF4 retains its ability to initiate PAR-1-mediated cytoprotective signaling. In summary, we propose that PF4 acts as a critical regulator of APC generation, but also differentially targets APC toward cytoprotective, rather than anticoagulant function at sites of vascular injury with concurrent platelet activation.	[Preston, Roger J. S.; Johnson, Jennifer A.; Ainle, Fionnuala Ni; Harmon, Shona; O'Donnell, James S.] St James Hosp, Haemostasis Res Grp, Inst Mol Med, Trin Coll Dublin, Dublin 8, Ireland; [Tran, Sinh; Dahlback, Bjorn] Lund Univ, Univ Hosp, Dept Lab Med, Wallenberg Lab, SE-20502 Malmo, Sweden; [White, Barry; Jenkins, P. Vince; O'Donnell, James S.] St James Hosp, Natl Ctr Hereditary Coagulat Disorders, Dublin 8, Ireland; [Smith, Owen P.] Our Ladys Childrens Hosp Crumlin, Dept Haematol, Dublin 12, Ireland	Trinity College Dublin; Lund University; Skane University Hospital; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin	Preston, RJS (corresponding author), St James Hosp, Haemostasis Res Grp, Inst Mol Med, Trin Coll Dublin, Dublin 8, Ireland.	prestonr@tcd.ie	O'Donnell, James/A-6171-2009; Smith, Owen/AAU-8929-2020	O'Donnell, James/0000-0003-0309-3313; Preston, Roger/0000-0003-0108-4077; Jenkins, P. Vincent/0000-0001-5301-464X; Dahlback, Bjorn/0000-0003-1546-0328; Ni Ainle, Fionnuala/0000-0003-0163-792X	Health Research Board Ireland Postdoctoral Fellowship [RP/2006/44]; Health Research Board Ph. D. Scholarship; Children's Medical and Research Foundation Award [RP348]; Science Foundation Ireland President of Ireland Young Researcher Award [06/Y12/0925]	Health Research Board Ireland Postdoctoral Fellowship; Health Research Board Ph. D. Scholarship; Children's Medical and Research Foundation Award; Science Foundation Ireland President of Ireland Young Researcher Award(Science Foundation Ireland)	This work was supported by a Health Research Board Ireland Postdoctoral Fellowship (RP/2006/44 to R.J.S.P.), a Health Research Board Ph.D. Scholarship (to J.A.J.), a Children's Medical and Research Foundation Award (RP348 to O.P.S. and F.N.A.), and a Science Foundation Ireland President of Ireland Young Researcher Award (06/Y12/0925, to J.S.O.D.).	Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; CAMIRE RM, 1995, J BIOL CHEM, V270, P20794, DOI 10.1074/jbc.270.35.20794; Camire RM, 1998, BLOOD, V91, P2818, DOI 10.1182/blood.V91.8.2818.2818_2818_2829; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; COMP PC, 1984, J CLIN INVEST, V74, P2082, DOI 10.1172/JCI111632; Dahlback B, 2005, FEBS LETT, V579, P3310, DOI 10.1016/j.febslet.2005.03.001; Domotor E, 2003, BLOOD, V101, P4797, DOI 10.1182/blood-2002-12-3680; Dudek AZ, 1997, J BIOL CHEM, V272, P31785, DOI 10.1074/jbc.272.50.31785; Eslin DE, 2004, BLOOD, V104, P3173, DOI 10.1182/blood-2003-11-3994; Esmon CT, 1999, HAEMATOLOGICA, V84, P363; FAY PJ, 1991, J BIOL CHEM, V266, P20139; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Fukudome K, 1998, J EXP MED, V187, P1029, DOI 10.1084/jem.187.7.1029; Griffin JH, 2007, J THROMB HAEMOST, V5, P73, DOI 10.1111/j.1538-7836.2007.02491.x; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; HANDIN RI, 1976, J BIOL CHEM, V251, P4273; JANE SM, 1989, J CLIN INVEST, V83, P222, DOI 10.1172/JCI113862; KALAFATIS M, 1993, J BIOL CHEM, V268, P27246; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kowalska MA, 2007, BLOOD, V110, P1903, DOI 10.1182/blood-2007-03-081901; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Norstrom EA, 2003, J BIOL CHEM, V278, P24904, DOI 10.1074/jbc.M303829200; Oliver JA, 2002, BLOOD, V100, P539, DOI 10.1182/blood.V100.2.539; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; Regan LM, 1997, J BIOL CHEM, V272, P26279, DOI 10.1074/jbc.272.42.26279; REITSMA PH, 1993, THROMB HAEMOSTASIS, V69, P77; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; SCHWARZ HP, 1984, BLOOD, V64, P1297; SELIGSOHN U, 1984, NEW ENGL J MED, V310, P559, DOI 10.1056/NEJM198403013100904; Sere KM, 2004, BLOOD, V104, P3624, DOI 10.1182/blood-2004-03-1146; SLUNGAARD A, 1994, J BIOL CHEM, V269, P25549; Slungaard A, 2005, INT J BIOCHEM CELL B, V37, P1162, DOI 10.1016/j.biocel.2004.12.003; Slungaard A, 2003, BLOOD, V102, P146, DOI 10.1182/blood-2002-11-3529; Smirnov MD, 1998, J BIOL CHEM, V273, P9031, DOI 10.1074/jbc.273.15.9031; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; STERN DM, 1986, J BIOL CHEM, V261, P713; Taube J, 1999, BLOOD, V93, P3792, DOI 10.1182/blood.V93.11.3792.411k06_3792_3797; Tran S, 2008, J BIOL CHEM, V283, P6648, DOI 10.1074/jbc.M708036200; WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7; WALKER FJ, 1980, J BIOL CHEM, V255, P5521	45	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5869	5875		10.1074/jbc.M804703200	http://dx.doi.org/10.1074/jbc.M804703200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19129181	Green Published, hybrid			2022-12-27	WOS:000263560600050
J	Van de Walle, GR; Kaufer, BB; Chbab, N; Osterrieder, N				Van de Walle, Gerlinde R.; Kaufer, Benedikt B.; Chbab, Najet; Osterrieder, Nikolaus			Analysis of the Herpesvirus Chemokine-binding Glycoprotein G Residues Essential for Chemokine Binding and Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; EQUINE HERPESVIRUS-4; VIRUS; PROTEINS; INHIBITOR; RECEPTORS; CYTOKINES; MUTANTS; DISEASE; HEPARIN	Viral chemokine-binding protein (vCKBP) are expressed by large DNA viruses, such as herpesviruses and poxviruses. vCKBP can bind chemokines with high affinity and efficiently neutralize their ability to induce cell migration. Recently, herpesvirus glycoprotein G (gG) was identified as a member of the vCKBP-4 subfamily. The structural domains of gG important for binding to chemokines and biological activity, however, are unknown. Here, we used equine herpesvirus type 1 (EHV-1) as a model to determine residues in EHV-1 gG that are involved in the processes of chemokine binding and interaction with target cells. First, comprehensive analysis of glycosylation of EHV-1 gG revealed that N-glycosylation is not required for binding of gG to chemokines but is essential for biological activity of the protein. Second, the epitope responsible for the binding to chemokines was localized to 40 amino acids in the hypervariable region (amino acids 301-340) of the protein. Third, hybrid molecules, designed as loss- and gain-of-function gG proteins, were engineered. In these hybrid glycoproteins the hypervariable regions of EHV-1 gG, a vCKBP, and the closely related EHV-4 gG, which does not display any chemokine binding capabilities, were exchanged. gG variants containing the EHV-1 hypervariable region were able to bind chemokines and were biologically active, whereas hybrid gGs containing the corresponding region of EHV-4 gG were not. Taking these results together, this report is the first to provide insight into the functional residues of an alphaherpesviral vCKBP.	[Van de Walle, Gerlinde R.; Kaufer, Benedikt B.; Chbab, Najet; Osterrieder, Nikolaus] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Van de Walle, Gerlinde R.] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9820 Merelbeke, Belgium; [Chbab, Najet; Osterrieder, Nikolaus] Free Univ Berlin, Inst Virol, D-10115 Berlin, Germany	Cornell University; Ghent University; Free University of Berlin	Osterrieder, N (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	no34@cornell.edu	Kaufer, Benedikt B./AAZ-8216-2020	Kaufer, Benedikt B./0000-0003-1328-2695; Osterrieder, Nikolaus/0000-0002-5313-2176; Van de Walle, Gerlinde/0000-0002-2064-8029	Deutsche Forschungsgemeinschaft [OS143/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Harry M. Zweig Memorial Fund for Equine Research at Cornell University and Grant OS143/4-1 from the Deutsche Forschungsgemeinschaft (to N.O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Allen G P, 1986, Prog Vet Microbiol Immunol, V2, P78; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bahar MW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040005; Beck CG, 2001, J BIOL CHEM, V276, P43270, DOI 10.1074/jbc.M106305200; Bryant NA, 2003, EMBO J, V22, P833, DOI 10.1093/emboj/cdg092; Carfi A, 1999, P NATL ACAD SCI USA, V96, P12379, DOI 10.1073/pnas.96.22.12379; COHEN JI, 1994, J GEN VIROL, V75, P3087, DOI 10.1099/0022-1317-75-11-3087; CRABB BS, 1993, J VIROL, V67, P6332, DOI 10.1128/JVI.67.10.6332-6338.1993; Drummer HE, 1998, J GEN VIROL, V79, P1205, DOI 10.1099/0022-1317-79-5-1205; Huang J, 2005, ARCH VIROL, V150, P2583, DOI 10.1007/s00705-005-0607-9; Kamil JP, 2005, J VIROL, V79, P6984, DOI 10.1128/JVI.79.11.6984-6996.2005; Lalani AS, 2000, IMMUNOL TODAY, V21, P100, DOI 10.1016/S0167-5699(99)01556-X; Lalani AS, 1997, J VIROL, V71, P4356, DOI 10.1128/JVI.71.6.4356-4363.1997; Lusso P, 2000, VIROLOGY, V273, P228, DOI 10.1006/viro.2000.0443; McFadden G, 1998, SEMIN CELL DEV BIOL, V9, P359, DOI 10.1006/scdb.1998.0245; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Patel JR, 2005, VET J, V170, P14, DOI 10.1016/j.tvjl.2004.04.018; PELLETT PE, 2007, HERPESVIRIDAE, P2479; PYCOCK JF, 1987, RES VET SCI, V42, P411, DOI 10.1016/S0034-5288(18)30727-6; Seet BT, 2002, J LEUKOCYTE BIOL, V72, P24; Seet BT, 2001, J BIOL CHEM, V276, P30504, DOI 10.1074/jbc.M011401200; VAN B, 2000, J VIROL, V74, P6741; Van de Walle GR, 2008, J VIROL, V82, P6090, DOI 10.1128/JVI.00098-08; Van de Walle GR, 2008, J VIROL, V82, P1714, DOI 10.1128/JVI.02137-07; Van de Walle GR, 2007, J IMMUNOL, V179, P4161, DOI 10.4049/jimmunol.179.6.4161; van Maanen C, 2002, VET QUART, V24, P57, DOI 10.1080/01652176.2002.9695126; von Einem J, 2007, VIROLOGY, V362, P151, DOI 10.1016/j.virol.2006.12.008; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Webb LMC, 2005, MINI-REV MED CHEM, V5, P833, DOI 10.2174/1389557054867110; Webb LMC, 2003, J VIROL, V77, P8588, DOI 10.1128/JVI.77.15.8588-8592.2003; WILSON ME, 1985, REV INFECT DIS, V7, P404	33	14	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5968	5976		10.1074/jbc.M808127200	http://dx.doi.org/10.1074/jbc.M808127200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19074431	hybrid			2022-12-27	WOS:000263560600060
J	Brombacher, E; Urwyler, S; Ragaz, C; Weber, SS; Kami, K; Overduin, M; Hilbi, H				Brombacher, Eva; Urwyler, Simon; Ragaz, Curdin; Weber, Stefan S.; Kami, Keiichiro; Overduin, Michael; Hilbi, Hubert			Rab1 Guanine Nucleotide Exchange Factor SidM Is a Major Phosphatidylinositol 4-Phosphate-binding Effector Protein of Legionella pneumophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; TRANSLOCATED SUBSTRATE; LEGIONNAIRES-DISEASE; ENDOPLASMIC-RETICULUM; HOMOLOGY-DOMAIN; HUMAN-MONOCYTES; EXIT SITES; BINDING; SYSTEM; GENES	The causative agent o f Legionnaires disease, Legionella pneumophila, forms a replicative vacuole in phagocytes by means of the intracellular multiplication/defective organelle trafficking (Icm/Dot) type IV secretion system and translocated effector proteins, some of which subvert host GTP and phosphoinositide (PI) metabolism. The Icm/Dot substrate SidC anchors to the membrane of Legionella-containing vacuoles (LCVs) by specifically binding to phosphatidylinositol 4-phosphate (PtdIns(4) P). Using a nonbiased screen for novel L. pneumophila PI-binding proteins, we identified the Rab1 guanine nucleotide exchange factor (GEF) SidM/DrrA as the predominant PtdIns(4) P-binding protein. Purified SidM specifically and directly bound to PtdIns(4) P, whereas the SidM-interacting Icm/Dot substrate LidA preferentially bound PtdIns(3) P but also PtdIns(4) P, and the L. pneumophila Arf1 GEF RalF did not bind to any PIs. The PtdIns(4) P-binding domain of SidM was mapped to the 12-kDa C-terminal sequence, termed "P4M" (PtdIns4P binding of SidM/DrrA). The isolated P4M domain is largely helical and displayed higher PtdIns(4) P binding activity in the context of the alpha-helical, monomeric full-length protein. SidM constructs containing P4M were translocated by Icm/Dot-proficient L. pneumophila and localized to the LCV membrane, indicating that SidM anchors to PtdIns(4) P on LCVs via its P4M domain. An L. pneumophila Delta sidM mutant strain displayed significantly higher amounts of SidC on LCVs, suggesting that SidM and SidC compete for limiting amounts of PtdIns(4) P on the vacuole. Finally, RNA interference revealed that PtdIns(4) P on LCVs is specifically formed by host PtdIns 4-kinase III beta. Thus, L. pneumophila exploits PtdIns(4) P produced by PtdIns 4-kinase III beta to anchor the effectors SidC and SidM to LCVs.	[Brombacher, Eva; Urwyler, Simon; Ragaz, Curdin; Weber, Stefan S.; Hilbi, Hubert] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Kami, Keiichiro; Overduin, Michael] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; Cancer Research UK; University of Birmingham	Hilbi, H (corresponding author), ETH, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	hilbi@micro.biol.ethz.ch	Hilbi, Hubert/AAU-5815-2020	Hilbi, Hubert/0000-0002-5462-9301; Overduin, Michael/0000-0002-3114-6585	Swiss National Science Foundation [631-065952, PP00A-112592]; ETH Zu r rich [TH 17/02-3, TH-26 06-2]; Novartis; Velux Foundation; OPO Foundation; Biotechnology and Biological Sciences Research Council [BBS/B/10714] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zu r rich; Novartis(Novartis); Velux Foundation(Velux Fonden); OPO Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Grants 631-065952 and PP00A-112592 from the Swiss National Science Foundation, Grants TH 17/02-3 and TH-26 06-2 from ETH Zu r rich, and grants from Novartis, the Velux Foundation, and the OPO Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albers U, 2007, MICROBIOL-SGM, V153, P3817, DOI 10.1099/mic.0.2007/009829-0; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Blumental-Perry A, 2006, DEV CELL, V11, P671, DOI 10.1016/j.devcel.2006.09.001; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Demmel L, 2008, MOL BIOL CELL, V19, P1991, DOI 10.1091/mbc.E06-10-0937; Derre I, 2005, INFECT IMMUN, V73, P4370, DOI 10.1128/IAI.73.7.4370-4380.2005; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Hilbi H, 2001, MOL MICROBIOL, V42, P603, DOI 10.1046/j.1365-2958.2001.02645.x; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Hilbi H, 2006, CELL MICROBIOL, V8, P1697, DOI 10.1111/j.1462-5822.2006.00793.x; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lu H, 2005, CELL MICROBIOL, V7, P995, DOI 10.1111/j.1462-5822.2005.00528.x; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Mampel J, 2006, APPL ENVIRON MICROB, V72, P2885, DOI 10.1128/AEM.72.4.2885-2895.2006; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mezzasalma TM, 2007, J BIOMOL SCREEN, V12, P418, DOI 10.1177/1087057106297984; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Newton HJ, 2006, INFECT IMMUN, V74, P1683, DOI 10.1128/IAI.74.3.1683-1691.2006; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; Ragaz C, 2008, CELL MICROBIOL, V10, P2416, DOI 10.1111/j.1462-5822.2008.01219.x; Robinson CG, 2006, CELL MICROBIOL, V8, P793, DOI 10.1111/j.1462-5822.2005.00666.x; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Seidel RD, 2004, BIOCHEMISTRY-US, V43, P15393, DOI 10.1021/bi0490385; Spirig T, 2008, J BIOL CHEM, V283, P18113, DOI 10.1074/jbc.M801929200; Stahelin RV, 2007, J BIOL CHEM, V282, P25737, DOI 10.1074/jbc.M702861200; Tiaden A, 2008, J BACTERIOL, V190, P7532, DOI 10.1128/JB.01002-08; Tiaden A, 2007, CELL MICROBIOL, V9, P2903, DOI 10.1111/j.1462-5822.2007.01005.x; Urwyler S, 2009, TRAFFIC, V10, P76, DOI 10.1111/j.1600-0854.2008.00851.x; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pD593, DOI 10.1093/nar/gkh077; WIATER LA, 1994, PLASMID, V32, P280, DOI 10.1006/plas.1994.1067	62	193	195	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4846	4856		10.1074/jbc.M807505200	http://dx.doi.org/10.1074/jbc.M807505200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095644	Green Published, hybrid			2022-12-27	WOS:000263416600013
J	Min, L; Jin, ZM; Caldovic, L; Morizono, H; Allewell, NM; Tuchman, M; Shi, D				Min, Li; Jin, Zhongmin; Caldovic, Ljubica; Morizono, Hiroki; Allewell, Norma M.; Tuchman, Mendel; Shi, Dashuang			Mechanism of Allosteric Inhibition of N-Acetyl-L-glutamate Synthase by L-Arginine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLGLUTAMATE SYNTHASE; ESCHERICHIA-COLI; BIOSYNTHESIS; SYNTHETASE; GENES; ARGA	N-Acetylglutamate synthase (NAGS) catalyzes the first committed step in L-arginine biosynthesis in plants and micro-organisms and is subject to feedback inhibition by L-arginine. This study compares the crystal structures of NAGS from Neisseria gonorrhoeae (ngNAGS) in the inactive T-state with L-arginine bound and in the active R-state complexed with CoA and L-glutamate. Under all of the conditions examined, the enzyme consists of two stacked trimers. Each monomer has two domains: an amino acid kinase (AAK) domain with an AAK-like fold but lacking kinase activity and an N-acetyltransferase (NAT) domain homologous to other GCN5-related transferases. Binding of L-arginine to the AAK domain induces a global conformational change that increases the diameter of the hexamer by similar to 10 A and decreases its height by similar to 20 angstrom. AAK dimers move 5 angstrom outward along their 2-fold axes, and their tilt relative to the plane of the hexamer decreases by similar to 4 degrees. The NAT domains rotate similar to 109 degrees relative to AAK domains enabling new interdomain interactions. Interactions between AAK and NAT domains on different subunits also change. Local motions of several loops at the L-arginine-binding site enable the protein to close around the bound ligand, whereas several loops at the NAT active site become disordered, markedly reducing enzymatic specific activity.	[Min, Li; Caldovic, Ljubica; Morizono, Hiroki; Tuchman, Mendel; Shi, Dashuang] George Washington Univ, Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Jin, Zhongmin] Argonne Natl Lab, Adv Photon Source, SER CAT, Argonne, IL 60439 USA; [Allewell, Norma M.] Univ Maryland, Coll Chem & Life Sci, Dept Chem & Biochem, College Pk, MD 20742 USA	Children's National Health System; George Washington University; United States Department of Energy (DOE); Argonne National Laboratory; University System of Maryland; University of Maryland College Park	Shi, D (corresponding author), George Washington Univ, Childrens Natl Med Ctr, Med Genet Res Ctr, 111 Michigan Ave NW, Washington, DC 20010 USA.	dshi@cnmcresearch.org	Morizono, Hiroki/E-9737-2013	Morizono, Hiroki/0000-0002-9678-5564; Shi, Dashuang/0000-0002-5491-1104; Caldovic, Ljubica/0000-0002-9140-5585	National Institutes of Health [DK064913, DK067935]; United States Dept of Energy [W-31-109-Eng-38]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK067935, R01DK064913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Dept of Energy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK064913 (to M. T.) and DK067935 (to D. S.). This work was also supported by United States Dept of Energy Contract W-31-109-Eng-38. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ABDELAL ATH, 1978, J BACTERIOL, V134, P528, DOI 10.1128/JB.134.2.528-536.1978; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADFORD M, 1976, ANAL BIOCHEM, V72, P1219; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2005, J BACTERIOL, V187, P3039, DOI 10.1128/JB.187.9.3039-3044.2005; HAAS D, 1972, EUR J BIOCHEM, V31, P290, DOI 10.1111/j.1432-1033.1972.tb02531.x; Haskins Nantaporn, 2008, BMC Biochemistry, V9, P24, DOI 10.1186/1471-2091-9-24; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LLACER JL, 2007, P NATL ACAD SCI USA, V282, P35733; MARVIL DK, 1977, J BIOL CHEM, V252, P3295; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MIZUNO Y, 2007, J BIOL CHEM, V63, P32; Morizono H, 2004, MOL GENET METAB, V81, pS4, DOI 10.1016/j.ymgme.2003.10.017; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Qu Qiuhao, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-4; Rajagopal BS, 1998, APPL ENVIRON MICROB, V64, P1805; Ramon-Maiques S, 2006, J MOL BIOL, V356, P695, DOI 10.1016/j.jmb.2005.11.079; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Sancho-Vaello E, 2008, FEBS LETT, V582, P1081, DOI 10.1016/j.febslet.2008.02.060; Shi D, 2008, J BIOL CHEM, V283, P7176, DOI 10.1074/jbc.M707678200; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007	31	22	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4873	4880		10.1074/jbc.M805348200	http://dx.doi.org/10.1074/jbc.M805348200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095660	Green Published, hybrid			2022-12-27	WOS:000263416600016
J	Nakamoto, T; Brown, DA; Catalan, MA; Gonzalez-Begne, M; Romanenko, VG; Melvin, JE				Nakamoto, Tetsuji; Brown, David A.; Catalan, Marcelo A.; Gonzalez-Begne, Mireya; Romanenko, Victor G.; Melvin, James E.			Purinergic P2X(7) Receptors Mediate ATP-induced Saliva Secretion by the Mouse Submandibular Gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAROTID ACINAR-CELLS; REFLEX SECRETION; NONCHOLINERGIC MECHANISMS; P-2Z PURINOCEPTORS; CONSCIOUS RATS; SUBSTANCE-P; DUCT CELLS; CHANNELS; CARBACHOL; RELEASE	Salivary glands express multiple isoforms of P2X and P2Y nucleotide receptors, but their in vivo physiological roles are unclear. P2 receptor agonists induced salivation in an ex vivo submandibular gland preparation. The nucleotide selectivity sequence of the secretion response was BzATP >> ATP > ADP >> UTP, and removal of external Ca2+ dramatically suppressed the initial ATP-induced fluid secretion (similar to 85%). Together, these results suggested that P2X receptors are the major purinergic receptor subfamily involved in the fluid secretion process. Mice with targeted disruption of the P2X(7) gene were used to evaluate the role of the P2X(7) receptor in nucleotideevoked fluid secretion. P2X(7) receptor protein and BzATPactivated inward cation currents were absent, and importantly, purinergic receptor agonist-stimulated salivation was suppressed by more than 70% in submandibular glands from P2X(7)-null mice. Consistent with these observations, the ATP-induced increases in [Ca2+](i) were nearly abolished in P2X(7)(-/-)submandibular acinar and duct cells. ATP appeared to also act through the P2X(7) receptor to inhibit muscarinic-induced fluid secretion. These results demonstrate that the ATP-sensitive P2X(7) receptor regulates fluid secretion in the mouse submandibular gland.	[Nakamoto, Tetsuji; Brown, David A.; Catalan, Marcelo A.; Gonzalez-Begne, Mireya; Romanenko, Victor G.; Melvin, James E.] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Nakamoto, Tetsuji; Romanenko, Victor G.; Melvin, James E.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Melvin, JE (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Box 611,601 Elmwood Ave, Rochester, NY 14642 USA.	james_melvin@urmc.rochester.edu	Catalan, Marcelo/AAW-3848-2020; Catalan, Marcelo/ABE-7044-2021	Catalan, Marcelo/0000-0003-3544-2821	National Institutes of Health [DE09692, DE08921]; NIDCR Training [T32DE07202]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE008921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202, R01DE009692, R37DE008921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE09692 and DE08921 (to J. E. M.) and NIDCR Training Grant T32DE07202 (to D. A. B. and M. G.- B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASZTELY A, 1994, ACTA PHYSIOL SCAND, V151, P373, DOI 10.1111/j.1748-1716.1994.tb09756.x; Brown DA, 2004, J BIOL CHEM, V279, P39485, DOI 10.1074/jbc.M406201200; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; COOK D, 1994, SECRETION MAJOR SALI; Dubyak GR, 2007, MOL PHARMACOL, V72, P1402, DOI 10.1124/mol.107.042077; EKSTROM J, 1993, J PHYSIOL-LONDON, V472, P233, DOI 10.1113/jphysiol.1993.sp019944; Ekstrom J, 1998, EUR J MORPHOL, V36, P208; Ekstrom J, 2001, EXP PHYSIOL, V86, P475, DOI 10.1113/eph8602199; Ekstrom J, 1998, EXP PHYSIOL, V83, P697, DOI 10.1113/expphysiol.1998.sp004150; EKSTROM J, 1988, Q J EXP PHYSIOL CMS, V73, P163, DOI 10.1113/expphysiol.1988.sp003129; EKSTROM J, 1994, ACTA PHYSIOL SCAND, V150, P83, DOI 10.1111/j.1748-1716.1994.tb09662.x; Fukushi Y, 1999, EUR J PHARMACOL, V364, P55, DOI 10.1016/S0014-2999(98)00824-3; GALLACHER DV, 1982, NATURE, V296, P83, DOI 10.1038/296083a0; Gonzalez-Begne M, 2007, J BIOL CHEM, V282, P35125, DOI 10.1074/jbc.M707266200; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; JORGENSEN TD, 1995, BIOCHEM J, V312, P457, DOI 10.1042/bj3120457; Lee MG, 1997, J BIOL CHEM, V272, P32951, DOI 10.1074/jbc.272.52.32951; Li Q, 2003, J BIOL CHEM, V278, P47554, DOI 10.1074/jbc.M308306200; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; MERRITT JE, 1987, J BIOL CHEM, V262, P14912; Metioui M, 1996, J CELL PHYSIOL, V168, P462, DOI 10.1002/(SICI)1097-4652(199608)168:2<462::AID-JCP25>3.0.CO;2-3; Nakamoto T, 2008, AM J PHYSIOL-CELL PH, V294, pC810, DOI 10.1152/ajpcell.00511.2007; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Novak I, 2003, NEWS PHYSIOL SCI, V18, P12, DOI 10.1152/nips.01409.2002; Pochet S, 2007, CELL SIGNAL, V19, P2155, DOI 10.1016/j.cellsig.2007.06.012; REID AM, 1988, Q J EXP PHYSIOL CMS, V73, P413, DOI 10.1113/expphysiol.1988.sp003157; RICHARDSON PJ, 1987, J NEUROCHEM, V48, P622, DOI 10.1111/j.1471-4159.1987.tb04138.x; Romanenko V, 2006, J BIOL CHEM, V281, P27964, DOI 10.1074/jbc.M603871200; Romanenko VG, 2007, J PHYSIOL-LONDON, V581, P801, DOI 10.1113/jphysiol.2006.127498; Sim JA, 2004, J NEUROSCI, V24, P6307, DOI 10.1523/JNEUROSCI.1469-04.2004; SOLTOFF SP, 1990, J GEN PHYSIOL, V95, P319, DOI 10.1085/jgp.95.2.319; SOLTOFF SP, 1990, ANN NY ACAD SCI, V603, P91; SOLTOFF SP, 1990, ANN N Y ACAD SCI, V603, P76; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Turner JT, 1999, CRIT REV ORAL BIOL M, V10, P210, DOI 10.1177/10454411990100020701	37	58	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4815	4822		10.1074/jbc.M808597200	http://dx.doi.org/10.1074/jbc.M808597200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19097994	Green Published, hybrid			2022-12-27	WOS:000263416600009
J	Sergeant, MJ; Li, JJ; Fox, C; Brookbank, N; Rea, D; Bugg, TDH; Thompson, AJ				Sergeant, Martin J.; Li, Jian-Jun; Fox, Christine; Brookbank, Nicola; Rea, Dean; Bugg, Timothy D. H.; Thompson, Andrew J.			Selective Inhibition of Carotenoid Cleavage Dioxygenases PHENOTYPIC EFFECTS ON SHOOT BRANCHING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCISIC-ACID BIOSYNTHESIS; NOSTOC SP PCC-7120; BETA-CAROTENE; 9-CIS-EPOXYCAROTENOID DIOXYGENASE; BIOCHEMICAL-CHARACTERIZATION; CHEMICAL GENETICS; IN-VITRO; IDENTIFICATION; ARABIDOPSIS; ENZYME	Members of the carotenoid cleavage dioxygenase family catalyze the oxidative cleavage of carotenoids at various chain positions, leading to the formation of a wide range of apocarotenoid signaling molecules. To explore the functions of this diverse enzyme family, we have used a chemical genetic approach to design selective inhibitors for different classes of carotenoid cleavage dioxygenase. A set of 18 arylalkyl-hydroxamic acids was synthesized in which the distance between an iron-chelating hydroxamic acid and an aromatic ring was varied; these compounds were screened as inhibitors of four different enzyme classes, either in vitro or in vivo. Potent inhibitors were found that selectively inhibited enzymes that cleave carotenoids at the 9,10 position; 50% inhibition was achieved at submicromolar concentrations. Application of certain inhibitors at 100 mu M to Arabidopsis node explants or whole plants led to increased shoot branching, consistent with inhibition of 9,10-cleavage.	[Sergeant, Martin J.; Thompson, Andrew J.] Univ Warwick, Warwick HRI, Wellesbourne CV35 9EF, Warwick, England; [Li, Jian-Jun; Fox, Christine; Brookbank, Nicola; Rea, Dean; Bugg, Timothy D. H.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Thompson, AJ (corresponding author), Univ Warwick, Warwick HRI, Wellesbourne CV35 9EF, Warwick, England.	a.j.thompson@warwick.ac.uk	Thompson, Andrew J./AAF-3017-2020	Thompson, Andrew J./0000-0002-7419-3402; Sergeant, Martin/0000-0001-7264-2668	UK Biological and Biotechnological Sciences Research Council; Selective Chemical Intervention in Biological Systems initiative [BB/D005787]; Biotechnology and Biological Sciences Research Council [BB/D005787/1] Funding Source: researchfish	UK Biological and Biotechnological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Selective Chemical Intervention in Biological Systems initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the UK Biological and Biotechnological Sciences Research Council, Selective Chemical Intervention in Biological Systems initiative ( Project BB/D005787).	Akiyama K, 2006, ANN BOT-LONDON, V97, P925, DOI 10.1093/aob/mcl063; Alder A, 2008, BIOCHEM J, V416, P289, DOI 10.1042/BJ20080568; Alija AJ, 2006, CARCINOGENESIS, V27, P1128, DOI 10.1093/carcin/bgi342; Armstrong JI, 2007, J SCI FOOD AGR, V87, P1985, DOI 10.1002/jsfa.2967; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Bennett T, 2006, CURR BIOL, V16, P553, DOI 10.1016/j.cub.2006.01.058; BERGERON RJ, 1989, TETRAHEDRON, V45, P4939, DOI 10.1016/S0040-4020(01)81074-7; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Borowski T, 2008, CHEM-EUR J, V14, P2264, DOI 10.1002/chem.200701344; Bouvier F, 2003, SCIENCE, V300, P2089, DOI 10.1126/science.1085162; Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; Burbidge A, 1999, PLANT J, V17, P427, DOI 10.1046/j.1365-313X.1999.00386.x; Chatfield SP, 2000, PLANT J, V24, P159, DOI 10.1046/j.1365-313x.2000.00862.x; Cunningham FX, 2007, PHOTOSYNTH RES, V92, P245, DOI 10.1007/s11120-007-9210-0; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.1105/tpc.8.9.1613; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; EISNER T, 1966, SCIENCE, V153, P1341, DOI 10.1126/science.153.3742.1341; Fester T, 2002, PLANTA, V216, P148, DOI 10.1007/s00425-002-0917-z; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Han SY, 2004, PLANT PHYSIOL, V135, P1574, DOI 10.1104/pp.104.039511; Han SY, 2004, BIOORG MED CHEM LETT, V14, P3033, DOI 10.1016/j.bmcl.2004.04.035; Holger S, 2006, J BIOL CHEM, V281, P9845, DOI 10.1074/jbc.M511668200; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; JUTTNER F, 1985, ARCH MICROBIOL, V141, P337, DOI 10.1007/BF00428846; Kaschani F, 2007, CURR OPIN CHEM BIOL, V11, P88, DOI 10.1016/j.cbpa.2006.11.038; KAWASE M, 1979, J CHEM SOC PERK T 1, P643, DOI 10.1039/p19790000643; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kitahata N, 2006, BIOORGAN MED CHEM, V14, P5555, DOI 10.1016/j.bmc.2006.04.025; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kontogiorgis CA, 2005, CURR MED CHEM, V12, P339, DOI 10.2174/0929867053363243; Marasco EK, 2006, J BIOL CHEM, V281, P31583, DOI 10.1074/jbc.M606299200; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; QUINLAN JD, 1990, HORTSCIENCE, V25, P60, DOI 10.21273/HORTSCI.25.1.60; Scherzinger D, 2008, MOL MICROBIOL, V69, P231, DOI 10.1111/j.1365-2958.2008.06282.x; Schwartz SH, 2004, J BIOL CHEM, V279, P46940, DOI 10.1074/jbc.M409004200; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Schwartz SH, 1997, PLANT PHYSIOL, V114, P798; Simkin AJ, 2004, PLANT J, V40, P882, DOI 10.1111/j.1365-313X.2004.02263.x; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Suzuki A, 2004, PLANT CELL PHYSIOL, V45, P914, DOI 10.1093/pcp/pch107; Taylor IB, 2005, J PLANT GROWTH REGUL, V24, P253, DOI 10.1007/s00344-005-0070-6; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Vogel JT, 2008, J BIOL CHEM, V283, P11364, DOI 10.1074/jbc.M710106200; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Walter MH, 2007, PHYTOCHEMISTRY, V68, P130, DOI 10.1016/j.phytochem.2006.09.032; Ward SP, 2004, CURR OPIN PLANT BIOL, V7, P73, DOI 10.1016/j.pbi.2003.10.002; WILSON AK, 1990, MOL GEN GENET, V222, P377, DOI 10.1007/BF00633843; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619; Yeh SL, 2006, CHEM-BIOL INTERACT, V163, P199, DOI 10.1016/j.cbi.2006.08.002; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.arplant.39.1.439	53	38	40	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5257	5264		10.1074/jbc.M805453200	http://dx.doi.org/10.1074/jbc.M805453200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098002	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000263416600056
J	Carrasco-Lopez, C; Godoy, C; de las Rivas, B; Fernandez-Lorente, G; Palomo, JM; Guisan, JM; Fernandez-Lafuente, R; Martinez-Ripoll, M; Hermoso, JA				Carrasco-Lopez, Cesar; Godoy, Cesar; de las Rivas, Blanca; Fernandez-Lorente, Gloria; Palomo, Jose M.; Guisan, Jose M.; Fernandez-Lafuente, Roberto; Martinez-Ripoll, Martin; Hermoso, Juan A.			Activation of Bacterial Thermoalkalophilic Lipases Is Spurred by Dramatic Structural Rearrangements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-STEAROTHERMOPHILUS L1; ALPHA/BETA-HYDROLASE FOLD; CRYSTAL-STRUCTURE; GEOBACILLUS-STEAROTHERMOPHILUS; IMMOBILIZED LIPASES; THERMOPHILIC LIPASE; THERMOSTABLE LIPASE; THERMOCATENULATUS; CLONING; PURIFICATION	The bacterial thermoalkalophilic lipases that hydrolyze saturated fatty acids at 60-75 degrees C and pH 8-10 are grouped as the lipase family I.5. We report here the crystal structure of the lipase from Geobacillus thermocatenulatus, the first structure of a member of the lipase family I.5 showing an open configuration. Unexpectedly, enzyme activation involves large structural rearrangements of around 70 amino acids and the concerted movement of two lids, the alpha 6- and alpha 7-helices, unmasking the active site. Central in the restructuring process of the lids are both the transfer of bulky hydrophobic residues out of the N-terminal end of the alpha 6-helix and the incorporation of short side chain residues to the alpha 6 C-terminal end. All these structural changes are stabilized by the Zn2+-binding domain, which is characteristic of this family of lipases. Two detergent molecules are placed in the active site, mimicking chains of the triglyceride substrate, demonstrating the position of the oxyanion hole and the three pockets that accommodate the sn-1, sn-2, and sn-3 fatty acids chains. The combination of structural and biochemical studies indicate that the lid opening is not mediated by temperature but triggered by interaction with lipid substrate.	[Carrasco-Lopez, Cesar; Martinez-Ripoll, Martin; Hermoso, Juan A.] CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estruct, E-28006 Madrid, Spain; [Godoy, Cesar; de las Rivas, Blanca; Palomo, Jose M.; Guisan, Jose M.; Fernandez-Lafuente, Roberto] CSIC, Inst Catalisis, Dept Biocatalisis, E-28049 Madrid, Spain; [Fernandez-Lorente, Gloria] CSIC, Inst Fermentac Ind, Dept Microbiol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fermentaciones Industriales (IFI)	Hermoso, JA (corresponding author), CSIC, Inst Rocasolano, Grp Cristal Macromol & Biol Estruct, Serrano 119, E-28006 Madrid, Spain.	xjuan@iqfr.csic.es	Hermoso, Juan/J-3433-2012; Palomo, Jose M/AAA-8667-2020; Guisan, Jose M/K-4110-2016; Fernandez-Lorente, Gloria/M-8455-2013; Godoy, Cesar/GQY-8806-2022; de las Rivas, Blanca/K-3899-2014; Martinez-Ripoll, Martin/A-8313-2012	Hermoso, Juan/0000-0002-1862-8950; Guisan, Jose M/0000-0003-1627-6522; de las Rivas, Blanca/0000-0002-8357-5226; Martinez-Ripoll, Martin/0000-0002-4019-0529; Godoy Vargas, Cesar Alonso/0000-0003-4393-9889; Carrasco-Lopez, Cesar/0000-0002-3853-8776; Lorente, Fernandez/0000-0002-0756-439X	Direccion General de Investigacion [BFU2005-01645]; "Factoria de Cristalizacion," CONSOLIDER [INGENIO-NIO-2010]	Direccion General de Investigacion(Spanish Government); "Factoria de Cristalizacion," CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Grant BFU2005-01645 from Direccion General de Investigacion and by "Factoria de Cristalizacion," CONSOLIDER INGENIO-NIO-2010.	[Anonymous], 1990, BIOCATAL BIOTRANSFOR; Bell PJL, 1999, BIOTECHNOL LETT, V21, P1003, DOI 10.1023/A:1005654701905; BJORKLING F, 1991, TRENDS BIOTECHNOL, V9, P360, DOI 10.1016/0167-7799(91)90119-3; BORNSCHEUER UT, 1995, ENZYME MICROB TECH, V17, P578, DOI 10.1016/0141-0229(94)00096-A; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrasco-Lopez C, 2008, ACTA CRYSTALLOGR F, V64, P1043, DOI 10.1107/S1744309108031928; Cho AR, 2000, FEMS MICROBIOL LETT, V186, P235, DOI 10.1016/S0378-1097(00)00150-6; Choi WC, 2005, FEBS LETT, V579, P3461, DOI 10.1016/j.febslet.2005.05.016; Cygler M, 1997, METHOD ENZYMOL, V284, P3; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; DEREWENDA ZS, 1993, TRENDS BIOCHEM SCI, V18, P20, DOI 10.1016/0968-0004(93)90082-X; Fernandez-Lorente G, 2008, BIOMACROMOLECULES, V9, P2553, DOI 10.1021/bm800609g; Fernandez-Lorente G, 2007, BIOTECHNOL BIOENG, V97, P242, DOI 10.1002/bit.21230; Fernandez-Lorente G, 2006, BIOMACROMOLECULES, V7, P2610, DOI 10.1021/bm060408+; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jeong ST, 2002, J BIOL CHEM, V277, P17041, DOI 10.1074/jbc.M200640200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim HK, 1998, BIOSCI BIOTECH BIOCH, V62, P66, DOI 10.1271/bbb.62.66; Matsumura H, 2008, PROTEINS, V70, P592, DOI 10.1002/prot.21799; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nardini M, 2000, J BIOL CHEM, V275, P31219, DOI 10.1074/jbc.M003903200; Nazina TN, 2001, INT J SYST EVOL MICR, V51, P433, DOI 10.1099/00207713-51-2-433; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Palomo JM, 2004, J CHROMATOGR A, V1038, P267, DOI 10.1016/j.chroma.2004.03.058; Palomo JM, 2003, BIOMACROMOLECULES, V4, P204, DOI 10.1021/bm020071l; Palomo JM, 2003, BIOMACROMOLECULES, V4, P1, DOI 10.1021/bm025729+; SARDA L, 1958, BIOCHIM BIOPHYS ACTA, V30, P513, DOI 10.1016/0006-3002(58)90097-0; SCHMIDTDANNERT C, 1994, BBA-LIPID LIPID MET, V1214, P43, DOI 10.1016/0005-2760(94)90008-6; SchmidtDannert C, 1996, BBA-LIPID LIPID MET, V1301, P105, DOI 10.1016/0005-2760(96)00027-6; SchmidtDannert C, 1997, METHOD ENZYMOL, V284, P194; STITES WE, 1991, J MOL BIOL, V221, P7, DOI 10.1016/0022-2836(91)80195-Z; Tyndall JDA, 2002, J MOL BIOL, V323, P859, DOI 10.1016/S0022-2836(02)01004-5	34	169	175	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4365	4372		10.1074/jbc.M808268200	http://dx.doi.org/10.1074/jbc.M808268200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19056729	hybrid			2022-12-27	WOS:000263134400035
J	Namba, T; Homan, T; Nishimura, T; Mima, S; Hoshino, T; Mizushima, T				Namba, Takushi; Homan, Takashi; Nishimura, Tomoko; Mima, Shinji; Hoshino, Tatsuya; Mizushima, Tohru			Up-regulation of S100P Expression by Non-steroidal Anti-inflammatory Drugs and Its Role in Anti-tumorigenic Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-MUCOSAL CELLS; PANCREATIC-CANCER GROWTH; GENE-EXPRESSION; COLON-CANCER; MATRIX METALLOPROTEINASES; INDUCED APOPTOSIS; SULINDAC SULFONE; RETINOIC ACID; BREAST-CANCER; PROTEIN	Epidemiological studies have revealed that prolonged use non-steroidal anti-inflammatory drugs ( NSAIDs) reduces risk of cancer. Various mechanisms, including induction of and inhibition of the growth and invasion of cancer have been implicated in this anti-tumorigenic activity. In study we focused on S100P, which is known to be in clinically isolated tumors and which functions through intracellular and extracellular mechanisms. We showed the of S100P expression in human gastric cells treated with various NSAIDs, including celecoxib. celecoxib-mediated up-regulation of S100P was suppressed the transfection of cells with small interfering RNA for transcription factor 4 (ATF4), a transcription factor in the endoplasmic reticulum stress response. deletion of ATF4 binding consensus sequence located in promoter of the S100P gene resulted in inhibition of transcriptional activation of the gene. These suggest that celecoxib up-regulates the expression of through an ATF4-mediated endoplasmic reticulum stress Celecoxib inhibited the growth and induced and these actions could be either suppressed or stimulated transfection of cells with S100P overexpression plasmid or interfering RNA, respectively. Celecoxib also inhibited the activity of the cells. Cromolyn, which inhibits the binding S100P to its receptor, enhanced the celecoxib-mediated of cell invasion and growth but did not affect These results suggest that S100P affects apoptosis, cell and invasion through either an intracellular or an mechanism and that the up-regulation of S100P expression NSAIDs reduces their anti-tumorigenic activity.	[Namba, Takushi; Homan, Takashi; Nishimura, Tomoko; Mima, Shinji; Hoshino, Tatsuya; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan	Kumamoto University	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp			Scientific Research from the Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency	Scientific Research from the Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Health, Labor, and Welfare of Japan, grants-in-aid from Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grants-in-aid from the Japan Science and Technology Agency. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aburaya M, 2006, J BIOL CHEM, V281, P33422, DOI 10.1074/jbc.M602074200; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Arumugam T, 2006, J NATL CANCER I, V98, P1806, DOI 10.1093/jnci/djj498; Averboukh L, 1996, PROSTATE, V29, P350; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; BECKER T, 1992, EUR J BIOCHEM, V207, P541, DOI 10.1111/j.1432-1033.1992.tb17080.x; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bertram J, 1998, ANTI-CANCER DRUG, V9, P311, DOI 10.1097/00001813-199804000-00004; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Fuentes MK, 2007, DIS COLON RECTUM, V50, P1230, DOI 10.1007/s10350-006-0850-5; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Hunter KW, 2004, TRENDS MOL MED, V10, P201, DOI 10.1016/j.molmed.2004.03.001; Huo R, 2004, CELL TISSUE RES, V316, P359, DOI 10.1007/s00441-004-0885-7; Jiang F, 2005, LEUKEMIA RES, V29, P1181, DOI 10.1016/j.leukres.2005.03.012; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kismet K, 2004, CANCER DETECT PREV, V28, P127, DOI 10.1016/j.cdp.2003.12.005; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; Koomagi R, 1999, ANTICANCER RES, V19, P4333; Logsdon CD, 2003, CANCER RES, V63, P2649; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mima S, 2005, CANCER RES, V65, P1868, DOI 10.1158/0008-5472.CAN-04-2770; Mima S, 2008, CARCINOGENESIS, V29, P1994, DOI 10.1093/carcin/bgn134; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Namba T, 2007, MOL PHARMACOL, V71, P860, DOI 10.1124/mol.106.027698; Piazza GA, 1997, CANCER RES, V57, P2909; Reddy BS, 1999, CANCER RES, V59, P3387; ROLLAND PH, 1980, JNCI-J NATL CANCER I, V64, P1061; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Sato N, 2004, ONCOGENE, V23, P1531, DOI 10.1038/sj.onc.1207269; Saukkonen K, 2001, CLIN CANCER RES, V7, P1923; Shyu RY, 2003, J BIOMED SCI, V10, P313, DOI 10.1159/000070096; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; Taraboletti G, 2000, EXP CELL RES, V258, P384, DOI 10.1006/excr.2000.4936; Tomisato W, 2004, BIOCHEM BIOPH RES CO, V323, P1032, DOI 10.1016/j.bbrc.2004.08.205; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Tsutsumi S, 2002, BBA-MOL CELL RES, V1589, P168, DOI 10.1016/S0167-4889(02)00171-4; Wang GZ, 2006, CANCER RES, V66, P1199, DOI 10.1158/0008-5472.CAN-05-2605; Wang Q, 2007, ONCOGENE, V26, P6560, DOI 10.1038/sj.onc.1210472; Wang WH, 2003, JNCI-J NATL CANCER I, V95, P1784, DOI 10.1093/jnci/djg106; Whiteman HJ, 2007, CANCER RES, V67, P8633, DOI 10.1158/0008-5472.CAN-07-0545; Xu YY, 2007, J CELL BIOCHEM, V100, P773, DOI 10.1002/jcb.21088; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000	57	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4158	4167		10.1074/jbc.M806051200	http://dx.doi.org/10.1074/jbc.M806051200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19073601	hybrid			2022-12-27	WOS:000263134400013
J	Sprouse, RO; Wells, MN; Auble, DT				Sprouse, Rebekka O.; Wells, Melissa N.; Auble, David T.			TATA-binding Protein Variants That Bypass the Requirement for Mot1 in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTION; GENE-EXPRESSION; TBP BINDING; CRYSTAL-STRUCTURE; MINOR-GROOVE; RNA; DNA; RECRUITMENT; PROMOTER; COMPLEX	Mot1 is an essential TATA-binding protein (TBP)-associated factor and Snf2/Swi2 ATPase that both represses and activates transcription. Biochemical and structural results support a model in which ATP binding and hydrolysis induce a conformational change in Mot1 that drives local translocation along DNA, thus removing TBP. Although this activity explains transcriptional repression, it does not as easily explain Mot1-mediated transcriptional activation, and several different models have been proposed to explain how Mot1 activates transcription. To better understand the function of Mot1 in yeast cells in vivo, particularly with regard to gene activation, TBP mutants were identified that bypass the requirement for Mot1 in vivo. Although TBP has been extensively mutated and analyzed previously, this screen uncovered two novel TBP variants that are unique in their ability to bypass the requirement for Mot1. Surprisingly, in vitro analyses reveal that rather than having acquired an improved biochemical activity, one of the TBPs was defective for interaction with polymerase II preinitiation complex (PIC) components and other regulators of TBP function. The other mutant was defective for DNA binding in vitro yet was still recruited to chromatin in vivo. These results suggest that Mot1-mediated dissociation of TBP (or TBP-containing complexes) from chromatin can explain the Mot1 activation mechanism at some promoters. The results also suggest that PICs can be dynamically unstable and that appropriate PIC instability is critical for the regulation of transcription in vivo.	[Sprouse, Rebekka O.; Wells, Melissa N.; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Auble, DT (corresponding author), 1340 Jefferson Pk Ave,POB 800733, Charlottesville, VA 22908 USA.	dta4n@virginia.edu			National Institutes of Health [GM55763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763, T32GM008136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55763 (to D. T. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adamkewicz JI, 2001, J BIOL CHEM, V276, P11883, DOI 10.1074/jbc.M010665200; Andrau JC, 2002, EMBO J, V21, P5173, DOI 10.1093/emboj/cdf485; ARNDT KM, 1995, EMBO J, V14, P1490, DOI 10.1002/j.1460-2075.1995.tb07135.x; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Blair WS, 1997, MOL CELL BIOL, V17, P2888, DOI 10.1128/MCB.17.5.2888; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Cang Y, 1999, EMBO J, V18, P6662, DOI 10.1093/emboj/18.23.6662; Chitikila C, 2002, MOL CELL, V10, P871, DOI 10.1016/S1097-2765(02)00683-4; COLGAN J, 1992, GENE DEV, V6, P304, DOI 10.1101/gad.6.2.304; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Dasgupta A, 2005, EMBO J, V24, P1717, DOI 10.1038/sj.emboj.7600646; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; Dasgupta A, 2007, MOL CELL BIOL, V27, P2886, DOI 10.1128/MCB.00054-07; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davidson I, 2003, TRENDS BIOCHEM SCI, V28, P391, DOI 10.1016/S0968-0004(03)00117-8; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; GANSHEROFF LJ, 1995, GENETICS, V139, P523; Geisberg JV, 2004, MOL CELL, V14, P479, DOI 10.1016/j.molcel.2004.05.003; Geisberg JV, 2002, MOL CELL BIOL, V22, P8122, DOI 10.1128/MCB.22.23.8122-8134.2002; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; HOOPES BC, 1992, J BIOL CHEM, V267, P11539; Huisinga KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r46; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jackson-Fisher AJ, 1999, MOL CELL, V3, P717, DOI 10.1016/S1097-2765(01)80004-6; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kim JW, 2004, MOL CELL BIOL, V24, P8104, DOI 10.1128/MCB.24.18.8104-8112.2004; KIM TK, 1995, J BIOL CHEM, V270, P10976, DOI 10.1074/jbc.270.18.10976; KLEIN C, 1994, SCIENCE, V266, P280, DOI 10.1126/science.7939664; Klejman MP, 2004, MOL CELL BIOL, V24, P10072, DOI 10.1128/MCB.24.22.10072-10082.2004; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lee M, 1997, MOL CELL BIOL, V17, P1336, DOI 10.1128/MCB.17.3.1336; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Liu DJ, 1998, CELL, V94, P573, DOI 10.1016/S0092-8674(00)81599-8; Masson P, 2008, NUCLEIC ACIDS RES, V36, P539, DOI 10.1093/nar/gkm1078; Matangkasombut O, 2004, ADV PROTEIN CHEM, V67, P67; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Muldrow TA, 1999, MOL CELL BIOL, V19, P2835; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Patterson GH, 1998, YEAST, V14, P813, DOI 10.1002/(SICI)1097-0061(19980630)14:9<813::AID-YEA280>3.0.CO;2-2; Pereira LA, 2003, GENE, V315, P1, DOI 10.1016/S0378-1119(03)00714-5; Petri V, 1998, BIOCHEMISTRY-US, V37, P15842, DOI 10.1021/bi981072u; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; RANISH JA, 1991, J BIOL CHEM, V266, P19320; Reese JC, 2003, CURR OPIN GENET DEV, V13, P114, DOI 10.1016/S0959-437X(03)00013-3; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SIKORSKI RS, 1989, GENETICS, V122, P19; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Sprouse RO, 2008, J BIOL CHEM, V283, P24935, DOI 10.1074/jbc.M803749200; Stargell LA, 1996, MOL CELL BIOL, V16, P4456; STARGELL LA, 1995, SCIENCE, V269, P75, DOI 10.1126/science.7604282; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Topalidou I, 2004, EMBO J, V23, P1943, DOI 10.1038/sj.emboj.7600199; van Oevelen CJC, 2005, MOL CELL BIOL, V25, P4863, DOI 10.1128/MCB.25.12.4863-4872.2005; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; Zanton SJ, 2004, P NATL ACAD SCI USA, V101, P16843, DOI 10.1073/pnas.0404988101	67	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4525	4535		10.1074/jbc.M808951200	http://dx.doi.org/10.1074/jbc.M808951200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098311	hybrid, Green Published			2022-12-27	WOS:000263134400053
J	Ren, Y; Jiang, H; Yang, F; Nakaso, K; Feng, J				Ren, Yong; Jiang, Houbo; Yang, Fang; Nakaso, Kazuhiro; Feng, Jian			Parkin Protects Dopaminergic Neurons against Microtubule-depolymerizing Toxins by Attenuating Microtubule-associated Protein Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTENONE INHIBITION; TUBULIN; DISEASE; PHOSPHORYLATION; PATHWAYS; CELLS	Mitogen-activated protein kinases, originally known as microtubule-associated protein (MAP) kinases, are activated in response to a variety of stimuli. Here we report that microtubule-depolymerizing agents such as colchicine or nocodazole induced strong activation of MAP kinases including JNK, ERK, and p38. This effect was markedly attenuated by parkin, whose mutations are linked to Parkinson disease (PD). Our previous study has shown that parkin stabilizes microtubules through strong interactions mediated by three independent domains. We found that each of the three microtubule-binding domains of parkin was sufficient to reduce MAP kinase activation induced by microtubule depolymerization. The ability to attenuate microtubule depolymerization and the ensuing MAP kinase activation was abrogated in B-lymphocytes and fibroblasts derived from PD patients with parkin mutations such as exon 4 deletion. Such mutations produced truncated parkin proteins lacking any microtubule binding domain and prevented parkin from protecting midbrain dopaminergic neurons against microtubule-depolymerizing toxins such as rotenone or colchicine. Consistent with these, blocking MAP kinase activation in midbrain dopaminergic neurons by knocking down MAP kinase kinases (MKK) significantly reduced the selective toxicity of rotenone or colchicine. Conversely, overexpression of MAP kinases caused marked toxicities that were significantly attenuated by parkin. Thus, the results suggest that parkin protects midbrain dopaminergic neurons against microtubule-depolymerizing PD toxins such as rotenone by stabilizing microtubules to attenuate MAP kinase activation.	[Ren, Yong; Jiang, Houbo; Yang, Fang; Feng, Jian] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; [Nakaso, Kazuhiro] Tottori Univ, Dept Neurol, Yonago, Tottori 6838504, Japan	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Tottori University	Feng, J (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 124 Sherman Hall, Buffalo, NY 14214 USA.	jianfeng@buffalo.edu			National Institutes of Health [NS41722]; New York State Center of Excellence in Bioinformatics and Life Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Center of Excellence in Bioinformatics and Life Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS41722 (to J. F.). This work was also supported by the New York State Center of Excellence in Bioinformatics and Life Sciences (to J. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BRINKLEY BR, 1974, EXP CELL RES, V85, P41, DOI 10.1016/0014-4827(74)90210-9; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Dogu O, 2004, MOVEMENT DISORD, V19, P812, DOI 10.1002/mds.20028; Feijoo C, 2005, J CELL SCI, V118, P397, DOI 10.1242/jcs.01655; Feng J, 2006, NEUROSCIENTIST, V12, P469, DOI 10.1177/1073858406293853; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; MARSHALL LE, 1978, BIOCHIM BIOPHYS ACTA, V543, P590, DOI 10.1016/0304-4165(78)90315-X; Nakaso K, 2006, NEUROSCI LETT, V400, P44, DOI 10.1016/j.neulet.2006.02.035; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Ren Y, 2003, J NEUROSCI, V23, P3316; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; STURGILL TW, 1986, BIOCHEM BIOPH RES CO, V134, P565, DOI 10.1016/S0006-291X(86)80457-0; Yang F, 2005, J BIOL CHEM, V280, P17154, DOI 10.1074/jbc.M500843200; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005	19	76	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					4009	4017		10.1074/jbc.M806245200	http://dx.doi.org/10.1074/jbc.M806245200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074146	Green Published, hybrid			2022-12-27	WOS:000262872500069
J	Zhong, M; Molday, LL; Molday, RS				Zhong, Ming; Molday, Laurie L.; Molday, Robert S.			Role of the C Terminus of the Photoreceptor ABCA4 Transporter in Protein Folding, Function, and Retinal Degenerative Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STARGARDT MACULAR DYSTROPHY; CONE-ROD DYSTROPHY; GENE ABCR; RETINITIS-PIGMENTOSA; TANGIER-DISEASE; RIM PROTEIN; SYNTHETIC PEPTIDES; CHOLESTEROL EFFLUX; MEMBRANE TOPOLOGY; LOCALIZATION	ABCA4 is an ATP-binding cassette transporter that is expressed in rod and cone photoreceptor cells and implicated in the removal of retinal derivatives from outer segments following photoexcitation. Mutations in the ABCA4 gene are responsible for a number of related retinal degenerative diseases, including Stargardt macular degeneration, cone-rod dystrophy, retinitis pigmentosa, and age-related macular degeneration. In order to determine the role of the C terminus of ABCA4 in protein structure and function and understand mechanisms by which C-terminal mutations cause retinal degenerative diseases, we have expressed and purified a series of deletion and substitution mutants of ABCA4 and ABCA1 in HEK 293T cells for analysis of their cellular localization and biochemical properties. Removal of the C-terminal 30 amino acids of ABCA4, including a conserved VFVNFA motif, resulted in a loss in N-retinylidene-phosphatidylethanolamine substrate binding, ATP photoaffinity labeling, and retinal-stimulated ATPase activity. This mutant was also retained in the endoplasmic reticulum of cells. Replacement of the VFVNFA motif with alanine residues also resulted in loss in function and cellular mislocalization. In contrast, C-terminal deletion mutants that retain the VFVNFA motif were functionally active and localized to intracellular vesicles similar to wild-type ABCA4. Our studies indicated that the VFVNFA motif is required for the proper folding of ABCA4 into a functionally active protein. This motif also contributes to the efficient folding of ABCA1 into an active protein. Our results provide a molecular based rationale for the disease phenotype displayed by individuals with mutations in the C terminus of ABCA4.	[Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Ophthalmol & Visual Sci, Ctr Macular Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	molday@interchange.ubc.ca			Canadian Institutes for Health Research [MT5822]; University of British Columbia	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); University of British Columbia	This work was supported by Canadian Institutes for Health Research Grant MT5822. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a University of British Columbia predoctoral studentship.	Ahn J, 2000, J BIOL CHEM, V275, P20399, DOI 10.1074/jbc.M000555200; Ahn JH, 2003, J BIOL CHEM, V278, P39600, DOI 10.1074/jbc.M304236200; Allikmets R, 2000, AM J HUM GENET, V67, P793, DOI 10.1086/303100; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Attie AD, 2007, TRENDS BIOCHEM SCI, V32, P172, DOI 10.1016/j.tibs.2007.02.001; Azarian SM, 1997, FEBS LETT, V409, P247, DOI 10.1016/S0014-5793(97)00517-6; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brousseau ME, 2000, J LIPID RES, V41, P433; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; FISHMAN GA, 1991, OPHTHALMOLOGY, V98, P957; FISHMAN GA, 1987, OPHTHALMOLOGY, V94, P809, DOI 10.1016/s0161-6420(87)33533-x; Fishman GA, 2003, ARCH OPHTHALMOL-CHIC, V121, P851, DOI 10.1001/archopht.121.6.851; Fitzgerald MEC, 2001, VISUAL NEUROSCI, V18, P299, DOI 10.1017/S0952523801182143; Fitzgerald ML, 2004, J BIOL CHEM, V279, P48477, DOI 10.1074/jbc.M409848200; Fumagalli A, 2001, HUM GENET, V109, P326, DOI 10.1007/s004390100583; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; GELISKEN O, 1985, INT OPHTHALMOL, V8, P225, DOI 10.1007/BF00137651; GOLDBERG AFX, 1995, BIOCHEMISTRY-US, V34, P14213, DOI 10.1021/bi00043a028; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Loewen CJR, 2001, J BIOL CHEM, V276, P22388, DOI 10.1074/jbc.M011710200; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Moritz OL, 1996, INVEST OPHTH VIS SCI, V37, P352; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; PAPERMASTER DS, 1978, J CELL BIOL, V78, P415, DOI 10.1083/jcb.78.2.415; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090; Rozet JM, 1999, MOL GENET METAB, V68, P310, DOI 10.1006/mgme.1999.2925; Shroyer NF, 1999, VISION RES, V39, P2537, DOI 10.1016/S0042-6989(99)00037-1; Stenirri S, 2006, CLIN CHEM LAB MED, V44, P533, DOI 10.1515/CCLM.2006.116; Sun H, 2000, NAT GENET, V26, P242, DOI 10.1038/79994; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Tamehiro N, 2008, BIOCHEMISTRY-US, V47, P6138, DOI 10.1021/bi800182t; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9	42	42	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3640	3649		10.1074/jbc.M806580200	http://dx.doi.org/10.1074/jbc.M806580200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19056738	hybrid, Green Accepted			2022-12-27	WOS:000262872500032
J	Han, D; Kim, K; Kim, Y; Kang, Y; Lee, JY; Kim, Y				Han, Dohyun; Kim, Kyunggon; Kim, Yeonjung; Kang, Yup; Lee, Ji Yoon; Kim, Youngsoo			Crystal Structure of the N-terminal Domain of Anaphase-promoting Complex Subunit 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATED STRUCTURE SOLUTION; PROTEIN-STRUCTURE; DENSITY MODIFICATION; SECONDARY-STRUCTURE; TPR SUBUNITS; CDH1; MODEL; APC/C; MITOSIS; COMPLEX/CYCLOSOME	Anaphase-promoting complex or cyclosome (APC/C) is an unusual E3 ubiquitin ligase and an essential protein that controls mitotic progression. APC/C includes at least 13 subunits, but no structure has been determined for any tetratricopeptide repeat (TPR)-containing subunit (Apc3 and -6-8) in the TPR subcomplex of APC/C. Apc7 is a TPR-containing subunit that exists only in vertebrate APC/C. Here we report the crystal structure of quad mutant of nApc7 (N-terminal fragment, residues 1-147) of human Apc7 at a resolution of 2.5 angstrom. The structure of nApc7 adopts a TPR-like motif and has a unique dimerization interface, although the protein does not contain the conserved TPR sequence. Based on the structure of nApc7, in addition to previous experimental findings, we proposed a putative homodimeric structure for full-length Apc7. This model suggests that TPR-containing subunits self-associate and bind to adaptors and substrates via an IR peptide in TPR-containing subunits of APC/C.	[Kim, Youngsoo] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Chongno Ku, Seoul 110799, South Korea; [Han, Dohyun; Kim, Kyunggon; Kim, Yeonjung; Kim, Youngsoo] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110799, South Korea; [Kang, Yup] Ajou Univ, Inst Med Sci, Sch Med, Suwon 442749, Kyunggi Do, South Korea; [Lee, Ji Yoon] Seoul Natl Univ, Natl Instrumentat Ctr Environm Management, Seoul 151921, South Korea	Seoul National University (SNU); Seoul National University (SNU); Ajou University; Seoul National University (SNU)	Kim, Y (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Chongno Ku, 28 Yongon Dong, Seoul 110799, South Korea.	biolab@snu.ac.kr	Han, Dohyun/AAU-7871-2020; Kim, Youngsoo/D-6046-2012	Han, Dohyun/0000-0002-0841-1598; 	Korean Ministry of Science and Technology [FPR 08-A2-110]; Innovative Research Institute for Cell Therapy, Republic of Korea [A062260]	Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Innovative Research Institute for Cell Therapy, Republic of Korea	This work was supported by the 21C Frontier Functional Proteomics Project of the Korean Ministry of Science and Technology Grant FPR 08-A2-110 and by the Innovative Research Institute for Cell Therapy, Republic of Korea, Grant A062260.	Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gieffers C, 2001, MOL CELL, V7, P907, DOI 10.1016/S1097-2765(01)00234-9; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gonzalez A, 2003, ACTA CRYSTALLOGR D, V59, P1935, DOI 10.1107/S0907444903017700; Han D, 2008, PROTEINS, V70, P900, DOI 10.1002/prot.21597; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAMB JR, 1994, EMBO J, V13, P4321, DOI 10.1002/j.1460-2075.1994.tb06752.x; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Nyarko A, 2007, BIOCHEMISTRY-US, V46, P11331, DOI 10.1021/bi700735t; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pal M, 2007, J CELL SCI, V120, P3238, DOI 10.1242/jcs.004762; Park KH, 2005, BREAST CANCER RES, V7, pR238, DOI 10.1186/bcr978; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Tanaka T, 2006, BIOPOLYMERS, V84, P161, DOI 10.1002/bip.20361; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wilson CGM, 2005, FEBS J, V272, P166, DOI 10.1111/j.1432-1033.2004.04397.x; Winn MD, 2002, ACTA CRYSTALLOGR D, V58, P1929, DOI 10.1107/S0907444902016116; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu YK, 2006, NAT STRUCT MOL BIOL, V13, P589, DOI 10.1038/nsmb1106; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3	46	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15137	15146		10.1074/jbc.M804887200	http://dx.doi.org/10.1074/jbc.M804887200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19091741	Green Published, hybrid			2022-12-27	WOS:000266288200049
J	Force, T; Woodgett, JR				Force, Thomas; Woodgett, James R.			Unique and Overlapping Functions of GSK-3 Isoforms in Cell Differentiation and Proliferation and Cardiovascular Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GLYCOGEN-SYNTHASE KINASE-3; PLURIPOTENT STEM-CELLS; SELF-RENEWAL; GLYCOGEN-SYNTHASE-KINASE-3-BETA; MOUSE; WNT; PHOSPHORYLATION; PROTEOLYSIS; ACTIVATION; EXPRESSION	Intensive study over the past 30 years has helped define the role of the GSK-3 ((g) under bar lycogen (s) under bar ynthase (k) under bar inase-(3) under bar) family in a variety of physiological and pathophysiological processes. However, the majority of these studies have relied upon overexpression approaches or nonselective small molecule inhibitors. Herein, we examine recent data derived from studies in gene-targeted embryonic stem cells and knock-out mice in an attempt to define the role these protein kinases play in critical decisions made by stem/progenitor cells and by early lineage-committed cardiomyocytes during development.	[Force, Thomas] Thomas Jefferson Univ, Ctr Translat Med, Div Cardiol, Philadelphia, PA 19107 USA; [Force, Thomas] Thomas Jefferson Univ, Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Woodgett, James R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Woodgett, James R.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X5, Canada	Jefferson University; Jefferson University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Force, T (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, Div Cardiol, Philadelphia, PA 19107 USA.	thomas.force@jefferson.edu	Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797; Force, Thomas/0000-0002-0450-8659	National Institutes of Health [HL61688, HL091799]; NHLBI; Canadian Institutes of Health Research [MOP 12858, 74711]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061688, P01HL091799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL61688 and HL091799 from NHLBI ( to T. F.). This work was also supported by Canadian Institutes of Health Research Grants MOP 12858 and 74711 ( to J. R. W.). This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Aghdam SY, 2007, CURR ALZHEIMER RES, V4, P21; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dugo L, 2007, SHOCK, V27, P113, DOI 10.1097/01.shk.0000238059.23837.68; Eisenberg LM, 2006, DEV BIOL, V293, P305, DOI 10.1016/j.ydbio.2006.02.014; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Guo Y, 2005, ONCOGENE, V24, P2599, DOI 10.1038/sj.onc.1208326; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lee HC, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-93; Liu SY, 2008, P NATL ACAD SCI USA, V105, P5248, DOI 10.1073/pnas.0704242105; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; MOENS CB, 1993, DEVELOPMENT, V119, P485; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rowe MK, 2007, NEUROSCI BIOBEHAV R, V31, P920, DOI 10.1016/j.neubiorev.2007.03.002; RUEL L, 1993, NATURE, V362, P557, DOI 10.1038/362557a0; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Smith TK, 2007, SEMIN CELL DEV BIOL, V18, P84, DOI 10.1016/j.semcdb.2006.12.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Yang K, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-33; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769	42	113	115	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9643	9647		10.1074/jbc.R800077200	http://dx.doi.org/10.1074/jbc.R800077200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19064989	hybrid, Green Published			2022-12-27	WOS:000264892900003
J	Contreras, X; Schweneker, M; Chen, CS; McCune, JM; Deeks, SG; Martin, J; Peterlin, BM				Contreras, Xavier; Schweneker, Marc; Chen, Ching-Shih; McCune, Joseph M.; Deeks, Steven G.; Martin, Jeffrey; Peterlin, B. Matija			Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; HISTONE DEACETYLASE INHIBITORS; ACTIVE ANTIRETROVIRAL THERAPY; P-TEFB; HEXAMETHYLENE BISACETAMIDE; TERMINAL DOMAIN; 7SK SNRNP; IN-VIVO	Human immunodeficiency virus (HIV) persists in a latent form in infected individuals treated effectively with highly active antiretroviral therapy (HAART). In part, these latent proviruses account for the rebound in viral replication observed after treatment interruption. A major therapeutic challenge is to purge this reservoir. In this study, we demonstrate that suberoylanilide hydroxamic acid (SAHA) reactivates HIV from latency in chronically infected cell lines and primary cells. Indeed, P-TEFb, a critical transcription cofactor for HIV, is released and then recruited to the viral promoter upon stimulation with SAHA. The phosphatidylinositol 3-kinase/Akt pathway is involved in the initiation of these events. Using flow cytometry-based single cell analysis of protein phosphorylation, we demonstrate that SAHA activates this pathway in several subpopulations of T cells, including memory T cells that are the major viral reservoir in peripheral blood. Importantly, SAHA activates HIV replication in peripheral blood mononuclear cells from individuals treated effectively with HAART. Thus SAHA, which is a Food and Drug Administration-approved drug, might be considered to accelerate the decay of the latent reservoir in HAART-treated infected humans.	[Contreras, Xavier; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Schweneker, Marc; McCune, Joseph M.] Univ Calif San Francisco, Div Expt Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Deeks, Steven G.] Univ Calif San Francisco, Div HIV AIDS, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Martin, Jeffrey] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University System of Ohio; Ohio State University	Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med, 533 Parnassus Ave,Rm U432,Box 0703, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu	contreras, xavier/ABA-3533-2020	contreras, xavier/0000-0003-0748-6923	National Institutes of Health [AI49104, AI058708, R01 AI40312, AI47062, DPI OD00329]; University of California, San Francisco; Center for AIDS Research Grants [P30 AI027763, P30 MH59037, CC99-SF-001]; Clinical and Translational Research Institute [UL1 RR024131]; National Institutes of Health Roadmap for Medical Research; California Foundation for AIDS Research; University-wide AIDS Research Program [F05-GI-219]; Burroughs Wellcome Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040312, R01AI047062, P01AI058708, P30AI027763, R01AI049104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco(University of California System); Center for AIDS Research Grants; Clinical and Translational Research Institute; National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Foundation for AIDS Research; University-wide AIDS Research Program; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants AI49104 and AI058708 ( to B. M. P.) and R01 AI40312 and AI47062 ( to J. M. M.). This work was also supported by the University of California, San Francisco, Center for AIDS Research Grants P30 AI027763, P30 MH59037, and CC99-SF-001 and the University of California, San Francisco, Clinical and Translational Research Institute Grant UL1 RR024131, a component of the National Institutes of Health Roadmap for Medical Research.; Supported by a grant from the California Foundation for AIDS Research.; Supported by the University-wide AIDS Research Program Grant F05-GI-219.; Recipient of National Institutes of Health Grant DPI OD00329 Director's Pioneer Award Program, part of the National Institutes of Health Roadmap for Medical Research) and the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research.	ANDREEFF M, 1992, BLOOD, V80, P2604; ANTONI BA, 1994, VIROLOGY, V202, P684, DOI 10.1006/viro.1994.1390; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bark-Jones SJ, 2006, ONCOGENE, V25, P1775, DOI 10.1038/sj.onc.1209205; BEDNARIK DP, 1990, EMBO J, V9, P1157, DOI 10.1002/j.1460-2075.1990.tb08222.x; Casse C, 1999, J BIOL CHEM, V274, P16097, DOI 10.1074/jbc.274.23.16097; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Contreras X, 2006, FUTURE VIROL, V1, P733, DOI 10.2217/17460794.1.6.733; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Fantin VR, 2008, CANCER RES, V68, P3785, DOI 10.1158/0008-5472.CAN-07-6091; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; Ishida T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-69; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Klichko V, 2006, J VIROL, V80, P4570, DOI 10.1128/JVI.80.9.4570-4579.2006; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Li NN, 2008, P NATL ACAD SCI USA, V105, P4796, DOI 10.1073/pnas.0712051105; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Marcello A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-7; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Nunnari G, 2005, EXPERT OPIN BIOL TH, V5, P1421, DOI 10.1517/14712598.5.11.1421; PEREZ VL, 1991, J IMMUNOL, V147, P3145; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rahmani M, 2003, ONCOGENE, V22, P6231, DOI 10.1038/sj.onc.1206646; Ramalingam SS, 2007, CLIN CANCER RES, V13, P3605, DOI 10.1158/1078-0432.CCR-07-0162; Richon VM, 1996, P NATL ACAD SCI USA, V93, P5705, DOI 10.1073/pnas.93.12.5705; Schweneker M, 2008, J IMMUNOL, V180, P6490, DOI 10.4049/jimmunol.180.10.6490; Scripture-Adams DD, 2002, J VIROL, V76, P13077, DOI 10.1128/JVI.76.24.13077-13082.2002; Sedaghat AR, 2008, P NATL ACAD SCI USA, V105, P4832, DOI 10.1073/pnas.0711372105; Siegel DS, 1998, P NATL ACAD SCI USA, V95, P162, DOI 10.1073/pnas.95.1.162; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; VLACH J, 1993, J GEN VIROL, V74, P2401, DOI 10.1099/0022-1317-74-11-2401; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yik JHN, 2005, J BIOL CHEM, V280, P16368, DOI 10.1074/jbc.M500912200	53	231	236	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6782	6789		10.1074/jbc.M807898200	http://dx.doi.org/10.1074/jbc.M807898200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136668	Green Published, hybrid			2022-12-27	WOS:000263919000023
J	Curwin, AJ; Fairn, GD; McMaster, CR				Curwin, Amy J.; Fairn, Gregory D.; McMaster, Christopher R.			Phospholipid Transfer Protein Sec14 Is Required for Trafficking from Endosomes and Regulates Distinct trans-Golgi Export Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL-TRANSFER PROTEIN; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; GTPASE ARL3P; YEAST; COMPLEX; PHOSPHATIDYLCHOLINE; DOMAIN; MUTANTS; ACETYLATION	A protein known to regulate both lipid metabolism and vesicular transport is the phosphatidylcholine/phosphatidylinositol transfer protein Sec14 of Saccharomyces cerevisiae. Sec14 is thought to globally affect secretion from the trans-Golgi. The results from a synthetic genetic array screen for genes whose inactivation impaired growth of cells with a temperature-sensitive SEC14 allele implied Sec14 regulates transport into and out of the Golgi. This prompted us to examine the role of Sec14 in various vesicular transport pathways. We determined that Sec14 function was required for the route followed by Bgl2, whereas trafficking of other secreted proteins, including Hsp150, Cts1, Scw4, Scw10, Exg1, Cis3, and Ygp1, still occurred, indicating Sec14 regulates specific trans-Golgi export pathways. Upon diminution of Sec14 function, the v-SNARE Snc1 accumulated in endosomes and the trans-Golgi. Its accumulation in endosomes is consistent with Sec14 being required for transport from endosomes to the trans-Golgi. Sec14 was also required for trafficking of Ste3 and the lipophilic dye FM4-64 from the plasma membrane to the vacuole at the level of the endosome. The combined genetic and cell biology data are consistent with regulation of endosome trafficking being a major role for Sec14. We further determined that lipid ligand occupancy differentially regulates Sec14 functions.	[McMaster, Christopher R.] Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada.	christopher.mcmaster@dal.ca	Curwin, Amy/O-8816-2015	Curwin, Amy/0000-0003-1086-2483; McMaster, Christopher/0000-0003-0822-5776; Fairn, Greg/0000-0001-6508-168X	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes for Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Chang HJ, 2002, GENETICS, V162, P29; Chen LY, 2000, J CELL BIOL, V151, P731, DOI 10.1083/jcb.151.3.731; Chen SH, 2005, MOL BIOL CELL, V16, P178, DOI 10.1091/mbc.E04-03-0258; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Curwin AJ, 2008, FUTURE LIPIDOL, V3, P399, DOI 10.2217/17460875.3.4.399; D'Angelo I, 2006, EMBO REP, V7, P174, DOI 10.1038/sj.embor.7400602; de Graaf P, 2004, MOL BIOL CELL, V15, P2038, DOI 10.1091/mbc.E03-12-0862; Demmel L, 2008, MOL BIOL CELL, V19, P1991, DOI 10.1091/mbc.E06-10-0937; Fairn GD, 2005, METHODS, V36, P102, DOI 10.1016/j.ymeth.2004.11.005; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Fernandez JP, 2005, J BIOL CHEM, V280, P8544, DOI 10.1074/jbc.M413999200; Goldstein A, 1975, Methods Enzymol, V42, P504; Gurunathan S, 2002, EMBO J, V21, P602, DOI 10.1093/emboj/21.4.602; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Harsay E, 2002, J CELL BIOL, V156, P271, DOI 10.1083/jcb.200109077; Henneberry AL, 2001, MOL BIOL CELL, V12, P511, DOI 10.1091/mbc.12.3.511; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kostenko EV, 2005, J BIOL CHEM, V280, P2807, DOI 10.1074/jbc.M411139200; Kozminski KG, 2006, TRAFFIC, V7, P1224, DOI 10.1111/j.1600-0854.2006.00467.x; Lafourcade C, 2004, MOL CELL BIOL, V24, P3815, DOI 10.1128/MCB.24.9.3815-3826.2004; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Liang Y, 2007, MOL BIOL CELL, V18, P2533, DOI 10.1091/mbc.e07-03-0221; Lustgarten V, 1999, MOL CELL BIOL, V19, P4480; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Mousley CJ, 2007, BBA-MOL CELL BIOL L, V1771, P727, DOI 10.1016/j.bbalip.2007.04.002; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; Phillips SE, 2006, CRIT REV BIOCHEM MOL, V41, P21, DOI 10.1080/10409230500519573; Phillips SE, 1999, MOL CELL, V4, P187, DOI 10.1016/S1097-2765(00)80366-4; Reggiori F, 2003, J BIOL CHEM, V278, P5009, DOI 10.1074/jbc.M210436200; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.e04-08-0700; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Sirokmany G, 2006, J BIOL CHEM, V281, P6096, DOI 10.1074/jbc.M510619200; SKINNER HB, 1995, P NATL ACAD SCI USA, V92, P112, DOI 10.1073/pnas.92.1.112; Sreenivas A, 1998, J BIOL CHEM, V273, P16635, DOI 10.1074/jbc.273.27.16635; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Ueda S, 2004, CELL SIGNAL, V16, P899, DOI 10.1016/j.cellsig.2004.01.007; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Welti S, 2007, J MOL BIOL, V366, P551, DOI 10.1016/j.jmb.2006.11.055; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346; Xie ZH, 2001, MOL BIOL CELL, V12, P1117, DOI 10.1091/mbc.12.4.1117	50	56	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7364	7375		10.1074/jbc.M808732200	http://dx.doi.org/10.1074/jbc.M808732200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129178	Green Published, hybrid			2022-12-27	WOS:000263919000082
J	Park, SW; Liu, PP; Forouhar, F; Vlot, AC; Tong, L; Tietjen, K; Klessig, DF				Park, Sang-Wook; Liu, Po-Pu; Forouhar, Farhad; Vlot, A. Corina; Tong, Liang; Tietjen, Klaus; Klessig, Daniel F.			Use of a Synthetic Salicylic Acid Analog to Investigate the Roles of Methyl Salicylate and Its Esterases in Plant Disease Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; TOBACCO-MOSAIC-VIRUS; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; TRANSLOCATED SIGNAL; PATHOGEN RESISTANCE; BINDING PROTEIN-2; JASMONIC ACID; DEFENSE; INDUCTION	We previously demonstrated that salicylic acid-binding protein 2 (SABP2) of tobacco is an integral component of systemic acquired resistance (SAR). SABP2 is a methyl salicylate (MeSA) esterase that has high affinity for SA, which feedback inhibits its esterase activity. MeSA esterase activity is required in distal, healthy tissue of pathogen-infected plants to hydrolyze MeSA, which functions as a long-distance, phloem-mobile SAR signal; this hydrolysis releases the biologically active defense hormone SA. In this study, we examined the inhibitory interaction of SA with SABP2, and identified a synthetic SA analog, 2,2,2,2'-tetra-fluoroacetophenone (tetraFA) that, like SA, competitively inhibits the activity of SABP2 and targets esterases, which utilize MeSA as a substrate. However, in contrast to SA, tetraFA does not induce downstream defense responses and, therefore, is effective in planta at blocking SAR development in tobacco mosaic virus (TMV)-infected tobacco and Pseudomonas syringae-infected Arabidopsis. These results confirm the importance of SABP2 and MeSA for SAR development in tobacco and establish similar roles for MeSA and the orthologs of SABP2 in Arabidopsis. Moreover, they demonstrate that tetraFA can be used to determine whether MeSA and its corresponding esterase(s) play a role in SAR signaling in other plant species. In planta analyses using tetraFA, in conjunction with leaf detachment assays and MeSA quantification, were used to assess the kinetics with which MeSA is generated in pathogen-infected leaves, transmitted through the phloem, and processed in the distal healthy leaves. In TMV-infected tobacco, these studies revealed that critical amounts of MeSA are generated, transmitted, and processed between 48 and 72 h post primary infection.	[Park, Sang-Wook; Liu, Po-Pu; Vlot, A. Corina; Klessig, Daniel F.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Forouhar, Farhad; Tong, Liang] Columbia Univ, NE Struct Genom Consortium, Dept Biol Sci, New York, NY 10027 USA; [Tietjen, Klaus] Bayer Crop Sci, Aktiengesell R F BF, D-40764 Monheim, Germany	Cornell University; Boyce Thompson Institute for Plant Research; Columbia University; Bayer AG; Bayer CropScience	Klessig, DF (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	dfk8@cornell.edu	Bruening, Stefan/B-8505-2011; Vlot-Schuster, Corina/M-7351-2014	Vlot-Schuster, Corina/0000-0002-8146-6018; Tong, Liang/0000-0002-0563-6468	National Institutes of Health [P50 GM62413]; National Science Foundation [IOS-0525360]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Protein Structure Initiative P50 GM62413 ( to L. T.). This work was also supported by National Science Foundation Grant IOS-0525360 ( to D. F. K.).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Ament K, 2004, PLANT PHYSIOL, V135, P2025, DOI 10.1104/pp.104.048694; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chaturvedi R, 2008, PLANT J, V54, P106, DOI 10.1111/j.1365-313X.2007.03400.x; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Cui J, 2005, P NATL ACAD SCI USA, V102, P1791, DOI 10.1073/pnas.0409450102; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; DEAN RA, 1986, PHYTOPATHOLOGY, V76, P966, DOI 10.1094/Phyto-76-966; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Dempsey DA, 1999, CRIT REV PLANT SCI, V18, P547, DOI 10.1080/07352689991309397; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Du H, 1997, PLANT PHYSIOL, V113, P1319, DOI 10.1104/pp.113.4.1319; Dudareva N, 1998, PLANT PHYSIOL, V116, P599, DOI 10.1104/pp.116.2.599; DURNER J, 1995, P NATL ACAD SCI USA, V92, P11312, DOI 10.1073/pnas.92.24.11312; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; ENYEDI AJ, 1992, P NATL ACAD SCI USA, V89, P2480, DOI 10.1073/pnas.89.6.2480; Forouhar F, 2005, P NATL ACAD SCI USA, V102, P1773, DOI 10.1073/pnas.0409227102; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; GILLESPIE RJ, 1992, INORG CHEM, V31, P1960, DOI 10.1021/ic00036a045; Guo AL, 2000, PLANT J, V21, P409, DOI 10.1046/j.1365-313x.2000.00692.x; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; JENNS AE, 1979, PHYTOPATHOLOGY, V69, P753, DOI 10.1094/Phyto-69-753; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Koo YJ, 2007, PLANT MOL BIOL, V64, P1, DOI 10.1007/s11103-006-9123-x; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Nandi A, 2004, PLANT CELL, V16, P465, DOI 10.1105/tpc.016907; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Pallas JA, 1996, PLANT J, V10, P281, DOI 10.1046/j.1365-313X.1996.10020281.x; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Seskar M, 1998, PLANT PHYSIOL, V116, P387, DOI 10.1104/pp.116.1.387; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; SHULAEV V, 1995, PLANT CELL, V7, P1691, DOI 10.1105/tpc.7.10.1691; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; VERNOOIJ B, 1994, PLANT CELL, V6, P959, DOI 10.1105/tpc.6.7.959; Vlot AC, 2008, PLANT J, V56, P445, DOI 10.1111/j.1365-313X.2008.03618.x; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; YALPANI N, 1991, PLANT CELL, V3, P809, DOI 10.1105/tpc.3.8.809; Yang Y, 2008, PLANT PHYSIOL, V147, P1034, DOI 10.1104/pp.108.118224	44	68	75	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7307	7317		10.1074/jbc.M807968200	http://dx.doi.org/10.1074/jbc.M807968200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131332	hybrid, Green Published			2022-12-27	WOS:000263919000077
J	Rigutto, S; Hoste, C; Grasberger, H; Milenkovic, M; Communi, D; Dumont, JE; Corvilain, B; Miot, F; De Deken, X				Rigutto, Sabrina; Hoste, Candice; Grasberger, Helmut; Milenkovic, Milutin; Communi, David; Dumont, Jacques E.; Corvilain, Bernard; Miot, Francoise; De Deken, Xavier			Activation of Dual Oxidases Duox1 and Duox2 DIFFERENTIAL REGULATION MEDIATED BY cAMP-DEPENDENT PROTEIN KINASE AND PROTEIN KINASE C-DEPENDENT PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN THYROID-CELLS; CONGENITAL HYPOTHYROIDISM; NADPH OXIDASE; HYDROGEN-PEROXIDE; H2O2-GENERATING SYSTEM; MATURATION FACTOR; H2O2 GENERATION; TSH RECEPTOR; GENE; MUTATIONS	Dual oxidases were initially identified as NADPH oxidases producing H2O2 necessary for thyroid hormone biosynthesis. The crucial role of Duox2 has been demonstrated in patients suffering from partial iodide organification defect caused by bi-allelic mutations in the DUOX2 gene. However, the Duox1 function in thyroid remains elusive. We optimized a functional assay by co-expressing Duox1 or Duox2 with their respective maturation factors, DuoxA1 and DuoxA2, to compare their intrinsic enzymatic activities under stimulation of the major signaling pathways active in the thyroid in relation to their membrane expression. We showed that basal activity of both Duox isoenzymes depends on calcium and functional EF-hand motifs. However, the two oxidases are differentially regulated by activation of intracellular signaling cascades. Duox1 but not Duox2 activity is stimulated by forskolin (EC50 = 0.1 mu M) via protein kinase A-mediated Duox1 phosphorylation on serine 955. In contrast, phorbol esters induce Duox2 phosphorylation via protein kinase C activation associated with high H2O2 generation (phorbol 12-myristate 13-acetate EC50 = 0.8 nM). These results were confirmed in human thyroid cells, suggesting that Duox1 is also involved in thyroid hormonogenesis. Our data provide, for the first time, detailed insights into the mechanisms controlling the activation of Duox1-2 proteins and reveal additional phosphorylation-mediated regulation.	[Rigutto, Sabrina; Hoste, Candice; Milenkovic, Milutin; Communi, David; Dumont, Jacques E.; Corvilain, Bernard; Miot, Francoise; De Deken, Xavier] Univ Libre Bruxelles, IRIBHM, Hop Erasme, B-1070 Brussels, Belgium; [Corvilain, Bernard] Univ Libre Bruxelles, Dept Endocrinol, Hop Erasme, B-1070 Brussels, Belgium; [Grasberger, Helmut] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Chicago	Rigutto, S (corresponding author), Univ Libre Bruxelles, IRIBHM, Campus Erasme,Bat C,808 Route Lenn, B-1070 Brussels, Belgium.	sabrina.rigutto@ulb.ac.be	Grasberger, Helmut/C-4148-2015	Grasberger, Helmut/0000-0002-4065-4418	Fonds National pour la Recherche Medicale; Actions de Recherches Concertees de la Communaute Francaise de Belgique; Fonds National de la Recherche Scientifique; Fondation Van Buren; Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture; Cancer Research Foundation; American Thyroid Association	Fonds National pour la Recherche Medicale(Fonds de la Recherche Scientifique - FNRS); Actions de Recherches Concertees de la Communaute Francaise de Belgique; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fondation Van Buren; Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture(Fonds de la Recherche Scientifique - FNRS); Cancer Research Foundation; American Thyroid Association	This work was supported by the "Fonds National pour la Recherche Medicale," "Actions de Recherches Concertees de la Communaute Francaise de Belgique," the "Fonds National de la Recherche Scientifique," and the Fondation Van Buren.; Recipients of a fellowship from the "Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture."; Recipient of research grants from the Cancer Research Foundation and the American Thyroid Association.	ALLGEIER A, 1994, J BIOL CHEM, V269, P13733; Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; BENARD B, 1971, UNION MED CAN, V100, P701; BUCHLER W, 1990, EUR J BIOCHEM, V188, P253, DOI 10.1111/j.1432-1033.1990.tb15397.x; Cheng GJ, 2004, J BIOL CHEM, V279, P34250, DOI 10.1074/jbc.M400660200; CORVILAIN B, 1994, J CLIN ENDOCR METAB, V79, P152, DOI 10.1210/jc.79.1.152; CORVILAIN B, 1991, ENDOCRINOLOGY, V128, P779, DOI 10.1210/endo-128-2-779; DARCANGELO D, 1995, J CLIN ENDOCR METAB, V80, P1136, DOI 10.1210/jc.80.4.1136; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; De Deken X, 2002, EXP CELL RES, V273, P187, DOI 10.1006/excr.2001.5444; Dumont J E, 1971, Vitam Horm, V29, P287; DUPUY C, 1989, EUR J BIOCHEM, V185, P597, DOI 10.1111/j.1432-1033.1989.tb15155.x; DUPUY C, 1986, BIOCHEM BIOPH RES CO, V141, P839, DOI 10.1016/S0006-291X(86)80249-2; DUPUY C, 1988, FEBS LETT, V233, P74, DOI 10.1016/0014-5793(88)81358-9; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; DUPUY C, 1991, J BIOL CHEM, V266, P3739; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Grasberger H, 2007, MOL ENDOCRINOL, V21, P1408, DOI 10.1210/me.2007-0018; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; Maruo Y, 2008, J CLIN ENDOCR METAB, V93, P4261, DOI 10.1210/jc.2008-0856; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Moreno Jose C., 2007, V10, P99, DOI 10.1159/000106822; NUNEZ J, 1982, VITAM HORM, V39, P175, DOI 10.1016/S0083-6729(08)61137-1; Ohye H, 2008, THYROID, V18, P561, DOI 10.1089/thy.2007.0258; Pachucki J, 2004, MOL CELL ENDOCRINOL, V214, P53, DOI 10.1016/j.mce.2003.11.026; Pacquelet S, 2008, J BIOL CHEM, V283, P24649, DOI 10.1074/jbc.M709108200; Pfarr N, 2006, CLIN ENDOCRINOL, V65, P810, DOI 10.1111/j.1365-2265.2006.02672.x; RASPE E, 1991, MOL CELL ENDOCRINOL, V81, P175, DOI 10.1016/0303-7207(91)90216-F; Rigutto S, 2007, EXP CELL RES, V313, P3892, DOI 10.1016/j.yexcr.2007.06.011; ROGER P, 1988, J CLIN ENDOCR METAB, V66, P1158, DOI 10.1210/jcem-66-6-1158; ROGER PP, 1982, MOL CELL ENDOCRINOL, V26, P165, DOI 10.1016/0303-7207(82)90014-4; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; UHLER MD, 1987, J BIOL CHEM, V262, P15202; Varela V, 2006, CLIN CHEM, V52, P182, DOI 10.1373/clinchem.2005.058321; Vassart G, 1995, ANN NY ACAD SCI, V766, P23, DOI 10.1111/j.1749-6632.1995.tb26645.x; Vigone Maria Cristina, 2005, Hum Mutat, V26, P395; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Zamproni I, 2008, J CLIN ENDOCR METAB, V93, P605, DOI 10.1210/jc.2007-2020	51	156	159	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6725	6734		10.1074/jbc.M806893200	http://dx.doi.org/10.1074/jbc.M806893200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19144650	hybrid, Green Published			2022-12-27	WOS:000263919000017
J	Wang, CY; Wang, Y; Huffman, NT; Cui, CY; Yao, XM; Midura, S; Midura, RJ; Gorski, JP				Wang, Chuanyi; Wang, Yong; Huffman, Nichole T.; Cui, Chaoying; Yao, Xiaomei; Midura, Sharon; Midura, Ronald J.; Gorski, Jeff P.			Confocal Laser Raman Microspectroscopy of Biomineralization Foci in UMR 106 Osteoblastic Cultures Reveals Temporally Synchronized Protein Changes Preceding and Accompanying Mineral Crystal Deposition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	9th International Conference on the Chemistry and Biology of Mineralized Tissues	NOV 04-08, 2007	Lakeland, TX				BONE ACIDIC GLYCOPROTEIN-75; INORGANIC-PHOSPHATE; MARROW ABLATION; MATRIX; SIALOPROTEIN; NUCLEATION; TISSUE; HYDROXYAPATITE; CALCIFICATION; HYPERCALCEMIA	Mineralization in UMR 106-01 osteoblastic cultures occurs within extracellular biomineralization foci (BMF) within 12 h after addition of beta-glycerol phosphate to cells at 64 h after plating. BMF are identified by their enrichment with an 85-kDa glycoprotein reactive with Maackia amurensis lectin. Laser Raman microspectroscopic scans were made on individual BMF at times preceding (64-76h) and following the appearance of mineral crystals(76-88 h). The range of variation between spectra for different BMF in the same culture was rather small. In contrast, significant differences were observed for spectral bands at 957-960, 1004, and 1660 cm(-1) when normalized BMF spectra at different times were compared. Protein-dependent spectral bands at 1004 and 1660 cm(-1) increased and then decreased preceding the detection of hydroxyapatite crystals via the phosphate stretching peak at 959-960 cm(-1). When sodium phosphate was substituted for beta-glycerol phosphate, mineralization occurred 3-6 h earlier. Irrespective of phosphate source, the Raman full peak width at half-maximum ratio for 88 h cultures was similar to that for 10-day-old marrow ablation primary bone. However, if mineralization was blocked with serine protease inhibitor 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride, 64-88-h BMF spectra remained largely invariant. In summary, Raman spectral data demonstrate for the first time that formation of hydroxyapatite crystals within individual BMF is a multistep process. Second, changes in protein-derived signals at 1004 and 1660 cm(-1) reflect events within BMFs that precede or accompany mineral crystal production because they are blocked by mineralization inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride. Finally, the low extent of spectral variability detected among different BMF at the same time point indicates that mineralization of individual BMF within a culture is synchronized.	[Huffman, Nichole T.; Gorski, Jeff P.] Univ Missouri, Sch Dent, Dept Oral Biol, Bone Biol Program, Kansas City, MO 64108 USA; [Wang, Chuanyi; Wang, Yong; Yao, Xiaomei] Univ Missouri, Sch Dent, Dept Oral Biol, Biomat Sect, Kansas City, MO 64108 USA; [Midura, Sharon; Midura, Ronald J.] Cleveland Clin, Dept Biomed Engn, Lerner Inst, Cleveland, OH 44195 USA; [Cui, Chaoying] Tibet Univ Med Coll, Lhasa 850002, Tibet, Peoples R China	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Cleveland Clinic Foundation; Tibet University	Gorski, JP (corresponding author), Univ Missouri, Sch Dent, Dept Oral Biol, Bone Biol Program, 625 E 25th St, Kansas City, MO 64108 USA.	GorskiJ@UMKC.edu	Wang, Yong/GPX-3217-2022; Wang, Chuanyi/AAO-6346-2020	Wang, Yong/0000-0002-2862-5075; Wang, Chuanyi/0000-0002-7146-115X	NIAMS NIH HHS [R01 AR052775-04, R01 AR052775, R01AR052775] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052775] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z; Balooch M, 2008, J STRUCT BIOL, V162, P404, DOI 10.1016/j.jsb.2008.02.010; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; BIANCO P, 1985, CALCIFIED TISSUE INT, V37, P684, DOI 10.1007/BF02554931; BIANCO P, 1993, J HISTOCHEM CYTOCHEM, V41, P193, DOI 10.1177/41.2.8419459; Bohic S, 1998, BIOCHEM BIOPH RES CO, V253, P506, DOI 10.1006/bbrc.1998.9781; BONUCCI E, 2007, BIOL CALCIFICATION N, P511; Carden A, 2003, CALCIFIED TISSUE INT, V72, P166, DOI 10.1007/s00223-002-1039-0; Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994; Conradas KA, 2005, MOL CELL PROTEOMICS, V4, P1284, DOI 10.1074/mcp.M500082-MCP200; Conrads KA, 2004, ELECTROPHORESIS, V25, P1342, DOI 10.1002/elps.200405892; Crane NJ, 2006, BONE, V39, P434, DOI 10.1016/j.bone.2006.02.059; Dempster DW., 2006, PRIMER METABOLIC BON, P7; Freeman JJ, 2001, CALCIFIED TISSUE INT, V68, P156, DOI 10.1007/s002230001206; Goldstein J, 2003, SCANNING ELECT MICRO, V3rd, P689, DOI [10.1007/978-1-4615-0215-9, DOI 10.1007/978-1-4615-0215-9]; Gorski JP, 2009, CELLS TISSUES ORGANS, V189, P25, DOI 10.1159/000151723; GORSKI JP, 1992, CALCIFIED TISSUE INT, V50, P391, DOI 10.1007/BF00296767; Gorski JP, 2004, J BIOL CHEM, V279, P25455, DOI 10.1074/jbc.M312408200; Gorski JP, 2002, J BIOL CHEM, V277, P18840, DOI 10.1074/jbc.M109578200; Gorski JP, 1998, CRIT REV ORAL BIOL M, V9, P201, DOI 10.1177/10454411980090020401; Gorski JP, 2000, BONE, V27, P103, DOI 10.1016/S8756-3282(00)00295-7; Grynpas MD, 2007, BONE, V41, P162, DOI 10.1016/j.bone.2007.04.176; Hale LV, 2000, CALCIFIED TISSUE INT, V67, P80, DOI 10.1007/s00223001101; Huffman NT, 2007, J BIOL CHEM, V282, P26002, DOI 10.1074/jbc.M701332200; Hulmes DJS, 1997, MATRIX BIOL, V16, P41, DOI 10.1016/S0945-053X(97)90115-3; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; Jell G, 2008, J BIOMED MATER RES A, V86A, P31, DOI 10.1002/jbm.a.31542; Kale S, 2000, NAT BIOTECHNOL, V18, P954, DOI 10.1038/79439; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane NE, 2006, J BONE MINER RES, V21, P466, DOI 10.1359/JBMR.051103; Lu YB, 2009, CELLS TISSUES ORGANS, V189, P175, DOI 10.1159/000151727; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Magnuson SK, 1997, J BONE MINER RES, V12, P200, DOI 10.1359/jbmr.1997.12.2.200; Meng ZJ, 2006, J PROTEOME RES, V5, P1931, DOI 10.1021/pr060009l; Midura RJ, 2004, J BIOL CHEM, V279, P25464, DOI 10.1074/jbc.M312409200; MIDURA RJ, 1990, J BIOL CHEM, V265, P5285; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Pasteris JD, 2004, BIOMATERIALS, V25, P229, DOI 10.1016/S0142-9612(03)00487-3; PENEL G, 2000, BONE ELMSFORD, V36, P893; Pettway GJ, 2005, BONE, V36, P959, DOI 10.1016/j.bone.2005.02.015; Rousseau M, 2008, J BIOMED MATER RES A, V85A, P487, DOI 10.1002/jbm.a.31553; SAUER GR, 1994, CALCIFIED TISSUE INT, V54, P414, DOI 10.1007/BF00305529; Schinke T, 1999, NAT GENET, V21, P150, DOI 10.1038/5928; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Stewart S, 2002, J RAMAN SPECTROSC, V33, P536, DOI 10.1002/jrs.892; TSUBOI M, 2005, BIOCHEMISTRY-US, V39, P2677; TSUDA H, 1993, J DENT RES, V72, P1609, DOI 10.1177/00220345930720121401; TURNER CH, 1994, J BONE MINER RES, V9, P87; Wang AM, 2000, J BIOL CHEM, V275, P11082, DOI 10.1074/jbc.275.15.11082	53	34	34	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7100	7113		10.1074/jbc.M805898200	http://dx.doi.org/10.1074/jbc.M805898200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	415FF	19116206	Green Published, hybrid			2022-12-27	WOS:000263919000058
J	Hakim, O; John, S; Ling, JQ; Biddie, SC; Hoffman, AR; Hager, GL				Hakim, Ofir; John, Sam; Ling, Jian Qun; Biddie, Simon C.; Hoffman, Andrew R.; Hager, Gordon L.			Glucocorticoid Receptor Activation of the Ciz1-Lcn2 Locus by Long Range Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN GENE; NUCLEAR-ORGANIZATION; CHROMATIN; GENOME; EXPRESSION; MECHANISMS; REVEALS; SITES; CELLS	The cellular response to glucocorticoid receptor (GR) activation involves a highly orchestrated series of regulatory actions influenced at multiple levels by a variety of mechanisms including the action of transcription factors and chromatin modifiers. Because the majority of GR binding sites (glucocorticoid-responsive elements (GREs)) are distant from promoters, it is likely that interactions at a distance play an important role in GR action. To determine whether long range chromosomal associations play a role in transcription regulation by GR, we utilized a chromosome conformation capture-based technique (associated chromosome trap) to identify unknown, remote sequences that interact with the GR-induced Lipocalin2 (Lcn2) gene. Our screen revealed that the Lcn2 GRE interacts with the Ciz1 gene, nearly 30 kb upstream. Ciz1 was subsequently found to be a novel GR-responsive gene. The GRE proximal to the Lcn2 promoter apparently functions to regulate both the Lcn2 gene and the distal Ciz1 gene. Using quantitative chromosome conformation capture, we find that a loop structure is organized between these two genes. This structure is hormone-independent and present only in cell types where the genes are active. The strong correlation between gene expression and loop structure in different cell lines suggests that high order interactions play a role in determining tissue-specific gene regulation.	[Hakim, Ofir; John, Sam; Biddie, Simon C.; Hager, Gordon L.] NCI, LRBGE, NIH, Bethesda, MD 20892 USA; [Ling, Jian Qun; Hoffman, Andrew R.] Palo Alto Hlth Care Syst, Dept Vet Affairs, Palo Alto, CA 94304 USA; [Ling, Jian Qun; Hoffman, Andrew R.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Hager, GL (corresponding author), NCI, LRBGE, NIH, Bldg 41,B602, Bethesda, MD 20892 USA.	hagerg@exchange.nih.gov	Hakim, Ofir/A-6239-2012	Hakim, Ofir/0000-0003-0063-2721; Biddie, Simon/0000-0002-8253-0253	National Institutes of Health; NCI; Center for Cancer Research; NATIONAL CANCER INSTITUTE [Z01BC005450, ZIABC005450, ZIABC010027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health grant from the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research.	BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fraser P, 2006, CURR OPIN GENET DEV, V16, P490, DOI 10.1016/j.gde.2006.08.002; Gao H, 2008, MOL ENDOCRINOL, V22, P10, DOI 10.1210/me.2007-0121; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hager GL, 2004, BBA-GENE STRUCT EXPR, V1677, P46, DOI 10.1016/j.bbaexp.2003.09.016; HANKINSON O, 1979, P NATL ACAD SCI USA, V76, P373, DOI 10.1073/pnas.76.1.373; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; JOHN S, 2009, ENDOCRINOLO IN PRESS; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Ling JQ, 2007, PEDIATR RES, V61, p11R, DOI 10.1203/pdr.0b013e31804575db; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Muller WG, 2007, J CELL BIOL, V177, P957, DOI 10.1083/jcb.200703157; RICHARDSON UI, 1981, ENDOCRINOLOGY, V108, P281, DOI 10.1210/endo-108-1-281; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Voss TC, 2006, MOL ENDOCRINOL, V20, P2641, DOI 10.1210/me.2006-0091; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; WASYLYK B, 1983, CELL, V32, P503, DOI 10.1016/0092-8674(83)90470-1; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; 2007, CURR OPIN GENET DEV, V17, P456; 2007, CURR OPIN CELL BIOL, V19, P317	35	56	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6048	6052		10.1074/jbc.C800212200	http://dx.doi.org/10.1074/jbc.C800212200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124469	Green Published, hybrid			2022-12-27	WOS:000263742700006
J	Silva, JP; Lelianova, V; Hopkins, C; Volynski, KE; Ushkaryov, Y				Silva, John-Paul; Lelianova, Vera; Hopkins, Colin; Volynski, Kirill E.; Ushkaryov, Yuri			Functional Cross-interaction of the Fragments Produced by the Cleavage of Distinct Adhesion G-protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-LATROTOXIN-BINDING; CHONDROITIN SULFATE; STORED CA2+; HUMAN EMR2; GPS MOTIF; CD97; LATROPHILIN; EXPRESSION; FAMILY; EXOCYTOSIS	The unusual adhesion G-protein-coupled receptors (aGPCRs) contain large extracellular N-terminal domains, which resemble cell-adhesion receptors, and C-terminal heptahelical domains, which may couple to G-proteins. These receptors are cleaved post-translationally between these domains into two fragments (NTF and CTF). Using the aGPCR latrophilin 1, we previously demonstrated that the fragments behave as independent cell-surface proteins. Upon binding the agonist, alpha-latrotoxin (LTX), latrophilin fragments reassemble and induce intracellular signaling. Our observations raised important questions: is the aGPCR signaling mediated by reassembled fragments or by any non-cleaved receptors? Also, can the fragments originating from distinct aGPCRs form hybrid complexes? To answer these questions, we created two types of chimerical constructs. One contained the CTF of latrophilin joined to the NTF of another aGPCR, EMR2; the resulting protein did not bind LTX but, similar to latrophilin, could couple to G-proteins. In another construct, the NTF of latrophilin was fused with the C terminus of neurexin; this chimera bound LTX but could not signal via G-proteins. Both constructs were efficiently cleaved in cells. When the two constructs were co-expressed, their fragments could cross-interact, as shown by immunoprecipitation. Furthermore, LTXN4C induced intracellular Ca2+ signaling only in cells expressing both constructs but not each individual construct. Finally, we demonstrated that fragments of unrelated aGPCRs can be cross-immunoprecipitated from live tissues. Thus, (i) aGPCR fragments behave as independent proteins, (ii) the complementary fragments from distinct aGPCRs can cross-interact, and (iii) these cross-complexes are functionally active. This unusual cross-assembly of aGPCR fragments could couple cell-surface interactions to multiple signaling pathways.	[Silva, John-Paul; Lelianova, Vera; Hopkins, Colin; Volynski, Kirill E.; Ushkaryov, Yuri] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England	Imperial College London	Ushkaryov, Y (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Exhibit Rd, London SW7 2AZ, England.	y.ushkaryov@imperial.ac.uk	Ushkaryov, Yuri/AAQ-2985-2020	Ushkaryov, Yuri/0000-0002-5712-8297; Volynski, Kirill/0000-0001-8208-1905	The Wellcome Trust [GR074359]; Biotechnology and Biological Sciences Research Council [BB/D523078]; Biotechnology and Biological Sciences Research Council [BB/D523078/1] Funding Source: researchfish; Medical Research Council [G0600089] Funding Source: researchfish; MRC [G0600089] Funding Source: UKRI	The Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by project grants from The Wellcome Trust (Grant GR074359) and the Biotechnology and Biological Sciences Research Council ( Grant BB/D523078) ( to Y. U. and C. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ashton AC, 2001, J BIOL CHEM, V276, P44695, DOI 10.1074/jbc.M108088200; BAUD V, 1995, GENOMICS, V26, P334, DOI 10.1016/0888-7543(95)80218-B; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; Capogna M, 2003, J NEUROSCI, V23, P4044; Chang GW, 2003, FEBS LETT, V547, P145, DOI 10.1016/S0014-5793(03)00695-1; Davies JQ, 2007, J BIOL CHEM, V282, P27343, DOI 10.1074/jbc.M704096200; Davletov BA, 1998, EMBO J, V17, P3909, DOI 10.1093/emboj/17.14.3909; Davletov BA, 1996, J BIOL CHEM, V271, P23239, DOI 10.1074/jbc.271.38.23239; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gray JX, 1996, J IMMUNOL, V157, P5438; Haitina T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-43; HAMANN J, 1995, J IMMUNOL, V155, P1942; Hamann J, 1998, EUR J IMMUNOL, V28, P1701, DOI 10.1002/(SICI)1521-4141(199805)28:05<1701::AID-IMMU1701>3.0.CO;2-2; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Hayflick JS, 2000, J RECEPT SIGNAL TR R, V20, P119, DOI 10.3109/10799890009150640; Huang Y, 2008, MOL CELL BIOCHEM, V308, P133, DOI 10.1007/s11010-007-9621-4; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Krasnoperov V, 2002, J BIOL CHEM, V277, P46518, DOI 10.1074/jbc.M206415200; Krasnoperov V, 1999, J BIOL CHEM, V274, P3590, DOI 10.1074/jbc.274.6.3590; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Kwakkenbos MJ, 2005, J LEUKOCYTE BIOL, V77, P112, DOI 10.1189/jlb.0704402; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Lin HH, 2000, GENOMICS, V67, P188, DOI 10.1006/geno.2000.6238; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian YM, 1999, IMMUNOLOGY, V98, P303; Rahman MA, 1999, PHILOS T ROY SOC B, V354, P379, DOI 10.1098/rstb.1999.0390; Stacey M, 2003, BLOOD, V102, P2916, DOI 10.1182/blood-2002-11-3540; Volynski KE, 2004, EMBO J, V23, P4423, DOI 10.1038/sj.emboj.7600443; Volynski KE, 2003, J BIOL CHEM, V278, P31058, DOI 10.1074/jbc.M210395200; Volynski KE, 2000, J BIOL CHEM, V275, P41175, DOI 10.1074/jbc.M005857200; Wei W, 2007, J BIOL CHEM, V282, P21729, DOI 10.1074/jbc.M703218200; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103	35	52	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6495	6506		10.1074/jbc.M806979200	http://dx.doi.org/10.1074/jbc.M806979200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124473	Green Published, hybrid			2022-12-27	WOS:000263742700052
J	Tan, M; Walwyn, WM; Evans, CJ; Xie, CW				Tan, Miao; Walwyn, Wendy M.; Evans, Christopher J.; Xie, Cui-Wei			p38 MAPK and beta-Arrestin 2 Mediate Functional Interactions between Endogenous mu-Opioid and alpha(2A)-Adrenergic Receptors in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHINE-TOLERANCE; DESENSITIZATION; KINASE; TRAFFICKING; ACTIVATION; INTERNALIZATION; ENDOCYTOSIS; HETERODIMERIZATION; PHOSPHORYLATION; OLIGOMERIZATION	Formation of receptor complexes between mu-opioid and alpha(2A)-adrenergic receptors has been demonstrated in transfected cells. The functional significance and underlying mechanisms of such receptor interactions remain to be determined in neuronal systems. We examined functional interactions between endogenous mu and alpha(2A) receptors in mouse dorsal root ganglion neurons. Acute application of the mu agonist [D-Ala(2), N-MePhe(4), Gly-ol(5)] enkephalin (DAMGO) or the alpha(2) agonist clonidine inhibited voltage-gated Ca2+ currents in these neurons. Prolonged treatment with either DAMGO or clonidine induced a mutual cross-desensitization between mu and alpha(2A) receptor-mediated current inhibition. The cross-desensitization was closely associated with simultaneous internalization of mu and alpha(2A) receptors. Morphine, a mu agonist triggering little mu receptor endocytosis, induced neither cross-desensitization nor internalization of alpha(2A) receptors. Furthermore, inhibition of p38 MAPK prevented the cross-desensitization as well as cointernalization of mu and alpha(2A) receptors. Changes in receptor trafficking profiles suggested that p38 MAPK activity was required for initiating mu receptor internalization and maintaining possible mu-alpha(2A) association during their cointernalization. Finally, the mu-alpha(2A) cross-desensitization was absent in dorsal root ganglion neurons lacking beta-arrestin 2. These findings demonstrated p38 MAPK- and beta-arrestin 2-dependent cross-regulation between neuronal mu and alpha(2A) receptors. By promoting receptor cross-desensitization and cointernalization, such functional interactions may serve as negative feedback mechanisms triggered by prolonged agonist exposure to modulate the signaling of functionally related G protein-coupled receptors.	[Tan, Miao; Walwyn, Wendy M.; Evans, Christopher J.; Xie, Cui-Wei] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Xie, CW (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci, 760 Westwood Plaza,Box 77, Los Angeles, CA 90024 USA.	cxie@mednet.ucla.edu		Walwyn, Wendy/0000-0001-8101-2844	NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER; NIDA NIH HHS [P50DA05010, P50 DA005010] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Afify EA, 1998, MOL BRAIN RES, V54, P24, DOI 10.1016/S0169-328X(97)00315-X; Arttamangkul S, 2006, J NEUROSCI, V26, P4118, DOI 10.1523/JNEUROSCI.0303-06.2006; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Borgland SL, 2003, J BIOL CHEM, V278, P18776, DOI 10.1074/jbc.M300525200; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Connor M, 2004, BRIT J PHARMACOL, V143, P685, DOI 10.1038/sj.bjp.0705938; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; Fairbanks CA, 1999, J PHARMACOL EXP THER, V288, P1107; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hasbi A, 2007, BIOCHEMISTRY-US, V46, P12997, DOI 10.1021/bi701436w; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Hein L, 1999, ANN NY ACAD SCI, V881, P265, DOI 10.1111/j.1749-6632.1999.tb09368.x; Jordan BA, 2003, MOL PHARMACOL, V64, P1317, DOI 10.1124/mol.64.6.1317; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; Lakhlani PP, 1997, P NATL ACAD SCI USA, V94, P9950, DOI 10.1073/pnas.94.18.9950; Law PY, 2000, MOL PHARMACOL, V58, P388, DOI 10.1124/mol.58.2.388; Law PY, 2005, J BIOL CHEM, V280, P11152, DOI 10.1074/jbc.M500171200; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Maldonado R, 1997, NEUROSCI BIOBEHAV R, V21, P91, DOI 10.1016/0149-7634(95)00061-5; Marie N, 2006, CELL SIGNAL, V18, P1815, DOI 10.1016/j.cellsig.2006.03.015; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; McLaughlin NJD, 2006, J IMMUNOL, V176, P7039, DOI 10.4049/jimmunol.176.11.7039; Nasser Y, 2006, J COMP NEUROL, V495, P529, DOI 10.1002/cne.20898; OSSIPOV MH, 1990, J PHARMACOL EXP THER, V255, P1107; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200; Qiu Y, 2003, J BIOL CHEM, V278, P36733, DOI 10.1074/jbc.M305857200; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Stone LS, 2004, NEUROSCI LETT, V361, P265, DOI 10.1016/j.neulet.2003.12.065; Stone LS, 1997, J NEUROSCI, V17, P7157; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tan M, 2003, J NEUROSCI, V23, P10292; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Uddin S, 2000, J BIOL CHEM, V275, P27634; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Walwyn WM, 2006, NEUROSCIENCE, V142, P493, DOI 10.1016/j.neuroscience.2006.06.021; Walwyn W, 2007, J NEUROSCI, V27, P5092, DOI 10.1523/JNEUROSCI.1157-07.2007; Walwyn WM, 2004, NEUROSCIENCE, V123, P111, DOI 10.1016/j.neuroscience.2003.08.060; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Williams JP, 2007, ANESTH ANALG, V105, P998, DOI 10.1213/01.ane.0000278865.11991.9d; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zhang YQ, 2004, BIOCHEM SOC T, V32, P856, DOI 10.1042/BST0320856	51	47	51	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6270	6281		10.1074/jbc.M806742200	http://dx.doi.org/10.1074/jbc.M806742200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19126537	Green Published, hybrid			2022-12-27	WOS:000263742700030
J	Yu, M; Gipp, J; Yoon, JW; Iannaccone, P; Walterhouse, D; Bushman, W				Yu, Min; Gipp, Jerry; Yoon, Joon Won; Iannaccone, Phillip; Walterhouse, David; Bushman, Wade			Sonic Hedgehog-responsive Genes in the Fetal Prostate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE INHIBITOR; TUMOR-GROWTH; EXPRESSION; TARGET; MORPHOGENESIS; PROTEIN; DIFFERENTIATION; PROLIFERATION; ANGIOGENESIS; ACTIVATION	The Hedgehog (Hh) signaling pathway plays an important role in prostate development and appears to play an equally important role in promoting growth of advanced prostate cancer. During prostate development, epithelial cells in the urogenital sinus (UGS) express Sonic Hedgehog (Shh) and secrete Shh peptide. The secreted Hh peptide acts on adjacent mesenchymal cells to activate the Hh signal transduction pathway and elicit paracrine effects on epithelial proliferation and differentiation. To identify mesenchymal targets of Shh signaling, we performed microarray analysis on a Shh-responsive, immortalized urogential sinus mesenchymal cell line. We found 68 genes that were up-regulated by Shh and 21 genes that were down-regulated. Eighteen of those were selected for further study with Ptc1 and Gli1 serving as reference controls. We found 10 of 18 were also Hh-regulated in primary UGS mesenchymal cells and 13 of 18 in the cultured UGS. Seven of 18 exhibited Shh-regulated expression in both assays (Igfbp-6, Igfbp-3, Fbn2, Ntrk3, Agpt4, Dmp1, and Mmp13). Three of the 18 genes contained putative Gli binding motifs that bound Gli1 peptide in electrophoretic mobility shift assays. With the exception of Tiam1, target gene expression generally showed no differences in the concentration dependence of ligand-induced expression, but we observed strikingly different responses to direct pathway activation by transfection with activated Smo, Gli1, and Gli2.	[Yu, Min] Univ Wisconsin, Sch Med, Mol & Environm Toxicol Ctr, Madison, WI 53705 USA; [Yu, Min; Gipp, Jerry; Bushman, Wade] Univ Wisconsin, Sch Med, Ctr Clin Sci, Dept Urol, Madison, WI 53792 USA; [Yoon, Joon Won; Iannaccone, Phillip; Walterhouse, David] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60614 USA; [Yoon, Joon Won; Iannaccone, Phillip; Walterhouse, David] Childrens Mem Res Ctr, Chicago, IL 60614 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Feinberg School of Medicine	Bushman, W (corresponding author), K6-562 CSC,600 Highland Ave, Madison, WI 53792 USA.	bushman@surgery.wisc.edu			National Institutes of Health [P50 DK065303, RO1DK056238]; Robert and Delores Schnoes Chair in Urologic Research.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK065303, R01DK056238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and Delores Schnoes Chair in Urologic Research.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 DK065303 andRO1DK056238. This work was also supported by the Robert and Delores Schnoes Chair in Urologic Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; Berman DM, 2004, DEV BIOL, V267, P387, DOI 10.1016/j.ydbio.2003.11.018; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Dakubo GD, 2006, J NEURO-ONCOL, V79, P221, DOI 10.1007/s11060-006-9132-2; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Doles JD, 2005, PROSTATE, V65, P390, DOI 10.1002/pros.20321; Eichberger T, 2004, J INVEST DERMATOL, V122, P1180, DOI 10.1111/j.0022-202X.2004.22505.x; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Freestone SH, 2003, DEV BIOL, V264, P352, DOI 10.1016/j.ydbio.2003.08.018; Garrett W.M., 1998, BIOCHEMICA, V1, P17; Gaur T, 2006, J CELL PHYSIOL, V208, P87, DOI 10.1002/jcp.20637; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Gill SE, 2006, DEV BIOL, V298, P540, DOI 10.1016/j.ydbio.2006.07.004; He J, 2006, J BIOL CHEM, V281, P35598, DOI 10.1074/jbc.C600200200; Hochman E, 2006, J BIOL CHEM, V281, P33860, DOI 10.1074/jbc.M605905200; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Izraeli S, 2001, GENESIS, V31, P72, DOI 10.1002/gene.10004; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; Lamm MLG, 2002, DEV BIOL, V249, P349, DOI 10.1006/dbio.2002.0774; Lipinski RJ, 2005, DEV DYNAM, V233, P829, DOI 10.1002/dvdy.20414; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Olsen MWB, 2006, NEOPLASIA, V8, P364, DOI 10.1593/neo.06127; Podlasek CA, 1999, DEV BIOL, V209, P28, DOI 10.1006/dbio.1999.9229; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Shaw A, 2007, J UROLOGY, V177, P832, DOI 10.1016/j.juro.2006.10.061; Shaw A, 2006, PROSTATE, V66, P1347, DOI 10.1002/pros.20357; Shukunami C, 2005, BIOCHEM BIOPH RES CO, V333, P299, DOI 10.1016/j.bbrc.2005.05.133; Spurbeck WW, 2002, BLOOD, V100, P3361, DOI 10.1182/blood.V100.9.3361; Teh MT, 2002, CANCER RES, V62, P4773; Wang BE, 2003, J BIOL CHEM, V278, P18506, DOI 10.1074/jbc.M300968200; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; Wu SCY, 1998, MECH DEVELOP, V70, P3, DOI 10.1016/S0925-4773(97)00157-3; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200	47	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5620	5629		10.1074/jbc.M809172200	http://dx.doi.org/10.1074/jbc.M809172200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19095649	Green Published, hybrid			2022-12-27	WOS:000263560600025
J	Zu, LX; He, JH; Jiang, HF; Xu, C; Pu, SS; Xu, GH				Zu, Luxia; He, Jinhan; Jiang, Hongfeng; Xu, Chong; Pu, Shenshen; Xu, Guoheng			Bacterial Endotoxin Stimulates Adipose Lipolysis via Toll-Like Receptor 4 and Extracellular Signal-regulated Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; HORMONE-SENSITIVE LIPASE; PRIMARY RAT ADIPOCYTES; NF-KAPPA-B; FACTOR-ALPHA; LIPID-METABOLISM; PROTEIN-KINASE; TRIGLYCERIDE LIPASE; INSULIN-RESISTANCE; IN-VITRO	Bacterial endotoxin/lipopolysaccharide elicits inflammatory responses and also elevates circulating levels of free fatty acids (FFAs) and impairs insulin sensitivity. Serum FFA elevation in acute endotoxemia has long been thought to be due to endotoxin dysregulating lipid disposal and counterregulatory hormones and cytokines. Here, we investigated the direct lipolysis effect of endotoxin in rodents and in isolated primary adipocytes. Endotoxin increases lipolysis in vivo in adipose tissues, elevates circulating FFA level, induces insulin resistance in rats, and directly stimulates chronic lipolysis in vitro in adipocytes. The lipolytic action of endotoxin is mediated via its lipid A moiety and is blocked by anti-endotoxin peptides. Neither adipocytokine secretion nor nuclear factor-kappa B activation is involved in endotoxin-induced lipolysis. Different from catecholamine, endotoxin stimulates lipolysis without elevating cAMP production and activating protein kinase A and protein kinase C. Instead, endotoxin induces phosphorylation of Raf-1, MEK1/2, and ERK1/2. Upon inhibition of ERK1/2 but not JNK and p38 MAPK, endotoxin-stimulated lipolysis ceases. Endotoxin causes perilipin down-regulation and phosphorylation and increases the activity and protein levels of hormone-sensitive lipase and adipose triglyceride lipase but does not induce hormone-sensitive lipase translocation to intracellular lipid droplets. In TLR4 (Toll-like receptor 4)-deficient mice and adipocytes, endotoxin fails to increase in vivo and in vitro lipolysis. These findings suggest that endotoxin stimulates lipolysis via TLR4 and ERK1/2 signaling in adipocytes. The lipolytic action of endotoxin liberates FFA efflux from adipocytes to the bloodstream, which is a possible basis for systemic FFA elevation and insulin resistance in endotoxemia or Gram-negative bacterial infection.	[Zu, Luxia; He, Jinhan; Jiang, Hongfeng; Xu, Chong; Pu, Shenshen; Xu, Guoheng] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China; [Zu, Luxia; Xu, Chong; Pu, Shenshen; Xu, Guoheng] Minist Educ China, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China	Peking University; Ministry of Education, China	Xu, GH (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	xug@bjmu.edu.cn	jiang, hongfeng/I-6188-2013		National Basic Research Program of China [2009CB941603, 2006CB503903]; National Natural Science Foundation of China [30890042, 30770803, 30670779]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2009CB941603 and 2006CB503903 and National Natural Science Foundation of China Grants 30890042, 30770803, and 30670779. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ajuwon KM, 2004, AM J PHYSIOL-REG I, V287, pR608, DOI 10.1152/ajpregu.00192.2004; ARNER P, 2002, DIABETES METAB RE S2, V18, P5; BELFRAGE P, 1969, J LIPID RES, V10, P341; Berg AH, 2004, AM J PHYSIOL-ENDOC M, V287, pE1178, DOI 10.1152/ajpendo.00002.2004; Bhor VM, 2005, MOL BIOSYST, V1, P213, DOI 10.1039/b500756a; FEINGOLD KR, 1992, J LIPID RES, V33, P1765; FONG YM, 1990, J CLIN INVEST, V85, P1896, DOI 10.1172/JCI114651; Fricke K, 2004, ENDOCRINOLOGY, V145, P4940, DOI 10.1210/en.2004-0803; GORIN E, 1990, ENDOCRINOLOGY, V126, P2973; GREEN A, 1994, ENDOCRINOLOGY, V134, P2581, DOI 10.1210/en.134.6.2581; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Guan HP, 2002, NAT MED, V8, P1122, DOI 10.1038/nm780; HAMBLETON J, 1995, J EXP MED, V182, P147, DOI 10.1084/jem.182.1.147; He JH, 2006, BBA-MOL CELL BIOL L, V1761, P247, DOI 10.1016/j.bbalip.2006.02.001; HIKAWYJYEVICH I, 1977, J SURG RES, V23, P106, DOI 10.1016/0022-4804(77)90197-4; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Jiang Z, 2004, INT IMMUNOPHARMACOL, V4, P527, DOI 10.1016/j.intimp.2004.02.004; Kawasaki M, 2004, BIOSCI BIOTECH BIOCH, V68, P72, DOI 10.1271/bbb.68.72; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Laurencikiene J, 2007, J LIPID RES, V48, P1069, DOI 10.1194/jlr.M600471-JLR200; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Matthews CK, 1996, BIOCHEMISTRY-US, P819; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; NONOGAKI K, 1994, ENDOCRINOLOGY, V135, P2644, DOI 10.1210/en.135.6.2644; POND CM, 1995, J LIPID RES, V36, P2219; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Ren TT, 2006, J MOL ENDOCRINOL, V37, P175, DOI 10.1677/jme.1.02061; Robidoux J, 2006, J BIOL CHEM, V281, P37794, DOI 10.1074/jbc.M605572200; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; SPITZER JA, 1990, CELL CALCIUM, V11, P405, DOI 10.1016/0143-4160(90)90052-V; SPITZER JA, 1986, CIRC SHOCK, V18, P21; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; VIRKAMAKI A, 1994, ENDOCRINOLOGY, V134, P2072, DOI 10.1210/en.134.5.2072; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zu LX, 2008, MOL PHARMACOL, V73, P215, DOI 10.1124/mol.107.039479	44	102	114	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5915	5926		10.1074/jbc.M807852200	http://dx.doi.org/10.1074/jbc.M807852200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19122198	hybrid			2022-12-27	WOS:000263560600055
J	Romanova, L; Grand, A; Zhang, LY; Rayner, S; Katoku-Kikyo, N; Kellner, S; Kikyo, N				Romanova, Liudmila; Grand, Anthony; Zhang, Liying; Rayner, Samuel; Katoku-Kikyo, Nobuko; Kellner, Steven; Kikyo, Nobuaki			Critical Role of Nucleostemin in Pre-rRNA Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; PROTEIN NUCLEOSTEMIN; FAMILY PROTEINS; MESSENGER-RNA; YEAST HOMOLOG; STEM-CELLS; PROLIFERATION; BIOGENESIS; MECHANISM; P53	Nucleostemin is a nucleolar protein widely expressed in proliferating cells. Nucleostemin is involved in the regulation of cell proliferation, and both depletion and overexpression of nucleostemin induce cell cycle arrest through the p53 signaling pathway. Although the presence of p53-independent functions of nucleostemin has been previously suggested, the identities of these additional functions remained to be investigated. Here, we show that nucleostemin has a novel role as an integrated component of ribosome biogenesis, particularly pre-rRNA processing. Nucleostemin forms a large protein complex (> 700 kDa) that co-fractionates with the pre-60 S ribosomal subunit in a sucrose gradient. This complex contains proteins related to pre-rRNA processing, such as Pes1, DDX21, and EBP2, in addition to several ribosomal proteins. We show that the nucleolar retention of DDX21 and EBP2 is dependent on the presence of nucleostemin in the nucleolus. Furthermore, the knockdown of nucleostemin delays the processing of 32 S pre-rRNA into 28 S rRNA. This is accompanied by a substantial decrease of protein synthesis as well as the levels of rRNAs and some mRNAs. In addition, overexpressed nucleostemin significantly promotes the processing of 32 S pre-rRNA. Collectively, these biochemical and functional studies demonstrate a novel role of nucleostemin in ribosome biogenesis. This is a key aspect of the role of nucleostemin in regulating cell proliferation.	[Romanova, Liudmila; Grand, Anthony; Zhang, Liying; Rayner, Samuel; Katoku-Kikyo, Nobuko; Kellner, Steven; Kikyo, Nobuaki] Univ Minnesota, Stem Cell Inst, Div Hematol Oncol & Transplantat, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kikyo, N (corresponding author), Univ Minnesota, Stem Cell Inst, Div Hematol Oncol & Transplantat, Dept Med, Rm 2-216,Mail Code 2873,2001 6th St SE, Minneapolis, MN 55455 USA.	kikyo001@umn.edu		Rayner, Samuel/0000-0002-2541-4221	National Institutes of Health [R01 GM068027]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM068027 (to N. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Bommer U, 1997, SUBCELLULAR FRACTION, P271; BOWMAN LH, 1981, NUCLEIC ACIDS RES, V9, P4951, DOI 10.1093/nar/9.19.4951; Curtis NE, 1998, J MOL ENDOCRINOL, V21, P225, DOI 10.1677/jme.0.0210225; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Du XM, 2006, MOL BIOL CELL, V17, P460, DOI 10.1091/mbc.E05-09-0848; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Fan Y, 2006, BRIT J CANCER, V94, P1658, DOI 10.1038/sj.bjc.6603145; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Gilles C, 2001, J CELL SCI, V114, P2967; Gonda K, 2006, J BIOL CHEM, V281, P8153, DOI 10.1074/jbc.M512890200; Grimm T, 2006, NUCLEIC ACIDS RES, V34, P3030, DOI 10.1093/nar/gkl378; Henning D, 2003, J BIOL CHEM, V278, P52307, DOI 10.1074/jbc.M310846200; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Huber MD, 2000, J BIOL CHEM, V275, P28764, DOI 10.1074/jbc.M000594200; Kafienah W, 2006, STEM CELLS, V24, P1113, DOI 10.1634/stemcells.2005-0416; Kapoor P, 2005, MOL CELL BIOL, V25, P4934, DOI 10.1128/MCB.25.12.4934-4945.2005; Kudron MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000181; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Meng LJ, 2007, MOL CELL BIOL, V27, P8670, DOI 10.1128/MCB.00635-07; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Politz JCR, 2005, MOL BIOL CELL, V16, P3401, DOI 10.1091/mbc.E05-02-0106; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Shirai C, 2004, J BIOL CHEM, V279, P25353, DOI 10.1074/jbc.M403338200; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; SYLVESTER JE, 1986, HUM GENET, V73, P193, DOI 10.1007/BF00401226; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; Wu H, 2000, EMBO REP, V1, P140, DOI 10.1093/embo-reports/kvd026; Yang HS, 2003, J BIOL CHEM, V278, P38847, DOI 10.1074/jbc.M302258200; Zhang L, 2007, BIOCHEM BIOPH RES CO, V361, P611, DOI 10.1016/j.bbrc.2007.07.089; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06	34	88	92	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4968	4977		10.1074/jbc.M804594200	http://dx.doi.org/10.1074/jbc.M804594200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106111	hybrid, Green Published			2022-12-27	WOS:000263416600027
J	Qin, KF; Zhao, LL; Ash, RD; McDonough, WF; Zhao, RY				Qin, Kefeng; Zhao, Lili; Ash, Richard D.; McDonough, William F.; Zhao, Richard Y.			ATM-mediated Transcriptional Elevation of Prion in Response to Copper-induced Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; BINDING-SITES; REPEAT REGION; PROTEIN GENE; FULL-LENGTH; CELL; RECOMBINANT; CHAPERONE; PRP; COORDINATION	Increasing evidence suggests that the cellular prion protein (PrPC) plays a protective role in response to oxidative stress, but the molecular mechanism is unclear. Here, we demonstrate that murine neuro-2a and human HeLa cells rapidly respond to an increase of intracellular copper concentration by up-regulating ataxia-telangiectasia mutated (ATM)-mediated transcription of PrPC. Copper stimulation activates ATM by phosphorylation at Ser-1981, which leads to phosphorylation of p53 at Ser-15 and the initiation of the mitogen-activated protein kinase kinase/extracellular-related kinases/extracellular-related kinases (MEK/ERK)/Sp1 pathway. As results, Sp1 and p53 bind to the PrP promoter, leading to increase PrPC expression. Elevated PrPC correlates with reduction of intracellular copper concentration and suppression of Cu(II)-induced accumulation of reactive oxygen species and cell death. Depletion of PrPC, ATM, p53, and/or Sp1 further demonstrates that ATM is a key regulatory protein to promote activation of p53 and Sp1 leading to PrPC elevation, which is required to reduce Cu(II) toxic effects and may play an important role in modulation of intracellular copper concentration.	[Qin, Kefeng; Zhao, Lili; Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Microbiol Immunol, Baltimore, MD 21201 USA; [Zhao, Richard Y.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Ash, Richard D.; McDonough, William F.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park	Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Pathol, 10 S Pine St,MSTF 700A, Baltimore, MD 21201 USA.	RZhao@som.umaryland.edu	Ash, Richard/AAD-4888-2021; McDonough, William F/I-7720-2012; McDonough, William F/C-4791-2009	Ash, Richard/0000-0003-2144-5917; McDonough, William F/0000-0001-9154-3673; McDonough, William F/0000-0001-9154-3673; Zhao, Richard Y./0000-0003-3424-2852	University of Maryland Medical Center; University of Maryland School of Medicine	University of Maryland Medical Center; University of Maryland School of Medicine	This work was supported in part by funding from the University of Maryland Medical Center (to R.Y.Z.) and an intramural award from the University of Maryland School of Medicine (to K. Q.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1998, J NEUROCHEM, V70, P1686; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Burns CS, 2002, BIOCHEMISTRY-US, V41, P3991, DOI 10.1021/bi011922x; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; Choi CJ, 2007, TOXICOL SCI, V98, P495, DOI 10.1093/toxsci/kfm099; Desoize B, 2003, IN VIVO, V17, P529; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Golding SE, 2007, CANCER RES, V67, P1046, DOI 10.1158/0008-5472.CAN-06-2371; Haigh CL, 2006, J NEUROCHEM, V98, P677, DOI 10.1111/j.1471-4159.2006.03906.x; Harada K, 2000, ORAL ONCOL, V36, P3, DOI 10.1016/S1368-8375(99)00049-4; Harrison MD, 1999, J BIOL INORG CHEM, V4, P145, DOI 10.1007/s007750050297; HOFFMAN PW, 1995, NUCLEIC ACIDS RES, V23, P2229, DOI 10.1093/nar/23.12.2229; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; Ischiropoulos H, 1999, METHOD ENZYMOL, V301, P367; Jones CE, 2004, J BIOL CHEM, V279, P32018, DOI 10.1074/jbc.M403467200; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; Leclerc E, 2006, ARCH VIROL, V151, P2103, DOI 10.1007/s00705-006-0804-1; Liang J, 2006, TUMOR BIOL, V27, P84, DOI 10.1159/000092488; Mahal SP, 2001, GENE, V268, P105, DOI 10.1016/S0378-1119(01)00424-3; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Manzl C, 2004, TOXICOLOGY, V196, P57, DOI 10.1016/j.tox.2003.11.001; Miura T, 2005, BIOCHEMISTRY-US, V44, P8712, DOI 10.1021/bi0501784; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Nordstrom EK, 2005, J NEUROSCI, V25, P8451, DOI 10.1523/JNEUROSCI.2349-05.2005; Paitel E, 2003, J BIOL CHEM, V278, P10061, DOI 10.1074/jbc.M211580200; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Possel H, 1997, FEBS LETT, V416, P175, DOI 10.1016/S0014-5793(97)01197-6; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Qin K, 2006, NEUROSCIENCE, V141, P1375, DOI 10.1016/j.neuroscience.2006.04.068; Qin K, 2006, NEUROSCIENCE, V141, P1, DOI 10.1016/j.neuroscience.2006.04.057; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Qin KF, 2002, J BIOL CHEM, V277, P1981, DOI 10.1074/jbc.M108744200; Radisky D, 1999, J BIOL CHEM, V274, P4481, DOI 10.1074/jbc.274.8.4481; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Rosenzweig AC, 2000, CURR OPIN CHEM BIOL, V4, P140, DOI 10.1016/S1367-5931(99)00066-6; Ruiz FH, 2000, BIOCHEM BIOPH RES CO, V269, P491, DOI 10.1006/bbrc.2000.2270; Shiraishi N, 2006, J BIOL CHEM, V281, P34880, DOI 10.1074/jbc.M606581200; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Varela-Nallar L, 2006, AM J PHYSIOL-CELL PH, V290, pC271, DOI 10.1152/ajpcell.00160.2005; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang VC, 2005, BIOCHEM BIOPH RES CO, V333, P95, DOI 10.1016/j.bbrc.2005.05.091; Wells MA, 2006, BIOCHEM J, V399, P435, DOI 10.1042/BJ20060458; WESTAWAY D, 1994, P NATL ACAD SCI USA, V91, P6418, DOI 10.1073/pnas.91.14.6418; Whittal RM, 2000, PROTEIN SCI, V9, P332; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhang Y, 2006, BIOCHEM BIOPH RES CO, V349, P759, DOI 10.1016/j.bbrc.2006.08.116	59	32	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4582	4593		10.1074/jbc.M808410200	http://dx.doi.org/10.1074/jbc.M808410200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19064990	hybrid			2022-12-27	WOS:000263134400058
J	Kliment, CR; Englert, JM; Gochuico, BR; Yu, GY; Kaminski, N; Rosas, I; Oury, TD				Kliment, Corrine R.; Englert, Judson M.; Gochuico, Bernadette R.; Yu, Guoying; Kaminski, Naftali; Rosas, Ivan; Oury, Tim D.			Oxidative Stress Alters Syndecan-1 Distribution in Lungs with Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-SUPEROXIDE-DISMUTASE; HEPARAN-SULFATE PROTEOGLYCANS; IN-VITRO; SOLUBLE SYNDECAN-1; WOUND REPAIR; MOUSE LUNG; EC-SOD; INFLAMMATION; INJURY; NEUTROPHILS	Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by severe, progressive fibrosis. Roles for inflammation and oxidative stress have recently been demonstrated, but despite advances in understanding the pathogenesis, there are still no effective therapies for IPF. This study investigates how extracellular superoxide dismutase (EC-SOD), a syndecan-binding antioxidant enzyme, inhibits inflammation and lung fibrosis. We hypothesize that EC-SOD protects the lung from oxidant damage by preventing syndecan fragmentation/shedding. Wild-type or EC-SOD-null mice were exposed to an intratracheal instillation of asbestos or bleomycin. Western blot was used to detect syndecans in the bronchoalveolar lavage fluid and lung. Human lung samples (normal and IPF) were also analyzed. Immunohistochemistry for syndecan-1 and EC-SOD was performed on human and mouse lungs. In vitro, alveolar epithelial cells were exposed to oxidative stress and EC-SOD. Cell supernatants were analyzed for shed syndecan-1 by Western blot. Syndecan-1 ectodomain was assessed in wound healing and neutrophil chemotaxis. Increases in human syndecan-1 are detected in lung homogenates and lavage fluid of IPF lungs. Syndecan-1 is also significantly elevated in the lavage fluid of EC-SOD-null mice after asbestos and bleomycin exposure. On IHC, syndecan-1 staining increases within fibrotic areas of human and mouse lungs. In vitro, EC-SOD inhibits oxidant-induced loss of syndecan-1 from A549 cells. Shed and exogenous syndecan-1 ectodomain induce neutrophil chemotaxis, inhibit alveolar epithelial wound healing, and promote fibrogenesis. Oxidative shedding of syndecan-1 is an underlying cause of neutrophil chemotaxis and aberrant wound healing that may contribute to pulmonary fibrosis.	[Kliment, Corrine R.; Englert, Judson M.; Oury, Tim D.] Univ Pittsburgh, Sch Med, Dept Cellular & Mol Pathol, Pittsburgh, PA 15213 USA; [Yu, Guoying; Kaminski, Naftali] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm, Pittsburgh, PA 15213 USA; [Gochuico, Bernadette R.] NHGRI, NIH, Bethesda, MD 20892 USA; [Rosas, Ivan] Brigham & Womens Hosp, Div Pulm, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Brigham & Women's Hospital	Oury, TD (corresponding author), Univ Pittsburgh, Dept Pathol, 200 Lothrop St,Biomed Sci Tower W904, Pittsburgh, PA 15261 USA.	tdoury@pitt.edu	Kliment, Corrine/HGE-0877-2022	Kaminski, Naftali/0000-0001-5917-4601	National Institutes of Health [1F30ES016483-01]; Research Project Grant [R01HL063700-07]; Intramural Research Program of the NGRI and NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES016483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Project Grant; Intramural Research Program of the NGRI and NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)NIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health under a Ruth L. Kirschstein National Research Service Award (1F30ES016483-01, to C. R. K.), a Research Project Grant (R01HL063700-07, to T.D.O.), and by the Intramural Research Program of the NGRI and NHLBI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bowler RP, 2004, AM J RESP CELL MOL, V31, P432, DOI 10.1165/rcmb.2004-0057OC; CANTIN AM, 1987, J CLIN INVEST, V79, P1665, DOI 10.1172/JCI113005; CARLSSON LM, 1995, P NATL ACAD SCI USA, V92, P6264, DOI 10.1073/pnas.92.14.6264; Daniil ZD, 2008, PULM PHARMACOL THER, V21, P26, DOI 10.1016/j.pupt.2006.10.005; Dempsey OJ, 2006, RESP MED, V100, P1871, DOI 10.1016/j.rmed.2006.08.017; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Elenius V, 2004, J BIOL CHEM, V279, P41928, DOI 10.1074/jbc.M404506200; Enghild JJ, 1999, J BIOL CHEM, V274, P14818, DOI 10.1074/jbc.274.21.14818; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fattman CL, 2000, BIOCHEM BIOPH RES CO, V275, P542, DOI 10.1006/bbrc.2000.3327; Fattman CL, 2006, FREE RADICAL BIO MED, V40, P601, DOI 10.1016/j.freeradbiomed.2005.09.030; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P763, DOI 10.1016/S0891-5849(03)00402-7; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Fattman CL, 2001, FREE RADICAL BIO MED, V31, P1198, DOI 10.1016/S0891-5849(01)00699-2; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P1722, DOI 10.1164/ajrccm.164.9.2103074; Folz RJ, 1999, J CLIN INVEST, V103, P1055, DOI 10.1172/JCI3816; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Heit B, 2005, J CELL SCI, V118, P5205, DOI 10.1242/jcs.02632; KARLSSON K, 1988, BIOCHEM J, V256, P29, DOI 10.1042/bj2560029; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Kinder BW, 2008, CHEST, V133, P226, DOI 10.1378/chest.07-1948; Kinnula VL, 2005, AM J RESP CRIT CARE, V172, P417, DOI 10.1164/rccm.200501-017PP; Kliment CR, 2008, ANTIOXID REDOX SIGN, V10, P261, DOI 10.1089/ars.2007.1906; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Manning CB, 2002, INT IMMUNOPHARMACOL, V2, P191, DOI 10.1016/S1567-5769(01)00172-2; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Obayashi Y, 1997, CHEST, V112, P1338, DOI 10.1378/chest.112.5.1338; Ojeh N, 2008, J INVEST DERMATOL, V128, P26, DOI 10.1038/sj.jid.5700967; Oury TD, 1996, BIOCHEM J, V317, P51, DOI 10.1042/bj3170051; Oury TD, 2002, AM J PHYSIOL-LUNG C, V283, pL777, DOI 10.1152/ajplung.00011.2002; Oury TD, 1996, LAB INVEST, V75, P617; OZAKI T, 1992, AM REV RESPIR DIS, V145, P85, DOI 10.1164/ajrccm/145.1.85; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Parish CR, 2005, NAT IMMUNOL, V6, P861, DOI 10.1038/ni0905-861; Petersen SV, 2004, J BIOL CHEM, V279, P13705, DOI 10.1074/jbc.M310217200; Raats CJI, 1997, J BIOL CHEM, V272, P26734, DOI 10.1074/jbc.272.42.26734; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Sergejeva S, 2005, AM J RESP CELL MOL, V33, P248, DOI 10.1165/rcmb.2004-0213OC; Tan RJ, 2006, AM J RESP CELL MOL, V34, P226, DOI 10.1165/rcmb.2005-0212OC; TERAMOTO S, 1995, BIOCHEM MOL MED, V55, P66, DOI 10.1006/bmme.1995.1033; Venkatesan N, 2002, AM J PHYSIOL-LUNG C, V283, pL806, DOI 10.1152/ajplung.00061.2002; Walter Nicholas, 2006, Proc Am Thorac Soc, V3, P330, DOI 10.1513/pats.200602-016TK; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Zen K, 2006, J IMMUNOL METHODS, V309, P86, DOI 10.1016/j.jim.2005.11.014	50	98	105	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3537	3545		10.1074/jbc.M807001200	http://dx.doi.org/10.1074/jbc.M807001200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073610	Green Published, hybrid			2022-12-27	WOS:000262872500021
J	Zhu, B; Yao, P; Tan, M; Eriani, G; Wang, ED				Zhu, Bin; Yao, Peng; Tan, Min; Eriani, Gilbert; Wang, En-Duo			tRNA-independent Pretransfer Editing by Class I Leucyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; RIBONUCLEIC-ACID SYNTHETASE; ISOLEUCYL-TRANSFER-RNA; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; AQUIFEX-AEOLICUS; MECHANISM; HYDROLYSIS; COMPLEX; ERRORS	Aminoacyl-tRNA synthetases catalyze the formation of aminoacyl-tRNA in a two-step reaction starting with amino acid activation followed by aminoacyl group transfer to tRNA. To clear mistakes that occasionally occur, some of these enzymes carry out editing activities, acting on the misactivated amino acid (pretransfer editing) or after the transfer on the tRNA (post-transfer editing). The post-transfer editing pathway of leucyl-tRNA synthetase has been extensively studied by structural and biochemical approaches. Here, we report the finding of a tRNA-independent pretransfer editing pathway in leucyl-tRNA synthetases from Aquifex aeolicus. Using a CP1-mutant defective in its post-transfer editing function, we showed that this new editing pathway is distinct from the post-transfer editing site and may occur at the synthetic catalytic site, as recently proposed for other aminoacyl-tRNA synthetases.	[Zhu, Bin; Yao, Peng; Tan, Min; Wang, En-Duo] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol,State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Eriani, Gilbert] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Wang, ED (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol,State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	edwang@sibs.ac.cn	Tan, Min/K-1780-2016; Yao, Peng/Y-8047-2019; Yao, Peng/G-5218-2015; Yao, Peng/J-4492-2013	Yao, Peng/0000-0002-1145-3967; Yao, Peng/0000-0003-1022-3948; Yao, Peng/0000-0002-7029-8629; Eriani, Gilbert/0000-0002-8518-4675	Natural Science Foundation of China [30570380, 30630463]; National Key Basic Research Foundation of China [2006CB910301]; Shanghai Committee of Science and Technology [06JC14076]; Exchange Program and Programme International de Cooperation Scientifique (CNRS) [3606]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Exchange Program and Programme International de Cooperation Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by Natural Science Foundation of China Grants 30570380 and 30630463, National Key Basic Research Foundation of China Grant 2006CB910301, and Shanghai Committee of Science and Technology Grant 06JC14076 and by Exchange Program and Programme International de Cooperation Scientifique (CNRS) Grant 3606. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apostol I, 1997, J BIOL CHEM, V272, P28980, DOI 10.1074/jbc.272.46.28980; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Beuning PJ, 2001, J BIOL CHEM, V276, P30779, DOI 10.1074/jbc.M104761200; Bishop AC, 2003, P NATL ACAD SCI USA, V100, P490, DOI 10.1073/pnas.0237335100; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; KISUMI M, 1976, J BIOCHEM-TOKYO, V80, P333, DOI 10.1093/oxfordjournals.jbchem.a131281; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; MULVEY RS, 1977, BIOCHEMISTRY-US, V16, P4731, DOI 10.1021/bi00640a031; NANDI S, 1953, NATURE, V172, P871; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nomanbhoy TK, 2000, P NATL ACAD SCI USA, V97, P5119, DOI 10.1073/pnas.090102197; Nordin BE, 2003, BIOCHEMISTRY-US, V42, P12989, DOI 10.1021/bi035052q; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Xu MG, 2002, J BIOL CHEM, V277, P41590, DOI 10.1074/jbc.M205126200; YARUS M, 1972, P NATL ACAD SCI USA, V69, P1915, DOI 10.1073/pnas.69.7.1915; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618; Zhu B, 2007, RNA, V13, P15, DOI 10.1261/rna.228707	39	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3418	3424		10.1074/jbc.M806717200	http://dx.doi.org/10.1074/jbc.M806717200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19068478	hybrid			2022-12-27	WOS:000262872500007
J	Flowers, S; Nagl, NG; Beck, GR; Moran, E				Flowers, Stephen; Nagl, Norman G., Jr.; Beck, George R., Jr.; Moran, Elizabeth			Antagonistic Roles for BRM and BRG1 SWI/SNF Complexes in Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEXES; MURINE MC3T3-E1 CELLS; OSTEOBLAST DIFFERENTIATION; CYCLE CONTROL; EXPRESSION; GENE; SUBUNITS; BONE; TRANSCRIPTION; ACETYLATION	The mammalian SWI/SNF chromatin-remodeling complex is essential for the multiple changes in gene expression that occur during differentiation. However, the basis within the complex for specificity in effecting positive versus negative changes in gene expression has only begun to be elucidated. The catalytic core of the complex can be either of two closely related ATPases, BRM or BRG1, with the potential that the choice of alternative subunits is a key determinant of specificity. Short hairpin RNA-mediated depletion of the ATPases was used to explore their respective roles in the well characterized multistage process of osteoblast differentiation. The results reveal an unexpected role for BRM-specific complexes. Instead of impeding differentiation as was seen with BRG1 depletion, depletion of BRM caused accelerated progression to the differentiation phenotype. Multiple tissue-specific differentiation markers, including the tightly regulated late stage marker osteocalcin, become constitutively up-regulated in BRM-depleted cells. Chromatin immunoprecipitation analysis of the osteocalcin promoter as a model for the behavior of the complexes indicates that the promoter is a direct target of both BRM- and BRG1-containing complexes. BRG1 complexes, which are required for activation, are associated with the promoter well before induction, but the concurrent presence of BRM- specific complexes overrides their activation function. BRM- specific complexes are present only on the repressed promoter and are required for association of the corepressor HDAC1. These findings reveal an unanticipated degree of specialization of function linked with the choice of ATPase and suggest a new paradigm for the roles of the alternative subunits during differentiation.	[Flowers, Stephen; Moran, Elizabeth] Univ Med & Dent New Jersey, Univ Hosp Canc Ctr, New Jersey Med Sch, Dept Orthopaed, Newark, NJ 07103 USA; [Nagl, Norman G., Jr.] Temple Univ, Sch Med, Fels Inst Canc Res, Philadelphia, PA 19140 USA; [Beck, George R., Jr.] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA 30322 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Emory University	Moran, E (corresponding author), NJMS UH Canc Ctr, G-1200,205 S Orange Ave, Newark, NJ 07101 USA.	MoranEL@umdnj.edu	Beck, George/AAO-2117-2020		National Institutes of Health [GM073257]; USPSH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPSH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073257 from the USPSH ( to E. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beck GR, 2001, CELL GROWTH DIFFER, V12, P61; Beck GR, 1998, J CELL BIOCHEM, V68, P269, DOI 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A; Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Brodeur MR, 2008, J BONE MINER RES, V23, P326, DOI 10.1359/JBMR.071022; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.3.CO;2-Q; Das AV, 2007, J BIOL CHEM, V282, P35187, DOI 10.1074/jbc.M706742200; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Inoue H, 2002, J BIOL CHEM, V277, P41674, DOI 10.1074/jbc.M205961200; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Klochendler-Yeivin A, 2002, CURR OPIN GENET DEV, V12, P73, DOI 10.1016/S0959-437X(01)00267-2; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Lee JS, 2006, J BONE MINER RES, V21, P921, DOI 10.1359/JBMR.060303; MARSHALL TW, 2003, CURR OPIN GENE DEV, V13, P136; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Montecino M, 2007, BIOCHEM CELL BIOL, V85, P419, DOI 10.1139/O07-070; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Reyes-Botella C, 2002, CELL PHYSIOL BIOCHEM, V12, P359, DOI 10.1159/000067906; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; YACIUK P, 1991, MOL CELL BIOL, V11, P5389, DOI 10.1128/MCB.11.11.5389; Yang XL, 2002, TRENDS MOL MED, V8, P340, DOI 10.1016/S1471-4914(02)02340-7	42	75	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10067	10075		10.1074/jbc.M808782200	http://dx.doi.org/10.1074/jbc.M808782200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19144648	hybrid, Green Published			2022-12-27	WOS:000264892900049
J	Temme, C; Weissbach, R; Lilie, H; Wilson, C; Meinhart, A; Meyer, S; Golbik, R; Schierhorn, A; Wahle, E				Temme, Claudia; Weissbach, Rebekka; Lilie, Hauke; Wilson, Clive; Meinhart, Anton; Meyer, Sylke; Golbik, Ralph; Schierhorn, Angelika; Wahle, Elmar			The Drosophila melanogaster Gene cg(4930) Encodes a High Affinity Inhibitor for Endonuclease G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC DNA-DEGRADATION; POLY(A)-BINDING PROTEIN; CRYSTAL-STRUCTURE; CELL-DEATH; NUCLEASE; COMPLEX; RIBONUCLEASE; INVOLVEMENT; GENERATION; IMMUNITY	Endonuclease G (EndoG) is a mitochondrial enzyme believed to be released during apoptosis to participate in the degradation of nuclear DNA. This paper describes a Drosophila protein, EndoGI, which inhibits EndoG specifically. EndoG and EndoGI associate with subpicomolar affinity, forming a 2: 1 complex in which dimeric EndoG is bound by two tandemly repeated homologous domains of monomeric EndoGI. Binding appears to involve the active site of EndoG. EndoGI is present in the cell nucleus at micromolar concentrations. Upon induction of apoptosis, levels of the inhibitor appear to be reduced, and it is relocalized to the cytoplasm. EndoGI, encoded by the predicted open reading frame cg4930, is expressed throughout Drosophila development. Flies homozygous for a hypomorphic EndoGI mutation have a strongly reduced viability, which is modulated by genetic background and diet. We propose that EndoGI protects the cell against low levels of EndoG outside mitochondria.	[Golbik, Ralph; Schierhorn, Angelika; Wahle, Elmar] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Wilson, Clive] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Meinhart, Anton] Max Planck Inst Med Res, Dept Biomol Mechanisms, D-69120 Heidelberg, Germany	Martin Luther University Halle Wittenberg; University of Oxford; Max Planck Society	Wahle, E (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	ewahle@biochemtech.uni-halle.de	Meinhart, Anton/M-9647-2014	Wahle, Elmar/0000-0003-2504-0677	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie ( to E. W.).	Acevedo SF, 2007, GENETICS, V177, P239, DOI 10.1534/genetics.107.072280; Bahi N, 2006, J BIOL CHEM, V281, P22943, DOI 10.1074/jbc.M601025200; Benoit B, 1999, NUCLEIC ACIDS RES, V27, P3771, DOI 10.1093/nar/27.19.3771; Bonisch C, 2007, J BIOL CHEM, V282, P21818, DOI 10.1074/jbc.M702998200; Buttner S, 2007, CELL CYCLE, V6, P1072, DOI 10.4161/cc.6.9.4218; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Carr S, 2000, STRUCTURE, V8, P949, DOI 10.1016/S0969-2126(00)00186-6; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; David KK, 2006, CELL DEATH DIFFER, V13, P1147, DOI 10.1038/sj.cdd.4401787; Dickson KA, 2005, PROG NUCLEIC ACID RE, V80, P349, DOI 10.1016/S0079-6603(05)80009-1; Fic W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000253; Franke I, 1999, J BIOL CHEM, V274, P825, DOI 10.1074/jbc.274.2.825; Fronz K, 2008, J BIOL CHEM, V283, P20408, DOI 10.1074/jbc.M802329200; GERSCHENSON M, 1995, NUCLEIC ACIDS RES, V23, P88, DOI 10.1093/nar/23.1.88; Ghosh M, 2007, J BIOL CHEM, V282, P5682, DOI 10.1074/jbc.M605986200; HARTLEY RW, 1989, TRENDS BIOCHEM SCI, V14, P450, DOI 10.1016/0968-0004(89)90104-7; Huang KJ, 2006, P NATL ACAD SCI USA, V103, P8995, DOI 10.1073/pnas.0603445103; Huang KJ, 2002, J BIOL CHEM, V277, P21071, DOI 10.1074/jbc.M201785200; Irvine RA, 2005, MOL CELL BIOL, V25, P294, DOI 10.1128/MCB.25.1.294-302.2005; Ishihara Y, 2006, J BIOL CHEM, V281, P6726, DOI 10.1074/jbc.M510382200; Kalinowska M, 2005, APOPTOSIS, V10, P821, DOI 10.1007/s10495-005-0410-9; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Kuhlmann UC, 1999, FEBS LETT, V463, P1, DOI 10.1016/S0014-5793(99)01499-4; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Miller MD, 1996, PROTEIN SCI, V5, P24; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; MUOPASTOR AM, 1997, J MOL BIOL, V268, P589; Niikura Y, 2007, J CELL BIOL, V178, P283, DOI 10.1083/jcb.200702134; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Parrish JZ, 2006, CHROMOSOMA, V115, P89, DOI 10.1007/s00412-005-0038-0; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Parrish JZ, 2003, MOL CELL, V11, P987, DOI 10.1016/S1097-2765(03)00095-9; Rudolph T, 1999, DROSOPHILA INF SERV, V82, P99; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Sauter C, 2003, NUCLEIC ACIDS RES, V31, P4091, DOI 10.1093/nar/gkg480; Schafer P, 2004, J MOL BIOL, V338, P217, DOI 10.1016/j.jmb.2004.02.069; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; van Loo G, 2001, CELL DEATH DIFFER, V8, P1136, DOI 10.1038/sj.cdd.4400944; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Widlak P, 2005, J CELL BIOCHEM, V94, P1078, DOI 10.1002/jcb.20409; Widlak P, 2001, J BIOL CHEM, V276, P48404, DOI 10.1074/jbc.M108461200; Zhao TB, 2007, J BIOL CHEM, V282, P12104, DOI 10.1074/jbc.M611006200	47	34	34	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8337	8348		10.1074/jbc.M808319200	http://dx.doi.org/10.1074/jbc.M808319200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19129189	Green Published, hybrid			2022-12-27	WOS:000264397800018
J	Irigoyen, N; Garriga, D; Navarro, A; Verdaguer, N; Rodriguez, JF; Caston, JR				Irigoyen, Nerea; Garriga, Damia; Navarro, Aitor; Verdaguer, Nuria; Rodriguez, Jose F.; Caston, Jose R.			Autoproteolytic Activity Derived from the Infectious Bursal Disease Virus Capsid Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC NECROSIS VIRUS; RNA-SILENCING SUPPRESSION; ICOSAHEDRAL VIRUSES; MATURATION PROCESS; CRYSTAL-STRUCTURE; MOLECULAR SWITCH; STRUCTURAL BASIS; SITE; CLEAVAGE; VP2	Viral capsids are envisioned as vehicles to deliver the viral genome to the host cell. They are nonetheless dynamic protective shells, as they participate in numerous processes of the virus cycle such as assembly, genome packaging, binding to receptors, and uncoating among others. In so doing, they undergo large scale conformational changes. Capsid proteins with essential enzymatic activities are being described more frequently. Here we show that the precursor (pVP2) of the capsid protein VP2 of the infectious bursal disease virus (IBDV), an avian double-stranded RNA virus, has autoproteolytic activity. The pVP2 C-terminal region is first processed by the viral protease VP4. VP2 Asp-431, lying in a flexible loop preceding the C-terminal most alpha-helix, is responsible for the endopeptidase activity that cleaves the Ala-441-Phe-442 bond to generate the mature VP2 polypeptide. The D431N substitution abrogates the endopeptidase activity without introducing a significant conformational change, as deduced from the three-dimensional structure of the mutant protein at 3.1 angstrom resolution. Combinations of VP2 polypeptides containing mutations affecting either the cleavage or the catalytic site revealed that pVP2 proteolytic processing is the result of a monomolecular cis-cleavage reaction. The D431N mutation does not affect the assembly of the VP2 trimers that constitute the capsid building block. Although VP2 D431N trimers are capable of assembling both pentamers and hexamers, expression of a polyprotein gene harboring the D431N mutation does not result in the assembly of IBDV virus-like particles. Reverse genetics analyses demonstrate that pVP2 self-processing is essential for the assembly of an infectious IBDV progeny.	[Caston, Jose R.] CSIC, Ctr Nacl Biotecnol, Dpto Estruct Macromol, Madrid 28049, Spain; [Irigoyen, Nerea; Rodriguez, Jose F.] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid 28049, Spain; [Garriga, Damia; Verdaguer, Nuria] CSIC, Inst Biol Mol Barcelona, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Caston, JR (corresponding author), CSIC, Ctr Nacl Biotecnol, Dpto Estruct Macromol, C Darwin 3, Madrid 28049, Spain.	jrcaston@cnb.csic.es	Irigoyen, Nerea/CAJ-2485-2022; Rodríguez, José F/T-8500-2017; Caston, Jose/AAB-8825-2021; Irigoyen, Nerea/A-7925-2017; Caston, Jose R/L-5896-2014	Irigoyen, Nerea/0000-0001-6346-3369; Rodríguez, José F/0000-0001-7944-5341; Caston, Jose/0000-0003-2350-9048; Irigoyen, Nerea/0000-0001-6346-3369; Caston, Jose R/0000-0003-2350-9048; Navarro Nieto, Aitor/0000-0002-1051-9290; Verdaguer, Nuria/0000-0001-8826-7129; Garriga, Damia/0000-0003-0410-538X	Spanish Direccion General de Investigacion (MEC) [BIO2006-09407, BFU2005-02376, BFU2005-06487]	Spanish Direccion General de Investigacion (MEC)(Spanish Government)	This work was supported by Spanish Direccion General de Investigacion (MEC) Grants BIO2006-09407, BFU2005-02376, and BFU2005-06487.	Ahlquist P, 2005, CURR BIOL, V15, pR465, DOI 10.1016/j.cub.2005.06.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; BLANC A, 1994, MOL CELL BIOL, V14, P2664, DOI 10.1128/MCB.14.4.2664; Bothner B, 2005, VIROLOGY, V334, P17, DOI 10.1016/j.virol.2005.01.017; Bottcher B, 1997, J VIROL, V71, P325; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canady MA, 2000, J MOL BIOL, V299, P573, DOI 10.1006/jmbi.2000.3723; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Caston Jose R., 2008, P133; Caston JR, 2001, J VIROL, V75, P10815, DOI 10.1128/JVI.75.22.10815-10828.2001; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chen HY, 2008, EMBO REP, V9, P754, DOI 10.1038/embor.2008.118; CHENG RH, 1994, STRUCTURE, V2, P271; Chevalier C, 2004, J VIROL, V78, P3296, DOI 10.1128/JVI.78.7.3296-3303.2004; Chevalier C, 2002, J VIROL, V76, P2384, DOI 10.1128/JVI.76.5.2384-2392.2002; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; DELMAS B, 2005, VIRUS TAXONOMY, P561; Dobos Peter, 1995, Annual Review of Fish Diseases, V5, P25, DOI 10.1016/0959-8030(95)00003-8; EARL PL, 1993, CURRENT PROTOCOLS MO; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Arias A, 1998, J GEN VIROL, V79, P1047, DOI 10.1099/0022-1317-79-5-1047; FernandezArias A, 1997, J VIROL, V71, P8014; GALLAGHER TM, 1988, J VIROL, V62, P3399, DOI 10.1128/JVI.62.9.3399-3406.1988; Galloux M, 2007, J BIOL CHEM, V282, P20774, DOI 10.1074/jbc.M701048200; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Garriga D, 2006, J VIROL, V80, P6895, DOI 10.1128/JVI.00368-06; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; Hanzlik TN, 1997, ADV VIRUS RES, V48, P101, DOI 10.1016/S0065-3527(08)60287-0; Hjalmarsson A, 1999, J VIROL, V73, P3484, DOI 10.1128/JVI.73.4.3484-3490.1999; Lee CC, 2006, J STRUCT BIOL, V155, P74, DOI 10.1016/j.jsb.2006.02.014; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; Lombardo E, 1999, J VIROL, V73, P6973, DOI 10.1128/JVI.73.8.6973-6983.1999; Luque D, 2007, J VIROL, V81, P6869, DOI 10.1128/JVI.00077-07; MACBETH KJ, 1995, P NATL ACAD SCI USA, V92, P8994, DOI 10.1073/pnas.92.19.8994; MACBETH KJ, 1995, J VIROL, V69, P3458, DOI 10.1128/JVI.69.6.3458-3464.1995; Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003; Martinez-Torrecuadrada JL, 2000, VIROLOGY, V278, P322, DOI 10.1006/viro.2000.0559; Morillas M, 2008, J MOL BIOL, V376, P721, DOI 10.1016/j.jmb.2007.11.055; Ona A, 2004, VIROLOGY, V322, P135, DOI 10.1016/j.virol.2004.01.025; Pan JH, 2007, P NATL ACAD SCI USA, V104, P7385, DOI 10.1073/pnas.0611599104; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Sanchez AB, 1999, VIROLOGY, V262, P190, DOI 10.1006/viro.1999.9910; Saugar I, 2005, STRUCTURE, V13, P1007, DOI 10.1016/j.str.2005.04.012; Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X; Tang JH, 2005, J MOL RECOGNIT, V18, P158, DOI 10.1002/jmr.724; Taylor DJ, 2005, PROTEIN SCI, V14, P401, DOI 10.1110/ps.041054605; Taylor DJ, 2002, J VIROL, V76, P9972, DOI 10.1128/JVI.76.19.9972-9980.2002; van den Berg TP, 2000, REV SCI TECH OIE, V19, P527; Villanueva RA, 2004, J VIROL, V78, P13829, DOI 10.1128/JVI.78.24.13829-13838.2004; WARD GA, 1995, P NATL ACAD SCI USA, V92, P6773, DOI 10.1073/pnas.92.15.6773; Xu HT, 2004, VIROLOGY, V322, P199, DOI 10.1016/j.virol.2004.01.024; ZLOTNICK A, 1994, J BIOL CHEM, V269, P13680	54	35	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8064	8072		10.1074/jbc.M808942200	http://dx.doi.org/10.1074/jbc.M808942200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144647	Green Published, hybrid			2022-12-27	WOS:000264195600069
J	Champaiboon, C; Sappington, KJ; Guenther, BD; Ross, KF; Herzberg, MC				Champaiboon, Chantrakorn; Sappington, Kaia J.; Guenther, Brian D.; Ross, Karen F.; Herzberg, Mark C.			Calprotectin S100A9 Calcium-binding Loops I and II Are Essential for Keratinocyte Resistance to Bacterial Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSIBLE ANTIMICROBIAL ACTIVITY; EPITHELIAL-CELLS; ARACHIDONIC-ACID; INTERMEDIATE-FILAMENTS; HUMAN NEUTROPHILS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; PROTEIN FAMILY; CA2+ BINDING; MRP14	Epithelial cells expressing calprotectin, a heterodimer of S100A8 and S100A9 proteins, are more resistant to bacterial invasion. To determine structural motifs that affect resistance to bacterial invasion, mutations were constructed in S100A9 targeting the calcium-binding loops I and II (E36Q, E78Q, E36Q, E78Q) and the Cterminus (S100A91-99 and S100A91-112), which contains putative antimicrobial zinc-binding and phosphorylation sites. The S100A8 and mutated S100A9 encoding plasmids were transfected into calprotectin-negative KB carcinoma cells. All transfected cells (except KB-sham) expressed 27E10-reactive heterodimers. In bacterial invasion assays with Listeria monocytogenes and Salmonella enterica serovar Typhimurium (Salmonella typhimurium), cell lines expressing S100A8 in complex with S100A9E36Q, S100A9E78Q, S100A91-99, or S100A91-112 mutants or the S100A91-114 (full-length) calprotectin resisted bacterial invasion better than KB-sham. When compared with KB-S100A8/A91-114, cells expressing truncated S100A91-99 or S100A91-112 with S100A8 also showed increased resistance to bacterial invasion. In contrast, glutamic acid residues 36 and 78 in calcium-binding loops I and II promote resistance in epithelial cells, because cells expressing S100A9E36Q, E78Q with S100A8 were unable to resist bacterial invasion. Mutations in S100A9 E36Q, E78Q were predicted to cause loss of the calcium-induced positive face in calprotectin, reducing interactions with microtubules and appearing to be crucial for keratinocyte resistance to bacterial invasion.	[Champaiboon, Chantrakorn; Sappington, Kaia J.; Guenther, Brian D.; Ross, Karen F.; Herzberg, Mark C.] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Herzberg, MC (corresponding author), 17-164 Moos Tower,515 Delaware St SE, Minneapolis, MN 55455 USA.	mcherzb@umn.edu			National Institutes of Health [R01DE11831]; Royal Thai Government; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Thai Government; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DE11831 (NIDCR). This work was also supported by a scholarship from the Royal Thai Government. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Buechau AS, 2007, J INVEST DERMATOL, V127, P2596, DOI 10.1038/sj.jid.5700946; CARLSTROM G, 1993, J MOL BIOL, V231, P415, DOI 10.1006/jmbi.1993.1291; Clohessy PA, 1996, J LEUKOCYTE BIOL, V60, P674, DOI 10.1002/jlb.60.5.674; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cuida M, 1997, EUR J ORAL SCI, V105, P228, DOI 10.1111/j.1600-0722.1997.tb00205.x; DALE I, 1985, AM J CLIN PATHOL, V84, P24, DOI 10.1093/ajcp/84.1.24; DALE I, 1983, EUR J BIOCHEM, V134, P1, DOI 10.1111/j.1432-1033.1983.tb07522.x; EDGEWORTH J, 1989, NATURE, V342, P189, DOI 10.1038/342189a0; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; GOEBELER M, 1995, BIOCHEM J, V309, P419, DOI 10.1042/bj3090419; Gottsch JD, 1999, INFECT IMMUN, V67, P6631; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMMER HB, 1995, CLIN EXP RHEUMATOL, V13, P59; Hatakeyama T, 2004, EUR J BIOCHEM, V271, P3765, DOI 10.1111/j.1432-1033.2004.04318.x; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hessian PA, 2001, EUR J BIOCHEM, V268, P353, DOI 10.1046/j.1432-1327.2001.01894.x; Ishikawa K, 2000, ACTA CRYSTALLOGR D, V56, P559, DOI 10.1107/S0907444900002833; Itou H, 2002, J MOL BIOL, V316, P265, DOI 10.1006/jmbi.2001.5340; Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113; Kerkhoff C, 1999, J BIOL CHEM, V274, P32672, DOI 10.1074/jbc.274.46.32672; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Lee KC, 2007, J INVEST DERMATOL, V127, P945, DOI 10.1038/sj.jid.5700663; Leslie CC, 2004, BIOCHEM CELL BIOL, V82, P1, DOI 10.1139/o03-080; Leukert N, 2005, BIOL CHEM, V386, P429, DOI 10.1515/BC.2005.051; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Loomans HJ, 1998, J INFECT DIS, V177, P812, DOI 10.1086/517816; Lusitani D, 2003, INFECT IMMUN, V71, P4711, DOI 10.1128/IAI.71.8.4711-4716.2003; Malik S, 2008, PROTEINS, V73, P28, DOI 10.1002/prot.22037; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; MAUNE JF, 1992, BIOCHEMISTRY-US, V31, P7779, DOI 10.1021/bi00149a006; MIYASAKI KT, 1993, J DENT RES, V72, P517, DOI 10.1177/00220345930720020801; MURTHY ARK, 1993, J IMMUNOL, V151, P6291; Nisapakultorn K, 2001, INFECT IMMUN, V69, P4242, DOI 10.1128/IAI.69.7.4242-4247.2001; Nisapakultorn K, 2001, INFECT IMMUN, V69, P3692, DOI 10.1128/IAI.69.6.3692-3696.2001; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Propper C, 1999, J BIOL CHEM, V274, P183, DOI 10.1074/jbc.274.1.183; Rammes A, 1997, J BIOL CHEM, V272, P9496; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; Ross KF, 2001, INFECT IMMUN, V69, P3248, DOI 10.1128/IAI.69.5.3248-3254.2001; ROTH J, 1993, BLOOD, V82, P1875; Rudney JD, 2006, ARCH ORAL BIOL, V51, P291, DOI 10.1016/j.archoralbio.2005.09.003; Rustandi RR, 2002, BIOCHEMISTRY-US, V41, P788, DOI 10.1021/bi0118308; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SOHNLE PG, 1991, J INFECT DIS, V163, P187, DOI 10.1093/infdis/163.1.187; SOHNLE PG, 1991, J INFECT DIS, V164, P137, DOI 10.1093/infdis/164.1.137; Sohnle PG, 2000, ANTIMICROB AGENTS CH, V44, P139, DOI 10.1128/AAC.44.1.139-142.2000; Sohnle PG, 1996, J INFECT DIS, V174, P1369, DOI 10.1093/infdis/174.6.1369; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; Sopalla C, 2002, BIOL CHEM, V383, P1895, DOI 10.1515/BC.2002.213; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Striz I, 2004, PHYSIOL RES, V53, P245; Vallely KM, 2002, BIOCHEMISTRY-US, V41, P12670, DOI 10.1021/bi020365r; vandenBos C, 1996, J IMMUNOL, V156, P1247; WATT KWK, 1983, IMMUNOLOGY, V48, P79; Zaia AA, 2009, MUCOSAL IMMUNOL, V2, P43, DOI 10.1038/mi.2008.63; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	59	54	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7078	7090		10.1074/jbc.M806605200	http://dx.doi.org/10.1074/jbc.M806605200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19122197	Green Published, hybrid			2022-12-27	WOS:000263919000056
J	Connaris, H; Crocker, PR; Taylor, GL				Connaris, Helen; Crocker, Paul R.; Taylor, Garry L.			Enhancing the Receptor Affinity of the Sialic Acid-binding Domain of Vibrio cholerae Sialidase through Multivalency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; CATALYTIC EFFICIENCY; CARBOHYDRATE; RECOGNITION; LECTINS; MODULES; ENHANCEMENT; ENERGY	Many glycoside hydrolases possess carbohydrate-binding modules (CBMs) that help target these enzymes to appropriate substrates and increase their catalytic efficiency. The Vibrio cholerae sialidase contains two CBMs, one of which is designated as a family CBM40 module and has been shown through structural and calorimetry studies to recognize the alpha-anomer of sialic acid with a K-D of similar to 30 mu M at 37 degrees C. The affinity of this V. cholerae CBM40 module for sialic acid is one of the highest reported for recognition of a monosaccharide by a CBM. As Nature often increases a weak substrate affinity through multi-valency, we have explored the potential of developing reagents with an increased affinity for sialic acid receptors through linking CBM40 modules together. The V. cholerae CBM40 was sub-cloned and crystallized in the presence of sialyllactose confirming its ability to recognize sialic acid. Calorimetry revealed that this CBM40 demonstrated specificity to alpha(2,3)-, alpha(2,6)-, and alpha(2,8)-linked sialosides. Polypeptides containing up to four CBM40 modules in tandem were created to determine if an increase in affinity to sialic acid could be achieved through an avidity effect. Using SPR and a multivalent alpha(2,3)-sialyllactose ligand, we show that increasing the number of linked modules does increase the affinity for sialic acid. The four-CBM40 module protein has a 700- to 1500-fold increase in affinity compared with the single-CBM40 module. Varying the linker length of amino acids between each CBM40 module had little effect on the binding of these polypeptides. Finally, fluorescence-activated cell sorting analysis demonstrated that a green fluorescent protein fused to three CBM40 modules bound to subpopulations of human leukocytes. These studies lay the foundation for creating high affinity, multivalent CBMs that could have broad application in glycobiology.	[Connaris, Helen; Taylor, Garry L.] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; [Crocker, Paul R.] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	University of St Andrews; University of Dundee	Connaris, H (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland.	hc6@st-and.ac.uk; glt2@st-and.ac.uk	Taylor, Garry/G-3017-2014	Crocker, Paul/0000-0001-6230-0293	Biotechnology and Biological Sciences Research Council; European Synchrotron Radiation Facility; European Union; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Synchrotron Radiation Facility; European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council. The staff at the European Synchrotron Radiation Facility and the European Union provided funds for access to the facility. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambrosi M, 2005, ORG BIOMOL CHEM, V3, P1476, DOI 10.1039/b411555b; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BIDDISON WE, 2001, CURR PROTOC CELL BIO, pCH2; Boraston AB, 2002, MOL MICROBIOL, V43, P187, DOI 10.1046/j.1365-2958.2002.02730.x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; CORFIELD T, 1992, GLYCOBIOLOGY, V2, P509, DOI 10.1093/glycob/2.6.509; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Ehrhardt C, 2004, ADV DRUG DELIVER REV, V56, P527, DOI 10.1016/j.addr.2003.10.029; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guillen D, 2007, APPL ENVIRON MICROB, V73, P3833, DOI 10.1128/AEM.02628-06; KAMERLING JP, 1982, BIOCHIM BIOPHYS ACTA, V714, P351, DOI 10.1016/0304-4165(82)90344-0; Lee RT, 2000, GLYCOCONJUGATE J, V17, P543, DOI 10.1023/A:1011070425430; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Liu HT, 2009, PROTEIN EXPRES PURIF, V63, P102, DOI 10.1016/j.pep.2008.09.008; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; MANDAL C, 1990, EXPERIENTIA, V46, P433, DOI 10.1007/BF01954221; McCartney L, 2004, ANAL BIOCHEM, V326, P49, DOI 10.1016/j.ab.2003.11.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Poon GMK, 2007, BIOCHEM SOC T, V35, P1574, DOI 10.1042/BST0351574; ROGERS CM, 1978, GUT, V19, P587, DOI 10.1136/gut.19.7.587; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387; Williams DH, 2004, J MOL BIOL, V340, P373, DOI 10.1016/j.jmb.2004.04.056; Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644; Williams DH, 2003, J MOL BIOL, V329, P389, DOI 10.1016/S0022-2836(03)00428-5	31	32	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7339	7351		10.1074/jbc.M807398200	http://dx.doi.org/10.1074/jbc.M807398200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19124471	Green Published, hybrid			2022-12-27	WOS:000263919000080
J	Dubey, RN; Nakwal, N; Bisht, KK; Saini, A; Haldar, S; Singh, J				Dubey, Rudra Narayan; Nakwal, Nandni; Bisht, Kamlesh Kumar; Saini, Ashok; Haldar, Swati; Singh, Jagmohan			Interaction of APC/C-E3 Ligase with Swi6/HP1 and Clr4/Suv39 in Heterochromatin Assembly in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ALPHA; CELL-CYCLE CONTROL; CHROMODOMAIN PROTEIN; HISTONE H3; LYSINE-4 METHYLATION; UBIQUITIN LIGASE; ANAPHASE; ESTABLISHMENT; MAINTENANCE; INHERITANCE	Heterochromatin assembly in fission yeast is initiated by binding of Swi6/HP1 to the Lys-9-dimethylated H3 followed by spreading via cooperative recruitment of Swi6/HP1. Recruitment of Cohesin by Swi6/HP1 further stabilizes the heterochromatin structure and integrity. Subsequently, polyubiquitylation of Cut2 by anaphase-promoting complex-cyclosome (APC/C)-ubiquitin-protein isopeptide ligase (E3 ligase) followed by degradation of Cut2 releases Cut1, which cleaves the Rad21 subunit of Cohesin, facilitating sister chromatid separation during mitosis. Here, we demonstrate a surprising role of APC/C in assembly of heterochromatin and silencing at mating type, centromere, and ribosomal DNA loci. Coincidentally with the loss of silencing, recruitment of Swi6, H3-Lys- 9-Me2, and Clr4 at dg-dh repeats at cen1 and the K region of mat locus is abrogated in mutants cut4, cut9, and nuc2. Surprisingly, both Cut4 and Cut9 are also highly enriched at these regions in wild type and depleted in swi6 Delta mutant. Cut4 and Cut9 interact directly with Swi6/HP1 and Clr4, whereas the mutant Cut4 does not, suggesting that a direct physical interaction of APC subunits Cut4 and Cut9 with Swi6 and Clr4 is instrumental in heterochromatin assembly. The silencing defect in APC mutants is causally related to ubiquitylation activity of APC-E3 ligase. Like swi6 mutant, APC mutants are also defective in Cohesin recruitment and exhibit defects like lagging chromosomes, chromosome loss, and aberrant recombination in the mat region. In addition, APC mutants exhibit a bidirectional expression of dh repeats, suggesting a role in the RNA interference pathway. Thus, APC and heterochromatin proteins Swi6 and Clr4 play a mutually cooperative role in heterochromatin assembly, thereby ensuring chromosomal integrity, inheritance, and segregation during mitosis and meiosis.	[Dubey, Rudra Narayan; Nakwal, Nandni; Bisht, Kamlesh Kumar; Saini, Ashok; Haldar, Swati; Singh, Jagmohan] Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Singh, J (corresponding author), Inst Microbial Technol, Sector 39A, Chandigarh 160036, India.	jag@imtech.res.in	Haldar, Swati/AAH-5388-2021	saini, ashok/0000-0001-6530-4281; Haldar, Swati/0000-0002-1566-1907	Department of Science and Technology, New Delhi	Department of Science and Technology, New Delhi(Department of Science & Technology (India))	This work was supported by a grant from the Department of Science and Technology, New Delhi. The costs of publication of this article were defrayed in part by the payment of page charges.	Ahmed S, 2001, J BIOL CHEM, V276, P47814, DOI 10.1074/jbc.M109186200; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BEACH DH, 1984, EMBO J, V3, P603, DOI 10.1002/j.1460-2075.1984.tb01855.x; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; EGEL R, 1984, P NATL ACAD SCI-BIOL, V81, P3481, DOI 10.1073/pnas.81.11.3481; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1996, J CELL SCI, V109, P2637; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grewal SIS, 1997, GENETICS, V146, P1221; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Horn PJ, 2006, CHROMOSOME RES, V14, P83, DOI 10.1007/s10577-005-1018-1; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Huang HH, 1997, MOL CELL BIOL, V17, P6693, DOI 10.1128/MCB.17.11.6693; JAMES SW, 1995, J CELL SCI, V108, P3485; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Jorgensen PM, 1998, MOL CELL BIOL, V18, P468; Kim HS, 2004, J BIOL CHEM, V279, P42850, DOI 10.1074/jbc.M407259200; KIPLING D, 1990, MOL CELL BIOL, V10, P265, DOI 10.1128/MCB.10.1.265; KUMADA K, 1995, J CELL SCI, V108, P895; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; LORENTZ A, 1994, GENE, V143, P139, DOI 10.1016/0378-1119(94)90619-X; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Naresh A, 2003, J BIOL CHEM, V278, P9185, DOI 10.1074/jbc.M212732200; Nielsen IS, 2002, EUKARYOT CELL, V1, P613, DOI 10.1128/EC1.4.613-625.2002; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Partridge J.F., 1999, PRACT APPROACH SER, P38; Pidoux AL, 2000, J CELL SCI, V113, P4177; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Shin JA, 2005, MOL CELL, V19, P817, DOI 10.1016/j.molcel.2005.08.021; SINGH J, 1993, NATURE, V361, P271, DOI 10.1038/361271a0; Singh J, 1998, MOL CELL BIOL, V18, P5511, DOI 10.1128/MCB.18.9.5511; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Thon G, 1999, GENETICS, V151, P945; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Thon G, 1997, GENETICS, V145, P685; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 2004, EXP CELL RES, V296, P80, DOI 10.1016/j.yexcr.2004.03.005; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000; Yamashita YM, 1996, NATURE, V384, P276, DOI 10.1038/384276a0; Yanagida M, 1999, PHILOS T R SOC B, V354, P1559, DOI 10.1098/rstb.1999.0499; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3	53	7	7	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7165	7176		10.1074/jbc.M806461200	http://dx.doi.org/10.1074/jbc.M806461200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19117951	hybrid, Green Published			2022-12-27	WOS:000263919000064
J	Cha, JYY; Maddileti, S; Mitin, N; Harden, TK; Der, CJ				Cha, Jiyoung Y.; Maddileti, Savitri; Mitin, Natalia; Harden, T. Kendall; Der, Channing J.			Aberrant Receptor Internalization and Enhanced FRS2-dependent Signaling Contribute to the Transforming Activity of the Fibroblast Growth Factor Receptor 2 IIIb C3 Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING SPECIFICITY; NEONATAL FC-RECEPTOR; EPITHELIAL-CELLS; PHOSPHOLIPASE-C; POINT MUTATION; MESSENGER-RNA; FGF RECEPTORS; ENDOCYTOSIS; ACTIVATION; EXPRESSION	Alternative splice variants of fibroblast growth factor receptor 2 (FGFR2) IIIb, designated C1, C2, and C3, possess progressive reduction in their cytoplasmic carboxyl termini ( 822, 788, and 769 residues, respectively), with preferential expression of the C2 and C3 isoforms in human cancers. We determined that the progressive deletion of carboxyl-terminal sequences correlated with increasing transforming potency. The highly transforming C3 variant lacks five tyrosine residues present in C1, and we determined that the loss of Tyr-770 alone enhanced FGFR2 IIIb C1 transforming activity. Because Tyr-770 may compose a putative YXXL sorting motif, we hypothesized that loss of Tyr-770 in the (YXXL)-Y-770 motif may cause disruption of FGFR2 IIIb C1 internalization and enhance transforming activity. Surprisingly, we found that mutation of Leu-773 but not Tyr-770 impaired receptor internalization and increased receptor stability and activation. Interestingly, concurrent mutations of Tyr-770 and Leu-773 caused 2-fold higher transforming activity than caused by the Y770F or L773A single mutations, suggesting loss of Tyr and Leu residues of the (YXXL773)-Y-770 motif enhances FGFR2 IIIb transforming activity by distinct mechanisms. We also determined that loss of Tyr-770 caused persistent activation of FRS2 by enhancing FRS2 binding to FGFR2 IIIb. Furthermore, we found that FRS2 binding to FGFR2 IIIb is required for increased FRS2 tyrosine phosphorylation and enhanced transforming activity by Y770F mutation. Our data support a dual mechanism where deletion of the 770YXXL773 motif promotes FGFR2 IIIb C3 transforming activity by causing aberrant receptor recycling and stability and persistent FRS2-dependent signaling.	[Cha, Jiyoung Y.; Maddileti, Savitri; Mitin, Natalia; Harden, T. Kendall; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Der, CJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, CB 7295, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu	Mitin, Natalia/E-8043-2012	Der, Channing/0000-0002-7751-2747	National Institutes of Health [CA69577, GM65533]; NATIONAL CANCER INSTITUTE [R01CA069577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM065533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA69577 (to C.J.D.) and GM65533 (to T.K.H.) (USPHS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BROWN HA, 1991, MOL PHARMACOL, V40, P648; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; Ceridono M, 2005, BIOCHEM BIOPH RES CO, V327, P523, DOI 10.1016/j.bbrc.2004.12.031; Cha JY, 2008, MOL CANCER RES, V6, P435, DOI 10.1158/1541-7786.MCR-07-0187; CHANG CP, 1993, J BIOL CHEM, V268, P19312; Chang JS, 1997, CANCER RES, V57, P5465; Chen J, 2005, BLOOD, V106, P328, DOI 10.1182/blood-2004-09-3686; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; DELL KR, 1992, J BIOL CHEM, V267, P21225; DeMali KA, 1997, J BIOL CHEM, V272, P9011; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fabbri M, 1999, EMBO J, V18, P4915, DOI 10.1093/emboj/18.18.4915; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; ITOH H, 1994, CANCER RES, V54, P3237; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MASON IJ, 1994, MECH DEVELOP, V45, P15, DOI 10.1016/0925-4773(94)90050-7; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Moffa AB, 2004, MOL CANCER RES, V2, P643; Moffa AB, 2007, J CELL PHYSIOL, V210, P720, DOI 10.1002/jcp.20880; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Reddi AL, 2007, J BIOL CHEM, V282, P29336, DOI 10.1074/jbc.M701797200; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Sharrocks AD, 2006, CURR BIOL, V16, pR540, DOI 10.1016/j.cub.2006.06.038; Smith MR, 1998, CARCINOGENESIS, V19, P177, DOI 10.1093/carcin/19.1.177; Wernick NLB, 2005, J BIOL CHEM, V280, P7309, DOI 10.1074/jbc.M410752200; Wu Z, 2001, J BIOL CHEM, V276, P5240, DOI 10.1074/jbc.M006684200; Yamasaki M, 1996, J BIOL CHEM, V271, P15918, DOI 10.1074/jbc.271.27.15918; YAN GC, 1992, MOL ENDOCRINOL, V6, P2123, DOI 10.1210/me.6.12.2123; YAYON A, 1992, EMBO J, V11, P1885, DOI 10.1002/j.1460-2075.1992.tb05240.x; ZHENG J, 1995, J CELL BIOL, V129, P843, DOI 10.1083/jcb.129.3.843	50	49	67	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6227	6240		10.1074/jbc.M803998200	http://dx.doi.org/10.1074/jbc.M803998200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19103595	Green Published, hybrid			2022-12-27	WOS:000263742700026
J	Graves, JA; Metukuri, M; Scott, D; Rothermund, K; Prochownik, EV				Graves, J. Anthony; Metukuri, Mallikarjuna; Scott, Donald; Rothermund, Kristi; Prochownik, Edward V.			Regulation of Reactive Oxygen Species Homeostasis by Peroxiredoxins and c-Myc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; DNA-DAMAGE; MAMMALIAN PEROXIREDOXIN; HYDROGEN-PEROXIDE; CELL-PROLIFERATION; TYROSINE KINASE; GENE-EXPRESSION; PROTEIN; CARCINOGENESIS; IDENTIFICATION	Peroxiredoxins (Prxs) are highly conserved proteins found in most organisms, where they function primarily to scavenge reactive oxygen species (ROS). Loss of the most ubiquitous member of the family, Prx1, is associated with the accumulation of oxidatively damaged DNA and a tumor-prone phenotype. Prx1 interacts with the transcriptional regulatory domain of the c-Myc oncoprotein and suppresses its transforming activity. The DNA damage in tissues of prx1(-/-) mice is associated in some cases with only modest increases in total ROS levels. However, these cells show dramatic increases in nuclear ROS and reduced levels of cytoplasmic ROS, which explains their mutational susceptibility. In the current work, we have investigated whether changes in other ROS scavengers might account for the observed ROS redistribution pattern in prx1(-/-) cells. We show similar to 5-fold increases in Prx5 levels in prx1(-/-) embryo fibroblasts relative to prx1(-/-) cells. Moreover, Prx5 levels normalize when Prx1 expression is restored. Prx5 levels also appear to be highly dependent on c-Myc, and chromatin immunoprecipitation experiments showed differential occupancy of c-Myc and Prx1 complexes at E-box elements in the prx5 gene proximal promoter. This study represents a heretofore unreported mechanism for the c-Myc-dependent regulation of one Prx family member by another and identifies a novel means by which cells reestablish ROS homeostasis when one of these family members is compromised.	[Graves, J. Anthony; Rothermund, Kristi; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Div Hematol Oncol, Dept Pediat, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Dept Microbiol & Biochem, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Metukuri, Mallikarjuna; Scott, Donald] Univ Pittsburgh, Sch Med, Div Endocrinol & Metab, Dept Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Hematol Oncol, Dept Pediat, 3705 5th Ave, Pittsburgh, PA 15213 USA.	procev@chp.edu			National Institutes of Health [RO1 CA105033, R01 DK065149]; K12 National Institutes of Health Mentored Clinical Scientist Development Program Award [HD052892]; Hyundai Hope on Wheels Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA105033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); K12 National Institutes of Health Mentored Clinical Scientist Development Program Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Hope on Wheels Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA105033 ( to E. V. P.) and R01 DK065149 ( to M. M. and D. S.). This work was also supported by K12 National Institutes of Health Mentored Clinical Scientist Development Program Award HD052892 and the Hyundai Hope on Wheels Scholarship ( to J. A. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Cao Zhenbo, 2007, V44, P295; Collier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE48, DOI 10.1152/ajpendo.00357.2006; Dang CV, 2005, CELL CYCLE, V4, P1465, DOI 10.4161/cc.4.11.2121; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; Fleming I, 2001, CIRC RES, V88, P44, DOI 10.1161/01.RES.88.1.44; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; ISHII T, 1993, J BIOL CHEM, V268, P18633; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Kropotov A, 2006, FEBS J, V273, P2607, DOI 10.1111/j.1742-4658.2006.05265.x; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nguyen-nhu NT, 2007, BBA-GENE STRUCT EXPR, V1769, P472, DOI 10.1016/j.bbaexp.2007.05.004; Oberley TD, 2001, FREE RADICAL BIO MED, V30, P412, DOI 10.1016/S0891-5849(00)00486-X; Park SY, 2007, CANCER RES, V67, P9294, DOI 10.1158/0008-5472.CAN-07-0651; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; PROSPERI MT, 1993, J BIOL CHEM, V268, P11050; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; RHEE SG, 2000, J SCI STKE, pPE1; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; SHAU HY, 1993, CELL IMMUNOL, V147, P1, DOI 10.1006/cimm.1993.1043; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Thorgeirsson SS, 2000, TOXICOL LETT, V112, P553, DOI 10.1016/S0378-4274(99)00224-6; TODARO GJ, 1964, P NATL ACAD SCI USA, V51, P66, DOI 10.1073/pnas.51.1.66; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Toyokuni S, 2008, IUBMB LIFE, V60, P441, DOI 10.1002/iub.61; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	51	69	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6520	6529		10.1074/jbc.M807564200	http://dx.doi.org/10.1074/jbc.M807564200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19098005	Green Published, hybrid			2022-12-27	WOS:000263742700054
J	Chen, JL; Olsen, J; Ford, S; Mirza, S; Walker, A; Murphy, JM; Young, IG				Chen, Jinglong; Olsen, Jane; Ford, Sally; Mirza, Shamaruh; Walker, Andrew; Murphy, James M.; Young, Ian G.			A New Isoform of Interleukin-3 Receptor alpha with Novel Differentiation Activity and High Affinity Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; ACUTE MYELOGENOUS LEUKEMIA; COMMON BETA-SUBUNIT; GM-CSF; SELF-RENEWAL; STRUCTURAL BASIS; MOUSE BASOPHIL; MAST-CELL; IN-VITRO; EXPRESSION	Interleukin-3 (IL-3) promotes both self-renewal and differentiation of early multipotential progenitors and is involved in inducible hematopoiesis in response to infections. Here we report new insights into these processes with the identification of a new isoform (SP2) of IL-3 receptor alpha(IL-3R alpha), present in mouse and human hematopoietic cells, which lacks domain 1 of the full-length receptor (SP1). Binding assays with beta(IL-3) mutants showed that mouse SP2 uses a different high affinity binding mode to SP1, although both mouse and human SP2 and SP1 can stimulate IL-3-dependent growth. In IL-3-dependent differentiation models, human SP2 and SP1 gave differential effects on lineage commitment or self-renewal dependent on the cellular context, suggesting that different modes of ectodomain binding may modulate intracellular signaling. In a multipotential factor dependent cell-Paterson mix, the transcription factors C/EBP alpha and PU.1 and microRNAs miRNA-15a, -223, and -181a were up-regulated in cells undergoing SP2-supported differentiation compared with SP1-supported self-renewal. Similarly in M1 cells, SP2 promoted differentiation compared with SP1 and gave up-regulation of PU.1 and miRNA-155 and -223. These findings suggest that IL-3-promoted lineage commitment uses similar mechanisms to those of steady-state hematopoiesis. Both the SP1 and SP2 isoforms activated the Jak2/STAT5, Akt, and Erk1/2 signaling pathways in M1 cells, although the activation was more prolonged for the SP2 isoform.	[Chen, Jinglong; Olsen, Jane; Ford, Sally; Mirza, Shamaruh; Walker, Andrew; Young, Ian G.] Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 2601, Australia; [Murphy, James M.] Walter & Eliza Hall Inst Med Res, Div Mol Med, Melbourne, Vic 3050, Australia	Australian National University; John Curtin School of Medical Research; Walter & Eliza Hall Institute	Young, IG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 2601, Australia.	ian.young@anu.edu.au	Walker, Andrew/D-2665-2012; Murphy, James/B-4863-2017	Walker, Andrew/0000-0003-1296-6593; Murphy, James/0000-0003-0195-3949	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia.	Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Barry SC, 1997, BLOOD, V89, P842, DOI 10.1182/blood.V89.3.842; Bellon T, 1997, BLOOD, V90, P1828, DOI 10.1182/blood.V90.5.1828; Brizzi MF, 2001, CIRCULATION, V103, P549, DOI 10.1161/01.CIR.103.4.549; Bruno L, 2004, MOL CELL BIOL, V24, P741, DOI 10.1128/MCB.24.2.741-756.2004; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen XN, 2008, AM J PSYCHIAT, V165, P13, DOI 10.1176/appi.ajp.2007.07121868; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; CORNELIS S, 1995, EMBO J, V14, P3395, DOI 10.1002/j.1460-2075.1995.tb07345.x; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Dentelli P, 2005, ONCOGENE, V24, P6394, DOI 10.1038/sj.onc.1208786; Dvorak AM, 2005, J HISTOCHEM CYTOCHEM, V53, P1043, DOI 10.1369/jhc.5R6647.2005; Dvorak AM, 2004, INT ARCH ALLERGY IMM, V134, P332, DOI 10.1159/000079536; Evans CA, 1999, BLOOD, V94, P1504, DOI 10.1182/blood.V94.5.1504.417a27_1504_1514; Falcone FH, 2000, BLOOD, V96, P4028; Fatica A, 2006, COLD SPRING HARB SYM, V71, P205, DOI 10.1101/sqb.2006.71.014; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; Heyworth C M, 1991, Growth Factors, V5, P87, DOI 10.3109/08977199109000274; Heyworth CM, 1990, GROWTH FACTORS, V2, P197, DOI 10.3109/08977199009071506; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Ishino T, 2004, J BIOL CHEM, V279, P9547, DOI 10.1074/jbc.M309327200; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lantz CS, 1997, J IMMUNOL, V158, P2517; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lee JJ, 2007, BLOOD, V109, P859, DOI 10.1182/blood-2006-06-027490; Lin YH, 2000, MOL CELL BIOL, V20, P2734, DOI 10.1128/MCB.20.8.2734-2742.2000; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Liu Z, 2007, CANCER RES, V67, P2712, DOI 10.1158/0008-5472.CAN-06-3843; Mack M, 2005, J IMMUNOL, V174, P735, DOI 10.4049/jimmunol.174.2.735; MAYER P, 1989, BLOOD, V74, P613; METCALF D, 1986, BLOOD, V68, P46; Munoz L, 2001, HAEMATOLOGICA, V86, P1261; Murphy JM, 2006, VITAM HORM, V74, P1, DOI 10.1016/S0083-6729(06)74001-8; Murphy JM, 2004, J BIOL CHEM, V279, P26500, DOI 10.1074/jbc.M402705200; Murphy JM, 2003, J BIOL CHEM, V278, P10572, DOI 10.1074/jbc.M211664200; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Robb L, 2007, ONCOGENE, V26, P6715, DOI 10.1038/sj.onc.1210756; Smith A, 1997, EMBO J, V16, P451, DOI 10.1093/emboj/16.3.451; SPIVAK JL, 1985, J CLIN INVEST, V76, P1613, DOI 10.1172/JCI112145; TAKAKI S, 1993, J EXP MED, V177, P1523, DOI 10.1084/jem.177.6.1523; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; Testa U, 2005, BLOOD, V106, P2527, DOI 10.1182/blood-2005-02-0540; Testa U, 2004, DRUG FUTURE, V29, P821, DOI 10.1358/dof.2004.029.08.854174; Testa U, 2002, BLOOD, V100, P2980, DOI 10.1182/blood-2002-03-0852; WAGEMAKER G, 1990, BLOOD, V76, P2235; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Zaks-Zilberman M, 2008, J BIOL CHEM, V283, P13398, DOI 10.1074/jbc.M710230200; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102	62	33	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5763	5773		10.1074/jbc.M808197200	http://dx.doi.org/10.1074/jbc.M808197200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19109256	hybrid			2022-12-27	WOS:000263560600040
J	Kadohara, K; Nagumo, M; Asami, S; Tsukumo, Y; Sugimoto, H; Igarashi, M; Nagai, K; Kataoka, T				Kadohara, Kimiko; Nagumo, Michiko; Asami, Shun; Tsukumo, Yoshinori; Sugimoto, Hikaru; Igarashi, Masayuki; Nagai, Kazuo; Kataoka, Takao			Caspase-8 Mediates Mitochondrial Release of Pro-apoptotic Proteins in a Manner Independent of Its Proteolytic Activity in Apoptosis Induced by the Protein Synthesis Inhibitor Acetoxycycloheximide in Human Leukemia Jurkat Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RIBOTOXIC STRESS-RESPONSE; CYTOCHROME-C RELEASE; FAS LIGAND; TERMINAL KINASE; TNF-ALPHA; GLUTARIMIDE ANTIBIOTICS; STRUCTURAL BASIS; ACTIVATION; DEATH	The cysteine protease caspase-8 plays an essential role in apoptosis induced by death receptors. The protein synthesis inhibitor acetoxycycloheximide (Ac-CHX) has been previously shown to induce rapid apoptosis mediated by the release of cytochrome c in human leukemia Jurkat cells. In this study, the novel molecular mechanism that links caspase-8 to the mitochondrial release of pro-apoptotic proteins has been identified. Jurkat cells deficient in caspase-8 were more resistant to Ac-CHX than wild-type Jurkat cells and manifested decreased apoptosis induction and caspase activation as well as inefficient release of cytochrome c, Smac/DIABLO, and AIF into the cytosol. In contrast to Fas ligand stimulation, the general caspase inhibitor barely prevented the mitochondrial release of these pro-apoptotic proteins in Ac-CHX-treated cells, suggesting that caspase-8 activity is dispensable for triggering the mitochondrial pathway in Ac-CHX-induced apoptosis. Consistent with this notion, caspase-8-deficient Jurkat cells reconstituted with catalytically inactive caspase-8 became sensitive to Ac-CHX and exhibited apoptosis, caspase activation, the liberation of pro-apoptotic proteins into the cytosol, and Bak conformational change as efficiently as wild-type Jurkat cells. Unlike caspase- 3, -6, -7, and -9, a small but significant portion of caspase-8 was found to localize in mitochondria before and after exposure to Ac-CHX. These results clearly demonstrate that caspase-8 is able to mediate the mitochondrial release of pro-apoptotic proteins in a manner independent of its proteolytic activity in Ac-CHX-induced apoptosis.	[Kadohara, Kimiko; Nagumo, Michiko; Asami, Shun; Tsukumo, Yoshinori; Kataoka, Takao] Tokyo Inst Technol, Ctr Biol Resources & Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Kadohara, Kimiko; Nagumo, Michiko; Asami, Shun; Tsukumo, Yoshinori; Sugimoto, Hikaru; Nagai, Kazuo; Kataoka, Takao] Tokyo Inst Technol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Igarashi, Masayuki] Microbial Chem Res Ctr, Bioact Mol Res Grp, Shinagawa Ku, Tokyo 1410021, Japan; [Nagai, Kazuo] Chubu Univ, Dept Biol Chem, Aichi 4878501, Japan; [Kataoka, Takao] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Chubu University; Kyoto Institute of Technology	Kataoka, T (corresponding author), Tokyo Inst Technol, Ctr Biol Resources & Informat, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	takao.kataoka@kit.ac.jp	Igarashi, Masayuki/AAG-1628-2020		Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Chen Y, 2001, J BIOL CHEM, V276, P8350, DOI 10.1074/jbc.M008431200; Chen YR, 1998, ONCOGENE, V17, P173, DOI 10.1038/sj.onc.1201941; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; ENNIS HL, 1968, BIOCHEM PHARMACOL, V17, P1197, DOI 10.1016/0006-2952(68)90056-7; Faris M, 1998, J IMMUNOL, V160, P134; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; JOHNSON F, 1968, J ORG CHEM, V33, P904, DOI 10.1021/jo01266a113; JOHNSON F, 1965, J AM CHEM SOC, V87, P3492, DOI 10.1021/ja01093a038; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kadohara K, 2005, BIOCHEM PHARMACOL, V69, P551, DOI 10.1016/j.bcp.2004.11.009; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kataoka T, 2002, EXP CELL RES, V273, P256, DOI 10.1006/excr.2001.5438; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MARTIN SJ, 1990, J IMMUNOL, V145, P1859; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Murphy BM, 2004, J BIOL CHEM, V279, P36916, DOI 10.1074/jbc.M402039200; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nguyen TK, 2007, BLOOD, V109, P4006, DOI 10.1182/blood-2006-09-045039; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; O'Reilly LA, 2004, CELL DEATH DIFFER, V11, P724, DOI 10.1038/sj.cdd.4401408; Ogura H, 2008, INT IMMUNOPHARMACOL, V8, P922, DOI 10.1016/j.intimp.2008.02.010; Ogura H, 2008, EXP CELL RES, V314, P1406, DOI 10.1016/j.yexcr.2008.01.019; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; RAO KV, 1960, J AM CHEM SOC, V82, P1127, DOI 10.1021/ja01490a026; RAO KV, 1960, J AM CHEM SOC, V82, P1129, DOI 10.1021/ja01490a027; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Shifrin VI, 1999, J BIOL CHEM, V274, P13985, DOI 10.1074/jbc.274.20.13985; Sidhu JS, 1998, J BIOL CHEM, V273, P4769, DOI 10.1074/jbc.273.8.4769; SIEGEL MR, 1966, BIOCHEM PHARMACOL, V15, P1213, DOI 10.1016/0006-2952(66)90286-3; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Stegh AH, 2002, J BIOL CHEM, V277, P4351, DOI 10.1074/jbc.M108947200; Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Sugimoto H, 2000, BIOCHEM BIOPH RES CO, V277, P330, DOI 10.1006/bbrc.2000.3680; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Tang DM, 1999, J BIOL CHEM, V274, P7245, DOI 10.1074/jbc.274.11.7245; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; TSUCHIDA H, 1995, J IMMUNOL, V154, P2403; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wajant H, 2000, J BIOL CHEM, V275, P24357, DOI 10.1074/jbc.M000811200; Wang XD, 2001, GENE DEV, V15, P2922; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012	79	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5478	5487		10.1074/jbc.M808523200	http://dx.doi.org/10.1074/jbc.M808523200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19112105	hybrid			2022-12-27	WOS:000263560600010
J	Peroz, D; Dahimene, S; Baro, I; Loussouarn, G; Merot, J				Peroz, David; Dahimene, Shehrazade; Baro, Isabelle; Loussouarn, Gildas; Merot, Jean			LQT1-associated Mutations Increase KCNQ1 Proteasomal Degradation Independently of Derlin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; TRANSMEMBRANE CONDUCTANCE REGULATOR; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; RETRO-TRANSLOCATION; CHANNEL; PROTEINS; TRAFFICKING; ER	Mutations in the potassium channel KCNQ1 that determine retention of the mutated proteins in the endoplasmic reticulum (ER) are associated with the autosomal dominant negative Romano-Ward LQT1 cardiac syndrome. In the present study, we have analyzed the consequences and the potential molecular mechanisms involved in the ER retention of three Romano-Ward mutations located in KCNQ1 N terminus (Y111C, L114P, and P117L). We showed that the mutant KCNQ1 proteins exhibited reduced expression levels with respect to wild-type (WT)-KCNQ1. Radiolabeling pulse-chase experiments revealed that the lower expression levels did not result from reduced rate of synthesis. Instead, using a combination of Western blot and pulse-chase experiments, we showed that the mutant channel Y111C-KCNQ1, used as a model, was ubiquitinated and degraded in the proteasome more rapidly (t(1/2) = 82 min) than WT-KCNQ1 channel (t(1/2) = 113 min). On the other hand, KCNQ1 degradation did not appear to involve the GTP-dependent pathway. We also showed that KCNE1 stabilized both wildtype and Y111C proteins. To identify potential actors involved in KCNQ1 degradation, we studied the implication of the ER-resident protein Derlin-1 in KCNQ1 degradation. We showed that although KCNQ1 and Derlin-1 share the same molecular complex and co-immunoprecipitate when co-expressed in HEK293FT cells, Derlin-1 did not affect KCNQ1 steady state expression and degradation. These data were confirmed in T84 cells that express endogenous KCNQ1 and Derlin-1. Small interfering RNA knock-down of Derlin-1 did not modify KCNQ1 expression level, and no interaction between endogenous KCNQ1 and Derlin-1 could be detected.	[Peroz, David; Dahimene, Shehrazade; Baro, Isabelle; Loussouarn, Gildas; Merot, Jean] INSERM, UMR915, F-44000 Nantes, France; [Peroz, David; Dahimene, Shehrazade; Baro, Isabelle; Loussouarn, Gildas; Merot, Jean] CNRS, ERL3147, F-44000 Nantes, France; [Peroz, David; Dahimene, Shehrazade; Baro, Isabelle; Loussouarn, Gildas; Merot, Jean] Univ Nantes, Fac Med, Inst Thorax, F-44000 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Nantes Universite; CHU de Nantes	Merot, J (corresponding author), INSERM, Fac Med, UMR915, 1 Rue G Veil, F-44035 Nantes 01, France.	jean.merot@univ-nantes.fr	Loussouarn, Gildas/ABH-6043-2020; Loussouarn, Gildas/D-3590-2015; MEROT, Jean/D-5741-2015; Baró, Isabelle/D-3604-2015; Baró, Isabelle/ABH-5667-2020	Loussouarn, Gildas/0000-0001-8007-5931; Loussouarn, Gildas/0000-0001-8007-5931; Baró, Isabelle/0000-0003-4850-4171; Baró, Isabelle/0000-0003-4850-4171	Agence Nationale de la Recherche [ANR/A05045GS, ANR/08GEN000602]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a grant from the Agence Nationale de la Recherche ( ANR/A05045GS and ANR/08GEN000602).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Dahimene S, 2006, CIRC RES, V99, P1076, DOI 10.1161/01.RES.0000250262.12219.95; De Keukeleire B, 2008, INT J BIOCHEM CELL B, V40, P1729, DOI 10.1016/j.biocel.2007.12.015; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Goldstein RF, 2007, AM J RESP CELL MOL, V36, P706, DOI 10.1165/rcmb.2006-0365OC; Haynes CM, 2002, J CELL BIOL, V158, P91, DOI 10.1083/jcb.200201053; Hegde NR, 2006, J BIOL CHEM, V281, P20910, DOI 10.1074/jbc.M602989200; Ikrar T, 2008, J CARDIOVASC ELECTR, V19, P541, DOI 10.1111/j.1540-8167.2007.01076.x; Jansen JA, 2008, BIOCHEM BIOPH RES CO, V367, P687, DOI 10.1016/j.bbrc.2007.12.168; Krumerman A, 2004, AM J PHYSIOL-CELL PH, V286, pC1453, DOI 10.1152/ajpcell.00275.2003; Kunjilwar K, 2004, J BIOL CHEM, V279, P54542, DOI 10.1074/jbc.M409721200; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Morin TJ, 2008, P NATL ACAD SCI USA, V105, P1478, DOI 10.1073/pnas.0710366105; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Roden DM, 2008, NEW ENGL J MED, V358, P169, DOI 10.1056/NEJMcp0706513; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Schmitt N, 2007, BIOCHEM BIOPH RES CO, V358, P304, DOI 10.1016/j.bbrc.2007.04.127; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Toyoda F, 2006, BIOCHEM BIOPH RES CO, V344, P814, DOI 10.1016/j.bbrc.2006.03.213; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Wu DM, 2006, HEART RHYTHM, V3, P1031, DOI 10.1016/j.hrthm.2006.05.022; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zafar KS, 2007, J NEUROCHEM, V102, P913, DOI 10.1111/j.1471-4159.2007.04637.x	38	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5250	5256		10.1074/jbc.M806459200	http://dx.doi.org/10.1074/jbc.M806459200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19114714	hybrid			2022-12-27	WOS:000263416600055
J	di Patti, MC; Maio, N; Rizzo, G; De Francesco, G; Persichini, T; Colasanti, M; Polticelli, F; Musci, G				Bonaccorsi di Patti, Maria Carmela; Maio, Nunziata; Rizzo, Gianluca; De Francesco, Giovanni; Persichini, Tiziana; Colasanti, Marco; Polticelli, Fabio; Musci, Giovanni			Dominant Mutants of Ceruloplasmin Impair the Copper Loading Machinery in Aceruloplasminemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED FORM; AMYOTROPHIC-LATERAL-SCLEROSIS; GOLGI-APPARATUS; GENE MUTATION; NEURODEGENERATIVE DISEASES; COMPOUND HETEROZYGOSITY; MOVEMENT-DISORDER; MISSENSE MUTATION; IRON OVERLOAD; EXPRESSION	The multicopper oxidase ceruloplasmin plays a key role in iron homeostasis, and its ferroxidase activity is required to stabilize cell surface ferroportin, the only known mammalian iron exporter. Missense mutations causing the rare autosomal neurodegenerative disease aceruloplasminemia were investigated by testing their ability to prevent ferroportin degradation in rat glioma C6 cells silenced for endogenous ceruloplasmin. Most of the mutants did not complement (i.e. did not stabilize ferroportin) because of the irreversible loss of copper binding ability. Mutant R701W, which was found in a heterozygous very young patient with severe neurological problems, was unable to complement per se but did so in the presence of copper-glutathione or when the yeast copper ATPase Ccc2p was co-expressed, indicating that the protein was structurally able to bind copper but that metal loading involving the mammalian copper ATPase ATP7B was impaired. Notably, R701W exerted a dominant negative effect on wild type, and it induced the subcellular relocalization of ATP7B. Our results constitute the first evidence of "functional silencing" of ATP7B as a novel molecular defect in aceruloplasminemia. The possibility to reverse the deleterious effects of some aceruloplasminemia mutations may disclose new possible therapeutic strategies.	[Maio, Nunziata; Rizzo, Gianluca; Persichini, Tiziana; Colasanti, Marco; Polticelli, Fabio; Musci, Giovanni] Univ Roma Tre, Dipartimento Biol, I-00146 Rome, Italy; [Bonaccorsi di Patti, Maria Carmela; De Francesco, Giovanni] Univ Roma La Sapienza, Dipartimento Sci Biochim, I-00185 Rome, Italy; [Musci, Giovanni] Univ Molise, Dipartimento Sci & Tecnol Agroaliment, I-86100 Campobasso, Italy	Roma Tre University; Sapienza University Rome; University of Molise	Musci, G (corresponding author), Univ Roma Tre, Dipartimento Biol, Viale Marconi 446, I-00146 Rome, Italy.	musci@unimol.it	Polticelli, Fabio/A-4573-2009; COLASANTI, MARCO/A-5616-2010; Musci, Giovanni/H-2862-2012; Bonaccorsi di Patti, Maria Carmela/F-1198-2011; Rizzo, Gianluca/J-6540-2019	Polticelli, Fabio/0000-0002-7657-2019; COLASANTI, MARCO/0000-0002-5752-4943; Musci, Giovanni/0000-0002-5196-709X; Bonaccorsi di Patti, Maria Carmela/0000-0002-4794-7037; Rizzo, Gianluca/0000-0002-5540-0621; PERSICHINI, TIZIANA/0000-0001-8291-6706; Maio, Nunziata/0000-0002-6225-6058	Telethon-Italy [GGP06173]	Telethon-Italy(Fondazione Telethon)	This work was supported by Telethon-Italy Grant GGP06173 (to G. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bosio S, 2002, BLOOD, V100, P2246, DOI 10.1182/blood-2002-02-0584; Chen L, 2003, MOL VIS, V9, P151; Daimon M, 2000, TOHOKU J EXP MED, V191, P119, DOI 10.1620/tjem.191.119; De Domenico I, 2005, P NATL ACAD SCI USA, V102, P8955, DOI 10.1073/pnas.0503804102; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; El Meskini R, 2003, J BIOL CHEM, V278, P12278, DOI 10.1074/jbc.M211413200; Fan J, 2008, INT J DEV NEUROSCI, V26, P523, DOI 10.1016/j.ijdevneu.2008.05.006; Fortna RR, 1999, BIOL REPROD, V61, P1042, DOI 10.1095/biolreprod61.4.1042; Fujita Y, 2000, J NEUROL SCI, V174, P137, DOI 10.1016/S0022-510X(00)00265-3; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hellman NE, 2002, J BIOL CHEM, V277, P46632, DOI 10.1074/jbc.M206246200; Hellman NE, 2002, J BIOL CHEM, V277, P1375, DOI 10.1074/jbc.M109123200; Hofmann WP, 2007, SCAND J GASTROENTERO, V42, P1088, DOI 10.1080/00365520701278810; HOLTZMAN NA, 1970, J BIOL CHEM, V245, P2354; Hsi G, 2008, HUM MUTAT, V29, P491, DOI 10.1002/humu.20674; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Jimenez-Huete A, 2008, J NEUROL, V255, P1083, DOI 10.1007/s00415-008-0823-9; Kono S, 2006, BIOL RES, V39, P15, DOI 10.4067/S0716-97602006000100003; Kono S, 2007, J HEPATOL, V47, P844, DOI 10.1016/j.jhep.2007.05.013; Kono S, 2006, NEUROMOL MED, V8, P361, DOI 10.1385/NMM:8:3:361; Kono S, 2006, GASTROENTEROLOGY, V131, P240, DOI 10.1053/j.gastro.2006.04.017; Kuhn J, 2005, J NEUROL, V252, P111, DOI 10.1007/s00415-005-0608-3; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mariani R, 2004, GUT, V53, P756, DOI 10.1136/gut.2003.030429; Miyajima H, 2003, NEUROPATHOLOGY, V23, P345, DOI 10.1046/j.1440-1789.2003.00521.x; Musci G, 1996, J BIOL CHEM, V271, P1972, DOI 10.1074/jbc.271.4.1972; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Perez-Aguilar F, 2005, J HEPATOL, V42, P947, DOI 10.1016/j.jhep.2005.02.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SATO M, 1991, J BIOL CHEM, V266, P5128; Sears IB, 1998, YEAST, V14, P783, DOI 10.1002/(SICI)1097-0061(19980615)14:8<783::AID-YEA272>3.0.CO;2-Y; Shang HF, 2006, MOVEMENT DISORD, V21, P2217, DOI 10.1002/mds.21121; Stieber A, 2004, J NEUROL SCI, V219, P45, DOI 10.1016/j.jns.2003.12.004; Stieber A, 1996, AM J PATHOL, V148, P415; Yomono Harumi, 2003, Rinsho Shinkeigaku, V43, P398; YOSHIDA K, 1995, NAT GENET, V9, P267, DOI 10.1038/ng0395-267; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	40	36	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4545	4554		10.1074/jbc.M805688200	http://dx.doi.org/10.1074/jbc.M805688200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19095659	hybrid			2022-12-27	WOS:000263134400055
J	Hsieh, JY; Hung, HC				Hsieh, Ju-Yi; Hung, Hui-Chih			Engineering of the Cofactor Specificities and Isoform-specific Inhibition of Malic Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASCARIS-SUUM; FUNCTIONAL ROLES; CRYSTAL-STRUCTURE; CDNA CLONING; BINDING-SITE; PURIFICATION; MECHANISM; MALATE; NAD; ATP	Malic enzyme (ME) is a family of enzymes that catalyze a reversible oxidative decarboxylation of L-malate to pyruvate with simultaneous reduction of NAD(P)(+) to NAD(P)H. According to the cofactor specificity, the mammalian enzyme can be categorized into three isoforms. The cytosolic (c) and mitochondrial (m) NADP(+)-dependent MEs utilize NADP(+) as the cofactor. The mitochondrial NAD(P)(+)-dependent ME can use either NAD(+) or NADP(+) as the cofactor. In addition, the m-NAD(P)-ME isoform can be inhibited by ATP and allosterically activated by fumarate. In this study, we delineated the determinants for cofactor specificity and isoform-specific inhibition among the ME isoforms. Our data strongly suggest that residue 362 is the decisive factor determining cofactor preference. All the mutants containing Q362K (Q362K, K346S/Q362K, Y347K/Q362K, and K346S/Y347K/Q362K) have a larger k(cat,NADP) value compared with the k(cat,NAD) value, indicating that the enzyme has changed to use NADP(+) as the preferred cofactor. Furthermore, we suggest that Lys-346 in m-NAD(P)-ME is crucial for the isoform-specific ATP inhibition. The enzymes containing the K346S mutation (K346S, K346S/Y347K, K346S/Q362K, and K346S/Y347K/Q362K) are much less inhibited by ATP and have a larger K-i,K-ATP value. Kinetic analysis also suggests that residue 347 functions in cofactor specificity. Here we demonstrate that the human K346S/Y347K/Q362K m-NAD(P)-ME has completely shifted its cofactor preference to become an NADP(+)-specific ME. In the triple mutant, Lys-362, Lys-347, and Ser-346 work together and function synergistically to increase the binding affinity for NADP(+).	[Hsieh, Ju-Yi; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Bioinformat, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University	Hung, HC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/G-4485-2013; Hung, Hui-Chih/L-8061-2019	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council [NSC-962311-B-005-005]; Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by the National Science Council Grant NSC-962311-B-005-005 and in part by the Ministry of Education, Taiwan, under the ATU plan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aktas DF, 2008, BIOCHEMISTRY-US, V47, P2539, DOI 10.1021/bi702261m; Aktas DF, 2008, BBA-PROTEINS PROTEOM, V1784, P2059, DOI 10.1016/j.bbapap.2008.07.014; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG GG, 1991, EUR J BIOCHEM, V202, P681, DOI 10.1111/j.1432-1033.1991.tb16423.x; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; Cleland WW, 2000, PROTEIN PEPTIDE LETT, V7, P305; Coleman DE, 2002, BIOCHEMISTRY-US, V41, P6928, DOI 10.1021/bi0255120; FAHIEN LA, 1992, J BIOL CHEM, V267, P10411; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hsieh JY, 2008, FEBS J, V275, P5383, DOI 10.1111/j.1742-4658.2008.06668.x; Hsieh JY, 2006, J BIOL CHEM, V281, P23237, DOI 10.1074/jbc.M603451200; HSU RY, 1982, MOL CELL BIOCHEM, V43, P3; Hsu WC, 2004, BIOCHEMISTRY-US, V43, P7382, DOI 10.1021/bi049600r; Hung HC, 2005, BIOCHEM J, V392, P39, DOI 10.1042/BJ20050641; Hung HC, 2005, BIOCHEMISTRY-US, V44, P12737, DOI 10.1021/bi050510b; Karsten WE, 2003, BIOCHEMISTRY-US, V42, P9712, DOI 10.1021/bi034101w; Kuo CC, 2000, BIOCHEM BIOPH RES CO, V270, P821, DOI 10.1006/bbrc.2000.2502; LAI CJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P214, DOI 10.1016/0003-9861(92)90266-Y; LANDSPERGER WJ, 1976, J BIOL CHEM, V251, P3599; LOEBER G, 1994, BIOCHEM J, V304, P687, DOI 10.1042/bj3040687; LOEBER G, 1994, FEBS LETT, V344, P181, DOI 10.1016/0014-5793(94)00386-6; LOEBER G, 1991, J BIOL CHEM, V266, P3016; MANDELLA RD, 1975, J BIOL CHEM, V250, P5877; MCKEEHAN WL, 1982, CELL BIOL INT REP, V6, P635, DOI 10.1016/0309-1651(82)90125-4; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; Sanz N, 1997, BRIT J CANCER, V75, P487, DOI 10.1038/bjc.1997.85; SAUER LA, 1973, BIOCHEM BIOPH RES CO, V50, P524, DOI 10.1016/0006-291X(73)90871-1; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Teller J K, 1990, Protein Expr Purif, V1, P151, DOI 10.1016/1046-5928(90)90009-N; TELLER JK, 1992, J BIOL CHEM, V267, P10423; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu YW, 1999, STRUCT FOLD DES, V7, P877, DOI 10.1016/S0969-2126(99)80115-4; Yang ZR, 2000, NAT STRUCT BIOL, V7, P251; Yang ZR, 2002, PROTEIN SCI, V11, P332, DOI 10.1110/ps.38002; Yang ZR, 2002, STRUCTURE, V10, P951, DOI 10.1016/S0969-2126(02)00788-8; ZDNIEROWICZ S, 1988, BIOCHEM MED METAB B, V39, P208	39	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4536	4544		10.1074/jbc.M807008200	http://dx.doi.org/10.1074/jbc.M807008200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19091740	hybrid			2022-12-27	WOS:000263134400054
J	Li, TB; Yang, YS; Canessa, CM				Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.			Interaction of the Aromatics Tyr-72/Trp-288 in the Interface of the Extracellular and Transmembrane Domains Is Essential for Proton Gating of Acid-sensing Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION; COOPERATIVITY; BINDING; MUTANT; PORE	Acid-sensing ion channels are proton-activated ion channels expressed in the nervous system. They belong to the family of ENaC/Degenerins whose members share a conserved structure but are activated by widely diverse stimuli. We show that interaction of two aromatic residues, Tyr-72, located immediately after the first transmembrane segment, and Trp-288, located at the tip of a loop of the extracellular domain directed toward the first transmembrane segment, is essential for proton activation of the acid-sensing ion channels. The subdomain containing Trp-288 is a module tethered to the rest of the extracellular domain by short linkers and intrasubunit interactions between residues in the putative "proton sensor." Mutations in these two areas shift the apparent affinity of protons toward a more acidic range and change the kinetics of activation and desensitization. These results are consisting with displacement of the module relative to the rest of the extracellular domain to allow interaction of Trp-288 with Tyr-72 during gating. We propose that such interaction may provide functional coupling between the extracellular domain and the pore domain.	[Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Canessa, CM (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	Cecilia.canessa@yale.edu	Li, Tianbo/C-6118-2012		National Institutes of Health [DK544602]; American Heart Association [R06523]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant DK544602 (NIDDK). This work was also supported by American Heart Association Grant-in-aid R06523 (to C. M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; Gervasio FL, 2002, PROTEINS, V48, P117, DOI 10.1002/prot.10116; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; HURLE MR, 1986, BIOCHEMISTRY-US, V25, P6356, DOI 10.1021/bi00369a002; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; PERRY KM, 1989, BIOCHEMISTRY-US, V28, P7961, DOI 10.1021/bi00445a061; Shaikh SA, 2008, BIOPHYS J, V95, P5153, DOI 10.1529/biophysj.108.141606; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Zhang P, 2002, J GEN PHYSIOL, V120, P553, DOI 10.1085/jgp.20028574	21	63	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4689	4694		10.1074/jbc.M805302200	http://dx.doi.org/10.1074/jbc.M805302200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074149	Green Published, hybrid			2022-12-27	WOS:000263134400068
J	Murase, D; Hachiya, A; Amano, Y; Ohuchi, A; Kitahara, T; Takema, Y				Murase, Daiki; Hachiya, Akira; Amano, Yasuko; Ohuchi, Atsushi; Kitahara, Takashi; Takema, Yoshinori			The Essential Role of p53 in Hyperpigmentation of the Skin via Regulation of Paracrine Melanogenic Cytokine Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELL FACTOR; NORMAL HUMAN MELANOCYTES; ULTRAVIOLET-B; HUMAN KERATINOCYTES; TYROSINASE GENE; GROWTH-FACTOR; EPIDERMAL HYPERPIGMENTATION; GLYCOSYLATION INHIBITORS; INDUCED APOPTOSIS; DNA-DAMAGE	Hyperpigmentation of the skin is characterized by increases in melanin synthesis and deposition. Although considered a significant psychosocial distress, little is known about the detailed mechanisms of hyperpigmentation. Recently, the tumor suppressor protein p53 has been demonstrated to promote ultraviolet B-induced skin pigmentation by stimulating the transcription of a melanogenic cytokine, POMC(pro-opiomelanocortin), in keratinocytes. Given that p53 can be activated by various kinds of diverse stresses, including sun exposure, inflammation, and aging, this finding led us to examine the involvement of p53 in cytokine receptor signaling, which might result in skin hyperpigmentation. Immunohistochemical and reverse transcription-PCR analyses revealed the increased expression and phosphorylation of p53 in the epidermis of hyperpigmented spots, accompanied by the higher expression of melanogenic cytokines, including stem cell factor, endothelin-1, and POMC. The involvement of p53 in hyperpigmentation was also indicated by the significantly higher expression of p53 transcriptional targets in the epidermis of hyperpigmented spots. Treatment of human keratinocytes and melanocytes with known p53 activators or inhibitors, including pifithrin-alpha (PFT), demonstrated significant increases or decreases, respectively, in the expression of melanogenic factors, including cytokines and their receptors. Additionally, PFT administration abolished stem cell factor-induced phosphorylation of mitogen-activated protein kinase in human melanocytes. Furthermore, when organ-cultured hyperpigmented spots, in vitro human skin substitutes, and mouse skin were treated with PFT or p53 small interfering RNA, the expression of melanogenic cytokines and their receptors was significantly decreased, as were levels of tyrosinase and melanogenesis. Taken together, these data reveal the essential role of p53 in hyperpigmentation of the skin via the regulation of paracrine-cytokine signaling, both in keratinocytes and in melanocytes.	[Murase, Daiki; Hachiya, Akira; Amano, Yasuko; Ohuchi, Atsushi; Kitahara, Takashi; Takema, Yoshinori] Kao Biol Sci Labs, Haga, Tochigi 3213497, Japan		Hachiya, A (corresponding author), Kao Biol Sci Labs, Haga, Tochigi 3213497, Japan.	hachiya.akira@kao.co.jp						ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bykov VJ, 2000, J INVEST DERMATOL, V114, P40, DOI 10.1046/j.1523-1747.2000.00821.x; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; CHEN CY, 1994, P NATL ACAD SCI USA, V91, P2684, DOI 10.1073/pnas.91.7.2684; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; EL DW, 1993, CELL, V75, P817; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Funasaka Y, 1998, BRIT J DERMATOL, V139, P216; FURUKAWA F, 1987, J INVEST DERMATOL, V89, P460, DOI 10.1111/1523-1747.ep12460904; Gilchrest BA, 1996, PHOTOCHEM PHOTOBIOL, V63, P1, DOI 10.1111/j.1751-1097.1996.tb02988.x; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; Hachiya A, 2004, AM J PATHOL, V165, P2099, DOI 10.1016/S0002-9440(10)63260-9; Hachiya A, 2001, J INVEST DERMATOL, V116, P578, DOI 10.1046/j.1523-1747.2001.01290.x; HALABAN R, 1988, J CELL BIOL, V107, P1611, DOI 10.1083/jcb.107.4.1611; Hao MM, 1996, J BIOL CHEM, V271, P29380, DOI 10.1074/jbc.271.46.29380; Hattori H, 2004, J INVEST DERMATOL, V122, P1256, DOI 10.1111/j.0022-202X.2004.22503.x; Hedley SJ, 1998, PIGM CELL RES, V11, P45, DOI 10.1111/j.1600-0749.1998.tb00710.x; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hou L, 2000, DEVELOPMENT, V127, P5379; Imokawa G, 2000, J BIOL CHEM, V275, P33321, DOI 10.1074/jbc.M004346200; IMOKAWA G, 1982, CANCER RES, V42, P1994; Imokawa G, 1996, BIOCHEM J, V314, P305, DOI 10.1042/bj3140305; Imokawa G, 1997, PIGM CELL RES, V10, P218, DOI 10.1111/j.1600-0749.1997.tb00488.x; IMOKAWA G, 1995, J INVEST DERMATOL, V105, P32, DOI 10.1111/1523-1747.ep12312500; IMOKAWA G, 1992, J BIOL CHEM, V267, P24675; IYENGAR B, 1994, MELANOMA RES, V4, P293; Kadekaro AL, 2003, ANN NY ACAD SCI, V994, P359, DOI 10.1111/j.1749-6632.2003.tb03200.x; Kadono S, 2001, J INVEST DERMATOL, V116, P571, DOI 10.1046/j.1523-1747.2001.01296.x; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Khlgatian MK, 2002, J INVEST DERMATOL, V118, P126, DOI 10.1046/j.0022-202x.2001.01667.x; Kichina J, 1996, PIGM CELL RES, V9, P85, DOI 10.1111/j.1600-0749.1996.tb00094.x; Kobayashi N, 1998, J INVEST DERMATOL, V110, P806, DOI 10.1046/j.1523-1747.1998.00178.x; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; MISHIMA Y, 1983, J INVEST DERMATOL, V81, P106, DOI 10.1111/1523-1747.ep12542192; Motokawa T, 2005, J DERMATOL SCI, V37, P120, DOI 10.1016/j.jdermsci.2004.10.009; OKAZAKI K, 1976, J INVEST DERMATOL, V67, P541, DOI 10.1111/1523-1747.ep12664554; Okazaki M, 2003, BRIT J DERMATOL, V148, P689, DOI 10.1046/j.1365-2133.2003.05283.x; PATHAK MA, 1983, J AM ACAD DERMATOL, V9, P724, DOI 10.1016/S0190-9622(83)70186-6; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; RomeroGraillet C, 1997, J CLIN INVEST, V99, P635, DOI 10.1172/JCI119206; ROSDAHL IK, 1978, J INVEST DERMATOL, V70, P143, DOI 10.1111/1523-1747.ep12258559; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; SCHAUER E, 1994, J CLIN INVEST, V93, P2258, DOI 10.1172/JCI117224; SCHWARZ A, 1995, J INVEST DERMATOL, V104, P922, DOI 10.1111/1523-1747.ep12606202; Scott G, 2001, J INVEST DERMATOL, V117, P1412, DOI 10.1046/j.0022-202x.2001.01575.x; Seiberg M, 2001, PIGM CELL RES, V14, P236, DOI 10.1034/j.1600-0749.2001.140402.x; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shishido E, 2001, J INVEST DERMATOL, V117, P627, DOI 10.1046/j.0022-202x.2001.01440.x; Singh S, 2007, FEBS LETT, V581, P289, DOI 10.1016/j.febslet.2006.12.035; Sirsjo A, 1996, BRIT J DERMATOL, V134, P643, DOI 10.1111/j.1365-2133.1996.tb06963.x; Tada A, 1998, CELL GROWTH DIFFER, V9, P575; Teraki E, 1996, BRIT J DERMATOL, V135, P918, DOI 10.1046/j.1365-2133.1996.d01-1095.x; Tsatmali M, 2000, PIGM CELL RES, V13, P125, DOI 10.1034/j.1600-0749.13.s8.22.x; Tsujimura T, 1996, BLOOD, V88, P1225, DOI 10.1182/blood.V88.4.1225.bloodjournal8841225; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wintzen M, 1996, J INVEST DERMATOL, V106, P3, DOI 10.1111/1523-1747.ep12326950; Wintzen M, 1996, J INVEST DERMATOL, V106, P673, DOI 10.1111/1523-1747.ep12345496; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; YADA Y, 1991, J BIOL CHEM, V266, P18352; YOHN JJ, 1993, J INVEST DERMATOL, V100, P23, DOI 10.1111/1523-1747.ep12349932; ZHAN QM, 1994, CANCER RES, V54, P2755; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	77	64	68	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4343	4353		10.1074/jbc.M805570200	http://dx.doi.org/10.1074/jbc.M805570200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098008	hybrid			2022-12-27	WOS:000263134400033
J	Ni, HM; Chen, XY; Shi, YH; Liao, Y; Beg, AA; Fan, J; Yin, XM				Ni, Hong-Min; Chen, Xiaoyun; Shi, Ying-Hong; Liao, Yong; Beg, Amer A.; Fan, Jia; Yin, Xiao-Ming			Genetic Delineation of the Pathways Mediated by Bid and JNK in Tumor Necrosis Factor-alpha-induced Liver Injury in Adult and Embryonic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INDUCED APOPTOSIS; TNF-ALPHA; INTRACELLULAR PATHWAYS; HEPATOCYTE APOPTOSIS; DEFICIENT MICE; ACTIVATION; DEATH; MITOCHONDRIA; INHIBITION	Tumor necrosis factor-alpha (TNF alpha)-induced hepatocyte death and liver injury can be mediated by multiple mechanisms, which could be evaluated by different animal models. Previous studies have defined the importance of Bid in mitochondrial apoptosis activation in adult mice treated with lipopolysaccharides in the presence of galactosamine (GalN), which suppresses NF-kappa B activation, but not in embryonic mice in which NF-kappa B activation is suppressed by genetic deletion of p65RelA. JNK has also been found important in TNF alpha-induced mitochondria activation and liver injury in the lipopolysaccharide/GalN and concanavalin A (ConA)/GalN models, but not in a ConA-only model in which NF-kappa B activation was not suppressed. To determine the mechanistic relationship of pathways mediated by Bid and JNK, we investigated these two molecules in TNF alpha injury models that had not been previously examined. Most importantly, we created and studied mice deficient in both Bid and JNK. We found that, like JNK, Bid was also required for TNF alpha-induced injury induced by concanavalin A/GalN but not by ConA alone. Furthermore, our results indicate that these two molecules function in a largely overlapped manner, with Bid being downstream of JNK in the adult livers. However, JNK, but not Bid, was able to contribute to the TNF alpha-induced liver apoptosis in RelA-deficient embryos. The Bid-independent role of JNK was also observed in the adult mice, mainly in the promotion of the lethal progression of the TNF alpha injury. This work defined both linear and parallel relationships of Bid and JNK in TNF alpha-induced hepatocyte apoptosis and liver injury.	[Ni, Hong-Min; Chen, Xiaoyun; Liao, Yong; Yin, Xiao-Ming] Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15261 USA; [Shi, Ying-Hong; Fan, Jia] Fudan Univ, Zhongshan Hosp, Dept Liver Surg, Liver Canc Inst, Shanghai 200032, Peoples R China; [Beg, Amer A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fudan University; H Lee Moffitt Cancer Center & Research Institute	Yin, XM (corresponding author), Univ Pittsburgh, Dept Pathol, Sch Med, 3550 Terrace St, Pittsburgh, PA 15261 USA.	xmyin@pitt.edu	Chen, Xiaoyun/K-4786-2019; Shi, Ying-Hong/B-7063-2017; Fan, Jia/C-6689-2017		National Institutes of Health [R01CA 83817]; NATIONAL CANCER INSTITUTE [R01CA083817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA 83817 (to X.-M. Y.).	BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen XY, 2007, MOL CELL BIOL, V27, P541, DOI 10.1128/MCB.01166-06; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Gantner F, 1997, J PHARMACOL EXP THER, V280, P53; GANTNER F, 1995, HEPATOLOGY, V21, P190, DOI 10.1002/hep.1840210131; GANTNER F, 1995, GASTROENTEROLOGY, V109, P166, DOI 10.1016/0016-5085(95)90282-1; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Gugasyan R, 2006, CELL DEATH DIFFER, V13, P1235, DOI 10.1038/sj.cdd.4401858; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kaufmann T, 2007, CELL DEATH DIFFER, V14, P637, DOI 10.1038/sj.cdd.4402061; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Kunstle G, 1999, HEPATOLOGY, V30, P1241, DOI 10.1002/hep.510300517; Kusters S, 1997, EUR J IMMUNOL, V27, P2870, DOI 10.1002/eji.1830271119; Lawson JA, 1998, HEPATOLOGY, V28, P761, DOI 10.1002/hep.510280324; Li SC, 2002, J BIOL CHEM, V277, P26912, DOI 10.1074/jbc.M200726200; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Ni HM, 2008, AM J PATHOL, V173, P962, DOI 10.2353/ajpath.2008.080358; Nowak M, 2000, AM J PHYSIOL-REG I, V278, pR1202, DOI 10.1152/ajpregu.2000.278.5.R1202; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Streetz K, 2001, J IMMUNOL, V167, P514, DOI 10.4049/jimmunol.167.1.514; Trautwein C, 1998, GASTROENTEROLOGY, V114, P1035, DOI 10.1016/S0016-5085(98)70324-5; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Van Molle W, 1999, J IMMUNOL, V163, P5235; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yin XM, 2003, CURR MOL MED, V3, P491, DOI 10.2174/1566524033479555; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zhao YG, 2003, GASTROENTEROLOGY, V125, P854, DOI 10.1016/S0016-5085(03)01066-7; Zhao YG, 2001, J BIOL CHEM, V276, P27432, DOI 10.1074/jbc.M102465200	40	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4373	4382		10.1074/jbc.M807259200	http://dx.doi.org/10.1074/jbc.M807259200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19060338	Green Published, hybrid			2022-12-27	WOS:000263134400036
J	Price, PA; Toroian, D; Chan, WS				Price, Paul A.; Toroian, Damon; Chan, Wai Si			Tissue-nonspecific Alkaline Phosphatase Is Required for the Calcification of Collagen in Serum A POSSIBLE MECHANISM FOR BIOMINERALIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXOSEPHOSPHORIC ESTERS; MINERALIZATION; BONE; INHIBITION; RESIDUES; ARTERIES; MATRIX; FETUIN; WATER; MICE	Previous studies have shown that the type I collagen of tendon and demineralized bone both calcify rapidly in serum. The speed, collagen matrix-type specificity, and extent of the re-calcification of demineralized bone in serum suggest that the serum calcification activity identified in these studies may participate in normal biomineralization. Because of its presence in serum and its long history of association with the normal mineralization of the collagen matrix of bone, tissue-nonspecific alkaline phosphatase (TNAP) is an obvious candidate for a protein that could be a component of serum calcification activity, and experiments were therefore carried out to test this possibility. These experiments show that the inactivation of TNAP in serum prevents collagen calcification, and that the addition of physiological levels of purified TNAP restores the ability of TNAP-deficient serum to calcify collagen. Additional experiments show that the role of TNAP in collagen calcification is to activate a serum nucleator of apatite crystal formation. Based on these and earlier studies, the mechanism of collagen calcification in serum requires at least four elements as follows. 1) A matrix (collagen fibrils) that is accessible to small apatite crystals but not large molecules (Toroian, D., Lim, J.E., and Price, P. A. (2007) J. Biol. Chem. 282, 22437-22447). 2) A large serum nucleator that generates small crystals, some of which diffuse into the fibrils. 3) A source of TNAP to activate the serum nucleator. 4) A large protein (fetuin) that selectively inhibits growth of crystals remaining in solution, thereby ensuring that only crystals within fibrils grow (Toroian, D. T., and Price, P. A. (2008) Calcif. Tissue Int. 82, 116-126).	[Price, Paul A.; Toroian, Damon; Chan, Wai Si] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Price, PA (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	pprice@ucsd.edu						Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; BEERTSEN W, 1992, J CLIN INVEST, V89, P1974, DOI 10.1172/JCI115805; BILTZ RM, 1969, J BONE JOINT SURG AM, VA 51, P456, DOI 10.2106/00004623-196951030-00003; Boivin G, 2002, CALCIFIED TISSUE INT, V70, P503, DOI 10.1007/s00223-001-2048-0; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Doty S B, 1976, Prog Histochem Cytochem, V8, P1; FALLON MD, 1980, LAB INVEST, V43, P489; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Fullerton GD, 2006, CELL BIOL INT, V30, P56, DOI 10.1016/j.cellbi.2005.09.008; GRIER RS, 1949, J BIOL CHEM, V180, P289; HALE JE, 1991, J BIOL CHEM, V266, P21145; Hamlin NJ, 2006, CALCIFIED TISSUE INT, V78, P326, DOI 10.1007/s00223-005-0205-6; Hamlin NJ, 2004, CALCIFIED TISSUE INT, V75, P231, DOI 10.1007/s00223-004-0190-1; IX JH, 2008, J BONE MINER RES; KLEMPERER FW, 1949, J BIOL CHEM, V180, P281; Kozlenkov A, 2004, J BONE MINER RES, V19, P1862, DOI 10.1359/JBMR.040608; Magnusson P, 2002, TUMOR BIOL, V23, P228, DOI 10.1159/000067254; Magnusson P, 2002, CALCIFIED TISSUE INT, V71, P508, DOI 10.1007/s00223-001-1137-4; MATSUZAWA T, 1971, J HISTOCHEM CYTOCHEM, V19, P801, DOI 10.1177/19.12.801; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Parfitt AM, 2000, BONE, V26, P319, DOI 10.1016/S8756-3282(00)80937-0; Price PA, 2006, ARTERIOSCL THROM VAS, V26, P1079, DOI 10.1161/01.ATV.0000216406.44762.7c; Price PA, 2004, J BIOL CHEM, V279, P19169, DOI 10.1074/jbc.M307880200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; Rattazzi M, 2005, ARTERIOSCL THROM VAS, V25, P1420, DOI 10.1161/01.ATV.0000166600.58468.1b; REJ R, 1980, CLIN CHEM, V26, P423; ROBINSON RA, 1957, J BONE JOINT SURG AM, V39, P167, DOI 10.2106/00004623-195739010-00015; Robison R, 1923, BIOCHEM J, V17, P286, DOI 10.1042/bj0170286; Robison R, 1924, BIOCHEM J, V18, P740, DOI 10.1042/bj0180740; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; STINSON RA, 1987, BIOCHIM BIOPHYS ACTA, V913, P272, DOI 10.1016/0167-4838(87)90135-X; TANIMURA A, 1986, Journal of Experimental Pathology (New York), V2, P261; THOMAS M, 1966, BIOCHEM J, V98, P94, DOI 10.1042/bj0980094; Toroian D, 2008, CALCIFIED TISSUE INT, V82, P116, DOI 10.1007/s00223-007-9085-2; Toroian D, 2007, J BIOL CHEM, V282, P22437, DOI 10.1074/jbc.M700591200; VANBELLE H, 1976, CLIN CHEM, V22, P972; Whyte M.P., 2001, METABOLIC MOL BASES, P5313; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439	40	38	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4594	4604		10.1074/jbc.M803205200	http://dx.doi.org/10.1074/jbc.M803205200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098289	hybrid			2022-12-27	WOS:000263134400059
J	Singh, LR; Kruger, WD				Singh, Laishram R.; Kruger, Warren D.			Functional Rescue of Mutant Human Cystathionine beta-Synthase by Manipulation of Hsp26 and Hsp70 Levels in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; YEAST; MUTATIONS; HOMOCYSTINURIA; METABOLISM; PROTEASOME; PATHWAY; CYTOSOL; HSP104	Many human diseases are caused by missense substitutions that result in misfolded proteins that lack biological function. Here we express a mutant form of the human cystathionine beta-synthase protein, I278T, in Saccharomyces cerevisiae and show that it is possible to dramatically restore protein stability and enzymatic function by manipulation of the cellular chaperone environment. We demonstrate that Hsp70 and Hsp26 bind specifically to I278T but that these chaperones have opposite biological effects. Ethanol treatment induces Hsp70 and causes increased activity and steady-state levels of I278T. Deletion of the SSA2 gene, which encodes a cytoplasmic isoform of Hsp70, eliminates the ability of ethanol to restore function, indicating that Hsp70 plays a positive role in proper I278T folding. In contrast, deletion of HSP26 results in increased I278T protein and activity, whereas overexpression of Hsp26 results in reduced I278T protein. The Hsp26-I278T complex is degraded via a ubiquitin/proteosome-dependent mechanism. Based on these results we propose a novel model in which the ratio of Hsp70 and Hsp26 determines whether misfolded proteins will either be refolded or degraded.	[Singh, Laishram R.; Kruger, Warren D.] Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Kruger, WD (corresponding author), Fox Chase Canc Ctr, Div Populat Sci, 333 Cottman Ave, Philadelphia, PA 19111 USA.	warren.kruger@fccc.edu	kruger, warren/A-6407-2008	kruger, warren/0000-0002-4990-3695	National Institutes of Health [HL57299, CA06927]; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057299, R29HL057299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL57299 and CA06927 ( core grant). This work was also supported by an appropriation from the Commonwealth of Pennsylvania. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Alexandre H, 2001, FEBS LETT, V498, P98, DOI 10.1016/S0014-5793(01)02503-0; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Chen X, 2006, HUM MUTAT, V27, P474, DOI 10.1002/humu.20320; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Ghaboosi N, 2007, MOL BIOL CELL, V18, P1953, DOI 10.1091/mbc.E06-10-0965; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Jhee KH, 2005, ANTIOXID REDOX SIGN, V7, P813, DOI 10.1089/ars.2005.7.813; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kim CE, 1997, HUM MOL GENET, V6, P2213, DOI 10.1093/hmg/6.13.2213; Kraus JP, 1999, HUM MUTAT, V13, P362; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; KRUGER WD, 1995, HUM MOL GENET, V4, P1155, DOI 10.1093/hmg/4.7.1155; Kruger WD, 2003, HUM MUTAT, V22, P434, DOI 10.1002/humu.10290; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Shan XY, 2001, HUM MOL GENET, V10, P635, DOI 10.1093/hmg/10.6.635; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011; Smith DF, 1998, PHARMACOL REV, V50, P493; van Slegtenhorst M, 2004, J BIOL CHEM, V279, P12706, DOI 10.1074/jbc.M313874200	27	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4238	4245		10.1074/jbc.M806387200	http://dx.doi.org/10.1074/jbc.M806387200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074437	Green Published, hybrid			2022-12-27	WOS:000263134400021
J	Bhunia, A; Tang, XY; Mohanram, H; Tan, SM; Bhattacharjya, S				Bhunia, Anirban; Tang, Xiao-Yan; Mohanram, Harini; Tan, Suet-Mien; Bhattacharjya, Surajit			NMR Solution Conformations and Interactions of Integrin alpha L beta 2 Cytoplasmic Tails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-LYMPHOCYTE MIGRATION; BINDING PROTEIN; TRANSMEMBRANE SEGMENT; STRUCTURAL BASIS; CHEMICAL-SHIFT; CELL-ADHESION; ALPHA-CHAIN; ACTIVATION; TALIN; DOMAIN	The integrins are bi-directional signal transducers. Devoid of enzymatic activity, the integrin cytoplasmic tail serves as a hub for the recruitment of cytosolic proteins, and many of these are signaling molecules. The leukocyte-restricted integrin alpha L beta 2 is essential for the adhesion, migration, and proliferation of leukocytes. Here we report solution conformations and interactions of the alpha L beta 2 cytoplasmic tails by NMR analyses. The alpha L tail is characterized by three helical segments in the order of helix 1-3 that are connected by two loops with helix 3 having a number of nuclear Overhauser effect contacts with helix 1 and helix 2. The conformation of the beta 2 tail is less defined with only a helical segment restricted at its N terminus. Acidic residues from the helix 2-loop-helix 3 motif of alpha L were found to be responsible for its binding to calcium ion. There were detectable interactions between alpha L and beta 2 tails, involving helix 1 and helix 3 of the alpha L tail and the N-terminal helix of the beta 2 tail. Talin head domain that contains the FERM domain showed binding affinity of K-d similar to 0.5 mu M with the beta 2 tail. The binding affinity of alpha L and beta 2 tails is K-d similar to 2.63 mu M. These data are in line with the activating property of talin head domain on alpha L beta 2 by which binding of talin head domain to beta 2 tail disrupts the interface of the alpha L and beta 2 tails that constrains alpha L beta 2 in a resting state.	[Bhunia, Anirban; Tang, Xiao-Yan; Mohanram, Harini; Tan, Suet-Mien; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	smtan@ntu.edu.sg; surajit@ntu.edu.sg	Tan, Suet/A-2224-2011; Bhattacharjya, SURAJIT/A-2183-2011; Mohanram, Harini/L-9207-2019	Mohanram, Harini/0000-0002-8179-2665; Tan, Suet-Mien/0000-0003-2371-8739; Bhunia, Anirban/0000-0002-8752-2842	A*STAR BMRC [04/1/22/19/358, 06/1/22/19/445, 06/01/22/19/446]	A*STAR BMRC(Agency for Science Technology & Research (A*STAR))	This work was supported by Grants A*STAR BMRC 04/1/22/19/358 and 06/1/22/19/445 (to X.-Y.T., and S.M.T.) and by Grant A*STAR BMRC 06/01/22/19/446 (to A.B., H.M., and S.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Barclay A. N., 1997, LEUCOCYTE ANTIGEN FA, V2nd; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; CHATILA TA, 1989, J CELL BIOL, V109, P3435, DOI 10.1083/jcb.109.6.3435; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Fagerholm S, 2002, J BIOL CHEM, V277, P1728, DOI 10.1074/jbc.M106856200; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Fagerholm SC, 2004, TRENDS BIOCHEM SCI, V29, P504, DOI 10.1016/j.tibs.2004.07.005; Geng X, 2005, IMMUNOLOGY, V115, P347, DOI 10.1111/j.1365-2567.2005.02175.x; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haas TA, 1996, J BIOL CHEM, V271, P6017, DOI 10.1074/jbc.271.11.6017; Hilden TJ, 2003, J IMMUNOL, V170, P4170, DOI 10.4049/jimmunol.170.8.4170; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KASSNER PD, 1993, J EXP MED, V178, P649, DOI 10.1084/jem.178.2.649; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2007, ADV IMMUNOL, V93, P185, DOI 10.1016/S0065-2776(06)93005-3; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Li YF, 2007, J BIOL CHEM, V282, P24310, DOI 10.1074/jbc.M701860200; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Liu SC, 2000, J CELL SCI, V113, P3563; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Nurmi SM, 2007, J BIOL CHEM, V282, P968, DOI 10.1074/jbc.M608524200; PAVALKO FM, 1993, J IMMUNOL, V151, P3795; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Reymond MT, 1997, PROTEIN SCI, V6, P706; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Smith A, 2007, IMMUNOL REV, V218, P135, DOI 10.1111/j.1600-065X.2007.00537.x; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tan SM, 2001, J BIOL CHEM, V276, P36370, DOI 10.1074/jbc.M102392200; Tang RH, 2006, FEBS LETT, V580, P4435, DOI 10.1016/j.febslet.2006.06.099; Tang XY, 2008, J IMMUNOL, V180, P4793, DOI 10.4049/jimmunol.180.7.4793; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; Ulmer TS, 2003, BIOCHEMISTRY-US, V42, P8307, DOI 10.1021/bi034384s; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Weber KSC, 1999, MOL BIOL CELL, V10, P861, DOI 10.1091/mbc.10.4.861; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Ziegler WH, 2008, BIOCHEM SOC T, V36, P235, DOI 10.1042/BST0360235	63	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3873	3884		10.1074/jbc.M807236200	http://dx.doi.org/10.1074/jbc.M807236200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073598	hybrid			2022-12-27	WOS:000262872500056
J	Brown, G; Singer, A; Lunin, VV; Proudfoot, M; Skarina, T; Flick, R; Kochinyan, S; Sanishvili, R; Joachimiak, A; Edwards, AM; Savchenko, A; Yakunin, AF				Brown, Greg; Singer, Alexander; Lunin, Vladimir V.; Proudfoot, Michael; Skarina, Tatiana; Flick, Robert; Kochinyan, Samvel; Sanishvili, Ruslan; Joachimiak, Andrzej; Edwards, Aled M.; Savchenko, Alexei; Yakunin, Alexander F.			Structural and Biochemical Characterization of the Type II Fructose-1,6-bisphosphatase GlpX from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL MONOPHOSPHATASE; FRUCTOSE 1,6-BISPHOSPHATASE; CRYSTAL-STRUCTURE; CORYNEBACTERIUM-GLUTAMICUM; PHOSPHATASE-ACTIVITIES; PUTATIVE TARGET; ENZYME; GENE; LITHIUM; EXPRESSION	Gluconeogenesis is an important metabolic pathway, which produces glucose from noncarbohydrate precursors such as organic acids, fatty acids, amino acids, or glycerol. Fructose-1,6-bisphosphatase, a key enzyme of gluconeogenesis, is found in all organisms, and five different classes of these enzymes have been identified. Here we demonstrate that Escherichia coli has two class II fructose-1,6-bisphosphatases, GlpX and YggF, which show different catalytic properties. We present the first crystal structure of a class II fructose-1,6-bisphosphatase (GlpX) determined in a free state and in the complex with a substrate (fructose 1,6-bisphosphate) or inhibitor (phosphate). The crystal structure of the ligand-free GlpX revealed a compact, globular shape with two alpha/beta-sandwich domains. The core fold of GlpX is structurally similar to that of Li+-sensitive phosphatases implying that they have a common evolutionary origin and catalytic mechanism. The structure of the GlpX complex with fructose 1,6-bisphosphate revealed that the active site is located between two domains and accommodates several conserved residues coordinating two metal ions and the substrate. The third metal ion is bound to phosphate 6 of the substrate. Inorganic phosphate strongly inhibited activity of both GlpX and YggF, and the crystal structure of the GlpX complex with phosphate demonstrated that the inhibitor molecule binds to the active site. Alanine replacement mutagenesis of GlpX identified 12 conserved residues important for activity and suggested that Thr(90) is the primary catalytic residue. Our data provide insight into the molecular mechanisms of the substrate specificity and catalysis of GlpX and other class II fructose-1,6-bisphosphatases.	[Brown, Greg; Singer, Alexander; Proudfoot, Michael; Skarina, Tatiana; Flick, Robert; Kochinyan, Samvel; Edwards, Aled M.; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Lunin, Vladimir V.] Natl Renewable Energy Lab, Chem & Biosci Ctr, Golden, CO 80401 USA; [Sanishvili, Ruslan; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Biosci Div, Argonne, IL 60439 USA; [Sanishvili, Ruslan; Joachimiak, Andrzej] Struct Biol Ctr, Argonne, IL 60439 USA	University of Toronto; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); Argonne National Laboratory	Yakunin, AF (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	a.iakounine@utoronto.ca	Yakunin, Alexander/J-1519-2014	Edwards, Aled/0000-0002-4782-6016; Yakunin, Alexander/0000-0003-0813-6490	National Institutes of Health [GM074942]; Genome Canada (through the Ontario Genomics Institute); United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Canada (through the Ontario Genomics Institute)(Genome Canada); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942. This work was also supported by Genome Canada (through the Ontario Genomics Institute) and by the United States Department of Energy, Office of Biological and Environmental Research, Contract DE-AC02-06CH11357. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albert A, 2000, J MOL BIOL, V295, P927, DOI 10.1006/jmbi.1999.3408; BABUL J, 1983, ARCH BIOCHEM BIOPHYS, V225, P944, DOI 10.1016/0003-9861(83)90109-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Becker J, 2005, APPL ENVIRON MICROB, V71, P8587, DOI 10.1128/AEM.71.12.8587-8596.2005; BONE R, 1992, P NATL ACAD SCI USA, V89, P10031, DOI 10.1073/pnas.89.21.10031; BONE R, 1994, BIOCHEMISTRY-US, V33, P9468, DOI 10.1021/bi00198a012; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Donahue JL, 2000, J BACTERIOL, V182, P5624, DOI 10.1128/JB.182.19.5624-5627.2000; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRAENKEL DG, 1966, ARCH BIOCHEM BIOPHYS, V114, P4, DOI 10.1016/0003-9861(66)90298-0; FRAENKEL DG, 1965, J BACTERIOL, V90, P837, DOI 10.1128/JB.90.4.837-842.1965; Fujita Y, 1998, J BACTERIOL, V180, P4309, DOI 10.1128/JB.180.16.4309-4313.1998; Fukuda C, 2007, APPL ENVIRON MICROB, V73, P5447, DOI 10.1128/AEM.02703-06; Hines JK, 2007, J BIOL CHEM, V282, P11696, DOI 10.1074/jbc.M611104200; Hines JK, 2006, J BIOL CHEM, V281, P18386, DOI 10.1074/jbc.M602553200; HORECKER BL, 1975, ADV ENZYMOL RAMB, V42, P193; INHORN RC, 1988, J BIOL CHEM, V263, P14559; Johnson KA, 2001, BIOCHEMISTRY-US, V40, P618, DOI 10.1021/bi0016422; KE HM, 1989, P NATL ACAD SCI USA, V86, P1475, DOI 10.1073/pnas.86.5.1475; Kelley-Loughnane N, 2002, BBA-PROTEIN STRUCT M, V1594, P6, DOI 10.1016/S0167-4838(01)00261-8; Kimber MS, 2003, PROTEINS, V51, P562, DOI 10.1002/prot.10340; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; LEECH AP, 1993, EUR J BIOCHEM, V212, P693, DOI 10.1111/j.1432-1033.1993.tb17707.x; MARCUS F, 1982, METHOD ENZYMOL, V90, P352; MATSUHISA A, 1995, J BACTERIOL, V177, P200, DOI 10.1128/jb.177.1.200-205.1995; MCALLISTER G, 1992, BIOCHEM J, V284, P749, DOI 10.1042/bj2840749; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Movahedzadeh F, 2004, MICROBIOL-SGM, V150, P3499, DOI 10.1099/mic.0.27204-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; NAHORSKI SR, 1991, TRENDS PHARMACOL SCI, V12, P297, DOI 10.1016/0165-6147(91)90581-C; NEUWALD AF, 1992, J BACTERIOL, V174, P415, DOI 10.1128/jb.174.2.415-425.1992; Nishimasu H, 2004, STRUCTURE, V12, P949, DOI 10.1016/j.str.2004.03.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel S, 2002, J MOL BIOL, V320, P1087, DOI 10.1016/S0022-2836(02)00564-8; Patel S, 2002, J MOL BIOL, V315, P677, DOI 10.1006/jmbi.2001.5271; POLLACK SJ, 1994, P NATL ACAD SCI USA, V91, P5766, DOI 10.1073/pnas.91.13.5766; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Rittmann D, 2003, ARCH MICROBIOL, V180, P285, DOI 10.1007/s00203-003-0588-6; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; SEDIVY JM, 1984, J BACTERIOL, V158, P1048, DOI 10.1128/JB.158.3.1048-1053.1984; Stec B, 2000, NAT STRUCT BIOL, V7, P1046, DOI 10.1038/80968; Stieglitz KA, 2002, J BIOL CHEM, V277, P22863, DOI 10.1074/jbc.M201042200; Tamoi M, 1998, BBA-PROTEIN STRUCT M, V1383, P232, DOI 10.1016/S0167-4838(97)00208-2; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verhees CH, 2002, J BACTERIOL, V184, P3401, DOI 10.1128/JB.184.12.3401-3405.2002; VILLERET V, 1995, BIOCHEMISTRY-US, V34, P4299, DOI 10.1021/bi00013a019; Wang YL, 2007, J BIOL CHEM, V282, P26989, DOI 10.1074/jbc.M701210200; Wright SW, 2002, J MED CHEM, V45, P3865, DOI 10.1021/jm010496a; XUE YF, 1994, P NATL ACAD SCI USA, V91, P12482, DOI 10.1073/pnas.91.26.12482; YORK JD, 1995, P NATL ACAD SCI USA, V92, P5149, DOI 10.1073/pnas.92.11.5149; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X; ZHANG YP, 1993, BIOCHEM BIOPH RES CO, V190, P1080, DOI 10.1006/bbrc.1993.1159	61	37	39	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3784	3792		10.1074/jbc.M808186200	http://dx.doi.org/10.1074/jbc.M808186200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073594	Green Published, hybrid			2022-12-27	WOS:000262872500047
J	Hunter, WN				Hunter, William N.			Structure-based Ligand Design and the Promise Held for Antiprotozoan Drug Discovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PLASMODIUM-FALCIPARUM; NATURAL-PRODUCTS; TARGETS; BIOLOGY; TRENDS	The development of the pharmaceutical industry, driven by progress in chemistry, biology, and technology, ranks as one of the most successful of human endeavors. However, serious health problems persist, among which are diseases caused by protozoan parasites, largely ignored in modern times. Advances in genomic sciences, molecular and structural biology, and computational and medicinal chemistry now set the scene for a renewed assault on such infections. A structure-centric approach to support discovery of antiparasitic compounds promises much. Current strategies and benefits of a structure-based approach to support early stage drug discovery will be described.	Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland	University of Dundee	Hunter, WN (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dow St, Dundee DD1 5EH, Scotland.	w.n.hunter@dundee.ac.uk	Hunter, William/AAE-3947-2019		Biotechnology and Biological Sciences Research Council; Wellcome Trust [082596, 083481]; European Union [Health-223461]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (Structural Proteomics of Rational Targets), Wellcome Trust Grants 082596 and 083481, and European Union FP7 Health-223461. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139; Brown D, 2003, DRUG DISCOV TODAY, V8, P1067, DOI 10.1016/S1359-6446(03)02902-7; Butler Mark S., 2008, V65; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Congreve M, 2005, DRUG DISCOV TODAY, V10, P895, DOI 10.1016/S1359-6446(05)03484-7; Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Dawson A, 2006, MOL MICROBIOL, V61, P1457, DOI 10.1111/j.1365-2958.2006.05332.x; Dearden JC, 2007, EXPERT OPIN DRUG MET, V3, P635, DOI 10.1517/17425225.3.5.635; Erlanson DA, 2004, J MED CHEM, V47, P3463, DOI 10.1021/jm040031v; Frearson JA, 2007, TRENDS PARASITOL, V23, P589, DOI 10.1016/j.pt.2007.08.019; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Goodman CD, 2008, CURR PHARM DESIGN, V14, P901, DOI 10.2174/138161208784041088; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keller TH, 2006, CURR OPIN CHEM BIOL, V10, P357, DOI 10.1016/j.cbpa.2006.06.014; Krauth-Siegel RL, 2003, BIOL CHEM, V384, P539, DOI 10.1515/BC.2003.062; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Muchmore SW, 2003, CURR OPIN DRUG DISC, V6, P544; Myler PJ, 2008, ADV EXP MED BIOL, V625, P133, DOI 10.1007/978-0-387-77570-8_11; Naula C, 2005, BBA-PROTEINS PROTEOM, V1754, P151, DOI 10.1016/j.bbapap.2005.08.018; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Rees DC, 2004, NAT REV DRUG DISCOV, V3, P660, DOI 10.1038/nrd1467; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Sahu NK, 2008, CHEM BIOL DRUG DES, V71, P287, DOI 10.1111/j.1747-0285.2008.00640.x; Schnur DM, 2008, CURR OPIN DRUG DISC, V11, P375; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Travis AS, 1991, BIOCHEMIST, V13, P9; Tuccinardi T, 2007, CURR MED CHEM, V14, P3105, DOI 10.2174/092986707782793970; WAKA S, 2006, NAT REV DRUG DISCOV, V5, P941; Yeh I, 2006, MINI-REV MED CHEM, V6, P177, DOI 10.2174/138955706775475957	48	39	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11749	11753		10.1074/jbc.R800072200	http://dx.doi.org/10.1074/jbc.R800072200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19103598	hybrid, Green Published			2022-12-27	WOS:000265494600004
J	Avruch, J; Xavier, R; Bardeesy, N; Zhang, XF; Praskova, M; Zhou, D; Xia, F				Avruch, Joseph; Xavier, Ramnik; Bardeesy, Nabeel; Zhang, Xian-Feng; Praskova, Maria; Zhou, Dawang; Xia, Fan			Rassf Family of Tumor Suppressor Polypeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ORGAN SIZE CONTROL; MICROTUBULE STABILITY; BIOCHEMICAL-ANALYSIS; HIPPO PATHWAY; KINASE MST1; APOPTOSIS; PROTEIN; ACTIVATION; DOMAINS; NORE1	The Rassf1-6 polypeptides each contain a Ras/Rap association domain, which enables binding to several GTP-charged Ras-like GTPases, at least in vitro or when overexpressed. The Ras/Rap association domains are followed by SARAH domains, which mediate Rassf heterodimerization with the Mst1/2 protein kinases. Rassf1A is unequivocally a tumor suppressor, and all Rassf proteins behave like tumor suppressors, exhibiting epigenetic silencing of expression in many human cancers and proapoptotic and/or anti-proliferative effects when re-expressed in tumor cell lines. Herein, we review the binding of the Rassf polypeptides to Ras-like GTPases and the Mst1/2 kinases and their role in Rassf function.	[Avruch, Joseph; Zhang, Xian-Feng; Praskova, Maria; Zhou, Dawang; Xia, Fan] Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA 02114 USA; [Bardeesy, Nabeel] Harvard Univ, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Xavier, Ramnik] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Avruch, Joseph; Zhang, Xian-Feng; Praskova, Maria; Zhou, Dawang; Xia, Fan] Harvard Univ, Sch Med, Diabet Unit, Med Serv, Boston, MA 02114 USA; [Xavier, Ramnik] Harvard Univ, Sch Med, Gastrointestinal Unit, Med Serv, Boston, MA 02114 USA; [Avruch, Joseph; Xavier, Ramnik; Bardeesy, Nabeel; Zhang, Xian-Feng; Praskova, Maria; Zhou, Dawang; Xia, Fan] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Avruch, J (corresponding author), Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA 02114 USA.	avruch@molbio.mgh.harvard.edu	Praskova, Maria/AAA-3531-2022; zhang, xian/GYA-0290-2022	Praskova, Maria/0000-0002-8149-9039; Zhou, Dawang/0000-0002-9053-5249	National Institutes of Health [DK17776, P30 DK57521, HL088297, DK043351, T32 DK007028]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, T32DK007028, R37DK017776, R01DK017776, P30DK057521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK17776 and P30 DK57521 (to J. A.), HL088297 and DK043351 (to R. X.), and T32 DK007028 (to D. Z.). This is the second article of three in the Thematic Minireview Series on Novel Ras Effectors. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Anand R, 2008, BIOCHEMISTRY-US, V47, P6719, DOI 10.1021/bi800309m; Aoyama Y, 2004, ONCOGENE, V23, P3426, DOI 10.1038/sj.onc.1207486; Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Ikeda M, 2007, EXP CELL RES, V313, P1484, DOI 10.1016/j.yexcr.2007.02.013; Ishiguro K, 2006, CELL SIGNAL, V18, P1647, DOI 10.1016/j.cellsig.2006.01.015; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kiel C, 2005, J MOL BIOL, V348, P759, DOI 10.1016/j.jmb.2005.02.046; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kinashi T, 2007, ADV IMMUNOL, V93, P185, DOI 10.1016/S0065-2776(06)93005-3; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Miertzschke M, 2007, J BIOL CHEM, V282, P30629, DOI 10.1074/jbc.M704361200; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; TOMMASI S, 2005, CANCER RES, V65, P645; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105	40	91	95	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11001	11005		10.1074/jbc.R800073200	http://dx.doi.org/10.1074/jbc.R800073200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19091744	Green Published, hybrid			2022-12-27	WOS:000265494500003
J	Brice, SE; Alford, CW; Cowart, LA				Brice, Sarah E.; Alford, Charlene W.; Cowart, L. Ashley			Modulation of Sphingolipid Metabolism by the Phosphatidylinositol-4-phosphate Phosphatase Sac1p through Regulation of Phosphatidylinositol in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN PROTEINS SLM1; DE-NOVO; HEAT-STRESS; SERINE PALMITOYLTRANSFERASE; ACTIN CYTOSKELETON; LIPID PHOSPHATASE; FREE SPHINGOSINE; PLASMA-MEMBRANE; DISTINCT ROLES; YEAST	Sphingolipids and phosphoinositides both play signaling roles in Saccharomyces cerevisiae. Although previous data indicate independent functions for these two classes of lipids, recent genetic studies have suggested interactions between phosphatidylinositol (PtdIns) phosphate effectors and sphingolipid biosynthetic enzymes. The present study was undertaken to further define the effects of phosphatidylinositol 4-phosphate (PtdIns(4)P) metabolism on cell sphingolipid metabolism. The data presented indicate that deletion of SAC1, a gene encoding a PtdIns(4) P phosphatase, increased levels of most sphingolipid species, including sphingoid bases, sphingoid base phosphates, and phytoceramide. In contrast, sac1 Delta dramatically reduced inositol phosphosphingolipids, which result from the addition of a PtdIns-derived phosphoinositol head group to ceramides through Aur1p. Deletion of SAC1 decreased PtdIns dramatically in both steady-state and pulse labeling studies, suggesting that the observed effects on sphingolipids may result from modulation of the availability of PtdIns as a substrate for Aur1p. Supporting this hypothesis, acute attenuation of PtdIns(4) P production through Stt4p immediately increased PtdIns and subsequently reduced sphingoid bases. This reduction was overcome by the inhibition of Aur1p. Moreover, modulation of sphingoid bases through perturbation of PtdIns(4) P metabolism initiated sphingolipid-dependent biological effects, supporting the biological relevance for this route of regulating sphingolipids. These findings suggest that, in addition to potential signaling effects of PtdInsP effectors on sphingolipid metabolism, PtdIns kinases may exert substantial effects on cell sphingolipid profiles at a metabolic level through modulation of PtdIns available as a substrate for complex sphingolipid synthesis.	[Brice, Sarah E.; Alford, Charlene W.; Cowart, L. Ashley] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Cowart, L. Ashley] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Cowart, LA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	cowartl@musc.edu			Centers of Biomedical Research Excellence in lipidomics and pathobiology at the Medical University of South Carolina	Centers of Biomedical Research Excellence in lipidomics and pathobiology at the Medical University of South Carolina(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the Centers of Biomedical Research Excellence in lipidomics and pathobiology at the Medical University of South Carolina	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05; Cameroni E, 2006, J BIOL CHEM, V281, P38139, DOI 10.1074/jbc.M601060200; Cerbon J, 2005, BIOCHEM J, V388, P169, DOI 10.1042/BJ20040475; Choi JY, 2006, BIOCHEM SOC T, V34, P404, DOI 10.1042/BST0340404; Chung N, 2000, J BIOL CHEM, V275, P17229, DOI 10.1074/jbc.C000229200; Chung NJ, 2001, J BIOL CHEM, V276, P35614, DOI 10.1074/jbc.M105653200; Cowart LA, 2007, J BIOL CHEM, V282, P12330, DOI 10.1074/jbc.M700685200; Cowart LA, 2006, BIOCHEM J, V393, P733, DOI 10.1042/BJ20050643; Cutler NS, 1997, J BIOL CHEM, V272, P27671, DOI 10.1074/jbc.272.44.27671; Daquinag A, 2007, MOL CELL BIOL, V27, P633, DOI 10.1128/MCB.00461-06; Desrivieres S, 2002, BIOCHEM J, V366, P945, DOI 10.1042/BJ20020429; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Fischl AS, 2000, METHOD ENZYMOL, V311, P123; Foti M, 2001, MOL BIOL CELL, V12, P2396, DOI 10.1091/mbc.12.8.2396; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Han GS, 2002, J BIOL CHEM, V277, P47709, DOI 10.1074/jbc.M207996200; HEIDLER SA, 1995, ANTIMICROB AGENTS CH, V39, P2765, DOI 10.1128/AAC.39.12.2765; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; LESTER RL, 1993, ADV LIPID RES, V26, P253; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Mousley CJ, 2006, BIOCHEM SOC T, V34, P346, DOI 10.1042/BST0340346; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; Nagiec MM, 1998, J BIOL CHEM, V273, P19437, DOI 10.1074/jbc.273.31.19437; Obeid LA, 2002, BBA-MOL CELL BIOL L, V1585, P163, DOI 10.1016/S1388-1981(02)00337-2; PINTO WJ, 1992, J BACTERIOL, V174, P2575, DOI 10.1128/jb.174.8.2575-2581.1992; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; Routt SM, 2005, TRAFFIC, V6, P1157, DOI 10.1111/j.1600-0854.2005.00350.x; SAHEKI S, 1985, ANAL BIOCHEM, V148, P277, DOI 10.1016/0003-2697(85)90229-5; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Sims KJ, 2004, BIOCHEM CELL BIOL, V82, P45, DOI 10.1139/o03-086; SMITH ER, 1995, J BIOL CHEM, V270, P18749, DOI 10.1074/jbc.270.32.18749; SYCHROVA H, 1985, FEBS LETT, V183, P21, DOI 10.1016/0014-5793(85)80945-5; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Tahirovic S, 2005, TRAFFIC, V6, P116, DOI 10.1111/j.1600-0854.2004.00255.x; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235; WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171	48	49	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7588	7596		10.1074/jbc.M808325200	http://dx.doi.org/10.1074/jbc.M808325200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19139096	Green Published, hybrid			2022-12-27	WOS:000264195600021
J	Kawashima, N; Yoon, SJ; Itoh, K; Nakayama, K				Kawashima, Nagako; Yoon, Seon-Joo; Itoh, Kohji; Nakayama, Ken-ichi			Tyrosine Kinase Activity of Epidermal Growth Factor Receptor Is Regulated by GM3 Binding through Carbohydrate to Carbohydrate Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNAC TERMINI; CELLS; OLIGOSACCHARIDES; PHOSPHORYLATION; GANGLIOSIDE; GLYCOSYNAPSE; CDNA; GENE	Epidermal growth factor receptor (EGFR), an N-glycosylated transmembrane protein with an intracellular kinase domain, undergoes dimerization by ligand binding resulting in activation of the kinase domain and phosphorylation. Ganglioside GM3 containing sialyllactose inhibits the tyrosine kinase activity of EGFR through carbohydrate to carbohydrate interactions (CCI) between N-glycans with GlcNAc termini on EGFR and oligosaccharides on GM3. In this study, we provide further evidence for CCI between EGFR and GM3. (i) In vitro and in situ, the inhibitory effect of GM3 on EGFR tyrosine kinase was much higher in A431 cells upon exposure of the GlcNAc termini of the N-glycans to glycosidase treatment (neuraminidase and beta-galactosidase) than in untreated A431 cells. Furthermore, the GM3-mediated inhibition was abrogated by co-incubation with N-glycan containing terminal GlcNAc. (ii) In situ, inhibition of EGFR phosphorylation by GM3 was not observed in alpha-mannosidase IB (ManIB)-knocked down A431 cells that accumulate high mannose- type N-glycans. (iii) EGFR binding to GM3 was enhanced in glycosidase-treated cells that accumulated GlcNAc termini, whereas GM3 did not bind to EGFR from ManIB-knocked down cells that accumulated high mannose- type N-glycans. These results indicate that GM3-mediated inhibition of EGFR phosphorylation is caused by interaction of GM3 with GlcNAc-terminated N-glycan on EGFR.	[Kawashima, Nagako; Nakayama, Ken-ichi] Natl Inst Adv Ind Sci & Technol, Hlth Technol Res Ctr, Kagawa 7610395, Japan; [Yoon, Seon-Joo] Univ Washington, Pacific NW Res Inst, Div Biomembrane Res, Seattle, WA 98122 USA; [Yoon, Seon-Joo] Univ Washington, Dept Microbiol, Seattle, WA 98122 USA; [Kawashima, Nagako; Itoh, Kohji] Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Med Resources, Dept Med Biotechnol, Tokushima 7708505, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tokushima University	Nakayama, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Hlth Technol Res Ctr, Kagawa 7610395, Japan.	k-nakayama@aist.go.jp						BLANKEN WM, 1985, ANAL BIOCHEM, V145, P322, DOI 10.1016/0003-2697(85)90369-0; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Fernandes H, 2001, J BIOL CHEM, V276, P5375, DOI 10.1074/jbc.M005599200; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Haga Y, 2008, CARBOHYD RES, V343, P3034, DOI 10.1016/j.carres.2008.09.002; Hakomori S, 2004, GLYCOCONJUGATE J, V21, P125, DOI 10.1023/B:GLYC.0000044844.95878.cf; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hakomori S, 2004, AN ACAD BRAS CIENC, V76, P553, DOI 10.1590/S0001-37652004000300010; HERSCOVICS A, 1994, J BIOL CHEM, V269, P9864; KATO K, 2006, GLYCOCONJ J, V23, P639; Miljan EA, 2002, J BIOL CHEM, V277, P10108, DOI 10.1074/jbc.M111669200; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Sato Y, 2001, J BIOL CHEM, V276, P11956, DOI 10.1074/jbc.M008551200; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Takahashi M, 2003, GLYCOCONJUGATE J, V20, P207, DOI 10.1023/B:GLYC.0000024252.63695.5c; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang XQ, 2002, J BIOL CHEM, V277, P47028, DOI 10.1074/jbc.M208257200; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Yoon SJ, 2006, GLYCOCONJUGATE J, V23, P639, DOI 10.1007/s10719-006-9001-4; ZHOU QG, 1994, J BIOL CHEM, V269, P1959	23	86	90	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6147	6155		10.1074/jbc.M808171200	http://dx.doi.org/10.1074/jbc.M808171200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124464	hybrid			2022-12-27	WOS:000263742700017
J	Casteel, DE; Zhuang, SH; Zeng, Y; Perrino, FW; Boss, GR; Goulian, M; Pilz, RB				Casteel, Darren E.; Zhuang, Shunhui; Zeng, Ying; Perrino, Fred W.; Boss, Gerry R.; Goulian, Mehran; Pilz, Renate B.			A DNA Polymerase-alpha.Primase Cofactor with Homology to Replication Protein A-32 Regulates DNA Replication in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSORY PROTEIN; ALPHA-PRIMASE; NUCLEAR ANTIGEN; BINDING DOMAIN; OB-FOLD; S-PHASE; A RPA; DAMAGE; CHECKPOINT; MECHANISM	alpha-Accessory factor (AAF) stimulates the activity of DNA polymerase-alpha-primase, the only enzyme known to initiate DNA replication in eukaryotic cells ( Goulian, M., Heard, C. J., and Grimm, S. L. (1990) J. Biol. Chem. 265, 13221-13230). We purified the AAF heterodimer composed of 44- and 132-kDa subunits from cultured cells and identified full-length cDNA clones using amino acid sequences from internal peptides. AAF-132 demonstrated no homologies to known proteins; AAF-44, however, is evolutionarily related to the 32-kDa subunit of replication protein A (RPA-32) and contains an oligonucleotide/oligosaccharide-binding (OB) fold domain similar to the OB fold domains of RPA involved in single-stranded DNA binding. Epitope-tagged versions of AAF-44 and -132 formed a complex in intact cells, and purified recombinant AAF-44 bound to single-stranded DNA and stimulated DNA primase activity only in the presence of AAF-132. Mutations in conserved residues within the OB fold of AAF-44 reduced DNA binding activity of the AAF-44.AAF-132 complex. Immunofluorescence staining of AAF-44 and AAF-132 in S phase-enriched HeLa cells demonstrated punctate nuclear staining, and AAF co-localized with proliferating cell nuclear antigen, a marker for replication foci containing DNA polymerase-alpha.primase and RPA. Small interfering RNA-mediated depletion of AAF-44 in tumor cell lines inhibited [methyl-H-3] thymidine uptake into DNA but did not affect cell viability. Weconclude that AAF shares structural and functional similarities with RPA-32 and regulates DNA replication, consistent with its ability to increase polymerase-alpha.primase template affinity and stimulate both DNA primase and polymerase-alpha activities in vitro.	[Casteel, Darren E.; Zhuang, Shunhui; Zeng, Ying; Boss, Gerry R.; Goulian, Mehran; Pilz, Renate B.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Casteel, Darren E.; Zhuang, Shunhui; Zeng, Ying; Boss, Gerry R.; Goulian, Mehran; Pilz, Renate B.] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; [Perrino, Fred W.] Wake Forest Univ, Dept Biochem, Ctr Canc, Winston Salem, NC 27157 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Wake Forest University	Pilz, RB (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	rpilz@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	NATIONAL CANCER INSTITUTE [K22CA124517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER; NCI NIH HHS [K22-CA124517] Funding Source: Medline; NIAMS NIH HHS [R01-AR051300, R01 AR051300, R01 AR051300-10] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bochkareva E, 1998, J BIOL CHEM, V273, P3932, DOI 10.1074/jbc.273.7.3932; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Chen YC, 2003, MOL CELL BIOL, V23, P4066, DOI 10.1128/MCB.23.12.4066-4082.2003; Crouch E, 1997, MUTAT RES-FUND MOL M, V374, P109, DOI 10.1016/S0027-5107(96)00231-X; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Dimitrova DS, 2000, EXP CELL RES, V254, P321, DOI 10.1006/excr.1999.4770; Dodson GE, 2004, J BIOL CHEM, V279, P34010, DOI 10.1074/jbc.C400242200; Fanning Ellen, 2006, V47, P627; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Feng DF, 1996, METHOD ENZYMOL, V266, P368; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; GOULIAN M, 1990, J BIOL CHEM, V265, P13231; GOULIAN M, 1990, J BIOL CHEM, V265, P13221; GOULIAN M, 1989, J BIOL CHEM, V264, P19407; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; Maga G, 2001, J BIOL CHEM, V276, P18235, DOI 10.1074/jbc.M009599200; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; PERRINO FW, 1992, J BIOL CHEM, V267, P23043; PERRINO FW, 1989, J BIOL CHEM, V264, P2898; Philimonenko AA, 2000, J STRUCT BIOL, V132, P201, DOI 10.1006/jsbi.2000.4326; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Zeng Y, 2006, J BIOL CHEM, V281, P16951, DOI 10.1074/jbc.M602099200; Zhang T, 2007, J BIOL CHEM, V282, P33367, DOI 10.1074/jbc.M707186200; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	43	120	123	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5807	5818		10.1074/jbc.M807593200	http://dx.doi.org/10.1074/jbc.M807593200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19119139	Green Published, hybrid			2022-12-27	WOS:000263560600044
J	de Zoeten, EF; Lee, I; Wang, LQ; Chen, CX; Ge, GH; Wells, AD; Hancock, WW; Ozkaynak, E				de Zoeten, Edwin F.; Lee, Iris; Wang, Liqing; Chen, Chunxia; Ge, Guanghui; Wells, Andrew D.; Hancock, Wayne W.; Ozkaynak, Engin			Foxp3 Processing by Proprotein Convertases and Control of Regulatory T Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER CHROMATIN; IMMUNE DYSREGULATION; CUTTING EDGE; HELPER-CELLS; ENTEROPATHY; PROTEIN; POLYENDOCRINOPATHY; EXPRESSION; RECEPTOR; IPEX	Foxp3 is a 47-kDa transcription factor central to regulatory Tcell (Treg) function. The importance of Foxp3(+) Tregs in controlling self-reactive T cells and preventing autoimmunity is well established. Our analysis of Foxp3 expression in natural Tregs led to identification of a shorter 41-kDa Foxp3 species in activated Tregs, indicating that Foxp3 may be processed by proteolytic cleavage upon cell activation. Searches of murine and human Foxp3 sequences for potential cleavage sites responsible for the generation of the short Foxp3 species revealed the presence of two RXXR proprotein convertase (PC) motifs, (RDLR51)-R-48 and (RKKR417)-R-414, located near the N- and C-terminal ends, respectively. We show, using retroviral expression of Foxp3 in CD4(+) T cells, that Foxp3 is cleaved at both the N- and C-terminal RXXR sites and that mutagenesis of the RXXR motif prevents cleavage. The cleaved forms of Foxp3 are found in the chromatin fraction but not in nuclear or cytoplasmic extracts. CD4(+) T cells expressing Foxp3 species engineered to mimic N- terminally, C-terminally, or N- and C-terminally cleaved Foxp3 forms are functionally distinct, as indicated by differences in expression of key Treg genes, such as interleukin-10 and cytotoxic T-lymphocyte antigen 4 (CTLA-4). In addition, CD4(+) cells expressing C-cleaved Foxp3 are superior to those that express WT Foxp3 in preventing experimental colitis. Coexpression of Foxp3 with PC1 or PC7 results in cleavage of the Foxp3 C terminus. The mechanism by which Foxp3 is processed likely extends to other members of the FoxP subfamily, because Foxp1 and Foxp2 also have N-terminal RXXR proteolytic cleavage motifs at similar locations to Foxp3. Our results indicate that the generation of fully functionally competent Tregs is complex and dependent on the generation of multiple forms of Foxp3 that have differing effects on Treg cytokine production and suppressive function.	[Lee, Iris; Wang, Liqing; Chen, Chunxia; Ge, Guanghui; Wells, Andrew D.; Hancock, Wayne W.; Ozkaynak, Engin] Childrens Hosp Philadelphia, Div Transplant Immunol, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [de Zoeten, Edwin F.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Lee, Iris; Wang, Liqing; Chen, Chunxia; Ge, Guanghui; Wells, Andrew D.; Hancock, Wayne W.; Ozkaynak, Engin] Childrens Hosp Philadelphia, Biesecker Ctr Pediat Liver Dis, Philadelphia, PA 19104 USA; [Lee, Iris; Wang, Liqing; Chen, Chunxia; Ge, Guanghui; Wells, Andrew D.; Hancock, Wayne W.; Ozkaynak, Engin] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Ozkaynak, E (corresponding author), Childrens Hosp Philadelphia, Div Transplantat Immunol Pathol & Lab Med, 916C ARC,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	ozkaynak@email.chop.edu		de Zoeten, Edwin/0000-0002-0946-9759	National Institutes of Health [AI54720]; Foerderer-Murray Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foerderer-Murray Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI54720 (to W.W.H.). This work was also supported by a Foerderer-Murray Award (to E.O.).	Allan SE, 2008, MOL THER, V16, P194, DOI 10.1038/sj.mt.6300341; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; GARRARD WT, 1974, BIOCHEM BIOPH RES CO, V58, P50, DOI 10.1016/0006-291X(74)90889-4; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Ostanin DV, 2006, AM J PHYSIOL-GASTR L, V290, pG109, DOI 10.1152/ajpgi.00214.2005; OZKAYNAK E, 1992, J BIOL CHEM, V267, P25220; PANYIM S, 1969, ARCH BIOCHEM BIOPHYS, V130, P337, DOI 10.1016/0003-9861(69)90042-3; PESU M, 2008, J NATURE, V455, P246; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; RUSSEV G, 1974, EUR J BIOCHEM, V43, P253, DOI 10.1111/j.1432-1033.1974.tb03407.x; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Stassen M, 2004, EUR J IMMUNOL, V34, P1303, DOI 10.1002/eji.200324656; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; VONDERDECKEN A, 1977, J NUTR, V107, P949, DOI 10.1093/jn/107.6.949; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; YI Z, 1993, J BIOL CHEM, V268, P5615; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	44	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5709	5716		10.1074/jbc.M807322200	http://dx.doi.org/10.1074/jbc.M807322200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117830	hybrid, Green Published			2022-12-27	WOS:000263560600034
J	Jenkinson, ER; Costa, A; Leech, AP; Patwardhan, A; Onesti, S; Chong, JPJ				Jenkinson, Elizabeth R.; Costa, Alessandro; Leech, Andrew P.; Patwardhan, Ardan; Onesti, Silvia; Chong, James P. J.			Mutations in Subdomain B of the Minichromosome Maintenance (MCM) Helicase Affect DNA Binding and Modulate Conformational Transitions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOTHERMOBACTER-THERMAUTOTROPHICUS MCM; METHANOBACTERIUM-THERMOAUTOTROPHICUM MCM; SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEX; REPLICATION; POLYMORPHISM; MICROSCOPY; INITIATION; SYMMETRY; MOTIFS	Minichromosome maintenance (MCM) proteins are believed to provide the replicative helicase activity in eukaryotes and archaea. The single MCM orthologue from Methanothermobacter thermautotrophicus (MthMCM) has been extensively characterized as a model of the eukaryotic heterohexameric MCM complex. MthMCM forms high molecular weight complexes in solution consistent with a dodecamer. Visualization of this complex by electron microscopy suggests that single and double heptameric or hexameric rings can form. We have mutated two arginine residues (Arg-137, Arg-160) in the N-terminal subdomain B of MthMCM based on their apparent potential to form inter-ring hydrogen bonds. Both the single R137A and the double R137A, R160A mutants were characterized by a combination of biophysical, biochemical, and electron microscopy techniques. Biophysical analysis coupled with electron microscopy studies shows that the R137A mutant forms a double heptameric ring, whereas the R137A, R160A protein assembles as a single heptamer. They both show a defect in DNA binding and a concomitant conformational change in subdomain A, with the double mutant displaying significant defects in helicase activity as well. We propose a model in which MCM loading and the subsequent activation of the helicase activity involve a conformational transition that is connected to a DNA binding event.	[Jenkinson, Elizabeth R.; Chong, James P. J.] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Leech, Andrew P.] Univ York, Technol Facil, York YO10 5YW, N Yorkshire, England; [Costa, Alessandro; Patwardhan, Ardan; Onesti, Silvia] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Onesti, Silvia] Sincrotrone Trieste, Elettra Synchrotron Light Lab, I-34012 Basovizza, TS, Italy	University of York - UK; University of York - UK; Imperial College London; Elettra Sincrotrone Trieste	Chong, JPJ (corresponding author), Univ York, Dept Biol, Area 5, POB 373, York YO10 5YW, N Yorkshire, England.	jpjc1@york.ac.uk	Chong, James/AAC-4957-2019	Onesti, Silvia/0000-0002-0612-7948; Jenkinson, Elizabeth/0000-0002-1826-7200; Patwardhan, Ardan/0000-0001-7663-9028; Chong, James/0000-0001-9447-7421	Biotechnology and Biological Sciences Research Council David Phillips Research Fellowship [86/AF/14817, BB/X510703/1]; University of York Innovation and Research Priming Funds; BBSRC [BB/F003099/1, BB/D525056/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F003099/1, BB/D525056/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council David Phillips Research Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of York Innovation and Research Priming Funds; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council David Phillips Research Fellowship (Refs 86/AF/14817 and BB/X510703/1) and University of York Innovation and Research Priming Funds ( to J.P.J.C.) and an Imperial College studentship ( to A. C.).	Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Carpentieri F, 2002, J BIOL CHEM, V277, P12118, DOI 10.1074/jbc.M200091200; Castella S, 2006, NUCLEIC ACIDS RES, V34, P3731, DOI 10.1093/nar/gkl554; Chen YJ, 2005, J MOL BIOL, V346, P389, DOI 10.1016/j.jmb.2004.11.076; Chong JPJ, 2005, NAT STRUCT MOL BIOL, V12, P734, DOI 10.1038/nsmb0905-734; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2008, EMBO J, V27, P2250, DOI 10.1038/emboj.2008.135; Costa A, 2008, J MOL BIOL, V378, P273, DOI 10.1016/j.jmb.2008.02.054; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Costa A, 2006, NUCLEIC ACIDS RES, V34, P5829, DOI 10.1093/nar/gkl708; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Edgell DR, 1997, CELL, V89, P995, DOI 10.1016/S0092-8674(00)80285-8; Fletcher RJ, 2005, J BIOL CHEM, V280, P42405, DOI 10.1074/jbc.M509773200; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gomez-Llorente Y, 2005, J BIOL CHEM, V280, P40909, DOI 10.1074/jbc.M509760200; Grainge I, 2003, NUCLEIC ACIDS RES, V31, P4888, DOI 10.1093/nar/gkg662; Hoang ML, 2007, MOL CELL BIOL, V27, P7594, DOI 10.1128/MCB.00997-07; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Jenkinson ER, 2006, P NATL ACAD SCI USA, V103, P7613, DOI 10.1073/pnas.0509297103; Kasiviswanathan R, 2004, J BIOL CHEM, V279, P28358, DOI 10.1074/jbc.M403202200; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; LI M, 1993, TRANSCRIPTION FACTOR, P181; LISZIEWICZ J, 1988, NUCLEIC ACIDS RES, V16, P11507, DOI 10.1093/nar/16.24.11507; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; ROARK DE, 1976, BIOPHYS CHEM, V5, P185, DOI 10.1016/0301-4622(76)80034-8; Sakakibara N, 2008, NUCLEIC ACIDS RES, V36, P1309, DOI 10.1093/nar/gkm1160; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Shin JH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni009; SHIN JH, J BIOL CHEM, V284, P540; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tye BK, 2000, P NATL ACAD SCI USA, V97, P2399, DOI 10.1073/pnas.97.6.2399; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Yu X, 2002, EMBO REP, V3, P792, DOI 10.1093/embo-reports/kvf160	41	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5654	5661		10.1074/jbc.M806973200	http://dx.doi.org/10.1074/jbc.M806973200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19116205	hybrid, Green Accepted			2022-12-27	WOS:000263560600029
J	Itahana, Y; Ke, HM; Zhang, YP				Itahana, Yoko; Ke, Hengming; Zhang, Yanping			p53 Oligomerization Is Essential for Its C-terminal Lysine Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; TETRAMERIZATION DOMAIN; DNA-BINDING; TUMOR-SUPPRESSOR; LI-FRAUMENI; IN-VITRO; PROTEIN; ACTIVATION; PHOSPHORYLATION; DEGRADATION	Acetylation of multiple lysine residues in the p53 plays critical roles in the protein stability and transcriptional activity of p53. To better understand how p53 acetylation is regulated, we generated a number of p53 mutants and examined acetylation of each mutant in transfected cells. We found that p53 mutants that are defective in tetramer formation are also defective in C-terminal lysine residue acetylation. Consistently, we found that several cancer-derived p53 mutants that bear mutations in the tetramerization domain cannot form oligomers and are defective in C-terminal lysine acetylation, and these mutants are inactive in p21 transactivation. We demonstrated that the acetyltransferase p300 interacts with and promotes acetylation of wild-type p53 but not with any of the artificially generated or human cancer-derived p53 mutants that are defective in oligomerization. These results, combined with a computer-aided crystal structure analysis, suggest a model in which p53 oligomerization precedes its acetylation by providing docking sites for acetyltransferases.	[Zhang, Yanping] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Itahana, Yoko; Ke, Hengming; Zhang, Yanping] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Zhang, Yanping] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Ke, Hengming] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zhang, YP (corresponding author), Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA.	ypzhang@med.unc.edu	, PEP-MX Core/AGV-4051-2022		National Institutes of Health; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA127770, R01CA100302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health grant. This work was also supported by a grant from the American Cancer Society (to Y. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Azran I, 2005, ONCOGENE, V24, P4521, DOI 10.1038/sj.onc.1208645; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chen YH, 2007, EXP PHYSIOL, V92, P99, DOI 10.1113/expphysiol.2006.036079; CLORE GM, 1994, SCIENCE, V265, P386, DOI 10.1126/science.8023159; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu L, 1999, MOL CELL BIOL, V19, P1202; Livengood JA, 2002, J BIOL CHEM, V277, P9054, DOI 10.1074/jbc.M108870200; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mateu MG, 1999, NAT STRUCT BIOL, V6, P191; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; O'Keefe K, 2003, MOL CELL BIOL, V23, P6396, DOI 10.1128/MCB.23.18.6396-6405.2003; Olivier M, 2003, CANCER RES, V63, P6643; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Poon GMK, 2007, J MOL BIOL, V365, P1217, DOI 10.1016/j.jmb.2006.10.051; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Van Orden K, 1999, J BIOL CHEM, V274, P26321, DOI 10.1074/jbc.274.37.26321; Varley JM, 1996, ONCOGENE, V12, P2437; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wadgaonkar R, 1999, J BIOL CHEM, V274, P13760, DOI 10.1074/jbc.274.20.13760; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	38	55	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5158	5164		10.1074/jbc.M805696200	http://dx.doi.org/10.1074/jbc.M805696200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106109	Green Published, hybrid			2022-12-27	WOS:000263416600046
J	Mangialavori, I; Giraldo, AMV; Buslje, CM; Gomes, MF; Caride, AJ; Rossi, JPFC				Mangialavori, Irene; Giraldo, Ana Maria Villamil; Buslje, Cristina Marino; Gomes, Mariela Ferreira; Caride, Ariel J.; Rossi, Juan Pablo F. C.			A New Conformation in Sarcoplasmic Reticulum Calcium Pump and Plasma Membrane Ca2+ Pumps Revealed by a Photoactivatable Phospholipidic Probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; CALMODULIN; ACTIVATION; TRANSPORT; PEPTIDE; REGION; CA-2; ATP	The purpose of this work was to obtain structural information about conformational changes in the membrane region of the sarcoplasmic reticulum (SERCA) and plasma membrane (PMCA) Ca2+ pumps. We have assessed changes in the overall exposure of these proteins to surrounding lipids by quantifying the extent of protein labeling by a photoactivatable phosphatidylcholine analog 1-palmitoyl-2-[9-[2'-[I-125] iodo-4'-(trifluoromethyldiazirinyl)benzyloxycarbonyl]-nonaoyl]-sn-glycero-3-phosphocholine ([I-125] TID-PC/16) under different conditions. We determined the following. 1) Incorporation of [I-125] TID-PC/16 to SERCA decreases 25% when labeling is performed in the presence of Ca2+. This decrease in labeling matches qualitatively the decrease in transmembrane surface exposed to the solvent calculated from crystallographic data for SERCA structures. 2) Labeling of PMCA incubated with Ca2+ and calmodulin decreases by approximately the same amount. However, incubation with Ca2+ alone increases labeling by more than 50%. Addition of C28, a peptide that prevents activation of PMCAby calmodulin, yields similar results. C28 has also been shown to inhibit ATPase SERCA activity. Interestingly, incubation of SERCA with C28 also increases [I-125] TID-PC/16 incorporation to the protein. These results suggest that in both proteins there are two different E-1 conformations as follows: one that is auto-inhibited and is in contact with a higher amount of lipids (Ca2+ + C28 for SERCA and Ca2+ alone for PMCA), and one in which the enzyme is fully active (Ca2+ for SERCA and Ca2+-calmodulin for PMCA) and that exhibits a more compact transmembrane arrangement. These results are the first evidence that there is an autoinhibited conformation in these P-type ATPases, which involves both the cytoplasmic regions and the transmembrane segments.	[Mangialavori, Irene; Giraldo, Ana Maria Villamil; Buslje, Cristina Marino; Gomes, Mariela Ferreira; Rossi, Juan Pablo F. C.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Quim & Fisicoquim Biol, RA-1113 Buenos Aires, DF, Argentina; [Caride, Ariel J.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Mayo Clinic	Rossi, JPFC (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Quim & Fisicoquim Biol, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	jprossi@mail.retina.ar	Marino-Buslje, Cristina/J-7438-2019	Marino-Buslje, Cristina/0000-0002-6564-1920; Rossi, Juan Pablo/0000-0001-7087-844X; Mangialavori, Irene/0000-0003-3187-3130	Fogarty International Center [R03TW006837]; Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad de Buenos Aires Ciencia y Tecnica from Argentina; FOGARTY INTERNATIONAL CENTER [R03TW006837] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires Ciencia y Tecnica from Argentina(University of Buenos Aires); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported, in whole or in part, by a National Institutes of Health grant. This work was also supported by Fogarty International Center Grant R03TW006837 and by Agencia Nacional de Promocion Cientifica y Tecnologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Universidad de Buenos Aires Ciencia y Tecnica from Argentina. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"	ADAMO HP, 1992, J BIOL CHEM, V267, P14244; ANDERSEN JP, 1985, J BIOL CHEM, V260, P371; BALL EH, 1986, ANAL BIOCHEM, V155, P23, DOI 10.1016/0003-2697(86)90218-6; BRUNNER J, 1981, BIOCHEMISTRY-US, V20, P7174, DOI 10.1021/bi00528a019; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; ENYEDI A, 1993, J BIOL CHEM, V268, P17120; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; FILOTEO AG, 1992, J BIOL CHEM, V267, P11800; Fiske C. H., 1925, J BIOL CHEM, V179, P66; Giraldo AMM, 2006, CELL BIOCHEM BIOPHYS, V44, P431, DOI 10.1385/CBB:44:3:431; Giraldo AMV, 2006, FEBS LETT, V580, P607, DOI 10.1016/j.febslet.2005.12.078; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAURIERE M, 1993, ANAL BIOCHEM, V212, P206, DOI 10.1006/abio.1993.1313; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LUTERBACHER S, 1983, EXPERIENTIA, V39, P311, DOI 10.1007/BF01955322; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Marsh D, 1998, BBA-REV BIOMEMBRANES, V1376, P267, DOI 10.1016/S0304-4157(98)00009-4; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Penheiter AR, 2005, BIOCHEMISTRY-US, V44, P2009, DOI 10.1021/bi0488552; ROSSI JPFC, 1981, BIOCHIM BIOPHYS ACTA, V648, P145, DOI 10.1016/0005-2736(81)90029-8; SARKADI B, 1986, J BIOL CHEM, V261, P9552; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; WEBER T, 1995, J AM CHEM SOC, V117, P3084, DOI 10.1021/ja00116a013; Ye YZ, 2005, BIOINFORMATICS, V21, P2362, DOI 10.1093/bioinformatics/bti353	36	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4823	4828		10.1074/jbc.M806912200	http://dx.doi.org/10.1074/jbc.M806912200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19074772	hybrid, Green Published			2022-12-27	WOS:000263416600010
J	Voevodskaya, N; Lendzian, F; Sanganas, O; Grundmeier, A; Graslund, A; Haumann, M				Voevodskaya, Nina; Lendzian, Friedhelm; Sanganas, Oliver; Grundmeier, Alexander; Graslund, Astrid; Haumann, Michael			Redox Intermediates of the Mn-Fe Site in Subunit R2 of Chlamydia trachomatis Ribonucleotide Reductase AN X-RAY ABSORPTION AND EPR STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; PHOTOSYNTHETIC WATER-OXIDATION; BIOLOGICAL METAL CENTERS; II-MANGANESE COMPLEX; VALENCE SUM ANALYSIS; LIGAND BOND LENGTHS; ESCHERICHIA-COLI; PHOTOSYSTEM-II; PROTEIN R2; METHANE MONOOXYGENASE	The R2 protein of class I ribonucleotide reductase (RNR) from Chlamydia trachomatis (Ct) can contain a Mn-Fe instead of the standard Fe-Fe cofactor. Ct R2 has a redox-inert phenylalanine replacing the radical-forming tyrosine of classic RNRs, which implies a different mechanism of O-2 activation. We studied the Mn-Fe site by x-ray absorption spectroscopy (XAS) and EPR. Reduced R2 in the R1R2 complex (R2(red)) showed an isotropic six-line EPR signal at g similar to 2 of the Mn(II)Fe(II) state. In oxidized R2 (R2(ox)), the Mn(III)Fe(III) state exhibited EPR g values of 2.013, 2.009, and 2.015. By XAS, Mn-Fe distances and oxidation states of intermediates were determined and assigned as follows: similar to 4.15 angstrom, Mn(II)Fe(II); similar to 3.25 angstrom, Mn(III)Fe(II); similar to 2.90 angstrom, Mn(III)Fe(III); and similar to 2.75 angstrom, Mn(IV)Fe(III). Shortening of the Mn/Fe-ligand bond lengths indicated formation of additional metal bridges, i.e. mu O(H) and/or peroxidic species, upon O-2 activation at the site. The structural parameters suggest overall configurations of the Mn-Fe site similar to those of homo-metallic sites in other R2 proteins. However, the similar to 2.90 angstrom and similar to 2.75 angstrom Mn-Fe distances, typical for di-mu O(H) metal bridging, are shorter than inter-metal distances in any R2 crystal structure. In diffraction data collection, such bridges may be lost due to rapid x-ray photoreduction of high-valent metal ions, as demonstrated here for Fe(III) by XAS.	[Sanganas, Oliver; Grundmeier, Alexander; Haumann, Michael] Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany; [Voevodskaya, Nina; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Lendzian, Friedhelm] Tech Univ Berlin, Max Volmer Inst, D-10623 Berlin, Germany	Free University of Berlin; Stockholm University; Technical University of Berlin	Haumann, M (corresponding author), Free Univ Berlin, Inst Expt Phys, Arnimallee 14, D-14195 Berlin, Germany.	michael.haumann@fu-berlin.de	MIchael, Haumann/A-7087-2013		Deutsche Forschungsgemeinschaft [SFB498-C8, SFB498-C9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants SFB498-C8 (to M. H.) and SFB498-C9 (to F. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adrait A, 2002, BIOCHEMISTRY-US, V41, P6510, DOI 10.1021/bi012043d; ATTA M, 1992, J BIOL CHEM, V267, P20682; Baldwin J, 2003, BIOCHEMISTRY-US, V42, P13269, DOI 10.1021/bi035198p; Baldwin MJ, 1999, INORG CHEM, V38, P4801, DOI 10.1021/ic990346e; Barra M, 2006, BIOCHEMISTRY-US, V45, P14523, DOI 10.1021/bi061842z; Bennati M, 2005, BIOL CHEM, V386, P1007, DOI 10.1515/BC.2005.117; Boelrijk AEM, 2000, INORG CHEM, V39, P3009, DOI 10.1021/ic9911769; Brunold TC, 2007, P NATL ACAD SCI USA, V104, P20641, DOI 10.1073/pnas.0710734105; Buhrke T, 2005, J BIOL CHEM, V280, P19488, DOI 10.1074/jbc.M500601200; BUNKER G, 1987, BIOCHEMISTRY-US, V26, P4708, DOI 10.1021/bi00389a017; Cerqueira NMFSA, 2007, RECENT PAT ANTI-CANC, V2, P11; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Dau H, 2004, PHYS CHEM CHEM PHYS, V6, P4781, DOI 10.1039/b408146c; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2005, PHYS SCRIPTA, VT115, P844; Davydov RM, 1997, BIOCHEMISTRY-US, V36, P9093, DOI 10.1021/bi9700375; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; GEREZ C, 1992, BIOCHEMISTRY-US, V31, P780, DOI 10.1021/bi00118a020; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Graslund A, 1996, ANNU REV BIOPH BIOM, V25, P259; Han WG, 2006, J INORG BIOCHEM, V100, P771, DOI 10.1016/j.jinorgbio.2006.01.032; Han WG, 2005, J AM CHEM SOC, V127, P15778, DOI 10.1021/ja050904q; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Iuzzolino L, 1998, BIOCHEMISTRY-US, V37, P17112, DOI 10.1021/bi9817360; Jiang W, 2008, BIOCHEMISTRY-US, V47, P8477, DOI 10.1021/bi800881m; Jiang W, 2008, BIOCHEMISTRY-US, V47, P4477, DOI 10.1021/bi702085z; Jiang W, 2007, BIOCHEMISTRY-US, V46, P8709, DOI 10.1021/bi700906g; Jiang W, 2007, J AM CHEM SOC, V129, P7504, DOI 10.1021/ja072528a; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Joo M S, 1990, Biol Met, V3, P171, DOI 10.1007/BF01140575; Klockenkamper R., 1996, TOTAL REFLECTION XRA; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Krebs C, 2007, BIOCHEMISTRY-US, V46, P10413, DOI 10.1021/bi701060g; Lange SJ, 1998, CURR OPIN CHEM BIOL, V2, P159, DOI 10.1016/S1367-5931(98)80057-4; LARSSON A, 1986, EMBO J, V5, P2037, DOI 10.1002/j.1460-2075.1986.tb04461.x; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; Liu A, 1998, BIOCHEM BIOPH RES CO, V246, P740, DOI 10.1006/bbrc.1998.8701; LIU WT, 1993, INORG CHEM, V32, P4102, DOI 10.1021/ic00071a023; Logan DT, 1996, STRUCTURE, V4, P1053, DOI 10.1016/S0969-2126(96)00112-8; Loscher S, 2007, INORG CHEM, V46, P11094, DOI 10.1021/ic701255p; Magnuson A, 2006, J INORG BIOCHEM, V100, P1234, DOI 10.1016/j.jinorgbio.2006.02.001; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Meinke C, 2000, BIOCHEMISTRY-US, V39, P7033, DOI 10.1021/bi9924258; Mitic N, 2007, J AM CHEM SOC, V129, P9049, DOI 10.1021/ja070909i; Mooney RCL, 1931, PHYS REV, V37, P1306, DOI 10.1103/PhysRev.37.1306; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; PECORARO VL, 1992, MANGANESE REDOX ENZY, P197; Penner-Hahn JE, 1999, METAL SITES PROTEINS, P1; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Riggs-Gelasco PJ, 2004, J AM CHEM SOC, V126, P8108, DOI 10.1021/ja048255q; Roshick C, 2000, J BIOL CHEM, V275, P38111, DOI 10.1074/jbc.M006367200; Rudd DJ, 2004, INORG CHEM, V43, P4579, DOI 10.1021/ic049716b; Saleh L, 2004, BIOCHEMISTRY-US, V43, P5953, DOI 10.1021/bi036099e; Schenk G, 2001, J BIOL CHEM, V276, P19084, DOI 10.1074/jbc.M009778200; Scott R.A, 2000, PHYS METHODS BIOINOR, P465; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Sommerhalter M, 2005, INORG CHEM, V44, P770, DOI 10.1021/ic0485256; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; STESMANS A, 1989, REV SCI INSTRUM, V60, P2949, DOI 10.1063/1.1140633; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Stubbe J, 1998, TRENDS BIOCHEM SCI, V23, P438, DOI 10.1016/S0968-0004(98)01296-1; THORP HH, 1992, INORG CHEM, V31, P1585, DOI 10.1021/ic00035a012; Tong W, 1998, BIOCHEMISTRY-US, V37, P5840, DOI 10.1021/bi9728811; Torrents E, 2002, J MOL EVOL, V55, P138, DOI 10.1007/s00239-002-2311-7; Visser H, 2001, J AM CHEM SOC, V123, P7031, DOI 10.1021/ja004306h; Voevodskaya N, 2006, P NATL ACAD SCI USA, V103, P9850, DOI 10.1073/pnas.0600603103; Voevodskaya N, 2007, BBA-PROTEINS PROTEOM, V1774, P1254, DOI 10.1016/j.bbapap.2007.07.001; Voevodskaya N, 2007, FEBS LETT, V581, P3351, DOI 10.1016/j.febslet.2007.06.023; Weng TC, 2004, J AM CHEM SOC, V126, P8070, DOI 10.1021/ja0494104; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Younker JM, 2008, J AM CHEM SOC, V130, P15022, DOI 10.1021/ja804365e; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zein S, 2008, INORG CHEM, V47, P134, DOI 10.1021/ic701293n	82	23	23	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4555	4566		10.1074/jbc.M807190200	http://dx.doi.org/10.1074/jbc.M807190200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19095645	hybrid			2022-12-27	WOS:000263134400056
J	Jang, S; Ohtani, K; Fukuoh, A; Yoshizaki, T; Fukuda, M; Motomura, W; Mori, K; Fukuzawa, J; Kitamoto, N; Yoshida, I; Suzuki, Y; Wakamiya, N				Jang, SeongJae; Ohtani, Katsuki; Fukuoh, Atsushi; Yoshizaki, Takayuki; Fukuda, Mitsuko; Motomura, Wataru; Mori, Kenichiro; Fukuzawa, Jun; Kitamoto, Noritoshi; Yoshida, Itsuro; Suzuki, Yasuhiko; Wakamiya, Nobutaka			Scavenger Receptor Collectin Placenta 1 (CL-P1) Predominantly Mediates Zymosan Phagocytosis by Human Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN BINDING; NITRIC-OXIDE SYNTHASE; C-TYPE LECTIN; BETA-GLUCAN; IN-VITRO; PHOSPHOINOSITIDE 3-KINASE; EXPRESSION CLONING; CLASS-B; MACROPHAGES; DECTIN-1	Collectin placenta 1 (CL-P1), a recently discovered scavenger receptor, mediates the uptake of oxidized low density lipoprotein and microbes. In this study, we investigated CL-P1-mediated binding and ingestion of yeast-derived zymosan bioparticles using Chinese hamster ovary (CHO) cells stably expressing human CL-P1 (CHO/CL-P1) and human vascular endothelial cells constitutively expressed CL-P1. The uptake of zymosan by CHO/CL-P1 was dependent upon the level of CL-P1 expressed on the membrane and was inhibited by cytochalasin D and wortmannin. The binding of zymosan was also inhibited by ligands of other scavenger receptors such as poly(I) and dextran sulfate. Real time reverse transcription-PCR analyses showed that other scavenger receptors, namely LOX-1, Stabilin-2, or macrophage receptor with collagenous structure (MARCO), were not expressed in human umbilical vein endothelial cells isolated from different individuals. Nonopsonic zymosan ingestion was inhibited in three primary cultured vascular endothelial cells, including different human umbilical vein endothelial cells from nine individuals treated with CL-P1 small interfering RNAs, although small interfering RNAs of other scavenger receptors had no effect on zymosan uptake in these cells. Furthermore, we confirmed that CL-P1 is expressed in human and murine vascular endothelial layers. Our results demonstrated that CL-P1 predominantly mediated phagocytosis for fungi in vascular endothelia.	[Jang, SeongJae; Ohtani, Katsuki; Fukuoh, Atsushi; Yoshizaki, Takayuki; Fukuda, Mitsuko; Motomura, Wataru; Mori, Kenichiro; Fukuzawa, Jun; Yoshida, Itsuro; Wakamiya, Nobutaka] Asahikawa Med Coll, Dept Microbiol & Immunochem, Asahikawa, Hokkaido 0788510, Japan; [Kitamoto, Noritoshi] Univ Hyogo, Sch Human Sci & Environm, Dept Microbiol, Himeji, Hyogo 6700092, Japan; [Suzuki, Yasuhiko] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Global Epidemiol, Sapporo, Hokkaido 0600818, Japan	Asahikawa Medical College; University of Hyogo; Hokkaido University	Wakamiya, N (corresponding author), Asahikawa Med Coll, Dept Microbiol & Immunochem, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	wakamiya@asahikawa-med.ac.jp	Suzuki, Yasuhiko/F-6890-2012; Jang, Seongjae/AAV-5628-2021	Jang, SeongJae/0000-0001-8116-2279	Ministry of Education, Culture, Sports, Science, and Technology [16390161, 19390227]; Japan Society for the Promotion of Sciences; Japan Health Sciences Foundation [KH21011]; Fuso Pharmaceutical Industry, Co.; Fugaku Trust for Medical Research; Smoking Research Foundation; Akiyama Foundation; Hokkaido Heart Association; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Health Sciences Foundation; Fuso Pharmaceutical Industry, Co.; Fugaku Trust for Medical Research; Smoking Research Foundation; Akiyama Foundation; Hokkaido Heart Association; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-aid for Scientific Research 16390161 and 19390227, National Project "Knowledge Cluster Initiative" (2nd Stage, "Sapporo Biocluster Bio-S") from the Ministry of Education, Culture, Sports, Science, and Technology, by a grant from Core Research for Evolution Science and Technology of the Japan Society for the Promotion of Sciences, by the Japan Health Sciences Foundation KH21011, grants from Fuso Pharmaceutical Industry, Co., the Fugaku Trust for Medical Research, the Smoking Research Foundation, the Akiyama Foundation, Hokkaido Heart Association Grants for Research, and the Takeda Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ACTON SL, 1994, J BIOL CHEM, V269, P21003; Adachi H, 1997, J BIOL CHEM, V272, P31217, DOI 10.1074/jbc.272.50.31217; Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; BONDESON J, 1999, J IMMUNOL, V236, P404; BROWN EJ, 1995, BIOESSAYS, V17, P109, DOI 10.1002/bies.950170206; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Coombs PJ, 2005, J BIOL CHEM, V280, P22993, DOI 10.1074/jbc.M504197200; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Estrada A, 1997, MICROBIOL IMMUNOL, V41, P991, DOI 10.1111/j.1348-0421.1997.tb01959.x; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; GASPARI AA, 1988, J IMMUNOL, V141, P2216; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Greaves DR, 1998, CURR OPIN LIPIDOL, V9, P425, DOI 10.1097/00041433-199810000-00006; HUGHES CCW, 1990, J EXP MED, V171, P1453, DOI 10.1084/jem.171.5.1453; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; KOYAMA S, 2005, GLYCOCONJ J, V22, P281; Langeggen H, 2003, FEMS IMMUNOL MED MIC, V36, P55, DOI 10.1016/S0928-8244(03)00033-6; Leverrier Y, 2003, J BIOL CHEM, V278, P38437, DOI 10.1074/jbc.M306649200; Li XA, 2002, J BIOL CHEM, V277, P11058, DOI 10.1074/jbc.M110985200; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Suzuki H, 1997, J Atheroscler Thromb, V4, P1; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P89, DOI 10.1016/S0962-8924(00)88956-4; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Underhill DM, 2002, CURR OPIN IMMUNOL, V14, P103, DOI 10.1016/S0952-7915(01)00304-1; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; WAGNER CR, 1985, HUM IMMUNOL, V13, P33, DOI 10.1016/0198-8859(85)90025-4; WARRENS AN, 1994, INT IMMUNOL, V6, P847, DOI 10.1093/intimm/6.6.847; Yoshida T, 2003, J BIOCHEM, V133, P271, DOI 10.1093/jb/mvg037; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Yun CH, 2003, FEMS IMMUNOL MED MIC, V35, P67, DOI 10.1016/S0928-8244(02)00460-1	38	48	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3956	3965		10.1074/jbc.M807477200	http://dx.doi.org/10.1074/jbc.M807477200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073604	Green Submitted, hybrid			2022-12-27	WOS:000262872500064
J	Hurtado-Guerrero, R; Schuttelkopf, AW; Mouyna, I; Ibrahim, AFM; Shepherd, S; Fontaine, T; Latge, JP; van Aalten, DMF				Hurtado-Guerrero, Ramon; Schuettelkopf, Alexander W.; Mouyna, Isabelle; Ibrahim, Adel F. M.; Shepherd, Sharon; Fontaine, Thierry; Latge, Jean-Paul; van Aalten, Daan M. F.			Molecular Mechanisms of Yeast Cell Wall Glucan Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; PH-REGULATED GENE; SACCHAROMYCES-CEREVISIAE; XYLOGLUCAN ENDOTRANSGLYCOSYLASE; ASPERGILLUS-FUMIGATUS; CANDIDA-ALBICANS; OLIVE POLLEN; FUNGAL CELL; SCHIZOSACCHAROMYCES-POMBE; PROTEIN STRUCTURES	Yeast cell wall remodeling is controlled by the equilibrium between glycoside hydrolases, glycosyltransferases, and transglycosylases. Family 72 glycoside hydrolases (GH72) are ubiquitous in fungal organisms and are known to possess significant transglycosylase activity, producing elongated beta(1-3) glucan chains. However, the molecular mechanisms that control the balance between hydrolysis and transglycosylation in these enzymes are not understood. Here we present the first crystal structure of a glucan transglycosylase, Saccharomyces cerevisiae Gas2 (ScGas2), revealing a multidomain fold, with a (beta alpha)(8) catalytic core and a separate glucan binding domain with an elongated, conserved glucan binding groove. Structures of ScGas2 complexes with different beta-glucan substrate/product oligosaccharides provide "snapshots" of substrate binding and hydrolysis/transglycosylation giving the first insights into the mechanisms these enzymes employ to drive beta(1-3) glucan elongation. Together with mutagenesis and analysis of reaction products, the structures suggest a "base occlusion" mechanism through which these enzymes protect the covalent protein-enzyme intermediate from a water nucleophile, thus controlling the balance between hydrolysis and transglycosylation and driving the elongation of beta(1-3) glucan chains in the yeast cell wall.	[Hurtado-Guerrero, Ramon; Schuettelkopf, Alexander W.; Shepherd, Sharon; van Aalten, Daan M. F.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Ibrahim, Adel F. M.] Univ Dundee, Coll Life Sci, Div Signal Transduct Therapy, CLS DNA Manipulat Team, Dundee DD1 5EH, Scotland; [Mouyna, Isabelle; Fontaine, Thierry; Latge, Jean-Paul] Inst Pasteur, Unite Aspergillus, F-75724 Paris, France	University of Dundee; University of Dundee; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Hurtado-Guerrero, R (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland.	R.Hurtadoguerrero@dundee.ac.uk; dmfvanaalten@dundee.ac.uk	Ibrahim, Adel FM/E-5273-2012; Fontaine, Thierry/F-8227-2011; mouyna, isabelle/F-3578-2011; Latge, Jean Paul/C-9846-2014; Mouyna, Isabelle/O-7697-2018; Fontaine, thierry/Q-2201-2018	Mouyna, Isabelle/0000-0003-3140-5927; Fontaine, thierry/0000-0002-8184-789X; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; van Aalten, Daan/0000-0002-1499-6908	Wellcome Trust senior research fellowship; European Union FP6 STREP Fungwall Programme	Wellcome Trust senior research fellowship(Wellcome Trust); European Union FP6 STREP Fungwall Programme(European Commission)	This work was supported by a Wellcome Trust senior research fellowship ( to D. M. F. v. A.) and European Union FP6 STREP Fungwall Programme. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. The atomic coordinates and structure factors ( codes 2W61, 2W62, and 2W63) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ ( http:// www. rcsb. org/).	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Andersen OA, 2008, CHEM BIOL, V15, P295, DOI 10.1016/j.chembiol.2008.02.015; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barral P, 2005, BIOCHEM J, V390, P77, DOI 10.1042/BJ20050456; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Coutinho PM, 1999, ROY SOC CH, P3; de Medina-Redondo M, 2008, MOL MICROBIOL, V68, P1283, DOI 10.1111/j.1365-2958.2008.06233.x; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleet G.H., 1991, YEASTS, VVol. 4, P199, DOI [10.1002/jobm.19720120411, DOI 10.1002/JOBM.19720120411]; Fontaine T, 2000, J BIOL CHEM, V275, P41528; Fontaine T, 2000, J BIOL CHEM, V275, P27594; GHANNOUM MA, 1995, INFECT IMMUN, V63, P4528, DOI 10.1128/IAI.63.11.4528-4530.1995; Hartland RP, 1996, J BIOL CHEM, V271, P26843, DOI 10.1074/jbc.271.43.26843; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hurtado-Guerrero R, 2007, CHEM BIOL, V14, P589, DOI 10.1016/j.chembiol.2007.03.015; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; Kauffman CA, 2008, SEMIN RESP CRIT CARE, V29, P211, DOI 10.1055/s-2008-1063859; Kitagaki H, 2002, MOL MICROBIOL, V46, P1011, DOI 10.1046/j.1365-2958.2002.03244.x; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Mouyna I, 2000, BIOCHEM J, V347, P741, DOI 10.1042/0264-6021:3470741; Muhlschlegel FA, 1997, MOL CELL BIOL, V17, P5960; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape D, 2004, ORTHOP CLIN N AM, V35, P293, DOI 10.1016/j.ocl.2004.04.001; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; POPOLO L, 1993, J BACTERIOL, V175, P1879, DOI 10.1128/JB.175.7.1879-1885.1993; Popolo L, 2008, J BIOL CHEM, V283, P18553, DOI 10.1074/jbc.M801562200; Ragni E, 2007, YEAST, V24, P297, DOI 10.1002/yea.1473; Ragni E, 2007, EUKARYOT CELL, V6, P302, DOI 10.1128/EC.00321-06; Ram AFJ, 1998, J BACTERIOL, V180, P1418, DOI 10.1128/JB.180.6.1418-1424.1998; Rodriguez R, 2007, J INVEST ALLERG CLIN, V17, P4; Rodriguez-Pena JM, 2000, MOL CELL BIOL, V20, P3245, DOI 10.1128/MCB.20.9.3245-3255.2000; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; SAPORITOIRWIN SM, 1995, MOL CELL BIOL, V15, P601; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Sulova Z, 1998, BIOCHEM J, V330, P1475, DOI 10.1042/bj3301475; Sulova Z, 2001, PLANT PHYSIOL BIOCH, V39, P927, DOI 10.1016/S0981-9428(01)01313-4; Tougan T, 2002, GENES CELLS, V7, P217, DOI 10.1046/j.1356-9597.2001.00511.x; Trevino MA, 2008, PROTEIN SCI, V17, P371, DOI 10.1110/ps.073230008; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0	51	61	63	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8461	8469		10.1074/jbc.M807990200	http://dx.doi.org/10.1074/jbc.M807990200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19097997	Green Published, hybrid			2022-12-27	WOS:000264397800030
J	Chen, CS; Nelson, CM; Khauv, D; Bennett, S; Radisky, ES; Hirai, Y; Bissell, MJ; Radisky, DC				Chen, Connie S.; Nelson, Celeste M.; Khauv, Davitte; Bennett, Simone; Radisky, Evette S.; Hirai, Yohei; Bissell, Mina J.; Radisky, Derek C.			Homology with Vesicle Fusion Mediator Syntaxin-1a Predicts Determinants of Epimorphin/Syntaxin-2 Function in Mammary Epithelial Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-BETA; ENRICHED INHIBITORY PROTEIN; C/EBP-BETA; EPIMORPHIN EXPRESSION; MESSENGER-RNA; SNARE COMPLEX; TRANSCRIPTIONAL ACTIVATOR; BRANCHING MORPHOGENESIS; 3-DIMENSIONAL STRUCTURE; UBIQUITINATED-CARGO	We have shown that branching morphogenesis of mammary ductal structures requires the action of the morphogen epimorphin/syntaxin-2. Epimorphin, originally identified as an extracellular molecule, is identical to syntaxin-2, an intracellular molecule that is a member of the extensively investigated syntaxin family of proteins that mediate vesicle trafficking. We show here that, although epimorphin/syntaxin-2 is highly homologous to syntaxin-1a, only epimorphin/syntaxin-2 can stimulate mammary branching morphogenesis. We construct a homology model of epimorphin/syntaxin-2 based on the published structure of syntaxin-1a, and we use this model to identify the structural motif responsible for the morphogenic activity. We identify four residues located within the cleft between helices B and C that differ between syntaxin-1a and epimorphin/syntaxin-2; through site-directed mutagenesis of these four amino acids, we confer the properties of epimorphin for cell adhesion, gene activation, and branching morphogenesis onto the inactive syntaxin-1a template. These results provide a dramatic demonstration of the use of structural information about one molecule to define a functional motif of a second molecule that is related at the sequence level but highly divergent functionally.	[Chen, Connie S.; Bennett, Simone; Bissell, Mina J.; Radisky, Derek C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Nelson, Celeste M.] Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA; [Khauv, Davitte; Radisky, Evette S.; Radisky, Derek C.] Mayo Clin, Ctr Canc, Jacksonville, FL 32224 USA; [Hirai, Yohei] Kyoto Univ, Inst Frontier Med Sci, Dept Morphoregulat, Sakyo Ku, Kyoto 6068507, Japan	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Princeton University; Mayo Clinic; Kyoto University	Bissell, MJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd,MS 977, Berkeley, CA 94720 USA.	mjbissell@lbl.gov; radisky.derek@mayo.edu	Nelson, Celeste/AAT-7612-2021; Radisky, Evette S/C-8526-2012; Radisky, Derek/B-6569-2018	Nelson, Celeste/0000-0001-9973-8870; Radisky, Evette S/0000-0003-3121-109X; Radisky, Derek/0000-0002-1962-8784	NATIONAL CANCER INSTITUTE [R21CA128660, R01CA122086, R01CA057621, R37CA064786, R01CA064786] Funding Source: NIH RePORTER; NCI NIH HHS [CA128660, CA57621, CA122086, CA64786] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akiyama M, 1999, BRIT J DERMATOL, V141, P447; Akutsu M, 2005, FEBS LETT, V579, P5385, DOI 10.1016/j.febslet.2005.08.076; Antonin W, 2002, J BIOL CHEM, V277, P36449, DOI 10.1074/jbc.M204369200; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Bascom JL, 2005, CANCER RES, V65, P8617, DOI 10.1158/0008-5472.CAN-05-1985; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Dearth LR, 2001, J CELL BIOCHEM, V82, P357, DOI 10.1002/jcb.1167; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fritsch C, 2002, J CLIN INVEST, V110, P1629, DOI 10.1172/200213588; Gilbert KA, 2004, AM J PHYSIOL-LUNG C, V286, pL1179, DOI 10.1152/ajplung.00188.2003; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; GUMBINER BM, 1992, CELL, V69, P385, DOI 10.1016/0092-8674(92)90440-N; Haga A, 2000, BBA-PROTEIN STRUCT M, V1480, P235, DOI 10.1016/S0167-4838(00)00075-3; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; HIRAI Y, 1992, CELL, V69, P471, DOI 10.1016/0092-8674(92)90448-L; Hirai Y, 2001, J CELL BIOL, V153, P785, DOI 10.1083/jcb.153.4.785; Hirai Y, 1998, J CELL BIOL, V140, P159, DOI 10.1083/jcb.140.1.159; Hirai Y, 2007, J CELL SCI, V120, P2032, DOI 10.1242/jcs.006247; Horikoshi S, 2001, EXP NEPHROL, V9, P412; Lehnert L, 2001, J CELL BIOL, V152, P911, DOI 10.1083/jcb.152.5.911; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Matsuzaki T, 2005, HISTOCHEM CELL BIOL, V123, P501, DOI 10.1007/s00418-005-0753-x; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; Mattera R, 2004, J BIOL CHEM, V279, P31409, DOI 10.1074/jbc.M402183200; Milde-Langosch K, 2003, BREAST CANCER RES TR, V79, P175, DOI 10.1023/A:1023929504884; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Miura K, 2003, BIOCHEM BIOPH RES CO, V311, P415, DOI 10.1016/j.bbrc.2003.09.225; OKA Y, 2006, DEV BIOL; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; PELHAM HRB, 1993, CELL, V73, P425, DOI 10.1016/0092-8674(93)90128-D; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Prudovsky I, 2003, J CELL SCI, V116, P4871, DOI 10.1242/jcs.00872; Radisky DC, 2003, TRENDS CELL BIOL, V13, P426, DOI 10.1016/S0962-8924(03)00146-6; Redfern OC, 2008, CURR OPIN STRUC BIOL, V18, P394, DOI 10.1016/j.sbi.2008.05.007; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Segawa D, 2005, J GASTROEN HEPATOL, V20, P1769, DOI 10.1111/j.1440-1746.2005.03944.x; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Shirasaka T, 2003, J GASTROEN HEPATOL, V18, P570, DOI 10.1046/j.1440-1746.2003.02972.x; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Simian M, 2001, DEVELOPMENT, V128, P3117; Song J, 2000, J CLIN INVEST, V106, P1209, DOI 10.1172/JCI10411; SPRING J, 1993, TRENDS BIOCHEM SCI, V18, P124, DOI 10.1016/0968-0004(93)90018-I; Suer S, 2003, P NATL ACAD SCI USA, V100, P4451, DOI 10.1073/pnas.0831133100; Sun YJ, 1999, P NATL ACAD SCI USA, V96, P5412, DOI 10.1073/pnas.96.10.5412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takebe K, 2003, FASEB J, V17, P2037, DOI 10.1096/fj.03-0386com; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Terasaki Y, 2000, AM J RESP CELL MOL, V23, P168, DOI 10.1165/ajrcmb.23.2.3973; Terasaki Y, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-6; TSUBURA A, 1991, HISTOPATHOLOGY, V18, P517, DOI 10.1111/j.1365-2559.1991.tb01478.x; Tulachan SS, 2006, DEV GROWTH DIFFER, V48, P65, DOI 10.1111/j.1440-169x.2006.00846.x; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Wang Y, 2006, J CLIN INVEST, V116, P1535, DOI 10.1172/JCI25442; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Zahnow CA, 2001, CANCER RES, V61, P261; Zhai P, 2003, BIOCHEMISTRY-US, V42, P13901, DOI 10.1021/bi035392b	67	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6877	6884		10.1074/jbc.M805908200	http://dx.doi.org/10.1074/jbc.M805908200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129200	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000263919000035
J	Race, PR; Bentley, ML; Melvin, JA; Crow, A; Hughes, RK; Smith, WD; Sessions, RB; Kehoe, MA; McCafferty, DG; Banfield, MJ				Race, Paul R.; Bentley, Matthew L.; Melvin, Jeff A.; Crow, Allister; Hughes, Richard K.; Smith, Wendy D.; Sessions, Richard B.; Kehoe, Michael A.; McCafferty, Dewey G.; Banfield, Mark J.			Crystal Structure of Streptococcus pyogenes Sortase A IMPLICATIONS FOR SORTASE MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; SORTING SIGNAL BINDING; IMIDAZOLIUM ION-PAIR; SURFACE-PROTEINS; CELL-WALL; SUBSTRATE-SPECIFICITY; KINETIC MECHANISM; A TRANSPEPTIDASE; ANCHOR STRUCTURE; SRTA GENE	Sortases are a family of Gram-positive bacterial transpeptidases that anchor secreted proteins to bacterial cell surfaces. These include many proteins that play critical roles in the virulence of Gram-positive bacterial pathogens such that sortases are attractive targets for development of novel antimicrobial agents. All Gram-positive pathogens express a "housekeeping" sortase that recognizes the majority of secreted proteins containing an LPXTG wall-sorting motif and covalently attaches these to bacterial cell wall peptidoglycan. Many Gram-positive pathogens also express additional sortases that link a small number of proteins, often with variant wall-sorting motifs, to either other surface proteins or peptidoglycan. To better understand the mechanisms of catalysis and substrate recognition by the housekeeping sortase produced by the important human pathogen Streptococcus pyogenes, the crystal structure of this protein has been solved and its transpeptidase activity established in vitro. The structure reveals a novel arrangement of key catalytic residues in the active site of a sortase, the first that is consistent with kinetic analysis. The structure also provides a complete description of residue positions surrounding the active site, overcoming the limitation of localized disorder in previous structures of sortase A-type proteins. Modification of the active site Cys through oxidation to its sulfenic acid form or by an alkylating reagent supports a role for a reactive thiol/thiolate in the catalytic mechanism. These new insights into sortase structure and function could have important consequences for inhibitor design.	[Crow, Allister; Hughes, Richard K.; Banfield, Mark J.] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Race, Paul R.; Smith, Wendy D.; Kehoe, Michael A.; Banfield, Mark J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bentley, Matthew L.; Melvin, Jeff A.; McCafferty, Dewey G.] Duke Univ, Dept Chem, Durham, NC 27708 USA; [Sessions, Richard B.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Newcastle University - UK; Duke University; University of Bristol	Banfield, MJ (corresponding author), John Innes Ctr Plant Sci Res, Dept Biol Chem, Colney Lne, Norwich NR4 7UH, Norfolk, England.	mark.banfield@bbsrc.ac.uk	Crow, Allister/F-2147-2018; Banfield, Mark/C-7453-2013; Hughes, Richard/E-9642-2015	Crow, Allister/0000-0001-6856-5962; Banfield, Mark/0000-0001-8921-3835; Hughes, Richard/0000-0001-9910-6566; Melvin, Jeffrey/0000-0003-2864-365X; Sessions, Richard/0000-0003-0320-0895	BBSRC [BBS/E/J/000C0624] Funding Source: UKRI; MRC [G0400849] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0624] Funding Source: Medline; Medical Research Council [G0400849, g0400849] Funding Source: Medline; NCRR NIH HHS [P41 RR006009] Funding Source: Medline; NIAID NIH HHS [AI46611, R01 AI046611] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046611] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnett TC, 2002, J BACTERIOL, V184, P2181, DOI 10.1128/JB.184.8.2181-2191.2002; Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Bolken TC, 2001, INFECT IMMUN, V69, P75, DOI 10.1128/IAI.69.1.75-80.2001; Clow F, 2008, BIOTECHNOL LETT, V30, P1603, DOI 10.1007/s10529-008-9718-1; Connolly KM, 2003, J BIOL CHEM, V278, P34061, DOI 10.1074/jbc.M305245200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; Garandeau C, 2002, INFECT IMMUN, V70, P1382, DOI 10.1128/IAI.70.3.1382-1390.2002; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Jonsson IM, 2002, J INFECT DIS, V185, P1417, DOI 10.1086/340503; Jonsson IM, 2003, MICROBES INFECT, V5, P775, DOI 10.1016/S1286-4579(03)00143-6; Kharat AS, 2003, INFECT IMMUN, V71, P2758, DOI 10.1128/IAI.71.5.2758-2765.2003; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Kruger RG, 2004, ANAL BIOCHEM, V326, P42, DOI 10.1016/j.ab.2003.10.023; Lee SF, 2003, INFECT IMMUN, V71, P676, DOI 10.1128/IAI.71.2.676-681.2003; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lewin A, 2006, J BIOL CHEM, V281, P35467, DOI 10.1074/jbc.M607047200; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; Mao HY, 2004, PROTEIN EXPRES PURIF, V37, P253, DOI 10.1016/j.pep.2004.06.013; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Marraffini LA, 2004, J BIOL CHEM, V279, P37763, DOI 10.1074/jbc.M405282200; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; SMITH WD, 2004, THESIS NEWCASTLE U N; Suree N, 2007, MINI-REV MED CHEM, V7, P991, DOI 10.2174/138955707782110097; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Ton-That H, 1999, J BIOL CHEM, V274, P24316, DOI 10.1074/jbc.274.34.24316; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; TonThat H, 1997, J BIOL CHEM, V272, P22285, DOI 10.1074/jbc.272.35.22285; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	59	106	114	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6924	6933		10.1074/jbc.M805406200	http://dx.doi.org/10.1074/jbc.M805406200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129180	Green Published, hybrid			2022-12-27	WOS:000263919000040
J	Sigal, N; Fluman, N; Siemion, S; Bibi, E				Sigal, Nadejda; Fluman, Nir; Siemion, Shira; Bibi, Eitan			The Secondary Multidrug/Proton Antiporter MdfA Tolerates Displacements of an Essential Negatively Charged Side Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TRANSPORTER MDFA; RESISTANCE PROTEIN; ACIDIC RESIDUES; EFFLUX; MECHANISMS; MODEL; TETRACYCLINE; RECOGNITION; PROMISCUITY	The largest family of solute transporters includes ion motive force-driven secondary transporters. Several well characterized solute-specific transport systems in this group have at least one irreplaceable acidic residue that plays a critical role in energy coupling during transport. Previous studies have established the importance of acidic residues in substrate recognition by major facilitator superfamily secondary multidrug transporters, but their role in the transport mechanism remained unknown. We have been investigating the involvement of acidic residues in the mechanism of MdfA, an Escherichia coli secondary multidrug/proton antiporter. We demonstrated that no single negatively charged side chain plays an irreplaceable role in MdfA. Accordingly, we hypothesized that MdfA might be able to utilize at least two acidic residues alternatively. In this study, we present evidence that indeed, unlike solute-specific secondary transporters, MdfA tolerates displacements of an essential negative charge to various locations in the putative drug translocation pathway. The results suggest that MdfA utilizes a proton translocation strategy that is less sensitive to perturbations in the geometry of the proton-binding site, further illustrating the exceptional structural promiscuity of multidrug transporters.	[Sigal, Nadejda; Fluman, Nir; Siemion, Shira; Bibi, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.bibi@weizmann.ac.il		Bibi, Eitan/0000-0003-3700-2707; Fluman, Nir/0000-0001-9909-0779	Israel Cancer Research Foundation; the Minerva Foundation; the Israel Science Foundation	Israel Cancer Research Foundation; the Minerva Foundation; the Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Cancer Research Foundation, the Minerva Foundation, and the Israel Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adler J, 2005, J BIOL CHEM, V280, P2721, DOI 10.1074/jbc.M412332200; Adler J, 2004, J BIOL CHEM, V279, P8957, DOI 10.1074/jbc.M313422200; Adler J, 2004, BIOCHEMISTRY-US, V43, P518, DOI 10.1021/bi035485t; BIBI E, 1993, P NATL ACAD SCI USA, V90, P9209, DOI 10.1073/pnas.90.19.9209; Diez-Sampedro A, 2004, BIOCHEMISTRY-US, V43, P13175, DOI 10.1021/bi048652d; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; Fujihira E, 1996, FEBS LETT, V391, P243, DOI 10.1016/0014-5793(96)00743-0; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Krulwich TA, 2005, NAT REV MICROBIOL, V3, P566, DOI 10.1038/nrmicro1181; Krulwich TA, 2001, J MOL MICROB BIOTECH, V3, P237; LEE JA, 1989, BIOCHEMISTRY-US, V28, P2540, DOI 10.1021/bi00432a029; Levy SB, 2002, J APPL MICROBIOL, V92, p65S, DOI 10.1046/j.1365-2672.92.5s1.4.x; Lewinson O, 2004, P NATL ACAD SCI USA, V101, P14073, DOI 10.1073/pnas.0405375101; Lewinson O, 2003, P NATL ACAD SCI USA, V100, P1667, DOI 10.1073/pnas.0435544100; Lewinson O, 2006, MOL MICROBIOL, V61, P277, DOI 10.1111/j.1365-2958.2006.05254.x; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Mine T, 1998, J BIOCHEM-TOKYO, V124, P187, DOI 10.1093/oxfordjournals.jbchem.a022078; Neyfakh AA, 1997, TRENDS MICROBIOL, V5, P309, DOI 10.1016/S0966-842X(97)01064-0; Nilsen IW, 1996, J BACTERIOL, V178, P3188, DOI 10.1128/jb.178.11.3188-3193.1996; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2595, DOI 10.1128/AAC.44.10.2595-2599.2000; POOLMAN B, 1995, J BIOL CHEM, V270, P12995, DOI 10.1074/jbc.270.22.12995; POURCHER T, 1993, J BIOL CHEM, V268, P3209; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sigal N, 2005, BIOCHEMISTRY-US, V44, P14870, DOI 10.1021/bi051574p; Sigal N, 2006, J MOL MICROB BIOTECH, V11, P308, DOI 10.1159/000095633; Sigal N, 2006, J BACTERIOL, V188, P5635, DOI 10.1128/JB.00422-06; Tamura N, 2003, CURR OPIN CHEM BIOL, V7, P570, DOI 10.1016/j.cbpa.2003.08.014; YAMAGUCHI A, 1992, BIOCHEMISTRY-US, V31, P8344, DOI 10.1021/bi00150a031; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; Zgurskaya HI, 2000, MOL MICROBIOL, V37, P219, DOI 10.1046/j.1365-2958.2000.01926.x	34	32	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6966	6971		10.1074/jbc.M808877200	http://dx.doi.org/10.1074/jbc.M808877200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129186	hybrid, Green Published			2022-12-27	WOS:000263919000044
J	Tourand, Y; Deneke, J; Moriarty, TJ; Chaconas, G				Tourand, Yvonne; Deneke, Jan; Moriarty, Tara J.; Chaconas, George			Characterization and in Vitro Reaction Properties of 19 Unique Hairpin Telomeres from the Linear Plasmids of the Lyme Disease Spirochete	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORRELIA-BURGDORFERI; RESOLVASE REST; STRAIN B31; SEQUENCE; GENOME; INFECTIVITY; RESOLUTION; EXCHANGE; DISTINCT; CYCLE	The genome of the Lyme disease pathogen Borrelia burgdorferi contains about a dozen linear DNA molecules that carry covalently closed hairpin telomeres as a specialized mechanism for dealing with the end-replication problem. The hairpin telomeres are generated from replicative intermediates through a two-step transesterification promoted by the telomere resolvase ResT. Although the genome of B. burgdorferi has been sequenced, the sequence of most telomeres has remained unknown because of difficulties in recovering and completely sequencing the covalently closed hairpin ends. In this study we report a new approach for the direct sequencing Borrelia telomeres and report the sequence, characterization, and in vitro reaction properties of 19 unique telomeres. Surprisingly, a variation of greater than 160-fold in the initial reaction rates of in vitro ResT-mediated telomere resolution was observed between the most active and least active telomeres. Moreover, three of the hairpin telomeres were completely inactive in vitro, but their in vivo functionality was demonstrated. Our results provide important new information on the structure and function of the B. burgdorferi telomeres and suggest the possibility that factors besides the telomere resolvase ResT may influence the reaction in vivo and rescue those telomeres that are not functional in vitro with ResT alone.	Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Chaconas, G (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	chaconas@ucalgary.ca	Moriarty, Tara J./K-1684-2016	Moriarty, Tara J./0000-0002-1751-5145	Canadian Institutes of Health [MOP-53086]; Canada Research Chairs Program; Alberta Heritage Fund for Medical Research	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Alberta Heritage Fund for Medical Research(Alberta Heritage Foundation for Medical Research)	This research was supported in part by the Canadian Institutes of Health Research Grant MOP-53086, the Canada Research Chairs Program, and the Alberta Heritage Fund for Medical Research. The costs of publication of this article were defrayed in part by the payment of page charges.	Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; Bankhead T, 2004, P NATL ACAD SCI USA, V101, P13768, DOI 10.1073/pnas.0405762101; Bankhead T, 2006, MOL MICROBIOL, V62, P895, DOI 10.1111/j.1365-2958.2006.05423.x; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1987, SCIENCE, V237, P409, DOI 10.1126/science.3603026; Barbour AG, 1997, NATURE, V390, P553, DOI 10.1038/37475; Beaurepaire C, 2005, MOL MICROBIOL, V57, P132, DOI 10.1111/j.1365-2958.2005.04688.x; Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000; Byram R, 2004, J BACTERIOL, V186, P3561, DOI 10.1128/JB.186.11.3561-3569.2004; Casjens S, 1997, MOL MICROBIOL, V26, P581, DOI 10.1046/j.1365-2958.1997.6051963.x; Casjens S, 2000, J MOL MICROB BIOTECH, V2, P401; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chaconas G, 2005, MOL MICROBIOL, V58, P625, DOI 10.1111/j.1365-2958.2005.04872.x; Chaconas G, 2001, EMBO J, V20, P3229, DOI 10.1093/emboj/20.12.3229; Deneke J, 2004, J BIOL CHEM, V279, P53699, DOI 10.1074/jbc.M409001200; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Grimm D, 2005, J MED ENTOMOL, V42, P676, DOI 10.1603/0022-2585(2005)042[0676:DPRBBB]2.0.CO;2; Grimm D, 2004, INFECT IMMUN, V72, P5938, DOI 10.1128/IAI.72.10.5938-5946.2004; HINNEBUSCH J, 1991, J BACTERIOL, V173, P7233, DOI 10.1128/jb.173.22.7233-7239.1991; HINNEBUSCH J, 1990, MOL MICROBIOL, V4, P811, DOI 10.1111/j.1365-2958.1990.tb00651.x; Huang WM, 2004, J BACTERIOL, V186, P4134, DOI 10.1128/JB.186.13.4134-4141.2004; Jewett MW, 2007, MOL MICROBIOL, V66, P975, DOI 10.1111/j.1365-2958.2007.05969.x; Jewett MW, 2007, MOL MICROBIOL, V64, P1358, DOI 10.1111/j.1365-2958.2007.05746.x; Kobryn K, 2005, J BIOL CHEM, V280, P26788, DOI 10.1074/jbc.M504530200; Kobryn K, 2005, MOL CELL, V17, P783, DOI 10.1016/j.molcel.2005.02.025; Kobryn K, 2002, MOL CELL, V9, P195, DOI 10.1016/S1097-2765(01)00433-6; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Lawrenz MB, 2002, INFECT IMMUN, V70, P4798, DOI 10.1128/IAI.70.9.4798-4804.2002; Miller JC, 2000, J BACTERIOL, V182, P6254, DOI 10.1128/JB.182.21.6254-6258.2000; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Picardeau M, 2000, MICROBIOL-UK, V146, P305, DOI 10.1099/00221287-146-2-305; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Revel AT, 2005, P NATL ACAD SCI USA, V102, P6972, DOI 10.1073/pnas.0502565102; Stewart PE, 2005, PLASMID, V53, P1, DOI 10.1016/j.plasmid.2004.10.006; Strother KO, 2005, VECTOR-BORNE ZOONOT, V5, P237, DOI 10.1089/vbz.2005.5.237; Tourand Y, 2003, MOL MICROBIOL, V48, P901, DOI 10.1046/j.1365-2958.2003.03485.x; Tourand Y, 2007, MOL MICROBIOL, V64, P580, DOI 10.1111/j.1365-2958.2007.05691.x; Tourand Y, 2006, J BACTERIOL, V188, P7378, DOI 10.1128/JB.00760-06; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8	42	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7264	7272		10.1074/jbc.M808918200	http://dx.doi.org/10.1074/jbc.M808918200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19122193	Green Published, hybrid			2022-12-27	WOS:000263919000073
J	Winkler, M; Lutz, R; Russ, U; Quast, U; Bryan, J				Winkler, Marcus; Lutz, Rebekka; Russ, Ulrich; Quast, Ulrich; Bryan, Joseph			Analysis of Two KCNJ11 Neonatal Diabetes Mutations, V59G and V59A, and the Analogous KCNJ8 I60G Substitution DIFFERENCES BETWEEN THE CHANNEL SUBTYPES FORMED WITH SUR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; SENSITIVE POTASSIUM CHANNELS; SULFONYLUREA RECEPTOR SUR2B; INSULIN-SECRETION; HIGH-AFFINITY; ACTIVATING MUTATIONS; N-TERMINUS; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; TOLBUTAMIDE SITE	beta-Cell-type K-ATP channels are octamers assembled from Kir6.2/KCNJ11 and SUR1/ABCC8. Adenine nucleotides play a major role in their regulation. Nucleotide binding to Kir6.2 inhibits channel activity, whereas ATP binding/hydrolysis on sulfonylurea receptor 1 (SUR1) opposes inhibition. Segments of the Kir6.2 N terminus are important for open-to-closed transitions, form part of the Kir ATP, sulfonylurea, and phosphoinositide binding sites, and interact with L0, an SUR cytoplasmic loop. Inputs from these elements link to the pore via the interfacial helix, which forms an elbow with the outer pore helix. Mutations that destabilize the interfacial helix increase channel activity, reduce sensitivity to inhibitory ATP and channel inhibitors, glibenclamide and repaglinide, and cause neonatal diabetes. We compared Kir6.x/SUR1 channels carrying the V59G substitution, a cause of the developmental delay, epilepsy, and neonatal diabetes syndrome, with a V59A substitution and the equivalent I60G mutation in the related Kir6.1 subunit from vascular smooth muscle. The substituted channels have increased PO values, decreased sensitivity to inhibitors, and impaired stimulation by phosphoinositides but retain sensitivity to Ba2+-block. The V59G and V59A channels are either not, or poorly, stimulated by phosphoinositides, respectively. Inhibition by sequestrating phosphatidylinositol 4,5-bisphosphate with neomycin and polylysine is reduced in V59A, and abolished in V59G channels. Stimulation by SUR1 is intact, and increasing the concentration of inhibitory-ATP restores the sensitivity of Val-59-substituted channels to glibenclamide. The I60G channels, strongly dependent on SUR stimulation, remain sensitive to sulfonylureas. The results suggest the interfacial helix dynamically links inhibitory inputs from the Kir N terminus to the gate and that sulfonylureas stabilize an inhibitory configuration.	[Bryan, Joseph] Pacific NW Diabet Res Inst, Seattle, WA 98122 USA; [Winkler, Marcus; Lutz, Rebekka; Russ, Ulrich; Quast, Ulrich] Univ Tubingen, Fac Med, Dept Pharmacol & Toxicol, D-72074 Tubingen, Germany	Pacific Northwest Diabetes Research Institute (PNDRI); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bryan, J (corresponding author), Pacific NW Diabet Res Inst, 720 Broadway, Seattle, WA 98122 USA.	jbryan@pnri.org			National Institutes of Health [DK044311]; Deutsche Forschungsgemeinschaft [Qu100/4-1]; Dr. Karl Kuhn-Stiftung; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dr. Karl Kuhn-Stiftung; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK044311 ( to J. B.). This work was also supported by the Deutsche Forschungsgemeinschaft Grant Qu100/4-1 ( to U. Q.) and a grant from the Dr. Karl Kuhn-Stiftung ( to U. R.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Babenko ADP, 2005, J MOL CELL CARDIOL, V39, P79, DOI 10.1016/j.yjmcc.2004.12.004; Babenko AP, 2008, J BIOL CHEM, V283, P8778, DOI 10.1074/jbc.C700243200; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 1999, FEBS LETT, V445, P131, DOI 10.1016/S0014-5793(99)00102-7; Babenko AP, 2002, J BIOL CHEM, V277, P43997, DOI 10.1074/jbc.M208085200; Babenko AP, 2001, J BIOL CHEM, V276, P49083, DOI 10.1074/jbc.M108763200; Babenko AP, 1999, BIOCHEM BIOPH RES CO, V255, P231, DOI 10.1006/bbrc.1999.0172; Babenko AP, 1999, FEBS LETT, V459, P367, DOI 10.1016/S0014-5793(99)01215-6; BEECH DJ, 1993, BRIT J PHARMACOL, V110, P573, DOI 10.1111/j.1476-5381.1993.tb13849.x; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Cukras CA, 2002, J GEN PHYSIOL, V120, P437, DOI 10.1085/jgp.20028621; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; DUNNE MJ, 1986, FEBS LETT, V208, P59, DOI 10.1016/0014-5793(86)81532-0; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Flanagan SE, 2007, DIABETES, V56, P1930, DOI 10.2337/db07-0043; Flanagan SE, 2006, DIABETOLOGIA, V49, P1190, DOI 10.1007/s00125-006-0246-z; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Haider S, 2007, EMBO J, V26, P3749, DOI 10.1038/sj.emboj.7601809; Hambrock A, 2001, MOL PHARMACOL, V60, P190, DOI 10.1124/mol.60.1.190; Hambrock A, 1998, BRIT J PHARMACOL, V125, P577, DOI 10.1038/sj.bjp.0702109; Hansen AMK, 2005, BRIT J PHARMACOL, V144, P551, DOI 10.1038/sj.bjp.0706082; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Kondo C, 1998, RECEPTOR CHANNEL, V6, P129; Koster JC, 2005, DIABETES, V54, P3065, DOI 10.2337/diabetes.54.11.3065; Koster JC, 2005, DIABETES, V54, P2645, DOI 10.2337/diabetes.54.9.2645; Koster JC, 1999, J PHYSIOL-LONDON, V515, P19, DOI 10.1111/j.1469-7793.1999.019ad.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lin CW, 2006, DIABETES, V55, P1738, DOI 10.2337/db05-1571; MacGregor GG, 2002, P NATL ACAD SCI USA, V99, P2726, DOI 10.1073/pnas.042688899; Matsuo M, 2005, J MOL CELL CARDIOL, V38, P907, DOI 10.1016/j.yjmcc.2004.11.021; MISLER S, 1986, P NATL ACAD SCI USA, V83, P7119, DOI 10.1073/pnas.83.18.7119; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Proks P, 2005, HUM MOL GENET, V14, P2717, DOI 10.1093/hmg/ddi305; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Reimann F, 1999, J PHYSIOL-LONDON, V518, P325, DOI 10.1111/j.1469-7793.1999.0325p.x; Rost Burkhard, 2003, Methods Biochem Anal, V44, P559; Russ U, 1999, MOL PHARMACOL, V56, P955, DOI 10.1124/mol.56.5.955; Satoh E, 1998, J PHYSIOL-LONDON, V511, P663, DOI 10.1111/j.1469-7793.1998.663bg.x; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Stephan D, 2006, DIABETOLOGIA, V49, P2039, DOI 10.1007/s00125-006-0307-3; Takano M, 1998, J PHYSIOL-LONDON, V512, P395, DOI 10.1111/j.1469-7793.1998.395be.x; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vila-Carriles WH, 2007, FASEB J, V21, P18, DOI 10.1096/fj.06-6730hyp; Winkler M, 2007, J PHARMACOL EXP THER, V322, P701, DOI 10.1124/jpet.107.123224; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	62	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6752	6762		10.1074/jbc.M805435200	http://dx.doi.org/10.1074/jbc.M805435200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139106	hybrid, Green Published			2022-12-27	WOS:000263919000020
J	AbdAlla, S; Lother, H; el Missiry, A; Sergeev, P; Langer, A; el Faramawy, Y; Quitterer, U				AbdAlla, Said; Lother, Heinz; el Missiry, Ahmed; Sergeev, Pavel; Langer, Andreas; el Faramawy, Yasser; Quitterer, Ursula			Dominant Negative AT(2) Receptor Oligomers Induce G-protein Arrest and Symptoms of Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE BRAIN; PHOSPHOINOSITIDE HYDROLYSIS; MUSCARINIC RECEPTOR; OXIDATIVE STRESS; TRANSGENIC MICE; KINASE-C; TRANSGLUTAMINASE; HETERODIMERS; G(Q)/G(11); SECRETION	Neurodegeneration in Alzheimer's disease ( AD) correlates with dysfunction of signaling mediated by G alpha(q/11). Nondissociable angiotensin II AT(2) receptor oligomers are linked to the impaired G alpha(q/11)-stimulated signaling of AD patients and transgenic mice with AD-like symptoms. To further analyze the role of AT(2) receptor oligomers, we induced the formation of AT(2) oligomers in an in vitro cell system. Similarly as in vivo, sequential oxidative and transglutaminase-dependent cross-linking steps triggered the formation of AT(2) oligomers in vitro. Elevated reactive oxygen species mediated oxidative cross-linking of AT(2) monomers to dimers involving tyrosine residues located at putative interreceptor contact sites of the cytoplasmic loop connecting transmembrane helices III/IV. Cross-linked AT(2) dimers were subsequently a substrate of activated transglutaminase-2, which targeted the carboxyl terminus of AT(2) dimers, as assessed by truncated and chimeric AT(2) receptors, respectively. AT(2) oligomers acted as dominant negative receptors in vitro by mediating G alpha(q/11) protein sequestration and G alpha(q/11) protein arrest. The formation of AT(2) oligomers and G-protein dysfunction could be suppressed in vitro and in vivo by an AT(2) receptor mutant. Inhibition of AT(2) oligomerization upon stereotactic expression of the AT(2) receptor mutant revealed that G alpha(q/11) sequestering AT(2) oligomers enhanced the development of neurodegenerative symptoms in the hippocampus of transgenic mice with AD-like pathology. Thus, AT(2) oligomers inducing G alpha(q/11) arrest are causally involved in inducing symptoms of neurodegeneration.	[AbdAlla, Said; Lother, Heinz; el Faramawy, Yasser] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; [el Missiry, Ahmed] Ain Shams Univ Hosp, Med Res Ctr, Cairo, Egypt; [Sergeev, Pavel; Langer, Andreas; Quitterer, Ursula] Swiss Fed Inst Technol, Dept Mol Pharmacol, CH-8057 Zurich, Switzerland; [Sergeev, Pavel; Langer, Andreas; Quitterer, Ursula] Univ Zurich, CH-8057 Zurich, Switzerland	Heinrich Pette Institute; University of Hamburg; Egyptian Knowledge Bank (EKB); Ain Shams University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Quitterer, U (corresponding author), Y17M70,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	ursula.quitterer@pharma.ethz.ch						AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; AbdAlla S, 2009, J BIOL CHEM, V284, P6554, DOI 10.1074/jbc.M807746200; Bonelli RM, 2002, NEUROBIOL DIS, V11, P106, DOI 10.1006/nbdi.2002.0535; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; FERRARIDILEO G, 1993, LIFE SCI, V53, pPL439, DOI 10.1016/0024-3205(93)90037-4; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; FOWLER CJ, 1995, MOL CELL BIOCHEM, V149, P287, DOI 10.1007/BF01076590; GREENWOOD AF, 1995, NEUROSCIENCE, V69, P125, DOI 10.1016/0306-4522(95)00220-D; Haring R, 1998, J NEUROCHEM, V71, P2094; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Johnson GVW, 1997, BRAIN RES, V751, P323, DOI 10.1016/S0006-8993(96)01431-X; JOPE RS, 1994, NEUROBIOL AGING, V15, P221, DOI 10.1016/0197-4580(94)90116-3; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; Miura M, 2002, J NEUROSCI, V22, P8379; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nurnberg A, 2008, J BIOL CHEM, V283, P35526, DOI 10.1074/jbc.M804972200; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Tsang SWY, 2006, NEUROBIOL AGING, V27, P1216, DOI 10.1016/j.neurobiolaging.2005.07.010; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06	26	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6566	6574		10.1074/jbc.M808277200	http://dx.doi.org/10.1074/jbc.M808277200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19074439	hybrid, Green Accepted			2022-12-27	WOS:000263742700059
J	Bengoechea-Alonso, MT; Ericsson, J				Bengoechea-Alonso, Maria T.; Ericsson, Johan			A Phosphorylation Cascade Controls the Degradation of Active SREBP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; DEPENDENT DEGRADATION; CYCLIN-E; TRANSCRIPTION FACTOR; C-MYC; NOTCH; COACTIVATOR; CHOLESTEROL; FAMILY; UBIQUITINATION	Sterol regulatory element-binding proteins (SREBPs) are a family of transcription factors that regulates cholesterol and lipid metabolism. The active forms of these transcription factors are targeted by a number of post-translational modifications, including phosphorylation. Phosphorylation of Thr-426 and Ser-430 in SREBP1a creates a docking site for the ubiquitin ligase Fbw7, resulting in the degradation of the transcription factor. Here, we identify a novel phosphorylation site in SREBP1a, Ser-434, which regulates the Fbw7-dependent degradation of SREBP1. We demonstrate that both SREBP1a and SREBP1c are phosphorylated on this residue (Ser-410 in SREBP1c). Importantly, we demonstrate that the mature form of endogenous SREBP1 is phosphorylated on Ser-434. Glycogen synthase kinase-3 phosphorylates Ser-434, and the phosphorylation of this residue is attenuated in response to insulin signaling. Interestingly, phosphorylation of Ser-434 promotes the glycogen synthase kinase-3-dependent phosphorylation of Thr-426 and Ser-430 and destabilizes SREBP1. Consequently, mutation of Ser-434 blocks the interaction between SREBP1 and Fbw7 and attenuates Fbw7-dependent degradation of SREBP1. Importantly, insulin fails to enhance the levels of mature SREBP1 in cells lacking Fbw7. Thus, the degradation of mature SREBP1 is controlled by cross-talk between multiple phosphorylated residues in its C-terminal domain and the phosphorylation of Ser-434 could function as a molecular switch to control these processes.	[Bengoechea-Alonso, Maria T.; Ericsson, Johan] Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 4, Ireland; [Bengoechea-Alonso, Maria T.; Ericsson, Johan] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	University College Dublin; Ludwig Institute for Cancer Research; Uppsala University	Ericsson, J (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 4, Ireland.	johan.ericsson@ucd.ie	Ericsson, Johan/AAA-6664-2020	Ericsson, Johan/0000-0003-1186-6574	Ludwig Institute for Cancer Research Ltd; Swedish Research Council; Novo Nordisk Foundation; Royal Swedish Academy of Sciences; Knut and Alice Wallenberg Foundation	Ludwig Institute for Cancer Research Ltd; Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Royal Swedish Academy of Sciences; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported in part by the Ludwig Institute for Cancer Research Ltd. and grants from the Swedish Research Council and the Novo Nordisk Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; A Research Fellow of the Royal Swedish Academy of Sciences through a grant from the Knut and Alice Wallenberg Foundation. To whom correspondence should be addressed: UCD Conway Institute, School of Medicine and Medical Science, University College Dublin, Belfield, Dublin 4, Ireland. Tel.: 353-1-716-6753; Fax: 353-1-716-6701; E-mail:johan.ericsson@ucd.ie.	Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; Bengoechea-Alonso MT, 2006, CELL CYCLE, V5, P1708, DOI 10.4161/cc.5.15.3131; Bengoechea-Alonso MT, 2005, P NATL ACAD SCI USA, V102, P11681, DOI 10.1073/pnas.0501494102; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Ericsson J, 1996, J BIOL CHEM, V271, P24359, DOI 10.1074/jbc.271.40.24359; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kotzka J, 2004, J BIOL CHEM, V279, P22404, DOI 10.1074/jbc.M401198200; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Sundqvist A, 2003, P NATL ACAD SCI USA, V100, P13833, DOI 10.1073/pnas.2335135100; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; WELCKER M, 2007, NAT REV CANCER, V20, P83; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	40	103	110	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5885	5895		10.1074/jbc.M807906200	http://dx.doi.org/10.1074/jbc.M807906200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19126544	hybrid			2022-12-27	WOS:000263560600052
J	Urban, A; Behm-Ansmant, I; Branlant, C; Motorin, Y				Urban, Alan; Behm-Ansmant, Isabelle; Branlant, Christiane; Motorin, Yuri			RNA Sequence and Two-dimensional Structure Features Required for Efficient Substrate Modification by the Saccharomyces cerevisiae RNA:Psi-Synthase Pus7p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC TRANSFER-RNAS; SMALL NUCLEAR RNAS; 5S RIBOSOMAL-RNA; PSEUDOURIDINE-SYNTHASE; U2 SNRNA; SUBCELLULAR-LOCALIZATION; CONSERVED PSEUDOURIDINE; TRANSFER RNA(TYR); YEAST; RECOGNITION	The RNA: pseudouridine (Psi) synthase Pus7p of Saccharomyces cerevisiae is a multisite-specific enzyme that is able to modify U-13 in several yeast tRNAs, U-35 in the pre-tRNA(Tyr) (G Psi A), U-35 in U2 small nuclear RNA, and U-50 in 5 S rRNA. Pus7p belongs to the universally conserved TruD-like family of RNA: Psi-synthases found in bacteria, archaea, and eukarya. Although several RNA substrates for yeast Pus7p have been identified, specificity of their recognition and modification has not been studied. However, conservation of a 7-nt-long sequence, including the modified U residue, in all natural Pus7p substrates suggested the importance of these nucleotides for Pus7p recognition and/or catalysis. Using site-directed mutagenesis, we designed a set of RNA variants derived from the yeast tRNA(Asp)(GUC), pre- tRNA(Tyr)(G Psi A), and U2 small nuclear RNA and tested their ability to be modified by Pus7p in vitro. We demonstrated that the highly conserved U-2 and A (+1) residues (nucleotide numbers refer to target U-0) are crucial identity elements for efficient modification by Pus7p. Nucleotide substitutions at other surrounding positions (-4, -3, -2, -3) have only a moderate effect. Surprisingly, the identity of the nucleotide immediately 5' to the target U-0 residue (position-1) is not important for efficient modification. Alteration of tRNA three-dimensional structure had no detectable effect on Pus7p activity at position 13. However, our results suggest that the presence of at least one stem-loop structure including or close to the target U nucleotide is required for Pus7p-catalyzed modification.	[Motorin, Yuri] Nancy Univ, Lab Maturat ARN & Enzymol Mol, UMR 7567, CNRS UHP Nancy 1,Fac Sci, F-54506 Vandoeuvre Les Nancy, France	Universite de Lorraine	Motorin, Y (corresponding author), Nancy Univ, Lab Maturat ARN & Enzymol Mol, UMR 7567, CNRS UHP Nancy 1,Fac Sci, BP 239, F-54506 Vandoeuvre Les Nancy, France.	Yuri.Motorin@maem.uhp-nancy.fr	MOTORIN, Yuri/E-2499-2011; MOTORIN, Yuri/AAQ-9527-2020; BEHM-ANSMANT, Isabelle/B-1406-2012	MOTORIN, Yuri/0000-0002-8018-334X; URBAN, Alan/0000-0002-6460-2364; Branlant, Christiane/0000-0003-4728-5499; Behm-Ansmant, Isabelle/0000-0001-8909-0660; Motorin, Alexandr/0000-0001-9622-4591	CNRS; Ministere de la Jeunesse; de l'Education Nationale et de la Recherche	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Jeunesse; de l'Education Nationale et de la Recherche	This work was supported by laboratory funds from the CNRS and the Ministere de la Jeunesse, de l'Education Nationale et de la Recherche."	Ansmant I, 2000, NUCLEIC ACIDS RES, V28, P1941, DOI 10.1093/nar/28.9.1941; Ansmant I, 2001, J BIOL CHEM, V276, P34934, DOI 10.1074/jbc.M103131200; ARES M, 1986, CELL, V47, P49, DOI 10.1016/0092-8674(86)90365-X; Auffinger P, 1998, J BIOMOL STRUCT DYN, V16, P693, DOI 10.1080/07391102.1998.10508281; Auffinger P, 2001, RNA, V7, P334, DOI 10.1017/S1355838201002382; Becker HF, 1997, J MOL BIOL, V274, P505, DOI 10.1006/jmbi.1997.1417; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; Behm-Ansmant I, 2004, J BIOL CHEM, V279, P52998, DOI 10.1074/jbc.M409581200; Behm-Ansmant I, 2003, RNA, V9, P1371, DOI 10.1261/rna.5520403; Behm-Ansmant I, 2006, RNA, V12, P1583, DOI 10.1261/rna.100806; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; BRANLANT C, 1982, EMBO J, V1, P1259, DOI 10.1002/j.1460-2075.1982.tb00022.x; CHOFFAT Y, 1988, MOL CELL BIOL, V8, P3332, DOI 10.1128/MCB.8.8.3332; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Decatur WA, 2008, MOL CELL BIOL, V28, P3089, DOI 10.1128/MCB.01574-07; Drawid A, 2000, J MOL BIOL, V301, P1059, DOI 10.1006/jmbi.2000.3968; Ericsson UB, 2004, FEBS LETT, V565, P59, DOI 10.1016/j.febslet.2004.03.085; Gu XR, 1998, BIOCHEMISTRY-US, V37, P339, DOI 10.1021/bi971590p; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hur S, 2006, J BIOL CHEM, V281, P38969, DOI 10.1074/jbc.R600034200; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; Jiang HQ, 1997, NUCLEIC ACIDS RES, V25, P2694, DOI 10.1093/nar/25.14.2694; JOHNSON PF, 1983, NATURE, V302, P681, DOI 10.1038/302681a0; Kaya Y, 2003, RNA, V9, P711, DOI 10.1261/rna.5230603; KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1; Kiparisov S, 2005, MOL GENET GENOMICS, V274, P235, DOI 10.1007/s00438-005-0020-9; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Lin Y, 2008, BIOCHEMISTRY-US, V47, P5503, DOI 10.1021/bi7022392; Ma XJ, 2003, EMBO J, V22, P1889, DOI 10.1093/emboj/cdg191; Massenet S, 1999, MOL CELL BIOL, V19, P2142; MORAS D, 1980, NATURE, V288, P669, DOI 10.1038/288669a0; Motorin Y, 1998, RNA, V4, P856, DOI 10.1017/S1355838298980396; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Newby MI, 2002, NAT STRUCT BIOL, V9, P958, DOI 10.1038/nsb873; NISHIKAW.K, 1974, FEBS LETT, V40, P106, DOI 10.1016/0014-5793(74)80904-X; Pienkowska J, 2002, BBA-GENE STRUCT EXPR, V1574, P137, DOI 10.1016/S0167-4781(01)00355-4; QUIGLEY GJ, 1976, SCIENCE, V194, P796, DOI 10.1126/science.790568; Roovers M, 2006, NUCLEIC ACIDS RES, V34, P4293, DOI 10.1093/nar/gkl530; Smith MW, 2001, MOL CELL BIOL, V21, P8264, DOI 10.1128/MCB.21.24.8264-8275.2001; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SWERDLOW H, 1984, J BIOL CHEM, V259, P5197; SZWEYKOWSKAKULINSKA Z, 1992, EMBO J, V11, P1907, DOI 10.1002/j.1460-2075.1992.tb05243.x; Szymanski M, 2002, NUCLEIC ACIDS RES, V30, P176, DOI 10.1093/nar/30.1.176; VANTOL H, 1988, NUCLEIC ACIDS RES, V16, P1951, DOI 10.1093/nar/16.5.1951; Yang CX, 2005, J BIOL CHEM, V280, P6655, DOI 10.1074/jbc.M413288200; ZERFASS K, 1992, NUCLEIC ACIDS RES, V20, P5911, DOI 10.1093/nar/20.22.5911	48	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5845	5858		10.1074/jbc.M807986200	http://dx.doi.org/10.1074/jbc.M807986200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19114708	hybrid, Green Published			2022-12-27	WOS:000263560600048
J	Huo, YL; McConnell, SC; Yang, SRLR; Zhang, TT; Sun, CW; Wu, LC; Ryan, TM				Huo, Yongliang; McConnell, Sean C.; Yang, Shan-Run Liu Rui; Zhang, Ting-Ting; Sun, Chiao-Wang; Wu, Li-Chen; Ryan, Thomas M.			Humanized Mouse Model of Cooley's Anemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN GENE; SICKLE-CELL-DISEASE; HUMAN GAMMA-GLOBIN; YEAST ARTIFICIAL CHROMOSOME; EMBRYONIC STEM-CELLS; TRANSGENIC MICE; DEVELOPMENTAL REGULATION; INEFFECTIVE ERYTHROPOIESIS; SPLICING MUTATION; THALASSEMIA	A novel humanized mouse model of Cooley's Anemia (CA) was generated by targeted gene replacement in embryonic stem (ES) cells. Because the mouse does not have a true fetal hemoglobin, a delayed switching human gamma to beta(0) globin gene cassette (gamma beta(0)) was inserted directly into the murine beta globin locus replacing both adult mouse beta globin genes. The inserted human beta(0) globin allele has a mutation in the splice donor site that produces the same aberrant transcripts in mice as described in human cells. No functional human beta globin polypeptide chains are produced. Heterozygous gamma beta(0) mice suffer from microcytic anemia. Unlike previously described animal models of beta thalassemia major, homozygous gamma beta(0) mice switch from mouse embryonic globin chains to human fetal gamma globin during fetal life. When bred with human alpha globin knockin mice, homozygous CA mice survive solely upon human fetal hemoglobin at birth. This preclinical animal model of CA can be utilized to study the regulation of globin gene expression, synthesis, and switching; the reactivation of human fetal globin gene expression; and the testing of genetic and cell-based therapies for the correction of thalassemia.	[Huo, Yongliang; McConnell, Sean C.; Yang, Shan-Run Liu Rui; Zhang, Ting-Ting; Sun, Chiao-Wang; Wu, Li-Chen; Ryan, Thomas M.] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Ryan, TM (corresponding author), 1918 Univ Blvd,MCLM 566A, Birmingham, AL 35294 USA.	tryan@uab.edu	McConnell, Sean/E-6775-2011	Ryan, Thomas/0000-0002-8982-0253; McConnell, Sean/0000-0002-0988-5373	National Institutes of Health [R01 HL072351, R01 HL073440]; UAB CMB Training [T32 GM008111]; Carmichael Scholarship; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073440, R01HL072351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB CMB Training; Carmichael Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL072351 (to T. M. R.) and R01 HL073440 (to T. M. R.); UAB CMB Training Grant T32 GM008111 (to S. C. M.); and the Carmichael Scholarship (to S. C. M. and T.-T. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bank A, 1985, Curr Top Hematol, V5, P1; BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; BEHRINGER RR, 1989, SCIENCE, V245, P971, DOI 10.1126/science.2772649; BUNN HF, 1986, HEMOGLOBIN MOL GENET, P333; CIAVATTA DJ, 1995, P NATL ACAD SCI USA, V92, P9259, DOI 10.1073/pnas.92.20.9259; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; FERGUSON DJ, 1990, AM J HEMATOL, V33, P13, DOI 10.1002/ajh.2830330104; FORGET BG, 1975, ANNU REV MED, V26, P345, DOI 10.1146/annurev.me.26.020175.002021; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; GAENSLER KML, 1993, P NATL ACAD SCI USA, V90, P11381, DOI 10.1073/pnas.90.23.11381; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Jamsai D, 2005, GENOMICS, V85, P453, DOI 10.1016/j.ygeno.2004.11.016; Kaufman RM, 1999, BLOOD, V94, P3178, DOI 10.1182/blood.V94.9.3178.421k23_3178_3184; KAZAZIAN HH, 1975, P NATL ACAD SCI USA, V72, P567, DOI 10.1073/pnas.72.2.567; Kean LS, 2002, EXP HEMATOL, V30, P394, DOI 10.1016/S0301-472X(02)00780-4; Kingsley PD, 2006, BLOOD, V107, P1665, DOI 10.1182/blood-2005-08-3097; Kollia P, 1992, Gene Geogr, V6, P59; Lewis J, 1998, BLOOD, V91, P2152, DOI 10.1182/blood.V91.6.2152.2152_2152_2156; Mathias LA, 2000, EXP HEMATOL, V28, P1343, DOI 10.1016/S0301-472X(00)00555-5; NIENHUIS AW, 1978, CELL, V15, P307, DOI 10.1016/0092-8674(78)90106-X; Nishino T, 2006, BRIT J HAEMATOL, V134, P100, DOI 10.1111/j.1365-2141.2006.06102.x; Nozaki M, 1999, LAB INVEST, V79, P293; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rivella S, 2003, BLOOD, V101, P2932, DOI 10.1182/blood-2002-10-3305; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; RYAN TM, 1989, P NATL ACAD SCI USA, V86, P37, DOI 10.1073/pnas.86.1.37; Ryan TM, 2000, NUCLEIC ACIDS RES, V28, P2736, DOI 10.1093/nar/28.14.2736; RYAN TM, 1990, SCIENCE, V247, P566, DOI 10.1126/science.2154033; RYAN TM, 1989, GENE DEV, V3, P314, DOI 10.1101/gad.3.3.314; SHEHEE WR, 1993, P NATL ACAD SCI USA, V90, P3177, DOI 10.1073/pnas.90.8.3177; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; STEINBERG MH, 1988, AM J MED SCI, V296, P308, DOI 10.1097/00000441-198811000-00004; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; TUAN D, 1984, P NATL ACAD SCI-BIOL, V81, P2718, DOI 10.1073/pnas.81.9.2718; Vadolas J, 2006, J BIOL CHEM, V281, P7399, DOI 10.1074/jbc.M512931200; WHITELAW E, 1990, MOL CELL BIOL, V10, P6596, DOI 10.1128/MCB.10.12.6596; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608; YUAN J, 1993, BLOOD, V82, P374, DOI 10.1182/blood.V82.2.374.bloodjournal822374	41	17	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4889	4896		10.1074/jbc.M805681200	http://dx.doi.org/10.1074/jbc.M805681200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098001	Green Published, hybrid			2022-12-27	WOS:000263416600018
J	Jennings, TA; Mackintosh, SG; Harrison, MK; Sikora, D; Sikora, B; Dave, B; Tackett, AJ; Cameron, CE; Raney, KD				Jennings, Thomas A.; Mackintosh, Samuel G.; Harrison, Melody K.; Sikora, Deniz; Sikora, Bartek; Dave, Bhuvanesh; Tackett, Alan J.; Cameron, Craig E.; Raney, Kevin D.			NS3 Helicase from the Hepatitis C Virus Can Function as a Monomer or Oligomer Depending on Enzyme and Substrate Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T4 DDA HELICASE; SINGLE-STRANDED-DNA; PROTEIN-PROTEIN INTERACTIONS; IN-VITRO; NONSTRUCTURAL PROTEIN-3; MACROMOLECULAR MACHINES; REPLICATION COMPLEX; UNWINDING ACTIVITY; CRYSTAL-STRUCTURE; HCVNS3 HELICASE	Hepatitis C virus NS3 helicase can unwind double-stranded DNA and RNA and has been proposed to form oligomeric structures. Here we examine the DNA unwinding activity of monomeric NS3. Oligomerization was measured by preparing a fluorescently labeled form of NS3, which was titrated with unlabeled NS3, resulting in a hyperbolic increase in fluorescence anisotropy and providing an apparent equilibrium dissociation constant of 236 nM. To evaluate the DNA binding activity of individual subunits within NS3 oligomers, two oligonucleotides were labeled with fluorescent donor or acceptor molecules and then titrated with NS3. Upon the addition of increasing concentrations of NS3, fluorescence energy transfer was observed, which reached a plateau at a 1: 1 ratio of NS3 to oligonucleotides, indicating that each subunit within the oligomeric form of NS3 binds to DNA. DNA unwinding was measured under multiple turnover conditions with increasing concentrations of NS3; however, no increase in specific activity was observed, even at enzyme concentrations greater than the apparent dissociation constant for oligomerization. An ATPase-deficient form of NS3, NS3(D290A), was prepared to explore the functional consequences of oligomerization. Under single turnover conditions in the presence of excess concentration of NS3 relative to DNA, NS3(D290A) exhibited a dominant negative effect. However, under multiple turnover conditions in which DNA concentration was in excess to enzyme concentration, NS3(D290A) did not exhibit a dominant negative effect. Taken together, these data support a model in which monomeric forms of NS3 are active. Oligomerization of NS3 occurs, but subunits can function independently or cooperatively, dependent upon the relative concentration of the DNA.	[Jennings, Thomas A.; Mackintosh, Samuel G.; Harrison, Melody K.; Sikora, Deniz; Sikora, Bartek; Dave, Bhuvanesh; Tackett, Alan J.; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Arkansas System; University of Arkansas Medical Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Raney, KD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	raneykevind@uams.edu			National Institutes of Health [AI060563]; Arkansas IDeA Networkof Biomedical Research Excellence Research [P20RR016460]; Arkansas Biosciences Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060563, R01AI060563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arkansas IDeA Networkof Biomedical Research Excellence Research; Arkansas Biosciences Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (AI060563 to K. D. R. and C. E. C.), Arkansas IDeA Networkof Biomedical Research Excellence Research Grant (P20RR016460), and the Arkansas Biosciences Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Cheng W, 2001, J MOL BIOL, V310, P327, DOI 10.1006/jmbi.2001.4758; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; DONG F, 1995, J BIOL CHEM, V270, P7462, DOI 10.1074/jbc.270.13.7462; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; FAILLA C, 1995, J VIROL, V69, P1769, DOI 10.1128/JVI.69.3.1769-1777.1995; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Gallinari P, 1999, BIOCHEMISTRY-US, V38, P5620, DOI 10.1021/bi982892+; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gwack Y, 1997, EUR J BIOCHEM, V250, P47, DOI 10.1111/j.1432-1033.1997.00047.x; Gwack Y, 1996, BIOCHEM BIOPH RES CO, V225, P654, DOI 10.1006/bbrc.1996.1225; Ishido S, 1998, BIOCHEM BIOPH RES CO, V244, P35, DOI 10.1006/bbrc.1998.8202; Jennings TA, 2008, BIOCHEMISTRY-US, V47, P1126, DOI 10.1021/bi701048a; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Kang LW, 1998, ACTA CRYSTALLOGR D, V54, P121, DOI 10.1107/S0907444997008883; Khu YL, 2001, J VIROL, V75, P205, DOI 10.1128/JVI.75.1.205-214.2001; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Locatelli GA, 2002, BIOCHEMISTRY-US, V41, P10332, DOI 10.1021/bi026082g; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; Morris PD, 2001, J BIOL CHEM, V276, P19691, DOI 10.1074/jbc.M010928200; Morris PD, 2001, METHODS, V23, P149, DOI 10.1006/meth.2000.1116; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Nanduri B, 2002, P NATL ACAD SCI USA, V99, P14722, DOI 10.1073/pnas.232401899; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Porter DJT, 1998, J BIOL CHEM, V273, P18906, DOI 10.1074/jbc.273.30.18906; Preugschat F, 2000, BIOCHEMISTRY-US, V39, P5174, DOI 10.1021/bi9923860; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Rajagopal V, 2008, J MOL BIOL, V376, P69, DOI 10.1016/j.jmb.2007.10.070; Rasnik I, 2004, J MOL BIOL, V336, P395, DOI 10.1016/j.jmb.2003.12.031; RestrepoHartwig MA, 1996, J VIROL, V70, P8908, DOI 10.1128/JVI.70.12.8908-8916.1996; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Sikora B, 2008, J BIOL CHEM, V283, P11516, DOI 10.1074/jbc.M708125200; Soultanas P, 2001, TRENDS BIOCHEM SCI, V26, P47, DOI 10.1016/S0968-0004(00)01734-5; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Tackett AJ, 2001, NUCLEIC ACIDS RES, V29, P565, DOI 10.1093/nar/29.2.565; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Zhang C, 2005, J VIROL, V79, P8687, DOI 10.1128/JVI.79.14.8687-8697.2005	59	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4806	4814		10.1074/jbc.M805540200	http://dx.doi.org/10.1074/jbc.M805540200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19088075	Green Published, hybrid			2022-12-27	WOS:000263416600008
J	Danielsen, JMR; Larsen, DH; Schou, KB; Freire, R; Falck, J; Bartek, J; Lukas, J				Danielsen, Jannie M. Rendtlew; Larsen, Dorthe Helena; Schou, Kenneth Bodtker; Freire, Raimundo; Falck, Jacob; Bartek, Jiri; Lukas, Jiri			HCLK2 Is Required for Activity of the DNA Damage Response Kinase ATR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINTS; DOUBLE-STRAND BREAKS; S-PHASE CHECKPOINT; CAENORHABDITIS-ELEGANS; IONIZING-RADIATION; ACTIVATION; CHK1; PROTEIN; TOPBP1; PHOSPHORYLATION	ATR is a protein kinase that orchestrates the cellular response to replication problems and DNA damage. HCLK2 has previously been reported to stabilize ATR and Chk1. Here we provide evidence that human HCLK2 acts at an early step in the ATR signaling pathway and contributes to full-scale activation of ATR kinase activity. We show that HCLK2 forms a complex with ATR-ATRIP and the ATR activator TopBP1. We demonstrate that HCLK2-induced ATR kinase activity toward substrates requires TopBP1 and vice versa and provides evidence that HCLK2 facilitates efficient ATR-TopBP1 association. Consistent with its role in ATR activation, HCLK2 depletion severely impaired phosphorylation of multiple ATR targets including Chk1, Nbs1, and Smc1 after DNA damage. We show that HCLK2 is required for and stimulates ATR autophosphorylation and activity toward different substrates in vitro. Furthermore, HCLK2 depletion abrogated the G(2) checkpoint and decreased survival of cells after exposure to DNA damaging agents and replicative stress. Overall, our data suggest that HCLK2 facilitates ATR activation and, therefore, contributes to ATR-mediated checkpoint signaling. Importantly, our results suggest that HCLK2 functions in the same pathway as TopBP1 but that the two proteins regulate different steps in ATR activation.	[Danielsen, Jannie M. Rendtlew; Larsen, Dorthe Helena; Schou, Kenneth Bodtker; Bartek, Jiri; Lukas, Jiri] Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; [Danielsen, Jannie M. Rendtlew; Larsen, Dorthe Helena; Schou, Kenneth Bodtker; Bartek, Jiri; Lukas, Jiri] Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Freire, Raimundo] Hosp Univ Canarias, Unidad Investigac, Tenerife 38320, Spain; [Falck, Jacob] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark	Danish Cancer Society; Danish Cancer Society; Universidad de la Laguna; Novo Nordisk	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	jb@cancer.dk; jil@cancer.dk	Larsen, Dorthe Helena/E-9771-2010; Freire, Raimundo/Q-7660-2019; Bartek, Jiri/G-5870-2014; Larsen, Dorthe Helena/Z-6206-2019	Larsen, Dorthe Helena/0000-0002-8280-1252; Freire, Raimundo/0000-0003-4473-8894; Larsen, Dorthe Helena/0000-0002-8280-1252; Lukas, Jiri/0000-0001-9087-506X	Danish Cancer Society, Danish National Research Foundation; Danish Medical Research Council and European Union ( DNA Repair)	Danish Cancer Society, Danish National Research Foundation(Danish Cancer SocietyDanmarks Grundforskningsfond); Danish Medical Research Council and European Union ( DNA Repair)	This work was supported by the Danish Cancer Society, Danish National Research Foundation, and Danish Medical Research Council and European Union ( DNA Repair). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Anderson CM, 2008, GENE DEV, V22, P854, DOI 10.1101/gad.1646208; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Benard C, 2001, DEVELOPMENT, V128, P4045; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; HARTMAN PS, 1982, GENETICS, V102, P159; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shikata M, 2007, J BIOL CHEM, V282, P5346, DOI 10.1074/jbc.M607432200; Syljuasen RG, 2004, CANCER RES, V64, P9035, DOI 10.1158/0008-5472.CAN-04-2434; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	36	36	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4140	4147		10.1074/jbc.M808174200	http://dx.doi.org/10.1074/jbc.M808174200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19097996	hybrid			2022-12-27	WOS:000263134400011
J	Mollicone, R; Moore, SEH; Bovin, N; Garcia-Rosasco, M; Candelier, JJ; Martinez-Duncker, I; Oriol, R				Mollicone, Rosella; Moore, Stuart E. H.; Bovin, Nicolai; Garcia-Rosasco, Marcela; Candelier, Jean-Jacques; Martinez-Duncker, Ivan; Oriol, Rafael			Activity, Splice Variants, Conserved Peptide Motifs, and Phylogeny of Two New alpha 1,3-Fucosyltransferase Families (FUT10 and FUT11)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUCOSYL-TRANSFERASE GENES; GROWTH FACTOR-LIKE; DROSOPHILA-MELANOGASTER; N-GLYCANS; SUBSTRATE-SPECIFICITY; SEQUENCE ALIGNMENT; MOLECULAR-CLONING; O-FUCOSYLATION; CDNA CLONING; AMINO-ACID	We report the cloning of three splice variants of the FUT10 gene, encoding for active alpha-L-fucosyltransferase-isoforms of 391, 419, and 479 amino acids, and two splice variants of the FUT11 gene, encoding for two related alpha-L-fucosyltransferases of 476 and 492 amino acids. The FUT10 and FUT11 appeared 830 million years ago, whereas the other alpha 1,3-fucosyltransferases emerged 450 million years ago. FUT10-391 and FUT10-419 were expressed in human embryos, whereas FUT10-479 was cloned from adult brain and was not found in embryos. Recombinant FUT10-419 and FUT10-479 have a type II trans-membrane topology and are retained in the endoplasmic reticulum (ER) by a membrane retention signal at their NH2 termini. The FUT10-479 has, in addition, a COOH-ER membrane retention signal. The FUT10-391 is a soluble protein without a transmembrane domain or ER retention signal that transiently localizes to the Golgi and then is routed to the lysosome. After transfection in COS7 cells, the three FUT10s and at least one FUT11, link alpha-L-fucose onto conalbumin glycopeptides and biantennary N-glycan acceptors but not onto short lactosaminyl acceptor substrates as do classical monoexonic alpha 1,3-fucosyltransferases. Modifications of the innermost core GlcNAc of the N-glycan, by substitution with ManNAc or with an opened GlcNAc ring or by the addition of an alpha 1,6-fucose, suggest that the FUT10 transfer is performed on the innermost GlcNAc of the core chitobiose. We can exclude alpha 1,3-fucosylation of the two peripheral GlcNAcs linked to the trimannosyl core of the acceptor, because the FUT10 fucosylated biantennary N-glycan product loses both terminal GlcNAc residues after digestion with human placenta alpha-N-acetylglucosaminidase.	[Mollicone, Rosella; Garcia-Rosasco, Marcela; Candelier, Jean-Jacques; Martinez-Duncker, Ivan; Oriol, Rafael] Univ Paris 11, INSERM, U602, F-94807 Villejuif, France; [Moore, Stuart E. H.] Univ Paris 07, INSERM, U773, CRB3, F-75018 Paris, France; [Bovin, Nicolai] Russian Acad Sci, MM Shemyakin Bioorgan Chem Inst, Moscow 117997, Russia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Mollicone, R (corresponding author), Univ Paris 11, INSERM, U602, 16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	rosella.mollicone@inserm.fr	Bovin, Nicolai/P-2948-2017; Duncker, Ivan Martinez/AAE-6105-2020; Moore, Stuart/AAF-3920-2021	Bovin, Nicolai/0000-0001-8669-4477; Duncker, Ivan Martinez/0000-0001-5626-2892; Moore, Stuart/0000-0002-1020-2242	INSERM; CNRS Groupement de Recherche 2590; Association de la Recherche contre le Cancer [RM-3611]; Fonds National pour la Science [ACI 0693]; EUROGLYCANET; Contract Interface	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS Groupement de Recherche 2590; Association de la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fonds National pour la Science; EUROGLYCANET; Contract Interface	This work was supported in part by INSERM, CNRS Groupement de Recherche 2590, Association de la Recherche contre le Cancer Grant RM-3611, Fonds National pour la Science (ACI 0693 Biologie Cellulaire, Moleculaire et Structurale BMCS152 2004), EUROGLYCANET, and a Contract Interface (INSERM/AP) (to S. E. H. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aebi M, 2001, TRENDS CELL BIOL, V11, P136, DOI 10.1016/S0962-8924(01)01925-0; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baboval T, 2002, MAMM GENOME, V13, P538, DOI 10.1007/s00335-001-2152-5; Bardor M, 2003, GLYCOBIOLOGY, V13, P427, DOI 10.1093/glycob/cwg024; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Breton C, 1998, GLYCOBIOLOGY, V8, P87, DOI 10.1093/glycob/8.1.87; Britten CJ, 1998, GLYCOBIOLOGY, V8, P321, DOI 10.1093/glycob/8.4.321; Cailleau-Thomas A, 2000, GLYCOBIOLOGY, V10, P789, DOI 10.1093/glycob/10.8.789; Candelier JJ, 2000, HISTOCHEM CELL BIOL, V114, P113; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clarke JL, 1996, J BIOL CHEM, V271, P10317, DOI 10.1074/jbc.271.17.10317; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Costache M, 1997, J BIOL CHEM, V272, P29721, DOI 10.1074/jbc.272.47.29721; Costache M, 1997, TRANSFUS CLIN BIOL, V4, P367, DOI 10.1016/S1246-7820(97)80042-0; Coullin P, 2003, CYTOGENET GENOME RES, V103, P111, DOI 10.1159/000076298; Dupuy F, 1999, J BIOL CHEM, V274, P12257, DOI 10.1074/jbc.274.18.12257; Dupuy F, 2004, GLYCOBIOLOGY, V14, P347, DOI 10.1093/glycob/cwh053; Dupuy F, 2002, MOL BIOL EVOL, V19, P815, DOI 10.1093/oxfordjournals.molbev.a004138; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; Faveeuw C, 2003, EUR J IMMUNOL, V33, P1271, DOI 10.1002/eji.200323717; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Javaud C, 2003, GENETICA, V118, P157, DOI 10.1023/A:1024101625214; Kageyama N, 1999, J BIOCHEM-TOKYO, V125, P838, DOI 10.1093/oxfordjournals.jbchem.a022357; KORCHAGINA EY, 1992, BIOORG KHIM+, V18, P283; LEGAULT DJ, 1995, J BIOL CHEM, V270, P20987, DOI 10.1074/jbc.270.36.20987; Leiter H, 1999, J BIOL CHEM, V274, P21830, DOI 10.1074/jbc.274.31.21830; LEMESLEVARLOOT L, 1990, BIOCHIMIE, V72, P555, DOI 10.1016/0300-9084(90)90120-6; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Loriol C, 2006, GLYCOBIOLOGY, V16, P736, DOI 10.1093/glycob/cwj124; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Martinez-Duncker I, 2004, GLYCOBIOLOGY, V14, P13, DOI 10.1093/glycob/cwh006; Martinez-Duncker I, 2003, GLYCOBIOLOGY, V13, p1C, DOI 10.1093/glycob/cwg113; MOLLICONE R, 1992, CARBOHYD RES, V228, P265, DOI 10.1016/S0008-6215(00)90564-0; MOORE SEH, 1994, J BIOL CHEM, V269, P12715; Natunen J, 2001, GLYCOBIOLOGY, V11, P209, DOI 10.1093/glycob/11.3.209; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; Oriol R., 1995, BLOOD CEL B, P37; PALCIC MM, 1988, GLYCOCONJUGATE J, V5, P49, DOI 10.1007/BF01048331; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Petit D, 2006, J MOL EVOL, V63, P353, DOI 10.1007/s00239-005-0189-x; Rendic D, 2006, J BIOL CHEM, V281, P3343, DOI 10.1074/jbc.M508334200; Rendic D, 2007, BIOCHEM J, V402, P105, DOI 10.1042/BJ20060964; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; Saunier K, 2001, MOL BIOL EVOL, V18, P2083, DOI 10.1093/oxfordjournals.molbev.a003749; Staudacher E, 1999, BBA-GEN SUBJECTS, V1473, P216, DOI 10.1016/S0304-4165(99)00181-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRETTER V, 1993, INT ARCH ALLERGY IMM, V102, P259, DOI 10.1159/000236534; van Tetering A, 1999, FEBS LETT, V461, P311, DOI 10.1016/S0014-5793(99)01489-1; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Wierinckx A, 1999, MOL BIOL EVOL, V16, P1535, DOI 10.1093/oxfordjournals.molbev.a026066; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261; Wilson IBH, 2001, BBA-GEN SUBJECTS, V1527, P88, DOI 10.1016/S0304-4165(01)00151-9; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626	66	48	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4723	4738		10.1074/jbc.M809312200	http://dx.doi.org/10.1074/jbc.M809312200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088067	hybrid			2022-12-27	WOS:000263134400072
J	Vetrivel, KS; Meckler, X; Chen, Y; Nguyen, PD; Seidah, NG; Vassar, R; Wong, PC; Fukata, M; Kounnas, MZ; Thinakaran, G				Vetrivel, Kulandaivelu S.; Meckler, Xavier; Chen, Ying; Nguyen, Phuong D.; Seidah, Nabil G.; Vassar, Robert; Wong, Philip C.; Fukata, Masaki; Kounnas, Maria Z.; Thinakaran, Gopal			Alzheimer Disease A beta Production in the Absence of S-Palmitoylation-dependent Targeting of BACE1 to Lipid Rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-PRECURSOR-PROTEIN; TRANS-GOLGI NETWORK; GAMMA-SECRETASE; CHOLESTEROL DEPLETION; CLEAVING ENZYME; GGA PROTEINS; ASPARTYL PROTEASE; HUMAN BRAIN; VHS DOMAIN; CLEAVAGE	Alzheimer disease beta-amyloid (A beta) peptides are generated via sequential proteolysis of amyloid precursor protein (APP) by BACE1 and gamma-secretase. A subset of BACE1 localizes to cholesterol-rich membrane microdomains, termed lipid rafts. BACE1 processing in raft microdomains of cultured cells and neurons was characterized in previous studies by disrupting the integrity of lipid rafts by cholesterol depletion. These studies found either inhibition or elevation of A beta production depending on the extent of cholesterol depletion, generating controversy. The intricate interplay between cholesterol levels, APP trafficking, and BACE1 processing is not clearly understood because cholesterol depletion has pleiotropic effects on Golgi morphology, vesicular trafficking, and membrane bulk fluidity. In this study, we used an alternate strategy to explore the function of BACE1 in membrane microdomains without altering the cellular cholesterol level. We demonstrate that BACE1 undergoes S-palmitoylation at four Cys residues at the junction of transmembrane and cytosolic domains, and Ala substitution at these four residues is sufficient to displace BACE1 from lipid rafts. Analysis of wild type and mutant BACE1 expressed in BACE1 null fibroblasts and neuroblastoma cells revealed that S-palmitoylation neither contributes to protein stability nor subcellular localization of BACE1. Surprisingly, non-raft localization of palmitoylation-deficient BACE1 did not have discernible influence on BACE1 processing of APP or secretion of A beta. These results indicate that post-translational S-palmitoylation of BACE1 is not required for APP processing, and that BACE1 can efficiently cleave APP in both raft and non-raft microdomains.	[Vetrivel, Kulandaivelu S.; Meckler, Xavier; Chen, Ying; Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Vetrivel, Kulandaivelu S.; Meckler, Xavier; Chen, Ying; Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Vetrivel, Kulandaivelu S.; Meckler, Xavier; Chen, Ying; Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Nguyen, Phuong D.; Kounnas, Maria Z.] TorreyPines Therapeut Inc, La Jolla, CA 92037 USA; [Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Vassar, Robert] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Fukata, Masaki] Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Membrane Physiol, Okazaki, Aichi 4448787, Japan	University of Chicago; University of Chicago; University of Chicago; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Thinakaran, G (corresponding author), Knapp R212,924 E 57th St, Chicago, IL 60637 USA.	gopal@uchicago.edu	Fukata, Masaki/AAZ-2476-2021; Seidah, Nabil/I-3596-2013	Fukata, Masaki/0000-0001-5200-9806; Seidah, Nabil/0000-0001-6503-9342	National Institutes of Health [AG021495, AG019070]; Alzheimer's Association [IIRG, NIRG]; Canadian Institutes of Health Research [MOP 44363]; American Federation for Aging Research Fellowship; NATIONAL INSTITUTE ON AGING [R01AG021495, R01AG019070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Federation for Aging Research Fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG021495 and AG019070 (to G. T.). This work was also supported by Alzheimer's Association Grants IIRG (to G. T.) and NIRG (to K. S. V.), Canadian Institutes of Health Research Grant MOP 44363 (to N. G. S.), and an American Federation for Aging Research Fellowship (to X. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Abbal C, 2006, BLOOD, V108, P3352, DOI 10.1182/blood-2006-04-013912; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Cheng HP, 2007, NAT CLIN PRACT NEURO, V3, P374, DOI 10.1038/ncpneuro0549; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hansen GH, 2000, J BIOL CHEM, V275, P5136, DOI 10.1074/jbc.275.7.5136; Hao MM, 2004, J BIOL CHEM, V279, P14171, DOI 10.1074/jbc.M309793200; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Hayashi T, 2005, J CEREBR BLOOD F MET, V25, P41, DOI 10.1038/sj.jcbfm.9600005; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2003, BIOCHEMISTRY-US, V42, P12174, DOI 10.1021/bi035199h; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Kirsch C, 2003, BIOCHEM PHARMACOL, V65, P843, DOI 10.1016/S0006-2952(02)01654-4; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lamb BT, 1999, NAT NEUROSCI, V2, P695, DOI 10.1038/11154; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Li T, 2003, J NEUROSCI, V23, P3272; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; McCormick PJ, 2008, TRAFFIC, V9, P1984, DOI 10.1111/j.1600-0854.2008.00814.x; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Onishi M, 1996, EXP HEMATOL, V24, P324; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Sakurai T, 2008, J CELL BIOL, V183, P339, DOI 10.1083/jcb.200804075; Shiba T, 2004, TRAFFIC, V5, P437, DOI 10.1111/j.1600-0854.2004.00188.x; Shvartsman DE, 2006, TRAFFIC, V7, P917, DOI 10.1111/j.1600-0854.2006.00437.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Wang YZ, 2000, TRAFFIC, V1, P952, DOI 10.1034/j.1600-0854.2000.011205.x; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Won JS, 2008, J NEUROCHEM, V105, P1536, DOI 10.1111/j.1471-4159.2008.05283.x; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xiu J, 2005, J NEUROSCI RES, V82, P531, DOI 10.1002/jnr.20658; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	72	119	123	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3793	3803		10.1074/jbc.M808920200	http://dx.doi.org/10.1074/jbc.M808920200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074428	hybrid, Green Published			2022-12-27	WOS:000262872500048
J	Maki, RA; Tyurin, VA; Lyon, RC; Hamilton, RL; DeKosky, ST; Kagan, VE; Reynolds, WF				Maki, Richard A.; Tyurin, Vladimir A.; Lyon, Robert C.; Hamilton, Ronald L.; DeKosky, Steven T.; Kagan, Valerian E.; Reynolds, Wanda F.			Aberrant Expression of Myeloperoxidase in Astrocytes Promotes Phospholipid Oxidation and Memory Deficits in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MILD COGNITIVE IMPAIRMENT; CORONARY-ARTERY-DISEASE; ACID RESPONSE ELEMENT; LIPID-PEROXIDATION; BREAST-CANCER; REDUCED RISK; POLYMORPHISM; PROTEIN; BRAIN; GENE	Myeloperoxidase (MPO) is expressed in Alzheimer disease ( AD) but not normal aged brain. A functional -463G/A MPO promoter polymorphism has been associated with AD risk through as yet unidentified mechanisms. Here we report that human MPO-463G allele, but not MPO-463A or mouse MPO, is strongly expressed in astrocytes and deposited in plaques in huMPO transgenic mice crossed to the APP23 model. MPO is similarly expressed in astrocytes in human AD tissue. In cortical homogenates of the MPOG-APP23 model, MPO expression correlated with increased levels of a lipid peroxidation product, 4-hydroxynonenal. Fluorescence high-performance liquid chromatography and electrospray ionization mass spectroscopy identified selective accumulation of phospholipid hydroperoxides in two classes of anionic phospholipids, phosphatidylserine (PS-OOH) and phosphatidylinositol (PI-OOH). The same molecular species of PS-OOH and PI-OOH were elevated in human AD brains as compared with non-demented controls. Augmented lipid peroxidation in MPOG-APP23 mice correlated with greater memory deficits. We suggest that aberrant huMPO expression in astrocytes leads to a specific pattern of phospholipid peroxidation and neuronal dysfunction contributing to AD.	[Maki, Richard A.; Lyon, Robert C.; Reynolds, Wanda F.] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; [Tyurin, Vladimir A.; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15219 USA; [Hamilton, Ronald L.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [DeKosky, Steven T.] Univ Pittsburgh, Dept Pathol & Neurol, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reynolds, WF (corresponding author), Sidney Kimmel Canc Ctr, 10905 Rd Cure, San Diego, CA 92121 USA.	wreynolds@skcc.org		DeKosky, Steven/0000-0003-3743-2758; Tyurin, Vladimir/0000-0002-3474-1697; Kagan, Valerian E./0000-0002-7245-1885	National Institutes of Health [AG-017879, HL088428, AG026539]; Pennsylvania Dept. of Health [4100027294]; PHS [R24-MH068855]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG026539, R01AG017879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Dept. of Health; PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG-017879, HL088428 ( to W. R.), and AG026539 ( to V. K.). This work was also supported by the Pennsylvania Dept. of Health ( Grant SAP 4100027294 to V. K.). Human brain tissue samples were generously provided by the Harvard Brain Repository, which is supported by PHS Grant R24-MH068855, and also by Douglas Walker ( Sun Health Research Institute), Eliezer Masliah, and Lawrence Hansen ( University of California at San Diego). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahn J, 2006, CLIN CANCER RES, V12, P7063, DOI 10.1158/1078-0432.CCR-06-0039; Ahn JY, 2004, CANCER RES, V64, P7634, DOI 10.1158/0008-5472.CAN-04-1843; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Ando Y, 1998, J NEUROL SCI, V156, P172, DOI 10.1016/S0022-510X(98)00042-2; Annangudi SP, 2008, CHEM RES TOXICOL, V21, P1384, DOI 10.1021/tx8000303; Asselbergs FW, 2004, AM J MED, V116, P429, DOI 10.1016/j.amjmed.2003.10.025; Astern JM, 2007, AM J PATHOL, V171, P349, DOI 10.2353/ajpath.2007.060831; Baldus S, 2001, J CLIN INVEST, V108, P1759; BOETTCHER C, 1961, ANAL CHIM ACTA, V24, P203, DOI 10.1016/0003-2670(61)80041-X; Borisenko GG, 2003, ARCH BIOCHEM BIOPHYS, V413, P41, DOI 10.1016/S0003-9861(03)00083-3; Bush AI, 2008, EUR BIOPHYS J BIOPHY, V37, P241, DOI 10.1007/s00249-007-0228-1; Butterfield DA, 2006, NEUROBIOL DIS, V22, P223, DOI 10.1016/j.nbd.2005.11.002; Butterfield DA, 2006, NEUROSCI LETT, V397, P170, DOI 10.1016/j.neulet.2005.12.017; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Cascorbi I, 2000, CANCER RES, V60, P644; Castellani LW, 2006, J LIPID RES, V47, P1366, DOI 10.1194/jlr.M600005-JLR200; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Choi DK, 2005, J NEUROSCI, V25, P6594, DOI 10.1523/JNEUROSCI.0970-05.2005; Crawford FC, 2001, EXP NEUROL, V167, P456, DOI 10.1006/exnr.2000.7560; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; FOLCH J, 1957, J BIOL CHEM, V226, P497; Green PS, 2004, J NEUROCHEM, V90, P724, DOI 10.1111/j.1471-4159.2004.02527.x; Heinecke JW, 2002, TOXICOLOGY, V177, P11, DOI 10.1016/S0300-483X(02)00192-0; Hoy A, 2002, CLIN CHEM LAB MED, V40, P2, DOI 10.1515/CCLM.2002.002; Kagan V E, 1998, Methods Mol Biol, V108, P71; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Keller JN, 2005, NEUROLOGY, V64, P1152, DOI 10.1212/01.WNL.0000156156.13641.BA; Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Koudinov AR, 2001, FASEB J, V15, P1858, DOI 10.1096/fj.00-0815fje; Kumar AP, 2005, NITRIC OXIDE-BIOL CH, V13, P42, DOI 10.1016/j.niox.2005.04.002; Kumar AP, 2005, BIOCHEM BIOPH RES CO, V331, P442, DOI 10.1016/j.bbrc.2005.03.204; Kumar AP, 2004, J BIOL CHEM, V279, P8300, DOI 10.1074/jbc.M311625200; Lange MLB, 2008, NEUROBIOL DIS, V29, P456, DOI 10.1016/j.nbd.2007.11.004; Lebig J, 2007, APOPTOSIS, V12, P1803, DOI 10.1007/s10495-007-0113-5; Leininger-Muller B, 2003, NEUROSCI LETT, V349, P95, DOI 10.1016/S0304-3940(03)00795-X; Lovell MA, 2008, NEUROBIOL DIS, V29, P169, DOI 10.1016/j.nbd.2007.07.030; Lovell MA, 2007, J NEUROSCI RES, V85, P3036, DOI 10.1002/jnr.21346; Makela R, 2003, LAB INVEST, V83, P919, DOI 10.1097/01.LAB.0000077981.49367.46; Markesbery WR, 2007, ARCH NEUROL-CHICAGO, V64, P954, DOI 10.1001/archneur.64.7.954; Markesbery WR, 1998, NEUROBIOL AGING, V19, P33, DOI 10.1016/S0197-4580(98)00009-8; Markesbery WR, 2005, ANN NEUROL, V58, P730, DOI 10.1002/ana.20629; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; McGrath LT, 2001, QJM-MON J ASSOC PHYS, V94, P485, DOI 10.1093/qjmed/94.9.485; Modi HR, 2008, J MEMBRANE BIOL, V221, P51, DOI 10.1007/s00232-007-9086-0; Moreira Paula I, 2005, Curr Alzheimer Res, V2, P403; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nikpoor B, 2001, AM HEART J, V142, P336, DOI 10.1067/mhj.2001.116769; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Picklo MJ, 2002, TOXICOL APPL PHARM, V184, P187, DOI 10.1006/taap.2002.9506; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Pope SK, 2006, AM J EPIDEMIOL, V163, P1084, DOI 10.1093/aje/kwj146; Reynolds WF, 2006, BIOCHEM BIOPH RES CO, V349, P846, DOI 10.1016/j.bbrc.2006.08.119; Reynolds WF, 2000, NEUROLOGY, V55, P1284, DOI 10.1212/WNL.55.9.1284; Reynolds WF, 1999, EXP NEUROL, V155, P31, DOI 10.1006/exnr.1998.6977; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Schabath MB, 2002, LUNG CANCER-J IASLC, V37, P35, DOI 10.1016/S0169-5002(02)00034-X; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sompol P, 2008, NEUROSCIENCE, V153, P120, DOI 10.1016/j.neuroscience.2008.01.044; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sultana R, 2006, NEUROBIOL AGING, V27, P1564, DOI 10.1016/j.neurobiolaging.2005.09.021; VANSANT G, 1995, P NATL ACAD SCI USA, V92, P8229, DOI 10.1073/pnas.92.18.8229; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Williams TI, 2006, NEUROBIOL AGING, V27, P1094, DOI 10.1016/j.neurobiolaging.2005.06.004; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Yang JJ, 2001, AM J PATHOL, V158, P581, DOI 10.1016/S0002-9440(10)64000-X; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zappia M, 2004, ARCH NEUROL-CHICAGO, V61, P341, DOI 10.1001/archneur.61.3.341; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	76	91	96	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3158	3169		10.1074/jbc.M807731200	http://dx.doi.org/10.1074/jbc.M807731200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19059911	Green Published, hybrid			2022-12-27	WOS:000262700900060
J	Carroll, RK; Liao, XB; Morgan, LK; Cicirelli, EM; Li, YH; Sheng, WY; Feng, XH; Kenney, LJ				Carroll, Ronan K.; Liao, Xiubei; Morgan, Leslie K.; Cicirelli, Elisha M.; Li, Yuanhe; Sheng, Wanyun; Feng, Xiuhong; Kenney, Linda J.			Structural and Functional Analysis of the C-terminal DNA Binding Domain of the Salmonella typhimurium SPI-2 Response Regulator SsrB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENICITY ISLAND 2; III SECRETION SYSTEM; ESCHERICHIA-COLI; ERWINIA-AMYLOVORA; CRYSTAL-STRUCTURE; H-NS; PROTEIN; OMPR; RECOGNITION; PHOSPHORYLATION	In bacterial pathogenesis, virulence gene regulation is controlled by two-component regulatory systems. In Escherichia coli, the EnvZ/OmpR two-component system is best understood as regulating expression of outer membrane proteins, but in Salmonella enterica, OmpR activates transcription of the SsrA/B two-component system located on Salmonella pathogenicity island 2 (SPI-2). The response regulator SsrB controls expression of a type III secretory system in which effectors modify the vacuolar membrane and prevent its degradation via the endocytic pathway. Vacuolar modification enables Salmonella to survive and replicate in the macrophage phagosome and disseminate to the liver and spleen to cause systemic infection. The signals that activate EnvZ and SsrA are unknown but are related to the acidic pH encountered in the vacuole. Our previous work established that SsrB binds to regions of DNA that are AT-rich, with poor sequence conservation. Although SsrB is a major virulence regulator in Salmonella, very little is known regarding how it binds DNA and activates transcription. In the present work, we solved the structure of the C-terminal DNA binding domain of SsrB (SsrBC) by NMR and analyzed the effect of amino acid substitutions on function. We identified residues in the DNA recognition helix (Lys(179), Met(186)) and the dimerization interface (Val(197), Leu(201)) that are important for SsrB transcriptional activation and DNA binding. An essential cysteine residue in the N-terminal receiver domain was also identified (Cys(45)), and the effect of Cys(203) on dimerization was evaluated. Our results suggest that although disulfide bond formation is not required for dimerization, dimerization occurs upon DNA binding and is required for subsequent activation of transcription. Disruption of the dimer interface by a C203E substitution reduces SsrB activity. Modification of Cys(203) or Cys(45) may be an important mode of SsrB inactivation inside the host.	[Carroll, Ronan K.; Morgan, Leslie K.; Cicirelli, Elisha M.; Kenney, Linda J.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Liao, Xiubei; Li, Yuanhe; Sheng, Wanyun] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA; [Feng, Xiuhong] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97202 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Oregon Health & Science University	Kenney, LJ (corresponding author), 835 S Wolcott,M-C 790, Chicago, IL 60612 USA.	kenneyl@uic.edu			National Institutes of Health [GM058746]; National Science Foundation [MCB0613014]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM058746 from the National Institutes of Health (to L.J.K.). This work was also supported by Grant MCB0613014 from the National Science Foundation.	Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; Chen GZ, 2007, P NATL ACAD SCI USA, V104, P16474, DOI 10.1073/pnas.0704843104; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Collazo CM, 1997, GENE, V192, P51, DOI 10.1016/S0378-1119(96)00825-6; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Ducros VMA, 2001, J MOL BIOL, V306, P759, DOI 10.1006/jmbi.2001.4443; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kurashima-Ito K, 2005, BIOCHEMISTRY-US, V44, P14835, DOI 10.1021/bi0509043; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Maris AE, 2005, BIOCHEMISTRY-US, V44, P14538, DOI 10.1021/bi050734u; Maris AE, 2005, J MOL BIOL, V350, P843, DOI 10.1016/j.jmb.2005.05.057; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Mattison K, 2002, J MOL BIOL, V315, P497, DOI 10.1006/jmbi.2001.5222; McCollister BD, 2005, J EXP MED, V202, P625, DOI 10.1084/jem.20050246; Milani M, 2005, STRUCTURE, V13, P1289, DOI 10.1016/j.str.2005.05.014; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; OSBORNE S, 2009, P NATL ACAD SCI USA, V106, P3892; Pristovsek P, 2003, J BIOL CHEM, V278, P17752, DOI 10.1074/jbc.M301328200; Rhee JE, 2008, J BIOL CHEM, V283, P8664, DOI 10.1074/jbc.M705550200; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Tran VK, 2000, J MOL BIOL, V299, P1257, DOI 10.1006/jmbi.2000.3809; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Wehland M, 1999, J BIOL CHEM, V274, P3300, DOI 10.1074/jbc.274.6.3300; Wisedchaisri G, 2005, J MOL BIOL, V354, P630, DOI 10.1016/j.jmb.2005.09.048; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; Zhang RG, 2002, NATURE, V417, P971, DOI 10.1038/nature00833	42	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12008	12019		10.1074/jbc.M806261200	http://dx.doi.org/10.1074/jbc.M806261200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19126546	Green Published, hybrid			2022-12-27	WOS:000265494600033
J	Hu, CL; Depuy, SD; Yao, JL; McIntire, WE; Barrett, PQ				Hu, Changlong; Depuy, Seth D.; Yao, Junlan; McIntire, William E.; Barrett, Paula Q.			Protein Kinase A Activity Controls the Regulation of T-type Ca(V)3.2 Channels by G beta gamma Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CALCIUM CURRENTS; ADRENAL GLOMERULOSA CELLS; DOPAMINE D2 RECEPTOR; CA2+ CHANNELS; ALDOSTERONE SECRETION; MOLECULAR-BASIS; GENE FAMILY; LOW-VOLTAGE; MODULATION; INHIBITION	Low voltage-activated (LVA), T-type, calcium channels mediate diverse biological functions and are inhibited by G beta gamma dimers, yet the molecular events required for channel inhibition remain unknown. Here, we identify protein kinase A (PKA) as a molecular switch that allows G beta(2)gamma x dimers to effect voltage-independent inhibition of Ca(v)3.2 channels. Inhibition requires phosphorylation of Ser(1107), a critical serine residue on the II-III loop of the channel pore protein. S1107A prevents inhibition of unitary currents by recombinant G beta(2)gamma x dimers but does not disrupt dimer binding nor change its specificity. G beta gamma dimers released upon receptor activation also require PKA activity for their inhibitory actions. Hence, dopamine inhibition of Cav3.2 whole cell current is precluded by G beta gamma-scavenger proteins or a peptide that blocks PKA catalytic activity. Fittingly, when used alone at receptor-selective concentrations, D-1 or D-2 agonists do not elicit channel inhibition yet together synergize to inhibit Cav3.2 channel currents. We propose that a dual-receptor regulatory mechanism is used by dopamine to control Cav3.2 channel activity. This mechanism, for example, would be important in aldosterone producing adrenal glomerulosa cells where channel dysregulation would lead to overproduction of aldosterone and consequent cardiac, renal, and brain target organ damage.	[Hu, Changlong; Depuy, Seth D.; Yao, Junlan; McIntire, William E.; Barrett, Paula Q.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Barrett, PQ (corresponding author), 1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	pqb4b@virginia.edu	Barrett, Paula/AAY-1056-2021; Hu, Changlong/AAQ-8348-2020	Hu, Changlong/0000-0002-8609-8947	NHLBI NIH HHS [HL36977] Funding Source: Medline; NIDDK NIH HHS [P30 DK067629] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alvarez JL, 1996, J PHYSIOL-LONDON, V491, P321, DOI 10.1113/jphysiol.1996.sp021218; Armando I, 2007, HYPERTENSION, V49, P672, DOI 10.1161/01.HYP.0000254486.00883.3d; Arnot MI, 2000, J PHYSIOL-LONDON, V527, P203, DOI 10.1111/j.1469-7793.2000.00203.x; Barrett PQ, 2000, AM J PHYSIOL-CELL PH, V279, pC1694, DOI 10.1152/ajpcell.2000.279.6.C1694; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; CAREY RM, 1980, J CLIN INVEST, V66, P10, DOI 10.1172/JCI109822; CAREY RM, 1982, J CLIN ENDOCR METAB, V54, P463, DOI 10.1210/jcem-54-2-463; Chemin J, 2007, J BIOL CHEM, V282, P32710, DOI 10.1074/jbc.M702746200; Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015; Chen C, 2000, IMMUNOL CELL BIOL, V78, P356, DOI 10.1046/j.1440-1711.2000.00917.x; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cote M, 2001, J CLIN ENDOCR METAB, V86, P4495, DOI 10.1210/jc.86.9.4495; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Depuy SD, 2006, P NATL ACAD SCI USA, V103, P14590, DOI 10.1073/pnas.0603945103; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Drolet P, 1997, MOL ENDOCRINOL, V11, P503, DOI 10.1210/me.11.4.503; Garcia DE, 1998, J NEUROSCI, V18, P9163; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; GROSS RA, 1990, P NATL ACAD SCI USA, V87, P7025, DOI 10.1073/pnas.87.18.7025; GROSS RA, 1990, J PHYSIOL-LONDON, V429, P483, DOI 10.1113/jphysiol.1990.sp018268; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Hopf FW, 2003, J NEUROSCI, V23, P5079; Jarvis SE, 2001, TRENDS PHARMACOL SCI, V22, P519, DOI 10.1016/S0165-6147(00)01800-9; Kawai F, 1999, NAT NEUROSCI, V2, P133, DOI 10.1038/5686; KEJA JA, 1992, J PHYSIOL-LONDON, V450, P409, DOI 10.1113/jphysiol.1992.sp019134; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; KOBRINSKY EM, 1994, NEUROSCIENCE, V58, P539, DOI 10.1016/0306-4522(94)90079-5; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Lenglet S, 2000, ENDOCR RES, V26, P597, DOI 10.3109/07435800009048577; LLEDO PM, 1990, BRAIN RES, V528, P143, DOI 10.1016/0006-8993(90)90207-R; LLEDO PM, 1990, ENDOCRINOLOGY, V127, P990, DOI 10.1210/endo-127-3-990; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Myung CS, 1999, J BIOL CHEM, V274, P16595, DOI 10.1074/jbc.274.23.16595; NILIUS B, 1985, NATURE, V316, P443, DOI 10.1038/316443a0; NOTH RH, 1980, J CLIN ENDOCR METAB, V51, P64, DOI 10.1210/jcem-51-1-64; OSIPENKO ON, 1994, ENDOCRINOLOGY, V134, P511, DOI 10.1210/en.134.1.511; PEREZREYES E, 1994, FEBS LETT, V342, P119, DOI 10.1016/0014-5793(94)80484-2; PFEIFFERLINN C, 1993, J GEN PHYSIOL, V102, P277, DOI 10.1085/jgp.102.2.277; Pivonello R, 2004, J CLIN ENDOCR METAB, V89, P4493, DOI 10.1210/jc.2003-031746; Ruiz-Velasco V, 2000, J NEUROSCI, V20, P2183; Schrier AD, 2001, AM J PHYSIOL-CELL PH, V280, pC265, DOI 10.1152/ajpcell.2001.280.2.C265; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Talley EM, 1999, J NEUROSCI, V19, P1895; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; WILLIAMS PJ, 1990, J NEUROSCI, V10, P757; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; Wu KD, 2001, J CLIN ENDOCR METAB, V86, P4460, DOI 10.1210/jc.86.9.4460; Yao JL, 2006, J CLIN INVEST, V116, P2403, DOI 10.1172/JCI27918; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zeng CY, 2004, PHYSIOL GENOMICS, V19, P233, DOI 10.1152/physiolgenomics.00127.2004	54	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7465	7473		10.1074/jbc.M808049200	http://dx.doi.org/10.1074/jbc.M808049200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19131331	Green Published, hybrid			2022-12-27	WOS:000264195600010
J	Hasadsri, L; Kreuter, J; Hattori, H; Iwasaki, T; George, JM				Hasadsri, Linda; Kreuter, Joerg; Hattori, Hiroaki; Iwasaki, Tadao; George, Julia M.			Functional Protein Delivery into Neurons Using Polymeric Nanoparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEIN; BLOOD-BRAIN-BARRIER; CHAPERONE-MEDIATED AUTOPHAGY; SOLID LIPID NANOPARTICLES; RESONANCE ENERGY-TRANSFER; ALPHA-SYNUCLEIN; GENE DELIVERY; HIGH-EFFICIENCY; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE	An efficient route for delivering specific proteins and peptides into neurons could greatly accelerate the development of therapies for various diseases, especially those involving intracellular defects such as Parkinson disease. Here we report the novel use of polybutylcyanoacrylate nanoparticles for delivery of intact, functional proteins into neurons and neuronal cell lines. Uptake of these particles is primarily dependent on endocytosis via the low density lipoprotein receptor. The nanoparticles are rapidly turned over and display minimal toxicity to cultured neurons. Delivery of three different functional cargo proteins is demonstrated. When primary neuronal cultures are treated with recombinant Escherichia coli beta-galactosidase as nanoparticle cargo, persistent enzyme activity is measured beyond the period of nanoparticle degradation. Delivery of the small GTPase rhoG induces neurite outgrowth and differentiation in PC12 cells. Finally, a monoclonal antibody directed against synuclein is capable of interacting with endogenous alpha-synuclein in cultured neurons following delivery via nanoparticles. Polybutylcyanoacrylate nanoparticles are thus useful for intracellular protein delivery in vitro and have potential as carriers of therapeutic proteins for treatment of neuronal disorders in vivo.	[George, Julia M.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Hasadsri, Linda] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Hasadsri, Linda] Univ Illinois, Coll Med, Med Scholars Program, Urbana, IL 61801 USA; [Kreuter, Joerg] Univ Frankfurt, Biozentrum, Inst Pharmazeut Technol, D-60439 Frankfurt, Germany; [Hattori, Hiroaki; Iwasaki, Tadao] BML Inc, Dept Adv Med Technol & Dev, Kawagoe, Saitama 3501101, Japan	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Goethe University Frankfurt; BML, Inc.	George, JM (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 524 Burrill Hall,407 S Goodwin Ave, Urbana, IL 61801 USA.	j-george@illinois.edu	George, Julia M/B-2169-2008	George, Julia M/0000-0001-6194-6914	NIA NIH HHS [R01 AG13762] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07283] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013762] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; AltmanHamamdzic S, 1997, GENE THER, V4, P815, DOI 10.1038/sj.gt.3300458; ALYAUTDIN R, 1995, EUR J PHARM BIOPHARM, V41, P44; Amalfitano Andrea, 2002, Current Gene Therapy, V2, P111, DOI 10.2174/1566523024605618; Barka T, 2000, J HISTOCHEM CYTOCHEM, V48, P1453, DOI 10.1177/002215540004801102; Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; Bender FLP, 2007, HISTOCHEM CELL BIOL, V127, P439, DOI 10.1007/s00418-006-0247-5; Bergen JM, 2008, PHARM RES-DORDR, V25, P983, DOI 10.1007/s11095-007-9439-5; Berges BK, 2007, MOL THER, V15, P20, DOI 10.1038/sj.mt.6300018; Blasi P, 2007, ADV DRUG DELIVER REV, V59, P454, DOI 10.1016/j.addr.2007.04.011; Buchser WJ, 2006, BIOTECHNIQUES, V41, P619, DOI 10.2144/000112279; Cai D, 2005, NAT METHODS, V2, P449, DOI 10.1038/NMETH761; Cesnulevicius K, 2006, STEM CELLS, V24, P2776, DOI 10.1634/stemcells.2006-0176; CHANDLER LP, 1985, J BIOL CHEM, V260, P3360; Chauvierre C, 2007, INT J PHARM, V338, P327, DOI 10.1016/j.ijpharm.2007.01.034; Day RN, 2003, MOL ENDOCRINOL, V17, P333, DOI 10.1210/me.2002-0136; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; DOUGLAS SJ, 1987, CRIT REV THER DRUG, V3, P233; Ehrengruber MU, 2001, MOL CELL NEUROSCI, V17, P855, DOI 10.1006/mcne.2001.0982; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Elkabetz Y, 2003, J BIOL CHEM, V278, P18922, DOI 10.1074/jbc.M208730200; Emadi S, 2004, BIOCHEMISTRY-US, V43, P2871, DOI 10.1021/bi036281f; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Gartner A, 2006, METHOD ENZYMOL, V406, P374, DOI 10.1016/S0076-6879(06)06027-7; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Goppert TM, 2005, J DRUG TARGET, V13, P179, DOI 10.1080/10611860500071292; Gresch O, 2004, METHODS, V33, P151, DOI 10.1016/j.ymeth.2003.11.009; Gulyaev AE, 1999, PHARM RES-DORDR, V16, P1564, DOI 10.1023/A:1018983904537; HAYLETT T, 1991, J BIOL CHEM, V266, P8322; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; Janson CG, 2001, TRENDS NEUROSCI, V24, P706, DOI 10.1016/S0166-2236(00)01954-8; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Kaushik S., 2008, V445, P227, DOI 10.1007/978-1-59745-157-4_15; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; Kosaka S, 2001, CIRCULATION, V103, P1142, DOI 10.1161/01.CIR.103.8.1142; Kreuter J, 2003, PHARM RES-DORDR, V20, P409, DOI 10.1023/A:1022604120952; Kreuter J, 2002, J DRUG TARGET, V10, P317, DOI 10.1080/10611860290031877; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; KREUTER J, 1995, BRAIN RES, V674, P171, DOI 10.1016/0006-8993(95)00023-J; KUBIAK C, 1989, BIOMATERIALS, V10, P553, DOI 10.1016/0142-9612(89)90062-8; Leclere PG, 2005, J NEUROSCI METH, V142, P137, DOI 10.1016/j.jneumeth.2004.08.012; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; MERESSE S, 1989, J NEUROCHEM, V53, P340, DOI 10.1111/j.1471-4159.1989.tb07340.x; Messer A, 2006, BIODRUGS, V20, P327, DOI 10.2165/00063030-200620060-00002; Mills JC, 1997, EXP CELL RES, V231, P337, DOI 10.1006/excr.1997.3474; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; MOGHIMI SM, 1993, BIOCHIM BIOPHYS ACTA, V1179, P157, DOI 10.1016/0167-4889(93)90137-E; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; MULLER RH, 1992, INT J PHARM, V84, P1, DOI 10.1016/0378-5173(92)90209-K; Nagel F, 2008, J NEUROCHEM, V105, P853, DOI 10.1111/j.1471-4159.2007.05204.x; Ohki EC, 2001, J NEUROSCI METH, V112, P95, DOI 10.1016/S0165-0270(01)00441-1; Olivier JC, 1999, PHARMACEUT RES, V16, P1836, DOI 10.1023/A:1018947208597; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Reis SA, 2004, J MOL HISTOL, V35, P389; Royo NC, 2008, BRAIN RES, V1190, P15, DOI 10.1016/j.brainres.2007.11.015; Sharma N, 2001, AM J PATHOL, V159, P339, DOI 10.1016/S0002-9440(10)61700-2; Slack RS, 1996, CURR OPIN NEUROBIOL, V6, P576, DOI 10.1016/S0959-4388(96)80088-2; SMITH RL, 1995, J VIROL, V69, P4593, DOI 10.1128/JVI.69.8.4593-4599.1995; Soto C, 2008, ARCH NEUROL-CHICAGO, V65, P184, DOI 10.1001/archneurol.2007.56; Takahashi M, 2001, CLIN GENET, V59, P290, DOI 10.1034/j.1399-0004.2001.590414.x; Teruel MN, 1999, J NEUROSCI METH, V93, P37, DOI 10.1016/S0165-0270(99)00112-0; VASILE E, 1983, J CELL BIOL, V96, P1677, DOI 10.1083/jcb.96.6.1677; Vauthier C, 2003, ADV DRUG DELIVER REV, V55, P519, DOI 10.1016/S0169-409X(03)00041-3; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Washbourne P, 2002, CURR OPIN NEUROBIOL, V12, P566, DOI 10.1016/S0959-4388(02)00365-3; Whittlesey KJ, 2006, BIOMATERIALS, V27, P2477, DOI 10.1016/j.biomaterials.2005.11.016; Windisch M, 2008, NEURODEGENER DIS, V5, P218, DOI 10.1159/000113707; Windisch M, 2004, J MOL NEUROSCI, V24, P155, DOI 10.1385/JMN:24:1:155; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Yu L, 2001, J CONTROL RELEASE, V72, P179, DOI 10.1016/S0168-3659(01)00274-7; Zeitelhofer M, 2007, NAT PROTOC, V2, P1692, DOI 10.1038/nprot.2007.226; Zhou C, 2004, MOL THER, V10, P1023, DOI 10.1016/j.ymthe.2004.08.019	75	102	127	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6972	6981		10.1074/jbc.M805956200	http://dx.doi.org/10.1074/jbc.M805956200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129199	Green Published, hybrid			2022-12-27	WOS:000263919000045
J	Elliott, JM; Rouge, L; Wiesmann, C; Scheer, JM				Elliott, J. Michael; Rouge, Lionel; Wiesmann, Christian; Scheer, Justin M.			Crystal Structure of Procaspase-1 Zymogen Domain Reveals Insight into Inflammatory Caspase Autoactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; ACTIVATION MECHANISM; INITIATOR CASPASES; ALLOSTERIC SITE; PROTEIN; GENERATION; DRONC; PURIFICATION; SPECIFICITY; INHIBITOR	One key event in inflammatory signaling is the activation of the initiator caspase, procaspase-1. Presented here is the crystal structure of the procaspase-1 zymogen without its caspase recruitment domain solved to 2.05 angstrom. Although the isolated domain is monomeric in solution, the protein appeared dimeric in crystals. The loop arrangements in the dimer provide insight into the first autoproteolytic events that occur during activation by oligomerization. Additionally, in contrast to other caspases, we demonstrate that autoproteolysis at the second cleavage site, Asp(316), is necessary for conversion to a stable dimer in solution. Critical elements of secondary structure are revealed in the crystal structure that explain why a dimeric protein is favored after proteolysis at this aspartic acid. Dimer stabilization is concurrent with a 130-fold increase in k(cat), the sole contributing kinetic factor to an activated and efficient mediator of inflammation.	[Elliott, J. Michael; Scheer, Justin M.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Rouge, Lionel; Wiesmann, Christian] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Scheer, JM (corresponding author), Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA.	scheer.justin@gene.com		Wiesmann, Christian/0000-0002-4092-9880	Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, United States Department of Energy [DE-AC03-76SF00098]	Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, United States Department of Energy(United States Department of Energy (DOE))	We acknowledge the Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, United States Department of Energy under Contract DE-AC03-76SF00098 at Lawrence Berkeley National Laboratory. We thank Richard Vandlen for support, guidance, and manuscript review; Jiansheng Wu and Katrina Nicholes for advice and suggestions; and Hok Seon Kim, Dan Yansura, Cecelia Brown, and Art Huang for providing materials.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; BLACK RA, 1989, J BIOL CHEM, V264, P5323; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; Chen M, 2002, J BIOL CHEM, V277, P50761, DOI 10.1074/jbc.M210356200; Cornelis S, 2007, CURR PHARM DESIGN, V13, P367, DOI 10.2174/138161207780163006; Dorstyn L, 2008, CELL DEATH DIFFER, V15, P461, DOI 10.1038/sj.cdd.4402288; Druilhe A, 2001, CELL DEATH DIFFER, V8, P649, DOI 10.1038/sj.cdd.4400881; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahr BT, 2006, BIOORG MED CHEM LETT, V16, P559, DOI 10.1016/j.bmcl.2005.10.048; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Joshi VD, 2002, INFECT IMMUN, V70, P6896, DOI 10.1128/IAI.70.12.6896-6903.2002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2004, J BIOL CHEM, V279, P51729, DOI 10.1074/jbc.M407891200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SH, 2001, J BIOL CHEM, V276, P34495, DOI 10.1074/jbc.M101415200; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Piana S, 2003, BIOCHEMISTRY-US, V42, P8720, DOI 10.1021/bi034032l; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Romanowski MJ, 2004, STRUCTURE, V12, P1361, DOI 10.1016/j.str.2004.05.010; Scheer JM, 2005, PROTEIN EXPRES PURIF, V41, P148, DOI 10.1016/j.pep.2005.01.008; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Scheer JM, 2009, CRC ENZYM INHIB SER, P225; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; Snipas SJ, 2008, CELL DEATH DIFFER, V15, P938, DOI 10.1038/cdd.2008.23; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Yan N, 2006, J BIOL CHEM, V281, P8667, DOI 10.1074/jbc.M513232200	48	60	60	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6546	6553		10.1074/jbc.M806121200	http://dx.doi.org/10.1074/jbc.M806121200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19117953	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000263742700057
J	Zang, Y; Yu, LF; Nan, FJ; Feng, LY; Li, J				Zang, Yi; Yu, Li-Fang; Nan, Fa-Jun; Feng, Lin-Yin; Li, Jia			AMP-activated Protein Kinase Is Involved in Neural Stem Cell Growth Suppression and Cell Cycle Arrest by 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and Glucose Deprivation by Down-regulating Phospho-retinoblastoma Protein and Cyclin D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATION IN-VITRO; SELF-RENEWAL; DIFFERENTIATION; BRAIN; PHOSPHORYLATION; APOPTOSIS; DERIVATIVES; GLYCOLYSIS; EXPRESSION; SURVIVAL	The fate of neural stem cells (NSCs), including their proliferation, differentiation, survival, and death, is regulated by multiple intrinsic signals and the extrinsic environment. We had previously reported that 5-aminoimidazole-4-carboxamide-1-beta D-ribofuranoside (AICAR) directly induces astroglial differentiation of NSCs by activation of the Janus kinase (JAK)/ Signal transducer and activator of transcription 3 (STAT3) pathway independently of AMP-activated protein kinase (AMPK). Here, we reported the observation that AICAR inhibited NSC proliferation and its underlying mechanism. Analysis of caspase activity and cell cycle showed that AICAR induced G(1)/G(0) cell cycle arrest in NSCs, associated with decreased levels of poly(ADP-ribose) polymerase, phosphoretinoblastoma protein (Rb), and cyclin D but did not cause apoptosis. Iodotubericidin and Compound C, inhibitors of adenosine kinase and AMPK, respectively, or overexpression of a dominant-negative mutant of AMPK, but not JAK inhibitor, were able to reverse the anti-proliferative effect of AICAR. Glucose deprivation also activated the AMPK pathway, induced G(0)/G(1) arrest, and suppressed the proliferation of NSCs, an effect associated with decreased levels of phospho-Rb and cyclin D protein. Furthermore, Compound C and overexpression of dominant-negative AMPK in C17.2 NSCs could block the glucose deprivation-mediated down-regulation of cyclin D and partially reverse the suppression of proliferation. These results suggest that AICAR and glucose deprivation might induce G(1)/G(0) cell cycle arrest and suppress proliferation of NSCs via phospho-Rb and cyclin D down-regulation. AMPK, but not JAK/STAT3, activation is key for this inhibitory effect and may play an important role in the responses of NSCs to metabolic stresses such as glucose deprivation.	[Zang, Yi; Yu, Li-Fang; Nan, Fa-Jun; Li, Jia] Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [Feng, Lin-Yin] Chinese Acad Sci, Neurol Pharmacol Dept, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS	Li, J (corresponding author), 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	jli@mail.shcnc.ac.cn	Zang, Yi/C-5683-2014; Li, Jia/F-9116-2011; li, jia/GVT-7587-2022	Zang, Yi/0000-0001-9835-922X; 	National Natural Science Foundation of China [30800559]; National Basic Research Program of China [2007CB914201, 2009CB940900]; Shanghai Commission of Science and Technology [08ZR1403700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by National Natural Science Foundation of China Grant 30800559, National Basic Research Program of China Grants 2007CB914201 and 2009CB940900, and Shanghai Commission of Science and Technology Grant 08ZR1403700.	Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Ambrogini P, 2005, NEUROENDOCRINOLOGY, V81, P244, DOI 10.1159/000087648; ANCHAN RM, 1995, J NEUROBIOL, V28, P133, DOI 10.1002/neu.480280202; Ayuso-Sacido Angel, 2006, Curr Stem Cell Res Ther, V1, P387; Blazquez C, 2001, FEBS LETT, V489, P149, DOI 10.1016/S0014-5793(01)02089-0; Brandenberger Ralph, 2004, BMC Developmental Biology, V4, P1; Brannvall K, 2002, MOL CELL NEUROSCI, V21, P512, DOI 10.1006/mcne.2002.1194; Carbone M, 2008, ONCOGENE, V27, P6083, DOI 10.1038/onc.2008.221; Carling D, 2004, CURR BIOL, V14, pR220, DOI 10.1016/j.cub.2004.02.048; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cremisi F, 2003, CURR OPIN NEUROBIOL, V13, P26, DOI 10.1016/S0959-4388(03)00005-9; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; De Blasio A, 2005, FEBS LETT, V579, P615, DOI 10.1016/j.febslet.2004.12.028; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fowler CD, 2005, J COMP NEUROL, V489, P166, DOI 10.1002/cne.20638; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Georgopoulou N, 2006, J BIOL CHEM, V281, P33606, DOI 10.1074/jbc.M602689200; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Harnacke K, 2005, EUR J CELL BIOL, V84, P885, DOI 10.1016/j.ejcb.2005.08.009; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hienola A, 2004, MOL CELL NEUROSCI, V26, P75, DOI 10.1016/j.mcn.2004.01.018; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Karsten SL, 2003, DEV BIOL, V261, P165, DOI 10.1016/S0012-1606(03)00274-4; Kishi Y, 2005, J NEUROSCI RES, V79, P279, DOI 10.1002/jnr.20362; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lasky JL, 2005, PEDIATR RES, V57, p104R, DOI 10.1203/01.PDR.0000159632.70510.3D; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Miller JP, 2007, CELL CYCLE, V6, P2932, DOI 10.4161/cc.6.23.5042; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Oliver TG, 2004, NEURON, V42, P885, DOI 10.1016/j.neuron.2004.06.011; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Sommer L, 2002, PROG NEUROBIOL, V66, P1, DOI 10.1016/S0301-0082(01)00022-3; Villa A, 2004, EXP CELL RES, V294, P559, DOI 10.1016/j.yexcr.2003.11.025; Wada K, 2006, J BIOL CHEM, V281, P12673, DOI 10.1074/jbc.M513786200; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Yeoh JSG, 2007, MECH AGEING DEV, V128, P17, DOI 10.1016/j.mad.2006.11.005; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2; Zang Y, 2008, J BIOL CHEM, V283, P6201, DOI 10.1074/jbc.M708619200; Zeng XM, 2007, STEM CELL REV, V3, P270, DOI 10.1007/s12015-007-9005-x; Zhang YH, 2006, FEBS J, V273, P4842, DOI 10.1111/j.1742-4658.2006.05483.x	56	40	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6175	6184		10.1074/jbc.M806887200	http://dx.doi.org/10.1074/jbc.M806887200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19144636	hybrid			2022-12-27	WOS:000263742700020
J	Bogachev, AV; Belevich, NP; Bertsova, YV; Verkhovsky, MI				Bogachev, Alexander V.; Belevich, Nikolai P.; Bertsova, Yulia V.; Verkhovsky, Michael I.			Primary Steps of the Na+-translocating NADH: Ubiquinone Oxidoreductase Catalytic Cycle Resolved by the Ultrafast Freeze-Quench Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINONE OXIDOREDUCTASE; VIBRIO-ALGINOLYTICUS; ELECTRON-TRANSFER; NQRC SUBUNITS; CHOLERAE; HARVEYI; REDUCTASE; PURIFICATION; RIBOFLAVIN; COMPLEX	The Na+-translocating NADH: ubiquinone oxidoreductase (Na+ - NQR) is a component of respiratory chain of various bacteria, and it generates a redox-driven transmembrane electrochemical Na+ potential. Primary steps of the catalytic cycle of Na+ - NQR from Vibrio harveyi were followed by the ultrafast freeze-quench approach in combination with conventional stopped-flow technique. The obtained sequence of events includes NADH binding (similar to 1.5 x 10(7) M-1 s(-1)), hydride ion transfer from NADH to FAD (similar to 3.5 x 10(3) s(-1)), and partial electron separation and formation of equivalent fractions of reduced 2Fe-2S cluster and neutral semiquinone of FAD (similar to 0.97 x 10(3) s(-1)). In the last step, a quasi-equilibrium is approached between the two states of FAD: two-electron reduced (50%) and one-electron reduced (the other 50%) species. The latter, neutral semiquinone of FAD, shares the second electron with the 2Fe-2S center. The transient midpoint redox potentials for the cofactors obtained during the fast kinetics measurements are very different from ones achieved during equilibrium redox titration and show that the functional states of the enzyme realized during its turning over cannot be modeled by the equilibrium approach.	[Bogachev, Alexander V.; Bertsova, Yulia V.] Moscow MV Lomonosov State Univ, Dept Mol Energet Microorganisms, Belozersky Inst Physicochem Biol, Moscow 119992, Russia; [Belevich, Nikolai P.; Verkhovsky, Michael I.] Univ Helsinki, Inst Biotechnol, Helsinki Bioenerget Grp, Helsinki 00014, Finland	Lomonosov Moscow State University; University of Helsinki	Verkhovsky, MI (corresponding author), Moscow MV Lomonosov State Univ, Dept Mol Energet Microorganisms, Belozersky Inst Physicochem Biol, Moscow 119992, Russia.	michael.verkhovsky@helsinki.fi	Bogachev, Alexander V/E-5844-2012; Bertsova, Yulia V./B-5505-2014	Bogachev, Alexander V/0000-0003-3035-4494; 	Biocentrum Helsinki [7919028]; Sigrid Juselius Foundation [4700827]; Academy of Finland [115108]; Russian Foundation for Basic Research [07-04-00619]	Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by grants from the Biocentrum Helsinki (Project Number 7919028), the Sigrid Juselius Foundation (Project Number 4700827), the Academy of Finland (Project Number 115108), and the Russian Foundation for Basic Research (Project Number 07-04-00619).	Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; BATIE CJ, 1984, J BIOL CHEM, V259, P1976; Bogachev AV, 2001, BIOCHEMISTRY-US, V40, P7318, DOI 10.1021/bi002545b; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; Bogachev AV, 2002, BBA-BIOENERGETICS, V1556, P113, DOI 10.1016/S0005-2728(02)00342-0; Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; Bogachev AV, 1997, FEBS LETT, V409, P475, DOI 10.1016/S0014-5793(97)00536-X; Cherepanov AV, 2004, BBA-BIOENERGETICS, V1656, P1, DOI 10.1016/j.bbabio.2004.02.006; Fadeeva MS, 2008, FEMS MICROBIOL LETT, V279, P116, DOI 10.1111/j.1574-6968.2007.01015.x; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Lin Y, 2003, ANAL CHEM, V75, P5381, DOI 10.1021/ac0346205; MORGAN JE, 1995, BIOCHEMISTRY-US, V34, P15633, DOI 10.1021/bi00048a005; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Palmer G., 1971, FLAVINS FLAVOPROTEIN, P123; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Tanaka M, 2003, BIOPHYS J, V84, P1998, DOI 10.1016/S0006-3495(03)75008-5; Turk K, 2004, J BIOL CHEM, V279, P21349, DOI 10.1074/jbc.M311692200; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s	25	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5533	5538		10.1074/jbc.M808984200	http://dx.doi.org/10.1074/jbc.M808984200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117949	hybrid			2022-12-27	WOS:000263560600016
J	Carra, S; Brunsting, JF; Lambert, H; Landry, J; Kampinga, HH				Carra, Serena; Brunsting, Jeanette F.; Lambert, Herman; Landry, Jacques; Kampinga, Harm H.			HspB8 Participates in Protein Quality Control by a Non-chaperone-like Mechanism That Requires eIF2 alpha Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; INITIATION-FACTOR 2-ALPHA; ENDOPLASMIC-RETICULUM; ALPHA-SUBUNIT; HSP22 HSPB8; IN-VIVO; HUNTINGTIN FRAGMENTS; MAMMALIAN HOMOLOG; UBIQUITIN LIGASE; FACTOR EIF-2	Aggregation of mutated proteins is a hallmark of many neurodegenerative disorders, including Huntington disease. We previously reported that overexpression of the HspB8 . Bag3 chaperone complex suppresses mutated huntingtin aggregation via autophagy. Classically, HspB proteins are thought to act as ATP-independent molecular chaperones that can bind unfolded proteins and facilitate their processing via the help of ATP-dependent chaperones such as the Hsp70 machine, in which Bag3 may act as a molecular link between HspB, Hsp70, and the ubiquitin ligases. However, here we show that HspB8 and Bag3 act in a non-canonical manner unrelated to the classical chaperone model. Rather, HspB8 and Bag3 induce the phosphorylation of the alpha-subunit of the translation initiator factor eIF2, which in turn causes a translational shut-down and stimulates autophagy. This function of HspB8 . Bag3 does not require Hsp70 and also targets fully folded substrates. HspB8 . Bag3 activity was independent of the endoplasmic reticulum (ER) stress kinase PERK, demonstrating that its action is unrelated to ER stress and suggesting that it activates stress-mediated translational arrest and autophagy through a novel pathway.	[Carra, Serena; Brunsting, Jeanette F.; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat & Stress Cell Biol, NL-9713 AV Groningen, Netherlands; [Lambert, Herman; Landry, Jacques] Univ Laval, Ctr Rech Cancerol, Hotel Dieu, Quebec City, PQ G1R 2J6, Canada	University of Groningen; Laval University	Carra, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiat & Stress Cell Biol, Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	s.carra@med.umcg.nl	Carra, Serena/O-2835-2015	Carra, Serena/0000-0003-0939-0140; Kampinga, Harm/0000-0002-8966-8466	Senter (Innovatiegerichte Onderzoeksprogramma Genomics [IGE07004]; Prinses Beatrix Foundation [WAR05-0129]	Senter (Innovatiegerichte Onderzoeksprogramma Genomics; Prinses Beatrix Foundation	This work was supported in part by Senter (Innovatiegerichte Onderzoeksprogramma Genomics Grant IGE07004) and by Prinses Beatrix Foundation Grant WAR05-0129.	Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Benndorf R, 2001, J BIOL CHEM, V276, P26753, DOI 10.1074/jbc.M103001200; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Carra S, 2008, AUTOPHAGY, V4, P237, DOI 10.4161/auto.5407; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Depre C, 2002, CIRC RES, V91, P1007, DOI 10.1161/01.RES.0000044380.54893.4B; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Fontaine JM, 2005, BIOCHEM BIOPH RES CO, V337, P1006, DOI 10.1016/j.bbrc.2005.09.148; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Gober MD, 2004, BIOCHEM BIOPH RES CO, V321, P267, DOI 10.1016/j.bbrc.2004.06.103; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haslbeck M, 2004, EMBO J, V23, P638, DOI 10.1038/sj.emboj.7600080; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kim MV, 2004, BIOCHEM BIOPH RES CO, V325, P649, DOI 10.1016/j.bbrc.2004.10.074; Kim MV, 2004, BIOCHEM BIOPH RES CO, V315, P796, DOI 10.1016/j.bbrc.2004.01.130; King MA, 2008, MOL PHARMACOL, V73, P1052, DOI 10.1124/mol.107.043398; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; LEROUX A, 1982, P NATL ACAD SCI-BIOL, V79, P2147, DOI 10.1073/pnas.79.7.2147; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li H, 2007, MOL CELL BIOL, V27, P5296, DOI 10.1128/MCB.01667-06; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pagliuca MG, 2003, FEBS LETT, V541, P11, DOI 10.1016/S0014-5793(03)00274-6; PATHAK VK, 1988, MOL CELL BIOL, V8, P993, DOI 10.1128/MCB.8.2.993; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rosas H D, 2004, NeuroRx, V1, P263, DOI 10.1602/neurorx.1.2.263; Rosati A, 2007, J CELL PHYSIOL, V210, P676, DOI 10.1002/jcp.20865; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Smith CC, 2000, J BIOL CHEM, V275, P25690, DOI 10.1074/jbc.M002140200; Sood R, 2000, GENETICS, V154, P787; Sun X, 2007, CELL STRESS CHAPERON, V12, P307, DOI 10.1379/CSC-276.1; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Young P, 2008, J GEN VIROL, V89, P866, DOI 10.1099/vir.0.83414-0	73	105	105	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5523	5532		10.1074/jbc.M807440200	http://dx.doi.org/10.1074/jbc.M807440200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19114712	hybrid			2022-12-27	WOS:000263560600015
J	Salcedo, E; Farrell, DM; Zheng, LJ; Phistry, M; Bagg, EE; Britt, SG				Salcedo, Ernesto; Farrell, David M.; Zheng, Lijun; Phistry, Meridee; Bagg, Eve E.; Britt, Steven G.			The Green-absorbing Drosophila Rh6 Visual Pigment Contains a Blue-shifting Amino Acid Substitution That Is Conserved in Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINYLIDENE SCHIFF-BASE; BOVINE RHODOPSIN; MOLECULAR-DYNAMICS; COLOR-VISION; ECTOPIC EXPRESSION; NIGHT BLINDNESS; PROTON AFFINITY; CONE PIGMENT; BACTERIORHODOPSIN; GENE	The molecular mechanisms that regulate invertebrate visual pigment absorption are poorly understood. Through sequence analysis and functional investigation of vertebrate visual pigments, numerous amino acid substitutions important for this adaptive process have been identified. Here we describe a serine/alanine (S/A) substitution in long wavelength-absorbing Drosophila visual pigments that occurs at a site corresponding to Ala-292 in bovine rhodopsin. This S/A substitution accounts for a 10-17-nm absorption shift in visual pigments of this class. Additionally, we demonstrate that substitution of a cysteine at the same site, as occurs in the blue-absorbing Rh5 pigment, accounts for a 4-nm shift. Substitutions at this site are the first spectrally significant amino acid changes to be identified for invertebrate pigments sensitive to visible light and are the first evidence of a conserved tuning mechanism in vertebrate and invertebrate pigments of this class.	[Salcedo, Ernesto; Zheng, Lijun; Phistry, Meridee; Bagg, Eve E.; Britt, Steven G.] Univ Colorado Denver, Dept Cell & Dev Biol, Aurora, CO 80045 USA; [Britt, Steven G.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO 80045 USA; [Farrell, David M.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Britt, Steven G.] Univ Colorado Denver, Rocky Mt Lions Eye Inst, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Britt, SG (corresponding author), Univ Colorado Denver, Dept Cell & Dev Biol, Mail Stop 8108,12801 E 17th Ave, Aurora, CO 80045 USA.	steve.britt@ucdenver.edu	Britt, Steven/GVT-1340-2022	Britt, Steven/0000-0001-7656-7984	National Institutes of Health [R01-EY10759]; National Science Foundation [IOB-0449367]; NATIONAL EYE INSTITUTE [R01EY010759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-EY10759 from the NEI (to S.G.B.). This work was also supported by Grant IOB-0449367 from the National Science Foundation.	Altun A, 2008, J PHYS CHEM B, V112, P6814, DOI 10.1021/jp709730b; Baudry J, 1997, J CHEM INF COMP SCI, V37, P1018, DOI 10.1021/ci9702398; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Detto T, 2007, P ROY SOC B-BIOL SCI, V274, P2785, DOI 10.1098/rspb.2007.1059; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; Dyer AG, 2004, J EXP BIOL, V207, P1683, DOI 10.1242/jeb.00941; Fasick JI, 1999, BIOCHEMISTRY-US, V38, P11593, DOI 10.1021/bi991600h; Fasick JI, 1998, BIOCHEMISTRY-US, V37, P433, DOI 10.1021/bi972500j; FEILER R, 1992, J NEUROSCI, V12, P3862; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2009, DOI 10.1021/bi020613j; HARANISHIMURA I, 1993, FEBS LETT, V317, P5, DOI 10.1016/0014-5793(93)81480-N; Hayashi S, 2000, J PHYS CHEM B, V104, P10678, DOI 10.1021/jp001508r; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunt DM, 2001, J EXP BIOL, V204, P3333; Hunt DM, 1996, VISION RES, V36, P1217, DOI 10.1016/0042-6989(95)00228-6; Janz JM, 2001, BIOCHEMISTRY-US, V40, P7219, DOI 10.1021/bi002937i; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Lin SW, 1998, J BIOL CHEM, V273, P24583, DOI 10.1074/jbc.273.38.24583; Marshall J, 2007, ARTHROPOD STRUCT DEV, V36, P420, DOI 10.1016/j.asd.2007.01.006; Maximov VV, 2000, PHILOS T ROY SOC B, V355, P1239, DOI 10.1098/rstb.2000.0675; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; NINA M, 1995, BIOPHYS J, V68, P25, DOI 10.1016/S0006-3495(95)80184-0; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porter ML, 2007, MOL BIOL EVOL, V24, P253, DOI 10.1093/molbev/msl152; Ramos LS, 2007, BIOCHEMISTRY-US, V46, P5330, DOI 10.1021/bi700138g; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Salcedo E, 2003, J NEUROSCI, V23, P10873; Sugawara T, 2005, P NATL ACAD SCI USA, V102, P5448, DOI 10.1073/pnas.0405302102; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; Tajkhorshid E, 1999, J PHYS CHEM B, V103, P5581, DOI 10.1021/jp983742b; Tajkhorshid E, 2000, BIOPHYS J, V78, P683, DOI 10.1016/S0006-3495(00)76626-4; Tajkhorshid E, 1997, J PHYS CHEM B, V101, P8021, DOI 10.1021/jp971283t; Takahashi Y, 2003, BIOCHEMISTRY-US, V42, P6025, DOI 10.1021/bi020629+; Wilkie SE, 2000, BIOCHEMISTRY-US, V39, P7895, DOI 10.1021/bi992776m; Yokoyama S, 1999, P NATL ACAD SCI USA, V96, P6279, DOI 10.1073/pnas.96.11.6279; Yokoyama S, 2000, P NATL ACAD SCI USA, V97, P7366, DOI 10.1073/pnas.97.13.7366; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	47	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5717	5722		10.1074/jbc.M807368200	http://dx.doi.org/10.1074/jbc.M807368200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19126545	Green Published, hybrid			2022-12-27	WOS:000263560600035
J	Knezevic, II; Predescu, SA; Neamu, RF; Gorovoy, MS; Knezevic, NM; Easington, C; Malik, AB; Predescu, DN				Knezevic, Ivana I.; Predescu, Sanda A.; Neamu, Radu F.; Gorovoy, Matvey S.; Knezevic, Nebojsa M.; Easington, Cordus; Malik, Asrar B.; Predescu, Dan N.			Tiam1 and Rac1 Are Required for Platelet-activating Factor-induced Endothelial Junctional Disassembly and Increase in Vascular Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCERYL ETHER PHOSPHORYLCHOLINE; LIGHT-CHAIN PHOSPHORYLATION; ACTIN-FILAMENT INTEGRITY; SMOOTH-MUSCLE-CELLS; BOTULINUM C2 TOXIN; PROTEIN-KINASE-C; MICROVASCULAR PERMEABILITY; GROWTH-FACTOR; BARRIER DYSFUNCTION; PHOSPHOLIPASE-C	It is known that platelet-activating factor (PAF) induces severe endothelial barrier leakiness, but the signaling mechanisms remain unclear. Here, using a wide range of biochemical and morphological approaches applied in both mouse models and cultured endothelial cells, we addressed the mechanisms of PAF-induced disruption of interendothelial junctions (IEJs) and of increased endothelial permeability. The formation of interendothelial gaps filled with filopodia and lamellipodia is the cellular event responsible for the disruption of endothelial barrier. We observed that PAF ligation of its receptor induced the activation of the Rho GTPase Rac1. Following PAF exposure, both Rac1 and its guanine nucleotide exchange factor Tiam1 were found associated with a membrane fraction from which they co-immunoprecipitated with PAF receptor. In the same time frame with Tiam1-Rac1 translocation, the junctional proteins ZO-1 and VE-cadherin were relocated from the IEJs, and formation of numerous interendothelial gaps was recorded. Notably, the response was independent of myosin light chain phosphorylation and thus distinct from other mediators, such as histamine and thrombin. The changes in actin status are driven by the PAF-induced localized actin polymerization as a consequence of Rac1 translocation and activation. Tiam1 was required for the activation of Rac1, actin polymerization, relocation of junctional associated proteins, and disruption of IEJs. Thus, PAF-induced IEJ disruption and increased endothelial permeability requires the activation of a Tiam1-Rac1 signaling module, suggesting a novel therapeutic target against increased vascular permeability associated with inflammatory diseases.	[Knezevic, Ivana I.; Predescu, Sanda A.; Easington, Cordus; Predescu, Dan N.] Rush Univ, Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA; [Neamu, Radu F.; Gorovoy, Matvey S.; Knezevic, Nebojsa M.; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Predescu, DN (corresponding author), 1735 W Harrison St,Jelke S Bldg,Rm 1415A, Chicago, IL 60612 USA.	Dan_Predescu@rush.edu	Knezevic, Nebojsa Nick/H-9921-2019	Knezevic, Nebojsa Nick/0000-0001-8028-1495; Malik, Asrar/0000-0002-8205-7128; Predescu, Sanda/0000-0002-9386-6756	National Institutes of Health [RO1-HLO89462, PO1-HL60678]; American Heart Association [SDG0635175N]; RUMC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084153, R01HL089462, P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); RUMC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HLO89462 ( to S. P.) and PO1-HL60678 ( to A. B. M.). This work was also supported by American Heart Association Grant SDG0635175N, and start-up funds from RUMC ( to D. N. P.).	Adamson RH, 2003, AM J PHYSIOL-HEART C, V285, pH406, DOI 10.1152/ajpheart.00021.2003; Adamson RH, 2002, J PHYSIOL-LONDON, V539, P295, DOI 10.1113/jphysiol.2001.013117; Aktories K, 2004, ANAEROBE, V10, P101, DOI 10.1016/j.anaerobe.2003.10.003; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Axelrad TW, 2004, FASEB J, V18, P568, DOI 10.1096/fj.03-0479fje; Baisden JM, 2001, ONCOGENE, V20, P6607, DOI 10.1038/sj.onc.1204802; Baldwin AL, 2001, CRIT REV BIOMED ENG, V29, P247, DOI 10.1615/CritRevBiomedEng.v29.i2.20; BALDWIN AL, 1995, AM J PHYSIOL-HEART C, V269, pH1528, DOI 10.1152/ajpheart.1995.269.5.H1528; BENVENISTE J, 1989, ADV PROSTAG THROMB L, V19, P355; BJORK J, 1983, EUR J PHARMACOL, V96, P87, DOI 10.1016/0014-2999(83)90532-0; Bogatcheva NV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P75, DOI 10.1023/A:1013904231324; BRAQUET P, 1991, MED RES REV, V11, P295, DOI 10.1002/med.2610110303; BURHOP KE, 1986, AM REV RESPIR DIS, V134, P548; BUSSOLINO F, 1994, J BIOL CHEM, V269, P2877; BUSSOLINO F, 1987, J IMMUNOL, V139, P2439; CAMUSSI G, 1983, INT ARCH ALLER A IMM, V70, P245, DOI 10.1159/000233331; CAMUSSI G, 1983, J IMMUNOL, V131, P2397; CHIGNARD M, 1979, NATURE, V279, P799, DOI 10.1038/279799a0; Cicchetti G, 2002, CRIT REV ORAL BIOL M, V13, P220, DOI 10.1177/154411130201300302; Cohen AW, 1999, AM J PHYSIOL-HEART C, V277, pH2038, DOI 10.1152/ajpheart.1999.277.5.H2038; Cook JA, 2003, J BIOL CHEM, V278, P35812, DOI 10.1074/jbc.M302878200; Dejana E, 1996, J CLIN INVEST, V98, P1949, DOI 10.1172/JCI118997; Deo DD, 2004, J BIOL CHEM, V279, P3497, DOI 10.1074/jbc.M304497200; DRENCKHAHN D, 1997, ENDOTHELIAL CONTRACT; DVORAK HF, 1995, AM J PATHOL, V146, P1029; FANNING AS, 2001, TIGHT JUNCTIONS, P265; Fleming IN, 2004, BIOCHEM J, V382, P857, DOI 10.1042/BJ20040916; Fleming IN, 1998, FEBS LETT, V429, P229, DOI 10.1016/S0014-5793(98)00566-3; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; GOTTLIEB AI, 1991, LAB INVEST, V65, P123; HALONEN M, 1980, AM REV RESPIR DIS, V122, P915; HUMPHREY DM, 1984, LAB INVEST, V50, P16; Lee TYJ, 2003, MICROSC RES TECHNIQ, V60, P115, DOI 10.1002/jemt.10250; LU ZP, 1993, CIRC SHOCK, V41, P8; Lum H, 1996, CAN J PHYSIOL PHARM, V74, P787, DOI 10.1139/cjpp-74-7-787; MADARA JL, 1987, AM J PHYSIOL, V253, pC854, DOI 10.1152/ajpcell.1987.253.6.C854; MAJNO G, 1961, J BIOPHYS BIOCHEM CY, V11, P571, DOI 10.1083/jcb.11.3.571; Marrache AM, 2002, J IMMUNOL, V169, P6474, DOI 10.4049/jimmunol.169.11.6474; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Meng WX, 2004, EMBO J, V23, P760, DOI 10.1038/sj.emboj.7600095; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Nicholson-Dykstra S, 2005, CURR BIOL, V15, pR346, DOI 10.1016/j.cub.2005.04.029; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; PINCKARD RN, 1980, J RETICULOENDOTH SOC, V28, pS95; PIROTZKY E, 1984, MICROCIRC ENDOTH LYM, V1, P107; PORTER K, 1972, P 5 ANN STER SCANN E, P1244; Predescu D, 1996, EUR J CELL BIOL, V69, P86; Predescu SA, 2001, MOL BIOL CELL, V12, P1019, DOI 10.1091/mbc.12.4.1019; Predescu SA, 2007, J BIOL CHEM, V282, P17166, DOI 10.1074/jbc.M608996200; Qian Y, 1998, ONCOGENE, V16, P2185, DOI 10.1038/sj.onc.1201753; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Ridley A J, 1999, Prog Mol Subcell Biol, V22, P1; Ridley AJ, 1999, BIOCHEM SOC SYMP, V65, P111; Robert EG, 2001, CURR PHARM DESIGN, V7, P1615, DOI 10.2174/1381612013397203; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Simionescu M, 2002, MICROSC RES TECHNIQ, V57, P269, DOI 10.1002/jemt.10086; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SNYDER F, 1995, BIOCHEM J, V305, P689, DOI 10.1042/bj3050689; Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693; Surks HK, 2005, J BIOL CHEM, V280, P42543, DOI 10.1074/jbc.M506863200; SVENSJO E, 1986, FASEB J, V45, P89; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; VERIN AD, 1995, AM J PHYSIOL-LUNG C, V269, pL99, DOI 10.1152/ajplung.1995.269.1.L99; WALSH CT, 2008, FASEB J IN PRESS; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; WEGNER A, 1988, J BIOL CHEM, V263, P13739; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042	77	68	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5381	5394		10.1074/jbc.M808958200	http://dx.doi.org/10.1074/jbc.M808958200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095647	Green Published, hybrid			2022-12-27	WOS:000263416600068
J	Liu, LF; Ishihara, K; Ichimura, T; Fujita, N; Hino, S; Tomita, S; Watanabe, S; Saitoh, N; Ito, T; Nakao, M				Liu, Lifeng; Ishihara, Ko; Ichimura, Takaya; Fujita, Naoyuki; Hino, Shinjiro; Tomita, Saori; Watanabe, Sugiko; Saitoh, Noriko; Ito, Takaaki; Nakao, Mitsuyoshi			MCAF1/AM Is Involved in Sp1-mediated Maintenance of Cancer-associated Telomerase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMORTAL HUMAN-CELLS; REVERSE-TRANSCRIPTASE GENE; HTERT GENE; HETEROCHROMATIN FORMATION; PROMOTER SEQUENCES; DNA METHYLATION; FACTOR FAMILY; RNA; ACTIVATION; REPRESSION	Telomerase maintains telomere length and is implicated in senescence and immortalization of mammalian cells. Two essential components for this enzyme are telomerase reverse transcriptase (TERT) and the telomerase RNA component (encoded by the TERC gene). These telomerase subunit genes are known to be mainly expressed by specificity protein 1 (Sp1). MBD1-containing chromatin-associated factor 1 (MCAF1), also known as ATFa-associated modulator (AM) and activating transcription factor 7-interacting protein (ATF7IP), mediates gene regulation, although the precise function of MCAF1 remains to be elucidated. Here, we report that MCAF1 is involved in Sp1-dependent maintenance of telomerase activity in cancer cells. Two evolutionarily conserved domains of MCAF1 directly interact with Sp1 and the general transcriptional apparatus. Selective depletion of MCAF1 or Sp1 down-regulates TERT and TERC genes in cultured cells, which results in decreased telomerase activity. The transcriptionally active form of RNA polymerase II and the general transcription factor ERCC3 decreased in the TERT promoter under the loss of MCAF1 or Sp1. Consistently, MCAF1 is found to be frequently overexpressed in naturally occurring cancers that originate in different tissues. Our data suggest that transcriptional function of MCAF1 facilitates telomerase expression by Sp1, which may be a common mechanism in proliferative cancer cells.	[Liu, Lifeng; Ishihara, Ko; Hino, Shinjiro; Tomita, Saori; Watanabe, Sugiko; Saitoh, Noriko; Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Regenerat Med, Kumamoto 8600811, Japan; [Ichimura, Takaya; Ito, Takaaki] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Kumamoto 8608556, Japan; [Fujita, Naoyuki] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Pharmacol, Kumamoto 8608556, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Nakao, M (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Regenerat Med, 2-2-1 Honjo, Kumamoto 8600811, Japan.	mnakao@gpo.kumamoto-u.ac.jp	Watanabe, Sugiko/Q-6201-2019	Watanabe, Sugiko/0000-0002-2120-9546	Ministry of Education, Culture, Sports, Science and Technology; Global COE (Center of Excellence) "Cell Fate Regulation Research and Education Unit," Kumamoto University	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE (Center of Excellence) "Cell Fate Regulation Research and Education Unit," Kumamoto University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (to M. N.) and a Grant-in-aid for Global COE (Center of Excellence) "Cell Fate Regulation Research and Education Unit," Kumamoto University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Aoto T, 2006, DEV BIOL, V298, P354, DOI 10.1016/j.ydbio.2006.04.450; Avilion AA, 1996, CANCER RES, V56, P645; Bellon M, 2008, JNCI-J NATL CANCER I, V100, P98, DOI 10.1093/jnci/djm269; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cairney CJ, 2008, BIOCHIMIE, V90, P13, DOI 10.1016/j.biochi.2007.07.025; Cao Y, 2008, CANCER SCI, V99, P1092, DOI 10.1111/j.1349-7006.2008.00815.x; Chang LK, 2005, NUCLEIC ACIDS RES, V33, P6528, DOI 10.1093/nar/gki956; Colgin LM, 1999, CURR OPIN GENET DEV, V9, P97, DOI 10.1016/S0959-437X(99)80014-8; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; De Graeve F, 2000, ONCOGENE, V19, P1807, DOI 10.1038/sj.onc.1203492; Devereux TR, 1999, CANCER RES, V59, P6087; Fujita N, 2003, MOL CELL BIOL, V23, P2834, DOI 10.1128/MCB.23.8.2834-2843.2003; Guilleret I, 2002, INT J CANCER, V101, P335, DOI 10.1002/ijc.10593; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Horikawa I, 1999, CANCER RES, V59, P826; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Janknecht R, 2004, FEBS LETT, V564, P9, DOI 10.1016/S0014-5793(04)00356-4; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kumakura S, 2005, CANCER RES, V65, P2778, DOI 10.1158/0008-5472.CAN-04-1819; Kyo S, 2002, ONCOGENE, V21, P688, DOI 10.1038/sj.onc.1205163; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Rooney PH, 1999, BRIT J CANCER, V80, P862, DOI 10.1038/sj.bjc.6690433; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takakura M, 1999, CANCER RES, V59, P551; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Yi XM, 1999, MOL CELL BIOL, V19, P3989; Yi XM, 2001, NUCLEIC ACIDS RES, V29, P4818, DOI 10.1093/nar/29.23.4818; Zhao JQ, 1998, ONCOGENE, V16, P1345, DOI 10.1038/sj.onc.1201892; Zhao JQ, 2000, NEOPLASIA, V2, P531, DOI 10.1038/sj.neo.7900114	50	42	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5165	5174		10.1074/jbc.M807098200	http://dx.doi.org/10.1074/jbc.M807098200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106100	hybrid			2022-12-27	WOS:000263416600047
J	Shelton, MD; Distler, AM; Kern, TS; Mieyal, JJ				Shelton, Melissa D.; Distler, Anne M.; Kern, Timothy S.; Mieyal, John J.			Glutaredoxin Regulates Autocrine and Paracrine Proinflammatory Responses in Retinal Glial (Muller) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B KINASE; PROTEIN S-GLUTATHIONYLATION; NECROSIS-FACTOR-ALPHA; DIABETIC-RETINOPATHY; OXIDATIVE STRESS; GROWTH-FACTOR; INTERLEUKIN-6; EXPRESSION; RAT; MECHANISMS	Protein S-glutathionylation is a reversible redox-dependent post-translational modification. Many cellular functions and signal transduction pathways involve proteins whose cysteine-dependent activities are modulated by glutathionylation. Glutaredoxin (Grx1) plays a key role in such regulation because it is a specific and efficient catalyst of deglutathionylation. We recently reported an increase in Grx1 in retinae of diabetic rats and in rat retinal Muller glial cells (rMC-1) cultured in high glucose. This up-regulation of Grx1 was concomitant with NF kappa B activation and induction of intercellular adhesion molecule-1 (ICAM-1). This proinflammatory response was replicated by adenoviral-directed up-regulation of Grx1 in cells in normal glucose. The site of regulation of NF kappa B was localized to the cytoplasm, where I kappa B kinase (IKK) is a master regulator of NF kappa B activation. In the current study, inhibition of IKK activity abrogated the increase in ICAM-1 induced by high glucose or by adenoviral-directed up-regulation of Grx1. Conditioned medium from the Muller cells overexpressing Grx1 was added to fresh cultures of Muller or endothelial cells and elicited increases in the Grx1 and ICAM-1 proteins in these cells. These effects correlate with a novel finding that secretion of interleukin-6 was elevated in the cultures of Grx overexpressing cells. Also, pure interleukin-6 increased Grx1 and ICAM-1 in the rMC-1 cells. Thus, Grx1 appears to play an important role in both autocrine and paracrine proinflammatory responses. Furthermore, IKK beta isolated from Muller cells in normal glucose medium was found to be glutathionylated on Cys-179. Hence Grx-mediated activation of IKK via deglutathionylation may play a central role in diabetic complications in vivo where Grx1 is increased.	[Shelton, Melissa D.; Distler, Anne M.; Kern, Timothy S.; Mieyal, John J.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Kern, Timothy S.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Shelton, Melissa D.; Kern, Timothy S.; Mieyal, John J.] Louis Stokes Cleveland Vet Affairs Med Res Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Mieyal, JJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 2109 Adelbert Rd,WRT300-9, Cleveland, OH 44106 USA.	jjm5@cwru.edu			NEI NIH HHS [5 T32 EY07157, T32 EY007157] Funding Source: Medline; NIA NIH HHS [R01 AG024413, P01 AG 15885] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015885, R01AG024413] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cameron NE, 2008, CURR DRUG TARGETS, V9, P60, DOI 10.2174/138945008783431718; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; ELASRAR AM, 1992, AM J OPHTHALMOL, V114, P731, DOI 10.1016/S0002-9394(14)74052-8; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; GRAVINA SA, 1993, THESIS CASE W RESERV; Gustavsson C, 2008, RETINA-J RET VIT DIS, V28, P645, DOI 10.1097/IAE.0b013e31815ec32d; Hosoya K, 2001, EXP EYE RES, V72, P163, DOI 10.1006/exer.2000.0941; Jeon KI, 2003, EXP MOL MED, V35, P61, DOI 10.1038/emm.2003.9; KAUFFMANN DJH, 1994, INVEST OPHTH VIS SCI, V35, P900; Li X, 2005, AM J PHYSIOL-HEART C, V288, pH1417, DOI 10.1152/ajpheart.00559.2004; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mukherjee TK, 2007, J IMMUNOL, V178, P1835, DOI 10.4049/jimmunol.178.3.1835; Murugeswari P, 2008, RETINA-J RET VIT DIS, V28, P817, DOI 10.1097/IAE.0b013e31816576d5; Mysliwiec M, 2008, DIABETES RES CLIN PR, V79, P141, DOI 10.1016/j.diabres.2007.07.011; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; Peltoniemi M, 2004, HUM PATHOL, V35, P1000, DOI 10.1016/j.humpath.2004.04.009; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Reynaert NL, 2007, AM J RESP CELL MOL, V36, P147, DOI 10.1165/rcmb.2006-0259RC; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sanchez RN, 2003, INVEST OPHTH VIS SCI, V44, P4006, DOI 10.1167/iovs.03-0040; Sappington RM, 2006, INVEST OPHTH VIS SCI, V47, P3860, DOI 10.1167/iovs.05-1408; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Seki T, 2006, ANN NY ACAD SCI, V1070, P535, DOI 10.1196/annals.1317.043; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shelton MD, 2007, J BIOL CHEM, V282, P12467, DOI 10.1074/jbc.M610863200; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; Srinivasan S, 2004, ARTERIOSCL THROM VAS, V24, P851, DOI 10.1161/01.ATV.zhq0504.2260; Takashima Y, 1999, IMMUNOL LETT, V68, P397, DOI 10.1016/S0165-2478(99)00087-5	31	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4759	4766		10.1074/jbc.M805464200	http://dx.doi.org/10.1074/jbc.M805464200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19074435	hybrid, Green Published			2022-12-27	WOS:000263416600003
J	Broca, C; Quoyer, J; Costes, S; Linck, N; Varrault, A; Deffayet, PM; Bockaert, J; Dalle, S; Bertrand, G				Broca, Christophe; Quoyer, Julie; Costes, Safia; Linck, Nathalie; Varrault, Annie; Deffayet, Pierre-Marie; Bockaert, Joeel; Dalle, Stephane; Bertrand, Gyslaine			beta-Arrestin 1 Is Required for PAC(1) Receptor-mediated Potentiation of Long-lasting ERK1/2 Activation by Glucose in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; ELEMENT-BINDING PROTEIN; ADENYLATE-CYCLASE; INSULIN-SECRETION; INTESTINAL POLYPEPTIDE; REGULATED KINASE; ISLETS; PACAP; SRC; LINE	In pancreatic beta-cells, the pituitary adenylate cyclase-activating polypeptide (PACAP) exerts a potent insulin secretory effect via PAC(1) and VPAC receptors (Rs) through the G alpha(s)/cAMP/protein kinase A pathway. Here, we investigated the mechanisms linking PAC(1)R to ERK1/2 activation in INS-1E beta-cells and pancreatic islets. PACAP caused a transient (5 min) increase in ERK1/2 phosphorylation via PAC(1)Rs and promoted nuclear translocation of a fraction of cytosolic p-ERK1/2. Both protein kinase A- and Src-dependent pathways mediated this transient ERK1/2 activation. Moreover, PACAP potentiated glucose-induced long-lasting ERK1/2 activation. Blocking Ca2+ influx abolished glucose-induced ERK1/2 activation and PACAP potentiating effect. Glucose stimulation during KC1 depolarization showed that, in addition to the triggering signal (rise in cytosolic [Ca2+]), the amplifying pathway was also involved in glucose-induced sustained ERK1/2 activation and was required for PACAP potentiation. The finding that at 30 min glucose-induced p-ERK1/2 was detected in both cytosol and nucleus while the potentiating effect of PACAP was only observed in the cytosol, suggested the involvement of the scaffold protein beta-arrestin. Indeed, beta-arrestin 1 (beta-arr1) depletion (in beta-arr1 knockout mouse islets or in INS-1E cells by siRNA) completely abolished PACAP potentiation of long-lasting ERK1/2 activation by glucose. Finally, PACAP potentiated glucose-induced CREB transcriptional activity and IRS-2 mRNA expression mainly via the ERK1/2 signaling pathway, and likewise, beta-arr1 depletion reduced the PACAP potentiating effect on IRS-2 expression. These results establish for the first time that PACAP potentiates glucose-induced long-lasting ERK1/2 activation via a beta-arr1-dependent pathway and thus provide new insights concerning the mechanisms of PACAP and glucose actions in pancreatic beta-cells.	[Bertrand, Gyslaine] Univ Montpellier I, Inst Genom Fonct, CNRS, INSERM,U661,Unite Mixte Rech 5203, F-34094 Montpellier 5, France; Univ Montpellier 2, F-34094 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Bertrand, G (corresponding author), Univ Montpellier I, Inst Genom Fonct, CNRS, INSERM,U661,Unite Mixte Rech 5203, F-34094 Montpellier 5, France.	gyslaine.bertrand@igf.cnrs.fr	, Costes/AAC-2820-2020; bertrand, gyslaine/AAC-6716-2020	, Costes/0000-0001-8323-1207; Linck, Nathalie/0000-0002-2218-239X; Broca, Christophe/0000-0002-7715-8231	INSERM; Region Languedoc-Roussillon	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France)	Supported by INSERM and the Region Languedoc-Roussillon.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; AfKlinteberg K, 1996, ENDOCRINOLOGY, V137, P2791, DOI 10.1210/en.137.7.2791; Arnette D, 2003, J BIOL CHEM, V278, P32517, DOI 10.1074/jbc.M301174200; Barki-Harrington L, 2008, PHYSIOLOGY, V23, P17, DOI 10.1152/physiol.00042.2007; Barthet G, 2007, MOL BIOL CELL, V18, P1979, DOI 10.1091/mbc.E06-12-1080; Benes C, 1998, J BIOL CHEM, V273, P15507, DOI 10.1074/jbc.273.25.15507; Bertrand G, 1996, BRIT J PHARMACOL, V117, P764, DOI 10.1111/j.1476-5381.1996.tb15256.x; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; Borboni P, 1999, ENDOCRINOLOGY, V140, P5530, DOI 10.1210/en.140.12.5530; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008; Conner DA, 1997, CIRC RES, V81, P1021; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dalle S, 2004, J BIOL CHEM, V279, P20345, DOI 10.1074/jbc.M312483200; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Filipsson K, 1997, J CLIN ENDOCR METAB, V82, P3093, DOI 10.1210/jc.82.9.3093; FRIDOLF T, 1992, CELL TISSUE RES, V269, P275, DOI 10.1007/BF00319618; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gibson TB, 2006, DIABETES, V55, P1066, DOI 10.2337/diabetes.55.04.06.db05-1266; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Harmar AJ, 2001, GENOME BIOL, V2; He Y, 2003, ELECTROPHORESIS, V24, P101, DOI 10.1002/elps.200390000; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Jamen F, 2000, J CLIN INVEST, V105, P1307, DOI 10.1172/JCI9387; Jamen F, 2002, ENDOCRINOLOGY, V143, P1253, DOI 10.1210/en.143.4.1253; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Khoo S, 1997, P NATL ACAD SCI USA, V94, P5599, DOI 10.1073/pnas.94.11.5599; Khoo S, 2004, CELL BIOCHEM BIOPHYS, P191; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; Lawrence M, 2008, ACTA PHYSIOL, V192, P11, DOI 10.1111/j.1748-1716.2007.01785.x; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Straub SG, 1996, J BIOL CHEM, V271, P1660, DOI 10.1074/jbc.271.3.1660; Tomimoto S, 2004, J PHARMACOL EXP THER, V309, P796, DOI 10.1124/jpet.103.062919; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaudry D, 2000, PHARMACOL REV, V52, P269; Werry TD, 2005, TRENDS ENDOCRIN MET, V16, P26, DOI 10.1016/j.tem.2004.11.008; Winzell MS, 2007, PEPTIDES, V28, P1805, DOI 10.1016/j.peptides.2007.04.024; YADA T, 1994, J BIOL CHEM, V269, P1290; Yamamoto K, 2003, DIABETES, V52, P1155, DOI 10.2337/diabetes.52.5.1155	55	34	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4332	4342		10.1074/jbc.M807595200	http://dx.doi.org/10.1074/jbc.M807595200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074139	hybrid			2022-12-27	WOS:000263134400032
J	Schnitzler, MMY; Rinne, S; Skrobek, L; Renigunta, V; Schlichthorl, G; Derst, C; Gudermann, T; Daut, J; Preisig-Muller, R				Mederos y Schnitzler, Michael; Rinne, Susanne; Skrobek, Lennart; Renigunta, Vijay; Schlichthoerl, Guenter; Derst, Christian; Gudermann, Thomas; Daut, Juergen; Preisig-Mueller, Regina			Mutation of Histidine 105 in the T1 Domain of the Potassium Channel Kv2.1 Disrupts Heteromerization with Kv6.3 and Kv6.4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED K+ CHANNELS; ALPHA-SUBUNITS; MOLECULAR DIVERSITY; SHAB; SHAKER; DETERMINANTS; EXCITABILITY; MODULATION; ACTIVATION; INTERFACE	The voltage-activated K+ channel subunit Kv2.1 can form heterotetramers with members of the Kv6 subfamily, generating channels with biophysical properties different from homomeric Kv2.1 channels. The N-terminal tetramerization domain (T1) has been shown previously to play a role in Kv channel assembly, but the mechanisms controlling specific heteromeric assembly are still unclear. In Kv6. x channels the histidine residue of the zinc ion-coordinating C3H1 motif of Kv2.1 is replaced by arginine or valine. Using a yeast two-hybrid assay, we found that substitution of the corresponding histidine 105 in Kv2.1 by valine (H105V) or arginine (H105R) disrupted the interaction of the T1 domain of Kv2.1 with the T1 domains of both Kv6.3 and Kv6.4, whereas interaction of the T1 domain of Kv2.1 with itself was unaffected by this mutation. Using fluorescence resonance energy transfer (FRET), interaction could be detected between the subunits Kv2.1/Kv2.1, Kv2.1/Kv6.3, and Kv2.1/Kv6.4. Reduced FRET signals were obtained after co-expression of Kv2.1(H105V) or Kv2.1(H105R) with Kv6.3 or Kv6.4. Wild-type Kv2.1 but not Kv2.1(H105V) could be co-immunoprecipitated with Kv6.4. Co-expression of dominant-negative mutants of Kv6.3 reduced the current produced Kv2.1, but not of Kv2.1(H105)R mutants. Co-expression of Kv6.3 or Kv6.4 with wt Kv2.1 but not with Kv2.1(H105V) or Kv2.1(H105R) changed the voltage dependence of activation of the channels. Our results suggest that His-105 in the T1 domain of Kv2.1 is required for functional heteromerization with members of the Kv6 subfamily. We conclude from our findings that Kv2.1 and Kv6. x subunits have complementary T1 domains that control selective heteromerization.	[Rinne, Susanne; Renigunta, Vijay; Schlichthoerl, Guenter; Derst, Christian; Daut, Juergen; Preisig-Mueller, Regina] Univ Marburg, Inst Physiol, D-35032 Marburg, Germany; [Mederos y Schnitzler, Michael; Skrobek, Lennart; Gudermann, Thomas] Univ Marburg, Inst Pharmacol & Toxicol, D-35037 Marburg, Germany; [Rinne, Susanne; Renigunta, Vijay; Schlichthoerl, Guenter; Derst, Christian; Daut, Juergen; Preisig-Mueller, Regina] Univ Marburg, Inst Physiol, D-35037 Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg	Daut, J (corresponding author), Univ Marburg, Inst Physiol, Deutschhausstr 2, D-35037 Marburg, Germany.	jdaut@staff.uni-marburg.de			Medizinstiftung; P. E.-Kempkes-Stiftung; SFB593	Medizinstiftung; P. E.-Kempkes-Stiftung; SFB593(German Research Foundation (DFG))	This study was supported by the Medizinstiftung (to M. M. S. and R. P. M.), P. E.-Kempkes-Stiftung (to R. P. M.), and SFB593 (TP A3, to T. G.; TP A4, to J. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barry DM, 1996, ANNU REV PHYSIOL, V58, P363, DOI 10.1146/annurev.ph.58.030196.002051; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Chiara MD, 1999, J NEUROSCI, V19, P6865, DOI 10.1523/JNEUROSCI.19-16-06865.1999; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hille B., 2001, ION CHANNELS EXCITAB, P131; Hugnot JP, 1996, EMBO J, V15, P3322, DOI 10.1002/j.1460-2075.1996.tb00697.x; Jahng AW, 2002, J BIOL CHEM, V277, P47885, DOI 10.1074/jbc.M208416200; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Malin SA, 2002, J NEUROSCI, V22, P10094; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Misonou H, 2005, J NEUROSCI METH, V144, P165, DOI 10.1016/j.jneumeth.2004.11.007; Misonou H, 2008, J NEUROSCI, V28, P8529, DOI 10.1523/JNEUROSCI.1417-08.2008; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Patel AJ, 1997, EMBO J, V16, P6615, DOI 10.1093/emboj/16.22.6615; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Post MA, 1996, FEBS LETT, V399, P177, DOI 10.1016/S0014-5793(96)01316-6; RAINEY WE, 1994, MOL CELL ENDOCRINOL, V100, P45, DOI 10.1016/0303-7207(94)90277-1; Robinson JM, 2005, NEURON, V45, P223, DOI 10.1016/j.neuron.2004.12.043; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Salinas M, 1997, J BIOL CHEM, V272, P24371, DOI 10.1074/jbc.272.39.24371; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; Sano Y, 2002, FEBS LETT, V512, P230, DOI 10.1016/S0014-5793(02)02267-6; SHEN NV, 1993, NEURON, V11, P67; Strang C, 2003, J BIOL CHEM, V278, P31361, DOI 10.1074/jbc.M304268200; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vega-Saenz de Miera E, 2004, MOL BRAIN RES, V123, P91, DOI 10.1016/j.molbrainres.2004.01.004; Wang GY, 2006, J GEN PHYSIOL, V127, P391, DOI 10.1085/jgp.200509442; Wang GY, 2005, J GEN PHYSIOL, V126, P55, DOI 10.1085/jgp.200509288; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P337	43	13	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4695	4704		10.1074/jbc.M808786200	http://dx.doi.org/10.1074/jbc.M808786200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074135	hybrid			2022-12-27	WOS:000263134400069
J	Yerbury, JJ; Kumita, JR; Meehan, S; Dobson, CM; Wilson, MR				Yerbury, Justin J.; Kumita, Janet R.; Meehan, Sarah; Dobson, Christopher M.; Wilson, Mark R.			alpha(2)-Macroglobulin and Haptoglobin Suppress Amyloid Formation by Interacting with Prefibrillar Protein Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-LIKE ACTIVITY; EXTRACELLULAR CHAPERONE; ALZHEIMERS-DISEASE; CLUSTERIN; BETA; PEPTIDE; CLEARANCE; BINDING; ALPHA-2-MACROGLOBULIN; SPECIFICITY	alpha(2)-Macroglobulin (alpha M-2) and haptoglobin ( Hp) are both abundant secreted glycoproteins that are best known for their protease trapping and hemoglobin binding activities, respectively. Like the small heat shock proteins, both these glycoproteins have in common the ability to protect a range of proteins from stress-induced amorphous aggregation and have been described as extracellular chaperones. Using an array of biophysical techniques, this study establishes that in vitro at substoichiometric levels and under physiological conditions alpha M-2 and Hp both inhibit the formation of amyloid fibrils from a range of proteins. We also provide evidence that both alpha M-2 and Hp interact with prefibrillar species to maintain the solubility of amyloidogenic proteins. These findings suggest that both alpha M-2 and Hp are likely to play an important role in controlling the inappropriate aggregation of proteins in the extracellular environment.	[Yerbury, Justin J.; Wilson, Mark R.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Kumita, Janet R.; Meehan, Sarah; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Wollongong; University of Cambridge	Wilson, MR (corresponding author), Univ Wollongong, Sch Biol Sci, Northfields Ave, Wollongong, NSW 2522, Australia.	mrw@uow.edu.au	Yerbury, Justin/AAC-7054-2022; Kumita, Janet/AAO-5254-2021; Wilson, Mark R/B-3254-2018	Yerbury, Justin/0000-0003-2528-7039; Wilson, Mark R/0000-0002-9551-7445	Rosemary Foundation Loader; Alzheimer's Australia Research; Biotechnology and Biological Sciences Research Council [BB/E019927/1] Funding Source: researchfish	Rosemary Foundation Loader; Alzheimer's Australia Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by a Rosemary Foundation Loader research grant through Alzheimer's Australia Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adler V, 2007, NEUROCHEM J+, V1, P43, DOI 10.1134/S1819712407010060; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P737; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Du YS, 1997, J NEUROCHEM, V69, P299; El-Ghmati SM, 2002, SCAND J IMMUNOL, V55, P352, DOI 10.1046/j.1365-3083.2002.01067.x; Ettrich R, 2002, BIOL CHEM, V383, P1667, DOI 10.1515/BC.2002.187; Fabrizi C, 2001, J NEUROCHEM, V78, P406, DOI 10.1046/j.1471-4159.2001.00419.x; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Graversen JH, 2002, INT J BIOCHEM CELL B, V34, P309, DOI 10.1016/S1357-2725(01)00144-3; Hatters DM, 2002, EUR J BIOCHEM, V269, P2789, DOI 10.1046/j.1432-1033.2002.02957.x; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095; Kumita JR, 2006, FEBS J, V273, P711, DOI 10.1111/j.1742-4658.2005.05099.x; LOUAGIE H, 1993, VACCINE, V11, P1188, DOI 10.1016/0264-410X(93)90041-U; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Mettenburg JM, 2002, J BIOL CHEM, V277, P13338, DOI 10.1074/jbc.M106792200; Motomiya Y, 2003, KIDNEY INT, V64, P2244, DOI 10.1046/j.1523-1755.2003.00315.x; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Narita M, 1997, J NEUROCHEM, V69, P1904; Pavlicek Z, 1999, COLLECT CZECH CHEM C, V64, P717, DOI 10.1135/cccc19990717; Poon S, 2002, FEBS LETT, V513, P259, DOI 10.1016/S0014-5793(02)02326-8; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; POWERS JM, 1981, J NEUROPATH EXP NEUR, V40, P592, DOI 10.1097/00005072-198111000-00002; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; SNELLMAN O, 1967, NATURE, V216, P1033, DOI 10.1038/2161033a0; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Starkey P. M., 1977, PROTEINASES MAMMALIA, P663; Strausak D, 2001, BRAIN RES BULL, V55, P175, DOI 10.1016/S0361-9230(01)00454-3; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com	39	79	79	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4246	4254		10.1074/jbc.M807242200	http://dx.doi.org/10.1074/jbc.M807242200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074141	hybrid			2022-12-27	WOS:000263134400022
J	Champagne, K; Shishido, A; Root, MJ				Champagne, Kelly; Shishido, Akira; Root, Michael J.			Interactions of HIV-1 Inhibitory Peptide T20 with the gp41 N-HR Coiled Coil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 FUSION; MEMBRANE-FUSION; POTENT INHIBITORS; TRANSMEMBRANE GLYCOPROTEIN; ENVELOPE GLYCOPROTEIN; ATOMIC-STRUCTURE; ENTRY INHIBITOR; HELICAL DOMAIN; 6-HELIX BUNDLE; BINDING-SITE	Cellular entry of human immunodeficiency virus type 1 (HIV-1) involves fusion of viral and cellular membranes and is mediated by structural transitions in viral glycoprotein gp41. The antiviral C-peptide T20 targets the gp41 N-terminal heptad repeat region (N-HR), blocking gp41 conformational changes essential for the entry process. To probe the T20 structure-activity relationship, we engineered a molecular mimic of the entire gp41 N-HR coiled coil using the 5-Helix design strategy. T20 bound this artificial protein (denoted 5H-ex) with nanomolar affinity (K-D = 30 nM), close to its IC50 concentration (similar to 3 nM) but much weaker than the affinity of a related inhibitory C-peptide C37 (K-D = 0.0007 nM). T20/C37 competitive binding assays confirmed that T20 interacts with the hydrophobic groove on the surface of the N-HR coiled coil outside of a deep pocket region crucial for C37 binding. We used 5H-ex to investigate how the T20 N and C termini contributed to the inhibitor binding activity. Mutating three aromatic residues at the T20 C terminus (WNWF -> ANAA) had no effect on affinity, suggesting that these amino acids do not participate in T20 binding to the gp41 N-HR. The results support recent evidence pointing to a different role for these residues in T20 inhibition (Peisajovich, S. G., Gallo, S. A., Blumenthal, R., and Shai, Y. (2003) J. Biol. Chem. 278, 21012-21017; Liu, S., Jing, W., Cheung, B., Lu, H., Sun, J., Yan, X., Niu, J., Farmar, J., Wu, S., and Jiang, S. (2007) J. Biol. Chem. 282, 9612-9620). By contrast, mutations near the T20 N terminus substantially influenced inhibitor binding strength. When Ile was substituted for Thr in the second T20 position, a 40-fold increase in binding affinity was measured (K-D = 0.75 nM). The effect of this affinity enhancement on T20 inhibitory potency varied among different viral strains. The original T20 and the higher affinity T20 variant had similar potency against wild type HIV-1. However, the higher affinity T20 variant was significantly more potent against T20-resistant virus. The findings suggest that other factors in addition to binding affinity play a role in limiting T20 potency. As a mimetic of the complete gp41 N-HR coiled coil region, 5H-ex will be a useful tool to further elucidate mechanistic profiles of C-peptide inhibitors.	[Champagne, Kelly; Shishido, Akira; Root, Michael J.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Root, MJ (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,Rm 802, Philadelphia, PA 19107 USA.	mroot@mail.jci.tju.edu	Shishido, Akira/AAD-5818-2022	Shishido, Akira/0000-0002-2649-4139	National Institutes of Health [5-T32-DK0775, R01 GM66682]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5-T32-DK0775 (to K. C.) and R01 GM66682 (to M. J. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Bellamy-Mclntyre AK, 2007, J BIOL CHEM, V282, P23104, DOI 10.1074/jbc.M703485200; BLACKLOW SC, 1995, BIOCHEMISTRY-US, V34, P14955, DOI 10.1021/bi00046a001; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FENOUILLET E, 1995, J GEN VIROL, V76, P1509, DOI 10.1099/0022-1317-76-6-1509; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Hamburger AE, 2005, J BIOL CHEM, V280, P12567, DOI 10.1074/jbc.M412770200; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kilgore NR, 2003, J VIROL, V77, P7669, DOI 10.1128/JVI.77.13.7669-7672.2003; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lawless MK, 1996, BIOCHEMISTRY-US, V35, P13697, DOI 10.1021/bi9606962; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lorizate M, 2006, BIOCHEMISTRY-US, V45, P14337, DOI 10.1021/bi0612521; Lorizate M, 2006, J MOL BIOL, V360, P45, DOI 10.1016/j.jmb.2006.04.056; Louis JM, 2003, J BIOL CHEM, V278, P20278, DOI 10.1074/jbc.M301627200; Louis JM, 2001, J BIOL CHEM, V276, P29485, DOI 10.1074/jbc.C100317200; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Nameki D, 2005, J VIROL, V79, P764, DOI 10.1128/JVI.79.2.764-770.2005; Peisajovich SG, 2003, J BIOL CHEM, V278, P21012, DOI 10.1074/jbc.M212773200; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Root MJ, 2003, P NATL ACAD SCI USA, V100, P5016, DOI 10.1073/pnas.0936926100; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Tallarida R., 2000, DRUG SYNERGISM DOSE, P1; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wexler-Cohen Y, 2006, J BIOL CHEM, V281, P9005, DOI 10.1074/jbc.M512475200; Wexler-Cohen Y, 2007, FASEB J, V21, P3677, DOI 10.1096/fj.07-8582com; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770	46	46	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3619	3627		10.1074/jbc.M809269200	http://dx.doi.org/10.1074/jbc.M809269200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073602	Green Published, hybrid			2022-12-27	WOS:000262872500030
J	Park, S; Guo, JP; Kim, D; Cheng, JQ				Park, Sungman; Guo, Jianping; Kim, Donghwa; Cheng, Jin Q.			Identification of 24p3 as a Direct Target of Foxo3a Regulated by Interleukin-3 through the Phosphoinositide 3-Kinase/Akt Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC-CELLS; APOPTOSIS; SURVIVAL; DEATH; GENE; SUPPRESSION; EXPRESSION; INDUCTION; RECEPTOR; SIGNALS	Pro-apoptotic protein 24p3, a member of lipocalin family, is induced upon interleukin-3 (IL-3) deprivation and plays a pivotal role in induction of apoptosis in hematopoietic cells. However, the molecular mechanism by which IL-3 regulates 24p3 expression remains largely unknown. Here, we show that 24p3 is a direct target of Foxo3a and that phosphoinositide 3-kinase (PI3K)/Akt mediates IL-3-repressed 24p3 through regulation of Foxo3a. Inhibition of the PI3K/Akt (but not MAPK) pathway induced 24p3 expression and programmed cell death in FL5.12 cells. Furthermore, constitutively active Akt largely attenuated 24p3 expression and apoptosis in response to IL-3 withdrawal. Foxo3a directly bound to the 24p3 promoter and induced promoter activity. Akt abrogated wild-type Foxo3a-induced (but notAkt-non-phosphorylatable Foxo3a(3A)-induced) 24p3expression and promoter activity. Therefore, these data indicate for the first time that 24p3 is a Foxo3a target gene and that PI3K/Akt (but not MAPK) mediates IL-3-regulated 24p3 expression in hematopoietic cells.	[Park, Sungman; Guo, Jianping; Kim, Donghwa; Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Cheng, JQ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr,SRB3, Tampa, FL 33612 USA.	jin.cheng@moffitt.org			National Institutes of Health [R01CA107098]; United States Department of Defense; NATIONAL CANCER INSTITUTE [R01CA107098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA107098 (to J.Q.C.). This work was also supported by the United States Department of Defense (to J.Q.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; GOLD MR, 1994, J BIOL CHEM, V269, P5403; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; KINOSHITA T, 1995, EMBO J, V14, P266, DOI 10.1002/j.1460-2075.1995.tb07000.x; Lin H, 2005, ONCOGENE, V24, P3246, DOI 10.1038/sj.onc.1208500; MCCUBREY J, 1989, ONCOGENE RES, V4, P97; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SCHEID MP, 1995, BIOCHEM J, V312, P159, DOI 10.1042/bj3120159; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000	26	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2187	2193		10.1074/jbc.M806131200	http://dx.doi.org/10.1074/jbc.M806131200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19056725	Green Published, hybrid			2022-12-27	WOS:000262545600028
J	Blount, AL; Schmidt, K; Justice, NJ; Vale, WW; Fischer, WH; Bilezikjian, LM				Blount, Amy L.; Schmidt, Karsten; Justice, Nicholas J.; Vale, Wylie W.; Fischer, Wolfgang H.; Bilezikjian, Louise M.			FoxL2 and Smad3 Coordinately Regulate Follistatin Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVIN-BINDING PROTEIN; GONADOTROPIN-RELEASING-HORMONE; SIGNAL-TRANSDUCTION; OVARIAN DEVELOPMENT; PITUITARY ACTIVIN; PROSTATE-CANCER; GRANULOSA-CELL; EXPRESSION; TISSUES; LOCALIZATION	Follistatin is a transcriptional target and a modulator of activin action. Through an autocrine/paracrine loop, activin controls follistatin levels and thus regulates its own bioavailability. In gonadotropic alpha T3-1 cells, activin induces follistatin transcription primarily through the action of Smad3 at an intronic Smad-binding element (SBE1). Using a proteomics approach, we searched for endogenous alpha T3-1 proteins that participate in SBE1-mediated transcription. We identified FoxL2, a member of the forkhead family, as a candidate modulator of SBE1 function. Mutations of FoxL2 are associated with the blepharophimosis/ptosis/epicanthus inversus syndrome characterized with craniofacial defects and premature ovarian failure. FoxL2 localizes to alpha-glycoprotein subunit-and follicle-stimulating hormone beta-positive cells of the adult mouse pituitary and is present in alpha T3-1 and L beta T2 cells, but its pituitary actions remain largely unknown. We have determined that FoxL2 binds to a forkhead-binding element (FKHB) located just downstream of the SBE1 site of the follistatin gene and functions as a Smad3 partner to drive SBE1-mediated transcription in alpha T3-1 cells treated with activin. Chromatin immunoprecipitation assays confirm that endogenous FoxL2 and Smad3 are recruited to the intronic enhancer of the follistatin gene where the SBE1 and FKHB sites are located. Exogenous FoxL2 enhances SBE1-mediated transcription, and short hairpin RNA-mediated knockdown of endogenous FoxL2 protein compromises this effect in alpha T3-1 cells. FoxL2 directly associates with Smad3 but not Smad2 or Smad4. This association between Smad3 and FoxL2 is mediated by the MH2 domain of Smad3 and is dependent on an intact forkhead domain in FoxL2. Altogether, these observations highlight a novel role for FoxL2 and suggest that it may function as a transcriptional regulator and a coordinator of Smad3 targets.	[Blount, Amy L.; Schmidt, Karsten; Justice, Nicholas J.; Vale, Wylie W.; Fischer, Wolfgang H.; Bilezikjian, Louise M.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute	Bilezikjian, LM (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bilezikjian@salk.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046941] Funding Source: NIH RePORTER; NICHD NIH HHS [5R01HD046941-05, R01 HD046941] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bartholin L, 2002, ONCOGENE, V21, P2227, DOI 10.1038/sj.onc.1205294; BENAYOUN BA, 2009, HUM MOL GEN IN PRESS; Besecke LM, 1996, ENDOCRINOLOGY, V137, P3667, DOI 10.1210/en.137.9.3667; Beysen D, 2008, HUM MUTAT, V29, pE205, DOI 10.1002/humu.20819; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Bilezikjian LM, 2003, ENDOCRINOLOGY, V144, P732, DOI 10.1210/en.2002-220703; BILEZIKJIAN LM, 1993, ENDOCRINOLOGY, V133, P2554, DOI 10.1210/en.133.6.2554; Blount AL, 2008, J BIOL CHEM, V283, P7016, DOI 10.1074/jbc.M709502200; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; Burger LL, 2002, ENDOCRINOLOGY, V143, P3243, DOI 10.1210/en.2002-220216; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; CORRIGAN AZ, 1991, ENDOCRINOLOGY, V128, P1682, DOI 10.1210/endo-128-3-1682; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Dalkin AC, 1996, ENDOCRINOLOGY, V137, P548, DOI 10.1210/en.137.2.548; Danila DC, 2000, J CLIN ENDOCR METAB, V85, P1009, DOI 10.1210/jc.85.3.1009; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; DEPAOLO LV, 1993, ENDOCRINOLOGY, V132, P2221, DOI 10.1210/en.132.5.2221; Ding Y, 2005, RNA, V11, P1157, DOI 10.1261/rna.2500605; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; ESCH FS, 1987, MOL ENDOCRINOL, V1, P849, DOI 10.1210/mend-1-11-849; Ethier JF, 2001, REPRODUCTION, V121, P667, DOI 10.1530/rep.0.1210667; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Guo QX, 1998, MOL ENDOCRINOL, V12, P96, DOI 10.1210/mend.12.1.0053; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; HORN F, 1991, MOL ENDOCRINOL, V5, P347, DOI 10.1210/mend-5-3-347; KAISER UB, 1992, ENDOCRINOLOGY, V130, P3048, DOI 10.1210/en.130.5.3048; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KOGAWA K, 1991, ENDOCRINOLOGY, V128, P1434, DOI 10.1210/endo-128-3-1434; KOGAWA K, 1991, ENDOCRINOL JAPON, V38, P383; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; LEBRUN JJ, 1997, INHIBIN ACTIVIN FOLL, P1; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; MICHEL U, 1992, J MOL ENDOCRINOL, V9, P147, DOI 10.1677/jme.0.0090147; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nallathambi Jeyabalan, 2008, Hum Mutat, V29, pE123, DOI 10.1002/humu.20809; Ogino H, 2008, CLIN CANCER RES, V14, P660, DOI 10.1158/1078-0432.CCR-07-1221; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Randall RA, 2004, MOL CELL BIOL, V24, P1106, DOI 10.1128/MCB.24.3.1106-1121.2004; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; Sardana G, 2008, J PROTEOME RES, V7, P3329, DOI 10.1021/pr8003216; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHIMASAKI S, 1989, MOL ENDOCRINOL, V3, P651, DOI 10.1210/mend-3-4-651; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; SHIMONAKA M, 1991, ENDOCRINOLOGY, V128, P3313, DOI 10.1210/endo-128-6-3313; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Thomas TZ, 1997, J CLIN ENDOCR METAB, V82, P3851, DOI 10.1210/jc.82.11.3851; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2006, MOL GENET METAB, V88, P225, DOI 10.1016/j.ymgme.2006.03.005; Vale W., 1990, HDB EXPT PHARM, P211; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; WIATER E, 2008, BIOL TGFSS FAMILY, P79; Winters SJ, 1997, ENDOCRINOLOGY, V138, P4324, DOI 10.1210/en.138.10.4324; Yeo CY, 1999, J BIOL CHEM, V274, P26584, DOI 10.1074/jbc.274.37.26584	70	90	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7631	7645		10.1074/jbc.M806676200	http://dx.doi.org/10.1074/jbc.M806676200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19106105	Green Published, hybrid			2022-12-27	WOS:000264195600025
J	Haggie, PM; Verkman, AS				Haggie, Peter M.; Verkman, A. S.			Unimpaired Lysosomal Acidification in Respiratory Epithelial Cells in Cystic Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOSOMAL ACIDIFICATION; CFTR; DISEASE; CLC-7; HYPERACIDIFICATION; ACCUMULATION; LEADS; PH	The mechanisms remain uncertain by which mutations in CFTR cause lung disease in cystic fibrosis (CF). Teichgraber et al. recently reported increased ceramide in CF lungs, which was proposed to result from defective lysosomal acidification in airway epithelial cells and consequent impairment of pH-dependent ceramide-metabolizing enzymes (Teichgraber, V., Ulrich, M., Endlich, N., Reithmuller, J., Wilker, B., Conceicao Ce Olivereira-Munding, C., van Heeckeren, A. M., Barr, M. L., von Kurthy, G., Schmid, K. W., Weller, M., Tummler, B., Lang, F., Grassme, H., Doring, G., and Gulbins, E. (2008) Nat. Med. 14, 382-391). Here, we measured lysosomal pH in several CFTR-expressing and -deficient cell lines, freshly isolated airway epithelial cells from non-CF and CF mice and humans, and well-differentiated primary cultures of human non-CF and CF airway epithelial cells. Lysosomal pH was measured by ratio imaging using a fluorescent pH indicator consisting of 40-kDa dextran conjugated to Oregon Green 488 and tetramethylrhodamine. In all cell types, lysosomal pH was similar to 4.5, unaffected by the thiazolidinone CFTR inhibitor CFTRinh-172, and increased to similar to 6.5 following bafilomycin inhibition of the vacuolar proton pump. Lysosomal pH did not differ significantly in airway epithelial cells from non-CF versus CF humans or mice. Our results provide direct evidence against the conclusions of Teichgraber et al. that lysosomal acidification is CFTR-dependent, impaired in CF, or responsible for ceramide accumulation. As such, alternative mechanisms are needed to explain increased ceramide in CF airways. Non-CFTR mechanisms, such as ClC-type chloride channels, are likely involved in maintaining electroneutrality during organellar acidification.	[Haggie, Peter M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Haggie, PM (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci E, San Francisco, CA 94143 USA.	peter.haggie@ucsf.edu			National Institutes of Health [EB00415, DK35124, HL73856, HL59198, EY13574, DK72517, DK81355]; Cystic Fibrosis Foundation (Research Development Program and Drug Discovery grants); American Heart Association [0765070Y]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081355, R37DK035124, P30DK072517, R01DK035124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation (Research Development Program and Drug Discovery grants); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EB00415, DK35124, HL73856, HL59198, EY13574, DK72517, and DK81355. This work was also supported by the Cystic Fibrosis Foundation (Research Development Program and Drug Discovery grants) and from the American Heart Association (0765070Y). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; BIWERSI J, 1994, AM J PHYSIOL, V266, pC149, DOI 10.1152/ajpcell.1994.266.1.C149; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; Chandy G, 2001, AM J PHYSIOL-CELL PH, V281, pC908, DOI 10.1152/ajpcell.2001.281.3.C908; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; DUNN KW, 1994, J BIOL CHEM, V269, P5336; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Haggie PM, 2007, J BIOL CHEM, V282, P31422, DOI 10.1074/jbc.M705296200; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Lamothe J, 2008, MICROBIOL-SGM, V154, P3825, DOI 10.1099/mic.0.2008/023200-0; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; LUKACS GL, 1992, J BIOL CHEM, V267, P14568; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Mohamed A, 1997, BIOCHEM J, V322, P259, DOI 10.1042/bj3220259; OHKUMA S, 1989, METHOD ENZYMOL, V174, P131; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Poschet JF, 2006, EMBO REP, V7, P553, DOI 10.1038/sj.embor.7400674; Poschet JF, 2002, J BIOL CHEM, V277, P13959, DOI 10.1074/jbc.M105441200; Poschet JF, 2001, P NATL ACAD SCI USA, V98, P13972, DOI 10.1073/pnas.241182598; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Seksek O, 1996, J BIOL CHEM, V271, P15542, DOI 10.1074/jbc.271.26.15542; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sonawane ND, 2003, J CELL BIOL, V160, P1129, DOI 10.1083/jcb.200211098; Sonawane ND, 2002, J BIOL CHEM, V277, P5506, DOI 10.1074/jbc.M110818200; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; VANDYKE RW, 1992, BIOCHEM BIOPH RES CO, V184, P300, DOI 10.1016/0006-291X(92)91192-S; Varghese B, 2008, MOL CELL BIOL, V28, P5275, DOI 10.1128/MCB.00350-08; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; VONBONSDORFF CH, 1985, EMBO J, V4, P2781, DOI 10.1002/j.1460-2075.1985.tb04004.x; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713, DOI 10.1152/ajplung.1992.262.6.L713; ZEN K, 1992, J CELL BIOL, V119, P99, DOI 10.1083/jcb.119.1.99	39	48	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7681	7686		10.1074/jbc.M809161200	http://dx.doi.org/10.1074/jbc.M809161200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19136560	hybrid, Green Published			2022-12-27	WOS:000264195600030
J	Murphy, RM; Lamb, GD				Murphy, Robyn M.; Lamb, Graham D.			Endogenous Calpain-3 Activation Is Primarily Governed by Small Increases in Resting Cytoplasmic [Ca2+] and Is Not Dependent on Stretch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-SPECIFIC CALPAIN; HUMAN SKELETAL-MUSCLE; DYSTROPHY TYPE 2A; MOUSE EDL MUSCLE; MUSCULAR-DYSTROPHY; IN-VIVO; ECCENTRIC CONTRACTIONS; PROTEIN EXPRESSION; CALCIUM-RELEASE; MU-CALPAIN	Proteolytically active calpain-3/p94 is clearly vital for normal muscle function, since its absence leads to limb girdle muscular dystrophy 2A, but its function and regulatory control are poorly understood. Here we use single muscle fibers, individually skinned by microdissection, to investigate the diffusibility and autolytic activation of calpain-3 in situ. Virtually all calpain-3 present in mature muscle fibers is tightly bound in the vicinity of the titin N2A line and triad junctions and remains so irrespective of fiber stretching or raised [Ca2+]. Most calpain-3 is evidently bound within the contractile filament lattice, because (i) its slow diffusional loss is slowed further by locking myosin and actin into rigor and (ii) detergent dispersion of membranes causes rapid washout of most ryanodine receptors and sarcoplasmic reticulum Ca2+ pumps with little accompanying washout of calpain-3. Calpain-3 autolyzes (becoming proteolytically active) in a tightly calcium-dependent manner. It remains in its nonactivated full-length form if [Ca2+] is maintained at <= 50 nM, the normal resting level, even with brief increases to 2-20 mu M during repeated tetanic contractions, but it becomes active (though still bound) if [Ca2+] is kept slightly elevated at 200 nM (similar to 20% autolysis in 1 h). Calpain-3 did not spontaneously autolyze even when free in solution with 200 nM Ca2+ for up to 60 min. These findings explain why calpain-3 remains quiescent with normal exercise but is activated following eccentric (stretching) contractions, when resting [Ca2+] is elevated, and how a protease such as calpain-3 can be very Ca2+-sensitive yet highly specific in its actions.	[Murphy, Robyn M.; Lamb, Graham D.] La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia	La Trobe University	Murphy, RM (corresponding author), La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia.	r.murphy@latrobe.edu.au		Murphy, Robyn/0000-0003-3697-589X	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anderson LVB, 1998, AM J PATHOL, V153, P1169, DOI 10.1016/S0002-9440(10)65661-1; ARMSTRONG RB, 1983, J APPL PHYSIOL, V54, P80, DOI 10.1152/jappl.1983.54.1.80; Baghdiguian S, 2001, J MOL MED, V79, P254, DOI 10.1007/s001090100225; BALNAVE CD, 1995, J PHYSIOL-LONDON, V488, P25, DOI 10.1113/jphysiol.1995.sp020943; Baylor SM, 2003, J PHYSIOL-LONDON, V551, P125, DOI 10.1113/jphysiol.2003.041608; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Branca D, 1999, EUR J BIOCHEM, V265, P839, DOI 10.1046/j.1432-1327.1999.00817.x; Diaz BEG, 2006, BIOCHEMISTRY-US, V45, P3714, DOI 10.1021/bi051917j; Diaz BG, 2004, J BIOL CHEM, V279, P27656, DOI 10.1074/jbc.M313290200; Duguez S, 2006, FEBS J, V273, P3427, DOI 10.1111/j.1742-4658.2006.05351.x; Fanin M, 2003, AM J PATHOL, V163, P1929, DOI 10.1016/S0002-9440(10)63551-1; Fougerousse F, 1998, GENOMICS, V48, P145, DOI 10.1006/geno.1997.5160; GIBALA MJ, 1995, J APPL PHYSIOL, V78, P702, DOI 10.1152/jappl.1995.78.2.702; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Granzier H, 2007, MUSCLE NERVE, V36, P740, DOI 10.1002/mus.20886; Huebsch KA, 2005, HUM MOL GENET, V14, P2801, DOI 10.1093/hmg/ddi313; Ingalls CP, 1998, J APPL PHYSIOL, V85, P58, DOI 10.1152/jappl.1998.85.1.58; Keira Y, 2003, J BIOCHEM, V133, P659, DOI 10.1093/jb/mvg084; Kinbara K, 1998, BIOCHEM J, V335, P589, DOI 10.1042/bj3350589; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Lamb GD, 1995, J PHYSIOL-LONDON, V489, P349, DOI 10.1113/jphysiol.1995.sp021056; LAMB GD, 1994, J PHYSIOL-LONDON, V478, P331, DOI 10.1113/jphysiol.1994.sp020253; Lynch GS, 1997, CELL CALCIUM, V22, P373, DOI 10.1016/S0143-4160(97)90022-1; Morgan DL, 2004, CLIN EXP PHARMACOL P, V31, P541, DOI 10.1111/j.1440-1681.2004.04029.x; Murphy RM, 2006, AM J PHYSIOL-CELL PH, V290, pC116, DOI 10.1152/ajpcell.00291.2005; MURPHY RM, 2009, EXP CELL RE IN PRESS; Murphy RM, 2007, J APPL PHYSIOL, V103, P926, DOI 10.1152/japplphysiol.01422.2006; Murphy RM, 2006, J PHYSIOL-LONDON, V576, P595, DOI 10.1113/jphysiol.2006.114090; Ojima K, 2007, J BIOL CHEM, V282, P14493, DOI 10.1074/jbc.M610806200; Ojima K, 2005, J MUSCLE RES CELL M, V26, P409, DOI 10.1007/s10974-005-9023-8; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Y, 2008, FEBS LETT, V582, P691, DOI 10.1016/j.febslet.2008.01.044; Posterino GS, 2000, J PHYSIOL-LONDON, V527, P131, DOI 10.1111/j.1469-7793.2000.t01-2-00131.x; Ravulapalli R, 2005, BIOCHEM J, V388, P585, DOI 10.1042/BJ20041821; Richard I, 1999, AM J HUM GENET, V64, P1524, DOI 10.1086/302426; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Spencer MJ, 1997, J NEUROL SCI, V146, P173, DOI 10.1016/S0022-510X(96)00304-8; Spencer MJ, 2002, P NATL ACAD SCI USA, V99, P8874, DOI 10.1073/pnas.132269299; STEPHENSON GMM, 1993, PFLUG ARCH EUR J PHY, V424, P30, DOI 10.1007/BF00375099; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Tavi P, 2003, J PHYSIOL-LONDON, V551, P5, DOI 10.1113/jphysiol.2003.042002; Verburg E, 2006, AM J PHYSIOL-CELL PH, V290, pC1199, DOI 10.1152/ajpcell.00469.2005; Warren GL, 2002, AM J PHYSIOL-REG I, V282, pR1122, DOI 10.1152/ajpregu.00671.2001	47	36	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7811	7819		10.1074/jbc.M808655200	http://dx.doi.org/10.1074/jbc.M808655200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144634	hybrid, Green Published			2022-12-27	WOS:000264195600043
J	Raschle, T; Speziga, D; Kress, W; Moccand, C; Gehrig, P; Amrhein, N; Weber-Ban, E; Fitzpatrick, TB				Raschle, Thomas; Speziga, Davide; Kress, Wolfgang; Moccand, Cyril; Gehrig, Peter; Amrhein, Nikolaus; Weber-Ban, Eilika; Fitzpatrick, Teresa B.			Intersubunit Cross-talk in Pyridoxal 5 '-Phosphate Synthase, Coordinated by the C Terminus of the Synthase Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; STRUCTURAL INSIGHTS; ESCHERICHIA-COLI; PLP SYNTHASE; AMINO-ACID; BIOSYNTHESIS; VITAMIN-B-6; SPECTROSCOPY; MUTAGENESIS; MECHANISM	Vitamin B-6 is essential in all organisms, due to its requirement as a cofactor in the form of pyridoxal 5 '-phosphate (PLP) for key metabolic enzymes. It can be synthesized de novo by either of two pathways known as deoxyxylulose 5-phosphate (DXP)-dependent and DXP-independent. The DXP-independent pathway is the predominant pathway and is found in most microorganisms and plants. A glutamine amidotransferase consisting of the synthase Pdx1 and its glutaminase partner, Pdx2, form a complex that directly synthesizes PLP from ribose 5-phosphate, glyceraldehyde 3-phosphate, and glutamine. The protein complex displays an ornate architecture consisting of 24 subunits, two hexameric rings of 12 Pdx1 subunits to which 12 Pdx2 subunits attach, with the glutaminase and synthase active sites remote from each other. The multiple catalytic ability of Pdx1, the remote glutaminase and synthase active sites, and the elaborate structure suggest regulation of activity on several levels. A missing piece in deciphering this intricate puzzle has been information on the Pdx1 C-terminal region that has thus far eluded structural characterization. Here we use fluorescence spectrophotometry and protein chemistry to demonstrate that the Pdx1 C terminus is indispensable for PLP synthase activity and mediates intersubunit cross-talk within the enzyme complex. We provide evidence that the C terminus can act as a flexible lid, bridging as well as shielding the active site of an adjacent protomer in Pdx1. We show that ribose 5-phosphate binding triggers strong cooperativity in Pdx1, and the affinity for this substrate is substantially enhanced upon interaction with the Michaelis complex of Pdx2 and glutamine.	[Moccand, Cyril; Fitzpatrick, Teresa B.] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland; [Raschle, Thomas; Speziga, Davide; Amrhein, Nikolaus; Fitzpatrick, Teresa B.] ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland; [Kress, Wolfgang; Weber-Ban, Eilika] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Gehrig, Peter] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland	University of Geneva; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Fitzpatrick, TB (corresponding author), Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland.	theresa.fitzpatrick@unige.ch		Weber-Ban, Eilika/0000-0002-5773-9274	Swiss National Science Foundation [3100A0-107975/1, PP00A_119186]; Novartis International	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis International	This work was supported by Swiss National Science Foundation Grants 3100A0-107975/1 (to N.A. and T. B. F.) and Grant PP00A_119186 (to T. B. F.) and a grant from Novartis International A. G. (to Duilio Arigoni, ETH Zurich). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bauer JA, 2004, J BIOL CHEM, V279, P2704, DOI 10.1074/jbc.M310311200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRZOVIC PS, 1993, BIOCHEMISTRY-US, V32, P10404, DOI 10.1021/bi00090a016; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; DeLano W, 2002, PYMOL 0 99; Desamero R, 2003, BIOCHEMISTRY-US, V42, P2941, DOI 10.1021/bi026994i; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Drewke C, 2001, VITAM HORM, V61, P121; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Garrido-Franco M, 2003, BBA-PROTEINS PROTEOM, V1647, P92, DOI 10.1016/S1570-9639(03)00065-7; Garrido-Franco M, 2002, J MOL BIOL, V321, P601, DOI 10.1016/S0022-2836(02)00695-2; GARRIDOFRANCO M, 2001, STRUCTURE, V9, P245; Gengenbacher M, 2006, J BIOL CHEM, V281, P3633, DOI 10.1074/jbc.M508696200; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P1; Neuwirth M, 2007, BIOCHEMISTRY-US, V46, P5131, DOI 10.1021/bi602602x; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; Raschle T, 2007, J BIOL CHEM, V282, P6098, DOI 10.1074/jbc.M610614200; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Singh SK, 1999, BIOCHEMISTRY-US, V38, P14906, DOI 10.1021/bi991615f; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Zein F, 2006, BIOCHEMISTRY-US, V45, P14609, DOI 10.1021/bi061464y; Zhu JH, 2005, J BIOL CHEM, V280, P27914, DOI 10.1074/jbc.M503642200	25	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7706	7718		10.1074/jbc.M804728200	http://dx.doi.org/10.1074/jbc.M804728200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19074821	hybrid, Green Published			2022-12-27	WOS:000264195600033
J	Tokutsu, R; Iwai, M; Minagawa, J				Tokutsu, Ryutaro; Iwai, Masakazu; Minagawa, Jun			CP29, a Monomeric Light-harvesting Complex II Protein, Is Essential for State Transitions in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCITATION-ENERGY TRANSFER; PHOTOSYSTEM-II; ELECTRON-TRANSPORT; PHOTOSYNTHETIC MEMBRANES; ANTENNA PROTEINS; GREEN PLANTS; PHOSPHORYLATION; FLUORESCENCE; ARABIDOPSIS; POLYPEPTIDES	In oxygen-evolving photosynthesis, the two photosystems, photosystem I (PSI) and photosystem II (PSII), function in parallel, and their excitation levels must be balanced to maintain an optimal photosynthetic rate under various light conditions. State transitions balance excitation energy between the two photosystems by redistributing light-harvesting complex II (LHCII) proteins. Here we describe two RNA interference (RNAi) mutants of the green alga Chlamydomonas reinhardtii with one of the minor monomeric LHCII proteins, CP29 or CP26, knocked down. These two proteins have been identified in PSI-LHCI supercomplexes that harbor mobile LHCII proteins from PSII under a state where PSII is preferentially excited (State 2). We show that both the CP29 and CP26 RNAi mutants undergo reductions in the PSII antenna size during a transition from State 1 (a state where PSI is preferentially excited) to State 2, as reflected by nonphotochemical quenching of fluorescence, low temperature fluorescence spectra, and functional absorption cross-section. However, the undocked LHCIIs from PSII do not re-associate with PSI in the CP29-RNAi (b4i) mutant because the antenna size of PSI was not complementary increased. The mobile LHCIIs in the CP26-RNAi (b5i) mutant, however, re-associate with PSI, whose PSI-LHCI/II supercomplex is visualized on a sucrose density gradient. This study clarifies that CP29, not CP26, is an essential component in state transitions and demonstrates that CP29 is crucial when mobile LHCIIs re-associate with PSI under State 2 conditions.	[Tokutsu, Ryutaro; Iwai, Masakazu; Minagawa, Jun] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan	Hokkaido University	Minagawa, J (corresponding author), Hokkaido Univ, Inst Low Temp Sci, North 19 West 8, Sapporo, Hokkaido 0600819, Japan.	minagawa@lowtem.hokudai.ac.jp	Tokutsu, Ryutaro/V-7596-2019; Tokutsu, Ryutaro/GRF-0208-2022	Tokutsu, Ryutaro/0000-0003-2037-255X; Iwai, Masakazu/0000-0002-0986-9015; Minagawa, Jun/0000-0002-3028-3203	Japan Science Society; Japan Society for the Promotion of Science [18004526]; Ministry of Education, Culture, Sports, Science and Technology [18GS0318]	Japan Science Society; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Sasakawa Scientific Research grant from The Japan Science Society (to R.T.), a Research Fellowship for Young Scientists from Japan Society for the Promotion of Science 18004526 (to M.I.) and Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology 18GS0318 (to J.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; BENNETT J, 1980, P NATL ACAD SCI-BIOL, V77, P5253, DOI 10.1073/pnas.77.9.5253; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Gohre V, 2006, PLANT CELL, V18, P1454, DOI 10.1105/tpc.105.038695; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Harrer R, 1998, EUR J BIOCHEM, V255, P196, DOI 10.1046/j.1432-1327.1998.2550196.x; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Iwai M, 2007, PHOTOSYNTH RES, V94, P307, DOI 10.1007/s11120-007-9220-y; KANNO A, 2005, PHOTOSYNTHESIS FUNDA, P483; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; LIN S, 1991, PHOTOSYNTH RES, V27, P157, DOI 10.1007/BF00035837; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Minagawa J, 2004, PHOTOSYNTH RES, V82, P241, DOI 10.1007/s11120-004-2079-2; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Nield J, 2000, NAT STRUCT BIOL, V7, P44; Rochaix JD, 2007, FEBS LETT, V581, P2768, DOI 10.1016/j.febslet.2007.04.038; Rohr J, 2004, PLANT J, V40, P611, DOI 10.1111/j.1365-313X.2004.02227.x; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Schroda M, 2006, CURR GENET, V49, P69, DOI 10.1007/s00294-005-0042-1; Shimogawara K, 1998, GENETICS, V148, P1821; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Turkina MV, 2006, MOL CELL PROTEOMICS, V5, P1412, DOI 10.1074/mcp.M600066-MCP200; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; WOLLMAN FA, 1988, BIOCHIM BIOPHYS ACTA, V933, P85, DOI 10.1016/0005-2728(88)90058-8; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z; Zito F, 2002, J BIOL CHEM, V277, P12446, DOI 10.1074/jbc.M110914200	38	57	57	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7777	7782		10.1074/jbc.M809360200	http://dx.doi.org/10.1074/jbc.M809360200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144643	Green Published, hybrid			2022-12-27	WOS:000264195600039
J	Ding, W; Liu, WL; Cooper, KL; Qin, XJ; Bergo, PLD; Hudson, LG; Liu, KJ				Ding, Wei; Liu, Wenlan; Cooper, Karen L.; Qin, Xu-Jun; Bergo, Patricia L. de Souza; Hudson, Laurie G.; Liu, Ke Jian			Inhibition of Poly(ADP-ribose) Polymerase-1 by Arsenite Interferes with Repair of Oxidative DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ULTRAVIOLET-RADIATION; MAMMALIAN-CELLS; METAL-COMPOUNDS; NITRIC-OXIDE; ZINC-FINGER; MOUSE SKIN; CANCER; EXPRESSION; GENERATION; INDUCTION	Arsenic enhances skin tumor formation when combined with other carcinogens, including UV radiation (UVR). In this study we report that low micromolar concentrations of arsenite synergistically increases UVR-induced oxidative DNA damage in human keratinocytes as detected by 8-hydroxyl-2'-deoxyguanine (8-OHdG) formation. Poly(ADP-ribose) polymerase-1 (PARP-1) is involved in base excision repair, a process that repairs 8-OHdG lesions. Arsenite suppresses UVR-induced PARP-1 activation in a concentration-dependent manner. Inhibition of PARP-1 activity by 3-aminobenzamide or small interfering RNA silencing of PARP-1 expression significantly increases UVR-induced 8-OHdG formation, suggesting that inhibition of PARP-1 activity by arsenite contributes to oxidative DNA damage. PARP-1 is a zinc finger protein, and mass spectrometry analysis reveals that arsenite can occupy a synthetic apopeptide representing the first zinc finger of PARP-1 (PARPzf). When the PARPzf peptide is preincubated with Zn(II) followed by incubation with increasing concentrations of arsenite, the ZnPARPzf signal is decreased while the AsPARPzf signal intensity is increased as a function of arsenite dose, suggesting a competition between zinc and arsenite for the same binding site. Addition of Zn(II) abolished arsenite enhancement of UVR-stimulated 8-OHdG generation and restored PARP-1 activity. Our findings demonstrate that arsenite inhibits oxidative DNA damage repair and suggest that interaction of arsenite with the PARP-1 zinc finger domain contributes to the inhibition of PARP-1 activity by arsenite. Arsenite inhibition of poly( ADP-ribosyl)ation is one likely mechanism for the reported co-carcinogenic activities of arsenic in UVR-induced skin carcinogenesis.	[Hudson, Laurie G.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA	University of New Mexico	Hudson, LG (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, MSC 09 5360, Albuquerque, NM 87131 USA.	lhudson@salud.unm.edu	Ding, Wei/L-1503-2014	de Souza Bergo, Patricia Luisa/0000-0002-4288-4903	NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015826, P30ES012072, R01ES012938] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA118100] Funding Source: Medline; NIEHS NIH HHS [R01 ES15826, P30 ES-012072, R01 ES012938] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Ahmed NU, 1999, BRIT J DERMATOL, V140, P226, DOI 10.1111/j.1365-2133.1999.02653.x; Asmuss M, 2000, CARCINOGENESIS, V21, P2097, DOI 10.1093/carcin/21.11.2097; Bal W, 2002, TOXICOL LETT, V127, P55, DOI 10.1016/S0378-4274(01)00483-0; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Begley TJ, 2004, DNA REPAIR, V3, P1123, DOI 10.1016/j.dnarep.2004.03.013; Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; De Blasio A, 2003, INT J ONCOL, V23, P1521; Ding W, 2005, MOL CELL BIOCHEM, V279, P105, DOI 10.1007/s11010-005-8227-y; Ding W, 2008, FREE RADICAL BIO MED, V45, P1065, DOI 10.1016/j.freeradbiomed.2008.06.022; Evans CD, 2004, CARCINOGENESIS, V25, P493, DOI 10.1093/carcin/bgg199; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Fischer JM, 2005, MUTAT RES-GEN TOX EN, V588, P35, DOI 10.1016/j.mrgentox.2005.09.003; Germolec DR, 1998, AM J PATHOL, V153, P1775, DOI 10.1016/S0002-9440(10)65692-1; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Hartwig A, 2002, ENVIRON HEALTH PERSP, V110, P797, DOI 10.1289/ehp.02110s5797; Hartwig A, 2003, TOXICOLOGY, V193, P161, DOI 10.1016/j.tox.2003.08.004; Hartwig A, 2002, TOXICOL LETT, V127, P47, DOI 10.1016/S0378-4274(01)00482-9; Hartwig A, 2003, INT J CANCER, V104, P1, DOI 10.1002/ijc.10911; Hei TK, 1998, P NATL ACAD SCI USA, V95, P8103, DOI 10.1073/pnas.95.14.8103; KAWAMITSU H, 1984, BIOCHEMISTRY-US, V23, P3771, DOI 10.1021/bi00311a032; Kessel M, 2002, MOL CELL BIOCHEM, V234, P301, DOI 10.1023/A:1015927406142; Kitchin KT, 2008, J INORG BIOCHEM, V102, P532, DOI 10.1016/j.jinorgbio.2007.10.021; Kitchin KT, 2005, TOXICOL APPL PHARM, V206, P66, DOI 10.1016/j.taap.2004.12.010; Le Rhun Y, 1998, BIOCHEM BIOPH RES CO, V245, P1; Liao XY, 2005, ENVIRON INT, V31, P791, DOI 10.1016/j.envint.2005.05.030; Liu F, 2000, FREE RADICAL BIO MED, V28, P55, DOI 10.1016/S0891-5849(99)00196-3; Liu WL, 2006, J NEUROSCI RES, V84, P360, DOI 10.1002/jnr.20895; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Matsui M, 1999, J INVEST DERMATOL, V113, P26, DOI 10.1046/j.1523-1747.1999.00630.x; Patel KS, 2005, ENVIRON GEOCHEM HLTH, V27, P131, DOI 10.1007/s10653-005-0120-9; PERSHAGEN G, 1981, ENVIRON HEALTH PERSP, V40, P93, DOI 10.2307/3429223; Piatek K, 2008, CHEM RES TOXICOL, V21, P600, DOI 10.1021/tx7003135; Poonepalli A, 2005, CANCER RES, V65, P10977, DOI 10.1158/0008-5472.CAN-05-2336; Qin XJ, 2008, TOXICOL APPL PHARM, V232, P41, DOI 10.1016/j.taap.2008.05.019; Qin XJ, 2008, CHEM RES TOXICOL, V21, P1806, DOI 10.1021/tx8001548; Ramirez P, 2000, CARCINOGENESIS, V21, P701, DOI 10.1093/carcin/21.4.701; Rossman TG, 2004, TOXICOL APPL PHARM, V198, P394, DOI 10.1016/j.taap.2003.10.016; Rossman TG, 2001, TOXICOL APPL PHARM, V176, P64, DOI 10.1006/taap.2001.9277; Schwerdtle T, 2003, DNA REPAIR, V2, P1449, DOI 10.1016/j.dnarep.2003.09.001; Shi HL, 2004, CHEM RES TOXICOL, V17, P871, DOI 10.1021/tx049939e; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Walter I, 2007, DNA REPAIR, V6, P61, DOI 10.1016/j.dnarep.2006.08.008; Yager JW, 1997, MUTAT RES-REV MUTAT, V386, P345, DOI 10.1016/S1383-5742(97)00011-2; YAMAMOTO S, 1995, CANCER RES, V55, P1271; Yarborough A, 1996, CANCER RES, V56, P683	48	119	120	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6809	6817		10.1074/jbc.M805566200	http://dx.doi.org/10.1074/jbc.M805566200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19056730	hybrid, Green Published			2022-12-27	WOS:000263919000026
J	Hirakawa, K; Kobayashi, S; Inoue, T; Endoh-Yamagami, S; Fukuda, R; Ohta, A				Hirakawa, Kiyoshi; Kobayashi, Satoshi; Inoue, Takuro; Endoh-Yamagami, Setsu; Fukuda, Ryouichi; Ohta, Akinori			Yas3p, an Opi1 Family Transcription Factor, Regulates Cytochrome P450 Expression in Response to n-Alkanes in Yarrowia lipolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID BIOSYNTHETIC GENES; LIPID-BINDING PROTEINS; LOOP-HELIX PROTEINS; SACCHAROMYCES-CEREVISIAE; CANDIDA-TROPICALIS; MULTIGENE FAMILY; HEMIASCOMYCETOUS YEASTS; DECANE ASSIMILATION; GENOMIC EXPLORATION; NEGATIVE REGULATOR	In the alkane-assimilating yeast Yarrowia lipolytica, the expression of ALK1, a gene encoding cytochrome P450 that catalyzes the first step of n-alkane oxidation, is induced by n-alkanes. We previously demonstrated that two basic helix-loop-helix proteins, Yas1p and Yas2p, activate the transcription of ALK1 in an alkane-dependent manner by forming a heterocomplex and binding to alkane-responsive element 1 (ARE1), a cis-acting element in the ALK1 promoter. Here we identified an Opi1 family transcription factor, Yas3p, involved in the alkane-dependent transcription regulation of ALK genes. Deletion of YAS3 caused a significant increase in ALK1 mRNA in cells grown on glucose, glycerol, and n-alkanes. The YAS3 deletion also resulted in a marked elevation of reporter gene expression driven by an ARE1-containing promoter on glycerol and n-decane. Bacterially expressed Yas3p bound specifically to Yas2p, but not to Yas1p, in vitro. In addition, although green fluorescent protein-tagged Yas3p was localized in the nucleus in glucose-containing medium, it changed its localization to an endoplasmic reticulum-like compartment upon transfer to medium containing n-decane. These findings suggest that Yas3p functions as a master regulator of transcriptional response, which changes its localization between the nucleus and endoplasmic reticulum membrane in response to different carbon sources. Furthermore, quantitative real time PCR analysis of 12 ALK genes in YAS1, YAS2, and YAS3 deletion mutants suggested that Yas3p is involved in the transcriptional repression of a variety of ALK genes, including ALK1. In contrast, YAS3 deletion did not affect the mRNA level of an INO1 ortholog in Y. lipolytica, indicating functional diversity of Opi1 family transcription factors.	[Hirakawa, Kiyoshi; Kobayashi, Satoshi; Inoue, Takuro; Endoh-Yamagami, Setsu; Fukuda, Ryouichi; Ohta, Akinori] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Ohta, A (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	aaohta@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was performed using the facilities of the Biotechnology Research Center of the University of Tokyo. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Broughton J, 1997, J CELL SCI, V110, P2715; CARDINI G, 1970, J BIOL CHEM, V245, P2789; Casaregola S, 2000, FEBS LETT, V487, P95, DOI 10.1016/S0014-5793(00)02288-2; Chang YF, 2006, J BIOL CHEM, V281, P4754, DOI 10.1074/jbc.M513064200; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Endoh-Yamagami S, 2007, EUKARYOT CELL, V6, P734, DOI 10.1128/EC.00412-06; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GREENBERG ML, 1982, GENETICS, V100, P19; Heyken WT, 2005, MOL MICROBIOL, V56, P696, DOI 10.1111/j.1365-2958.2004.04499.x; Heyken WT, 2003, YEAST, V20, P1177, DOI 10.1002/yea.1031; Hoppen J, 2007, MOL GENET GENOMICS, V278, P317, DOI 10.1007/s00438-007-0253-x; HOSHIZAKI DK, 1990, J BIOL CHEM, V265, P4736; Iida T, 1998, YEAST, V14, P1387; Kaadige MR, 2006, CURR GENET, V49, P30, DOI 10.1007/s00294-005-0021-6; Kaadige MR, 2003, MOL MICROBIOL, V48, P823, DOI 10.1046/j.1365-2958.2003.03472.x; Kagiwada S, 2003, J BIOCHEM, V133, P515, DOI 10.1093/jb/mvg068; Kobayashi S, 2008, BIOSCI BIOTECH BIOCH, V72, P2219, DOI 10.1271/bbb.80230; LEBEAULT JM, 1971, BIOCHEM BIOPH RES CO, V42, P413, DOI 10.1016/0006-291X(71)90386-X; Lida T, 2000, YEAST, V16, P1077, DOI 10.1002/1097-0061(20000915)16:12<1077::AID-YEA601>3.0.CO;2-K; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Nikawa JI, 2004, J BIOSCI BIOENG, V97, P369, DOI 10.1016/S1389-1723(04)70220-0; NIKOLOFF DM, 1992, NUCLEIC ACIDS RES, V20, P3253, DOI 10.1093/nar/20.12.3253; OHKUMA M, 1995, DNA CELL BIOL, V14, P163, DOI 10.1089/dna.1995.14.163; OHKUMA M, 1991, DNA CELL BIOL, V10, P271, DOI 10.1089/dna.1991.10.271; SANGLARD D, 1987, BIOCHEM BIOPH RES CO, V144, P251, DOI 10.1016/S0006-291X(87)80503-X; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; SCHWANK S, 1995, NUCLEIC ACIDS RES, V23, P230, DOI 10.1093/nar/23.2.230; SEGHEZZI W, 1992, DNA CELL BIOL, V11, P767, DOI 10.1089/dna.1992.11.767; SEGHEZZI W, 1991, GENE, V106, P51, DOI 10.1016/0378-1119(91)90565-S; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; Sreenivas A, 2003, J BIOL CHEM, V278, P20673, DOI 10.1074/jbc.M300132200; Sreenivas A, 2001, J BIOL CHEM, V276, P29915, DOI 10.1074/jbc.M105147200; Sumita T, 2002, BIOCHEM BIOPH RES CO, V294, P1071, DOI 10.1016/S0006-291X(02)00607-1; TANAKA A, 1989, YEASTS, V3, P261; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; WHITE MJ, 1991, J BIOL CHEM, V266, P863; Yamagami S, 2004, J BIOL CHEM, V279, P22183, DOI 10.1074/jbc.M313313200; Yamagami S, 2001, BIOCHEM BIOPH RES CO, V282, P832, DOI 10.1006/bbrc.2001.4653	49	38	38	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7126	7137		10.1074/jbc.M806864200	http://dx.doi.org/10.1074/jbc.M806864200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131334	Green Published, hybrid			2022-12-27	WOS:000263919000060
J	Nezu, A; Parvin, MN; Turner, RJ				Nezu, Akihiro; Parvin, Most. Nahid; Turner, R. James			A Conserved Hydrophobic Tetrad near the C Terminus of the Secretory Na+-K+-2Cl(-) Cotransporter (NKCC1) Is Required for Its Correct Intracellular Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; ENDOPLASMIC-RETICULUM; CHLORIDE COTRANSPORTERS; FUNCTIONAL EXPRESSION; CARBOXYL-TERMINUS; QUALITY-CONTROL; RECEPTOR; PROTEIN; TRANSPORT; DOMAIN	Little is known about the intracellular folding and trafficking of integral membrane proteins. Here we identify a hydrophobic amino acid tetrad (ILLV) close to the C terminus of the secretory Na+-K+-2Cl(-) cotransporter (NKCC1) that is important for the proper intracellular processing of this protein. This tetrad appears in a C-terminal sequence pattern that is conserved across species in a number of members of the NKCC1 gene family (slc12) of electroneutral salt transporters. We studied the effects of various mutations of these amino acids on NKCC1 transiently transfected into HEK-293 cells. Our results show that mutation of two of these residues to alanine leads to a>50% reduction in expression and complex glycosylation levels and that multiple mutations to alanine have cumulative effects. By contrast, scrambling of these amino acids, or mutation of other nearby conserved C-terminal residues, has little effect on these parameters. Mutation of ILLV to AAA reduces complex glycosylation of NKCC1 by similar to 90% and results in a protein that does not form stable dimers and is retained in the endoplasmic reticulum in a highly aggregated state. Our results are consistent with the hypothesis that mutation of the hydrophobic tetrad ILLV to AAAA leads to the ab initio misfolding and concomitant aggregation of this NKCC1 mutant, resulting in its retention in the endoplasmic reticulum.	[Nezu, Akihiro; Parvin, Most. Nahid; Turner, R. James] Natl Inst Hlth, Membrane Biol Sect, Mol Physiol & Therapeut Branch, NIDCR,Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Turner, RJ (corresponding author), Natl Inst Hlth, Membrane Biol Sect, Mol Physiol & Therapeut Branch, NIDCR,Dept Hlth & Human Serv, Bldg 10,Rm 1A01,10 Ctr Dr,MSC 1190, Bethesda, MD 20892 USA.	rjturner@nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000415, Z01DE000415] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Cheung JC, 2008, BIOCHEMISTRY-US, V47, P1465, DOI 10.1021/bi702209s; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Dehaye JP, 2003, J BIOL CHEM, V278, P11811, DOI 10.1074/jbc.M213148200; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Dohke Y, 2002, J BIOL CHEM, V277, P15215, DOI 10.1074/jbc.C100646200; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Evans RL, 2000, J BIOL CHEM, V275, P26720; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Iodice L, 2001, J BIOL CHEM, V276, P28920, DOI 10.1074/jbc.M103558200; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kasir J, 1999, J BIOL CHEM, V274, P24873, DOI 10.1074/jbc.274.35.24873; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Krause G, 2000, MOL PHARMACOL, V57, P232; Kurihara K, 1999, AM J PHYSIOL-CELL PH, V277, pC1184, DOI 10.1152/ajpcell.1999.277.6.C1184; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; Lippincott-Schwartz Jennifer, 2006, Trends Cell Biol, V16, pe1, DOI 10.1016/j.tcb.2006.08.008; Loo TW, 2005, J BIOL CHEM, V280, P2522, DOI 10.1074/jbc.M411483200; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Mueller GM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M707339200; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Parvin MN, 2007, BIOCHEMISTRY-US, V46, P9630, DOI 10.1021/bi700881a; Pena-Muzenmayer G, 2005, J CELL SCI, V118, P4243, DOI 10.1242/jcs.02525; Robben JH, 2005, AM J PHYSIOL-RENAL, V289, pF265, DOI 10.1152/ajprenal.00404.2004; Robben JH, 2006, AM J PHYSIOL-RENAL, V291, pF257, DOI 10.1152/ajprenal.00491.2005; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Sorensen S, 2006, J BIOL CHEM, V281, P468, DOI 10.1074/jbc.M507071200; White SH, 2004, CURR OPIN STRUC BIOL, V14, P397, DOI 10.1016/j.sbi.2004.07.003; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	33	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6869	6876		10.1074/jbc.M804302200	http://dx.doi.org/10.1074/jbc.M804302200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129177	Green Published			2022-12-27	WOS:000263919000034
J	Liu, AG; Garg, P; Yang, SQ; Gong, P; Pallero, MA; Annis, DS; Liu, YY; Passaniti, A; Mann, D; Mosher, DF; Murphy-Ullrich, JE; Goldblum, SE				Liu, Anguo; Garg, Pallavi; Yang, Shiqi; Gong, Ping; Pallero, Manuel A.; Annis, Douglas S.; Liu, Yuanyuan; Passaniti, Antonino; Mann, Dean; Mosher, Deane F.; Murphy-Ullrich, Joanne E.; Goldblum, Simeon E.			Epidermal Growth Factor-like Repeats of Thrombospondins Activate Phospholipase C gamma and Increase Epithelial Cell Migration through Indirect Epidermal Growth Factor Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF RECEPTOR; TYROSINE PHOSPHORYLATION; KINASE ACTIVATION; SIGNATURE DOMAINS; TERMINAL DOMAIN; BINDING; PROTEIN; TYPE-1; ROLES; MATRIX-METALLOPROTEINASE-9	Thrombospondin (TSP) 1 is a trimeric multidomain protein that contains motifs that recognize distinct host cell receptors coupled to multiple signaling pathways. Selected TSP1-induced cellular responses are tyrosine kinase-dependent, and TSP1 contains epidermal growth factor (EGF)-like repeats. Specific receptor interactions or functions for the EGF-like repeats have not been identified. We asked whether one or more biological responses to TSP1 might be explained through EGF receptor (EGFR) activation. In A431 cells, TSP1 increased autophosphorylation of Tyr-1068 of EGFR in a dose- and time-dependent manner. The ability of TSP1 to activate EGFR was replicated by the tandem EGF-like repeats as a recombinant protein. The three EGF-like repeats alone produced a high level of Tyr-1068 phosphorylation. EGF-like repeats from TSP2 and TSP4 also activated EGFR. Tyr-1068 phosphorylation was less when individual EGF-like repeats were tested or flanking sequences were added to the three EGF-like repeats. TSP1 and its EGF-like repeats also increased phosphorylation of EGFR Tyr-845, Tyr-992, Tyr-1045, Tyr-1086, and Tyr-1173, activated phospholipase C gamma, and increased cell migration. No evidence was found for binding of the EGF-like repeats to EGFR. Instead, EGFR activation in response to TSP1 or its EGF-like repeats required matrix metalloprotease activity, including activity of matrix metalloprotease 9. Access to the ligand-binding portion of the EGFR ectodomain was also required. These findings suggest release of an endogenous EGFR ligand in response to ligation of a second unknown receptor by the TSPs.	[Liu, Anguo; Garg, Pallavi; Yang, Shiqi; Gong, Ping; Passaniti, Antonino; Mann, Dean; Goldblum, Simeon E.] Univ Maryland, Mucosal Biol Res Ctr, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Liu, Anguo; Garg, Pallavi; Yang, Shiqi; Gong, Ping; Passaniti, Antonino; Mann, Dean; Goldblum, Simeon E.] Univ Maryland, Mucosal Biol Res Ctr, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Liu, Anguo; Garg, Pallavi; Yang, Shiqi; Gong, Ping; Passaniti, Antonino; Mann, Dean; Goldblum, Simeon E.] Univ Maryland, Sch Med, Marlene & Stewart Greenbaum Canc Ctr, Baltimore, MD 21201 USA; [Pallero, Manuel A.; Murphy-Ullrich, Joanne E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Annis, Douglas S.; Liu, Yuanyuan; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Annis, Douglas S.; Liu, Yuanyuan; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Goldblum, SE (corresponding author), Univ Maryland, Mucosal Biol Res Ctr, Sch Med, Dept Med, 20 Penn St,Rm 351, Baltimore, MD 21201 USA.	sgoldblu@mbrc.umaryland.edu	Liu, Yuanyuan/E-9439-2013		National Institutes of Health [HL084223, HL54462, HL079644]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants HL084223 (to S. E. G.), HL54462 (to D. F. M.), and HL079644 (to J.M.-U.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; APPELLA E, 1988, FEBS LETT, V231, P1, DOI 10.1016/0014-5793(88)80690-2; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Bein K, 2000, J BIOL CHEM, V275, P32167, DOI 10.1074/jbc.M003834200; Bonnefoy A, 2006, BLOOD, V107, P955, DOI 10.1182/blood-2004-12-4856; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Calzada MJ, 2004, J BIOL CHEM, V279, P41734, DOI 10.1074/jbc.M406267200; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Chattopadhyay A, 1999, J BIOL CHEM, V274, P26091, DOI 10.1074/jbc.274.37.26091; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; DiPietro LA, 1996, AM J PATHOL, V148, P1851; Donnini S, 2004, LIFE SCI, V74, P2975, DOI 10.1016/j.lfs.2003.09.075; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; GILL GN, 1984, J BIOL CHEM, V259, P7755; Goldblum SE, 1999, MOL BIOL CELL, V10, P1537, DOI 10.1091/mbc.10.5.1537; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; KIM JW, 1990, J BIOL CHEM, V265, P3940; KOSFELD MD, 1993, J BIOL CHEM, V268, P8808; Kruger A, 2005, CANCER RES, V65, P3523, DOI 10.1158/0008-5472.CAN-04-3570; Kurisaki T, 2003, MOL CELL BIOL, V23, P55, DOI 10.1128/MCB.23.1.55-61.2003; LAHAV J, 1993, BIOCHIM BIOPHYS ACTA, V1182, P1, DOI 10.1016/0925-4439(93)90146-R; LAWLER J, 1985, J BIOL CHEM, V260, P3762; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LAWLER J, 1986, BLOOD, V67, P1197; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; Mariner DJ, 2004, J CELL SCI, V117, P1339, DOI 10.1242/jcs.01001; MARINIDES GN, 1994, KIDNEY INT, V46, P350, DOI 10.1038/ki.1994.281; Misenheimer TM, 2005, J BIOL CHEM, V280, P41229, DOI 10.1074/JBC.M504696200; Misenheimer TM, 2003, BIOCHEMISTRY-US, V42, P5125, DOI 10.1021/bi026983p; Misenheimer TM, 2000, J BIOL CHEM, V275, P40938, DOI 10.1074/jbc.M007022200; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; O-charoenrat P, 2000, CANCER RES, V60, P1121; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Ringerike T, 2002, J CELL SCI, V115, P1331; ROBERTS DD, 1985, J BIOL CHEM, V260, P9405; Rocks N, 2008, BIOCHIMIE, V90, P369, DOI 10.1016/j.biochi.2007.08.008; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145; Soula-Rothhut M, 2005, EXP CELL RES, V304, P187, DOI 10.1016/j.yexcr.2004.10.026; Streit M, 2000, EMBO J, V19, P3272, DOI 10.1093/emboj/19.13.3272; Swindle CS, 2001, J CELL BIOL, V154, P459, DOI 10.1083/jcb.200103103; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; TARABOLETTI G, 1987, J CELL BIOL, V105, P2409, DOI 10.1083/jcb.105.5.2409; TUSZYNSKI GP, 1987, CANCER RES, V47, P4130; Uno K, 2004, BIOCHEM BIOPH RES CO, V315, P928, DOI 10.1016/j.bbrc.2004.01.146; Wang WG, 1999, J CELL BIOCHEM, V73, P321; Xie H, 1998, J CELL SCI, V111, P615; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702	66	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6389	6402		10.1074/jbc.M809198200	http://dx.doi.org/10.1074/jbc.M809198200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129184	Green Published, hybrid			2022-12-27	WOS:000263742700042
J	Tang, GQ; Paratkar, S; Patel, SS				Tang, Guo-Qing; Paratkar, Swaroopa; Patel, Smita S.			Fluorescence Mapping of the Open Complex of Yeast Mitochondrial RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RATE-LIMITING STEP; DNA COPY NUMBER; SPECIFICITY FACTOR; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; PROMOTER DNA; SCHNEIDER CELLS; SIGMA-FACTORS; SC-MTTFB; INITIATION	The mitochondrial RNA polymerase (mtRNAP) of Saccharomyces cerevisiae, consisting of a complex of Rpo41 and Mtf1, is homologous to the phage single polypeptide T7/T3 RNA polymerases. The yeast mtRNAP recognizes a conserved nonanucleotide sequence to initiate specific transcription. In this work, we have defined the region of the nonanucleotide that is melted by the mtRNAP using 2-aminopurine (2AP) fluorescence that is sensitive to changes in base stacking interactions. We show that mtRNAP spontaneously melts the promoter from -4 to +2 forming a bubble around the transcription start site at +1. The location and size of the DNA bubble in this open complex of the mtRNAP closely resembles that of the T7 RNA polymerase. We show that DNA melting requires the simultaneous presence of Rpo41 and Mtf1. Adding the initiating nucleotide ATP does not expand the size of the initially melted DNA, but the initiating nucleotide differentially affects base stacking interactions at -1 and -2. Thus, the promoter structure upstream of the transcription start site is slightly rearranged during early initiation from its structure in the pre-initiation stage. Unlike on the duplex promoter, Rpo41 alone was able to form a competent open complex on a pre-melted promoter. The results indicate that Rpo41 contains the elements for recognizing the melted promoter through interactions with the template strand. We propose that Mtf1 plays a role in base pair disruption during the early stages of open complex formation.	[Tang, Guo-Qing; Paratkar, Swaroopa; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	patelss@umdnj.edu			National Institutes of Health [GM51966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051966, R01GM051966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51966 (to S. S. P.).	Amiott EA, 2006, J BIOL CHEM, V281, P34982, DOI 10.1074/jbc.M608638200; Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; Bandwar RP, 2001, J BIOL CHEM, V276, P14075, DOI 10.1074/jbc.M011289200; Biswas TK, 1998, GENE, V212, P305, DOI 10.1016/S0378-1119(98)00133-4; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Carrodeguas JA, 1996, GENE EXPRESSION, V6, P219; Cermakian N, 1996, NUCLEIC ACIDS RES, V24, P648, DOI 10.1093/nar/24.4.648; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; Cliften PF, 1997, GENE DEV, V11, P2897, DOI 10.1101/gad.11.21.2897; Cliften PF, 2000, MOL CELL BIOL, V20, P7013, DOI 10.1128/MCB.20.18.7013-7023.2000; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fedoriw AM, 1998, BIOCHEMISTRY-US, V37, P11971, DOI 10.1021/bi980980o; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; JANG SH, 1991, J BIOL CHEM, V266, P22671; Jean JM, 2001, P NATL ACAD SCI USA, V98, P37, DOI 10.1073/pnas.011442198; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; Kashkina E, 2007, J BIOL CHEM, V282, P21578, DOI 10.1074/jbc.C700098200; Kravchenko JE, 2005, NATURE, V436, P735, DOI 10.1038/nature03848; Liu CH, 2002, J BIOL CHEM, V277, P2725, DOI 10.1074/jbc.M108856200; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsunaga M, 2004, PROTEIN EXPRES PURIF, V35, P126, DOI 10.1016/j.pep.2003.12.022; Matsunaga M, 2004, J BIOL CHEM, V279, P2012, DOI 10.1074/jbc.M307819200; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; OSINGA KA, 1982, NUCLEIC ACIDS RES, V10, P7993, DOI 10.1093/nar/10.24.7993; Roy S, 2004, EMBO J, V23, P869, DOI 10.1038/sj.emboj.7600098; Saluz Hans Peter, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P1; SCHINKEL AH, 1987, J BIOL CHEM, V262, P12785; SCHINKEL AH, 1986, EMBO J, V5, P1041, DOI 10.1002/j.1460-2075.1986.tb04320.x; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schroeder LA, 2007, NUCLEIC ACIDS RES, V35, P4141, DOI 10.1093/nar/gkm431; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; SHADEL GS, 1995, MOL CELL BIOL, V15, P2101; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4947, DOI 10.1021/bi052292s; Ujvari A, 1996, BIOCHEMISTRY-US, V35, P14574, DOI 10.1021/bi961165g; WINKLEY CS, 1985, J BIOL CHEM, V260, P4214; Young BA, 2002, CELL, V109, P417, DOI 10.1016/S0092-8674(02)00752-3	44	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5514	5522		10.1074/jbc.M807880200	http://dx.doi.org/10.1074/jbc.M807880200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19116203	Green Published, hybrid			2022-12-27	WOS:000263560600014
J	Tongaonkar, P; Selsted, ME				Tongaonkar, Prasad; Selsted, Michael E.			SDF2L1, a Component of the Endoplasmic Reticulum Chaperone Complex, Differentially Interacts with alpha-, beta-, and theta-Defensin Propeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; SWISS-MODEL; INFECTION; CELLS; IDENTIFICATION; THYROGLOBULIN; MATURATION; IMMUNITY; ERP72	Mammalian defensins are cationic antimicrobial peptides that play a central role in host innate immunity and as regulators of acquired immunity. In animals, three structural defensin subfamilies, designated as alpha, beta, and theta, have been characterized, each possessing a distinctive tridisulfide motif. Mature alpha- and beta-defensins are produced by simple proteolytic processing of their prepropeptide precursors. In contrast, the macrocyclic beta-defensins are formed by the head-to-tail splicing of nonapeptides excised from a pair of prepropeptide precursors. Thus, elucidation of the theta-defensin biosynthetic pathway provides an opportunity to identify novel factors involved in this unique process. We incorporated the theta-defensin precursor, proRTD1a, into a bait construct for a yeast two-hybrid screen that identified rhesus macaque stromal cell-derived factor 2-like protein 1 (SDF2L1), as an interactor. SDF2L1 is a component of the endoplasmic reticulum (ER) chaperone complex, which we found to also interact with alpha- and beta-defensins. However, analysis of the SDF2L1 domain requirements for binding of representative alpha-, beta-, and theta-defensins revealed that alpha- and beta-defensins bind SDF2L1 similarly, but differently from the interactions that mediate binding of SDF2L1 to pro-theta-defensins. Thus, SDF2L1 is a factor involved in processing and/or sorting of all three defensin subfamilies.	[Tongaonkar, Prasad; Selsted, Michael E.] Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92697 USA; [Selsted, Michael E.] Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Tongaonkar, P (corresponding author), Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92697 USA.	ptongaon@uci.edu			National Institutes of Health [AI058129, AI022931, DE015517]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058129, R01AI022931, R37AI022931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058129, AI022931, and DE015517. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994; BANIAHMAD C, 1994, BIOTECHNIQUES, V16, P194; Bastian A, 2001, REGUL PEPTIDES, V101, P157, DOI 10.1016/S0167-0115(01)00282-8; Bies C, 2004, BIOL CHEM, V385, P389, DOI 10.1515/BC.2004.043; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Fukuda S, 2001, BIOCHEM BIOPH RES CO, V280, P407, DOI 10.1006/bbrc.2000.4111; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Gruber CW, 2007, J BIOL CHEM, V282, P20435, DOI 10.1074/jbc.M700018200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Herwig S, 1996, BLOOD, V87, P350, DOI 10.1182/blood.V87.1.350.bloodjournal871350; Hiratsuka T, 2000, NEPHRON, V85, P34, DOI 10.1159/000045627; KUZNETSOV G, 1994, J BIOL CHEM, V269, P22990; Lillard JW, 1999, P NATL ACAD SCI USA, V96, P651, DOI 10.1073/pnas.96.2.651; Linnik KM, 1998, J BIOL CHEM, V273, P21368, DOI 10.1074/jbc.273.33.21368; LIU L, 1995, BLOOD, V85, P1095, DOI 10.1182/blood.V85.4.1095.bloodjournal8541095; MADURA K, 1993, J BIOL CHEM, V268, P12046; Mambula SS, 2000, INFECT IMMUN, V68, P6257, DOI 10.1128/IAI.68.11.6257-6264.2000; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Newman SL, 2000, INFECT IMMUN, V68, P5668, DOI 10.1128/IAI.68.10.5668-5672.2000; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P48; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Tani K, 2000, INT IMMUNOL, V12, P691, DOI 10.1093/intimm/12.5.691; VALORE EV, 1992, BLOOD, V79, P1538; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277	34	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5602	5609		10.1074/jbc.M806664200	http://dx.doi.org/10.1074/jbc.M806664200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19109254	Green Published, hybrid			2022-12-27	WOS:000263560600023
J	Yang, YW; Wang, XX; Hawkins, CA; Chen, K; Vaynberg, J; Mao, X; Tu, YZ; Zuo, XB; Wang, JB; Wang, YX; Wu, CY; Tjandra, N; Qin, J				Yang, Yanwu; Wang, Xiaoxia; Hawkins, Cheryl A.; Chen, Kan; Vaynberg, Julia; Mao, Xian; Tu, Yizeng; Zuo, Xiaobing; Wang, Jinbu; Wang, Yun-xing; Wu, Chuanyue; Tjandra, Nico; Qin, Jun			Structural Basis of Focal Adhesion Localization of LIM-only Adaptor PINCH by Integrin-linked Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; RESIDUAL DIPOLAR COUPLINGS; CELL-SHAPE MODULATION; KAPPA-B COMPLEX; ANKYRIN REPEAT; MOLECULAR DISSECTION; ILK; MATRIX; SURVIVAL; DOMAIN	The LIM-only adaptor PINCH (the particularly interesting cysteine- and histidine-rich protein) plays a pivotal role in the assembly of focal adhesions (FAs), supramolecular complexes that transmit mechanical and biochemical information between extracellular matrix and actin cytoskeleton, regulating diverse cell adhesive processes such as cell migration, cell spreading, and survival. A key step for the PINCH function is its localization to FAs, which depends critically on the tight binding of PINCH to integrin-linked kinase (ILK). Here we report the solution NMR structure of the core ILK.PINCH complex (28 kDa, K-D similar to 68 nM) involving the N-terminal ankyrin repeat domain (ARD) of ILK and the first LIM domain (LIM1) of PINCH. We show that the ILK ARD exhibits five sequentially stacked ankyrin repeat units, which provide a large concave surface to grip the two contiguous zinc fingers of the PINCH LIM1. The highly electrostatic interface is evolutionally conserved but differs drastically from those of known ARD and LIM bound to other types of protein domains. Consistently mutation of a hot spot in LIM1, which is not conserved in other LIM domains, disrupted the PINCH binding to ILK and abolished the PINCH targeting to FAs. These data provide atomic insight into a novel modular recognition and demonstrate how PINCH is specifically recruited by ILK to mediate the FA assembly and cell-extracellular matrix communication.	[Yang, Yanwu; Wang, Xiaoxia; Vaynberg, Julia; Qin, Jun] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Yang, Yanwu; Qin, Jun] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44102 USA; [Hawkins, Cheryl A.; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Chen, Kan; Tu, Yizeng; Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Zuo, Xiaobing; Wang, Jinbu; Wang, Yun-xing] NCI, Prot Nucle Acid Interact Sect, Struct Biophys Lab, NIH, Frederick, MD 21702 USA; [Mao, Xian; Qin, Jun] Cleveland Ctr Struct Biol, Cleveland, OH 44102 USA	Cleveland Clinic Foundation; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Qin, J (corresponding author), Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, NB20,9500 Euclid Ave, Cleveland, OH 44195 USA.	qinj@ccf.org	Zuo, Xiaobing/F-1469-2010; Qin, Jun/D-5559-2009	Qin, Jun/0000-0002-2647-9270	National Institutes of Health [HL58758, GM62823, DK54639, GM65188]; NHLBI; NCI; American Heart Association [0530067N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006064, R01HL058758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188, R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58758 and GM62823 (to J.Q.) and DK54639 and GM65188 (to C. W.) and by the National Institutes of Health intramural research program of the NHLBI (to N.T.) and NCI (to Y.-X.W.). This work was also supported by American Heart Association Grant 0530067N (to Y.Y.).	Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Braun A, 2003, EXP CELL RES, V284, P239, DOI 10.1016/S0014-4827(02)00039-3; Chen H, 2005, LAB INVEST, V85, P1342, DOI 10.1038/labinvest.3700345; Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; Clore GM, 1998, CURR OPIN CHEM BIOL, V2, P564, DOI 10.1016/S1367-5931(98)80084-7; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; de Alba E, 2002, PROG NUCL MAG RES SP, V40, P175, DOI 10.1016/S0079-6565(01)00042-5; Deane JE, 2003, EMBO J, V22, P2224, DOI 10.1093/emboj/cdg196; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Huang HC, 2007, ONCOGENE, V26, P2781, DOI 10.1038/sj.onc.1210078; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li FG, 1999, J CELL SCI, V112, P4589; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Liang XQ, 2005, MOL CELL BIOL, V25, P3056, DOI 10.1128/MCB.25.8.3056-3062.2005; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Srivastava D, 2006, GENE DEV, V20, P2327, DOI 10.1101/gad.1472506; Stanchi F, 2005, J CELL SCI, V118, P5899, DOI 10.1242/jcs.02686; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Vaynberg J, 2005, MOL CELL, V17, P513, DOI 10.1016/j.molcel.2004.12.031; Velyvis A, 2001, J BIOL CHEM, V276, P4932, DOI 10.1074/jbc.M007632200; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Wu CY, 2004, BBA-MOL CELL RES, V1692, P55, DOI 10.1016/j.bbamcr.2004.01.006; Xu Z, 2005, J BIOL CHEM, V280, P27631, DOI 10.1074/jbc.M504189200; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	39	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5836	5844		10.1074/jbc.M805319200	http://dx.doi.org/10.1074/jbc.M805319200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117955	hybrid, Green Published			2022-12-27	WOS:000263560600047
J	Endo, M; Antonyak, MA; Cerione, RA				Endo, Makoto; Antonyak, Marc A.; Cerione, Richard A.			Cdc42-mTOR Signaling Pathway Controls Hes5 and Pax6 Expression in Retinoic Acid-dependent Neural Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; CENTRAL-NERVOUS-SYSTEM; RHO-GTPASES; IN-VITRO; SKELETAL MYOGENESIS; RADIAL GLIA; P19 CELLS; NEURONS; STEM; ACTIVATION	The conditional knockout of the small GTPase Cdc42 from neuroepithelial (NE) and radial glial (RG) cells in the mouse telencephalon has been shown to have a significant impact on brain development by causing these neural progenitor cells to detach from the apical/ventricular surface and to lose their cell identity. This has been attributed to the requirement for Cdc42 in establishing properapical/basal cell polarity and cell-cell adhesions. In the present study, we provide new insights into the role played by Cdc42 in the maintenance of neural progenitor cells, using the mouse embryonal carcinoma P19 cell line as a model system. We show that the ability of P19 cells to undergo the transition from an Oct3/4-positive, undifferentiated status to microtubule-associated protein 2-positive neurons and glial fibrillary acidic protein-positive astrocytes, upon treatment with retinoic acid (RA), requires RA-induced activation of Cdc42 during the neural cell lineage specification phase. Experiments using chemical inhibitors and RNA interference suggest that the actions of Cdc42 are mediated through signaling pathways that start with fibroblast growth factors and Delta/Notch proteins and lead to Cdc42-dependent mTOR activation, culminating in the up-regulation of Hes5 and Pax6, two transcription factors that are essential for the maintenance of NE and RG cells. The constitutively active Cdc42(F28L) mutant was sufficient to up-regulate Hes5 and Pax6 in P19 cells, even in the absence of RA treatment, ultimately promoting their transition to neural progenitor cells. The ectopic Cdc42 expression also significantly augmented the RA-dependent up-regulation of these transcription factors, resulting in P19 cells maintaining their neural progenitor status but being unable to undergo terminal differentiation. These findings shed new light on how Cdc42 influences neural progenitor cell fate by regulating gene expression.	[Endo, Makoto; Antonyak, Marc A.; Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu		Endo, Makoto/0000-0002-2055-5471	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM047458] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ameerun RF, 1996, CELL GROWTH DIFFER, V7, P1679; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Armour C, 1999, EXP CELL RES, V251, P79, DOI 10.1006/excr.1999.4567; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Chen F, 2000, CURR BIOL, V10, P758, DOI 10.1016/S0960-9822(00)00571-6; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Dono R, 2003, AM J PHYSIOL-REG I, V284, pR867, DOI 10.1152/ajpregu.00533.2002; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Farah MH, 2000, DEVELOPMENT, V127, P693; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Murray RC, 2000, DEV DYNAM, V218, P189, DOI 10.1002/(SICI)1097-0177(200005)218:1<189::AID-DVDY16>3.0.CO;2-4; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; SKERJANC IS, 1994, MOL CELL BIOL, V14, P8451, DOI 10.1128/MCB.14.12.8451; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Staines WA, 1996, NEUROSCIENCE, V71, P845, DOI 10.1016/0306-4522(95)00494-7; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; van der Heyden MAG, 2003, CARDIOVASC RES, V58, P292, DOI 10.1016/S0008-6363(02)00771-X; Wang C, 2006, MOL BIOL CELL, V17, P3075, DOI 10.1091/mbc.E05-11-1087; Wang LY, 2008, J NEUROSCI RES, V86, P1254, DOI 10.1002/jnr.21578; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Wu XW, 2007, DEV DYNAM, V236, P2767, DOI 10.1002/dvdy.21309; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	44	43	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5107	5118		10.1074/jbc.M807745200	http://dx.doi.org/10.1074/jbc.M807745200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19097998	Green Published, hybrid			2022-12-27	WOS:000263416600041
J	Kurabe, N; Arai, S; Nishijima, A; Kubota, N; Suizu, F; Mori, M; Kurokawa, J; Kondo-Miyazaki, M; Ide, T; Murakami, K; Miyake, K; Ueki, K; Koga, H; Yatomi, Y; Tashiro, F; Noguchi, M; Kadowaki, T; Miyazaki, T				Kurabe, Nobuya; Arai, Satoko; Nishijima, Akemi; Kubota, Naoto; Suizu, Futoshi; Mori, Mayumi; Kurokawa, Jun; Kondo-Miyazaki, Miki; Ide, Tomohiro; Murakami, Kouji; Miyake, Katsuhisa; Ueki, Kohjiro; Koga, Hisashi; Yatomi, Yutaka; Tashiro, Fumio; Noguchi, Masayuki; Kadowaki, Takashi; Miyazaki, Toru			The Death Effector Domain-containing DEDD Supports S6K1 Activity via Preventing Cdk1-dependent Inhibitory Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-GROWTH; INSULIN-RESISTANCE; CONTAINING PROTEIN; SIZE CONTROL; KINASE; MTOR; CANCER; NUTRIENT; DIVISION; TARGET	Cell cycle regulation and biochemical responses upon nutrients and growth factors are the major regulatory mechanisms for cell sizing in mammals. Recently, we identified that the death effector domain-containing DEDD impedes mitotic progression by inhibiting Cdk1 (cyclin-dependent kinase 1) and thus maintains an increase of cell size during the mitotic phase. Here we found that DEDD also associates with S6 kinase 1 (S6K1), downstream of phosphatidylinositol 3-kinase, and supports its activity by preventing inhibitory phosphorylation of S6K1 brought about by Cdk1 during the mitotic phase. DEDD-/- cells showed reduced S6K1 activity, consistently demonstrating decreased levels in activating phosphorylation at the Thr-389 site. In addition, levels of Cdk1-dependent inhibitory phosphorylation at the C terminus of S6K1 were enhanced in DEDD-/- cells and tissues. Consequently, as in S6K1(-/-) mice, the insulin mass within pancreatic islets was reduced in DEDD-/- mice, resulting in glucose intolerance. These findings suggest a novel cell sizing mechanism achieved by DEDD through the maintenance of S6K1 activity prior to cell division. Our results also suggest that DEDD may harbor important roles in glucose homeostasis and that its deficiency might be involved in the pathogenesis of type 2 diabetes mellitus.	[Kurabe, Nobuya; Arai, Satoko; Nishijima, Akemi; Mori, Mayumi; Kurokawa, Jun; Kondo-Miyazaki, Miki; Miyazaki, Toru] Univ Tokyo, Div Mol Biomed Pathogenesis, Ctr Dis Biol & Integrat Med, Tokyo 1130033, Japan; [Kubota, Naoto; Ueki, Kohjiro; Yatomi, Yutaka; Kadowaki, Takashi] Univ Tokyo, Fac Med, Dept Internal Med, Tokyo 1130033, Japan; [Suizu, Futoshi; Noguchi, Masayuki] Hokkaido Univ, Div Canc Biol, Inst Med Genet, Sapporo, Hokkaido 060, Japan; [Ide, Tomohiro; Murakami, Kouji] Kyorin Pharmaceut Co Ltd, Metab Discovery Res Labs, Biosci Div, Tochigi 3290114, Japan; [Miyake, Katsuhisa] Fukuoka Univ, Sch Med, Dept Internal Med, Div Nephrol & Rheumatol, Fukuoka 8128581, Japan; [Koga, Hisashi] Kazusa DNA Res Inst, Dept Human Genome Res, Chiba 2920818, Japan; [Tashiro, Fumio] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Chiba 2788510, Japan	University of Tokyo; University of Tokyo; Hokkaido University; Kyorin Pharmaceutical Co Ltd; Fukuoka University; Kazusa DNA Research Institute; Tokyo University of Science	Miyazaki, T (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	tm@m.u-tokyo.ac.jp	Kubota, Naoto/N-7892-2015; Suizu, Futoshi/G-3530-2019	Suizu, Futoshi/0000-0003-0206-4289; Yatomi, Yutaka/0000-0003-1719-4297; Miyazaki, Toru/0000-0003-3842-4362; Mori, Mayumi/0000-0001-6190-9785; Arai, Satoko/0000-0002-6145-8686	National Institutes of Health [5RO1AI50948-05]; Ministry of Education, Sports, Culture, Science, and Technology, Japan; Takeda Science Foundation; Mitsubishi Pharma Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Danone Institute of Nutrition for Health; Uehara Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; Kanzawa Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Sports, Culture, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Danone Institute of Nutrition for Health(Danone Nutricia); Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1AI50948-05. This work was also supported by grants-in-aid from the Ministry of Education, Sports, Culture, Science, and Technology, Japan, the Takeda Science Foundation (to T. M. and S. A.), the Mitsubishi Pharma Research Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Danone Institute of Nutrition for Health, the Uehara Memorial Foundation (to T. M.), the Kanae Foundation for the Promotion of Medical Science, and the Kanzawa Medical Research Foundation (to S. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arai S, 2007, P NATL ACAD SCI USA, V104, P2289, DOI 10.1073/pnas.0611167104; Arechiga AF, 2007, J IMMUNOL, V179, P5291, DOI 10.4049/jimmunol.179.8.5291; Boyer D, 2008, MOL CELL BIOCHEM, V307, P59, DOI 10.1007/s11010-007-9584-5; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Cooper S, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-35; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Hou ZB, 2007, J BIOL CHEM, V282, P6922, DOI 10.1074/jbc.M607836200; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Miyazaki T, 2007, CELL CYCLE, V6, P1419; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Montagne Jacques, 2000, Molecular Cell Biology Research Communications, V4, P195, DOI 10.1006/mcbr.2001.0284; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Papst PJ, 1998, J BIOL CHEM, V273, P15077, DOI 10.1074/jbc.273.24.15077; Park S, 2008, EMBO REP, V9, P766, DOI 10.1038/embor.2008.102; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; Schmidt T, 2007, HISTOCHEM CELL BIOL, V127, P123, DOI 10.1007/s00418-006-0255-5; Schumann DM, 2007, P NATL ACAD SCI USA, V104, P2861, DOI 10.1073/pnas.0611487104; Shah OJ, 2003, J BIOL CHEM, V278, P16433, DOI 10.1074/jbc.M300435200; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Stegh AH, 1998, EMBO J, V17, P5974, DOI 10.1093/emboj/17.20.5974; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; VALMIKI MG, CELL MOL LI IN PRESS; Vogt PK, 2001, TRENDS MOL MED, V7, P482, DOI 10.1016/S1471-4914(01)02161-X; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103	41	8	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5050	5055		10.1074/jbc.M808598200	http://dx.doi.org/10.1074/jbc.M808598200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106089	hybrid, Green Published			2022-12-27	WOS:000263416600035
J	Hinson, ER; Cresswell, P				Hinson, Ella R.; Cresswell, Peter			The N-terminal Amphipathic alpha-Helix of Viperin Mediates Localization to the Cytosolic Face of the Endoplasmic Reticulum and Inhibits Protein Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE CURVATURE; GOLGI TRANSPORT; INTERFERON; REPLICATION; VIRUS; EXPRESSION; CELLS; IDENTIFICATION; TRIGGER; SAR1P	Viperin is an evolutionarily conserved interferon-inducible protein that localizes to the endoplasmic reticulum (ER) and inhibits a number of DNA and RNA viruses. In this study, we report that viperin specifically localizes to the cytoplasmic face of the ER and that an amphipathic alpha-helix at its N terminus is necessary for the ER localization of viperin and sufficient to promote ER localization of a reporter protein, dsRed. Overexpression of intact viperin but not the amphipathic alpha-helix fused to dsRed induced crystalloid ER. Consistent with other proteins that induce crystalloid ER, viperin self-associates, and it does so independently of the amphipathic alpha-helix. Viperin expression also affected the transport of soluble but not membrane-associated proteins. Expression of intact viperin or an N-terminal alpha-helix-dsRed fusion protein significantly reduced secretion of soluble alkaline phosphatase and reduced its rate of ER-to-Golgi trafficking. Similarly, viperin expression inhibited bulk protein secretion and secretion of endogenous alpha(1)-antitrypsin and serum albumin from HepG2 cells. Converting hydrophobic residues in the N-terminal alpha-helix to acidic residues partially or completely restored normal transport of soluble alkaline phosphatase, suggesting that the extended amphipathic nature of the N-terminal alpha-helical domain is essential for inhibiting protein secretion.	[Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Hinson, Ella R.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA; [Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St,TAC S670, New Haven, CT 06520 USA.	peter.cresswell@yale.edu			Ellison Foundation; Howard Hughes Medical Institute	Ellison Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The work was supported by the Ellison Foundation and the Howard Hughes Medical Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Folsch H, 2003, J CELL BIOL, V163, P351, DOI 10.1083/jcb.200309020; Fukuda M, 2001, J BIOL CHEM, V276, P41112, DOI 10.1074/jbc.M106209200; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; ORCI L, 1984, CELL, V36, P835, DOI 10.1016/0092-8674(84)90033-3; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rivieccio MA, 2006, J IMMUNOL, V177, P4735, DOI 10.4049/jimmunol.177.7.4735; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Stephens DJ, 2004, J CELL SCI, V117, P3635, DOI 10.1242/jcs.01269; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Yamamoto A, 1996, J CELL SCI, V109, P1727; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	24	115	120	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4705	4712		10.1074/jbc.M807261200	http://dx.doi.org/10.1074/jbc.M807261200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074433	Green Published, hybrid			2022-12-27	WOS:000263134400070
J	Hizume, M; Kobayashi, A; Teruya, K; Ohashi, H; Ironside, JW; Mohri, S; Kitamoto, T				Hizume, Masaki; Kobayashi, Atsushi; Teruya, Kenta; Ohashi, Hiroaki; Ironside, James W.; Mohri, Shirou; Kitamoto, Tetsuyuki			Human Prion Protein (PrP) 219K Is Converted to PrPSc but Shows Heterozygous Inhibition in Variant Creutzfeldt-Jakob Disease Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCRAPIE; MICE; PRNP; SUSCEPTIBILITY; AMPLIFICATION; TRANSMISSION; CODON-219; INSERTION; SEQUENCE; KURU	Prion protein gene (PRNP) E219K is a human polymorphism commonly occurring in Asian populations but is rarely found in patients with sporadic Creutzfeldt-Jakob disease (CJD). Thus the polymorphism E219K has been considered protective against sporadic CJD. The corresponding mouse prion protein (PrP) polymorphism variant (mouse PrP 218K) is not converted to the abnormal isoform (PrPSc) and shows a dominant negative effect on wild-type PrP conversion. To define the conversion activity of this human molecule, we herein established knock-in mice with human PrP 219K and performed a series of transmission experiments with human prions. Surprisingly, the human PrP 219K molecule was converted to PrPSc in variant CJD infection, and the conversion occurred more efficiently than PrP 219E molecule. Notably the knock-in mice with PRNP codon 219E/K showed the least efficient conversion compared with their hemizygotes with PRNP codon 219E/0 or codon 219K/0, or homozygotes with PRNP codon 219E/E or codon 219K/K. This phenomenon indicated heterozygous inhibition. This heterozygous inhibition was observed also in knock-in mice with PRNP codon 129M/V genotype. In addition to variant CJD infection, the human PrP 219K molecule is conversion-competent in transmission experiments with sporadic CJD prions. Therefore, the protective effect of PRNP E219K against sporadic CJD might be due to heterozygous inhibition.	[Hizume, Masaki; Kobayashi, Atsushi; Kitamoto, Tetsuyuki] Tohoku Univ, Grad Sch Med, Dept Prion Res, Div CJD Sci & Technol, Sendai, Miyagi 9808575, Japan; [Teruya, Kenta] Tohoku Univ, Grad Sch Med, Dept Prion Res, Div Prion Biol, Sendai, Miyagi 9808575, Japan; [Ohashi, Hiroaki] Cent Inst Expt Anim, Kawasaki, Kanagawa 2160011, Japan; [Ironside, James W.] Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Mohri, Shirou] Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 3050856, Japan; [Hizume, Masaki] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo 1138519, Japan	Tohoku University; Tohoku University; University of Edinburgh; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Tokyo Medical & Dental University (TMDU)	Kitamoto, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Prion Res, Div CJD Sci & Technol, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan.	kitamoto@mail.tain.tohoku.ac.jp	Mohri, Shirou/AAK-1281-2020; Teruya, Kenta/L-1530-2019	Ironside, James/0000-0001-5869-2108	National Institute of Biomedical Innovation; Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science and Technology; Medical Research Council [G0600953, G0900580] Funding Source: researchfish; MRC [G0600953, G0900580] Funding Source: UKRI	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Promotion of Fundamental Studies in Health Science of National Institute of Biomedical Innovation (to H. O., S. M., and T. K.), a grant from the Ministry of Health, Labor, and Welfare (to A. K., S. M., and T. K.), and a Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (to A. K. and T. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asano M, 2006, BIOCHEM BIOPH RES CO, V342, P293, DOI 10.1016/j.bbrc.2006.01.149; Asante EA, 2006, P NATL ACAD SCI USA, V103, P10759, DOI 10.1073/pnas.0604292103; Bartz JC, 2007, J VIROL, V81, P689, DOI 10.1128/JVI.01751-06; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; BELLINGERKAWAHARA CG, 1988, VIROLOGY, V164, P537, DOI 10.1016/0042-6822(88)90569-7; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Brown P, 2006, NEUROLOGY, V67, P389, DOI 10.1212/01.wnl.0000231528.65069.3f; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; FURUKAWA H, 1995, MOL BRAIN RES, V30, P385, DOI 10.1016/0169-328X(95)00034-P; GAJDUSEK DC, 1957, NEW ENGL J MED, V257, P974, DOI 10.1056/NEJM195711142572005; Grathwohl KUD, 1996, ARCH VIROL, V141, P1863, DOI 10.1007/BF01718200; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Jeong BH, 2005, NEUROGENETICS, V6, P229, DOI 10.1007/s10048-005-0016-y; Jones M, 2007, J PATHOL, V213, P21, DOI 10.1002/path.2204; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KITAMOTO T, 1994, PHILOS T R SOC B, V343, P391, DOI 10.1098/rstb.1994.0034; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V191, P709, DOI 10.1006/bbrc.1993.1275; Kitamoto T, 2002, BIOCHEM BIOPH RES CO, V294, P280, DOI 10.1016/S0006-291X(02)00476-X; KITAMOTO T, 1991, BRAIN RES, V545, P319, DOI 10.1016/0006-8993(91)91306-L; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Kobayashi A, 2007, J BIOL CHEM, V282, P30022, DOI 10.1074/jbc.M704597200; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Lee CI, 2007, PROTEIN SCI, V16, P2166, DOI 10.1110/ps.072954607; Manuelidis L, 1998, P NATL ACAD SCI USA, V95, P2520, DOI 10.1073/pnas.95.5.2520; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; Nishida Y, 2004, NEUROLOGY, V63, P1978, DOI 10.1212/01.WNL.0000144196.43430.E1; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Pocchiari M, 2004, BRAIN, V127, P2348, DOI 10.1093/brain/awh249; PRUSINER SB, 1994, PHILOS T ROY SOC B, V343, P447, DOI 10.1098/rstb.1994.0043; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Shibuya S, 1998, ANN NEUROL, V43, P826, DOI 10.1002/ana.410430618; Taguchi Y, 2003, AM J PATHOL, V163, P2585, DOI 10.1016/S0002-9440(10)63613-9; Tahiri-Alaoui A, 2006, J BIOL CHEM, V281, P34171, DOI 10.1074/jbc.M606606200; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Yamada M, 2006, LANCET, V367, P874, DOI 10.1016/S0140-6736(06)68344-X; Yu SL, 2004, EUR J HUM GENET, V12, P867, DOI 10.1038/sj.ejhg.5201245	40	51	51	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3603	3609		10.1074/jbc.M809254200	http://dx.doi.org/10.1074/jbc.M809254200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074151	hybrid			2022-12-27	WOS:000262872500028
J	Ikonomov, OC; Fligger, J; Sbrissa, D; Dondapati, R; Mlak, K; Deeb, R; Shisheva, A				Ikonomov, Ognian C.; Fligger, Jason; Sbrissa, Diego; Dondapati, Rajeswari; Mlak, Krzysztof; Deeb, Robert; Shisheva, Assia			Kinesin Adapter JLP Links PIKfyve to Microtubule-based Endosome-to-Trans-Golgi Network Traffic of Furin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTIC RECYCLING COMPARTMENT; SCAFFOLD PROTEIN JLP; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; MAMMALIAN ORTHOLOG; SIGNALING MODULES; AXONAL-TRANSPORT; KINASE; MEMBRANE; PROGRESSION; ACTIVATION	JIPs (c-Jun N-terminal kinase interacting proteins), which scaffold JNK/p38 MAP kinase signaling modules, also bind conventional kinesins and are implicated in microtubule-based membrane trafficking in neuronal cells. Here we have identified a novel splice variant of the Jip4 gene product JLP(L) (JNK-interacting leucine zipper protein) in yeast-two hybrid screens with the phosphoinositide kinase PIKfyve. The interaction was confirmed by pulldown and coimmunoprecipitation assays in native cells. It engages the PIKfyve cpn60_TCP1 consensus sequence and the last 75 residues of the JLP C terminus. Subpopulations of both proteins cofractionated and populated similar structures at the cell perinuclear region. Because PIKfyve is essential in endosome-to-trans-Golgi network (TGN) cargo transport, we tested whether JLP is a PIKfyve functional partner in this trafficking pathway. Short interfering RNA (siRNA)-mediated depletion of endogenous JLP or PIKfyve profoundly delayed the microtubule-based transport of chimeric furin (Tac-furin) from endosomes to the TGN in a CHO cell line, which was rescued upon ectopic expression of siRNA-resistant JLP or PIKfyve constructs. Peptides from the contact sites in PIKfyve and JLP, or a dominant-negative PIKfyve mutant introduced into cells by ectopic expression or microinjection, induced a similar defect. Because Tac-TGN38 delivery from endosomes to the TGN, unlike that of Tac-furin, does not require intact microtubules, we monitored the effect of JLP and PIKfyve depletion or the interacting peptides administration on Tac-TGN38 trafficking. Remarkably, neither maneuver altered the Tac-TGN38 delivery to the TGN. Our data indicate that JLP interacts with PIKfyve and that both proteins and their association are required in microtubule-based, but not in microtubule-independent, endosome-to-TGN cargo transport.	[Ikonomov, Ognian C.; Fligger, Jason; Sbrissa, Diego; Dondapati, Rajeswari; Mlak, Krzysztof; Deeb, Robert; Shisheva, Assia] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA	Wayne State University	Shisheva, A (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield, Detroit, MI 48201 USA.	ashishev@med.wayne.edu			National Institutes of Health Research [DK58058]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058058] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Research Grant DK58058. This work was also supported by a grant from the American Diabetes Association (to A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; HARLOW E, 1988, ANTIBODIES LAB MANUA, P271; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Horiuchi D, 2005, CURR BIOL, V15, P2137, DOI 10.1016/j.cub.2005.10.047; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2003, J BIOL CHEM, V278, P50863, DOI 10.1074/jbc.M307260200; Ikonomov OC, 2003, MOL BIOL CELL, V14, P4581, DOI 10.1091/mbc.E03-04-0222; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Iwanaga A, 2008, TRANSGENIC RES, V17, P1045, DOI 10.1007/s11248-008-9191-6; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jeffries TR, 2004, MOL BIOL CELL, V15, P2652, DOI 10.1091/mbc.E03-10-0732; Kashef K, 2005, BIOCHEMISTRY-US, V44, P14090, DOI 10.1021/bi050604l; Kashef K, 2006, J CELL BIOCHEM, V98, P715, DOI 10.1002/jcb.20930; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Lin SX, 2004, MOL BIOL CELL, V15, P721, DOI 10.1091/mbc.E03-07-0497; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; Mallet WG, 1999, J CELL BIOL, V146, P345, DOI 10.1083/jcb.146.2.345; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Nguyen Q, 2005, J BIOL CHEM, V280, P30185, DOI 10.1074/jbc.M505499200; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2004, ENDOCRINOLOGY, V145, P4853, DOI 10.1210/en.2004-0489; Sbrissa D, 2001, MOL CELL ENDOCRINOL, V181, P35, DOI 10.1016/S0303-7207(01)00539-1; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Schapiro FB, 2004, MOL BIOL CELL, V15, P2884, DOI 10.1091/mbc.E03-09-0653; Schnapp BJ, 2003, J CELL SCI, V116, P2125, DOI 10.1242/jcs.00488; Shisheva A, 1999, MOL CELL BIOL, V19, P623; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Wolins N, 1997, J CELL BIOL, V139, P1735, DOI 10.1083/jcb.139.7.1735; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	55	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3750	3761		10.1074/jbc.M806539200	http://dx.doi.org/10.1074/jbc.M806539200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19056739	Green Published, hybrid			2022-12-27	WOS:000262872500043
J	Ballottari, M; Mozzo, M; Croce, R; Morosinotto, T; Bassi, R				Ballottari, Matteo; Mozzo, Milena; Croce, Roberta; Morosinotto, Tomas; Bassi, Roberto			Occupancy and Functional Architecture of the Pigment Binding Sites of Photosystem II Antenna Complex Lhcb5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; RESOLVED FLUORESCENCE ANALYSIS; HIGHER-PLANTS; MUTATION ANALYSIS; IN-VITRO; CHLOROPHYLL FLUORESCENCE; ENERGY-DISSIPATION; PROTEIN CP26; SPECTROSCOPIC CHARACTERIZATION; CHROMOPHORE-BINDING	Lhcb5 is an antenna protein that is highly conserved in plants and green algae. It is part of the inner layer of photosystem II antenna system retained in high light acclimated plants. To study the structure-function relation and the role of individual pigments in this complex, we (i) "knocked out" each of the chromophores bound to multiple (nine total) chlorophyll sites and (ii) exchanged the xanthophylls bound to the three xanthophyll sites. The occupancy and associated energy of the pigment binding sites were determined. The role of the individual pigments in protein folding, stability, energy transfer, and dissipation was studied in vitro. The results indicate that lutein has a primary role in the folding and stability of the complex, whereas violaxanthin and zeaxanthin have a negative effect on folding yield and stability, respectively. The data showed a distinct function for the L1 and L2 carotenoid binding sites, the former preferentially involved in gathering the excitation energy to chlorophyll a (Chl a), whereas the latter modulates the concentration of chlorophyll singlet excited states dependent on the xanthophylls bound to it, likely via an interaction with Chl-603. Our results also underscored the role of zeaxanthin and lutein in quenching the excitation energy, whereas violaxanthin was shown to be very effective in energy transfer. The characteristics of the isolated proteins were consistent with the observed role of Lhcb5 in vivo in catalyzing fluorescence quenching upon zeaxanthin binding.	[Ballottari, Matteo; Bassi, Roberto] Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy; [Mozzo, Milena; Croce, Roberta] Univ Groningen, Groningen Biotechnol & Biochem Sci Inst, Dept Biophys Chem, NL-9747 AG Groningen, Netherlands; [Morosinotto, Tomas] Univ Padua, Dipartimento Biol, I-35121 Padua, Italy	University of Verona; University of Groningen; University of Padua	Bassi, R (corresponding author), Univ Verona, Dipartimento Sci & Tecnol, Ca Vignal 1,Str Grazie 15, I-37134 Verona, Italy.	bassi@sci.univr.it	Croce, Roberta/HGU-9554-2022; Croce, Roberta/ABG-3595-2021; Ballottari, Matteo/N-1916-2019; Croce, Roberta/F-1174-2014; Morosinotto, Tomas/AAC-3188-2019; Croce, Roberta/N-4067-2014	Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Ballottari, Matteo/0000-0001-8410-3397; Morosinotto, Tomas/0000-0002-0803-7591; Croce, Roberta/0000-0003-3469-834X; bassi, roberto/0000-0002-4140-8446	Italian Ministry of Research Special Fund for Basic Research [FIRB RBLA03455F-002, RBIP06CPBR006]; The Netherlands Organization for Scientific Research; Earth and Life Science	Italian Ministry of Research Special Fund for Basic Research(Ministry of Education, Universities and Research (MIUR)); The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Earth and Life Science	This work was supported by Grants FIRB RBLA03455F-002 and RBIP06CPBR006 from the Italian Ministry of Research Special Fund for Basic Research and by a Vidi grant (to R. C.) from The Netherlands Organization for Scientific Research (NWO), Earth and Life Science.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; ALBERTSSON PA, 1990, FEBS LETT, V273, P36, DOI 10.1016/0014-5793(90)81045-P; Alboresi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002033; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Avenson TJ, 2009, J BIOL CHEM, V284, P2830, DOI 10.1074/jbc.M807192200; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Crimi M, 2001, EUR J BIOCHEM, V268, P260, DOI 10.1046/j.1432-1033.2001.01874.x; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Croce R, 2000, PHOTOSYNTH RES, V64, P221, DOI 10.1023/A:1006455230379; DAINESE P, 1991, J BIOL CHEM, V266, P8136; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DEMMIGADAMS B, 1989, PLANT BIOLOGY, V8, P375; Eggink LL, 2000, J BIOL CHEM, V275, P9087, DOI 10.1074/jbc.275.13.9087; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; Frank HA, 2001, BIOCHEMISTRY-US, V40, P1220, DOI 10.1021/bi001160q; Ganeteg U, 2004, PLANT PHYSIOL, V134, P502, DOI 10.1104/pp.103.033324; Gastaldelli M, 2003, J BIOL CHEM, V278, P19190, DOI 10.1074/jbc.M212125200; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; GOODWIN TW, 1981, CHEM BIOCH PLANT PIG, P3; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Hoober JK, 1999, PHOTOSYNTH RES, V61, P197; Horn R, 2004, J BIOL CHEM, V279, P44400, DOI 10.1074/jbc.M407188200; Horn R, 2007, J MOL BIOL, V366, P1045, DOI 10.1016/j.jmb.2006.11.069; JAHNS P, 1995, PLANT PHYSIOL BIOCH, V33, P683; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Matsubara S, 2007, PLANT PHYSIOL, V144, P926, DOI 10.1104/pp.107.099077; Morosinotto T, 2005, J BIOL CHEM, V280, P20612, DOI 10.1074/jbc.M500705200; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Mozzo M, 2008, BBA-BIOENERGETICS, V1777, P1263, DOI 10.1016/j.bbabio.2008.04.036; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Mozzo M, 2006, BBA-BIOENERGETICS, V1757, P1607, DOI 10.1016/j.bbabio.2006.06.018; NAGAI K, 1987, METHOD ENZYMOL, V153, P461; NOCTOR G, 1991, BIOCHIM BIOPHYS ACTA, V1057, P320, DOI 10.1016/S0005-2728(05)80143-4; Novoderezhkin VI, 2005, J PHYS CHEM B, V109, P10493, DOI 10.1021/jp044082f; Pagano A, 1998, J BIOL CHEM, V273, P17154, DOI 10.1074/jbc.273.27.17154; Pascal A, 1999, EUR J BIOCHEM, V262, P817, DOI 10.1046/j.1432-1327.1999.00457.x; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; van Amerongen H, 2001, J PHYS CHEM B, V105, P604, DOI 10.1021/jp0028406; Wentworth M, 2000, FEBS LETT, V471, P71, DOI 10.1016/S0014-5793(00)01369-7; Young AJ, 1996, J PHOTOCH PHOTOBIO B, V36, P3, DOI 10.1016/S1011-1344(96)07397-6	64	35	35	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8103	8113		10.1074/jbc.M808326200	http://dx.doi.org/10.1074/jbc.M808326200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19129188	Green Published, hybrid			2022-12-27	WOS:000264195600073
J	Chan, W; Tian, R; Lee, YF; Sit, ST; Lim, L; Manser, E				Chan, Wing; Tian, Rui; Lee, Yeow-Fong; Sit, Soon Tuck; Lim, Louis; Manser, Ed			Down-regulation of Active ACK1 Is Mediated by Association with the E3 Ubiquitin Ligase Nedd4-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDC42-ASSOCIATED TYROSINE KINASE; GROWTH-FACTOR RECEPTOR; EPITHELIAL NA+ CHANNEL; UBA DOMAINS; NEGATIVE REGULATOR; WW DOMAIN; TARGET; CDC42; DEGRADATION; INTERACTS	ACK1 (activated Cdc42-associated kinase 1) is a cytoplasmic tyrosine kinase implicated in trafficking through binding to epidermal growth factor (EGF) receptor and clathrin. Here, we have identified a new ACK1-binding partner, the E3 ubiquitin ligase Nedd4-2, which binds ACK1 via a conserved PPXY-containing region. We show that this motif also binds Nedd4-related proteins and several other WW domain-containing proteins, including the tumor suppressor oxidoreductase Wwox. In HeLa cells ACK1 colocalizes with Nedd4-2 in clathrin-rich vesicles, requiring this PPXY motif. Nedd4-2 strongly down-regulates ACK1 levels when coexpressed, and this process can be blocked by proteasome inhibitor MG132. ACK1 degradation via Nedd4 requires their mutual interaction and a functional E3 ligase; it is also driven by ACK1 activity. ACK1 is polyubiquitinated in vivo, and dominant inhibitory Nedd4 blocks endogenous ACK1 turnover in response to acute EGF treatment. Because EGF stimulation activates ACK1 (Galisteo, M., Y., Y., Urena, J., and Schlessinger, J. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 9796 - 9801), our result suggest that EGF receptor-mediated ACK1 activation allows Nedd4-2 to drive kinase degradation. Thus the interplay between Nedd4-2-related E3 ligases that regulate ACK1 levels and Cbl that modifies EGF receptor impinges on cell receptor dynamics. These processes are particularly pertinent given the report of genomic amplification of the ACK1 locus in metastatic tumors.	[Chan, Wing; Tian, Rui; Lee, Yeow-Fong; Sit, Soon Tuck; Lim, Louis; Manser, Ed] Inst Mol & Cell Biol, GSK, Singapore 138673, Singapore; [Lim, Louis] UCL, Inst Neurol, Dept Mol Sci, London WC1N PJ, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); GlaxoSmithKline; University of London; University College London	Manser, E (corresponding author), Inst Mol & Cell Biol, GSK, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbmansr@imcb.a-star.edu.sg	Manser, Edward/ABD-2301-2020		GSK (Singapore) Research Fund	GSK (Singapore) Research Fund(GlaxoSmithKline)	This work was supported by the GSK (Singapore) Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Haglund K, 2002, P NATL ACAD SCI USA, V99, P12191, DOI 10.1073/pnas.192462299; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Kato-Stankiewicz J, 2001, BIOCHEM BIOPH RES CO, V284, P470, DOI 10.1006/bbrc.2001.5004; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Leung T, 1996, MOL CELL BIOL, V16, P5313; Lin Q, 2002, J BIOL CHEM, V277, P10134, DOI 10.1074/jbc.M110329200; Lott JS, 2002, BIOCHEM J, V361, P481, DOI 10.1042/0264-6021:3610481; Lougheed JC, 2004, J BIOL CHEM, V279, P44039, DOI 10.1074/jbc.M406703200; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; MANMOR M, 2004, ONCOGENE, V23, P2057; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Omerovic J, 2007, FASEB J, V21, P2849, DOI 10.1096/fj.06-7925com; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Sanchez-Perez A, 2007, BIOCHEM BIOPH RES CO, V359, P611, DOI 10.1016/j.bbrc.2007.05.134; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Teo M, 2001, J BIOL CHEM, V276, P18392, DOI 10.1074/jbc.M008795200; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; vanDelft S, 1997, J BIOL CHEM, V272, P14013, DOI 10.1074/jbc.272.22.14013; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Xu DZ, 2005, J BIOL CHEM, V280, P2924, DOI 10.1074/jbc.M408907200; Yang W, 2004, BIOCHEM J, V382, P199, DOI 10.1042/BJ20040623; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819; Yang WN, 1999, J BIOL CHEM, V274, P8524, DOI 10.1074/jbc.274.13.8524; Yang WN, 2001, J BIOL CHEM, V276, P43987, DOI 10.1074/jbc.M104819200; Yang WN, 2001, J BIOL CHEM, V276, P17468, DOI 10.1074/jbc.M010893200; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; Yeow-Fong L, 2005, FEBS LETT, V579, P5040, DOI 10.1016/j.febslet.2005.07.093; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200	48	48	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8185	8194		10.1074/jbc.M806877200	http://dx.doi.org/10.1074/jbc.M806877200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144635	Green Published, hybrid			2022-12-27	WOS:000264195600080
J	Kaur, KH; Baur, R; Sigel, E				Kaur, Kuldeep H.; Baur, Roland; Sigel, Erwin			Unanticipated Structural and Functional Properties of delta-Subunit-containing GABA(A) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC ACID(A) RECEPTOR; TONIC INHIBITION; A RECEPTORS; NEUROSTEROID MODULATION; ACTIVATION; RECOMBINANT; SENSITIVITY; DIVERSITY; CHANNELS; SUBTYPES	GABA(A) receptors mediate inhibitory neurotransmission in the mammalian brain via synaptic and extrasynaptic receptors. The delta (delta)-subunit-containing receptors are expressed exclusively extra-synaptically and mediate tonic inhibition. In the present study, we were interested in determining the architecture of receptors containing the delta-subunit. To investigate this, we predefined the subunit arrangement by concatenation. We prepared five dual and three triple concatenated subunit constructs. These concatenated dual and triple constructs were used to predefine nine different GABA(A) receptor pentamers. These pentamers composed of alpha(1)-, beta(3)-, and delta-subunits were expressed in Xenopus oocytes and maximal currents elicited in response to 1 mM GABA were determined in the presence and absence of THDOC (3 alpha, 21-dihydroxy-5 alpha-pregnane-20-one). beta(3)- alpha(1)- delta/alpha(1)-beta(3) and beta(3)-alpha(1)-delta/beta(3)-alpha(1) resulted in the expression of large currents in response to GABA. Interestingly, the presence of the neurosteroid THDOC uncovered alpha(1)-beta(3)-alpha(1)/beta(3)-delta receptors, additionally. The functional receptors were characterized in detail using the agonist GABA, THDOC, Zn2+, and ethanol and their properties were compared with those of non-concatenated alpha(1)beta(3) and alpha(1)beta(3)delta receptors. Each concatenated receptor isoform displayed a specific set of properties, but none of them responded to 30 mM ethanol. We conclude from the investigated receptors that delta can assume multiple positions in the receptor pentamer. The GABA dose-response properties of alpha(1)-beta(3)-alpha(1)/beta(3)-delta and beta(3)-alpha(1)-delta/alpha(1)-beta(3) match most closely the properties of non-concatenated alpha 1 beta 3 delta receptors. Furthermore, we show that the delta-subunit can contribute to the formation of an agonist site in alpha 1-beta 3-alpha 1/beta 3-delta receptors.	[Kaur, Kuldeep H.; Baur, Roland; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Biol, CH-3012 Bern, Switzerland	University of Bern	Sigel, E (corresponding author), Univ Bern, Inst Biochem & Mol Biol, Buhlstr 28, CH-3012 Bern, Switzerland.	erwin.sigel@mci.unibe.ch	Sigel, Erwin/F-7736-2015		Swiss National Science Foundation [3100A0-105272/1, 3100A0-105272/2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation Grants 3100A0-105272/1 and 3100A0-105272/2. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Araujo F, 1998, EUR J PHARMACOL, V347, P347, DOI 10.1016/S0014-2999(98)00122-8; Barnard EA, 1998, PHARMACOL REV, V50, P291; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Baumann SW, 2003, J NEUROSCI, V23, P11158; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Bianchi MT, 2003, J NEUROSCI, V23, P10934; Boileau AJ, 2002, NEUROPHARMACOLOGY, V43, P695, DOI 10.1016/S0028-3908(02)00036-9; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feng HJ, 2004, J NEUROPHYSIOL, V92, P1577, DOI 10.1152/jn.00285.2004; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Hadley SH, 2007, J PHYSIOL-LONDON, V581, P1001, DOI 10.1113/jphysiol.2007.132886; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Herd MB, 2007, PHARMACOL THERAPEUT, V116, P20, DOI 10.1016/j.pharmthera.2007.03.007; Jechlinger M, 1998, J NEUROSCI, V18, P2449; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Jones A, 1997, J NEUROSCI, V17, P1350; Krishek BJ, 1998, J PHYSIOL-LONDON, V507, P639, DOI 10.1111/j.1469-7793.1998.639bs.x; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; MERTENS S, 1993, J BIOL CHEM, V268, P5965; Minier F, 2004, TRENDS PHARMACOL SCI, V25, P499, DOI 10.1016/j.tips.2004.07.005; Minier F, 2004, P NATL ACAD SCI USA, V101, P7769, DOI 10.1073/pnas.0400220101; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Mody I, 2001, NEUROCHEM RES, V26, P907, DOI 10.1023/A:1012376215967; Mody I, 2008, NEUROCHEM INT, V52, P60, DOI 10.1016/j.neuint.2007.07.010; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; QUIRK K, 1995, EUR J PHARM-MOLEC PH, V290, P175, DOI 10.1016/0922-4106(95)00061-5; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Saxena NC, 1996, MOL PHARMACOL, V49, P567; SAXENA NC, 1994, J NEUROSCI, V14, P7077; Scimemi A, 2006, EUR J NEUROSCI, V24, P1157, DOI 10.1111/j.1460-9568.2006.04989.x; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Storustovu SI, 2006, J PHARMACOL EXP THER, V316, P1351, DOI 10.1124/jpet.105.092403; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002; Zheleznova N, 2008, BRIT J PHARMACOL, V153, P1062, DOI 10.1038/sj.bjp.0707665; Zhu WJ, 1996, J NEUROSCI, V16, P6648	52	64	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7889	7896		10.1074/jbc.M806484200	http://dx.doi.org/10.1074/jbc.M806484200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19141615	Green Published, hybrid			2022-12-27	WOS:000264195600050
J	Frago, S; Velazquez-Campoy, A; Medina, M				Frago, Susana; Velazquez-Campoy, Adrian; Medina, Milagros			The Puzzle of Ligand Binding to Corynebacterium ammoniagenes FAD Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; ISOTHERMAL TITRATION CALORIMETRY; RIBOFLAVIN KINASE REVEALS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; RAT-LIVER; FLAVIN-BINDING; PURIFICATION; PROTEIN; BIOSYNTHESIS	In bacteria, riboflavin phosphorylation and subsequent conversion of FMN into FAD are carried out by FAD synthetase, a single bifunctional enzyme. Both reactions require ATP and Mg2+. The N-terminal domain of FAD synthetase appears to be responsible for the adenylyltransferase activity, whereas the C-terminal domain would be in charge of the kinase activity. Binding to Corynebacterium ammoniagenes FAD synthetase of its products and substrates, as well as of several analogues, is analyzed. Binding parameters for adenine nucleotides to each one of the two adenine nucleotide sites are reported. In addition, it is demonstrated for the first time that the enzyme presents two independent flavin sites, each one related with one of the enzymatic activities. The binding parameters of flavins to these sites are also provided. The presence of Mg2+ and of both adenine nucleotides and flavins cooperatively modulates the interaction parameters for the other ligands. Our data also suggest that during its double catalytic cycle FAD synthetase must suffer conformational changes induced by adenine nucleotide-Mg2+ or flavin binding. They might include not only rearrangement of the different protein loops but also alternative conformations between domains.	[Frago, Susana; Medina, Milagros] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Fac Ciencias, E-50009 Zaragoza, Spain; [Frago, Susana; Medina, Milagros] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, E-50009 Zaragoza, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Fdn Aragon I D, E-50009 Zaragoza, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, E-50009 Zaragoza, Spain	University of Zaragoza; University of Zaragoza; University of Zaragoza; University of Zaragoza	Medina, M (corresponding author), Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Fac Ciencias, Pedro Cerbuna 12, E-50009 Zaragoza, Spain.	mmedina@unizar.es	Medina, Milagros/F-8310-2012; Frago, Susana/L-1477-2017; Velazquez-Campoy, Adrian/E-7946-2012	Medina, Milagros/0000-0001-8743-0182; Frago, Susana/0000-0002-1369-1328; Velazquez-Campoy, Adrian/0000-0001-5702-4538	Spanish Ministry of Education and Science [BIO2007-65890-C02-01, SAF2004-07722]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported by Spanish Ministry of Education and Science Grants BIO2007-65890-C02-01 ( to M. M.) and SAF2004-07722 ( to A. V.-C.).; Recipient of a Ramon y Cajal Research Contract from the Spanish Ministry of Science and Technology.	Barile M, 2000, EUR J BIOCHEM, V267, P4888, DOI 10.1046/j.1432-1327.2000.01552.x; Bauer S, 2003, J MOL BIOL, V326, P1463, DOI 10.1016/S0022-2836(03)00059-7; BURROWS SD, 1994, BIOCHEMISTRY-US, V33, P12741, DOI 10.1021/bi00209a002; D'Angelo I, 2000, STRUCTURE, V8, P993, DOI 10.1016/S0969-2126(00)00190-8; Efimov I, 1998, BIOCHEMISTRY-US, V37, P9716, DOI 10.1021/bi972817j; Frago S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-160; Freire E, 1995, METHOD ENZYMOL, V259, P144; Freire E, 1995, Methods Mol Biol, V40, P191; Galluccio M, 2007, PROTEIN EXPRES PURIF, V52, P175, DOI 10.1016/j.pep.2006.09.002; Garavaglia S, 2004, J BIOL CHEM, V279, P40980, DOI 10.1074/jbc.M406586200; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; Giancaspero TA, 2009, FEBS J, V276, P219, DOI 10.1111/j.1742-4658.2008.06775.x; HAGIHARA T, 1995, APPL MICROBIOL BIOT, V42, P724; Izard T, 1999, EMBO J, V18, P2021, DOI 10.1093/emboj/18.8.2021; Izard T, 2002, J MOL BIOL, V315, P487, DOI 10.1006/jmbi.2001.5272; Karthikeyan S, 2003, BIOCHEMISTRY-US, V42, P12532, DOI 10.1021/bi035450t; Karthikeyan S, 2003, STRUCTURE, V11, P265, DOI 10.1016/S0969-2126(03)00024-8; Krupa A, 2003, TRENDS BIOCHEM SCI, V28, P9, DOI 10.1016/S0968-0004(02)00009-9; Mack M, 1998, J BACTERIOL, V180, P950, DOI 10.1128/JB.180.4.950-955.1998; MANSTEIN DJ, 1986, J BIOL CHEM, V261, P6169; McCormick DB, 1997, METHOD ENZYMOL, V280, P407; MERRILL AH, 1980, J BIOL CHEM, V255, P1335; NAKAGAWA S, 1995, BIOSCI BIOTECH BIOCH, V59, P694, DOI 10.1271/bbb.59.694; OKA M, 1987, J BIOL CHEM, V262, P7418; Perozzo R, 2000, J BIOL CHEM, V275, P16139, DOI 10.1074/jbc.M000509200; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; SANCHO J, 1991, ARCH BIOCHEM BIOPHYS, V288, P231, DOI 10.1016/0003-9861(91)90189-P; Santos MA, 2000, J BIOL CHEM, V275, P28618, DOI 10.1074/jbc.M004621200; Saridakis V, 2003, J BIOL CHEM, V278, P34356, DOI 10.1074/jbc.M205369200; Velazquez-Campoy A, 2006, BIOPHYS J, V91, P1887, DOI 10.1529/biophysj.106.086561; Velazquez-Campoy Adrian, 2004, Methods Mol Biol, V261, P35; Wang WR, 2005, PROTEINS, V58, P246, DOI 10.1002/prot.20207; Wang WR, 2003, PROTEINS, V52, P633, DOI 10.1002/prot.10353; YAMADA Y, 1990, ARCH BIOCHEM BIOPHYS, V278, P125, DOI 10.1016/0003-9861(90)90240-Y; Zhang H, 2002, STRUCTURE, V10, P69, DOI 10.1016/S0969-2126(01)00693-1	35	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6610	6619		10.1074/jbc.M808142200	http://dx.doi.org/10.1074/jbc.M808142200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136717	Green Published, hybrid			2022-12-27	WOS:000263919000005
J	Jerga, A; Miller, DJ; White, SW; Rock, CO				Jerga, Agoston; Miller, Darcie J.; White, Stephen W.; Rock, Charles O.			Molecular Determinants for Interfacial Binding and Conformational Change in a Soluble Diacylglycerol Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE ANALOG; PHOSPHOLIPASE-C; CRYSTAL-STRUCTURE; VENOM PHOSPHOLIPASE-A2; STAPHYLOCOCCUS-AUREUS; ACTIVE-SITE; ACTIVATION; COMPLEX; ALPHA; MODULATION	DgkB is a soluble diacylglycerol (DAG) kinase that is essential for membrane lipid homeostasis in many Gram-positive pathogens. Anionic phospholipids, like phosphatidylglycerol (PtdGro), were required for DgkB to recognize diacylglycerol embedded in a phospholipid bilayer. An activity-independent vesicle binding assay was used to determine the role of specific residues in DgkB-PtdGro interactions. Lys15 and Lys165 were required for DgkB to dock with PtdGro vesicles and flank the entrance to the DgkB active site. Mg2+ was required for vesicle binding. The compromised vesicle binding by mutants in the key asparate residues forming the structural Mg2+-aspartate-water network within the substrate binding domain revealed that interfacial binding of DgkB required a Mg2+-dependent conformational change. DgkB interaction with phospholipid vesicles was not influenced by the presence of ATP, but anionic vesicles decreased the Km of the enzyme for ATP. Arg(100) and Lys15 are two surface residues in the ATP binding domain that were necessary for high affinity ATP binding. The key residues responsible for the structural Mg2+ binding site, the conformational changes that increase ATP affinity, and interfacial recognition of anionic phospholipids were identical in DgkB and the mammalian diacylglycerol kinase catalytic cores. This sequence conservation suggests that the mammalian enzymes also require a structural divalent cation and surface positively charged residues to bind phospholipid bilayers and trigger conformational changes that accelerate catalysis.	[Miller, Darcie J.; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Jerga, Agoston; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	White, Stephen W/N-8164-2018		National Institutes of Health [GM34496]; Cancer Center [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34496. This work was also supported by Cancer Center Support Grant CA21765 and the American Lebanese Syrian Associated Charities. The costs of publication of this article were defrayed in part by the payment of page charges.	Abe T, 2003, BIOCHEM J, V375, P673, DOI 10.1042/BJ20031052; ANDERSON KS, 1988, BIOCHEMISTRY-US, V27, P1604, DOI 10.1021/bi00405a032; Boyer, 1970, ENZYMES, P341, DOI DOI 10.1016/S1874-6047(08)60170-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNIE S, 1985, J BIOL CHEM, V260, P9742; Fanani ML, 2004, BIOCHEMISTRY-US, V43, P14767, DOI 10.1021/bi049145z; Feng JW, 2003, J BIOL CHEM, V278, P24651, DOI 10.1074/jbc.M301207200; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; Guo S, 2008, BIOCHEMISTRY-US, V47, P4201, DOI 10.1021/bi702269u; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Jain MK, 2006, CURR OPIN CHEM BIOL, V10, P473, DOI 10.1016/j.cbpa.2006.08.015; Jerga A, 2007, J BIOL CHEM, V282, P21738, DOI 10.1074/jbc.M703536200; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Liu JY, 2005, J MOL BIOL, V354, P289, DOI 10.1016/j.jmb.2005.09.026; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miller DJ, 2008, STRUCTURE, V16, P1036, DOI 10.1016/j.str.2008.03.019; Nichols CE, 2007, PROTEINS, V68, P13, DOI 10.1002/prot.21386; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Saccani J, 2004, LANGMUIR, V20, P9190, DOI 10.1021/la0489920; Sakane F, 1996, BIOCHEM J, V318, P583, DOI 10.1042/bj3180583; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; Shao CH, 2007, J BIOL CHEM, V282, P9228, DOI 10.1074/jbc.M610918200; Stokka AJ, 2006, BIOCHEM J, V400, P493, DOI 10.1042/BJ20060962; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Tatulian SA, 1997, J MOL BIOL, V268, P809, DOI 10.1006/jmbi.1997.1014; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Thirugnanam S, 2001, BIOCHEMISTRY-US, V40, P10607, DOI 10.1021/bi010609s; Thomas WE, 1999, BIOCHEMISTRY-US, V38, P3320, DOI 10.1021/bi982567m; THUNNISSEN MMGM, 1990, NATURE, V347, P689, DOI 10.1038/347689a0; Tu-Sekine B, 2007, BIOCHEMISTRY-US, V46, P924, DOI 10.1021/bi061170c; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Ullman EF, 1996, CLIN CHEM, V42, P1518; VANDENBERG B, 1995, NAT STRUCT BIOL, V2, P402, DOI 10.1038/nsb0595-402; WALSH JP, 1986, J BIOL CHEM, V261, P6239; WHITE DC, 1967, J BACTERIOL, V94, P1854, DOI 10.1128/JB.94.6.1854-1867.1967; WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787; Winget JM, 2006, BBA-MOL CELL BIOL L, V1761, P1260, DOI 10.1016/j.bbalip.2006.08.002; Zhang X, 2004, J BIOL CHEM, V279, P20490, DOI 10.1074/jbc.M401016200	41	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7246	7254		10.1074/jbc.M805962200	http://dx.doi.org/10.1074/jbc.M805962200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19112175	Green Published, hybrid			2022-12-27	WOS:000263919000071
J	AbdAlla, S; Lother, H; el Missiry, A; Langer, A; Sergeev, P; el Faramawy, Y; Quitterer, U				AbdAlla, Said; Lother, Heinz; el Missiry, Ahmed; Langer, Andreas; Sergeev, Pavel; el Faramawy, Yasser; Quitterer, Ursula			Angiotensin II AT(2) Receptor Oligomers Mediate G-protein Dysfunction in an Animal Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; TRANSGENIC MICE; NEURONAL LOSS; PHOSPHOINOSITIDE HYDROLYSIS; MUSCARINIC RECEPTOR; TYPE-2 RECEPTOR; KINASE-C; BRAIN; STRESS; AGE	Progressive neurodegeneration and decline of cognitive functions are major hallmarks of Alzheimer disease (AD). Neurodegeneration in AD correlates with dysfunction of diverse signal transduction mechanisms, such as the G-protein-stimulated phosphoinositide hydrolysis mediated by G alpha(q/11). We report here that impaired G alpha(q/11)-stimulated signaling in brains of AD patients and mice correlated with the appearance of crosslinked oligomeric angiotensin II AT(2) receptors sequestering G alpha(q/11). Amyloid beta (A beta) was causal to AT(2) oligomerization, because cerebral microinjection of A beta triggered AT(2) oligomerization in the hippocampus of mice in a dose- dependent manner. A beta induced AT(2) oligomerization by a two-step process of oxidative and transglutaminase-dependent cross-linking. The induction of AT(2) oligomers in a transgenic mouse model with AD-like symptoms was associated with G alpha(q/11) dysfunction and enhanced neurodegeneration. Vice versa, stereotactic inhibition of AT(2) oligomers by RNA interference prevented the impairment of G alpha(q/11) and delayed Tau phosphorylation. Thus, A beta induces the formation of cross-linked AT(2) oligomers that contribute to the dysfunction of G alpha(q/11) in an animal model of Alzheimer disease.	[Langer, Andreas; Sergeev, Pavel; Quitterer, Ursula] Swiss Fed Inst Technol, Dept Mol Pharmacol, CH-8057 Zurich, Switzerland; [Langer, Andreas; Sergeev, Pavel; Quitterer, Ursula] Univ Zurich, CH-8057 Zurich, Switzerland; [AbdAlla, Said; Lother, Heinz; el Faramawy, Yasser] Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; [el Missiry, Ahmed] Ain Shams Univ Hosp, Med Res Ctr, Cairo, Egypt	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Heinrich Pette Institute; Egyptian Knowledge Bank (EKB); Ain Shams University	Quitterer, U (corresponding author), Y17M70,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	ursula.quitterer@pharma.ethz.ch						AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; AbdAlla S, 2009, J BIOL CHEM, V284, P6566, DOI 10.1074/jbc.M808277200; Bonelli RM, 2002, NEUROBIOL DIS, V11, P106, DOI 10.1006/nbdi.2002.0535; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Chen SH, 2000, EMBO J, V19, P4265, DOI 10.1093/emboj/19.16.4265; Dickstein DL, 2006, FASEB J, V20, P426, DOI 10.1096/fj.05-3956com; FERRARIDILEO G, 1993, LIFE SCI, V53, pPL439, DOI 10.1016/0024-3205(93)90037-4; FOWLER CJ, 1995, MOL CELL BIOCHEM, V149, P287, DOI 10.1007/BF01076590; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GREENWOOD AF, 1995, NEUROSCIENCE, V69, P125, DOI 10.1016/0306-4522(95)00220-D; Haring R, 1998, J NEUROCHEM, V71, P2094; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Jeong YH, 2006, FASEB J, V20, P729, DOI 10.1096/fj.05-4265fje; Johnson GVW, 1997, BRAIN RES, V751, P323, DOI 10.1016/S0006-8993(96)01431-X; JOPE RS, 1994, NEUROBIOL AGING, V15, P221, DOI 10.1016/0197-4580(94)90116-3; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; Miura M, 2002, J NEUROSCI, V22, P8379; MONLEON S, 1995, PSYCHOPHARMACOLOGY, V117, P453, DOI 10.1007/BF02246218; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nurnberg A, 2008, J BIOL CHEM, V283, P35526, DOI 10.1074/jbc.M804972200; Peavy GM, 2007, BIOL PSYCHIAT, V62, P472, DOI 10.1016/j.biopsych.2007.03.013; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Shenoy UV, 1999, ENDOCRINOLOGY, V140, P500, DOI 10.1210/en.140.1.500; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Thal DR, 2000, EXP NEUROL, V163, P98, DOI 10.1006/exnr.2000.7380; Tsang SWY, 2006, NEUROBIOL AGING, V27, P1216, DOI 10.1016/j.neurobiolaging.2005.07.010; Vervoort VS, 2002, SCIENCE, V296, P2401; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06; Wilson RS, 2006, NEUROEPIDEMIOLOGY, V27, P143, DOI 10.1159/000095761	41	63	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6554	6565		10.1074/jbc.M807746200	http://dx.doi.org/10.1074/jbc.M807746200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19074441	Green Accepted, hybrid			2022-12-27	WOS:000263742700058
J	Chagot, B; Potet, F; Balser, JR; Chazin, WJ				Chagot, Benjamin; Potet, Franck; Balser, Jeffrey R.; Chazin, Walter J.			Solution NMR Structure of the C-terminal EF-hand Domain of Human Cardiac Sodium Channel Na(V)1.5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARRHYTHMOGENIC MECHANISM; BRUGADA-SYNDROME; LQT-3 MUTATION; ALPHA-SUBUNIT; CALCIUM; SIMULATION; PROTEINS; INSIGHTS; SITE	The voltage-gated sodium channel Na(V)1.5 is responsible for the initial upstroke of the action potential in cardiac tissue. Levels of intracellular calcium modulate inactivation gating of Na(V)1.5, in part through a C-terminal EF-hand calcium binding domain. The significance of this structure is underscored by the fact that mutations within this domain are associated with specific cardiac arrhythmia syndromes. In an effort to elucidate the molecular basis for calcium regulation of channel function, we have determined the solution structure of the C-terminal EF-hand domain using multidimensional heteronuclear NMR. The structure confirms the existence of the four-helix bundle common to EF-hand domain proteins. However, the location of this domain is shifted with respect to that predicted on the basis of a consensus 12-residue EF-hand calcium binding loop in the sequence. This finding is consistent with the weak calcium affinity reported for the isolated EF-hand domain; high affinity binding is observed only in a construct with an additional 60 residues C-terminal to the EF-hand domain, including the IQ motif that is central to the calcium regulatory apparatus. The binding of an IQ motif peptide to the EF-hand domain was characterized by isothermal titration calorimetry and nuclear magnetic resonance spectroscopy. The peptide binds between helices I and IV in the EF-hand domain, similar to the binding of target peptides to other EF-hand calcium-binding proteins. These results suggest a molecular basis for the coupling of the intrinsic (EF-hand domain) and extrinsic (calmodulin) components of the calcium-sensing apparatus of Na(V)1.5.	[Chagot, Benjamin; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Potet, Franck; Balser, Jeffrey R.] Vanderbilt Univ, Dept Anesthesiol, Nashville, TN 37232 USA; [Chagot, Benjamin; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Balser, Jeffrey R.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Balser, Jeffrey R.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Chazin, WJ (corresponding author), Vanderbilt Univ, Struct Biol Ctr, 5140 BIOSCI MRBIII, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu	Chagot, Benjamin/AAC-6495-2019; Chagot, Benjamin/H-3258-2011	Chagot, Benjamin/0000-0002-9153-0060; 	National Institutes of Health [RO1GM56307]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM56307. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abriel H, 2000, CIRCULATION, V102, P921; Abriel H, 2001, CIRC RES, V88, P740, DOI 10.1161/hh0701.089668; An RH, 1998, CIRC RES, V83, P141, DOI 10.1161/01.RES.83.2.141; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; DeLano W.L, PYMOL MOL GRAPHICS S; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fujiwara T, 2003, BRAIN, V126, P531, DOI 10.1093/brain/awg053; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Glaaser IW, 2006, J BIOL CHEM, V281, P24015, DOI 10.1074/jbc.M605473200; Goddard T. D., 2006, SPARKY; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hubbard S., 1992, NACCESS; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Maler L, 2002, J MOL BIOL, V317, P279, DOI 10.1006/jmbi.2002.5421; MINAMI Y, 1987, J BIOCHEM-TOKYO, V101, P889, DOI 10.1093/oxfordjournals.jbchem.a121956; MINAMI Y, 1988, J BIOCHEM-TOKYO, V104, P927, DOI 10.1093/oxfordjournals.jbchem.a122585; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PALMER AG, 1998, CURVEFIT; Petitprez S, 2008, CARDIOVASC RES, V78, P494, DOI 10.1093/cvr/cvn023; Priori SG, 2002, CIRCULATION, V105, P1342, DOI 10.1161/hc1102.105288; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Smits JPP, 2002, J AM COLL CARDIOL, V40, P350, DOI 10.1016/S0735-1097(02)01962-9; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Vatta M, 2002, MOL GENET METAB, V75, P317, DOI 10.1016/S1096-7192(02)00006-9; Voehler MW, 2006, J MAGN RESON, V183, P102, DOI 10.1016/j.jmr.2006.08.002; Wehrens XHT, 2000, CIRCULATION, V102, P584; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207	49	58	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6436	6445		10.1074/jbc.M807747200	http://dx.doi.org/10.1074/jbc.M807747200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19074138	Green Published, hybrid			2022-12-27	WOS:000263742700046
J	Furuta, A; Yagi, T; Yanagisawa, H; Higuchi, H; Kamiya, R				Furuta, Akane; Yagi, Toshiki; Yanagisawa, Haru-aki; Higuchi, Hideo; Kamiya, Ritsu			Systematic Comparison of in Vitro Motile Properties between Chlamydomonas Wild-type and Mutant Outer Arm Dyneins Each Lacking One of the Three Heavy Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER-ARM; MICROTUBULE TRANSLOCATION; ADENOSINE-TRIPHOSPHATASE; FLAGELLAR AXONEMES; ATPASE ACTIVITY; ALPHA-BETA; ADP; MOVEMENT; SUBUNIT; PROTEIN	Outer arm dynein (OAD) of cilia and flagella contains two or three distinct heavy chains, each having a motor function. To elucidate their functional difference, we compared the in vitro motile properties of Chlamydomonas wild-type OAD containing the alpha, beta, and gamma heavy chains and three kinds of mutant OADs, each lacking one of the three heavy chains. For systematic comparison, a method was developed to introduce a biotin tag into a subunit, LC2, which served as the specific anchoring site on an avidin-coated glass surface. Wild-type OAD displayed microtubule gliding in the presence of ATP and ADP, with a maximal velocity of 5.0 mu m/s, which is approximately 1/4 of the microtubule sliding velocity in the axoneme. The duty ratio was estimated to be as low as 0.08. The absence of the beta heavy chain lowered both the gliding velocity and ATPase activity, whereas the absence of the gamma heavy chain increased both activities. Strikingly, the absence of the alpha heavy chain lowered the gliding velocity but increased the ATPase activity. Thus, the three heavy chains are likely to play distinct roles and regulate each other to achieve coordinated force production.	[Furuta, Akane; Yanagisawa, Haru-aki; Kamiya, Ritsu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Higuchi, Hideo] Univ Tokyo, Grad Sch Sci, Dept Phys, Tokyo 1130033, Japan; [Yagi, Toshiki] Kyoto Univ, Grad Sch Sci, Dept Biol Sci, Kyoto 6068502, Japan	University of Tokyo; University of Tokyo; Kyoto University	Kamiya, R (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, 7-3-1 Hongo, Tokyo 1130033, Japan.	kamiyar@biol.s.u-tokyo.ac.jp		Yanagisawa, Haruaki/0000-0003-0313-2343	Ministry of Education, Culture, Sports, Science and Technology of Japan [17207009, 20051007]; MEXT	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid 17207009 and 20051007 from Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Global COE program Integrative Life Science Based on the Study of Bio-signaling Mechanisms of MEXT. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BERLINER E, 1994, J BIOL CHEM, V269, P8610; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; deCastro MJ, 1999, BIOCHEMISTRY-US, V38, P5076, DOI 10.1021/bi9829175; DiBella LM, 2005, MOL BIOL CELL, V16, P5661, DOI 10.1091/mbc.E05-08-0732; DiBella LM, 2001, J BIOL CHEM, V276, P14366, DOI 10.1074/jbc.M011456200; FALL RR, 1971, P NATL ACAD SCI USA, V68, P1512, DOI 10.1073/pnas.68.7.1512; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; GIBBONS IR, 1979, J BIOL CHEM, V254, P187; GOODENOUGH UW, 1987, J MOL BIOL, V194, P481, DOI 10.1016/0022-2836(87)90676-0; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Inoue Y, 2007, CELL MOTIL CYTOSKEL, V64, P690, DOI 10.1002/cm.20216; Ishikawa R, 2007, CELL STRUCT FUNCT, V32, P17, DOI 10.1247/csf.06035; Ishikawa T, 2007, J MOL BIOL, V368, P1249, DOI 10.1016/j.jmb.2007.02.072; KAGAMI O, 1992, J CELL SCI, V103, P653; Kamiya R, 2002, INT REV CYTOL, V219, P115; Kamiya R, 2000, METHODS, V22, P383, DOI 10.1006/meth.2000.1090; Kikushima K, 2004, FEBS LETT, V563, P119, DOI 10.1016/S0014-5793(04)00278-9; KINOSHITA S, 1995, CELL MOTIL CYTOSKEL, V32, P46, DOI 10.1002/cm.970320106; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; Kotani N, 2007, BIOPHYS J, V93, P886, DOI 10.1529/biophysj.106.101964; KURIMOTO E, 1991, CELL MOTIL CYTOSKEL, V19, P275, DOI 10.1002/cm.970190406; Lesich KA, 2008, BIOPHYS J, V95, P472, DOI 10.1529/biophysj.107.127951; LINDEMANN CB, 1972, EXP CELL RES, V73, P255, DOI 10.1016/0014-4827(72)90131-0; Liu ZM, 2008, EUKARYOT CELL, V7, P1136, DOI 10.1128/EC.00102-08; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; MIMORI Y, 1994, CELL MOTIL CYTOSKEL, V27, P180, DOI 10.1002/cm.970270209; MOSS AG, 1992, J CELL BIOL, V118, P1189, DOI 10.1083/jcb.118.5.1189; MOSS AG, 1992, J CELL BIOL, V118, P1177, DOI 10.1083/jcb.118.5.1177; Nakamura K, 1997, CELL MOTIL CYTOSKEL, V37, P338; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Oda T, 2007, J CELL BIOL, V177, P243, DOI 10.1083/jcb.200609038; OMOTO CK, 1986, BIOCHEMISTRY-US, V25, P419, DOI 10.1021/bi00350a022; Omoto CK, 1996, CELL MOTIL CYTOSKEL, V33, P88; PatelKing RS, 1997, J CELL BIOL, V137, P1081, DOI 10.1083/jcb.137.5.1081; Pazour GJ, 1999, MOL BIOL CELL, V10, P3507, DOI 10.1091/mbc.10.10.3507; PFISTER KK, 1984, J BIOL CHEM, V259, P2072; PIPERNO G, 1979, J BIOL CHEM, V254, P3084; Sakakibara H, 1998, J CELL SCI, V111, P1155; Sakakibara H, 1999, NATURE, V400, P586, DOI 10.1038/23066; SAKAKIBARA H, 1991, J CELL BIOL, V113, P615, DOI 10.1083/jcb.113.3.615; SAKAKIBARA H, 1993, J CELL BIOL, V122, P653, DOI 10.1083/jcb.122.3.653; SALE WS, 1988, J CELL BIOL, V107, P1793, DOI 10.1083/jcb.107.5.1793; Shima T, 2006, J STRUCT BIOL, V156, P182, DOI 10.1016/j.jsb.2006.03.014; Shingyoji C, 1998, NATURE, V393, P711, DOI 10.1038/31520; Shiroguchi K, 2001, CELL MOTIL CYTOSKEL, V49, P189, DOI 10.1002/cm.1032; TAKADA S, 1992, J BIOCHEM, V111, P758, DOI 10.1093/oxfordjournals.jbchem.a123832; Tanner CA, 2008, MOL BIOL CELL, V19, P3724, DOI 10.1091/mbc.E08-04-0362; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; YAGI T, 1994, CELL MOTIL CYTOSKEL, V29, P177, DOI 10.1002/cm.970290209; Yagi T, 2000, CELL STRUCT FUNCT, V25, P263, DOI 10.1247/csf.25.263; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; YOKOTA E, 1987, J BIOCHEM, V102, P31, DOI 10.1093/oxfordjournals.jbchem.a122038; YOKOTA E, 1994, J CELL SCI, V107, P353; Yoshimura A, 2007, CELL MOTIL CYTOSKEL, V64, P777, DOI 10.1002/cm.20222	58	48	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5927	5935		10.1074/jbc.M807830200	http://dx.doi.org/10.1074/jbc.M807830200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19124458	hybrid			2022-12-27	WOS:000263560600056
J	Martin, L; Fluhrer, R; Haass, C				Martin, Lucas; Fluhrer, Regina; Haass, Christian			Substrate Requirements for SPPL2b-dependent Regulated Intramembrane Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; SIGNAL PEPTIDE PEPTIDASE; DISEASE GAMMA-SECRETASE; TERMINAL PAL MOTIF; CATALYTIC PORE; C-TERMINUS; TNF-ALPHA; PRESENILIN; CLEAVAGE; IDENTIFICATION	Intramembrane proteolysis is now widely recognized as an important physiological pathway required for reverse signaling and membrane protein degradation. Aspartyl intramembrane cleaving proteases of the GXGD-type play an important regulatory role in health and disease. Besides gamma-secretase/presenilin, signal peptide peptidase (SPP) and SPP-like (SPPL) peptidases also belong to the family of GXGD-type aspartyl proteases. Although recently the first SPPL2a/b substrates have been identified, very little is known about substrate requirements, which allow them to be efficiently processed within the membrane. We demonstrate that similar to gamma-secretase substrates, intramembrane proteolysis of Bri2 (Itm2b) is greatly facilitated by an initial shedding event mediated by ADAM-10. Serial deletions revealed that the length of the ectodomain negatively correlates with efficient intramembrane proteolysis. Bri3 (Itm2c), which is highly homologous to Bri2, fails to be shed. Failure of shedding of Bri3 is accompanied by a lack of intramembrane proteolysis by SPPL2b. Surprisingly, a low molecular weight membrane-retained stub of Bri3 also fails to be processed by SPPL2b, indicating that shedding per se is not sufficient for subsequent intramembrane proteolysis. Extensive domain swapping analysis reveals that primary sequence determinants within the intracellular domain and the transmembrane domain together with short luminal juxtamembrane sequences are required for efficient intramembrane proteolysis.	[Fluhrer, Regina] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany; Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany	University of Munich; University of Munich	Fluhrer, R (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany.	rfluhrer@med.uni-muenchen.de; chaass@med.uni-muenchen.de	Fluhrer, Regina/F-2642-2011		Deutsche Forschungsgemeinschaft; Sonderforschungsbereich [SFB 596]; Center for Integrated Protein Science Munich; Boehringer Ingelheim Pharma GmbH Co.;  [HA1737-11-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; Boehringer Ingelheim Pharma GmbH Co.(Boehringer Ingelheim); 	This work is supported by the Leibniz Award of the Deutsche Forschungsgemeinschaft ( to C. H.), the Deutsche Forschungsgemeinschaft Grant HA1737-11-1 ( to C. H. and R. F.), Sonderforschungsbereich Grant SFB 596 ( to C. H.), the Center for Integrated Protein Science Munich (CIPSM), and the Boehringer Ingelheim Pharma GmbH & Co. KG.	Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Choi SC, 2001, MOL CELLS, V12, P391; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; Hemming ML, 2008, PLOS BIOL, V6, P2314, DOI 10.1371/journal.pbio.0060257; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Okamoto T, 2008, J VIROL, V82, P3480, DOI 10.1128/JVI.02253-07; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pittois K, 1998, GENE, V217, P141, DOI 10.1016/S0378-1119(98)00354-0; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wickham L, 2005, J NEUROCHEM, V92, P93, DOI 10.1111/j.1471-4159.2004.02840.x; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006	46	42	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5662	5670		10.1074/jbc.M807485200	http://dx.doi.org/10.1074/jbc.M807485200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19114711	Green Published, hybrid			2022-12-27	WOS:000263560600030
J	Paulucci-Holthauzen, AA; Vergara, LA; Bellot, LJ; Canton, D; Scott, JD; O'Connor, KL				Paulucci-Holthauzen, Adriana A.; Vergara, Leoncio A.; Bellot, Larry J.; Canton, David; Scott, John D.; O'Connor, Kathleen L.			Spatial Distribution of Protein Kinase A Activity during Cell Migration Is Mediated by A-kinase Anchoring Protein AKAP Lbc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CYCLIC-AMP; SIGNALING COMPLEX; CARDIAC MYOCYTES; ADENYLYL-CYCLASE; CARCINOMA-CELLS; ALPHA-6-BETA-4 INTEGRIN; LAMELLAE FORMATION; RHOA ACTIVATION; CAMP	Protein kinase A (PKA) has been suggested to be spatially regulated in migrating cells due to its ability to control signaling events that are critical for polarized actin cytoskeletal dynamics. Here, using the fluorescence resonance energy transfer-based A-kinase activity reporter (AKAR1), we find that PKA activity gradients form with the strongest activity at the leading edge and are restricted to the basal surface in migrating cells. The existence of these gradients was confirmed using immunocytochemistry using phospho-PKA substrate antibodies. This observation holds true for carcinoma cells migrating randomly on laminin-1 or stimulated to migrate on collagen I with lysophosphatidic acid. Phosphodiesterase inhibition allows the formation of PKA activity gradients; however, these gradients are no longer polarized. PKA activity gradients are not detected when a non-phosphorylatable mutant of AKAR1 is used, if PKA activity is inhibited with H-89 or protein kinase inhibitor, or when PKA anchoring is perturbed. We further find that a specific A-kinase anchoring protein, AKAP-Lbc, is a major contributor to the formation of these gradients. In summary, our data show that PKA activity gradients are generated at the leading edge of migrating cells and provide additional insight into the mechanisms of PKA regulation of cell motility.	[O'Connor, Kathleen L.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Vergara, Leoncio A.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Paulucci-Holthauzen, Adriana A.; Bellot, Larry J.; O'Connor, Kathleen L.] Univ Texas Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA; [Canton, David; Scott, John D.] Univ Washington, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	O'Connor, KL (corresponding author), Univ Texas Med Branch, Dept Surg, 301 Univ Blvd, Galveston, TX 77555 USA.	kloconno@utmb.edu	Canton, David/N-7463-2015; O'Connor, Kathleen L/H-2569-2013	O'Connor, Kathleen L/0000-0002-1088-9734	National Institutes of Health [R21-GM071928, R01-CA109136, HL088366]; Fondation Leducq Transatlantic Network; NATIONAL CANCER INSTITUTE [R01CA109136] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM071928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq Transatlantic Network(Leducq Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21-GM071928 and R01-CA109136. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1; Supported by National Institutes of Health Grant HL088366 and the Fondation Leducq Transatlantic Network.	Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; CORBIN JD, 1977, J BIOL CHEM, V252, P3854; Deming PB, 2008, J BIOL CHEM, V283, P35199, DOI 10.1074/jbc.M804448200; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Dormond O, 2002, J BIOL CHEM, V277, P45838, DOI 10.1074/jbc.M209213200; Fleming YM, 2004, J CELL SCI, V117, P2377, DOI 10.1242/jcs.01096; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; HAYES JS, 1982, J CYCLIC NUCL PROT, V8, P1; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Iancu RV, 2007, BIOPHYS J, V92, P3317, DOI 10.1529/biophysj.106.095356; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Laudanna C, 1997, J BIOL CHEM, V272, P24141, DOI 10.1074/jbc.272.39.24141; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; Meyer CJ, 2000, NAT CELL BIOL, V2, P666, DOI 10.1038/35023621; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; NISHIYAMA T, 1994, MOL CELL BIOL, V14, P2447, DOI 10.1128/MCB.14.4.2447; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Paulucci-Holthauzen AA, 2006, ANAL BIOCHEM, V355, P175, DOI 10.1016/j.ab.2006.06.002; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; Takenawa T, 2001, J CELL SCI, V114, P1801; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; TAYLOR SS, 1992, FARADAY DISCUSS, V93, P143, DOI 10.1039/fd9929300143; TRON L, 1984, BIOPHYS J, V45, P939, DOI 10.1016/S0006-3495(84)84240-X; Valentin G, 2005, NAT METHODS, V2, P801, DOI 10.1038/nmeth1105-801; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Whittard JD, 2001, J CELL SCI, V114, P3265; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; YOUVAN DC, 1997, BIOTECHNOLOGY ALIA, V1, P1; Zaccolo M, 2002, CURR OPIN CELL BIOL, V14, P160, DOI 10.1016/S0955-0674(02)00316-2; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	65	42	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5956	5967		10.1074/jbc.M805606200	http://dx.doi.org/10.1074/jbc.M805606200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106088	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000263560600059
J	Perkovic, M; Schmidt, S; Marino, D; Russell, RA; Stauch, B; Hofmann, H; Kopietz, F; Kloke, BP; Zielonka, J; Strover, H; Hermle, J; Lindemann, D; Pathak, VK; Schneider, G; Lochelt, M; Cichutek, K; Munk, C				Perkovic, Mario; Schmidt, Stanislaw; Marino, Daniela; Russell, Rebecca A.; Stauch, Benjamin; Hofmann, Henning; Kopietz, Ferdinand; Kloke, Bjoern-Philipp; Zielonka, Joerg; Stroever, Heike; Hermle, Johannes; Lindemann, Dirk; Pathak, Vinay K.; Schneider, Gisbert; Loechelt, Martin; Cichutek, Klaus; Muenk, Carsten			Species-specific Inhibition of APOBEC3C by the Prototype Foamy Virus Protein Bet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EDITING ENZYME APOBEC3G; TYPE-1 VIF; HIV-1 VIF; ANTIRETROVIRAL DEFENSE; CYTIDINE DEAMINASES; ANTIVIRAL ACTIVITY; LEUKEMIA-VIRUS; MURINE APOBEC3; 2 DISTINCT; SOCS-BOX	The APOBEC3 cytidine deaminases are part of the intrinsic defense of cells against retroviruses. Lentiviruses and spumaviruses have evolved essential accessory proteins, Vif and Bet, respectively, which counteract the APOBEC3 proteins. We show here that Bet of the Prototype foamy virus inhibits the antiviral APOBEC3C activity by a mechanism distinct to Vif: Bet forms a complex with APOBEC3C without inducing its degradation. Bet abolished APOBEC3C dimerization as shown by co-immunoprecipitation and cross-linking experiments. These findings implicate a physical interaction between Bet and the APOBEC3C. Subsequently, we identified the Bet interaction domain in human APOBEC3C in the predicted APOBEC3C dimerization site. Taken together, these data support the hypothesis that Bet inhibits incorporation of APOBEC3Cs into retroviral particles. Bet likely achieves this by trapping APOBEC3C protein in complexes rendering them unavailable for newly generated viruses due to direct immobilization.	[Perkovic, Mario; Schmidt, Stanislaw; Marino, Daniela; Hofmann, Henning; Kopietz, Ferdinand; Kloke, Bjoern-Philipp; Zielonka, Joerg; Stroever, Heike; Hermle, Johannes; Cichutek, Klaus; Muenk, Carsten] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany; [Russell, Rebecca A.; Pathak, Vinay K.] NCI, HIV Drug Resistance Program, NIH, Ctr Canc Res, Frederick, MD 21702 USA; [Stauch, Benjamin; Schneider, Gisbert] Univ Frankfurt, Inst Organ Chem & Chem Biol, D-60323 Frankfurt, Germany; [Lindemann, Dirk] Tech Univ Dresden, Inst Virol, D-01307 Dresden, Germany; [Loechelt, Martin] German Canc Res Ctr, Res Program Infect & Canc, Dept Genome Modificat & Carcinogenesis, D-69120 Heidelberg, Germany; [Hofmann, Henning; Zielonka, Joerg; Muenk, Carsten] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany	Paul Ehrlich Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Goethe University Frankfurt; Technische Universitat Dresden; Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf	Munk, C (corresponding author), Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany.	carsten.muenk@med.uni-duesseldorf.de	Stauch, Benjamin/AAK-2559-2021; Lindemann, Dirk/H-5857-2013; Perkovic, Mario/AAZ-2653-2021; Stauch, Benjamin/AAL-4105-2020	Stauch, Benjamin/0000-0001-7626-2021; Lindemann, Dirk/0000-0002-0320-4223; Schneider, Gisbert/0000-0001-6706-1084; Perkovic, Mario/0000-0002-8969-5157; Pathak, Vinay/0000-0003-2441-8412; Moore, Rebecca/0000-0002-6517-6483	National Institutes of Health; DFG [MU1608/3-1]; NATIONAL CANCER INSTITUTE [ZIABC010595, Z01BC010595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant from the Intramural Research Program of NCI, NIH, Center for Cancer Research. This work was also supported by the DFG (Grant MU1608/3-1 to C.M.).	Abudu A, 2006, CURR BIOL, V16, P1565, DOI 10.1016/j.cub.2006.06.055; ACHONG BG, 1971, J NATL CANCER I, V46, P299; Alke A, 2000, VIROLOGY, V275, P170, DOI 10.1006/viro.2000.0537; Alke A, 2001, VIROLOGY, V287, P310, DOI 10.1006/viro.2001.1065; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bock M, 1998, VIROLOGY, V250, P194, DOI 10.1006/viro.1998.9362; Browne EP, 2008, J VIROL, V82, P1305, DOI 10.1128/JVI.01371-07; Calattini S, 2007, EMERG INFECT DIS, V13, P1314, DOI 10.3201/eid1309.061162; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Derse D, 2007, P NATL ACAD SCI USA, V104, P2915, DOI 10.1073/pnas.0609444104; Diaz-Griffero F, 2007, J VIROL, V81, P10362, DOI 10.1128/JVI.00703-07; Doehle BP, 2005, J VIROL, V79, P8201, DOI 10.1128/JVI.79.13.8201-8207.2005; Duda A, 2004, J VIROL, V78, P13865, DOI 10.1128/JVI.78.24.13865-13870.2004; HAHN H, 1994, J GEN VIROL, V75, P2635, DOI 10.1099/0022-1317-75-10-2635; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Heneine W, 2003, CURR TOP MICROBIOL, V277, P181; Herchenroder O, 1995, VIROLOGY, V214, P685, DOI 10.1006/viro.1995.0086; Hill CL, 1999, J GEN VIROL, V80, P2003, DOI 10.1099/0022-1317-80-8-2003; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kao S, 2007, VIROLOGY, V369, P329, DOI 10.1016/j.virol.2007.08.005; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Linial ML, 1999, J VIROL, V73, P1747, DOI 10.1128/JVI.73.3.1747-1755.1999; LOCHELT M, 1991, VIROLOGY, V184, P43, DOI 10.1016/0042-6822(91)90820-2; Lochelt M, 2005, P NATL ACAD SCI USA, V102, P7982, DOI 10.1073/pnas.0501445102; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Meiering CD, 2002, P NATL ACAD SCI USA, V99, P15130, DOI 10.1073/pnas.242491999; Muckenfuss H, 2007, NUCLEIC ACIDS RES, V35, P3784, DOI 10.1093/nar/gkm340; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Munk C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r48; Pietschmann T, 1999, J VIROL, V73, P2613, DOI 10.1128/JVI.73.4.2613-2621.1999; Rulli SJ, 2008, J VIROL, V82, P6566, DOI 10.1128/JVI.01357-07; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; SIMM M, 1995, J VIROL, V69, P4582, DOI 10.1128/JVI.69.7.4582-4586.1995; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Weikel J, 2003, J VET MED A, V50, P415, DOI 10.1046/j.0931-184X.2003.00565.x; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	62	61	65	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5819	5826		10.1074/jbc.M808853200	http://dx.doi.org/10.1074/jbc.M808853200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19074429	hybrid, Green Published			2022-12-27	WOS:000263560600045
J	Scruggs, SB; Hinken, AC; Thawornkaiwong, A; Robbins, J; Walker, LA; de Tombe, PP; Geenen, DL; Buttrick, PM; Solaro, RJ				Scruggs, Sarah B.; Hinken, Aaron C.; Thawornkaiwong, Ariyaporn; Robbins, Jeffrey; Walker, Lori A.; de Tombe, Pieter P.; Geenen, David L.; Buttrick, Peter M.; Solaro, R. John			Ablation of Ventricular Myosin Regulatory Light Chain Phosphorylation in Mice Causes Cardiac Dysfunction in Situ and Affects Neighboring Myofilament Protein Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-A PHOSPHORYLATION; SKELETAL-MUSCLE FIBERS; PERFUSED RABBIT HEART; CANINE LEFT-VENTRICLE; TROPONIN-I; RAT HEARTS; INORGANIC-PHOSPHATE; FORCE DEVELOPMENT; CA2+ SENSITIVITY; ISOMETRIC FORCE	There is little direct evidence on the role of myosin regulatory light chain phosphorylation in ejecting hearts. In studies reported here we determined the effects of regulatory light chain (RLC) phosphorylation on in situ cardiac systolic mechanics and in vitro myofibrillar mechanics. We compared data obtained from control nontransgenic mice (NTG) with a transgenic mouse model expressing a cardiac specific nonphosphorylatable RLC (TG-RLC(P-). We also determined whether the depression in RLC phosphorylation affected phosphorylation of other sarcomeric proteins. TG-RLC(P-) demonstrated decreases in base-line load-independent measures of contractility and power and an increase in ejection duration together with a depression in phosphorylation of myosin-binding protein-C (MyBP-C) and troponin I (TnI). Although TG-RLC(P-) displayed a significantly reduced response to beta(1)-adrenergic stimulation, MyBP-C and TnI were phosphorylated to a similar level in TG-RLC(P-) and NTG, suggesting cAMP-dependent protein kinase signaling to these proteins was not disrupted. A major finding was that NTG controls were significantly phosphorylated at RLC serine 15 following beta(1)-adrenergic stimulation, a mechanism prevented in TG-RLC(P-), thus providing a biochemical difference in beta(1)-adrenergic responsiveness at the level of the sarcomere. Our measurements of Ca2+ tension and Ca2+-ATPase rate relations in detergent-extracted fiber bundles from LV trabeculae demonstrated a relative decrease in maximum Ca2+-activated tension and tension cost in TG-RLC(P-) fibers, with no change in Ca2+ sensitivity. Our data indicate that RLC phosphorylation is critical for normal ejection and response to beta(1)-adrenergic stimulation. Our data also indicate that the lack of RLC phosphorylation promotes compensatory changes in MyBP-C and TnI phosphorylation, which when normalized do not restore function.	[Scruggs, Sarah B.; Hinken, Aaron C.; Thawornkaiwong, Ariyaporn; de Tombe, Pieter P.; Geenen, David L.; Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Scruggs, Sarah B.; Hinken, Aaron C.; Thawornkaiwong, Ariyaporn; de Tombe, Pieter P.; Geenen, David L.; Solaro, R. John] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL 60612 USA; [Robbins, Jeffrey] Cincinnati Childrens Hosp, Dept Mol Cardiovasc Biol, Cincinnati, OH 45229 USA; [Walker, Lori A.; Buttrick, Peter M.] Univ Colorado, Div Cardiol, Aurora, CO 80045 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cincinnati Children's Hospital Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Solaro, RJ (corresponding author), 835 S Wolcott Ave,M-C 901, Chicago, IL 60612 USA.	solarorj@uic.edu	Walker, Lori/J-7098-2013	Walker, Lori/0000-0003-2556-8076	National Institutes of Health [PO1 HL62426, RO1 HL22231, T32 HL07962, F32 HL086023]; American Heart Association [0710031Z]; Temple Hoyne Buell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL086023, R01HL022231, T32HL007692, P01HL062426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Temple Hoyne Buell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL62426 (to R. J. S., P. P. D., and P. M. B.), RO1 HL22231 (to R. J. S.), T32 HL07962 (to S. B. S. and A. C. H.), and F32 HL086023 (to A. C. H.). This work was also supported by American Heart Association Grant 0710031Z (to S. B. S.) and funds from the Temple Hoyne Buell Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAKER SP, 1980, MEMBRANE BIOCHEM, V3, P185, DOI 10.3109/09687688009063885; BARANY K, 1983, ELECTROPHORESIS, V4, P138, DOI 10.1002/elps.1150040207; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chu GX, 2004, CIRC RES, V94, P184, DOI 10.1161/01.RES.0000107198.90218.21; CLEMENT O, 1992, BIOCHEM J, V285, P311, DOI 10.1042/bj2850311; Davis JS, 2002, COLD SPRING HARB SYM, V67, P345, DOI 10.1101/sqb.2002.67.345; Davis JS, 2002, BIOPHYS J, V83, P359, DOI 10.1016/S0006-3495(02)75175-8; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; DETOMBE PP, 1995, CIRC RES, V76, P734, DOI 10.1161/01.RES.76.5.734; Epstein ND, 2006, CIRC RES, V98, P1110, DOI 10.1161/01.RES.0000223888.99864.3c; FREARSON N, 1975, BIOCHEM J, V151, P99, DOI 10.1042/bj1510099; FREARSON N, 1976, NATURE, V264, P801, DOI 10.1038/264801a0; FRITZ JD, 1989, ANAL BIOCHEM, V180, P205, DOI 10.1016/0003-2697(89)90116-4; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; HIGH CW, 1980, AM J PHYSIOL, V239, pH756, DOI 10.1152/ajpheart.1980.239.6.H756; Hinken AC, 2007, PHYSIOLOGY, V22, P73, DOI 10.1152/physiol.00043.2006; Hinken AC, 2004, AM J PHYSIOL-CELL PH, V287, pC500, DOI 10.1152/ajpcell.00049.2004; HOFMANN PA, 1991, J PHYSIOL-LONDON, V439, P701, DOI 10.1113/jphysiol.1991.sp018689; HOLROYDE MJ, 1979, BIOCHIM BIOPHYS ACTA, V587, P628, DOI 10.1016/0304-4165(79)90014-X; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; JEACOCKE SA, 1980, BIOCHEM J, V188, P763, DOI 10.1042/bj1880763; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; Montgomery DE, 2005, AM J PHYSIOL-HEART C, V289, pH1881, DOI 10.1152/ajpheart.00454.2005; Morano I, 1997, J MOL CELL CARDIOL, V29, P1177, DOI 10.1006/jmcc.1996.0353; MORANO I, 1986, BASIC RES CARDIOL, V81, P611, DOI 10.1007/BF02005185; MORANO I, 1988, BASIC RES CARDIOL, V83, P350, DOI 10.1007/BF02005820; Nagayama T, 2007, CIRCULATION, V116, P2399, DOI 10.1161/CIRCULATIONAHA.107.706523; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Palmer BM, 2004, CIRC RES, V94, P1249, DOI 10.1161/01.RES.0000126898.95550.31; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Scruggs SB, 2006, J MOL CELL CARDIOL, V40, P465, DOI 10.1016/j.yjmcc.2005.12.009; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; Solaro RJ, 1998, CIRC RES, V83, P471, DOI 10.1161/01.RES.83.5.471; SOLARO RJ, 2001, HDB PHYSL 2, V1, P264; SOLARO RJ, 2001, HEART PHYSL PATHOPHY, P519; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Stelzer JE, 2006, J GEN PHYSIOL, V128, P261, DOI 10.1085/jgp.200609547; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; SWEENEY HL, 1986, AM J PHYSIOL, V250, pC657, DOI 10.1152/ajpcell.1986.250.4.C657; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Thawornkaiwong A, 2003, LIFE SCI, V72, P1813, DOI 10.1016/S0024-3205(02)02473-6; van der Velden J, 2003, CARDIOVASC RES, V57, P505, DOI 10.1016/S0008-6363(02)00662-4; van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5; van der Velden J, 2001, CIRCULATION, V104, P1140, DOI 10.1161/hc3501.095485; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Wang XJ, 2001, CIRCULATION, V103, P2402, DOI 10.1161/01.cir.103.19.2402; Weisberg A, 1996, P NATL ACAD SCI USA, V93, P8999, DOI 10.1073/pnas.93.17.8999; WESTWOOD SA, 1981, BIOCHEM J, V197, P185, DOI 10.1042/bj1970185; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894	59	86	87	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5097	5106		10.1074/jbc.M807414200	http://dx.doi.org/10.1074/jbc.M807414200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106098	Green Published, hybrid			2022-12-27	WOS:000263416600040
J	Joe, PA; Banerjee, A; Luduena, RF				Joe, Patrick A.; Banerjee, Asok; Luduena, Richard F.			Roles of beta-Tubulin Residues Ala(428) and Thr(429) in Microtubule Formation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYROSINATED ALPHA-TUBULIN; CARBOXY-TERMINAL TAILS; POSTTRANSLATIONAL MODIFICATIONS; CYTOPLASMIC DYNEIN; BOVINE BRAIN; C-TERMINUS; GENES; ISOTYPES; SEQUENCE; KINESIN	The C termini of beta-tubulin isotypes are regions of high sequence variability that bind to microtubule-associated proteins and motors and undergo various post-translational modifications such as polyglutamylation and polyglycylation. Crystallographic analyses have been unsuccessful in resolving tubulin C termini. Here, we used a stepwise approach to study the role of this region in microtubule assembly. We generated a series of truncation mutants of human beta I and beta III tubulin. Transient transfection of HeLa cells with the mutants shows that mutants with deletions of up to 22 residues from beta III and 16 from beta I can assemble normally. Interestingly, removal of the next residue (Ala(428)) results in a complete loss of microtubule formation without affecting dimer formation. C-terminal tail switching of human beta I and beta III tubulin suggests that C-terminal tails are functionally equivalent. In short, residues outside of 1-429 of human beta-tubulins make no contribution to microtubule assembly. Ala(428), in the C-terminal sequence motif N-QQYQDA(428), lies at the end of helix H12 of beta-tubulin. We hypothesize that this residue is important for maintaining helix H12 structure. Deletion of Ala(428) may lead to unwinding of helix H12, resulting in tubulin dimers incapable of assembly. Thr(429) plays a more complex role. In the beta I isotype of tubulin, Thr(429) is not at all necessary for assembly; however, in the beta III isotype, its presence strongly favors assembly. This result is consistent with a likely more complex function of beta III as well as with the observation that evolutionary conservation is total for Ala(428) and frequent for Thr(429).	[Joe, Patrick A.; Banerjee, Asok; Luduena, Richard F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Luduena, RF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	luduena@uthscsa.edu			United States Army Breast Cancer Research Program [W81XWH-05-1-0238]; San Antonio Cancer Institute [P30 CA54174]; State of Texas Higher Coordinating Board, and Welch Foundation [AQ-0726]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	United States Army Breast Cancer Research Program(United States Department of Defense); San Antonio Cancer Institute; State of Texas Higher Coordinating Board, and Welch Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States Army Breast Cancer Research Program Grant W81XWH-05-1-0238, San Antonio Cancer Institute Grant P30 CA54174, the State of Texas Higher Coordinating Board, and Welch Foundation Grant AQ-0726 (to R. F. L.).	AIZAWA H, 1991, J BIOL CHEM, V266, P9841; ALEXANDER JE, 1991, P NATL ACAD SCI USA, V88, P4685, DOI 10.1073/pnas.88.11.4685; AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; Banerjee A, 1999, BIOCHEMISTRY-US, V38, P5438, DOI 10.1021/bi981572n; Banerjee A, 2002, BIOCHEM BIOPH RES CO, V293, P598, DOI 10.1016/S0006-291X(02)00269-3; Banerjee A, 2002, J BIOL CHEM, V277, P46140, DOI 10.1074/jbc.M208065200; Bre MH, 1998, MOL BIOL CELL, V9, P2655, DOI 10.1091/mbc.9.9.2655; Brehm K, 2000, MOL BIOCHEM PARASIT, V107, P297, DOI 10.1016/S0166-6851(00)00178-X; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; CHAPIN SJ, 1991, J CELL SCI, V98, P27; DEANIN GG, 1980, EUR J BIOCHEM, V109, P207, DOI 10.1111/j.1432-1033.1980.tb04786.x; DeLano W, 2002, PYMOL 0 99; DETRICH HW, 1993, CELL MOTIL CYTOSKEL, V24, P156, DOI 10.1002/cm.970240303; DIAZNIDO J, 1990, J BIOL CHEM, V265, P13949; Dossou SJY, 2007, CELL MOTIL CYTOSKEL, V64, P847, DOI 10.1002/cm.20229; Duan JM, 2002, CURR BIOL, V12, P313, DOI 10.1016/S0960-9822(02)00651-6; DUPUIS P, 1992, EMBO J, V11, P3713, DOI 10.1002/j.1460-2075.1992.tb05456.x; Gagnon C, 1996, J CELL SCI, V109, P1545; Gerbod D, 2004, MOL PHYLOGENET EVOL, V31, P572, DOI 10.1016/j.ympev.2003.09.013; Gioio AE, 2004, EUR J NEUROSCI, V20, P865, DOI 10.1111/j.1460-9568.2004.03538.x; GOOD PJ, 1989, NUCLEIC ACIDS RES, V17, P8000, DOI 10.1093/nar/17.19.8000; GUNDERSEN GG, 1986, J CELL BIOL, V102, P1118, DOI 10.1083/jcb.102.3.1118; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; HAGIWARA H, 1994, J BIOL CHEM, V269, P3581; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; HARLOW P, 1988, J MOL EVOL, V27, P56, DOI 10.1007/BF02099730; HARPER DS, 1989, P NATL ACAD SCI USA, V86, P3252, DOI 10.1073/pnas.86.9.3252; Hartwig J, 2003, J THROMB HAEMOST, V1, P1580, DOI 10.1046/j.1538-7836.2003.00331.x; Henriquez JP, 1996, MOL CELL BIOCHEM, V158, P149, DOI 10.1007/BF00225841; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Jensen-Smith HC, 2003, CELL MOTIL CYTOSKEL, V55, P213, DOI 10.1002/cm.10122; Ji SJ, 2002, BIOCHEM BIOPH RES CO, V296, P1245, DOI 10.1016/S0006-291X(02)02069-7; Jimenez MA, 1999, PROTEIN SCI, V8, P788; Jost W, 2004, GENE, V340, P151, DOI 10.1016/j.gene.2004.06.009; KIRKMASON KE, 1988, NUCLEIC ACIDS RES, V16, P2733, DOI 10.1093/nar/16.6.2733; Knipling L, 2006, BIOCHEM BIOPH RES CO, V341, P433, DOI 10.1016/j.bbrc.2005.12.201; LEWIS SA, 1987, CELL, V49, P539, DOI 10.1016/0092-8674(87)90456-9; LEWIS SA, 1985, J CELL BIOL, V101, P852, DOI 10.1083/jcb.101.3.852; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luchko T, 2008, BIOPHYS J, V94, P1971, DOI 10.1529/biophysj.107.115113; Luduena RF, 1998, INT REV CYTOL, V178, P207; LUDUENA RF, 1988, FEBS LETT, V230, P142, DOI 10.1016/0014-5793(88)80658-6; Moreno FJ, 1999, EUR J BIOCHEM, V262, P557, DOI 10.1046/j.1432-1327.1999.00408.x; Mukherjee M, 2003, J APPL MICROBIOL, V95, P861, DOI 10.1046/j.1365-2672.2003.02061.x; Njue AI, 2003, PARASITOLOGY, V127, P579, DOI 10.1017/S0031182003004086; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1999, CELL MOL LIFE SCI, V56, P133, DOI 10.1007/s000180050012; Okamura S, 1999, CELL STRUCT FUNCT, V24, P117, DOI 10.1247/csf.24.117; Okamura S, 1997, CELL STRUCT FUNCT, V22, P291, DOI 10.1247/csf.22.291; Popodi EM, 2005, CELL MOTIL CYTOSKEL, V62, P48, DOI 10.1002/cm.20085; Priel A, 2005, EUR BIOPHYS J BIOPHY, V35, P40, DOI 10.1007/s00249-005-0003-0; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; RUDIGER A, 1995, ANAL BIOCHEM, V224, P532, DOI 10.1006/abio.1995.1083; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; SACKETT DL, 1985, J BIOL CHEM, V260, P43; Schwarz PM, 1998, BIOCHEMISTRY-US, V37, P4687, DOI 10.1021/bi972763d; Schwer HD, 2001, CURR BIOL, V11, P579, DOI 10.1016/S0960-9822(01)00153-1; SERRANO L, 1985, EUR J BIOCHEM, V153, P595, DOI 10.1111/j.1432-1033.1985.tb09342.x; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; SERRANO L, 1988, BIOCHEM J, V252, P683, DOI 10.1042/bj2520683; SHARMA J, 1994, J PROTEIN CHEM, V13, P165, DOI 10.1007/BF01891975; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; SULLIVAN KF, 1985, MOL CELL BIOL, V5, P2454, DOI 10.1128/MCB.5.9.2454; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOMAREV SI, 1993, BIOCHIM BIOPHYS ACTA, V1216, P245, DOI 10.1016/0167-4781(93)90151-3; Tucker C, 1997, J BIOL CHEM, V272, P9481; VASSILEVSKAIA TD, 1993, PLANT MOL BIOL, V22, P715, DOI 10.1007/BF00047413; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; Yamamoto E, 1999, PLANT MOL BIOL, V39, P45, DOI 10.1023/A:1006108412801	72	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4283	4291		10.1074/jbc.M807491200	http://dx.doi.org/10.1074/jbc.M807491200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074767	Green Published, hybrid			2022-12-27	WOS:000263134400026
J	Jurek, A; Amagasaki, K; Gembarska, A; Heldin, CH; Lennartsson, J				Jurek, Aleksandra; Amagasaki, Kenichi; Gembarska, Agnieszka; Heldin, Carl-Henrik; Lennartsson, Johan			Negative and Positive Regulation of MAPK Phosphatase 3 Controls Platelet-derived Growth Factor-induced Erk Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PHOSPHATASE; FEEDBACK-REGULATION; IN-VIVO; SPECIFICITY; PATHWAYS; PHOSPHORYLATION; DEGRADATION; CASCADE; FAMILY; SITES	MAPK phosphatases (MKPs) are dual specificity phosphatases that dephosphorylate and thereby inactivate MAPKs. In the present study, we provide evidence that platelet-derived growth factor BB (PDGF-BB) regulates MKP3 (DUSP6), which is considered to be a phosphatase highly selective for Erk. Intriguingly, we observed that Mek is positively regulated by MKP3, whereas Erk itself is negatively regulated. In addition, we found that activation of PDGF receptor alpha or beta leads to a rapid proteasomal degradation of MKP3 in a manner that requires Mek activation; this feed-forward mechanism was found to be essential for efficient Erk phosphorylation. We could also demonstrate that PDGF-BB stimulation induces phosphorylation of MKP3 at Ser-174 and Ser-300; phosphorylation of Ser-174 is involved in PDGF-induced MKP3 degradation, since mutation of this site stabilized MKP3. Moreover, activated Erk induces mkp3 expression, leading to restoration of MKP3 levels after 1-2 h and a concomitant dephosphorylation of Erk in cells with activated PDGFR alpha. Reducing the MKP3 level by small interfering RNA leads to an increased Erk activation and mitogenic response to PDGF-BB. In conclusion, MKP3 is an important regulator of PDGF-induced Erk phosphorylation acting in both a rapid positive feed-forward and a later negative feed-back loop.	[Lennartsson, Johan] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University	Lennartsson, J (corresponding author), Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, Box 595, SE-75124 Uppsala, Sweden.	Johan.Lennartsson@LICR.uu.se			Swedish Research Council; TRANSFOG integrated European Union project	Swedish Research Council(Swedish Research CouncilEuropean Commission); TRANSFOG integrated European Union project	This work was supported by grants from the Swedish Research Council, Ake Wibergs stiftelse, Magnus Bergvalls stiftelse, and the TRANSFOG integrated European Union project. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bermudez O, 2008, ONCOGENE, V27, P3685, DOI 10.1038/sj.onc.1211040; BLUMEJENSEN P, 1995, J BIOL CHEM, V270, P14192, DOI 10.1074/jbc.270.23.14192; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Camps M, 1998, FEBS LETT, V425, P271, DOI 10.1016/S0014-5793(98)00250-6; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cook SJ, 1996, BIOCHEM J, V320, P237, DOI 10.1042/bj3200237; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hirsch DD, 1997, J BIOL CHEM, V272, P4568, DOI 10.1074/jbc.272.7.4568; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marti F, 2001, J IMMUNOL, V166, P197, DOI 10.4049/jimmunol.166.1.197; MELOCHE S, 1992, MOL ENDOCRINOL, V6, P845, DOI 10.1210/me.6.5.845; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Muda M, 1996, J BIOL CHEM, V271, P4319; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	28	56	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4626	4634		10.1074/jbc.M808490200	http://dx.doi.org/10.1074/jbc.M808490200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19106095	hybrid			2022-12-27	WOS:000263134400062
J	Kuhn, FJP; Kuhn, C; Luckhoff, A				Kuehn, Frank J. P.; Kuehn, Cornelia; Lueckhoff, Andreas			Inhibition of TRPM8 by Icilin Distinct from Desensitization Induced by Menthol and Menthol Derivatives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN-RECEPTOR; PROSTATE-CANCER; COLD; CHANNEL; ACTIVATION; SENSITIVITY; REVEALS; IDENTIFICATION; MECHANISM; NEURONS	TRPM8 is a cation channel activated by cold temperatures and the chemical stimuli menthol and icilin. Both compounds use different mechanisms of current activation; amino acid residues within the S2-S3 linker have been identified critical for current activation by icilin but not by menthol. Current decline in the course of menthol stimulation reflects Ca2+-dependent desensitization attributed to phosphatidylinositol 4,5-bisphosphate depletion. Carboxyamide derivatives chemically resembling menthol have been described as activators of TRPM8 analogous to icilin. Our aim was a detailed analysis of whether differences exist between all these substances with respect to their activation and inactivation of currents. We studied wildtype TRPM8 as well as an s3-TRPM8 mutant with mutations in the S2-S3 linker region that could not be activated by icilin. Menthol and menthol derivatives behaved indistinguishable in evoking currents through both channels in a Ca2+-independent manner as well as inducing Ca2+-dependent desensitization. Icilin, in contrast, activated currents only in wild type TRPM8 and in the presence of Ca2+. Moreover, it completely reversed currents induced by menthol, menthol derivatives, and cold temperatures in wild type TRPM8 and s3-TRPM8; this current inhibition was independent of Ca2+. Finally, icilin suppressed current activation by the other agonists. None of the inhibiting effects of icilin occurred in the cation channel TRPA1 that is also stimulated by both menthol and icilin. Thus, icilin specifically inhibits TRPM8 independently of its interaction site within the S2-S3 linker through a process distinct from desensitization.	[Kuehn, Frank J. P.; Kuehn, Cornelia; Lueckhoff, Andreas] Rhein Westfal TH Aachen, Fac Med, Inst Physiol, D-52057 Aachen, Germany	RWTH Aachen University	Kuhn, FJP (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Physiol, D-52057 Aachen, Germany.	fkuehn@physiology.rwth-aachen.de	Kuehn, Frank JP/H-5889-2018		Deutsche Forschungsgemeinschaft [2271/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft Grant DFG KU 2271/1-1. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Beck B, 2007, CELL CALCIUM, V41, P285, DOI 10.1016/j.ceca.2006.07.002; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; HENSEL H, 1951, ACTA PHYSIOL SCAND, V24, P27, DOI 10.1111/j.1748-1716.1951.tb00824.x; Hui KY, 2005, BIOCHEM BIOPH RES CO, V333, P374, DOI 10.1016/j.bbrc.2005.05.123; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kim D, 2008, AM J PHYSIOL-CELL PH, V295, pC92, DOI 10.1152/ajpcell.00023.2008; Kuhn FJP, 2007, J BIOL CHEM, V282, P27598, DOI 10.1074/jbc.M702247200; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Tsavaler L, 2001, CANCER RES, V61, P3760; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; WEI ET, 1983, J PHARM PHARMACOL, V35, P110, DOI 10.1111/j.2042-7158.1983.tb04279.x; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yamamura H, 2008, AM J PHYSIOL-CELL PH, V295, pC296, DOI 10.1152/ajpcell.00499.2007	30	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4102	4111		10.1074/jbc.M806651200	http://dx.doi.org/10.1074/jbc.M806651200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19095656	hybrid			2022-12-27	WOS:000263134400007
J	Sugatani, T; Hruska, KA				Sugatani, Toshifumi; Hruska, Keith A.			Impaired Micro-RNA Pathways Diminish Osteoclast Differentiation and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PU.1; NF-KAPPA-B; GENE-EXPRESSION; NUCLEAR-FACTOR; T-CELLS; NFATC1; PROMOTER; MITF; IDENTIFICATION; PROLIFERATION	Micro-RNAs (miRNAs) are important in regulating cell fate determination because many of their target mRNA transcripts are engaged in cell proliferation, differentiation, and apoptosis. DGCR8, Dicer, and Ago2 are essential factors for miRNA homeostasis. Here we show that these three factors have critical roles in osteoclast differentiation and function. Gene silencing of DGCR8, Dicer, or Ago2 by small interfering RNA revealed global inhibition of osteoclast transcription factor expression and function, decreased osteoclastogenesis, and decreased bone resorption in vitro. In vivo, CD11b(+)-cre/Dicer-null mice had mild osteopetrosis caused by decreased osteoclast number and bone resorption. These results suggest that miRNAs play important roles in differentiation and function of osteoclasts in vitro and in vivo. We found a novel mechanism mediating these results in which PU.1, miRNA-223, NFI-A, and the macrophage colony-stimulating factor receptor (M-CSFR) are closely linked through a positive feedback loop. PU.1 stimulates miRNA-223 expression, and this up-regulation is implicated in stimulating differentiation and function of osteoclasts through negative regulation of NFI-A levels. Down-regulation of NFI-A levels is important for expression of the M-CSFR, which is critical for osteoclast differentiation and function. NFI-A overexpression decreased osteoclast formation and function with down-regulation of M-CSFR levels. Forced expression of the M-CSFR in M-CSF-dependent bone marrow macrophages from Dicer-deficient mice rescued osteoclast differentiation with up-regulation of PU.1 levels. Our studies provide new molecular mechanisms controlling osteoclast differentiation and function by the miRNA system and specifically by miRNA-223, which regulates NFI-A and the M-CSFR levels.	[Sugatani, Toshifumi; Hruska, Keith A.] Washington Univ, Dept Pediat, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Hruska, KA (corresponding author), McDonnell Pediatr, Res Bldg,Campus Box 8208,660 S Euclid Ave, St Louis, MO 63110 USA.	hruska_k@kids.wustl.edu			National Institutes of Health [DK070790, AR41677]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK070790 and AR41677 (to K. A. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Crotti TN, 2006, GENE, V372, P92, DOI 10.1016/j.gene.2005.12.012; DEL FA, 2008, ARCH BIOCHEM BIOPHYS, V473, P147; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kwon OH, 2005, BIOCHEM BIOPH RES CO, V335, P437, DOI 10.1016/j.bbrc.2005.07.092; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Pang M, 2007, GENE, V403, P151, DOI 10.1016/j.gene.2007.08.007; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Shen Z, 2007, BBA-GENE STRUCT EXPR, V1769, P659, DOI 10.1016/j.bbaexp.2007.08.005; Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Walsh NC, 2003, GENE, V307, P111, DOI 10.1016/S0378-1119(03)00449-9; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	49	171	192	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4667	4678		10.1074/jbc.M805777200	http://dx.doi.org/10.1074/jbc.M805777200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19059913	Green Published, hybrid			2022-12-27	WOS:000263134400066
J	Dinman, JD				Dinman, Jonathan D.			The Eukaryotic Ribosome: Current Status and Challenges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-SYNTHESIS; TRANSFER-RNA; TRANSLATION; SUBUNIT; GENE; IDENTIFICATION; RECONSTITUTION; CONFORMATION; PHENOTYPE; CANDIDATE	Despite having been identified first, their greater degree of complexity has resulted in our understanding of eukaryotic ribosomes lagging behind that of their bacterial and archaeal counterparts. A much more complicated biogenesis program results in ribosomes that are structurally, biochemically, and functionally more complex. However, recent advances in molecular genetics and structural biology are helping to reveal the intricacies of the eukaryotic ribosome and to address many longstanding questions regarding its many roles in the regulation of gene expression.	Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Dinman, JD (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dinman@umd.edu		Dinman, Jonathan/0000-0002-2402-9698	National Institutes of Health [GM058859]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM058859. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Budkevich TV, 2008, NUCLEIC ACIDS RES, V36, P4736, DOI 10.1093/nar/gkn424; Dai MS, 2007, CELL CYCLE, V6, P2735, DOI 10.4161/cc.6.22.4895; Dong J, 2008, GENE DEV, V22, P2242, DOI 10.1101/gad.1696608; Ellis SR, 2006, MED HYPOTHESES, V66, P643, DOI 10.1016/j.mehy.2005.09.010; Frank J, 2003, BIOPOLYMERS, V68, P223, DOI 10.1002/bip.10210; FRIED HM, 1982, NUCLEIC ACIDS RES, V10, P3133, DOI 10.1093/nar/10.10.3133; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Gilbertt RJC, 2007, P NATL ACAD SCI USA, V104, P5788, DOI 10.1073/pnas.0606880104; HAGE AE, 2004, RNA BIOL, V1, P45; Hamaguchi N, 2002, CYTOTECHNOLOGY, V40, P85, DOI 10.1023/A:1023970222898; Hinnebusch AG, 2004, ANN NY ACAD SCI, V1038, P60, DOI 10.1196/annals.1315.012; HOSOKAWA K, 1966, P NATL ACAD SCI USA, V55, P198, DOI 10.1073/pnas.55.1.198; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; King TH, 2003, MOL CELL, V11, P425, DOI 10.1016/S1097-2765(03)00040-6; Kiparisov S, 2005, MOL GENET GENOMICS, V274, P235, DOI 10.1007/s00438-005-0020-9; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Korostelev A, 2008, CURR OPIN CHEM BIOL, V12, P674, DOI 10.1016/j.cbpa.2008.08.037; LaRiviere FJ, 2006, MOL CELL, V24, P619, DOI 10.1016/j.molcel.2006.10.008; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; MELNICK MB, 1993, GENETICS, V135, P553; Merrick W C, 1979, Methods Enzymol, V60, P108, DOI 10.1016/S0076-6879(79)60011-3; Meskauskas A, 2003, MOL CELL BIOL, V23, P1602, DOI 10.1128/MCB.23.5.1602-1613.2003; Meskauskas A, 2001, RNA, V7, P1084, DOI 10.1017/S1355838201001480; Meskauskas A, 2008, NUCLEIC ACIDS RES, V36, P6175, DOI 10.1093/nar/gkn642; Meskauskas A, 2008, NUCLEIC ACIDS RES, V36, P1826, DOI 10.1093/nar/gkn034; Munro JB, 2008, BIOPOLYMERS, V89, P565, DOI 10.1002/bip.20961; Nilsson J, 2007, J MOL BIOL, V369, P429, DOI 10.1016/j.jmb.2007.03.035; PALADE GE, 1956, J BIOPHYS BIOCHEM CY, V2, P171, DOI 10.1083/jcb.2.2.171; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Petrov AN, 2008, NUCLEIC ACIDS RES, V36, P6187, DOI 10.1093/nar/gkn643; Polacek N, 2005, CRIT REV BIOCHEM MOL, V40, P285, DOI 10.1080/10409230500326334; Rakauskaite R, 2008, NUCLEIC ACIDS RES, V36, P1497, DOI 10.1093/nar/gkm1179; Rakauskaite R, 2006, MOL CELL BIOL, V26, P8992, DOI 10.1128/MCB.01311-06; Rheinberger H.-J., 2004, PROTEIN SYNTHESIS RI, P1; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Stark H, 2002, CURR PROTEIN PEPT SC, V3, P79, DOI 10.2174/1389203023380873; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Sylvester JE, 2004, GENET MED, V6, P73, DOI 10.1097/01.GIM.0000117333.21213.17; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; Weijers D, 2001, DEVELOPMENT, V128, P4289; Wickner RB, 1996, ANNU REV GENET, V30, P109, DOI 10.1146/annurev.genet.30.1.109; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Yamamoto T, 2007, PATHOL INT, V57, P1, DOI 10.1111/j.1440-1827.2007.02049.x; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008	50	29	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11761	11765		10.1074/jbc.R800074200	http://dx.doi.org/10.1074/jbc.R800074200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19117941	Green Published, hybrid			2022-12-27	WOS:000265494600006
J	Inoue, T; Okino, N; Kakuta, Y; Hijikata, A; Okano, H; Goda, HM; Tani, M; Sueyoshi, N; Kambayashi, K; Matsumura, H; Kai, Y; Ito, M				Inoue, Tsuyoshi; Okino, Nozomu; Kakuta, Yoshimitsu; Hijikata, Atsushi; Okano, Hiroyuki; Goda, Hatsumi M.; Tani, Motohiro; Sueyoshi, Noriyuki; Kambayashi, Kouji; Matsumura, Hiroyoshi; Kai, Yasushi; Ito, Makoto			Mechanistic Insights into the Hydrolysis and Synthesis of Ceramide by Neutral Ceramidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; SPHINGOSINE 1-PHOSPHATE; ALKALINE CERAMIDASE; PURIFICATION; MEMBRANE; GENE; LOCALIZATION; METABOLISM; EXPRESSION; APOPTOSIS	Ceramidase (CDase; EC 3.5.1.23) hydrolyzes ceramide to generate sphingosine and fatty acid. The enzyme plays a regulatory role in a variety of physiological events in eukaryotes and also functions as an exotoxin in particular bacteria. The crystal structures of neutral CDase from Pseudomonas aeruginosa (PaCD) in the C2-ceramide-bound and -unbound forms were determined at 2.2 and 1.4 angstrom resolutions, respectively. PaCD consists of two domains, and the Zn2+- and Mg2+/Ca2+-binding sites are found within the center of the N-terminal domain and the interface between the domains, respectively. The structural comparison between the C2-ceramide-bound and unbound forms revealed an open-closed conformational change occurring to loop I upon binding of C2-ceramide. In the closed state, this loop sits above the Zn2+ coordination site and over the opening to the substrate binding site. Mutational analyses of residues surrounding the Zn2+ of PaCD and rat neutral CDase revealed that the cleavage or creation of the N-acyl linkage of ceramide follows a similar mechanism as observed for the Zn2+-dependent carboxypeptidases. The results provide an understanding of the molecular mechanism of hydrolysis and synthesis of ceramide	[Inoue, Tsuyoshi; Okano, Hiroyuki; Kambayashi, Kouji; Matsumura, Hiroyoshi; Kai, Yasushi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Okino, Nozomu; Kakuta, Yoshimitsu; Goda, Hatsumi M.; Tani, Motohiro; Sueyoshi, Noriyuki; Ito, Makoto] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 8128581, Japan; [Hijikata, Atsushi] RIKEN, Res Ctr Allergy & Immunol, Lab Immunogen, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Okino, Nozomu; Ito, Makoto] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Kyushu University; RIKEN; Japan Science & Technology Agency (JST)	Inoue, T (corresponding author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	inouet@chem.eng.osaka-u.ac.jp; makotoi@agr.kyushu-u.ac.jp	Ito, Makoto/Q-6164-2019; Okino, Nozomu/AAY-2635-2021	Matsumura, Hiroyoshi/0000-0003-0361-3796; Hijikata, Atsushi/0000-0003-4297-8368; ito, Makoto/0000-0003-3159-7818; Tani, Motohiro/0000-0003-4316-8260				Acharya JK, 2008, NEURON, V57, P69, DOI 10.1016/j.neuron.2007.10.041; Acharya U, 2004, P NATL ACAD SCI USA, V101, P1922, DOI 10.1073/pnas.0308693100; Acharya U, 2003, SCIENCE, V299, P1740, DOI 10.1126/science.1080549; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galadari S, 2006, BIOCHEM J, V393, P687, DOI 10.1042/BJ20050682; GATT S, 1963, J BIOL CHEM, V238, P3131; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; HANNUN YA, 1987, SCIENCE, V235, P670, DOI 10.1126/science.3101176; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hwang YH, 2005, BIOCHEM BIOPH RES CO, V331, P37, DOI 10.1016/j.bbrc.2005.03.134; ITO M, 2002, MOL B INT U, V21, P41; KABSCH W, 1983, FEBS LETT, V155, P179, DOI 10.1016/0014-5793(82)80597-8; Kita K, 2000, BBA-MOL CELL BIOL L, V1485, P111, DOI 10.1016/S1388-1981(00)00029-9; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; MERRILL AH, 1986, J BIOL CHEM, V261, P3764; Mitsutake S, 2001, J BIOL CHEM, V276, P26249, DOI 10.1074/jbc.M102233200; Monjusho H, 2003, BIOCHEM J, V376, P473, DOI 10.1042/BJ20030652; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILSSON A, 1969, BIOCHIM BIOPHYS ACTA, V176, P339, DOI 10.1016/0005-2760(69)90192-1; Ohlsson L, 2007, BIOCHIMIE, V89, P950, DOI 10.1016/j.biochi.2007.03.009; Okino N, 2003, J BIOL CHEM, V278, P29948, DOI 10.1074/jbc.M303310200; Okino N, 1998, J BIOL CHEM, V273, P14368, DOI 10.1074/jbc.273.23.14368; Okino N, 1999, J BIOL CHEM, V274, P36616, DOI 10.1074/jbc.274.51.36616; Okino N, 2007, J BIOL CHEM, V282, P6021, DOI 10.1074/jbc.M603088200; Olsson M, 2004, AM J PHYSIOL-GASTR L, V287, pG929, DOI 10.1152/ajpgi.00155.2004; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Rohrbough J, 2004, J NEUROSCI, V24, P7789, DOI 10.1523/JNEUROSCI.1146-04.2004; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shtraizent N, 2008, J BIOL CHEM, V283, P11253, DOI 10.1074/jbc.M709166200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Tani M, 2005, J BIOL CHEM, V280, P36592, DOI 10.1074/jbc.M506827200; Tani M, 2004, J BIOL CHEM, V279, P29351, DOI 10.1074/jbc.M404012200; Tani M, 2000, J BIOL CHEM, V275, P11229, DOI 10.1074/jbc.275.15.11229; Tani M, 2003, J BIOL CHEM, V278, P10523, DOI 10.1074/jbc.M207932200; Tani M, 2000, J BIOL CHEM, V275, P3462, DOI 10.1074/jbc.275.5.3462; Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wu BX, 2007, J LIPID RES, V48, P600, DOI 10.1194/jlr.M600423-JLR200; Yoshimura Y, 2004, J BIOL CHEM, V279, P44012, DOI 10.1074/jbc.M405598200; Yoshimura Y, 2002, J BIOCHEM, V132, P229, DOI 10.1093/oxfordjournals.jbchem.a003215	56	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9566	9577		10.1074/jbc.M808232200	http://dx.doi.org/10.1074/jbc.M808232200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19088069	Green Published, hybrid			2022-12-27	WOS:000264669100063
J	Kurokawa, K; Lee, H; Roh, KB; Asanuma, M; Kim, YS; Nakayama, H; Shiratsuchi, A; Choi, Y; Takeuchi, O; Kang, HJ; Dohmae, N; Nakanishi, Y; Akira, S; Sekimizu, K; Lee, BL				Kurokawa, Kenji; Lee, Hanna; Roh, Kyung-Baeg; Asanuma, Miwako; Kim, Young Sook; Nakayama, Hiroshi; Shiratsuchi, Akiko; Choi, Youngnim; Takeuchi, Osamu; Kang, Hee Jung; Dohmae, Naoshi; Nakanishi, Yoshinobu; Akira, Shizuo; Sekimizu, Kazuhisa; Lee, Bok Luel			The Triacylated ATP Binding Cluster Transporter Substrate-binding Lipoprotein of Staphylococcus aureus Functions as a Native Ligand for Toll-like Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOTEICHOIC ACID; BACTERIAL LIPOPROTEINS; IMMUNE ACTIVATION; ESCHERICHIA-COLI; INNATE IMMUNITY; CUTTING EDGE; RECOGNITION; LIPOPEPTIDE; DISCRIMINATION; INFECTION	Some synthetic lipopeptides, in addition to native lipoproteins derived from both Gram-negative bacteria and mycoplasmas, are known to activate TLR2 (Toll-like receptor 2). However, the native lipoproteins inherent to Gram-positive bacteria, which function as TLR2 ligands, have not been characterized. Here, we have purified a native lipoprotein to homogeneity from Staphylococcus aureus to study as a native TLR2 ligand. The purified 33-kDa lipoprotein was capable of stimulating TLR2 and was identified as a triacylated SitC lipoprotein, which belongs to a family of ATP binding cluster (ABC) transporter substrate-binding proteins. Analyses of the SitC-mediated production of cytokine using mouse peritoneal macrophages revealed that the SitC protein (3 nM) induced the production of tumor necrosis factor-alpha and interleukin-6. Moreover, analysis of knock-out mice showed that SitC required TLR2 and MyD88, but not TLR1 or TLR6, for the induction of cytokines. In addition to the S. aureus SitC lipoprotein, we purified two other native ABC transporter substrate-binding lipoproteins from Bacillus subtilis and Micrococcus luteus, which were both shown to stimulate TLR2. These results demonstrate that S. aureus SitC lipoprotein is triacylated and that the ABC transporter substrate-binding lipoproteins of Gram-positive bacteria function as native ligands for TLR2.	[Kurokawa, Kenji; Lee, Hanna; Roh, Kyung-Baeg; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea; [Kurokawa, Kenji; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo 1130033, Japan; [Asanuma, Miwako; Nakayama, Hiroshi; Dohmae, Naoshi] RIKEN, Biomol Characterizat Team, Wako, Saitama 3510198, Japan; [Kim, Young Sook; Choi, Youngnim] Seoul Natl Univ, Sch Dent, Dept Oromaxillofacial Infect & Immun, Seoul 110749, South Korea; [Shiratsuchi, Akiko; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Lee, Hanna; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Kang, Hee Jung] Hallym Univ, Coll Med, Dept Lab Med, Gyeonggi Do 431070, South Korea	Pusan National University; University of Tokyo; RIKEN; Seoul National University (SNU); Kanazawa University; Osaka University; Hallym University	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea.	brlee@pusan.ac.kr	Akira, Shizuo/C-3134-2009; Choi, Youngnim/AAL-8140-2020; Nakanishi, Yoshinobu/D-4602-2014; Dohmae, Naoshi/C-2040-2011; Takeuchi, Osamu/D-6007-2011; Shiratsuchi, Akiko/D-8391-2015; Takeuchi, Osamu/AAG-9359-2019; Asanuma, Miwako/AAI-1843-2019	Choi, Youngnim/0000-0002-6496-5560; Nakanishi, Yoshinobu/0000-0002-8767-3587; Dohmae, Naoshi/0000-0002-5242-9410; Shiratsuchi, Akiko/0000-0002-7811-4409; Takeuchi, Osamu/0000-0002-1260-6232; 	National Research Laboratory Grants [M10400000028-04J0000-02]; MOST/KOSEF Bioscience Grant [20080576001]; BK21 program	National Research Laboratory Grants(Korea Science and Engineering Foundation); MOST/KOSEF Bioscience Grant(Korea Science and Engineering Foundation); BK21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by National Research Laboratory Grants M10400000028-04J0000-02 and MOST/KOSEF Bioscience Grant 20080576001. This work was also partially supported by the BK21 program.	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Bullen J J, 1978, Curr Top Microbiol Immunol, V80, P1; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; CHOI DS, 1986, J BIOL CHEM, V261, P8953; Cockayne A, 1998, INFECT IMMUN, V66, P3767, DOI 10.1128/IAI.66.8.3767-3774.1998; FISCHER W, 1994, MED MICROBIOL IMMUN, V183, P61, DOI 10.1007/BF00277157; GAN K, 1993, J BIOL CHEM, V268, P16544; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Lee SJ, 2007, TRENDS MICROBIOL, V15, P389, DOI 10.1016/j.tim.2007.08.002; Li SL, 1998, J BIOCHEM-TOKYO, V124, P332, DOI 10.1093/oxfordjournals.jbchem.a022116; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Oku Y, 2009, J BACTERIOL, V191, P141, DOI 10.1128/JB.01221-08; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; TOKUNAGA M, 1982, P NATL ACAD SCI-BIOL, V79, P2255, DOI 10.1073/pnas.79.7.2255; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103	31	115	117	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8406	8411		10.1074/jbc.M809618200	http://dx.doi.org/10.1074/jbc.M809618200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19139093	Green Published, hybrid			2022-12-27	WOS:000264397800024
J	Kim, SH; Shi, YL; Hanson, KA; Williams, LM; Sakasai, R; Bowler, MJ; Tibbetts, RS				Kim, Sang Hwa; Shi, Yuling; Hanson, Keith A.; Williams, Leah M.; Sakasai, Ryo; Bowler, Michael J.; Tibbetts, Randal S.			Potentiation of Amyotrophic Lateral Sclerosis (ALS)-associated TDP-43 Aggregation by the Proteasome-targeting Factor, Ubiquilin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; SUPEROXIDE-DISMUTASE GENE; NUCLEAR FACTOR TDP-43; HUNTINGTONS-DISEASE; AXONAL-TRANSPORT; MOTOR-NEURONS; BINDING-PROPERTIES; RNA INTERFERENCE; PROTEIN; AUTOPHAGY	TDP-43 (43-kDa TAR DNA-binding domain protein) is a major constituent of ubiquitin-positive cytoplasmic aggregates present in neurons of patients with fronto-temporal lobular dementia and amyotrophic lateral sclerosis (ALS). The pathologic significance of TDP-43 aggregation is not known; however, dominant mutations in TDP-43 cause a subset of ALS cases, suggesting that misfolding and/or altered trafficking of TDP-43 is relevant to the disease process. Here, we show that the presenilin-binding protein ubiquilin 1 (UBQLN) plays a role in TDP-43 aggregation. TDP-43 interacted with UBQLN both in yeast and in vitro, and the carboxyl-terminal ubiquitin-associated domain of UBQLN was both necessary and sufficient for binding to polyubiquitylated forms of TDP-43. Overexpression of UBQLN recruited TDP-43 to detergent-resistant cytoplasmic aggregates that colocalized with the autophagosomal marker, LC3. UBQLN-dependent aggregation required the UBQLN UBA domain, was mediated by non-overlapping regions of TDP-43, and was abrogated by a mutation in UBQLN previously linked to Alzheimer disease. Four ALS-associated alleles of TDP-43 also coaggregated with UBQLN, and the extent of aggregation correlated with in vitro UBQLN binding affinity. Our findings suggest that UBQLN is a polyubiquitin-TDP-43 cochaperone that mediates the autophagosomal delivery and/or proteasome targeting of TDP-43 aggregates.	[Kim, Sang Hwa; Shi, Yuling; Hanson, Keith A.; Williams, Leah M.; Sakasai, Ryo; Bowler, Michael J.; Tibbetts, Randal S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297; Sakasai, Ryo/0000-0002-4495-5437	National Institutes of Health [CA124722]; American Cancer Society and a Shaw Scientist Award; Greater Milwaukee Foundation; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society and a Shaw Scientist Award(American Cancer Society); Greater Milwaukee Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA124722. This work was also supported by the American Cancer Society and a Shaw Scientist Award (to R. S. T.) from the Greater Milwaukee Foundation.	Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Borchelt DR, 1998, NEUROBIOL DIS, V5, P27, DOI 10.1006/nbdi.1998.0178; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Conklin D, 2000, GENE, V249, P91, DOI 10.1016/S0378-1119(00)00122-0; DAOUD H, 2009, J MED GENET IN PRESS; Davidson JD, 2000, HUM MOL GENET, V9, P2305, DOI 10.1093/oxfordjournals.hmg.a018922; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Feng PH, 2004, MOL CELL BIOL, V24, P3938, DOI 10.1128/MCB.24.9.3938-3948.2004; Ford DL, 2007, BIOCHEMISTRY-US, V46, P8827, DOI 10.1021/bi700604q; Ford DL, 2006, BIOCHEM J, V399, P397, DOI 10.1042/BJ20060441; Forman MS, 2007, CURR OPIN NEUROBIOL, V17, P548, DOI 10.1016/j.conb.2007.08.005; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Ganguly A, 2008, HUM MOL GENET, V17, P293, DOI 10.1093/hmg/ddm305; Gross GG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002495; Heir R, 2006, EMBO REP, V7, P1252, DOI 10.1038/sj.embor.7400823; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Ikeda K, 2004, NEUROPATHOLOGY, V24, P117, DOI 10.1111/j.1440-1789.2003.00537.x; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KATAOKA T, 1994, J IMMUNOL, V153, P3938; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Massey LK, 2005, BIOCHEM J, V391, P513, DOI 10.1042/BJ20050491; Massey LK, 2004, J ALZHEIMERS DIS, V6, P79; Mitsumoto H., 1998, AMYOTROPHIC LATERAL; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rubinsztein DC, 2007, NEURON, V54, P854, DOI 10.1016/j.neuron.2007.06.005; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sasaki S, 2005, ACTA NEUROPATHOL, V110, P48, DOI 10.1007/s00401-005-1021-9; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Slifer MA, 2005, NEW ENGL J MED, V352, P2752; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Towne C, 2008, MOL THER, V16, P1018, DOI 10.1038/mt.2008.73; Velde CV, 2004, NEUROMOL MED, V5, P193, DOI 10.1385/NMM:5:3:193; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wang H, 2006, HUM MOL GENET, V15, P1025, DOI 10.1093/hmg/ddl017; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Winslow AR, 2008, BBA-MOL BASIS DIS, V1782, P723, DOI 10.1016/j.bbadis.2008.06.010; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065	67	95	99	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8083	8092		10.1074/jbc.M808064200	http://dx.doi.org/10.1074/jbc.M808064200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19112176	Green Published, hybrid			2022-12-27	WOS:000264195600071
J	Kuzuhara, T; Kise, D; Yoshida, H; Horita, T; Murazaki, Y; Nishimura, A; Echigo, N; Utsunomiya, H; Tsuge, H				Kuzuhara, Takashi; Kise, Daisuke; Yoshida, Hiroko; Horita, Takahiro; Murazaki, Yoshimi; Nishimura, Akie; Echigo, Noriko; Utsunomiya, Hiroko; Tsuge, Hideaki			Structural Basis of the Influenza A Virus RNA Polymerase PB2 RNA-binding Domain Containing the Pathogenicity-determinant Lysine 627 Residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID; SUBUNIT; NUCLEOPROTEIN; OSELTAMIVIR; PROMOTER; PROGRAM; PROTEIN	Because the influenza A virus has an RNA genome, its RNA-dependent RNA polymerase, comprising the PA, PB1, and PB2 subunits, is essential for viral transcription and replication. The binding of RNAprimers/promoters to the polymerases is an initiation step in viral transcription. In our current study, we reveal the 2.7 A tertiary structure of the C-terminal RNA-binding domain of PB2 by x-ray crystallography. This domain incorporates lysine 627 of PB2, and this residue is associated with the high pathogenicity and host range restriction of influenza A virus. We found from our current analyses that this lysine is located in a unique "phi"-shaped structure consisting of a helix and an encircled loop within the PB2 domain. By electrostatic analysis, we identified a highly basic groove along with this phi loop and found that lysine 627 is located in the phi loop. A PB2 domain mutant in which glutamic acid is substituted at position 627 shows significantly lower RNA binding activity. This is the first report to show a relationship between RNA binding activity and the pathogenicity-determinant lysine 627. Using the Matras program for protein three-dimensional structural comparisons, we further found that the helix bundles in the PB2 domain are similar to that of activator 1, the 40-kDa subunit of DNA replication clamp loader (replication factor C), which is also an RNA-binding protein. This suggests a functional and structural relationship between the RNA-binding mechanisms underlying both influenza A viral transcription and cellular DNA replication. Our present results thus provide important new information for developing novel drugs that target the primer/promoter RNA binding of viral RNA polymerases.	[Kuzuhara, Takashi; Kise, Daisuke; Yoshida, Hiroko; Horita, Takahiro; Murazaki, Yoshimi; Nishimura, Akie; Echigo, Noriko] Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima 7708514, Japan; [Utsunomiya, Hiroko; Tsuge, Hideaki] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima 7708514, Japan	Tokushima Bunri University; Tokushima Bunri University	Kuzuhara, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Yamashiro Cho, Tokushima 7708514, Japan.	kuzuhara@ph.bunri-u.ac.jp; tsuge@tokushima.bunri-u.ac.jp	Tsuge, Hideaki/ABF-6424-2021	Kuzuhara, Takashi/0000-0003-0565-6060; Tsuge, Hideaki/0000-0003-0166-9163	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Crescenzo-Chaigne B, 2002, VIROLOGY, V303, P240, DOI 10.1006/viro.2002.1637; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Honda A, 1997, BIOL CHEM, V378, P483; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Izumi Y, 2007, NEUROSCI LETT, V426, P54, DOI 10.1016/j.neulet.2007.08.054; Jung TE, 2006, J GEN VIROL, V87, P679, DOI 10.1099/vir.0.81453-0; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Morse SS, 2007, NAT MED, V13, P681, DOI 10.1038/nm1597; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reece PA, 2007, J MED VIROL, V79, P1577, DOI 10.1002/jmv.20951; SHI LC, 1995, VIROLOGY, V208, P38, DOI 10.1006/viro.1995.1127; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	33	77	83	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6855	6860		10.1074/jbc.C800224200	http://dx.doi.org/10.1074/jbc.C800224200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19144639	hybrid, Green Published			2022-12-27	WOS:000263919000032
J	Ortel, I; Keller, U				Ortel, Ingo; Keller, Ullrich			Combinatorial Assembly of Simple and Complex D-Lysergic Acid Alkaloid Peptide Classes in the Ergot Fungus Claviceps purpurea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-CLUSTER; ADENYLATION DOMAINS; CONDENSATION DOMAIN; LYS2 GENE; SYNTHETASE; BIOSYNTHESIS; ENDOPHYTE; SEQUENCE; EPIMERIZATION; ERGOVALINE	The ergot fungus Claviceps purpurea produces both ergopeptines and simple D-lysergic acid alkylamides. In the ergopeptines, such as ergotamine, D-lysergic acid is linked to a bicyclic tripeptide in amide-like fashion, whereas in the D-lysergylalkanolamides it is linked to an amino alcohol derived from alanine. We show here that these compound classes are synthesized by a set of three non-ribosomal lysergyl peptide synthetases (LPSs), which interact in a combinatorial fashion for synthesis of the relevant product. The trimodular LPS1 assembles with LPS2, the D-lysergic acid recruiting module, to synthesize the D-lysergyltripeptide precursors of ergopeptines from D-lysergic acid and the three amino acids of the peptide chain. Alternatively, LPS2 can assemble with a distinct monomodular non-ribosomal peptide synthetase (NRPS) subunit (ergometrine synthetase) to synthesize the D-lysergic acid alkanolamide ergometrine from D-lysergic acid and alanine. The synthesis proceeds via covalently bound D-lysergyl alanine and release of dipeptide as alcohol with consumption of NADPH. Enzymatic and immunochemical analyses showed that ergometrine synthetase is most probably the enzyme LPS3 whose gene had been identified previously as part of the ergot alkaloid biosynthesis gene cluster in C. purpurea. Inspections of all LPS sequences showed no recognizable peptide linkers for their protein-protein interactions as in NRPS subunits of bacteria. Instead, they all carry conserved N-terminal domains (C0-domains) with similarity to the C-terminal halves of NRPS condensation domains pointing to an alternative mechanism of subunit-subunit interactions in fungal NRPS systems. Phylogenetic analysis of LPS modules and the C0-domains suggests that these enzyme systems most probably evolved by module duplications and rearrangements from a bimodular ancestor.	[Ortel, Ingo; Keller, Ullrich] Tech Univ Berlin, Inst Chem, Arbeitsgrp Biochem & Mol Biol, D-10587 Berlin, Germany	Technical University of Berlin	Keller, U (corresponding author), Tech Univ Berlin, Inst Chem, Arbeitsgrp Biochem & Mol Biol, Franklinstr 29, D-10587 Berlin, Germany.	ullrich.keller@tu-berlin.de			Deutsche Forschungsgemeinschaft SPP 1152 [Ke 452/11-4]	Deutsche Forschungsgemeinschaft SPP 1152(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SPP 1152 ( Grant Ke 452/11-4).	AGURELL S, 1966, ACTA PHARM SUEC, V3, P71; BASMADJIAN GP, 1969, CHEM COMMUN, V1, P418; Berde B., 1978, INTRO PHARM ERGOT AL, P1, DOI 10.1007/978-3-642-66775-6_1; Bergendahl V, 2002, EUR J BIOCHEM, V269, P620, DOI 10.1046/j.0014-2956.2001.02691.x; Burkhalter A, 1998, BASIC CLIN PHARM, P261; Casqueiro J, 1998, MOL GEN GENET, V259, P549, DOI 10.1007/s004380050847; CASTAGNO.N, 1970, BIOCHEM J, V117, P451, DOI 10.1042/bj1170451; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Correia T, 2003, CHEM BIOL, V10, P1281, DOI 10.1016/j.chembiol.2003.11.013; Damrongkool P, 2005, DNA SEQUENCE, V16, P379, DOI 10.1080/10425170500273005; De Costa C, 2002, LANCET, V359, P1768, DOI 10.1016/S0140-6736(02)08658-0; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Fedorov A, 2002, P NATL ACAD SCI USA, V99, P16128, DOI 10.1073/pnas.242624899; Fleetwood DJ, 2007, APPL ENVIRON MICROB, V73, P2571, DOI 10.1128/AEM.00257-07; Flieger M, 1997, FOLIA MICROBIOL, V42, P3, DOI 10.1007/BF02898641; Gaitatzis N, 2001, P NATL ACAD SCI USA, V98, P11136, DOI 10.1073/pnas.201167098; Gokhale RS, 2000, CURR OPIN CHEM BIOL, V4, P22, DOI 10.1016/S1367-5931(99)00046-0; Haarmann T, 2005, PHYTOCHEMISTRY, V66, P1312, DOI 10.1016/j.phytochem.2005.04.011; Haarmann T, 2006, CHEMBIOCHEM, V7, P645, DOI 10.1002/cbic.200500487; Hahn M, 2004, P NATL ACAD SCI USA, V101, P15585, DOI 10.1073/pnas.0404932101; Hillson NJ, 2004, BIOCHEMISTRY-US, V43, P11344, DOI 10.1021/bi0489199; HOFMANN A, 1964, MUTTERKORNALKALOIDE; Hornbogen T, 2005, MYCOLOGY S, V22, P449; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; KELLER U, 1988, BIOCHEMISTRY-US, V27, P6164, DOI 10.1021/bi00416a051; KELLER U, 1982, APPL ENVIRON MICROB, V46, P580; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Klotz JL, 2006, J ANIM SCI, V84, P3167, DOI 10.2527/jas.2006-038; Kobel H, 1986, BIOTECHNOLOGY, P569, DOI Weinheim; Linne U, 2000, BIOCHEMISTRY-US, V39, P10439, DOI 10.1021/bi000768w; MORRIS ME, 1991, GENE, V98, P141, DOI 10.1016/0378-1119(91)90117-T; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Panaccione DG, 2003, J AGR FOOD CHEM, V51, P6429, DOI 10.1021/jf0346859; Panaccione DG, 2001, P NATL ACAD SCI USA, V98, P12820, DOI 10.1073/pnas.221198698; POSPIECH A, 1995, MICROBIOL-SGM, V141, P1793, DOI 10.1099/13500872-141-8-1793; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Riederer B, 1996, J BIOL CHEM, V271, P27524, DOI 10.1074/jbc.271.44.27524; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Stadler P. A., 1984, NATURAL PRODUCTS DRU, P463; STADLER PA, 1982, PLANTA MED, V46, P131, DOI 10.1055/s-2007-970038; Tanaka A, 2005, MOL MICROBIOL, V57, P1036, DOI 10.1111/j.1365-2958.2005.04747.x; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tudzynski P, 1999, MOL GEN GENET, V261, P133, DOI 10.1007/s004380050950; Walzel B, 1997, CHEM BIOL, V4, P223, DOI 10.1016/S1074-5521(97)90292-1; WALZEL B, 1997, THESIS TU BERLIN GER	47	41	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6650	6660		10.1074/jbc.M807168200	http://dx.doi.org/10.1074/jbc.M807168200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139103	hybrid, Green Published			2022-12-27	WOS:000263919000009
J	Uesugi, K; Oinuma, I; Katoh, H; Negishi, M				Uesugi, Kanami; Oinuma, Izumi; Katoh, Hironori; Negishi, Manabu			Different Requirement for Rnd GTPases of R-Ras GAP Activity of Plexin-C1 and Plexin-D1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-FAMILY; ACTIVATING PROTEIN; AXONAL REPULSION; RECEPTOR; GROWTH; NEURONS; CELLS; EFFECTOR; COLLAPSE; ADHESION	Plexins, comprising Plexin-A, -B, -C, and -D subfamilies, are receptors for semaphorins governing cell adhesion, migration, and axon guidance. Among plexin subfamilies, Plexin-A1 and Plexin-B1 have been shown to function as an R-Ras GAP, inducing repulsive responses, and the expression of R-Ras GAP activity requires the binding of Rnd1, a member of Rnd subfamily of Rho GTPases. However, signaling pathways of Plexin-D1 and Plexin-C1 still remain obscure. Here, we found that Plexin-D1 displayed R-Ras GAP activity and inhibited migration of COS-7 cells, and these actions required Rnd2, another Rnd subfamily GTPase. Rnd2 bound to Plexin-D1 in cortical neurons, and Sema3E/Plexin-D1-induced inhibition of axon outgrowth of cortical neurons required Rnd2 and down-regulation of R-Ras activity. On the other hand, Plexin-C1 displayed R-Ras GAP activity and inhibited cell migration of COS-7 cells without Rnd proteins. Therefore, R-Ras GAP activity is a common function of plexin subfamilies but the regulation of R-Ras GAP activity of plexins by Rnd proteins is different among plexin subfamilies.	[Uesugi, Kanami; Oinuma, Izumi; Katoh, Hironori; Negishi, Manabu] Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Negishi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan.	mnegishi@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.	Aoki J, 2000, BIOCHEM BIOPH RES CO, V278, P604, DOI 10.1006/bbrc.2000.3842; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Christensen CRL, 1998, CANCER RES, V58, P1238; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Decourt B, 2005, DEV BRAIN RES, V159, P36, DOI 10.1016/j.devbrainres.2005.06.013; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Ito Y, 2006, EMBO REP, V7, P704, DOI 10.1038/sj.embor.7400737; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kumanogoh A, 2003, J CELL SCI, V116, P3463, DOI 10.1242/jcs.00674; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Nakamura K, 2006, NEUROSCI RES, V54, P149, DOI 10.1016/j.neures.2005.10.008; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Nishi M, 1999, MOL BRAIN RES, V67, P74, DOI 10.1016/S0169-328X(99)00039-X; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Oinuma I, 2006, J CELL BIOL, V173, P601, DOI 10.1083/jcb.200508204; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tanaka H, 2006, J BIOL CHEM, V281, P10355, DOI 10.1074/jbc.M511314200; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Van Der Zwaag B, 2002, DEV DYNAM, V225, P336, DOI 10.1002/dvdy.10159; Walzer T, 2005, J IMMUNOL, V174, P51, DOI 10.4049/jimmunol.174.1.51; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002	38	70	70	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6743	6751		10.1074/jbc.M805213200	http://dx.doi.org/10.1074/jbc.M805213200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136556	Green Published, hybrid			2022-12-27	WOS:000263919000019
J	Sherrer, SM; Brown, JA; Pack, LR; Jasti, VP; Fowler, JD; Basu, AK; Suo, ZC				Sherrer, Shanen M.; Brown, Jessica A.; Pack, Lindsey R.; Jasti, Vijay P.; Fowler, Jason D.; Basu, Ashis K.; Suo, Zucai			Mechanistic Studies of the Bypass of a Bulky Single-base Lesion Catalyzed by a Y-family DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYN THYMINE DIMER; ERROR-FREE BYPASS; ABASIC LESION; STEADY-STATE; CRYSTAL-STRUCTURE; ADDUCT STRUCTURE; FIDELITY; DPO4; REPLICATION; 1-NITROPYRENE	1-Nitropyrene, the most abundant nitro polycyclic aromatic hydrocarbon in diesel emissions, has been found to react with DNA to form predominantly N-(deoxyguanosin-8-yl)-1-aminopyrene (dG(AP)). This bulky adduct has been shown to induce genetic mutations, which may implicate Y-family DNA polymerases in its bypass in vivo. To establish a kinetic mechanism for the bypass of such a prototype single-base lesion, we employed pre-steady-state kinetic methods to investigate individual nucleotide incorporations upstream, opposite, and downstream from a site-specifically placed dGAP lesion catalyzed by Sulfolobus solfataricus DNA polymerase IV (Dpo4), a model Y-family DNA polymerase. Dpo4 was able to bypassd G(AP) but paused strongly at two sites: opposite the lesion and immediately downstream from the lesion. Both nucleotide incorporation efficiency and fidelity decreased significantly at the pause sites, especially during extension of the bypass product. Interestingly, a 4-fold tighter binding affinity of damaged DNA to Dpo4 promoted catalysis through putative interactions between the active site residues of Dpo4 and 1-aminopyrene moiety at the first pause site. In the presence of a DNA trap, the kinetics of nucleotide incorporation at these sites was biphasic in which a small, fast phase preceded a larger, slow phase. In contrast, only a large, fast phase was observed during nucleotide incorporation at non-pause sites. Our kinetic studies support a general kinetic mechanism for lesion bypass catalyzed by numerous DNA polymerases.	[Sherrer, Shanen M.; Brown, Jessica A.; Pack, Lindsey R.; Fowler, Jason D.; Suo, Zucai] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Sherrer, Shanen M.; Brown, Jessica A.; Fowler, Jason D.; Suo, Zucai] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Suo, Zucai] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Suo, Zucai] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Jasti, Vijay P.; Basu, Ashis K.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Suo, Zucai] Ohio State Univ, Ohio State Biophys Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Connecticut; University System of Ohio; Ohio State University	Suo, ZC (corresponding author), 740 Biol Sci,484 West 12th Ave, Columbus, OH 43210 USA.	suo.3@osu.edu	Brown, Jessica/E-2172-2017	Sherrer, Shanen/0000-0002-3269-3134	National Science Foundation Career Award [MCB-0447889]; National Institutes of Health [ES-09127]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009127, R56ES009127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008512] Funding Source: NIH RePORTER	National Science Foundation Career Award(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Science Foundation Career Award Grant MCB-0447889 (to Z.S.). This work was also supported by National Institutes of Health Grant ES-09127 (to A.K.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Bauer J, 2007, P NATL ACAD SCI USA, V104, P14905, DOI 10.1073/pnas.0700717104; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Brown JA, 2008, NUCLEIC ACIDS RES, V36, P3867, DOI 10.1093/nar/gkn309; Broyde S, 2008, CHEM RES TOXICOL, V21, P45, DOI 10.1021/tx700193x; Chang KL, 1996, CHINESE J PHYS, V34, P1; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Choi JY, 2004, J BIOL CHEM, V279, P19217, DOI 10.1074/jbc.M313759200; Duvauchelle JB, 2002, NUCLEIC ACIDS RES, V30, P2061, DOI 10.1093/nar/30.9.2061; Einolf HJ, 2001, J BIOL CHEM, V276, P3764, DOI 10.1074/jbc.M006696200; ELBAYOUMY K, 1984, CARCINOGENESIS, V5, P1449, DOI 10.1093/carcin/5.11.1449; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2116, DOI 10.1021/bi035746z; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Fiala KA, 2008, NUCLEIC ACIDS RES, V36, P1990, DOI 10.1093/nar/gkn004; Fiala KA, 2007, J BIOL CHEM, V282, P8199, DOI 10.1074/jbc.M610719200; Fiala KA, 2007, J BIOL CHEM, V282, P8188, DOI 10.1074/jbc.M610718200; Fiala KA, 2007, J MOL BIOL, V365, P590, DOI 10.1016/j.jmb.2006.10.008; Fowler JD, 2006, CHEM REV, V106, P2092, DOI 10.1021/cr040445w; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Gu ZT, 1999, BIOCHEMISTRY-US, V38, P10843, DOI 10.1021/bi9912138; Hatanaka N, 2001, MUTAT RES-GEN TOX EN, V497, P223, DOI 10.1016/S1383-5718(01)00254-6; HIROSE M, 1984, CANCER RES, V44, P1158; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P12359, DOI 10.1073/pnas.0504380102; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kokoska RJ, 2002, J BIOL CHEM, V277, P19633, DOI 10.1074/jbc.M202021200; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Liu YY, 2005, BIOCHEM J, V385, P519, DOI 10.1042/BJ20041151; MALIA SA, 1995, BIOCHEMISTRY-US, V34, P96, DOI 10.1021/bi00001a012; Malia SA, 1996, BIOCHEMISTRY-US, V35, P4568, DOI 10.1021/bi9525132; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Miller H, 1997, BIOCHEMISTRY-US, V36, P15336, DOI 10.1021/bi971927n; Mitchelmore CL, 1998, BIOMARKERS, V3, P21, DOI 10.1080/135475098231345; Mizukami S, 2006, BIOCHEMISTRY-US, V45, P2772, DOI 10.1021/bi051961z; Nolan SJ, 1996, CARCINOGENESIS, V17, P133, DOI 10.1093/carcin/17.1.133; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Pohjola SK, 2004, POLYCYCL AROMAT COMP, V24, P451, DOI 10.1080/10406630490471465; Pohjola SK, 2003, MUTAGENESIS, V18, P429, DOI 10.1093/mutage/geg021; RAFII F, 1991, APPL ENVIRON MICROB, V57, P962, DOI 10.1128/AEM.57.4.962-968.1991; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Sabbioni G, 2002, BIOMARKERS, V7, P347, DOI 10.1080/13547500210147253; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Suo ZC, 1999, BIOCHEMISTRY-US, V38, P715, DOI 10.1021/bi981854n; Wang LH, 2006, NUCLEIC ACIDS RES, V34, P785, DOI 10.1093/nar/gkj479; Watt DL, 2007, CHEM RES TOXICOL, V20, P1658, DOI 10.1021/tx700131e; Wong JH, 2008, J MOL BIOL, V379, P317, DOI 10.1016/j.jmb.2008.03.038; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; WOOSTER R, 1994, NAT GENET, V6, P152, DOI 10.1038/ng0294-152; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zang H, 2006, CHEM RES TOXICOL, V19, P859, DOI 10.1021/tx060056s; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4147, DOI 10.1093/nar/28.21.4147; Zou Y, 2003, BIOCHEMISTRY-US, V42, P12654, DOI 10.1021/bi034446e	60	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6379	6388		10.1074/jbc.M808161200	http://dx.doi.org/10.1074/jbc.M808161200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124465	hybrid, Green Published			2022-12-27	WOS:000263742700041
J	Henriques, BJ; Rodrigues, JV; Olsen, RK; Bross, P; Gomes, CM				Henriques, Barbara J.; Rodrigues, Joao V.; Olsen, Rikke K.; Bross, Peter; Gomes, Claudio M.			Role of Flavinylation in a Mild Variant of Multiple Acyl-CoA Dehydrogenation Deficiency A MOLECULAR RATIONALE FOR THE EFFECTS OF RIBOFLAVIN SUPPLEMENTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER FLAVOPROTEIN; COENZYME-A DEHYDROGENASE; FATTY-ACID OXIDATION; TRANSFERRING-FLAVOPROTEIN; BETA-OXIDATION; GLUTARIC ACIDURIA; RESPIRATORY-CHAIN; FAD; MUTATIONS; MITOCHONDRIA	Mutations in the genes encoding the alpha-subunit and beta-subunit of the mitochondrial electron transfer flavoprotein (ETF) and the electron transfer flavoprotein: ubiquinone oxidoreductase ( ETF: QO) cause multiple acyl-CoA dehydrogenation deficiency ( MADD), a disorder of fatty acid and amino acid metabolism. Point mutations in ETF, which may compromise folding, and/or activity, are associated with both mild and severe forms of MADD. Here we report the investigation on the conformational and stability properties of the disease-causing variant ETF beta-D128N, and our findings on the effect of flavinylation in modulating protein conformational stability and activity. A combination of biochemical and biophysical methods including circular dichroism, visible absorption, flavin, and tryptophan fluorescence emission allowed the analysis of structural changes and of the FAD moiety. The ETF beta-D128N variant retains the overall fold of the wild type, but under stress conditions its flavin becomes less tightly bound. Flavinylation is shown to improve the conformational stability and biological activity of a destabilized D128N variant protein. Moreover, the presence of flavin prevented proteolytic digestion by avoiding protein destabilization. A patient homozygous for the ETF beta-D128N mutation developed severe disease symptoms in association with a viral infection and fever. In agreement, our results suggest that heat inactivation of the mutant may be more relevant at temperatures above 37 degrees C. To mimic a situation of fever in vitro, the flavinylation status was tested at 39 degrees C. FAD exerts the effect of a pharmacological chaperone, improving ETF conformation, and yielding a more stable and active enzyme. Our results provide a structural and functional framework that could help to elucidate the role that an increased cellular FAD content obtained from riboflavin supplementation may play in the molecular pathogenesis of not only MADD, but genetic disorders of flavoproteins in general.	[Henriques, Barbara J.; Rodrigues, Joao V.; Gomes, Claudio M.] UNL, ITQB, P-2780756 Oeiras, Portugal; [Olsen, Rikke K.; Bross, Peter] Aarhus Univ Hosp, Res Unit Mol Med, DK-8200 Skejby, Arhus N, Denmark	Universidade Nova de Lisboa; Aarhus University	Gomes, CM (corresponding author), UNL, ITQB, Av Republ 127, P-2780756 Oeiras, Portugal.	gomes@itqb.unl.pt	Rodrigues, Joao V/B-4877-2016; Rodrigues, João/GVU-7735-2022; Gomes, Cláudio M./A-8152-2008; Bross, Peter/B-7219-2013; Henriques, Bárbara J/A-1814-2016; Rodrigues, João/B-4235-2008	Rodrigues, Joao V/0000-0002-5605-656X; Gomes, Cláudio M./0000-0003-4662-6933; Bross, Peter/0000-0001-9526-8525; Henriques, Bárbara J/0000-0002-1724-9545; Rodrigues, João/0000-0002-5605-656X; Olsen, Rikke/0000-0003-3470-5589				AMENDT BA, 1986, J CLIN INVEST, V78, P205, DOI 10.1172/JCI112553; Ames BN, 2002, AM J CLIN NUTR, V75, P616, DOI 10.1093/ajcn/75.4.616; ANTOZZI C, 1994, NEUROLOGY, V44, P2153, DOI 10.1212/WNL.44.11.2153; Beresford MW, 2006, NEUROMUSCULAR DISORD, V16, P269, DOI 10.1016/j.nmd.2006.01.001; BRANDT NJ, 1979, J PEDIATR-US, V94, P669, DOI 10.1016/S0022-3476(79)80048-7; BROSS P, 1995, J BIOL CHEM, V270, P10284, DOI 10.1074/jbc.270.17.10284; DURAN M, 1992, PEDIATR RES, V31, P39, DOI 10.1203/00006450-199201000-00007; Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Frerman F. E., 2001, METABOLIC MOL BASES, P2357, DOI DOI 10.1036/OMMBID.131; Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054; Gianazza E, 2006, ELECTROPHORESIS, V27, P1182, DOI 10.1002/elps.200500687; Goodman SI, 2002, MOL GENET METAB, V77, P86, DOI 10.1016/S1096-7192(02)00138-5; GREGERSEN N, 1982, PEDIATR RES, V16, P861, DOI 10.1203/00006450-198210000-00012; Gregersen N, 2004, EUR J BIOCHEM, V271, P470, DOI 10.1046/j.1432-1033.2003.03949.x; GREGERSEN N, 1985, J INHERIT METAB DIS, V8, P65, DOI 10.1007/BF01800662; Hansen J, 2005, BIOCHEM BIOPH RES CO, V333, P1160, DOI 10.1016/j.bbrc.2005.06.024; HERRICK KR, 1994, J BIOL CHEM, V269, P32239; KMOCH S, 1995, J INHERIT METAB DIS, V18, P227, DOI 10.1007/BF00711774; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lakshmi AV, 1998, INDIAN J MED RES, V108, P182; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Lundemose JB, 1997, J CLIN PATHOL-MOL PA, V50, P212, DOI 10.1136/mp.50.4.212; Manore MM, 2000, AM J CLIN NUTR, V72, p598S, DOI 10.1093/ajcn/72.2.598S; MCKEAN MC, 1983, J BIOL CHEM, V258, P1866; NAGAO M, 1992, J BIOL CHEM, V267, P17925; Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135; Olsen RKJ, 2003, HUM MUTAT, V22, P12, DOI 10.1002/humu.10226; Pallotta ML, 1998, FEBS LETT, V428, P245, DOI 10.1016/S0014-5793(98)00544-4; Powers HJ, 2003, AM J CLIN NUTR, V77, P1352; RHEAD W, 1993, PEDIATR RES, V33, P129, DOI 10.1203/00006450-199302000-00008; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Royer C A, 1995, Methods Mol Biol, V40, P65; RUZICKA FJ, 1977, J BIOL CHEM, V252, P8440; SAIJO T, 1995, J BIOL CHEM, V270, P1899, DOI 10.1074/jbc.270.4.1899; Salazar D, 1997, J BIOL CHEM, V272, P26425, DOI 10.1074/jbc.272.42.26425; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Sato K, 1996, J BIOCHEM-TOKYO, V120, P276; Sato K, 1997, J BIOCHEM, V121, P477; Schiff M, 2006, MOL GENET METAB, V88, P153, DOI 10.1016/j.ymgme.2006.01.009; Shirley B A, 1995, Methods Mol Biol, V40, P177; Vergani L, 1999, BRAIN, V122, P2401, DOI 10.1093/brain/122.12.2401; WINDMUELLER HG, 1964, AM J CLIN NUTR, V15, P73, DOI 10.1093/ajcn/15.2.73; Yotsumoto Y, 2008, MOL GENET METAB, V94, P61, DOI 10.1016/j.ymgme.2008.01.002	44	62	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4222	4229		10.1074/jbc.M805719200	http://dx.doi.org/10.1074/jbc.M805719200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088074	hybrid			2022-12-27	WOS:000263134400019
J	Paugh, BS; Bryan, L; Paugh, SW; Wilczynska, KM; Alvarez, SM; Singh, SK; Kapitonov, D; Rokita, H; Wright, S; Griswold-Prenner, I; Milstien, S; Spiegel, S; Kordula, T				Paugh, Barbara S.; Bryan, Lauren; Paugh, Steven W.; Wilczynska, Katarzyna M.; Alvarez, Silvina M.; Singh, Sandeep K.; Kapitonov, Dmitri; Rokita, Hanna; Wright, Sarah; Griswold-Prenner, Irene; Milstien, Sheldon; Spiegel, Sarah; Kordula, Tomasz			Interleukin-1 Regulates the Expression of Sphingosine Kinase 1 in Glioblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ASTROCYTE-SPECIFIC EXPRESSION; GENE-EXPRESSION; GROWTH-FACTOR; ALPHA(1)-ANTICHYMOTRYPSIN GENE; TUMOR INVASIVENESS; ACTIVATION; INHIBITOR; INVASION; LINE	Chronic inflammation and inflammatory cytokines have recently been implicated in the development and progression of various types of cancer. In the brain, neuroinflammatory cytokines affect the growth and differentiation of both normal and malignant glial cells, with interleukin 1 (IL-1) shown to be secreted by the majority of glioblastoma cells. Recently, elevated levels of sphingosine kinase 1 (SphK1), but not SphK2, were correlated with a shorter survival prognosis for patients with glioblastoma multiforme. SphK1 is a lipid kinase that produces the pro-growth, anti-apoptotic sphingosine 1-phosphate, which can induce invasion of glioblastoma cells. Here, we show that the expression of IL-1 correlates with the expression of SphK1 in glioblastoma cells, and neutralizing anti-IL-1 antibodies inhibit both the growth and invasion of glioblastoma cells. Furthermore, IL-1 up-regulates SphK1 mRNA levels, protein expression, and activity in both primary human astrocytes and various glioblastoma cell lines; however, it does not affect SphK2 expression. The IL-1-induced SphK1 up-regulation can be blocked by the inhibition of JNK, the overexpression of the dominant-negative c-Jun(TAM67), and the down-regulation of c-Jun expression by small interference RNA. Activation of SphK1 expression by IL-1 occurs on the level of transcription and is mediated via a novel AP-1 element located within the first intron of the sphk1 gene. In summary, our results suggest that SphK1 expression is transcriptionally regulated by IL-1 in glioblastoma cells, and this pathway may be important in regulating survival and invasiveness of glioblastoma cells.	[Paugh, Barbara S.; Bryan, Lauren; Paugh, Steven W.; Wilczynska, Katarzyna M.; Alvarez, Silvina M.; Singh, Sandeep K.; Kapitonov, Dmitri; Spiegel, Sarah; Kordula, Tomasz] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Paugh, Barbara S.; Bryan, Lauren; Paugh, Steven W.; Wilczynska, Katarzyna M.; Alvarez, Silvina M.; Singh, Sandeep K.; Kapitonov, Dmitri; Spiegel, Sarah; Kordula, Tomasz] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Milstien, Sheldon] NIMH, Bethesda, MD 20892 USA; [Rokita, Hanna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Wright, Sarah; Griswold-Prenner, Irene] Elan Pharmaceut, San Francisco, CA 94080 USA	Virginia Commonwealth University; Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Jagiellonian University	Kordula, T (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	tkordula@vcu.edu	Alvarez, Silvina Monica/GOE-5780-2022; Paugh, Barbara/B-3625-2009; Paugh, Steven/A-7739-2008	Paugh, Steven/0000-0001-5697-9228; Rokita, Hanna/0000-0003-2675-2393; Kapitonov, Dmitri/0000-0001-9177-5239; Wright, Sarah/0000-0002-3156-3792; Alvarez, Silvina/0000-0001-7522-7208	National Institutes of Health (NIH) [R21NS063283]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063283, F31NS060433] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R21NS063283 (to T. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apte RN, 2006, EUR J CANCER, V42, P751, DOI 10.1016/j.ejca.2006.01.010; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Bektas M, 2005, ONCOGENE, V24, P178, DOI 10.1038/sj.onc.1208019; Belda-Iniesta Cristobal, 2006, Clin Transl Oncol, V8, P635, DOI 10.1007/s12094-006-0033-9; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; CINQUE S, 1992, IMMUNOL LETT, V34, P267, DOI 10.1016/0165-2478(92)90223-B; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Deb P, 2005, NEUROL INDIA, V53, P329; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Eberhardt W, 2000, J IMMUNOL, V165, P5788, DOI 10.4049/jimmunol.165.10.5788; Edsall LC, 1999, ANAL BIOCHEM, V272, P80, DOI 10.1006/abio.1999.4157; Francy JM, 2007, BBA-GENE STRUCT EXPR, V1769, P253, DOI 10.1016/j.bbaexp.2007.03.005; French KJ, 2003, CANCER RES, V63, P5962; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; GIULIAN D, 1988, J NEUROSCI, V8, P709; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; Gondi CS, 2004, NEURON GLIA BIOL, V1, P165, DOI 10.1017/S1740925X04000237; Gopalan S, 2005, J NEUROCHEM, V94, P763, DOI 10.1111/j.1471-4159.2005.03204.x; Gopalan SM, 2006, J BIOL CHEM, V281, P13126, DOI 10.1074/jbc.M601194200; Gopalan SM, 2006, J BIOL CHEM, V281, P1956, DOI 10.1074/jbc.M510935200; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hill C, 2003, ADV ANAT PATHOL, V10, P212, DOI 10.1097/00125480-200307000-00004; Huwiler A, 2006, BBA-MOL CELL BIOL L, V1761, P367, DOI 10.1016/j.bbalip.2006.02.007; Imamura T, 2004, J VET MED SCI, V66, P1387, DOI 10.1292/jvms.66.1387; Imamura T, 2001, GENOMICS, V76, P117, DOI 10.1006/geno.2001.6607; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kiss DL, 2005, J NEUROCHEM, V92, P730, DOI 10.1111/j.1471-4159.2004.02900.x; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kordula T, 2000, J NEUROSCI, V20, P7510; Laerum OD, 2001, J NEURO-ONCOL, V54, P1; Lakka SS, 2005, J BIOL CHEM, V280, P21882, DOI 10.1074/jbc.M408520200; Lu T, 2007, P NATL ACAD SCI USA, V104, P4365, DOI 10.1073/pnas.0700118104; Muracciole X, 2002, INT J RADIAT ONCOL, V52, P592, DOI 10.1016/S0360-3016(01)02699-2; Murakami M, 2007, J NEUROCHEM, V102, P1585, DOI 10.1111/j.1471-4159.2007.04673.x; Nakade Y, 2003, BBA-MOL CELL BIOL L, V1635, P104, DOI 10.1016/j.bbalip.2003.11.001; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Saklatvala J, 1999, BIOCHEM SOC SYMP, P63; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; Schichor C, 2005, J NEURO-ONCOL, V73, P9, DOI 10.1007/s11060-004-3341-3; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; Sobue S, 2005, J NEUROCHEM, V95, P940, DOI 10.1111/j.1471-4159.2005.03399.x; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; TADA M, 1993, J NEURO-ONCOL, V17, P261, DOI 10.1007/BF01049981; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Van Brocklyn JR, 2003, CANCER LETT, V199, P53, DOI 10.1016/S0304-3835(03)00334-3; Van Brocklyn JR, 2002, CANCER LETT, V181, P195, DOI 10.1016/S0304-3835(02)00050-2; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wilczynska KM, 2006, J BIOL CHEM, V281, P34955, DOI 10.1074/jbc.M604616200; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200	56	75	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3408	3417		10.1074/jbc.M807170200	http://dx.doi.org/10.1074/jbc.M807170200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074142	Green Published, hybrid			2022-12-27	WOS:000262872500006
J	Summers, DW; Douglas, PM; Ren, HY; Cyr, DM				Summers, Daniel W.; Douglas, Peter M.; Ren, Hong-Yu; Cyr, Douglas M.			The Type I Hsp40 Ydj1 Utilizes a Farnesyl Moiety and Zinc Finger-like Region to Suppress Prion Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE; CO-CHAPERONE; PEPTIDE SUBSTRATE; CRYSTAL-STRUCTURE; HSP70 CHAPERONES; YEAST HSP40; PIN+ PRION; PROTEIN; DNAJ; BINDING	Type I Hsp40s are molecular chaperones that protect neurons from degeneration by modulating the aggregation state of amyloid-forming proteins. How Type I Hsp40s recognize beta-rich, amyloid-like substrates is currently unknown. Thus, we examined the mechanism for binding between the Type I Hsp40 Ydj1 and the yeast prion [RNQ(+)]. Ydj1 recognized the Gln/Asn-rich prion domain from Rnq1 specifically when it assembled into the amyloid-like [RNQ(+)] prion state. Upon deletion of YDJ1, overexpression of the Rnq1 prion domain killed yeast. Surprisingly, binding and suppression of prion domain toxicity by Ydj1 was dependent upon farnesylation of its C-terminal CAAX box and action of a zinc finger-like region. In contrast, folding of luciferase was independent of farnesylation, yet required the zinc finger-like region of Ydj1 and a conserved hydrophobic peptide-binding pocket. Type I Hsp40s contain at least three different domains that work in concert to bind different protein conformers. The combined action of a farnesyl moiety and zinc finger-like region enable Type I Hsp40s to recognize amyloid-like substrates and prevent formation of cytotoxic protein species.	[Summers, Daniel W.; Douglas, Peter M.; Ren, Hong-Yu; Cyr, Douglas M.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Cyr, DM (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	dmcyr@med.unc.edu		Cyr, Douglas/0000-0002-4928-3414; Summers, Daniel/0000-0001-7228-8849	National Institutes of Health Pre-doctoral Training [5T32GM008581-09, 5R01GM067785-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008581, R01GM067785] Funding Source: NIH RePORTER	National Institutes of Health Pre-doctoral Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Pre-doctoral Training Grant 5T32GM008581-09 (to D. W. S.) and Grant 5R01GM067785-06 (to D. M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aron R, 2007, EMBO J, V26, P3794, DOI 10.1038/sj.emboj.7601811; Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; CAPLAN AJ, 1991, J CELL BIOL, V114, P609, DOI 10.1083/jcb.114.4.609; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; Chai YH, 1999, J NEUROSCI, V19, P10338; Chapple JP, 2003, J BIOL CHEM, V278, P19087, DOI 10.1074/jbc.M212349200; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; Cyr DM, 2008, CELL, V133, P945, DOI 10.1016/j.cell.2008.05.036; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Fan CY, 2005, J BIOL CHEM, V280, P695, DOI 10.1074/jbc.M410645200; Fan CY, 2004, MOL BIOL CELL, V15, P761, DOI 10.1091/mbc.E03-03-0146; Fiala JC, 2007, ACTA NEUROPATHOL, V114, P551, DOI 10.1007/s00401-007-0284-8; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Kurahashi H, 2008, MOL CELL BIOL, V28, P3313, DOI 10.1128/MCB.01900-07; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Li JZ, 2005, BIOCHEM J, V386, P453, DOI 10.1042/BJ20041050; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Linke K, 2003, J BIOL CHEM, V278, P44457, DOI 10.1074/jbc.M307491200; Lopez N, 2003, MOL BIOL CELL, V14, P1172, DOI 10.1091/mbc.E02-09-0593; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Pylypenko O, 2008, J MOL BIOL, V377, P1334, DOI 10.1016/j.jmb.2008.01.099; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; Tkach JM, 2008, TRAFFIC, V9, P39, DOI 10.1111/j.1600-0854.2007.00666.x; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Vitrenko YA, 2007, CURR GENET, V51, P309, DOI 10.1007/s00294-007-0127-0; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Wu YK, 2005, J MOL BIOL, V346, P1005, DOI 10.1016/j.jmb.2004.12.040; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065	53	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3628	3639		10.1074/jbc.M807369200	http://dx.doi.org/10.1074/jbc.M807369200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19056735	Green Published, hybrid			2022-12-27	WOS:000262872500031
J	Taylor, RP; Geisler, TS; Chambers, JH; McClain, DA				Taylor, Rodrick P.; Geisler, Taylor S.; Chambers, Jefferson H.; McClain, Donald A.			Up-regulation of O-GlcNAc Transferase with Glucose Deprivation in HepG2 Cells Is Mediated by Decreased Hexosamine Pathway Flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; RNA-POLYMERASE-II; TETRATRICOPEPTIDE REPEATS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; PROTEINS; GLYCOSYLATION; GLCNACYLATION; NUCLEAR; DOMAIN	O-Linked N-acetylglucosamine (O-GlcNAc) is a post-translational modification of proteins that functions as a nutrient sensing mechanism. We have previously shown a significant induction of O-GlcNAc modification under conditions of glucose deprivation. Increased O-GlcNAc modification was mediated by increased mRNA for nucleocytoplasmic O-linked N-acetylglucosaminyltransferase (ncOGT). We have investigated the mechanism mediating ncOGT induction with glucose deprivation. The signal does not appear to be general energy depletion because no differences in AMP-dependent kinase protein levels or phosphorylation were observed between glucose-deprived and normal glucose-treated cells. However, treatment of glucose-deprived cells with a small dose (1 mM) of glucosamine blocked the induction of ncOGT mRNA and subsequent increase in O-GlcNAc protein modification, suggesting that decreased hexosamine flux is the signal for ncOGT up-regulation. Consistent with this, treatment of glucose-deprived cells with an inhibitor of O-GlcNAcase (O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino N-phenyl carbamat) completely prevented the subsequent up-regulation of ncOGT. Glucosamine treatment also resulted in a 40% rescue of the down-regulation of glycogen synthase activity normally seen after glucose deprivation. We conclude that deglycosylation of proteins within the first few hours of glucose deprivation promotes ncOGT induction. These findings suggest a novel negative feedback regulatory loop for OGT and O-GlcNAc regulation.	[McClain, Donald A.] Univ Utah, Sch Med, Div Endocrinol, Dept Biochem, Salt Lake City, UT 84132 USA; [Taylor, Rodrick P.; Geisler, Taylor S.; Chambers, Jefferson H.; McClain, Donald A.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA; [McClain, Donald A.] Vet Affairs Med Ctr, Res Serv, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)	McClain, DA (corresponding author), Univ Utah, Sch Med, Div Endocrinol, Dept Biochem, 30 N 2030 East, Salt Lake City, UT 84132 USA.	donald.mcclain@hsc.utah.edu		McClain, Don/0000-0002-3310-2359	National Institutes of Health Grant [RO1-DK43526]; Research Service of the Veterans Administration; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043526] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Veterans Administration; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DK43526. This work was also supported by the Research Service of the Veterans Administration. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Dauphinee SM, 2005, J CELL BIOCHEM, V96, P579, DOI 10.1002/jcb.20508; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Gazdag AC, 2000, AM J PHYSIOL-REG I, V278, pR504, DOI 10.1152/ajpregu.2000.278.2.R504; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Nelson BA, 1997, AM J PHYSIOL-ENDOC M, V272, pE848, DOI 10.1152/ajpendo.1997.272.5.E848; Nolte D, 2002, MAMM GENOME, V13, P62, DOI 10.1007/s00335-001-2108-9; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; ROBINSON KA, 1995, DIABETES, V44, P1438, DOI 10.2337/diabetes.44.12.1438; Steinmetz EJ, 1997, CELL, V89, P491, DOI 10.1016/S0092-8674(00)80230-5; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yki-Jarvinen H, 1998, METABOLISM, V47, P449, DOI 10.1016/S0026-0495(98)90058-0; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007	28	73	75	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3425	3432		10.1074/jbc.M803198200	http://dx.doi.org/10.1074/jbc.M803198200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073609	Green Published, hybrid			2022-12-27	WOS:000262872500008
J	Granneman, JG; Moore, HPH; Mottillo, EP; Zhu, ZX				Granneman, James G.; Moore, Hsiao-Ping H.; Mottillo, Emilio P.; Zhu, Zhengxian			Functional Interactions between Mldp (LSDP5) and Abhd5 in the Control of Intracellular Lipid Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANARIN-DORFMAN-SYNDROME; TRIGLYCERIDE LIPASE PNPLA2; FATTY-ACID; PROTEIN TRAFFICKING; DROPLET PROTEINS; STORAGE DISEASE; ACYL-COA; PERILIPIN; LIPOLYSIS; CGI-58	Cellular lipid metabolism is regulated in part by protein-protein interactions near the surface of intracellular lipid droplets. This work investigated functional interactions between Abhd5, a protein activator of the lipase Atgl, and Mldp, a lipid droplet scaffold protein that is highly expressed in oxidative tissues. Abhd5 was highly targeted to individual lipid droplets containing Mldp in microdissected cardiac muscle fibers. Mldp bound Abhd5 in transfected fibroblasts and directed it to lipid droplets in proportion to Mldp concentration. Analysis of protein-protein interactions in situ demonstrated that the interaction of Abhd5 and Mldp occurs mainly, if not exclusively, on the surface of lipid droplets. Oleic acid treatment rapidly increased the interaction between Abhd5 and Mldp, and this effect was suppressed by pharmacological inhibition of triglyceride synthesis. The functional role of the Abhd5-Mldp interaction was explored using a mutant of mouse Abhd5 (E262K) that has greatly reduced binding to Mldp. Mldp promoted the subcellular colocalization and interaction of Atgl with wild type, but not mutant, Abhd5. This differential interaction was reflected in cellular assays of Atgl activity. In the absence of Mldp, wild type and mutant Abhd5 were equally effective in reducing lipid droplet formation. In contrast, mutant Abhd5 was unable to prevent lipid droplet accumulation in cells expressing Mldp despite considerable targeting of Atgl to lipid droplets containing Mldp. These results indicate that the interaction between Abhd5 and Mldp is dynamic and essential for regulating the activity of Atgl at lipid droplets containing Mldp.	[Granneman, James G.; Moore, Hsiao-Ping H.; Mottillo, Emilio P.; Zhu, Zhengxian] Wayne State Univ, Sch Med, CIMER, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA	Wayne State University	Granneman, JG (corresponding author), Wayne State Univ, Sch Med, CIMER, Dept Psychiat & Behav Neurosci, 550 E Canfield, Detroit, MI 48201 USA.	jgranne@med.wayne.edu			National Institutes of Health [DK062292, NS061634]; American Diabetes Association [07-06-RA-50]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062292, R56DK062292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS061634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK062292 and NS061634. This work was also provided by American Diabetes Association Grant 07-06-RA-50) and the Department of Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama M, 2007, MUSCLE NERVE, V36, P856, DOI 10.1002/mus.20869; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Caux F, 2004, AM J MED GENET A, V129A, P214, DOI 10.1002/ajmg.a.30228; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Dickie R, 2006, MICROVASC RES, V72, P20, DOI 10.1016/j.mvr.2006.05.003; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Michnick SW, 2003, CURR OPIN BIOTECH, V14, P610, DOI 10.1016/j.copbio.2003.10.014; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; NEGOESCU A, 1994, J HISTOCHEM CYTOCHEM, V42, P433, DOI 10.1177/42.3.7508473; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200	29	111	115	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3049	3057		10.1074/jbc.M808251200	http://dx.doi.org/10.1074/jbc.M808251200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19064991	hybrid, Green Published			2022-12-27	WOS:000262700900049
J	Pankratz, SL; Tan, EY; Fine, Y; Mercurio, AM; Shaw, LM				Pankratz, Shannon L.; Tan, Ernest Y.; Fine, Yumiko; Mercurio, Arthur M.; Shaw, Leslie M.			Insulin Receptor Substrate-2 Regulates Aerobic Glycolysis in Mouse Mammary Tumor Cells via Glucose Transporter 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; GLUCOSE-UPTAKE; GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; GROWTH; EXPRESSION; METASTASIS; KINASE; TRAFFICKING; ACTIVATION	The insulin receptor substrate (IRS) proteins are cytoplasmic adaptor molecules that function as signaling intermediates downstream of activated cell surface receptors. Based on data implicating IRS-2 but not IRS-1 in breast cancer invasion, survival, and metastasis, we assessed the contribution of IRS-1 and IRS-2 to aerobic glycolysis, which is known to impact tumor growth and progression. For this purpose, we used tumor cell lines derived from transgenic mice that express the polyoma virus middle T antigen (PyV-MT) in the mammary gland and that are wild-type (WT) or null for either Irs-1 (Irs-1(-/-)) or Irs-2 (Irs-2(-/-)). Aerobic glycolysis, as assessed by the rate of lactic acid production and glucose consumption, was diminished significantly in Irs-2(-/-) cells when compared with WT and Irs-1(-/-) cells. Expression of exogenous Irs-2 in Irs-2(-/-) cells restored the rate of glycolysis to that observed in WT cells. The transcription factor FoxO1 does not appear to be involved in Irs-2-mediated glycolysis. However, Irs-2 does regulate the surface expression of glucose transporter 1 (Glut1) as assessed by flow cytometry using a Glut1-specific ligand. Suppression of Glut1 expression inhibits Irs-2-dependent invasion, which links glycolysis to mammary tumor progression. Irs-2 was shown to be important for mammalian target of rapamycin (mTor) activation, and Irs-2-dependent regulation of Glut1 surface expression is rapamycin-sensitive. Collectively, our data indicate that Irs-2, but not Irs-1, promotes invasion by sustaining the aerobic glycolysis of mouse mammary tumor cells and that it does so by regulating the mTor-dependent surface expression of Glut1.	[Shaw, Leslie M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Shaw, LM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB 409,364 Plantat St, Worcester, MA 01605 USA.	leslie.shaw@umassmed.edu			National Institutes of Health [CA090583]; Susan G. Komen Foundation [BCTR0706837]; NATIONAL CANCER INSTITUTE [R01CA090583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA090583 ( to L. M. S.). This work was also supported by Grant BCTR0706837 from the Susan G. Komen Foundation ( to A. M. M. and L. M. S.).	Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Byron SA, 2006, BRIT J CANCER, V95, P1220, DOI 10.1038/sj.bjc.6603354; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cui XJ, 2006, CANCER RES, V66, P5304, DOI 10.1158/0008-5472.CAN-05-2858; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dunn SE, 1998, CANCER RES, V58, P3353; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guo SD, 2006, MOL ENDOCRINOL, V20, P3389, DOI 10.1210/me.2006-0092; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Inoue G, 1998, J BIOL CHEM, V273, P11548, DOI 10.1074/jbc.273.19.11548; Jackson JG, 2001, ONCOGENE, V20, P7318, DOI 10.1038/sj.onc.1204920; Jiang XY, 2008, AM J PATHOL, V172, P1748, DOI 10.2353/ajpath.2008.070958; Kaburagi Y, 1997, J BIOL CHEM, V272, P25839, DOI 10.1074/jbc.272.41.25839; Kang SS, 2002, JPN J CANCER RES, V93, P1123, DOI 10.1111/j.1349-7006.2002.tb01214.x; Kim Felix J, 2004, Retrovirology, V1, P41, DOI 10.1186/1742-4690-1-41; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Ma ZF, 2006, MOL CELL BIOL, V26, P9338, DOI 10.1128/MCB.01032-06; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Moadel RM, 2005, CANCER RES, V65, P698; Morelli C, 2004, ONCOGENE, V23, P7517, DOI 10.1038/sj.onc.1208014; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; QUON MJ, 1994, J BIOL CHEM, V269, P27920; Sachdev D, 2004, J BIOL CHEM, V279, P5017, DOI 10.1074/jbc.M305403200; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Sisci D, 2007, J CLIN PATHOL, V60, P633, DOI 10.1136/jcp.2006.039107; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Trojanek J, 2003, MOL CELL BIOL, V23, P7510, DOI 10.1128/MCB.23.21.7510-7524.2003; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhang XH, 2004, BREAST CANCER RES TR, V83, P161, DOI 10.1023/B:BREA.0000010709.31256.c6; Zhou QL, 2008, BIOCHEM J, V411, P647, DOI 10.1042/BJ20071084	40	33	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2031	2037		10.1074/jbc.M804776200	http://dx.doi.org/10.1074/jbc.M804776200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19056742	hybrid, Green Published			2022-12-27	WOS:000262545600010
J	Campbell, ZT; Baldwin, TO				Campbell, Zachary T.; Baldwin, Thomas O.			Fre Is the Major Flavin Reductase Supporting Bioluminescence from Vibrio harveyi Luciferase in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH-FMN OXIDOREDUCTASE; BACTERIAL LUCIFERASE; NAD(P)H-FLAVIN OXIDOREDUCTASE; REDUCED FLAVIN; CRYSTAL-STRUCTURE; STRUCTURAL GENES; MECHANISM; FISCHERI; IDENTIFICATION; CLONING	Unlike the vast majority of flavoenzymes, bacterial luciferase requires an exogenous source of reduced flavin mononucleotide for bioluminescence activity. Within bioluminescent bacterial cells, species-specific oxidoreductases are believed to provide reduced flavin for luciferase activity. The source of reduced flavin in Escherichia coli-expressing bioluminescence is not known. There are two candidate proteins potentially involved in this process in E. coli, a homolog of the Vibrio harveyi Frp oxidoreductase, NfsA, and a luxG type oxidoreductase, Fre. Using single gene knock-out strains, we show that deletion of fre decreased light output by greater than two orders of magnitude, yet had no effect on luciferase expression in E. coli. Purified Fre is capable of supporting bioluminescence in vitro with activity comparable to that with the endogenous V. harveyi reductase (Frp), using either FMN or riboflavin as substrate. In a pull-down experiment, we found that neither Fre nor Frp co-purify with luciferase. In contrast to prior work, we find no evidence for stable complex formation between luciferase and oxidoreductase. We conclude that in E. coli, an enzyme primarily responsible for riboflavin reduction (Fre) can also be utilized to support high levels of bioluminescence.	Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; [Baldwin, Thomas O.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of Arizona; University of California System; University of California Riverside	Baldwin, TO (corresponding author), Coll Nat & Agr Sci, 302 Coll Bldg N, Riverside, CA 92521 USA.	thomas.baldwin@ucr.edu		Campbell, Zachary/0000-0002-3768-6996	National Science Foundation [0078363]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 0078363. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BALDWIN TO, 1984, BIOCHEMISTRY-US, V23, P3663, DOI 10.1021/bi00311a014; BALDWIN TO, 1992, CHEM BIOCH FLAVOENZY, P467; BALNY C, 1975, BIOCHEMISTRY-US, V14, P4719, DOI 10.1021/bi00692a024; Becker D, 1997, EUR J BIOCHEM, V249, P739, DOI 10.1111/j.1432-1033.1997.t01-1-00739.x; BLANC V, 1995, J BACTERIOL, V177, P5206, DOI 10.1128/jb.177.18.5206-5214.1995; DEVINE JH, 1989, P NATL ACAD SCI USA, V86, P5688, DOI 10.1073/pnas.86.15.5688; DUANE W, 1975, MOL CELL BIOCHEM, V6, P53, DOI 10.1007/BF01731866; EBERHARD A, 1972, BIOCHEM BIOPH RES CO, V47, P348, DOI 10.1016/0006-291X(72)90719-X; Fieschi F, 1995, J BIOL CHEM, V270, P30392, DOI 10.1074/jbc.270.51.30392; FRANCISCO WA, 1993, J BIOL CHEM, V268, P24734; Francisco WA, 1998, BIOCHEMISTRY-US, V37, P2596, DOI 10.1021/bi972266x; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; GAUDU P, 1994, J BIOL CHEM, V269, P8182; GIBSON QH, 1962, BIOCHEM J, V83, P368, DOI 10.1042/bj0830368; Gordon S, 1998, METH MOL B, V101, P235, DOI 10.1385/0-89603-471-2:235; HASTINGS JW, 1978, METHODS ENZYMOLOGY; Ingelman M, 1999, BIOCHEMISTRY-US, V38, P7040, DOI 10.1021/bi982849m; INOUYE S, 1994, FEBS LETT, V347, P163, DOI 10.1016/0014-5793(94)00528-1; JABLONSKI E, 1976, P NATL ACAD SCI USA, V73, P3848, DOI 10.1073/pnas.73.11.3848; JABLONSKI E, 1977, BIOCHEMISTRY-US, V16, P2932, DOI 10.1021/bi00632a020; Jeffers CE, 2003, BIOCHEMISTRY-US, V42, P529, DOI 10.1021/bi026877n; Koike H, 1998, J MOL BIOL, V280, P259, DOI 10.1006/jmbi.1998.1871; LEI BF, 1994, J BIOL CHEM, V269, P5612; LEI BF, 1994, J BACTERIOL, V176, P3552, DOI 10.1128/JB.176.12.3552-3558.1994; Lei BF, 1998, BIOCHEMISTRY-US, V37, P14623, DOI 10.1021/bi981841+; Li X, 2006, ARCH BIOCHEM BIOPHYS, V454, P26, DOI 10.1016/j.abb.2006.07.016; Lin JW, 1998, BIOCHEM BIOPH RES CO, V246, P446, DOI 10.1006/bbrc.1998.8641; LIU Y, 1995, J BACTERIOL, V177, P2080, DOI 10.1128/jb.177.8.2080-2086.1995; MEIGHEN EA, 1973, BIOCHEMISTRY-US, V12, P1482, DOI 10.1021/bi00732a003; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Parry RJ, 1997, J BIOL CHEM, V272, P23303, DOI 10.1074/jbc.272.37.23303; PUGET K, 1972, BIOCHIMIE, V54, P1197, DOI 10.1016/S0300-9084(72)80024-5; RAUSHEL FM, 1989, BIOCHEM BIOPH RES CO, V164, P1137, DOI 10.1016/0006-291X(89)91787-7; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMIDT TM, 1989, APPL ENVIRON MICROB, V55, P2607, DOI 10.1128/AEM.55.10.2607-2612.1989; Sparks JM, 2001, BIOCHEMISTRY-US, V40, P15436, DOI 10.1021/bi0111855; SPYROU G, 1991, J BACTERIOL, V173, P3673, DOI 10.1128/JB.173.12.3673-3679.1991; Tanner JJ, 1999, PROTEIN SCI, V8, P1725, DOI 10.1110/ps.8.9.1725; TU S, 1975, BIOCHEMISTRY-US, V14, P4310, DOI 10.1021/bi00690a027; TU SC, 1980, P NATL ACAD SCI-BIOL, V77, P249, DOI 10.1073/pnas.77.1.249; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; Tu SC, 2000, J NUTR, V130, p331S, DOI 10.1093/jn/130.2.331S; Wang H, 2000, BIOCHEMISTRY-US, V39, P7813, DOI 10.1021/bi0003745; ZENNO S, 1994, J BACTERIOL, V176, P3536, DOI 10.1128/JB.176.12.3536-3543.1994; Zenno S, 1998, J BACTERIOL, V180, P422, DOI 10.1128/JB.180.2.422-425.1998; Zenno S, 1996, J BACTERIOL, V178, P4508, DOI 10.1128/jb.178.15.4508-4514.1996; ZENNO S, 1994, J BACTERIOL, V176, P3544, DOI 10.1128/JB.176.12.3544-3551.1994; Zenno SH, 1996, J BACTERIOL, V178, P4731, DOI 10.1128/jb.178.15.4731-4733.1996	51	35	36	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8322	8328		10.1074/jbc.M808977200	http://dx.doi.org/10.1074/jbc.M808977200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19139094	Green Published, hybrid			2022-12-27	WOS:000264397800016
J	Cheng, CM; Kong, XF; Wang, HZ; Gan, HC; Hao, YQ; Zou, WY; Wu, JW; Chi, YY; Yang, JW; Hong, Y; Chen, KL; Gu, JX				Cheng, Chunming; Kong, Xiangfei; Wang, Hanzhou; Gan, Huachen; Hao, Yuqing; Zou, Weiying; Wu, Jingwen; Chi, Yayun; Yang, Junwu; Hong, Yi; Chen, Kangli; Gu, Jianxin			Trihydrophobin 1 Interacts with PAK1 and Regulates ERK/MAPK Activation and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P21-ACTIVATED KINASE; PROTEIN-KINASE; DROSOPHILA-MELANOGASTER; SIGNAL-TRANSDUCTION; MAPK ACTIVATION; PHOSPHORYLATION; ACTIN; ERK; MOTILITY; ASSOCIATION	The Rac1/Cdc42 effector, p21-activated kinase (PAK), is activated by various signaling cascades, including receptor-tyrosine kinases and integrins, and regulates a number of processes such as cell proliferation and motility. PAK activity has been shown to be required for maximal activation of the canonical RAF-MEK-MAPK signaling cascade, possibly because of PAK co-activation of RAF and MEK. Here we have shown that trihydrophobin 1 (TH1), originally identified as a negative regulator of A-RAF kinase, also interacted with PAK1 in cultured cells. Confocal microscopy assay indicated that TH1 colocalized with PAK1 in both the cytoplasm and nucleus, which is consistent with our previous results. GST pulldown and coimmunoprecipitation experiments demonstrated that TH1 interacted directly with PAK1 and bound selectively to the carboxyl-terminal kinase domain of PAK1, and the ability of the binding was enhanced along with activation of PAK1. The binding pattern of PAK1 implies that this interaction was mediated in part by PAK1 kinase activity. As indicated by in vitro kinase activity assays and Western blot detections, TH1 inhibited PAK1 kinase activity and negatively regulated MAPK signal transduction. Interestingly, TH1 bound with MEK1/ERK in cells and in vitro without directly suppressing their kinase activity. Furthermore, we observed that TH1 localized to focal adhesions and filopodia in the leading edge of cells, where TH1 reduced cell migration through affecting actin and adhesion dynamics. Based on these observations, we propose a model in which TH1 interacts with PAK1 and specifically restricts the activation of MAPK modules through the upstream region of the MAPK pathway, thereby influencing cell migration.	[Chi, Yayun; Yang, Junwu; Hong, Yi; Chen, Kangli; Gu, Jianxin] Fudan Univ, Shanghai Med Coll, Ctr Gene Res, Shanghai 200032, Peoples R China; [Cheng, Chunming; Gu, Jianxin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Gu, JX (corresponding author), Fudan Univ, Shanghai Med Coll, Ctr Gene Res, Box 103,181 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.	jxgu@shmu.edu.cn	Wang, Hanzhou/G-9814-2012; cheng, chunming/AAU-6273-2021; Gan, Huachen/AAE-5925-2021	Wang, Hanzhou/0000-0002-0493-827X; cheng, chunming/0000-0001-9036-1683; 				Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; BANGA SS, 1995, MOL GEN GENET, V246, P148, DOI 10.1007/BF00294677; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bonthron DT, 2000, HUM GENET, V107, P165, DOI 10.1007/s004390000344; Buchwald G, 2001, MOL CELL BIOL, V21, P5179, DOI 10.1128/MCB.21.15.5179-5189.2001; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Dan C, 2002, MOL CELL BIOL, V22, P567, DOI 10.1128/MCB.22.2.567-577.2002; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Guo DG, 2007, CELL, V128, P341, DOI 10.1016/j.cell.2006.11.048; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Jo M, 2002, J BIOL CHEM, V277, P12479, DOI 10.1074/jbc.M111147200; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Koh CG, 2002, CURR BIOL, V12, P317, DOI 10.1016/S0960-9822(02)00652-8; Krueger JS, 2001, ONCOGENE, V20, P4209, DOI 10.1038/sj.onc.1204541; Kumar R, 2002, J CELL PHYSIOL, V193, P133, DOI 10.1002/jcp.10167; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; Liu WC, 2004, J BIOL CHEM, V279, P10167, DOI 10.1074/jbc.M307994200; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pullikuth A, 2005, MOL CELL BIOL, V25, P5119, DOI 10.1128/MCB.25.12.5119-5133.2005; Rayala SK, 2006, CANCER RES, V66, P1694, DOI 10.1158/0008-5472.CAN-05-2922; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Stahle M, 2003, J CELL SCI, V116, P3835, DOI 10.1242/jcs.00679; Sundberg-Smith LJ, 2005, J BIOL CHEM, V280, P2055, DOI 10.1074/jbc.M406013200; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Wu WS, 2008, CANCER METAST REV, V27, P303, DOI 10.1007/s10555-008-9112-4; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Yang YZ, 2007, J CELL BIOCHEM, V101, P167, DOI 10.1002/jcb.21164; Zang MW, 2002, J BIOL CHEM, V277, P4395, DOI 10.1074/jbc.M110000200	62	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8786	8796		10.1074/jbc.M806144200	http://dx.doi.org/10.1074/jbc.M806144200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19136554	hybrid, Green Published			2022-12-27	WOS:000264397800062
J	Parachoniak, CA; Park, M				Parachoniak, Christine A.; Park, Morag			Distinct Recruitment of Eps15 via Its Coiled-coil Domain Is Required For Efficient Down-regulation of the Met Receptor Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; CLATHRIN-MEDIATED ENDOCYTOSIS; UBIQUITIN-INTERACTING MOTIF; GRB2 BINDING-SITE; EGF RECEPTORS; JUXTAMEMBRANE DOMAIN; PLASMA-MEMBRANE; COATED PITS; CBL; INTERNALIZATION	Down-regulation of receptor tyrosine kinases (RTK) through receptor internalization and degradation is critical for appropriate biological responses. The hepatocyte growth factor RTK (also known as Met) regulates epithelial remodeling, dispersal, and invasion and is deregulated in human cancers. Impaired down-regulation of the Met RTK leads to sustained signaling, cell transformation, and tumorigenesis, hence understanding mechanisms that regulate this process is crucial. Here we report that, following Met activation, the endocytic adaptor protein, Eps15, is recruited to the plasma membrane and becomes both tyrosine-phosphorylated and ubiquitinated. Recruitment of Eps15 requires Met receptor kinase activity and involves two distinct Eps15 domains. Unlike previous reports for the EGF RTK, which requires the Eps15 ubiquitin interacting motif, recruitment of Eps15 to Met involves the coiled-coil domain of Eps15 and the signaling adaptor molecule, Grb2, which binds through a proline-rich motif in the third domain of Eps15. Expression of the coiled-coil domain is sufficient to displace the wild-type Eps15 protein complex from Met, resulting in loss of tyrosine phosphorylation of Eps15. Knockdown of Eps15 results in delayed Met degradation, which can be rescued by expression of Eps15 WT but not an Eps15 mutant lacking the coiled-coil domain, identifying a role for this domain in Eps15-mediated Met down-modulation. This study demonstrates a new mechanism of recruitment for Eps15 downstream of the Met receptor, involving the coiled- coil domain of Eps15 as well as interaction of Eps15 with Grb2. This highlights distinct regulation of Eps15 recruitment and the diversity and adaptability of endocytic molecules in promoting RTK trafficking.	[Parachoniak, Christine A.; Park, Morag] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Park, Morag] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University	Park, M (corresponding author), Goodman Canc Ctr, 1160 Ave Pins Ouest,Canc Pavil,Room 511, Montreal, PQ H3G 1Y6, Canada.	morag.park@mcgill.ca			Canadian Institutes of Health Research (CIHR); Canada Graduate Scholarship Doctoral Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Graduate Scholarship Doctoral Award	This work was supported in part by a fellowship ( to C. P.) from the Canadian Institutes of Health Research (CIHR) Canada Graduate Scholarship Doctoral Award and by an operating grant ( to M. P.) from CIHR.	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bean AJ, 2000, J BIOL CHEM, V275, P15271, DOI 10.1074/jbc.275.20.15271; Belleudi F, 2003, FEBS LETT, V553, P262, DOI 10.1016/S0014-5793(03)01020-2; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 1995, J CELL BIOL, V131, P1831, DOI 10.1083/jcb.131.6.1831; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Confalonieri S, 2000, J CELL BIOL, V150, P905, DOI 10.1083/jcb.150.4.905; Cupers P, 1997, J BIOL CHEM, V272, P33430, DOI 10.1074/jbc.272.52.33430; de Melker AA, 2004, J BIOL CHEM, V279, P55465, DOI 10.1074/jbc.M409765200; de Melker AA, 2004, J CELL SCI, V117, P5001, DOI 10.1242/jcs.01354; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Fourier TM, 1996, J BIOL CHEM, V271, P22211, DOI 10.1074/jbc.271.36.22211; Funakoshi H, 2003, CLIN CHIM ACTA, V327, P1, DOI 10.1016/S0009-8981(02)00302-9; GORDEN P, 1978, P NATL ACAD SCI USA, V75, P5025, DOI 10.1073/pnas.75.10.5025; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; HILLMAN GM, 1982, BIOCHEMISTRY-US, V21, P1667, DOI 10.1021/bi00536a030; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Li N, 2005, TRAFFIC, V6, P459, DOI 10.1111/j.1600-0854.2005.00290.x; Li N, 2007, J BIOL CHEM, V282, P16764, DOI 10.1074/jbc.M610835200; Lock LS, 2002, MOL BIOL CELL, V13, P2132, DOI 10.1091/mbc.02-02-0031; Ma PC, 2003, CANCER RES, V63, P6272; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Naslavsky N, 2007, J BIOL CHEM, V282, P16612, DOI 10.1074/jbc.M609493200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Riezman H, 2002, NATURE, V416, P381, DOI 10.1038/416381a; RODRIGUES GA, 1991, MOL CELL BIOL, V11, P2962, DOI 10.1128/MCB.11.6.2962; Roxrud I, 2008, J CELL BIOL, V180, P1205, DOI 10.1083/jcb.200708115; Schmidt PR, 1997, J ANTHROPOL ARCHAEOL, V16, P73, DOI 10.1006/jaar.1997.0305; SCHUMACHER C, 1995, J BIOL CHEM, V270, P15341, DOI 10.1074/jbc.270.25.15341; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sorkina T, 2002, J BIOL CHEM, V277, P27433, DOI 10.1074/jbc.M201595200; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; Torrisi MR, 1999, MOL BIOL CELL, V10, P417, DOI 10.1091/mbc.10.2.417; vanDelft S, 1997, J CELL BIOL, V136, P811, DOI 10.1083/jcb.136.4.811; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292	67	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8382	8394		10.1074/jbc.M807607200	http://dx.doi.org/10.1074/jbc.M807607200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19109251	hybrid, Green Published			2022-12-27	WOS:000264397800022
J	Hidaka, M; Nishimoto, M; Kitaoka, M; Wakagi, T; Shoun, H; Fushinobu, S				Hidaka, Masafumi; Nishimoto, Mamoru; Kitaoka, Motomitsu; Wakagi, Takayoshi; Shoun, Hirofumi; Fushinobu, Shinya			The Crystal Structure of Galacto-N-biose/Lacto-N-biose I Phosphorylase A LARGE DEFORMATION OF A TIM BARREL SCAFFOLD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSIDE HYDROLASE FAMILY; BIFIDOBACTERIUM-BIFIDUM; CLOSTRIDIUM-PERFRINGENS; BETA-GALACTOSIDASE; NEUTRAL OLIGOSACCHARIDES; CONFORMATIONAL ITINERARY; MILK OLIGOSACCHARIDES; VIBRIO-VULNIFICUS; MOLECULAR-CLONING; IDENTIFICATION	Galacto-N-biose/lacto-N-biose I phosphorylase (GLNBP) from Bifidobacterium longum, a key enzyme for intestinal growth, phosphorolyses galacto-N-biose and lacto-N-biose I with anomeric inversion. GLNBP homologues are often found in human pathogenic and commensal bacteria, and their substrate specificities potentially define the nutritional acquisition ability of these microbes in their habitat. We report the crystal structures of GLNBP in five different ligand-binding forms. This is the first three-dimensional structure of glycoside hydrolase (GH) family 112. The GlcNAc-and GalNAc-bound forms provide structural insights into distinct substrate preferences of GLNBP and its homologues from pathogens. The catalytic domain consists of a partially broken TIM barrel fold that is structurally similar to a thermophilic beta-galactosidase, strongly supporting the current classification of GLNBP homologues as one of the GH families. Anion binding induces a large conformational change by rotating a half-unit of the barrel. This is an unusual example of molecular adaptation of a TIM barrel scaffold to substrates.	[Hidaka, Masafumi; Wakagi, Takayoshi; Shoun, Hirofumi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Nishimoto, Mamoru; Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	University of Tokyo; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Wakagi, Takayoshi/AAJ-4145-2021; Kitaoka, Motomitsu/R-1536-2019; Fushinobu, Shinya/E-4987-2011	Kitaoka, Motomitsu/0000-0002-0083-1838; Fushinobu, Shinya/0000-0003-1346-6435	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Japan Society for the Promotion of Science for Young Scientists Research Fellowship [17-00182]	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Japan Society for the Promotion of Science for Young Scientists Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) and Japan Society for the Promotion of Science for Young Scientists Research Fellowship 17-00182 (to M. H.). The costs of publication of this article were defrayed in part by the payment of page charges.	Akanuma S, 2008, J MOL BIOL, V382, P458, DOI 10.1016/j.jmb.2008.07.040; Asakuma S, 2008, EUR J CLIN NUTR, V62, P488, DOI 10.1038/sj.ejcn.1602738; Bezirtzoglou E, 2006, COMP IMMUNOL MICROB, V29, P345, DOI 10.1016/j.cimid.2006.09.002; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Daniels G., 2002, HUMAN BLOOD GROUPS; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; Derensy-Dron D, 1999, BIOTECHNOL APPL BIOC, V29, P3; DESLONGCHAMPS P, 1993, PURE APPL CHEM, V65, P1161, DOI 10.1351/pac199365061161; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erney RM, 2000, J PEDIATR GASTR NUTR, V30, P181, DOI 10.1097/00005176-200002000-00016; Espinosa JF, 1998, J AM CHEM SOC, V120, P1309, DOI 10.1021/ja972291q; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Fushinobu S, 2007, J APPL GLYCOSCI, V54, P95; Fushinobu S, 2008, CARBOHYD RES, V343, P1023, DOI 10.1016/j.carres.2008.02.026; Gagnon M, 2004, INT J FOOD MICROBIOL, V92, P69, DOI 10.1016/j.ijfoodmicro.2003.07.010; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Haarman M, 2005, APPL ENVIRON MICROB, V71, P2318, DOI 10.1128/AEM.71.5.2318-2324.2005; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; Hocker B, 2001, NAT STRUCT BIOL, V8, P32; Iwabuchi N, 2007, MICROBIOL IMMUNOL, V51, P649, DOI 10.1111/j.1348-0421.2007.tb03953.x; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35, DOI 10.4052/tigg.14.35; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Knol J, 2005, J PEDIATR GASTR NUTR, V40, P36, DOI 10.1097/00005176-200501000-00007; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; MAGNANI JL, 1983, CANCER RES, V43, P5489; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; MCDONEL JL, 1980, PHARMACOL THERAPEUT, V10, P617, DOI 10.1016/0163-7258(80)90031-5; Mocchetti I, 2005, CELL MOL LIFE SCI, V62, P2283, DOI 10.1007/s00018-005-5188-y; Moro G, 2006, ARCH DIS CHILD, V91, P814, DOI 10.1136/adc.2006.098251; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Motes ML, 1998, APPL ENVIRON MICROB, V64, P1459; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima M, 2008, APPL ENVIRON MICROB, V74, P6333, DOI 10.1128/AEM.02846-07; Nakajima M, 2008, APPL MICROBIOL BIOT, V78, P465, DOI 10.1007/s00253-007-1319-8; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1587, DOI 10.1271/bbb.70064; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parracho H, 2007, P NUTR SOC, V66, P405, DOI 10.1017/S0029665107005678; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; RING M, 1990, ARCH BIOCHEM BIOPHYS, V283, P342, DOI 10.1016/0003-9861(90)90652-F; SAAVEDRA JM, 1994, LANCET, V344, P1046, DOI 10.1016/S0140-6736(94)91708-6; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Springer G F, 1990, Immunol Ser, V53, P587; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Broek LAM, 2008, MOL NUTR FOOD RES, V52, P146, DOI 10.1002/mnfr.200700121; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05; Withers SG, 2002, CHEM BIOL, V9, P1270, DOI 10.1016/S1074-5521(02)00291-0; Yasui H, 1999, ANTON LEEUW INT J G, V76, P383, DOI 10.1023/A:1002041616085	67	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7273	7283		10.1074/jbc.M808525200	http://dx.doi.org/10.1074/jbc.M808525200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19124470	Green Published, hybrid			2022-12-27	WOS:000263919000074
J	Shi, S; Mercer, S; Eckert, GJ; Trippel, SB				Shi, Shuiliang; Mercer, Scott; Eckert, George J.; Trippel, Stephen B.			Growth Factor Regulation of Growth Factors in Articular Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFECTS IN-VIVO; FACTOR-BETA; IGF-I; PROTEOGLYCAN SYNTHESIS; OSTEOGENIC PROTEIN-1; CARTILAGE EXPLANTS; ENHANCED REPAIR; TGF-BETA; METABOLISM; COLLAGEN	Several lines of evidence indicate that polypeptide growth factors are important in articular cartilage homeostasis and repair. It is not yet clear how these growth factors are regulated. We tested the hypothesis that the growth factors responsible for regulating cartilage are themselves regulated by growth factors. We delivered insulin-like growth factor I (IGF-I), fibroblast growth factor-2 (FGF-2), and/or transforming growth factor-beta 1 (TGF-beta 1) to adult bovine articular chondrocytes in primary culture and measured the resulting changes in IGF-I, FGF-2, and TGF-beta 1 gene expression and protein production. These growth factors differentially regulated their own and each others gene expression and protein production. In concert, they regulated each other in an interactive fashion. Their interactions ranged from inhibitory to synergistic. The time course of the regulatory effects differed among the individual growth factors and combinations. Growth factor-induced changes in growth factor protein production by articular chondrocytes generally corresponded to the changes in gene expression patterns. These studies suggest that interactions among IGF-I, FGF-2, and TGF-beta 1 substantially modulate their regulatory functions. The results may help guide the application of growth factors to articular cartilage repair.	[Shi, Shuiliang; Mercer, Scott; Trippel, Stephen B.] Indiana Univ, Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA; [Eckert, George J.] Indiana Univ, Sch Med, Dept Med, Div Biostat, Indianapolis, IN 46202 USA; [Trippel, Stephen B.] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Trippel, SB (corresponding author), 541 Clin Dr,CL600, Indianapolis, IN 46202 USA.	strippel@iupui.edu			NIAMS [AR047702]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047702] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR047702 from NIAMS ( to S. B. T.) and the Department of Veterans Affairs.	Bonassar LJ, 2001, J ORTHOP RES, V19, P11, DOI 10.1016/S0736-0266(00)00004-8; BRADHAM DM, 1994, J CELL PHYSIOL, V158, P61, DOI 10.1002/jcp.1041580109; Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J; CARRINGTON JL, 1990, EXP CELL RES, V186, P368, DOI 10.1016/0014-4827(90)90318-5; Chopra R, 1998, J RHEUMATOL, V25, P1578; Cucchiarini M, 2005, MOL THER, V12, P229, DOI 10.1016/j.ymthe.2005.03.012; Danielpour D, 2006, CYTOKINE GROWTH F R, V17, P59, DOI 10.1016/j.cytogfr.2005.09.007; ELFORD PR, 1990, ENDOCRINOLOGY, V127, P1635, DOI 10.1210/endo-127-4-1635; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fanning PJ, 2003, J BIOL CHEM, V278, P50940, DOI 10.1074/jbc.M305107200; FROGERGAILLARD B, 1989, ENDOCRINOLOGY, V124, P2365, DOI 10.1210/endo-124-5-2365; Fujimoto E, 1999, ARCH ORTHOP TRAUM SU, V119, P139, DOI 10.1007/s004020050377; GUERNE PA, 1994, J CELL PHYSIOL, V158, P476, DOI 10.1002/jcp.1041580312; Henson FMD, 2005, OSTEOARTHR CARTILAGE, V13, P537, DOI 10.1016/j.joca.2005.02.007; HORTON WE, 1989, J CELL PHYSIOL, V141, P8, DOI 10.1002/jcp.1041410103; KATO Y, 1987, J CELL PHYSIOL, V133, P491, DOI 10.1002/jcp.1041330309; Loeser RF, 2005, ARTHRITIS RHEUM-US, V52, P3910, DOI 10.1002/art.21472; Loeser RF, 2003, ARTHRITIS RHEUM, V48, P2188, DOI 10.1002/art.11209; LUYTEN FP, 1988, ARCH BIOCHEM BIOPHYS, V267, P416, DOI 10.1016/0003-9861(88)90047-1; Madry H, 2001, GENE THER, V8, P1443, DOI 10.1038/sj.gt.3301535; Madry H, 2005, GENE THER, V12, P1171, DOI 10.1038/sj.gt.3302515; Madry H, 2000, GENE THER, V7, P286, DOI 10.1038/sj.gt.3301086; MCQUILLAN DJ, 1986, BIOCHEM J, V240, P423, DOI 10.1042/bj2400423; MORALES TI, 1988, J BIOL CHEM, V263, P12828; Nixon AJ, 1999, J ORTHOPAED RES, V17, P475, DOI 10.1002/jor.1100170404; Nixon AJ, 2001, J ORTHOPAED RES, V19, P26, DOI 10.1016/S0736-0266(00)00013-9; OSBORN KD, 1989, J ORTHOP RES, V7, P35, DOI 10.1002/jor.1100070106; PRAEMER A, 1999, MUSCULOSKELETAL COND, P3; PRINS APA, 1982, ARTHRITIS RHEUM, V25, P1228, DOI 10.1002/art.1780251012; REDINI F, 1988, FEBS LETT, V234, P172, DOI 10.1016/0014-5793(88)81327-9; ROSIER RN, 1989, CONNECT TISSUE RES, V20, P295, DOI 10.3109/03008208909023900; SAH RL, 1994, ARCH BIOCHEM BIOPHYS, V308, P137, DOI 10.1006/abbi.1994.1020; SANDELL LJ, 1988, J ORTHOP T, V12, P377; Shida J, 2001, J ORTHOPAED RES, V19, P259, DOI 10.1016/S0736-0266(00)90009-3; Trippel S B, 1997, Instr Course Lect, V46, P473; TRIPPEL SB, 1995, J RHEUMATOL, V22, P129; TRIPPEL SB, 1989, PEDIATR RES, V25, P76, DOI 10.1203/00006450-198901000-00017; TSUKAZAKI T, 1994, EXP CELL RES, V215, P9, DOI 10.1006/excr.1994.1307; VANDERKRAAN PM, 1992, ANN RHEUM DIS, V51, P643, DOI 10.1136/ard.51.5.643; WELLMITZ G, 1980, EXP PATHOL-JENA, V18, P282, DOI 10.1016/S0014-4908(80)80033-0; WROBLEWSKI J, 1995, J BONE MINER RES, V10, P735	41	39	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6697	6704		10.1074/jbc.M807859200	http://dx.doi.org/10.1074/jbc.M807859200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136669	Green Published, hybrid			2022-12-27	WOS:000263919000014
J	Boyman, L; Mikhasenko, H; Hiller, R; Khananshvili, D				Boyman, Liron; Mikhasenko, Helen; Hiller, Reuben; Khananshvili, Daniel			Kinetic and Equilibrium Properties of Regulatory Calcium Sensors of NCX1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC NA+-CA2+ EXCHANGER; NA+/CA2+ EXCHANGER; CA2+-BINDING DOMAIN; BINDING PROPERTIES; MEMBRANE-BINDING; CONFORMATIONAL-CHANGES; DYNAMIC PROPERTIES; STOPPED-FLOW; STEADY-STATE; CA2+	The crystal structures of the CBD1 and CBD2 domains of the Na+/Ca2+ exchanger protein (NCX1) provided a major breakthrough in Ca2+-dependent regulation of NCX1, although the dynamic aspects of the underlying molecular mechanisms are still not clear. Here we provide new experimental approaches for evaluating the kinetic and equilibrium properties of Ca2+ interaction with regulatory sites by using purified preparations of CBD1, CBD2, and CBD12 proteins. CBD12 binds similar to 6 Ca2+ ions (mol/mol), whereas the binding of only similar to 2Ca(2+) ions is observed (with a Hill coefficient of n(H) = similar to 2) either for CBD1 or CBD2. In the absence of Mg2+, CBD1 has a much higher affinity for Ca2+ (K-d = 0.3 +/- 1.2 mu M) than CBD2 (K-d = 5.0 +/- 1.2 mu M). The Ca2+ dissociation from CBD2 (k(off) = 230 +/- 70 s(-1)) is at least 25 times faster than from CBD1(koff = 10 +/- 3 s(-1)), whereas the k(on) values indicate fast kinetics for Ca2+ binding (k(on) = k(off)/K-d = 10(7) - 10(8) MG(2+), CBD1) for both CBDs. At 2-5 mM Mg2+, both CBDs bind Ca2+, with a K-d of 1-2 mu M (Mg2+ has very little effect on Ca2+ off rates). Mg2+ cannot occupy the primary site of CBD2, whereas the other Ca2+ sites of CBDs interact with Mg2+ as well. There is no competition between Na+ and Ca2+ for any CBD site. The kinetically diverse [Ca2+] sensors may sense differentially the dynamic swings in [Ca2+] within specific subcellular compartments (dyadic cleft, submembrane space, bulk cytosol, etc.).	[Boyman, Liron; Mikhasenko, Helen; Hiller, Reuben; Khananshvili, Daniel] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Khananshvili, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel.	dhanan@post.tau.ac.il		Khananshvili, Daniel/0000-0002-4202-9966	Israeli Ministry of Health [3000003019]; United States-Israeli Binational Research [2003-372]	Israeli Ministry of Health; United States-Israeli Binational Research	This work was supported in part by Israeli Ministry of Health Grant 3000003019 and United States-Israeli Binational Research Grant 2003-372.	Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; BAYLEY P, 1984, BIOCHEM BIOPH RES CO, V120, P185, DOI 10.1016/0006-291X(84)91431-1; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2007, ANN NY ACAD SCI, V1099, P326, DOI 10.1196/annals.1387.060; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blaustein MP, 2007, P NATL ACAD SCI USA, V104, P18349, DOI 10.1073/pnas.0709008104; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; EBERHARD M, 1994, EUR J BIOCHEM, V222, P21, DOI 10.1111/j.1432-1033.1994.tb18836.x; EBERHARD M, 1991, EUR J BIOCHEM, V202, P1333, DOI 10.1111/j.1432-1033.1991.tb16508.x; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Guatimosim S, 2002, J MOL CELL CARDIOL, V34, P941, DOI 10.1006/jmcc.2002.2032; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; Jerala R, 1996, J BIOMOL NMR, V7, P107; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; Kargacin GJ, 2003, J THEOR BIOL, V221, P245, DOI 10.1006/jtbi.2003.3187; KHANANSHVILI D, 1995, BIOCHEMISTRY-US, V34, P10290, DOI 10.1021/bi00032a024; KHANANSHVILI D, 1994, BIOCHEMISTRY-US, V33, P312, DOI 10.1021/bi00167a041; Khananshvili D, 1996, ANN NY ACAD SCI, V779, P217, DOI 10.1111/j.1749-6632.1996.tb44789.x; KHANANSHVILI D, 1998, ADV MOL CEL A&B, V23, P311; KOFUJI P, 1994, J BIOL CHEM, V269, P5145; LADANT D, 1995, J BIOL CHEM, V270, P3179; LEE SL, 1994, J BIOL CHEM, V269, P14849; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; Levitsky DO, 1996, MOL CELL BIOCHEM, V161, P27, DOI 10.1007/BF00240027; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; MARTIN SR, 1992, EUR J BIOCHEM, V205, P1107, DOI 10.1111/j.1432-1033.1992.tb16879.x; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Nalefski EA, 1997, BIOCHEMISTRY-US, V36, P12011, DOI 10.1021/bi9717340; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Ottolia M, 2004, BIOPHYS J, V87, P899, DOI 10.1529/biophysj.104.043471; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; REEVES JP, 1985, CURR TOP MEMBR TRANS, V25, P77; Reuter H, 2005, CARDIOVASC RES, V67, P198, DOI 10.1016/j.cardiores.2005.04.031; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Sher AA, 2008, PROG BIOPHYS MOL BIO, V96, P377, DOI 10.1016/j.pbiomolbio.2007.07.018; Urbanczyk J, 2006, J PHYSIOL-LONDON, V575, P693, DOI 10.1113/jphysiol.2006.113910; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Wei SK, 2002, CARDIOVASC RES, V53, P334, DOI 10.1016/S0008-6363(01)00501-6; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Xie Y, 2008, AM J PHYSIOL-CELL PH, V295, pC388, DOI 10.1152/ajpcell.00178.2008	52	53	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6185	6193		10.1074/jbc.M809012200	http://dx.doi.org/10.1074/jbc.M809012200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19141619	hybrid			2022-12-27	WOS:000263742700021
J	Sasaki-Suzuki, N; Arai, K; Ogata, T; Kasahara, K; Sakoda, H; Chida, K; Asano, T; Pessin, JE; Hakuno, F; Takahashi, SI				Sasaki-Suzuki, Naoko; Arai, Kiyoshi; Ogata, Tomomi; Kasahara, Kouhei; Sakoda, Hideyuki; Chida, Kazuhiro; Asano, Tomoichiro; Pessin, Jeffrey E.; Hakuno, Fumihiko; Takahashi, Shin-Ichiro			Growth Hormone Inhibition of Glucose Uptake in Adipocytes Occurs without Affecting GLUT4 Translocation through an Insulin Receptor Substrate-2-Phosphatidylinositol 3-Kinase-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT/PROTEIN KINASE-B; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION; 3T3-L1 ADIPOCYTES; PHOSPHOINOSITIDE 3-KINASE; TYROSINE KINASE; FACTOR-I; RAT ADIPOCYTES; SIGNAL-TRANSDUCTION; FRTL-5 CELLS; TRANSPORT	Growth hormone (GH) pretreatment of 3T3-L1 adipocytes resulted in a concentration- and time-dependent inhibition of insulin-stimulated glucose uptake. Surprisingly, this occurred without significant effect on insulin-stimulated glucose transporter (GLUT)4 translocation or fusion with the plasma membrane. In parallel, the inhibitory actions of chronic GH pretreatment also impaired insulin-dependent activation of phosphatidylinositol (PI) 3-kinase bound to insulin receptor substrate (IRS)-2 but not to IRS-1. In addition, insulin-stimulated Akt phosphorylation was inhibited by GH pretreatment. In contrast, overexpression of IRS-2 or expression of a constitutively active Akt mutant prevented the GH-induced insulin resistance of glucose uptake. Moreover, small interfering RNA-mediated IRS-2 knockdown also inhibited insulin-stimulated Akt activation and glucose uptake without affecting GLUT4 translocation and plasma membrane fusion. Together, these data support a model in which chronic GH stimulation inhibits insulin-dependent activation of phosphatidylinositol 3-kinase through a specific interaction of phosphatidylinositol 3-kinase bound to IRS-2. This inhibition leads to suppression of Akt activation coupled to glucose transport activity but not translocation or plasma membrane fusion of GLUT4.	[Sasaki-Suzuki, Naoko; Arai, Kiyoshi; Ogata, Tomomi; Kasahara, Kouhei; Chida, Kazuhiro; Hakuno, Fumihiko; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Dept Anim Sci, Tokyo 1138657, Japan; [Sasaki-Suzuki, Naoko; Arai, Kiyoshi; Ogata, Tomomi; Kasahara, Kouhei; Chida, Kazuhiro; Hakuno, Fumihiko; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Sasaki-Suzuki, Naoko; Pessin, Jeffrey E.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Sakoda, Hideyuki; Asano, Tomoichiro] Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo 1138655, Japan; [Asano, Tomoichiro] Hiroshima Univ, Grad Sch Biomed Sci, Div Mol Med Sci, Minami Ku, Hiroshima 7348553, Japan; [Pessin, Jeffrey E.] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Pessin, Jeffrey E.] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	University of Tokyo; University of Tokyo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tokyo; Hiroshima University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Takahashi, SI (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Dept Anim Sci, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atkshin@mail.ecc.u-tokyo.ac.jp		Hakuno, Fumihiko/0000-0002-4447-6225; Takahashi, Shin-Ichiro/0000-0002-2323-2010	National Institutes of Health grant; Japan Society for the Promotion of Science [11460126]; Ministry of Education, Science and Culture of Japan [15658080, 16208028]; Program for Promotion of Basic Research Activities for Innovative Biosciences	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic Research Activities for Innovative Biosciences	This work was supported, in whole or in part, by a National Institutes of Health grant ( to J. E. P.). This work was also supported by a grant-in-aid for international joint research ( to S.-I.T.) from Japan Society for the Promotion of Science, Grants-in-aid for Scientific Research ( B)( 2) 11460126, Exploratory Research 15658080, and Scientific Research ( A)( 2) 16208028) from the Ministry of Education, Science and Culture of Japan ( to S.- I. T.), and by the Program for Promotion of Basic Research Activities for Innovative Biosciences ( to F. H.).	Ariga M, 2000, BIOCHEM J, V348, P409, DOI 10.1042/0264-6021:3480409; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BECK P, 1965, J LAB CLIN MED, V66, P366; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CERASI E, 1964, LANCET, V2, P769; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Cho Y, 2006, ENDOCRINOLOGY, V147, P5374, DOI 10.1210/en.2006-0518; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; Ducluzeau PH, 2002, DIABETES METAB, V28, P85; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Funaki M, 2004, MOL CELL BIOL, V24, P7567, DOI 10.1128/MCB.24.17.7567-7577.2004; Galetic I, 1999, PHARMACOL THERAPEUT, V82, P409, DOI 10.1016/S0163-7258(98)00071-0; GRONBORG M, 1993, J BIOL CHEM, V268, P23435; Guilherme A, 1998, J BIOL CHEM, V273, P33119, DOI 10.1074/jbc.273.50.33119; Hakuno F, 2007, J BIOL CHEM, V282, P37747, DOI 10.1074/jbc.M702472200; HARE JF, 1989, BIOCHEMISTRY-US, V28, P574, DOI 10.1021/bi00428a024; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V209, P343, DOI 10.1006/bbrc.1995.1509; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Nedachi T, 2000, ENDOCRINOLOGY, V141, P2429, DOI 10.1210/en.141.7.2429; Nelson BA, 2000, DIABETES, V49, P981, DOI 10.2337/diabetes.49.6.981; OKADA T, 1994, J BIOL CHEM, V269, P3568; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; Sakoda H, 2000, DIABETES, V49, P1700, DOI 10.2337/diabetes.49.10.1700; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sasson S, 1997, DIABETOLOGIA, V40, P30, DOI 10.1007/s001250050639; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SMITH RM, 1993, ARCH BIOCHEM BIOPHYS, V300, P238, DOI 10.1006/abbi.1993.1033; Sweeney G, 2001, ENDOCRINOLOGY, V142, P4806, DOI 10.1210/en.142.11.4806; Takano A, 2001, DIABETES, V50, P1891, DOI 10.2337/diabetes.50.8.1891; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Venable CL, 2000, J BIOL CHEM, V275, P18318, DOI 10.1074/jbc.M908392199; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Watson RT, 2001, RECENT PROG HORM RES, V56, P175, DOI 10.1210/rp.56.1.175; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; WHITE MF, 1997, DIABETOLOGIA, V40, P2; Yuen K, 2002, CLIN ENDOCRINOL, V57, P333, DOI 10.1046/j.1365-2265.2002.01601.x	44	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6061	6070		10.1074/jbc.M808282200	http://dx.doi.org/10.1074/jbc.M808282200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19122000	Green Published, hybrid			2022-12-27	WOS:000263742700008
J	Stewart, AK; Kurschat, CE; Vaughan-Jones, RD; Alper, SL				Stewart, Andrew K.; Kurschat, Christine E.; Vaughan-Jones, Richard D.; Alper, Seth L.			Putative Re-entrant Loop 1 of AE2 Transmembrane Domain Has a Major Role in Acute Regulation of Anion Exchange by pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; COEXPRESSED FRAGMENTS; CL-/HCO3-EXCHANGER; INTRACELLULAR PH; BAND-3; PROTEIN; TOPOLOGY; TRANSPORT; REGION; COMPLEMENTATION	Normal pH sensitivity of the SLC4A2/AE2 anion exchanger requires transmembrane domain (TMD) amino acid (aa) residues not conserved in the homologous but relatively pH-insensitive SLC4A1/AE1 polypeptide. We tested the hypothesis that the nonconserved aa cluster (DKPK1078)-D-1075 within the first putative re-entrant loop (RL1) of AE2 TMD contributes to pH sensor function by studying anion exchange function of AE2 mutants in which these and other RL1 aa were systematically substituted with corresponding RL1 aa from AE1. Regulation of Cl-/Cl- and Cl-/HCO3- exchange by intracellular pH (pH(i)) or extracellular pH (pH(o)) was measured as 4,4'-di-isothiocyanatostilbene-2,2' disulfonic acid- sensitive Cl-36(-) efflux from Xenopus oocytes. AE2 RL1 mutants (1075)AAAQ(1078) and (1075)AAAQN(1079) showed reduced pHi sensitivity and pHo sensitivity was acid- shifted by similar to 1 pH unit. Individual mutants D1075A and P1077A exhibited moderately altered pH sensitivity, whereas a range of substitutions at conserved AE2 Ile-1079 substantially altered sensitivity to pH(o) and/or pH(i). Substitution of the complete AE1 RL1 with AE2 RL1 failed to confer AE2-like pH sensitivity onto AE1. Replacement, however, of AE1 RL1 (763)SGPGAAAQ(770) with AE2 (1071)VAPGDKPK(1078) restored pHi sensitivity to the chimera AE2((1-920))/AE1((613-929)) without affecting its low sensitivity to pHo. The results show that acute regulation of AE2 by pH requires RL1 of the TMD. We propose that critical segments of RL1 constitute part of an AE2 pH sensor that, together with residues within the N-terminal half of the TMD, constrain the AE2 polypeptide in a conformation required for regulation of anion exchange by pHi.	[Stewart, Andrew K.; Kurschat, Christine E.; Alper, Seth L.] Beth Israel Deaconess Med Ctr, Mol & Vasc Med Unit, Boston, MA 02215 USA; [Stewart, Andrew K.; Kurschat, Christine E.; Alper, Seth L.] Beth Israel Deaconess Med Ctr, Renal Unit, Boston, MA 02215 USA; [Stewart, Andrew K.; Kurschat, Christine E.; Alper, Seth L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Vaughan-Jones, Richard D.] Univ Oxford, Univ Lab Physiol, Burdon Sanderson Cardiac Sci Ctr, Oxford OX1 3PT, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Oxford	Alper, SL (corresponding author), Beth Israel Deaconess Med Ctr, Mol & Vasc Med Unit, RW763 E Campus,330 Brookline Ave, Boston, MA 02215 USA.	salper@caregroup.harvard.edu			National Institutes of Health [DK43495]; Beth Israel Deaconess Medical Center [RR017927]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043495, R37DK043495] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/016/26423] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beth Israel Deaconess Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); British Heart Foundation(British Heart Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grants DK43495 ( to S. L. A.) and RR017927 ( Shared Instrument Grant) to Beth Israel Deaconess Medical Center.	BROSIUS FC, 1989, J BIOL CHEM, V264, P7784; Chernova MN, 2003, AM J PHYSIOL-CELL PH, V284, pC1235, DOI 10.1152/ajpcell.00522.2002; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; GRINSTEIN S, 1978, BIOCHIM BIOPHYS ACTA, V507, P294, DOI 10.1016/0005-2736(78)90424-8; Groves JD, 1998, BIOCHEM J, V332, P161, DOI 10.1042/bj3320161; Groves JD, 1999, BIOCHEM J, V344, P687, DOI 10.1042/0264-6021:3440687; Hackel M, 1999, BIOPHYS CHEM, V82, P35, DOI 10.1016/S0301-4622(99)00104-0; JEAN T, 1985, J BIOL CHEM, V260, P9678; Kanki T, 2002, BIOCHEMISTRY-US, V41, P13973, DOI 10.1021/bi026619q; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; Kuma H, 2002, BIOCHEMISTRY-US, V41, P3380, DOI 10.1021/bi015879p; Kurschat CE, 2006, J BIOL CHEM, V281, P1885, DOI 10.1074/jbc.M509734200; LINN SC, 1992, J BIOL CHEM, V267, P7927; Matta CF, 2003, PROTEINS, V52, P360, DOI 10.1002/prot.10414; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Niederer SA, 2008, BIOPHYS J, V94, P2385, DOI 10.1529/biophysj.107.118885; Popov M, 1999, BIOCHEM J, V339, P269, DOI 10.1042/0264-6021:3390269; Sackin H, 2006, BIOPHYS J, V90, P3582, DOI 10.1529/biophysj.105.076653; Stewart AK, 2007, J PHYSIOL-LONDON, V584, P59, DOI 10.1113/jphysiol.2007.136119; Stewart AK, 2007, PFLUG ARCH EUR J PHY, V454, P373, DOI 10.1007/s00424-007-0220-8; Stewart AK, 2007, AM J PHYSIOL-CELL PH, V292, pC909, DOI 10.1152/ajpcell.00265.2006; Stewart AK, 2004, J BIOL CHEM, V279, P52664, DOI 10.1074/jbc.M408108200; Stewart AK, 2002, J GEN PHYSIOL, V120, P707, DOI 10.1085/jgp.20028641; Stewart AK, 2001, AM J PHYSIOL-CELL PH, V281, pC1344, DOI 10.1152/ajpcell.2001.281.4.C1344; STEWART AK, 2007, KIDNEY, V2, P1499; Tang XB, 1998, J BIOL CHEM, V273, P22545, DOI 10.1074/jbc.273.35.22545; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; VAUGHANJONES RD, 1990, J PHYSIOL-LONDON, V428, P441, DOI 10.1113/jphysiol.1990.sp018221; Wang L, 1997, J BIOL CHEM, V272, P10631; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; WOOD PG, 1992, PROGR CELL RES, V2, P325; Zhang Y, 1996, J BIOL CHEM, V271, P5741, DOI 10.1074/jbc.271.10.5741; Zhu QS, 2004, J BIOL CHEM, V279, P23565, DOI 10.1074/jbc.M401380200; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200	36	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6126	6139		10.1074/jbc.M802051200	http://dx.doi.org/10.1074/jbc.M802051200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19103596	hybrid, Green Published			2022-12-27	WOS:000263742700015
J	Herbert, SP; Odell, AF; Ponnambalam, S; Walker, JH				Herbert, Shane P.; Odell, Adam F.; Ponnambalam, Sreenivasan; Walker, John H.			Activation of Cytosolic Phospholipase A(2)-alpha as a Novel Mechanism Regulating Endothelial Cell Cycle Progression and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; PROLIFERATING CELLS; DNA-REPLICATION; ANTIBODY KI-67; IN-VITRO; A(2); EXPRESSION; MEMBRANE; PATHWAY; ANTIGEN	Release of endothelial cells from contact-inhibition and cell cycle re-entry is required for the induction of new blood vessel formation by angiogenesis. Using a combination of chemical inhibition, loss of function, and gain of function approaches, we demonstrate that endothelial cell cycle re-entry, S phase progression, and subsequent angiogenic tubule formation are dependent upon the activity of cytosolic phospholipase A(2)-alpha (cPLA(2)alpha). Inhibition of cPLA(2)alpha activity and small interfering RNA (siRNA)-mediated knockdown of endogenous cPLA(2)alpha reduced endothelial cell proliferation. In the absence of cPLA(2)alpha activity, endothelial cells exhibited retarded progression from G(1) through S phase, displayed reduced cyclin A/cdk2 expression, and generated less arachidonic acid. In quiescent endothelial cells, cPLA(2)alpha is inactivated upon its sequestration at the Golgi apparatus. Upon the stimulation of endothelial cell proliferation, activation of cPLA(2)alpha by release from the Golgi apparatus was critical to the induction of cyclin A expression and efficient cell cycle progression. Consequently, inhibition of cPLA(2)alpha was sufficient to block angiogenic tubule formation in vitro. Furthermore, the siRNA-mediated retardation of endothelial cell cycle re-entry and proliferation was reversed upon overexpression of an siRNA-resistant form of cPLA(2)alpha. Thus, activation of cPLA(2)alpha acts as a novel mechanism for the regulation of endothelial cell cycle re-entry, cell cycle progression, and angiogenesis.	[Herbert, Shane P.; Odell, Adam F.; Ponnambalam, Sreenivasan; Walker, John H.] Univ Leeds, Endothelial Cell Biol Unit, Inst Mol & Cell Biol, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Walker, JH (corresponding author), Univ Leeds, Endothelial Cell Biol Unit, Inst Mol & Cell Biol, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England.	j.h.walker@leeds.ac.uk	Odell, Adam/J-1386-2012	Herbert, Shane/0000-0003-2517-1845; Ponnambalam, Sreenivasan/0000-0002-4452-7619	Biotechnology and Biological Sciences Research Council; Yorkshire Cancer Research; British Heart Foundation; Wellcome Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Yorkshire Cancer Research; British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Biotechnology and Biological Sciences Research Council Ph. D. studentship ( to S. P. H.), a Yorkshire Cancer Research pump priming grant ( to S. P. H. and J.H.W.), a British Heart Foundation project grant ( to S. P. and J.H.W.), a Wellcome Trust project grant ( to S. P. and J.H.W.), and a Wellcome Trust equipment award to the Leeds Bioimaging Facility ( to S. P.).	ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Boonstra Johannes, 2003, Prog Cell Cycle Res, V5, P181; BREM H, 1993, J PEDIATR SURG, V28, P1253, DOI 10.1016/S0022-3468(05)80308-2; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; Dormond O, 2002, ANTICANCER RES, V22, P3159; EVANS CE, 1984, PROSTA LEUKOTR MED, V14, P255, DOI 10.1016/0262-1746(84)90209-9; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Ezan J, 2004, CARDIOVASC RES, V63, P731, DOI 10.1016/j.cardiores.2004.05.006; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; GERDES J, 1984, J IMMUNOL, V133, P1710; Ghomashchi F, 2001, BBA-BIOMEMBRANES, V1513, P160, DOI 10.1016/S0005-2736(01)00349-2; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Herbert SP, 2007, J BIOL CHEM, V282, P34468, DOI 10.1074/jbc.M701541200; Herbert SP, 2006, J BIOL CHEM, V281, P35709, DOI 10.1074/jbc.M600699200; Herbert SP, 2005, MOL BIOL CELL, V16, P3800, DOI 10.1091/mbc.E05-02-0164; Howell GJ, 2004, MOL MEMBR BIOL, V21, P413, DOI 10.1080/09687860400011571; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; Jaffe EA, 1984, BIOL ENDOTHELIAL CEL, P1; Jiang YJ, 2003, MOL CELL BIOCHEM, V246, P31, DOI 10.1023/A:1023495626568; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mariggio S, 2006, FASEB J, V20, P2567, DOI 10.1096/fj.05-5397fje; Murakami M, 2000, BBA-MOL CELL BIOL L, V1488, P159, DOI 10.1016/S1388-1981(00)00118-9; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Ni Z, 2006, J BIOL CHEM, V281, P16245, DOI 10.1074/jbc.M513874200; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; Sauane M, 2000, BIOCHEM BIOPH RES CO, V270, P11, DOI 10.1006/bbrc.2000.2383; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Scott KF, 1999, J LEUKOCYTE BIOL, V66, P535, DOI 10.1002/jlb.66.4.535; Shappell SB, 2001, CANCER RES, V61, P497; Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x; TAKAHASHI T, 1993, J NEUROCYTOL, V22, P1096, DOI 10.1007/BF01235751; Tian W, 2008, J BIOL CHEM, V283, P3960, DOI 10.1074/jbc.M707345200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van Rossum GSAT, 2002, CELL MOL LIFE SCI, V59, P181, DOI 10.1007/s00018-002-8414-x; WHATLEY RE, 1994, J CLIN INVEST, V94, P1889, DOI 10.1172/JCI117539; Yazlovitskaya EM, 2008, CELL DEATH DIFFER, V15, P1641, DOI 10.1038/cdd.2008.93; Zhang XH, 2006, J CELL SCI, V119, P1005, DOI 10.1242/jcs.02821; Zhang XH, 2007, J CELL SCI, V120, P4134, DOI 10.1242/jcs.015834	50	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5784	5796		10.1074/jbc.M807282200	http://dx.doi.org/10.1074/jbc.M807282200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19119141	Green Published, hybrid			2022-12-27	WOS:000263560600042
J	Miki, T; Okawa, K; Sekimoto, T; Yoneda, Y; Watanabe, S; Ishizaki, T; Narumiya, S				Miki, Takashi; Okawa, Katsuya; Sekimoto, Toshihiro; Yoneda, Yoshihiro; Watanabe, Sadanori; Ishizaki, Toshimasa; Narumiya, Shuh			mDia2 Shuttles between the Nucleus and the Cytoplasm through the Importin-alpha/beta- and CRM1-mediated Nuclear Transport Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOREGULATORY DOMAIN; RIBOSOMAL-SUBUNITS; EXPORT SIGNALS; FORMIN MDIA1; ACTIN; PROTEIN; LOCALIZATION; BINDING; TRANSCRIPTION; PROFILIN	Mammalian homolog of Drosophila diaphanous (mDia) consisting of three isoforms, mDia1, mDia2, and mDia3, is an effector of Rho GTPases that catalyzes actin nucleation and polymerization. Although the mDia actions on actin dynamics in the cytoplasm have been well studied, whether mDia accumulates and functions in the nucleus remains largely unknown. Given the presence of actin and actin-associated proteins in the nucleus, we have examined nuclear localization of mDia isoforms. We expressed each of mDia isoforms as a green fluorescent protein fusion protein and examined their localization. Although all the mDia isoforms were localized predominantly in the cytoplasm under the steady-state conditions, mDia2 and not mDia1 or mDia3 accumulated extensively in the nucleus upon treatment with leptomycin B (LMB), an inhibitor of CRM1-dependent nuclear export. The LMB-inducednuclear accumulation was confirmed for endogenous mDia2 by using an antibody specific to mDia2. Studies using green fluorescent protein fusions of various truncation mDia2 mutants and point mutants of some of these proteins identified a functional nuclear localization signal in the N terminus of mDia2 and at least one functional nuclear export signal in the C terminus. The nuclear localization signal of mDia2 bound to importin-alpha and was imported into the nucleus by importin-alpha/beta complex in an in vitro transport assay. Consistently, depletion of importin-beta with RNA interference suppressed the LMB-induced nuclear localization of endogenous mDia2. These results suggest that mDia2 continuously shuttles between the nucleus and the cytoplasm using specific nuclear transport machinery composing of importin-alpha/beta and CRM1.	[Miki, Takashi; Watanabe, Sadanori; Ishizaki, Toshimasa; Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan; [Okawa, Katsuya] Kyoto Univ, Fac Med, Frontier Technol Ctr, Kyoto 6068501, Japan; [Sekimoto, Toshihiro; Yoneda, Yoshihiro] Osaka Univ, Dept Biochem, Grad Sch Med, Suita, Osaka 5650871, Japan; [Yoneda, Yoshihiro] Osaka Univ, Labs Biomol Networks, Dept Frontier Biosci, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Yoneda, Yoshihiro] CREST, JST, Suita, Osaka 5650871, Japan	Kyoto University; Kyoto University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Narumiya, S (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan.	snaru@mfour.med.kyoto-u.ac.jp	Miki, Takashi/AGV-9237-2022; Miki, Takashi/S-7569-2018	Miki, Takashi/0000-0003-3715-7039; Miki, Takashi/0000-0003-3715-7039	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Kiseleva E, 2004, J CELL SCI, V117, P2481, DOI 10.1242/jcs.01098; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Macchi P, 2004, J BIOL CHEM, V279, P31440, DOI 10.1074/jbc.C400226200; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Menard I, 2006, APOPTOSIS, V11, P1863, DOI 10.1007/s10495-006-0087-8; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Miki T, 2004, J BIOL CHEM, V279, P47473, DOI 10.1074/jbc.M407883200; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Pederson T, 2005, MOL BIOL CELL, V16, P5055, DOI 10.1091/mbc.E05-07-0656; Pederson T, 2008, J CELL BIOL, V180, P1061, DOI 10.1083/jcb.200709082; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Percipalle P, 2006, J CELL BIOL, V172, P967, DOI 10.1083/jcb.200512083; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Skare P, 2003, EXP CELL RES, V286, P12, DOI 10.1016/S0014-4827(03)00102-2; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Suetsugu S, 2003, J BIOL CHEM, V278, P42515, DOI 10.1074/jbc.M302177200; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Yasuda S, 2004, NATURE, V428, P767, DOI 10.1038/nature02452; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	49	38	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5753	5762		10.1074/jbc.M806191200	http://dx.doi.org/10.1074/jbc.M806191200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117945	hybrid			2022-12-27	WOS:000263560600039
J	Tang, TD; Zheng, B; Chen, SH; Murphy, AN; Kudlicka, K; Zhou, HL; Farquhar, MG				Tang, Tingdong; Zheng, Bin; Chen, Sheng-Hong; Murphy, Anne N.; Kudlicka, Krystyna; Zhou, Huilin; Farquhar, Marilyn G.			hNOA1 Interacts with Complex I and DAP3 and Regulates Mitochondrial Respiration and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CELL-DEATH; ENDOPLASMIC-RETICULUM; PROTEIN; FISSION; IDENTIFICATION; MUTATIONS; MEDIATOR; BINDING; FUSION	Mitochondria are dynamic organelles that play key roles in metabolism, energy production, and apoptosis. Coordination of these processes is essential to maintain normal cellular functions. Here we characterized hNOA1, the human homologue of AtNOA1 (Arabidopsis thaliana nitric oxide-associated protein 1), a large mitochondrial GTPase. By immunofluorescence, immunoelectron microscopy, and mitochondrial subfractionation, endogenous hNOA1 is localized within mitochondria where it is peripherally associated with the inner mitochondrial membrane facing the mitochondrial matrix. Overexpression and knockdown of hNOA1 led to changes in mitochondrial shape implying effects on mitochondrial dynamics. To identify the interaction partners of hNOA1 and to further understand its cellular functions, we performed immunoprecipitation-mass spectrometry analysis of endogenous hNOA1 from enriched mitochondrial fractions and found that hNOA1 interacts with both Complex I of the electron transport chain and DAP3 (death-associated protein 3), a positive regulator of apoptosis. Knockdown of hNOA1 reduces mitochondrial O-2 consumption similar to 20% in a Complex I-dependent manner, supporting a functional link between hNOA1 and Complex I. Moreover, knockdown of hNOA1 renders cells more resistant to apoptotic stimuli such as gamma-interferon and staurosporine, supporting a role for hNOA1 in regulating apoptosis. Thus, based on its interactions with both Complex I and DAP3, hNOA1 may play a role in mitochondrial respiration and apoptosis.	[Farquhar, Marilyn G.] Univ Calif San Diego, Dept Cellular & Mol Med, George Palade Labs Cellular & Mol Med, La Jolla, CA 92093 USA; [Murphy, Anne N.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Chen, Sheng-Hong; Zhou, Huilin] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Farquhar, MG (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, George Palade Labs Cellular & Mol Med, Rm 210,9500 Gilman Dr, La Jolla, CA 92093 USA.	mfarquhar@ucsd.edu	Chen, Sheng-hong/AAU-4018-2021; Murphy, Anne N/H-3217-2016	Chen, Sheng-hong/0000-0002-7722-2221; Murphy, Anne N/0000-0002-5222-9902; Zheng, Bin/0000-0002-0998-7177; Zhou, Huilin/0000-0002-1350-4430	National Institutes of Health [CA100768, DKI7780]; NATIONAL CANCER INSTITUTE [R01CA100768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100768 and DKI7780 ( to M. G. F.).	ALBERTS B, 2008, MOL BIOL CELL, V5, P827; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Berger T, 2000, J CELL SCI, V113, P3603; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Cardol P, 2002, J MOL BIOL, V319, P1211, DOI 10.1016/S0022-2836(02)00407-2; CAVDAR KE, 2001, FEBS LETT, V492, P166; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; CORTESE JD, 1995, BBA-BIOENERGETICS, V1228, P216, DOI 10.1016/0005-2728(94)00178-8; Crawford NM, 2006, TRENDS PLANT SCI, V11, P526, DOI 10.1016/j.tplants.2006.09.007; DiMauro S, 2001, SEMIN CELL DEV BIOL, V12, P397, DOI 10.1006/scdb.2001.0277; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fukushima NH, 2001, MOL BIOL CELL, V12, P2756, DOI 10.1091/mbc.12.9.2756; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Hobman TC, 1998, MOL BIOL CELL, V9, P1265, DOI 10.1091/mbc.9.6.1265; Huang S, 1997, J NEUROCHEM, V69, P2516; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Jofuku A, 2005, BIOCHEM BIOPH RES CO, V333, P650, DOI 10.1016/j.bbrc.2005.05.154; Kim HR, 2007, FASEB J, V21, P188, DOI 10.1096/fj.06-6283com; Kim R, 2006, CANCER CHEMOTH PHARM, V57, P545, DOI 10.1007/s00280-005-0111-7; KISSIL JL, 1995, J BIOL CHEM, V270, P27932, DOI 10.1074/jbc.270.46.27932; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; LAPIDUS RG, 1993, ARCH BIOCHEM BIOPHYS, V306, P246, DOI 10.1006/abbi.1993.1507; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lehtonen S, 2008, MOL BIOL CELL, V19, P2949, DOI 10.1091/mbc.E07-05-0521; Lenaz G, 2006, BBA-BIOENERGETICS, V1757, P1406, DOI 10.1016/j.bbabio.2006.05.007; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Mukamel Z, 2004, J BIOL CHEM, V279, P36732, DOI 10.1074/jbc.M400041200; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Nagai M, 2003, MOL BIOL CELL, V14, P4984, DOI 10.1091/mbc.E03-06-0385; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Parihar A, 2008, LIFE SCI, V82, P1077, DOI 10.1016/j.lfs.2008.03.019; Parihar MS, 2008, BBA-GEN SUBJECTS, V1780, P921, DOI 10.1016/j.bbagen.2008.02.006; Parihar MS, 2008, BIOCHEM BIOPH RES CO, V367, P761, DOI 10.1016/j.bbrc.2008.01.015; Parihar MS, 2008, BIOCHEM BIOPH RES CO, V366, P23, DOI 10.1016/j.bbrc.2007.11.056; Santel A, 2001, J CELL SCI, V114, P867; Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Suzuki T, 2001, J BIOL CHEM, V276, P33181, DOI 10.1074/jbc.M103236200; Tondera D, 2005, J CELL SCI, V118, P3049, DOI 10.1242/jcs.02415; Venkatakrishnan P, 2008, FASEB J, V22; Vrbacky M, 2003, PHYSIOL RES, V52, P545; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Zemojtel T, 2006, FEBS LETT, V580, P455, DOI 10.1016/j.febslet.2005.12.038; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008; Zheng B, 2004, MOL BIOL CELL, V15, p322A, DOI 10.1091/mbc.e04-06-0446; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	57	32	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5414	5424		10.1074/jbc.M807797200	http://dx.doi.org/10.1074/jbc.M807797200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103604	Green Published, hybrid			2022-12-27	WOS:000263416600071
J	Tan, YW; Chan, SL; Ong, TC; Yit, LY; Tiong, YS; Chew, FT; Sivaraman, J; Mok, YK				Tan, Yih Wan; Chan, Siew Leong; Ong, Tan Ching; Yit, Le Yau; Tiong, Yuen Sung; Chew, Fook Tim; Sivaraman, J.; Mok, Yu Keung			Structures of Two Major Allergens, Bla g 4 and Per a 4, from Cockroaches and Their IgE Binding Epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOCALIN PROTEIN FAMILY; BOVINE BETA-LACTOGLOBULIN; CRYSTAL-STRUCTURE; MOLECULAR-STRUCTURE; STRUCTURE ALIGNMENT; APOLIPOPROTEIN-D; RESOLUTION; ANTIBODY; CLONING; SITE	Inhalant allergens from cockroaches are an important cause of asthma to millions of individuals worldwide. Here we report for the first time the structures of two major cockroach allergens, Bla g 4 and Per a 4, that adopt a typical lipocalin fold but with distinct structural features as compared with other known lipocalin allergens. Both Bla g 4 and Per a 4 contain two long-range disulfide bonds linking the N and C termini to a beta-barrel. The C-terminal helix of Bla g 4 is bent and greatly extended toward the N terminus. Bla g 4 is found to be a monomer, whereas Per a 4 exists as a dimer in solution with a novel dimeric interface involving residues from loops at the top and bottom of the beta-barrel. Putative ligand binding sites of both allergens are determined by docking of the juvenile hormone III inside the beta-barrel and found to interact with the ligand using non-conserved residues. Bla g 4 and Per a 4 are found to be cross-reactive in sera IgE binding, at least in the Singaporean Chinese population tested. A major IgE binding epitope unique to Per a 4 is found on the loops at the bottom of the beta-barrel that may aid the development of hypoallergens for immunotherapy.	[Tan, Yih Wan; Chan, Siew Leong; Ong, Tan Ching; Yit, Le Yau; Tiong, Yuen Sung; Chew, Fook Tim; Sivaraman, J.; Mok, Yu Keung] Natl Univ Singapore, Dept Biol Sci, Singapore 17543, Singapore	National University of Singapore	Sivaraman, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 17543, Singapore.	dbsjayar@dbs.nus.edu.sg; dbsmokh@nus.edu.sg	Sivaraman, J/H-8028-2012; Chew, Fook Tim/E-7259-2010; Mok, Yu Keung/H-8019-2012	Chew, Fook Tim/0000-0003-1337-5146; Mok, Yu Keung/0000-0002-2829-4878; J, Sivaraman/0000-0001-9781-5326	Academic Research Fund; National University of Singapore [R-154-000-349-112, R-154-000-245112]; Biomedical Research Council [04/1/21/19/315]; Agency for Science Technology and Research (A*STAR)	Academic Research Fund(Ministry of Education, Singapore); National University of Singapore(National University of Singapore); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency for Science Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This work was supported by Academic Research Fund, National University of Singapore Grants R-154-000-349-112 ( to Y. K. M.) and R-154-000-245112 ( to J.S.) and Biomedical Research Council Grant 04/1/21/19/315 from the Agency for Science Technology and Research (A*STAR), Singapore ( to F. T. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arruda LK, 1995, J BIOL CHEM, V270, P31196, DOI 10.1074/jbc.270.52.31196; ARRUDA LK, 1995, J BIOL CHEM, V270, P19563, DOI 10.1074/jbc.270.33.19563; BERNTON HS, 1964, J ALLERGY, V35, P506, DOI 10.1016/0021-8707(64)90082-6; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Breustedt DA, 2006, BBA-PROTEINS PROTEOM, V1764, P161, DOI 10.1016/j.bbapap.2005.12.006; Brownlow S, 1997, STRUCTURE, V5, P481, DOI 10.1016/S0969-2126(97)00205-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calderone V, 2003, J MOL BIOL, V329, P841, DOI 10.1016/S0022-2836(03)00468-6; Chan SL, 2008, J IMMUNOL, V181, P2586, DOI 10.4049/jimmunol.181.4.2586; Chaudhuri BN, 1999, ACTA CRYSTALLOGR D, V55, P753, DOI 10.1107/S0907444998017211; Chew FT, 1999, ALLERGY, V54, P1150, DOI 10.1034/j.1398-9995.1999.00050.x; DeLano W, 2002, PYMOL 0 99; Eggleston PA, 1998, J ALLERGY CLIN IMMUN, V102, P563, DOI 10.1016/S0091-6749(98)70272-6; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan Y, 2005, INSECT MOL BIOL, V14, P45, DOI 10.1111/j.1365-2583.2004.00530.x; FLOWER DR, 1994, FEBS LETT, V354, P7, DOI 10.1016/0014-5793(94)01078-1; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Gao YF, 2007, J ALLERGY CLIN IMMUN, V120, P105, DOI 10.1016/j.jaci.2007.02.032; Gore JC, 2007, ANNU REV ENTOMOL, V52, P439, DOI 10.1146/annurev.ento.52.110405.091313; HOLDEN HM, 1987, EMBO J, V6, P1565, DOI 10.1002/j.1460-2075.1987.tb02401.x; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; Kauppinen J, 1999, CLIN EXP ALLERGY, V29, P989; Kontopidis G, 2002, J MOL BIOL, V318, P1043, DOI 10.1016/S0022-2836(02)00017-7; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Lucke C, 1999, EUR J BIOCHEM, V266, P1210, DOI 10.1046/j.1432-1327.1999.00984.x; Melen E, 1999, J ALLERGY CLIN IMMUN, V103, P859, DOI 10.1016/S0091-6749(99)70430-6; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Ortlund E, 2002, BIOCHEMISTRY-US, V41, P7030, DOI 10.1021/bi025696i; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pomes A, 2007, PROTEIN PEPTIDE LETT, V14, P960, DOI 10.2174/092986607782541178; Pomes A, 2002, AM J RESP CRIT CARE, V165, P391, DOI 10.1164/ajrccm.165.3.2104027; REDDY BMMMK, 1992, MOL IMMUNOL, V29, P511, DOI 10.1016/0161-5890(92)90008-L; Rouvinen J, 1999, J BIOL CHEM, V274, P2337, DOI 10.1074/jbc.274.4.2337; Shimamoto S, 2007, J BIOL CHEM, V282, P31373, DOI 10.1074/jbc.M700123200; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Smith W, 2004, CLIN EXP ALLERGY, V34, P1732, DOI 10.1111/j.1365-2222.2004.02090.x; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; YANG CY, 1994, BIOCHEMISTRY-US, V33, P12451, DOI 10.1021/bi00207a011	50	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3148	3157		10.1074/jbc.M807209200	http://dx.doi.org/10.1074/jbc.M807209200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19056737	hybrid			2022-12-27	WOS:000262700900059
J	Emadi, S; Kasturirangan, S; Wang, MS; Schulz, P; Sierks, MR				Emadi, Sharareh; Kasturirangan, Srinath; Wang, Min S.; Schulz, Philip; Sierks, Michael R.			Detecting Morphologically Distinct Oligomeric Forms of alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BY-PASSING IMMUNIZATION; MULTIPLE SYSTEM ATROPHY; A-BETA COMPONENT; PARKINSONS-DISEASE; PROTEIN MORPHOLOGIES; CEREBROSPINAL-FLUID; HUMAN-ANTIBODIES; PHAGE DISPLAY; LEWY BODIES; CELL-DEATH	Neuropathologic and genetics studies as well as transgenic animal models have provided strong evidence linking misfolding and aggregation of alpha-synuclein to the progression of Parkinson disease (PD) and other related disorders. A growing body of evidence implicates various oligomeric forms of alpha-synuclein as the toxic species responsible for neurodegeneration and neuronal cell death. Although numerous different oligomeric forms of alpha-synuclein have been identified in vitro, it is not known which forms are involved in PD or how, when, and where different forms contribute to the progression of PD. Reagents that can interact with specific aggregate forms of alpha-synuclein would be very useful not only as tools to study how different aggregate forms affect cell function, but also as potential diagnostic and therapeutic agents for PD. Here we show that a single chain antibody fragment (syn-10H scFv) isolated from a phage display antibody library binds to a larger, later stage oligomeric form of alpha-synuclein than a previously reported oligomeric specific scFv isolated in our laboratory. The scFv described here inhibits aggregation of alpha-synuclein in vitro, blocks extracellular alpha-synuclein-induced toxicity in both undifferentiated and differentiated human neuroblastoma cell lines (SH-SY5Y), and specifically recognizes naturally occurring aggregates in PD but not in healthy human brain tissue.	[Emadi, Sharareh; Kasturirangan, Srinath; Wang, Min S.; Schulz, Philip; Sierks, Michael R.] Arizona State Univ, Dept Chem Engn, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Sierks, MR (corresponding author), Box 876006, Tempe, AZ 85287 USA.	sierks@asu.edu	Wang, Min/C-6495-2009	Wang, Min/0000-0002-8978-4918	Michael J. Fox Foundation; Michael J. Fox Foundation, the Arizona Department of Health Services for the Arizona Alzheimer's Consortium; Arizona Biomedical Research Commission	Michael J. Fox Foundation; Michael J. Fox Foundation, the Arizona Department of Health Services for the Arizona Alzheimer's Consortium; Arizona Biomedical Research Commission	This work was supported by grants from the Michael J. Fox Foundation, the Arizona Department of Health Services for the Arizona Alzheimer's Consortium, and the Arizona Biomedical Research Commission. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apetri MM, 2006, J MOL BIOL, V355, P63, DOI 10.1016/j.jmb.2005.10.071; Baba M, 1998, AM J PATHOL, V152, P879; Barkhordarian H, 2006, PROTEIN ENG DES SEL, V19, P497, DOI 10.1093/protein/gzl036; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Bodles AM, 2000, EUR J BIOCHEM, V267, P2186, DOI 10.1046/j.1432-1327.2000.01219.x; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Emadi S, 2007, J MOL BIOL, V368, P1132, DOI 10.1016/j.jmb.2007.02.089; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Golts N, 2002, J BIOL CHEM, V277, P16116, DOI 10.1074/jbc.M107866200; Gomez-Tortosa E, 1999, NEUROLOGY, V53, P1284, DOI 10.1212/WNL.53.6.1284; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel Hilal A., 2004, V299, P19; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Liu RT, 2004, BIOCHEMISTRY-US, V43, P6959, DOI 10.1021/bi049933o; Marcus WD, 2006, BIOCHEM BIOPH RES CO, V342, P1123, DOI 10.1016/j.bbrc.2006.02.073; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Murphy RC, 2004, MOL BRAIN RES, V121, P141, DOI 10.1016/j.molbrainres.2003.11.011; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; PAHLMAN S, 1995, EUR J CANCER, V31A, P453, DOI 10.1016/0959-8049(95)00033-F; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Presgraves SP, 2004, NEUROTOX RES, V5, P579, DOI 10.1007/bf03033178; Price DL, 1999, NATURE, V399, pA3, DOI 10.1038/399a003; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schapira AHV, 1997, BAILLIERE CLIN NEUR, V6, P15; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wakabayashi K, 1998, ACTA NEUROPATHOL, V96, P445, DOI 10.1007/s004010050918; Wang MS, 2009, LANGMUIR, V25, P912, DOI 10.1021/la8025914; Wheeler YRY, 2003, MOL THER, V8, P355, DOI 10.1016/S1525-0016(03)00183-7; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zameer A, 2008, J MOL BIOL, V384, P917, DOI 10.1016/j.jmb.2008.09.068; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou C, 2004, MOL THER, V10, P1023, DOI 10.1016/j.ymthe.2004.08.019	66	74	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11048	11058		10.1074/jbc.M806559200	http://dx.doi.org/10.1074/jbc.M806559200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19141614	Green Published, hybrid			2022-12-27	WOS:000265494500009
J	Tremblay, F; Revett, T; Huard, C; Zhang, Y; Tobin, JF; Martinez, RV; Gimeno, RE				Tremblay, Frederic; Revett, Tracy; Huard, Christine; Zhang, Ying; Tobin, James F.; Martinez, Robert V.; Gimeno, Ruth E.			Bidirectional Modulation of Adipogenesis by the Secreted Protein Ccdc80/DRO1/URB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; GLYCOGEN-SYNTHASE KINASE-3-BETA; ADIPOSE-TISSUE; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; GENE-EXPRESSION; KINASE PATHWAY; INHIBITION; OBESITY	Adipocyte-secreted proteins play important roles in metabolic regulation through autocrine, paracrine, and endocrine mechanisms. Using transcriptional profiling, we identified coiled-coil domain containing 80 (Ccdc80; also known as DRO1 and URB) as a novel secreted protein highly expressed in white adipose tissue. In 3T3-L1 cells Ccdc80 is expressed and secreted in a biphasic manner with high levels in postconfluent preadipocytes and terminally differentiated adipocytes. To determine whether Ccdc80 regulates adipocyte differentiation, Ccdc80 expression was manipulated using both knockdown and overexpression approaches. Small hairpin RNA-mediated silencing of Ccdc80 in 3T3-L1 cells inhibits adipocyte differentiation. This phenotype was partially reversed by treating the knockdown cells with Ccdc80-containing conditioned medium from differentiated 3T3-L1 cells. Molecular studies indicate that Ccdc80 is required for the full inhibition of T-cell factor-mediated transcriptional activity, down-regulation of Wnt/beta-catenin target genes during clonal expansion, and the subsequent induction of C/EBP alpha and peroxisome proliferator-activated receptor gamma. Surprisingly, overexpression of Ccdc80 in 3T3-L1 cells also inhibits adipocyte differentiation without affecting the repression of the Wnt/beta-catenin signaling pathway. Taken together, these data suggest that Ccdc80 plays dual roles in adipogenesis by mechanisms that involve at least in part down-regulation of Wnt/beta-catenin signaling and induction of C/EBP alpha and peroxisome proliferator-activated receptor gamma.	[Tremblay, Frederic; Revett, Tracy; Tobin, James F.; Gimeno, Ruth E.] Wyeth Res, Dept Metab Dis, Cambridge, MA 02140 USA; [Huard, Christine; Zhang, Ying; Martinez, Robert V.] Wyeth Res, Dept Biol Technol, Cambridge, MA 02140 USA	Pfizer; Pfizer	Gimeno, RE (corresponding author), Wyeth Res, Dept Metab Dis, 200 Cambridge Pk Dr, Cambridge, MA 02140 USA.	rgimeno@wyeth.com						Aoki K, 2002, BIOCHEM BIOPH RES CO, V290, P1282, DOI 10.1006/bbrc.2002.6337; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Berasi SP, 2006, J BIOL CHEM, V281, P27167, DOI 10.1074/jbc.M602416200; Bommer GT, 2005, J BIOL CHEM, V280, P7962, DOI 10.1074/jbc.M412593200; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Christodoulides C, 2006, DIABETOLOGIA, V49, P678, DOI 10.1007/s00125-006-0144-4; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lee KW, 2002, J ENDOCRINOL, V175, P33, DOI 10.1677/joe.0.1750033; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI [10.1074/jbc.M402920200, 10.1074/jbc.M407050200]; Liu Y, 2004, BIOCHEM BIOPH RES CO, V322, P497, DOI 10.1016/j.bbrc.2004.07.161; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; MACDOUGALD OA, 1995, P NATL ACAD SCI USA, V92, P9034, DOI 10.1073/pnas.92.20.9034; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Marcantonio D, 2001, ENDOCRINOLOGY, V142, P2409, DOI 10.1210/endo.142.6.8154; Mei BS, 2002, BIOCHEM J, V364, P137, DOI 10.1042/bj3640137; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nawrocki AR, 2005, DRUG DISCOV TODAY, V10, P1219, DOI 10.1016/S1359-6446(05)03569-5; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Okada T, 2008, BIOCHEM BIOPH RES CO, V367, P370, DOI 10.1016/j.bbrc.2007.12.164; Orlicky DJ, 2001, J LIPID RES, V42, P460; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Visconti R, 2003, ONCOGENE, V22, P1087, DOI 10.1038/sj.onc.1206194; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Wang YH, 2006, MOL CELL BIOL, V26, P5421, DOI 10.1128/MCB.02437-05; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339	55	41	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8136	8147		10.1074/jbc.M809535200	http://dx.doi.org/10.1074/jbc.M809535200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19141617	Green Published, hybrid			2022-12-27	WOS:000264195600076
J	Figueredo, SM; Weeks, CS; Young, SK; Ouellette, AJ				Figueredo, Sharel M.; Weeks, Colby S.; Young, Steven K.; Ouellette, Andre J.			Anionic Amino Acids near the Pro-alpha-defensin N Terminus Mediate Inhibition of Bactericidal Activity in Mouse Pro-cryptdin-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANETH CELL; ANTIMICROBIAL PEPTIDES; MATRIX METALLOPROTEINASE-7; INNATE IMMUNITY; SMALL-INTESTINE; CRYPTDIN-4; ACTIVATION; MEMBRANE; DETERMINANTS; RECOGNITION	In mouse Paneth cells, alpha-defensins, termed cryptdins (Crps), are activated by matrix metalloproteinase-7-mediated proteolysis of inactive precursors (pro-Crps) to bactericidal forms. The activating cleavage step at Ser(43) down arrow Ile(44) in mouse pro-Crp4-(20-92) removes nine acidic amino acids that collectively block the membrane-disruptive behavior of the Crp4 moiety of the proform. This inhibitory mechanism has been investigated further to identify whether specific cluster(s) of electronegative amino acids in pro-Crp4-(20-43) are responsible for blocking bactericidal activity and membrane disruption. To test whether specific cluster(s) of electronegative amino acids in pro-Crp4-(20 43) have specific positional effects that block bactericidal peptide activity and membrane disruption, acidic residues positioned at the distal (Asp(20), Asp(26), Glu(27), and Glu(28)), mid (Glu(32) and Glu(33)), and proximal (Glu(37), Glu(38), and Asp(39)) clusters in pro-Crp4-(20-92) were mutagenized, and variants were assayed for differential effects of mutagenesis on bactericidal peptide activity. Substitution of the mid and proximal Asp and Glu clusters with Gly produced additive effects with respect to the induction of both bactericidal activity and membrane permeabilization of live Escherichia coli ML35 cells. In contrast, substitution of distal Glu and Asp residues with Gly or their deletion resulted in pro-Crp4-(20-92) variants with bactericidal and membrane-disruptive activities equal to or greater than that of fully mature Crp4. These findings support the conclusion that the most distal N-terminal anionic residues of pro-Crp4-(20-92) are primarily responsible for blocking Crp4-mediated membrane disruption in the precursor.	[Ouellette, Andre J.] Univ Calif Irvine, Coll Hlth Sci, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92697 USA; [Ouellette, Andre J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [Ouellette, Andre J.] Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Ouellette, AJ (corresponding author), Univ Calif Irvine, Coll Hlth Sci, Sch Med, Dept Pathol & Lab Med, Med Sci I D440, Irvine, CA 92697 USA.	aouellet@uci.edu		Young, Steven/0000-0002-1586-5651	NIAID NIH HHS [AI059346] Funding Source: Medline; NIDDK NIH HHS [DK044632] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044632, R01DK044632] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ayabe T, 2002, J BIOL CHEM, V277, P3793, DOI 10.1074/jbc.M107507200; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; GANZ T, 1993, BLOOD, V82, P641; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ganz T, 2004, CR BIOL, V327, P539, DOI 10.1016/j.crvi.2003.12.007; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Hristova K, 1997, J BIOL CHEM, V272, P24224, DOI 10.1074/jbc.272.39.24224; Jing WG, 2004, BIOCHEMISTRY-US, V43, P15759, DOI 10.1021/bi048645p; Kamdar K, 2008, J BIOL CHEM, V283, P32361, DOI 10.1074/jbc.M805296200; KULIAWAT R, 1992, J CELL BIOL, V118, P521, DOI 10.1083/jcb.118.3.521; LIU L, 1995, BLOOD, V85, P1095, DOI 10.1182/blood.V85.4.1095.bloodjournal8541095; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P15144, DOI 10.1021/bi9811617; MICHAELSON D, 1992, J LEUKOCYTE BIOL, V51, P634, DOI 10.1002/jlb.51.6.634; Ouellette AJ, 2005, SPRINGER SEMIN IMMUN, V27, P133, DOI 10.1007/s00281-005-0202-x; Ouellette AJ, 1999, AM J PHYSIOL-GASTR L, V277, pG257, DOI 10.1152/ajpgi.1999.277.2.G257; Ouellette Andre J., 2005, P175; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; Selsted M E, 1993, Genet Eng (N Y), V15, P131; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; VALORE EV, 1992, BLOOD, V79, P1538; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wu ZB, 2007, J MOL BIOL, V368, P537, DOI 10.1016/j.jmb.2007.02.040; Zanetti M, 1997, ANN NY ACAD SCI, V832, P147, DOI 10.1111/j.1749-6632.1997.tb46244.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zou GZ, 2008, J MOL BIOL, V381, P1281, DOI 10.1016/j.jmb.2008.06.066	36	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6826	6831		10.1074/jbc.M807024200	http://dx.doi.org/10.1074/jbc.M807024200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19106102	Green Published, hybrid			2022-12-27	WOS:000263919000028
J	Palmer, SM; Playford, MP; Craig, SW; Schaller, MD; Campbell, SL				Palmer, Sean M.; Playford, Martin P.; Craig, Susan W.; Schaller, Michael D.; Campbell, Sharon L.			Lipid Binding to the Tail Domain of Vinculin SPECIFICITY AND THE ROLE OF THE N AND C TERMINI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INTRAMOLECULAR ASSOCIATION; ACTIN-FILAMENTS; HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; ACIDIC PHOSPHOLIPIDS; MISSENSE MUTATION; CRYSTAL-STRUCTURE; CELL-MIGRATION; TALIN-BINDING	Vinculin is a highly conserved and abundant cytoskeletal protein involved in linking the actin cytoskeleton to the cell membrane at sites of cellular adhesion. At these sites of adhesion, vinculin plays a role in physiological processes such as cell motility, migration, development, and wound healing. Loss of normal vinculin function has been associated with cancer phenotypes, cardiovascular disease, and lethal errors in embryogenesis. The tail domain of vinculin (Vt) binds to acidic phospholipids and has been proposed to play a role in vinculin activation and focal adhesion turnover. To better characterize Vt-lipid specificity, we conducted a series of lipid co-sedimentation experiments and find that Vt shows specific association with phosphatidylinositol 4,5-bisphosphate (PIP2), compared with phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidylserine (PS), or phosphatidylinositol (PI) in the context of mixed lipid vesicles. The C terminus of Vt has been proposed to be important for PIP2 association, as various mutations and deletions within the C-terminal reduce PIP2 association. Lipid co-sedimentation and NMR analyses indicate that removal of the hydrophobic hairpin does not alter Vt structure or PIP2 association. However, more extensive deletions within the C-terminal introduce Vt structural perturbations and reduce PIP2 binding. Intriguingly, a significant increase in PIP2 binding was observed for multiple Vt variants that perturb interactions between the N-terminal strap and helix bundle, suggesting that a rearrangement of this N-terminal strap may be required for PIP2 binding.	[Palmer, Sean M.; Campbell, Sharon L.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Playford, Martin P.; Schaller, Michael D.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Schaller, Michael D.; Campbell, Sharon L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Playford, Martin P.] NHLBI, NIH, Bethesda, MD 20892 USA; [Craig, Susan W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University	Campbell, SL (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	sharon_campbell@med.unc.edu	, UNC Biomolecular NMR Facility/AAD-7901-2022	campbell, sharon/0000-0003-0311-409X	NIGMS NIH HHS [R01 GM080568-01A1, R01 GM080568] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080568] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; BARSTEAD RJ, 1991, J CELL BIOL, V114, P715, DOI 10.1083/jcb.114.4.715; BELKIN AM, 1988, J BIOL CHEM, V263, P6631; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; Cullen PJ, 2001, CURR BIOL, V11, pR882, DOI 10.1016/S0960-9822(01)00523-1; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; FERNANDEZ JLR, 1992, J CELL BIOL, V119, P427, DOI 10.1083/jcb.119.2.427; FERNANDEZ JLR, 1993, J CELL BIOL, V122, P1285, DOI 10.1083/jcb.122.6.1285; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; GEIGER B, 1980, P NATL ACAD SCI-BIOL, V77, P4127, DOI 10.1073/pnas.77.7.4127; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Goldmann WH, 2002, BIOCHEM BIOPH RES CO, V290, P749, DOI 10.1006/bbrc.2001.6243; GROESCH ME, 1990, CELL MOTIL CYTOSKEL, V15, P41, DOI 10.1002/cm.970150107; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; Johnson RP, 2000, J BIOL CHEM, V275, P95, DOI 10.1074/jbc.275.1.95; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1995, BIOCHEM BIOPH RES CO, V210, P159, DOI 10.1006/bbrc.1995.1641; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Miller GJ, 2001, J BIOL CHEM, V276, P28829, DOI 10.1074/jbc.M102561200; Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025; MOLONY L, 1985, J CELL BIOCHEM, V29, P31, DOI 10.1002/jcb.240290104; Palmer SM, 2008, BIOMOL NMR ASSIGM, V2, P69, DOI 10.1007/s12104-008-9087-7; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; RASBAND WS, 2006, IMAGE J VERSION 1 37; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Vasile VC, 2006, MOL GENET METAB, V87, P169, DOI 10.1016/j.ymgme.2005.08.006; Vasile VC, 2006, BIOCHEM BIOPH RES CO, V349, P709, DOI 10.1016/j.bbrc.2006.08.106; Vasile VC, 2006, BIOCHEM BIOPH RES CO, V345, P998, DOI 10.1016/j.bbrc.2006.04.151; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Winkler J, 1996, J STRUCT BIOL, V116, P270, DOI 10.1006/jsbi.1996.0042; Xu WM, 1998, DEVELOPMENT, V125, P327; Xu WM, 1998, J CELL SCI, V111, P1535; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Ziegler WH, 2002, J BIOL CHEM, V277, P7396, DOI 10.1074/jbc.M110008200; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	61	48	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7223	7231		10.1074/jbc.M807842200	http://dx.doi.org/10.1074/jbc.M807842200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19110481	Green Published, hybrid			2022-12-27	WOS:000263919000069
J	Suarez, J; Ranguelova, K; Jarzecki, AA; Manzerova, J; Krymov, V; Zhao, XB; Yu, SW; Metlitsky, L; Gerfen, GJ; Magliozzo, RS				Suarez, Javier; Ranguelova, Kalina; Jarzecki, Andrzej A.; Manzerova, Julia; Krymov, Vladimir; Zhao, Xiangbo; Yu, Shengwei; Metlitsky, Leonid; Gerfen, Gary J.; Magliozzo, Richard S.			An Oxyferrous Heme/Protein-based Radical Intermediate Is Catalytically Competent in the Catalase Reaction of Mycobacterium tuberculosis Catalase-Peroxidase (KatG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; HIGH-FIELD EPR; COLI RIBONUCLEOTIDE REDUCTASE; SITE-DIRECTED MUTAGENESIS; CYTOCHROME-C PEROXIDASE; TRP CROSS-LINK; ESCHERICHIA-COLI; COMPOUND-I; HYDROGEN-PEROXIDE; TYROSYL RADICALS	Amechanism accounting for the robust catalase activity in catalase-peroxidases (KatG) presents a new challenge in heme protein enzymology. In Mycobacterium tuberculosis, KatG is the sole catalase and is also responsible for peroxidative activation of isoniazid, an anti-tuberculosis pro-drug. Here, optical stopped-flow spectrophotometry, rapid freeze-quench EPR spectroscopy both at the X-band and at the D-band, and mutagenesis are used to identify catalase reaction intermediates in M. tuberculosis KatG. In the presence of millimolar H2O2 at neutral pH, oxyferrous heme is formed within milliseconds from ferric (resting) KatG, whereas at pH 8.5, low spin ferric heme is formed. Using rapid freeze-quench EPR at X-band under both of these conditions, a narrow doublet radical signal with an 11 G principal hyperfine splitting was detected within the first milliseconds of turnover. The radical and the unique heme intermediates persist in wild-type KatG only during the time course of turnover of excess H2O2 (1000-fold or more). Mutation of Met(255), Tyr(229), or Trp(107), which have covalently linked side chains in a unique distal side adduct (MYW) in wild-type KatG, abolishes this radical and the catalase activity. The D-band EPR spectrum of the radical exhibits a rhombic g tensor with dual g(x) values (2.00550 and 2.00606) and unique g(y) (2.00344) and g(z) values (2.00186) similar to but not typical of native tyrosyl radicals. Density functional theory calculations based on a model of an MYW adduct radical built from x-ray coordinates predict experimentally observed hyperfine interactions and a shift in g values away from the native tyrosyl radical. A catalytic role for an MYW adduct radical in the catalase mechanism of KatG is proposed.	[Suarez, Javier; Ranguelova, Kalina; Jarzecki, Andrzej A.; Zhao, Xiangbo; Yu, Shengwei; Metlitsky, Leonid; Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Suarez, Javier; Jarzecki, Andrzej A.; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Chem, New York, NY 10016 USA; [Suarez, Javier; Jarzecki, Andrzej A.; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Biochem, New York, NY 10016 USA; [Manzerova, Julia; Krymov, Vladimir; Gerfen, Gary J.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Yeshiva University; Albert Einstein College of Medicine	Magliozzo, RS (corresponding author), CUNY Brooklyn Coll, Dept Chem, 2900 Bedford Ave, Brooklyn, NY 11210 USA.	rmaglioz@brooklyn.cun.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060014, R01AI060014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075920] Funding Source: NIH RePORTER; NIAID NIH HHS [AI060014] Funding Source: Medline; NIGMS NIH HHS [GM075920] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson KK, 2002, SPECTROCHIM ACTA A, V58, P1101, DOI 10.1016/S1386-1425(01)00700-4; BAERENDS EJ, 2007, ADF 2007 01 SCM; BEERS RF, 1952, J BIOL CHEM, V195, P133; BENDER CJ, 1989, J AM CHEM SOC, V111, P8076, DOI 10.1021/ja00203a002; Bleifuss G, 2001, BIOCHEMISTRY-US, V40, P15362, DOI 10.1021/bi010707d; BOX HC, 1976, J CHEM SOC PERK T 2, P553, DOI 10.1039/p29760000553; BURGHAUS O, 1992, MEAS SCI TECHNOL, V3, P765, DOI 10.1088/0957-0233/3/8/013; Carpena X, 2006, BIOCHEMISTRY-US, V45, P5171, DOI 10.1021/bi060017f; Chouchane S, 2000, BIOCHEMISTRY-US, V39, P9975, DOI 10.1021/bi0005815; Chouchane S, 2002, J BIOL CHEM, V277, P42633, DOI 10.1074/jbc.M207916200; Collins DM, 1996, TRENDS MICROBIOL, V4, P426, DOI 10.1016/0966-842X(96)10066-4; Cossi M, 2002, J CHEM PHYS, V117, P43, DOI 10.1063/1.1480445; DeGray JA, 1997, J BIOL CHEM, V272, P2359; Denisov IG, 2002, J BIOL CHEM, V277, P42706, DOI 10.1074/jbc.M207949200; Dorlet P, 2002, BIOCHEMISTRY-US, V41, P6107, DOI 10.1021/bi015871f; Duboc-Toia C, 2003, J AM CHEM SOC, V125, P38, DOI 10.1021/ja026690j; Faller P, 2003, P NATL ACAD SCI USA, V100, P8732, DOI 10.1073/pnas.1530926100; Farrar CT, 1997, J PHYS CHEM B, V101, P6634, DOI 10.1021/jp9709518; Frisch M.J., 2016, GAUSSIAN16 REV B01; Garcia-Serres R, 2007, J AM CHEM SOC, V129, P1402, DOI 10.1021/ja067209i; Gerfen GJ, 1996, J PHYS CHEM-US, V100, P16739, DOI 10.1021/jp960709l; GERFEN GJ, 1993, J AM CHEM SOC, V115, P6420, DOI 10.1021/ja00067a071; Gerfen GJ, 1996, J AM CHEM SOC, V118, P8192, DOI 10.1021/ja960363s; Ghiladi RA, 2005, BIOCHEMISTRY-US, V44, P15093, DOI 10.1021/bi051463q; Ghiladi RA, 2005, J BIOL CHEM, V280, P22651, DOI 10.1074/jbc.M502486200; Glendening E. D., 2001, NBO 5 0; Gunther MR, 2000, FREE RADICAL BIO MED, V28, P709, DOI 10.1016/S0891-5849(00)00164-7; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; Ivancich A, 1999, J AM CHEM SOC, V121, P5743, DOI 10.1021/ja990562m; Ivancich A, 2001, J AM CHEM SOC, V123, P5050, DOI 10.1021/ja0036514; Ivancich A, 1997, BIOCHEMISTRY-US, V36, P9356, DOI 10.1021/bi970886s; Ivancich A, 1996, J AM CHEM SOC, V118, P12852, DOI 10.1021/ja9628361; Jakopitsch C, 2005, J BIOL CHEM, V280, P9037, DOI 10.1074/jbc.M413317200; Jakopitsch C, 2005, J BIOL CHEM, V280, P42411, DOI 10.1074/jbc.M508009200; Jakopitsch C, 2003, J BIOL CHEM, V278, P20185, DOI 10.1074/jbc.M211625200; Jakopitsch C, 2007, BIOCHEMISTRY-US, V46, P1183, DOI 10.1021/bi062266+; Jakopitsch C, 2006, J INORG BIOCHEM, V100, P1091, DOI 10.1016/j.jinorgbio.2006.02.009; Jeschke G, 2005, BBA-BIOENERGETICS, V1707, P91, DOI 10.1016/j.bbabio.2004.02.012; JOHNSSON K, 1995, J AM CHEM SOC, V117, P5009, DOI 10.1021/ja00122a038; Kato S, 2004, J BIOL CHEM, V279, P52376, DOI 10.1074/jbc.M403532200; KOU WWH, 1976, J CHEM PHYS, V64, P3060, DOI 10.1063/1.432568; Lendzian F, 1996, J AM CHEM SOC, V118, P8111, DOI 10.1021/ja960917r; Liu AM, 2000, J AM CHEM SOC, V122, P1974, DOI 10.1021/ja990123n; MARCINKEVICIENE JA, 1995, J BIOL CHEM, V270, P22290, DOI 10.1074/jbc.270.38.22290; MILLER MA, 1992, BIOCHEMISTRY-US, V31, P2789, DOI 10.1021/bi00125a020; MIYAGAWA I, 1960, J CHEM PHYS, V6, P1599; Pogni R, 2005, BIOCHEMISTRY-US, V44, P4267, DOI 10.1021/bi047474l; Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458; Pym A. S., 2002, Bacterial resistance to antimicrobials, P355; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Ranguelova K, 2008, BIOCHEMISTRY-US, V47, P11377, DOI 10.1021/bi800952b; Ranguelova K, 2007, J BIOL CHEM, V282, P6255, DOI 10.1074/jbc.M607309200; Regelsberger G, 1999, BIOCHEMISTRY-US, V38, P10480, DOI 10.1021/bi990886n; Regelsberger G, 2001, BIOCHEM SOC T, V29, P99; Singh R, 2007, J AM CHEM SOC, V129, P15954, DOI 10.1021/ja075108u; Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046; Un S, 2005, MAGN RESON CHEM, V43, pS229, DOI 10.1002/mrc.1660; Un S, 2001, J AM CHEM SOC, V123, P3048, DOI 10.1021/ja003650b; VANDERDONK WA, 1995, J AM CHEM SOC, V117, P8908, DOI 10.1021/ja00140a003; Vidossich P, 2007, J AM CHEM SOC, V129, P13436, DOI 10.1021/ja072245i; Vlasits J, 2007, FEBS LETT, V581, P320, DOI 10.1016/j.febslet.2006.12.037; Wilson JC, 2005, J AM CHEM SOC, V127, P1618, DOI 10.1021/ja043853q; Winterbourn CC, 2004, BIOCHEM J, V381, P241, DOI 10.1042/BJ20040259; Yu SW, 2003, J BIOL CHEM, V278, P14769, DOI 10.1074/jbc.M300326200; Yu SW, 2002, PROTEIN SCI, V11, P58, DOI 10.1110/ps.ps.09902; Yu SW, 2003, J BIOL CHEM, V278, P44121, DOI 10.1074/jbc.M304757200; Zhao XB, 2004, J BIOL CHEM, V279, P7606, DOI 10.1074/jbc.M311884200; Zhao XB, 2009, J BIOL CHEM, V284, P7030, DOI 10.1074/jbc.M808107200	69	66	68	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7017	7029		10.1074/jbc.M808106200	http://dx.doi.org/10.1074/jbc.M808106200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139099	Green Published, hybrid			2022-12-27	WOS:000263919000050
J	Xu, S; Huo, J; Lee, KG; Kurosaki, T; Lam, KP				Xu, Shengli; Huo, Jianxin; Lee, Koon-Guan; Kurosaki, Tomohiro; Lam, Kong-Peng			Phospholipase C gamma 2 Is Critical for Dectin-1-mediated Ca2+ Flux and Cytokine Production in Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN RECEPTOR; C-TYPE LECTINS; ANTIGEN RECEPTOR; TYROSINE KINASE; B-CELLS; PNEUMOCYSTIS-CARINII; ANTIFUNGAL IMMUNITY; CANDIDA-ALBICANS; INNATE IMMUNITY; DC-SIGN	Dectin-1 is a C-type lectin that recognizes beta-glucan in the cell walls of fungi and plays an important role in anti-fungal immunity. It signals via tyrosine kinase Syk and adaptor protein Card9 to activate NF-kappa B leading to proinflammatory cytokine production in dendritic cells (DCs). Other than this, not much else is known of the mechanism of Dectin-1 signaling. We demonstrate here that stimulation of DCs with zymosan triggers an intracellular Ca2+ flux that can be attenuated by a blocking anti-Dectin-1 antibody or by pre-treatment of cells with the phospholipase C( PLC) gamma-inhibitor U73122, suggesting that Dectin-1 signals via a PLC gamma pathway to induce Ca2+ flux in DCs. Interestingly, treatment of DCs with particulate curdlan, which specifically engages Dectin-1, results in the phosphorylation of both PLC gamma 1 and PLC gamma 2. However, we show that PLC gamma 2 is the critical enzyme for Dectin-1 signaling in DCs. PLC gamma 2-deficient DCs have drastic impairment of Ca2+ signaling and are defective in their secretion of interleukin 2 (IL-2), IL-6, IL-10, IL-12, IL-23, and tumor necrosis factor alpha. PLC gamma 2-deficient DCs also exhibit impaired activation of ERK and JNK MAPKs and AP-1 and NFAT transcription factors in response to Dectin-1 stimulation. In addition, PLC gamma 2-deficient DCs are also impaired in their activation of NF-kappa B upon Dectin-1 engagement due to defective assembly of the Card9-Bcl10-Malt1 complex and impaired IKK alpha/beta activation and I kappa B alpha degradation. Thus, our data indicate that pattern recognition receptors such as Dectin-1 could elicit Ca2+ signaling and that PLC gamma 2 is a critical player in the Dectin-1 signal transduction pathway.	[Kurosaki, Tomohiro] RIKEN Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Yokohama, Kanagawa 2300045, Japan; [Xu, Shengli; Huo, Jianxin; Lee, Koon-Guan; Lam, Kong-Peng] Agcy Sci Technol & Res, Bioproc Technol Inst, Immunol Lab, Singapore 138668, Singapore	RIKEN; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI)	Lam, KP (corresponding author), 20 Biopolis Way,06-01 Centros, Singapore 138668, Singapore.	lam_kong_peng@bti.a-star.edu.sg	Kurosaki, Tomohiro/D-1306-2009; Lam, Kong-Peng/G-5374-2012; HUO, JIANXIN/GXH-0232-2022	Kurosaki, Tomohiro/0000-0002-6352-304X; HUO, JIANXIN/0000-0003-2913-6537; Lam, Kong-Peng/0000-0002-1316-4333	Biomedical Research Council of A*STAR	Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of A*STAR. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Bush TJV, 2008, EUR J IMMUNOL, V38, P400, DOI 10.1002/eji.200737602; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kurosaki T, 2000, IMMUNOL REV, V176, P19; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lee KG, 2008, J BIOL CHEM, V283, P11189, DOI 10.1074/jbc.M708516200; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rothfuchs AG, 2007, J IMMUNOL, V179, P3463, DOI 10.4049/jimmunol.179.6.3463; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Seminario MC, 2003, IMMUNOL REV, V192, P80, DOI 10.1034/j.1600-065X.2003.00013.x; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Weiss A, 1991, Semin Immunol, V3, P313; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Xu SL, 2007, BLOOD, V109, P3377, DOI 10.1182/blood-2006-07-036418; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758	42	114	115	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7038	7046		10.1074/jbc.M806650200	http://dx.doi.org/10.1074/jbc.M806650200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136564	Green Published, hybrid			2022-12-27	WOS:000263919000052
J	Mariscotti, JF; Garcia-del Portillo, F; Pucciarelli, MG				Mariscotti, Javier F.; Garcia-del Portillo, Francisco; Graciela Pucciarelli, M.			The Listeria monocytogenes Sortase-B Recognizes Varied Amino Acids at Position 2 of the Sorting Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; SURFACE-PROTEINS; STAPHYLOCOCCUS-AUREUS; LPXTG MOTIF; BACILLUS-ANTHRACIS; EPITHELIAL-CELLS; BACTERIA; SRTA; VIRULENCE; INIB	Sortases are bacterial enzymes that anchor surface proteins covalently to the peptidoglycan upon cleavage of a motif located at their C-terminal end. Motifs recognized by sortases of the class-B (SrtB) are defined by the consensus sequence NP(Q/K)(T/S)(N/G/S)(D/A). Evidence supporting this consensus is limited to IsdC of Staphylococcus aureus and Bacillus anthracis, cleaved at motifs NPQTN and NPKTG, respectively. In Listeria monocytogenes, StrB has two substrates, Lmo2185 and Lmo2186, containing NAKTN and NKVTN (or the overlapping sequence NPKSS) as putative sorting motifs. Some of these motifs do not match the consensus, because they lack either proline (P) at position 2 or glutamine/lysine (Q/K) at position 3. Here, we identified NPKSS as a sorting motif of Lmo2186 by monitoring anchoring to peptidoglycan of chimeras lacking each of its two predicted motifs. Motif-swapping experiments confirmed that NPKSS, but not NKVTN, could replace NAKTN for anchoring of an Lmo2185 chimera. Residue substitutions in the NPKSS sequence revealed the essentiality of proline at position 2 for recognition of this particular motif. Lysine at position 3 was however dispensable. Deletion of NAKTN, on the other hand, abrogated SrtB-mediated anchoring of the Lmo2185 chimera. NAKTN, therefore, represents an exception to the rule of a conserved proline in position 2 of the sorting motif. Taken together, our data indicate that proline is not absolutely required for substrate recognition by sortases of the class-B. In addition, they prove the capacity of a single sortase, as SrtB of L. monocytogenes, to recognize varied amino acids at position 2 of the sorting motif.	[Mariscotti, Javier F.; Garcia-del Portillo, Francisco; Graciela Pucciarelli, M.] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid 28049, Spain; [Mariscotti, Javier F.; Graciela Pucciarelli, M.] Univ Autonoma Madrid, Dept Biol Mol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid	Pucciarelli, MG (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Darwin 3, Madrid 28049, Spain.	mg.pucciarelli@uam.es	García-del Portillo, Francisco/D-2576-2009	Mariscotti, Javier Fernando/0000-0002-0103-9885; Garcia-del Portillo, Francisco/0000-0002-4120-0530; Pucciarelli Morrone, Maria Graciela/0000-0002-4268-2316	Ministry of Science and Innovation of Spain [BIO2006-14230, GEN2006-27774-C2-1-E/PAT]	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Grants BIO2006-14230 ( to M. G. P.) and GEN2006-27774-C2-1-E/PAT ( to F. G.-P.) from the Ministry of Science and Innovation of Spain.	Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Boekhorst J, 2005, J BACTERIOL, V187, P4928, DOI 10.1128/JB.187.14.4928-4934.2005; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; DeDent AC, 2007, J BACTERIOL, V189, P4473, DOI 10.1128/JB.00227-07; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2008, FEMS MICROBIOL REV, V32, P307, DOI 10.1111/j.1574-6976.2008.00102.x; Garandeau C, 2002, INFECT IMMUN, V70, P1382, DOI 10.1128/IAI.70.3.1382-1390.2002; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Glaser P, 2001, SCIENCE, V294, P849; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; Litou Zoi I., 2008, Journal of Bioinformatics and Computational Biology, V6, P387, DOI 10.1142/S0219720008003382; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Pucciarelli M. G., 2007, LISTERIA MONOCYTOGEN, P81; Pucciarelli MG, 2005, PROTEOMICS, V5, P4808, DOI 10.1002/pmic.200402075; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861	30	17	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6140	6146		10.1074/jbc.M807989200	http://dx.doi.org/10.1074/jbc.M807989200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129190	hybrid			2022-12-27	WOS:000263742700016
J	Park, J; Feng, J; Li, Y; Hammarsten, O; Brazil, DP; Hemmings, BA				Park, Jongsun; Feng, Jianhua; Li, Yuwen; Hammarsten, Ola; Brazil, Derek P.; Hemmings, Brian A.			DNA-dependent Protein Kinase-mediated Phosphorylation of Protein Kinase B Requires a Specific Recognition Sequence in the C-terminal Hydrophobic Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; IN-VIVO; TYROSINE PHOSPHORYLATION; ATAXIA-TELANGIECTASIA; CATALYTIC SUBUNIT; SIGNALING PATHWAY; CANCER-CELLS; ACTIVATION; ATM; PK	DNA-dependent protein kinase (DNA-PK) has been implicated in a variety of nuclear processes including DNA double strand break repair, V(D)J recombination, and transcription. A recent study showed that DNA-PK is responsible for Ser-473 phosphorylation in the hydrophobic motif of protein kinase B (PKB/Akt) in genotoxic-stressed cells, suggesting a novel role for DNA-PK in cell signaling. Here, we report that DNA-PK activity toward PKB peptides is impaired in DNA-PK knock-out mouse embryonic fibroblast cells when compared with wild type. In addition, human glioblastoma cells expressing a mutant form of DNA-PK (M059J) displayed a lower DNA-PK activity when compared with glioblastoma cells expressing wild-type DNA- PK (M059K) when PKB peptide substrates were tested. DNA- PK preferentially phosphorylated PKB on Ser-473 when compared with its known in vitro substrate, p53. A consensus hydrophobic amino acid surrounding the Ser-473 phospho-acceptor site in PKB containing amino acids Phe at position +1 and +4 and Tyr at position -1 are critical for DNA- PK activity. Thus, these data define the specificity of DNA- PK action as a Ser-473 kinase for PKB in DNA repair signaling.	[Park, Jongsun; Li, Yuwen] Chungnam Natl Univ, Coll Med, Dept Pharmacol,Canc Res Inst,Res Inst Med Sci, Cell Signaling Lab,Daejeon Reg Canc Ctr, Taejon 301131, South Korea; [Park, Jongsun; Feng, Jianhua; Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Hammarsten, Ola] Goeteborg Univ, Sahlgrens Univ Hosp, Dept Clin Chem, S-41345 Gothenburg, Sweden; [Brazil, Derek P.] Univ Coll Dublin, Conway Inst, Sch Med & Med Sci, Dublin 2, Ireland	Chungnam National University; Friedrich Miescher Institute for Biomedical Research; Sahlgrenska University Hospital; University College Dublin	Park, J (corresponding author), Chungnam Natl Univ, Coll Med, Dept Pharmacol,Canc Res Inst,Res Inst Med Sci, Cell Signaling Lab,Daejeon Reg Canc Ctr, 6 Munhwa Dong, Taejon 301131, South Korea.	insulin@cnu.ac.kr; hemmings@fmi.ch	Hammarsten, Ola/A-2791-2012; Park, Jongsun/E-7465-2010; li, yuwen/HGU-6435-2022	Park, Jongsun/0000-0002-4690-1854; Brazil, Derek/0000-0003-1375-1076	Korean government [R112002- 100-02006-0]; Basic Research Program [R01-2005-000-10240-0, F01-2005-000-10011-0]; Ministry of Health and Welfare : National RD Program [0720560]	Korean government(Korean Government); Basic Research Program; Ministry of Health and Welfare : National RD Program	This work was supported by grants from the Korean government (Ministry of Science and Technology: Engineering Research Center Program (R112002- 100-02006-0), Basic Research Program (R01-2005-000-10240-0 and F01-2005-000-10011-0); and Ministry of Health and Welfare: National R&D Program (0720560)).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Beamish HJ, 2000, NUCLEIC ACIDS RES, V28, P1506, DOI 10.1093/nar/28.7.1506; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Byrum J, 2004, NUCLEIC ACIDS RES, V32, P2776, DOI 10.1093/nar/gkh592; Caporali S, 2008, MOL PHARMACOL, V74, P173, DOI 10.1124/mol.107.044743; Chan DW, 2000, J BIOL CHEM, V275, P7803, DOI 10.1074/jbc.275.11.7803; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Gottschalk AR, 2005, INT J RADIAT ONCOL, V63, P1221, DOI 10.1016/j.ijrobp.2005.08.014; Gupta AK, 2003, INT J RADIAT ONCOL, V56, P846, DOI 10.1016/S0360-3016(03)00214-1; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Jeggo P, 2002, DNA REPAIR, V1, P771, DOI 10.1016/S1568-7864(02)00096-4; Jeggo PA, 2005, CELL CYCLE, V4, P359, DOI 10.4161/cc.4.3.1527; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; Li B, 2004, ONCOGENE, V23, P4594, DOI 10.1038/sj.onc.1207602; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Ma YM, 2002, J BIOL CHEM, V277, P10756, DOI 10.1074/jbc.C200030200; Martensson S, 2002, J BIOL CHEM, V277, P3020, DOI 10.1074/jbc.M106711200; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Quevedo C, 2007, CURR BIOL, V17, P286, DOI 10.1016/j.cub.2006.12.038; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Surucu B, 2008, J BIOL CHEM, V283, P30025, DOI 10.1074/jbc.M803053200; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200	48	49	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6169	6174		10.1074/jbc.C800210200	http://dx.doi.org/10.1074/jbc.C800210200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19144640	hybrid			2022-12-27	WOS:000263742700019
J	Volonte, D; Kahkonen, B; Shapiro, S; Di, YP; Galbiati, F				Volonte, Daniela; Kahkonen, Beth; Shapiro, Steven; Di, YuanPu; Galbiati, Ferruccio			Caveolin-1 Expression Is Required for the Development of Pulmonary Emphysema through Activation of the ATM-p53-p21 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOKE-INDUCED EMPHYSEMA; CIGARETTE-SMOKE; CELLULAR SENESCENCE; LUNG FIBROBLASTS; OXIDATIVE STRESS; PREMATURE SENESCENCE; PLASMA-MEMBRANE; CELLS; GROWTH; MICE	Free radicals play a role in aging and age-related human diseases, including pulmonary emphysema. Cigarette smoke represents a source of oxidants and is considered an environmental hazard that causes pulmonary emphysema. Here, we show that caveolin-1 activates ataxia telangiectasia-mutated (ATM) after oxidative stress by sequestering the ATM inhibitor, the catalytic subunit of protein phosphatase 2A, into caveolar membranes. We demonstrate that cigarette smoke extracts promote stress-induced premature senescence in wild type but not caveolin-1 null lung fibroblasts and that caveolin-1 expression is required for activation of the ATM-p53-p21(Waf1/Cip1) pathway following stimulation with cigarette smoke extracts in vitro. In vivo studies show that caveolin-1 expression is necessary for cigarette smoking-induced senescence of lung fibroblasts and pulmonary emphysema. These findings bring new insights into the molecular mechanism underlying free radical activation of the ATM-p53 pathway and indicate that caveolin-1 is a novel therapeutic target for the treatment and/or prevention of pulmonary emphysema.	[Volonte, Daniela; Galbiati, Ferruccio] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Kahkonen, Beth; Di, YuanPu] Univ Pittsburgh, Sch Med, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Shapiro, Steven] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Galbiati, F (corresponding author), 200 Lothrop St, Pittsburgh, PA 15261 USA.	feg5@pitt.edu	Di, Yuanpu Peter/H-4191-2016; Galbiati, Ferruccio/AAF-3527-2020	Di, Yuanpu Peter/0000-0003-2028-2087; 	National Institutes of Health [AG022548]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES011033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG022548 (to F. G.).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bernhard D, 2007, EXP GERONTOL, V42, P160, DOI 10.1016/j.exger.2006.09.016; Boren E, 2004, AUTOIMMUN REV, V3, P401, DOI 10.1016/j.autrev.2004.03.004; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen K, 2003, J BIOL CHEM, V278, P39527, DOI 10.1074/jbc.M304423200; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203; Cohen PTW, 2002, J CELL SCI, V115, P241; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; MacNee W, 1999, AM J RESP CRIT CARE, V160, pS58, DOI 10.1164/ajrccm.160.supplement_1.15; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; Moiseeva O, 2006, MOL BIOL CELL, V17, P1583, DOI 10.1091/mbc.E05-09-0858; MOLDOVAN NI, 1995, EXP CELL RES, V219, P309, DOI 10.1006/excr.1995.1233; Muller KC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-32; Nobukuni S, 2002, RESPIROLOGY, V7, P217, DOI 10.1046/j.1440-1843.2002.00400.x; Noordhoek JA, 2003, EXP LUNG RES, V29, P291, DOI 10.1080/01902140303789; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Shackelford RE, 2001, J BIOL CHEM, V276, P21951, DOI 10.1074/jbc.M011303200; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; SNIDER GL, 1992, AM REV RESPIR DIS, V146, P1615, DOI 10.1164/ajrccm/146.6.1615; Tsuji T, 2004, AM J RESP CELL MOL, V31, P643, DOI 10.1165/rcmb.2003-0290OC; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529	40	55	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5462	5466		10.1074/jbc.C800225200	http://dx.doi.org/10.1074/jbc.C800225200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19103597	hybrid, Green Published			2022-12-27	WOS:000263560600008
J	Xie, P; Guo, SB; Fan, YN; Zhang, H; Gu, DF; Li, HH				Xie, Ping; Guo, Shubin; Fan, Yongna; Zhang, Hua; Gu, Dongfeng; Li, Huihua			Atrogin-1/MAFbx Enhances Simulated Ischemia/Reperfusion-induced Apoptosis in Cardiomyocytes through Degradation of MAPK Phosphatase-1 and Sustained JNK Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE ATROPHY; DEPENDENT CARDIAC-HYPERTROPHY; FOXO TRANSCRIPTION FACTORS; JUN NH2-TERMINAL KINASE; INDUCED CELL-DEATH; N-TERMINAL KINASE; PROTEIN-KINASE; MYOCARDIAL-ISCHEMIA; INFARCT SIZE; P38 MAPK	Atrogin-1/MAFbx is a major atrophy-related E3 ubiquitin ligase that is expressed specifically in striated muscle. Although the contribution of atrogin-1 to cardiac and muscle hypertrophy/atrophy has been examined extensively, it remains unclear whether atrogin-1 plays an essential role in the simulated ischemia/reperfusion-induced apoptosis of primary cardiomyocytes. Here we showed that atrogin-1 markedly enhanced ischemia/reperfusion-induced apoptosis in cardiomyocytes via activation of JNK signaling. Overexpression of atrogin-1 increased phosphorylation of JNK and c-Jun and decreased phosphorylation of Foxo3a. In addition, atrogin-1 decreased Bcl-2, increased Bax, and enhanced the activation of caspases. Furthermore, JNK inhibitor SP600125 markedly blocked the effect of atrogin-1 on cell apoptosis and the expression of apoptotic-related proteins and caspases. Importantly, atrogin-1 induced sustained activation of JNK through a mechanism that involved degradation of MAPK phosphatase-1 (MKP-1) protein. Atrogin-1 interacted with and triggered MKP-1 for ubiquitin-mediated degradation. In contrast, proteasome inhibitors markedly blocked the degradation of MKP-1. Taken together, these results demonstrate that atrogin-1 promotes degradation of MKP-1 through the ubiquitin-proteasome pathway, thereby leading to persistent activation of JNK signaling and further cardiomyocyte apoptosis following ischemia/reperfusion injury.	[Xie, Ping; Fan, Yongna; Zhang, Hua; Li, Huihua] Peking Union Med Coll, Dept Pathol, Beijing 100005, Peoples R China; [Xie, Ping; Fan, Yongna; Zhang, Hua; Li, Huihua] Peking Union Med Coll, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Guo, Shubin] Peking Union Med Coll, Dept Acute Med, Peking Union Med Hosp, Chinese Acad Med Sci, Beijing 100005, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Peking Union Med Coll, Div Populat Genet & Prevent, Cardiovasc Inst, Beijing 100037, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Peking Union Med Coll, Div Populat Genet & Prevent, Fuwai Hosp, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Li, HH (corresponding author), Peking Union Med Coll, Dept Pathol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	hhli1995@yahoo.com			China Natural Science Foundation [2006CB503805, 2006CB910306, 30670860]; Ministry of Education of China [20060023051, 20070023022]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by China Natural Science Foundation Grants 2006CB503805, 2006CB910306, and 30670860 (to H. L.) and The Ph.D. Programs Foundation of Ministry of Education of China Grants 20060023051 and 20070023022 (to H. L.).	Adams V, 2007, CARDIOVASC RES, V73, P120, DOI 10.1016/j.cardiores.2006.10.026; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Assimakopoulou M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-202; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Capano M, 2006, BIOCHEM J, V395, P57, DOI 10.1042/BJ20051654; CHARLES CH, 1992, ONCOGENE, V7, P187; CHEN QL, 1995, J BIOL CHEM, V270, P28499, DOI 10.1074/jbc.270.48.28499; Choi BH, 2006, J CELL SCI, V119, P1329, DOI 10.1242/jcs.02837; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; EMSLIE EA, 1994, HUM GENET, V93, P513; Engelbrecht A-M, 2004, BASIC RES CARDIOL, V99, P338, DOI 10.1007/s00395-004-0478-3; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; Hreniuk D, 2001, MOL PHARMACOL, V59, P867, DOI 10.1124/mol.59.4.867; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Michel MC, 2001, N-S ARCH PHARMACOL, V363, P245, DOI 10.1007/s002100000363; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Thompson SJ, 2008, CURR OPIN PHARMACOL, V8, P90, DOI 10.1016/j.coph.2007.09.010; Venugopal SK, 2007, J BIOL CHEM, V282, P31900, DOI 10.1074/jbc.M703729200; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Xifro X, 2006, J BIOL CHEM, V281, P6801, DOI 10.1074/jbc.M504571200; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zhang L, 2007, CELL CYCLE, V6, P1479; Zhou JY, 2006, CANCER RES, V66, P4888, DOI 10.1158/0008-5472.CAN-05-4229	48	76	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5488	5496		10.1074/jbc.M806487200	http://dx.doi.org/10.1074/jbc.M806487200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117950	hybrid			2022-12-27	WOS:000263560600011
J	Ahuja, N; Korkin, D; Chaba, R; Cezairliyan, BO; Sauer, RT; Kim, KK; Gross, CA				Ahuja, Nidhi; Korkin, Dmitry; Chaba, Rachna; Cezairliyan, Brent O.; Sauer, Robert T.; Kim, Kyeong Kyu; Gross, Carol A.			Analyzing the Interaction of RseA and RseB, the Two Negative Regulators of the sigma(E) Envelope Stress Response, Using a Combined Bioinformatic and Experimental Strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI SIGMA(E); MULTIPLE SEQUENCE ALIGNMENT; EXTRACYTOPLASMIC STRESS; CRYSTAL-STRUCTURE; PERIPLASMIC STRESS; PDZ DOMAIN; PROTEIN; PROTEOLYSIS; BINDING; RPOE	The Escherichia coli envelope stress response is controlled by the alternative sigma factor, sigma(E), and is induced when unfolded outer membrane proteins accumulate in the periplasm. The response is initiated by sequential cleavage of the membrane-spanning anti-sigma factor, RseA. RseB is an important negative regulator of envelope stress response that exerts its negative effects on sigma(E) activity through its binding to RseA. In this study, we analyze the interaction between RseA and RseB. We found that tight binding of RseB to RseA required intact RseB. Using programs that performed global and local sequence alignment of RseB and RseA, we found regions of high similarity and performed alanine substitution mutagenesis to test the hypothesis that these regions were functionally important. This protocol is based on the hypothesis that functionally dependent regions of two proteins co-evolve and therefore are likely to be sequentially conserved. This procedure allowed us to identify both an N-terminal and C-terminal region in RseB important for binding to RseA. We extensively analyzed the C-terminal region, which aligns with a region of RseA coincident with the major RseB binding determinant in RseA. Both allele-specific suppression analysis and cysteine-mediated disulfide bond formation indicated that this C-terminal region of similarity of RseA and RseB identifies a contact site between the two proteins. We suggest a similar protocol can be successfully applied to pairs of non-homologous but functionally linked proteins to find specific regions of the protein sequences that are important for establishing functional linkage.	[Ahuja, Nidhi; Chaba, Rachna; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Gross, Carol A.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA; [Korkin, Dmitry] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Korkin, Dmitry] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [Cezairliyan, Brent O.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Kim, Kyeong Kyu] Sungkyunkwan Univ, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Massachusetts Institute of Technology (MIT); Sungkyunkwan University (SKKU)	Gross, CA (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, GH S376,600 16th St, San Francisco, CA 94158 USA.	cgross@cgl.ucsf.edu	Kim, Kyeong Kyu/ABH-1988-2020	Kim, Kyeong Kyu/0000-0003-2515-8894; Sauer, Robert/0000-0002-1719-5399	National Institutes of Health [GM-32678, AI-16892]; Korean Ministry of Education, Science, and Technology [FPR08B2-270]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-32678 ( to C. A. G.) and AI-16892 ( to R. T. S.). This work was also supported by FPR08B2-270 of the 21C Frontier Functional Proteomics Project ( to K. K. K.) from the Korean Ministry of Education, Science, and Technology.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Beck BJ, 1997, J BACTERIOL, V179, P6504, DOI 10.1128/jb.179.21.6862-6864.1997; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Cezairliyan BO, 2007, P NATL ACAD SCI USA, V104, P3771, DOI 10.1073/pnas.0611567104; Chaba R, 2007, GENE DEV, V21, P124, DOI 10.1101/gad.1496707; Collinet B, 2000, J BIOL CHEM, V275, P33898, DOI 10.1074/jbc.M006214200; Connolly L, 1997, GENE DEV, V11, P2012, DOI 10.1101/gad.11.15.2012; CUNNINGHAM MW, 1989, J IMMUNOL, V143, P2677; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Grigorova IL, 2004, GENE DEV, V18, P2686, DOI 10.1101/gad.1238604; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kim DY, 2007, P NATL ACAD SCI USA, V104, P8779, DOI 10.1073/pnas.0703117104; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Miller J. H, 1972, EXPT MOL GENETICS; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rezuchova B, 2003, FEMS MICROBIOL LETT, V225, P1, DOI 10.1016/S0378-1097(03)00480-4; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Sambrook J., 2001, MOL CLONING LAB MANU; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wollmann P, 2007, J MOL BIOL, V372, P927, DOI 10.1016/j.jmb.2007.06.039	36	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5403	5413		10.1074/jbc.M806012200	http://dx.doi.org/10.1074/jbc.M806012200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103591	hybrid, Green Published			2022-12-27	WOS:000263416600070
J	Ji, CH; Kopetzki, E; Jekle, A; Stubenrauch, KG; Liu, XR; Zhang, J; Rao, E; Schlothauer, T; Fischer, S; Cammack, N; Heilek, G; Ries, S; Sankuratri, S				Ji, Changhua; Kopetzki, Erhard; Jekle, Andreas; Stubenrauch, Kay-Gunnar; Liu, Xingrong; Zhang, Jun; Rao, Eileen; Schlothauer, Tilman; Fischer, Stephan; Cammack, Nick; Heilek, Gabrielle; Ries, Stefan; Sankuratri, Surya			CD4-anchoring HIV-1 Fusion Inhibitor with Enhanced Potency and in Vivo Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENTRY INHIBITORS; ANTIRETROVIRAL ACTIVITY; RESISTANCE MUTATIONS; ANTI-CD4 ANTIBODY; RHESUS-MONKEYS; ENFUVIRTIDE; INFECTION; TYPE-1; GP41	In this study, we describe a novel CD4-targeting bifunctional human immunodeficiency virus (HIV-1) fusion inhibitor (CD4-BFFI) that blocks HIV-1 entry by inhibiting both HIV-1 attachment and fusion and is highly potent against both R5 and X4 HIV-1 viruses in various antiviral assays, including peripheral blood mononuclear cell (PBMC) infection assays. Previously, we have reported a CCR5 antibody-based bifunctional HIV-1 fusion inhibitor (BFFI) that was highly active in blocking R5 HIV-1 infection but was ineffective against X4 viruses infecting human PBMCs (Kopetzki, E., Jekle, A., Ji, C., Rao, E., Zhang, J., Fischer, S., Cammack, N., Sankuratri, S., and Heilek, G.(2008) Virology J. 5,56-65). CD4-BFFI, which consists of two HIV-1 fusion inhibitor (FI) T-651 variant peptides recombinantly fused to the Fc end of a humanized anti-CD4 monoclonal antibody, has demonstrated more than 100-fold greater antiviral activity than T-651 variant or the parental CD4 monoclonal antibody. Mechanistic studies revealed that CD4-BFFI primarily blocks the HIV-1-cell fusion step through its FI peptide moieties. The enhanced antiviral activity of CD4-BFFI is most likely due to avid binding of the bivalent FI peptides as well as the increased local concentration of CD4-BFFI via attachment to the target cell surface receptor CD4. In vivo pharmacokinetic studies demonstrated that CD4-BFFI was stable in monkey blood, and a dose of 10 mg/kg maintained serum concentrations greater than 2,000-fold over the IC90 value for 7 days postdosing. This novel bifunctional inhibitor with improved potency and favorable pharmacokinetic properties may offer a novel approach for HIV-1 therapy.	[Ji, Changhua; Jekle, Andreas; Zhang, Jun; Rao, Eileen; Cammack, Nick; Heilek, Gabrielle; Sankuratri, Surya] Roche Palo Alto, Virol Dis Area, Palo Alto, CA 94304 USA; [Liu, Xingrong] Roche Palo Alto, Nonclin Safety, Palo Alto, CA 94304 USA; [Kopetzki, Erhard; Stubenrauch, Kay-Gunnar; Schlothauer, Tilman; Fischer, Stephan; Ries, Stefan] Roche Penzberg, Div Pharmaceut, D-82377 Penzberg, Germany	Roche Holding; Roche Holding; Roche Holding	Ji, CH (corresponding author), Roche Palo Alto, Virol Dis Area, 3431 Hillview Ave, Palo Alto, CA 94304 USA.	changhua.ji@roche.com		Jekle, Andreas/0000-0001-9416-2622				Boon L, 2002, TOXICOLOGY, V172, P191, DOI 10.1016/S0300-483X(02)00002-1; Borkow G., 2005, Current Drug Targets - Infectious Disorders, V5, P3, DOI 10.2174/1568005053174645; Carter NJ, 2007, DRUGS, V67, P2277, DOI 10.2165/00003495-200767150-00010; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Coakley E, 2005, CURR OPIN INFECT DIS, V18, P9, DOI 10.1097/00001432-200502000-00003; Dimitrov A, 2007, CURR OPIN INVEST DR, V8, P653; DUENSING T, 2006, 13 C RETR OPP INF DE; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Goethals O, 2008, J VIROL, V82, P10366, DOI 10.1128/JVI.00470-08; Ji CH, 2006, J BIOMOL SCREEN, V11, P65, DOI 10.1177/1087057105282959; Ji C, 2007, MOL PHARMACOL, V72, P18, DOI 10.1124/mol.107.035055; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kopetzki E, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-56; Kuritzkes DR, 2004, J INFECT DIS, V189, P286, DOI 10.1086/380802; Lazzarin A, 2005, EXPERT OPIN PHARMACO, V6, P453, DOI 10.1517/14656566.6.3.453; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Marr P, 2008, EXPERT OPIN PHARMACO, V9, P2349, DOI 10.1517/14656566.9.13.2349 ; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Reimann KA, 2002, AIDS RES HUM RETROV, V18, P747, DOI 10.1089/08892220260139486; Reimann KA, 1997, AIDS RES HUM RETROV, V13, P933, DOI 10.1089/aid.1997.13.933; Rusconi S, 2007, CURR TOP MED CHEM, V7, P1273; Shafer RW, 2008, AIDS REV, V10, P67; Walter BL, 2005, J VIROL, V79, P4828, DOI 10.1128/JVI.79.8.4828-4837.2005; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Zhang XQ, 2006, ANTIMICROB AGENTS CH, V50, P2231, DOI 10.1128/AAC.00761-05	28	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5175	5185		10.1074/jbc.M808745200	http://dx.doi.org/10.1074/jbc.M808745200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19097993	hybrid			2022-12-27	WOS:000263416600048
J	Chiang, YJ; Jordan, MS; Horai, R; Schwartzberg, PL; Koretzky, GA; Hodes, RJ				Chiang, Y. Jeffrey; Jordan, Martha S.; Horai, Reiko; Schwartzberg, Pamela L.; Koretzky, Gary A.; Hodes, Richard J.			Cbl Enforces an SLP76-dependent Signaling Pathway for T Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN SLP-76; C-CBL; NEGATIVE REGULATION; ANTIGEN RECEPTOR; TYROSINE PHOSPHORYLATION; THYMOCYTE DEVELOPMENT; POSITIVE SELECTION; ACTIVATION; TCR; MICE	A signaling pathway involving ZAP-70, LAT, and SLP76 has been regarded as essential for receptor-driven T cell development and activation. Consistent with this model, mice deficient in SLP76 have a complete block at the double negative 3 stage of T cell development. Recently, however, it has been reported that inactivation of Cbl, a ubiquitin-protein isopeptide ligase, partially rescues T cell development in SLP76-deficient mice. To probe the influence of Cbl on domain-specific SLP76 functions, we reconstituted SLP76(-/-) Cbl(-/-) mice with Slp76 transgenes bearing mutations in each of three functional domains of SLP76 as follows: Y3F, in which the amino-terminal tyrosine residues of SLP76 were mutated, eliminating sites of SLP76 interaction with Vav, Nck, and Itk; Delta 20, in which 20 amino acids in the proline-rich region of SLP76 were deleted, removing a binding site for Gads; and RK, in which arginine 448 of SLP76 was replaced by lysine, abolishing function of the Src homology 2 domain. Although each of these transgenes has been shown to partially rescue T cell development in SLP76(-/-) mice, we report here that Cbl inactivation completely reverses the severe double negative 3 developmental block that occurs in SLP76-deficient mice expressing the Y3F transgene (Y3F mice) and partially rescues the defect in positive selection in T cell receptor transgenic Y3F mice, but in contrast fails to rescue thymic development of SLP76-deficient mice expressing the Delta 20 or RK transgene. Rescue in SLP76(-/-) Cbl(-/-) Y3F double-positive thymocytes is associated with enhanced tyrosine phosphorylation of signaling molecules, including Lck, Vav, PLC-gamma 1, and ERKs, but not Itk, in response to T cell receptor stimulation. Thus, our data demonstrate that Cbl suppresses activation of a bypass signaling pathway and thereby enforces SLP76 dependence of early T cell development.	[Chiang, Y. Jeffrey; Hodes, Richard J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Chiang, Y. Jeffrey; Hodes, Richard J.] NIA, NIH, Bethesda, MD 20892 USA; [Jordan, Martha S.; Koretzky, Gary A.] Univ Penn, Signal Transduct Program, Abramson Family Canc Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Horai, Reiko; Schwartzberg, Pamela L.] NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Chiang, YJ (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10,4B36, Bethesda, MD 20892 USA.	chiangj@mail.nih.gov	Koretzky, Gary/AAU-5381-2021		National Institutes of Health grant (NCI Intramural Research Program); NATIONAL CANCER INSTITUTE [ZIABC009281, Z01BC009255, ZICBC009255] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123, Z01HG000123] Funding Source: NIH RePORTER	National Institutes of Health grant (NCI Intramural Research Program)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by a National Institutes of Health grant (NCI Intramural Research Program).	Alonso A, 2004, J BIOL CHEM, V279, P4922, DOI 10.1074/jbc.M308978200; Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Chiang YJ, 2004, J EXP MED, V200, P25, DOI 10.1084/jem.20040262; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Fagerholm S, 2002, EUR J IMMUNOL, V32, P1670, DOI 10.1002/1521-4141(200206)32:6<1670::AID-IMMU1670>3.0.CO;2-M; GRIFFITHS EK, 2002, SCI STKE, pRE3; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Hawash IY, 2002, J BIOL CHEM, V277, P5683, DOI 10.1074/jbc.M110002200; Jordan MS, 2008, IMMUNITY, V28, P359, DOI 10.1016/j.immuni.2008.01.010; Jordan MS, 2006, J IMMUNOL, V176, P2430, DOI 10.4049/jimmunol.176.4.2430; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Kumar L, 2002, P NATL ACAD SCI USA, V99, P884, DOI 10.1073/pnas.022619199; Laky K, 2006, IMMUNOL REV, V209, P274, DOI 10.1111/j.0105-2896.2006.00358.x; Lucas JA, 2002, J IMMUNOL, V168, P6142, DOI 10.4049/jimmunol.168.12.6142; Manetz TS, 2001, MOL CELL BIOL, V21, P3763, DOI 10.1128/MCB.21.11.3763-3774.2001; Mazza C, 2007, SEMIN IMMUNOL, V19, P225, DOI 10.1016/j.smim.2007.03.003; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Myung PS, 2001, IMMUNITY, V15, P1011, DOI 10.1016/S1074-7613(01)00253-9; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; Seet BT, 2007, EMBO J, V26, P678, DOI 10.1038/sj.emboj.7601535; SHORTMAN K, 1988, IMMUNOL CELL BIOL, V66, P423, DOI 10.1038/icb.1988.54; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thien CBF, 1999, J IMMUNOL, V162, P7133; Yamasaki S, 2007, TRENDS IMMUNOL, V28, P39, DOI 10.1016/j.it.2006.11.006; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	34	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4429	4438		10.1074/jbc.M808679200	http://dx.doi.org/10.1074/jbc.M808679200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074136	Green Published, hybrid			2022-12-27	WOS:000263134400043
J	Davidge, KS; Sanguinetti, G; Yee, CH; Cox, AG; McLeod, CW; Monk, CE; Mann, BE; Motterlini, R; Poole, RK				Davidge, Kelly S.; Sanguinetti, Guido; Yee, Chu Hoi; Cox, Alan G.; McLeod, Cameron W.; Monk, Claire E.; Mann, Brian E.; Motterlini, Roberto; Poole, Robert K.			Carbon Monoxide-releasing Antibacterial Molecules Target Respiration and Global Transcriptional Regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; NITRIC-OXIDE; GENE-EXPRESSION; METAL-BINDING; ZINC; PROTEIN; SYSTEM; SIGNAL; COMPLEXES; MEMBRANE	Carbon monoxide, a classical respiratory inhibitor, also exerts vasodilatory, anti-inflammatory, and antiapoptotic effects. CO-releasing molecules have therapeutic value, increasing phagocytosis and reducing sepsis-induced lethality. Here we identify for the first time the bacterial targets of Ru(CO)(3)Cl(glycinate) (CORM-3), a ruthenium-based carbonyl that liberates CO rapidly under physiological conditions. Contrary to the expectation that CO would be preferentially inhibitory at low oxygen tensions or anaerobically, Escherichia coli cultures were also sensitive to CORM-3 at concentrations equimolar with oxygen. CORM-3, assayed as ruthenium, was taken up by bacteria and rapidly delivered CO intracellularly to terminal oxidases. Microarray analysis of CORM-3-treated cells revealed extensively modified gene expression, notably down-regulation of genes encoding key aerobic respiratory complexes. Genes involved in metal metabolism, homeostasis, or transport were also differentially expressed, and free intracellular zinc levels were elevated. Probabilistic modeling of transcriptomic data identified the global transcription regulators ArcA, CRP, Fis, FNR, Fur, BaeR, CpxR, and IHF as targets and potential CO sensors. Our discovery that CORM-3 is an effective inhibitor and global regulator of gene expression, especially under aerobic conditions, has important implications for administration of CO-releasing agents in sepsis and inflammation.	[Davidge, Kelly S.; Yee, Chu Hoi; Monk, Claire E.; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Sanguinetti, Guido] Univ Sheffield, Dept Comp Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Cox, Alan G.; McLeod, Cameron W.] Univ Sheffield, Ctr Analyt Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Mann, Brian E.] Univ Sheffield, Dept Chem, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Motterlini, Roberto] Italian Inst Technol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; Istituto Italiano di Tecnologia - IIT	Poole, RK (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	r.poole@sheffield.ac.uk	Motterlini, Roberto/Q-1890-2019; Motterlini, Roberto/G-2489-2013	Motterlini, Roberto/0000-0003-2684-2612; Motterlini, Roberto/0000-0003-2684-2612; Davidge, Sandra/0000-0002-5559-4905	Biotechnology and Biological Sciences Research Council (UK); Society for General Microbiology; Biotechnology and Biological Sciences Research Council [BB/E015883/1] Funding Source: researchfish; BBSRC [BB/E015883/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Society for General Microbiology; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (UK) and a Vacation Studentship from the Society for General Microbiology (to R. K. P. and C. H. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALANI FT, 1988, J CHEM SOC DA, V9, P2329; Barbe JM, 2004, DALTON T, P1208, DOI 10.1039/b316706b; Beard SJ, 1997, MOL MICROBIOL, V25, P883, DOI 10.1111/j.1365-2958.1997.mmi518.x; Binet MRB, 2000, FEBS LETT, V473, P67, DOI 10.1016/S0014-5793(00)01509-X; Binet MRB, 2002, FEMS MICROBIOL LETT, V213, P121, DOI 10.1016/S0378-1097(02)00803-0; Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; Borisov VB, 2001, J BIOL CHEM, V276, P22095, DOI 10.1074/jbc.M011542200; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; David G, 2003, J BIOL CHEM, V278, P43728, DOI 10.1074/jbc.M304484200; Desmard M, 2005, CELL MOL BIOL, V51, P403, DOI 10.1170/T644; Desmard M, 2009, FASEB J, V23, P1023, DOI 10.1096/fj.08-122804; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; Foresti R, 2005, CELL MOL BIOL, V51, P409, DOI 10.1170/T645; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; GIBSON JF, 1986, ARCH ENVIRON CON TOX, V15, P519, DOI 10.1007/BF01056564; GIBSON JF, 1984, ARCH MICROBIOL, V139, P265, DOI 10.1007/BF00402012; Gilberthorpe NJ, 2008, J BIOL CHEM, V283, P11146, DOI 10.1074/jbc.M708019200; Guo YR, 2004, AM J PHYSIOL-HEART C, V286, pH1649, DOI 10.1152/ajpheart.00971.2003; Husain M, 2008, J BIOL CHEM, V283, P7682, DOI 10.1074/jbc.M708845200; IUCHI S, 1990, J BACTERIOL, V172, P6020, DOI 10.1128/jb.172.10.6020-6025.1990; Jung WS, 2008, FEMS MICROBIOL LETT, V284, P109, DOI 10.1111/j.1574-6968.2008.01187.x; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; Keilin D., 1966, HIST CELL RESP CYTOC, P252; Kershaw CJ, 2007, BIOCHEM BIOPH RES CO, V364, P66, DOI 10.1016/j.bbrc.2007.09.094; Lee LJ, 2005, J BACTERIOL, V187, P1124, DOI 10.1128/JB.187.3.1124-1134.2005; Li H, 2007, J MOL BIOL, V368, P1358, DOI 10.1016/j.jmb.2007.02.107; LOMIS TJ, 1989, INORG CHEM, V28, P2369, DOI 10.1021/ic00311a023; MARKS GS, 1991, TRENDS PHARMACOL SCI, V12, P185, DOI 10.1016/0165-6147(91)90544-3; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Motterlini R, 2007, BIOCHEM SOC T, V35, P1142, DOI 10.1042/BST0351142; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Neidhardt FC, 1990, PHYSL BACTERIAL CELL, P1; Nobre LS, 2007, ANTIMICROB AGENTS CH, V51, P4303, DOI 10.1128/AAC.00802-07; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Overhaus M, 2006, AM J PHYSIOL-GASTR L, V290, pG695, DOI 10.1152/ajpgi.00152.2005; Partridge JD, 2007, J BIOL CHEM, V282, P11230, DOI 10.1074/jbc.M700728200; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Poole RK, 1996, J BACTERIOL, V178, P5487, DOI 10.1128/jb.178.18.5487-5492.1996; POOLE RK, 1979, BIOCHEM J, V184, P379, DOI 10.1042/bj1840379; Puskarova A, 2002, MICROBIOL-SGM, V148, P3801, DOI 10.1099/00221287-148-12-3801; Raffa RG, 2002, MOL MICROBIOL, V45, P1599, DOI 10.1046/j.1365-2958.2002.03112.x; Ragsdale SW, 2004, CRIT REV BIOCHEM MOL, V39, P165, DOI 10.1080/10409230490496577; Raivio TL, 2000, MOL MICROBIOL, V37, P1186, DOI 10.1046/j.1365-2958.2000.02074.x; Roberts GP, 2004, MICROBIOL MOL BIOL R, V68, P453, DOI 10.1128/MMBR.68.3.453-473.2004; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; SCHUBERT MP, 1933, J AM CHEM SOC, V55, P4563; Scragg JL, 2008, J BIOL CHEM, V283, P24412, DOI 10.1074/jbc.M803037200; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Velayudhan J, 2007, MOL MICROBIOL, V63, P1495, DOI 10.1111/j.1365-2958.2007.05600.x; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; WOOD PM, 1984, BIOCHIM BIOPHYS ACTA, V768, P293, DOI 10.1016/0304-4173(84)90020-X; Yamamoto K, 2008, J BIOTECHNOL, V133, P196, DOI 10.1016/j.jbiotec.2007.08.002; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0; Yoshimura-Suzuki T, 2005, J BACTERIOL, V187, P6678, DOI 10.1128/JB.187.19.6678-6682.2005	60	120	120	3	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4516	4524		10.1074/jbc.M808210200	http://dx.doi.org/10.1074/jbc.M808210200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19091747	hybrid, Green Accepted			2022-12-27	WOS:000263134400052
J	Demidova, AR; Aau, MY; Zhuang, L; Yu, Q				Demidova, Anastasia R.; Aau, Mei Yee; Zhuang, Li; Yu, Qiang			Dual Regulation of Cdc25A by Chk1 and p53-ATF3 in DNA Replication Checkpoint Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINTS; S-PHASE CHECKPOINT; TRANSCRIPTIONAL REPRESSOR ATF3; INDUCED DOWN-REGULATION; G(2) CHECKPOINT; CANCER-CELLS; INDUCED APOPTOSIS; GENOTOXIC STRESS; G2 CHECKPOINT; P53	Eukaryotic cells respond to DNA damage and stalled replication forks by activating signaling pathways that promote cell cycle arrest and DNA repair. A systematic screening of the protein kinase small interfering RNA library reveals that Chk1 and ataxia telangiectasia-mutated (ATM) and Rad3-related (ATR) are the main kinases responsible for intra-S-phase checkpoint upon topoisomerase I inhibitor camptothecin-induced DNA damage. It is well known that ATR-Chk1-mediated protein degradation of Cdc25A protein phosphatase is a crucial mechanism conferring this checkpoint activation. Here we describe another mechanism underlying Cdc25A down-regulation in response to DNA damage that occurs at the transcriptional level. We show that activation of tumor suppressor p53 by DNA damage results in inhibition of Cdc25A transcription as a result of activation of transcriptional repressor ATF3 that directly binds to the Cdc25A promoter. In cells deficient in both Chk1 and p53, Cdc25A down-regulation upon camptothecin-induced DNA damage is completely abolished, leading to severe defects in cell cycle checkpoints and remarkable cell death in mitosis. Our findings reveal two independent mechanisms acting in concert in regulation of Cdc25A in DNA damage response. Although Chk1 affects Cdc25A via rapid phosphorylation and protein turnover, inhibition of Cdc25A transcription by p53-ATF3 is required for the maintenance of cell cycle arrest.	ASTAR, Canc Biol & Pharmacol Genome Inst Singapore, Singapore 138672, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Demidova, AR (corresponding author), ASTAR, Canc Biol & Pharmacol Genome Inst Singapore, 02-01 Genome Bldg,60 Biopolis St, Singapore 138672, Singapore.	demidovaa@gis.a-star.edu.sg; yuq@gis.a-star.edu.sg	Goloudina, Anastasia/T-4989-2019; Goloudina, Anastasia/T-4985-2019	Yu, Qiang/0000-0003-2132-8278	Agency for Science, Technology and Research of Singapore	Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by grants from the Agency for Science, Technology and Research of Singapore. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; Fuchs C, 2006, CANCER TREAT REV, V32, P491, DOI 10.1016/j.ctrv.2006.07.001; Goloudina A, 2003, CELL CYCLE, V2, P473, DOI 10.4161/cc.2.5.482; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Gupta M, 1997, CLIN CANCER RES, V3, P1653; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Jurvansuu J, 2007, J MOL BIOL, V372, P397, DOI 10.1016/j.jmb.2007.06.077; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawabe T, 2004, MOL CANCER THER, V3, P513; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Koniaras K, 2001, ONCOGENE, V20, P7453, DOI 10.1038/sj.onc.1204942; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Le Gac G, 2006, J BIOL CHEM, V281, P24161, DOI 10.1074/jbc.M603724200; LEE KAW, 1987, P NATL ACAD SCI USA, V84, P8355, DOI 10.1073/pnas.84.23.8355; Legarza K, 2006, ANTICANCER RES, V26, P3301; Levesque AA, 2005, ONCOGENE, V24, P3786, DOI 10.1038/sj.onc.1208451; Levesque AA, 2008, MOL CANCER THER, V7, P252, DOI 10.1158/1535-7163.MCT-07-2066; Luo Y, 2001, ANTICANCER RES, V21, P23; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Mashima T, 2001, J CELL PHYSIOL, V188, P352, DOI 10.1002/jcp.1130; Matthew EM, 2007, CELL CYCLE, V6, P2571, DOI 10.4161/cc.6.20.5079; Mukhopadhyay UK, 2005, CANCER RES, V65, P2872, DOI 10.1158/0008-5472.CAN-04-2502; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Playle LC, 2002, BRIT J CANCER, V87, P352, DOI 10.1038/sj.bjc.6600492; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Rother K, 2007, ONCOGENE, V26, P1949, DOI 10.1038/sj.onc.1209989; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shao RG, 1997, CANCER RES, V57, P4029; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Srivastava V, 2005, BIOORGAN MED CHEM, V13, P5892, DOI 10.1016/j.bmc.2005.05.066; St Clair S, 2004, MOL CELL, V16, P725; Tse AN, 2004, CANCER RES, V64, P6635, DOI 10.1158/0008-5472.CAN-04-0841; Tse AN, 2007, CLIN CANCER RES, V13, P591, DOI 10.1158/1078-0432.CCR-06-1424; Wang YL, 2004, CANCER BIOL THER, V3, P305, DOI 10.4161/cbt.3.3.697; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhang C, 2002, BIOCHEM BIOPH RES CO, V297, P1302, DOI 10.1016/S0006-291X(02)02382-3; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	54	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4132	4139		10.1074/jbc.M808118200	http://dx.doi.org/10.1074/jbc.M808118200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19060337	hybrid			2022-12-27	WOS:000263134400010
J	Schmidt, BZ; Watts, RJ; Aridor, M; Frizzell, RA				Schmidt, Bela Z.; Watts, Rebecca J.; Aridor, Meir; Frizzell, Raymond A.			Cysteine String Protein Promotes Proteasomal Degradation of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Increasing Its Interaction with the C Terminus of Hsp70-interacting Protein and Promoting CFTR Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; EPITHELIAL-CELLS; ATPASE ACTIVITY; LATE STEPS; CHAPERONE; HSP70; DROSOPHILA; CHIP; P97; BIOGENESIS	Cysteine string protein (Csp) is a J-domain-containing protein whose overexpression blocks the exit of cystic fibrosis transmembrane conductance regulator ( CFTR) from the endoplasmic reticulum ( ER). Another method of blocking ER exit, the overexpression of Sar1-GTP, however, yielded twice as much immature CFTR compared with Csp overexpression. This finding suggested that Csp not only inhibits CFTR ER exit but also facilitates the degradation of immature CFTR. This was confirmed by treatment with a proteasome inhibitor, which returned the level of immature CFTR to that found in cells expressing Sar1-GTP only. CspH43Q, which does not interact with Hsc70/Hsp70 efficiently, did not promote CFTR degradation, suggesting that the pro-degradative effect of Csp requires Hsc70/Hsp70 binding/activation. In agreement with this, Csp overexpression increased the amount of Hsc70/Hsp70 co-immunoprecipitated with CFTR, whereas overexpression of CspH43Q did not. The Hsc70/Hsp70 binding partner C terminus of Hsp70-interacting protein ( CHIP) can target CFTR for proteasome-mediated degradation. Csp overexpression also increased the amount of CHIP co-immunoprecipitated with CFTR. In addition, CHIP interacted directly with Csp, which was confirmed by in vitro binding experiments. Csp overexpression also increased CFTR ubiquitylation and reduced the half-life of immature CFTR. These findings indicate that Csp not only regulates the exit of CFTR from the ER, but that this action is accompanied by Hsc70/Hsp70 and CHIP-mediated CFTR degradation.	[Schmidt, Bela Z.; Watts, Rebecca J.; Aridor, Meir; Frizzell, Raymond A.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Frizzell, RA (corresponding author), S362 BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	Frizzell@pitt.edu		Watters, Rebecca/0000-0001-7486-7510; Schmidt, Bela Z/0000-0003-1085-9372	National Institutes of Health [DK68196, DK72506,, DK62318]; Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506, R56DK062318, R01DK062318, R01DK068196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK68196, DK72506, and DK62318. This work was also supported by the Cystic Fibrosis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Brown H, 1998, EMBO J, V17, P5048, DOI 10.1093/emboj/17.17.5048; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chamberlain LH, 1996, J BIOL CHEM, V271, P19514, DOI 10.1074/jbc.271.32.19514; Chamberlain LH, 1996, J BIOL CHEM, V271, P7320, DOI 10.1074/jbc.271.13.7320; Chamberlain LH, 2000, J NEUROCHEM, V74, P1781, DOI 10.1046/j.1471-4159.2000.0741781.x; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; Evans GJO, 2002, BIOCHEM J, V364, P343, DOI 10.1042/BJ20020123; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Graham ME, 2000, J NEUROSCI, V20, P1281; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Lei DC, 1996, GENE THER, V3, P427; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Nie ZP, 1999, J NEUROSCI, V19, P10270; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ranjan R, 1998, J NEUROSCI, V18, P956; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Westhoff B, 2005, CURR BIOL, V15, P1058, DOI 10.1016/j.cub.2005.04.058; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang H, 1999, J CELL SCI, V112, P1345; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200; Zhang H, 2002, J BIOL CHEM, V277, P28948, DOI 10.1074/jbc.M111706200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	45	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4168	4178		10.1074/jbc.M806485200	http://dx.doi.org/10.1074/jbc.M806485200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098309	Green Published, hybrid			2022-12-27	WOS:000263134400014
J	Zhao, RB; Min, SH; Wang, YH; Campanella, E; Low, PS; Goldman, ID				Zhao, Rongbao; Min, Sang Hee; Wang, Yanhua; Campanella, Estela; Low, Philip S.; Goldman, I. David			A Role for the Proton-coupled Folate Transporter (PCFT-SLC46A1) in Folate Receptor-mediated Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOROID-PLEXUS; FUNCTIONAL-CHARACTERIZATION; BINDING PROTEIN; TUMOR-CELLS; CARRIER; RAT; DEFICIENCY; IMPACT; PH; IDENTIFICATION	Recently, this laboratory identified a proton-coupled folate transporter (PCFT), with optimal activity at low pH. PCFT is critical to intestinal folate absorption and transport into the central nervous system because there are loss-of-function mutations in this gene in the autosomal recessive disorder, hereditary folate malabsorption. The current study addresses the role PCFT might play in another transport pathway, folate receptor (FR)-mediated endocytosis. FR alpha cDNA was transfected into novel PCFT+ and PCFT- HeLa sublines. FR alpha was shown to bind and trap folates in vesicles but with minimal export into the cytosol in PCFT- cells. Cotransfection of FR alpha and PCFT resulted in enhanced folate transport into cytosol as compared with transfection of FR alpha alone. Probenecid did not inhibit folate binding to FR, but inhibited PCFT- mediated transport at endosomal pH, and blocked FR alpha-mediated transport into the cytosol. FR alpha and PCFT co-localized to the endosomal compartment. These observations (i) indicate that PCFT plays a role in FR alpha-mediated endocytosis by serving as a route of export of folates from acidified endosomes and (ii) provide a functional role for PCFT in tissues in which it is expressed, such as the choroid plexus, where the extracellular milieu is at neutral pH.	[Zhao, Rongbao; Min, Sang Hee; Goldman, I. David] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Zhao, Rongbao; Min, Sang Hee; Goldman, I. David] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Wang, Yanhua] Med Coll Penn & Hahnemann Univ, Dept Pathol, Philadelphia, PA 19129 USA; [Campanella, Estela; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Drexel University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Goldman, ID (corresponding author), Chanin 2,1300 Morris Pk Ave, Bronx, NY 10461 USA.	igoldman@aecom.yu.edu		Puchulu-Campanella, Estela/0000-0002-3951-3925; Low, Philip/0000-0001-9042-5528	National Institutes of Health [CA-82621]; Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE [R01CA082621, P30CA013330, P30CA023168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-82621 from the NCI. This work was also supported by a grant from the Mesothelioma Applied Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Andrews NC, 2007, CELL METAB, V5, P5, DOI 10.1016/j.cmet.2006.12.004; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; GARRICK MD, 1993, J BIOL CHEM, V268, P14867; Geller J, 2002, MEDICINE, V81, P51, DOI 10.1097/00005792-200201000-00004; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; He W, 2007, P NATL ACAD SCI USA, V104, P11760, DOI 10.1073/pnas.0703875104; Inoue K, 2008, AM J PHYSIOL-GASTR L, V294, pG660, DOI 10.1152/ajpgi.00309.2007; Kamen BA, 2004, ADV DRUG DELIVER REV, V56, P1085, DOI 10.1016/j.addr.2004.01.002; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; KAMEN BA, 1991, J CLIN INVEST, V87, P1442, DOI 10.1172/JCI115150; Kennedy MD, 2003, PHARM RES-DORDR, V20, P714, DOI 10.1023/A:1023421232689; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; LEAMON CP, 1992, J BIOL CHEM, V267, P24966; LEAMON CP, 1993, J BIOL CHEM, V268, P24847; MASON JB, 1994, PHYSL GASTROINTESTIN; MCEWAN GTA, 1990, J MED ENG TECHNOL, V14, P16, DOI 10.3109/03091909009028758; Min SH, 2008, J PEDIATR-US, V153, P435, DOI 10.1016/j.jpeds.2008.04.009; Moretti P, 2008, J AUTISM DEV DISORD, V38, P1170, DOI 10.1007/s10803-007-0492-z; Patrick TA, 1997, J NEURO-ONCOL, V32, P111, DOI 10.1023/A:1005713115147; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; PRASAD PD, 1994, BBA-MOL CELL RES, V1222, P309, DOI 10.1016/0167-4889(94)90184-8; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P276, DOI 10.1055/s-2008-1065354; Ramaekers VT, 2005, NEW ENGL J MED, V352, P1985, DOI 10.1056/NEJMoa043160; Ramaekers VT, 2004, DEV MED CHILD NEUROL, V46, P843, DOI 10.1017/S0012162204001471; Schaer CA, 2008, J LEUKOCYTE BIOL, V83, P325, DOI 10.1189/jlb.0407226; Schwartz RS, 2005, NEW ENGL J MED, V352, P1948, DOI 10.1056/NEJMp058034; Segal MB, 2000, CELL MOL NEUROBIOL, V20, P183, DOI 10.1023/A:1007045605751; SELHUB J, 1984, J BIOL CHEM, V259, P6601; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; SPECTOR R, 1975, SCIENCE, V187, P540, DOI 10.1126/science.1167256; SPECTOR R, 1975, AM J PHYSIOL, V229, P777, DOI 10.1152/ajplegacy.1975.229.3.777; Subramanian VS, 2008, AM J PHYSIOL-CELL PH, V295, pC828, DOI 10.1152/ajpcell.00249.2008; Umapathy NS, 2007, INVEST OPHTH VIS SCI, V48, P5299, DOI 10.1167/iovs.07-0288; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; Wang YH, 2001, BBA-BIOMEMBRANES, V1513, P49, DOI 10.1016/S0005-2736(01)00340-6; WEITMAN SD, 1992, CANCER RES, V52, P3396; WEITMAN SD, 1992, CANCER RES, V52, P6708; Wollack JB, 2008, J NEUROCHEM, V104, P1494, DOI 10.1111/j.1471-4159.2007.05095.x; Yang J, 2007, J PHARMACOL EXP THER, V321, P462, DOI 10.1124/jpet.106.117648; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2004, CLIN CANCER RES, V10, P718, DOI 10.1158/1078-0432.CCR-1066-03; Zhao RB, 1997, J BIOL CHEM, V272, P21207, DOI 10.1074/jbc.272.34.21207; Zhao RB, 2008, MOL PHARMACOL, V74, P854, DOI 10.1124/mol.108.045443; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2007, CANCER METAST REV, V26, P129, DOI 10.1007/s10555-007-9047-1	51	112	117	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4267	4274		10.1074/jbc.M807665200	http://dx.doi.org/10.1074/jbc.M807665200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074442	hybrid, Green Published			2022-12-27	WOS:000263134400024
J	Brockmeier, A; Brockmeier, U; Williams, DB				Brockmeier, Achim; Brockmeier, Ulf; Williams, David B.			Distinct Contributions of the Lectin and Arm Domains of Calnexin to Its Molecular Chaperone Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM CHAPERONE; I HISTOCOMPATIBILITY MOLECULES; PEPTIDE-BINDING-SPECIFICITY; CALRETICULIN P-DOMAIN; HEAT-SHOCK-PROTEIN; CIRCULAR-DICHROISM; QUALITY-CONTROL; SUBSTRATE-BINDING; ESCHERICHIA-COLI; CONFORMATIONAL STATES	Calnexin is a Ca2+-binding transmembrane chaperone of the endoplasmic reticulum that recognizes Glc(1)Man(5-9)GlcNAc(2) oligosaccharides on folding glycoproteins as well as non-native elements of the polypeptide backbone. This latter mode of recognition enables calnexin to suppress the aggregation of both glycosylated and nonglycosylated substrates. The luminal portion of calnexin (S-Cnx) consists of two domains, a globular lectin domain and an extended arm domain. To understand the function of these domains during the interaction of calnexin with non-native protein conformers, we tested deletion mutants of S-Cnx for their abilities to suppress the aggregation of nonglycosylated firefly luciferase. The arm domain alone exhibited no capacity to suppress aggregation. However, stepwise truncation of the arm domain in S-Cnx resulted in a progressive reduction in aggregation suppression potency to the point where the globular domain alone exhibited 25% potency. To characterize the polypeptide-binding site, we used hydrophobic peptides that were competitors of the ability of S-Cnx to suppress luciferase aggregation. Direct binding experiments revealed a single site of peptide binding in the globular domain (K-d = 0.9 mu M) at a location distinct from the lectin site. Progressive truncation of the arm domain in S-Cnx had no effect on the binding of small peptides but reduced the binding affinity of S-Cnx for large, non-native protein substrates. Because protein substrates exhibited no binding to the isolated arm domain, our findings support a model in which calnexin suppresses aggregation through a polypeptide-binding site in its globular domain, with the arm domain enhancing aggregation suppression by sterically constraining large substrates.	[Williams, David B.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Williams, DB (corresponding author), Univ Toronto, Dept Biochem, Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.williams@utoronto.ca			Canadian Institutes of Health Research; Canadian Cancer Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by grants from the Canadian Institutes of Health Research and the Canadian Cancer Society (to D. B. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnaud N, 1997, ANALYST, V122, P143, DOI 10.1039/a605279g; BAKSH S, 1991, J BIOL CHEM, V266, P21458; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Caramelo JJ, 2004, J BIOL CHEM, V279, P46280, DOI 10.1074/jbc.M408404200; Culina S, 2004, J BIOL CHEM, V279, P54210, DOI 10.1074/jbc.M410841200; Davis DP, 1999, J IMMUNOL, V163, P3842; Duus K, 2008, PROTEIN PEPTIDE LETT, V15, P103; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; FRESKGARD PO, 1994, BIOCHEMISTRY-US, V33, P14281, DOI 10.1021/bi00251a041; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; GREENE LE, 1995, J BIOL CHEM, V270, P2967, DOI 10.1074/jbc.270.7.2967; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; High S, 2000, FEBS LETT, V476, P38, DOI 10.1016/S0014-5793(00)01666-5; HIRST JD, 1994, J MOL BIOL, V243, P173, DOI 10.1006/jmbi.1994.1644; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Kapoor M, 2004, BIOCHEMISTRY-US, V43, P97, DOI 10.1021/bi0355286; Kapoor M, 2003, J BIOL CHEM, V278, P6194, DOI 10.1074/jbc.M209132200; KOSEN PA, 1981, BIOCHEMISTRY-US, V20, P5744, DOI 10.1021/bi00523a017; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Lentze N, 2004, BIOCHEM BIOPH RES CO, V325, P401, DOI 10.1016/j.bbrc.2004.10.043; Li Jingzhi, 2004, Biol Proced Online, V6, P204, DOI 10.1251/bpo90; Li JZ, 2005, BIOCHEM J, V386, P453, DOI 10.1042/BJ20041050; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Meacock SL, 2000, ESSAYS BIOCHEM, V36, P1; NUNNARI J, 1992, Current Opinion in Cell Biology, V4, P573, DOI 10.1016/0955-0674(92)90074-M; OKAZAKI A, 1994, NAT STRUCT BIOL, V1, P439, DOI 10.1038/nsb0794-439; Patil AR, 2000, J BIOL CHEM, V275, P24348, DOI 10.1074/jbc.M003102200; Pollock S, 2004, EMBO J, V23, P1020, DOI 10.1038/sj.emboj.7600119; RICHARME G, 1993, J BIOL CHEM, V268, P24074; RICHARME G, 1994, J BIOL CHEM, V269, P7095; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Sandhu N, 2007, BBA-PROTEINS PROTEOM, V1774, P701, DOI 10.1016/j.bbapap.2007.03.019; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Singh J., 1992, ATLAS PROTEIN SIDE C; Stronge VS, 2001, J BIOL CHEM, V276, P39779, DOI 10.1074/jbc.M107091200; Tan Y, 2006, BBA-GEN SUBJECTS, V1760, P745, DOI 10.1016/j.bbagen.2006.02.003; Taylor SC, 2004, NAT STRUCT MOL BIOL, V11, P128, DOI 10.1038/nsmb715; Thammavongsa V, 2005, J BIOL CHEM, V280, P33497, DOI 10.1074/jbc.M503648200; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; TJOELKER LW, 1994, BIOCHEMISTRY-US, V33, P3229, DOI 10.1021/bi00177a013; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Urbanova N, 2008, ANAL SCI, V24, P727, DOI 10.2116/analsci.24.727; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Xu XH, 2004, FEBS LETT, V570, P155, DOI 10.1016/j.febslet.2004.06.039; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	65	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3433	3444		10.1074/jbc.M804866200	http://dx.doi.org/10.1074/jbc.M804866200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074423	hybrid			2022-12-27	WOS:000262872500009
J	Trojer, P; Zhang, J; Yonezawa, M; Schmidt, A; Zheng, HY; Jenuwein, T; Reinberg, D				Trojer, Patrick; Zhang, Jin; Yonezawa, Masato; Schmidt, Andreas; Zheng, Haiyan; Jenuwein, Thomas; Reinberg, Danny			Dynamic Histone H1 Isotype 4 Methylation and Demethylation by Histone Lysine Methyltransferase G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKER-HISTONE; FACULTATIVE HETEROCHROMATIN; SUBSTRATE-SPECIFICITY; CHROMATIN-STRUCTURE; MOUSE DEVELOPMENT; EUGLENA-GRACILIS; GENE-EXPRESSION; MICE LACKING; IN-VIVO; G9A	The linker histone H1 generally participates in the establishment of chromatin structure. However, of the seven somatic H1 isotypes in humans some are also implicated in the regulation of local gene expression. Histone H1 isotype 4 (H1.4) represses transcription, and its lysine residue 26 (Lys(26)) was found to be important in this aspect. H1.4K26 is known to be methylated and acetylated in vivo, but the enzymes responsible for these post-translational modifications and the regulatory cues that promote H1.4 residence on chromatin are poorly characterized. Here we report that the euchromatic histone lysine methyltransferase G9a/KMT1C mediates H1.4K26 mono- and dimethylation in vitro and in vivo and thereby provides a recognition surface for the chromatin-binding proteins HP1 and L3MBTL1. Moreover, we show evidence that G9a promotes H1 deposition and is required for retention of H1 on chromatin. We also identify members of the JMJD2/KDM4 subfamily of jumonji-C type histone demethylases as being responsible for the removal of H1.4K26 methylation.	[Trojer, Patrick; Reinberg, Danny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Trojer, Patrick; Zhang, Jin; Reinberg, Danny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Yonezawa, Masato; Jenuwein, Thomas] Vienna Bioctr, Res Inst Mol Pathol, IMP, A-1030 Vienna, Austria; [Schmidt, Andreas] Univ Vienna, Vienna Bioctr, Christian Doppler Lab Proteome Anal, Dept Biochem, A-1030 Vienna, Austria; [Zheng, Haiyan] Univ Med & Dent New Jersey, Ctr Adv Biotechnol & Med, Dept Pharmacol, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; New York University; New York University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Vienna; Vienna Biocenter (VBC); Rutgers State University New Brunswick; Rutgers State University Medical Center	Reinberg, D (corresponding author), 522 1st Ave, New York, NY 10016 USA.	reinbd01@nyumc.org		Reinberg, Danny/0000-0003-4288-2016	National Institutes of Health [RR020932, RR017992, GM64844]; Howard Hughes Medical Institute; Institute of Molecular Pathology (IMP) [HPRN-CT2000-00078]; Austrian GEN-AU Initiative (financed by the Austrian Ministry of Education, Science, and Culture); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017992, S10RR020932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Institute of Molecular Pathology (IMP); Austrian GEN-AU Initiative (financed by the Austrian Ministry of Education, Science, and Culture); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Shared Instrumentation Grants RR020932 and RR017992 ( to P. L.) and National Institutes of Health Grant GM64844 ( to D. R.). This work was also supported by a grant from the Howard Hughes Medical Institute ( to D. R.), the Institute of Molecular Pathology (IMP) through Boehringer Ingelheim, European Union network Grant HPRN-CT2000-00078, and the Austrian GEN-AU Initiative (financed by the Austrian Ministry of Education, Science, and Culture) ( to T. J.).	Alami R, 2003, P NATL ACAD SCI USA, V100, P5920, DOI 10.1073/pnas.0736105100; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Barra JL, 2000, MOL CELL BIOL, V20, P61, DOI 10.1128/MCB.20.1.61-69.2000; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Escher D, 1997, MOL GEN GENET, V256, P456, DOI 10.1007/s004380050589; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Garcia BA, 2006, MOL CELL PROTEOMICS, V5, P1593, DOI 10.1074/mcp.M600086-MCP200; Godde JS, 2008, J BIOCHEM, V143, P287, DOI 10.1093/jb/mvn013; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Jason LJM, 2005, J BIOL CHEM, V280, P4975, DOI 10.1074/jbc.M410203200; Koop R, 2003, EMBO J, V22, P588, DOI 10.1093/emboj/cdg052; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; LANGAN TA, 1967, FED PROC, V26, P603; Lee N, 2007, NAT STRUCT MOL BIOL, V14, P341, DOI 10.1038/nsmb1216; Lin QC, 2000, MOL CELL BIOL, V20, P2122, DOI 10.1128/MCB.20.6.2122-2128.2000; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; OHE Y, 1986, J BIOCHEM-TOKYO, V100, P359, DOI 10.1093/oxfordjournals.jbchem.a121722; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Perez-Burgos L, 2004, METHOD ENZYMOL, V376, P234; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Ramon A, 2000, MOL MICROBIOL, V35, P223, DOI 10.1046/j.1365-2958.2000.01702.x; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Sarcevic B, 2003, ONCOLOGY-BASEL, V64, P443, DOI 10.1159/000070305; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; SYED S, 1992, J PROTEIN CHEM, V11, P239, DOI 10.1007/BF01024862; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Trojer P, 2008, NAT CHEM BIOL, V4, P332, DOI 10.1038/nchembio0608-332; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; TUCK MT, 1985, J BIOL CHEM, V260, P7114; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Villar-Garea A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001553; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	59	146	149	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8395	8405		10.1074/jbc.M807818200	http://dx.doi.org/10.1074/jbc.M807818200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19144645	Green Published, hybrid			2022-12-27	WOS:000264397800023
J	Wientjes, E; Oostergetel, GT; Jansson, S; Boekema, EJ; Croce, R				Wientjes, Emilie; Oostergetel, Gert T.; Jansson, Stefan; Boekema, Egbert J.; Croce, Roberta			The Role of Lhca Complexes in the Supramolecular Organization of Higher Plant Photosystem I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; ANGSTROM RESOLUTION; PIGMENT-BINDING; ANTENNA POLYPEPTIDES; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; PSI-LHCI; PROTEINS; FLUORESCENCE; CHLOROPHYLLS	In this work, Photosystem I supercomplexes have been purified from Lhca-deficient lines of Arabidopsis thaliana using a mild detergent treatment that does not induce loss of outer antennas. The complexes have been studied by integrating biochemical analysis with electron microscopy. This allows the direct correlation of changes in protein content with changes in supramolecular structure of Photosystem I to get information about the position of the individual Lhca subunits, the association of the antenna to the core, and the influence of the individual subunits on the stability of the system. Photosystem I complexes with only two or three antenna complexes were purified, showing that the binding of Lhca1/4 and Lhca2/3 dimers to the core is not interdependent, although weak binding of Lhca2/3 to the core is stabilized by the presence of Lhca4. Moreover, Lhca2 and Lhca4 can be associated with the core in the absence of their "dimeric partners." The structure of Photosystem I is very rigid, and the absence of one antenna complex leaves a "hole" in the structure that cannot be filled by other Lhcas, clearly indicating that the docking sites for the individual subunits are highly specific. There is, however, an exception to the rule: Lhca5 can substitute for Lhca4, yielding highly stable PSI supercomplexes with a supramolecular organization identical to the WT.	[Wientjes, Emilie; Oostergetel, Gert T.; Boekema, Egbert J.; Croce, Roberta] Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Jansson, Stefan] Umea Plant Sci Ctr, Dept Plant Physiol, SE-90189 Umea, Sweden	University of Groningen; Umea University	Croce, R (corresponding author), Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	R.Croce@rug.nl	Croce, Roberta/ABG-3595-2021; Croce, Roberta/N-4067-2014; Wientjes, Emilie/M-6387-2014; Croce, Roberta/HGU-9554-2022; Jansson, Stefan/A-1119-2009; Croce, Roberta/F-1174-2014; Wientjes, Emilie/AAC-8491-2019	Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Wientjes, Emilie/0000-0003-2625-8045; Croce, Roberta/0000-0003-3469-834X; Jansson, Stefan/0000-0002-7906-6891; Wientjes, Emilie/0000-0003-2625-8045	Nederlandse Organisatie voor Wetenschappelijk Onderzoek via a VIDI	Nederlandse Organisatie voor Wetenschappelijk Onderzoek via a VIDI(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Council for Earth and Life Sciences of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek via a VIDI grant (to R.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Amunts A, 2008, PLANT PHYSIOL BIOCH, V46, P228, DOI 10.1016/j.plaphy.2007.12.013; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; Ballottari M, 2004, EUR J BIOCHEM, V271, P4659, DOI 10.1111/j.1432-1033.2004.04426.x; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Boekema EJ, 2001, BIOCHEMISTRY-US, V40, P1029, DOI 10.1021/bi0015358; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Croce R, 1996, BIOCHEMISTRY-US, V35, P8572, DOI 10.1021/bi960214m; Croce R, 1998, BIOCHEMISTRY-US, V37, P17355, DOI 10.1021/bi9813227; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Fromme P, 2001, BBA-BIOENERGETICS, V1507, P5, DOI 10.1016/S0005-2728(01)00195-5; Ganeteg U, 2004, PLANT MOL BIOL, V54, P641, DOI 10.1023/B:PLAN.0000040813.05224.94; Ganeteg U, 2004, PLANT PHYSIOL, V134, P502, DOI 10.1104/pp.103.033324; Ganeteg U, 2001, PLANT PHYSIOL, V127, P150, DOI 10.1104/pp.127.1.150; GANETEG U, 2004, THESIS UMEA PLANT SC; Ihalainen JA, 2005, FEBS LETT, V579, P4787, DOI 10.1016/j.febslet.2005.06.091; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jennings RC, 2003, BBA-BIOENERGETICS, V1557, P91, DOI 10.1016/S0005-2728(02)00399-7; Jensen PE, 2000, J BIOL CHEM, V275, P24701, DOI 10.1074/jbc.M000550200; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Klimmek F, 2005, BIOCHEMISTRY-US, V44, P3065, DOI 10.1021/bi047873g; KNOETZEL J, 1992, EUR J BIOCHEM, V206, P209, DOI 10.1111/j.1432-1033.1992.tb16918.x; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lucinski R, 2006, FEBS LETT, V580, P6485, DOI 10.1016/j.febslet.2006.10.063; Morosinotto T, 2005, J BIOL CHEM, V280, P31050, DOI 10.1074/jbc.M502935200; Morosinotto T, 2003, J BIOL CHEM, V278, P49223, DOI 10.1074/jbc.M309203200; NUSSBERGER S, 1994, BIOCHEMISTRY-US, V33, P14775, DOI 10.1021/bi00253a016; Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9; PETER GF, 1991, J BIOL CHEM, V266, P16745; Ruban AV, 2003, NATURE, V421, P648, DOI 10.1038/nature01344; Schmid VHR, 1997, P NATL ACAD SCI USA, V94, P7667, DOI 10.1073/pnas.94.14.7667; Schmid VHR, 2002, J BIOL CHEM, V277, P37307, DOI 10.1074/jbc.M205889200; Storf S, 2005, J BIOL CHEM, V280, P5163, DOI 10.1074/jbc.M411248200; Storf S, 2004, BIOCHEMISTRY-US, V43, P9214, DOI 10.1021/bi0498196; Tikkanen M, 2006, PLANT MOL BIOL, V62, P795, DOI 10.1007/s11103-006-9088-9; van Oort B, 2008, BIOPHYS J, V95, P5851, DOI 10.1529/biophysj.108.140467; Varotto C, 2002, PLANT PHYSIOL, V129, P616, DOI 10.1104/pp.002089; Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2	43	76	81	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7803	7810		10.1074/jbc.M808395200	http://dx.doi.org/10.1074/jbc.M808395200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19139095	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000264195600042
J	Jin, Z; Shi, J; Saraf, A; Mei, W; Zhu, GZ; Strack, S; Yang, J				Jin, Zhigang; Shi, Jianli; Saraf, Amit; Mei, Wenyan; Zhu, Guo-Zhang; Strack, Stefan; Yang, Jing			The 48-kDa Alternative Translation Isoform of PP2A:B56 epsilon Is Required for Wnt Signaling during Midbrain-Hindbrain Boundary Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; REGULATORY SUBUNIT; GENE IEX-1; PP2A; EXPRESSION; GENOME; FAMILY; RNA; INITIATION; INDUCTION	Alternative translation is an underappreciated post-transcriptional regulation mechanism. Although only a small number of genes are found to be alternatively translated, most genes undergoing alternative translation play important roles in tumorigenesis and development. Protein phosphatase 2A (PP2A) is involved in many cellular events during tumorigenesis and development. The specificity, localization, and activity of PP2A are regulated by B regulatory subunits. B56 epsilon, a member of the B56 regulatory subunit family, is involved in multiple signaling pathways and regulates a number of developmental processes. Here we report that B56 epsilon is alternatively translated, leading to the production of a full-length form and a shorter isoform that lacks the N-terminal 76 amino acid residues of the full-length form. Alternative translation of B56 epsilon occurs through a cap-dependent mechanism. We provide evidence that the shorter isoform is required for Wnt signaling and regulates the midbrain/hindbrain boundary formation during Xenopus embryonic development. This demonstrates that the shorter isoform of B56 epsilon has important biological functions. Furthermore, we show that the N-terminal sequence of B56 epsilon, which is not present in the shorter isoform, contains a nuclear localization signal, whereas the C terminus of B56 epsilon contains a nuclear export signal. The shorter isoform, which lacks the N-terminal nuclear localization signal, is restricted to the cytoplasm. In contrast, the full-length form can be localized to the nucleus in a cell type-specific manner. The finding that B56 epsilon is alternatively translated adds a new level of regulation to PP2A holoenzymes.	[Jin, Zhigang; Shi, Jianli; Mei, Wenyan; Yang, Jing] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Cell & Dev Biol,Dept Pediat, Columbus, OH 43205 USA; [Saraf, Amit; Strack, Stefan] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Zhu, Guo-Zhang] Marshall Univ, Dept Biol Sci, Huntington, WV 25755 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Iowa; Marshall University	Yang, J (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Cell & Dev Biol,Dept Pediat, Columbus, OH 43205 USA.	Jing.Yang@nationwidechildrens.org	Saraf, amit/GZL-0533-2022; Jin, Zhigang/T-7125-2019	Saraf, amit/0000-0002-0823-2266; Jin, Zhigang/0000-0001-7557-2968; Strack, Stefan/0000-0002-6175-7280	Nationwide Children's Hospital internal startup fund; Madison Foundation	Nationwide Children's Hospital internal startup fund; Madison Foundation	This work was supported by a Nationwide Children's Hospital internal startup fund (to J. Y.) and by The Madison Foundation. The costs of publication of this article were defrayed in part by the payment of page charges.	BRADLEY LC, 1993, MECH DEVELOP, V40, P73, DOI 10.1016/0925-4773(93)90089-G; Cameron RA, 2000, P NATL ACAD SCI USA, V97, P9514, DOI 10.1073/pnas.160261897; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; CHRISTIAN JL, 1991, DEV BIOL, V143, P230, DOI 10.1016/0012-1606(91)90073-C; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Deardorff' MA, 1998, DEVELOPMENT, V125, P2687; Deardorff MA, 2001, DEVELOPMENT, V128, P3655; Eichhorn P.J., 2008, BBA-REV CANCER, V1795, P1, DOI DOI 10.1016/J.BBCAN.2008.05.005; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Gingras AC, 2001, GENE DEV, V15, P2852; Hannus M, 2002, DEVELOPMENT, V129, P3493; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; Holland AJ, 2007, J BIOL CHEM, V282, P24623, DOI 10.1074/jbc.M702545200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Liu W, 2007, MOL CELL PROTEOMICS, V6, P319, DOI 10.1074/mcp.M600272-MCP200; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Mayer C, 2003, BIOCHEMISTRY-US, V42, P4787, DOI 10.1021/bi034011r; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; McGrew LL, 1999, MECH DEVELOP, V87, P21, DOI 10.1016/S0925-4773(99)00136-7; MOODY SA, 1987, DEV BIOL, V119, P560, DOI 10.1016/0012-1606(87)90059-5; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Muneer S, 2002, GENOMICS, V79, P344, DOI 10.1006/geno.2002.6721; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Pennisi E, 2003, SCIENCE, V300, P1484, DOI 10.1126/science.300.5625.1484b; Ratcliffe MJ, 2000, J BIOL CHEM, V275, P35680, DOI 10.1074/jbc.C000639200; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Rorick AM, 2007, DEV BIOL, V302, P477, DOI 10.1016/j.ydbio.2006.10.011; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; SHARPE CR, 1987, CELL, V50, P749, DOI 10.1016/0092-8674(87)90333-3; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sive H., 2000, EARLY DEV XENOPUS LA, P91; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762	47	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7190	7200		10.1074/jbc.M807907200	http://dx.doi.org/10.1074/jbc.M807907200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129191	Green Published, hybrid			2022-12-27	WOS:000263919000066
J	Lee, YY; Cevallos, RC; Jan, E				Lee, Yun-Young; Cevallos, Randal C.; Jan, Eric			An Upstream Open Reading Frame Regulates Translation of GADD34 during Cellular Stresses That Induce eIF2 alpha Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA TRANSLATION; INDUCED GENE-EXPRESSION; INITIATION FACTOR-II; EUKARYOTIC RIBOSOMES; DISTINCT MECHANISMS; PROTEIN TRANSLATION; MAMMALIAN-CELLS; GROWTH ARREST; ENTRY SITE	Cellular stress such as endoplasmic reticulum stress, hypoxia, and viral infection activates an integrated stress response, which includes the phosphorylation of the eukaryotic initiation factor 2 alpha (eIF2 alpha) to inhibit overall protein synthesis. Paradoxically, this leads to translation of a subset of mRNAs, like transcription factor ATF4, which in turn induces transcription of downstream stress-induced genes such as growth arrest DNA-inducible gene 34 (GADD34). GADD34 interacts with protein phosphatase 1 to dephosphorylate eIF2 alpha, resulting in a negative feedback loop to recover protein synthesis and allow translation of stress-induced transcripts. Here, we show that GADD34 is not only transcriptionally induced but also translationally regulated to ensure maximal expression during eIF2 alpha phosphorylation. GADD34 mRNAs are preferentially associated with polysomes during eIF2 alpha phosphorylation, which is mediated by its 5'-untranslated region (5'UTR). The human GADD34 5'UTR contains two non-overlapping upstream open reading frames (uORFs), whereas the mouse version contains two overlapping and out of frame uORFs. Using 5'UTR GADD34 reporter constructs, we show that the downstream uORF mediates repression of basal translation and directs translation during eIF2 alpha phosphorylation. Furthermore, we show that the upstream uORF is poorly translated and that a proportion of scanning ribosomes bypasses the upstream uORF to recognize the downstream uORF. These findings suggest that GADD34 translation is regulated by a unique 5'UTR uORF mechanism to ensure proper GADD34 expression during eIF2 alpha phosphorylation. This mechanism may serve as a model for understanding how other 5'UTR uORF-containing mRNAs are regulated during cellular stress.	[Lee, Yun-Young; Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Cevallos, Randal C.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	University of British Columbia; Stanford University	Jan, E (corresponding author), 5457-2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ej@interchange.ubc.ca	Jan, Eric/O-1923-2019		Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by a Canadian Institutes for Health Research operating grant ( to E. J.).	Adler HT, 1999, MOL CELL BIOL, V19, P7050; Alwine JC, 2008, CURR TOP MICROBIOL, V325, P263; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Calkhoven CF, 2000, GENE DEV, V14, P1920; CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729; Child SJ, 1999, J BIOL CHEM, V274, P24335, DOI 10.1074/jbc.274.34.24335; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Fang P, 2000, J BIOL CHEM, V275, P26710; Fang P, 2004, P NATL ACAD SCI USA, V101, P4059, DOI 10.1073/pnas.0400554101; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Gaba A, 2005, MOL CELL, V20, P449, DOI 10.1016/j.molcel.2005.09.019; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; GRANT CM, 1994, MOL CELL BIOL, V14, P2616, DOI 10.1128/MCB.14.4.2616; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hollander MC, 2003, ONCOGENE, V22, P3827, DOI 10.1038/sj.onc.1206567; Hollander MC, 1997, J BIOL CHEM, V272, P13731, DOI 10.1074/jbc.272.21.13731; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; Jackson R. J., 2007, TRANSLATIONAL CONTRO, P197; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Kenzelmann M, 2007, P NATL ACAD SCI USA, V104, P6164, DOI 10.1073/pnas.0610439104; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; KOSTURA M, 1989, MOL CELL BIOL, V9, P1576, DOI 10.1128/MCB.9.4.1576; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Poyry TAA, 2007, GENE DEV, V21, P3149, DOI 10.1101/gad.439507; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Ron D, 2007, TRANSLATIONAL CONTRO, P345; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Sachs MS, 2006, GENE DEV, V20, P915, DOI 10.1101/gad.1427006; SCHNEIDER RJ, 2007, TRANSLATIONAL CONTRO, P401; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	56	148	149	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6661	6673		10.1074/jbc.M806735200	http://dx.doi.org/10.1074/jbc.M806735200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131336	hybrid, Green Published			2022-12-27	WOS:000263919000010
J	Dang, HX; Liu, Y; Pang, W; Li, CH; Wang, NP; Shyy, JYJ; Zhu, Y				Dang, Huaixin; Liu, Yan; Pang, Wei; Li, Chenghong; Wang, Nanping; Shyy, John Y. -J.; Zhu, Yi			Suppression of 2,3-Oxidosqualene Cyclase by High Fat Diet Contributes to Liver X Receptor-alpha-mediated Improvement of Hepatic Lipid Profile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; CHOLESTEROL HOMEOSTASIS; LANOSTEROL CYCLASE; BINDING; LIGAND; ATHEROSCLEROSIS; TRANSCRIPTION; MACROPHAGES; INSULIN; PROTEIN	The liver X receptors (LXRs) sense oxysterols and regulate genes involved in cholesterol metabolism. Synthetic agonists of LXRs are potent stimulators of fatty acid synthesis, which is mediated largely by sterol regulatory element-binding protein-1c (SREBP-1c). Paradoxically, an improved hepatic lipid profile by LXR was observed in mice fed a Western high fat (HF) diet. To explore the underlying mechanism, we administered mice normal chow or an HF diet and overexpressed LXR alpha in the liver. The HF diet with tail-vein injection of adenovirus of LXR alpha increased the expression of LXR-targeted genes involved in cholesterol reverse transport but not those involved in fatty acid synthesis. A similar effect was also observed with the use of 22R-hydroxycholesterol, an LXR ligand, in cultured hepatocytes. Consequently, SREBP-1c maturation was inhibited by the HF diet, which resulted from the induction of Insig-2a. Importantly, increased cholesterol level suppressed the expression of 2,3-oxidosqualene cyclase (OSC), which led to an increase in endogenous LXR ligand(s). Furthermore, siRNA-mediated knockdown of OSC expression enhanced LXR activity and selectively up-regulated LXR-targeted genes involved in cholesterol reverse transport. Thus, down-regulation of OSC may account for a novel mechanism underlying the LXR-mediated lipid metabolism in the liver of mice fed an HF diet.	[Dang, Huaixin; Liu, Yan; Pang, Wei; Li, Chenghong; Zhu, Yi] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100083, Peoples R China; [Wang, Nanping] Peking Univ, Inst Cardiovasc Res, Beijing 100083, Peoples R China; [Shyy, John Y. -J.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA	Peking University; Peking University; University of California System; University of California Riverside	Zhu, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100083, Peoples R China.	zhuyi@hsc.pku.edu.cn	Liu, Yan/S-6650-2017; Liu, Yan/J-7597-2019; Wang, Nanping/G-1818-2011	Liu, Yan/0000-0002-3961-9172; Liu, Yan/0000-0002-3961-9172; Wang, Nanping/0000-0002-8528-8132	National Institutes of Health [HL77448]; National Natural Science Foundation of China [30570713, 30630032, 30890040]; Major National Basic Research Grant of China [2006BC503802]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Basic Research Grant of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL77448 ( to J. Y. S.). This study was also supported in part by grants from the National Natural Science Foundation of China (30570713, 30630032, 30890040), the "111" Project and the Major National Basic Research Grant of China ( 2006BC503802, to Y. Z.).	Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Lehrke M, 2005, CELL METAB, V1, P297, DOI 10.1016/j.cmet.2005.04.005; Lu M, 2006, AM J PHYSIOL-CELL PH, V290, pC1477, DOI 10.1152/ajpcell.00374.2005; McDonald JG, 2007, METHOD ENZYMOL, V432, P145, DOI 10.1016/S0076-6879(07)32006-5; Ory DS, 2004, CIRC RES, V95, P660, DOI 10.1161/01.RES.0000143422.83209.be; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; RIDDELL DR, 2007, MOL CELL NEUROSCI; Rowe AH, 2003, CIRC RES, V93, P717, DOI 10.1161/01.RES.0000097606.43659.F4; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shimano H, 2000, TRENDS CARDIOVAS MED, V10, P275, DOI 10.1016/S1050-1738(00)00079-7; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Telford DE, 2005, ARTERIOSCL THROM VAS, V25, P2608, DOI 10.1161/01.ATV.0000189158.28455.94; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Wang NP, 2001, ARTERIOSCL THROM VAS, V21, P1414, DOI 10.1161/hq0901.095549; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Wong J, 2008, J BIOL CHEM, V283, P700, DOI 10.1074/jbc.M706416200; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zeng LF, 2004, J BIOL CHEM, V279, P48801, DOI 10.1074/jbc.M407817200; Zhu MJ, 2008, ARTERIOSCL THROM VAS, V28, P527, DOI 10.1161/ATVBAHA.107.143487; Zhu Y, 2005, CARDIOVASC RES, V68, P425, DOI 10.1016/j.cardiores.2005.07.003	37	16	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6218	6226		10.1074/jbc.M803702200	http://dx.doi.org/10.1074/jbc.M803702200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19119143	hybrid, Green Published			2022-12-27	WOS:000263742700025
J	Lee, IH; Finkel, T				Lee, In Hye; Finkel, Toren			Regulation of Autophagy by the p300 Acetyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; LIFE-SPAN; MICE; RESTRICTION; EXTENSION; DISEASE; GENES; CELLS; MTOR	Autophagy is a regulated process of intracellular catabolism required for normal cellular maintenance, as well as serving as an adaptive response under various stress conditions, including starvation. The molecular regulation of autophagy in mammalian cells remains incompletely understood. Here we demonstrate a role for protein acetylation in the execution and regulation of autophagy. In particular, we demonstrate that the p300 acetyltransferase can regulate the acetylation of various known components of the autophagy machinery. Knockdown of p300 reduces acetylation of Atg5, Atg7, Atg8, and Atg12, although overexpressed p300 increases the acetylation of these same proteins. Furthermore, p300 and Atg7 colocalize within cells, and the two proteins physically interact. The interaction between p300 and Atg7 is dependent on nutrient availability. Finally, we demonstrate that knockdown of p300 can stimulate autophagy, whereas overexpression of p300 inhibits starvation-induced autophagy. These results demonstrate a role for protein acetylation and particularly p300 in the regulation of autophagy under conditions of limited nutrient availability.	[Lee, In Hye; Finkel, Toren] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Finkel, T (corresponding author), NHLBI, Translat Med Branch, NIH, Bldg 10,CRC 5-3330,10 Ctr Dr, Bethesda, MD 20892 USA.	finkelt@nih.gov	LEE, IN HYE/T-2714-2019	LEE, IN HYE/0000-0003-2334-3594	National Institutes of Health staff; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005012, ZICHL006019, ZIAHL005012] Funding Source: NIH RePORTER	National Institutes of Health staff(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was authored, in whole or in part, by National Institutes of Health staff. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bergamini E, 2007, ANN NY ACAD SCI, V1114, P69, DOI 10.1196/annals.1396.020; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Mavrakis M, 2006, HUM MOL GENET, V15, P2962, DOI 10.1093/hmg/ddl239; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618	17	189	205	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6322	6328		10.1074/jbc.M807135200	http://dx.doi.org/10.1074/jbc.M807135200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124466	Green Published, hybrid			2022-12-27	WOS:000263742700035
J	Thomas, CG; Spyrou, G				Thomas, Christophoros G.; Spyrou, Giannis			ERdj5 Sensitizes Neuroblastoma Cells to Endoplasmic Reticulum Stress-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN RESPONSE; HUMAN HEPATOCELLULAR-CARCINOMA; INDUCED GENE-EXPRESSION; ER STRESS; TUMOR-GROWTH; CANCER-CELLS; THIOREDOXIN REDUCTASE; DISULFIDE-ISOMERASE; UP-REGULATION; TRANSLATION	Down-regulation of the unfolded protein response (UPR) can be therapeutically valuable in cancer treatment, and endoplasmic reticulum (ER)-resident chaperone proteins may thus be targets for developing novel chemotherapeutic strategies. ERdj5 is a novel ER chaperone that regulates the ER-associated degradation of misfolded proteins through its associations with EDEM and the ER stress sensor BiP. To investigate whether ERdj5 can regulate ER stress signaling pathways, we exposed neuroblastoma cells overexpressing ERdj5 to ER stress inducers. ERdj5 promoted apoptosis in tunicamycin, thapsigargin, and bortezomib-treated cells. To provide further evidence that ERdj5 induces ER stress-regulated apoptosis, we targeted Bcl-2 to ER of ERdj5-overexpressing cells. Targeting the Bcl-2 to ER prevented the apoptosis induced by ER stress inducers but not by non-ER stress apoptotic stimuli, suggesting induction of ER stress-regulated apoptosis by ERdj5. ERdj5 enhanced apoptosis by abolishing the ER stress-induced phosphorylation of eukaryotic translation initiation factor 2 alpha(eIF2 alpha) and the subsequent translational repression. ERdj5 was found to inhibit the eIF2 alpha phosphorylation under ER stress through inactivating the pancreatic endoplasmic reticulum kinase. The compromised integrated stress response observed in ERdj5-overexpressing ER-stressed cells due to repressed eIF2 alpha phosphorylation correlated with impaired neuroblastoma cell resistance under ER stress. These results demonstrate that ERdj5 decreases neuroblastoma cell survival by down-regulating the UPR, raising the possibility that this protein could be a target for anti-tumor approaches.	[Thomas, Christophoros G.] Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden; [Spyrou, Giannis] Acad Athens, Fdn Biomed Res, Athens 11527, Greece	Karolinska Institutet; Academy of Athens	Thomas, CG (corresponding author), Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden.	chrtho@ki.se			Swedish Research Council [K99-13X-10370]; Karolinska Institute and Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute and Foundation(Karolinska Institutet)	This work was supported by the Swedish Research Council Project K99-13X-10370, Karolinska Institute and Foundation for Biomedical Research, Academy of Athens. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Cai B, 1998, J CELL PHYSIOL, V177, P282, DOI 10.1002/(SICI)1097-4652(199811)177:2<282::AID-JCP10>3.0.CO;2-C; Castilla J, 2004, CURR MOL MED, V4, P397, DOI 10.2174/1566524043360654; Corazzari M, 2007, BRIT J CANCER, V96, P1062, DOI 10.1038/sj.bjc.6603672; Cunnea P, 2007, INT J IMMUNOPATH PH, V20, P17, DOI 10.1177/039463200702000103; Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Delom F, 2007, CELL DEATH DIFFER, V14, P586, DOI 10.1038/sj.cdd.4402012; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Fassio A, 2002, HISTOCHEM CELL BIOL, V117, P151, DOI 10.1007/s00418-001-0364-0; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gan L, 2005, J CELL BIOCHEM, V96, P653, DOI 10.1002/jcb.20585; Garber K, 2006, J NATL CANCER I, V98, P512, DOI 10.1093/jnci/djj174; Gladyshev VN, 1998, BIOCHEM BIOPH RES CO, V251, P488, DOI 10.1006/bbrc.1998.9495; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hayashi E, 2005, PROTEOMICS, V5, P1024, DOI 10.1002/pmic.200401132; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luk JM, 2006, PROTEOMICS, V6, P1049, DOI 10.1002/pmic.200500306; Mann MI, 2006, CANCER BIOL THER, V5, P736, DOI 10.4161/cbt.5.7.2969; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Okunaga T, 2006, CANCER RES, V66, P8662, DOI 10.1158/0008-5472.CAN-05-4256; Richardson Paul G, 2003, Clin Adv Hematol Oncol, V1, P596; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; York TP, 2005, MOL CARCINOGEN, V44, P242, DOI 10.1002/mc.20139	43	28	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6282	6290		10.1074/jbc.M806189200	http://dx.doi.org/10.1074/jbc.M806189200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19122239	hybrid			2022-12-27	WOS:000263742700031
J	Li, ZZ; Berk, M; McIntyre, TM; Feldstein, AE				Li, Zheng Zheng; Berk, Michael; McIntyre, Thomas M.; Feldstein, Ariel E.			Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease ROLE OF STEAROYL-CoA DESATURASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; ANIMAL-MODELS; STEATOHEPATITIS; STEATOSIS; MICE; LIPOTOXICITY; EXPRESSION; PROTECTS; INJURY	Hepatic lipid overloading mainly in the form of triglycerides is considered a prerequisite for the development of nonalcoholic fatty liver disease (NAFLD). However, triglyceride accumulation in the liver in response to lipid overflow may represent a protective mechanism against lipotoxicity. Our aims were to assess the fundamental cellular mechanisms that link lipid compartmentation in hepatocytes to liver damage and disease progression in NAFLD by using both in vivo dietary models of NAFLD and in vitro cell models of lipid overloading. Exposure of murine or human hepatocytes to monounsaturated fatty acids (MUFAs) resulted in lipid accumulation without changes in cell viability. In contrast, cell incubation with saturated fatty acids (SFAs) significantly decreased cell viability and increased caspase activation and apoptosis, with only minor lipid droplet accumulation. Genetic or pharmacological inhibition of stearoyl-CoA desaturase-1 (SCD1), the enzyme that converts SFA to MUFA, sensitized cells to SFA-induced apoptosis. Hepatic SCD1 expression increased in experimental steatosis resulting from high fat diet and decreased in a methionine-choline-deficient (MCD) dietary model of steatohepatitis resulting in the latter situation in significantly increased hepatic SFA levels. SCD1(-/-) mice on the MCD diet had decreased steatosis and markedly increased hepatocellular apoptosis, liver injury, and fibrosis compared with the SCD1(+/+), whereas MUFA feeding prevents the MCD-induced injury. In conclusion, this study suggests hepatic SCD1 plays a key role in prevention of steatohepatitis by partitioning excess lipid into MUFA that can be safely stored. This concept has important implications for the development of novel treatment strategies for patients with this condition.	[Li, Zheng Zheng; Berk, Michael; McIntyre, Thomas M.; Feldstein, Ariel E.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Feldstein, Ariel E.] Cleveland Clin, Dept Pediat Gastroenterol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Feldstein, AE (corresponding author), Cleveland Clin, Dept Pediat Gastroenterol & Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	feldsta@ccf.org	Berk, Michael/M-7891-2013; Berk, Michael/M-3585-2019	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946	National Institutes of Health [DK076852]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076852. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 2004, HUM PATHOL, V35, P1070, DOI 10.1016/j.humpath.2004.04.017; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Canbay A, 2003, J CLIN INVEST, V112, P152, DOI 10.1172/JCI200317740; Chen C, 2008, CELL METAB, V7, P135, DOI 10.1016/j.cmet.2007.12.003; Clark JM, 2003, JAMA-J AM MED ASSOC, V289, P3000, DOI 10.1001/jama.289.22.3000; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Dam-Larsen S, 2005, SCAND J GASTROENTERO, V40, P460, DOI 10.1080/00365520510012217; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e; Diehl AM, 2002, AM J PHYSIOL-GASTR L, V282, pG1, DOI 10.1152/ajpgi.00384.2001; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feldstein AE, 2003, J HEPATOL, V39, P978, DOI 10.1016/S0168-8278(03)00460-4; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; London Roslyn M, 2007, Clin Liver Dis, V11, P55, DOI 10.1016/j.cld.2007.02.010; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; McClain CJ, 2007, HEPATOLOGY, V45, P1343, DOI 10.1002/hep.21788; Nanji Amin A, 2004, Clin Liver Dis, V8, P559, DOI 10.1016/j.cld.2004.04.002; Ntambi JM, 2002, CAN J APPL PHYSIOL, V27, P617, DOI 10.1139/h02-036; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Wieckowska A, 2005, CURR OPIN PEDIATR, V17, P636, DOI 10.1097/01.mop.0000172816.79637.c5	39	296	305	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5637	5644		10.1074/jbc.M807616200	http://dx.doi.org/10.1074/jbc.M807616200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19119140	Green Published, hybrid			2022-12-27	WOS:000263560600027
J	Maestro, JL; Cobo, J; Belles, X				Maestro, Jose L.; Cobo, Juliana; Belles, Xavier			Target of Rapamycin (TOR) Mediates the Transduction of Nutritional Signals into Juvenile Hormone Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSECT BLATTELLA-GERMANICA; DEVELOPMENTAL PATTERN; TISSUE EXPRESSION; CORPORA ALLATA; CELL-GROWTH; COCKROACH; RHEB; DICTYOPTERA; DROSOPHILA; MOSQUITO	Anautogeny is a reproductive strategy by which females do not reproduce until they feed. Therefore, nutritional signals must inform the reproductive tissues, and cells that the organism has reached a nutritional status suitable for triggering reproductive processes. One of the possible pathways involved in anautogeny is the "target of rapamycin" (TOR) pathway, which has been described as connecting the nutritional status with growth, proliferation, and cancer. The German cockroach, Blattella germanica, is an anautogenous species whose vitellogenesis is governed by juvenile hormone. In the present report, we describe the cloning of TOR cDNA from B. germanica (BgTOR). Expression studies showed that BgTOR is expressed in adult female corpora allata and fat body. BgTOR knockdown using systemic RNAi in vivo produced a severe inhibition of juvenile hormone synthesis in adult female corpora allata, together with a reduction of mRNA levels corresponding to 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase-1, HMG-CoA synthase-2, and HMG-CoA reductase. In addition, there was a reduction of vitellogenin mRNA in the fat body, and ovaries did not grow. Analysis of TOR expression in corpora allata of fed and starved females suggested that TOR is not regulated at the transcriptional level. Nevertheless, there was a reduction in HMG-CoA synthases and reductase mRNA in corpora allata (but not in the fat body) of starved females, together with a dramatic reduction of juvenile hormone production and ovary development. Taken together, our results indicate that TOR knockdown mimics starvation in terms of corpora allata activity, and suggest that nutritional signals that activate juvenile hormone biosynthesis and vitellogenin production are mediated by the TOR pathway.	[Maestro, Jose L.; Belles, Xavier] UPF, CSIC, Inst Biol Evolut, Barcelona 08003, Spain; [Cobo, Juliana] Univ Fed Uberlandia, Inst Genet & Bioquim, BR-38400902 Uberlandia, MG, Brazil	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Universidade Federal de Uberlandia	Maestro, JL (corresponding author), UPF, CSIC, Inst Biol Evolut, Passeig Maritim Barceloneta 37-49, Barcelona 08003, Spain.	joseluis.maestro@ibe.upf-csic.es; xavier.belles@ibe.upf-csic.es	Belles, Xavier/G-2354-2015; Maestro, Jose/K-3708-2014	Belles, Xavier/0000-0002-1566-303X; Maestro, Jose/0000-0001-6117-0458	Spanish Ministry of Science and Technology [BFU2006-01090, AGL2005-00773, CGL2008-03517/BOS]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministry of Science and Technology (Projects BFU2006-01090 (to J. L. M.) and AGL2005-00773 and CGL2008-03517/BOS (to X. B.).	Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Belgacem YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000187; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Belles X, 2005, REPRO BIOL, V12, P157; BUESA C, 1994, J BIOL CHEM, V269, P11707; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chiang AS, 1996, ARCH INSECT BIOCHEM, V32, P299, DOI 10.1002/(SICI)1520-6327(1996)32:3/4<299::AID-ARCH4>3.0.CO;2-O; Cruz J, 2006, DEV BIOL, V297, P158, DOI 10.1016/j.ydbio.2006.06.048; Grewal SS, 2007, J CELL BIOL, V179, P1105, DOI 10.1083/jcb.200709044; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAGEDORN HH, 1975, P NATL ACAD SCI USA, V72, P3255, DOI 10.1073/pnas.72.8.3255; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Maestro JL, 2006, ARCH INSECT BIOCHEM, V62, P73, DOI 10.1002/arch.20123; Maestro O, 2005, MOL CELL ENDOCRINOL, V238, P27, DOI 10.1016/j.mce.2005.04.004; Mane-Padros D, 2008, DEV BIOL, V315, P147, DOI 10.1016/j.ydbio.2007.12.015; Martin D, 1995, INVERTEBR REPROD DEV, V28, P171, DOI 10.1080/07924259.1995.9672479; MARTINEZGONZALEZ J, 1993, EUR J BIOCHEM, V213, P233, DOI 10.1111/j.1432-1033.1993.tb17753.x; MARTINEZGONZALEZ J, 1993, EUR J BIOCHEM, V217, P691, DOI 10.1111/j.1432-1033.1993.tb18295.x; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Osorio S, 1998, J INSECT PHYSIOL, V44, P31, DOI 10.1016/S0022-1910(97)00102-9; PIULACHS MD, 1992, J INSECT PHYSIOL, V38, P555, DOI 10.1016/0022-1910(92)90105-M; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	29	76	80	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5506	5513		10.1074/jbc.M807042200	http://dx.doi.org/10.1074/jbc.M807042200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106101	hybrid, Green Published			2022-12-27	WOS:000263560600013
J	Zhang, T; Liu, WD; Saunee, NA; Breslin, MB; Lan, MS				Zhang, Tao; Liu, Wei-Dong; Saunee, Nicolle A.; Breslin, Mary B.; Lan, Michael S.			Zinc Finger Transcription Factor INSM1 Interrupts Cyclin D1 and CDK4 Binding and Induces Cell Cycle Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROENDOCRINE DIFFERENTIATION; GENE-EXPRESSION; BETA-CELLS; IA-1; PROGENITORS; MECHANISM; REPRESSOR; PANCREAS; PROTEIN; RECRUITMENT	INSM1 is a zinc finger transcription factor that plays an important role in pancreatic beta-cell development. To further evaluate its role in cell fate determination, we investigated INSM1 effects on cell cycle function. The cyclin box of cyclin D1 is essential for INSM1 binding. Competitive pull-down and co-immunoprecipitation revealed that INSM1 binding to cyclin D1 interrupts its association with CDK4 and induces hypophosphorylation of the retinoblastoma protein. An inducible Tet-on-system was established in Cos-7 and Panc-1 cells. Using serum starvation, we synchronized the cell cycle and subsequently induced cell cycle progression by serum stimulation. Comparison of the INSM1 induction group with the noninduced control group, INSM1 ectopic expression causes cell cycle arrest, whereas the INSM1-mediated cell cycle arrest could be reversed by cyclin D1 and CDK4 overexpression. The proline-rich N-terminal portion of INSM1 is required for cyclin D1 binding. Mutation of proline residues abolished cyclin D1 binding and also diminished its ability to induce cell cycle arrest. Cellular proliferation of Panc-1 cells was inhibited by INSM1 overexpression demonstrated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, soft agar colony formation, as well as tumor growth in a nude mouse model. Taken together, we provide evidence to support that INSM1 binds to cyclin D1, interrupts cell cycle signaling, and inhibits cellular proliferation.	[Lan, Michael S.] Childrens Hosp, Res Inst Children, New Orleans, LA 70118 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA	Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Lan, MS (corresponding author), Childrens Hosp, Res Inst Children, 200 Henry Clay Ave,Res & Educ Bldg,Rm 2211, New Orleans, LA 70118 USA.	mlan@chnola-research.org	Lan, Michael/CAF-1839-2022; zhang, tao/F-2905-2010		National Institutes of Health [DK61436]; Research Institute for Children, Children's Hospital at New Orleans; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Institute for Children, Children's Hospital at New Orleans; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK61436 ( to M. S. L.). This work was also supported by funds from the Research Institute for Children, Children's Hospital at New Orleans. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adnane J, 1999, ONCOGENE, V18, P239, DOI 10.1038/sj.onc.1202297; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Breslin MB, 2007, FEBS LETT, V581, P949, DOI 10.1016/j.febslet.2007.01.087; Breslin MB, 2003, J BIOL CHEM, V278, P38991, DOI 10.1074/jbc.M306795200; Breslin MB, 2002, NUCLEIC ACIDS RES, V30, P1038, DOI 10.1093/nar/30.4.1038; Candal E, 2007, DEV BIOL, V309, P1, DOI 10.1016/j.ydbio.2007.04.038; De Smaele E, 2008, NEOPLASIA, V10, P89, DOI 10.1593/neo.07891; Duggan A, 2008, J COMP NEUROL, V507, P1497, DOI 10.1002/cne.21629; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Ganter B, 1998, EMBO J, V17, P255, DOI 10.1093/emboj/17.1.255; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; GOTO Y, 1992, J BIOL CHEM, V267, P15252; GOUYER V, 1994, INT J CANCER, V58, P818, DOI 10.1002/ijc.2910580612; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Knudsen KE, 1999, CANCER RES, V59, P2297; LAN MS, 1993, CANCER RES, V53, P4169; Lin HM, 2002, J BIOL CHEM, V277, P28733, DOI 10.1074/jbc.M203380200; Liu WD, 2006, BIOCHEM J, V397, P169, DOI 10.1042/BJ20051669; Lubensky IA, 2007, ENDOCR PATHOL, V18, P156, DOI 10.1007/s12022-007-9007-x; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; MORI N, 1990, ONCOGENE, V5, P1713; Ratineau C, 2002, J BIOL CHEM, V277, P8847, DOI 10.1074/jbc.M110747200; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Skapek SX, 1996, MOL CELL BIOL, V16, P7043; Wang HY, 2008, BIOELECTROMAGNETICS, V29, P39, DOI 10.1002/bem.20360; Wildner H, 2008, DEVELOPMENT, V135, P473, DOI 10.1242/dev.011783; Wildwater M, 2007, DEV CELL, V12, P841, DOI 10.1016/j.devcel.2007.05.005; Xie JP, 2002, GENOMICS, V80, P54, DOI 10.1006/geno.2002.6800; Zhu M, 2002, PANCREAS, V24, P139, DOI 10.1097/00006676-200203000-00004; Zwicker J, 1999, ONCOGENE, V18, P19, DOI 10.1038/sj.onc.1202286	36	35	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5574	5581		10.1074/jbc.M808843200	http://dx.doi.org/10.1074/jbc.M808843200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19124461	Green Published, hybrid			2022-12-27	WOS:000263560600020
J	Larbat, R; Hehn, A; Hans, J; Schneider, S; Jugde, H; Schneider, B; Matern, U; Bourgaud, F				Larbat, Romain; Hehn, Alain; Hans, Joachim; Schneider, Sarah; Jugde, Helene; Schneider, Bernd; Matern, Ulrich; Bourgaud, Frederic			Isolation and Functional Characterization of CYP71AJ4 Encoding for the First P450 Monooxygenase of Angular Furanocoumarin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED INACTIVATION; AMMI-MAJUS L; MICROSOMAL CONVERSION; PSORALEN DERIVATIVES; PAPILIO-POLYXENES; RUTA-GRAVEOLENS; HIGH-EFFICIENCY; CYTOCHROME-P450; CLONING; PLANTS	The biosynthesis of linear and angular furanocoumarins is still poorly understood at the molecular level, with only psoralen synthase (CYP71AJ1) identified from Ammi majus. Using cDNA probes inferred from CYP71AJ1, three orthologs were isolated from Apium graveolens (CYP71AJ2) and Pastinaca sativa (CYP71AJ3 and -4) and functionally expressed in yeast cells. CYP71AJ2 and CYP71AJ3 displayed psoralen synthase activity, whereas CYP71AJ4 only catalyzed the conversion of (+)-columbianetin to angelicin and negligible amounts of a hydroxylated columbianetin by-product. CYP71AJ4 thus constitutes the first fully characterized P450 monooxygenase specific for the angular furanocoumarin pathway. The angelicin synthase exhibited an apparent K-m of 2.1 +/- 0.4 mu M for (+)-columbianetin and a k(cat) of 112 +/- 14 min(-1). Moreover, the use of 3'-deuterated (+)-columbianetin as substrate led to an almost complete "metabolic switch," resulting in the synthesis of anti-3'-hydroxy-3'-deuterated (+)-columbianetin. This confirms that angelicin synthase attacks columbianetin by syn-elimination of hydrogen from C-3'. Sequence comparison between psoralen synthase (CYP71AJ3) and angelicin synthase (CYP71AJ4) showed 70% identity, whereas the identity dropped to 40% in those regions thought to provide the substrate recognition sites. Accordingly, CYP71AJ3 and CYP71AJ4 might be derived from a common ancestor of unknown functionality by gene duplication and subsequent molecular evolution.	[Larbat, Romain; Hehn, Alain; Jugde, Helene; Bourgaud, Frederic] Nancy Univ, Inst Natl Rech Agron Agron Environm Nancy Colmar, UMR 1121, F-54505 Vandoeuvre Les Nancy, France; [Hans, Joachim; Schneider, Sarah; Matern, Ulrich] Univ Marburg, Inst Pharmazeut Biol, D-35037 Marburg, Germany; [Schneider, Bernd] Max Planck Inst Chem Ecol, D-07745 Jena, Germany	INRAE; Universite de Lorraine; Philipps University Marburg; Max Planck Society	Bourgaud, F (corresponding author), Nancy Univ, Inst Natl Rech Agron Agron Environm Nancy Colmar, UMR 1121, 2 Ave Foret Haye, F-54505 Vandoeuvre Les Nancy, France.	frederic.bourgaud@ensaia.inpl-nancy.fr	Larbat, Romain/GQZ-8786-2022; Larbat, Romain/C-8576-2013; Schneider, Bernd/A-3287-2014; Larbat, Romain/V-4270-2019	Schneider, Bernd/0000-0003-4788-1565; Larbat, Romain/0000-0002-9060-5040; Hehn, Alain/0000-0003-4507-8031; Bourgaud, Frederic/0000-0002-9898-2625	Region Lorraine; Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	Region Lorraine(Region Grand-Est); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Region Lorraine (to F. B.), Deutsche Forschungsgemeinschaft, and Fonds der Chemischen Industrie (to U. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Both of these authors contributed equally to this work.	BASKIN JM, 1967, PHYTOCHEMISTRY, V6, P1209, DOI 10.1016/S0031-9422(00)86083-5; BEIER RC, 1983, PHYTOCHEMISTRY, V22, P2595, DOI 10.1016/0031-9422(83)80173-3; BERENBAUM M, 1981, SCIENCE, V212, P927, DOI 10.1126/science.212.4497.927; Berenbaum MR, 2006, ECOLOGY, V87, P3070, DOI 10.1890/0012-9658(2006)87[3070:PWAHPA]2.0.CO;2; Bourgaud F., 2006, Phytochemistry Reviews, V5, P293, DOI 10.1007/s11101-006-9040-2; BOURGAUD F, 1989, NATURAL SOURCES FURO, P219; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAPPELLETTI EM, 1998, BIOTECHNOLOGY AGR FO, V41, P238; DALLACQUA F, 1978, PHOTOCHEM PHOTOBIOL, V27, P33, DOI 10.1111/j.1751-1097.1978.tb07561.x; DHILLON DS, 1976, ARCH BIOCHEM BIOPHYS, V177, P74, DOI 10.1016/0003-9861(76)90417-3; Endler A, 2008, PLANT MOL BIOL, V67, P335, DOI 10.1007/s11103-008-9323-7; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GOTOH O, 1992, J BIOL CHEM, V267, P83; Gravot A, 2004, ARCH BIOCHEM BIOPHYS, V422, P71, DOI 10.1016/j.abb.2003.12.013; HAMERSKI D, 1988, EUR J BIOCHEM, V171, P369, DOI 10.1111/j.1432-1033.1988.tb13800.x; HAMERSKI D, 1988, FEBS LETT, V239, P263, DOI 10.1016/0014-5793(88)80930-X; Hehmann M, 2004, EUR J BIOCHEM, V271, P932, DOI 10.1111/j.1432-1033.2004.03995.x; Ito Y, 2005, J CHROMATOGR A, V1065, P145, DOI 10.1016/j.chroma.2004.12.044; Kai K, 2008, PLANT J, V55, P989, DOI 10.1111/j.1365-313X.2008.03568.x; Kawase M, 2005, IN VIVO, V19, P705; Koenigs LL, 1998, BIOCHEMISTRY-US, V37, P13184, DOI 10.1021/bi981198r; Larbat R, 2007, J BIOL CHEM, V282, P542, DOI 10.1074/jbc.M604762200; LETTERON P, 1986, J PHARMACOL EXP THER, V238, P685; Li WM, 2003, P NATL ACAD SCI USA, V100, P14593, DOI 10.1073/pnas.1934643100; Liu RM, 2005, J CHROMATOGR A, V1076, P127, DOI 10.1016/j.chroma.2005.04.041; MA RL, 1994, ARCH BIOCHEM BIOPHYS, V310, P332, DOI 10.1006/abbi.1994.1175; Murray R.D.H., 1982, NATURAL COUMARINS; Murray RDH, 2002, PROG CH ORG NAT PROD, V83, P1; NEAL JJ, 1994, PESTIC BIOCHEM PHYS, V50, P43, DOI 10.1006/pest.1994.1056; Ojala T, 2000, J ETHNOPHARMACOL, V73, P299, DOI 10.1016/S0378-8741(00)00279-8; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pereira LE, 2007, EXP BIOL MED, V232, P1338, DOI 10.3181/0705-RM-148; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Scott JG, 1996, INSECT BIOCHEM MOLEC, V26, P645, DOI 10.1016/S0965-1748(96)00008-2; Stanjek V, 1998, HELV CHIM ACTA, V81, P1596, DOI 10.1002/(SICI)1522-2675(19980909)81:9<1596::AID-HLCA1596>3.0.CO;2-F; Stanjek V, 1997, TETRAHEDRON, V53, P17699, DOI 10.1016/S0040-4020(97)10237-X; Stanjek V, 1999, PHYTOCHEMISTRY, V50, P1141, DOI 10.1016/S0031-9422(98)00650-5; Stanjek V, 1999, ANGEW CHEM INT EDIT, V38, P400, DOI 10.1002/(SICI)1521-3773(19990201)38:3<400::AID-ANIE400>3.0.CO;2-K; STANJEK V, 1998, THESIS U BONN GERMAN; STEMMER WPC, 1992, BIOTECHNIQUES, V13, P214; Stern RS, 2007, NEW ENGL J MED, V357, P682, DOI 10.1056/NEJMct072317; Takahashi S, 2005, J BIOL CHEM, V280, P3686, DOI 10.1074/jbc.M411870200; Takahashi S, 2007, J BIOL CHEM, V282, P31744, DOI 10.1074/jbc.M703378200; Wei Y, 2006, J CHROMATOGR A, V1115, P112, DOI 10.1016/j.chroma.2006.02.081; WENDORFF H, 1986, EUR J BIOCHEM, V161, P391, DOI 10.1111/j.1432-1033.1986.tb10458.x; Zschocke S, 1998, PHYTOCHEM ANALYSIS, V9, P283, DOI 10.1002/(SICI)1099-1565(199811/12)9:6&lt;283::AID-PCA419&gt;3.0.CO;2-9; ZUMWALT JG, 1993, COMP BIOCHEM PHYS C, V106, P111, DOI 10.1016/0742-8413(93)90261-I	47	49	55	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4776	4785		10.1074/jbc.M807351200	http://dx.doi.org/10.1074/jbc.M807351200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098286	hybrid, Green Published			2022-12-27	WOS:000263416600005
J	Li, H; Mittal, A; Paul, PK; Kumar, M; Srivastava, DS; Tyagi, SC; Kumar, A				Li, Hong; Mittal, Ashwani; Paul, Pradyut K.; Kumar, Mukesh; Srivastava, Daya S.; Tyagi, Suresh C.; Kumar, Ashok			Tumor Necrosis Factor-related Weak Inducer of Apoptosis Augments Matrix Metalloproteinase 9 (MMP-9) Production in Skeletal Muscle through the Activation of Nuclear Factor-kappa B-inducing Kinase and p38 Mitogen-activated Protein Kinase A POTENTIAL ROLE OF MMP-9 IN MYOPATHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; IKK-BETA; EXPRESSION; INHIBITION; PATHWAY; COMPLEX; DOMAIN; TWEAK; P65; STIMULATION	Destruction of skeletal muscle extracellular matrix is an important pathological consequence of many diseases involving muscle wasting. However, the underlying mechanisms leading to extracellular matrix breakdown in skeletal muscle tissues remain unknown. Using a microarray approach, we investigated the effect of tumor necrosis factor-related weak inducer of apoptosis (TWEAK), a recently identified muscle-wasting cytokine, on the expression of extracellular proteases in skeletal muscle. Among several other matrix metalloproteinases(MMPs), we found that the expression of MMP-9, a type IV collagenase, was drastically increased in myotubes in response to TWEAK. The level of MMP-9 was also higher in myofibers of TWEAK transgenic mice. TWEAK increased the activation of both classical and alternative nuclear factor-kappa B (NF-kappa B) signaling pathways. Inhibition of NF-kappa B activity blocked the TWEAK-induced production of MMP-9 in myotubes. TWEAK also increased the activation of AP-1, and its inhibition attenuated the TWEAK-induced MMP-9 production. Overexpression of a kinase-dead mutant of NF-kappa B-inducing kinase or I kappa B kinase-beta but not I kappa B kinase-alpha significantly inhibited the TWEAK-induced activation of MMP-9 promoter. The activation of MMP-9 also involved upstream recruitment of TRAF2 and cIAP2 proteins. TWEAK increased the activity of ERK1/2, JNK1, and p38 MAPK. However, the inhibition of only p38 MAPK blocked the TWEAK-induced expression of MMP-9 in myotubes. Furthermore the loss of body and skeletal muscle weights, inflammation, fiber necrosis, and degradation of basement membrane around muscle fibers were significantly attenuated in Mmp9 knock-out mice on chronic administration of TWEAK protein. The study unveils a novel mechanism of skeletal muscle tissue destruction in pathological conditions.	[Li, Hong; Mittal, Ashwani; Paul, Pradyut K.; Kumar, Mukesh; Srivastava, Daya S.; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA; [Tyagi, Suresh C.] Univ Louisville, Sch Med, Dept Physiol & Biophys, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Kumar, A (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu	Mittal, Ashwani/J-2124-2012; LI, HONG/A-7133-2013	Mittal, Ashwani/0000-0002-6588-6194; Kumar, Ashok/0000-0002-2444-9529; Kumar, Ashok/0000-0001-8571-2848	National Institutes of Health [RO1 AG129623]; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AG129623 (to A. K.).	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Cai BY, 2000, AM J PATHOL, V156, P1789, DOI 10.1016/S0002-9440(10)65050-X; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chandler S, 1997, J NEUROIMMUNOL, V72, P155, DOI 10.1016/S0165-5728(96)00179-8; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chung JY, 2002, J CELL SCI, V115, P679; Das S, 2003, MOL CELL BIOCHEM, V253, P31, DOI 10.1023/A:1026093016148; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Han SW, 2006, J BIOL CHEM, V281, P29614, DOI 10.1074/jbc.M604013200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heymans S, 2005, AM J PATHOL, V166, P15, DOI 10.1016/S0002-9440(10)62228-6; Hu WH, 2005, J BIOL CHEM, V280, P29233, DOI 10.1074/jbc.M501670200; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Jiang X, 2003, BIOCHEM BIOPH RES CO, V301, P583, DOI 10.1016/S0006-291X(03)00011-1; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Jin BW, 2007, J CELL BIOCHEM, V100, P960, DOI 10.1002/jcb.21060; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Kleiner DE, 1999, CANCER CHEMOTH PHARM, V43, pS42, DOI 10.1007/s002800051097; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kumar A, 2002, J BIOL CHEM, V277, P46493, DOI 10.1074/jbc.M203654200; Lewis MP, 2001, EUR J ORAL SCI, V109, P209, DOI 10.1034/j.1600-0722.2001.00021.x; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Luschen S, 2004, EXP CELL RES, V293, P196, DOI 10.1016/j.yexcr.2003.10.009; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Mujumdar VS, 2001, INT J CARDIOL, V79, P277, DOI 10.1016/S0167-5273(01)00449-1; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nair RR, 2005, BIOCHEM SOC T, V33, P1135, DOI 10.1042/BST0331135; Nho CW, 2004, J BIOL CHEM, V279, P26019, DOI 10.1074/jbc.M309022200; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Park S, 1998, CANCER LETT, V127, P23, DOI 10.1016/S0304-3835(97)00543-0; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Rangaswami H, 2004, J BIOL CHEM, V279, P38921, DOI 10.1074/jbc.M404674200; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Shiao T, 2004, HUM MOL GENET, V13, P1873, DOI 10.1093/hmg/ddh204; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Srivastava AK, 2007, J BIOL CHEM, V282, P35113, DOI 10.1074/jbc.M705329200; Tanabe K, 2003, J NEUROSCI, V23, P9675; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wittwer T, 2008, BIOCHEM BIOPH RES CO, V371, P294, DOI 10.1016/j.bbrc.2008.04.069; Zhong D, 2006, BIOCHEM BIOPH RES CO, V345, P867, DOI 10.1016/j.bbrc.2006.05.004	59	92	100	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4439	4450		10.1074/jbc.M805546200	http://dx.doi.org/10.1074/jbc.M805546200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074147	hybrid, Green Published			2022-12-27	WOS:000263134400044
J	Zhang, XYZ; Goemaere, EL; Thome, R; Gavioli, M; Cascales, E; Lloubes, R				Zhang, Xiang Y. -Z.; Goemaere, Emilie L.; Thome, Remi; Gavioli, Marthe; Cascales, Eric; Lloubes, Roland			Mapping the Interactions between Escherichia coli Tol Subunits ROTATION OF THE TolR TRANSMEMBRANE HELIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; BACTERIAL FLAGELLAR MOTOR; OUTER-MEMBRANE INTEGRITY; CONFORMATIONAL CHANGE; PERIPLASMIC DOMAIN; INNER MEMBRANE; CELL-ENVELOPE; PAL PROTEINS; KEY RESIDUES; COMPLEX	The TolQRA proteins of Escherichia coli form an inner membrane complex involved in the maintenance of the outer membrane stability and in the late stages of cell division. The TolQR complex uses the proton motive force to regulate TolA conformation and its interaction with the outer membrane Pal lipoprotein. It has been proposed that an ion channel forms at the TolQR transmembrane helix (TMH) interface. This complex assembles with a minimal TolQ: TolR ratio of 4-6:2 and therefore involves 14-20 TMHs. To define the organization of the transmembrane helices in the membrane within the TolQR complex, we initiated a cysteine scanning study. In this study, we report results for the systematic replacement of each residue of the TolR TMH. Phenotypic analyses first showed that most of the mutants are functional. Three mutants, TolR L22C, D23C, and V24C, were shown to affect TolQR functioning. Disulfide bond complex formation further showed that two TolR anchors are close enough to interact. Two substitutions, L22C and V24C, form high level of dimers, suggesting that the TolR helix rotates as molecular gears between these two positions and that disulfide bond formation between these residues blocked the rotary motion. Mutations of critical residues located within the TolQ TMH2 and TMH3 and the TolR TMH and proposed to form the ion pathway prevent rotation between these two residues. TolR anchors may form molecular gears that oscillate in response to proton motive force to regulate channel activity.	[Zhang, Xiang Y. -Z.; Goemaere, Emilie L.; Thome, Remi; Gavioli, Marthe; Cascales, Eric; Lloubes, Roland] CNRS, Inst Biol Struct & Microbiol, UPR 9027, Lab Ingn Syst Macromol, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lloubes, R (corresponding author), CNRS, Inst Biol Struct & Microbiol, UPR 9027, Lab Ingn Syst Macromol, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	lloubes@ibsm.cnrs-mrs.fr	CASCALES, ERIC/G-7420-2011	CASCALES, ERIC/0000-0003-0611-9179; LLOUBES, Roland/0000-0002-9520-1053	Centre National de la Recherche Scientifique; Agence National de la Recherche Projet Blanc SODATOL; SODATOL; Fondation pour la Recherche Medicale fellowship	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche Projet Blanc SODATOL(French National Research Agency (ANR)); SODATOL; Fondation pour la Recherche Medicale fellowship(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de la Recherche Scientifique and a grant from Agence National de la Recherche Projet Blanc SODATOL. This work was also supported by funds from SODATOL ( to X. Y.-Z.Z.) and by a Fondation pour la Recherche Medicale fellowship ( to E. L. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; BLAIR DF, 1991, J BACTERIOL, V173, P4049, DOI 10.1128/jb.173.13.4049-4055.1991; BOUVERET E, 1995, J BIOL CHEM, V270, P11071, DOI 10.1074/jbc.270.19.11071; Braun TF, 2001, BIOCHEMISTRY-US, V40, P13051, DOI 10.1021/bi011264g; Braun TF, 2004, BIOCHEMISTRY-US, V43, P35, DOI 10.1021/bi035406d; Braun V, 1996, J BACTERIOL, V178, P2836, DOI 10.1128/jb.178.10.2836-2845.1996; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2004, MOL MICROBIOL, V51, P873, DOI 10.1046/j.1365-2958.2003.03881.x; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; DEROUICHE R, 1995, J BIOL CHEM, V270, P11078, DOI 10.1074/jbc.270.19.11078; DUCHE D, 1994, J BIOL CHEM, V269, P24820; Garcia-Herrero A, 2007, MOL MICROBIOL, V66, P872, DOI 10.1111/j.1365-2958.2007.05957.x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Germon P, 1998, J BACTERIOL, V180, P6433, DOI 10.1128/JB.180.24.6433-6439.1998; Germon P, 2001, J BACTERIOL, V183, P4110, DOI 10.1128/JB.183.14.4110-4114.2001; Goemaere EL, 2007, J BIOL CHEM, V282, P17749, DOI 10.1074/jbc.M701002200; Goemaere EL, 2007, J MOL BIOL, V366, P1424, DOI 10.1016/j.jmb.2006.12.020; GUIHARD G, 1994, J BIOL CHEM, V269, P5874; Higgs PI, 1998, J BACTERIOL, V180, P6031, DOI 10.1128/JB.180.22.6031-6038.1998; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; Journet L, 2001, MOL MICROBIOL, V42, P331, DOI 10.1046/j.1365-2958.2001.02592.x; Journet L, 1999, J BACTERIOL, V181, P4476, DOI 10.1128/JB.181.15.4476-4484.1999; KAMPFENKEL K, 1993, J BACTERIOL, V175, P4485, DOI 10.1128/JB.175.14.4485-4491.1993; Kojima S, 2001, BIOCHEMISTRY-US, V40, P13041, DOI 10.1021/bi011263o; Kojima S, 2004, INT REV CYTOL, V233, P93, DOI 10.1016/S0074-7696(04)33003-2; Kojima S, 2000, J BACTERIOL, V182, P3314, DOI 10.1128/JB.182.11.3314-3318.2000; LAZZARONI JC, 1995, J MOL BIOL, V246, P1, DOI 10.1006/jmbi.1994.0058; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; MULLER MM, 1993, J BACTERIOL, V175, P6059, DOI 10.1128/JB.175.18.6059-6061.1993; Parsons LM, 2008, BIOCHEMISTRY-US, V47, P3131, DOI 10.1021/bi702283x; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; SUN TP, 1987, J BACTERIOL, V169, P2667, DOI 10.1128/jb.169.6.2667-2674.1987; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; Walburger A, 2002, MOL MICROBIOL, V44, P695, DOI 10.1046/j.1365-2958.2002.02895.x; WEBSTER RE, 1991, MOL MICROBIOL, V5, P1005, DOI 10.1111/j.1365-2958.1991.tb01873.x; Zhai YF, 2003, BBA-BIOMEMBRANES, V1614, P201, DOI 10.1016/S0005-2736(03)00176-7; Zhou JD, 1998, J BACTERIOL, V180, P2729, DOI 10.1128/JB.180.10.2729-2735.1998	39	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4275	4282		10.1074/jbc.M805257200	http://dx.doi.org/10.1074/jbc.M805257200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19075020	hybrid, Green Published			2022-12-27	WOS:000263134400025
J	Radziszewska, A; Choi, D; Nguyen, KTT; Schroer, SA; Tajmir, P; Wang, L; Suzuki, A; Mak, TW; Evan, GI; Woo, M				Radziszewska, Anna; Choi, Diana; Nguyen, Kinh-Tung T.; Schroer, Stephanie A.; Tajmir, Panteha; Wang, Linyuan; Suzuki, Akira; Mak, Tak W.; Evan, Gerard I.; Woo, Minna			PTEN Deletion and Concomitant c-Myc Activation Do Not Lead to Tumor Formation in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; GENE; BINDING; BAD; SUPPRESSOR; RESISTANCE; DOMAIN; LIVE	Phosphatase and tensin homologue (PTEN) deleted on chromosome 10 is a dual-specific phosphatase and a potent antagonist of the phosphoinositide 3-kinase signaling pathway. Although first discovered as a tumor suppressor, emerging evidence supports PTEN as a potential therapeutic target for diabetes. PTEN deletion in beta cells leads to increased beta cell mass and protection from streptozotocin-induced diabetes. Importantly, PTEN deletion does not lead to tumor formation in beta cells. To further assess the potential tumorigenic role of PTEN, we tested the biological role of PTEN in the context of activation of the proto-oncogene c-Myc. We generated and characterized beta cell-specific PTEN knock-out mice expressing an inducible c-Myc transgene in beta cells. Surprisingly, we found that PTEN loss did not confer protection from the overwhelming apoptosis and diabetes development seen with c-Myc activation. Importantly, despite the combined effect of the loss of a tumor suppressor and activation of an oncogene in beta cells, there was no evidence of tumor development with sustained c-Myc activation.	[Radziszewska, Anna; Schroer, Stephanie A.; Tajmir, Panteha; Wang, Linyuan; Mak, Tak W.; Woo, Minna] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Choi, Diana; Nguyen, Kinh-Tung T.; Woo, Minna] Univ Toronto, Inst Med Sci, Toronto, ON M5G 2M9, Canada; [Suzuki, Akira] Akita Univ, Sch Med, Dept Mol Biol, Akita 0108543, Japan; [Mak, Tak W.] Univ Toronto, Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada; [Evan, Gerard I.] Univ Calif San Francisco, Ctr Comprehens Canc, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Evan, Gerard I.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Woo, Minna] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Woo, Minna] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; Akita University; University of Toronto; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Woo, M (corresponding author), Ontario Canc Inst, 610 Univ Ave Rm 8-113, Toronto, ON M5G 2M9, Canada.	mwoo@uhnresearch.ca	Suzuki, Akira/GYD-6697-2022	Suzuki, Akira/0000-0002-5950-8808; Radziszewska, Ania/0000-0002-3885-3477	Canadian Institutes for Health Research; Canadian Diabetes Association; Banting and Best Diabetes Centre-Yom Kam-Yuen Studentship	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; Banting and Best Diabetes Centre-Yom Kam-Yuen Studentship	This work was supported by grants from the Canadian Institutes for Health Research and the Canadian Diabetes Association (to M. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Supported by the Banting and Best Diabetes Centre-Yom Kam-Yuen Studentship.	Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Gajewski TF, 1996, CELL, V87, P589, DOI 10.1016/S0092-8674(00)81377-X; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Klefstrom J, 2002, J BIOL CHEM, V277, P43224, DOI 10.1074/jbc.M206967200; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; Lazar DF, 2006, NAT REV DRUG DISCOV, V5, P333, DOI 10.1038/nrd2007; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Nguyen KTT, 2006, MOL CELL BIOL, V26, P4511, DOI 10.1128/MCB.00238-06; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	25	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2917	2922		10.1074/jbc.M805183200	http://dx.doi.org/10.1074/jbc.M805183200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19056726	hybrid			2022-12-27	WOS:000262700900036
